PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	DISCALA, C; GRANT, CC; BROOKE, MM; GANS, BM				DISCALA, C; GRANT, CC; BROOKE, MM; GANS, BM			FUNCTIONAL OUTCOME IN CHILDREN WITH TRAUMATIC BRAIN INJURY - AGREEMENT BETWEEN CLINICAL JUDGMENT AND THE FUNCTIONAL INDEPENDENCE MEASURE	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						DISABILITY; PEDIATRICS, HEAD INJURY, TRAUMA		As improvements in the delivery of trauma care have increased survival from injury, it has become essential to assess the resulting morbidity to plan for medical and psychosocial services, particularly for children whose needs may be wide and long term. This paper focuses on the assessment of disability of 598 children, age 8 to 19 yr, hospitalized for traumatic brain injury with or without injury to other body regions, exclusive of spinal cord injury. The disability was measured at discharge from acute care in nine areas of functional activities and a recovery time assigned by a clinician. For the study, children were divided into three groups: those whose recovery was expected in <7 months (Group A: n = 463), in 7 to 24 months (Group B: n = 66) and in >2 yr (Group C: n = 69). The clinician's expectation of recovery time significantly (P < 0.01) reflected the injury severity as measured by the Glasgow Coma Scale and the injury Severity Score. By the Glasgow Coma Scale, 16.4% were comatose on admission in Group A, 51.5% in Group B and 58% in Group C. The injury Severity Score was significantly different with 25.5% severely injured in Group A, 68.2% in Group B and 84% in Group C. At discharge, 15% in Group A had four or more areas of impairments, 61% in Group B and 84% in Group C. The Functional independence Measure confirmed the clinician's assessment of compromise with significantly (P < 0.01) different average values of 110, 80 and 58 for Groups A, B and C, respectively.	REHABIL INST MICHIGAN,DETROIT,MI; WAYNE STATE UNIV,SCH MED,DETROIT,MI 48201		DISCALA, C (corresponding author), TUFTS UNIV,NEW ENGLAND MED CTR,DEPT REHABIL MED,RES & TRAINING CTR REHABIL & CHILDHOOD TRAUMA,BOSTON,MA 02111, USA.						BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Data Management Service of the Uniform Data System for Medical Rehabilitation and the Center for Functional Assessment Research, 1990, GUIDE USE UNIFORM DA; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; EMHOFF TA, 1991, J TRAUMA, V9, P1227; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Keith R A, 1987, Adv Clin Rehabil, V1, P6; OSBERG JS, 1990, AM J PHYS MED REHAB, V69, P67, DOI 10.1097/00002060-199004000-00004; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1989, J PEDIATR SURG, V24, P156, DOI 10.1016/S0022-3468(89)80237-4; WESSON DE, 1989, J TRAUMA, V5, P589; 1990, AM J DIS CHILD, V144, P627	11	37	37	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUN	1992	71	3					145	148		10.1097/00002060-199206000-00004			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	HY972	WOS:A1992HY97200004	1385712				2022-02-06	
J	MESSENHEIMER, JA; ROBERTSON, KR; WILKINS, JW; KALKOWSKI, JC; HALL, CD				MESSENHEIMER, JA; ROBERTSON, KR; WILKINS, JW; KALKOWSKI, JC; HALL, CD			EVENT-RELATED POTENTIALS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A PROSPECTIVE-STUDY	ARCHIVES OF NEUROLOGY			English	Article							AIDS DEMENTIA COMPLEX; HUNTINGTONS-DISEASE; P300; LATENCY; SCALP	P3 event-related evoked potentials (ERP) were recorded from 47 human immunodeficiency virus (HIV)-positive subjects examined twice and 29 HIV-positive subjects examined three times at 6-month intervals. The P3 latency significantly increased over time for asymptomatic subjects and subjects with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. N2 latency was prolonged relative to control values in both HIV-positive groups but did not increase with time. The P3 latency correlated with neuropsychologic measures of motor control and speed of mental processing. Confounding factors (active or previous substance abuse, developmental disabilities, and history of closed head injury or epilepsy) did not significantly affect ERP latencies. Endogenous ERP components are frequently abnormal in HIV-positive subjects and the P3 latency progressively increases over time. Continued follow-up is required to determine the clinical utility of ERP studies in the HIV-positive population.			MESSENHEIMER, JA (corresponding author), UNIV N CAROLINA, SCH MED, DEPT NEUROL, CTR AIDS NEUROL, 7025 BURNETT WOMACK BLDG, CHAPEL HILL, NC 27599 USA.				NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS026680] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR00046] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1 PO1 NS26680-01] Funding Source: Medline		BALL SS, 1989, J GERONTOL, V44, pM195, DOI 10.1093/geronj/44.6.M195; EVERALL IP, 1991, LANCET, V337, P1119, DOI 10.1016/0140-6736(91)92786-2; GOODIN DS, 1990, ANN NEUROL, V27, P414, DOI 10.1002/ana.410270409; GOODIN DS, 1986, BRAIN, V109, P1103, DOI 10.1093/brain/109.6.1103; GRANT I, 1990, J CONSULT CLIN PSYCH, V58, P22, DOI 10.1037/0022-006X.58.1.22; GRANT I, 1987, ANN INTERN MED, V107, P828, DOI 10.7326/0003-4819-107-6-828; HANSCH EC, 1982, ANN NEUROL, V11, P599, DOI 10.1002/ana.410110608; HO DD, 1989, ANN INTERN MED, V111, P400, DOI 10.7326/0003-4819-111-5-400; HOMBERG V, 1986, ELECTROEN CLIN NEURO, V63, P552, DOI 10.1016/0013-4694(86)90143-4; JOHNSON R, 1988, BRAIN, V111, P1517, DOI 10.1093/brain/111.6.1517; KARNISKI W, 1989, ELECTROEN CLIN NEURO, V72, P373, DOI 10.1016/0013-4694(89)90043-6; MCARTHUR JC, 1989, ANN NEUROL, V26, P601, DOI 10.1002/ana.410260504; McCarthy G, 1987, Electroencephalogr Clin Neurophysiol Suppl, V39, P331; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; NAVIA BA, 1986, ANN NEUROL, V19, P525, DOI 10.1002/ana.410190603; NEWTON MR, 1989, BRAIN, V112, P1637, DOI 10.1093/brain/112.6.1637; OLLO C, 1991, NEUROLOGY, V41, P209, DOI 10.1212/WNL.41.2_Part_1.209; PERRAULT N, 1984, ELECTROEN CLIN NEURO, V59, P261, DOI 10.1016/0168-5597(84)90044-3; POLICH J, 1990, ELECTROEN CLIN NEURO, V77, P179, DOI 10.1016/0168-5597(90)90036-D; ROSENBERG C, 1985, ARCH NEUROL-CHICAGO, V42, P984, DOI 10.1001/archneur.1985.04060090066016; SKLARE DA, 1984, ELECTROEN CLIN NEURO, V59, P420, DOI 10.1016/0168-5597(84)90043-1; Syndulko K, 1982, CLIN APPLICATIONS EV, P279; WILKINS JW, 1990, J ACQ IMMUN DEF SYND, V3, P938; WOOD CC, 1982, ANN NY ACAD SCI, V388, P139, DOI 10.1111/j.1749-6632.1982.tb50789.x; [No title captured]	25	37	38	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0003-9942	1538-3687		ARCH NEUROL-CHICAGO	Arch. Neurol.	APR	1992	49	4					396	400		10.1001/archneur.1992.00530280086027			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM463	WOS:A1992HM46300020	1558522				2022-02-06	
J	LEVIN, HS				LEVIN, HS			NEUROBEHAVIORAL RECOVERY	JOURNAL OF NEUROTRAUMA			English	Article							CLOSED-HEAD-INJURY; BEHAVIORAL SEQUELAE; PRACTICAL SCALE; BRAIN-LESIONS; AMNESIA TEST; MEMORY; CONSCIOUSNESS; PERFORMANCE; MILD; ORIENTATION	This review discusses recent programs in early and late neurobehavioral recovery from closed head injury (CHI). The research on early recovery has encompassed the relationship of localized brain lesions to the duration of impaired consciousness and features of posttraumatic amnesia. Of the research on late neurobehavioral outcome of CHI, studies emanating from the Traumatic Coma Data Bank are reviewed in detail, including analysis of acute neurologic indices in relation to recovery of memory, information processing speed, and other cognitive measures. Recent studies concerning the neurobehavioral outcome of CHI in children are discussed as are investigations of behavioral disturbance, psychosocial outcome, and family variables. The review concludes with an assessment of recent studies concerning the efficacy of rehabilitation directed toward the cognitive sequelae of CHI and preliminary trials to evaluate the potential use of psychoactive drugs in the postacute management of head injured patients.			LEVIN, HS (corresponding author), UNIV TEXAS,MED BRANCH,DIV NEUROSURG,D-73,GALVESTON,TX 77550, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS032339, R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889, NS 3-2339] Funding Source: Medline		ALBERT ML, 1976, ARCH NEUROL-CHICAGO, V33, P453, DOI 10.1001/archneur.1976.00500060059013; ALEXANDER MP, 1989, BRAIN LANG, V37, P656, DOI 10.1016/0093-934X(89)90118-1; ALEXANDER MP, 1988, NEUROLOGY, V38, P802, DOI 10.1212/WNL.38.5.802; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BECKER DP, 1985, CENTRAL NERVOUS SYST; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Butters N., 1980, ALCOHOLIC KORSAKOFFS; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; HUPPERT FA, 1979, CORTEX, V15, P385, DOI 10.1016/S0010-9452(79)80065-9; JENNETT B, 1975, LANCET, V1, P480; Kinsella G, 1989, Int Disabil Stud, V11, P9; LEDOUX JE, 1977, ANN NEUROL, V2, P417, DOI 10.1002/ana.410020513; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1989, LANCET, V2, P1001; LEVIN HS, 1985, CENTRAL NERVOUS SYST, P281; LUDLOW CL, 1987, ANN NEUROL, V22, P60, DOI 10.1002/ana.410220114; MENTIS M, 1987, J SPEECH HEAR RES, V30, P89; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SALAZAR AM, 1986, NEUROLOGY, V36, P178, DOI 10.1212/WNL.36.2.178; SANO K, 1983, J NEUROSURG, V58, P223, DOI 10.3171/jns.1983.58.2.0223; SERAFETINIDES EA, 1965, BRAIN, V88, P107, DOI 10.1093/brain/88.1.107; SHUM DH, J CLIN EXP NEUROPSYC, V12, P247; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TEASDALE G, 1974, LANCET, V2, P81; WEINGARTNER H, 1983, SCIENCE, V221, P380, DOI 10.1126/science.6867715; WHETSELL LA, 1989, J TRAUMA, V29, P1158, DOI 10.1097/00005373-198908000-00015; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; [No title captured]	59	37	37	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	1992	9			1			S359	S373					15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HN806	WOS:A1992HN80600036	1588627				2022-02-06	
J	COSTANTINO, PD; RUSSELL, E; REISCH, D; BREIT, RA; HART, C				COSTANTINO, PD; RUSSELL, E; REISCH, D; BREIT, RA; HART, C			RUPTURED PETROUS CAROTID ANEURYSM PRESENTING WITH OTORRHAGIA AND EPISTAXIS	AMERICAN JOURNAL OF OTOLOGY			English	Article							DETACHABLE BALLOON; SKULL BASE; ARTERY; MANAGEMENT; RESECTION; SURGERY	Aneurysm formation and rupture within the petrous internal carotid artery (ICA) is an extremely rare occurrence with approximately 10 such cases in the literature. Etiologies of petrous ICA aneurysms include atherosclerosis, closed head trauma, iatrogenic injury during mastoid surgery, chronic middle ear infections, and congenital causes. Therapeutic options include carotid artery ligation, aneurysm resection with or without reconstruction, and radiographically controlled vessel occlusion. The case of a patient who presented with otorrhagia, epistaxis, and transient focal neurologic signs due to a ruptured petrous ICA aneurysm is presented. The incidence, etiology, and anatomy of these aneurysms is reviewed, and the various tests for determining adequacy of collateral cerebral blood flow are described. Factors that affect the selection of surgical versus radiologic control of these lesions are also discussed.	NORTHWESTERN UNIV,SCH MED,DEPT OTOLARYNGOL HEAD & NECK SURG,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT RADIOL,DIV NEURORADIOL,CHICAGO,IL 60611; UNIV ALABAMA,CTR MED,DEPT SURG,BIRMINGHAM,AL 35294								ANDERSON RD, 1972, RADIOLOGY, V102, P639, DOI 10.1148/102.3.639; BARRETT JH, 1960, ARCHIV OTOLARYNGOL, V72, P366; BARROW DL, 1982, J NEUROSURG, V56, P396, DOI 10.3171/jns.1982.56.3.0396; BUSBY DR, 1968, ARCH OTOLARYNGOL, V87, P295; CHANDY MJ, 1986, J LARYNGOL OTOL, V103, P425; Chiappetta F, 1982, J Neurosurg Sci, V26, P205; DEBRUN G, 1978, J NEUROSURG, V49, P635, DOI 10.3171/jns.1978.49.5.0635; DEVRIES EJ, 1988, LARYNGOSCOPE, V98, P960; FISCH U, 1984, OTOLARYNG CLIN N AM, V17, P513; FISCH U, 1982, NEUROLOGICAL SURGERY, P269; GLASSOCK ME, 1983, LARYNGOSCOPE, V93, P1445; GUNTHER R, 1981, FORTSCHR RONTEGENSTR, V135, P532; HIRANANDANI L H, 1962, J Laryngol Otol, V76, P703, DOI 10.1017/S0022215100059922; HOLTZMAN N, 1979, J NEUROSURG, V51, P258; KELLY JJ, 1979, ARCH SURG-CHICAGO, V114, P1361; KOPANIKY D, 1981, SURG NEUROL, V15, P141, DOI 10.1016/0090-3019(81)90034-3; LEONETTI JP, 1990, OTOLARYNG HEAD NECK, V102, P3, DOI 10.1177/019459989010200102; MILLER JD, 1977, J NEUROL NEUROSUR PS, V40, P64, DOI 10.1136/jnnp.40.1.64; MOORE O, 1955, CANCER, V8, P712, DOI 10.1002/1097-0142(1955)8:4<712::AID-CNCR2820080414>3.0.CO;2-L; Morantz R A, 1976, Surg Neurol, V6, P313; Myerson MC, 1934, ARCHIV OTOLARYNGOL, V20, P195; PECKER J, 1960, PRESSE MED, V68, P1023; PIERINI E A, 1954, Prensa Med Argent, V41, P945; SEFTEL DM, 1959, ARCHIV OTOLARYNGOL, V70, P52; SEKHAR LN, 1986, NEUROSURGERY, V19, P967, DOI 10.1227/00006123-198612000-00012; SEKHAR LN, 1987, TUMORS CRANIAL BASE, P641; SPETZLER RF, 1985, NEUROSURGERY, V16, P111, DOI 10.1227/00006123-198501000-00026; STALLINGS JO, 1969, ARCH OTOLARYNGOL, V90, P65; TRANMER BI, 1985, NEUROSURGERY, V6, P381; WILLINSKY R, 1987, NEURORADIOLOGY, V29, P570, DOI 10.1007/BF00350444	30	37	38	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0192-9763			AM J OTOL	Am. J. Otol.	SEP	1991	12	5					378	383					6	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	GD873	WOS:A1991GD87300013	1789309				2022-02-06	
J	BAYLESS, JD; VARNEY, NR; ROBERTS, RJ				BAYLESS, JD; VARNEY, NR; ROBERTS, RJ			TINKER TOY TEST-PERFORMANCE AND VOCATIONAL OUTCOME IN PATIENTS WITH CLOSED-HEAD INJURIES	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article									VET ADM MED CTR,PSYCHOL SERV 116-B,IOWA CITY,IA 52240; UNIV IOWA,IOWA CITY,IA 52240								BENTON AL, 1983, TEST 3 DIMENSIONAL C; HARLOW J, 1868, MASSACHUSETTS MED SO, V2, P329; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445	3	37	37	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	DEC	1989	11	6					913	917		10.1080/01688638908400944			5	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	CC215	WOS:A1989CC21500010	2592530				2022-02-06	
J	Drake, SA; Holcomb, JB; Yang, YJ; Thetford, C; Myers, L; Brock, M; Wolf, DA; Cron, S; Persse, D; McCarthy, J; Kao, LL; Todd, SR; Naik-Mathuria, BJ; Cox, C; Kitagawa, R; Sandberg, G; Wade, CE				Drake, Stacy A.; Holcomb, John B.; Yang, Yijiong; Thetford, Caitlin; Myers, Lauren; Brock, Morgan; Wolf, Dwayne A.; Cron, Stanley; Persse, David; McCarthy, James; Kao, Lillian; Todd, S. Rob; Naik-Mathuria, Bindi J.; Cox, Charles; Kitagawa, Ryan; Sandberg, Glenn; Wade, Charles E.			Establishing a Regional Trauma Preventable/Potentially Preventable Death Rate	ANNALS OF SURGERY			English	Article						trauma preventable death rate; trauma surgery; trauma system research; trauma system; trauma	POSITION STATEMENT; NATIONAL ACADEMIES; INJURY SEVERITY; MEDICINE REPORT; SYSTEM; CARE; EPIDEMIOLOGY; MILITARY; TRENDS; TOURNIQUET	Objective: To establish a trauma preventable/potentially preventable death rate (PPPDR) within a heavily populated county in Texas. The National Academies of Sciences estimated the trauma preventable death rate in the United States to be 20%, issued a call for zero preventable deaths, while acknowledging that an accurate preventable death rate was lacking. In this absence, effective strategies to improve quality of care across trauma systems will remain difficult. Methods: A retrospective review of death-related records that occurred during 2014 in Harris County, TX, a diverse population of 4.4 million. Patient demographics, mechanism of injury, cause, timing, and location of deaths were assessed. Deaths were categorized using uniform criteria and recorded as preventable, potentially preventable or nonpreventable. Results: Of 1848 deaths, 85% had an autopsy and 99.7% were assigned a level of preventability, resulting in a trauma PPPDR of 36.2%. Sex, age, and race/ethnicity varied across preventability categories (P< 0.01). Of 847 prehospital deaths, 758 (89.5%) were nonpreventable. Among 89 prehospital preventable/potentially preventable (P/PP) deaths, hemorrhage accounted for 55.1%. Of the 657 initial acute care setting deaths, 292 (44.4%) were P/PP; of these, hemorrhage, sepsis, and traumatic brain injury accounted for 73.3%. Of 339 deaths occurring after initial hospitalization, 287 (84.7%) were P/PP, of these 117 resulted from sepsis and 31 from pulmonary thromboembolism, accounted for 51.6%. Conclusions: The trauma PPPDR was almost double that estimated by the National Academies of Sciences. Data regarding P/PP deaths offers opportunity to target research, prevention, intervention, and treatment corresponding to all phases of the trauma system.	[Drake, Stacy A.; Yang, Yijiong; Thetford, Caitlin; Cron, Stanley] Univ Texas Hlth Sci Ctr Houston, Cizak Sch Nursing, Houston, TX 77030 USA; [Drake, Stacy A.; Holcomb, John B.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX 77030 USA; [Holcomb, John B.; McCarthy, James; Kao, Lillian; Cox, Charles; Kitagawa, Ryan; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, McGovern Sch Med, Houston, TX 77030 USA; [Thetford, Caitlin] Houston Methodist Hosp, Houston, TX 77030 USA; [Myers, Lauren; Naik-Mathuria, Bindi J.] Texas Childrens Hosp, Houston, TX 77030 USA; [Brock, Morgan] Lyndon B Johnson Gen Hosp, Houston, TX USA; [Wolf, Dwayne A.; Sandberg, Glenn] Harris Cty Inst Forens Sci, Houston, TX USA; [Persse, David] Dept Hlth & Human Serv City Houston, Houston, TX USA; [McCarthy, James] Mem Hermann Hosp, Houston, TX USA; [Todd, S. Rob; Naik-Mathuria, Bindi J.] Baylor Coll Med, Houston, TX 77030 USA		Drake, SA (corresponding author), Univ Texas Hlth Sci Ctr Houston, 6901 Bertner Ave 593, Houston, TX 77030 USA.	Stacy.A.Drake@uth.tmc.edu		holcomb, john/0000-0001-8312-9157	internal PARTNERS Grant from UTHEALTH; Center for Translational Injury Research (CeTIR) from UTHEALTH	The study was in part funded from grants received from an internal PARTNERS Grant and Center for Translational Injury Research (CeTIR) both from UTHEALTH.	ANDERSON ID, 1988, BRIT MED J, V296, P1305, DOI 10.1136/bmj.296.6632.1305; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Boman H, 1999, EUR J SURG, V165, P828; CALES RH, 1985, JAMA-J AM MED ASSOC, V254, P1059, DOI 10.1001/jama.254.8.1059; CDC, 2014, CDC NAT HLTH REP LEA; Chang MH, 2016, J PUBLIC HEALTH MAN, V22, pS13, DOI 10.1097/PHH.0000000000000267; Davis JS, 2014, J TRAUMA ACUTE CARE, V77, P213, DOI 10.1097/TA.0000000000000292; Drake Stacy A, 2017, Trauma Surg Acute Care Open, V2, pe000106, DOI 10.1136/tsaco-2017-000106; Dwyer-Lindgren L, 2018, JAMA-J AM MED ASSOC, V319, P1013, DOI 10.1001/jama.2018.0900; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Falconer JA, 2010, NEW ZEAL MED J, V123, P11; Hanzlick R, 1997, ARCH PATHOL LAB MED, V121, P377; Hartnett T., 2010, CONSENSUS ORIENTED D; Hicks CW, 2015, ANN SURG, V262, P179, DOI 10.1097/SLA.0000000000000809; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Jacobs LM, 2017, J AM COLL SURGEONS, V224, P1084, DOI 10.1016/j.jamcollsurg.2017.02.013; Janak JC, 2018, JAMA SURG, V153, P367, DOI 10.1001/jamasurg.2017.6105; Jenkins DH, 2016, J TRAUMA ACUTE CARE, V81, P819, DOI 10.1097/TA.0000000000001217; Jenkins DH, 2016, J TRAUMA ACUTE CARE, V81, P816, DOI 10.1097/TA.0000000000001218; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kleber C, 2013, WORLD J SURG, V37, P1154, DOI 10.1007/s00268-013-1964-2; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Kragh JF, 2009, ANN SURG, V249, P1, DOI 10.1097/SLA.0b013e31818842ba; Kwon AM, 2014, EUR J TRAUMA EMERG S, V40, P279, DOI 10.1007/s00068-013-0364-5; Losonczy LI, 2014, J HEALTH CARE POOR U, V25, P308, DOI 10.1353/hpu.2014.0021; Maio RF, 1996, J TRAUMA, V41, P83, DOI 10.1097/00005373-199607000-00013; Martin M, 2009, J TRAUMA, V66, pS51, DOI 10.1097/TA.0b013e31819d86ad; National Academies of Sciences [NAS], 2016, NAT TRAUM CAR SYST I; Navarro S, 2014, WORLD J SURG, V38, P2273, DOI 10.1007/s00268-014-2587-y; NCIPC (National Center for Injury Prevention and Control), 2015, WISQARSTM FAT INJ RE; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Rogers FB, 1997, ARCH SURG-CHICAGO, V132, P376; Sampalis JS, 1995, J TRAUMA, V39, P1029, DOI 10.1097/00005373-199512000-00002; Sanddal TL, 2011, J TRAUMA, V70, P970, DOI 10.1097/TA.0b013e3181fec9ba; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Scerbo MH, 2017, J TRAUMA ACUTE CARE, V83, P1165, DOI 10.1097/TA.0000000000001666; SHACKFORD SR, 1987, J TRAUMA, V27, P866, DOI 10.1097/00005373-198708000-00004; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Staudenmayer K, 2016, AM SURGEON, V82, P356; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Teixeira PGR, 2018, J AM COLL SURGEONS, V226, P769, DOI 10.1016/j.jamcollsurg.2018.01.047; Zafar SN, 2015, J TRAUMA ACUTE CARE, V78, P852, DOI 10.1097/TA.0000000000000557	42	36	37	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	FEB	2020	271	2					375	382		10.1097/SLA.0000000000002999			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	NC5ZL	WOS:000561296300031	30067544				2022-02-06	
J	Navratilova, E; Rau, J; Oyarzo, J; Tien, J; Mackenzie, K; Stratton, J; Remeniuk, B; Schwedt, T; Anderson, T; Dodick, D; Porreca, F				Navratilova, Edita; Rau, Jill; Oyarzo, Janice; Tien, Jason; Mackenzie, Kimberly; Stratton, Jennifer; Remeniuk, Bethany; Schwedt, Todd; Anderson, Trent; Dodick, David; Porreca, Frank			CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice	CEPHALALGIA			English	Article						Post-traumatic headache (PTH); acute post-traumatic headache (APTH); persistent post-traumatic headache (PPTH); mild traumatic brain injury (mTBI); concussion; CGRP; CGRP monoclonal antibody; cutaneous allodynia	GENE-RELATED PEPTIDE; EXTRACEREBRAL CIRCULATION; CALCITONIN RECEPTOR; MIGRAINE HEADACHE; DOUBLE-BLIND; RISK-FACTORS; MAST-CELLS; ALLODYNIA; MODEL; PAIN	Background Acute and persistent post-traumatic headache are often debilitating consequences of traumatic brain injury. Underlying physiological mechanisms of post-traumatic headache and its persistence remain unknown, and there are currently no approved therapies for these conditions. Post-traumatic headache often presents with a migraine-like phenotype. As calcitonin-gene related peptide promotes migraine headache, we explored the efficacy and timing of intervention with an anti- calcitonin-gene related peptide monoclonal antibody in novel preclinical models of acute post-traumatic headache and persistent post-traumatic headache following a mild traumatic brain injury event in mice. Methods Male, C57Bl/6 J mice received a sham procedure or mild traumatic brain injury resulting from a weight drop that allowed free head rotation while under minimal anesthesia. Periorbital and hindpaw tactile stimulation were used to assess mild traumatic brain injury-induced cutaneous allodynia. Two weeks after the injury, mice were challenged with stress, a common aggravator of migraine and post-traumatic headache, by exposure to bright lights (i.e. bright light stress) and cutaneous allodynia was measured hourly for 5 hours. A murine anti- calcitonin-gene related peptide monoclonal antibody was administered after mild traumatic brain injury at different time points to allow evaluation of the consequences of either early and sustained calcitonin-gene related peptide sequestration or late administration only prior to bright light stress. Results Mice with mild traumatic brain injury, but not a sham procedure, exhibited both periorbital and hindpaw cutaneous allodynia that resolved by post-injury day 13. Following resolution of injury-induced cutaneous allodynia, exposure to bright light stress re-instated periorbital and hindpaw cutaneous allodynia in injured, but not sham mice. Repeated administration of anti-calcitonin-gene related peptide monoclonal antibody at 2 hours, 7 and 14 days post mild traumatic brain injury significantly attenuated the expression of cutaneous allodynia when evaluated over the 14-day post injury time course and also prevented bright light stress-induced cutaneous allodynia in injured mice. Administration of anti-calcitonin-gene related peptide monoclonal antibody only at 2 hours and 7 days after mild traumatic brain injury blocked injury-induced cutaneous allodynia and partially prevented bright light stress-induced cutaneous allodynia. A single administration of anti-calcitonin-gene related peptide monoclonal antibody after the resolution of the peak injury-induced cutaneous allodynia, but prior to bright light stress challenge, did not prevent bright light stress-induced cutaneous allodynia. Conclusions We used a clinically relevant mild traumatic brain injury event in mice along with a provocative stimulus as novel models of acute post-traumatic headache and persistent post-traumatic headache. Following mild traumatic brain injury, mice demonstrated transient periorbital and hindpaw cutaneous allodynia suggestive of post-traumatic headache-related pain and establishment of central sensitization. Following resolution of injury-induced cutaneous allodynia, exposure to bright light stress re-established cutaneous allodynia, suggestive of persistent post-traumatic headache-related pain. Continuous early sequestration of calcitonin-gene related peptide prevented both acute post-traumatic headache and persistent post-traumatic headache. In contrast, delayed anti-calcitonin-gene related peptide monoclonal antibody treatment following establishment of central sensitization was ineffective in preventing persistent post-traumatic headache. These observations suggest that mechanisms involving calcitonin-gene related peptide underlie the expression of acute post-traumatic headache, and drive the development of central sensitization, increasing vulnerability to headache triggers and promoting persistent post-traumatic headache. Early and continuous calcitonin-gene related peptide blockade following mild traumatic brain injury may represent a viable treatment option for post-traumatic headache and for the prevention of post-traumatic headache persistence.	[Navratilova, Edita; Remeniuk, Bethany; Porreca, Frank] Univ Arizona, Arizona Hlth Sci Ctr, Dept Pharmacol, Tucson, AZ USA; [Rau, Jill; Oyarzo, Janice; Schwedt, Todd; Dodick, David; Porreca, Frank] Mayo Clin, Scottsdale, AZ USA; [Tien, Jason; Mackenzie, Kimberly; Stratton, Jennifer] Teva Biol, Redwood City, CA USA; [Anderson, Trent] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA		Porreca, F (corresponding author), Univ Arizona, Dept Pharmacol, Tucson, AZ 85724 USA.	frankp@medadmin.arizona.edu		Tien, Jason/0000-0003-3853-0827; Remeniuk, Bethany/0000-0003-1961-5163	TEVATeva Pharmaceutical Industries	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by an unrestricted grant from TEVA to FP.	Ashkenazi A, 2007, CEPHALALGIA, V27, P111, DOI 10.1111/j.1468-2982.2006.01255.x; Benemei S, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0811-5; Bharadwaj VN, 2018, NANOMED-NANOTECHNOL, V14, P2155, DOI 10.1016/j.nano.2018.06.004; Bigal ME, 2008, NEUROLOGY, V70, P1525, DOI 10.1212/01.wnl.0000310645.31020.b1; Bower RL, 2016, AM J PHYSIOL-REG I, V310, pR788, DOI 10.1152/ajpregu.00539.2015; Bree D, 2019, PAIN, V160, P1050, DOI 10.1097/j.pain.0000000000001481; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 2001, PAIN, V89, P107, DOI 10.1016/S0304-3959(00)00478-4; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Cady RK, 2009, HEADACHE, V49, P1258, DOI 10.1111/j.1526-4610.2009.01523.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention (CDC), 2010, FACTS CONC BRAIN INJ; Cernuda-Morollon E, 2013, NEUROLOGY, V81, P1191, DOI 10.1212/WNL.0b013e3182a6cb72; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; De Felice M, 2010, ANN NEUROL, V67, P325, DOI 10.1002/ana.21897; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Dodick DW, 2019, CEPHALALGIA, V39, P1075, DOI 10.1177/0333102419858355; Dodick DW, 2019, CEPHALALGIA, V39, P873, DOI 10.1177/0333102418825346; Dodick DW, 2019, CEPHALALGIA, V39, P445, DOI 10.1177/0333102418821662; Dodick DW, 2018, JAMA-J AM MED ASSOC, V319, P1999, DOI 10.1001/jama.2018.4853; Dodick DW, 2018, CEPHALALGIA, V38, P1026, DOI 10.1177/0333102418759786; Edvinsson L, 2017, HEADACHE, V57, P47, DOI 10.1111/head.13081; Eftekhari S, 2010, NEUROSCIENCE, V169, P683, DOI 10.1016/j.neuroscience.2010.05.016; Eftekhari S, 2016, J COMP NEUROL, V524, P90, DOI 10.1002/cne.23828; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Ferrari MD, 2001, LANCET, V358, P1668, DOI 10.1016/S0140-6736(01)06711-3; Giani L, 2019, NEUROL SCI, V40, pS129, DOI 10.1007/s10072-019-03786-7; Goadsby PJ, 2019, NEW ENGL J MED, V381, P132, DOI 10.1056/NEJMoa1813440; GOADSBY PJ, 1988, ANN NEUROL, V23, P193, DOI 10.1002/ana.410230214; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Hansen JM, 2010, CEPHALALGIA, V30, P1179, DOI 10.1177/0333102410368444; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Holland PR, 2018, NEUROTHERAPEUTICS, V15, P304, DOI 10.1007/s13311-018-0617-4; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; Iyengar S, 2017, PAIN, V158, P543, DOI 10.1097/j.pain.0000000000000831; Juhasz G, 2005, CEPHALALGIA, V25, P179, DOI 10.1111/j.1468-2982.2005.00836.x; Kandasamy R, 2015, HANDB EXP PHARMACOL, V227, P15, DOI 10.1007/978-3-662-46450-2_2; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kopruszinski CM, 2017, CEPHALALGIA, V37, P560, DOI 10.1177/0333102416650702; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lennerz JK, 2008, J COMP NEUROL, V507, P1277, DOI 10.1002/cne.21607; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Manning BM, 2016, ACS CHEM BIOL, V11, P3077, DOI 10.1021/acschembio.6b00616; Marcus R, 2014, CEPHALALGIA, V34, P114, DOI 10.1177/0333102413500727; Markus TE, 2016, J CHILD NEUROL, V31, P1213, DOI 10.1177/0883073816650036; Martelletti P, 2019, EXPERT OPIN PHARMACO, V20, P209, DOI 10.1080/14656566.2018.1549223; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Moye LS, 2019, CEPHALALGIA, V39, P77, DOI 10.1177/0333102418777507; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Mychasiuk R, 2014, JOVE-J VIS EXP, V94; Nation KM, 2018, PAIN, V159, P919, DOI 10.1097/j.pain.0000000000001167; Nordhaug LH, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0838-2; Price TJ, 2015, PROG MOL BIOL TRANSL, V131, P409, DOI 10.1016/bs.pmbts.2014.11.010; Ramachandran R, 2018, SEMIN IMMUNOPATHOL, V40, P301, DOI 10.1007/s00281-018-0676-y; Silverberg ND, 2019, J NEUROTRAUM, V36, P1544, DOI 10.1089/neu.2018.6025; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Skljarevski V, 2018, CEPHALALGIA, V38, P1442, DOI 10.1177/0333102418779543; Stemper BD, 2016, ANN BIOMED ENG, V44, P3252, DOI 10.1007/s10439-016-1647-x; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tepper SJ, 2019, NEUROL SCI, V40, pS99, DOI 10.1007/s10072-019-03769-8; Tepper SJ, 2018, HEADACHE, V58, P238, DOI 10.1111/head.13379; Theoharides TC, 2005, BRAIN RES REV, V49, P65, DOI 10.1016/j.brainresrev.2004.11.006; Voss T, 2016, CEPHALALGIA, V36, P887, DOI 10.1177/0333102416653233; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Wang XJ, 2010, HEADACHE, V50, P579, DOI 10.1111/j.1526-4610.2010.01632.x; Warfvinge K, 2019, CEPHALALGIA, V39, P342, DOI 10.1177/0333102417728873; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429	83	36	37	1	7	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	DEC	2019	39	14					1762	1775	0333102419877662	10.1177/0333102419877662		SEP 2019	14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT6CT	WOS:000491780000001	31550910				2022-02-06	
J	Beaudouin, F; der Funten, KA; Tross, T; Reinsberger, C; Meyer, T				Beaudouin, Florian; der Fuenten, Karen Aus; Troess, Tobias; Reinsberger, Claus; Meyer, Tim			Head injuries in professional male football (soccer) over 13 years: 29% lower incidence rates after a rule change (red card)	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							UEFA CHAMPIONS LEAGUE; ELITE FOOTBALL; CONSENSUS STATEMENT; MUSCLE INJURIES; CONCUSSION; MECHANISMS; PLAYERS; PATTERNS; SPORT	Background Absolute numbers of head injuries in football (soccer) are considerable because of its high popularity and the large number of players. In 2006 a rule was changed to reduce head injuries. Players were given a red card (sent off) for intentional elbow-head contact. Aims To describe the head injury mechanism and examine the effect of the rule change. Methods Based on continuously recorded data from the German football magazine "kicker", a database of all head injuries in the 1st German Male Bundesliga was generated comprising seasons 2000/01-2012/13. Injury mechanisms were analysed from video recordings. Injury incidence rates (IR) and 95% confidence intervals (95% CI) as well as incidence rate ratios (IRR) to assess differences before and after the rule change were calculated. Results 356 head injuries were recorded (IR 2.22, 95% CI 2.00 to 2.46 per 1000 match hours). Contact with another player caused most head injuries, more specifically because of head-head (34%) or elbow-head (17%) contacts. After the rule change, head injuries were reduced by 29% (IRR 0.71, 95% CI 0.57 to 0.86, p=0.002). Lacerations/abrasions declined by 42% (95% CI 0.39 to 0.85), concussions by 29% (95% CI 0.46 to 1.09), contusions by 18% (95% CI 0.43 to 1.55) and facial fractures by 16% (95% CI 0.55 to 1.28). Conclusions This rule change appeared to reduce the risk of head injuries in men's professional football.	[Beaudouin, Florian; der Fuenten, Karen Aus; Troess, Tobias; Meyer, Tim] Saarland Univ, FIFA Med Ctr Excellence, Inst Sports & Prevent Med, Saarbrucken, Germany; [Reinsberger, Claus] Univ Paderborn, Inst Sports Med, Paderborn, Germany		Beaudouin, F (corresponding author), Saarland Univ, Inst Sports & Prevent Med, Bldg B 8-2, D-66123 Saarbrucken, Germany.	florian.beaudouin@uni-saarland.de			German Federal Institute of Sports Science	This study was funded by the German Federal Institute of Sports Science.	Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Bjorneboe J, 2013, BRIT J SPORT MED, V47, P508, DOI 10.1136/bjsports-2012-091522; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Camargo AV, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01729; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Dvorak J, 2000, AM J SPORT MED, V28, pS3; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Ekstrand J, 2013, BRIT J SPORT MED, V47, P732, DOI 10.1136/bjsports-2013-092394; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Funten KAD, 2014, J ATHL TRAINING, V49, P786, DOI 10.4085/1062-6050-49.3.51; Fuller CW, 2004, AM J SPORT MED, V32, p43S, DOI 10.1177/0363546503261248; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Junge A, 2013, BRIT J SPORT MED, V47, P782, DOI 10.1136/bjsports-2013-092205; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Leventer L, 2016, INT J SPORTS MED, V37, P898, DOI 10.1055/s-0042-108201; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Niedfeldt MW, 2011, CURR SPORT MED REP, V10, P324, DOI 10.1249/JSR.0b013e318237be53; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Tscholl P, 2007, BRIT J SPORT MED, V41, pI8, DOI 10.1136/bjsm.2007.036871; Tscholl P, 2007, BRIT J SPORT MED, V41, pI15, DOI 10.1136/bjsm.2007.036889; Walden M, 2005, BRIT J SPORT MED, V39, P542, DOI 10.1136/bjsm.2004.014571; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182	32	36	36	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	AUG	2019	53	15					948	+		10.1136/bjsports-2016-097217			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IM3ME	WOS:000477896500007	28646098				2022-02-06	
J	Hirad, AA; Bazarian, JJ; Merchant-Borna, K; Garcea, FE; Heilbronner, S; Paul, D; Hintz, EB; van Wijngaarden, E; Schifitto, G; Wright, DW; Espinoza, TR; Mahon, BZ				Hirad, Adnan A.; Bazarian, Jeffrey J.; Merchant-Borna, Kian; Garcea, Frank E.; Heilbronner, Sarah; Paul, David; Hintz, Eric B.; van Wijngaarden, Edwin; Schifitto, Giovanni; Wright, David W.; Espinoza, Tamara R.; Mahon, Bradford Z.			A common neural signature of brain injury in concussion and subconcussion	SCIENCE ADVANCES			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; WHITE-MATTER; AXONAL INJURY; HEAD IMPACTS; PROFESSIONAL FOOTBALL; PLAYER; DAMAGE; COMA	The midbrain is biomechanically susceptible to force loading from repetitive subconcussive head impacts (RSHI), is a site of tauopathy in chronic traumatic encephalopathy (CTE), and regulates functions (e.g., eye movements) often disrupted in concussion. In a prospective longitudinal design, we demonstrate there are reductions in midbrain white matter integrity due to a single season of collegiate football, and that the amount of reduction in midbrain white matter integrity is related to the amount of rotational acceleration to which players' brains are exposed. We then replicate the observation of reduced midbrain white matter integrity in a retrospective cohort of individuals with frank concussion, and further show that variance in white matter integrity is correlated with levels of serum-based tau, a marker of blood-brain barrier disruption. These findings mean that noninvasive structural MRI of the midbrain is a succinct index of both clinically silent white matter injury as well as frank concussion.	[Hirad, Adnan A.; Bazarian, Jeffrey J.; Merchant-Borna, Kian] Univ Rochester, Dept Emergency Med, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA; [Hirad, Adnan A.] Univ Rochester, Dept Clin & Translat Sci, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA; [Garcea, Frank E.; Mahon, Bradford Z.] Univ Rochester, Ctr Visual Sci, 601 Elmwood Ave, Rochester, NY 14642 USA; [Garcea, Frank E.] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Heilbronner, Sarah] Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, 601 Elmwood Ave, Rochester, NY 14642 USA; [Heilbronner, Sarah] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Paul, David; Mahon, Bradford Z.] Univ Rochester, Med Ctr, Dept Neurosurg, 601 Elmwood Ave, Rochester, NY 14642 USA; [Hintz, Eric B.] San Antonio Mil Med Ctr, Div Neurosurg, San Antonio, TX 78234 USA; [van Wijngaarden, Edwin] Univ Rochester, Dept Publ Hlth Sci, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA; [Schifitto, Giovanni; Mahon, Bradford Z.] Univ Rochester, Med Ctr, Dept Neurol, 601 Elmwood Ave, Rochester, NY 14642 USA; [Wright, David W.; Espinoza, Tamara R.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Mahon, Bradford Z.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Mahon, Bradford Z.] Carnegie Mellon Univ, Carnegie Mellon Neurosci Inst, Pittsburgh, PA 15213 USA; [Mahon, Bradford Z.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA		Hirad, AA (corresponding author), Univ Rochester, Dept Emergency Med, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.; Hirad, AA (corresponding author), Univ Rochester, Dept Clin & Translat Sci, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.; Mahon, BZ (corresponding author), Univ Rochester, Ctr Visual Sci, 601 Elmwood Ave, Rochester, NY 14642 USA.; Mahon, BZ (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, 601 Elmwood Ave, Rochester, NY 14642 USA.; Mahon, BZ (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, 601 Elmwood Ave, Rochester, NY 14642 USA.; Mahon, BZ (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.; Mahon, BZ (corresponding author), Carnegie Mellon Univ, Carnegie Mellon Neurosci Inst, Pittsburgh, PA 15213 USA.; Mahon, BZ (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA.	adnan_hirad@urmc.rochester.edu; bmahon@andrew.cmu.edu	Paul, David/AAZ-8514-2020	BAZARIAN, JEFFREY/0000-0001-7100-3805; Merchant-Borna, Kian/0000-0002-6643-1597; van Wijngaarden, Edwin/0000-0001-7583-4630; Paul, David/0000-0002-3517-8787; Hirad, Adnan/0000-0002-0601-7423	NFL Charities; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K24 HD064754, R01 MH099921, R21NS076176, R01NS089609, R01EY028535, T32 GM007356, R01MH118257]; National Institute of Nursing Research Intramural Research Program; U.S. Army Rapid Innovation Fund [W911NF-11-R-0017]; University of Rochester via the NIH/National Center for Advancing Translational Sciences [UL1 TR002001]; BWF-IIMP; University of Rochester Center for Visual Science (NIH) [5T32EY007125-24]; Moss Rehabilitation Research Institute [NIH T32HD007425]; University of Rochester Clinical and Translational Science Institute [CTSI TL1 TR000096];  [TL1 TR002000]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002001, TL1TR002000] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [T32EY007125, R01EY028535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH099921, R01MH118257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS089609] Funding Source: NIH RePORTER	This study was supported by funds from the NFL Charities (www.nflcharities-org.ezpminer.urmc.rochester.edu/) and NIH K24 HD064754 to J.J.B., National Institute of Nursing Research Intramural Research Program, U.S. Army Rapid Innovation Fund (W911NF-11-R-0017) to D.W.W., NIH grant R01 MH099921 to G.S., and NIH grants R21NS076176, R01NS089609, and R01EY028535 to B.Z.M. A.A.H. is a trainee in the Medical Scientist Training Program funded by NIH T32 GM007356. Further support for A.A.H. was provided by University of Rochester UL1 TR002001 via the NIH/National Center for Advancing Translational Sciences, BWF-IIMP Pilot Project, and a predoctoral training grant to the Clinical & Translational Sciences Institute (TL1 TR002000). F.E.G. was supported by a University of Rochester Center for Visual Science predoctoral training fellowship (NIH training grant 5T32EY007125-24) and a Moss Rehabilitation Research Institute postdoctoral training fellowship (NIH T32HD007425). S.H. was supported, in part, by NIH grant R01MH118257. D.P. was supported by a grant from the University of Rochester Clinical and Translational Science Institute (CTSI TL1 TR000096). The opinions in this manuscript do not constitute endorsement by the Brooke Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information contained therein. More generally, no funders had a role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang L, 2012, J IMMUNOL METHODS, V378, P102, DOI 10.1016/j.jim.2012.02.011; Chernoff BL, 2018, J COGNITIVE NEUROSCI, V30, P752, DOI 10.1162/jocn_a_01244; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Garcea FE, 2017, CURR BIOL, V27, P2684, DOI 10.1016/j.cub.2017.07.051; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 2007, AM J PSYCHIAT, V164, P1005, DOI 10.1176/appi.ajp.164.7.1005; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rostowsky KA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00948; Seghier ML, 2008, MAGN RESON IMAGING, V26, P594, DOI 10.1016/j.mri.2007.10.010; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	50	36	36	2	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	AUG	2019	5	8							eaau3460	10.1126/sciadv.aau3460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IR9WX	WOS:000481798400001	31457074	Green Published, gold			2022-02-06	
J	Mustafi, SM; Harezlak, J; Koch, KM; Nencka, AS; Meier, TB; West, JD; Giza, CC; DiFiori, JP; Guskiewicz, KM; Mihalik, JP; LaConte, SM; Duma, SM; Broglio, SP; Saykin, AJ; McCrea, M; McAllister, TW; Wu, YC				Mustafi, Sourajit Mitra; Harezlak, Jaroslaw; Koch, Kevin M.; Nencka, Andrew S.; Meier, Timothy B.; West, John D.; Giza, Christopher C.; DiFiori, John P.; Guskiewicz, Kevin M.; Mihalik, Jason P.; LaConte, Stephen M.; Duma, Stefan M.; Broglio, Steven P.; Saykin, Andrew J.; McCrea, Michael; McAllister, Thomas W.; Wu, Yu-Chien			Acute White-Matter Abnormalities in Sports-Related Concussion: A Diffusion Tensor Imaging Study from the NCAA-DoD CARE Consortium	JOURNAL OF NEUROTRAUMA			English	Article						acute; CARE; diffusion tensor imaging; sports-related concussion; tract-based spatial statistics; white matters	TRAUMATIC BRAIN-INJURY; AXONAL INJURY; WATER DIFFUSION; SPINAL-CORD; MRI; DYSMYELINATION; EPIDEMIOLOGY; DEGENERATION; DEPENDENCE; NETWORKS	Sports-related concussion (SRC) is an important public health issue. Although standardized assessment tools are useful in the clinical management of acute concussion, the underlying pathophysiology of SRC and the time course of physiological recovery after injury remain unclear. In this study, we used diffusion tensor imaging (DTI) to detect white matter alterations in football players within 48h after SRC. As part of the NCAA-DoD CARE Consortium study of SRC, 30 American football players diagnosed with acute concussion and 28 matched controls received clinical assessments and underwent advanced magnetic resonance imaging scans. To avoid selection bias and partial volume effects, whole-brain skeletonized white matter was examined by tract-based spatial statistics to investigate between-group differences in DTI metrics and their associations with clinical outcome measures. Mean diffusivity was significantly higher in brain white matter of concussed athletes, particularly in frontal and subfrontal long white matter tracts. In the concussed group, axial diffusivity was significantly correlated with the Brief Symptom Inventory and there was a similar trend with the symptom severity score of the Sport Concussion Assessment Tool. In addition, concussed athletes with higher fractional anisotropy performed better on the cognitive component of the Standardized Assessment of Concussion. Overall, the results of this study are consistent with the hypothesis that SRC is associated with changes in white matter tracts shortly after injury, and these differences are correlated clinically with acute symptoms and functional impairments.	[Mustafi, Sourajit Mitra; West, John D.; Saykin, Andrew J.; Wu, Yu-Chien] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, 355 West 16th St,Suite 4100, Indianapolis, IN 46202 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychol, Indianapolis, IN 46202 USA; [Harezlak, Jaroslaw] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Koch, Kevin M.; Nencka, Andrew S.] Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Meier, Timothy B.; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp UCLA Los Angeles, Dept Neurosurg,Div Pediat Neurol, Los Angeles, CA 90095 USA; [DiFiori, John P.] Univ Calif Los Angeles, Dept Family Med, Div Sports Med, Los Angeles, CA USA; [DiFiori, John P.] Univ Calif Los Angeles, Dept Orthoped, Div Sports Med, Los Angeles, CA USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [LaConte, Stephen M.] Wake Forest & Virginia Tech Univ, Virginia Tech, Carilion Res Inst, Sch Biomed Engn & Sci, Roanoke, VA USA; [Duma, Stefan M.] Wake Forest & Virginia Tech Univ, Sch Biomed Engn & Sci, Blacksburg, VA USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA		Wu, YC (corresponding author), Indiana Univ Sch Med, Dept Radiol & Imaging Sci, 355 West 16th St,Suite 4100, Indianapolis, IN 46202 USA.	yucwu@iupui.edu	Koch, Kevin/AAD-6403-2021; Harezlak, Jaroslaw/P-8557-2014	Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS075791, R01 AG053993, P30 AG010133, R01 AG019771]; ICTSI NIH/NCRR [UL1TR001108]; U.S. Army Medical Research Acquisition Activity (Chandler Street, Fort Detrick, MD); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG019771, R01AG053993, P30AG010133] Funding Source: NIH RePORTER	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity (820 Chandler Street, Fort Detrick, MD 21702-5014) is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds). Other funding supports include National Institutes of Health grant R21 NS075791 (to Y.C.W. and T.W.M.), R01 AG053993 (to Y.C.W.), P30 AG010133 and R01 AG019771 (to A.J.S.), and a Project Development Team within the ICTSI NIH/NCRR Grant Number UL1TR001108 (to Y.C.W.).	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cabeen RP, 2017, NEUROIMAGE, V146, P100, DOI 10.1016/j.neuroimage.2016.11.020; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Derogatis L.R., 1993, BSI BRIEF SYMPTOM IN; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Field AS, 2004, J MAGN RESON IMAGING, V20, P555, DOI 10.1002/jmri.20169; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; Goni J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058070; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones D.K, 2011, DIFFUSION MRI THEORY, p[1, xvi]; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kinoshita M, 2010, J NEURO-ONCOL, V96, P409, DOI 10.1007/s11060-009-9979-0; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; Lee JE, 2007, NEUROSCI LETT, V424, P127, DOI 10.1016/j.neulet.2007.07.042; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1996, STANDARDIZED ASSESSM; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Nencka AS, 2018, BRAIN IMAGING BEHAV, V12, P1121, DOI 10.1007/s11682-017-9775-y; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Pan J, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15607; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Prabhu SP, 2011, CLIN SPORT MED, V30, P103, DOI 10.1016/j.csm.2010.09.003; Rocca MA, 2016, MULT SCLER J, V22, P620, DOI 10.1177/1352458515596600; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Suri AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142288; Thomas AW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178360; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wechsler D., 1987, MANUAL WECHSLER ADUL; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wu Y.C., 2006, MED PHYS, P150; Wu YC, 2011, NEUROIMAGE, V58, P829, DOI 10.1016/j.neuroimage.2011.06.067; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	88	36	37	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	22					2653	2664		10.1089/neu.2017.5158			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GZ0MO	WOS:000449057900005	29065805	Green Published			2022-02-06	
J	Marion, CM; Radomski, KL; Cramer, NP; Galdzicki, Z; Armstrong, RC				Marion, Christina M.; Radomski, Kryslaine L.; Cramer, Nathan P.; Galdzicki, Zygmunt; Armstrong, Regina C.			Experimental Traumatic Brain Injury Identifies Distinct Early and Late Phase Axonal Conduction Deficits of White Matter Pathophysiology, and Reveals Intervening Recovery	JOURNAL OF NEUROSCIENCE			English	Article						axon damage; CLARITY; myelin; nerve conduction; node of Ranvier; paranode	CORPUS-CALLOSUM; UNMYELINATED AXONS; MYELINATED NERVES; MILD; SPEED; NODES; HEAD; PATHOLOGY; RANVIER; DEMYELINATION	Traumatic brain injury (TBI) patients often exhibit slowed information processing speed that can underlie diverse symptoms. Processing speed depends on neural circuit function at synapses, in the soma, and along axons. Long axons in white matter (WM) tracts are particularly vulnerable to TBI. We hypothesized that disrupted axon-myelin interactions that slow or block action potential conduction in WM tracts may contribute to slowed processing speed after TBI. Concussive TBI in male/female mice was used to produce traumatic axonal injury in the corpus callosum (CC), similar to WM pathology in human TBI cases. Compound action potential velocity was slowed along myelinated axons at 3 d after TBI with partial recovery by 2 weeks, suggesting early demyelination followed by remyelination. Ultrastructurally, dispersed demyelinated axons and disorganized myelin attachment to axons at paranodes were apparent within CC regions exhibiting traumatic axonal injury. Action potential conduction is exquisitely sensitive to paranode abnormalities. Molecular identification of paranodes and nodes of Ranvier detected asymmetrical paranode pairs and abnormal heminodes after TBI. Fluorescent labeling of oligodendrocyte progenitors in NG2CreER;mTmG mice showed increased synthesis of new membranes extended along axons to paranodes, indicating remyelination after TBI. At later times after TBI, an overall loss of conducting axons was observed at 6 weeks followed by CC atrophy at 8 weeks. These studies identify a progression of both myelinated axon conduction deficits and axon-myelin pathology in the CC, implicating WM injury in impaired information processing at early and late phases after TBI. Furthermore, the intervening recovery reveals a potential therapeutic window.	[Marion, Christina M.; Radomski, Kryslaine L.; Cramer, Nathan P.; Galdzicki, Zygmunt; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Radomski, Kryslaine L.; Cramer, Nathan P.; Galdzicki, Zygmunt; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Marion, Christina M.; Galdzicki, Zygmunt; Armstrong, Regina C.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Program Neurosci, Bethesda, MD 20814 USA		Armstrong, RC (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	regina.armstrong@usuhs.edu	Marion, Christina M/B-8120-2015	Marion, Christina M/0000-0003-0381-4109; Cramer, Nathan/0000-0001-6146-3664; Armstrong, Regina/0000-0001-7296-6750	U.S. Department of Defense in the Center for Neuroscience and Regenerative Medicine [CNRM703386, CNRM702720, CNRM702577]; Uniformed Services University of the Health Sciences Program [308430]; Congressionally Directed Medical Research ProgramUnited States Department of Defense [SC160213]; Center for Neuroscience and Regenerative Medicine Preclinical Models Core and Microscopy Core	This work was supported by the U.S. Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM703386 to R.C.A.; CNRM702720 to R.C.A.; CNRM702577 to Z.G.), Uniformed Services University of the Health Sciences Program Project 308430 to Z.G., and the Congressionally Directed Medical Research Program SC160213 to R.C.A. We thank Dr. Fengshan Yu, Dr. Genevieve Sullivan, and Xiaomei Zi for technical assistance; Dr. Cara Olsen for advice with statistical analysis; Center for Neuroscience and Regenerative Medicine Preclinical Models Core and Microscopy Core for support, particularly Dr. Fritz Lishka; and Dr. Amanda Mierzwa for initial development of the myelin remodeling experiments.	Almeida RG, 2017, J NEUROSCI, V37, P10023, DOI 10.1523/JNEUROSCI.3185-16.2017; Amor V, 2017, ELIFE, V6, DOI 10.7554/eLife.21392; Arancibia-Carcamo IL, 2017, ELIFE, V6, DOI 10.7554/eLife.23329; Arancibia-Carcamo IL, 2014, ACTA NEUROPATHOL, V128, P161, DOI 10.1007/s00401-014-1305-z; Armstrong RC, 2002, J NEUROSCI, V22, P8574; Armstrong RC, 2006, J NEUROPATH EXP NEUR, V65, P245, DOI 10.1097/01.jnen.0000205142.08716.7e; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Babbs CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067767; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Benjamini D, 2016, NEUROIMAGE, V135, P333, DOI 10.1016/j.neuroimage.2016.04.052; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Brivio V, 2017, CURR BIOL, V27, P1068, DOI 10.1016/j.cub.2017.01.025; Budd JML, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00042; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Chung S, 2018, J NEUROTRAUM, V35, P1015, DOI 10.1089/neu.2017.5320; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Freeman SA, 2016, CELL MOL LIFE SCI, V73, P723, DOI 10.1007/s00018-015-2081-1; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Griggs RB, 2017, NEUROSCI RES, V116, P77, DOI 10.1016/j.neures.2016.09.010; Gu YZ, 2017, J CELL BIOL, V216, P2179, DOI 10.1083/jcb.201606065; Hamada MS, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00045; Hartline DK, 2007, CURR BIOL, V17, pR29, DOI 10.1016/j.cub.2006.11.042; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Huang CYM, 2017, J NEUROSCI, V37, P11323, DOI 10.1523/JNEUROSCI.2113-17.2017; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kohan ED, 2018, MED BIOL ENG COMPUT, V56, P395, DOI 10.1007/s11517-017-1691-1; Kourtidou P, 2013, J HEAD TRAUMA REHAB, V28, P433, DOI 10.1097/HTR.0b013e3182585d06; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Powers BE, 2013, P NATL ACAD SCI USA, V110, P4075, DOI 10.1073/pnas.1210293110; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Saporta MA, 2009, BRAIN, V132, P3263, DOI 10.1093/brain/awp274; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Sullivan GM, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9342534; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Susuki K, 2013, ASN NEURO, V5, DOI 10.1042/AN20130025; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Takagishi Y, 2016, NEUROBIOL AGING, V43, P34, DOI 10.1016/j.neurobiolaging.2016.03.020; Takano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052904; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Volman V, 2014, J COMPUT NEUROSCI, V37, P439, DOI 10.1007/s10827-014-0515-7; Waxman SG, 2006, NAT REV NEUROSCI, V7, P932, DOI 10.1038/nrn2023; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	70	36	36	0	2	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 10	2018	38	41					8723	8736		10.1523/JNEUROSCI.0819-18.2018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GW3XH	WOS:000446842200001	30143572	Green Published, hybrid			2022-02-06	
J	Martens, G; Lejeune, N; O'Brien, AT; Fregni, F; Martial, C; Wannez, S; Laureys, S; Thibaut, A				Martens, Geraldine; Lejeune, Nicolas; O'Brien, Anthony Terrence; Fregni, Felipe; Martial, Charlotte; Wannez, Sarah; Laureys, Steven; Thibaut, Aurore			Randomized controlled trial of home-based 4-week tDCS in chronic minimally conscious state	BRAIN STIMULATION			English	Article						Transcranial direct current stimulation (tDCS); Consciousness; Minimally conscious state; Traumatic brain injury	DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; VEGETATIVE STATE; MAJOR DEPRESSION; CLINICAL-TRIAL; LATE RECOVERY; DISORDERS; RECOMMENDATIONS; DEFINITION; AMANTADINE	Background: Patients with chronic disorders of consciousness face a significant lack of treatment options. Objective: We aimed at investigating the feasibility and the behavioral effects of home-based transcranial direct current stimulation (tDCS), applied by relatives or caregivers, in chronic patients in minimally conscious state (MCS). Methods: Each participant received, in a randomized order, 20 sessions of active and 20 sessions of sham tDCS applied over the prefrontal cortex for 4 weeks; separated by 8 weeks of washout. Level of consciousness was assessed using the Coma Recovery Scale-Revised before the first stimulation (baseline), at the end of the 20 tDCS sessions (direct effects) and 8 weeks after the end of each stimulation period (long-term effects). Reported adverse events and data relative to the adherence (i.e., amount of sessions effectively received) were collected as well. Results: Twenty-seven patients completed the study and 22 patients received at least 80% of the stimulation sessions. All patients tolerated tDCS well, no severe adverse events were noticed after real stimulation and the overall adherence (i.e., total duration of stimulation) was good. A moderate effect size (0.47 and 0.53, for modified intention to treat and per protocol analysis, respectively) was observed at the end of the 4 weeks of tDCS in favor of the active treatment. Conclusions: We demonstrated that home-based tDCS can be used adequately outside a research facility or hospital by patients' relatives or caregivers. In addition, 4 weeks of tDCS moderately improved the recovery of signs of consciousness in chronic MCS patients. (c) 2018 Elsevier Inc. All rights reserved.	[Martens, Geraldine; Lejeune, Nicolas; Martial, Charlotte; Wannez, Sarah; Laureys, Steven; Thibaut, Aurore] Univ Liege, GIGA Consciousness, GIGA Res, Coma Sci Grp, Liege, Belgium; [Martens, Geraldine; Lejeune, Nicolas; Martial, Charlotte; Wannez, Sarah; Laureys, Steven; Thibaut, Aurore] Univ Liege, Neurol Dept, Ave Hop 11, Liege, Belgium; [Martens, Geraldine; Lejeune, Nicolas; Martial, Charlotte; Wannez, Sarah; Laureys, Steven; Thibaut, Aurore] Univ Hosp Liege, Ave Hop 11, Liege, Belgium; [Lejeune, Nicolas] Catholic Univ Louvain, St Luc Univ Clin, Ctr Hosp Neurol William Lennox, Louvain, Belgium; [O'Brien, Anthony Terrence; Fregni, Felipe; Thibaut, Aurore] Harvard Med Sch, Spaulding Rehabil Hosp, Neuromodulat Ctr, Boston, MA USA		Laureys, S (corresponding author), Univ Liege, GIGA Consciousness, GIGA Res, Coma Sci Grp, Liege, Belgium.; Martens, G (corresponding author), Univ Liege, Neurol Dept, Ave Hop 11, Liege, Belgium.; Martens, G (corresponding author), Univ Hosp Liege, Ave Hop 11, Liege, Belgium.; Martens, G (corresponding author), Univ Liege, GIGA Res Coma Sci Grp, Ave Hop 11, Liege, Belgium.	geraldine.martens@ulg.ac.be; coma@uliege.be	Martial, Charlotte/O-6703-2016; Thibaut, Aurore/U-8101-2019; Laureys, Steven/A-3349-2011; Martens, Geraldine/ABF-1147-2020; Laureys, Steven/AAN-2097-2021	Martial, Charlotte/0000-0001-6291-3460; Martens, Geraldine/0000-0001-7038-7165; Laureys, Steven/0000-0002-3096-3807; Lejeune, Nicolas/0000-0001-6059-606X; Fregni, Felipe/0000-0001-9359-8643	University and University Hospital of Liege (Belgium); Belgian National Funds for Scientific Research (FRS-FNRS)Fonds de la Recherche Scientifique - FNRS; Human Brain ProjectUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [EU-H2020-fetflagshiphbp-sga1-ga720270]; Luminous project [EU-H2020-fetopenga686764]; Center-TBI project; James McDonnell Foundation; European Space AgencyEuropean Space AgencyEuropean Commission; BelspoBelgian Federal Science Policy Office; Fondazione Europea di Ricerca Biomedica; BIAL FoundationBial Foundation; Wallonia Brussels Federation Concerted Research Action; Cefaly Technology and Mind Science Foundation	This research was supported by University and University Hospital of Liege (Belgium), Belgian National Funds for Scientific Research (FRS-FNRS), Human Brain Project (EU-H2020-fetflagshiphbp-sga1-ga720270), Luminous project (EU-H2020-fetopenga686764), Center-TBI project, James McDonnell Foundation, European Space Agency, Belspo, Fondazione Europea di Ricerca Biomedica, the BIAL Foundation, Wallonia Brussels Federation Concerted Research Action, Cefaly Technology and Mind Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman C, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5651; Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Brunoni AR, 2011, PROG NEURO-PSYCHOPH, V35, P96, DOI 10.1016/j.pnpbp.2010.09.010; Brunoni AR, 2013, JAMA PSYCHIAT, V70, P383, DOI 10.1001/2013.jamapsychiatry.32; Castillo-Saavedra L, 2016, J PAIN, V17, P14, DOI 10.1016/j.jpain.2015.09.009; Charvet L, 2018, NEUROMODULATION, V21, P383, DOI 10.1111/ner.12583; Charvet LE, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00026; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Dunlay SM, 2011, MAYO CLIN PROC, V86, P273, DOI 10.4065/mcp.2010.0732; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2017, J NEUROL SCI, V375, P464, DOI 10.1016/j.jns.2017.02.036; Ferrucci R, 2009, J AFFECT DISORDERS, P118; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Fregni F, 2006, COGN BEHAV NEUROL, V19, P21, DOI 10.1097/00146965-200603000-00003; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries O, 2014, CURR PHARM DESIGN, V20, P4167; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Huang WS, 2017, BRAIN STIMUL, V10, P718, DOI 10.1016/j.brs.2017.02.001; Kang EK, 2009, RESTOR NEUROL NEUROS, V27, P645, DOI 10.3233/RNN-2009-0514; Leuchter AF, 2015, BRAIN STIMUL, V8, P787, DOI 10.1016/j.brs.2015.05.005; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Nair DG, 2011, RESTOR NEUROL NEUROS, V29, P411, DOI 10.3233/RNN-2011-0612; Raine TR, 2005, JAMA-J AM MED ASSOC, V293, P54, DOI 10.1001/jama.293.1.54; Russo C, 2017, NEUROMODULATION, V20, P215, DOI 10.1111/ner.12574; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00057; Saout V., 2010, Annals of Physical and Rehabilitation Medicine, V53, P96, DOI 10.1016/j.rehab.2010.01.002; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Simis M, 2014, NEUROMODULATION, V17, P497, DOI 10.1111/ner.12140; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Thibaut A, 2017, EXPERT REV MED DEVIC, V14, P633, DOI 10.1080/17434440.2017.1352470; Thibaut A, 2017, BRAIN INJURY, V31, P466, DOI 10.1080/02699052.2016.1274776; Thibaut A, 2015, BRAIN STIMUL, V8, P1116, DOI 10.1016/j.brs.2015.07.024; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962	41	36	43	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	SEP-OCT	2018	11	5					982	990		10.1016/j.brs.2018.04.021			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GR2QP	WOS:000442423400003	29759943	Green Published			2022-02-06	
J	Fuentes, MM; Wang, J; Haarbauer-Krupa, J; Yeates, KO; Durbin, D; Zonfrillo, MR; Jaffe, KM; Temkin, N; Tulsky, D; Bertisch, H; Rivara, FP				Fuentes, Molly M.; Wang, Jin; Haarbauer-Krupa, Juliet; Yeates, Keith Owen; Durbin, Dennis; Zonfrillo, Mark R.; Jaffe, Kenneth M.; Temkin, Nancy; Tulsky, David; Bertisch, Hilary; Rivara, Frederick P.			Unmet Rehabilitation Needs After Hospitalization for Traumatic Brain Injury	PEDIATRICS			English	Article							QUALITY-OF-LIFE; ITEM BANKS; CHILDREN; OUTCOMES; SERVICES; RECOVERY	OBJECTIVES: In this study, we describe unmet service needs of children hospitalized for traumatic brain injury (TBI) during the first 2 years after injury and examine associations between child, family, and injury-related characteristics and unmet needs in 6 domains (physical therapy, occupational therapy, speech therapy, mental health services, educational services, and physiatry). METHODS: Prospective cohort study of children age 8 to 18 years old admitted to 6 hospitals with complicated mild or moderate to severe TBI. Service need was based on dysfunction identified via parent-report compared with retrospective baseline at 6, 12, and 24 months. Needs were considered unmet if the child had no therapy services in the previous 4 weeks, no physiatry services since the previous assessment, or no educational services since injury. Analyses were used to compare met and unmet needs for each domain and time point. Generalized multinomial logit models with robust SEs were used to assess factors associated with change in need from pre-injury baseline to each study time point. RESULTS: Unmet need varied by injury severity, time since injury, and service domain. Unmet need was highest for physiatry, educational services, and speech therapy. Among children with service needs, increased time after TBI and complicated mild TBI were associated with a higher likelihood of unmet rather than met service needs. CONCLUSIONS: Children hospitalized for TBI have persistent dysfunction with unmet needs across multiple domains. After initial hospitalization, children with TBI should be monitored for functional impairments to improve identification and fulfillment of service needs.	[Fuentes, Molly M.; Jaffe, Kenneth M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Wang, Jin; Jaffe, Kenneth M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; [Fuentes, Molly M.; Wang, Jin; Jaffe, Kenneth M.; Temkin, Nancy; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Haarbauer-Krupa, Juliet] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Durbin, Dennis] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Durbin, Dennis] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Durbin, Dennis] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Dept Pediat, Providence, RI USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Dept Emergency Med, Providence, RI USA; [Zonfrillo, Mark R.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Tulsky, David] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Tulsky, David] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA; [Tulsky, David] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE USA; [Bertisch, Hilary; Rivara, Frederick P.] NYU, Sch Med, Rusk Rehabil, New York, NY USA		Fuentes, MM (corresponding author), Seattle Childrens Hosp, Dept Rehabil Med, CW8-6 POB 5371, Seattle, WA 98121 USA.	molly.fuentes@seattlechildrens.org	Zonfrillo, Mark R./H-9403-2017; Durbin, Dennis/AAD-7829-2022; Yeates, Keith/AAJ-4223-2020	Zonfrillo, Mark R./0000-0002-0610-9563; Yeates, Keith/0000-0001-7680-2892; Fuentes, Molly/0000-0001-8971-228X; Tulsky, David/0000-0002-4335-4509	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002196]; Rehabilitation Medicine Scientist Training Program - National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12HD001097]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, T32HD057822] Funding Source: NIH RePORTER	This study was funded by the Centers for Disease Control and Prevention (CDC) (grant U01CE002196). Dr Fuentes was also supported by the Rehabilitation Medicine Scientist Training Program, funded by the National Institutes of Health (grant K12HD001097). This article does not reflect the official policy or opinions of the CDC or the US Department of Health and Human Services and does not constitute an endorsement of the individuals or their programs by CDC, Health and Human Services, or other components of the federal government and none should be inferred. Funded by the National Institutes of Health (NIH).	Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Bertisch H, 2017, QUAL LIFE RES, V26, P1887, DOI 10.1007/s11136-017-1524-6; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Gershon R, 2010, QUAL LIFE RES, V19, P677, DOI 10.1007/s11136-010-9634-4; Gershon Richard C, 2010, J Appl Meas, V11, P304; Greenspan AI, 2000, BRAIN INJURY, V14, P417; HealthMeasures, 2017, PROMIS; Irwin DE, 2010, QUAL LIFE RES, V19, P595, DOI 10.1007/s11136-010-9619-3; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Kramer ME, 2013, J HEAD TRAUMA REHAB, V28, P361, DOI 10.1097/HTR.0b013e31824da031; Lai JS, 2012, NEUROREHAB NEURAL RE, V26, P36, DOI 10.1177/1545968311412054; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Rivara FP, 2011, PEDIATRICS, V128; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Steinberg AM, 2013, J TRAUMA STRESS, V26, P1, DOI 10.1002/jts.21780; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	23	36	36	0	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	MAY	2018	141	5							e20172859	10.1542/peds.2017-2859			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	GE5AV	WOS:000431231300011	29674358	Green Published, Bronze			2022-02-06	
J	Swanson, RL; Hampton, S; Green-McKenzie, J; Diaz-Arrastia, R; Grady, MS; Verma, R; Biester, R; Duda, D; Wolf, RL; Smith, DH				Swanson, Randel L., II; Hampton, Stephen; Green-McKenzie, Judith; Diaz-Arrastia, Ramon; Grady, M. Sean; Verma, Ragini; Biester, Rosette; Duda, Diana; Wolf, Ronald L.; Smith, Douglas H.			Neurological Manifestations Among US Government Personnel Reporting Directional Audible and Sensory Phenomena in Havana, Cuba	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; BALANCE; VALIDITY; CONSISTENCY; DISORDERS; INVENTORY; ILLNESS	IMPORTANCE From late 2016 through August 2017, US government personnel serving on diplomatic assignment in Havana, Cuba, reported neurological symptoms associated with exposure to auditory and sensory phenomena. OBJECTIVE To describe the neurological manifestations that followed exposure to an unknown energy source associated with auditory and sensory phenomena. DESIGN, SETTING, AND PARTICIPANTS Preliminary results from a retrospective case series of US government personnel in Havana, Cuba. Following reported exposure to auditory and sensory phenomena in their homes or hotel rooms, the individuals reported a similar constellation of neurological symptoms resembling brain injury. These individuals were referred to an academic brain injury center for multidisciplinary evaluation and treatment. EXPOSURES Report of experiencing audible and sensory phenomena emanating from a distinct direction (directional phenomena) associated with an undetermined source, while serving on US government assignments in Havana, Cuba, since 2016. MAIN OUTCOMES AND MEASURES Descriptions of the exposures and symptoms were obtained from medical record review of multidisciplinary clinical interviews and examinations. Additional objective assessments included clinical tests of vestibular (dynamic and static balance, vestibulo-ocular reflex testing, caloric testing), oculomotor (measurement of convergence, saccadic, and smooth pursuit eye movements), cognitive (comprehensive neuropsychological battery), and audiometric (pure tone and speech audiometry) functioning. Neuroimaging was also obtained. RESULTS Of 24 individuals with suspected exposure identified by the US Department of State, 21 completed multidisciplinary evaluation an average of 203 days after exposure. Persistent symptoms (>3 months after exposure) were reported by these individuals including cognitive (n = 17, 81%), balance (n = 15, 71%), visual (n = 18, 86%), and auditory (n = 15, 68%) dysfunction, sleep impairment (n = 18, 86%), and headaches (n = 16, 76%). Objective findings included cognitive (n = 16, 76%), vestibular (n = 17, 81%), and oculomotor (n = 15, 71%) abnormalities. Moderate to severe sensorineural hearing loss was identified in 3 individuals. Pharmacologic intervention was required for persistent sleep dysfunction (n = 15, 71%) and headache (n = 12, 57%). Fourteen individuals (67%) were held from work at the time of multidisciplinary evaluation. Of those, 7 began graduated return to work with restrictions in place, home exercise programs, and higher-level work-focused cognitive rehabilitation. CONCLUSIONS AND RELEVANCE In this preliminary report of a retrospective case series, persistent cognitive, vestibular, and oculomotor dysfunction, as well as sleep impairment and headaches, were observed among US government personnel in Havana, Cuba, associated with reports of directional audible and/or sensory phenomena of unclear origin. These individuals appeared to have sustained injury to widespread brain networks without an associated history of head trauma.	[Grady, M. Sean; Smith, Douglas H.] Univ Penn, Perelman Sch Med, Dept Neurosurg, 3320 Smith Walk,105 Hayden Hall, Philadelphia, PA 19104 USA; [Swanson, Randel L., II; Hampton, Stephen; Biester, Rosette] Univ Penn, Dept Phys Med & Rehabil, Perelman Sch Med, Philadelphia, PA 19104 USA; [Swanson, Randel L., II; Hampton, Stephen; Green-McKenzie, Judith; Diaz-Arrastia, Ramon; Grady, M. Sean; Verma, Ragini; Biester, Rosette; Duda, Diana; Wolf, Ronald L.; Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Green-McKenzie, Judith] Univ Penn, Div Occupat & Environm Med, Dept Emergency Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Verma, Ragini; Wolf, Ronald L.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Duda, Diana] Univ Penn, Penn Therapy & Fitness, Good Shepherd Penn Partners, Philadelphia, PA 19104 USA		Smith, DH (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosurg, 3320 Smith Walk,105 Hayden Hall, Philadelphia, PA 19104 USA.; Smith, DH (corresponding author), Univ Penn, Perelman Sch Med, Ctr Brain Injury & Repair, 3320 Smith Walk,105 Hayden Hall, Philadelphia, PA 19104 USA.	smithdou@upenn.edu		McKenzie, Judith/0000-0003-3994-6568	Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); National Institute for Occupational Safety and HealthUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Green-McKenzie reported receiving grants from Health Resources and Services Administration and the National Institute for Occupational Safety and Health. No other disclosures were reported.	Alahmari KA, 2014, ARCH PHYS MED REHAB, V95, P65, DOI 10.1016/j.apmr.2013.09.011; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Barin K., 2008, BALANCE FUNCTION ASS, P229; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1993, BECK ANXIETY INVENTO; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Brown SG, 2004, BRAIN COGNITION, V55, P283, DOI 10.1016/j.bandc.2004.02.010; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Chlebowski C, 2011, WECHSLER MEMORY SCAL; Delis D.C., 2000, CALIFORNIA VERBAL LE; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Garzia R P, 1990, J Am Optom Assoc, V61, P124; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Horn Linda B, 2015, Arch Phys Med Rehabil, V96, P1747; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones TF, 2000, NEW ENGL J MED, V342, P96, DOI 10.1056/NEJM200001133420206; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Malloy PF., 2002, FRONTAL SYSTEMS BEHA; McCutchan PK, 2016, MIL MED, V181, P1002, DOI 10.7205/MILMED-D-15-00444; McInnes K, 2017, PLOS ONE, V12; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nashner L.M., 1993, HDB BALANCE FUNCTION, P280; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Scheiman M., 2014, CLIN MANAGEMENT BINO; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shepard NT, 1996, PRACTICAL MANAGEMENT; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Weathers FW, 1991, PCL C FOR DSM 4; Wechsler, 2008, WAIS 4 TECHNICAL MAN; Weir E, 2005, CAN MED ASSOC J, V172, P36, DOI 10.1503/cmaj.045027; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	37	36	37	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2018	319	11					1125	1133		10.1001/jama.2018.1742			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FZ8LL	WOS:000427860200017	29450484	Green Published, Bronze			2022-02-06	
J	Sun, DW; Wang, WY; Wang, XT; Wang, Y; Xu, XT; Ping, F; Du, Y; Jiang, W; Cui, DR				Sun, Dawei; Wang, Wenying; Wang, Xintao; Wang, Yan; Xu, Xiaotao; Ping, Feng; Du, Yu; Jiang, Wei; Cui, Derong			bFGF plays a neuroprotective role by suppressing excessive autophagy and apoptosis after transient global cerebral ischemia in rats	CELL DEATH & DISEASE			English	Article							FIBROBLAST-GROWTH-FACTOR; HIPPOCAMPAL NEURONAL DEATH; BRAIN-INJURY; CELL-DEATH; ALZHEIMERS-DISEASE; ACTIVATION; RECOVERY; MEMORY; DAMAGE; STRESS	Transient global cerebral ischemia (tGCI) is a cerebrovascular disorder that can cause apoptotic neuronal damage and functional deficits. Basic fibroblast growth factor (bFGF) was reported to be highly expressed in the central nervous system (CNS) and to exert neuroprotective effects against different CNS diseases. However, the effects of bFGF on tGCI have not been studied intensively. This study was conducted to investigate the effect of bFGF and its underlying mechanism in an animal model of tGCI. After intracerebroventricular (i.c.v.) injection of bFGF, functional improvement was observed, and the number of viable neurons increased in the ischemia-vulnerable hippocampal CA1 region. Apoptosis was induced after tGCI and could be attenuated by bFGF treatment via inhibition of p53 mitochondrial translocation. In addition, autophagy was activated during this process, and bFGF could inhibit activation of autophagy through the mTOR pathway. Rapamycin, an activator of autophagy, was utilized to explore the relationship among bFGF, apoptosis, and autophagy. Apoptosis deteriorated after rapamycin treatment, which indicated that excessive autophagy could contribute to the apoptosis process. In conclusion, these results demonstrate that bFGF could exert neuroprotective effects in the hippocampal CA1 region by suppressing excessive autophagy via the mTOR pathway and inhibiting apoptosis by preventing p53 mitochondrial translocation. Furthermore, our results suggest that bFGF may be a promising therapeutic agent to for treating tGCI in response to major adverse events, including cardiac arrest, shock, extracorporeal circulation, traumatic hemorrhage, and asphyxiation.	[Sun, Dawei; Wang, Wenying; Wang, Xintao; Wang, Yan; Xu, Xiaotao; Ping, Feng; Jiang, Wei; Cui, Derong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Anesthesiol, Shanghai 200233, Peoples R China; [Du, Yu] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurol, Shanghai 200233, Peoples R China		Jiang, W; Cui, DR (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Anesthesiol, Shanghai 200233, Peoples R China.; Jiang, W; Cui, DR (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurol, Shanghai 200233, Peoples R China.	jiangw@sjtu.edu.cn; cuishuning118@163.com		Sun, Dawei/0000-0002-6631-8527	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671879]; Shanghai Municipal Commission of Health and Family Planning [201740118]; Medicine-Engineering Joint Foundation of Shanghai Jiaotong University [YG2016MS17]	This work was supported by the National Natural Science Foundation of China (No. 81671879), grant (No. 201740118) from Shanghai Municipal Commission of Health and Family Planning and the Medicine-Engineering Joint Foundation of Shanghai Jiaotong University (No. YG2016MS17).	Bendel O, 2005, J CEREBR BLOOD F MET, V25, P1586, DOI 10.1038/sj.jcbfm.9600153; Block F, 1999, PROG NEUROBIOL, V58, P279, DOI 10.1016/S0301-0082(98)00085-9; Bogousslavsky J, 2002, CEREBROVASC DIS, V14, P239, DOI 10.1159/000065683; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cui DR, 2013, NEUROSCIENCE, V246, P117, DOI 10.1016/j.neuroscience.2013.04.054; Cui DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep27642; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Ham PB, 2017, PROG NEUROBIOL, V157, P92, DOI 10.1016/j.pneurobio.2016.06.006; Kawamata T, 1997, P NATL ACAD SCI USA, V94, P8179, DOI 10.1073/pnas.94.15.8179; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JY, 2014, NEUROPHARMACOLOGY, V79, P161, DOI 10.1016/j.neuropharm.2013.11.011; Lu Q, 2016, MOL NEUROBIOL, V53, P5344, DOI 10.1007/s12035-015-9455-0; Matsuse D, 2011, TISSUE ENG PT A, V17, P1993, DOI [10.1089/ten.tea.2010.0585, 10.1089/ten.TEA.2010.0585]; Meng QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033053; Moscovitch M, 2016, ANNU REV PSYCHOL, V67, P105, DOI 10.1146/annurev-psych-113011-143733; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nguyen TH, 2013, NAT CHEM, V5, P221, DOI [10.1038/nchem.1573, 10.1038/NCHEM.1573]; Niizuma K, 2009, STROKE, V40, P618, DOI 10.1161/STROKEAHA.108.524447; Papadakis M, 2013, NAT MED, V19, P351, DOI 10.1038/nm.3097; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Puyal J, 2013, PROG NEUROBIOL, V105, P24, DOI 10.1016/j.pneurobio.2013.03.002; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]; Schimanski LA, 2004, NEUROSCI BIOBEHAV R, V28, P463, DOI 10.1016/j.neubiorev.2004.04.002; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Spencer SJ, 2008, STROKE, V39, P975, DOI 10.1161/STROKEAHA.107.497016; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Chung TN, 2017, CRIT CARE MED, V45, pE508, DOI 10.1097/CCM.0000000000002289; Tang DW, 2010, BIOMATERIALS, V31, P9320, DOI 10.1016/j.biomaterials.2010.08.058; Thorburn A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001967; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang ZG, 2012, TOXICOL LETT, V212, P137, DOI 10.1016/j.toxlet.2012.05.006; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wu Dafang, 2005, NeuroRx, V2, P120, DOI 10.1007/BF03206648; Xing SH, 2012, AUTOPHAGY, V8, P63, DOI 10.4161/auto.8.1.18217; Zechel S, 2010, NEUROSCIENTIST, V16, P357, DOI 10.1177/1073858410371513; Zhang C, 2014, INT J PHARMACEUT, V461, P192, DOI 10.1016/j.ijpharm.2013.11.049; Zhang HY, 2013, CNS NEUROSCI THER, V19, P20, DOI 10.1111/cns.12013; Zhang XN, 2014, AUTOPHAGY, V10, P1801, DOI 10.4161/auto.32136; Zhao YN, 2017, ONCOTARGET, V8, P23353, DOI 10.18632/oncotarget.15058; Zhao YZ, 2016, J CONTROL RELEASE, V224, P165, DOI 10.1016/j.jconrel.2016.01.017; Zhou XY, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.34; Zuo W, 2014, NEUROPHARMACOLOGY, V86, P103, DOI 10.1016/j.neuropharm.2014.07.002	52	36	46	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	FEB 7	2018	9								172	10.1038/s41419-017-0229-7			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FZ2IN	WOS:000427401400014	29416039	gold, Green Published			2022-02-06	
J	Huang, YN; Yang, LY; Greig, NH; Wang, YC; Lai, CC; Wang, JY				Huang, Ya-Ni; Yang, Ling-Yu; Greig, Nigel H.; Wang, Yu-Chio; Lai, Chien-Cheng; Wang, Jia-Yi			Neuroprotective effects of pifithrin-alpha against traumatic brain injury in the striatum through suppression of neuroinflammation, oxidative stress, autophagy, and apoptosis	SCIENTIFIC REPORTS			English	Article							CELL-DEATH; FUNCTIONAL OUTCOMES; ANTIOXIDANT THERAPIES; GLIAL ACTIVATION; HEME OXYGENASE-1; GENE-EXPRESSION; NERVOUS-SYSTEM; NEURONAL DEATH; DNA-DAMAGE; P53	Cortical and hippocampal neuronal damages caused by traumatic brain injury (TBI) are associated with motor and cognitive impairments; however, only little attention paid to the striatal damage. It is known that the p53 tumor-suppressor transcription factor participated in TBI-induced secondary brain damage. We investigated how the p53 inactivator pifithrin (PFT)-alpha affected TBI-induced striatal neuronal damage at 24 h post-injury. Sprague-Dawley rats subjected to a controlled cortical impact were used as TBI models. We observed that p53 mRNA significantly increased, whereas p53 protein expression was distributed predominantly in neurons but not in glia cells in striatum after TBI. PFT-alpha improved motor deficit following TBI. PFT-alpha suppressed TBI-induced striatal glial activation and expression of proinflammatory cytokines. PFT-alpha alleviated TBI-induced oxidative damage TBI induced autophagy was evidenced by increased protein expression of Beclin-1 and shift of microtubule-associated light chain (LC) 3-I to LC3-II, and decreased p62. These effects were reduced by PFT-alpha. Post-injury PFT-alpha treatment reduced the number of degenerating (FJC-positive) and apoptotic neurons. Our results suggest that PFT-alpha may provide neuroprotective effects via p53-dependent or -independent mechanisms depending on the cell type and timing after the TBI and can possibly be developed into a novel therapy to ameliorate TBI-induced neuronal damage.	[Huang, Ya-Ni] Hsin Sheng Jr Coll Med Care & Management, Dept Nursing, Taoyuan, Taiwan; [Huang, Ya-Ni] Hsin Sheng Jr Coll Med Care & Management, Dept Optometry, Taoyuan, Taiwan; [Yang, Ling-Yu; Wang, Yu-Chio; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Wang, Yu-Chio] Taipei Med Univ, Coll Med, Sch Med, Taipei, Taiwan; [Lai, Chien-Cheng] Far Eastern Mem Hosp, Div Orthoped, Dept Surg, New Taipei, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Coll Med, Dept Physiol, Taipei, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Dept Physiol, Taipei, Taiwan.	jywang2010@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST104-2923-B-038-001-MY3]; Taipei Medical University, Taiwan [104-5432-010-111]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000311] Funding Source: NIH RePORTER	This work was supported by a grant (MOST104-2923-B-038-001-MY3) to JYW from the Ministry of Science and Technology, Taiwan, and a grant (104-5432-010-111) to YNH from Taipei Medical University, Taiwan.	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barone E, 2015, J NEUROSCI RES, V93, P1728, DOI 10.1002/jnr.23627; Budanov Andrei V, 2014, Subcell Biochem, V85, P337, DOI 10.1007/978-94-017-9211-0_18; Chen CJ, 2010, J GEN VIROL, V91, P1028, DOI 10.1099/vir.0.013565-0; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chung YH, 2002, NEUROL RES, V24, P324, DOI 10.1179/016164102101199828; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Davenport CM, 2010, J NEUROCHEM, V112, P552, DOI 10.1111/j.1471-4159.2009.06485.x; Dijsselbloem N, 2007, J IMMUNOL, V178, P5048, DOI 10.4049/jimmunol.178.8.5048; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Duan WZ, 2002, ANN NEUROL, V52, P597, DOI 10.1002/ana.10350; Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Ferrandiz ML, 2008, CURR PHARM DESIGN, V14, P473, DOI 10.2174/138161208783597399; Fleiss B, 2015, DEV NEUROSCI-BASEL, V37, P363, DOI 10.1159/000370031; Gao Z., 2017, MOL NEUROBIOLOGY; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Harmon JL, 2017, J NEUROTRAUM, V34, P487, DOI 10.1089/neu.2015.4395; Hoagland MS, 2005, J PHARMACOL EXP THER, V314, P603, DOI 10.1124/jpet.105.084186; Hong MY, 2012, CHINESE MED J-PEKING, V125, P2019, DOI 10.3760/cma.j.issn.0366-6999.2012.11.032; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Jayadev S, 2011, GLIA, V59, P1402, DOI 10.1002/glia.21178; Jebelli J, 2014, NEUROSCI LETT, V583, P92, DOI 10.1016/j.neulet.2014.08.049; Jebelli JD, 2012, GLIA, V60, P515, DOI 10.1002/glia.22268; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karve I. P., 2015, BRIT J PHARM; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Komarova EA, 2003, J BIOL CHEM, V278, P15465, DOI 10.1074/jbc.C300011200; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kumar A., 2012, BRAIN BEHAV IMMUNITY, V26; LANGEVELD CH, 1995, NEUROSCI LETT, V192, P13, DOI 10.1016/0304-3940(95)11596-O; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; Li L., 2015, CELL MOL NEUROBIOL; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Long J, 2013, NEURAL REGEN RES, V8, P1491, DOI 10.3969/j.issn.1673-5374.2013.16.006; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mancuso C, 2004, ANTIOXID REDOX SIGN, V6, P878, DOI 10.1089/1523086041798097; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Morrison R. S., 2000, CELL DEATH DIFFERENT, V7; Morrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103; Murphy PJM, 2004, J BIOL CHEM, V279, P30195, DOI 10.1074/jbc.M403539200; Nijboer CH, 2011, ANN NEUROL, V70, P255, DOI 10.1002/ana.22413; Nopparat C, 2010, J PINEAL RES, V49, P382, DOI 10.1111/j.1600-079X.2010.00805.x; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Pietrancosta N., 2006, J MED CHEM, V49; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Potucek YD, 2006, NEUROCHEM INT, V49, P204, DOI 10.1016/j.neuint.2006.04.005; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reed TT, 2009, J NEUROSCI RES, V87, P408, DOI 10.1002/jnr.21872; Rock RB, 2006, J NEUROIMMUNE PHARM, V1, P117, DOI 10.1007/s11481-006-9012-8; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; Senol N, 2014, NEUROCHEM RES, V39, P685, DOI 10.1007/s11064-014-1255-9; Shin SS, 2012, J NEUROTRAUM, V29, P843, DOI 10.1089/neu.2011.1966; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Sohn D, 2009, CELL DEATH DIFFER, V16, P869, DOI 10.1038/cdd.2009.17; Sparfel L, 2006, CARCINOGENESIS, V27, P656, DOI 10.1093/carcin/bgi256; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Su W, 2014, J IMMUNOL, V192, P358, DOI 10.4049/jimmunol.1301397; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wan CH, 2013, J MOL NEUROSCI, V51, P695, DOI 10.1007/s12031-013-0050-4; Wang DB, 2014, BBA-MOL BASIS DIS, V1842, P1186, DOI 10.1016/j.bbadis.2013.12.015; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xu Fa-Lin, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P137; Ya JC, 2015, MOL MED REP, V12, P6591, DOI 10.3892/mmr.2015.4292; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0	98	36	39	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 5	2018	8								2368	10.1038/s41598-018-19654-x			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8FC	WOS:000424087700040	29402897	Green Published, gold			2022-02-06	
J	Caccese, JB; Buckley, TA; Tierney, RT; Arbogast, KB; Rose, WC; Glutting, JJ; Kaminski, TW				Caccese, Jaclyn B.; Buckley, Thomas A.; Tierney, Ryan T.; Arbogast, Kristy B.; Rose, William C.; Glutting, Joseph J.; Kaminski, Thomas W.			Head and neck size and neck strength predict linear and rotational acceleration during purposeful soccer heading	SPORTS BIOMECHANICS			English	Article						Concussion; subconcussion; mild traumatic brain injury; paediatric	SEGMENT DYNAMIC STABILIZATION; CONCUSSION; FOOTBALL; CHILDREN; PLAYERS; IMPACTS; SPINE	There is increasing societal concern about the long-term effects of repeated impacts from soccer heading, but there is little information about ways to reduce head impact severity. The purpose of this study was to identify factors that contribute to head acceleration during soccer heading. One-hundred soccer players completed 12 controlled soccer headers. Peak linear (PLA) and rotational (PRA) accelerations were measured using a triaxial accelerometer and gyroscope. Head acceleration contributing factors were grouped into 3 categories: size (head mass, neck girth), strength (sternocleidomastoid, upper trapezius) and technique [kinematics (trunk, head-to-trunk range-of-motion), sternocleidomastoid and upper trapezius activity]. Multiple regression analyses indicated size variables explained 22.1% of the variance in PLA and 23.3% of the variance in PRA; strength variables explained 13.3% of the variance in PLA and 17.2% of the variance in PRA; technique variables did not significantly predict PLA or PRA. These findings suggest that head and neck size and neck strength predict PLA and PRA. Anthropometric and neck strength measurements should be considered when determining an athlete's readiness to begin soccer heading.	[Caccese, Jaclyn B.; Buckley, Thomas A.; Rose, William C.; Kaminski, Thomas W.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA; [Tierney, Ryan T.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Glutting, Joseph J.] Univ Delaware, Sch Educ, Newark, DE USA		Caccese, JB (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA.	jcaccese@udel.edu	Caccese, Jaclyn B./AAH-4571-2020; Buckley, Thomas A/B-7525-2016	Caccese, Jaclyn B./0000-0003-2329-3603; Buckley, Thomas A/0000-0002-0515-0150; Arbogast, Kristy/0000-0002-1694-4562			Arbogast KB, 2009, STAPP CAR CRASH JO, V53, P329; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Falla D, 2002, CLIN NEUROPHYSIOL, V113, P57, DOI 10.1016/S1388-2457(01)00708-8; Federation Internationale de Football Association, 2007, FIFA BIG COUNT 2006, P31; Funk J, 2009, 2009010251 SAE, DOI [10.4271/2009-01-0251, DOI 10.4271/2009-01-0251]; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hales C, 2014, NEUROLOGY, V83, P2307, DOI 10.1212/WNL.0000000000001081; Hermens H.J., 1999, EUROPEAN RECOMMENDAT, V8, P13, DOI 10.1016/S1050-6411(00)00027-4; Higgins MJ, 2009, P I MECH ENG P-J SPO, V223, P117, DOI 10.1243/17543371JSET15; JENSEN RK, 1986, J BIOMECH, V19, P359, DOI 10.1016/0021-9290(86)90012-6; Karton C., 2016, ISBS C P ARCH TSUK J, V34; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Mansell J, 2005, J ATHL TRAINING, V40, P310; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Parnell D, 2018, SPORT SOC, V21, DOI 10.1080/17430437.2016.1207787; Peterson-Kendall F., 2005, MUSCLES TESTING FUNC; PLAGENHOEF S, 1983, RES Q EXERCISE SPORT, V54, P169, DOI 10.1080/02701367.1983.10605290; Rooney M., 2010, ULTIMATE WARRIOR WOR; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Seacrist T, 2012, J BIOMECH, V45, P99, DOI 10.1016/j.jbiomech.2011.09.016; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Tarnutzer A. A., BRIT J SPORTS MED; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338	31	36	36	1	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.		2018	17	4					462	476		10.1080/14763141.2017.1360385			15	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	GV1AM	WOS:000445798400004	29037111				2022-02-06	
J	Olesen, J				Olesen, Jes			Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition Asbtracts	CEPHALALGIA			English	Article							TENSION-TYPE HEADACHE; TRAUMATIC BRAIN-INJURY; DAILY-PERSISTENT HEADACHE; MEDICATION-OVERUSE HEADACHE; CHRONIC PAROXYSMAL HEMICRANIA; CENTRAL-NERVOUS-SYSTEM; NECK-TONGUE-SYNDROME; ICE-CREAM HEADACHE; FAMILIAL HEMIPLEGIC MIGRAINE; CHIARI-I MALFORMATION		[Olesen, Jes] Int Headache Soc, Headache Classificat Comm, London, England		Olesen, J (corresponding author), Int Headache Soc, Headache Classificat Comm, London, England.						Aaseth K, 2010, CEPHALALGIA, V30, P152, DOI 10.1111/j.1468-2982.2009.01877.x; Aaseth K, 2011, EUR J PAIN, V15, P186, DOI 10.1016/j.ejpain.2010.06.005; Abadie V, 2014, CEPHALALGIA, V34, P887, DOI 10.1177/0333102414523340; ABBOTT PJ, 1986, MED J AUSTRALIA, V145, P518, DOI 10.5694/j.1326-5377.1986.tb139455.x; Abhinav K, 2012, CLIN NEUROL NEUROSUR, V114, P361, DOI 10.1016/j.clineuro.2011.11.018; Abu-Arafeh I, 2017, ARCH DIS CHILD, V102, P210, DOI 10.1136/archdischild-2016-312137; Abu-Bakra M, 2001, J LARYNGOL OTOL, V115, P629; ABUARAFEH I, 1995, ARCH DIS CHILD, V72, P413, DOI 10.1136/adc.72.5.413; Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Afridi S, 2003, J NEUROL NEUROSUR PS, V74, P680, DOI 10.1136/jnnp.74.5.680; Aggarwal VR, 2007, J OROFAC PAIN, V21, P203; Aggarwal VR, 2006, INT J EPIDEMIOL, V35, P468, DOI 10.1093/ije/dyi265; Agrawal K, 2016, HEADACHE, V56, P1380, DOI 10.1111/head.12873; Aidi Saadia, 1999, Headache, V39, P559, DOI 10.1046/j.1526-4610.1999.3908559.x; Aiken AH, 2012, AM J NEURORADIOL, V33, P1901, DOI 10.3174/ajnr.A3068; Akhtar N D, 2001, Semin Pediatr Neurol, V8, P27, DOI 10.1053/spen.2001.23329; Akinci A, 2008, J AAPOS, V12, P290, DOI 10.1016/j.jaapos.2007.11.018; Aktan C, 2017, CEPHALALGIA, V37, P1074, DOI 10.1177/0333102416665878; Al-Twaijri WA, 2002, PEDIATR NEUROL, V26, P365, DOI 10.1016/S0887-8994(01)00416-7; ALAHURULA V, 1981, HEADACHE, V21, P240, DOI 10.1111/j.1526-4610.1981.hed2106240.x; Alberti A, 2005, ACTA NEUROL SCAND, V111, P309, DOI 10.1111/j.1600-0404.2005.00372.x; ALDRICH MS, 1990, ARCH INTERN MED, V150, P1265, DOI 10.1001/archinte.150.6.1265; Alfano DP, 2006, BRAIN COGNITION, V60, P194; Algin O, 2013, CAN ASSOC RADIOL J, V64, P56, DOI 10.1016/j.carj.2011.12.011; Allet JL, 2006, CURR OPIN PSYCHIATR, V19, P413, DOI 10.1097/01.yco.0000228764.25732.21; Alonso AA, 2006, J ENDODONT, V32, P1110, DOI 10.1016/j.joen.2006.02.033; Altura BM, 2000, J MENT SCI, V104, P972; Alvarez FK, 2007, J ORAL PATHOL MED, V36, P347, DOI 10.1111/j.1600-0714.2006.00489.x; Ambrose HE, 2011, J CLIN MICROBIOL, V49, P3576, DOI 10.1128/JCM.00862-11; Ambrosini A, 2005, NEUROLOGY, V65, P1826, DOI 10.1212/01.wnl.0000187072.71931.c0; Ambrosini A, 2001, ACTA NEUROL BELG, V101, P166; Amorim JA, 2012, CEPHALALGIA, V32, P916, DOI 10.1177/0333102412453951; AMY JR, 1987, HEADACHE, V27, P351, DOI 10.1111/j.1526-4610.1987.hed2706351.x; ANDERSSON PG, 1975, HEADACHE, V15, P118, DOI 10.1111/j.1526-4610.1975.hed1502118.x; Antonaci F, 2001, Curr Pain Headache Rep, V5, P387, DOI 10.1007/s11916-001-0030-1; Antonaci F, 2001, CEPHALALGIA, V21, P573, DOI 10.1046/j.0333-1024.2001.00207.x; Antoniazzi AL, 2003, CEPHALALGIA, V23, P146, DOI 10.1046/j.1468-2982.2003.00510.x; Antoniazzi Ana Luisa de Lima, 2007, Curr Pain Headache Rep, V11, P297; Antonini G, 2014, PAIN, V155, P1464, DOI 10.1016/j.pain.2014.04.020; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; APPENZELLER O, 1972, HEADACHE, V12, P126; Arafah BM, 2000, J CLIN ENDOCR METAB, V85, P1789, DOI 10.1210/jc.85.5.1789; Arngrim N, 2014, CEPHALALGIA, V34, P1169, DOI 10.1177/0333102414534085; Arnold M, 2006, J NEUROL NEUROSUR PS, V77, P1021, DOI 10.1136/jnnp.2006.094359; Arredondo M, 2012, AIDS RES HUM RETROV, V28, P889, DOI [10.1089/aid.2011.0149, 10.1089/AID.2011.0149]; Arruda MA, 2010, CEPHALALGIA, V30, P1056, DOI 10.1177/0333102409361214; Ashina M, 1999, PAIN, V79, P201, DOI 10.1016/S0304-3959(98)00167-5; Ashina M, 1999, LANCET, V353, P287, DOI 10.1016/S0140-6736(98)01079-4; Ashina M, 2000, BRAIN, V123, P1830, DOI 10.1093/brain/123.9.1830; Ashina M, 2004, CEPHALALGIA, V24, P161, DOI 10.1111/j.1468-2982.2003.00644.x; Ashina M, 2003, CEPHALALGIA, V23, P109, DOI 10.1046/j.1468-2982.2003.00520.x; Ashina M, 2002, BRAIN, V125, P320, DOI 10.1093/brain/awf029; Ashina M, 2000, CEPHALALGIA, V20, P919, DOI 10.1046/j.1468-2982.2000.00150.x; Ashina Messoud, 2002, Expert Opin Pharmacother, V3, P395, DOI 10.1517/14656566.3.4.395; Ashina S, 2006, CEPHALALGIA, V26, P940, DOI 10.1111/j.1468-2982.2006.01150.x; Ashina S, 2005, EUR J NEUROL, V12, P543, DOI 10.1111/j.1468-1331.2005.01023.x; Ashina S, 2004, PAIN, V108, P108, DOI 10.1016/j.pain.2003.12.012; ASKMARK H, 1989, HEADACHE, V29, P441, DOI 10.1111/j.1526-4610.1989.hed2907441.x; Aurora SK, 2009, CEPHALALGIA, V29, P597, DOI 10.1111/j.1468-2982.2008.01811.x; Avery RA, 2010, NEW ENGL J MED, V363, P891, DOI 10.1056/NEJMc1004957; Azevedo LL, 2011, EUR NEUROL, V66, P133, DOI 10.1159/000330675; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Bakar B, 2008, J KOREAN NEUROSURG S, V44, P285, DOI 10.3340/jkns.2008.44.5.285; Ballegaard V, 2008, CEPHALALGIA, V28, P832, DOI 10.1111/j.1468-2982.2008.01597.x; Banik R, 2006, J NEUROL SCI, V247, P71, DOI 10.1016/j.jns.2006.03.016; BARTLESON JD, 1981, NEUROLOGY, V31, P1257, DOI 10.1212/WNL.31.10.1257; Bartsch T, 2005, HEADACHE CURR, V2, P42, DOI 10.1111/j.1743-5013.2005.20201.x; BASSI P, 1991, ACTA NEUROL SCAND, V84, P277, DOI 10.1111/j.1600-0404.1991.tb04954.x; Batzdorf U, 2013, J NEUROSURG, V118, P232, DOI 10.3171/2012.10.JNS12305; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; Beck HG, 1940, J AMER MED ASSOC, V115, P1; Beekman R, 2001, HEADACHE, V41, P410, DOI 10.1046/j.1526-4610.2001.111006410.x; Belcastro V, 2011, CEPHALALGIA, V31, P999, DOI 10.1177/0333102411410083; Belcastro V, 2011, J HEADACHE PAIN, V12, P289, DOI 10.1007/s10194-011-0318-4; Bellamio M, 2017, CEPHALALGIA, V37, P491, DOI 10.1177/0333102416652094; Beltramone M, 2014, CEPHALALGIA, V34, P633, DOI 10.1177/0333102414520763; BENDTSEN L, 1995, CEPHALALGIA, V15, P205, DOI 10.1046/j.1468-2982.1995.015003205.x; Bendtsen L, 1996, ARCH NEUROL-CHICAGO, V53, P373, DOI 10.1001/archneur.1996.00550040113021; Bendtsen L, 2000, CEPHALALGIA, V20, P603, DOI 10.1046/j.1468-2982.2000.00087.x; Bendtsen L, 2000, CEPHALALGIA, V20, P486, DOI 10.1046/j.1468-2982.2000.00070.x; Bendtsen L, 2004, NEUROLOGY, V62, P1706, DOI 10.1212/01.WNL.0000127282.90920.8C; Bendtsen L, 1996, PAIN, V65, P259, DOI 10.1016/0304-3959(95)00239-1; Bendtsen L, 2010, EUR J NEUROL, V17, P1318, DOI 10.1111/j.1468-1331.2010.03070.x; Bendtsen L, 1996, J NEUROL NEUROSUR PS, V61, P285, DOI 10.1136/jnnp.61.3.285; Bendtsen L, 2010, CEPHALALGIA, V30, P1, DOI 10.1111/j.1468-2982.2009.01948.x; Bendtsen L, 2006, CURR OPIN NEUROL, V19, P305; Benoliel R, 2005, ORAL SURG ORAL MED O, V99, P657, DOI 10.1016/j.tripleo.2004.10.014; Benoliel R, 1998, CEPHALALGIA, V18, P85, DOI 10.1046/j.1468-2982.1998.1802085.x; Benoliel R, 2012, J OROFAC PAIN, V26, P49; Benoliel R, 2009, J OROFAC PAIN, V23, P330; Bento MS, 2000, HEADACHE, V40, P52, DOI 10.1046/j.1526-4610.2000.00010.x; Beretta E, 2017, NEUROL SCI, V38, pS95, DOI 10.1007/s10072-017-2950-5; BERG MJ, 1995, NEUROLOGY, V45, P1648, DOI 10.1212/WNL.45.9.1648; Bergdahl M, 1999, J ORAL PATHOL MED, V28, P350; Berger JR, 2010, SEMIN NEUROL, V30, P66, DOI 10.1055/s-0029-1244996; Berilgen MS, 2011, CEPHALALGIA, V31, P1266, DOI 10.1177/0333102411413159; Berilgen MS, 2006, CEPHALALGIA, V26, P707, DOI 10.1111/j.1468-2982.2006.01096.x; Bezov D, 2010, HEADACHE, V50, P1144, DOI 10.1111/j.1526-4610.2010.01699.x; Bharucha DX, 2007, PEDIATR NEUROL, V37, P59, DOI 10.1016/j.pediatrneurol.2007.03.008; Bhatoe HS, 1998, BRIT J NEUROSURG, V12, P165; BICKERSTAFF ER, 1961, LANCET, V1, P15; Biehl K, 2007, CEPHALALGIA, V27, P1271, DOI 10.1111/j.1468-2982.2007.01381.x; Bigal ME, 2007, CEPHALALGIA, V27, P230, DOI 10.1111/j.1468-2982.2006.01274.x; Bigal ME, 2008, NEUROLOGY, V71, P559, DOI 10.1212/01.wnl.0000323925.29520.e7; Bigal ME, 2008, CURR PAIN HEADACHE R, V12, P292, DOI 10.1007/s11916-008-0049-7; Bigal ME, 2008, HEADACHE, V48, P7, DOI 10.1111/j.1526-4610.2007.00969.x; Bigal ME, 2004, NEUROLOGY, V63, P843, DOI 10.1212/01.WNL.0000137039.08724.18; Bigal ME, 2002, CEPHALALGIA, V22, P432, DOI 10.1046/j.1468-2982.2002.00384.x; Bigal ME, 2005, HEADACHE, V45, P582, DOI 10.1111/j.1526-4610.2005.05112.x; Bigal ME, 2004, CEPHALALGIA, V24, P483, DOI 10.1111/j.1468-2982.2004.00691.x; Bing R, 1930, NERVENARZT, V3, P506; Biousse V, 1999, NEUROLOGY, V53, P1537, DOI 10.1212/WNL.53.7.1537; BIOUSSE V, 1995, STROKE, V26, P235, DOI 10.1161/01.STR.26.2.235; BIRD N, 1992, HEADACHE, V32, P35, DOI 10.1111/j.1526-4610.1992.hed3201035.x; Birk S, 2006, CEPHALALGIA, V26, P1304, DOI 10.1111/j.1468-2982.2006.01218.x; Bisdorff A, 2009, J VESTIBUL RES-EQUIL, V19, P1, DOI 10.3233/VES-2009-0343; BLACKY RA, 1987, AM J CARDIOL, V60, P730, DOI 10.1016/0002-9149(87)90394-8; Blau JN, 2004, HEADACHE, V44, P411, DOI 10.1111/j.1526-4610.2004.04092.x; Bloudek LM, 2012, J HEADACHE PAIN, V13, P361, DOI 10.1007/s10194-012-0460-7; Blumenfeld A, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0343-x; Blumenthal HJ, 2001, HEADACHE, V41, P883, DOI 10.1046/j.1526-4610.2001.01160.x; Boes CJ, 2005, NEUROLOGY, V64, P1093, DOI 10.1212/01.WNL.0000154470.19225.49; Boes CJ, 2003, CEPHALALGIA, V23, P24, DOI 10.1046/j.1468-2982.2003.00406.x; BOGDUK N, 1985, MED J AUSTRALIA, V143, P202, DOI 10.5694/j.1326-5377.1985.tb122915.x; BOGDUK N, 1981, J NEUROL NEUROSUR PS, V44, P202, DOI 10.1136/jnnp.44.3.202; Bogduk N, 2001, Curr Pain Headache Rep, V5, P382, DOI 10.1007/s11916-001-0029-7; Bogduk N, 2005, PHYS MED REH CLIN N, V14, P455; Bogduk N, 1997, HEADACHE, P369; Bohara Manoj, 2015, Hiroshima Journal of Medical Sciences, V64, P39; BOHR V, 1983, J INFECTION, V7, P102, DOI 10.1016/S0163-4453(83)90443-7; Bonnet G F, 1971, Sem Hop, V47, P2441; Bono G, 2006, CLIN EXP HYPERTENS, V28, P233, DOI 10.1080/10641960600549116; BORDINI C, 1991, HEADACHE, V31, P20, DOI 10.1111/j.1526-4610.1991.hed3101020.x; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Borkum JM, 2010, CURR PAIN HEADACHE R, V14, P55, DOI 10.1007/s11916-009-0084-z; Botha SS, 2010, CEPHALALGIA, V30, P1495, DOI 10.1177/0333102410370876; BOUHASSIRA D, 1994, CEPHALALGIA, V14, P168, DOI 10.1046/j.1468-2982.1994.1402168.x; Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7; Bousser MG, 2000, CEPHALALGIA, V20, P155, DOI 10.1046/j.1468-2982.2000.00035.x; BOWEN J, 1993, HEADACHE, V33, P238, DOI 10.1111/j.1526-4610.1993.hed3305238.x; Bowsher D, 1998, NEUROLOGY, V51, P1352, DOI 10.1212/WNL.51.5.1352; Bowsher D, 1997, J NEUROSURG, V86, P190, DOI 10.3171/jns.1997.86.2.0190; Brantberg K, 2011, ACTA OTO-LARYNGOL, V131, P722, DOI 10.3109/00016489.2011.556661; Breen JC, 1996, NEUROLOGY, V46, P175, DOI 10.1212/WNL.46.1.175; BREW BJ, 1993, NEUROLOGY, V43, P1098, DOI 10.1212/WNL.43.6.1098; BREWERTON TD, 1992, HEADACHE, V32, P217, DOI 10.1111/j.1526-4610.1992.hed3205217.x; BROESKE D, 1993, J CHILD NEUROL, V8, P235, DOI 10.1177/088307389300800305; BROOKS RG, 1986, ANN NEUROL, V20, P91, DOI 10.1002/ana.410200116; Brostigen CS, 2017, ACTA NEUROL SCAND, V135, P484, DOI 10.1111/ane.12632; Brott TG, 2016, NEW ENGL J MED, V374, P1021, DOI 10.1056/NEJMoa1505215; BRUYN GW, 1984, CEPHALALGIA, V4, P191, DOI 10.1046/j.1468-2982.1984.0403191.x; Buchgreitz L, 2008, PAIN, V137, P623, DOI 10.1016/j.pain.2007.10.023; Buchgreitz L, 2006, PAIN, V123, P19, DOI 10.1016/j.pain.2006.01.040; Buchgreitz L, 2008, BRAIN, V131, P3232, DOI 10.1093/brain/awn199; Bui SBD, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0628-7; Burkhart CG, 2006, INT J DERMATOL, V45, P1116, DOI 10.1111/j.1365-4632.2006.02790.x; Burtscher M, 2011, CEPHALALGIA, V31, P706, DOI 10.1177/0333102410394678; Buse D, 2012, HEADACHE, V52, P3, DOI 10.1111/j.1526-4610.2011.02046.x; Buse DC, 2012, HEADACHE, V52, P1456, DOI 10.1111/j.1526-4610.2012.02223.x; BUSSONE G, 1991, CEPHALALGIA, V11, P123, DOI 10.1046/j.1468-2982.1991.1103123.x; Buzzi MG, 2003, CEPHALALGIA, V23, P672; Buzzi MG, 2003, HEADACHE, V43, P404, DOI 10.1046/j.1526-4610.2003.03076.x; Byard RW, 2016, J FORENSIC SCI, V61, P1538, DOI 10.1111/1556-4029.13180; Byrum EP, 2009, AM J NEURORADIOL, V30, P1059, DOI 10.3174/ajnr.A1382; Cady RK, 2005, MAYO CLIN PROC, V80, P908, DOI 10.4065/80.7.908; Cakirer S, 2003, EUR J RADIOL, V45, P83, DOI 10.1016/S0720-048X(02)00012-8; Calabrese LH, 2007, ANN INTERN MED, V146, P34, DOI 10.7326/0003-4819-146-1-200701020-00007; Calabrese LH, 1997, ARTHRITIS RHEUM, V40, P1189, DOI 10.1002/art.2; CALABRESE LH, 1992, CLEV CLIN J MED, V59, P293, DOI 10.3949/ccjm.59.3.293; CALL GK, 1988, STROKE, V19, P1159, DOI 10.1161/01.STR.19.9.1159; Caminero AB, 1998, CEPHALALGIA, V18, P159, DOI 10.1046/j.1468-2982.1998.1803159.x; Fabri GMC, 2009, ARQ NEURO-PSIQUIAT, V67, P474, DOI 10.1590/S0004-282X2009000300018; Canestri P, 2001, CEPHALALGIA, V21, P288; Canuet L, 2008, EPILEPSY BEHAV, V13, P570, DOI 10.1016/j.yebeh.2008.05.013; Cao Y, 1999, ARCH NEUROL-CHICAGO, V56, P548, DOI 10.1001/archneur.56.5.548; Capelli E, 2010, INT J IMMUNOPATH PH, V23, P981, DOI 10.1177/039463201002300402; CAPLAN LR, 1991, NEUROLOGY, V41, P55, DOI 10.1212/WNL.41.1.55; Cariga P, 2002, SPINAL CORD, V40, P77, DOI 10.1038/sj.sc.3101259; Carney N, 2014, NEUROSURGERY, V75, pS2; Carroll D, 1970, Headache, V10, P9, DOI 10.1111/j.1526-4610.1970.hed1001009.x; CASELLI RJ, 1993, RHEUM DIS CLIN N AM, V19, P941; Cass SP, 1997, ANN OTO RHINOL LARYN, V106, P182, DOI 10.1177/000348949710600302; Castillo J, 1999, HEADACHE, V39, P190, DOI 10.1046/j.1526-4610.1999.3903190.x; Cathcart S, 2008, EUR J NEUROL, V15, P552, DOI 10.1111/j.1468-1331.2008.02124.x; Cathcart S, 2010, CEPHALALGIA, V30, P285, DOI 10.1111/j.1468-2982.2009.01917.x; Cathcart S, 2010, HEADACHE, V50, P403, DOI 10.1111/j.1526-4610.2009.01545.x; Centonze V, 2001, CEPHALALGIA, V21, P71, DOI 10.1046/j.1468-2982.2001.00152.x; Chabriat H, 1996, REV NEUROL-FRANCE, V152, P536; CHABRIAT H, 1995, LANCET, V346, P934, DOI 10.1016/S0140-6736(95)91557-5; CHAKERES DW, 1989, RADIOL CLIN N AM, V27, P265; Chakravarty A, 2006, CEPHALALGIA, V26, P202, DOI 10.1111/j.1468-2982.2005.01027.x; Chakravarty A, 2005, CEPHALALGIA, V25, P795, DOI 10.1111/j.1468-2982.2005.00958.x; CHALSTREY S, 1991, J ROY SOC MED, V84, P193, DOI 10.1177/014107689108400404; Chang CL, 1999, BMJ-BRIT MED J, V318, P13; Chapman KM, 2003, HEADACHE, V43, P892, DOI 10.1046/j.1526-4610.2003.03168.x; Charidimou A, 2012, STROKE, V43, P2324, DOI 10.1161/STROKEAHA.112.657759; Charles A, 2009, CEPHALALGIA, V29, P1115, DOI 10.1111/j.1468-2982.2009.01983.x; Chavez A, 2014, J CLIN NEUROSCI, V21, P2201, DOI 10.1016/j.jocn.2014.06.009; Chen PK, 2009, CEPHALALGIA, V29, P1079, DOI 10.1111/j.1468-2982.2009.01844.x; Chen PK, 2011, CEPHALALGIA, V31, P829, DOI 10.1177/0333102411403635; Chen SP, 2006, NEUROLOGY, V67, P2164, DOI 10.1212/01.wnl.0000249115.63436.6d; Chen SP, 2009, CEPHALALGIA, V29, P401, DOI 10.1111/j.1468-2982.2008.01744.x; Chen SP, 2010, ANN NEUROL, V67, P648, DOI 10.1002/ana.21951; Chen SP, 2004, EUR NEUROL, V51, P221, DOI 10.1159/000078489; Chen WT, 2011, BRAIN, V134, P2387, DOI 10.1093/brain/awr157; Chen WT, 2001, HEADACHE, V41, P823, DOI 10.1046/j.1526-4610.2001.01150.x; Chen YY, 2004, CEPHALALGIA, V24, P694, DOI 10.1111/j.1468-2982.2004.00739.x; CHENG TMW, 1993, NEUROLOGY, V43, P2298, DOI 10.1212/WNL.43.11.2298; Cheshire WP, 2001, HEADACHE, V41, P235, DOI 10.1046/j.1526-4610.2001.111006235.x; Chhiber SS, 2010, NEUROL INDIA, V58, P654, DOI 10.4103/0028-3886.68698; Cho SJ, 2016, CEPHALALGIA, V36, P454, DOI 10.1177/0333102415597890; Choi JC, 2014, CEPHALALGIA, V34, P22, DOI 10.1177/0333102413497598; Choi KS, 2014, ACTA NEUROCHIR, V156, P1281, DOI 10.1007/s00701-014-2095-8; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; Christensen MB, 2005, CEPHALALGIA, V25, P1061, DOI 10.1111/j.1468-2982.2005.00962.x; Chronicle EP, 1996, CEPHALALGIA, V16, P525, DOI 10.1046/j.1468-2982.1996.1608525.x; Chu MK, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-28; CHUN CH, 1986, MEDICINE, V65, P415, DOI 10.1097/00005792-198611000-00006; Cianchetti C, 2013, SEIZURE-EUR J EPILEP, V22, P679, DOI 10.1016/j.seizure.2013.05.017; Cittadini E, 2008, BRAIN, V131, P1142, DOI 10.1093/brain/awn010; Cittadini E, 2010, BRAIN, V133, P1973, DOI 10.1093/brain/awq137; CLARK GT, 1995, CEPHALALGIA, V15, P511, DOI 10.1046/j.1468-2982.1995.1506511.x; Clarke C, 2006, POSTGRAD MED J, V82, P748, DOI 10.1136/pgmj.2006.047662; Cleophas TJM, 1996, ANGIOLOGY, V47, P679, DOI 10.1177/000331979604700707; Close LG, 1997, SEMIN NEUROL, V17, P351, DOI 10.1055/s-2008-1040948; Cochius J I, 1989, Clin Exp Neurol, V26, P183; COFFEY RJ, 1991, SURG NEUROL, V35, P49, DOI 10.1016/0090-3019(91)90202-K; Cohen AS, 2006, BRAIN, V129, P2746, DOI 10.1093/brain/awl202; Cohen ME, 1994, BRAIN TUMORS CHILDRE; COHN DF, 1979, EUR NEUROL, V18, P373, DOI 10.1159/000115107; Colby CC, 2011, ARCH OTOLARYNGOL, V137, P248, DOI 10.1001/archoto.2011.25; Cologno D, 1998, CEPHALALGIA, V18, P690, DOI 10.1046/j.1468-2982.1998.1810690.x; CONNOR RCR, 1962, LANCET, V2, P1072; Contini C., 2008, Parassitologia (Rome), V50, P45; CORBETT JJ, 1983, NEUROLOGY, V33, P1386, DOI 10.1212/WNL.33.10.1386; Corral F, 2001, ARCH NEUROL-CHICAGO, V58, P1143, DOI 10.1001/archneur.58.7.1143; Couch JR, 2009, EUR J NEUROL, V16, DOI 10.1111/j.1468-1331.2008.02362.x; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; COUCH JR, 1983, HEADACHE, V23, P94; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; CREGLER LL, 1986, NEW ENGL J MED, V315, P1495, DOI 10.1056/NEJM198612043152327; Cruccu G, 2009, PAIN, V143, P186, DOI 10.1016/j.pain.2008.12.026; Cruccu G, 2016, NEUROLOGY, V87, P220, DOI 10.1212/WNL.0000000000002840; Cruccu G, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0248-2; CSALA B, 1994, NERVENARZT, V65, P75; Cuadrado ML, 2010, CEPHALALGIA, V30, P200, DOI 10.1111/j.1468-2982.2009.01895.x; Cuadrado ML, 2009, CEPHALALGIA, V29, P583, DOI 10.1111/j.1468-2982.2008.01815.x; Cumurciuc R, 2005, J NEUROL NEUROSUR PS, V76, P1084, DOI 10.1136/jnnp.2004.056275; Cure J, 2007, HEADACHE, V47, P1091, DOI 10.1111/j.1526-4610.2007.00878.x; Curioso EP, 1999, NEUROLOGY, V52, pA471; Curone M, 2017, NEUROL SCI, V38, pS91, DOI 10.1007/s10072-017-2915-8; CUTRER FM, 1992, HEADACHE, V32, P300, DOI 10.1111/j.1526-4610.1992.hed3206300.x; Cutrer FM, 2004, NEUROL CLIN, V22, P133, DOI 10.1016/S0733-8619(03)00092-6; Cutrer FM, 1998, ANN NEUROL, V43, P25, DOI 10.1002/ana.410430108; Da Motta LA, 1991, J NEUROSURG SCI, V43, P25; DALTON K, 1975, HEADACHE, V15, P188, DOI 10.1111/j.1526-4610.1975.hed1503188.x; DANGOND F, 1993, HEADACHE, V33, P257, DOI 10.1111/j.1526-4610.1993.hed3305257.x; Daroff RB, 1998, HEADACHE, V38, P661, DOI 10.1046/j.1526-4610.1998.3809661.x; Daum K M, 1988, J Am Optom Assoc, V59, P691; Davies PTG, 2011, J HEADACHE PAIN, V12, P287, DOI 10.1007/s10194-011-0344-2; DAVIS LE, 1983, ANN NEUROL, V13, P192, DOI 10.1002/ana.410130215; DAY JW, 1986, LANCET, V2, P1247; de Arcaya AA, 1999, HEADACHE, V39, P321, DOI 10.1046/j.1526-4610.1999.3905321.x; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; de Coo IF, 2016, CEPHALALGIA, V36, P547, DOI 10.1177/0333102415607856; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; de Gray LC, 2005, ANAESTHESIA, V60, P693, DOI 10.1111/j.1365-2044.2005.03997.x; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; de Noronha RJ, 2003, J NEUROL NEUROSUR PS, V74, P752, DOI 10.1136/jnnp.74.6.752; de Vries B, 2009, HUM GENET, V126, P115, DOI 10.1007/s00439-009-0684-z; DeBenedittis G, 1996, NEUROSURGERY, V38, P466, DOI 10.1097/00006123-199603000-00008; DeBenedittis G, 1996, CEPHALALGIA, V16, P503, DOI 10.1046/j.1468-2982.1996.1607503.x; Debette S, 2015, LANCET NEUROL, V14, P640, DOI 10.1016/S1474-4422(15)00009-5; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; deBruijn SFTM, 1996, LANCET, V348, P1623, DOI 10.1016/S0140-6736(96)07294-7; DEMARINIS M, 1992, CEPHALALGIA, V12, P197; DEMARINIS M, 1991, HEADACHE, V31, P159; DEMARINIS M, 1991, J NEUROL NEUROSUR PS, V54, P314, DOI 10.1136/jnnp.54.4.314; Denes E, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13107; Denier C, 2004, ANN NEUROL, V55, P213, DOI 10.1002/ana.10804; DENNING DW, 1988, BIOMED PHARMACOTHER, V42, P11; Depreitere B, 2003, ACTA NEUROCHIR, V145, P541, DOI 10.1007/s00701-003-0020-7; Desmond RA, 2006, ANTIMICROB AGENTS CH, V50, P2409, DOI 10.1128/AAC.00227-06; DEXTER JD, 1978, HEADACHE, V18, P91, DOI 10.1111/j.1526-4610.1978.hed1802091.x; DHOPESH V, 1991, HEADACHE, V31, P17, DOI 10.1111/j.1526-4610.1991.hed3101017.x; DHUNA A, 1991, J NEUROL NEUROSUR PS, V54, P803, DOI 10.1136/jnnp.54.9.803; Di Fabio R, 2012, HEADACHE, V52, P385, DOI 10.1111/j.1526-4610.2011.01994.x; Di Stefano G, 2018, CEPHALALGIA, V38, P1049, DOI 10.1177/0333102417721677; Diamond S, 2000, HEADACHE Q-CURR TREA, V11, P177; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Diener HC, 2012, NAT REV NEUROL, V8, P162, DOI 10.1038/nrneurol.2012.13; Diener Hans-Christoph, 2010, Handb Clin Neurol, V97, P547, DOI 10.1016/S0072-9752(10)97050-4; DIENER HC, 1989, J NEUROL, V236, P9, DOI 10.1007/BF00314210; Diener HC, 2006, HEADACHES, P971; Dieterich M, 1999, J NEUROL, V246, P883, DOI 10.1007/s004150050478; Dignan F, 2001, ARCH DIS CHILD, V84, P415, DOI 10.1136/adc.84.5.415; Dinwiddie SH, 2010, J ECT, V26, P116, DOI 10.1097/YCT.0b013e3181b07c0a; Diyora Batuk, 2013, Asian J Neurosurg, V8, P162, DOI 10.4103/1793-5482.121689; Dlamini N, 2011, J CHILD NEUROL, V26, P1203, DOI 10.1177/0883073811408904; Dodick DW, 2000, CEPHALALGIA, V20, P509, DOI 10.1046/j.1468-2982.2000.00073.x; Dodick DW, 2000, HEADACHE, V40, P748, DOI 10.1046/j.1526-4610.2000.00131.x; Dodick DW, 1999, CEPHALALGIA, V19, P118, DOI 10.1046/j.1468-2982.1999.019002118.x; Dodick DW, 2000, HEADACHE, V40, P830, DOI 10.1046/j.1526-4610.2000.00150.x; Dodick DW, 1998, NEUROLOGY, V50, P1510, DOI 10.1212/WNL.50.5.1510; Doepp F, 2008, CEPHALALGIA, V28, P182, DOI 10.1111/j.1468-2982.2007.01484.x; Domachowske JB, 1996, PEDIATR INFECT DIS J, V15, P871, DOI 10.1097/00006454-199610000-00008; Domingues RB, 2006, CEPHALALGIA, V26, P879, DOI 10.1111/j.1468-2982.2006.01100.x; Donnet A, 2009, CEPHALALGIA, V29, P928, DOI 10.1111/j.1468-2982.2008.01826.x; Donnet A, 2009, NEUROLOGY, V72, pA419; Doran M, 2004, J NEUROL, V251, P100, DOI 10.1007/s00415-004-0219-4; Dowman CE, 1928, ARCH NEURO PSYCHIATR, V20, P1312, DOI 10.1001/archneurpsyc.1928.02210180163008; Drake KW, 2009, NEUROLOGY, V73, P1780, DOI 10.1212/WNL.0b013e3181c34b69; Drangsholt M, 2001, J EVID BASE DENT PRA, V1, P41, DOI DOI 10.1067/med.2001.116846; Dreier JP, 2005, NEUROLOGY, V64, P2145, DOI 10.1212/01.WNL.0000176298.63840.99; DREXLER ED, 1990, POSTGRAD MED, V87, P164; Drigo P, 2000, BRAIN DEV-JPN, V22, P169, DOI 10.1016/S0387-7604(00)00099-1; Drigo P, 2001, BRAIN DEV-JPN, V23, P38, DOI 10.1016/S0387-7604(01)00175-9; Drossman Douglas A, 2006, J Gastrointestin Liver Dis, V15, P237; Drummond P D, 1984, Clin Exp Neurol, V20, P93; Du Y, 2011, J CLIN NEUROSCI, V18, P902, DOI 10.1016/j.jocn.2010.11.011; Ducros A, 2012, BMJ-BRIT MED J, V345, pe8557; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Ducros A, 2010, STROKE, V41, P2505, DOI 10.1161/STROKEAHA.109.572313; DUNN DW, 1976, AM J DIS CHILD, V130, P1099, DOI 10.1001/archpedi.1976.02120110061008; Dworkin RH, 1996, PAIN, V67, P241, DOI 10.1016/0304-3959(96)03122-3; Eastwood JD, 1998, AM J NEURORADIOL, V19, P1789; EDIS RH, 1988, LANCET, V1, P993; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Edmonds RC, 1992, DIVING SUBAQUATIVE M, P404; Egermark I, 2001, ACTA ODONTOL SCAND, V59, P40, DOI 10.1080/000163501300035788; EHNI G, 1984, J NEUROSURG, V61, P961, DOI 10.3171/jns.1984.61.5.0961; EKBOM K, 1968, ARCH NEUROL-CHICAGO, V19, P487, DOI 10.1001/archneur.1968.00480050057005; EKBOM K, 1994, CEPHALALGIA, V14, P266, DOI 10.1046/j.1468-2982.1994.1404266.x; Ekbom K, 1947, ACTA PSYCHIAT SCAND, V46, P106; Eliav E, 2007, J AM DENT ASSOC, V138, P628, DOI 10.14219/jada.archive.2007.0234; ELISEVICH K, 1984, J NEUROL NEUROSUR PS, V47, P407, DOI 10.1136/jnnp.47.4.407; ELMALLAKH RS, 1991, HEADACHE, V31, P584; ELMALLAKH RS, 1987, HEADACHE, V27, P442; Empl M, 2003, CEPHALALGIA, V23, P584; Englund M, 2003, AVIAT SPACE ENVIR MD, V74, P236; EPSTEIN MA, 1990, J CHILD NEUROL, V5, P27, DOI 10.1177/088307389000500105; EPSTEIN MT, 1975, LANCET, V1, P543, DOI 10.1016/s0140-6736(75)91558-5; Eriksen MK, 2006, HEADACHE, V46, P286, DOI 10.1111/j.1526-4610.2006.00286.x; Eriksen MK, 2005, CEPHALALGIA, V25, P801, DOI 10.1111/j.1468-2982.2005.00955.x; Eriksen MK, 2004, CEPHALALGIA, V24, P564, DOI 10.1111/j.1468-2982.2003.00718.x; Eulenberg A, 1878, LEHRBUCH NERVENKRANK; Evans Randolph W, 2003, Curr Pain Headache Rep, V7, P303, DOI 10.1007/s11916-003-0051-z; Evans RW, 2000, HEADACHE, V40, P696, DOI 10.1046/j.1526-4610.2000.040008696.x; Evans RW, 2000, HEADACHE, V40, P692, DOI 10.1046/j.1526-4610.2000.040008692.x; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Evans RW, 1996, NEUROL CLIN, V14, P1, DOI 10.1016/S0733-8619(05)70240-1; Evans RW, 2001, HEADACHE, V41, P830, DOI 10.1046/j.1526-4610.2001.01152.x; Evers S, 2000, PAIN, V85, P191, DOI 10.1016/S0304-3959(99)00266-3; Evers S, 2003, NEUROLOGY, V60, P905, DOI 10.1212/01.WNL.0000046582.21771.9C; Evers S, 1999, CLIN NEUROPHARMACOL, V22, P201; FANCIULLACCI M, 1995, PAIN, V60, P119, DOI 10.1016/0304-3959(94)00097-X; Farazmand P, 2011, INT J STD AIDS, V22, P306, DOI 10.1258/ijsa.2010.010405; FARQUHAR HG, 1956, BRIT MED J, V1, P1082, DOI 10.1136/bmj.1.4975.1082; Fasano V A, 1982, Adv Neurol, V33, P399; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fazzone HE, 2003, OPHTHALMOLOGY, V110, P1646, DOI 10.1016/S0161-6420(03)00477-9; FENICHEL GM, 1967, J PEDIATR-US, V71, P114, DOI 10.1016/S0022-3476(67)80239-7; FENICHEL NM, 1948, ANN INTERN MED, V29, P456, DOI 10.7326/0003-4819-29-3-456; Fernandez-De-Las-Penas C, 2007, CEPHALALGIA, V27, P383, DOI 10.1111/j.1468-2982.2007.01295.x; Fernandez-de-las-Penas C, 2007, CEPHALALGIA, V27, P182, DOI 10.1111/j.1468-2982.2007.01253.x; Fernandez-de-las-Penas C, 2007, CLIN J PAIN, V23, P346, DOI 10.1097/AJP.0b013e31803b3770; Fernandez-de-las-Penas C, 2007, HEADACHE, V47, P662, DOI 10.1111/j.1526-4610.2006.00632.x; Fernandez-de-las-Penas C, 2006, MANUAL THER, V11, P225, DOI 10.1016/j.math.2006.07.003; Fernandez-De-Las-Penas C, 2006, HEADACHE, V46, P1264, DOI 10.1111/j.1526-4610.2006.00440.x; Fernandaz-de-las-Penas C, 2009, CURR OPIN NEUROL, V22, P254, DOI 10.1097/WCO.0b013e32832973ce; FERRO JM, 1995, HEADACHE, V35, P544, DOI 10.1111/j.1526-4610.1995.hed3509544.x; Ferro JM, 1998, NEUROLOGY, V50, P203, DOI 10.1212/WNL.50.1.203; FERRO JM, 1995, HEADACHE, V35, P315, DOI 10.1111/j.1526-4610.1995.hed3506315.x; Find NL, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0612-2; Fisayo A, 2016, NEUROLOGY, V86, P341, DOI 10.1212/WNL.0000000000002318; Fisher C M, 1971, Clin Neurosurg, V18, P267; Fisher C M, 1968, Trans Am Neurol Assoc, V93, P211; FISHER CM, 1980, CAN J NEUROL SCI, V7, P9; FISHER CM, 1982, HEADACHE, V22, P60, DOI 10.1111/j.1526-4610.1982.hed2202060.x; Fitzek S, 2001, ANN NEUROL, V49, P493; FLEETCROFT R, 1985, J ROY SOC MED, V78, P676, DOI 10.1177/014107688507800817; Fleisher DR, 1999, J PEDIATR-US, V134, P533, DOI 10.1016/S0022-3476(99)70234-9; Forbes HS, 1924, ARCH NEURO PSYCHIATR, V11, P264, DOI 10.1001/archneurpsyc.1924.02190330014002; Forderreuther S, 2002, HEADACHE, V42, P649, DOI 10.1046/j.1526-4610.2002.02154.x; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; Forssell H, 2002, PAIN, V99, P41, DOI 10.1016/S0304-3959(02)00052-0; Forssell H, 2007, NEUROLOGY, V69, P1451, DOI 10.1212/01.wnl.0000277274.83301.c0; FORSYTH PA, 1993, NEUROLOGY, V43, P1678, DOI 10.1212/WNL.43.9.1678; FORTIN CJ, 1985, HEADACHE, V25, P255, DOI 10.1111/j.1526-4610.1985.hed2505255.x; FRANCKE E, 1987, POSTGRAD MED, V82, P175, DOI 10.1080/00325481.1987.11699934; Franco AL, 2010, J OROFAC PAIN, V24, P287; Fredriksen TA, 2000, CLIN EXP RHEUMATOL, V18, pS16; French H, 2014, OCHSNER J, V14, P188; Frese A, 2007, CEPHALALGIA, V27, P1265, DOI 10.1111/j.1468-2982.2007.01449.x; Frese A, 2003, NEUROLOGY, V61, P796, DOI 10.1212/01.WNL.0000083988.98336.A3; Friedenberg S, 2000, HEADACHE, V40, P487, DOI 10.1046/j.1526-4610.2000.00074.x; Friedman DI, 2017, HEADACHE, V57, P1195, DOI 10.1111/head.13153; Friedman DI, 2013, NEUROLOGY, V81, P1159, DOI 10.1212/WNL.0b013e3182a55f17; Friedman DI, 2004, J NEURO-OPHTHALMOL, V24, P138, DOI 10.1097/00041327-200406000-00009; Friedman J, 2001, NEUROL CLIN, V19, P681, DOI 10.1016/S0733-8619(05)70040-2; Fritsche G, 2010, PAIN, V151, P404, DOI 10.1016/j.pain.2010.07.032; FROMM GH, 1990, NEUROLOGY, V40, P1493, DOI 10.1212/WNL.40.10.1493; Fuentes B, 1998, CEPHALALGIA, V18, P570, DOI 10.1046/j.1468-2982.1998.1808570.x; Fuh JL, 2007, CEPHALALGIA, V27, P1005, DOI 10.1111/j.1468-2982.2007.01365.x; Fuh JL, 2003, CEPHALALGIA, V23, P977, DOI 10.1046/j.1468-2982.2003.00620.x; Fumal A, 2005, CEPHALALGIA, V25, P754, DOI 10.1111/j.1468-2982.2004.00945.x; Fumal A, 2008, LANCET NEUROL, V7, P70, DOI 10.1016/S1474-4422(07)70325-3; Furlan JC, 2011, NEUROLOGY, V77, P792, DOI 10.1212/WNL.0b013e31822afff1; Fusco C, 2003, BRAIN DEV-JPN, V25, P237, DOI 10.1016/S0387-7604(02)00216-4; Gaist D, 1998, BMJ-BRIT MED J, V316, P1352, DOI 10.1136/bmj.316.7141.1352; Gaist D, 1996, EUR J CLIN PHARMACOL, V50, P161, DOI 10.1007/s002280050086; Gambini O, 2010, NEUROL SCI, V31, P111, DOI 10.1007/s10072-010-0300-y; Garg RK, 2001, CEPHALALGIA, V21, P78, DOI 10.1046/j.1468-2982.2001.00171.x; Garza I, 2008, HEADACHE, V48, P1120, DOI 10.1111/j.1526-4610.2008.01149.x; GEDDE-DAHL T W, 1980, NIPH (National Institute of Public Health) Annals (Oslo), V3, P31; Gee JR, 2003, HEADACHE, V43, P276, DOI 10.1046/j.1526-4610.2003.03053.x; Gelfand AA, 2018, CEPHALALGIA, V38, P374, DOI 10.1177/0333102416681570; Gelfand AA, 2012, J CHILD NEUROL, V27, P759, DOI 10.1177/0883073811426502; Gelfand AA, 2010, NEUROLOGY, V75, pE16, DOI 10.1212/WNL.0b013e3181ebdd53; Gentile S, 2009, CEPHALALGIA, V29, P687, DOI 10.1111/j.1468-2982.2008.01803.x; Gerling J, 1998, NEURO-OPHTHALMOLOGY, V19, P93, DOI 10.1076/noph.19.2.93.3947; GHOSE K, 1984, NEUROPSYCHOBIOLOGY, V12, P122, DOI 10.1159/000118123; Giffin NJ, 2016, NEUROLOGY, V87, P309, DOI 10.1212/WNL.0000000000002789; Giffin NJ, 2002, DEV MED CHILD NEUROL, V44, P490; Gil-Gouveia R, 2007, J NEUROL, V254, P646, DOI 10.1007/s00415-006-0424-4; Gil-Gouveia R, 2007, J NEUROL, V254, P591, DOI 10.1007/s00415-006-0330-9; Gil-Gouveia RS, 2008, J HEADACHE PAIN, V9, P327, DOI 10.1007/s10194-008-0057-3; GINSBERG MD, 1985, J TOXICOL-CLIN TOXIC, V23, P281, DOI 10.3109/15563658508990635; Gipponi S, 2010, NEUROL SCI, V31, P171, DOI 10.1007/s10072-010-0322-5; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Glaros AG, 2007, CEPHALALGIA, V27, P542, DOI 10.1111/j.1468-2982.2007.01325.x; Goadsby PJ, 2008, HEADACHE, V48, P799, DOI 10.1111/j.1526-4610.2008.01157.x; Goadsby PJ, 1997, BRAIN, V120, P193, DOI 10.1093/brain/120.1.193; Goadsby PJ, 2006, BMJ-BRIT MED J, V332, P25, DOI 10.1136/bmj.332.7532.25; Goadsby PJ, 2005, HEADACHE, V45, pS14, DOI 10.1111/j.1526-4610.2005.4501003.x; Goadsby PJ, 2002, J NEUROL NEUROSUR PS, V72, P297, DOI 10.1136/jnnp.72.3.297; Goadsby PJ, 2002, J NEUROL NEUROSUR PS, V72, P6; Goadsby PJ, 2002, LANCET NEUROL, V1, P251, DOI 10.1016/S1474-4422(02)00104-7; Goadsby PJ, 2001, CEPHALALGIA, V21, P82, DOI 10.1046/j.1468-2982.2001.00175.x; Goadsby PJ, 2001, HEADACHE, V41, P608, DOI 10.1046/j.1526-4610.2001.041006608.x; Gobel H, 2001, PAIN, V91, P195, DOI 10.1016/S0304-3959(01)00292-5; Gobel H, 2000, HEADACHES, P891; Gobel H, 2000, HEADACHES, P899; Gobel H, 2000, HEADACHES, P905; Gobel H, 1997, MUNCHEN MED WOCHEN, V139, P456; Goksan B, 2009, CEPHALALGIA, V29, P635, DOI 10.1111/j.1468-2982.2008.01781.x; Goksel BK, 2006, HEADACHE, V46, P40, DOI 10.1111/j.1526-4610.2006.00295.x; GomezAranda F, 1997, BRAIN, V120, P1105, DOI 10.1093/brain/120.7.1105; Gonzalez-Gay MA, 2005, MEDICINE, V84, P269, DOI 10.1097/01.md.0000180042.42156.d1; Gordon GE, 2001, OPHTHAL PHYSL OPT, V21, P45; GORELICK PB, 1986, NEUROLOGY, V36, P1445, DOI 10.1212/WNL.36.11.1445; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; GOTO Y, 1989, J NEUROL, V236, P448, DOI 10.1007/BF00328504; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Grace A, 1997, CEPHALALGIA, V17, P195, DOI 10.1046/j.1468-2982.1997.1703195.x; Graff-Radford J, 2016, EUR J NEUROL, V23, P839, DOI 10.1111/ene.12926; Grande RB, 2011, EUR J NEUROL, V18, P129, DOI 10.1111/j.1468-1331.2010.03094.x; Grande RB, 2009, CEPHALALGIA, V29, P1149, DOI 10.1111/j.1468-2982.2009.01842.x; Grande RB, 2009, J NEUROL NEUROSUR PS, V80, P784, DOI 10.1136/jnnp.2008.168864; GRANELLA F, 1994, CEPHALALGIA, V14, P16, DOI 10.1046/j.1468-2982.1994.1401016.x; Grazzi L, 2011, NEUROL SCI, V32, P299, DOI 10.1007/s10072-011-0696-z; Green MW, 2001, MED CLIN N AM, V85, P1085, DOI 10.1016/S0025-7125(05)70361-8; Greenough Glen P, 2002, Sleep Med, V3, P361, DOI 10.1016/S1389-9457(02)00006-0; Grosberg BM, 2006, CEPHALALGIA, V26, P1275, DOI 10.1111/j.1468-2982.2006.01206.x; Grosberg Brian M, 2007, Curr Pain Headache Rep, V11, P310, DOI 10.1007/s11916-007-0209-1; Guerrero AL, 2012, CEPHALALGIA, V32, P649, DOI 10.1177/0333102412447537; Guerrero AL, 2010, HEADACHE, V50, P451, DOI 10.1111/j.1526-4610.2009.01607.x; Guey S, 2016, CEPHALALGIA, V36, P1038, DOI 10.1177/0333102415620909; Guidetti V, 1998, CEPHALALGIA, V18, P455, DOI 10.1046/j.1468-2982.1998.1807455.x; Guillon B, 1998, J NEUROL SCI, V153, P146, DOI 10.1016/S0022-510X(97)00287-6; Gunduz A, 2012, HEADACHE, V52, P544, DOI 10.1111/j.1526-4610.2012.02096.x; Gunther M, 2010, OTOL NEUROTOL, V31, P1493, DOI 10.1097/MAO.0b013e3181f0c524; Gus M, 2001, ARCH INTERN MED, V161, P252, DOI 10.1001/archinte.161.2.252; Gutierrez-Morlote J, 2002, CEPHALALGIA, V22, P765, DOI 10.1046/j.1468-2982.2002.00418.x; Haan J, 2000, NEUROLOGY, V55, P1588, DOI 10.1212/WNL.55.10.1588; Haan J, 2002, CEPHALALGIA, V22, P552, DOI 10.1046/j.1468-2982.2002.00420.x; Haanpaa M, 1998, NEUROLOGY, V51, P1405, DOI 10.1212/WNL.51.5.1405; HAAS DC, 1982, ANN NEUROL, V11, P197; HAAS DC, 1991, HEADACHE, V31, P509, DOI 10.1111/j.1526-4610.1991.hed3108509.x; Hache M, 2016, J CHILD NEUROL, V31, P899, DOI 10.1177/0883073815627882; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hajj-Ali RA, 2011, LANCET NEUROL, V10, P561, DOI 10.1016/S1474-4422(11)70081-3; Hamilton W, 2007, BRIT J GEN PRACT, V57, P695; Hannerz J, 1998, CEPHALALGIA, V18, P124, DOI 10.1046/j.1468-2982.1998.1803123-4.x; HANNERZ J, 1993, CEPHALALGIA, V13, P361, DOI 10.1046/j.1468-2982.1993.1305361.x; Hansen AP, 2015, CEPHALALGIA, V35, P399, DOI 10.1177/0333102414545894; Hansen JM, 2016, CEPHALALGIA, V36, P216, DOI 10.1177/0333102415584601; Hansen JM, 2012, NEUROLOGY, V79, P2044, DOI 10.1212/WNL.0b013e3182749eed; Hansen JM, 2011, HEADACHE, V51, P1289, DOI 10.1111/j.1526-4610.2011.01963.x; Hansen JM, 2010, NEUROLOGY, V74, P594, DOI 10.1212/WNL.0b013e3181cff79d; HARNER SG, 1993, AM J OTOL, V14, P552; HARRIS LF, 1985, SOUTH MED J, V78, P704, DOI 10.1097/00007611-198506000-00022; Harris W, 1936, BRIT MED J, V1936, P457; Carvalho MDL, 2017, CEPHALALGIA, V37, P938, DOI 10.1177/0333102416658714; Cuadrado ML, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0557-9; Cuadrado ML, 2010, J HEADACHE PAIN, V11, P75, DOI 10.1007/s10194-009-0172-9; Traumatic Brain Injury (TBI) Task Force for the US Department of the Army, 2008, REP SURG GEN; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; AEBELHOLTKRABBE A, 1980, PAIN, V8, P253, DOI 10.1016/0304-3959(88)90012-7; [Anonymous], 1999, CEPHALALGIA, V19, P67, DOI 10.1046/j.1468-2982.1999.1901067.x; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Ribeiro MDD, 2013, CEPHALALGIA, V33, P897, DOI 10.1177/0333102413479833; Lucas CD, 2007, ACTA NEUROCHIR, V149, P1249, DOI 10.1007/s00701-007-1367-y; Fernandez-De-Las-Penas C, 2006, HEADACHE, V46, P1195, DOI 10.1111/j.1526-4610.2006.00511.x; HARRIS KG, 1994, AM J NEURORADIOL, V15, P317; Haviv Y, 2016, CEPHALALGIA, V36, P730, DOI 10.1177/0333102415611405; Hayashi T, 2000, NEUROL MED-CHIR, V40, P419, DOI 10.2176/nmc.40.419; HECKERLING PS, 1987, ANN INTERN MED, V107, P174, DOI 10.7326/0003-4819-107-2-174; Heckman Bernadette Davantes, 2006, Curr Pain Headache Rep, V10, P439, DOI 10.1007/s11916-006-0075-2; Heckmann JG, 1997, HEADACHE, V37, P597; HEDGES TR, 1976, STROKE, V7, P379, DOI 10.1161/01.STR.7.4.379; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Helbok R, 2009, J NEUROL, V256, P168, DOI 10.1007/s00415-009-0122-0; HERING R, 1991, LANCET, V337, P1442, DOI 10.1016/0140-6736(91)93129-W; Hernandez A, 1998, EUR J NEUROL, V5, P499, DOI 10.1046/j.1468-1331.1998.550499.x; Herrero-Velazquez S, 2011, REV NEUROLOGIA, V53, P531, DOI 10.33588/rn.5309.2011421; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Hill DL, 2007, J NEURO-OPHTHALMOL, V27, P3, DOI 10.1097/WNO.0b013e3180335222; HODGES J, 1986, Q J MED, V59, P387; HOLLANDER H, 1987, AM J MED, V83, P813, DOI 10.1016/0002-9343(87)90635-8; Holle D, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0505-0; Holle D, 2011, ANN NEUROL, V69, P533, DOI 10.1002/ana.22188; Holle D, 2010, CEPHALALGIA, V30, P1435, DOI 10.1177/0333102410375727; Holle D, 2011, CEPHALALGIA, V31, P286, DOI 10.1177/0333102410381146; Holroyd KA, 2000, HEADACHE, V40, P3, DOI 10.1046/j.1526-4610.2000.00001.x; Holroyd KA, 2001, JAMA-J AM MED ASSOC, V285, P2208, DOI 10.1001/jama.285.17.2208; Hong JH, 2010, EUR NEUROL, V64, P163, DOI 10.1159/000319040; HORTON B T, 1952, J Lancet, V72, P92; Hottenga JJ, 2005, CEPHALALGIA, V25, P1168, DOI 10.1111/j.1468-2982.2005.00994.x; Hou CC, 2011, EUR J PHARMACOL, V667, P6, DOI 10.1016/j.ejphar.2011.05.075; HUBBARD DR, 1993, SPINE, V18, P1803, DOI 10.1097/00007632-199310000-00015; HUNDER GG, 1990, RHEUM DIS CLIN N AM, V16, P399; Hung CI, 2009, J AFFECT DISORDERS, V117, P108, DOI 10.1016/j.jad.2008.12.015; Iizuka T, 2012, J NEUROL NEUROSUR PS, V83, P205, DOI 10.1136/jnnp-2011-300843; ILLE O, 1995, STROKE, V26, P488, DOI 10.1161/01.STR.26.3.488; Irimia P, 2008, CEPHALALGIA, V28, P626, DOI 10.1111/j.1468-2982.2008.01565.x; Ito M, 2004, CEPHALALGIA, V24, P23, DOI 10.1111/j.1468-2982.2004.00628.x; Ito M, 2003, PSYCHIAT CLIN NEUROS, V57, P385, DOI 10.1046/j.1440-1819.2003.01136.x; Iversen H, 1987, CEPHALALGIA S7, V6, P394; IVERSEN HK, 1989, PAIN, V38, P17, DOI 10.1016/0304-3959(89)90067-5; Jaaskelainen SK, 2005, PAIN, V117, P349, DOI 10.1016/j.pain.2005.06.028; Jaaskelainen SK, 1997, PAIN, V73, P455, DOI 10.1016/S0304-3959(97)00140-1; Jacob Mary K, 2014, Middle East Afr J Ophthalmol, V21, P344, DOI 10.4103/0974-9233.142275; Jafarian S, 2007, CEPHALALGIA, V27, P899, DOI 10.1111/j.1468-2982.2007.01351.x; Jager HR, 2005, CEPHALALGIA, V25, P323, DOI 10.1111/j.1468-2982.2004.00858.x; JAMESON MD, 1990, MED CLIN N AM, V74, P945, DOI 10.1016/S0025-7125(16)30528-4; Janke EA, 2004, PAIN, V111, P230, DOI 10.1016/j.pain.2004.06.007; JENSEN K, 1986, ACTA NEUROL SCAND, V73, P359, DOI 10.1111/j.1600-0404.1986.tb03290.x; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Jensen R, 1999, CEPHALALGIA, V19, P602, DOI 10.1046/j.1468-2982.1999.019006602.x; Jensen R, 1996, PAIN, V64, P251, DOI 10.1016/0304-3959(95)00114-X; JENSEN R, 1993, PAIN, V52, P193, DOI 10.1016/0304-3959(93)90131-8; JENSEN R, 1992, PAIN, V48, P197, DOI 10.1016/0304-3959(92)90059-K; Jensen R, 1998, HEADACHE, V38, P10, DOI 10.1046/j.1526-4610.1998.3801010.x; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Jensen R, 2010, CEPHALALGIA, V30, P1214, DOI 10.1177/0333102410361403; JENSEN TS, 1982, ACTA NEUROL SCAND, V65, P182; Jensen TS, 2000, HEADACHES, P781; John S, 2016, CEPHALALGIA, V36, P387, DOI 10.1177/0333102415591507; JONES HR, 1989, BRAIN, V112, P1295; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1857, DOI 10.1212/01.WNL.0000127310.11526.FD; Kaczorowski M, 2002, BRIT MED J, V325, P1445, DOI 10.1136/bmj.325.7378.1445; Kahn EN, 2015, NEUROSURG CLIN N AM, V26, P501, DOI 10.1016/j.nec.2015.06.006; Kalita J, 2011, PAIN MED, V12, P282, DOI 10.1111/j.1526-4637.2010.01046.x; Kalladka M, 2016, OR SURG OR MED OR PA, V122, pE55, DOI 10.1016/j.oooo.2016.05.012; Kallela M, 1999, CEPHALALGIA, V19, P151, DOI 10.1046/j.1468-2982.1999.1903151.x; Kandan SR, 2010, BRIT J NEUROSURG, V24, P441, DOI 10.3109/02688697.2010.487131; Karaali-Savrun F, 2002, SEIZURE-EUR J EPILEP, V11, P67, DOI 10.1053/seiz.2001.0583; Katsarava Z, 2011, CEPHALALGIA, V31, P520, DOI 10.1177/0333102410383590; Katsarava Z, 2001, NEUROLOGY, V57, P1694, DOI 10.1212/WNL.57.9.1694; KAUBE H, 1994, BRIT MED J, V308, P1573, DOI 10.1136/bmj.308.6943.1573d; Kaur A, 2000, NEUROSURGERY, V47, P633; Kelman L, 2004, HEADACHE, V44, P865, DOI 10.1111/j.1526-4610.2004.04168.x; Kennard C, 1991, CLIN NEUROLOGY, P446; Kennedy PG, 1998, NEUROPATHOL APPL NEU, V14, P395; Kennedy PG, 1988, OJM, V86, P533; Kenny TJ, 2001, OTOLARYNG HEAD NECK, V125, P40, DOI 10.1067/mhn.2001.116779; Kernick DP, 2008, BRIT J GEN PRACT, V58, P880, DOI 10.3399/bjgp08X376203; Kertesz DP, 2015, J ECT, V31, P105, DOI 10.1097/YCT.0000000000000179; Killeen A, 2015, J CLIN NEUROSCI, V22, P133, DOI 10.1016/j.jocn.2014.06.008; Kim JG, 2015, CEPHALALGIA, V35, P516, DOI 10.1177/0333102414547135; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kirby S, 2010, CEPHALALGIA, V30, P387, DOI 10.1111/j.1468-2982.2009.02023.x; Kirchmann M, 2006, NEUROLOGY, V66, P880, DOI 10.1212/01.wnl.0000203647.48422.dd; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kirkland KE, 2012, HEADACHE, V52, P455, DOI 10.1111/j.1526-4610.2011.02025.x; Kivelev J, 2010, J NEUROSURG, V112, P140, DOI 10.3171/2009.3.JNS081693; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; KLAPPER J, 1994, HEADACHE, V34, P521, DOI 10.1111/j.1526-4610.1994.hed3409521.x; Klasser GD, 2007, J OROFAC PAIN, V21, P171; KLIMEK A, 1987, CEPHALALGIA, V7, P161, DOI 10.1046/j.1468-2982.1987.0702161.x; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Klopstock T, 1996, NEUROLOGY, V46, P1735, DOI 10.1212/WNL.46.6.1735; Knackstedt H, 2010, CEPHALALGIA, V30, P1468, DOI 10.1177/0333102410368442; Koerbel A, 2005, BRIT J RADIOL, V78, P646, DOI 10.1259/bjr/60601877; Kone L, 2017, CEPHALALGIA, V37, P442, DOI 10.1177/0333102416648654; KOO B, 1993, ANN NEUROL, V34, P25, DOI 10.1002/ana.410340107; Koopman JSHA, 2009, PAIN, V147, P122, DOI 10.1016/j.pain.2009.08.023; Kraemer M, 2017, CEPHALALGIA, V37, P496, DOI 10.1177/0333102416643516; Kreiner M, 1996, J CRANIO MAXILL SURG, V24, P289, DOI 10.1016/S1010-5182(96)80061-8; Kristiansen HA, 2012, CEPHALALGIA, V32, P451, DOI 10.1177/0333102411431900; Kristiansen HA, 2011, J HEADACHE PAIN, V12, P63, DOI 10.1007/s10194-010-0265-5; Kristoffersen ES, 2016, J NEUROL, V263, P344, DOI 10.1007/s00415-015-7975-1; Kristoffersen ES, 2015, J NEUROL NEUROSUR PS, V86, P505, DOI 10.1136/jnnp-2014-308548; Kruszewski P, 2000, J HYPERTENS, V18, P437, DOI 10.1097/00004872-200018040-00013; Kruuse C, 2003, BRAIN, V126, P241, DOI 10.1093/brain/awg009; Kruuse C, 2002, J CEREBR BLOOD F MET, V22, P1124, DOI 10.1097/00004647-200209000-00010; Kruuse C, 2000, J CEREBR BLOOD F MET, V20, P1372, DOI 10.1097/00004647-200009000-00012; Krymchantowski AV, 2010, CURR PAIN HEADACHE R, V14, P321, DOI 10.1007/s11916-010-0122-x; KUDROW DB, 1989, HEADACHE, V29, P280, DOI 10.1111/j.1526-4610.1989.hed2905280.x; Kudrow L, 1980, CLUSTER HEADACHE MEC; KULALI A, 1990, ACTA NEUROCHIR, V107, P140, DOI 10.1007/BF01405793; KUMAR KL, 1993, J GEN INTERN MED, V8, P333, DOI 10.1007/BF02600150; Kumar R, 1997, J NEUROL NEUROSUR PS, V62, P649, DOI 10.1136/jnnp.62.6.649; Kung E, 2009, CEPHALALGIA, V29, P17, DOI 10.1111/j.1468-2982.2008.01647.x; Kunkle E. Charles, 1942, BULL NEW YORK ACAD MED, V18, P400; Kurtuncu M, 2013, CEPHALALGIA, V33, P123, DOI 10.1177/0333102412463494; Kwan P, 2008, EPILEPSIA, V49, P1099, DOI 10.1111/j.1528-1167.2008.01574.x; La Mantia L, 2006, CEPHALALGIA, V26, P772, DOI 10.1111/j.1468-2982.2006.01115.x; Leal PRL, 2014, J NEUROSURG, V120, P1484, DOI 10.3171/2014.2.JNS131288; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lake AE, 2005, HEADACHE, V45, P493, DOI 10.1111/j.1526-4610.2005.05101.x; Lake AE, 2001, MED CLIN N AM, V85, P1055, DOI 10.1016/S0025-7125(05)70359-X; Lam DK, 2001, J OROFAC PAIN, V15, P146; Lam S, 2015, J PEDIATR NEUROSCI, V10, P321, DOI 10.4103/1817-1745.174443; LANCE JW, 1976, J NEUROL NEUROSUR PS, V39, P1226, DOI 10.1136/jnnp.39.12.1226; LANCE JW, 1980, J NEUROL NEUROSUR PS, V43, P97, DOI 10.1136/jnnp.43.2.97; Lance JW, 1998, HEADACHE, V38, P315, DOI 10.1046/j.1526-4610.1998.3804315.x; Lance JW, 2001, CEPHALALGIA, V21, P84, DOI 10.1046/j.1468-2982.2001.00160.x; LANCE JW, 1976, ARCH NEUROL-CHICAGO, V33, P281, DOI 10.1001/archneur.1976.00500040065011; Landtblom AM, 2002, CEPHALALGIA, V22, P354, DOI 10.1046/j.1468-2982.2002.00368.x; Lanfranconi S, 2009, J NEUROL SCI, V285, P227, DOI 10.1016/j.jns.2009.06.009; LANGEMARK M, 1993, ARCH NEUROL-CHICAGO, V50, P1061, DOI 10.1001/archneur.1993.00540100056015; LANGEMARK M, 1989, PAIN, V38, P203, DOI 10.1016/0304-3959(89)90239-X; LANGEMARK M, 1987, CEPHALALGIA, V7, P249, DOI 10.1046/j.1468-2982.1987.0704249.x; Langridge B, 2017, WORLD NEUROSURG, V104, P213, DOI 10.1016/j.wneu.2017.04.082; Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9; LASKA EM, 1984, JAMA-J AM MED ASSOC, V251, P1711, DOI 10.1001/jama.251.13.1711; LASSEN LH, 1995, NEUROREPORT, V6, P1475, DOI 10.1097/00001756-199507310-00003; Laurell K, 2011, EUR J NEUROL, V18, P1220, DOI 10.1111/j.1468-1331.2011.03364.x; Lauria G, 2005, PAIN, V115, P332, DOI 10.1016/j.pain.2005.03.028; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lawrence John E, 2015, Psychiatr Danub, V27 Suppl 1, pS315; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lebedeva ER, 2018, CEPHALALGIA, V38, P561, DOI 10.1177/0333102417702121; Lee AG, 1999, J AM GERIATR SOC, V47, P1364, DOI 10.1111/j.1532-5415.1999.tb07442.x; Lee A, 2014, J NEUROSURG, V120, P1048, DOI 10.3171/2014.1.JNS131410; Lee CC, 2000, AM J EMERG MED, V18, P328, DOI 10.1016/S0735-6757(00)90130-X; Lee MJ, 2016, J HEADACHE PAIN, V17, DOI [10.1186/s10194-016-0662-5, 10.1186/s10194-016-0615-z]; LEFKOWITZ D, 1982, ARCH NEUROL-CHICAGO, V39, P130, DOI 10.1001/archneur.1982.00510140064019; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Leistad RB, 2006, CEPHALALGIA, V26, P64, DOI 10.1111/j.1468-2982.2005.00997.x; Leker RR, 1999, EUR J NEUROL, V6, P601, DOI 10.1046/j.1468-1331.1999.650601.x; Leligdowicz A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1325-2; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Lempert T, 2009, ANN NY ACAD SCI, V1164, P242, DOI 10.1111/j.1749-6632.2009.03852.x; Lenaerts M, 2015, CEPHALALGIA, V35, P143; Lenaerts ME, 2008, CEPHALALGIA, V28, P12, DOI 10.1111/j.1468-2982.2008.01608.x; Lenck S, 2017, NEUROSURGERY, V80, P393, DOI 10.1227/NEU.0000000000001261; Leniger T, 2001, EPILEPSIA, V42, P1176, DOI 10.1046/j.1528-1157.2001.37500.x; Leo L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002129; LEON AS, 1989, ARCH INTERN MED, V149, P2318, DOI 10.1001/archinte.149.10.2318; Leone M, 2000, NEUROLOGY, V55, P136, DOI 10.1212/WNL.55.1.136; Leone M, 1998, PAIN, V78, P1, DOI 10.1016/S0304-3959(98)00116-X; LEONE M, 1995, HEADACHE, V35, P461, DOI 10.1111/j.1526-4610.1995.hed3508461.x; Leotta N, 2005, J PAEDIATR CHILD H, V41, P508, DOI 10.1111/j.1440-1754.2005.00693.x; Levine HL, 2000, ARCH OTOLARYNGOL, V126, P234; LEVITON A, 1975, HEADACHE, V15, P207, DOI 10.1111/j.1526-4610.1975.hed1503207.x; Levy MJ, 2005, BRAIN, V128, P1921, DOI 10.1093/brain/awh525; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lewis DW, 2003, HEADACHE, V43, P132, DOI 10.1046/j.1526-4610.2003.03032.x; Lewis J, 1998, HEADACHE, V38, P684, DOI 10.1046/j.1526-4610.1998.3809684.x; Li B U, 2001, Semin Pediatr Neurol, V8, P13, DOI 10.1053/spen.2001.23456; Li BUK, 2008, J PEDIATR GASTR NUTR, V47, P379, DOI 10.1097/MPG.0b013e318173ed39; Li D, 2002, CEPHALALGIA, V22, P66, DOI 10.1046/j.1468-2982.2002.00326.x; Li D, 2015, CEPHALALGIA, V35, P748, DOI 10.1177/0333102414559731; Liang JF, 2008, CEPHALALGIA, V28, P209, DOI 10.1111/j.1468-2982.2007.01496.x; Liang JF, 2014, CEPHALALGIA, V34, P795, DOI 10.1177/0333102414537914; Lichten EM, 1996, HEADACHE, V36, P367, DOI 10.1046/j.1526-4610.1996.3606367.x; LIE JT, 1992, HUM PATHOL, V23, P164, DOI 10.1016/0046-8177(92)90238-X; Liesegang TJ, 2008, OPHTHALMOLOGY, V115, pS3, DOI 10.1016/j.ophtha.2007.10.009; Limmroth V, 1999, LANCET, V353, P378, DOI 10.1016/S0140-6736(05)74950-3; Limmroth V, 2002, NEUROLOGY, V59, P1011, DOI 10.1212/WNL.59.7.1011; Linde M, 2017, EUR J NEUROL, V24, P1055, DOI 10.1111/ene.13334; Lindelof K, 2010, CEPHALALGIA, V30, P860, DOI 10.1177/0333102409354783; Lindelof K, 2009, CLIN NEUROPHYSIOL, V120, P1364, DOI 10.1016/j.clinph.2009.04.013; Linn FHH, 2002, NEUROLOGIST, V8, P279, DOI 10.1097/00127893-200209000-00001; LINN FHH, 1994, LANCET, V344, P590, DOI 10.1016/S0140-6736(94)91970-4; Linn FHH, 1998, J NEUROL NEUROSUR PS, V65, P791, DOI 10.1136/jnnp.65.5.791; Linn FHH, 1999, J NEUROL, V246, P946, DOI 10.1007/s004150050488; Lipton RB, 2004, NEUROLOGY, V63, P427, DOI 10.1212/01.WNL.0000133301.66364.9B; LIPTON RB, 1989, HEADACHE, V29, P225, DOI 10.1111/j.1526-4610.1989.hed22904225.x; Lipton RB, 1997, HEADACHE, V37, P392, DOI 10.1046/j.1526-4610.1997.3706392.x; Lipton RB, 1997, NEUROLOGY, V49, P813, DOI 10.1212/WNL.49.3.813; Lisotto C, 2004, CEPHALALGIA, V24, P1001, DOI 10.1111/j.1468-2982.2004.00784.x; List T, 2001, J OROFAC PAIN, V15, P218; List T, 2008, PAIN, V139, P333, DOI 10.1016/j.pain.2008.05.002; LIU GT, 1995, NEUROLOGY, V45, P664, DOI 10.1212/WNL.45.4.664; Loh KC, 1997, QJM-MON J ASSOC PHYS, V90, P51; Loh NK, 1999, ARCH INTERN MED, V159, P1765, DOI 10.1001/archinte.159.15.1765; LORD SM, 1994, J NEUROL NEUROSUR PS, V57, P1187, DOI 10.1136/jnnp.57.10.1187; Lord SM, 1996, J MUSCULOSKELET PAIN, V4, P81; Lowry JK, 1998, ARCH NEUROL-CHICAGO, V55, P922, DOI 10.1001/archneur.55.7.922; Lu SR, 2004, NEUROLOGY, V62, P1414, DOI 10.1212/01.WNL.0000120669.85649.77; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lucchesi LM, 2010, CEPHALALGIA, V30, P1477, DOI 10.1177/0333102410368440; LUDA E, 1991, HEADACHE, V31, P582, DOI 10.1111/j.1526-4610.1991.hed3109582.x; LUNDBERG PO, 1988, FRONT GYN E, P149; Lundqvist C, 2012, PAIN, V153, P682, DOI 10.1016/j.pain.2011.12.008; Lyngberg AC, 2005, EUR J EPIDEMIOL, V20, P243, DOI 10.1007/s10654-004-6519-2; Maarbjerg S, 2015, BRAIN, V138, P311, DOI 10.1093/brain/awu349; MacGowan DJL, 1997, NEUROLOGY, V49, P120, DOI 10.1212/WNL.49.1.120; MacGregor EA, 1998, BRIT J FAM PLAN, V24, P53; Mack KJ, 2009, CURR PAIN HEADACHE R, V13, P47, DOI 10.1007/s11916-009-0010-4; Mack KJ, 2004, PEDIATR NEUROL, V31, P122, DOI 10.1016/j.pediatrneurol.2004.02.006; Maggioni F, 2008, HEADACHE, V48, P1129, DOI 10.1111/j.1526-4610.2008.01091.x; Magnusson T, 2000, J OROFAC PAIN, V14, P310; MAGOS AL, 1986, BRIT J OBSTET GYNAEC, V93, P1290, DOI 10.1111/j.1471-0528.1986.tb07868.x; Mainardi F, 2012, CEPHALALGIA, V32, P592, DOI 10.1177/0333102412441720; Mainardi F, 2018, CEPHALALGIA, V38, P1119, DOI 10.1177/0333102417724154; Maizels M, 2004, HEADACHE, V44, P983, DOI 10.1111/j.1526-4610.2004.04192.x; Malek AM, 1998, NEUROIMAG CLIN N AM, V8, P445; MALOUF R, 1985, ANN NEUROL, V17, P421, DOI 10.1002/ana.410170502; Mannelli M, 1999, EUR J ENDOCRINOL, V141, P619, DOI 10.1530/eje.0.1410619; MANZONI GC, 1991, CEPHALALGIA, V11, P169, DOI 10.1046/j.1468-2982.1991.1104169.x; MANZONI GC, 1983, CEPHALALGIA, V3, P21, DOI 10.1046/j.1468-2982.1983.0301021.x; Manzoni GC, 1998, CEPHALALGIA, V18, P138, DOI 10.1046/j.1468-2982.1998.1803138.x; Manzoni GC, 2011, J HEADACHE PAIN, V12, P585, DOI 10.1007/s10194-011-0393-6; Marazziti D, 1999, INT CLIN PSYCHOPHARM, V14, P247, DOI 10.1097/00004850-199907000-00007; Marchioni E, 2006, CEPHALALGIA, V26, P1427, DOI 10.1111/j.1468-2982.2006.01213.x; MARKS DA, 1993, NEUROLOGY, V43, P2476, DOI 10.1212/WNL.43.12.2476; MARKUS HS, 1991, J NEUROL NEUROSUR PS, V54, P1117, DOI 10.1136/jnnp.54.12.1117; Martelletti Paolo, 2005, J Headache Pain, V6, P261, DOI 10.1007/s10194-005-0202-1; Martin TJ, 2001, WOLFFS HEADACHE OTHE, P459; Martinez-Salio A, 2000, HEADACHE, V40, P682, DOI 10.1046/j.1526-4610.2000.040008682.x; MARTINS IP, 1993, HEADACHE, V33, P227, DOI 10.1111/j.1526-4610.1993.hed3305227.x; MARTINS IP, 1995, HEADACHE, V35, P107, DOI 10.1111/j.1526-4610.1995.hed3502107.x; Martsen BH, 1990, J NEUROL NEUROSUR PS, V53, P1029; MAS JL, 1986, STROKE, V17, P1019, DOI 10.1161/01.STR.17.5.1019; Matharu MS, 2001, NEUROLOGY, V56, P273, DOI 10.1212/WNL.56.2.273; Mathew NT, 2006, CURR NEUROL NEUROSCI, V6, P100, DOI 10.1007/s11910-996-0031-x; MATHEW NT, 1987, HEADACHE, V27, P102, DOI 10.1111/j.1526-4610.1987.hed2702102.x; Mathias CJ, 1999, J NEUROL, V246, P893, DOI 10.1007/s004150050479; Mattsson P, 2001, CEPHALALGIA, V21, P230, DOI 10.1046/j.1468-2982.2001.00211.x; Maurino J, 2001, ARCH NEUROL-CHICAGO, V58, P629, DOI 10.1001/archneur.58.4.629; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; May A, 1999, J CEREBR BLOOD F MET, V19, P115, DOI 10.1097/00004647-199902000-00001; MAYBERG MR, 1994, STROKE, V25, P2315, DOI 10.1161/01.STR.25.11.2315; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCabe DJH, 1999, STROKE, V30, P2483, DOI 10.1161/01.STR.30.11.2483; McCluskey PJ, 1999, OPHTHALMOLOGY, V106, P2380, DOI 10.1016/S0161-6420(99)90543-2; McCrory P, 1997, PHYSICIAN SPORTSMED, V25, P33, DOI 10.3810/psm.1997.02.1133; MCFADZEAN RM, 1991, NEUROSURGERY, V29, P669, DOI 10.1227/00006123-199111000-00005; MCINTYRE PB, 1991, MED J AUSTRALIA, V154, P653, DOI 10.5694/j.1326-5377.1991.tb121250.x; Mea E, 2009, CEPHALALGIA, V29, P418, DOI 10.1111/j.1468-2982.2008.01747.x; Mea E, 2011, NEUROL SCI, V32, P291, DOI 10.1007/s10072-011-0698-x; Meineri P, 2004, NEUROL SCI, V25, pS281, DOI 10.1007/s10072-004-0310-8; Melo TP, 1996, NEUROLOGY, V47, P494, DOI 10.1212/WNL.47.2.494; MENDEZ MF, 1993, J NEUROPSYCH CLIN N, V5, P283; Merlino G, 2007, HEADACHE, V47, P919, DOI 10.1111/j.1526-4610.2007.00829.x; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; Mills RJ, 2010, BRIT J RADIOL, V83, P493, DOI 10.1259/bjr/65228893; Minagar A, 2000, NEUROLOGY, V54, P1368, DOI 10.1212/WNL.54.6.1368; Mirsattari SM, 1999, HEADACHE, V39, P3, DOI 10.1046/j.1526-4610.1999.3901003.x; Missori P, 2000, ACTA NEUROCHIR, V142, P697, DOI 10.1007/s007010070115; Mitsikostas DD, 2008, CEPHALALGIA, V28, P139, DOI 10.1111/j.1468-2982.2007.01473.x; Mitsikostas DD, 1999, CEPHALALGIA, V19, P211, DOI 10.1046/j.1468-2982.1999.019004211.x; Molina OF, 2000, CRANIO, V18, P205, DOI 10.1080/08869634.2000.11746134; Monzillo PH, 2000, ARQ NEURO-PSIQUIAT, V58, P518, DOI 10.1590/S0004-282X2000000300019; Moon J, 2010, CEPHALALGIA, V30, P1527, DOI 10.1177/0333102410368445; Moore PM, 1994, SEMIN NEUROL, V14, P313; MORALES F, 1994, CEPHALALGIA, V14, P301, DOI 10.1046/j.1468-2982.1994.1404301.x; Moreau T, 1998, CEPHALALGIA, V18, P687, DOI 10.1046/j.1468-2982.1998.1810687.x; Moris G, 2014, JAMA INTERN MED, V174, P1511, DOI 10.1001/jamainternmed.2014.2918; Mork H, 2004, CEPHALALGIA, V24, P466, DOI 10.1111/j.1468-2982.2004.00709.x; Mork H, 2003, EUR J NEUROL, V10, P249, DOI 10.1046/j.1468-1331.2003.00570.x; Morrison DG, 2003, OPHTHALMOLOGY, V110, P115, DOI 10.1016/S0161-6420(02)01444-6; MORRISON DP, 1990, CEPHALALGIA, V10, P273, DOI 10.1046/j.1468-2982.1990.1006273.x; Mortimer AM, 2013, CLIN RADIOL, V68, pE101, DOI 10.1016/j.crad.2012.08.032; MOSEK A, 1995, NEUROLOGY, V45, P1953, DOI 10.1212/WNL.45.11.1953; Mueller D, 2011, CEPHALALGIA, V31, P1542, DOI 10.1177/0333102411424619; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P318, DOI 10.1136/ard.2008.088351; Mulero P, 2011, J HEADACHE PAIN, V12, P535, DOI 10.1007/s10194-011-0353-1; Mulleners WM, 1996, NEUROLOGY, V47, P302, DOI 10.1212/WNL.47.1.302; MUNARI LM, 1994, CEPHALALGIA, V14, P127, DOI 10.1046/j.1468-2982.1994.1402127.x; MURPHREE HB, 1967, FED PROC, V26, P1468; Murphy E, 2001, J Ir Dent Assoc, V47, P46; Mutton Kenneth, 2011, Infectious Disorders - Drug Targets, V11, P206; Nakatomi H, 1997, STROKE, V28, P1278, DOI 10.1161/01.STR.28.6.1278; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nappi RE, 2001, MATURITAS, V38, P157, DOI 10.1016/S0378-5122(00)00215-2; Natoli JL, 2010, CEPHALALGIA, V30, P599, DOI 10.1111/j.1468-2982.2009.01941.x; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Neff BA, 2012, OTOL NEUROTOL, V33, P1235, DOI 10.1097/MAO.0b013e31825d644a; Nesher R, 2014, ACTA NEUROL BELG, V114, P269, DOI 10.1007/s13760-014-0290-2; Nestoriuc Y, 2008, J CONSULT CLIN PSYCH, V76, P379, DOI 10.1037/0022-006X.76.3.379; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; Neuhauser HK, 2006, NEUROLOGY, V67, P1028, DOI 10.1212/01.wnl.0000237539.09942.06; NEWMAN DS, 1989, HEADACHE, V29, P82, DOI 10.1111/j.1526-4610.1989.hed2902082.x; NEWMAN LC, 1990, NEUROLOGY, V40, P1904, DOI 10.1212/WNL.40.12.1904-a; NEWMAN LC, 1994, NEUROLOGY, V44, P2111, DOI 10.1212/WNL.44.11.2111; NICHOLS FT, 1990, STROKE, V21, P555, DOI 10.1161/01.STR.21.4.555; NICHOLS FT, 1993, HEADACHE, V33, P87, DOI 10.1111/j.1526-4610.1993.hed3302087.x; Nicholson RA, 2010, CURR PAIN HEADACHE R, V14, P47, DOI 10.1007/s11916-009-0087-9; Nicolodi M, 1997, INT J CLIN PHARM RES, V17, P79; Nomura Motohiro, 2016, J Clin Med Res, V8, P342, DOI 10.14740/jocmr2489w; Norval DA, 2004, SAMJ S AFR MED J, V94, P450; Nowak DA, 2003, CEPHALALGIA, V23, P218, DOI 10.1046/j.1468-2982.2003.00507.x; O'Connor AB, 2008, PAIN, V137, P96, DOI 10.1016/j.pain.2007.08.024; Obelieniene D, 1999, J NEUROL NEUROSUR PS, V66, P279, DOI 10.1136/jnnp.66.3.279; Obermann M, 2007, NEUROLOGY, V69, P835, DOI 10.1212/01.wnl.0000269670.30045.6b; Obermann M, 2007, CEPHALALGIA, V27, P504, DOI 10.1111/j.1468-2982.2007.01316.x; Obermann M, 2010, CEPHALALGIA, V30, P528, DOI 10.1111/j.1468-2982.2009.01972.x; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Obermann M, 2011, CURR PAIN HEADACHE R, V15, P314, DOI 10.1007/s11916-011-0193-3; Obermann M, 2009, EXPERT REV NEUROTHER, V9, P1361, DOI [10.1586/ern.09.84, 10.1586/ERN.09.84]; Odabasi Z, 1997, CLIN NEUROL NEUROSUR, V99, P151, DOI 10.1016/S0303-8467(97)00013-9; Ogawa K, 2010, ACTA NEUROL BELG, V110, P190; OGUS H, 1978, J ROY SOC MED, V71, P748, DOI 10.1177/014107687807101009; Oh AK, 2001, AM J MED GENET, V100, P287, DOI 10.1002/ajmg.1294; Ojaimi J, 1998, CEREBROVASC DIS, V8, P102, DOI 10.1159/000015826; Oldenburg MS, 2015, OTOL NEUROTOL, V36, P1735, DOI 10.1097/MAO.0000000000000891; OLESEN J, 1990, ANN NEUROL, V28, P791, DOI 10.1002/ana.410280610; OLESEN J, 1993, BRAIN, V116, P187, DOI 10.1093/brain/116.1.187; OLESEN J, 1991, PAIN, V46, P125, DOI 10.1016/0304-3959(91)90066-7; Olesen J, 2014, CEPHALALGIA, V34, P1193, DOI 10.1177/0333102414534327; ONEILL B, 1972, AM J PUBLIC HEALTH N, V62, P399, DOI 10.2105/AJPH.62.3.399; Onishi A, 2012, J CLIN MICROBIOL, V50, P7, DOI 10.1128/JCM.05267-11; ORRELL RW, 1994, J NEUROL NEUROSUR PS, V57, P348, DOI 10.1136/jnnp.57.3.348; Osterberg A, 2005, EUR J PAIN, V9, P531, DOI 10.1016/j.ejpain.2004.11.005; Osterberg A, 2010, EUR J PAIN, V14, P104, DOI 10.1016/j.ejpain.2009.03.003; Ostergard JR, 2000, HEADACHES, P789; Ozge Aynur, 2006, J Headache Pain, V7, P37, DOI 10.1007/s10194-006-0264-8; Ozge C, 2005, EUR J PAIN, V9, P383, DOI 10.1016/j.ejpain.2004.09.007; PACHNER AR, 1985, NEUROLOGY, V35, P47, DOI 10.1212/WNL.35.1.47; PACHNER AR, 1984, YALE J BIOL MED, V57, P481; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; Packard Russell C, 2005, Curr Pain Headache Rep, V9, P59, DOI 10.1007/s11916-005-0076-6; Pakalnis A, 2001, J CHILD NEUROL, V16, P731, DOI 10.1177/088307380101601005; Pareja JA, 2008, CEPHALALGIA, V28, P257, DOI 10.1111/j.1468-2982.2007.01515.x; Pareja JA, 2008, CEPHALALGIA, V28, P186, DOI 10.1111/j.1468-2982.2007.01490.x; Pareja JA, 2005, CEPHALALGIA, V25, P305, DOI 10.1111/j.1468-2982.2004.00864.x; Pareja JA, 2004, HEADACHE, V44, P611, DOI 10.1111/j.1526-4610.2004.446011.x; Pareja JA, 2002, NEUROLOGY, V58, P1678, DOI 10.1212/WNL.58.11.1678; Pareja JA, 1996, CEPHALALGIA, V16, P93, DOI 10.1046/j.1468-2982.1996.1602093.x; Pareja JA, 2012, CURR NEUROL NEUROSCI, V12, P118, DOI 10.1007/s11910-011-0247-2; Pareja JA, 2012, J HEADACHE PAIN, V13, P175, DOI 10.1007/s10194-011-0407-4; Parisi P, 2012, CEPHALALGIA, V32, P723, DOI 10.1177/0333102412447536; Parisi P, 2010, EPILEPSIA, V51, P932, DOI 10.1111/j.1528-1167.2009.02407.x; Parissis D, 2011, HEADACHE, V51, P1285, DOI 10.1111/j.1526-4610.2011.01884.x; Pascual J, 1996, NEUROLOGY, V46, P1520, DOI 10.1212/WNL.46.6.1520; PASCUAL J, 1993, CEPHALALGIA, V13, P205, DOI 10.1046/j.1468-2982.1993.1303205.x; Pascual J, 2008, J HEADACHE PAIN, V9, P259, DOI 10.1007/s10194-008-0063-5; Pascual Julio, 2005, Curr Pain Headache Rep, V9, P272, DOI 10.1007/s11916-005-0036-1; Pascual-Castroviejo I, 2008, CAN J NEUROL SCI, V35, P301, DOI 10.1017/S0317167100008878; Patel A, 2002, NEUROSURGERY, V50, P705, DOI 10.1097/00006123-200204000-00004; Paterson R W, 2013, Cerebrovasc Dis Extra, V3, P81, DOI 10.1159/000347114; Patil SA, 2012, J IMMUNOASS IMMUNOCH, V33, P140, DOI 10.1080/15321819.2011.606862; Patton LL, 2007, ORAL SURG ORAL MED O, V103, P1; PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409; PEARCE J, 1971, J NEUROL NEUROSUR PS, V34, P154, DOI 10.1136/jnnp.34.2.154; Pearce JMS, 1996, J NEUROL NEUROSUR PS, V61, P324, DOI 10.1136/jnnp.61.3.324; Peet MM, 1935, ANN SURG, V101, P256, DOI 10.1097/00000658-193501000-00026; Peng KP, 2011, CEPHALALGIA, V31, P1561, DOI 10.1177/0333102411424620; Pepe G, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-16; Perenboom M, 2015, CEPHALALGIA, V35, P1224; Peres MFP, 2011, CEPHALALGIA, V31, P250, DOI 10.1177/0333102410383588; Peres MFP, 2006, EXPERT OPIN INV DRUG, V15, P367, DOI 10.1517/13543784.15.4.367; Perini F, 1998, CEPHALALGIA, V18, P493, DOI 10.1046/j.1468-2982.1998.1807493.x; Perucca P, 2010, NEUROLOGY, V75, P373, DOI 10.1212/WNL.0b013e3181ea1612; PESTRONK A, 1983, NEW ENGL J MED, V308, P226; PFAFFENRATH V, 1993, CEPHALALGIA, V13, P84, DOI 10.1177/0333102493013S1218; Pfund Z, 1999, CEPHALALGIA, V19, P787, DOI 10.1046/j.1468-2982.1999.1909787.x; Phuong HL, 2004, J CLIN NEUROSCI, V11, P758, DOI 10.1016/j.jocn.2003.07.013; Pielsticker A, 2005, PAIN, V118, P215, DOI 10.1016/j.pain.2005.08.019; Pinto A, 2001, ORAL SURG ORAL MED O, V92, P180, DOI 10.1067/moe.2001.114006; Planche V, 2014, CEPHALALGIA, V34, P73, DOI 10.1177/0333102413505237; Poceta JS, 1995, HEADACHE, V35, P586, DOI 10.1111/j.1526-4610.1995.hed3510586.x; Polycarpou N, 2005, INT ENDOD J, V38, P169, DOI 10.1111/j.1365-2591.2004.00923.x; PONEPRASERT B, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P599; Porcelli M. Jay, 1995, Journal of the American Osteopathic Association, V95, P718; PORTENOY RK, 1984, STROKE, V15, P1009, DOI 10.1161/01.STR.15.6.1009; Poulikakos P J, 2010, J Infect Public Health, V3, P192, DOI 10.1016/j.jiph.2010.09.006; Prakash S, 2010, J HEADACHE PAIN, V11, P59, DOI 10.1007/s10194-009-0171-x; Prandota Joseph, 2007, Am J Ther, V14, P63, DOI 10.1097/01.mjt.0000208272.42379.aa; Pulec Jack L, 2002, Ear Nose Throat J, V81, P30; Putzki N, 2009, EUR J NEUROL, V16, P262, DOI 10.1111/j.1468-1331.2008.02406.x; Queiroz LP, 2011, CEPHALALGIA, V31, P1652, DOI 10.1177/0333102411430263; Queral-Godoy E, 2006, J ORAL MAXIL SURG, V64, P402, DOI 10.1016/j.joms.2005.11.010; Radat F, 2005, CEPHALALGIA, V25, P165, DOI 10.1111/j.1468-2982.2004.00839.x; Radat F, 1999, HEADACHE, V39, P477, DOI 10.1046/j.1526-4610.1999.3907477.x; Radat F, 2000, REV NEUROL-FRANCE, V156, P62; Radat F, 2011, HEADACHE, V51, P789, DOI 10.1111/j.1526-4610.2011.01883.x; Radtke A, 2011, CEPHALALGIA, V31, P906, DOI 10.1177/0333102411405228; Rains JC, 2001, CEPHALALGIA, V21, P584, DOI 10.1046/j.1468-2982.2001.00210.x; RAMADAN NM, 1995, HEADACHE, V35, P21, DOI 10.1111/j.1526-4610.1995.hed3501021.x; RAMADAN NM, 1991, NEUROLOGY, V41, P1084, DOI 10.1212/WNL.41.7.1084; RamirezLassepas M, 1997, ARCH NEUROL-CHICAGO, V54, P1506, DOI 10.1001/archneur.1997.00550240058013; Rapoport A, 1996, HEADACHE, V36, P14, DOI 10.1046/j.1526-4610.1996.3601014.x; RAPS EC, 1993, ARCH NEUROL-CHICAGO, V50, P265, DOI 10.1001/archneur.1993.00540030031010; Rashed H, 1999, DIGEST DIS SCI, V44, p74S; RASKIN NH, 1988, HEADACHE, V28, P534, DOI 10.1111/j.1526-4610.1988.hed2808534.x; RASKIN NH, 1995, NEUROLOGY, V45, P1784, DOI 10.1212/WNL.45.9.1784; RASKIN NH, 1990, HEADACHE, V30, P550, DOI 10.1111/j.1526-4610.1990.hed30s2550.x; RASKIN NH, 1976, HEADACHE, V16, P222, DOI 10.1111/j.1526-4610.1976.hed1605222.x; RASKIN NH, 1980, NEUROLOGY, V30, P203, DOI 10.1212/WNL.30.2.203; RASMUSSEN BK, 1991, CEPHALALGIA, V11, P129, DOI 10.1046/j.1468-2982.1991.1103129.x; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; RASMUSSEN BK, 1992, CEPHALALGIA, V12, P221, DOI 10.1046/j.1468-2982.1992.1204221.x; RASMUSSEN P, 1991, ACTA NEUROCHIR, V108, P100, DOI 10.1007/BF01418516; RASMUSSEN P, 1991, ACTA NEUROCHIR, V108, P53, DOI 10.1007/BF01407667; RASMUSSEN P, 1990, ACTA NEUROCHIR, V107, P121, DOI 10.1007/BF01405790; Ravnik J, 2014, BOSNIAN J BASIC MED, V14, P132, DOI 10.17305/bjbms.2014.3.38; Raza-Knight S, 2017, ARCH DIS CHILD, V102, P238, DOI 10.1136/archdischild-2016-310662; Reinstein E, 2013, EUR J HUM GENET, V21, P386, DOI 10.1038/ejhg.2012.191; Relja G, 2005, CEPHALALGIA, V25, P56, DOI 10.1111/j.1468-2982.2004.00808.x; Renton T, 2011, J OROFAC PAIN, V25, P333; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Richter M, 2000, EUR SPINE J, V9, P109, DOI 10.1007/s005860050220; Rico M, 2014, HEADACHE, V54, P545, DOI 10.1111/head.12197; Riederer F, 2010, J HEADACHE PAIN, V11, P335, DOI 10.1007/s10194-010-0207-2; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rinaldi R, 1997, HEADACHE, V37, P443, DOI 10.1046/j.1526-4610.1997.3707443.x; Robbins MS, 2010, NEUROLOGY, V74, P1358, DOI 10.1212/WNL.0b013e3181dad5de; ROBINSON JR, 1991, J NEUROSURG, V75, P709, DOI 10.3171/jns.1991.75.5.0709; Rocha PAS, 2010, CEPHALALGIA, V30, P509, DOI 10.1111/j.1468-2982.2009.01992.x; Rocha PAS, 2008, CEPHALALGIA, V28, P41, DOI 10.1111/j.1468-2982.2007.01465.x; Rocha-Filho PAS, 2010, CEPHALALGIA, V30, P560, DOI 10.1111/j.1468-2982.2009.02010.x; Rogawski MA, 2008, ARCH NEUROL-CHICAGO, V65, P709, DOI 10.1001/archneur.65.6.709; Romberg MH, 1840, LEHRBUCH NERVENKRANK; Ronne-Engstrom E, 2015, UPSALA J MED SCI, V120, P59, DOI 10.3109/03009734.2014.988309; Rosenfield K, 2016, NEW ENGL J MED, V374, P1011, DOI 10.1056/NEJMoa1515706; Rosman NP, 2009, J CHILD NEUROL, V24, P155, DOI 10.1177/0883073808322338; ROSSI LN, 1989, CHILD NERV SYST, V5, P307, DOI 10.1007/BF00274519; Rothrock JF, 1997, NEUROLOGY, V48, P261, DOI 10.1212/WNL.48.1.261; ROTHROCK JF, 1988, ARCH NEUROL-CHICAGO, V45, P63, DOI 10.1001/archneur.1988.00520250069023; Rozen TD, 2006, CEPHALALGIA, V26, P1182, DOI 10.1111/j.1468-2982.2006.01187.x; Rozen T, 2007, HEADACHE, V47, P1050, DOI 10.1111/j.1526-4610.2006.00722.x; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Ruscheweyh R, 2010, CEPHALALGIA, V30, P249, DOI 10.1111/j.1468-2982.2009.01893.x; Russell George, 2002, Paediatr Drugs, V4, P1; Russell MB, 1996, EUR J NEUROL, V3, P424, DOI 10.1111/j.1468-1331.1996.tb00243.x; Russell MB, 1996, CEPHALALGIA, V16, P431, DOI 10.1046/j.1468-2982.1996.1606431.x; RUSSELL MB, 1995, J MED GENET, V32, P954, DOI 10.1136/jmg.32.12.954; Russell MB, 2014, CEPHALALGIA, V34, P752, DOI 10.1177/0333102414538551; Saers SJF, 2011, J LARYNGOL OTOL, V125, P520, DOI 10.1017/S0022215110002677; SAGE JI, 1985, NEUROLOGY, V35, P1470, DOI 10.1212/WNL.35.10.1470; Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496; Salhofer-Polanyi S, 2012, HEADACHE, V52, P1236, DOI 10.1111/j.1526-4610.2012.02166.x; Salvarani C, 2007, ANN NEUROL, V62, P442, DOI 10.1002/ana.21226; Saman Y, 2010, J LARYNGOL OTOL, V124, P1305, DOI 10.1017/S0022215110001556; Samanci B, 2016, CEPHALALGIA, V36, P998, DOI 10.1177/0333102415620253; Rocha PAS, 2015, HEADACHE, V55, P733, DOI 10.1111/head.12563; San-Juan OD, 2007, CEPHALALGIA, V27, P456, DOI 10.1111/j.1468-2982.2007.01307.x; Sanahuja J, 2005, CEPHALALGIA, V25, P547, DOI 10.1111/j.1468-2982.2005.00882.x; Sances G, 2009, EPILEPSIA, V50, P2487, DOI 10.1111/j.1528-1167.2009.02265.x; Sandrini G, 2006, CEPHALALGIA, V26, P782, DOI 10.1111/j.1468-2982.2006.01130.x; SANTONI JR, 1993, INTERNAL MED, V32, P530, DOI 10.2169/internalmedicine.32.530; Sardella A, 2009, Minerva Stomatol, V58, P289; Sardella A, 2012, ARCH ORAL BIOL, V57, P94, DOI 10.1016/j.archoralbio.2011.07.007; SARKOZI J, 1984, ARTHRITIS RHEUM, V27, P708, DOI 10.1002/art.1780270618; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Sauerbrei A, 2002, J CLIN VIROL, V25, pS45, DOI 10.1016/S1386-6532(02)00033-1; Savage COS, 2000, BRIT MED J, V320, P1325, DOI 10.1136/bmj.320.7245.1325; Scala A, 2003, CRIT REV ORAL BIOL M, V14, P275, DOI 10.1177/154411130301400405; SCHACHTER SC, 1995, J EPILEPSY, V8, P41, DOI 10.1016/0896-6974(94)00007-M; Schaller B, 2003, OTOLARYNG HEAD NECK, V128, P387, DOI 10.1067/mhn.2003.104; Schankin CJ, 2007, CEPHALALGIA, V27, P904, DOI 10.1111/j.1468-2982.2007.01368.x; Schankin CJ, 2014, HEADACHE, V54, P957, DOI 10.1111/head.12378; Schankin CJ, 2014, BRAIN, V137, P1419, DOI 10.1093/brain/awu050; Scher AI, 1998, HEADACHE, V38, P497, DOI 10.1046/j.1526-4610.1998.3807497.x; Scher AI, 2003, PAIN, V106, P81, DOI 10.1016/S0304-3959(03)00293-8; Scherer A, 2001, ROFO-FORTSCHR RONTG, V173, P315, DOI 10.1055/s-2001-12464; Schievink WI, 2008, AM J NEURORADIOL, V29, P853, DOI 10.3174/ajnr.A0956; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Schievink WI, 2011, HEADACHE, V51, P1442, DOI 10.1111/j.1526-4610.2011.01911.x; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; Schiffman E, 2012, CEPHALALGIA, V32, P683, DOI 10.1177/0333102412446312; SCHIFFMAN SS, 1987, NEW ENGL J MED, V317, P1181, DOI 10.1056/NEJM198711053171903; Schmidt-Hansen PT, 2007, PAIN, V129, P113, DOI 10.1016/j.pain.2006.09.037; Schmidt-Wilcke T, 2005, NEUROLOGY, V65, P1483, DOI 10.1212/01.wnl.0000183067.94400.80; SCHNIDER P, 1994, CEPHALALGIA, V14, P162, DOI 10.1046/j.1468-2982.1994.1402162.x; Schnider P, 1996, CEPHALALGIA, V16, P481, DOI 10.1046/j.1468-2982.1996.1607481.x; SCHOENEN J, 1991, CEPHALALGIA, V11, P135, DOI 10.1046/j.1468-2982.1991.1103135.x; SCHON F, 1987, J NEUROL NEUROSUR PS, V50, P1148, DOI 10.1136/jnnp.50.9.1148; Schoonman GG, 2006, CEPHALALGIA, V26, P1209, DOI 10.1111/j.1468-2982.2006.01195.x; Schoonman GG, 2006, CEPHALALGIA, V26, P816, DOI 10.1111/j.1468-2982.2006.01112.x; Schoser BGH, 1997, J NEUROL, V244, P101, DOI 10.1007/s004150050057; Melo ES, 2017, HEADACHE, V57, P161, DOI 10.1111/head.12875; Stosch RSV, 2008, CEPHALALGIA, V28, P908, DOI 10.1111/j.1468-2982.2008.01633_1.x; Jarosch-von Schweder L, 2011, J ECT, V27, P296, DOI 10.1097/YCT.0b013e31821ff3bd; LUTZ G, 1991, CEPHALALGIA, V11, P353, DOI 10.1177/0333102491011S11189; SCHOENEN J, 1991, PAIN, V47, P145, DOI 10.1016/0304-3959(91)90198-7; Schulz UG, 2009, STROKE, V40, P3740, DOI 10.1161/STROKEAHA.109.558163; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1007/s11916-010-0146-2; Schwedt TJ, 2006, HEADACHE, V46, P520, DOI 10.1111/j.1526-4610.2006.00386_3.x; Schwedt Todd J, 2007, Curr Pain Headache Rep, V11, P56, DOI 10.1007/s11916-007-0023-9; Schwedt TJ, 2006, LANCET NEUROL, V5, P621, DOI 10.1016/S1474-4422(06)70497-5; Schytz HW, 2014, CEPHALALGIA, V34, P712, DOI 10.1177/0333102414520767; Seiden AM, 2001, OTOLARYNG CLIN N AM, V34, P227, DOI 10.1016/S0030-6665(05)70308-X; Selekler HM, 2004, CEPHALALGIA, V24, P293, DOI 10.1111/j.1468-2982.2004.00674.x; Selekler HM, 2004, EUR NEUROL, V51, P6, DOI 10.1159/000074910; Seller EM, 1998, CLIN PHARMACOL THER, V63, P121; SELLICK JA, 1989, J AM OSTEOPATH ASSOC, V89, P806; Seol HJ, 2005, J NEUROSURG, V103, P439, DOI 10.3171/ped.2005.103.5.0439; Serrano-Duenas Marcos, 2007, Expert Rev Neurother, V7, P245, DOI 10.1586/14737175.7.3.245; Service FJ, 1992, CECILS TXB MED, P1310; Seven H, 2005, EUR ARCH OTO-RHINO-L, V262, P847, DOI 10.1007/s00405-004-0903-0; SEYMOUR JJ, 1995, AM J EMERG MED, V13, P43, DOI 10.1016/0735-6757(95)90240-6; SHARIF AA, 1995, NEUROLOGY, V45, P1929, DOI 10.1212/WNL.45.10.1929; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Sheftell FD, 2007, NEUROL SCI, V28, pS203, DOI 10.1007/s10072-007-0777-1; Shin HY, 2013, CLIN NEUROPHYSIOL, V124, P598, DOI 10.1016/j.clinph.2012.08.013; Shin JH, 2007, CEPHALALGIA, V27, P1101, DOI 10.1111/j.1468-2982.2007.01395.x; Shindler KS, 2005, NEUROLOGY, V65, P757, DOI 10.1212/01.wnl.0000174435.37184.c3; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Shoja MM, 2010, CHILD NERV SYST, V26, P373, DOI 10.1007/s00381-009-0965-9; SHUAIB A, 1988, ARCH NEUROL-CHICAGO, V45, P911, DOI 10.1001/archneur.1988.00520320109024; SHUAIB A, 1989, CEPHALALGIA, V9, P59, DOI 10.1046/j.1468-2982.1989.0901059.x; SICUTERI F, 1987, HEADACHE, V27, P180, DOI 10.1111/j.1526-4610.1987.hed2704180.x; Sidman R, 1996, ACAD EMERG MED, V3, P827, DOI 10.1111/j.1553-2712.1996.tb03526.x; Siegel AM, 1999, EPILEPSIA, V40, P845, DOI 10.1111/j.1528-1157.1999.tb00790.x; Silber E, 2003, NEUROLOGY, V60, P1167, DOI 10.1212/01.WNL.0000055876.26737.B9; Silberstein SD, 2004, LANCET, V363, P381, DOI 10.1016/S0140-6736(04)15440-8; Silberstein SD, 1996, NEUROLOGY, V47, P871, DOI 10.1212/WNL.47.4.871; SILBERSTEIN SD, 1994, HEADACHE, V34, P1, DOI 10.1111/j.1526-4610.1994.hed3401001.x; Silberstein SD, 2000, NEUROLOGY, V54, P219, DOI 10.1212/WNL.54.1.219; SILBERT PL, 1991, J NEUROL NEUROSUR PS, V54, P417, DOI 10.1136/jnnp.54.5.417; SILBERT PL, 1995, NEUROLOGY, V45, P1517, DOI 10.1212/WNL.45.8.1517; SILVERMAN K, 1992, NEW ENGL J MED, V327, P1109, DOI 10.1056/NEJM199210153271601; SINGER JI, 1980, J PEDIATR-US, V96, P559, DOI 10.1016/S0022-3476(80)80866-3; Singh RR, 2009, INDIAN J PEDIATR, V76, P1109, DOI 10.1007/s12098-009-0233-8; Singhal AB, 2011, ARCH NEUROL-CHICAGO, V68, P1005, DOI 10.1001/archneurol.2011.68; Sjaastad O, 1997, FUNCT NEUROL, V12, P305; Sjaastad O, 2008, ACTA NEUROL SCAND, V117, P173, DOI 10.1111/j.1600-0404.2007.00962.x; Sjaastad O, 2006, CEPHALALGIA, V26, P233, DOI 10.1111/j.1468-2982.2006.00926.x; Sjaastad O, 2005, CEPHALALGIA, V25, P581, DOI 10.1111/j.1468-2982.2005.00927.x; Sjaastad O, 2003, CEPHALALGIA, V23, P803, DOI 10.1046/j.1468-2982.2003.00588.x; Sjaastad O, 2002, CEPHALALGIA, V22, P784, DOI 10.1046/j.1468-2982.2002.00466.x; SJAASTAD O, 1974, HEADACHE, V14, P105; Sjaastad O, 2002, FUNCT NEUROL, V17, P35; SJAASTAD O, 1989, CEPHALALGIA, V9, P147, DOI 10.1046/j.1468-2982.1989.0902147.x; Sjaastad O, 2001, CEPHALALGIA, V21, P207, DOI 10.1046/j.1468-2982.2001.00189.x; Sjostrand C, 2000, CEPHALALGIA, V20, P653, DOI 10.1046/j.1468-2982.2000.00104.x; SLIVKA A, 1995, HEADACHE, V35, P1, DOI 10.1111/j.1526-4610.1995.hed3501001.x; Sliwka U, 1998, AVIAT SPACE ENVIR MD, V69, P299; Sluder G, 1910, AM J MED SCI, V140, P868, DOI 10.1097/00000441-191012000-00009; Smith JH, 2014, EUR J NEUROL, V21, P577, DOI 10.1111/ene.12312; Smith M, 2002, NEUROLOGY, V58, P1308, DOI 10.1212/WNL.58.8.1308-a; Smitherman TA, 2008, CURR PAIN HEADACHE R, V12, P305, DOI 10.1007/s11916-008-0051-0; SOLOMON S, 1985, CEPHALALGIA, V5, P83, DOI 10.1046/j.1468-2982.1985.0502083.x; SOLOMON S, 1987, J AM GERIATR SOC, V35, P163, DOI 10.1111/j.1532-5415.1987.tb01348.x; Solomon S, 2001, ARCH NEUROL-CHICAGO, V58, P661, DOI 10.1001/archneur.58.4.661; Solomon S, 2009, HEADACHE, V49, P1112, DOI 10.1111/j.1526-4610.2009.01462.x; Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014; SOMERVIL.BW, 1972, NEUROLOGY, V22, P355, DOI 10.1212/WNL.22.4.355; SOMERVILLE BW, 1975, NEUROLOGY, V25, P239, DOI 10.1212/WNL.25.3.239; SOMERVILLE BW, 1975, NEUROLOGY, V25, P245, DOI 10.1212/WNL.25.3.245; SOMERVILLE BW, 1971, NEUROLOGY, V21, P853, DOI 10.1212/WNL.21.8.853; Soriani S, 1996, HEADACHE, V36, P565, DOI 10.1046/j.1526-4610.1996.3609565.x; SPITZER WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Sprenger T, 2010, J CLIN NEUROSCI, V17, P547, DOI 10.1016/j.jocn.2009.09.030; Stam AH, 2016, BRAIN, V139, P2909, DOI 10.1093/brain/aww217; Stewart WF, 2001, CEPHALALGIA, V21, P279; Stovner LJ, 2009, EUR J NEUROL, V16, pE14, DOI 10.1111/j.1468-1331.2008.02359.x; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; STRAUBE A, 1993, HEADACHE, V33, P446, DOI 10.1111/j.1526-4610.1993.hed3308446.x; Sturm JW, 2000, CEPHALALGIA, V20, P132, DOI 10.1046/j.1468-2982.2000.00053.x; STURZENEGGER M, 1994, HEADACHE, V34, P187, DOI 10.1111/j.1526-4610.1994.hed3404187.x; STURZENEGGER MH, 1985, HEADACHE, V25, P408; SUWANWELA N, 1994, HEADACHE, V34, P435, DOI 10.1111/j.1526-4610.1994.hed3407435.x; Suzuki K, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0540-6; SWANSON JW, 1978, NEUROLOGY, V28, P782, DOI 10.1212/WNL.28.8.782; Sweeney CJ, 2001, J NEUROL NEUROSUR PS, V71, P149, DOI 10.1136/jnnp.71.2.149; Syvertsen M, 2007, J HEADACHE PAIN, V8, P224, DOI 10.1007/s10194-007-0398-3; Szatmary Z, 2006, J NEUROL NEUROSUR PS, V77, P693, DOI 10.1136/jnnp.2005.082719; Takagi Kiyoshi, 2013, Acta Neurochir Suppl, V118, P293, DOI 10.1007/978-3-7091-1434-6_57; Takahashi S, 2012, J STROKE CEREBROVASC, V21, P338, DOI 10.1016/j.jstrokecerebrovasdis.2009.12.011; Takase Y, 2004, CEPHALALGIA, V24, P955, DOI 10.1111/j.1468-2982.2004.00771.x; Takeuchi S, 2010, J CLIN NEUROSCI, V17, P153, DOI 10.1016/j.jocn.2009.03.043; Tanaka BS, 2016, MOL MED, V22, P338, DOI 10.2119/molmed.2016.00131; Tanrikulu Levent, 2015, Surg Neurol Int, V6, P189, DOI 10.4103/2152-7806.172534; Tatrow K, 2003, HEADACHE, V43, P755, DOI 10.1046/j.1526-4610.2003.03133.x; ter Berg HWM, 2001, HEADACHE, V41, P326; Terwindt GM, 1998, BRAIN, V121, P303, DOI 10.1093/brain/121.2.303; TFELTHANSEN P, 1981, CEPHALALGIA, V1, P29, DOI 10.1111/j.1468-2982.1981.tb00005.x; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2012, CEPHALALGIA, V32, P589, DOI 10.1177/0333102412445220; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Thibault M, 2007, CAN J ANAESTH, V54, P544, DOI 10.1007/BF03022318; Thielen KR, 1998, MAYO CLIN PROC, V73, P444; Thiessen Paul N, 2002, Pediatr Rev, V23, P39, DOI 10.1542/pir.23-2-39; THOMAS JE, 1966, J AMER MED ASSOC, V197, P754, DOI 10.1001/jama.197.10.754; Thomsen LL, 2007, BRAIN, V130, P346, DOI 10.1093/brain/awl334; Thomsen LL, 2003, NEUROLOGY, V60, P595, DOI 10.1212/01.WNL.0000046524.25369.7D; Thomsen LL, 2002, BRAIN, V125, P1379, DOI 10.1093/brain/awf132; Thomsen LL, 1994, EUR J NEUROL, V1, P71; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tietjen GE, 2000, NEUROEPIDEMIOLOGY, V19, P13, DOI 10.1159/000026233; Toldo I, 2014, HEADACHE, V54, P899, DOI 10.1111/head.12341; TONJUM T, 1983, NIPH (National Institute of Public Health) Annals (Oslo), V6, P175; Tosun F, 2000, HEADACHE, V40, P237, DOI 10.1046/j.1526-4610.2000.00034.x; TROOST BT, 1979, ANN NEUROL, V5, P199, DOI 10.1002/ana.410050216; Troost T, 2000, HEADACHES, P511; Truini A, 2008, PAIN, V140, P405, DOI 10.1016/j.pain.2008.08.018; Truini A, 2016, NEUROLOGY, V86, P2094, DOI 10.1212/WNL.0000000000002720; Truini A, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00105; Tubbs R Shane, 2013, World Neurosurg, V79, P763, DOI 10.1016/j.wneu.2012.03.023; Tuveson B, 2009, PAIN, V143, P84, DOI 10.1016/j.pain.2009.02.002; TYCHSEN L, 1984, OPHTHALMOLOGY, V91, P1075; Tzourio C, 2002, NEUROLOGY, V59, P435, DOI 10.1212/WNL.59.3.435; Tzourio C, 2000, CEPHALALGIA, V20, P190, DOI 10.1046/j.1468-2982.2000.00041.x; Ulrich V, 1999, ANN NEUROL, V45, P242, DOI 10.1002/1531-8249(199902)45:2<242::AID-ANA15>3.0.CO;2-1; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Vahedi K, 2007, NEUROLOGY, V69, P1564, DOI 10.1212/01.wnl.0000295994.46586.e7; Vahedi K, 2004, ARCH NEUROL-CHICAGO, V61, P1237, DOI 10.1001/archneur.61.8.1237; Vahedi K, 2003, NEUROLOGY, V60, P57, DOI 10.1212/WNL.60.1.57; Vail HH, 1932, ANN OTO RHINOL LARYN, V41, P837; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Valentinis L, 2010, CEPHALALGIA, V30, P389, DOI 10.1111/j.1468-2982.2009.01970.x; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; VANAST WJ, 1986, HEADACHE, V26, P317; VANDERWEE N, 1995, J NEUROL NEUROSUR PS, V58, P357, DOI 10.1136/jnnp.58.3.357; VANDUSSELDORP M, 1990, BRIT MED J, V300, P1558, DOI 10.1136/bmj.300.6739.1558; Vanmolkot KR, 2006, EUR J HUM GENET, V14, P555, DOI 10.1038/sj.ejhg.5201607; Vaughan CJ, 2000, LANCET, V356, P411, DOI 10.1016/S0140-6736(00)02539-3; VAZQUEZBARQUERO A, 1994, CEPHALALGIA, V14, P270, DOI 10.1046/j.1468-2982.1994.1404270.x; Vein AA, 2009, CEPHALALGIA, V29, P683, DOI 10.1111/j.1468-2982.2008.01775.x; Velioglu SK, 1999, CEPHALALGIA, V19, P797, DOI 10.1046/j.1468-2982.1999.1909797.x; Verdelho A, 2008, CEPHALALGIA, V28, P346, DOI 10.1111/j.1468-2982.2007.01514.x; VERNAY D, 1989, HEADACHE, V29, P350, DOI 10.1111/j.1526-4610.1989.hed2906350.x; Verrotti A, 2011, EPILEPSY BEHAV, V21, P52, DOI 10.1016/j.yebeh.2011.03.004; Versino M, 2003, FUNCT NEUROL, V18, P97; VERWEIJ RD, 1988, ARCH NEUROL-CHICAGO, V45, P1019, DOI 10.1001/archneur.1988.00520330109018; Vetvik KG, 2015, CEPHALALGIA, V35, P410, DOI 10.1177/0333102414545891; Vetvik KG, 2014, CEPHALALGIA, V34, P280, DOI 10.1177/0333102413507637; Vetvik KG, 2015, CEPHALALGIA, V35, P1261, DOI 10.1177/0333102415575723; Viana M, 2016, CEPHALALGIA, V36, P413, DOI 10.1177/0333102415593089; VIJAYAN N, 1995, HEADACHE, V35, P98, DOI 10.1111/j.1526-4610.1995.hed3502098.x; Voigt K, 2010, J PSYCHOSOM RES, V68, P403, DOI 10.1016/j.jpsychores.2010.01.015; Vollbracht S, 2014, HEADACHE, V54, P170, DOI 10.1111/head.12252; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WAIND APB, 1956, BRIT MED J, V1, P901, DOI 10.1136/bmj.1.4972.901; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Wall M, 2014, JAMA NEUROL, V71, P693, DOI 10.1001/jamaneurol.2014.133; Wang SJ, 2010, CURR PAIN HEADACHE R, V14, P41, DOI 10.1007/s11916-009-0083-0; Wang YF, 2009, NEUROLOGY, V73, P1892, DOI 10.1212/WNL.0b013e3181c3fd99; Wang YF, 2008, CEPHALALGIA, V28, P1298, DOI 10.1111/j.1468-2982.2008.01679.x; Wang YF, 2015, BRAIN, V138, P1492, DOI 10.1093/brain/awv016; Wasay M, 2010, J HEADACHE PAIN, V11, P137, DOI 10.1007/s10194-010-0186-3; WATSON P, 1985, HEADACHE, V25, P123, DOI 10.1111/j.1526-4610.1985.hed2503123.x; WEBB J, 1984, J RHEUMATOL, V11, P530; Wei JH, 2008, CEPHALALGIA, V28, P892, DOI 10.1111/j.1468-2982.2008.01590.x; Wei YX, 2017, BRIT J NEUROSURG, V31, P101, DOI 10.1080/02688697.2016.1233321; WEINKE T, 1989, J NEUROL, V236, P38, DOI 10.1007/BF00314216; Weir B, 1998, SUBARACHNOID HEMORRH, P144; Weiss AH, 2004, PEDIATR NEUROL, V30, P64, DOI 10.1016/S0887-8994(03)00424-7; WEISS NS, 1972, NEW ENGL J MED, V287, P631, DOI 10.1056/NEJM197209282871303; Welch KMA, 1999, DIGEST DIS SCI, V44, p26S; West B, 2001, LARYNGOSCOPE, V111, P581, DOI 10.1097/00005537-200104000-00006; Whiteley W, 2006, NEUROLOGY, V67, P1690, DOI 10.1212/01.wnl.0000242704.60275.e9; Wig S, 2009, J RHEUMATOL, V36, P857, DOI 10.3899/jrheum.080993; WIJDICKS EFM, 1988, LANCET, V2, P1020; WIJDICKS EFM, 1988, LANCET, V2, P68; Wijman CAC, 1998, STROKE, V29, P1539, DOI 10.1161/01.STR.29.8.1539; Wilker SC, 2009, BRIT J OPHTHALMOL, V93, P1657, DOI 10.1136/bjo.2008.155150; Wilson MH, 2013, ANN NEUROL, V73, P381, DOI 10.1002/ana.23796; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Witham TF, 2000, AM J EMERG MED, V18, P88, DOI 10.1016/S0735-6757(00)90058-5; Woda A, 1999, J OROFAC PAIN, V13, P172; Wolf ME, 2011, NEUROLOGY, V76, P1911, DOI 10.1212/WNL.0b013e31821d74d5; Wong SL, 2008, CEPHALALGIA, V28, P994, DOI 10.1111/j.1468-2982.2008.01625.x; Wu JW, 2017, BRAIN, V140, P344, DOI 10.1093/brain/aww328; Xu HM, 2016, WORLD NEUROSURG, V88, P289, DOI 10.1016/j.wneu.2015.12.028; Yadav YR, 2015, TURK NEUROSURG, V25, P362, DOI 10.5137/1019-5149.JTN.11086-14.1; Yalin OO, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0616-y; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Yanguela J, 2004, NEUROLOGY, V62, P1134, DOI 10.1212/01.WNL.0000118841.97273.5D; Yanguela J, 2002, NEUROLOGY, V58, P802, DOI 10.1212/WNL.58.5.802; Yankovsky AE, 2005, EPILEPSIA, V46, P1241, DOI 10.1111/j.1528-1167.2005.64804.x; Yeh YC, 2010, CEPHALALGIA, V30, P1329, DOI 10.1177/0333102410364675; YEN PT, 1995, OTOLARYNG HEAD NECK, V113, P15, DOI 10.1016/S0194-5998(95)70139-7; Yildirmak Taner, 2014, Surg Neurol Int, V5, P142, DOI 10.4103/2152-7806.141891; Yip V, 2012, QJM-INT J MED, V105, P895, DOI 10.1093/qjmed/hcr141; Yoon MS, 2010, CEPHALALGIA, V30, P92, DOI 10.1111/j.1468-2982.2009.01899.x; YOUNG GB, 1983, BRAIN, V106, P537, DOI 10.1093/brain/106.3.537; Young WB, 2010, NEUROLOGY, V74, P1338, DOI 10.1212/WNL.0b013e3181de7fb9; Yri HM, 2015, CEPHALALGIA, V35, P553, DOI 10.1177/0333102414550109; Yutzy S, 2003, PSYCHIATRY, P1419; Zach V, 2010, J HEADACHE PAIN, V11, P79, DOI 10.1007/s10194-009-0181-8; Zampaglione B, 1996, HYPERTENSION, V27, P144, DOI 10.1161/01.HYP.27.1.144; Zaragoza-Casares P, 2009, HEADACHE, V49, P476, DOI 10.1111/j.1526-4610.2008.01259.x; Zasler ND, 1999, J HEAD TRAUMA REHAB, V14, P1, DOI 10.1097/00001199-199902000-00003; Zeeberg P, 2009, CEPHALALGIA, V29, P214, DOI 10.1111/j.1468-2982.2008.01710.x; Zeeberg P, 2006, NEUROLOGY, V66, P1894, DOI 10.1212/01.wnl.0000217914.30994.bd; Zhang S R, 1989, Zhonghua Nei Ke Za Zhi, V28, P202; Zhang YX, 2016, CEPHALALGIA, V36, P240, DOI 10.1177/0333102415587704; Zukerman E, 2000, NEUROLOGY, V54, P1524, DOI 10.1212/WNL.54.7.1524	1213	36	37	0	40	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	JAN	2018	38	1					1	211					211	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FW2QP	WOS:000425149500001					2022-02-06	
J	Zeiler, FA; Donnelly, J; Menon, DK; Smielewski, P; Zweifel, C; Brady, K; Czosnyka, M				Zeiler, Frederick A.; Donnelly, Joseph; Menon, David K.; Smielewski, Peter; Zweifel, Christian; Brady, Ken; Czosnyka, Marek			Continuous Autoregulatory Indices Derived from Multi-Modal Monitoring: Each One Is Not Like the Other	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; autoregulation index; co-variance; multi-modal monitoring	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; NEAR-INFRARED SPECTROSCOPY; CEREBROVASCULAR REACTIVITY; INTRACRANIAL-PRESSURE; NEUROCRITICAL CARE; OXYGEN-PRESSURE; HEAD-INJURY; OSCILLATIONS; EXPERIENCE	We assess the relationships between various continuous measures of autoregulatory capacity in a cohort of adults with traumatic brain injury (TBI). We assessed relationships between autoregulatory indices derived from intracranial pressure (ICP: PRx, PAx, RAC), transcranial Doppler (TCD: Mx, Sx, Dx), brain tissue-oxygenation (ORx), and spatially resolved near infrared spectroscopy (NIRS resolved: TOx, THx). Relationships between indices were assessed using Pearson correlation coefficient, Friedman test, principal component analysis (PCA), agglomerative hierarchal clustering (AHC) and k-means cluster analysis (KMCA). All analytic techniques were repeated for a range of temporal resolutions of data, including minute-by-minute averages, moving means of 30 samples, and grand mean for each patient. Thirty-seven patients were studied. The PRx displayed strong association with PAx/RAC across all the analytical techniques: Pearson correlation (r = 0.682/r = 0.677, p < 0.0001), PCA, AHC, and KMCA in the grand mean data sheet. Most TCD-based indices (Mx, Dx) were correlated and co-clustered on PCA, AHC, and KMCA. The Sx was found to be more closely associated with ICP-derived indices on Pearson correlation, PCA, AHC, and KMCA. The NIRS indices displayed variable correlation with each other and with indices derived from ICP and TCD signals. Of interest, TOx and THx co-cluster with ICP-based indices on PCA and AHC. The ORx failed to display any meaningful correlations with other indices in neither of the analytical method used. Thirty-minute moving average and minute-by-minute data set displayed similar results across all the methods. The RAC, Mx, and Sx were the strongest predictors of outcome at six months. Continuously updating autoregulatory indices are not all correlated with one another. Caution must be advised when utilizing less commonly described autoregulation indices (i.e., ORx) for the clinical assessment of autoregulatory capacity, because they appear to not be related to commonly measured/establish indices, such as PRx. Further prospective validation is required.	[Zeiler, Frederick A.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Donnelly, Joseph; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Sect Brain Phys, Cambridge, England; [Zweifel, Christian] Cantonal Hosp Chur, Dept Neurosurg, Basel, Switzerland; [Brady, Ken] Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada.	umzeiler@myumanitoba.ca	Donnelly, Joseph/E-9235-2018; Donnelly, Joseph/N-6803-2019	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Zeiler, Frederick/0000-0003-1737-0510	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; R. Samuel McLaughlin Research and Education Award; Manitoba Medical Service Foundation; University of Manitoba Faculty of Medicine Dean's Fellowship Fund; National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award; European Union Framework Program 7 grant (CENTER-TBI) [602150]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery, the University of Manitoba Clinician Investigator Program, R. Samuel McLaughlin Research and Education Award, the Manitoba Medical Service Foundation, and the University of Manitoba Faculty of Medicine Dean's Fellowship Fund.; These studies were supported by the National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award to DKM. Authors were also supported by a European Union Framework Program 7 grant (CENTER-TBI; Grant Agreement No. 602150).	Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Crawley M.J., 2013, R BOOK, P809; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka M, 2002, ACT NEUR S, V81, P117; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2000, ACT NEUR S, V76, P483; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Dengler J, 2013, NEUROCRIT CARE, V19, P74, DOI 10.1007/s12028-012-9686-0; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Diedler J, 2011, ANESTH ANALG, V113, P849, DOI 10.1213/ANE.0b013e3182285dc0; Easley RB, 2013, NEUROL RES, V35, P344, DOI 10.1179/1743132812Y.0000000145; Eide PK, 2007, NEUROL RES, V29, P578, DOI 10.1179/016164107X172167; Gao L, 2016, J NEUROTRAUM, V33, P2011, DOI 10.1089/neu.2015.4228; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Highton D, 2012, CRIT CARE, V16, pS106; Highton D, 2015, ANESTH ANALG, V121, P198, DOI 10.1213/ANE.0000000000000790; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Lang EW, 2015, NEUROCRIT CARE, V23, P85, DOI 10.1007/s12028-014-0074-9; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Menzel M, 2003, J NEUROSURG ANESTH, V15, P33, DOI 10.1097/00008506-200301000-00006; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Pandey M., 2015, BIOSTATISTICS BASIC, P454; Smielewski P, 2009, J NEUROTRAUM, V26, pA47; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	32	36	36	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3070	3080		10.1089/neu.2017.5129			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000002	28571485	Green Submitted			2022-02-06	
J	Haarbauer-Krupa, J; Ciccia, A; Dodd, J; Ettel, D; Kurowski, B; Lumba-Brown, A; Suskauer, S				Haarbauer-Krupa, Juliet; Ciccia, Angela; Dodd, Jonathan; Ettel, Deborah; Kurowski, Brad; Lumba-Brown, Angela; Suskauer, Stacy			Service Delivery in the Healthcare and Educational Systems for Children Following Traumatic Brain Injury: Gaps in Care	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; education; healthcare; rehabilitation; traumatic brain injury	BEHAVIOR PROBLEMS; UNITED-STATES; INPATIENT REHABILITATION; EARLY-CHILDHOOD; YOUNG-CHILDREN; SHORT-TERM; PREDICTORS; OUTCOMES; PERFORMANCE; STUDENTS	Objective: To provide a review of evidence and consensus-based description of healthcare and educational service delivery and related recommendations for children with traumatic brain injury. Methods: Literature review and group discussion of best practices in management of children with traumatic brain injury (TBI) was performed to facilitate consensus-based recommendations from the American Congress on Rehabilitation Medicine's Pediatric and Adolescent Task Force on Brain Injury. This group represented pediatric researchers in public health, medicine, psychology, rehabilitation, and education. Results: Care for children with TBI in healthcare and educational systems is not well coordinated or integrated, resulting in increased risk for poor outcomes. Potential solutions include identifying at-risk children following TBI, evaluating their need for rehabilitation and transitional services, and improving utilization of educational services that support children across the lifespan. Conclusion: Children with TBI are at risk for long-term consequences requiring management as well as monitoring following the injury. Current systems of care have challenges and inconsistencies leading to gaps in service delivery. Further efforts to improve knowledge of the long-term TBI effects in children, child and family needs, and identify best practices in pathways of care are essential for optimal care of children following TBI.	[Haarbauer-Krupa, Juliet] Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,MS-F62, Atlanta, GA 30341 USA; [Ciccia, Angela] Dept Psychol Sci, Program Commun Sci, Cleveland, OH USA; [Dodd, Jonathan] St Louis Childrens Hosp, Dept Psychol, St Louis, MO 63178 USA; [Dodd, Jonathan] Washington Univ, Sch Med, St Louis, MO USA; [Ettel, Deborah] Eugene Sch Dist 4J, Educ Support Serv, Eugene, OR USA; [Kurowski, Brad] Univ Cincinnati, Cincinnati Childrens HospitalMed Ctr, Div Phys Med & Rehabil, Dept Pediat & Neurol & Rehabil Med,Coll Med, Cincinnati, OH 45221 USA; [Lumba-Brown, Angela] Washington Univ, Sch Med, St Louis Childrens Hosp, Pediat Emergency Med, St Louis, MO 63130 USA; [Suskauer, Stacy] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD USA		Haarbauer-Krupa, J (corresponding author), Ctr Dis Control & Prevent, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,MS-F62, Atlanta, GA 30341 USA.	JHaarbauerKrupa@cdc.gov	Ciccia, Angela/J-5967-2019	Lumba-Brown, Angela/0000-0002-9102-8791	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [L40 HD066480, K23 HD074683] Funding Source: Medline; Intramural CDC HHS [CC999999] Funding Source: Medline		Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Ballard DW, 2013, ACAD EMERG MED, V20, P352, DOI 10.1111/acem.12109; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Begali V., 1992, HEAD INJURY CHILDREN; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; BULGREN JA, 2006, TEACHING ADOLESCENTS, P79; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2010, STUD NEUROPSYCHOL NE, P439; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Connery AK, 2016, CLIN NEUROPSYCHOL, V30, P579, DOI 10.1080/13854046.2016.1177596; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Crowe LM, 2005, HDB CLIN NEUROLOGY, V128, P661; Dettmer J, 2014, J HEAD TRAUMA REHAB, V29, P224, DOI 10.1097/HTR.0b013e3182a1cd68; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; [Division of Unintentional Injury National Center for Injury Prevention and Control Centers for Disease Control], RAT TBI REL HOSP AG; Donders J, 2004, ASSESSMENT, V11, P275, DOI 10.1177/1073191104268914; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Faul M, 2010, TRAUMATIC BRAIN INJU; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2008, NEUROREHABILTIATION, V23, P13; Glang A, 2015, EXCEPTIONALITY, V23, P211, DOI 10.1080/09362835.2014.986612; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Haarbauer-Krupa J., 2012, ASHA LEADER; Haarbauer-Krupa J, 2009, BRAIN INJURY PROFESS, V6; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2016, J PEDIATR-US, V169, P244, DOI 10.1016/j.jpeds.2015.10.014; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Pineda JA, 2013, LANCET NEUROL, V12, P45, DOI 10.1016/S1474-4422(12)70269-7; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Savage RC, 1995, PERSPECT NETW, V3; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schootman M, 2000, BRAIN INJURY, V14, P373; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 2015, J HEAD TRAUMA REHAB, V4, P1; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Yeates KO., 2006, EXCEPTIONALITY, V14, P141, DOI DOI 10.1207/S15327035EX1403_; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, Vxiv; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	82	36	36	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					367	377		10.1097/HTR.0000000000000287			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100092	28060211	Green Accepted			2022-02-06	
J	Wade, SL; Cassedy, AE; Shultz, EL; Zang, HY; Zhang, NH; Kirkwood, MW; Stancin, T; Yeates, KO; Taylor, HG				Wade, Shari L.; Cassedy, Amy E.; Shultz, Emily L.; Zang, Huaiyu; Zhang, Nanhua; Kirkwood, Michael W.; Stancin, Terry; Yeates, Keith O.; Taylor, H. Gerry			Randomized Clinical Trial of Online Parent Training for Behavior Problems After Early Brain Injury	JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						traumatic brain injury; behavior problems; parenting	CHILD INTERACTION THERAPY; OUTCOMES; INTERVENTION; ADOLESCENTS; MODERATORS; PROGRAM; HARSH; TERM	Objective: To evaluate the effectiveness of Internet-based Interacting Together Everyday: Recovery After Childhood TBI (I-InTERACT) versus abbreviated parent training (Express) or access to online resources (internet resources comparison [IRC]) in improving parenting skills and decreasing behavior problems after early traumatic brain injury (TBI).& para;& para;Method: In this randomized, controlled, clinical trial, 113 children 3 to 9 years old previously hospitalized for moderate to severe TBI were randomly assigned to receive Express (n = 36), I-InTERACT (n = 39), or IRC (n = 38). Express included 7 online parent skills sessions, and I-InTERACT delivered 10 to 14 sessions addressing parenting skills, TBI education, stress, and anger management. The 2 interventions coupled online modules with therapist coaching through a Health Insurance Portability and Accountability Act-compliant Skype link. The IRC group received access to online TBI and parent skills resources. Co-primary outcomes were blinded ratings of parenting skills and parent report of behavior problems and problem intensity on the Eyberg Child Behavior Inventory (ECBI). Outcomes were assessed before treatment and 3 and 6 months after treatment, with the latter constituting the primary endpoint.& para;& para;Results: The Express and I-InTERACT groups displayed higher levels of positive parenting at follow-up. Only the I-InTERACT group had lower levels of negative parenting at 6 months. The Express group had lower ECBI intensity scores than the IRC group. Baseline symptom levels moderated improvements; children in the Express and I-InTERACT groups with higher baseline symptoms demonstrated greater improvements than those in the IRC group. Changes in parenting skills mediated improvements in behavior in those with higher baseline symptoms.& para;& para;Conclusion: Brief online parent skills training can effectively decrease behavior problems after early TBI in children with existing behavioral symptoms.	[Wade, Shari L.; Shultz, Emily L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Cassedy, Amy E.; Zang, Huaiyu; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Shultz, Emily L.] Univ Cincinnati, Cincinnati, OH 45221 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Denver, CO USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA; [Stancin, Terry; Taylor, H. Gerry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Yeates, Keith O.] Univ Calgary, Calgary, ON, Canada; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA		Wade, SL (corresponding author), 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Zang, Huaiyu/AAY-6603-2021; Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892; Zhang, Nanhua/0000-0001-5796-3404	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090010]	This study w as funded by the National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research (grant H133B090010).	Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Bradley RH, 2007, DEV PSYCHOL, V43, P1390, DOI 10.1037/0012-1649.43.6.1390; Brown FL, 2014, J CHILD PSYCHOL PSYC, V55, P1172, DOI 10.1111/jcpp.12227; Brown FL, 2013, BRAIN IMPAIR, V14, P253, DOI 10.1017/BrImp.2013.18; Cohen LL, 2015, J PEDIATR PSYCHOL, V40, P526, DOI 10.1093/jpepsy/jsu162; Eyberg S. M., 2005, MANUAL DYADIC PARENT; EYBERG SM, 1995, PSYCHOPHARMACOL BULL, V31, P83; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Hayes, 2018, INTRO MEDIATION MODE; Hayes AF, 2015, MULTIVAR BEHAV RES, V50, P1, DOI 10.1080/00273171.2014.962683; Kaminski JW, 2008, J ABNORM CHILD PSYCH, V36, P567, DOI 10.1007/s10802-007-9201-9; Kazdin AE, 2003, J CHILD PSYCHOL PSYC, V44, P1116, DOI 10.1111/1469-7610.00195; Kurowski BG, 2013, PM&R, V5, P1026, DOI 10.1016/j.pmrj.2013.08.589; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lundahl B, 2006, CLIN PSYCHOL REV, V26, P86, DOI 10.1016/j.cpr.2005.07.004; Lundahl BW, 2006, APSAC ADVIS, V18, P7; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Narad ME, 2017, DIGIT HEALTH, V3, DOI 10.1177/2055207617719423; Nixon RDV, 2003, J CONSULT CLIN PSYCH, V71, P251, DOI 10.1037/0022-006X.71.2.251; Owens PL, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200206000-00013; Pincus, 1999, EYBERG CHILD BEHAV I; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Waller R, 2012, J CHILD PSYCHOL PSYC, V53, P946, DOI 10.1111/j.1469-7610.2012.02550.x; Webster-Stratton C, 2004, J CLIN CHILD ADOLESC, V33, P105, DOI 10.1207/S15374424JCCP3301_11; Woods D, 2015, SOCIAL CARE NEURODIS, V5, P70, DOI [DOI 10.1108/SCN-01-2014-0001, 10.1108/SCN-01-2014-0001]; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	34	36	36	4	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0890-8567	1527-5418		J AM ACAD CHILD PSY	J. Am. Acad. Child Adolesc. Psychiatr.	NOV	2017	56	11					930	939		10.1016/j.jaac.2017.09.413			10	Psychology, Developmental; Pediatrics; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	FM2MG	WOS:000414818300008	29096775				2022-02-06	
J	De Vos, A; Bjerke, M; Brouns, R; De Roeck, N; Jacobs, D; Van den Abbeele, L; Guldolf, K; Zetterberg, H; Blennow, K; Engelborghs, S; Vanmechelen, E				De Vos, Ann; Bjerke, Maria; Brouns, Raf; De Roeck, Naomi; Jacobs, Dirk; Van den Abbeele, Lien; Guldolf, Kaat; Zetterberg, Henrik; Blennow, Kaj; Engelborghs, Sebastiaan; Vanmechelen, Eugeen			Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke	BMC NEUROLOGY			English	Article						AIS; Neurogranin; Tau; Plasma; CSF; Elisa; Simoa; NIHSS; mRS; Biomarker	ALZHEIMERS-DISEASE; NEUROBIOCHEMICAL MARKERS; PROTEIN NEUROGRANIN; COGNITIVE DECLINE; BRAIN-DAMAGE; CORRELATE; BIOMARKER; SEVERITY	Background: While neurogranin has no value as plasma biomarker for Alzheimer's disease, it may be a potential blood biomarker for traumatic brain injury. This evokes the question whether there are changes in neurogranin levels in blood in other conditions of brain injury, such as acute ischemic stroke (AIS). Methods: We therefore explored neurogranin in paired cerebrospinal fluid (CSF)/plasma samples of AIS patients (n = 50) from a well-described prospective study. In parallel, we investigated another neuronal protein, i.e. tau, which has already been suggested as potential AIS biomarker in CSF and blood. ELISA as well as Single Molecule Array (Simoa) technology were used for the biochemical analyses. Statistical analyses included Shapiro-Wilk testing, Mann-Whitney analyses and Pearson's correlation analysis. Results: In contrast to tau, of which high levels in both CSF and plasma were related to stroke characteristics like severity and long-term outcome, plasma neurogranin levels were only correlated with infarct volume. Likewise, CSF neurogranin levels were significantly higher in patients with an infarct volume > 5 mL than in patients with smaller infarct volumes. Finally, neurogranin and tau were significantly correlated in CSF, whereas a weaker relationship was observed in plasma. Conclusions: These findings indicate that although plasma and CSF neurogranin may reflect the volume of acute cerebral ischemia, this synaptic protein is less likely to be a potential AIS biomarker. Levels of tau correlated with severity and outcome of stroke in both plasma and CSF, in the present study as well as previous reports, confirming the potential of tau as an AIS biomarker.	[De Vos, Ann; Jacobs, Dirk; Van den Abbeele, Lien; Vanmechelen, Eugeen] ADx NeuroSci NV, Technol Pk 4, B-9052 Ghent, Belgium; [Bjerke, Maria; De Roeck, Naomi; Guldolf, Kaat; Engelborghs, Sebastiaan] Univ Antwerp, Inst Born Bunge, Reference Ctr Biol Markers Dementia BIODEM, Antwerp, Belgium; [Brouns, Raf] Hosp ZorSaam, Dept Neurol, Terneuzen, Netherlands; [Guldolf, Kaat; Engelborghs, Sebastiaan] Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Dept Neurol, Antwerp, Belgium; [Guldolf, Kaat; Engelborghs, Sebastiaan] Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Memory Clin, Antwerp, Belgium; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, London, England		Vanmechelen, E (corresponding author), ADx NeuroSci NV, Technol Pk 4, B-9052 Ghent, Belgium.	Eugeen.vanmechelen@adxneurosciences.com	Vanmechelen, Eugeen/AAA-8005-2019; Brouns, Raf/E-1044-2013	De Vos, Ann/0000-0002-8200-5336; Vanmechelen, Eugeen/0000-0002-9466-5366; Brouns, Raf/0000-0001-6540-5699	Agency for Innovation by Science and Technology (VLAIO) [140,105]; University of Antwerp Research Fund; Alzheimer Research Foundation (SAO-FRA); Institute Born-Bunge (IBB); Belgian Science Policy Office Interuniversity Attraction Poles (IAP) program (BELSPO); Flemish Government initiated Methusalem excellence grant (EWI); Flanders Impulse Program on Networks for Dementia Research (VIND); Research Foundation Flanders (FWO)FWO; VINNOVAVinnova; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences	This work was funded in part by the Agency for Innovation by Science and Technology (VLAIO, www.vlaio.be, grant nr 140,105); University of Antwerp Research Fund; the Alzheimer Research Foundation (SAO-FRA, http://alzh.org); the Institute Born-Bunge (IBB,www.bornbunge.be); the Belgian Science Policy Office Interuniversity Attraction Poles (IAP) program (BELSPO, www.belspo.be); the Flemish Government initiated Methusalem excellence grant (EWI, www.ewi-vlaanderen.be); the Flanders Impulse Program on Networks for Dementia Research (VIND); the Research Foundation Flanders (FWO,www.fwo.be); VINNOVA; the Swedish Research Council (www.vr.se/inenglish); the Swedish Brain Foundation (www.hjarnfonden.se) and Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences. The funding sources had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; Bielewicz J, 2011, J MOL NEUROSCI, V43, P241, DOI 10.1007/s12031-010-9403-4; Bitsch A, 2002, EUR NEUROL, V47, P45, DOI 10.1159/000047946; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brouns R, 2008, CLIN CHIM ACTA, V397, P27, DOI 10.1016/j.cca.2008.07.016; Brouns R, 2011, EUR NEUROL, V65, P23, DOI 10.1159/000321965; Brouns R, 2010, CLIN CHEM, V56, P451, DOI 10.1373/clinchem.2009.134122; Brouns R, 2009, NEUROCHEM RES, V34, P1642, DOI 10.1007/s11064-009-9954-3; Dage JL, 2016, ALZHEIMERS DEMENT, V12, P1226, DOI 10.1016/j.jalz.2016.06.001; De Vos A, 2016, J ALZHEIMERS DIS, V53, P1523, DOI 10.3233/JAD-160227; De Vos A, 2015, ALZHEIMERS DEMENT, V11, P1461, DOI 10.1016/j.jalz.2015.05.012; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Duncan PW, 2000, STROKE, V31, P1429, DOI 10.1161/01.STR.31.6.1429; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199; Hjalmarsson C, 2014, J CENT NERV SYST DIS, V6, P51, DOI 10.4137/JCNSD.S13821; Janelidze S, 2016, ANN CLIN TRANSL NEUR, V3, P12, DOI 10.1002/acn3.266; Kaerst L, 2013, J NEUROL, V260, P2722, DOI 10.1007/s00415-013-7047-3; Kehoe K, 2015, NEUROCHEM RES, V40, P81, DOI 10.1007/s11064-014-1468-y; Kester MI, 2015, JAMA NEUROL, V72, P1275, DOI 10.1001/jamaneurol.2015.1867; Kvartsberg H, 2015, ALZHEIMERS DEMENT, V11, P1180, DOI 10.1016/j.jalz.2014.10.009; Kvartsberg H, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0124-3; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; Portelius E, 2015, BRAIN, V138, DOI 10.1093/brain/awv267; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; STRAND T, 1984, STROKE, V15, P138, DOI 10.1161/01.STR.15.1.138; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Tarawneh R, 2016, JAMA NEUROL, V73, P561, DOI 10.1001/jamaneurol.2016.0086; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thorsell A, 2010, BRAIN RES, V1362, P13, DOI 10.1016/j.brainres.2010.09.073; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Willemse JL, 2008, J THROMB HAEMOST, V6, P200; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Yang J, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0468-0; Yang J, 2015, CLIN BIOCHEM, V48, P843, DOI 10.1016/j.clinbiochem.2015.05.015	37	36	36	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	AUG 30	2017	17								170	10.1186/s12883-017-0945-8			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FF2JY	WOS:000408724900001	28854881	gold, Green Published			2022-02-06	
J	Jin, T; Wang, P; Hitchens, TK; Kim, SG				Jin, Tao; Wang, Ping; Hitchens, T. Kevin; Kim, Seong-Gi			Enhancing sensitivity of pH-weighted MRI with combination of amide and guanidyl CEST	NEUROIMAGE			English	Article						CEST; Amide; Guanidyl; pH; APT; Stroke	EXCHANGE SATURATION-TRANSFER; NUCLEAR OVERHAUSER ENHANCEMENT; ACUTE CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; TRANSFER APT MRI; PROTON-TRANSFER; MAGNETIZATION-TRANSFER; TISSUE PH; INTRACELLULAR PH; LACTIC-ACIDOSIS	Amide-proton-transfer weighted (APTw) MRI has emerged as a non-invasive pH-weighted imaging technique for studies of several diseases such as ischemic stroke. However, its pH-sensitivity is relatively low, limiting its capability to detect small pH changes. In this work, computer simulations, protamine phantom experiments, and in vivo gas challenge and experimental stroke in rats showed that, with judicious selection of the saturation pulse power, the amide-CEST at 3.6 ppm and guanidyl-CEST signals at 2.0 ppm changed in opposite directions with decreased pH. Thus, the difference between amide-CEST and guanidyl-CEST can enhance the pH measurement sensitivity, and is dubbed as pH(enh). Acidification induced a negative contrast in APTw, but a positive contrast in pHenh. In vivo experiments showed that pHenh can detect hypercapnia-induced acidosis with about 3-times higher sensitivity than APTw. Also, pHenh slightly reduced gray and white matter contrast compared to APTw. In stroke animals, the CEST contrast between the ipsilateral ischemic core and contralateral normal tissue was -1.85 +/- 0.42% for APTw and 3.04 +/- 0.61% (n = 5) for pHenh, and the contrast to noise was 2.9 times higher for pHenh than APTw. Our results suggest that pHenh can be a useful tool for non-invasive pH-weighted imaging.	[Jin, Tao; Wang, Ping] Univ Pittsburgh, Dept Radiol, 3025 E Carson St,Room 156, Pittsburgh, PA 15260 USA; [Jin, Tao] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Hitchens, T. Kevin] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA; [Kim, Seong-Gi] Inst Basic Sci, Ctr Neurosci Imaging Res, Suwon, South Korea; [Kim, Seong-Gi] Sungkyunkwan Univ, Dept Biomed Engn, Suwon, South Korea		Jin, T (corresponding author), Univ Pittsburgh, Dept Radiol, 3025 E Carson St,Room 156, Pittsburgh, PA 15260 USA.	taj6@pitt.edu	Kim, Seong-Gi/A-2691-2008; Jin, Tao/D-5101-2009		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EB003324, P30-NS076405, P30-CA047904]; Institute for Basic Science in Korea [IBS-R015-D1]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB003324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS076405] Funding Source: NIH RePORTER	We thank Kristy Hendrich for maintaining the 9.4 T system. This work is supported by NIH grants EB003324, P30-NS076405 and P30-CA047904, and the Institute for Basic Science in Korea (IBS-R015-D1).	Anderson RE, 1999, STROKE, V30, P160, DOI 10.1161/01.STR.30.1.160; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Autio JA, 2014, J CEREBR BLOOD F MET, V34, P768, DOI 10.1038/jcbfm.2014.16; BACK T, 1994, STROKE, V25, P494, DOI 10.1161/01.STR.25.2.494; BERECZKI D, 1993, METAB BRAIN DIS, V8, P125, DOI 10.1007/BF00996926; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Duncan JS, 1997, BRAIN, V120, P339, DOI 10.1093/brain/120.2.339; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Gerweck LE, 1996, CANCER RES, V56, P1194; Guo YK, 2016, NEUROIMAGE, V141, P242, DOI 10.1016/j.neuroimage.2016.07.025; Heo HY, 2016, MAGN RESON MED, V75, P137, DOI 10.1002/mrm.25581; Hua J, 2007, MAGN RESON MED, V58, P786, DOI 10.1002/mrm.21387; Jin T, 2013, P INT SOC MAGN RESON, V21, P2528; Jin T, 2013, MAGN RESON MED, V69, P760, DOI 10.1002/mrm.24315; Jin T, 2012, MAGN RESON MED, V68, P1056, DOI 10.1002/mrm.24449; Jin T, 2011, MAGN RESON MED, V65, P1448, DOI 10.1002/mrm.22721; Jin T, 2010, NEUROIMAGE, V51, P1378, DOI 10.1016/j.neuroimage.2010.03.047; Jokivarsi KT, 2007, MAGN RESON MED, V57, P647, DOI 10.1002/mrm.21181; Jones CK, 2013, NEUROIMAGE, V77, P114, DOI 10.1016/j.neuroimage.2013.03.047; Jones CK, 2012, MAGN RESON MED, V67, P1579, DOI 10.1002/mrm.23141; Koizumi, 1986, JPN J STROKE, V8, P8, DOI [10.3995/jstroke.8.1, DOI 10.3995/jstroke.8.1]; LAXER KD, 1992, EPILEPSIA, V33, P618, DOI 10.1111/j.1528-1157.1992.tb02337.x; Lee JK, 2013, SOCIAL MEDIA AND STRATEGIC COMMUNICATIONS, P3; Li H, 2015, NMR BIOMED, V28, P200, DOI 10.1002/nbm.3243; Liepinsh E, 1996, MAGNET RESON MED, V35, P30, DOI 10.1002/mrm.1910350106; Liu DP, 2013, MAGN RESON MED, V70, P1070, DOI 10.1002/mrm.24560; Lu J, 2009, NEUROIMAGE, V45, P1126, DOI 10.1016/j.neuroimage.2008.11.037; Magnotta VA, 2012, P NATL ACAD SCI USA, V109, P8270, DOI 10.1073/pnas.1205902109; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; McVicar N, 2014, J CEREBR BLOOD F MET, V34, P690, DOI 10.1038/jcbfm.2014.12; Mori S, 1998, MAGNET RESON MED, V40, P36, DOI 10.1002/mrm.1910400105; MORRISON C, 1995, J MAGN RESON SER B, V108, P103, DOI 10.1006/jmrb.1995.1111; Narvainen J, 2010, J MAGN RESON, V207, P242, DOI 10.1016/j.jmr.2010.09.004; NISHIMURA M, 1989, J APPL PHYSIOL, V66, P2181, DOI 10.1152/jappl.1989.66.5.2181; PEEK KE, 1989, METAB BRAIN DIS, V4, P261, DOI 10.1007/BF00999772; Pouwels PJW, 1999, PEDIATR RES, V46, P474, DOI 10.1203/00006450-199910000-00019; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; SAKO K, 1985, STROKE, V16, P828, DOI 10.1161/01.STR.16.5.828; Scheidegger R, 2011, MAGN RESON MED, V66, P1275, DOI 10.1002/mrm.22912; Sheth VR, 2012, MAGN RESON MED, V67, P760, DOI 10.1002/mrm.23038; Song XL, 2012, MAGN RESON MED, V68, P1074, DOI 10.1002/mrm.23312; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; Sun PZ, 2012, NEUROIMAGE, V60, P1, DOI 10.1016/j.neuroimage.2011.11.091; Sun PZ, 2011, MAGN RESON MED, V66, P1042, DOI 10.1002/mrm.22894; Sun PZ, 2011, J CEREBR BLOOD F MET, V31, P1743, DOI 10.1038/jcbfm.2011.23; TANNOCK IF, 1989, CANCER RES, V49, P4373; Tee YK, 2014, NMR BIOMED, V27, P1019, DOI 10.1002/nbm.3147; Tietze A, 2014, NMR BIOMED, V27, P163, DOI 10.1002/nbm.3048; TOMLINSON FH, 1993, STROKE, V24, P435, DOI 10.1161/01.STR.24.3.435; WAGNER KR, 1992, J CEREBR BLOOD F MET, V12, P213, DOI 10.1038/jcbfm.1992.31; Warach S, 2001, STROKE, V32, P2460; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Xu JD, 2014, MAGN RESON MED, V71, P1798, DOI 10.1002/mrm.24850; Zaiss M, 2017, MAGN RESON MED, V77, P196, DOI 10.1002/mrm.26100; Zaiss M, 2011, J MAGN RESON, V211, P149, DOI 10.1016/j.jmr.2011.05.001; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907; Zong XP, 2014, MAGN RESON MED, V71, P118, DOI 10.1002/mrm.24639; Zu ZL, 2013, MAGN RESON MED, V69, P637, DOI 10.1002/mrm.24284	60	36	36	0	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	AUG 15	2017	157						341	350		10.1016/j.neuroimage.2017.06.007			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FG6WU	WOS:000410539800028	28602944	Green Accepted			2022-02-06	
J	Giordano, C; Zappala, S; Kleiven, S				Giordano, Chiara; Zappala, Stefano; Kleiven, Svein			Anisotropic finite element models for brain injury prediction: the sensitivity of axonal strain to white matter tract inter-subject variability	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Axonal strain; Brain anisotropy; Traumatic brain injury; Finite element analysis	IN-DIFFUSION MRI; FIBER TRACTS; HEAD; TOLERANCE; TRAUMA; DAMAGE	Computational models incorporating anisotropic features of brain tissue have become a valuable tool for studying the occurrence of traumatic brain injury. The tissue deformation in the direction of white matter tracts (axonal strain) was repeatedly shown to be an appropriate mechanical parameter to predict injury. However, when assessing the reliability of axonal strain to predict injury in a population, it is important to consider the predictor sensitivity to the biological inter-subject variability of the human brain. The present study investigated the axonal strain response of 485 white matter subject-specific anisotropic finite element models of the head subjected to the same loading conditions. It was observed that the biological variability affected the orientation of the preferential directions (coefficient of variation of 39.41% for the elevation angle-coefficient of variation of 29.31% for the azimuth angle) and the determination of the mechanical fiber alignment parameter in the model (gray matter volume 55.55-70.75%). The magnitude of the maximum axonal strain showed coefficients of variation of 11.91%. On the contrary, the localization of the maximum axonal strain was consistent: the peak of strain was typically located in a 2 cm(3) volume of the brain. For a sport concussive event, the predictor was capable of discerning between non-injurious and concussed populations in several areas of the brain. It was concluded that, despite its sensitivity to biological variability, axonal strain is an appropriate mechanical parameter to predict traumatic brain injury.	[Giordano, Chiara; Zappala, Stefano; Kleiven, Svein] Royal Inst Technol KTH, Sch Technol & Hlth, Halsovagen 11C, S-14157 Huddinge, Sweden		Giordano, C (corresponding author), Royal Inst Technol KTH, Sch Technol & Hlth, Halsovagen 11C, S-14157 Huddinge, Sweden.	chiaragi@kth.se		Zappala, Stefano/0000-0002-7057-8575	NIH Institutes and CentersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U54MH091657] Funding Source: NIH RePORTER	Data were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University.	Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Caminiti R, 2013, J NEUROSCI, V33, P14501, DOI 10.1523/JNEUROSCI.0761-13.2013; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Corouge I, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P344; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Faul M, 2010, TRAUMATIC BRAIN INJU; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Gennarelli T, 2015, P 2015 IRCOBI C LYON; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Gerig G, 2004, P 26 ANN INT C IEEE; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano Chiara, 2016, Stapp Car Crash J, V60, P363; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Hardy W, 2007, STAPP CAR CRASH J, P51; Hardy W N, 2001, Stapp Car Crash J, V45, P337; HCP, 2014, WU MINN HCP 500 SUBJ, P101; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Jenkinson M, 2015, TEMPLATES ATLASES IN; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koay CG, 2006, MAGN RESON MED, V55, P930, DOI 10.1002/mrm.20832; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Kristoffersen A, 2011, MAGN RESON MED, V66, P1639, DOI 10.1002/mrm.22960; Lee CEC, 2009, NEURORADIOLOGY, V51, P3, DOI 10.1007/s00234-008-0441-3; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Newman J A, 2000, Stapp Car Crash J, V44, P215; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Sadeghi N, 2015, NEUROIMAGE, V109, P480, DOI 10.1016/j.neuroimage.2014.12.084; Sahoo D, 2015, P IRCOBI C LYON FRAN; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Takhounts EG, 2008, STAPP CAR C, V52, P1; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Veenith TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065941; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Yendiki A., 2011, FRONT NEUROINFORM, V5, P1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	54	36	36	1	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	AUG	2017	16	4					1269	1293		10.1007/s10237-017-0887-5			25	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	FA5NH	WOS:000405489600012	28233136	Green Published, hybrid			2022-02-06	
J	Wang, RL; Li, JC; Duan, YX; Tao, Z; Zhao, HP; Luo, YM				Wang, Rongliang; Li, Jincheng; Duan, Yunxia; Tao, Zhen; Zhao, Haiping; Luo, Yumin			Effects of Erythropoietin on Gliogenesis during Cerebral Ischemic/Reperfusion Recovery in Adult Mice	AGING AND DISEASE			English	Article						Brain ischemia; Erythropoietin; Microglial polarization; Gliogenesis; White matter injury	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INJURY; MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; SPINAL-CORD-INJURY; NEUROLOGICAL FUNCTION; M2 MICROGLIA; ISCHEMIA; NEUROINFLAMMATION; NEUROGENESIS; ASTROCYTES	Erythropoietin (EPO) promotes oligodendrogenesis and attenuates white matter injury in neonatal rats. However, it is unknown whether this effect extends to adult mice and whether EPO regulate microglia polarization after ischemic stroke. Male adult C57BL/6 mice (25-30g) were subjected to 45 min of middle cerebral artery occlusion (MCAO). EPO (5000 IU/kg) or saline was injected intraperitoneally every other day after reperfusion. Neurological function was evaluated using the rotarod test at 1, 3, 7 and 14 days after MCAO. Brain tissue loss volume was determined by hematoxylin-eosin staining. Immunofluorescence staining and Western blot were also used to assess the severity of white matter injury and phenotypic changes in microglia/macrophages. Bromodeoxyuridine (BrdU) was injected intraperitoneally daily for 1 week to analyze the number of newly proliferating glia cells (oligodendrocytes, microglia, and astrocytes). We found that EPO significantly reduced Brain tissue loss volume, ameliorated white matter injury, and improved neurobehavioral outcomes at 14 days after MCAO (P< 0.05). In addition, EPO also increased the number of newly generated oligodendrocytes and attenuated the rapid hypertrophy and hyperplasia of microglia and astrocytes after ischemic stroke (P< 0.05). Furthermore, EPO reduced M1 microglia and increased M2 microglia (P< 0.05). Taken together, our results suggest that EPO treatment improves white matter integrity after cerebral ischemia, which could be attributed to EPO attenuating gliosis and facilitating the microglial polarization toward the beneficial M2 phenotype to promote oligodendrogenesis.	[Wang, Rongliang; Tao, Zhen; Zhao, Haiping; Luo, Yumin] Capital Med Univ, Xuanwu Hosp, Cerebrovasc Dis Res Inst, Beijing 100053, Peoples R China; [Wang, Rongliang; Tao, Zhen; Zhao, Haiping; Luo, Yumin] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing 100053, Peoples R China; [Wang, Rongliang; Duan, Yunxia; Tao, Zhen; Zhao, Haiping; Luo, Yumin] Beijing Inst Brain Disorders, Beijing 100053, Peoples R China; [Wang, Rongliang; Duan, Yunxia; Tao, Zhen; Zhao, Haiping; Luo, Yumin] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing 100053, Peoples R China; [Li, Jincheng] Zibo Cent Hosp, Dept Neurol, Zibo 255036, Peoples R China		Zhao, HP; Luo, YM (corresponding author), Capital Med Univ, Xuanwu Hosp, Cerebrovasc Dis Res Inst, Beijing 100053, Peoples R China.	zhaohaiping1980@163.com; yumin111@ccmu.edu.cn	zhao, haiping/I-1306-2014		Natural Science Foundation in ChinaNational Natural Science Foundation of China (NSFC) [81471340, 81641054]	This project was supported by Natural Science Foundation in China (81471340, 81641054).	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; Chen YZ, 2013, BRAIN RES, V1495, P11, DOI 10.1016/j.brainres.2012.12.006; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Frisen J, 2016, ANNU REV CELL DEV BI, V32, P127, DOI 10.1146/annurev-cellbio-111315-124953; Goldman SA, 2014, NAT NEUROSCI, V17, P483, DOI 10.1038/nn.3685; Han LJ, 2015, STROKE, V46, P2628, DOI 10.1161/STROKEAHA.115.010091; Hao Z, 2015, TRANSL STROKE RES, V6, P407; Ho PW, 2005, STROKE, V36, P2742, DOI 10.1161/01.STR.0000189748.52500.a7; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Iwai M, 2010, STROKE, V41, P1032, DOI 10.1161/STROKEAHA.109.570325; Kuhn HG, 2015, COLD SPRING HARB PER, V7; Lynch AM, 2010, AGING DIS, V1, P262; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; Ma QF, 2016, AGING DIS, V7, P705, DOI 10.14336/AD.2016.0320; Matute C, 2013, STROKE, V44, P1204, DOI 10.1161/STROKEAHA.112.658328; McIver SR, 2010, NEUROSCIENCE, V169, P1364, DOI 10.1016/j.neuroscience.2010.04.070; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Suenaga J, 2015, EXP NEUROL, V272, P109, DOI 10.1016/j.expneurol.2015.03.021; Susarla BT, 2014, ASN NEURO, V6, P94; Vitellaro-Zuccarello L, 2008, NEUROSCIENCE, V151, P452, DOI 10.1016/j.neuroscience.2007.11.004; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Xu W, 2016, SHOCK VIB, V2016, P1, DOI DOI 10.1016/J.SEPPUR.2016.01.012; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y	31	36	37	1	5	INT SOC AGING & DISEASE	FORT WORTH	EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA	2152-5250			AGING DIS	Aging Dis.	JUL	2017	8	4					410	419		10.14336/AD.2016.1209			10	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	FB6EM	WOS:000406234100005	28840056	Green Published, Green Submitted, gold			2022-02-06	
J	Finan, JD; Sundaresh, SN; Elkin, BS; McKhann, GM; Morrison, B				Finan, John D.; Sundaresh, Sowmya N.; Elkin, Benjamin S.; McKhann, Guy M., II; Morrison, Barclay, III			Regional mechanical properties of human brain tissue for computational models of traumatic brain injury	ACTA BIOMATERIALIA			English	Article						Human brain; Material properties; Viscoelasticity; Hippocampus; Cortex	VISCOELASTIC PROPERTIES; DISEASE	To determine viscoelastic shear moduli, stress relaxation indentation tests were performed on samples of human brain tissue resected in the course of epilepsy surgery. Through the use of a 500 mm diameter indenter, regional mechanical properties were measured in cortical grey and white matter and subregions of the hippocampus. All regions were highly viscoelastic. Cortical grey matter was significantly more compliant than the white matter or hippocampus which were similar in modulus. Although shear modulus was not correlated with the age of the donor, cortex from male donors was significantly stiffer than from female donors. The presented material properties will help to populate finite element models of the brain as they become more anatomically detailed. Statement of Significance We present the first mechanical characterization of fresh, post-operative human brain tissue using an indentation loading mode. Indentation generates highly localized data, allowing structure-specific mechanical properties to be determined from small tissue samples resected during surgery. It also avoids pitfalls of cadaveric tissue and allows data to be collected before degenerative processes alter mechanical properties. To correctly predict traumatic brain injury, finite element models must calculate intracranial deformation during head impact. The functional consequences of injury depend on the anatomical structures injured. Therefore, morbidity depends on the distribution of deformation across structures. Accurate prediction of structure-specific deformation requires structure-specific mechanical properties. This data will facilitate deeper understanding of the physical mechanisms that lead to traumatic brain injury. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Finan, John D.] NorthShore Univ Hlth Syst, Dept Neurosurg, 1001 Univ Pl, Evanston, IL 60201 USA; [Sundaresh, Sowmya N.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA; [Elkin, Benjamin S.] MEA Forens Engineers & Scientists, 22 Voyager Court South, Toronto, ON M9W 5M7, Canada; [McKhann, Guy M., II] Columbia Univ, Med Ctr, Dept Neurol Surg, New York Presbyterian Hosp, 710 West 168th St, New York, NY 10032 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA.	Bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Finan, John/0000-0003-4626-9702	National Highway Traffic Safety Administration [DTNH22-08-C-00088]	The authors gratefully acknowledge Dr. A.A. Sosunov at the Columbia University Medical Center and the patients who provided samples of brain tissue. This work was funded in part by the National Highway Traffic Safety Administration, project No. DTNH22-08-C-00088.	ARMSTRONG E, 1995, CEREB CORTEX, V5, P56, DOI 10.1093/cercor/5.1.56; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bilston LE, 1997, BIORHEOLOGY, V34, P377, DOI 10.1016/S0006-355X(98)00022-5; Chatelin S., 2015, J CEREB BLOOD FLOW M; Chen FQ, 2015, ANN BIOMED ENG, V43, P2903, DOI 10.1007/s10439-015-1350-3; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Elkin BS, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025386; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; Faul M, 2010, TRAUMATIC BRAIN INJU; Finan J. D, 2012, IRCOBI C DUBL IREL, V40, P474; Finan JD, 2014, BIOMECH MODEL MECHAN, V13, P573, DOI 10.1007/s10237-013-0519-7; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Garo A, 2007, BIORHEOLOGY, V44, P51; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Laksari K, 2012, J BIOMECH, V45, P642, DOI 10.1016/j.jbiomech.2011.12.023; Mao H., 2013, J NEUROTRAUMA; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McKee AC, 2015, ACTA NEUROPATHOL; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Moran R, 2014, J BIOMECH, V47, P3762, DOI 10.1016/j.jbiomech.2014.09.030; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Ono K. E, 2015, AM J SPORTS MED; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907	28	36	36	5	36	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	JUN	2017	55						333	339		10.1016/j.actbio.2017.03.037			7	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	EX7FU	WOS:000403414500025	28351681				2022-02-06	
J	Kelley, ME; Urban, JE; Miller, LE; Jones, DA; Espeland, MA; Davenport, EM; Whitlow, CT; Maldjian, JA; Stitzel, JD				Kelley, Mireille E.; Urban, Jillian E.; Miller, Logan E.; Jones, Derek A.; Espeland, Mark A.; Davenport, Elizabeth M.; Whitlow, Christopher T.; Maldjian, Joseph A.; Stitzel, Joel D.			Head Impact Exposure in Youth Football: Comparing Age- and Weight-Based Levels of Play	JOURNAL OF NEUROTRAUMA			English	Article						biomechanics; football; impact frequency; impact magnitude; mild traumatic brain injury; pediatric	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; STATES HIGH-SCHOOL; LEAGUE PLAYERS; CONCUSSION; ENCEPHALOPATHY; EPIDEMIOLOGY; KINEMATICS; SPORTS	Approximately 5,000,000 athletes play organized football in the United States, and youth athletes constitute the largest proportion with similar to 3,500,000 participants. Investigations of head impact exposure (HIE) in youth football have been limited in size and duration. The objective of this study was to evaluate HIE of athletes participating in three age-and weight-based levels of play within a single youth football organization over four seasons. Head impact data were collected using the Head Impact Telemetry (HIT) System. Mixed effects linear models were fitted, and Wald tests were used to assess differences in head accelerations and number of impacts among levels and session type (competitions vs. practices). The three levels studied were levels A (n = 39, age = 10.8 +/- 0.7 years, weight = 97.5 +/- 11.8 lb), B (n = 48, age = 11.9 +/- 0.5 years, weight = 106.1 +/- 13.8 lb), and C (n = 32, age = 13.0 +/- 0.5 years, weight = 126.5 +/- 18.6 lb). A total of 40,538 head impacts were measured. The median/95th percentile linear head acceleration for levels A, B, and C was 19.8/49.4g, 20.6/51.0g, and 22.0/57.9g, respectively. Level C had significantly greater mean linear acceleration than both levels A (p = 0.005) and B (p = 0.02). There were a significantly greater number of impacts per player in a competition than in a practice session for all levels (A, p = 0.0005, B, p = 0.0019, and C, p < 0.0001). Athletes at lower levels experienced a greater percentage of their high magnitude impacts (>= 80g) in practice, whereas those at the highest level experienced a greater percentage of their high magnitude impacts in competition. These data improve our understanding of HIE within youth football and are an important step in making evidence-based decisions to reduce HIE.	[Kelley, Mireille E.; Urban, Jillian E.; Miller, Logan E.; Jones, Derek A.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, Winston Salem, NC USA; [Espeland, Mark A.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Dept Radiol Neuroradiol, Winston Salem, NC USA; [Whitlow, Christopher T.] Wake Forest Sch Med, Clin & Translat Sci Inst, Winston Salem, NC USA; [Kelley, Mireille E.; Urban, Jillian E.; Miller, Logan E.; Jones, Derek A.; Whitlow, Christopher T.; Stitzel, Joel D.] Virginia Tech, Wake Forest Sch Biomed Engn & Sci, Winston Salem, NC USA; [Maldjian, Joseph A.] Univ Texas Southwestern, Dept Radiol, Dallas, TX USA		Stitzel, JD (corresponding author), Wake Forest Sch Med, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA.	jstitzel@wakehealth.edu	Stitzel, Joel/B-4045-2012	Stitzel, Joel/0000-0001-9762-3033; Maldjian, Joseph/0000-0002-6384-1072	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410, R01NS082453]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421]; Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001421] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Numbers R01NS094410 and R01NS082453. The National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2TR001421 supported Dr. Jillian E. Urban. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors give special thanks to the Childress Institute for Pediatric Trauma at Wake Forest Baptist Medical Center for providing support for this study. The authors also thank the youth football league's coordinators, coaches, parents, athletes, and athletic trainer whose support made this study possible. The authors also thank Amanda Dunn, Matt Bennett, Eliza Szuch, Danielle Rocheleau, Joeline Kane, Katie Fabian, Ana Katsafanas, Megan Anderson, and Leslie Hoyt for their valuable assistance in data collection.	Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Herman-Giddens ME, 2012, PEDIATRICS, V130, pE1058, DOI 10.1542/peds.2011-3291; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	41	36	35	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2017	34	11					1939	1947		10.1089/neu.2016.4812			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EV4KD	WOS:000401727500004	28274184	Green Published			2022-02-06	
J	Lewis, LM; Schloemann, DT; Papa, L; Fucetola, RP; Bazarian, J; Lindburg, M; Welch, RD				Lewis, Lawrence M.; Schloemann, Derek T.; Papa, Linda; Fucetola, Robert P.; Bazarian, Jeffrey; Lindburg, Miranda; Welch, Robert D.			Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury	ACADEMIC EMERGENCY MEDICINE			English	Article							FIBRILLARY ACIDIC PROTEIN; CONCUSSION SYMPTOMS QUESTIONNAIRE; C-TERMINAL HYDROLASE; MINOR HEAD-INJURY; INTRACRANIAL LESIONS; NEUROSURGICAL INTERVENTION; COLLABORATING-CENTER; COMPUTED-TOMOGRAPHY; TASK-FORCE; S100B	Objective: The objective was to compare test characteristics of a single serum concentration of glial fibrillary acidic protein (GFAP), S-100 beta, and ubiquitin carboxyl terminal hydrolase L1 (UCH-L1), obtained within 6 hours of head injury, to diagnose mild traumatic brain injury (mTBI) in head-injured subjects. Methods: Adults aged 18 to 80 years who presented to one of seven EDs with a blunt closed head injury underwent head CT within 4 hours of injury and had blood drawn for biomarker analysis within 6 hours of injury were eligible. Subjects were considered to have mTBI if they had an initial Glasgow Coma Scale (GCS) > 13 and met one or more of the following criteria: loss of consciousness (LOC), posttraumatic amnesia, or confusion. Subjects with mTBI and an abnormal head computed tomography (CT) scan were categorized as complicated mTBI; those with a normal head CT were categorized as uncomplicated mTBI; and subjects with a GCS = 15, no LOC, no posttraumatic amnesia, and no confusion were considered to not have a mTBI. Biomarker concentration measurements for GFAP and UCH-L1 were performed using an enzyme-linked immunosorbent assay. S-100 beta concentration was determined using an electrochemiluminescence immunoassay. Median biomarker concentration for each group was compared using the Kruskal-Wallis test. Logistic regression was used to determine area under the receiver operating curve (AUC) for each of the three biomarkers. Sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and negative and positive likelihood ratios (LRs) for the three biomarkers to differentiate between complicated mTBI, uncomplicated mTBI, and no mTBI were calculated. Results: A total of 247 subjects were enrolled and had adequate clinical and biomarker information for analysis. A total of 188 met criteria for mTBI, with 34 (18.1%) having an acute abnormality on CT (complicated mTBI). The mean (+/- SD) age of the study population was 45.8 (+/- 17.3) years, and 59.9% were male. Median serum concentrations for all biomarkers were significantly different between groups, lowest in the no mTBI group, and progressively increasing in the uncomplicated and complicated mTBI groups (p < 0.0001). All three biomarkers were significant classifiers of mTBI versus no mTBI, with the following AUCs: GFAP, 0.70; S-100 beta, 0.69; and UCHL1, 0.65 (p = 0.17). Sensitivity for mTBI was highest for S-100 beta (96.5%). NPVs ranged from 31% for UCH-L1 to 35% for GFAP. PPVs ranged from 75.5% for S-100 beta to 96.5% for GFAP. Negative LR ranged from 0.59 for GFAP to 0.71 for UCH-L1, with positive LR ranging from 1.0 for both UCH-L1 and S-100 beta to 8.7 for GFAP. Conclusion: A single serum concentration of GFAP, UCH-L1, or S-100 beta within 6 hours of head injury may be useful in identifying and stratifying the severity of brain injury in emergency department patients with head trauma, but cannot reliably exclude a diagnosis of concussion. A positive GFAP was associated with the presence of concussion.	[Lewis, Lawrence M.; Schloemann, Derek T.; Lindburg, Miranda] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO 63130 USA; [Fucetola, Robert P.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Papa, Linda] Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL USA; [Bazarian, Jeffrey] Univ Rochester, Sch Med, Dept Emergency Med, Rochester, NY USA; [Welch, Robert D.] Wayne State Univ, Dept Emergency Med, Detroit, MI USA		Lewis, LM (corresponding author), Washington Univ, Sch Med, Div Emergency Med, St Louis, MO 63130 USA.	lewisl@wustl.edu			U. S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-06-1-0517, W81XWH-10-C-0251]; Washington University; Banyan Biomarkers, Inc.; Orlando Regional Medical Center; University of Rochester School of Medicine; Wayne State University	This work is supported by the U. S. Army Medical Research and Materiel Command under Contract W81XWH-06-1-0517 and Contract W81XWH-10-C-0251. The views, opinions, and/or findings contained in this report are those of the authors and should not be construed as an official Department of the Army position, policy, or decision unless so designated by other documentation. LL reports grant money to Washington University to conduct research conceived and sponsored by Banyan Biomarkers, Inc. LP reports grant money to Orlando Regional Medical Center to conduct research conceived and sponsored by Banyan Biomarkers, Inc. She has also served as an unpaid consultant for Banyan Biomarkers, Inc. JB reports grant money to the University of Rochester School of Medicine to conduct research conceived and sponsored by Banyan Biomarkers, Inc. RW reports grant money to Wayne State University to conduct research conceived and sponsored by Banyan Biomarkers, Inc. None of the authors received consulting fees, and none have ownership in this company or other biomarker companies. DS and ML report no conflicts of interest.	Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CRITCHLOW DE, 1991, COMMUN STAT THEORY, V20, P127, DOI 10.1080/03610929108830487; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Dwass M, 1960, CONTRIBUTIONS PROBAB; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1997, NEUROLOGY, V48, P581; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Missler U, 1999, CLIN CHEM, V45, P138; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; National Hospital Discharge Survey (NHDS) 2010; National Hospital Ambulatory Medical Care Survey (NHAMCS) 2010; National Vital Statistics System (NVSS), 2010, ALL DAT SOURC MAINT; Osafo N, 2014, 40 ANN E ATL STUD RE; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Steel RGD, 1960, TECHNOMETRICS, V2, P197, DOI DOI 10.1080/00401706.1960.10489894; Swann I, 1999, TRAUMA, V1, P143; Thurman DJ., 1995, GUIDELINES SURVEILLA; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou X-H, 2009, STAT METHODS DIAGNOS; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	37	36	37	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUN	2017	24	6					710	720		10.1111/acem.13174			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine	FA2BC	WOS:000405244600007	28170122	Bronze			2022-02-06	
J	Taylor, DJ; Peterson, AL; Pruiksma, KE; Young-McCaughan, S; Nicholson, K; Mintz, J				Taylor, Daniel J.; Peterson, Alan L.; Pruiksma, Kristi E.; Young-McCaughan, Stacey; Nicholson, Karin; Mintz, Jim		STRONG STAR Consortium	Internet and In-Person Cognitive Behavioral Therapy for Insomnia in Military Personnel: A Randomized Clinical Trial	SLEEP			English	Article						Insomnia; cognitive behavior therapy; military; unguided Internet intervention; randomized clinical trial	TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCE; PSYCHIATRIC-DISORDERS; OLDER-ADULTS; POSTTRAUMATIC-STRESS; METAANALYSIS; EFFICACY; DEPRESSION; VALIDATION; SYMPTOMS	Study Objectives: Compare in-person and unguided Internet-delivered cognitive behavioral therapy for insomnia (CBTi) with a minimal contact control condition in military personnel. Methods: A three-arm parallel randomized clinical trial of 100 active duty US Army personnel at Fort Hood, Texas. Internet and in-person CBTi were comparable, except for the delivery format. The control condition consisted of phone call assessments. Results: Internet and in-person CBTi performed significantly better than the control condition on diary-assessed sleep efficiency (d = 0.89 and 0.53, respectively), sleep onset latency (d = -0.68 and -0.53), number of awakenings (d = -0.42 and -0.54), wake time after sleep onset (d = -0.88 and -0.50), the Insomnia Severity Index (d = -0.98 and -0.51), and the Dysfunctional Beliefs and Attitudes About Sleep Scale (d = -1.12 and -0.54). In-person treatment was better than Internet treatment on self-reported sleep quality (d = 0.80) and dysfunctional beliefs and attitudes about sleep (d = -0.58). There were no differences on self-reported daytime sleepiness or actigraphy-assessed sleep parameters (except total sleep time; d = -0.55 to -0.60). There were technical difficulties with the Internet treatment which prevented tailored sleep restriction upward titration for some participants. Conclusions: Despite the unique, sleep-disrupting occupational demands of military personnel, in-person and Internet CBTi are efficacious treatments for this population. The effect sizes for in-person were consistently better than Internet and both were similar to those found in civilians. Dissemination of CBTi should be considered for maximum individual and population benefits, possibly in a stepped-care model.	[Taylor, Daniel J.] Univ North Texas, Dept Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA; [Peterson, Alan L.; Pruiksma, Kristi E.; Young-McCaughan, Stacey; Mintz, Jim] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Peterson, Alan L.] South Texas Vet Hlth Care Syst, Res & Dev Serv, San Antonio, TX USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Nicholson, Karin] Carl R Darnall Army Med Ctr, Dept Med, Ft Hood, TX USA; [Mintz, Jim] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA		Taylor, DJ (corresponding author), Univ North Texas, Dept Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA.	Daniel.Taylor@unt.edu	Mintz, Jim/N-7385-2014	Mintz, Jim/0000-0002-8299-5851; Taylor, Daniel/0000-0003-3433-2516; Roache, John/0000-0002-7010-8119	US Department of Defense through the US Army Medical Research and Materiel Command; Congressionally Directed Medical Research ProgramsUnited States Department of Defense; Psychological Health and Traumatic Brain Injury Research Program [W81XWH-10-1-0828]	This study was conducted with support from the US Department of Defense through the US Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs, Psychological Health and Traumatic Brain Injury Research Program award W81XWH-10-1-0828 (PI: Dr Taylor). There was no other financial support for this research.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Andersson G, 2016, ANNU REV CLIN PSYCHO, V12, P157, DOI 10.1146/annurev-clinpsy-021815-093006; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Blom K, 2015, BEHAV RES THER, V70, P47, DOI 10.1016/j.brat.2015.05.002; Blom K, 2015, SLEEP, V38, P267, DOI 10.5665/sleep.4412; Bootzin RR, 1972, P AM PSYCHOL ASSOC, V7, P395, DOI DOI 10.1037/E465522008-198; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; Carney C. E., 2012, SLEEP, V35; CHAMBERS MJ, 1994, SLEEP, V17, P405, DOI 10.1093/sleep/17.5.405; Chang PP, 1997, AM J EPIDEMIOL, V146, P105; Cheng SK, 2012, PSYCHOTHER PSYCHOSOM, V81, P206, DOI 10.1159/000335379; Chervin RD, 1997, J PSYCHOSOM RES, V42, P145, DOI 10.1016/S0022-3999(96)00239-5; Clum GA, 2001, J NERV MENT DIS, V189, P618, DOI 10.1097/00005053-200109000-00008; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; COURSEY RD, 1980, BIOFEEDBACK SELF-REG, V5, P57, DOI 10.1007/BF00999064; de Bruin EJ, 2014, BEHAV SLEEP MED, V12, P235, DOI 10.1080/15402002.2013.784703; DRYMAN A, 1991, ACTA PSYCHIAT SCAND, V84, P1, DOI 10.1111/j.1600-0447.1991.tb01410.x; Edinger JD, 2009, SLEEP, V32, P499, DOI 10.1093/sleep/32.4.499; Epstein DR, 2012, SLEEP, V35, P797, DOI 10.5665/sleep.1878; Espie CA, 2001, BEHAV RES THER, V39, P45, DOI 10.1016/S0005-7967(99)00157-6; Espie CA, 2007, SLEEP, V30, P574, DOI 10.1093/sleep/30.5.574; Espie CA, 2009, SLEEP, V32, P1549, DOI 10.1093/sleep/32.12.1549; Espie CA, 2012, SLEEP, V35, P769, DOI 10.5665/sleep.1872; FAWCETT J, 1990, AM J PSYCHIAT, V147, P1189; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Gehrman PR., 2011, J AGGRESS MALTREAT T, V20, P904, DOI DOI 10.1080/10926771.2011.613448; Geiger-Brown JM, 2015, SLEEP MED REV, V23, P54, DOI 10.1016/j.smrv.2014.11.007; Godet-Cayre V, 2006, SLEEP, V29, P179, DOI 10.1093/sleep/29.2.179; Hall RCW, 1999, PSYCHOSOMATICS, V40, P18, DOI 10.1016/S0033-3182(99)71267-3; Ho FYY, 2015, SLEEP MED REV, V19, P17, DOI 10.1016/j.smrv.2014.06.010; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HUEDOMEDINA TB, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E8343; Irwin MR, 2006, HEALTH PSYCHOL, V25, P3, DOI 10.1037/0278-6133.25.1.3; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; JOHNS MW, 1994, SLEEP, V17, P703, DOI 10.1093/sleep/17.8.703; JOHNSON LC, 1983, MIL MED, V148, P727; Koffel EA, 2015, SLEEP MED REV, V19, P6, DOI 10.1016/j.smrv.2014.05.001; Koren D, 2002, AM J PSYCHIAT, V159, P855, DOI 10.1176/appi.ajp.159.5.855; Lancee J, 2016, SLEEP, V39, P183, DOI 10.5665/sleep.5344; Lancee J, 2013, BEHAV RES THER, V51, P797, DOI 10.1016/j.brat.2013.09.004; Leger D, 2006, SLEEP, V29, P171; Lichstein KL, 2006, SLEEP, V29, P232; Margolies SO, 2013, J CLIN PSYCHOL, V69, P1026, DOI 10.1002/jclp.21970; MATSUKAWA Y, 1994, LUPUS, V3, P31, DOI 10.1177/096120339400300107; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P1659; Mitchell MD, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-40; Morgenthaler T, 2006, SLEEP, V29, P1415; Morin CM, 2007, SLEEP, V30, P1547, DOI 10.1093/sleep/30.11.1547; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Morin CM, 1999, JAMA-J AM MED ASSOC, V281, P991, DOI 10.1001/jama.281.11.991; Morin CM, 1999, SLEEP, V22, P1134, DOI 10.1093/sleep/22.8.1134; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Morrow CE, 2013, MIL PSYCHOL, V25, P568, DOI 10.1037/mil0000021; MURTAGH DRR, 1995, J CONSULT CLIN PSYCH, V63, P79, DOI 10.1037/0022-006X.63.1.79; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Okajima I, 2011, SLEEP BIOL RHYTHMS, V9, P24, DOI 10.1111/j.1479-8425.2010.00481.x; Ozminkowski RJ, 2007, SLEEP, V30, P263, DOI 10.1093/sleep/30.3.263; PAFFENBARGER RS, 1994, ACTA PSYCHIAT SCAND, V89, P16, DOI 10.1111/j.1600-0447.1994.tb05796.x; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Peterson AL, 2013, CONTEMP CLIN TRIALS, V34, P152, DOI 10.1016/j.cct.2012.10.009; Pruiksma KE, 2016, HDB PSYCHOSOCIAL INT, P113; Respironics, 2005, ACT INSTR MAN SOFTW; Riemann D, 2009, SLEEP MED REV, V13, P205, DOI 10.1016/j.smrv.2008.06.001; Ritterband LM, 2012, PSYCHO-ONCOLOGY, V21, P695, DOI 10.1002/pon.1969; Ritterband LM, 2009, ARCH GEN PSYCHIAT, V66, P692, DOI 10.1001/archgenpsychiatry.2009.66; Roberts RE, 2000, AM J PSYCHIAT, V157, P81, DOI 10.1176/ajp.157.1.81; Rybarczyk B, 2002, PSYCHOL AGING, V17, P288, DOI 10.1037/0882-7974.17.2.288; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; Smith MT, 2005, CLIN PSYCHOL REV, V25, P559, DOI 10.1016/j.cpr.2005.04.004; SPIELMAN AJ, 1987, SLEEP, V10, P45; Strom L, 2004, J CONSULT CLIN PSYCH, V72, P113, DOI 10.1037/0022-006X.72.1.113; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; Taylor DJ, 2016, SLEEP, V39, P1795, DOI 10.5665/sleep.6156; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; van Straten A, 2014, PSYCHOL MED, V44, P1521, DOI 10.1017/S0033291713002249; Walsh JK, 1999, SLEEP, V22, pS386; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Weissman MM, 1997, GEN HOSP PSYCHIAT, V19, P245, DOI 10.1016/S0163-8343(97)00056-X; Wilson SJ, 2010, J PSYCHOPHARMACOL, V24, P1577, DOI 10.1177/0269881110379307; Young- McCaughan S, 2011, RTOMPHFM205; Zachariae R, 2016, SLEEP MED REV, V30, P1, DOI 10.1016/j.smrv.2015.10.004	89	36	37	2	14	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	JUN	2017	40	6							zsx075	10.1093/sleep/zsx075			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FA6VR	WOS:000405583100016	28472528	Bronze			2022-02-06	
J	Watson, PMD; Kavanagh, E; Allenby, G; Vassey, M				Watson, P. Marc D.; Kavanagh, Edel; Allenby, Gary; Vassey, Matthew			Bioengineered 3D Glial Cell Culture Systems and Applications for Neurodegeneration and Neuroinflammation	SLAS DISCOVERY			English	Article						Glial cell; neurodegenerative diseases; neuroinflammation; CNS and PNS diseases; 3D	IN-VITRO MODEL; PLURIPOTENT STEM-CELL; 3-DIMENSIONAL CULTURE; SNAPSHOT GENETICS; ASTROCYTE INTERACTIONS; EXTRACELLULAR-MATRIX; INDUCE RAMIFICATION; BRAIN-DEVELOPMENT; GFAP EXPRESSION; DRUG-DELIVERY	Neurodegeneration and neuroinflammation are key features in a range of chronic central nervous system (CNS) diseases such as Alzheimer's and Parkinson's disease, as well as acute conditions like stroke and traumatic brain injury, for which there remains significant unmet clinical need. It is now well recognized that current cell culture methodologies are limited in their ability to recapitulate the cellular environment that is present in vivo, and there is a growing body of evidence to show that three-dimensional (3D) culture systems represent a more physiologically accurate model than traditional two-dimensional (2D) cultures. Given the complexity of the environment from which cells originate, and their various cell-cell and cell-matrix interactions, it is important to develop models that can be controlled and reproducible for drug discovery. 3D cell models have now been developed for almost all CNS cell types, including neurons, astrocytes, microglia, and oligodendrocyte cells. This review will highlight a number of current and emerging techniques for the culture of astrocytes and microglia, glial cell types with a critical role in neurodegenerative and neuroinflammatory conditions. We describe recent advances in glial cell culture using electrospun polymers and hydrogel macromolecules, and highlight how these novel culture environments influence astrocyte and microglial phenotypes in vitro, as compared to traditional 2D systems. These models will be explored to illuminate current trends in the techniques used to create 3D environments for application in research and drug discovery focused on astrocytes and microglial cells.	[Watson, P. Marc D.; Kavanagh, Edel] Cerevance, 418 Cambridge Sci Pk Milton Rd, Cambridge CB4 0PZ, England; [Allenby, Gary; Vassey, Matthew] Aurelia Biosci, Pennyfoot St, Nottingham NG1 1GF, England		Watson, PMD (corresponding author), Cerevance, 418 Cambridge Sci Pk Milton Rd, Cambridge CB4 0PZ, England.; Vassey, M (corresponding author), Aurelia Biosci, Pennyfoot St, Nottingham NG1 1GF, England.	marc.watson@cerevance.com; vassey@aureliabio.com					Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145; Andersen Therese, 2015, Microarrays (Basel), V4, P133, DOI 10.3390/microarrays4020133; Andreasson KI, 2016, J NEUROCHEM, V138, P653, DOI 10.1111/jnc.13667; Baiguera S, 2010, J MATER SCI-MATER M, V21, P1353, DOI 10.1007/s10856-009-3944-5; Balasubramanian S, 2016, TISSUE ENG PT A, V22, P885, DOI [10.1089/ten.TEA.2016.0103, 10.1089/ten.tea.2016.0103]; Barata D, 2016, ACTA BIOMATER, V34, P1, DOI 10.1016/j.actbio.2015.09.009; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Bergstrom JS, 2016, ANN BIOMED ENG, V44, P330, DOI 10.1007/s10439-015-1455-8; Bernardinelli Y, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/232105; Beutner C, 2013, GLIA, V61, P1429, DOI 10.1002/glia.22524; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; BOOHER J, 1972, Neurobiology (Copenhagen), V2, P97; Bras J, 2015, CELL, V160, P570, DOI 10.1016/j.cell.2015.01.019; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Caliari SR, 2016, NAT METHODS, V13, P405, DOI 10.1038/nmeth.3839; Cao HQ, 2012, MACROMOL BIOSCI, V12, P666, DOI 10.1002/mabi.201100436; Casano AM, 2015, DEV CELL, V32, P469, DOI 10.1016/j.devcel.2015.01.018; Chen Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13708; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Choi J, 2015, BIOTECHNOL J, V10, P1682, DOI 10.1002/biot.201500092; Choi Se Hoon, 2015, US Neurol, V11, P102; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082; Cruz-Acuna R., 2017, MATRIX BIOL; Dash TK, 2012, MOL PHARMACEUT, V9, P2365, DOI 10.1021/mp3001952; Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064; Daud MFB, 2012, BIOMATERIALS, V33, P5901, DOI 10.1016/j.biomaterials.2012.05.008; Doorn KJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00084; Du F, 2010, J CELL BIOCHEM, V109, P30, DOI 10.1002/jcb.22375; Duke DC, 2004, DEV NEUROSCI-BASEL, V26, P30, DOI 10.1159/000080709; Durafourt Bryce A, 2013, Methods Mol Biol, V1041, P199, DOI 10.1007/978-1-62703-520-0_19; East E, 2013, REGEN MED, V8, P739, DOI 10.2217/rme.13.61; East E, 2012, TISSUE ENG PART C-ME, V18, P526, DOI [10.1089/ten.tec.2011.0587, 10.1089/ten.TEC.2011.0587]; East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017; East E, 2009, J TISSUE ENG REGEN M, V3, P634, DOI 10.1002/term.209; Figuera-Losada M, 2014, J BIOMOL SCREEN, V19, P17, DOI 10.1177/1087057113499406; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Ge D, 2013, APPL BIOCHEM BIOTECH, V170, P406, DOI 10.1007/s12010-013-0211-5; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Grodecki J, 2015, BIOTECHNOL PROGR, V31, P1406, DOI 10.1002/btpr.2123; Grubman A, 2016, J MOL NEUROSCI, V60, P390, DOI 10.1007/s12031-016-0825-5; Guerreiro R, 2015, CELL, V160, P798, DOI 10.1016/j.cell.2015.01.052; Guerreiro R, 2013, CELL, V155, P968, DOI 10.1016/j.cell.2013.10.037; Guerrini R, 2014, NEUROTHERAPEUTICS, V11, P269, DOI 10.1007/s13311-014-0267-0; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hansen E, 2010, J ALZHEIMERS DIS, V19, P451, DOI 10.3233/JAD-2010-1233; Haw RTY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-134; Hawkins BT, 2015, BRAIN RES, V1608, P167, DOI 10.1016/j.brainres.2015.02.025; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Heppner FL, 1998, GLIA, V22, P180, DOI 10.1002/(SICI)1098-1136(199802)22:2<180::AID-GLIA9>3.0.CO;2-B; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hoing S, 2012, CELL STEM CELL, V11, P620, DOI 10.1016/j.stem.2012.07.005; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hongisto V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077232; Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003; Howes AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108283; Hristovska I, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00073; Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0; Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005; Joers V., 2017, PROG NEUROBIOL; Jose S, 2015, CELL BIOL INT, V39, P1355, DOI 10.1002/cbin.10516; Joshi P, 2015, BIOSENSORS-BASEL, V5, P768, DOI 10.3390/bios5040768; Jung SM, 2012, IN VITRO CELL DEV-AN, V48, P633, DOI 10.1007/s11626-012-9566-0; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Khorshidi S, 2016, J TISSUE ENG REGEN M, V10, P715, DOI 10.1002/term.1978; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Kim SH, 2012, COLLOID SURFACE B, V90, P113, DOI 10.1016/j.colsurfb.2011.10.004; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Knight E, 2015, J ANAT, V227, P746, DOI 10.1111/joa.12257; Labour MN, 2016, ACTA BIOMATER, V37, P38, DOI 10.1016/j.actbio.2016.04.001; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lange SC, 2012, NEUROCHEM RES, V37, P2569, DOI 10.1007/s11064-012-0868-0; Langer G, 2016, HANDB EXP PHARMACOL, V232, P171, DOI 10.1007/164_2015_18; Lau CL, 2014, J NEUROCHEM, V130, P215, DOI 10.1111/jnc.12702; Lee Jae-Kyung, 2013, Methods Mol Biol, V1041, P17, DOI 10.1007/978-1-62703-520-0_3; Lins L. C., 2017, BIOMACROMOLECULES; Liu ZW, 2014, J ZHEJIANG UNIV-SC B, V15, P1013, DOI 10.1631/jzus.B1400163; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lozano R, 2015, BIOMATERIALS, V67, P264, DOI 10.1016/j.biomaterials.2015.07.022; Macaya DJ, 2013, BIOMATERIALS, V34, P3591, DOI 10.1016/j.biomaterials.2012.12.050; Maclean FL, 2016, NEUROCHEM RES, V41, P589, DOI 10.1007/s11064-015-1697-8; Mandrycky C, 2016, BIOTECHNOL ADV, V34, P422, DOI 10.1016/j.biotechadv.2015.12.011; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McKenzie JL, 2004, BIOMATERIALS, V25, P1309, DOI 10.1016/j.biomaterials.2003.08.006; Medda X, 2016, J BIOMOL SCREEN, V21, P804, DOI 10.1177/1087057116638029; Meli L, 2014, STEM CELL RES, V13, P36, DOI 10.1016/j.scr.2014.04.004; Min SK, 2015, IN VITRO CELL DEV-AN, V51, P933, DOI 10.1007/s11626-015-9925-8; Min SK, 2015, SCI REP-UK, V5, DOI 10.1038/srep14418; Min SK, 2013, J BIOMED MATER RES A, V101, P3467, DOI 10.1002/jbm.a.34654; Min SK, 2013, J BIOMED MATER RES B, V101, P1267, DOI 10.1002/jbm.b.32939; Min SK, 2013, NEUROSCI LETT, V534, P80, DOI 10.1016/j.neulet.2012.11.015; Mollers S, 2009, TISSUE ENG PT A, V15, P461, DOI 10.1089/ten.tea.2007.0107; Montanez-Sauri SI, 2015, CELL MOL LIFE SCI, V72, P237, DOI 10.1007/s00018-014-1738-5; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Nam KH, 2015, JALA-J LAB AUTOM, V20, P201, DOI 10.1177/2211068214557813; Nath S, 2016, PHARMACOL THERAPEUT, V163, P94, DOI 10.1016/j.pharmthera.2016.03.013; Nierode G, 2016, MICROBIOL BIOTECHN L, V26, P213, DOI 10.4014/jmb.1508.08007; Nierode GJ, 2016, STEM CELL REP, V7, P970, DOI 10.1016/j.stemcr.2016.10.001; Noel G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017559; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4; O'Shea RD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00050; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Ooms F, 2002, BBA-MOL BASIS DIS, V1587, P118, DOI 10.1016/S0925-4439(02)00074-1; Park J, 2015, LAB CHIP, V15, P141, DOI 10.1039/c4lc00962b; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Peretz H, 2007, TISSUE ENG, V13, P461, DOI 10.1089/ten.2005.0522; Phillips JB, 2014, METHODS MOL BIOL, V1162, P113, DOI 10.1007/978-1-4939-0777-9_9; Phillips MJ, 2011, INVEST OPHTH VIS SCI, V52, P1439, DOI 10.1167/iovs.10-6400; Pires LR, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1224; Pottler M, 2006, NEUROSCI LETT, V410, P137, DOI 10.1016/j.neulet.2006.09.082; Prasad A, 2016, REGEN MED, V11, P181, DOI 10.2217/rme.16.5; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Puschmann TB, 2014, J NEUROCHEM, V128, P878, DOI 10.1111/jnc.12519; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Ransohoff RM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020560; Ransom BR, 2012, METHODS MOL BIOL, V814, P3, DOI 10.1007/978-1-61779-452-0_1; Rao SS, 2013, ACS APPL MATER INTER, V5, P9276, DOI 10.1021/am402097j; Reilly JF, 1998, GLIA, V22, P202, DOI 10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Reyes RC, 2012, ASN NEURO, V4, P33, DOI 10.1042/AN20110059; Rezaie P, 2002, EXP CELL RES, V274, P68, DOI 10.1006/excr.2001.5431; Rocha DN, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00577, 10.3389/fncel.2015.00377]; Rosenstiel P, 2001, MICROSC RES TECHNIQ, V54, P18, DOI 10.1002/jemt.1116; Ruedinger F, 2015, APPL MICROBIOL BIOT, V99, P623, DOI 10.1007/s00253-014-6253-y; Ryan SL, 2016, ASSAY DRUG DEV TECHN, V14, P19, DOI 10.1089/adt.2015.670; Sawcer S, 2014, LANCET NEUROL, V13, P700, DOI 10.1016/S1474-4422(14)70041-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schafer DP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020545; Schilling T, 2001, EUR J NEUROSCI, V14, P463, DOI 10.1046/j.0953-816x.2001.01661.x; Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112; Shan JL, 2014, CELL BIOL INT, V38, P1233, DOI 10.1002/cbin.10325; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Singh S, 2007, J NANOSCI NANOTECHNO, V7, P2596, DOI 10.1166/jnn.2007.909; Singh V, 2014, CHEM RES TOXICOL, V27, P895, DOI 10.1021/tx500046k; Slepko N, 1996, GLIA, V16, P241; Smith I, 2015, NEUROSCI LETT, V609, P198, DOI 10.1016/j.neulet.2015.10.044; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song Q, 2014, BIOMATERIALS, V35, P6930, DOI 10.1016/j.biomaterials.2014.05.002; Sreekanthreddy Peddagangannagari, 2015, F1000Res, V4, P1279, DOI 10.12688/f1000research.7142.2; Sun YQ, 2016, ACS APPL MATER INTER, V8, P2348, DOI 10.1021/acsami.5b11473; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111; Thorne N, 2016, STEM CELL TRANSL MED, V5, P613, DOI 10.5966/sctm.2015-0170; Tieng V, 2014, STEM CELLS DEV, V23, P1535, DOI 10.1089/scd.2013.0442; Tiryaki VM, 2015, NANOMEDICINE-UK, V10, P529, DOI 10.2217/nnm.14.33; Tiryaki VM, 2012, INT J NANOMED, V7, P3891, DOI 10.2147/IJN.S32681; Tunesi M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00146; Tyzack G, 2016, CURR STEM CELL REP, V2, P236, DOI 10.1007/s40778-016-0049-1; Ugbode CI, 2016, NEUROCHEM RES, V41, P1857, DOI 10.1007/s11064-016-1911-3; Wang JD, 2016, MOL PHARMACEUT, V13, P895, DOI 10.1021/acs.molpharmaceut.5b00805; Wang P. Y., 2017, ACTA BIOMATERIAL; Watanabe K, 2007, RESTOR NEUROL NEUROS, V25, P109; Wes PD, 2016, GLIA, V64, P1710, DOI 10.1002/glia.22988; Wiebe J, 2015, CURR OPIN CARDIOL, V30, P650, DOI 10.1097/HCO.0000000000000229; Wollmer MA, 2001, J NEUROIMMUNOL, V115, P19, DOI 10.1016/S0165-5728(01)00257-0; Wu YW, 2015, TRENDS IMMUNOL, V36, P605, DOI 10.1016/j.it.2015.08.008; Xia Haijian, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P1569; Yip PK, 2009, J NEUROSCI METH, V183, P223, DOI 10.1016/j.jneumeth.2009.07.002; Yu PP, 2012, METHODS MOL BIOL, V814, P327, DOI 10.1007/978-1-61779-452-0_21; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhao Y, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/045002; Zhou K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151589; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044; Zierler S, 2005, BRAIN RES, V1039, P162, DOI 10.1016/j.brainres.2005.01.086; Zorn S, 2016, NAT REV DRUG DISCOV, V15, P302, DOI 10.1038/nrd.2016.70; Zuidema JM, 2014, BIOMATERIALS, V35, P1439, DOI 10.1016/j.biomaterials.2013.10.079	183	36	36	1	25	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2472-5552	2472-5560		SLAS DISCOV	SLAS Discov.	JUN	2017	22	5			SI		583	601		10.1177/2472555217691450			19	Biochemical Research Methods; Biotechnology & Applied Microbiology; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry	EV4KF	WOS:000401727800013	28346104	Bronze			2022-02-06	
J	DeVience, SJ; Lu, X; Proctor, J; Rangghran, P; Melhem, ER; Gullapalli, R; Fiskum, GM; Mayer, D				DeVience, Stephen J.; Lu, Xin; Proctor, Julie; Rangghran, Parisa; Melhem, Elias R.; Gullapalli, Rao; Fiskum, Gary M.; Mayer, Dirk			Metabolic imaging of energy metabolism in traumatic brain injury using hyperpolarized [1-C-13] pyruvate	SCIENTIFIC REPORTS			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; IN-VIVO; LACTATE; MODELS; RATIO	Traumatic brain injury (TBI) is known to cause perturbations in the energy metabolism of the brain, but current tests of metabolic activity are only indirect markers of energy use or are highly invasive. Here we show that hyperpolarized C-13 magnetic resonance spectroscopic imaging (MRSI) can be used as a direct, non-invasive method for studying the effects of TBI on energy metabolism. Measurements were performed on rats with moderate TBI induced by controlled cortical impact on one cerebral hemisphere. Following injection of hyperpolarized [1-C-13] pyruvate, the resulting C-13-bicarbonate signal was found to be 24 +/- 6% lower in the injured hemisphere compared with the non-injured hemisphere, while the hyperpolarized bicarbonate-to-lactate ratio was 33 +/- 8% lower in the injured hemisphere. In a control group, no significant difference in signal was found between sides of the brain. The results suggest an impairment in mitochondrial pyruvate metabolism, resulting in a decrease in aerobic respiration at the location of injury following TBI.	[DeVience, Stephen J.; Lu, Xin; Melhem, Elias R.; Gullapalli, Rao; Mayer, Dirk] Univ Maryland, Dept Diagnost Radiol & Nucl Med, Sch Med, 22 S Greene St, Baltimore, MD 21201 USA; [DeVience, Stephen J.; Lu, Xin; Melhem, Elias R.; Gullapalli, Rao; Mayer, Dirk] Univ Maryland, Ctr Metab Imaging Therapeut, Med Ctr, 22 S Greene St, Baltimore, MD 21201 USA; [Proctor, Julie; Rangghran, Parisa; Fiskum, Gary M.] Univ Maryland, Dept Anesthesiol, Sch Med, 22 S Greene St, Baltimore, MD 21201 USA; [Proctor, Julie; Rangghran, Parisa; Fiskum, Gary M.] Univ Maryland, Ctr Shock Trauma & Anesthesiol Res STAR, Sch Med, 22 S Greene St, Baltimore, MD 21201 USA; [Fiskum, Gary M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA		Mayer, D (corresponding author), Univ Maryland, Dept Diagnost Radiol & Nucl Med, Sch Med, 22 S Greene St, Baltimore, MD 21201 USA.; Mayer, D (corresponding author), Univ Maryland, Ctr Metab Imaging Therapeut, Med Ctr, 22 S Greene St, Baltimore, MD 21201 USA.	dmayer@som.umaryland.edu	DeVience, Stephen J/D-7274-2012; Mayer, Dirk/AAJ-5906-2020	DeVience, Stephen J/0000-0003-3142-7296; Mayer, Dirk/0000-0001-7557-9019	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS096575, R01 DK106395]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK106395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS096575] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health grants R21 NS096575 and R01 DK106395.	Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Day SE, 2011, MAGN RESON MED, V65, P557, DOI 10.1002/mrm.22698; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Golman K, 2006, P NATL ACAD SCI USA, V103, P11270, DOI 10.1073/pnas.0601319103; Guglielmetti C., 2016, P INT SOC MAG RESON, V24, P863; Hurd RE, 2013, MAGN RESON MED, V70, P936, DOI 10.1002/mrm.24544; Hurd RE, 2010, MAGN RESON MED, V63, P1137, DOI 10.1002/mrm.22364; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Kettunen MI, 2010, MAGN RESON MED, V63, P872, DOI 10.1002/mrm.22276; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Mayer D, 2011, MAGN RESON MED, V65, P1228, DOI 10.1002/mrm.22707; McKenna MC, 2015, NEUROCHEM RES, V40, P2527, DOI 10.1007/s11064-015-1600-7; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Park JM, 2016, NMR BIOMED, V29, P650, DOI 10.1002/nbm.3509; Park JM, 2013, NEURO-ONCOLOGY, V15, P433, DOI 10.1093/neuonc/nos319; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Serrao EM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00059; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	34	36	36	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 15	2017	7								1907	10.1038/s41598-017-01736-x			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX2OT	WOS:000425901600003	28507314	Green Published, gold			2022-02-06	
J	Houben, T; Loonen, ICM; Baca, SM; Schenke, M; Meijer, JH; Ferrari, MD; Terwindt, GM; Voskuyl, RA; Charles, A; van den Maagdenberg, AMJM; Tolner, EA				Houben, Thijs; Loonen, Inge C. M.; Baca, Serapio M.; Schenke, Maarten; Meijer, Johanna H.; Ferrari, Michel D.; Terwindt, Gisela M.; Voskuyl, Rob A.; Charles, Andrew; van den Maagdenberg, Arn M. J. M.; Tolner, Else A.			Optogenetic induction of cortical spreading depression in anesthetized and freely behaving mice	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Behavior; electrophysiology; non-invasive; optogenetics; vascular dynamics	TRAUMATIC BRAIN-INJURY; CEREBRAL-CORTEX; ANOXIC DEPOLARIZATION; TRANSGENIC MICE; MOVING RATS; MIGRAINE; CHANNELRHODOPSIN-2; PROPAGATION; ANESTHESIA; ISCHEMIA	Cortical spreading depression, which plays an important role in multiple neurological disorders, has been studied primarily with experimental models that use highly invasive methods. We developed a relatively non-invasive optogenetic model to induce cortical spreading depression by transcranial stimulation of channelrhodopsin-2 ion channels expressed in cortical layer 5 neurons. Light-evoked cortical spreading depression in anesthetized and freely behaving mice was studied with intracortical DC-potentials, multi-unit activity and/or non-invasive laser Doppler flowmetry, and optical intrinsic signal imaging. In anesthetized mice, cortical spreading depression induction thresholds and propagation rates were similar for invasive (DC-potential) and non-invasive (laser Doppler flowmetry) recording paradigms. Cortical spreading depression-related vascular and parenchymal optical intrinsic signal changes were similar to those evoked with KCl. In freely behaving mice, DC-potential and multi-unit activity recordings combined with laser Doppler flowmetry revealed cortical spreading depression characteristics comparable to those under anesthesia, except for a shorter cortical spreading depression duration. Cortical spreading depression resulted in a short increase followed by prolonged reduction of spontaneous active behavior. Motor function, as assessed by wire grip tests, was transiently and unilaterally suppressed following a cortical spreading depression. Optogenetic cortical spreading depression induction has significant advantages over current models in that multiple cortical spreading depression events can be elicited in a non-invasive and cell type-selective fashion.	[Houben, Thijs; Ferrari, Michel D.; Terwindt, Gisela M.; van den Maagdenberg, Arn M. J. M.; Tolner, Else A.] Leiden Univ, Med Ctr, Dept Neurol, POB 9600, Leiden, Netherlands; [Loonen, Inge C. M.; Schenke, Maarten; Voskuyl, Rob A.; van den Maagdenberg, Arn M. J. M.; Tolner, Else A.] Leiden Univ, Med Ctr, Dept Human Genet, POB 9600, Leiden, Netherlands; [Baca, Serapio M.; Charles, Andrew] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Meijer, Johanna H.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Lab Neurophysiol, Leiden, Netherlands		van den Maagdenberg, AMJM (corresponding author), Leiden Univ, Med Ctr, Dept Neurol, POB 9600, Leiden, Netherlands.; van den Maagdenberg, AMJM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, POB 9600, Leiden, Netherlands.	A.M.J.M.van_den_Maagdenberg@lumc.nl	Ferrari, Michel D./ABE-3758-2021; van den Maagdenberg, Arn M.J.M./AAE-9052-2019	Ferrari, Michel D./0000-0001-9691-9449; Loonen, Inge/0000-0001-9055-8419; Tolner, Else/0000-0002-6501-9971	European Union's (EU) Seventh Framework programme "EUROHEADPAIN'' [602633]; EU Marie Curie IAPP Program "BRAINPATH'' [612360]; LUMC Fellowship; Migraine Research Foundation [20142781]; Dutch Organization for Scientific Research NWO (Spinoza) [91711319]	The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: This work was supported by the European Union's (EU) Seventh Framework programme "EUROHEADPAIN'' (nr. 602633), EU Marie Curie IAPP Program "BRAINPATH'' (nr 612360), a LUMC Fellowship, the Migraine Research Foundation (nr. 20142781), and the Dutch Organization for Scientific Research NWO (Spinoza 2009, nr. 91711319).	Akcali D, 2010, CEPHALALGIA, V30, P1195, DOI 10.1177/0333102409360828; Aksenov DP, 2015, J CEREBR BLOOD F MET, V35, P1819, DOI 10.1038/jcbfm.2015.130; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; ASANUMA H, 1975, BRAIN RES, V96, P103, DOI 10.1016/0006-8993(75)90579-X; Ayata C, 2000, NEUROSCIENCE, V95, P639; Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Ayata C, 2013, CEPHALALGIA, V33, P604, DOI 10.1177/0333102412470216; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039346; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Brennan KC, 2007, J NEUROPHYSIOL, V97, P4143, DOI 10.1152/jn.00028.2007; Brodkin J, 2014, J NEUROSCI METH, V224, P48, DOI 10.1016/j.jneumeth.2013.12.010; Chang JC, 2010, BRAIN, V133, P996, DOI 10.1093/brain/awp338; Charles AC, 2013, NAT REV NEUROL, V9, P637, DOI 10.1038/nrneurol.2013.192; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Faraguna U, 2010, CEREB CORTEX, V20, P2939, DOI 10.1093/cercor/bhq041; Farkas E, 2010, NEUROIMAGE, V51, P734, DOI 10.1016/j.neuroimage.2010.02.055; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Godukhin OV, 2001, J NEUROPHYSIOL, V86, P2109, DOI 10.1152/jn.2001.86.4.2109; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Hentschke H, 1999, BRAIN RES, V830, P123, DOI 10.1016/S0006-8993(99)01399-2; Hira R, 2009, J NEUROSCI METH, V179, P258, DOI 10.1016/j.jneumeth.2009.02.001; Jasnow AM, 2013, J NEUROSCI, V33, P10396, DOI 10.1523/JNEUROSCI.5539-12.2013; LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; Muramatsu H, 2004, J CEREBR BLOOD F MET, V24, P1167, DOI 10.1097/01.WCB.0000134714.38679.2C; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Osawa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060928; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Pradhan AA, 2014, BRIT J PHARMACOL, V171, P2375, DOI 10.1111/bph.12591; Seidel JL, 2016, GLIA, V64, P5, DOI 10.1002/glia.22824; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; SUGAYA E, 1975, J NEUROPHYSIOL, V38, P822, DOI 10.1152/jn.1975.38.4.822; Sukhotinsky I, 2011, CEPHALALGIA, V31, P1601, DOI 10.1177/0333102411425865; Tepe N, 2015, EUR J NEUROSCI, V41, P120, DOI 10.1111/ejn.12753; TOBIASZ C, 1982, BRAIN RES, V241, P329, DOI 10.1016/0006-8993(82)91071-X; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Whalen MJ, 1999, J NEUROTRAUM, V16, P299, DOI 10.1089/neu.1999.16.299	44	36	37	4	21	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2017	37	5					1641	1655		10.1177/0271678X16645113			15	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	ET8CG	WOS:000400525200007	27107026	Green Published, Bronze			2022-02-06	
J	Register-Mihalik, JK; McLeod, TCV; Linnan, LA; Guskiewicz, KM; Marshall, SW				Register-Mihalik, Johna K.; McLeod, Tamara C. Valovich; Linnan, Laura A.; Guskiewicz, Kevin M.; Marshall, Stephen W.			Relationship Between Concussion History and Concussion Knowledge, Attitudes, and Disclosure Behavior in High School Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						disclosure; brain injury; education	CANCER; CARE	Objective: Examine the association between self-reported concussion history and measures of concussion knowledge, attitude, and disclosure behavior. Design: Cross-sectional survey. Setting: Classroom. Participants: A convenience sample of high school athletes (n = 167; mean age = 15.7 years) from multiple sports completed a validated survey. Independent Variables: Concussion history (main predictor) was defined as the number of self-recalled concussions during participants' high school career. Main Outcome Measures: The outcomes were recalled concussion disclosure behavior (3 measures) and scales assessing both concussion knowledge and concussion attitude. Results: A greater number of previous concussions was associated with worse attitude to concussion and negative concussion disclosure behavior. For every 3 additional self-recalled concussions, there was a mean decrease of 7.2 points (range of possible scores = 14-98) in concussion attitude score (P = 0.002), a 48% decrease in the self-reported proportion of concussion events disclosed (P = 0.013), and an increased prevalence of self-reported participation in games (67%) and practices (125%) while experiencing signs and symptoms of concussion (P< 0.001). Increased concussion history did not affect concussion knowledge score (P = 0.333). Conclusions: Negative trends in concussion disclosure behavior were identified in youth athletes with a positive history of concussion. Improving disclosure in this subgroup will require targeted efforts addressing negative attitude to concussion.	[Register-Mihalik, Johna K.; Guskiewicz, Kevin M.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Register-Mihalik, Johna K.; Guskiewicz, Kevin M.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA; [McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ USA; [McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med, Mesa, AZ USA; [Linnan, Laura A.] Univ North Carolina Chapel Hill, Dept Hlth Behav, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA		Register-Mihalik, JK (corresponding author), Matthew Gfeller Sport Related TBI Res Ctr, 2207 Stallings Evans Sports Med Ctr, Chapel Hill, NC 27599 USA.	johnakay@email.unc.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722	NFL Charities Medical Research Grant; ICRC award from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention [R49/CE002479]	Funded in part by a NFL Charities Medical Research Grant. J.R.M. and S.W.M. are partially supported by an ICRC award (R49/CE002479) from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.	Bickell NA, 2012, J CLIN ONCOL, V30, P1791, DOI 10.1200/JCO.2011.38.7605; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Corner J, 2006, SOC SCI MED, V62, P1381, DOI 10.1016/j.socscimed.2005.08.012; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; FISHBEIN M, 1975, ATTITUDE INTENTION B; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188	10	36	36	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2017	27	3					321	324		10.1097/JSM.0000000000000349			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	ET9NV	WOS:000400635100013	27437911				2022-02-06	
J	Senthinathan, A; Mainwaring, LM; Hutchison, M				Senthinathan, Arrani; Mainwaring, Lynda M.; Hutchison, Michael			Heart Rate Variability of Athletes Across Concussion Recovery Milestones: A Preliminary Study	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mild traumatic brain injury; concussion; athletes; heart rate variability	TRAUMATIC BRAIN-INJURY; SAMPLE ENTROPY; BLOOD-PRESSURE; MENTAL STRESS; WORK; REST; RISK	Objective: To assess heart rate variability (HRV) in athletes with concussion across three phases of recovery. Design: A prospective matched control group design included the collection of HRV and symptoms measured by the Rivermead Post-Concussion Questionnaire. These measures were taken at 3 phases of recovery [(1) symptomatic; (2). asymptomatic; and (3) one-week after return-to-play (RTP)]. The same protocol was completed by noninjured athletes. Setting: Interuniversity sports teams at a single institution. Participants: 11 athletes, across 7 sports, diagnosed with concussion, and 11 matched-athlete controls volunteered for the study. Intervention: Physician diagnosed concussion and a sitting to standing protocol for HRV monitoring. Main Outcome Measures: The frequency, time, and nonlinear domains of HRV were assessed along with the absolute difference between sitting and standing for each. Results: A 2 x 3 (group x phase) repeated-measures analysis of variance revealed significant interactions for sitting High Frequency (HF) norm, sitting Low Frequency (LF) norm, the difference between sitting and standing HF norm, and difference between sitting and standing LF norm. Acutely, athletes with concussion displayed increased LF norm and decreased HF norm while sitting and a decreased change in their HF and LF norm measures between sitting and standing. A significant group effect for sample entropy when standing was detected, with the concussed group displaying decreased values compared with the matched controls. Conclusions: Athletes with concussion displayed autonomic dysfunction in some measures of HRV that persisted beyond RTP and were related to a previous history of concussion.	[Senthinathan, Arrani; Mainwaring, Lynda M.; Hutchison, Michael] Univ Toronto, Fac Kinesiol & Phys Educ, Exercise Sci, Toronto, ON, Canada		Mainwaring, LM (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, 55 Harbord St, Toronto, ON M5S 2W6, Canada.	lynda.mainwaring@utoronto.ca			Canadian Institute for Health ResearchCanadian Institutes of Health Research (CIHR); Ontario Neurotrauma Foundation; Faculty of Kinesiology and Physical Education	This study was funded by the Canadian Institute for Health Research, the Ontario Neurotrauma Foundation, and the Faculty of Kinesiology and Physical Education.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Al-Angari HM, 2007, IEEE T BIO-MED ENG, V54, P1900, DOI 10.1109/TBME.2006.889772; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Beaumont LD, 2011, HDB SPORT NEUROPSYCH, P155; Bigler ED, 2012, NEUROSCI LETT, V509, P1, DOI 10.1016/j.neulet.2011.12.009; Bilchick KC, 2006, J CARDIOVASC ELECTR, V17, P691, DOI 10.1111/j.1540-8167.2006.00501.x; Billman GE, 2006, J APPL PHYSIOL, V100, P896, DOI 10.1152/japplphysiol.01328.2005; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Boullosa DA, 2012, EUR J APPL PHYSIOL, V112, P2233, DOI 10.1007/s00421-011-2202-y; Buchheit M, 2010, EUR J APPL PHYSIOL, V109, P571, DOI 10.1007/s00421-010-1385-y; Camm AJ, 1996, EUR HEART J, V17, P354; Frodl T, 2013, NEUROBIOL DIS, V52, P24, DOI 10.1016/j.nbd.2012.03.012; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Henden PL, 2014, J NEUROSURG ANESTH, V26, P50, DOI 10.1097/ANA.0b013e3182a47b62; Hjortskov N, 2004, EUR J APPL PHYSIOL, V92, P84, DOI 10.1007/s00421-004-1055-z; Kahn AAS, 2013, INT C INF EL VIS, P17; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King ML, 1997, BRAIN INJURY, V11, P445; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; La Fountaine MF, 2011, J ATHL TRAINING, V46, P230; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lewis MJ, 2007, PHYSIOL MEAS, V28, P731, DOI 10.1088/0967-3334/28/6/011; McCraty Rollin, 2015, Glob Adv Health Med, V4, P46, DOI 10.7453/gahmj.2014.073; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Renu C. H., 2010, INT J COMPUTER THEOR, V2, P1793; RenuMadhavi C.H., 2010, INT J COMPUTER APPL, V8, P10; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Uusitalo A, 2011, APPL ERGON, V42, P830, DOI 10.1016/j.apergo.2011.01.005; Vrijkotte TGM, 2000, HYPERTENSION, V35, P880, DOI 10.1161/01.HYP.35.4.880; Vuksanovic V, 2007, MED ENG PHYS, V29, P344, DOI 10.1016/j.medengphy.2006.05.011; Yarnell J, 2008, EUR HEART J, V29, P579, DOI 10.1093/eurheartj/ehm641; Young FLS, 2011, APPL PHYSIOL NUTR ME, V36, P210, DOI [10.1139/h10-103, 10.1139/H10-103]	37	36	37	0	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2017	27	3					288	295		10.1097/JSM.0000000000000337			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	ET9NV	WOS:000400635100009	27379659				2022-02-06	
J	Fu, WW; Fu, TS; Jing, R; McFaull, SR; Cusimano, MD				Fu, Wayne W.; Fu, Terence S.; Jing, Rowan; McFaull, Steven R.; Cusimano, Michael D.			Predictors of falls and mortality among elderly adults with traumatic brain injury: A nationwide, population-based study	PLOS ONE			English	Article							OLDER-ADULTS; MULTIFACTORIAL INTERVENTION; REDUCE FALLS; RISK; AGE; HOSPITALIZATION; EPIDEMIOLOGY; METAANALYSIS; PREVENTION; SEVERITY	Background Elderly adults are at particular risk of sustaining a traumatic brain injury (TBI), and tend to suffer worse outcomes compared to other age groups. Falls are the leading cause of TBI among the elderly. Methods We examined nationwide trends in TBI hospitalizations among elderly adults (ages 65 and older) between April 2006 and March 2011 using a population-based database that is mandatory for all hospitals in Canada. Trends in admission rates were analyzed using linear regression. Predictors of falls and in-hospital mortality were identified using logistic regression. Results Between 2006 and 2011, there were 43,823 TBI hospitalizations resulting in 6,939 deaths among elderly adults in Canada. Over the five-year study period, the overall rate of TBI admissions increased by an average of 6% per year from 173.2 to 214.7 per 100,000, while the rate of fall-related TBI increased by 7% annually from 138.6 to 179.2 per 100,000. There were significant trends towards increasing age and comorbidity level (p< 0.001 and p = 0.002). Advanced age, comorbidity, and injury severity were independent predictors of both TBI-related falls and mortality on multivariate analysis. Conclusion Prevention efforts should be targeted towards vulnerable demographics including the "older old" (ages 85 and older) and those with multiple medical comorbidities. Additionally, hospitals and long-term care facilities should be prepared to manage the burgeoning population of older patients with more complex comorbidities.	[Fu, Wayne W.] Albany Med Coll, Albany, NY USA; [Fu, Terence S.; Jing, Rowan; Cusimano, Michael D.] St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Fu, Terence S.; Jing, Rowan; Cusimano, Michael D.] Keenan Res Ctr, Li Ka Shing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada; [Fu, Terence S.; Jing, Rowan; Cusimano, Michael D.] Univ Toronto, Toronto, ON, Canada; [McFaull, Steven R.] Publ Hlth Agcy Canada, Hlth Surveillance & Epidemiol Div, Injury Sect, Ottawa, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada		Cusimano, MD (corresponding author), St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Keenan Res Ctr, Li Ka Shing Knowledge Inst, Injury Prevent Res Off, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Univ Toronto, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019		Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946 and the Ontario Neurotrauma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Bohnert N., 2014, POPULATION PROJECTIO; Campbell AJ, 2007, AGE AGEING, V36, P656, DOI 10.1093/ageing/afm122; Centers for Disease Control and Prevention, 2010, EXT CAUS INJ MORT MA; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CIoHI, 2012, CIHI DAT QUAL STUD 2; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Coronado VG, 2012, EPIDEMIOLOGY PREVENT, P45; Cryer C, 2006, INJURY PREV, V12, P67, DOI 10.1136/ip.2006.011668; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; de Vries OJ, 2010, ARCH INTERN MED, V170, P1110, DOI 10.1001/archinternmed.2010.169; Donohue JT, 2007, J TRAUMA, V62, P419, DOI 10.1097/01.ta.0000219286.88179.18; Faul M, 2010, TRAUMATIC BRAIN INJU; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fu TS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145469; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; Gillespie LD, 2012, COCHRANE DATABASE SY, V9; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Huang AR, 2012, DRUG AGING, V29, P359, DOI 10.2165/11599460-000000000-00000; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murphy TE, 2014, J GERONTOL GERIATR R, V3, P3; Ortman JM, 2014, AGING NATION OLDER P, V1140, P1; Perula LA, 2012, ARCH PHYS MED REHAB, V93, P1677, DOI 10.1016/j.apmr.2012.03.035; Petridou ET, 2009, J AGING HEALTH, V21, P713, DOI 10.1177/0898264309338298; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Selassie AW, 2014, J HEAD TRAUMA REHAB, V29, pE8, DOI 10.1097/HTR.0b013e3182976ad3; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ., 1995, STANDARDS SURVEILLAN; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	46	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2017	12	4							e0175868	10.1371/journal.pone.0175868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES9KN	WOS:000399876100019	28430782	Green Submitted, gold, Green Published			2022-02-06	
J	Barrett, JP; Henry, RJ; Villapol, S; Stoica, BA; Kumar, A; Burns, MP; Faden, AI; Loane, DJ				Barrett, James P.; Henry, Rebecca J.; Villapol, Sonia; Stoica, Bogdan A.; Kumar, Alok; Burns, Mark P.; Faden, Alan I.; Loane, David J.			NOX2 deficiency alters macrophage phenotype through an IL-10/ STAT3 dependent mechanism: implications for traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						NADPH oxidase; NOX2; Traumatic brain injury; Macrophage; Neuroinflammation; Interleukin-10	LIPOPOLYSACCHARIDE-INDUCED NEUROTOXICITY; NADPH OXIDASE; ALTERNATIVE ACTIVATION; GENE-EXPRESSION; FUNCTIONAL RECOVERY; OXIDATIVE STRESS; INTERLEUKIN-10; POLARIZATION; INHIBITION; MICROGLIA	Background: NADPH oxidase (NOX2) is an enzyme system that generates reactive oxygen species (ROS) in microglia and macrophages. Excessive ROS production is linked with neuroinflammation and chronic neurodegeneration following traumatic brain injury (TBI). Redox signaling regulates macrophage/ microglial phenotypic responses (pro-inflammatory versus anti-inflammatory), and NOX2 inhibition following moderate-tosevere TBI markedly reduces pro-inflammatory activation of macrophages/ microglia resulting in concomitant increases in anti-inflammatory responses. Here, we report the signaling pathways that regulate NOX2-dependent macrophage/ microglial phenotype switching in the TBI brain. Methods: Bone marrow-derived macrophages (BMDMs) prepared from wildtype (C57Bl/ 6) and NOX2 deficient (NOX2-/-) mice were treated with lipopolysaccharide (LPS; 10 ng/ ml), interleukin-4 (IL-4; 10 ng/ml), or combined LPS/ IL-4 to investigate signal transduction pathways associated with macrophage activation using western immunoblotting and qPCR analyses. Signaling pathways and activation markers were evaluated in ipsilateral cortical tissue obtained from adult male wildtype and NOX2-/-mice that received moderate-level controlled cortical impact (CCI). A neutralizing anti-IL-10 approach was used to determine the effects of IL-10 on NOX2-dependent transitions from pro-to anti-inflammatory activation states. Results: Using an LPS/ IL-4-stimulated BMDM model that mimics the mixed pro-and anti-inflammatory responses observed in the injured cortex, we show that NOX2-/-significantly reduces STAT1 signaling and markers of proinflammatory activation. In addition, NOX2-/-BMDMs significantly increase anti-inflammatory marker expression; IL-10-mediated STAT3 signaling, but not STAT6 signaling, appears to be critical in regulating this anti-inflammatory response. Following moderate-level CCI, IL-10 is significantly increased in microglia/macrophages in the injured cortex of NOX2-/-mice. These changes are associated with increased STAT3 activation, but not STAT6 activation, and a robust anti-inflammatory response. Neutralization of IL-10 in NOX2(-/-)BMDMs or CCI mice blocks STAT3 activation and the anti-inflammatory response, thereby demonstrating a critical role for IL-10 in regulating NOX2-dependent transitions between pro-and anti-inflammatory activation states. Conclusions: These studies indicate that following TBI NOX2 inhibition promotes a robust anti- inflammatory response in macrophages/ microglia that is mediated by the IL-10/ STAT3 signaling pathway. Thus, therapeutic interventions that inhibit macrophage/ microglial NOX2 activity may improve TBI outcomes by not only limiting pro- inflammatory neurotoxic responses, but also enhancing IL-10-mediated anti- inflammatory responses that are neuroprotective.	[Barrett, James P.; Henry, Rebecca J.; Stoica, Bogdan A.; Kumar, Alok; Faden, Alan I.; Loane, David J.] Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res STAR Ctr, 655 West Baltimore St,6-011, Baltimore, MD 21201 USA; [Villapol, Sonia; Burns, Mark P.] Georgetown Univ, Dept Neurosci, Lab Brain Injury & Dementia, Washington, DC USA		Loane, DJ (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res STAR Ctr, 655 West Baltimore St,6-011, Baltimore, MD 21201 USA.	dloane@anes.umm.edu	Loane, David/ABD-5177-2021; STOICA, BOGDAN/H-9782-2013; Villapol, Sonia/D-1949-2014	Loane, David/0000-0003-0393-3503; STOICA, BOGDAN/0000-0002-2501-6434; Villapol, Sonia/0000-0002-6174-4113; Burns, Mark P/0000-0003-4750-2000; Barrett, James/0000-0002-0924-9449; Henry, Rebecca/0000-0001-8548-1170; Faden, Alan I./0000-0003-0128-2348	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS082308 (D.J.Loane), R01NS037313 (A.I. Faden), R01 NS067417 (M.P. Burns)]; National Institute on Aging (NIA) Claude D. Pepper Older Americans Independence Center [P30-AG028747]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046717, R01NS082308, R01NS037313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG028747] Funding Source: NIH RePORTER	This work was supported by NIH grant R01NS082308 (D.J.Loane), R01NS037313 (A.I. Faden), R01 NS067417 (M.P. Burns), and The National Institute on Aging (NIA) Claude D. Pepper Older Americans Independence Center P30-AG028747 ( D.J. Loane).	Barrett JP, 2015, EXP CELL RES, V335, P258, DOI 10.1016/j.yexcr.2015.05.015; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Bermudez S, 2016, MOL CELL NEUROSCI, V77, P53, DOI 10.1016/j.mcn.2016.10.001; Brune B, 2013, ANTIOXID REDOX SIGN, V19, P595, DOI 10.1089/ars.2012.4785; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Byrnes KR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-130; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grilli M, 2000, EUR J NEUROSCI, V12, P2265, DOI 10.1046/j.1460-9568.2000.00090.x; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Ishii H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.234; Kelly B, 2015, J BIOL CHEM, V290, P20348, DOI 10.1074/jbc.M115.662114; Khayrullina G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0391-8; Kim CC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0581-z; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Ma SF, 2015, BRAIN BEHAV IMMUN, V45, P157, DOI 10.1016/j.bbi.2014.11.007; Makita N, 2015, INT IMMUNOL, V27, P131, DOI 10.1093/intimm/dxu090; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Padgett LE, 2015, DIABETES, V64, P4171, DOI 10.2337/db15-0546; Perez-de Puig I, 2013, J CEREBR BLOOD F MET, V33, P1955, DOI 10.1038/jcbfm.2013.155; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qian L, 2006, J PHARMACOL EXP THER, V319, P44, DOI 10.1124/jpet.106.106351; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Tian DS, 2016, J NEUROCHEM, V139, P96, DOI 10.1111/jnc.13751; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001	63	36	37	1	16	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	MAR 24	2017	14								65	10.1186/s12974-017-0843-4			17	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	EP9BO	WOS:000397668900002	28340575	gold, Green Published			2022-02-06	
J	Bretzin, AC; Mansell, JL; Tierney, RT; McDevitt, JK				Bretzin, Abigail C.; Mansell, Jamie L.; Tierney, Ryan T.; McDevitt, Jane K.			Sex Differences in Anthropometrics and Heading Kinematics Among Division I Soccer Athletes: A Pilot Study	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						biomechanics; head injuries/concussion; neck strength; cervical musculature	TRAUMATIC BRAIN-INJURY; SEGMENT DYNAMIC STABILIZATION; DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; MUSCLE STRENGTH; NECK STRENGTH; PLAYERS; ACCELERATION; CONCUSSION; BIOMECHANICS	Background: Soccer players head the ball repetitively throughout their careers; this is also a potential mechanism for a concussion. Although not all soccer headers result in a concussion, these subconcussive impacts may impart acceleration, deceleration, and rotational forces on the brain, leaving structural and functional deficits. Stronger neck musculature may reduce head-neck segment kinematics. Hypothesis: The relationship between anthropometrics and soccer heading kinematics will not differ between sexes. The relationship between anthropometrics and soccer heading kinematics will not differ between ball speeds. Study Design: Pilot, cross-sectional design. Methods: Division I soccer athletes (5 male, 8 female) were assessed for head-neck anthropometric and neck strength measurements in 6 directions (ie, flexion, extension, right and left lateral flexions and rotations). Participants headed the ball 10 times (25 or 40 mph) while wearing an accelerometer secured to their head. Kinematic measurements (ie, linear acceleration and rotational velocity) were recorded at 2 ball speeds. Results: Sex differences were observed in neck girth (t = 5.09, P < 0.001), flexor and left lateral flexor strength (t = 3.006, P = 0.012 and t = 4.182, P = 0.002, respectively), and rotational velocity at both speeds (t = -2.628, P = 0.024 and t = -2.227, P = 0.048). Neck girth had negative correlations with both linear acceleration (r = -0.599, P = 0.031) and rotational velocity at both speeds (r = -0.551, P = 0.012 and r = -0.652, P = 0.016). Also, stronger muscle groups had lower linear accelerations at both speeds (P < 0.05). Conclusion: There was a significant relationship between anthropometrics and soccer heading kinematics for sex and ball speeds.	[Bretzin, Abigail C.] Michigan State Univ, Dept Kinesiol, 308 West Circle Dr, E Lansing, MI 48824 USA; [Mansell, Jamie L.; Tierney, Ryan T.] Temple Univ, Dept Kinesiol, Philadelphia, PA 19122 USA; [McDevitt, Jane K.] East Stroudsburg Univ, Dept Athlet Training, East Stroudsburg, PA USA		Bretzin, AC (corresponding author), Michigan State Univ, Dept Kinesiol, 308 West Circle Dr, E Lansing, MI 48824 USA.	bretzina@msu.edu		Bretzin, Abigail/0000-0003-3730-2849			Aagaard P, 2001, J PHYSIOL-LONDON, V534, P613, DOI 10.1111/j.1469-7793.2001.t01-1-00613.x; Agel J, 2007, J ATHL TRAINING, V42, P270; ALWAY SE, 1989, J APPL PHYSIOL, V66, P2725, DOI 10.1152/jappl.1989.66.6.2725; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; De Witt JK, 2012, SPORT BIOMECH, V11, P382, DOI 10.1080/14763141.2012.661757; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Dick R, 2007, J ATHL TRAINING, V42, P278; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Ferraz R, 2012, J HUM KINET, V35, P97, DOI 10.2478/v10078-012-0083-8; Gilchrist MD, 2004, STRAIN, V40, P180, DOI 10.1111/j.1475-1305.2004.00168.x; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; MACDOUGALL JD, 1979, MED SCI SPORT EXER, V11, P164; Mansell J, 2005, J ATHL TRAINING, V40, P310; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PLAGENHOEF S, 1983, RES Q EXERCISE SPORT, V54, P169, DOI 10.1080/02701367.1983.10605290; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Zaumseil F., 2011, FOOTWEAR SCI S1, V3, pS172	33	36	36	1	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAR-APR	2017	9	2					168	173		10.1177/1941738116678615			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EY5WQ	WOS:000404052200010	28225689	Green Published			2022-02-06	
J	Swanson, TM; Isaacson, BM; Cyborski, CM; French, LM; Tsao, JW; Pasquina, PF				Swanson, Thomas M.; Isaacson, Brad M.; Cyborski, Cherina M.; French, Louis M.; Tsao, Jack W.; Pasquina, Paul F.			Traumatic Brain Injury Incidence, Clinical Overview, and Policies in the US Military Health System Since 2000	PUBLIC HEALTH REPORTS			English	Article						blast injury; classification; military; TBI; traumatic brain injury	GLASGOW COMA SCALE; SERVICE MEMBERS; SUBARACHNOID HEMORRHAGE; COGNITIVE COMPLAINTS; ENDURING FREEDOM; IRAQI FREEDOM; HEAD-INJURY; MILD; MANAGEMENT; REHABILITATION	Exposure to explosive armaments during Operation Iraqi Freedom and Operation Enduring Freedom contributed to approximately 14% of the 352612 traumatic brain injury (TBI) diagnoses in the US military between 2000 and 2016. The US Department of Defense issued guidelines in 2009 to (1) standardize TBI diagnostic criteria; (2) classify TBI according to mechanism and severity; (3) categorize TBI symptoms as somatic, psychological, or cognitive; and (4) systematize types of care given during the acute and rehabilitation stages of TBI treatment. Polytrauma and associated psychological and neurologic conditions may create barriers to optimal rehabilitation from TBI. Given the completion of recent combat operations and the transition of TBI patients into long-term care within the US Department of Veterans Affairs system, a review of the literature concerning TBI is timely. Long-term follow-up care for patients who have sustained TBI will remain a critical issue for the US military.	[Swanson, Thomas M.; Isaacson, Brad M.; Cyborski, Cherina M.; French, Louis M.; Tsao, Jack W.; Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Ctr Rehabil Sci Res, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA; [Swanson, Thomas M.; Isaacson, Brad M.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Swanson, Thomas M.] Walter Reed Natl Mil Med Ctr, Dept Orthopaed, Bethesda, MD USA; [Cyborski, Cherina M.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [French, Louis M.] Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Tsao, Jack W.] US Navy, Bur Med & Surg Wounded Ill & Injured, Falls Church, VA USA; [Pasquina, Paul F.] Walter Reed Natl Mil Med Ctr, Dept Rehabil, Bethesda, MD USA		Swanson, TM (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Rehabil Sci Res, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA.	tmswanson@live.com	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604	Center for Rehabilitation Science Research, Department of Physical Medicine and Rehabilitation, Uniformed Services University of the Health Sciences, Bethesda, MD, USA [HU0001-11-1-0004, HU0001-15-2-0003]	This work is supported by the Center for Rehabilitation Science Research, Department of Physical Medicine and Rehabilitation, Uniformed Services University of the Health Sciences, Bethesda, MD, USA, awards HU0001-11-1-0004 and HU0001-15-2-0003.	Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Bagalman, 2013, TRAUMATIC BRAIN INJU; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Centers for Disease Control and Prevention, 2008, EXPL BLAST INJ PRIM; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cifu D, 2011, OVERCOMING POSTDEPLO; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Curry R, 2008, PEDIATR CRIT CARE ME, V9, P141; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Dunn IF, 2008, ACUTE BRAIN SPINAL C, P1; Fischer H., 2014, GUIDE US MILITARY CA; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Greenwald BA, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50052; Gruen P, 2002, NEUROIMAG CLIN N AM, V12, P339, DOI 10.1016/S1052-5149(02)00013-8; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Isaacson BM, 2014, ORTHOP RES REV, V6, P27, DOI 10.2147/ORR.S56636; Isaacson Brad M, 2010, US Army Med Dep J, P31; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kennedy JE, 2010, NEUROREHABILITATION, V26, P191, DOI 10.3233/NRE-2010-0555; Kim E, 2002, NEUROREHABILITATION, V17, P297; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Management of Concussion/mTBI Working Group, 2016, VA DOD CLIN PRACT GU; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Schmid Kara E, 2012, Front Neurol, V3, P90, DOI 10.3389/fneur.2012.00090; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Taber KH, 2010, PTSD RES Q, V21, P1; Taielian T, 2008, INVISIBLE WOUNDS WAR; TEASDALE G, 1974, LANCET, V2, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thornton KE, 2008, APPL PSYCHOPHYS BIOF, V33, P101, DOI 10.1007/s10484-008-9056-z; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; US Department of Defense, 2016 DOD TBI WORLDW; US Department of Defense US Department of Veterans Affairs, TRAUM BRAIN INJ TBI; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wortzel HS, 2011, J AM ACAD PSYCHIATRY, V39, P511; Yang FPG, 2011, P INT SOC MAG RESON, V19, P346; Yuh EL, 2010, NEUROIMAG CLIN N AM, V20, P597, DOI 10.1016/j.nic.2010.07.012; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	85	36	38	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0033-3549	1468-2877		PUBLIC HEALTH REP	Public Health Rep.	MAR-APR	2017	132	2					251	259		10.1177/0033354916687748			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	EP5XU	WOS:000397453100018	28135424	Green Published, Bronze			2022-02-06	
J	Zhong, JJ; Cheng, CJ; Liu, H; Huang, ZJ; Wu, Y; Teng, ZP; He, JC; Zhang, HR; Wu, JC; Cao, F; Jiang, L; Sun, XC				Zhong, Jianjun; Cheng, Chongjie; Liu, Han; Huang, Zhijian; Wu, Yue; Teng, Zhipeng; He, Junchi; Zhang, Hongrong; Wu, Jinchuan; Cao, Fang; Jiang, Li; Sun, Xiaochuan			BEXAROTENE PROTECTS AGAINST TRAUMATIC BRAIN INJURY IN MICE PARTIALLY THROUGH APOLIPOPROTEIN E	NEUROSCIENCE			English	Article						traumatic brain injury; bexarotene; apolipoprotein E; inflammation; apoptosis	CLOSED-HEAD INJURY; E-DEFICIENT MICE; PPAR-GAMMA AGONIST; AD MOUSE MODELS; INFLAMMATORY RESPONSES; ALZHEIMERS-DISEASE; REVERSE DEFICITS; MOTOR DEFICITS; X-RECEPTORS; NEUROPROTECTION	Bexarotene has been proved to have neuroprotective effects in many animal models of neurological diseases. However, its neuroprotection in traumatic brain injury (TBI) is still unknown. This study aims to explore the neuroprotective effects of bexarotene on TBI and its possible mechanism. Controlled cortical impact (CCI) model was used to simulate TBI in C57BL/6 mice as well as APOE gene knockout (APOE-KO) mice. After CCI, mice were daily dosed with bexarotene or vehicle solution intraperitoneally. The motor function, learning and memory, inflammatory factors, microglia amount, apoptosis condition around injury site and main side-effects were all measured. The results showed that, after CCI, bexarotene treatment markedly improved the motor function and spatial memory in C57BL/6 compare to APOE-KO mice which showed no improvement. The inflammatory cytokines, microglia amount, cell apoptosis rate, and protein of cleaved caspase-3 around the injury site were markedly upregulated after TBI in both C57BL/6 and APOE-KO mice, and all these upregulation were significantly mitigated by bexarotene treatment in C57BL/6 mice, but not in APOE-KO mice. No side-effects were detected after consecutive administration. Taken together, bexarotene inhibits the inflammatory response as well as cell apoptosis and improves the neurological function of mice after TBI partially through apolipoprotein E. This may make it a promising candidate for the therapeutic treatment after TBI. (C) 2016 Published by Elsevier Ltd on behalf of IBRO.	[Zhong, Jianjun; Cheng, Chongjie; Liu, Han; Huang, Zhijian; Wu, Yue; Teng, Zhipeng; He, Junchi; Zhang, Hongrong; Wu, Jinchuan; Jiang, Li; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China; [Cao, Fang] Zunyi Med Coll, Affiliated Hosp 1, Dept Cerebrovasc, Zunyi 653000, Guizhou, Peoples R China		Jiang, L; Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China.		He, Junchi/AAD-8482-2019	sun, xiao chuan/0000-0001-6992-332X; Huang, Zhijian/0000-0002-8241-0761	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159, 81371319]; Chongqing Graduate Innovation Project [40010200100417]	This work was supported by grants from the National Natural Science Foundation of China (grant No.: 81571159, 81371319) and the Chongqing Graduate Innovation Project (grant No.: 40010200100417). We express special acknowledgement to "Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology" for providing experimental platform. We also appreciate Yong Jiang from Southwest Medical University, Jie Ma, Xiaocui Tian and Mei Yang from Chongqing Medical University for their technical support, Rami Darwazeh from the first affiliated hospital of Chongqing Medical University for language modification.	Aicardi G, 2013, REJUV RES, V16, P524, DOI 10.1089/rej.2013.1497; Bachmeier C, 2013, J MOL NEUROSCI, V49, P270, DOI 10.1007/s12031-012-9866-6; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Bennett RE, 2014, J NEUROTRAUM, V31, P1647, DOI 10.1089/neu.2013.3320; Bomben V, 2014, NEUROBIOL AGING, V35, P2091, DOI 10.1016/j.neurobiolaging.2014.03.029; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Christensen DJ, 2011, J IMMUNOL, V186, P2535, DOI 10.4049/jimmunol.1002847; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Fang Cao YJ, 2015, APOLIPOPROTEIN E MIM; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; Jiang L, 2015, NEUROSCIENCE, V301, P375, DOI 10.1016/j.neuroscience.2015.06.005; Jiang L, 2011, NEUROSCI LETT, V505, P160, DOI 10.1016/j.neulet.2011.10.011; Jiang Y, 2008, ACTA NEUROCHIR SUPPL, V105, P233; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Lerner V, 2013, J CLIN PSYCHIAT, V74, P1224, DOI 10.4088/JCP.12m08160; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lomnitski L, 1999, BBA-MOL BASIS DIS, V1453, P359, DOI 10.1016/S0925-4439(99)00010-1; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; McFarland K, 2013, ACS CHEM NEUROSCI, V4, P1430, DOI 10.1021/cn400100f; Namjoshi DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053529; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Riancho J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00250; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Siopi E, 2013, NEUROPHARMACOLOGY, V67, P183, DOI 10.1016/j.neuropharm.2012.11.009; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Xu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122744; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zhai PP, 2015, NEUROPHARMACOLOGY, V95, P1, DOI 10.1016/j.neuropharm.2015.02.026; Zhang CL, 2006, DERMATOL THER, V19, P264, DOI 10.1111/j.1529-8019.2006.00083.x; Zhou S, 2013, FEBS LETT, V587, P254, DOI 10.1016/j.febslet.2012.12.003	45	36	39	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	FEB 20	2017	343						434	448		10.1016/j.neuroscience.2016.05.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ5PB	WOS:000393269100041	27235741				2022-02-06	
J	Ngo, KT; Varner, EL; Michael, AC; Weber, SG				Ngo, Khanh T.; Varner, Erika L.; Michael, Adrian C.; Weber, Stephen G.			Monitoring Dopamine Responses to Potassium Ion and Nomifensine by in Vivo Microdialysis with Online Liquid Chromatography at One-Minute Resolution	ACS CHEMICAL NEUROSCIENCE			English	Article						Capillary liquid chromatography; electrochemical detection; principal component analysis; dexamethasone; chronic implantation	FREELY MOVING RATS; EXTRACELLULAR DOPAMINE; QUANTITATIVE MICRODIALYSIS; ELECTROCHEMICAL DETECTION; SPREADING DEPRESSION; FLUORESCENCE DETECTION; TEMPORAL RESOLUTION; BRAIN MICRODIALYSIS; PENETRATION INJURY; NUCLEUS-ACCUMBENS	Recently, our laboratory has demonstrated the technical feasibility of monitoring dopamine at 1 min temporal resolution with microdialysis and online liquid chromatography. Here, we monitor dopamine in the rat striatum during local delivery of high potassium/low sodium or nomifensine in awake behaving rats. Microdialysis probes were implanted and perfused continuously with or without dexamethasone in the perfusion fluid for 4 days. Dexamethasone is an anti-inflammatory agent that exhibits several positive effects on the apparent health of the 0 brain tissue surrounding microdialysis probes. Dopamine was monitored 1 or 4 days after implantation under basal conditions, during 10 min applications of 60 mM or 100 mM K+, and during 15 mM applications of 10 mu M nomifensine. High K+ and nomifensine were delivered locally by adding them to the microdialysis perfusion fluid using a computer-controlled, low-dead volume six-port valve. Each day/K+/dexamethasone combination elicited specific dopamine responses. Dexamethasone treatment increased dopamine levels in basal dialysates (i.e., in the absence of K+ or nomifensine). Applications of 60 mM K+ evoked distinct responses on days one and four after probe implantation, depending upon the presence or absence of dexamethasone, consistent with dexamethasone's ability to mitigate the traumatic effect of probe implantation. Applications of 100 mM evoked dramatic oscillations in dopamine levels that correlated with changes in the field potential at a metal electrode implanted adjacent to the microdialysis probe. This combination of results indicates the role of spreading depolarization in response to 100 mM K+. With 1 min temporal resolution, we find that it is possible to characterize the pharmacokinetics of the response to the local delivery of nomifensine. Overall, the findings reported here confirm the benefits arising from the ability to monitor dopamine via microdialysis at high sensitivity and at high temporal resolution.	[Ngo, Khanh T.; Varner, Erika L.; Michael, Adrian C.; Weber, Stephen G.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA		Weber, SG (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	sweber@pitt.edu	Weber, Stephen G/AAJ-9255-2020	/0000-0002-0101-0249; Weber, Stephen/0000-0002-7970-2632; Ngo, Khanh/0000-0003-2325-5236	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH104386]; National Science FoundationNational Science Foundation (NSF) [DGE-1247842]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH104386] Funding Source: NIH RePORTER	Funding for this work was provided by National Institutes of Health under award number R01 MH104386 (S.G.W.) and a Graduate Research Fellowship from the National Science Foundation, DGE-1247842 (E.L.V.).	Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; Brimblecombe K. R., 2016, ACS CHEM NEUROSCI, DOI [10.1021/acschemneuro.6b00333, DOI 10.1021/ACSCHEMNEURO.6B00333.]; BUTCHER SP, 1988, J NEUROCHEM, V50, P346, DOI 10.1111/j.1471-4159.1988.tb02919.x; Chefer Vladimir I, 2009, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0701s47; Chen KC, 2005, J NEUROCHEM, V92, P46, DOI 10.1111/j.1471-4159.2004.02848.x; CHURCH WH, 1989, ADV CHROMATOGR, V28, P165; COSFORD RJO, 1994, NEUROSCI LETT, V178, P175, DOI 10.1016/0304-3940(94)90753-6; Davies MI, 1999, ANAL CHIM ACTA, V379, P227, DOI 10.1016/S0003-2670(98)00633-3; DONZANTI BA, 1988, LIFE SCI, V43, P913, DOI 10.1016/0024-3205(88)90267-6; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Gu H, 2015, ANAL CHEM, V87, P6088, DOI 10.1021/acs.analchem.5b00633; Hauber W, 2000, BEHAV BRAIN RES, V111, P39, DOI 10.1016/S0166-4328(99)00197-7; Hows MEP, 2004, J NEUROSCI METH, V138, P123, DOI 10.1016/j.jneumeth.2004.03.021; HURD YL, 1989, LIFE SCI, V45, P283, DOI 10.1016/0024-3205(89)90137-9; Jaquins-Gerstl A, 2011, ANAL CHEM, V83, P7662, DOI 10.1021/ac200782h; JUSTICE JB, 1993, J NEUROSCI METH, V48, P263, DOI 10.1016/0165-0270(93)90097-B; KAMETANI H, 1995, NEUROBIOL AGING, V16, P639, DOI 10.1016/0197-4580(95)00047-I; Kehr J, 1998, J CHROMATOGR B, V708, P27, DOI 10.1016/S0378-4347(97)00677-4; Kennedy RT, 2013, CURR OPIN CHEM BIOL, V17, P860, DOI 10.1016/j.cbpa.2013.06.012; KIHARA T, 1993, J NEUROCHEM, V61, P1859, DOI 10.1111/j.1471-4159.1993.tb09827.x; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEVI G, 1993, TRENDS NEUROSCI, V16, P415, DOI 10.1016/0166-2236(93)90010-J; Nandi P, 2009, ANAL CHIM ACTA, V651, P1, DOI 10.1016/j.aca.2009.07.064; Nesbitt KM, 2015, ACS CHEM NEUROSCI, V6, P163, DOI 10.1021/cn500257x; Nesbitt KM, 2013, ANAL CHEM, V85, P8173, DOI 10.1021/ac401201x; Oyamada T, 1998, NEUROCHEM INT, V32, P171, DOI 10.1016/S0197-0186(97)00068-5; Perry M, 2009, ANAL CHIM ACTA, V653, P1, DOI 10.1016/j.aca.2009.08.038; Peters JL, 1998, J NEUROCHEM, V70, P594; Pusic KM, 2014, GLIA, V62, P1176, DOI 10.1002/glia.22672; Reinhoud NJ, 2013, ACS CHEM NEUROSCI, V4, P888, DOI 10.1021/cn400044s; Richter DW, 1999, J PHYSIOL-LONDON, V514, P567, DOI 10.1111/j.1469-7793.1999.567ae.x; Ripley TL, 1997, J NEUROSCI METH, V78, P7, DOI 10.1016/S0165-0270(97)00129-5; Saigusa T, 2001, J Oral Sci, V43, P129; Saylor RA, 2015, J CHROMATOGR A, V1382, P48, DOI 10.1016/j.chroma.2014.12.086; Shackman HM, 2007, J NEUROSCI METH, V159, P86, DOI 10.1016/j.jneumeth.2006.06.020; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Szalay G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11499; Tang A, 2003, J NEUROSCI METH, V126, P1, DOI 10.1016/S0165-0270(03)00003-7; TELLEZ S, 1992, J CHROMATOGR-BIOMED, V581, P257, DOI 10.1016/0378-4347(92)80279-Y; TOSSMAN U, 1985, NEUROSCI LETT, V62, P231, DOI 10.1016/0304-3940(85)90360-X; TOSSMAN U, 1981, Neuroscience Letters, pS479; Varner EL, 2016, ACS CHEM NEUROSCI, V7, P728, DOI 10.1021/acschemneuro.5b00331; WAGES SA, 1986, ANAL CHEM, V58, P1649, DOI 10.1021/ac00121a012; WESTERINK BHC, 1989, J NEUROCHEM, V52, P722, DOI 10.1111/j.1471-4159.1989.tb02514.x; WISE RA, 1995, PSYCHOPHARMACOLOGY, V120, P10, DOI 10.1007/BF02246140; Yang H, 2000, ANAL CHEM, V72, P2042, DOI 10.1021/ac991186r; Yang HY, 2015, ACS CHEM NEUROSCI, V6, P1487, DOI 10.1021/acschemneuro.5b00132; Yang HY, 2013, ACS CHEM NEUROSCI, V4, P790, DOI 10.1021/cn400072f; Yoshitake T, 2006, BIOMED CHROMATOGR, V20, P267, DOI 10.1002/bmc.560; Yoshitake T, 2003, ANAL BIOCHEM, V312, P125, DOI 10.1016/S0003-2697(02)00435-9; Zhang J, 2013, ANAL CHEM, V85, P9889, DOI 10.1021/ac4023605; Zhang J, 2012, J CHROMATOGR A, V1251, P54, DOI 10.1016/j.chroma.2012.06.002	52	36	36	3	28	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	FEB	2017	8	2			SI		329	338		10.1021/acschemneuro.6b00383			10	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	EL2XH	WOS:000394483300015	28094974	Green Accepted			2022-02-06	
J	Scheenen, ME; Spikman, JM; de Koning, ME; van der Horn, HJ; Roks, G; Hageman, G; van der Naalt, J				Scheenen, Myrthe E.; Spikman, Jacoba M.; de Koning, Myrthe E.; van der Horn, Harm J.; Roks, Gerwin; Hageman, Gerard; van der Naalt, Joukje			Patients "At Risk'' of Suffering from Persistent Complaints after Mild Traumatic Brain Injury: The Role of Coping, Mood Disorders, and Post-Traumatic Stress	JOURNAL OF NEUROTRAUMA			English	Article						neuropsychology; recovery; rehabilitation; traumatic brain injury	SYMPTOMS FOLLOWING MILD; QUALITY-OF-LIFE; POSTCONCUSSIVE SYMPTOMS; EVENT SCALE; ANXIETY; PREDICTORS; DEPRESSION; PREVALENCE; VALIDATION; RECOVERY	Although most patients recover fully following mild traumatic brain injury (mTBI), a minority (15-25%) of all patients develop persistent post-traumatic complaints (PTC) that interfere with the resumption of previous activities. An early identification of patients who are at risk for PTC is currently performed by measuring the number of complaints in the acute phase. However, only part of this group will actually develop persisting complaints, stressing the need for studies on additional risk factors. This study aimed to compare this group of patients with many complaints with patients with few and no complaints to identify potential additional discriminating characteristics and to evaluate which of these factors have the most predictive value for being at risk. We evaluated coping style, presence of psychiatric history, injury characteristics, mood-related symptoms, and post-traumatic stress. We included 820 patients (Glasgow Coma Scale [GCS] score 13-15) admitted to three level-1 trauma centers as part of the UPFRONT-study. At 2 weeks after injury, 60% reported three or more complaints (PTC-high), 25% reported few complaints (PTC-low), and 15% reported no complaints (PTC-zero). Results showed that PTC-high consisted of more females (78% vs. 73% and 52%, p < 0.001), were more likely to have a psychiatric history (7% vs. 2% and 5%), and had a higher number of reported depression (22% vs. 6% and 3%, p < 0.001), anxiety (25% vs. 7% and 5%), and post-traumatic stress (37% vs. 27% and 19%, p < 0.001) than the PTC-low and PTC-zero groups. We conclude that in addition to reported complaints, psychological factors such as coping style, depression, anxiety, and post-traumatic stress symptoms had the highest predictive value and should be taken into account in the identification of at-risk patients for future treatment studies.	[Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands; [de Koning, Myrthe E.; van der Horn, Harm J.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Roks, Gerwin] St Elizabeth Hosp, Dept Neurol, Tilburg, Netherlands; [Hageman, Gerard] Med Spectrum Twente Enschede, Dept Neurol, Enschede, Netherlands		van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	j.van.der.naalt@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Feinstein A, 2000, BRAIN COGNITION, V44, P78; Ford AH, 2015, BRIT J PSYCHIAT, V207, P286, DOI 10.1192/bjp.bp.115.166595; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; IBM Corporation, 2013, IBM SPSS STAT WINDOW; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Matuseviciene G., 2015, J REHABIL MED, V48, P1977; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; SCHREURS PJG, 1984, GEDRAG GEZOND, V12, P101; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; STAVRAKAKI C, 1986, BRIT J PSYCHIAT, V149, P7, DOI 10.1192/bjp.149.1.7; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	44	36	36	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					31	37		10.1089/neu.2015.4381			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100005	27560623	Green Submitted			2022-02-06	
J	Scheiman, MM; Talasan, H; Mitchell, GL; Alvarez, TL				Scheiman, Mitchell M.; Talasan, Henry; Mitchell, G. Lynn; Alvarez, Tara L.			Objective Assessment of Vergence after Treatment of Concussion-Related CI: A Pilot Study	OPTOMETRY AND VISION SCIENCE			English	Article						convergence insufficiency; vision therapy; concussion; vision rehabilitation	RANDOMIZED CLINICAL-TRIAL; INSUFFICIENCY SYMPTOM SURVEY; CONVERGENCE INSUFFICIENCY; DISPARITY VERGENCE; PEAK VELOCITY; EYE-MOVEMENTS; DYSFUNCTIONS; FREQUENCY; DYNAMICS; CHILDREN	Purpose. To evaluate changes in objective measures of disparity vergence after office-based vision therapy (OBVT) for concussion-related convergence insufficiency (CI) and determine the feasibility of using this objective assessment as an outcome measure in a clinical trial. Methods. This was a prospective, observational trial. All participants were treated with weekly OBVT with home reinforcement. Participants included two adolescents and three young adults with concussion-related, symptomatic CI. The primary outcome measure was average peak velocity for 4 degrees symmetrical convergence steps. Other objective outcome measures of disparity vergence included time to peak velocity, latency, accuracy, settling time, and main sequence. We also evaluated saccadic eye movements using the same outcome measures. Changes in clinical measures (near point of convergence, positive fusional vergence at near, Convergence Insufficiency Symptom Survey [CISS] score) were evaluated. Results. There were statistically significant and clinically meaningful changes in all clinical measures for convergence. Four of the five subjects met clinical success criteria. For the objective measures, we found a statistically significant increase in peak velocity, response accuracy to 4 degrees symmetrical convergence and divergence step stimuli, and the main sequence ratio for convergence step stimuli. Objective saccadic eye movements (5 and 10 degrees) appeared normal pre-OBVT and did not show any significant change after treatment. Conclusions. This is the first report of the use of objective measures of disparity vergence as outcome measures for concussion-related convergence insufficiency. These measures provide additional information that is not accessible with clinical tests about underlying physiological mechanisms leading to changes in clinical findings and symptoms. The study results also demonstrate that patients with concussion can tolerate the visual demands (over 200 vergence and versional eye movements) during the 25-minute testing time and suggest that these measures could be used in a large-scale randomized clinical trial of concussion-related CI as outcome measures.	[Scheiman, Mitchell M.] Salus Univ, Penn Coll Optometry, 8360 Old York Rd, Elkins Pk, PA 19027 USA; [Talasan, Henry; Alvarez, Tara L.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Mitchell, G. Lynn] Ohio State Univ, Coll Optometry, 338 W 10th Ave, Columbus, OH 43210 USA		Scheiman, MM (corresponding author), Salus Univ, Penn Coll Optometry, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	mscheiman@salus.edu	Mitchell, Gladys/E-7973-2012	Alvarez, Tara/0000-0002-8797-1613; Scheiman, Mitchell/0000-0002-9274-5696	NSF MRINational Science Foundation (NSF)NSF - Office of the Director (OD) [CBET 1428425]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01EY023261]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY023261] Funding Source: NIH RePORTER	This research was supported in part by NSF MRI CBET 1428425 to T.L.A. and NIH 1R01EY023261 to T.L.A. and M.S.	Alvarez TL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00419; Alvarez TL, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00050; Alvarez TL, 2013, INVEST OPHTH VIS SCI, V54, P4122, DOI 10.1167/iovs.13-11797; Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; Alvarez TL, 2000, VISION RES, V40, P341, DOI 10.1016/S0042-6989(99)00175-3; Alvarez TL, 2005, J VISION, V5, P640, DOI 10.1167/5.7.4; Alvarez TL, 2002, CAH PSYCHOL COGN, V21, P243; Alvarez TL, 1998, J NEUROPHYSIOL, V79, P37, DOI 10.1152/jn.1998.79.1.37; Alvarez TL, 1999, ANN BIOMED ENG, V27, P380, DOI 10.1114/1.162; BAHILL AT, 1982, BIOL CYBERN, V45, P1, DOI 10.1007/BF00387207; Barnhardt C, 2012, OPTOMETRY VISION SCI, V89, P1512, DOI 10.1097/OPX.0b013e318269c8f9; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Borsting Eric, 2003, Optometry, V74, P25; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bucci MP, 2004, EXP BRAIN RES, V157, P286, DOI 10.1007/s00221-004-1842-0; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Chen YF, 2010, J MED BIOL ENG, V30, P1; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ducic S, 1988, CAN J OPTOM, V50, P194; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Guo Y, 2011, JOVE-J VIS EXP, P49; Han SJ, 2010, OPHTHAL PHYSL OPT, V30, P95, DOI 10.1111/j.1475-1313.2009.00681.x; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; HSU FK, 1976, COMPUT PROG BIOMED, V6, P108, DOI 10.1016/0010-468X(76)90032-5; Jainta S, 2011, VISION RES, V51, P1845, DOI 10.1016/j.visres.2011.06.014; JONES R, 1980, AM J OPTOM PHYS OPT, V57, P640; Kim E, 2011, IEEE ENG MED BIO, P1664, DOI 10.1109/IEMBS.2011.6090479; Kim EH, 2012, CURR EYE RES, V37, P1054, DOI 10.3109/02713683.2012.694551; Kim EH, 2012, VISION RES, V63, P9, DOI 10.1016/j.visres.2012.04.013; Kim EH, 2010, INVEST OPHTH VIS SCI, V51, P4017, DOI 10.1167/iovs.09-4560; KOTULAK JC, 1987, VISION RES, V27, P1797, DOI 10.1016/0042-6989(87)90108-8; Lee YY, 2012, J EYE MOVEMENT RES, V5; Leigh RJ, 2015, NEUROLOGY EYE MOVEME; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Porcar E, 1997, OPTOMETRY VISION SCI, V74, P111, DOI 10.1097/00006324-199702000-00023; Rambold H, 2005, ANN NY ACAD SCI, V1039, P567, DOI 10.1196/annals.1325.069; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Rouse MW, 1999, OPTOMETRY VISION SCI, V76, P643, DOI 10.1097/00006324-199909000-00022; Sander T, 2009, BRAIN, V132, P103, DOI 10.1093/brain/awn306; Scheiman M, 2005, BRIT J OPHTHALMOL, V89, P1318, DOI 10.1136/bjo.2005.068197; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Scheiman M, 2014, OPTOM VIS PERF, V2, P10; Scheiman M., 2014, CLIN MANAGEMENT BINO; Scheiman M, 2011, INVEST OPHTHALMOL VI, V53; Scheiman M, 2008, ARCH OPHTHALMOL-CHIC, V126, P1336, DOI 10.1001/archopht.126.10.1336; Scheiman M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006768.pub2; SEMMLOW JL, 1993, OPHTHAL PHYSL OPT, V13, P48, DOI 10.1111/j.1475-1313.1993.tb00426.x; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Talasan H, 2016, J VISION, V16, DOI 10.1167/16.1.7; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; Yuan WH, 1999, IEEE T BIO-MED ENG, V46, P1191, DOI 10.1109/10.790495; ZEE DS, 1992, J NEUROPHYSIOL, V68, P1624, DOI 10.1152/jn.1992.68.5.1624	58	36	36	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					74	88		10.1097/OPX.0000000000000936			15	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EM5ZZ	WOS:000395393900011	27464574	Green Accepted			2022-02-06	
J	Kawoos, U; Gu, M; Lankasky, J; McCarron, RM; Chavko, M				Kawoos, Usmah; Gu, Ming; Lankasky, Jason; McCarron, Richard M.; Chavko, Mikulas			Effects of Exposure to Blast Overpressure on Intracranial Pressure and Blood-Brain Barrier Permeability in a Rat Model	PLOS ONE			English	Article							CLOSED-HEAD INJURY; SHOCK-WAVES; MOUSE MODEL; TIME-COURSE; IN-VITRO; INFLAMMATION; DYSFUNCTION; DISRUPTION; MILD; PATHOPHYSIOLOGY	Exposure to blast overpressure (BOP) activates a cascade of pathological processes including changes in intracranial pressure (ICP) and blood-brain barrier (BBB) permeability resulting in traumatic brain injury (TBI). In this study the effect of single and multiple exposures at two intensities of BOP on changes in ICP and BBB permeability in Sprague-Dawley rats was evaluated. Animals were exposed to a single or three repetitive (separated by 0.5 h) BOPs at 72 kPa or 110 kPa. ICP was monitored continuously via telemetry for 6 days after exposure to BOP. The alteration in the permeability of BBB was determined by extravasation of Evans Blue (EB) into brain parenchyma. A significant increase in ICP was observed in all groups except the single 72 kPa BOP group. At the same time a marked increase in BBB permeability was also seen in various parts of the brain. The extent of ICP increase as well as BBB permeability change was dependent on intensity and frequency of blast.	[Kawoos, Usmah; Gu, Ming; Lankasky, Jason; McCarron, Richard M.; Chavko, Mikulas] Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA; [McCarron, Richard M.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [McCarron, Richard M.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA		Kawoos, U (corresponding author), Naval Med Res Ctr, Dept Neurotrauma, Silver Spring, MD 20910 USA.	Usmah.kawoos.ctr@mail.mil			Office of Naval Research (ONR)Office of Naval Research [601152N.0000.000.A1308]	This work was supported by Office of Naval Research (ONR) Work Unit 601152N.0000.000.A1308. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Fritz HG, 2005, J NEUROTRAUM, V22, P807, DOI 10.1089/neu.2005.22.807; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Guild SJ, 2015, J APPL PHYSIOL, V119, P576, DOI 10.1152/japplphysiol.00165.2015; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Jamali S, 1998, BRAIN INJURY, V12, P525, DOI 10.1080/026990598122485; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kawoos U, 2014, IEEE T BIO-MED ENG, V61, P841, DOI 10.1109/TBME.2013.2291239; Leonardi AD, 2013, ANN BIOMED ENG, V41, P2488, DOI 10.1007/s10439-013-0850-2; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Paxinos G, 1998, ACTA NEUROBIOLOGIAE; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	46	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2016	11	12							e0167510	10.1371/journal.pone.0167510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE3JC	WOS:000389482700176	27907158	Green Published, gold, Green Submitted			2022-02-06	
J	Rizzo, JR; Hudson, TE; Dai, WW; Birkemeier, J; Pasculli, RM; Selesnick, I; Balcer, LJ; Galetta, SL; Rucker, JC				Rizzo, John-Ross; Hudson, Todd E.; Dai, Weiwei; Birkemeier, Joel; Pasculli, Rosa M.; Selesnick, Ivan; Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.			Rapid number naming in chronic concussion: eye movements in the King-Devick test	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; SUPERIOR COLLICULUS; 1ST YEAR; SACCADES; OCULOMOTOR; DEFICITS; NEURONS; STATEMENT; RECOVERY	ObjectiveThe King-Devick (KD) test, which is based on rapid number naming speed, is a performance measure that adds vision and eye movement assessments to sideline concussion testing. We performed a laboratory-based study to characterize ocular motor behavior during the KD test in a patient cohort with chronic concussion to identify features associated with prolonged KD reading times. MethodsTwenty-five patients with a concussion history (mean age: 31) were compared to control participants with no concussion history (n = 42, mean age: 32). Participants performed a computerized KD test under infrared-based video-oculography. ResultsAverage intersaccadic intervals for task-specific saccades were significantly longer among concussed patients compared to controls (324.4 85.6 msec vs. 286.1 +/- 49.7 msec, P = 0.027). Digitized KD reading times were prolonged in concussed participants versus controls (53.43 +/- 14.04 sec vs. 43.80 +/- 8.55 sec, P = 0.004) and were highly correlated with intersaccadic intervals. Concussion was also associated with a greater number of saccades during number reading and larger average deviations of saccade endpoint distances from the centers of the to-be-read numbers (1.22 +/- 0.29 degrees vs. 0.98 +/- 0.27 degrees, P = 0.002). There were no differences in saccade peak velocity, duration, or amplitude. InterpretationProlonged intersaccadic intervals, greater numbers of saccades, and larger deviations of saccade endpoints underlie prolonged KD reading times in chronic concussion. The KD test relies upon a diffuse neurocognitive network that mediates the fine control of efferent visual function. One sequela of chronic concussion may be disruption of this system, which may produce deficits in spatial target selection and planning of eye movements.	[Rizzo, John-Ross; Hudson, Todd E.; Birkemeier, Joel; Pasculli, Rosa M.] NYU Sch Med, Dept Phys Med & Rehabil, New York, NY USA; [Rizzo, John-Ross; Hudson, Todd E.; Balcer, Laura J.; Galetta, Steven L.; Rucker, Janet C.] NYU Sch Med, Dept Neurol, New York, NY USA; [Dai, Weiwei; Selesnick, Ivan] NYU Tandon Sch Engn, Dept Elect & Comp Engn, New York, NY USA; [Balcer, Laura J.] NYU Sch Med, Dept Populat Hlth, New York, NY USA; [Balcer, Laura J.; Galetta, Steven L.] NYU Sch Med, Dept Ophthalmol, New York, NY USA		Rucker, JC (corresponding author), Ctr Ambulatory Care, Dept Neurol, Neurol, 240 East 38th St,20th Floor, New York, NY 10016 USA.	janet.rucker@nyumc.org		Rizzo, John-Ross/0000-0002-4084-0085; Rucker, Janet/0000-0002-0397-0999	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K12HDOO1097]; NCMRR, National Institutes of Health Rehabilitation Medicine Scientist Training Program; Empire Clinical Research Investigator Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001073] Funding Source: NIH RePORTER	This work was supported by 5K12HDOO1097 NICHD and NCMRR, National Institutes of Health Rehabilitation Medicine Scientist Training Program (JRR) and Empire Clinical Research Investigator Program (ECRIP).	[Anonymous], TBI ID METH; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Carpenter RHS, 2000, CURR BIOL, V10, pR291, DOI 10.1016/S0960-9822(00)00430-9; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta K.M., 2015, CONCUSSION, V1, P1; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Horn AKE, 2003, ANN NY ACAD SCI, V1004, P19, DOI 10.1196/annals.1303.003; HORN AKE, 1995, J COMP NEUROL, V359, P350, DOI 10.1002/cne.903590212; KEATING EG, 1986, BEHAV BRAIN RES, V22, P191, DOI 10.1016/0166-4328(86)90064-1; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kulp MT, 1996, OPTOMETRY VISION SCI, V73, P283, DOI 10.1097/00006324-199604000-00011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Leigh RJ, 2015, NEUROLOGY EYE MOVEME; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Mangione CM., 2000, NATL EYE I 25 ITEM V; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; OHTSUKA K, 1991, NEUROSCI RES, V10, P290, DOI 10.1016/0168-0102(91)90086-E; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; PIERROTDESEILLIGNY C, 1991, J NEUROL NEUROSUR PS, V54, P1106, DOI 10.1136/jnnp.54.12.1106; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Raphael BA, 2006, AM J OPHTHALMOL, V142, P1026, DOI 10.1016/j.ajo.2006.06.060; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Roos JCP, 2008, EXP BRAIN RES, V187, P283, DOI 10.1007/s00221-008-1304-1; Sachdev PS, 2014, NAT REV NEUROL, V10, P634, DOI 10.1038/nrneurol.2014.181; Servadei P, 1994, J Neurosurg Sci, V38, P129; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2	48	36	36	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	OCT	2016	3	10					801	811		10.1002/acn3.345			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ2IZ	WOS:000385666800006	27752515	Green Published, gold			2022-02-06	
J	Houck, Z; Asken, B; Bauer, R; Pothast, J; Michaudet, C; Clugston, J				Houck, Zachary; Asken, Breton; Bauer, Russell; Pothast, Jason; Michaudet, Charlie; Clugston, James			Epidemiology of Sport-Related Concussion in an NCAA Division I Football Bowl Subdivision Sample	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; football; incidence rate; epidemiology	STATES HIGH-SCHOOL; COLLEGIATE FOOTBALL; PLAYERS; ASSOCIATION; INJURIES	Background: Concussions are common in football, and knowledge of their incidence rates across settings is needed to develop strategies to decrease occurrence. Purpose: To examine sports-related concussion rates in a National Collegiate Athletic Association (NCAA) Division I Football Bowl Subdivision sample based on the activity setting where injuries occurred, during which type of play, and when relative to the 2010 NCAA concussion management policy. Study Design: Descriptive epidemiology study. Methods: Medical records from January 2006 to January 2015 for an NCAA Division I Football Bowl Subdivision program were analyzed. Concussion rates (per 1000 athlete-exposures [AEs]) were compared among the following settings: spring practice, preseason training camp, regular season high-contact practice, regular season low-contact practice, bowl game practice, and game competition. Play-type analyses examined incidence rates during offensive, defensive, and special teams plays. Changes in concussion rate coinciding with the 2010 NCAA concussion management policy were also studied. Results: Of the 452 unique players on the roster during the 9-year study period, 118 (26.1%) were diagnosed with a concussion. The concussion rate during games was significantly higher than all practices combined (P < .001). However, when game rate (4.46 per 1000 AEs) was compared with preseason training camp alone (3.81 per 1000 AEs), there was no significant difference (P = .433). The concussion rate during special teams plays was significantly higher than that during offensive (P < .001) or defensive plays (P < .001). The concussion rate in the 4 seasons (2010-2014) after the 2010 NCAA concussion management policy was initiated was significantly higher than the 4 seasons (2006-2009) preceding the policy (P = .036). Conclusion: Study results show that (1) based on activity type, games and preseason training camp present the greatest risk of sustaining a concussion; (2) based on play type, special teams plays pose the greatest risk of sustaining a concussion; and (3) the 2010 NCAA concussion management policy coincided with a significant increase in recognition of concussion.	[Houck, Zachary; Asken, Breton; Bauer, Russell; Pothast, Jason; Michaudet, Charlie; Clugston, James] Univ Florida, Yon Hall East Stadium,2nd Floor,Room 226, Gainesville, FL 32608 USA		Houck, Z (corresponding author), Univ Florida, Yon Hall East Stadium,2nd Floor,Room 226, Gainesville, FL 32608 USA.	zhouck@phhp.ufl.edu		Clugston, James/0000-0002-2103-1039; Asken, Breton/0000-0001-8419-142X			[Anonymous], CONC MAN PLAN; Barth JT, 1989, MILD HEAD INJURY, P257; Booher MA, 2003, CLIN J SPORT MED, V13, P93, DOI 10.1097/00042752-200303000-00005; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dick R, 2002, 2001 2002 NCAA INJUR; Dick R, 2007, J ATHL TRAINING, V42, P221; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kerr ZY, 2015, AM J SPORT MED, V43, P1134, DOI 10.1177/0363546515570622; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mueller FO, ANN SURVEY FOOTBALL; National Collegiate Athletic Association Sport Science Institute, CONC SAF PROT CHECKL; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005	21	36	36	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2016	44	9					2269	2275		10.1177/0363546516645070			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DV6CU	WOS:000383019300015	27159307				2022-02-06	
J	Mannix, R; Meehan, WP; Pascual-Leone, A				Mannix, Rebekah; Meehan, William P., III; Pascual-Leone, Alvaro			OPINION Sports-related concussions - media, science and policy	NATURE REVIEWS NEUROLOGY			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; WHITE-MATTER INTEGRITY; FOOTBALL-LEAGUE PLAYER; QUALITY-OF-LIFE; BRAIN-INJURY; SOCCER PLAYERS; RECURRENT CONCUSSION; PROFESSIONAL SOCCER; LONG-TERM; PARTICIPATION	Although growing awareness about the potential long-term deleterious effects of sport-related concussion has led to increased attention to the risks of collision sports, calls to ban these sports, such as American football, might be premature. Collision sports have a relatively high incidence of concussions, but participation in these sports also confers a host of benefits. In addition, the associated risks of participation, including concussion, have not been definitively shown to outweigh the benefits they provide, and the risk benefit ratio might vary among individuals. The risks of concussion and repetitive concussions associated with collision sports are unknown in the general population and not well characterized even in elite athlete populations. In this article, we discuss current knowledge on sports-related concussion, its neurological consequences, and implications for regulation of the practice of collision sports.	[Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA; [Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, 300 Longwood Ave, Boston, MA 02115 USA; [Pascual-Leone, Alvaro] Beth Israel Deaconess Med Ctr, Div Cognit Neurol, 330 Brookline Ave, Boston, MA 02115 USA		Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	rebekah.mannix@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020; Pascual-Leone, Alvaro/AAC-5101-2019	Pascual-Leone, Alvaro/0000-0001-8975-0382	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD40128-11A1]; Harvard Clinical and Translational Science Center (NCRR and the NCATS NIH) [UL1 RR025758]; Sidney R. Baer, Jr. Foundation; Football Players Health Study at Harvard University; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER	R.M. is supported by a training grant from the National Institute of Child Health and Human Development (T32 HD40128-11A1). A.P.-L is supported by funding from the Harvard Clinical and Translational Science Center (NCRR and the NCATS NIH, UL1 RR025758), the Sidney R. Baer, Jr. Foundation, the Football Players Health Study at Harvard University, and various grants from the NIH.	bissinger B., 2012, WALL STREET J; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dobosz RP, 1999, ADOLESCENCE, V34, P215; Dodge T, 2009, J YOUTH ADOLESCENCE, V38, P813, DOI 10.1007/s10964-008-9371-y; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Institute of Medicine, 2011, SCI AD RISK TAK WORK; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; MADDOCKS DL, 1995, MED J AUSTRALIA, V162, P167, DOI 10.5694/j.1326-5377.1995.tb138497.x; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCabe K. O., 2016, J YOUTH ADOLESC; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; Noda H, 2005, J AM COLL CARDIOL, V46, P1761, DOI 10.1016/j.jacc.2005.07.038; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; OLSON HW, 1977, J SPORT MED PHYS FIT, V17, P321; Omalu B., 2015, NY TIMES; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pate RR, 2000, ARCH PEDIAT ADOL MED, V154, P904, DOI 10.1001/archpedi.154.9.904; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Sabo Don, 2005, Int Rev Sociol Sport, V40, P5, DOI 10.1177/1012690205052160; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tymula A, 2012, P NATL ACAD SCI USA, V109, P17135, DOI 10.1073/pnas.1207144109; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Vella SA, 2014, J PEDIATR-US, V164, P1469, DOI 10.1016/j.jpeds.2014.01.071; Wafa SWWBSST, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0474-y; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	51	36	36	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4758	1759-4766		NAT REV NEUROL	Nat. Rev. Neurol.	AUG	2016	12	8					486	490		10.1038/nrneurol.2016.99			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DT8CX	WOS:000381717800008	27364748	Green Accepted			2022-02-06	
J	Sen, T; Sen, N				Sen, Tanusree; Sen, Nilkantha			Treatment with an activator of hypoxia-indutible factor 1, DMOG provides neuroprotection after traumatic brain injury	NEUROPHARMACOLOGY			English	Article						DMOG; HIF-1 alpha; Angiogenesis; Traumatic brain injury; Cell death; Lesion volume	CELL-DEATH MECHANISMS; CEREBRAL EDEMA; INDUCIBLE FACTOR-1; UP-REGULATION; NEUROGENESIS; CREB; INHIBITION; PLASTICITY; RECOVERY; PATHWAY	Traumatic brain injury (TBI) is one of the major cause of morbidity and mortality and it affects more than 1.7 million people in the USA. A couple of regenerative pathways including activation of hypoxia-inducible transcription factor 1 alpha (HIF-1 alpha) are initiated to reduce cellular damage following TBI; however endogenous activation of these pathways is not enough to provide neuroprotection after TBI. Thus we aimed to see whether sustained activation of HIF-1 alpha can provide neuroprotection and neuro-repair following TBI. We found that chronic treatment with dimethyloxaloylglycine (DMOG) markedly increases the expression level of HIF-1 alpha and mRNA levels of its downstream proteins such as Vascular endothelial growth factor (VEGF), Phosphoinositide-dependent kinase-1 and 4 (PDK1, PDK4) and Erythropoietin (EPO). Treatment of DMOG activates a major cell survival protein kinase Akt and reduces both cell death and lesion volume following TBI. Moreover, administration of DMOG augments cluster of differentiation 31 (CD31) staining in pericontusional cortex after TBI, which suggests that DMOG stimulates angiogenesis after TBI. Treatment with DMOG also improves both memory and motor functions after TBI. Taken together our results suggest that sustained activation of HIF-1 alpha provides significant neuroprotection following TBI. Published by Elsevier Ltd.	[Sen, Tanusree; Sen, Nilkantha] Augusta Univ, Dept Neurosci & Regenerat Med, 1120 15th St,CA2018, Augusta, GA 30912 USA; [Sen, Tanusree] Univ Georgia, Coll Vet Med, Dept Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA		Sen, N (corresponding author), Augusta Univ, Dept Neurosci & Regenerat Med, 1120 15th St,CA2018, Augusta, GA 30912 USA.	nsen@gru.edu	Sen, Nilkantha/AAW-9788-2020		National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY025622]; Augusta University, GA; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094516] Funding Source: NIH RePORTER	This work is supported by the grant from the National Institute of Health (EY025622) and the startup funding provided by the Augusta University, GA.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Bachevalier J, 1996, HIPPOCAMPUS, V6, P553, DOI 10.1002/(SICI)1098-1063(1996)6:5<553::AID-HIPO8>3.0.CO;2-J; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunson KL, 2001, P NATL ACAD SCI USA, V98, P8856, DOI 10.1073/pnas.151224898; Cao D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-432; Caravatta L, 2008, J CELL PHYSIOL, V214, P192, DOI 10.1002/jcp.21186; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Chopp M, 2008, J NEUROL SCI, V265, P97, DOI 10.1016/j.jns.2007.06.013; del Puerto A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00197; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Hewitson KS, 2004, DRUG DISCOV TODAY, V9, P704, DOI 10.1016/S1359-6446(04)03202-7; Hirjak D, 2013, NEUROPSYCHOBIOLOGY, V68, P91, DOI 10.1159/000350999; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Kayani NA, 2009, PUBLIC HEALTH REP, V124, P551, DOI 10.1177/003335490912400412; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu SJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-66; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x; Mir S, 2014, MOL CELL, V56, P786, DOI 10.1016/j.molcel.2014.10.019; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Ockaili R, 2005, AM J PHYSIOL-HEART C, V289, pH542, DOI 10.1152/ajpheart.00089.2005; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Sen N, 2011, P NATL ACAD SCI USA, V108, P20178, DOI 10.1073/pnas.1117820108; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Sheldon RA, 2009, DEV NEUROSCI-BASEL, V31, P452, DOI 10.1159/000232563; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; Siddiq A, 2009, J NEUROSCI, V29, P8828, DOI 10.1523/JNEUROSCI.1779-09.2009; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tian SF, 2013, J BIOL CHEM, V288, P15988, DOI 10.1074/jbc.M112.428789; Trollmann R, 2009, BRAIN DEV-JPN, V31, P503, DOI 10.1016/j.braindev.2009.03.007; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Xiong Y, 2008, J NEUROSURG, V109, P510, DOI 10.3171/JNS/2008/109/9/0510; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhao ZR, 2013, J CEREBR BLOOD F MET, V33, P1897, DOI 10.1038/jcbfm.2013.144	60	36	37	1	23	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	AUG	2016	107						79	88		10.1016/j.neuropharm.2016.03.009			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DQ1HZ	WOS:000378953400009	26970014	Green Accepted			2022-02-06	
J	Hue, CD; Cho, FS; Cao, S; Nicholls, RE; Vogel, EW; Sibindi, C; Arancio, O; Bass, CRD; Meaney, DF; Morrison, B				Hue, Christopher D.; Cho, Frances S.; Cao, Siqi; Nicholls, Russell E.; Vogel, Edward W., III; Sibindi, Cosmas; Arancio, Ottavio; Bass, Cameron R.Dale; Meaney, David F.; Morrison, Barclay, III			Time Course and Size of Blood Brain Barrier Opening in a Mouse Model of Blast-Induced Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blast injury; blood brain barrier; dextran; shock tube; traumatic brain injury	RAT MODEL; INFLAMMATION; DISRUPTION; EXPOSURE; RECOVERY; OVERPRESSURE; EXPRESSION; MICROGLIA; STRESS; RANGE	An increasing number of studies have reported blood brain barrier (BBB) dysfunction after blast-induced traumatic brain injury (bTBI). Despite this evidence, there is limited quantitative understanding of the extent of BBB opening and the time course of damage after blast injury. In addition, many studies do not report kinematic parameters of head motion, making it difficult to separate contributions of primary and tertiary blast-loading. Detailed characterization of blast-induced BBB damage may hold important implications for serum constituents that may potentially cross the compromised barrier and contribute to neurotoxicity, neuroinflammation, and persistent neurologic deficits. Using an in vivo bTBI model, systemic administration of sodium fluorescein (NaFl; 376 Da), Evans blue (EB; 69 kDa when bound to serum albumin), and dextrans (3-500 kDa) was used to estimate the pore size of BBB opening and the time required for recovery. Exposure to blast with 272 +/- 6 kPa peak overpressure, 0.69 +/- 0.01 ms duration, and 65 +/- 1 kPa*ms impulse resulted in significant acute extravasation of NaFl, 3 kDa dextran, and EB. However, there was no significant acute extravasation of 70 kDa or 500 kDa dextrans, and minimal to no extravasation of NaFl, dextrans, or EB 1 day after exposure. This study presents a detailed analysis of the time course and pore size of BBB opening after bTBI, supported by a characterization of kinematic parameters associated with blast-induced head motion.	[Hue, Christopher D.; Cho, Frances S.; Cao, Siqi; Vogel, Edward W., III; Sibindi, Cosmas; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC8904,1210 Amsterdam Ave, New York, NY 10027 USA; [Nicholls, Russell E.; Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA; [Bass, Cameron R.Dale] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	arancio, ottavio/AAB-7959-2019; Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Meaney, David/0000-0002-0954-4122; , Siqi/0000-0001-9779-4174; arancio, ottavio/0000-0001-6335-164X			Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adams J H, 1981, Acta Neuropathol Suppl, V7, P26; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chen H, 2014, J CEREBR BLOOD F MET, V34, P1197, DOI 10.1038/jcbfm.2014.71; Chen Y, 2013, J NEUROPSYCH CLIN N, V25, P103, DOI 10.1176/appi.neuropsych.12030058; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Choi JJ, 2010, ULTRASOUND MED BIOL, V36, P58, DOI 10.1016/j.ultrasmedbio.2009.08.006; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; ENTERS EK, 1992, BRAIN RES, V576, P271; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; MAXWELL WL, 1992, ACTA NEUROPATHOL, V84, P289; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; WOLMAN M, 1981, ACTA NEUROPATHOL, V54, P55, DOI 10.1007/BF00691332; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Yen LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068595; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	52	36	38	3	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2016	33	13					1202	+		10.1089/neu.2015.4067			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DP2QY	WOS:000378336200386	26414212				2022-02-06	
J	Baugh, CM; Kroshus, E; Stamm, JM; Daneshvar, DH; Pepin, MJ; Meehan, WP				Baugh, Christine M.; Kroshus, Emily; Stamm, Julie M.; Daneshvar, Daniel H.; Pepin, Michael J.; Meehan, William P.			Clinical Practices in Collegiate Concussion Management	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; clinical practice; best practices; health policy; college	ATHLETIC TRAINERS; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; PRACTICE PATTERNS; SPORT HELD; POSITION; SYMPTOMS; ZURICH	Background: In recent years, sports leagues and sports medicine experts have developed guidelines for concussion management. The extent to which current clinical practice is consistent with guideline recommendations is unclear. At the collegiate level, there have been few examinations of concussion management practices and the extent to which meaningful differences across divisions of competition exist. Purpose: The purposes of this study were to (1) examine current practices in concussion diagnosis and management at National Collegiate Athletic Association (NCAA) member colleges, (2) explore the extent to which current practices reflect current recommendations for concussion diagnosis and management, and (3) determine whether there are differences in management patterns across divisions of competition. Design: Descriptive epidemiology study. Methods: An electronic questionnaire was sent to sports medicine clinicians at all NCAA member colleges during September and October 2013. Clinicians were asked about baseline assessments, diagnosis and management practices, return-to-play protocols, the perceived prevalence of underdiagnosis, and basic demographic information. Results: Approximately 30% (n = 866) of contacted clinicians, representing nearly 50% (n = 527) of NCAA member colleges, responded to the questionnaire. Preparticipation baseline examinations were administered at the majority of schools (95%), but most (87.5%) administered baseline assessments only to selected high-risk athletes. Computerized neurocognitive testing and balance assessments were most commonly used as preseason baseline and postinjury assessments. Multimodal examination in line with NCAA and other guidance was used only at a minority of institutions. Athletic trainers most commonly administered and interpreted the preseason baseline examination. Most clinicians reported that their institutions' practices were in line with NCAA guidelines during the first 24 hours of an athlete's concussion diagnosis, with exact percentages varying across measures. Differences across divisions of competition included shorter return-to-play time at Division I schools than Division III schools (9.13 vs 10.31 days, respectively) and more frequently referring concussed athletes to a physician within 24 hours of diagnosis at Division I schools. Conclusion: Concussion management at many colleges in the United States incorporates elements recommended by current guidelines; however, there is room to improve. Increasing the use of a multimodal baseline and postinjury examination will elevate the concussion care provided to college athletes and better align with best practice guidance.	Harvard Univ, Cambridge, MA 02138 USA; Boston Univ, Boston, MA 02215 USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, 14 Story St,Fourth Floor, Cambridge, MA 02138 USA; [Baugh, Christine M.; Pepin, Michael J.; Meehan, William P.] Boston Childrens Hosp, Div Sports Med, Micheli Ctr Sport Injury Prevent, Boston, MA USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Stamm, Julie M.] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Daneshvar, Daniel H.] Boston Univ, Sch Med, Chron Traumat Encephalopathy Ctr, Boston, MA 02118 USA		Baugh, CM (corresponding author), Harvard Univ, Interfac Initiat Hlth Policy, 14 Story St,Fourth Floor, Cambridge, MA 02138 USA.	cbaugh@g.harvard.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Daneshvar, Daniel/0000-0003-3691-9513	NCAA; National Institute of Mental Health of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; National Football League Players' Association; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: C.M.B. is an NCAA Graduate Student Research Grant award winner; no funds from that grant were used toward the conduct of this project. C.M.B.'s doctoral education and related research is supported by the National Institute of Mental Health of the National Institutes of Health under award number T32MH019733. E.K. was a postdoctoral research fellow with the National Collegiate Athletic Association Sport Science Institute from 2014 to 2015 and is currently a consultant with the institute. C.M.B. and E.K. both have research funded by the National Football League Players' Association. W.P.M. receives royalties from ABC-Clio publishing for the sale of his book Kids, Sports, and Concussion: A Guide for Coaches and Parents and royalties from Wolters Kluwer for working as an author for UpToDate. He is under contract with ABC-Clio publishing for a future book entitled Concussions and with Springer International publishing for a future book entitled Head and Neck Injuries in Young Athletes. His research is funded in part by a grant from the National Football League Players Association and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament.	Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Ferrara Michael S., 2001, J Athl Train, V36, P145; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; NCAA, 2014, CONC GUID DIAGN MAN; NCAA, 2012 2013 NCAA SPORT; NCAA, 2013, 2013 2014 NCAA SPORT, P56; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279	24	36	36	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUN	2016	44	6					1391	1399		10.1177/0363546516635639			9	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	DO5KJ	WOS:000377821700011	27037282	Green Accepted			2022-02-06	
J	Wolf, JA; Koch, PF				Wolf, John A.; Koch, Paul F.			Disruption of Network Synchrony and Cognitive Dysfunction After Traumatic Brain Injury	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						TBI; concussion; axonal injury; synchrony; ensemble coding; oscillations; limbic system; hippocampus	DIFFUSE AXONAL INJURY; HIGH-FREQUENCY OSCILLATIONS; SHARP-WAVE RIPPLES; THETA-OSCILLATIONS; WORKING-MEMORY; SYNAPTIC-TRANSMISSION; GAMMA OSCILLATIONS; NEURONAL ENSEMBLES; PATH-INTEGRATION; STRIATAL NEURONS	Traumatic brain injury (TBI) is a heterogeneous disorder with many factors contributing to a spectrum of severity, leading to cognitive dysfunction that may last for many years after injury. Injury to axons in the white matter, which are preferentially vulnerable to biomechanical forces, is prevalent in many TBIs. Unlike focal injury to a discrete brain region, axonal injury is fundamentally an injury to the substrate by which networks of the brain communicate with one another. The brain is envisioned as a series of dynamic, interconnected networks that communicate via long axonal conduits termed the "connectome". Ensembles of neurons communicate via these pathways and encode information within and between brain regions in ways that are timing dependent. Our central hypothesis is that traumatic injury to axons may disrupt the exquisite timing of neuronal communication within and between brain networks, and that this may underlie aspects of post-TBI cognitive dysfunction. With a better understanding of how highly interconnected networks of neurons communicate with one another in important cognitive regions such as the limbic system, and how disruption of this communication occurs during injury, we can identify new therapeutic targets to restore lost function. This requires the tools of systems neuroscience, including electrophysiological analysis of ensemble neuronal activity and circuitry changes in awake animals after TBI, as well as computational modeling of the effects of TBI on these networks. As more is revealed about how inter-regional neuronal interactions are disrupted, treatments directly targeting these dysfunctional pathways using neuromodulation can be developed.	[Wolf, John A.; Koch, Paul F.] Univ Penn, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Wolf, John A.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA		Wolf, JA (corresponding author), Univ Penn, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.; Wolf, JA (corresponding author), Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA.	wolfjo@upenn.edu	Wolf, John A/A-1034-2007	Wolf, John A/0000-0002-6950-2303	Department of Veterans Affairs Rehabilitation Research and DevelopmentUS Department of Veterans Affairs [B1097-I, IK2-RX001479]; CURE Taking Flight Award; Codman Neurotrauma Award; Veterans AffairsUS Department of Veterans Affairs [IK2RX001479] Funding Source: NIH RePORTER	This work was made possible due to financial support provided by the Department of Veterans Affairs Rehabilitation Research and Development (Merit Review Award #B1097-I, Career Development Award #IK2-RX001479), the CURE Taking Flight Award, and the Codman Neurotrauma Award.	ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Aertsen A, 1996, J PHYSIOLOGY-PARIS, V90, P243, DOI 10.1016/S0928-4257(97)81432-5; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Backus AR, 2016, CURR BIOL, V26, P450, DOI 10.1016/j.cub.2015.12.048; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bragin A, 2010, CURR OPIN NEUROL, V23, P151, DOI 10.1097/WCO.0b013e3283373ac8; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; BUZSAKI G, 1987, BRAIN RES, V400, P321, DOI 10.1016/0006-8993(87)90631-7; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1987, NEUROSCIENCE, V22, P871, DOI 10.1016/0306-4522(87)92966-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Colley BS, 2010, EXP NEUROL, V224, P241, DOI 10.1016/j.expneurol.2010.03.026; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Dragoi G, 1999, J NEUROSCI, V19, P6191, DOI 10.1523/JNEUROSCI.19-14-06191.1999; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Foffani G, 2007, NEURON, V55, P930, DOI 10.1016/j.neuron.2007.07.040; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; FREUND TF, 1988, NATURE, V336, P170, DOI 10.1038/336170a0; Friese U, 2013, NEUROIMAGE, V66, P642, DOI 10.1016/j.neuroimage.2012.11.002; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Graham D I, 1988, Prog Clin Biol Res, V264, P159; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Hyafil A, 2015, TRENDS NEUROSCI, V38, P725, DOI 10.1016/j.tins.2015.09.001; Ibarz JM, 2010, J NEUROSCI, V30, P16249, DOI 10.1523/JNEUROSCI.3357-10.2010; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; JURKO MF, 1974, BEHAV BIOL, V10, P377, DOI 10.1016/S0091-6773(74)91964-6; Kaplan R, 2016, CURR BIOL, V26, P686, DOI 10.1016/j.cub.2016.01.017; KEREN O, 1991, Brain Injury, V5, P233, DOI 10.3109/02699059109008094; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lashley K.S., 1950, SOC EXPT BIOL S, V4, P2; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Likhtik E, 2014, NAT NEUROSCI, V17, P106, DOI 10.1038/nn.3582; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Logothetis NK, 2012, NATURE, V491, P547, DOI 10.1038/nature11618; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020; MacDonald CL, 2008, NEUROLOGY, V71, P1199, DOI 10.1212/01.wnl.0000327521.69520.7f; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Maris E, 2011, NEUROIMAGE, V54, P836, DOI 10.1016/j.neuroimage.2010.09.029; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Merkow MB, 2014, HIPPOCAMPUS, V24, P1562, DOI 10.1002/hipo.22335; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morgalla M H, 2014, Neurodiagn J, V54, P338; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Ortiz F, 2015, EXP NEUROL, V271, P319, DOI 10.1016/j.expneurol.2015.06.009; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Peredeny JV, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00017; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rajji TK, 2017, CEREB CORTEX, V27, P1482, DOI 10.1093/cercor/bhv326; RAPPAPORT M, 1991, CLIN ELECTROENCEPHAL, V22, P199, DOI 10.1177/155005949102200407; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Seager MA, 2002, P NATL ACAD SCI USA, V99, P1616, DOI 10.1073/pnas.032662099; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Skelton RW, 1998, BEHAV BRAIN RES, V96, P13, DOI 10.1016/S0166-4328(97)00199-X; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strich S., 1961, SHEARING NERVE FIBRE, V278, P443, DOI [10.1016/S0140-6736(61)92426-6, DOI 10.1016/S0140-6736(61)92426-6]; Stujenske JM, 2014, NEURON, V83, P919, DOI 10.1016/j.neuron.2014.07.026; STUMPF C, 1962, ELECTROEN CLIN NEURO, V14, P212, DOI 10.1016/0013-4694(62)90031-7; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Tonegawa S, 2008, NEURON, V57, P175, DOI 10.1016/j.neuron.2008.01.005; Tonegawa S, 2015, CURR OPIN NEUROBIOL, V35, P101, DOI 10.1016/j.conb.2015.07.009; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; TOTH K, 1993, J NEUROSCI, V13, P3712; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Vandecasteele M, 2014, P NATL ACAD SCI USA, V111, P13535, DOI 10.1073/pnas.1411233111; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	153	36	37	1	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5137		FRONT SYST NEUROSCI	Front. Syst. Neurosci.	MAY 17	2016	10								43	10.3389/fnsys.2016.00043			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DM0OD	WOS:000376044400001	27242454	Green Published, gold			2022-02-06	
J	Weil, ZM; Karelina, K; Gaier, KR; Corrigan, TED; Corrigan, JD				Weil, Zachary M.; Karelina, Kate; Gaier, Kristopher R.; Corrigan, Timothy E. D.; Corrigan, John D.			Juvenile Traumatic Brain Injury Increases Alcohol Consumption and Reward in Female Mice	JOURNAL OF NEUROTRAUMA			English	Article						alcohol; BDNF; development; environmental enrichment; sex differences; traumatic brain injury	SEX-DIFFERENCES; ETHANOL-CONSUMPTION; NUCLEUS-ACCUMBENS; SUBSTANCE-ABUSE; NEUROTROPHIC FACTOR; DOPAMINE RELEASE; CONTROLLED-TRIAL; USE DISORDERS; RATS; DRINKING	Traumatic brain injury (TBI) is closely and bi-directionally linked with alcohol use, as by some estimates intoxication is the direct or indirect cause of one-third to one-half of all TBI cases. Alcohol use following injury can reduce the efficacy of rehabilitation and increase the chances for additional injury. Finally, TBI itself may be a risk factor for the development of alcohol use disorders. Children who suffer TBIs have poorer life outcomes and more risk of substance abuse. We used a standardized closed-head injury to model mild traumatic brain injuries. We found that mice injured as juveniles but not during adulthood exhibited much greater alcohol self-administration in adulthood. Further, this phenomenon was limited to female mice. Using behavioral testing, including conditioned place preference assays, we showed that early injuries increase the rewarding properties of alcohol. Environmental enrichment administered after injury reduced axonal degeneration and prevented the increase in drinking behavior. Additionally, brain-derived neurotrophic factor gene expression, which was reduced by TBI, was normalized by environmental enrichment. Together, these results suggest a novel model of alterations in reward circuitry following trauma during development.	[Weil, Zachary M.; Karelina, Kate; Gaier, Kristopher R.; Corrigan, Timothy E. D.] Ohio State Univ, Dept Neurosci, Wexner Med Ctr, Columbus, OH 43210 USA; [Weil, Zachary M.; Karelina, Kate; Gaier, Kristopher R.; Corrigan, Timothy E. D.] Ohio State Univ, Grp Behav Neuroendocrinol, Wexner Med Ctr, Columbus, OH 43210 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Wexner Med Ctr, Columbus, OH 43210 USA		Weil, ZM (corresponding author), Biomedical Res Tower 618,460 West 12th Ave, Columbus, OH 43210 USA.	Zachary.weil@osumc.edu	Corrigan, John D./E-2921-2011; Weil, Zachary M/B-5003-2008; Weil, Zachary M/A-2439-2008	Weil, Zachary M/0000-0003-3758-1809; Weil, Zachary M/0000-0003-3758-1809; Karelina Weil, Kate/0000-0002-6628-0768			Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barker J. M., 2014, BRAIN RES; Barker JM, 2010, J NEUROSCI, V30, P9140, DOI 10.1523/JNEUROSCI.0548-10.2010; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; BLANCHARD BA, 1993, ALCOHOL CLIN EXP RES, V17, P968, DOI 10.1111/j.1530-0277.1993.tb05650.x; Cailhol S, 2001, ALCOHOL CLIN EXP RES, V25, P594, DOI 10.1111/j.1530-0277.2001.tb02255.x; Ceylan-Isik AF, 2010, LIFE SCI, V87, P133, DOI 10.1016/j.lfs.2010.06.002; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; CRABBE JC, 1981, BEHAV NEURAL BIOL, V33, P188, DOI 10.1016/S0163-1047(81)91625-3; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Epstein EE, 2007, J WOMEN AGING, V19, P31, DOI 10.1300/J074v19n01_03; FARACE E, 2000, NEUROSURGICAL FOCUS, V0008, P00001, DOI [DOI 10.3171/F0C.2000.8.1.152, DOI 10.3171/foc.2000.8.1.152]; Faul M, 2010, TRAUMATIC BRAIN INJU; GEORGE SR, 1995, J PHARMACOL EXP THER, V273, P373; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; Huang MC, 2011, ALCOHOL CLIN EXP RES, V35, P126, DOI 10.1111/j.1530-0277.2010.01329.x; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Lancaster FE, 1996, ALCOHOL CLIN EXP RES, V20, P1043, DOI 10.1111/j.1530-0277.1996.tb01945.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Machens HG, 2006, SURGERY, V139, P550, DOI 10.1016/j.surg.2005.09.001; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; McBride WJ, 1998, CRIT REV NEUROBIOL, V12, P339, DOI 10.1615/CritRevNeurobiol.v12.i4.40; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Middaugh LD, 1999, ALCOHOL, V17, P175, DOI 10.1016/S0741-8329(98)00055-X; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Pascual M, 2009, J NEUROCHEM, V108, P920, DOI 10.1111/j.1471-4159.2008.05835.x; Patton GC, 2004, PEDIATRICS, V114, pE300, DOI 10.1542/peds.2003-0626-F; Philpot RM, 2009, INT J DEV NEUROSCI, V27, P805, DOI 10.1016/j.ijdevneu.2009.08.009; REID LD, 1985, PHARMACOL BIOCHEM BE, V22, P483, DOI 10.1016/0091-3057(85)90051-6; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Torres OV, 2014, ALCOHOL CLIN EXP RES, V38, P108, DOI 10.1111/acer.12213; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Witt ED, 2007, NEUROTOXICOL TERATOL, V29, P81, DOI 10.1016/j.ntt.2006.10.013; Zanardini R, 2011, ALCOHOL CLIN EXP RES, V35, P1529, DOI 10.1111/j.1530-0277.2011.01489.x; Zandy SL, 2015, PSYCHOPHARMACOLOGY, V232, P777, DOI 10.1007/s00213-014-3712-1	53	36	37	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					895	903		10.1089/neu.2015.3953			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800011	26153729	Green Published			2022-02-06	
J	Slomine, BS; Silverstein, FS; Christensen, JR; Holubkov, R; Page, K; Dean, JM; Moler, FW				Slomine, Beth S.; Silverstein, Faye S.; Christensen, James R.; Holubkov, Richard; Page, Kent; Dean, J. Michael; Moler, Frank W.		THAPCA Trial Grp	Neurobehavioral Outcomes in Children After Out-of-Hospital Cardiac Arrest	PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; TERM NEUROPSYCHOLOGICAL OUTCOMES; PEDIATRIC INTENSIVE-CARE; CARDIOPULMONARY-RESUSCITATION; FOLLOW-UP; LIFE; PLASTICITY; SURVIVAL; BEHAVIOR; AGE	OBJECTIVE: This study examined 12-month neurobehavioral outcomes in children who survived out-of-hospital cardiac arrest (OH-CA), were comatose after resuscitation, and were enrolled in a clinical trial to evaluate targeted temperature management to hypothermia (33.0 degrees C) or normothermia (36.8 degrees C) (Therapeutic Hypothermia after Pediatric Cardiac Arrest, Out-of-Hopsital [ THAPCA-OH]; NCT00878644). METHODS: Baseline functioning was assessed by caregiver responses on the Vineland Adaptive Behavior Scales-Second Edition (VABS-II) soon after OH-CA (based on functioning before OH-CA); children with broadly normal baseline functioning (VABS-II >= 70) were included in the THAPCA-OH primary outcome. VABS-II was completed again 12 months later. Then, face-to-face cognitive evaluations were completed. Analyses evaluated changes in VABS-II composite, domain, and subdomain scores and cognitive functioning at follow-up. RESULTS: Ninety-six of 295 enrolled children were alive at 12 months; 87 of 96 had broadly normal baseline functioning (VABS-II >= 70). Follow-up was obtained on 85/87. Forty-two of 85 had VABS-II >= 70 at 12 months. VABS-II composite, domain, and subdomain scores declined significantly between baseline and 12-month follow-up (P<.001). Declines were greatest in older children. Most children displayed well below average cognitive functioning. Older age at cardiac arrest and higher baseline VABS-II scores were predictive of greater decline in neurobehavioral function. Treatment with hypothermia did not influence neurobehavioral outcomes. CONCLUSIONS: This is the largest study exploring long-term neurobehavioral outcomes in children surviving OH-CA who were comatose after resuscitation. Results revealed significant neurobehavioral morbidity across multiple functional domains, based both on caregiver reports and performance on objective cognitive measures, in survivors 1 year later.	[Slomine, Beth S.] Kennedy Krieger Inst, Dept Neuropsychol, 707 N Broadway, Baltimore, MD 21205 USA; [Christensen, James R.] Kennedy Krieger Inst, Dept Phys Med & Rehabil, Baltimore, MD USA; [Slomine, Beth S.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Slomine, Beth S.; Christensen, James R.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD USA; [Christensen, James R.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Silverstein, Faye S.; Moler, Frank W.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Silverstein, Faye S.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Holubkov, Richard; Page, Kent; Dean, J. Michael] Univ Utah, Dept Pediat, Salt Lake City, UT USA		Slomine, BS (corresponding author), Kennedy Krieger Inst, Dept Neuropsychol, 707 N Broadway, Baltimore, MD 21205 USA.	slomine@kennedykrieger.org		Holubkov, Richard/0000-0003-0431-3381	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01HL094345, U01HL094339]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA;  [UL1TR000003];  [P30HD040677];  [P30HD062171];  [U07MC09174];  [UL1 RR 024986];  [UL1 TR 000433]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD040677, P30HD062171, U10HD049981, U54HD079123, U01HD049934, U10HD049983, U10HD050012, UG1HD050096, U10HD050096] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U10HD049945, R21HD044955, R34HD050531] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000003, KL2TR000434, UL1TR000433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024986, KL2RR024987] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL094345, U01HL094339] Funding Source: NIH RePORTER	Primary support for the conduct of the Therapeutic Hypothermia after Pediatric Cardiac Arrest, Out-of-Hospital Trial was funding from National Institutes of Health U01HL094345 (Dr Moler) and U01HL094339 (Dr Dean). Additional support from the following federal grants contributed to the planning of the Therapeutic Hypothermia after Pediatric Cardiac Arrest Trials: Eunice Kennedy Shriver National Institute of Child Health and Development, Bethesda, MD, HD044955 (Dr Moler) and HD050531 (Dr Moler). In part, support was from the participation of the following research networks: Pediatric Emergency Care Applied Research Network from cooperative agreements U03MC00001, U03MC00003, U03MC00006, U03MC00007, and U03MC00008; and the Collaborative Pediatric Critical Care Research Network from cooperative agreements U10HD500009, U10HD050096, U10HD049981, U10HD049945, U10HD049983, U10HD050012, and U01HD049934. At several centers, clinical research support was supplemented by the following grants or cooperative agreements: UL1TR000003, P30HD040677, P30HD062171, U07MC09174, UL1 RR 024986, and UL1 TR 000433. Funded by the National Institutes of Health (NIH).	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Horisberger T, 2002, INTENS CARE MED, V28, P365, DOI 10.1007/s00134-001-1188-z; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; KRIEL RL, 1994, PEDIATR NEUROL, V10, P207, DOI 10.1016/0887-8994(94)90024-8; Li GH, 1999, J TRAUMA, V47, P1, DOI 10.1097/00005373-199907000-00001; Lux AL, 2005, LANCET NEUROL, V4, P712, DOI 10.1016/S1474-4422(05)70199-X; Maryniak A, 2008, RESUSCITATION, V77, P46, DOI 10.1016/j.resuscitation.2007.10.024; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; Ment LR, 2003, JAMA-J AM MED ASSOC, V289, P705, DOI 10.1001/jama.289.6.705; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Moler FW, 2009, CRIT CARE MED, V37, P2259, DOI 10.1097/CCM.0b013e3181a00a6a; Mullen E.M., 1995, MULLEN SCALES EARLY; Recla M, 2013, BRAIN INJURY, V27, P862, DOI 10.3109/02699052.2013.775499; Sparrow S.S., 2005, VINELAND ADAPTIVE BE; Suominen PK, 2014, RESUSCITATION, V85, P1059, DOI 10.1016/j.resuscitation.2014.03.307; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; van Zellem L, 2015, PEDIATR CRIT CARE ME, V16, P693, DOI 10.1097/PCC.0000000000000452; van Zellem L, 2015, INTENS CARE MED, V41, P1057, DOI 10.1007/s00134-015-3789-y; Wechsler D., 2011, WECHSLER ABBREVIATED; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; Young KD, 2004, PEDIATRICS, V114, P157, DOI 10.1542/peds.114.1.157; ZARITSKY A, 1995, RESUSCITATION, V30, P95, DOI 10.1016/0300-9572(95)00884-V	28	36	36	0	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	APR	2016	137	4							e20153412	10.1542/peds.2015-3412			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	DI0OU	WOS:000373197500038	26940987	Green Published, Green Accepted			2022-02-06	
J	Sussman, ES; Ho, AL; Pendharkar, AV; Ghajar, J				Sussman, Eric S.; Ho, Allen L.; Pendharkar, Arjun V.; Ghajar, Jamshid			Clinical evaluation of concussion: the evolving role of oculomotor assessments	NEUROSURGICAL FOCUS			English	Article						concussion screening; concussion diagnosis; vision tracking; eye tracking; oculomotor tracking; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; SPORTS-RELATED CONCUSSION; VISUAL SCREENING TOOL; HIGH-SCHOOL; EYE-MOVEMENTS; KING-DEVICK; HEAD-INJURY; DEFICITS; COLLEGIATE	Sports-related concussion is a change in brain function following a direct or an indirect force to the head, identified in awake individuals and accounting for a considerable proportion of mild traumatic brain injury. Although the neurological signs and symptoms of concussion can be subtle and transient, there can be persistent sequelae, such as impaired attention and balance, that make affected patients particularly vulnerable to further injury. Currently, there is no accepted definition or diagnostic criteria for concussion, and there is no single assessment that is accepted as capable of identifying all patients with concussion. In this paper, the authors review the available screening tools for concussion, with particular emphasis on the role of visual function testing. In particular, they discuss the oculomotor assessment tools that are being investigated in the setting of concussion screening.	[Sussman, Eric S.; Ho, Allen L.; Pendharkar, Arjun V.; Ghajar, Jamshid] Stanford Univ, Sch Med, Dept Neurosurg, 300 Pasteur Dr,R200, Stanford, CA 94305 USA		Ghajar, J (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, 300 Pasteur Dr,R200, Stanford, CA 94305 USA.	jghajar@stanford.edu					Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bernstein DM, 2009, BRAIN INJURY, V13, P151; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Crevits L, 2000, J NEUROL, V247, P179, DOI 10.1007/s004150050559; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hunt AW, 2015, J HEAD TRAUMA REHAB, V1, P1; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mullen SJ, 2014, CAN J NEUROL SCI, V41, P58, DOI 10.1017/S0317167100016279; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Poltavski DV, 2014, BRAIN INJURY, V28, P475, DOI 10.3109/02699052.2014.888771; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Saigal Rajiv, 2014, Neurosurgery, V75 Suppl 4, pS149, DOI 10.1227/NEU.0000000000000497; Samadani U, 2015, CONCUSSION, V2015, pCNC3; Samadani U, 2015, NEURAL REGEN RES, V10, P1231, DOI 10.4103/1673-5374.162752; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Samadani U, 2015, J NEUROSURG, V122, P707, DOI 10.3171/2014.10.JNS14762; Schneiders AG, 2012, SCAND J MED SCI SPOR, V22, P85, DOI 10.1111/j.1600-0838.2010.01141.x; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Ventura R, 2014, NEUROL CLIN PRACT; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482	56	36	36	2	41	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	APR	2016	40	4							E7	10.3171/2016.1.FOCUS15610			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI4NL	WOS:000373476500006	27032924	gold, Green Submitted			2022-02-06	
J	Wrocklage, KM; Schweinsburg, BC; Krystal, JH; Trejo, M; Roy, A; Weisser, V; Moore, TM; Southwick, SM; Scott, JC				Wrocklage, Kristen M.; Schweinsburg, Brian C.; Krystal, John H.; Trejo, Marcia; Roy, Alicia; Weisser, Valerie; Moore, Tyler M.; Southwick, Steven M.; Scott, J. Cobb			Neuropsychological Functioning in Veterans with Posttraumatic Stress Disorder: Associations with Performance Validity, Comorbidities, and Functional Outcomes	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Posttraumatic stress disorder; Neuropsychology; Cognitive abilities; Memory; Executive functions; Quality of life; Occupational functioning	TRAUMATIC BRAIN-INJURY; COMBAT EXPOSURE; VERBAL MEMORY; PTSD; HEALTH; ATTENTION; SYMPTOMS; DEFICITS; COGNITION; SCHIZOPHRENIA	Objectives: Numerous studies have shown that individuals with posttraumatic stress disorder (PTSD) display reduced performances on neuropsychological tests, although most prior research has not adequately accounted for comorbidities or performance validity concerns that are common in this population and could partially account for the observed neurocognitive findings. Moreover, few studies have examined the functional implications of neuropsychological results in PTSD. Methods: We examined neuropsychological functioning in 44 veterans with PTSD and 40 veteran trauma comparison (TC) participants with combat exposure and no PTSD. Results: After excluding four veterans with PTSD for performance validity concerns, multivariate analyses of variance by neurocognitive domain revealed significantly worse performance by the PTSD group in the domains of speed of information processing (p = .035) and executive functions (p = .017), but no group differences in attention/working memory, verbal/language functioning, visuoconstruction, or episodic memory. Group differences by PTSD status were still present after covarying for depression, a history of head injuries, and substance use disorders. Executive functioning performance was associated with poorer self-reported occupational functioning and physical health-related quality of life, while speed of information processing performance was associated with poorer physical health-related quality of life. Discussion: These results are generally consistent with a fronto-limbic conceptualization of PTSD-associated neuropsychological dysfunction and show that cognitive functioning may be associated with critical functional outcomes. Taken together, results suggest that consideration of neurocognitive functioning may enhance the clinical management of individuals with PTSD.	[Wrocklage, Kristen M.; Schweinsburg, Brian C.; Krystal, John H.; Trejo, Marcia; Roy, Alicia; Weisser, Valerie; Southwick, Steven M.] Natl Ctr PTSD, Clin Neurosci Div, West Haven, CT USA; [Wrocklage, Kristen M.; Schweinsburg, Brian C.; Krystal, John H.; Trejo, Marcia; Roy, Alicia; Weisser, Valerie; Southwick, Steven M.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Schweinsburg, Brian C.; Krystal, John H.; Roy, Alicia; Southwick, Steven M.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Krystal, John H.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Krystal, John H.] Yale New Haven Med Ctr, Psychiat Serv, 20 York St, New Haven, CT 06504 USA; [Moore, Tyler M.; Scott, J. Cobb] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Scott, J. Cobb] Philadelphia VA Med Ctr, Mental Illness Res Educ & Clin Ctr VISN4, Philadelphia, PA 19104 USA		Scott, JC (corresponding author), Philadelphia VA Med Ctr, MIRECC 116, 3900 Woodland Ave, Philadelphia, PA 19104 USA.	scott1@upenn.edu		Scott, J. Cobb/0000-0001-6538-9043; Moore, Tyler/0000-0002-1384-0151	Department of Veterans Affairs Career Development AwardUS Department of Veterans Affairs [IK2CX000772]; National Center for PTSD (NCPTSD); National Center for Advancing Translational Science [1UH2TR000960-01]; Department of Veterans Affairs (NCPTSD)US Department of Veterans Affairs; National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50AA12870, M01RR00125]; Yale Center for Clinical Investigation [UL1 RR024139]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UH2TR000960] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000125, UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50AA012870] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX000772] Funding Source: NIH RePORTER	This work was supported by a Department of Veterans Affairs Career Development Award (IK2CX000772) to Dr. Scott, as well as the National Center for PTSD (NCPTSD). Dr. Krystal's participation was supported by the National Center for Advancing Translational Science (1UH2TR000960-01), the Department of Veterans Affairs (NCPTSD), the National Institute on Alcohol Abuse and Alcoholism (P50AA12870, M01RR00125), and the Yale Center for Clinical Investigation (UL1 RR024139). Portions of this research were presented at the 2014 Annual Meeting of the American Psychological Association (APA). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs. The authors declare no conflicts of interest.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Andreou C, 2013, CURR OPIN PSYCHIATR, V26, P54, DOI 10.1097/YCO.0b013e32835a2acf; Antshel K. M., 2014, J ATTENTION DISORDER; Antshel KM, 2013, J CLIN PSYCHIAT, V74, pE197, DOI 10.4088/JCP.12m07698; Asmundson GJG, 2004, J TRAUMA STRESS, V17, P467, DOI 10.1007/s10960-004-5795-7; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Barker MJ, 2005, J INT NEUROPSYCH SOC, V11, P281, DOI 10.1017/S1355617705050332; Barker MJ, 2004, ARCH CLIN NEUROPSYCH, V19, P437, DOI 10.1016/S0887-6177(03)00096-9; Barrash J, 2007, MIL MED, V172, P697, DOI 10.7205/MILMED.172.7.697; Beck A., 1996, BECK DEPRESSION INVE; Berndt ER, 2000, HEALTH AFFAIR, V19, P244, DOI 10.1377/hlthaff.19.4.244; Berry D.T.R., 1991, CLIN NEUROPSYCHOL, V5, P143, DOI [10.1080/13854049108403298, DOI 10.1080/13854049108403298]; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Bremner JD, 1995, PSYCHIAT RES, V59, P97; Breslau N, 2006, ARCH GEN PSYCHIAT, V63, P1238, DOI 10.1001/archpsyc.63.11.1238; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Burriss L, 2008, DEPRESS ANXIETY, V25, P149, DOI 10.1002/da.20291; Bustamante V, 2001, J TRAUMA STRESS, V14, P791, DOI 10.1023/A:1013050423901; Casada JH, 2005, J NERV MENT DIS, V193, P102, DOI 10.1097/01.nmd.0000152809.20938.37; Cohen BE, 2013, J CLIN PSYCHIAT, V74, P1063, DOI 10.4088/JCP.12m08291; Conners C. K., 2000, CONNERS CONTINUOUS P; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Danckwerts A, 2003, NEUROPSYCHOL REV, V13, P221, DOI 10.1023/B:NERV.0000009485.76839.b7; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demakis GJ, 2008, CLIN NEUROPSYCHOL, V22, P879, DOI 10.1080/13854040701564482; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; ERRICO AL, 1990, PSYCHOL ASSESSMENT, V2, P45, DOI DOI 10.1037/1040-3590.2.1.45; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Flaks MK, 2014, J PSYCHIATR RES, V48, P32, DOI 10.1016/j.jpsychires.2013.10.009; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Geuze E, 2009, DEPRESS ANXIETY, V26, P7, DOI 10.1002/da.20476; Gilbertson MW, 2006, J ABNORM PSYCHOL, V115, P484, DOI 10.1037/0021-843X.115.3.484; Golier JA, 2006, ANN NY ACAD SCI, V1071, P54, DOI 10.1196/annals.1364.006; Harrington KM, 2012, COMPR PSYCHIAT, V53, P679, DOI 10.1016/j.comppsych.2011.12.001; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hinkin CH, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200418001-00004; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Horner MD, 2002, NEUROPSYCHOL REV, V12, P15, DOI 10.1023/A:1015439106231; Horner MD, 2013, CNS SPECTRUMS, V18, P90, DOI 10.1017/S1092852912000909; Jelinek L, 2006, J CLIN EXP NEUROPSYC, V28, P940, DOI 10.1080/13803390591004347; Jones D, 2001, J Ambul Care Manage, V24, P68; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kazis L. E., 2008, VETERANS RAND UNPUB; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2004, J OCCUP ENVIRON MED, V46, pS23, DOI 10.1097/01.jom.0000126683.75201.c5; Marcotte TA, 2008, ARCH PHYS MED REHAB, V89, P1753, DOI 10.1016/j.apmr.2007.12.049; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; McGurk SR, 2006, ADM POLICY MENT HLTH, V33, P598, DOI 10.1007/s10488-006-0070-2; MCNALLY RJ, 1995, AM J PSYCHIAT, V152, P936; Meyers JE., 1995, REY COMPLEX FIGURE T; Mohamed S, 2008, AM J PSYCHIAT, V165, P978, DOI 10.1176/appi.ajp.2008.07111713; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Nijdam MJ, 2015, J CLIN PSYCHIAT, V76, pE1023, DOI 10.4088/JCP.14m09438; O'Bryant SE, 2008, APPL NEUROPSYCHOL, V15, P113, DOI 10.1080/09084280802083921; Olff M, 2014, NEUROBIOL LEARN MEM, V112, P114, DOI 10.1016/j.nlm.2014.01.003; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Pietrzak RH, 2012, AM J GERIAT PSYCHIAT, V20, P380, DOI 10.1097/JGP.0b013e31820d92e7; Pirogovsky E, 2012, J INT NEUROPSYCH SOC, V18, P986, DOI 10.1017/S1355617712000781; Richardson-Vejlgaard R, 2009, PSYCHIAT RES, V169, P70, DOI 10.1016/j.psychres.2008.06.018; Roca V, 2001, AM J PSYCHIAT, V158, P1738, DOI 10.1176/appi.ajp.158.10.1738-a; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rourke S. B., 2009, NEUROPSYCHOLOGICAL A, P398; Samuelson KW, 2006, NEUROPSYCHOLOGY, V20, P716, DOI 10.1037/0894-4105.20.6.716; Scherrer JF, 2008, COMPR PSYCHIAT, V49, P297, DOI 10.1016/j.comppsych.2007.11.001; Schnittker J, 2005, SOC SCI RES, V34, P821, DOI 10.1016/j.ssresearch.2005.01.003; Schroeder RW, 2011, CLIN NEUROPSYCHOL, V25, P437, DOI 10.1080/13854046.2011.556668; Schuitevoerder S, 2013, J ANXIETY DISORD, V27, P550, DOI 10.1016/j.janxdis.2013.01.001; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Shucard JL, 2008, BIOL PSYCHOL, V79, P223, DOI 10.1016/j.biopsycho.2008.05.005; Tas C, 2013, COMPR PSYCHIAT, V54, P262, DOI 10.1016/j.comppsych.2012.08.001; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Twamley EW, 2004, PSYCHIAT RES, V126, P265, DOI 10.1016/j.psychres.2004.01.008; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Wechsler D., 2008, WECHSLER ADULT INTEL; WechslerD, 2001, WECHSLER TEST ADULT; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Woods SP, 2003, CLIN NEUROPSYCHOL, V17, P383, DOI 10.1076/clin.17.3.383.18079; Woods SP, 2008, COGN BEHAV NEUROL, V21, P28, DOI 10.1097/WNN.0b013e3181684414	92	36	38	1	21	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2016	22	4					399	411		10.1017/S1355617716000059			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	DI1ZK	WOS:000373295300003	26892753				2022-02-06	
J	Shear, DA; Dixon, CE; Bramlett, HM; Mondello, S; Dietrich, WD; Deng-Bryant, Y; Schmid, KE; Wang, KKW; Hayes, RL; Povlishock, JT; Kochanek, PM; Tortella, FC				Shear, Deborah A.; Dixon, C. Edward; Bramlett, Helen M.; Mondello, Stefania; Dietrich, W. Dalton; Deng-Bryant, Ying; Schmid, Kara E.; Wang, Kevin K. W.; Hayes, Ronald L.; Povlishock, John T.; Kochanek, Patrick M.; Tortella, Frank C.			Nicotinamide Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy	JOURNAL OF NEUROTRAUMA			English	Article						therapy; fluid percussion; rat; biomarker; vitamin B; neuroprotection; penetrating ballistic-like brain injury; controlled cortical impact	FOCAL CEREBRAL-ISCHEMIA; IMPROVES FUNCTIONAL RECOVERY; CORTICAL CONTUSION INJURY; FLUID PERCUSSION INJURY; INFARCT VOLUME; WISTAR RATS; HYPOTHERMIA THERAPY; DELAYED TREATMENT; MODEL; PRECURSOR	Nicotinamide (vitamin B-3) was the first drug selected for cross-model testing by the Operation Brain Trauma Therapy (OBTT) consortium based on a compelling record of positive results in pre-clinical models of traumatic brain injury (TBI). Adult male Sprague-Dawley rats were exposed to either moderate fluid percussion injury (FPI), controlled cortical impact injury (CCI), or penetrating ballistic-like brain injury (PBBI). Nicotinamide (50 or 500 mg/kg) was delivered intravenously at 15 min and 24 h after injury with subsequent behavioral, biomarker, and histopathological outcome assessments. There was an intermediate effect on balance beam performance with the high (500 mg/kg) dose in the CCI model, but no significant therapeutic benefit was detected on any other motor task across the OBTT TBI models. There was an intermediate benefit on working memory with the high dose in the FPI model. A negative effect of the low (50 mg/kg) dose, however, was observed on cognitive outcome in the CCI model, and no cognitive improvement was observed in the PBBI model. Lesion volume analysis showed no treatment effects after either FPI or PBBI, but the high dose of nicotinamide resulted in significant tissue sparing in the CCI model. Biomarker assessments included measurements of glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase-1 (UCH-L1) in blood at 4 or 24 h after injury. Negative effects (both doses) were detected on biomarker levels of GFAP after FPI and on biomarker levels of UCH-L1 after PBBI. The high dose of nicotinamide, however, reduced GFAP levels after both PBBI and CCI. Overall, our results showed a surprising lack of benefit from the low dose nicotinamide. In contrast, and partly in keeping with the literature, some benefit was achieved with the high dose. The marginal benefits achieved with nicotinamide, however, which appeared sporadically across the TBI models, has reduced enthusiasm for further investigation by the OBTT Consortium.	[Shear, Deborah A.; Deng-Bryant, Ying; Schmid, Kara E.; Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect Neurorestorat, Silver Spring, MD USA; [Dixon, C. Edward] Univ Pittsburgh, Sch Med, Brain Trauma Res Ctr, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Bramlett, Helen M.; Dietrich, W. Dalton] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA; [Bramlett, Helen M.] Vet Affairs Med Ctr, Bruce W Carter Dept, Miami, FL 33125 USA; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat & Neurosci, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Ctr Neuroprote & Biomarkers Res, Ctr Innovat Res, Alachua, FL USA; [Povlishock, John T.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 Fifth Ave, Pittsburgh, PA 15260 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Mondello, Stefania/A-1813-2012	Mondello, Stefania/0000-0002-8587-3614; Wang, Kevin/0000-0002-9343-6473			Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; Ayoub IA, 2002, NEUROREPORT, V13, P213, DOI 10.1097/00001756-200202110-00008; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; Klaidman LK, 2001, BBA-GEN SUBJECTS, V1525, P136, DOI 10.1016/S0304-4165(00)00181-1; Klaidman LK, 1996, NEUROSCI LETT, V206, P5, DOI 10.1016/0304-3940(96)12446-0; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Li FQ, 2006, CURR MED CHEM, V13, P883, DOI 10.2174/092986706776361058; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Mokudai T, 2000, STROKE, V31, P1679, DOI 10.1161/01.STR.31.7.1679; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Peterson TC, 2015, J NEUROTRAUM, V32, P765, DOI 10.1089/neu.2014.3530; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Sakakibara Y, 2000, NEUROSCI LETT, V281, P111, DOI 10.1016/S0304-3940(00)00854-5; Sakakibara Y, 2002, BRAIN RES, V931, P68, DOI 10.1016/S0006-8993(02)02263-1; SCHALLERT T, 1990, CAN J PSYCHOL, V44, P276, DOI 10.1037/h0084244; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; SPECTOR R, 1979, J NEUROCHEM, V33, P895, DOI 10.1111/j.1471-4159.1979.tb09919.x; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Zhang ZQ, 2011, TRANSL STROKE RES, V2, P455, DOI 10.1007/s12975-011-0137-6; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	42	36	39	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 15	2016	33	6					523	537		10.1089/neu.2015.4115			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DG6HN	WOS:000372184800003	26670792				2022-02-06	
J	Park, S; Theodoros, D; Finch, E; Cardell, E				Park, Stacie; Theodoros, Deborah; Finch, Emma; Cardell, Elizabeth			Be Clear: A New Intensive Speech Treatment for Adults With Nonprogressive Dysarthria	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							SILVERMAN-VOICE-TREATMENT; NEURAL PLASTICITY; ACOUSTIC CHARACTERISTICS; CONTEXTUAL INTERFERENCE; CONVERSATIONAL SPEECH; PRINCIPLED APPROACH; PARKINSONS-DISEASE; TREATMENT LSVT; INDIVIDUALS; INTELLIGIBILITY	Purpose: This article describes the effects of a new intensive dysarthria treatment program (Be Clear) on speech intelligibility in adults with dysarthria secondary to stroke and traumatic brain injury. Method: A small group-repeated measures research design was used to examine the effects of treatment on the speech of 8 participants with nonprogressive dysarthria. Treatment consisted of a 1-hr prepractice session followed by 1-hr therapy sessions, 4 times per week, for 4 weeks (16 sessions). Paired-comparison ratings of speech intelligibility served as the primary outcome measure for the study. Perceptual data, quality of life, and communication partner opinion were obtained at 3 time intervals: (a) prior to treatment, (b) immediately posttreatment, and (c) 1-3 months posttreatment. Results: Following treatment, group data demonstrated substantial improvements in speech intelligibility as perceived by naive listeners on a paired-comparison rating task. Word intelligibility was clinically significantly improved posttreatment and sentence intelligibility demonstrated statistically significant improvement. Communication partner ratings of speech intelligibility and overall communicative function were statistically significantly improved posttreatment. Conclusions: The results of this study suggest that this new intensive treatment may have potential as an effective intervention for nonprogressive dysarthria. However, controlled studies are required to establish treatment efficacy.	[Park, Stacie; Theodoros, Deborah; Finch, Emma] Univ Queensland, St Lucia, Qld, Australia; [Finch, Emma] Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Finch, Emma] Metro South Hlth, Ctr Functioning & Hlth Res, Brisbane, Qld, Australia; [Cardell, Elizabeth] Griffith Univ, Griffith Hlth Inst, Gold Coast, Australia		Park, S (corresponding author), Univ Queensland, St Lucia, Qld, Australia.	s.park3@uq.edu.au	Finch, Emma/B-3067-2011; Cardell, Elizabeth/AAV-8394-2020	Finch, Emma/0000-0002-9690-8165; Cardell, Elizabeth/0000-0002-8327-1003			Albaret JM, 1998, ACTA PSYCHOL, V100, P9, DOI 10.1016/S0001-6918(98)00022-5; Ballard KJ, 2007, APHASIOLOGY, V21, P1195, DOI 10.1080/02687030601047858; Ballard KJ, 2012, MOTOR CONTROL, V16, P106, DOI 10.1123/mcj.16.1.106; Beukelman D.R., 1984, ASSESSMENT INTELLIGI; Beukelman DR, 2002, J MED SPEECH-LANG PA, V10, P237; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Blanchet P., 2014, J COMMUN DISORD, V2, P106; Blanchet PG, 2010, PERCEPT MOTOR SKILL, V110, P965, DOI 10.2466/PMS.110.3.965-982; Blanchet PG, 2009, J MED SPEECH-LANG PA, V17, P1; Bradlow AR, 2003, J SPEECH LANG HEAR R, V46, P80, DOI 10.1044/1092-4388(2003/007); Brady MC, 2011, CLIN REHABIL, V25, P935, DOI 10.1177/0269215511405079; Bunton Kate, 2008, Seminars in Speech and Language, V29, P267, DOI 10.1055/s-0028-1103390; Clark HM, 2003, AM J SPEECH-LANG PAT, V12, P400, DOI 10.1044/1058-0360(2003/086); Dickson S, 2008, INT J LANG COMM DIS, V43, P135, DOI 10.1080/13682820701862228; Duffy JR., 2013, MOTOR SPEECH DISORDE; Dykstra Allyson D., 2007, Seminars in Speech and Language, V28, P301, DOI 10.1055/s-2007-986527; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Ferguson SH, 2007, J SPEECH LANG HEAR R, V50, P1241, DOI 10.1044/1092-4388(2007/087); Fox CM, 2002, AM J SPEECH-LANG PAT, V11, P111, DOI 10.1044/1058-0360(2002/012); Fox Cynthia M., 2006, Seminars in Speech and Language, V27, P283, DOI 10.1055/s-2006-955118; Goberman AM, 2005, J COMMUN DISORD, V38, P215, DOI 10.1016/j.jcomdis.2004.10.001; HOGAN EA, 1987, ACAD MANAGE J, V30, P354, DOI 10.2307/256279; INCE LP, 1973, ARCH PHYS MED REHAB, V54, P233; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Knock TR, 2000, APHASIOLOGY, V14, P653, DOI 10.1080/026870300401379; Krause JC, 2004, J ACOUST SOC AM, V115, P362, DOI 10.1121/1.1635842; Landin D, 1997, RES Q EXERCISE SPORT, V68, P357, DOI 10.1080/02701367.1997.10608017; Lawrence ES, 2001, STROKE, V32, P1279, DOI 10.1161/01.STR.32.6.1279; LEE TD, 1983, J EXP PSYCHOL LEARN, V9, P730, DOI 10.1037/0278-7393.9.4.730; Ludlow CL, 2008, J SPEECH LANG HEAR R, V51, pS240, DOI 10.1044/1092-4388(2008/019); Maas E, 2008, AM J SPEECH-LANG PAT, V17, P277, DOI 10.1044/1058-0360(2008/025); Mackenzie C, 2007, INT J LANG COMM DIS, V42, P131, DOI 10.1080/13682820600861776; Mackenzie C, 2010, INT J LANG COMM DIS, V45, P617, DOI 10.3109/13682820903470577; Merbah S, 2011, PSYCHOL BELG, V51, P15, DOI 10.5334/pb-51-1-15; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; PAYTON KL, 1994, J ACOUST SOC AM, V95, P1581, DOI 10.1121/1.408545; PICHENY MA, 1986, J SPEECH HEAR RES, V29, P434, DOI 10.1044/jshr.2904.434; Ramig LO, 2001, MOVEMENT DISORD, V16, P79, DOI 10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H; Robertson S, 2001, INT J LANG COMM DIS, V36, P292, DOI 10.3109/13682820109177900; Robey RR, 2004, J COMMUN DISORD, V37, P401, DOI 10.1016/j.jcomdis.2004.04.003; Sapir S, 2003, AM J SPEECH-LANG PAT, V12, P387, DOI 10.1044/1058-0360(2003/085); Schmidt R. A., 2011, MOTOR CONTROL LEARNI; Sellars C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002088.pub2; Shea J., 1983, MEMORY CONTROL ACTIO, V12, P345, DOI [10.1016/S0166-4115(08)61998-6, DOI 10.1016/S0166-4115(08)61998-6]; Shepperd JA, 2002, PSYCHOL SCI, V13, P85, DOI 10.1111/1467-9280.00416; Spielman J, 2007, AM J SPEECH-LANG PAT, V16, P95, DOI 10.1044/1058-0360(2007/014); Walshe M, 2009, INT J LANG COMM DIS, V44, P693, DOI 10.1080/13682820802317536; Wenke RJ, 2011, J MED SPEECH-LANG PA, V19, P1; Wulf G., 2007, BEWEGUNG TRAINING, V1, P1; Yorkston KM, 2007, J MED SPEECH-LANG PA, V15, pXI; Yorkston KM, 1996, J SPEECH HEAR RES, V39, pS46, DOI 10.1044/jshr.3905.s46; Yorkston KM, 1989, J HEAD TRAUMA REHAB, V4, P1	52	36	37	1	39	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	FEB	2016	25	1					97	110		10.1044/2015_AJSLP-14-0113			14	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	DI3XO	WOS:000373433900007	26882004				2022-02-06	
J	Tang, Q; Song, PP; Li, JJ; Kong, FL; Sun, L; Xu, LZ				Tang, Qi; Song, Peipei; Li, Jiajia; Kong, Fanlei; Sun, Long; Xu, Lingzhong			Control of antibiotic resistance in China must not be delayed: The current state of resistance and policy suggestions for the government, medical facilities, and patients	BIOSCIENCE TRENDS			English	Article						Antibiotic resistance; antibiotic misuse; China	SURGICAL SITE INFECTIONS; MULTIDISCIPLINARY TEAM; CDC DEFINITIONS; ANTIBACTERIAL; BURDEN	Antibiotics are medicines used to prevent and treat bacterial infections. Antibiotic resistance occurs when bacteria change in response to the use of these medicines. Antibiotic resistance is rising to dangerously high levels in all parts of the world, leading to higher medical costs, prolonged hospital stays, and increased mortality. In the European Union alone, drug-resistant bacteria are estimated to cause 25,000 deaths and cost more than US$1.5 billion every year in healthcare expenses and productivity losses. The problems of antibiotic misuse and antibiotic resistance are quite serious in China. In 2015, results of a study by the State Key Laboratory of Organic Geochemistry, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences indicated that the total antibiotic usage in China in 2013 was approximately 162,000 tons, including human use (48%) and use in animals (52%). This amount accounted for about half of the antibiotic usage worldwide. The per-capita use of antibiotics in China is more than 5 times that in Europe and the United States. These data mean that China is one of the world's leading countries with serious problems in terms of antibiotic misuse and antibiotic resistance. The current article analyzes the current state and harms of antibiotic misuse and causes of antibiotic resistance in China. The Government needs to pay close attention to the issue of antibiotic resistance in China and formulate a strategy at the national level. Thus, the following suggestions are offered: i) The Chinese Government should implement policies that promote antibiotic research and development; ii) Medical facilities in China should create multidisciplinary teams (MDTs) and encourage early action by MDTs to control the spread of multi-drug-resistant bacteria (MDRB); iii) An intervention in the form of health education should target patients and accompanying family members (AFM) in China. In other words, antibiotic resistance is not a personal problem but an urgent public health problem. Without urgent action, China is heading for a post-antibiotic era in which common infections and minor injuries can once again kill. Therefore, the aforementioned proposals have been offered with the hope that policy suggestions help to limit the phenomenon of antibiotic misuse and antibiotic resistance in China.	[Tang, Qi; Li, Jiajia; Kong, Fanlei; Sun, Long; Xu, Lingzhong] Shandong Univ, Sch Publ Hlth, Dept Social Med & Med Serv Management, Box 110,44 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Song, Peipei] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan		Xu, LZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Social Med & Med Serv Management, Box 110,44 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.	lzxu@sdu.edu.cn		Sun, Long/0000-0002-3070-8427			Ai RT, 2012, GUIDE CHINA MED, V10, P284; Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; [Anonymous], 2015, CHINA HLTH FAMILY PL; Boltz MM, 2011, SURGERY, V150, P934, DOI 10.1016/j.surg.2011.04.006; Brown ED, 2013, CAN J MICROBIOL, V59, P153, DOI 10.1139/cjm-2013-0089; Dramowski A, 2015, PAEDIATR INT CHILD H, V35, P265, DOI 10.1179/2046905515Y.0000000029; Edwards JR, 2008, AM J INFECT CONTROL, V36, P609, DOI 10.1016/j.ajic.2008.08.001; Fankam AG, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0726-0; Feng Fing-jing, 2014, Zhongguo Kangshengsu Zazhi, V39, P14; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gu JF, 2010, P 2010 CHIN PHARM C; Hoque R, 2015, THER CLIN RISK MANAG, V11, P1177, DOI 10.2147/TCRM.S90110; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Juayang AC, 2015, INT J BACTERIOL, V2015; Kirby T, 2015, LANCET INFECT DIS, V15, P271, DOI 10.1016/S1473-3099(15)70072-1; Li FC, 2014, CHINESE J CLIN RATIO, V26, P175; Li XP, 2005, MED PHILOS, V26, P20; Magedanz L, 2012, INT J CLIN PHARM-NET, V34, P290, DOI 10.1007/s11096-012-9621-7; Morrison KD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19043; National Health and Family Planning Commission, 2015, REP MON BACT DRUG RE; Rawson TM, 2015, J VASC SURG, V62, P1686, DOI 10.1016/j.jvs.2015.07.081; [宋丹妮 SONG Danni], 2005, [广东微量元素科学, Guangdong Weiliang Yuansu Kexue], V12, P64; [王丹 Wang Dan], 2014, [科学通报, Chinese Science Bulletin], V59, P743; Wang XL, 2012, CHINESE J PHARMACOEP, V10, P491; Wang YP, 2008, CHINESE J ANTIBIOTIC, V9, P519; World Health Organization, 2015, FACT SHEET ANT RES; World Health Organization, 2015, WHO MULT SURV REV WI; World Health Organization, 2015, WORLDW COUNTR SIT AN; Yang ZY, 2011, HLTH NEWS, V01, P03008; [张梦 Zhang Meng], 2016, [中国新药杂志, Chinese Journal New Drugs], V25, P13; Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729; [邹英 ZOU Ying], 2006, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V28, P724	32	36	38	2	31	IRCA-BSSA	TOKYO	PEARL CITY KOISHIKAWA 603, 2-4-5 KASUGA, BUNKYO-KU, TOKYO, 112-0003, JAPAN	1881-7815	1881-7823		BIOSCI TRENDS	BioSci. Trends	FEB	2016	10	1					1	6		10.5582/bst.2016.01034			6	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	DG1GM	WOS:000371814100001	26961210	Bronze			2022-02-06	
J	Richardson, JD; Dalton, SG				Richardson, Jessica D.; Dalton, Sarah Grace			Main concepts for three different discourse tasks in a large non-clinical sample	APHASIOLOGY			English	Article						aphasia; AphasiaBank; discourse analysis; main concept; normative reference	TRAUMATIC BRAIN-INJURY; WORD RETRIEVAL; APHASIC DISCOURSE; YOUNG-ADULTS; STROKE; IMPAIRMENT; RELIABILITY; CINDERELLA; SPEECH; PEOPLE	Background: Semi-spontaneous speech production tasks are commonly elicited to assess discourse ability. When knowledge of a topic, story, or event is shared, it is possible to gauge the informativeness of discourse by evaluating how accurately and completely an individual produces the concepts considered to be essential to the shared topic. This analysis, main concept analysis (MCA), quantifies the degree to which speakers are able to communicate the overall gist of an event. Though MCA is an easy-to-perform, informative, and reliable measure of discourse adequacy, its widespread adoption depends on the development of standardisation and normative reference. Given the large collection of control discourse transcripts available on the AphasiaBank database, it is possible to generate main concept lists based upon a large sample of control speakers and to characterise their performance to establish preliminary normative reference.Aims: The first aim of this study was to develop main concept checklists drawn from a control population for three semi-spontaneous discourse tasks included in the AphasiaBank protocola picture sequence narrative (Broken Window), storytelling (Cinderella), and a procedure (Peanut Butter and Jelly). The second aim was to report MCA results for control speakers to provide a normative reference and to stratify the normative information by age.Methods & Procedures: Ninety-two control transcripts, stratified into four age groups (20-39years; 40-59 years; 60-79 years; 80+ years), were downloaded from the AphasiaBank database. Relevant concepts were identified, and those spoken by at least one-third of the control sample were considered to be main concepts. A multilevel coding system was used to determine the accuracy and completeness of the main concepts produced by control speakers.Outcomes & Results: Main concept checklists for three discourse tasks are provided. Descriptive statistics are reported and examined to assist readers with evaluation of the normative data. No differences between age groups were observed for the Broken Window narrative. For the remaining discourse tasks, the younger half of the sample generally performed differently than the older half of the sample. Additionally, the two younger age groups did not differ significantly from each other, nor did the two older groups.Conclusions: This study provides main concept checklists drawn from a large control sample. Normative information for main concept production is provided for three discourse tasks. The sample distribution is evaluated relative to the normal probability distribution and the sample composition is described, enabling readers to determine the adequacy of normative characteristics of the sample and also the fit between their patient or client and the normative sample. This study also provides information about main concept or event production for four age groups.	[Richardson, Jessica D.; Dalton, Sarah Grace] Univ S Carolina, Dept Commun Sci & Disorders, Columbia, SC 29208 USA		Richardson, JD (corresponding author), Univ New Mexico, Dept Speech & Hearing Sci, Albuquerque, NM 87131 USA.	j.d.richardson@sc.edu		Dalton, Sarah Grace/0000-0002-1504-8002; Richardson, Jessica/0000-0003-2769-3014	Chapman Foundation	This work was supported by the Chapman Foundation.	Andreetta S, 2012, NEUROPSYCHOLOGIA, V50, P1787, DOI 10.1016/j.neuropsychologia.2012.04.003; Armstrong E, 2000, APHASIOLOGY, V14, P875, DOI 10.1080/02687030050127685; Armstrong L, 2007, APHASIOLOGY, V21, P355, DOI 10.1080/02687030600911310; Boyle M, 2014, J SPEECH LANG HEAR R, V57, P966, DOI 10.1044/2014_JSLHR-L-13-0171; Boyle M, 2011, APHASIOLOGY, V25, P1308, DOI 10.1080/02687038.2011.596185; Brandão Lenisa, 2009, Psychol. Neurosci., V2, P147, DOI 10.3922/j.psns.2009.2.006; Brownell, 1990, DISCOURSE ABILITY BR, P69, DOI 10.1007/978-1-4612-3262-9_4; Busch RM, 2005, GERIATRIC NEUROPSYCH, P133; Capilouto G, 2005, J COMMUN DISORD, V38, P431, DOI 10.1016/j.jcomdis.2005.03.005; Capilouto GJ, 2006, APHASIOLOGY, V20, P205, DOI 10.1080/02687030500473122; Chandler J. D, 1901, BOSTON COOKING SCH M; Code C, 2011, INT J SPEECH-LANG PA, V13, P3, DOI 10.3109/17549507.2010.520090; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Demir SO, 2006, BRAIN INJURY, V20, P1383, DOI 10.1080/02699050601081844; DEMR SO, 2006, BRAIN INJURY, V20, P1383, DOI DOI 10.1080/02699050601081844; Doyle P. J., 1995, AM J SPEECH-LANG PAT, V4, P130, DOI [10.1044/1058-0360.0404.130, DOI 10.1044/1058-0360.0404.130]; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fergadiotis G, 2011, APHASIOLOGY, V25, P1414, DOI 10.1080/02687038.2011.603898; Fergadiotis G, 2011, APHASIOLOGY, V25, P1261, DOI 10.1080/02687038.2011.606974; Forbes MM, 2012, SEMIN SPEECH LANG, V33, P217, DOI 10.1055/s-0032-1320041; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grimes N., 2005, WALT DISNEYS CINDERE; Hankey GJ, 2013, JAMA-J AM MED ASSOC, V309, P1171, DOI 10.1001/jama.2013.2319; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Herbert R, 2008, APHASIOLOGY, V22, P184, DOI 10.1080/02687030701262613; Hilari K, 2012, ARCH PHYS MED REHAB, V93, pS86, DOI 10.1016/j.apmr.2011.05.028; Hilari K, 2011, DISABIL REHABIL, V33, P211, DOI 10.3109/09638288.2010.508829; HOPKINS KD, 1990, EDUC PSYCHOL MEAS, V50, P717, DOI 10.1177/0013164490504001; Hopper T, 2002, APHASIOLOGY, V16, P745, DOI 10.1080/02687030244000059; Kauhanen ML, 2000, CEREBROVASC DIS, V10, P455, DOI 10.1159/000016107; Kazdin A., 1982, SINGLE CASE RES DESI; Keppel G., 2004, DESIGN ANAL RES HDB, V4th ed.; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Kong APH, 2011, J SPEECH LANG HEAR R, V54, P148, DOI 10.1044/1092-4388(2010/09-0240); Kong APH, 2009, J COMMUN DISORD, V42, P442, DOI 10.1016/j.jcomdis.2009.06.002; MacWhinney B., 2000, CHILDES PROJECT; MacWhinney B, 2011, APHASIOLOGY, V25, P1286, DOI 10.1080/02687038.2011.589893; MacWhinney B, 2010, APHASIOLOGY, V24, P856, DOI 10.1080/02687030903452632; Mayer JF, 2003, APHASIOLOGY, V17, P481, DOI 10.1080/02687030344000148; Menn L, 1998, BRAIN LANG, V61, P183, DOI 10.1006/brln.1997.1838; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; NICHOLAS LE, 1995, J SPEECH HEAR RES, V38, P146, DOI 10.1044/jshr.3801.145; NICHOLAS LE, 1993, CLIN APHASIOL, V21, P87; Olness G. S., 2002, APHASIOLOGY, V16, P623, DOI [DOI 10.1080/02687030244000095, 10.1080/02687030244000095]; Prins R, 2004, APHASIOLOGY, V18, P1075, DOI 10.1080/02687030444000534; Ross KB, 1999, APHASIOLOGY, V13, P113, DOI 10.1080/026870399402235; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Singhal AB, 2013, NEUROLOGY, V81, P1089, DOI 10.1212/WNL.0b013e3182a4a451; Snyder T., 2011, DIGEST ED STAT 2010; Spaccavento S, 2014, NEUROPSYCH DIS TREAT, V10, P27, DOI 10.2147/NDT.S52357; Stark JA, 2010, APHASIOLOGY, V24, P709, DOI 10.1080/02687030903524729; Sullivan M, 2003, STAT INFORM DECISION; Susan Carey, 1988, MIND LANG, V3, P167, DOI DOI 10.1111/J.1468-0017.1988.TB00141.X; ULATOWSKA HK, 1981, BRAIN LANG, V13, P345, DOI 10.1016/0093-934X(81)90100-0; Ulatowska HK, 2003, APHASIOLOGY, V17, P511, DOI 10.1080/0268703034400102; van Dijk TA, 2006, DISCOURSE STUD, V8, P159, DOI 10.1177/1461445606059565; West S. G., 1995, STRUCTURAL EQUATION, P56, DOI DOI 10.1037/0008-400X.26.2.210; Wright HH, 2011, J SPEECH LANG HEAR R, V54, P900, DOI 10.1044/1092-4388(2010/09-0253); Wright HH, 2005, APHASIOLOGY, V19, P263, DOI 10.1080/02687030444000732; YORKSTON KM, 1980, J SPEECH HEAR DISORD, V45, P27, DOI 10.1044/jshd.4501.27	63	36	37	0	29	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	JAN 2	2016	30	1					45	73		10.1080/02687038.2015.1057891			29	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	CU1TI	WOS:000363303800003					2022-02-06	
J	Dretsch, MN; Williams, K; Emmerich, T; Crynen, G; Ait-Ghezala, G; Chaytow, H; Mathura, V; Crawford, FC; Iverson, GL				Dretsch, Michael N.; Williams, Kathy; Emmerich, Tanja; Crynen, Gogce; Ait-Ghezala, Ghania; Chaytow, Helena; Mathura, Venkat; Crawford, Fiona C.; Iverson, Grant L.			Brain-derived neurotropic factor polymorphisms, traumatic stress, mild traumatic brain injury, and combat exposure contribute to postdeployment traumatic stress	BRAIN AND BEHAVIOR			English	Article						BDNF; deployment; genetics; military; posttraumatic stress disorder; psychological health; traumatic brain injury	DOPAMINE-RECEPTOR GENE; DRD2 GENE; COGNITIVE RESERVE; APOE GENOTYPE; ALCOHOL-USE; DISORDER; PTSD; ASSOCIATION; BDNF; DEPLOYMENT	Background In addition to experiencing traumatic events while deployed in a combat environment, there are other factors that contribute to the development of posttraumatic stress disorder (PTSD) in military service members. This study explored the contribution of genetics, childhood environment, prior trauma, psychological, cognitive, and deployment factors to the development of traumatic stress following deployment. Methods Both pre- and postdeployment data on 231 of 458 soldiers were analyzed. Postdeployment assessments occurred within 30days from returning stateside and included a battery of psychological health, medical history, and demographic questionnaires; neurocognitive tests; and blood serum for the D2 dopamine receptor (DRD2), apolipoprotein E (APOE), and brain-derived neurotropic factor (BDNF) genes. Results Soldiers who screened positive for traumatic stress at postdeployment had significantly higher scores in depression (d=1.91), anxiety (d=1.61), poor sleep quality (d=0.92), postconcussion symptoms (d=2.21), alcohol use (d=0.63), traumatic life events (d=0.42), and combat exposure (d=0.91). BDNF Val66 Met genotype was significantly associated with risk for sustaining a mild traumatic brain injury (mTBI) and screening positive for traumatic stress. Predeployment traumatic stress, greater combat exposure and sustaining an mTBI while deployed, and the BDNF Met/Met genotype accounted for 22% of the variance of postdeployment PTSD scores (R-2=0.22, P<0.001). However, predeployment traumatic stress, alone, accounted for 17% of the postdeployment PTSD scores. Conclusion These findings suggest predeployment traumatic stress, genetic, and environmental factors have unique contributions to the development of combat-related traumatic stress in military service members.	[Dretsch, Michael N.] US Army, Aeromed Res Lab, 6901 Farrel Rd, Ft Rucker, AL USA; [Dretsch, Michael N.; Williams, Kathy] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA; [Dretsch, Michael N.] Headquarters Army Training & Doctrine Command HQ, Human Dimens Div, 950 Jefferson Ave, Ft Eustis, VA 23604 USA; [Emmerich, Tanja; Crynen, Gogce; Ait-Ghezala, Ghania; Chaytow, Helena; Mathura, Venkat; Crawford, Fiona C.] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Iverson, Grant L.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Iverson, Grant L.] Harvard Univ, Sch Med, Ctr Hlth & Rehabil, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA		Dretsch, MN (corresponding author), HQ TRADOC, Human Dimens Div, 950 Jefferson Ave, Ft Eustis, VA USA.	michael.n.dretsch.mil@mail.mil		Crynen, Gogce/0000-0001-6066-9900; Emmerich, Tanja/0000-0001-5064-7150; Chaytow, Helena/0000-0003-2257-7620; Ait-Ghezala, Ghania/0000-0002-9836-8617; Iverson, Grant/0000-0001-7348-9570	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	Funding for this study was provided by the US Army Medical Research and Materiel Command.	Alschuler KN, 2014, PSYCHOL SERV, V11, P273, DOI 10.1037/a0036201; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Andersen SB, 2014, J CLIN PSYCHIAT, V75, P1001, DOI 10.4088/JCP.13m08914; Angelucci F, 2014, BRAIN COGNITION, V84, P118, DOI 10.1016/j.bandc.2013.11.012; [Anonymous], 2012, VETERANS HLTH ADM TR; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Breslau N, 2006, ARCH GEN PSYCHIAT, V63, P1238, DOI 10.1001/archpsyc.63.11.1238; Burke J R, 1991, Int J Neurol, V25-26, P41; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carlson JM, 2014, CEREB CORTEX, V24, P2249, DOI 10.1093/cercor/bht089; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Comings DE, 1996, BIOL PSYCHIAT, V40, P368, DOI 10.1016/0006-3223(95)00519-6; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; D'Onofrio G, 2011, INT J GERIATR PSYCH, V26, P1062, DOI 10.1002/gps.2644; Delahanty DL, 2006, ANN NY ACAD SCI, V1071, P27, DOI 10.1196/annals.1364.003; Esiri MM, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt105; Gerlock AA, 2014, J MARITAL FAM THER, V40, P344, DOI 10.1111/jmft.12017; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jonsson EG, 1999, MOL PSYCHIATR, V4, P290, DOI 10.1038/sj.mp.4000532; Kim TY, 2013, DEPRESS ANXIETY, V30, P1194, DOI 10.1002/da.22138; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Lawford BR, 2006, EUR PSYCHIAT, V21, P180, DOI 10.1016/j.eurpsy.2005.01.006; Lyons MJ, 2013, AM J MED GENET B, V162, P762, DOI 10.1002/ajmg.b.32154; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Valente NLM, 2011, J MOL NEUROSCI, V44, P59, DOI 10.1007/s12031-011-9513-7; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Montag C, 2008, NEUROIMAGE, V42, P1554, DOI 10.1016/j.neuroimage.2008.06.008; Montag C, 2010, PSYCHIAT RES, V179, P86, DOI 10.1016/j.psychres.2008.08.005; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Panza F, 2012, AGEING RES REV, V11, P87, DOI 10.1016/j.arr.2011.06.005; Pivac N, 2012, WORLD J BIOL PSYCHIA, V13, P306, DOI 10.3109/15622975.2011.582883; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Raber J, 2000, J NEUROSCI, V20, P2064; Ritchie T, 2003, NEUROCHEM RES, V28, P73, DOI 10.1023/A:1021648128758; Rojas SM, 2014, J ANXIETY DISORD, V28, P318, DOI 10.1016/j.janxdis.2014.02.004; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seripa D, 2011, REJUV RES, V14, P491, DOI 10.1089/rej.2011.1169; Soldan A, 2015, HUM BRAIN MAPP, V36, P2826, DOI 10.1002/hbm.22810; Spinhoven P, 2014, CHILD ABUSE NEGLECT, V38, P1320, DOI 10.1016/j.chiabu.2014.01.017; Stander VA, 2014, CLIN PSYCHOL REV, V34, P87, DOI 10.1016/j.cpr.2013.12.002; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Uher R, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00048; Vandrey R, 2014, INT REV PSYCHIATR, V26, P237, DOI 10.3109/09540261.2014.901300; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; Voisey J, 2009, DEPRESS ANXIETY, V26, P28, DOI 10.1002/da.20517; Vranceanu Ana-Maria, 2014, J Bone Joint Surg Am, V96, pe20, DOI 10.2106/JBJS.L.00479; Weathers F. W., 1991, PCL M FOR DSM 4; Wong AHC, 2000, EUR J PHARMACOL, V410, P183; Youngner CG, 2012, WEST J EMERG MED, V13, P220, DOI 10.5811/westjem.2012.3.11777; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zerach G, 2013, ISR J PSYCHIATR REL, V50, P91; Zhang HP, 2006, AM J MED GENET B, V141B, P387, DOI 10.1002/ajmg.b.30332; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	65	36	36	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	JAN	2016	6	1							e00392	10.1002/brb3.392			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	DB8OV	WOS:000368777200006	27110438	Green Published, gold			2022-02-06	
J	Newcombe, VFJ; Correia, MM; Ledig, C; Abate, MG; Outtrim, JG; Chatfield, D; Geeraerts, T; Manktelow, AE; Garyfallidis, E; Pickard, JD; Sahakian, BJ; Hutchinson, PJA; Rueckert, D; Coles, JP; Williams, GB; Menon, DK				Newcombe, Virginia F. J.; Correia, Marta M.; Ledig, Christian; Abate, Maria G.; Outtrim, Joanne G.; Chatfield, Doris; Geeraerts, Thomas; Manktelow, Anne E.; Garyfallidis, Eleftherios; Pickard, John D.; Sahakian, Barbara J.; Hutchinson, Peter J. A.; Rueckert, Daniel; Coles, Jonathan P.; Williams, Guy B.; Menon, David K.			Dynamic Changes in White Matter Abnormalities Correlate With Late Improvement and Deterioration Following TBI: A Diffusion Tensor Imaging Study	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; magnetic resonance imaging; diffusion tensor imaging	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; AXONAL INJURY; INTEGRITY; SEVERITY; RAT; MRI; DYSFUNCTION; TOMOGRAPHY; ACTIVATION	Objective. Traumatic brain injury (TBI) is not a single insult with monophasic resolution, but a chronic disease, with dynamic processes that remain active for years. We aimed to assess patient trajectories over the entire disease narrative, from ictus to late outcome. Methods. Twelve patients with moderate-to-severe TBI underwent magnetic resonance imaging in the acute phase (within 1 week of injury) and twice in the chronic phase of injury (median 7 and 21 months), with some undergoing imaging at up to 2 additional time points. Longitudinal imaging changes were assessed using structural volumetry, deterministic tractography, voxel-based diffusion tensor analysis, and region of interest analyses (including corpus callosum, parasagittal white matter, and thalamus). Imaging changes were related to behavior. Results. Changes in structural volumes, fractional anisotropy, and mean diffusivity continued for months to years postictus. Changes in diffusion tensor imaging were driven by increases in both axial and radial diffusivity except for the earliest time point, and were associated with changes in reaction time and performance in a visual memory and learning task (paired associates learning). Dynamic structural changes after TBI can be detected using diffusion tensor imaging and could explain changes in behavior. Conclusions. These data can provide further insight into early and late pathophysiology, and begin to provide a framework that allows magnetic resonance imaging to be used as an imaging biomarker of therapy response. Knowledge of the temporal pattern of changes in TBI patient populations also provides a contextual framework for assessing imaging changes in individuals at any given time point.	[Newcombe, Virginia F. J.; Correia, Marta M.; Abate, Maria G.; Outtrim, Joanne G.; Chatfield, Doris; Geeraerts, Thomas; Manktelow, Anne E.; Pickard, John D.; Sahakian, Barbara J.; Hutchinson, Peter J. A.; Coles, Jonathan P.; Williams, Guy B.; Menon, David K.] Univ Cambridge, Cambridge CB2 2QQ, England; [Ledig, Christian; Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, London, England; [Abate, Maria G.] Gerardo Hosp, Milan, Italy; [Geeraerts, Thomas] Univ Hosp Toulouse, Toulouse, France; [Garyfallidis, Eleftherios] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada		Newcombe, VFJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 2QQ, England.	vfjn2@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745; Morgado Correia, Marta/0000-0002-3231-7040; Newcombe, Virginia/0000-0001-6044-9035; Hutchinson, Peter/0000-0002-2796-1835; Ledig, Christian/0000-0003-4862-3138; Coles, Jonathan/0000-0003-4013-679X	Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390 ID 65883]; UK National Institute of Health Research Biomedical Research Centre at CambridgeNational Institute for Health Research (NIHR); Technology Platform - UK Department of Health; Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship; Societe Francaise d'Anesthesie et de Reanimation (SFAR); National Institute for Health Research Professorship; NIHR Senior Investigator Award; FP7 grant from the European Commission; Academy of Medical Sciences (AMS)Academy of Medical Sciences (AMS) [AMS-CSF4-Newcombe] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354B, G9439390, G0001237, G0600986, G1000183B, G0001354, G0601025, G1002277] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090, NF-SI-0508-10327, ACF-2009-14-007, NIHR-RP-R3-12-013] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G1002277, G0601025, G0001237, G0600986] Funding Source: UKRI	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a Medical Research Council (UK) Program Grant (Acute brain injury: heterogeneity of mechanisms, therapeutic targets and outcome effects [G9439390 ID 65883]), the UK National Institute of Health Research Biomedical Research Centre at Cambridge, and the Technology Platform funding provided by the UK Department of Health. VFJN is supported by a Health Foundation/Academy of Medical Sciences Clinician Scientist Fellowship. TG was supported by the Societe Francaise d'Anesthesie et de Reanimation (SFAR). PJAH is supported by a National Institute for Health Research Professorship. DKM is supported by an NIHR Senior Investigator Award and by an FP7 grant from the European Commission.	Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Garyfallidis E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00175; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Heck RH, 2014, QUANT METH SER, P1; Hedman AM, 2012, HUM BRAIN MAPP, V33, P1987, DOI 10.1002/hbm.21334; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; JENNETT B, 1975, LANCET, V1, P480; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Ledig C, 2014, IEEE 11 INT S BIOM I; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Leung KK, 2012, NEUROIMAGE, V59, P3995, DOI 10.1016/j.neuroimage.2011.10.068; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; Newcombe VFJ, 2008, ACTA NEUROCHIR SUPPL, V102, P247, DOI 10.1007/978-3-211-85578-2_47; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Puig J, 2013, STROKE, V44, P1162, DOI 10.1161/STROKEAHA.111.678110; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; WAGNER DP, 1984, MED DECIS MAKING, V4, P297, DOI 10.1177/0272989X8400400305; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson S, 2004, J NEUROTRAUM, V21, P239, DOI 10.1089/089771504322972031; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739	48	36	37	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JAN	2016	30	1					49	62		10.1177/1545968315584004			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	CZ5VH	WOS:000367169900005	25921349				2022-02-06	
J	Whiteneck, GG; Cuthbert, JP; Corrigan, JD; Bogner, JA				Whiteneck, Gale G.; Cuthbert, Jeffery P.; Corrigan, John D.; Bogner, Jennifer A.			Risk of Negative Outcomes After Traumatic Brain Injury: A Statewide Population-Based Survey	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activities of daily living; epidemiology; health status; mild cognitive impairment; mild traumatic brain injury; postconcussive symptoms; quality of life; surveys; traumatic brain injury	UNITED-STATES; MILD; RELIABILITY; VALIDITY; PREVALENCE; HISTORY; COHORT	Objective: To investigate the rates of negative outcomes associated with all severities of traumatic brain injury (TBI), treated in all settings or not treated at all, in comparison to the general population. Participants: Coloradoans without injury, with injury but no TBI, with mild TBI but no loss of consciousness (LOC), mild TBI with LOC, moderate TBI, or severe TBI. Design: Statewide population-based survey. Main measures: Computer-assisted, modified Ohio State University TBI Identification Method; Behavioral Risk Factor Surveillance System and National Health Interview Survey questions; Satisfaction with Life Scale; and postconcussive symptoms. Results: Up to 42.5% of participants reported a lifetime history of at least 1 TBI. Multiple negative outcomes were found to increase in prevalence in a stepwise fashion in association with greater TBI severity, with the clearest patterns observed for disability, poor life satisfaction, and impaired memory. Conclusions: Traumatic brain injury was found to be associated with disability and other negative outcomes in a general population survey. This study does not allow us to examine the proximate causes of disability, but it suggests that TBI may serve to both cause disability directly and exacerbate the influence of other etiologies. These relations should be examined in subsequent studies.	[Whiteneck, Gale G.; Cuthbert, Jeffery P.] Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA; [Corrigan, John D.; Bogner, Jennifer A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Whiteneck, GG (corresponding author), Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA.	gale@craig-hospital.org			Colorado Injury Control Research Center through Centers for Disease Control and Prevention [R49 CE001168]; National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of Education, TBI Model System Centers grantsUS Department of Education [H133A070029]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001168] Funding Source: NIH RePORTER	This publication was supported by the Colorado Injury Control Research Center through grant number R49 CE001168 from the Centers for Disease Control and Prevention and the National Institute on Disability and Rehabilitation Research, Office of Special Education and Rehabilitative Services, US Department of Education, TBI Model System Centers grants to Ohio State University (H133A070029). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the National Institute on Disability and Rehabilitation Research.	Adams P F, 1992, Vital Health Stat 10, P1; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; [Anonymous], 2011, STAT STAT SOFTW REL; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bureau of Health Statistics and Data Management, 1998, NEW HAMPSH BEH RISK; Butterworth P, 2004, J CLIN EPIDEMIOL, V57, P742, DOI 10.1016/j.jclinepi.2003.10.015; Caplan B, 1996, J HEAD TRAUMA REHAB, V11, P1; Centers for Disease Control and Prevention, 2000, BRFSS 2000 SURV DAT; Centers for Disease Control and Prevention, 1994, NAT HLTH INT SURV 19; Centers for Disease Control and Prevention, 2013, DIS HLTH DAT SYST ME; Centers for Disease Control and Prevention Department of Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1315; Cuthbert JP, 2016, J HEAD TRAUMA REHAB, V31, pE36, DOI 10.1097/HTR.0000000000000075; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E., 2006, UNDERSTANDING SCORES; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Health Statistics Section, 2001, COL BEH RISK FACT SU; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2009, GULF WAR HLTH, V7; Izrael D, 2000, 25 ANN SAS US GROUP; Izrael D, 2000, P 25 ANN SAS US GROU; Izrael D, 2009, SAS GLOB FOR; Kalton G., 2003, J OFF STAT, V19, P81; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Rosenthal M, 1999, REHABILITATION ADULT; Rosenthal M, 1993, J HEAD TRAUMA REHAB, V8, P1; SAS Institute Inc, 2012, SAS 9 3; Selassie A, 2003, S CAROLINA TRAUMATIC; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sugerman D., 2012, BRAIN INJURY MED, P45; Thurman D, 1996, W J MED, V165, P196; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Whiteneck G, J HEAD TRAU IN PRESS; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090; [No title captured]	52	36	36	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					E43	E54		10.1097/HTR.0000000000000141			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000005	25931188				2022-02-06	
J	Melnick, ER; Shafer, K; Rodulfo, N; Shi, J; Hess, EP; Wears, RL; Qureshi, RA; Post, LA				Melnick, Edward R.; Shafer, Katherine; Rodulfo, Nayeli; Shi, Joyce; Hess, Erik P.; Wears, Robert L.; Qureshi, Rija A.; Post, Lori A.			Understanding Overuse of Computed Tomography for Minor Head Injury in the Emergency Department: A Triangulated Qualitative Study	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	Academic-Emergency-Medicine (AEM) Consensus Conference	MAY 12, 2015	San Diego, CA	Acad Emergency Med			SHARED DECISION-MAKING; CLUSTER-RANDOMIZED-TRIAL; COGNITIVE TASK-ANALYSIS; PATIENT SATISFACTION; TECHNICAL WORK; BRAIN-INJURY; HEALTH-CARE; MEDICINE; CT; INFORMATION	Background: Overuse of computed tomography (CT) for minor head injury continues despite developed and rigorously validated clinical decision rules like the Canadian CT Head Rule (CCHR). Adherence to this sensitive and specific rule could decrease the number of CT scans performed in minor head injury by 35%. But in practice, the CCHR has failed to reduce testing, despite its accurate performance. Objectives: The objective was to identify nonclinical, human factors that promote or inhibit the appropriate use of CT in patients presenting to the emergency department (ED) with minor head injury. Methods: This was a qualitative study in three phases, each with interview guides developed by a multidisciplinary team. Subjects were recruited from patients treated and released with minor head injuries and providers in an urban academic ED and a satellite community ED. Focus groups of patients (four groups, 22 subjects total) and providers (three groups, 22 subjects total) were conducted until thematic saturation was reached. The findings from the focus groups were triangulated with a cognitive task analysis, including direct observation in the ED (>150 hours), and individual semistructured interviews using the critical decision method with four senior physician subject matter experts. These experts are recognized by their peers for their skill in safely minimizing testing while maintaining patient safety and engagement. Focus groups and interviews were audio recorded and notes were taken by two independent note takers. Notes were entered into ATLAS.ti and analyzed using the constant comparative method of grounded theory, an iterative coding process to determine themes. Data were double-coded and examined for discrepancies to establish consensus. Results: Five core domains emerged from the analysis: establishing trust, anxiety (patient and provider), constraints related to ED practice, the influence of others, and patient expectations. Key themes within these domains included patient engagement, provider confidence and experience, ability to identify and manage patient anxiety, time constraints, concussion knowledge gap, influence of health care providers, and patient expectations to get a CT. Conclusions: Despite high-quality evidence informing use of CT in minor head injury, multiple factors influence the decision to obtain CT in practice. Identifying and disseminating approaches and designing systems that help clinicians establish trust and manage uncertainty within the ED context could optimize CT use in minor head injury. (C) 2015 by the Society for Academic Emergency Medicine	[Melnick, Edward R.; Shafer, Katherine; Rodulfo, Nayeli; Post, Lori A.] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06520 USA; [Hess, Erik P.] Mayo Clin, Coll Med, Dept Emergency Med, Rochester, MN USA; [Wears, Robert L.] Univ Florida, Dept Emergency Med, Jacksonville, FL USA; [Shi, Joyce] Yale Univ, New Haven, CT USA; [Qureshi, Rija A.] Ziauddin Med Univ, Karachi, Pakistan		Melnick, ER (corresponding author), Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06520 USA.	edward.melnick@yale.edu	Post, Lori/AAQ-9653-2021		Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS021271]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS021271] Funding Source: NIH RePORTER	This project was supported by grant number K08HS021271 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.	American College of Emergency Physicians, 10 THINGS PHYS PAT S; [Anonymous], 2014, DAT BOOK HLTH CAR SP; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Chisholm CD, 2000, ACAD EMERG MED, V7, P1239, DOI 10.1111/j.1553-2712.2000.tb00469.x; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Davis MA, 1999, ACAD EMERG MED, V6, P781, DOI 10.1111/j.1553-2712.1999.tb01206.x; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; DEYO RA, 1987, ARCH INTERN MED, V147, P141, DOI 10.1001/archinte.147.1.141; DEYO RA, 1986, SPINE, V11, P28, DOI 10.1097/00007632-198601000-00008; Djulbegovic B, 2011, HBK PHILOS SCI, V16, P299; Elwyn G, 2005, HEALTH EXPECT, V8, P34, DOI 10.1111/j.1369-7625.2004.00311.x; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; Gupta A, 2014, J AM MED INFORM ASSN, V21, pE347, DOI 10.1136/amiajnl-2013-002536; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hess EP, 2012, CIRC-CARDIOVASC QUAL, V5, P251, DOI 10.1161/CIRCOUTCOMES.111.964791; Kanzaria HK, 2015, ACAD EMERG MED, V22, P399, DOI 10.1111/acem.12627; Karsh BT, 2010, J AM MED INFORM ASSN, V17, P617, DOI 10.1136/jamia.2010.005637; KASSIRER JP, 1989, NEW ENGL J MED, V320, P1489, DOI 10.1056/NEJM198906013202211; Katz SJ, 2013, JAMA-J AM MED ASSOC, V310, P1559, DOI 10.1001/jama.2013.278944; KLEIN GA, 1989, IEEE T SYST MAN CYB, V19, P462, DOI 10.1109/21.31053; Korley FK, 2010, JAMA-J AM MED ASSOC, V304, P1465, DOI 10.1001/jama.2010.1408; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Militello LG, 1998, BIOMED INSTRUM TECHN, V32, P535; Montori V, EMPATHIC DECISION MA; Moskop JC, 2009, ANN EMERG MED, V53, P605, DOI 10.1016/j.annemergmed.2008.09.019; Nemeth CP, 2007, ANN EMERG MED, V50, P384, DOI 10.1016/j.annemergmed.2007.08.013; Nemeth CP, 2004, IEEE T SYST MAN CY A, V34, P689, DOI 10.1109/TSMCA.2004.836802; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Probst MA, 2014, AM J EMERG MED, V32, P645, DOI 10.1016/j.ajem.2014.01.003; Rosenbaum L, 2015, NEW ENGL J MED, V372, P7, DOI 10.1056/NEJMp1413816; Schuur JD, 2014, JAMA INTERN MED, V174, P509, DOI 10.1001/jamainternmed.2013.12688; Smith-Bindman R, 2011, AM J EMERG MED, V29, P656, DOI 10.1016/j.ajem.2010.01.038; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4146; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Thompson DA, 1996, ANN EMERG MED, V28, P657, DOI 10.1016/S0196-0644(96)70090-2; Wears RL, 2005, HARWOOD NUSS CLIN PR; Weir CR, 2007, J AM MED INFORM ASSN, V14, P65, DOI 10.1197/jamia.M2231; Wright DW, 2011, TINTINALLIS EMERGENC; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171	46	36	36	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	DEC	2015	22	12			SI		1474	1483		10.1111/acem.12824			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	DA5FP	WOS:000367828900014	26568523				2022-02-06	
J	Phang, I; Papadopoulos, MC				Phang, Isaac; Papadopoulos, Marios C.			Intraspinal Pressure Monitoring in a Patient with Spinal Cord Injury Reveals Different Intradural Compartments: Injured Spinal Cord Pressure Evaluation (ISCoPE) Study	NEUROCRITICAL CARE			English	Article						Intensive care; Intraspinal pressure; Neuromonitoring; Spinal cord injury; Spinal cord perfusion pressure	INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; ANIMAL-MODEL; DECOMPRESSION	We recently described a technique for monitoring intraspinal pressure (ISP) after traumatic spinal cord injury (TSCI). This is analogous to intracranial pressure monitoring after brain injury. We showed that, after severe TSCI, ISP at the injury site is elevated as the swollen cord is compressed against the dura. In a patient with complete thoracic TSCI, we sequentially monitored subdural ISP above the injury, at the injury site, and below the injury intraoperatively. Postoperatively, we simultaneously monitored subdural ISP and intraparenchymal ISP at the injury site and compared the two ISP signals as well as their Fast Fourier Transform spectra. Subdural ISP recorded from the injury site was higher than subdural ISP recorded from above or below the injury site by more than 10 mmHg. The subdural and intraparenchymal ISP signals recorded from the injury site had comparable amplitudes and Fast Fourier Transform spectra. Intraparenchymal pulse pressure was twofold larger than subdural pulse pressure. After severe TSCI, three intradural compartments form (space above injury, injury site, space below injury) with different ISPs. At the level of maximum spinal cord swelling (injury site), subdural ISP is comparable to intraparenchymal ISP.	[Phang, Isaac; Papadopoulos, Marios C.] Univ London St Georges Hosp, Acad Neurosurg Unit, London SW17 0RE, England		Papadopoulos, MC (corresponding author), Univ London St Georges Hosp, Acad Neurosurg Unit, Room 0-136 Jenner Wing,Cranmer Terrace, London SW17 0RE, England.	mpapadop@sgul.ac.uk		Papadopoulos, Marios/0000-0001-9174-4176	Fletcher Fund; Wings for Life Spinal Cord Research Foundation; Neurosciences Research Foundation; Guthy Jackson Charitable Foundation; London Deanery	MCP was financially supported by Fletcher Fund, Wings for Life Spinal Cord Research Foundation, Neurosciences Research Foundation, and Guthy Jackson Charitable Foundation, and IP was financially supported by Fletcher Fund, Neurosciences Research Foundation and London Deanery. The funders had no input at any stage of this research.	Awwad Waleed, 2014, Eur J Orthop Surg Traumatol, V24 Suppl 1, pS261, DOI 10.1007/s00590-013-1409-5; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Jones CF, 2012, SPINE, V37, pE1422, DOI 10.1097/BRS.0b013e31826ba7cd; Jones CF, 2012, J NEUROSURG-SPINE, V16, P624, DOI 10.3171/2012.3.SPINE11970; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Phang I, 2015, J NEUROTRAUMA; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Smith JS, 2010, J BONE JOINT SURG AM, V92A, P1206, DOI 10.2106/JBJS.I.00740; van Middendorp JJ, 2013, J NEUROTRAUM, V30, P1781, DOI 10.1089/neu.2013.2932; Varsos GV, 2015, J NEUROSURG SPINE; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Werndle MC, 2012, J NEUROTRAUM, V29, P880, DOI 10.1089/neu.2011.2038	14	36	37	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2015	23	3					414	418		10.1007/s12028-015-0153-6			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV8WN	WOS:000364569000017	26136148	Green Accepted			2022-02-06	
J	Scott, G; Hellyer, PJ; Ramlackhansingh, AF; Brooks, DJ; Matthews, PM; Sharp, DJ				Scott, Gregory; Hellyer, Peter J.; Ramlackhansingh, Anil F.; Brooks, David J.; Matthews, Paul M.; Sharp, David J.			Thalamic inflammation after brain trauma is associated with thalamo-cortical white matter damage	JOURNAL OF NEUROINFLAMMATION			English	Article						Microglia; Translocator protein; Positron emission tomography; Traumatic brain injury; Traumatic axonal injury; PK11195; Thalamus	MICROGLIAL ACTIVATION; AXONAL INJURY; ISCHEMIC-STROKE; IN-VIVO; NEUROINFLAMMATION; SINGLE	Background: Traumatic brain injury can trigger chronic neuroinflammation, which may predispose to neurodegeneration. Animal models and human pathological studies demonstrate persistent inflammation in the thalamus associated with axonal injury, but this relationship has never been shown in vivo. Findings: Using [C-11]-PK11195 positron emission tomography, a marker of microglial activation, we previously demonstrated thalamic inflammation up to 17 years after traumatic brain injury. Here, we use diffusion MRI to estimate axonal injury and show that thalamic inflammation is correlated with thalamo-cortical tract damage. Conclusions: These findings support a link between axonal damage and persistent inflammation after brain injury.	[Scott, Gregory; Hellyer, Peter J.; Ramlackhansingh, Anil F.; Brooks, David J.; Matthews, Paul M.; Sharp, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, London, England; [Hellyer, Peter J.] Kings Coll London, Ctr Neuroimaging Sci, IoPPN, London WC2R 2LS, England; [Brooks, David J.] Aarhus Univ, Inst Clin Med, Aarhus, Denmark; [Sharp, David J.] Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, London W12 0NN, England		Sharp, DJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Brain Sci, Hammersmith Hosp Campus, London, England.	david.sharp@imperial.ac.uk	Sharp, David J/A-2119-2013; Hellyer, Peter J/F-7112-2013	Hellyer, Peter J/0000-0002-5139-3401; Scott, Gregory/0000-0001-8063-5871; Brooks, David/0000-0003-2602-2518	Wellcome Trust-GlaxoSmithKline Translational Medicine Training Programme; MS Society of Great Britain; Progressive MS Alliance; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); GlaxoSmithKlineGlaxoSmithKline; Edmund J. Safra Foundation; Lily Safra; MRC (UK) Clinician Scientist Fellowship; National Institute for Health Research (NIHR) Imperial Biomedical Research Centre; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701951, MR/L022141/1, MR/K501013/1, MC_U120036861, G0900897, G1100810] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0514-10022, NIHR-RP-011-048] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0701951, G0900897, MC_U120036861, G1100810, MR/L022141/1] Funding Source: UKRI	GS was supported by a clinical research fellowship awarded in the Wellcome Trust-GlaxoSmithKline Translational Medicine Training Programme. The Medical Research Council (UK) supported PH. PM has research support from the MS Society of Great Britain, the Progressive MS Alliance, the MRC and GlaxoSmithKline and personal support from the Edmund J. Safra Foundation and from Lily Safra. DJS has been supported by an MRC (UK) Clinician Scientist Fellowship and currently holds a National Institute of Health Research Professorship-RP-011-048 (DJS). The research was also supported by the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Banati RB, 2001, NEUROREPORT, V12, P3439, DOI 10.1097/00001756-200111160-00012; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Cagnin A, 2001, BRAIN, V124, P2014, DOI 10.1093/brain/124.10.2014; Cagnin Annachiara, 2003, P379; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; Graeber MB, 2014, BRAIN PATHOL, V24, P620, DOI 10.1111/bpa.12192; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones EG., 2012, THALAMUS; Liu GJ, 2014, BRAIN PATHOL, V24, P631, DOI 10.1111/bpa.12196; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Pappata S, 2000, NEUROLOGY, V55, P1052, DOI 10.1212/WNL.55.7.1052; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Squarcina L, 2012, NEUROIMAGE, V63, P779, DOI 10.1016/j.neuroimage.2012.07.016; Thiel A, 2010, J NUCL MED, V51, P1404, DOI 10.2967/jnumed.110.076612; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	27	36	36	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	DEC 1	2015	12								224	10.1186/s12974-015-0445-y			5	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	CX5ZY	WOS:000365782200001	26627199	Green Published, gold			2022-02-06	
J	Biederman, J; Feinberg, L; Chan, J; Adeyemo, BO; Woodworth, KY; Panis, W; McGrath, N; Bhatnagar, S; Spencer, TJ; Uchida, M; Kenworthy, T; Grossman, R; Zafonte, R; Faraone, SV				Biederman, Joseph; Feinberg, Leah; Chan, James; Adeyemo, Bamidele O.; Woodworth, K. Yvonne; Panis, Walter; McGrath, Neal; Bhatnagar, Saurabha; Spencer, Thomas J.; Uchida, Mai; Kenworthy, Tara; Grossman, Rebecca; Zafonte, Ross; Faraone, Stephen V.			Mild Traumatic Brain Injury and Attention-Deficit Hyperactivity Disorder in Young Student Athletes	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Traumatic brain injury; mild; attention-deficit hyperactivity disorder; student athlete	PROFESSIONAL FOOTBALL PLAYERS; DEFICIT/HYPERACTIVITY DISORDER; RECURRENT CONCUSSION; LEAGUE PLAYER; HEAD-INJURY; ADOLESCENTS; CHILDREN; IMPACT; ENCEPHALOPATHY; RECOVERY	A recent meta-analysis documented a significant statistical association between mild traumatic brain injury (mTBI) and attention deficit hyperactivity disorder (ADHD) (Adeyemo et al., 2014), but the direction of this effect was unclear. In this study, we hypothesized that ADHD would be an antecedent risk factor for mTBI. Participants were student athletes ages 12 to 25 who had sustained a mTBI and Controls of similar age and sex selected from studies of youth with and without ADHD. Subjects were assessed for symptoms of ADHD, concussion severity, and cognitive function. mTBI subjects had a significantly higher rate of ADHD than Controls, and in all cases the age of onset of ADHD was before mTBI onset. mTBI+ADHD subjects also had more severe concussion symptoms (fatigue and poor concentration) than mTBI-ADHD subjects. These results support ADHD as an antecedent risk factor for mTBI in student athletes and that its presence complicates the course of mTBI.	[Biederman, Joseph; Feinberg, Leah; Chan, James; Woodworth, K. Yvonne; Spencer, Thomas J.; Uchida, Mai; Kenworthy, Tara; Grossman, Rebecca] Massachusetts Gen Hosp, Clin & Res Programs Pediat Psychopharmacol & Adul, Boston, MA 02114 USA; [Biederman, Joseph; Adeyemo, Bamidele O.; Bhatnagar, Saurabha; Spencer, Thomas J.; Uchida, Mai; Zafonte, Ross] Harvard Univ, Sch Med, Boston, MA USA; [Adeyemo, Bamidele O.] Emory Univ, Sch Med, Dept Phys Med & Rehabil, Atlanta, GA USA; [Panis, Walter; Bhatnagar, Saurabha; Zafonte, Ross] Massachusetts Gen Hosp, Spaulding Rehabil Hospital, Dept Phys Med & Rehabil, Charlestown, MA USA; [McGrath, Neal] Sports Concuss New England, Brookline, MA USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Neurosci, Syracuse, NY 13210 USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Physiol, Syracuse, NY 13210 USA; [Faraone, Stephen V.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway		Biederman, J (corresponding author), Massachusetts Gen Hosp, 55 Fruit St,YAW 6A, Boston, MA 02114 USA.	jbiederman@partners.org	Faraone, Stephen/AAE-7334-2019; Meijer, Anna/K-5118-2016; Kenworthy, Tara/M-8712-2019; Faraone, Stephen V/O-7239-2018	Faraone, Stephen/0000-0002-9217-3982; Faraone, Stephen V/0000-0002-9217-3982	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01MH050657, R01HD036317]; Pediatric Psychopharmacology Research Council Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD036317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH050657] Funding Source: NIH RePORTER	This work was supported by NIH grants (J.B., grant numbers R01MH050657, R01HD036317) and by the Pediatric Psychopharmacology Research Council Fund. The authors thank Elana Kagan for her contributions to the early stages of coordinating this study.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, P567; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th, P1; Antshel KM, 2009, PSYCHOL MED, V39, P1325, DOI 10.1017/S0033291708004959; BARKLEY RA, 1993, PEDIATRICS, V92, P212; Biederman J, 2006, PSYCHOL MED, V36, P167, DOI 10.1017/S0033291705006410; Biederman J, 1996, ARCH GEN PSYCHIAT, V53, P437; Biederman J, 1999, J AM ACAD CHILD PSY, V38, P966, DOI 10.1097/00004583-199908000-00012; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Biederman J, 2006, BIOL PSYCHIAT, V60, P1098, DOI 10.1016/j.biopsych.2006.02.031; Biederman J, 2006, AM J PSYCHIAT, V163, P1730, DOI 10.1176/appi.ajp.163.10.1730; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Fischer, 2010, ADHD ADULTS WHAT SCI; Gerring J, 2000, BRAIN INJURY, V14, P205; Gioia G.A., 2000, BRIEF BEHAV RATING I; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Iverson GL, 2006, BRAIN INJURY MED PRI, P373; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; LAHEY BB, 1994, AM J PSYCHIAT, V151, P1673; Lam L T, 2002, J Atten Disord, V6, P77, DOI 10.1177/108705470200600204; Lambert NM, 1995, ANAL DRIVING HISTORI, P1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M, 2000, IMPACT IMMEDIATE POS; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Orvaschel H, 1994, SCHEDULE AFFECTIVE D; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Puig-Antich J., 1987, SCHEDULE AFFECTIVE D; R Core Team, 2014, R LANG ENV STAT COMP; Roth R.M., 2005, BRIEF BEHAV RATING I; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Swensen, 2004, J ADOLESCENT HEALTH, V35, DOI [DOI 10.1016/J.JAD0HEALTH.2003.12.003, 10.1016/j.jadohealth.2003.12.003]; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D, 2011, WASI 2 WECHSLER ABBR	44	36	36	1	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	NOV	2015	203	11					813	819		10.1097/NMD.0000000000000375			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	CV7UW	WOS:000364482100001	26461480	Green Accepted			2022-02-06	
J							COUNCIL SPORTS MED FITNESS	Tackling in Youth Football	PEDIATRICS			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; HIGH-SCHOOL FOOTBALL; CERVICAL-SPINE INJURIES; HEAD IMPACT EXPOSURE; BRAIN-INJURY; 2ND IMPACT; RISK-FACTORS; BIOMECHANICAL ANALYSIS; 2ND-IMPACT SYNDROME; POSITION STATEMENT	American football remains one of the most popular sports for young athletes. The injuries sustained during football, especially those to the head and neck, have been a topic of intense interest recently in both the public media and medical literature. The recognition of these injuries and the potential for long-term sequelae have led some physicians to call for a reduction in the number of contact practices, a postponement of tackling until a certain age, and even a ban on high school football. This statement reviews the literature regarding injuries in football, particularly those of the head and neck, the relationship between tackling and football-related injuries, and the potential effects of limiting or delaying tackling on injury risk.							National Football League Players Association	Dr. Meehan participates in research funded, in part, by the National Football League Players Association and receives compensation from ABC-Clio Publishing, Wolters Kluwer, and Springer International Publishing for his authored works. Dr. Landry has indicated he does not have a financial relationship relevant to this article to disclose.	Adickes MS, 2004, SPORTS MED, V34, P201, DOI 10.2165/00007256-200434030-00005; ALVES WM, 1987, CLIN SPORT MED, V6, P211; Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Banerjee R, 2004, AM J SPORT MED, V32, P1077, DOI 10.1177/0363546504265605; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Bjorklund DF, 1998, CHILD DEV, V69, P604, DOI 10.1111/j.1467-8624.1998.00604.x; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Boden BP, 2006, AM J SPORT MED, V34, P1223, DOI 10.1177/0363546506288306; Boden BP, 2005, J AM ACAD ORTHOP SUR, V13, P445, DOI 10.5435/00124635-200511000-00004; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Cantu R., 2012, CONCUSSIONS OUR KIDS; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Chao S, 2010, SPORTS MED, V40, P59, DOI 10.2165/11319650-000000000-00000; Chomitz VR, 2009, J SCHOOL HEALTH, V79, P30, DOI 10.1111/j.1746-1561.2008.00371.x; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Damore DT, 2003, PEDIATR EMERG CARE, V19, P65, DOI 10.1097/00006565-200304000-00001; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Demorest Rebecca A, 2003, Curr Sports Med Rep, V2, P337; Dompier TP, 2007, J ATHL TRAINING, V42, P395; Donnelly JE, 2011, PREV MED, V52, pS36, DOI 10.1016/j.ypmed.2011.01.021; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Emery CA, 2011, BRIT J SPORT MED, V45, P1289, DOI 10.1136/bjsports-2011-090538; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fainaru S, 2013, YOUTH FOOTBALL PARTI; Forbes JA, 2014, CHILD NERV SYST, V30, P197, DOI 10.1007/s00381-013-2318-y; Frollo J, 2011, FOOTBALL REMAINS 1 H; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; GOLDBERG B, 1988, PEDIATRICS, V81, P255; Goldstein LB, 2011, CIRCULATION, V123, P816, DOI 10.1161/CIR.0b013e31820a5528; Gorden JA, 2003, J ATHL TRAINING, V38, P209; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris D, 2012, HIGHSCHOOL FOOTBALL; Haskell WL, 2007, CIRCULATION, V116, P1081, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Heck J F, 1996, J Athl Train, V31, P31; Heck JF, 2004, J ATHL TRAINING, V39, P101; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Knowles SB, 2006, AM J EPIDEMIOL, V164, P1209, DOI 10.1093/aje/kwj337; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; LaBella C, 2012, COMPARATIVE ANAL INJ; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Levy ML, 2004, NEUROSURGERY, V55, P661; LINDER MM, 1995, CLIN J SPORT MED, V5, P167, DOI 10.1097/00042752-199507000-00006; Macpherson A, 2006, PEDIATRICS, V117; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Mihalik JP, 2010, PEDIATRICS, V125; Mueller FO, 1998, CLIN SPORT MED, V17, P169, DOI 10.1016/S0278-5919(05)70071-5; MUELLER FO, 1987, CLIN SPORT MED, V6, P185; Mueller FO, 1977, ANNUAL SURVEY CATAST; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; Robbins L, 2012, REAL CLEAR SPORTS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rowson S, 2007, BIOMED SCI INSTRUM, V43, P200; Rowson S, 2008, CLIN J SPORT MED, V18, P316, DOI 10.1097/JSM.0b013e31817f016a; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Singh GD, 2009, DENT TRAUMATOL, V25, P515, DOI 10.1111/j.1600-9657.2009.00808.x; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stuart MJ, 2002, MAYO CLIN PROC, V77, P317, DOI 10.4065/77.4.317; Tator CH, 2014, BRIT J SPORT MED, V48, P81, DOI 10.1136/bjsports-2013-093040; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; TORG JS, 1979, JAMA-J AM MED ASSOC, V241, P1477, DOI 10.1001/jama.241.14.1477; Trojian TH, 2012, CURR SPORT MED REP, V11, P304, DOI 10.1249/JSR.0b013e31827558c8; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Winters Jackson, 2014, General Dentistry, V62, P34; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280; Zemper ED, 2010, BRIT J SPORT MED, V44, P13, DOI 10.1136/bjsm.2009.069096; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44; Zoch T W, 1996, Wis Med J, V95, P570	115	36	36	0	14	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	NOV	2015	136	5					E1419	E1430		10.1542/peds.2015-3282			12	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	CV0US	WOS:000363969600033	26498638	Bronze			2022-02-06	
J	Failla, MD; Myrga, JM; Ricker, JH; Dixon, CE; Conley, YP; Wagner, AK				Failla, Michelle D.; Myrga, John M.; Ricker, Joseph H.; Dixon, C. Edward; Conley, Yvette P.; Wagner, Amy K.			Posttraumatic Brain Injury Cognitive Performance Is Moderated by Variation Within ANKK1 and DRD2 Genes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						ANKK1; cognitive deficits; DRD2; dopamine; genetic variation; Rehabilomics; traumatic brain injury	DOPAMINE-RECEPTOR GENE; TRANSPORTER EXPRESSION; ATTENTION DEFICITS; KINASE GENE; A1 ALLELE; REHABILITATION; POLYMORPHISMS; ASSOCIATION; GENOTYPE; MEMORY	Objective: As dopamine neurotransmission impacts cognition, we hypothesized that variants in the linked dopamine D2 receptor (DRD2) and ankyrin repeat and kinase domain (ANKK1) genes might account for some individual variability in cognitive recovery following traumatic brain injury (TBI). Participants: Prospective cohort of 108 survivors of severe TBI, recruited consecutively from a level 1 trauma center. Design: We examined relationships between DRD2 genetic variation and functional recovery at 6 and 12 months post-TBI. Main Measures: Cognitive performance was evaluated using 8 neuropsychological tests targeting different cognitive domains. An overall cognitive composite was developed using normative data. We also assessed functional cognition, depression status, and global outcome. Subjects were genotyped for 6 DRD2 tagging single-nucleotide polymorphisms and Taq1A within ANKK1. Results: ANKK1 Taq1A heterozygotes performed better than homozygotes across several cognitive domains at both time points postinjury. When adjusting for age, Glasgow Coma Scale score, and education, the Taq1A (ANKK1) and rs6279 (DRD2) variants were associated with overall composite scores at 6 months post-TBI (P =. 0453 and P=. 0452, respectively). At 12months, only Taq1A remained a significant genetic predictor of cognition (P =.0128). Following multiple-comparisons correction, there were no significant associations between examined genetic variants and functional cognition, depression status, and global outcome. Conclusion: These data suggest that genetic variation within DRD2 influences cognitive recovery post-TBI. Understanding genetic influences on dopaminergic systems post-TBI may impact current treatment paradigms.	[Failla, Michelle D.; Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Failla, Michelle D.; Myrga, John M.; Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Dixon, C. Edward] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Hlth Promot & Dev, Sch Nursing, Pittsburgh, PA 15213 USA; [Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Ricker, Joseph H.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Dixon, C. Edward] Pittsburgh VA Healthcare Syst, Pittsburgh, PA USA		Wagner, AK (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, Sch Med, 3471 Fifth Ave,Ste 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Failla, Michelle/AAI-3788-2021	Failla, Michelle/0000-0001-9734-3373; Ricker, Joseph/0000-0003-3415-991X; Conley, Yvette/0000-0002-1784-6067	DODUnited States Department of Defense [W81XWH-071-0701]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD048162, R01NR013342]; NIDRR [H133A120087]; NIH University of Pittsburgh Clinical and Translational Science Institute [UL1TR000005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013342] Funding Source: NIH RePORTER	This research was supported by DOD W81XWH-071-0701, NIH R01 HD048162, NIDRR H133A120087, NIH R01NR013342, and NIH UL1TR000005 University of Pittsburgh Clinical and Translational Science Institute.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLEIBERG J, 1993, NEUROPSY NEUROPSY BE, V6, P245; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Braver TS, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P713; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Comings DE, 2000, MOL GENET METAB, V71, P19, DOI 10.1006/mgme.2000.3015; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Delis D.C., 2000, CALIFORNIA VERBAL LE; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fleming J, 1999, BRAIN INJURY, V13, P417; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; GOLDMAN D, 1993, ALCOHOL CLIN EXP RES, V17, P199, DOI 10.1111/j.1530-0277.1993.tb00749.x; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; JENNETT B, 1975, LANCET, V1, P480; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Laakso A, 2005, PHARMACOGENET GENOM, V15, P387, DOI 10.1097/01213011-200506000-00003; Laine TPJ, 2001, ALCOHOL ALCOHOLISM, V36, P262, DOI 10.1093/alcalc/36.3.262; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Leon-Carrion J, 2013, BRAIN INJURY, V27, P1119, DOI 10.3109/02699052.2013.804204; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; Mi HY, 2011, PHARMACOGENET GENOM, V21, P350, DOI 10.1097/FPC.0b013e32833ee605; Monakhov M, 2008, SCHIZOPHR RES, V100, P302, DOI 10.1016/j.schres.2008.01.007; Munafo MR, 2007, MOL PSYCHIATR, V12, P454, DOI 10.1038/sj.mp.4001938; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Ponce G, 2009, NEUROTOX RES, V16, P50, DOI 10.1007/s12640-009-9046-9; Reitan R, 1985, HALSTEAD REITAN NEUR; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Susman M, 2002, J TRAUMA, V53, p[219, 223]; Thompson J, 1997, PHARMACOGENETICS, V7, P479, DOI 10.1097/00008571-199712000-00006; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; van Veelen NMJ, 2010, SCHIZOPHR RES, V120, P191, DOI 10.1016/j.schres.2010.04.011; Voisey J, 2009, DEPRESS ANXIETY, V26, P28, DOI 10.1002/da.20517; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wagner AK, 2012, BRAIN INJURY, V26, P1658, DOI 10.3109/02699052.2012.700089; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; Willmott C, 2013, BRAIN INJURY, V27, P1281, DOI 10.3109/02699052.2013.809553; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Zawarynski P, 1998, FEBS LETT, V441, P383, DOI 10.1016/S0014-5793(98)01588-9; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	73	36	36	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2015	30	6					E54	E66		10.1097/HTR.0000000000000118			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JN	WOS:000369606300007	25931179	Green Accepted			2022-02-06	
J	Zhu, YJ; Liu, FX; Zou, XC; Torbey, M				Zhu, Yongjin; Liu, Fuxin; Zou, Xunchang; Torbey, Michel			Comparison of unbiased estimation of neuronal number in the rat hippocampus with different staining methods	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Unbiased estimation; Stereological analysis; Hippocampal neuron; Histological study	TRAUMATIC BRAIN-INJURY; AMYOTROPHIC-LATERAL-SCLEROSIS; STEREOLOGICAL ESTIMATION; SUBSTANTIA-NIGRA; SYNAPTIC PLASTICITY; DENTATE GYRUS; CELL NUMBER; SURVIVAL; DISEASE; CORTEX	Background: NeuN and Nissl staining (toluidine blue, cresyl violet staining) are routinely used methods in unbiased stereological estimation of the total number of hippocampal neurons. New method: In the present study, we stained serial frozen coronal sections from 5 normal adult male Sprague-Dawley rat brains with different methods, measured the deformation of hippocampal area in brain sections and estimated the total number of hippocampal neurons using the optical fractionator. Results: The deformation in x, y-axis was not obviously different with different staining protocols, but shrinkage in z-axis was significant after staining (p < 0.001). NeuN staining produced significant higher estimate number than cresyl violet staining by 24% (p = 0.002), however, NeuN and Cresyl Violet staining showed a high degree of correlation in quantification of total neuronal numbers and both methods are suitable for unbiased stereological estimation. Comparison with existing method (s): NeuN is more reliable but if time is limited or the number of animals used in experiments is high, cresyl violet staining may be a feasible method. Conclusions: Compared with previous estimates of the neurons number in rat hippocampus, our present data is reliable and the stereological analysis based on our system is a cost-effective unbiased method for estimation of neuron number. (C) 2015 Elsevier B.V. All rights reserved.	[Zhu, Yongjin; Liu, Fuxin; Zou, Xunchang; Torbey, Michel] Ohio State Univ, Wexner Med Ctr, Dept Neurol, Columbus, OH 43210 USA; [Torbey, Michel] Ohio State Univ, Wexner Med Ctr, Neurosurg, Columbus, OH 43210 USA		Torbey, M (corresponding author), Ohio State Univ, Cerebrovasc & Neurocrit Care Div, Comprehens Stroke & Neurovasc Ctr, Wexner Med Ctr,Dept Neurol & Neurosurg, 395 W 12th Ave,7th Floor, Columbus, OH 43210 USA.	michel.torbey@osumc.edu			Department of Defense, USAUnited States Department of Defense [W81XWH-11-2-0095]	This work was supported by Congressionally Directed Medical Research Programs (NO. W81XWH-11-2-0095), Department of Defense, USA.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Azcoitia I, 2005, NEUROBIOL AGING, V26, P697, DOI 10.1016/j.neurobiolaging.2004.06.007; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Benes FM, 2001, TRENDS NEUROSCI, V24, P11, DOI 10.1016/S0166-2236(00)01660-X; Bertucco L, 1996, PROCEEDINGS OF THE 1998 IEEE INTERNATIONAL CONFERENCE ON CONTROL APPLICATIONS, VOLS 1 AND 2, P341; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; BOSS BD, 1987, BRAIN RES, V406, P280, DOI 10.1016/0006-8993(87)90793-1; BOSS BD, 1985, BRAIN RES, V338, P144, DOI 10.1016/0006-8993(85)90257-4; BRAENDGAARD H, 1990, J MICROSC-OXFORD, V157, P285, DOI 10.1111/j.1365-2818.1990.tb02967.x; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Cardoso A, 2011, BEHAV BRAIN RES, V225, P538, DOI 10.1016/j.bbr.2011.07.057; Collins CE, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.005.2010; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Gittins R, 2004, BRAIN RES BULL, V63, P155, DOI 10.1016/j.brainresbull.2004.02.005; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Gredal O, 2000, J NEUROSCI METH, V95, P171, DOI 10.1016/S0165-0270(99)00175-2; Hamidi M, 2004, BIOL PSYCHIAT, V55, P563, DOI 10.1016/j.biopsych.2003.11.006; Hatton WJ, 1999, J COMP NEUROL, V409, P169; Heggland I, 2015, EUR J NEUROSCI, V41, P1245, DOI 10.1111/ejn.12876; Hosseini-Sharifabad M, 2007, J NEUROSCI METH, V162, P206, DOI 10.1016/j.jneumeth.2007.01.009; Howard C.V., 1998, UNBIASED STEREOLOGY, V1; Jinno S, 2007, GLIA, V55, P1334, DOI 10.1002/glia.20552; Jongen-Relo AL, 2002, PHYSIOL BEHAV, V76, P449, DOI 10.1016/S0031-9384(02)00732-1; Kaae SS, 2012, SYNAPSE, V66, P667, DOI 10.1002/syn.21553; Kawagishi K, 2014, NEUROSCIENCE, V272, P29, DOI 10.1016/j.neuroscience.2014.04.050; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kulesza RJ, 2002, HEARING RES, V168, P12, DOI 10.1016/S0378-5955(02)00374-X; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Li W, 2015, NEUROBIOL DIS, V80, P93, DOI 10.1016/j.nbd.2015.05.002; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lyck L, 2007, EUR J NEUROSCI, V26, P1749, DOI 10.1111/j.1460-9568.2007.05763.x; Ma SY, 1997, J NEUROL SCI, V151, P83, DOI 10.1016/S0022-510X(97)00100-7; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Miyamoto K., 1994, PARTICLE NUMBER SIZE; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Oberlaender M, 2009, J NEUROSCI METH, V180, P147, DOI 10.1016/j.jneumeth.2009.03.008; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; Smith AM, 2008, NEUROTOXICOL TERATOL, V30, P495, DOI 10.1016/j.ntt.2008.05.001; Theoret H, 1999, BRAIN RES, V835, P354, DOI 10.1016/S0006-8993(99)01598-X; von Bartheld CS, 2001, TRENDS NEUROSCI, V24, P504, DOI 10.1016/S0166-2236(00)01960-3; West MJ, 1996, J COMP NEUROL, V370, P11; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wirenfeldt M, 2003, GLIA, V44, P129, DOI 10.1002/glia.10277; Woeffler-Maucler C, 2014, J NEUROSCI METH, V225, P32, DOI 10.1016/j.jneumeth.2014.01.009; Young NA, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00027; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Zhu YJ, 2015, DRUG DISCOV TODAY, V20, P65, DOI 10.1016/j.drudis.2014.08.016	55	36	36	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 30	2015	254						73	79		10.1016/j.jneumeth.2015.07.022			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	CS1XI	WOS:000361861800008	26238727				2022-02-06	
J	Piatt, JH				Piatt, Joseph H., Jr.			Pediatric spinal injury in the US: epidemiology and disparities	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						disparity; epidemiology; pediatric; SCIWORA; spinal cord injury; spinal dislocation; spinal fracture; spine; trauma	TRAUMATIC BRAIN-INJURY; CERVICAL-SPINE; HEAD TRAUMA; CORD-INJURY; EMERGENCY-DEPARTMENT; CLINICAL ARTICLE; UNITED-STATES; CHILD-ABUSE; MORTALITY; OUTCOMES	OBJECT In the US, race and economic status have pervasive associations with mechanisms of injury, severity of injury, management, and outcomes of trauma. The goal of the current study was to examine these relationships on a large scale in the setting of pediatric spinal injury. METHODS Admissions for spinal fracture without or with spinal cord injury (SCI), spinal dislocation, and SCI without radiographic abnormality were-identified in the Kids' Inpatient Database (KID) and the National Trauma Data Bank (NTDB) registry for 2009. Patients ranged in age from birth up to 21 years. Data from the KID were used to estimate nationwide annual incidences. Data from the NTDB were used to describe patterns of injury in relation to age, race, and payor, with corroboration from the KID. Multiple logistic regression was used to model rates of mortality and spinal fusion. RESULTS In 2009, the estimated incidence of hospital admission for spinal injury in the US was 170 per 1 million in the population under 21 years of age. The incidence of SCI was 24 per 1 million. Incidences varied regionally. Adolescents predominated. Patterns of injury varied by age, race, and payor. Black patients were more severely injured than patients of other races as measured by Injury Severity Scale scores. Among black patients with spinal injury in the NTDB, 23.9% suffered firearm injuries; only 1% of white patients suffered firearm injuries. The overall mortality rate in the NTDB was 3.9%. In a multivariate analysis that included a large panel of clinical and nonclinical factors, black race retained significance as a predictor of mortality (p = 0.006; adjusted OR 1.571 [1.141-2.163]). Rates of spinal fusion were associated with race and payor in the NTDB data and with payor in the KID: patients with better insurance underwent spinal fusion at higher rates. CONCLUSIONS The epidemiology of pediatric spinal injury in the US cannot be understood apart from considerations of race and economic status.	[Piatt, Joseph H., Jr.] Alfred I DuPont Hosp Children, Nemours Neurosci Ctr, Wilmington, DE 19803 USA; [Piatt, Joseph H., Jr.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Piatt, Joseph H., Jr.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pediat, Philadelphia, PA 19107 USA		Piatt, JH (corresponding author), Alfred I DuPont Hosp Children, Nemours Neurosci Ctr, 1600 Rockland Rd, Wilmington, DE 19803 USA.	jpiatt@nemours.org		Piatt, Joseph/0000-0002-9332-8376			APPLE JS, 1987, PEDIATR RADIOL, V17, P45, DOI 10.1007/BF02386594; Barber I, 2013, PEDIATR RADIOL, V43, P1507, DOI 10.1007/s00247-013-2726-x; BAYLESS P, 1989, AM J EMERG MED, V7, P139, DOI 10.1016/0735-6757(89)90125-3; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Brown RL, 2010, CURR OPIN PEDIATR, V22, P321, DOI 10.1097/MOP.0b013e3283395f13; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Chien LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039264; Choudhary AK, 2012, RADIOLOGY, V262, P216, DOI 10.1148/radiol.11102390; Cirak B, 2004, J PEDIATR SURG, V39, P607, DOI 10.1016/j.jpedsurg.2003.12.011; DICKMAN CA, 1991, J SPINAL DISORD, V4, P296, DOI 10.1097/00002517-199109000-00006; Eleraky MA, 2000, J NEUROSURG, V92, P12, DOI 10.3171/spi.2000.92.1.0012; Falcone RA, 2008, J PEDIATR SURG, V43, P1858, DOI 10.1016/j.jpedsurg.2008.01.058; Falcone RA, 2007, J PEDIATR SURG, V42, P1031, DOI 10.1016/j.jpedsurg.2007.01.038; Finch GD, 1998, J PEDIATR ORTHOPED, V18, P811, DOI 10.1097/00004694-199811000-00022; Firth GB, 2012, SPINE, V37, pE599, DOI 10.1097/BRS.0b013e31824079ea; Fujii Tomoko, 2013, J Emerg Trauma Shock, V6, P252, DOI 10.4103/0974-2700.120365; Gepp RD, 2012, CHILD NERV SYST, V28, P1919, DOI 10.1007/s00381-012-1846-1; Hackl W, 2001, ORAL SURG ORAL MED O, V92, P370, DOI 10.1067/moe.2001.116894; HADLEY MN, 1988, J NEUROSURG, V68, P18, DOI 10.3171/jns.1988.68.1.0018; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Hagen EM, 2011, SPINAL CORD, V49, P981, DOI 10.1038/sc.2011.42; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hakmeh W, 2010, ACAD EMERG MED, V17, P809, DOI 10.1111/j.1553-2712.2010.00819.x; HILLS MW, 1993, J TRAUMA, V34, P549, DOI 10.1097/00005373-199304000-00011; Hofbauer M, 2012, J TRAUMA ACUTE CARE, V73, P156, DOI 10.1097/TA.0b013e31824e32b5; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Howard I, 2005, ETHNIC DIS, V15, pS51; Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018; Katz JS, 2010, J NEUROSURG-PEDIATR, V5, P470, DOI 10.3171/2009.11.PEDS09291; Knox JB, 2014, J PEDIATR ORTHOPED, V34, P698, DOI 10.1097/BPO.0000000000000167; LAHAM JL, 1994, PEDIATR NEUROSURG, V21, P221, DOI 10.1159/000120839; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; Martin BW, 2004, ARCH DIS CHILD, V89, P860, DOI 10.1136/adc.2003.029223; Martin CA, 2010, AM J SURG, V199, P210, DOI 10.1016/j.amjsurg.2009.05.001; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; MICHAEL D B, 1989, Journal of Neurotrauma, V6, P177; Mohseni S, 2011, J PEDIATR SURG, V46, P1771, DOI 10.1016/j.jpedsurg.2011.03.007; Mortazavi MM, 2011, CHILD NERV SYST, V27, P1095, DOI 10.1007/s00381-010-1348-y; OMALLEY KF, 1988, J TRAUMA, V28, P1476, DOI 10.1097/00005373-198810000-00013; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; Piatt JH, 2006, J NEUROSURG-SPINE, V5, P210, DOI 10.3171/spi.2006.5.3.210; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Platzer P, 2007, J TRAUMA, V62, P389, DOI 10.1097/01.ta.0000221802.83549.46; Ramirez M, 2013, JAMA SURG, V148, P76, DOI 10.1001/2013.jamasurg.3; Rangel EL, 2010, J TRAUMA, V69, P20, DOI 10.1097/TA.0b013e3181bbd7c3; Rangel EL, 2009, J PEDIATR SURG, V44, P1229, DOI 10.1016/j.jpedsurg.2009.02.044; Rosen H, 2009, J PEDIATR SURG, V44, P1952, DOI 10.1016/j.jpedsurg.2008.12.026; RUGE JR, 1988, J NEUROSURG, V68, P25, DOI 10.3171/jns.1988.68.1.0025; Rush JK, 2013, J PEDIATR ORTHOPED, V33, P393, DOI 10.1097/BPO.0b013e318279c7cb; Sabharwal S, 2007, J PEDIATR ORTHOPED, V27, P690, DOI 10.1097/BPO.0b013e3181425653; Schenarts PJ, 2001, J TRAUMA, V51, P663, DOI 10.1097/00005373-200110000-00007; Slover J, 2005, J PEDIATR ORTHOPED, V25, P717, DOI 10.1097/01.bpo.0000184835.79345.0e; SOICHER E, 1991, BRIT J SURG, V78, P1013, DOI 10.1002/bjs.1800780837; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031	57	36	36	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2015	16	4					463	471		10.3171/2015.2.PEDS1515			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	CS1XS	WOS:000361862800017	26114993	Bronze			2022-02-06	
J	Steuer, J; Bjorck, M; Sonesson, B; Resch, T; Dias, N; Hultgren, R; Tunesi, R; Wanhainen, A; Lachat, M; Pfammatter, T				Steuer, J.; Bjorck, M.; Sonesson, B.; Resch, T.; Dias, N.; Hultgren, R.; Tunesi, R.; Wanhainen, A.; Lachat, M.; Pfammatter, T.			Editor's Choice - Durability of Endovascular Repair in Blunt Traumatic Thoracic Aortic Injury: Long-Term Outcome from Four Tertiary Referral Centers	EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY			English	Article						Blunt injury; Endovascular technique; Thoracic aorta	AMERICAN-ASSOCIATION; STENT-GRAFT; MULTICENTER; EXPERIENCE; SURGERY; TRIAL	Objectives: To analyze the early and long-term survival and re-intervention rate in patients undergoing TEVAR for blunt traumatic thoracic aortic injury. Methods: This was a consecutive case series. Between the years 2001 and 2010, a total of 74 patients underwent TEVAR for blunt traumatic thoracic aortic injury at four tertiary referral centers, three in Sweden and one in Switzerland. The median age of the patients was 41 years, and 16% were women. Demographic, procedural, and outcome data were collected and reviewed retrospectively. The patients were followed up during 2013-2014. Results: Early (30 day) mortality was 9% (7 patients), with only two cases directly related to the aortic injury; in hospital mortality was 14% as three patients died during the primary hospital admission within the first 6 months. Most patients had sustained severe injuries to other organ systems, and among all in hospital deaths brain injury was the predominant cause. Five year survival in the whole group was 81%. Re-intervention was needed in 16% (12 patients) during the first year, half of them within the first month. Only one patient underwent re-intervention more than 1 year after the initial procedure. Infolding and partial stentgraft collapse was the reason for the secondary procedure in five of the 13 patients; in three it occurred within 3 weeks of the acute TEVAR. Conclusion: TEVAR allows rapid and effective therapy in trauma patients with blunt aortic injury. The outcome is dependent on the severity of the concomitant injuries. The treatment is durable during the first decade after the procedure, but even longer follow up is needed to determine the impact of TEVAR in young patients on the degenerative changes that take place in the aging aorta. (C) 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.	[Steuer, J.; Bjorck, M.; Wanhainen, A.] Uppsala Univ, Dept Surg Sci, Vasc Surg, Uppsala, Sweden; [Steuer, J.; Tunesi, R.; Lachat, M.] Univ Zurich Hosp, Cardiovasc Surg Clin, CH-8091 Zurich, Switzerland; [Steuer, J.] Stockholm South Hosp, Dept Surg, SE-11883 Stockholm, Sweden; [Sonesson, B.; Resch, T.; Dias, N.] Skane Univ Hosp, Vasc Ctr, Malmo, Sweden; [Hultgren, R.] Karolinska Univ Hosp, Dept Vasc Surg, Stockholm, Sweden; [Pfammatter, T.] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland		Steuer, J (corresponding author), Stockholm South Hosp, Vasc Surg Sect, Dept Surg, SE-11883 Stockholm, Sweden.	joste@live.se	Hultgren, Rebecka/K-8738-2012; Resch, Tim/AAW-9630-2020; Lachat, Mario/G-4826-2011	Hultgren, Rebecka/0000-0002-8869-0493; Lachat, Mario/0000-0001-7812-2110; Dias, Nuno/0000-0002-6907-6148			Azizzadeh A, 2013, J VASC SURG, V57, P108, DOI 10.1016/j.jvs.2012.05.110; Azizzadeh A, 2009, J VASC SURG, V49, P1403, DOI 10.1016/j.jvs.2009.02.234; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; COPES WS, 1988, J TRAUMA, V28, P78, DOI 10.1097/00005373-198801000-00011; Demetriades D, 2008, J TRAUMA, V64, P561, DOI 10.1097/TA.0b013e3181641bb3; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Forbes TL, 2010, J VASC SURG, V52, P45, DOI 10.1016/j.jvs.2010.01.094; Jonker FHW, 2010, J ENDOVASC THER, V17, P725, DOI 10.1583/10-3130.1; Khoynezhad A, 2013, J VASC SURG, V57, P899, DOI 10.1016/j.jvs.2012.10.099; Lachat M, 2002, EUR J CARDIO-THORAC, V21, P959, DOI 10.1016/S1010-7940(02)00062-3; Martinelli O, 2013, J VASC SURG, V58, P832, DOI 10.1016/j.jvs.2013.02.243; Mattox KL, 2008, J TRAUMA, V64, P570; Mitchell RS, 2002, J ENDOVASC THER, V9, P98; Neschis DG, 2008, NEW ENGL J MED, V359, P1708, DOI 10.1056/NEJMra0706159; Orend KH, 2007, EUR J VASC ENDOVASC, V34, P666, DOI 10.1016/j.ejvs.2007.06.022; PARMLEY LF, 1958, CIRCULATION, V17, P1086, DOI 10.1161/01.CIR.17.6.1086; Rabin J, 2014, ANN THORAC SURG, V98, P46, DOI 10.1016/j.athoracsur.2014.04.025; Rabin J, 2014, J THORAC CARDIOV SUR, V147, P143, DOI 10.1016/j.jtcvs.2013.08.053; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Starnes BW, 2012, J VASC SURG, V55, P47, DOI 10.1016/j.jvs.2011.07.073; Steuer J, 2012, J VASC SURG, V56, P973, DOI 10.1016/j.jvs.2012.03.259; Watson J, 2013, J VASC SURG, V58, P380, DOI 10.1016/j.jvs.2013.01.045	22	36	38	0	4	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1078-5884	1532-2165		EUR J VASC ENDOVASC	Eur. J. Vasc. Endovasc. Surg.	OCT	2015	50	4					460	465		10.1016/j.ejvs.2015.05.012			6	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	CS1XK	WOS:000361862000011	26143100	Bronze			2022-02-06	
J	Stucky, EC; Schloss, RS; Yarmush, ML; Shreiber, DI				Stucky, Elizabeth C.; Schloss, Rene S.; Yarmush, Martin L.; Shreiber, David I.			Alginate micro-encapsulation of mesenchymal stromal cells enhances modulation of the neuro-inflammatory response	CYTOTHERAPY			English	Article						co-culture; inflammation mediators; mesenchymal stromal cells; organ culture; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; PGE(2) EP2 RECEPTOR; BONE-MARROW; STEM-CELLS; INDUCIBLE CYCLOOXYGENASE; PROSTAGLANDIN E-2; IFN-GAMMA; TNF-ALPHA	Background aims. Modulation of inflammation after brain trauma is a key therapeutic goal aimed at limiting the consequences of the subsequent injury cascade. Mesenchymal stromal cells (MSCs) have been demonstrated to dynamically regulate the inflammatory environment in several tissue systems, including the central nervous system. There has been limited success, however, with the use of direct implantation of cells in the brain caused by low viability and engraftment at the injury site. To circumvent this, we encapsulated MSCs in alginate microspheres and evaluated the ability of these encapsulated MSCs to attenuate inflammation in rat organotypic hippocarnpal slice cultures (OHSC). Methods. OHSC were administered lipopolysaccharide to induce inflammation and immediately co-cultured with encapsulated or monolayer human MSCs. After 24 h, culture media was assayed for the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) produced by OHSC, as well as MSC-produced trophic mediators. Results. Encapsulated MSCs reduced TNF-alpha more effectively than did monolayer MSCs. Additionally, there was a strong correlation between increased prostaglandin E-2 (PGE(2)) and reduction of TNF-alpha. In contrast to monolayer MS Cs, inflammatory signals were not required to stimulate PGE(2) production by encapsulated MSCs. Further encapsulation-stimulated changes were revealed in a multiplex panel analyzing 27 MSC-produced cytokines and growth factors, from which additional mediators with strong correlations to TNF-alpha levels were identified. Conclusions. These results suggest that alginate encapsulation of MSCs may not only provide an improved delivery vehicle for transplantation but may also enhance MSC therapeutic benefit for treating neuro-inflammation.	[Stucky, Elizabeth C.; Yarmush, Martin L.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA; [Schloss, Rene S.; Yarmush, Martin L.; Shreiber, David I.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA; [Yarmush, Martin L.] Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA		Yarmush, ML (corresponding author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.	yarmush@rci.rutgers.edu; shreiber@rci.rutgers.edu	Shreiber, David/ABE-8254-2021	Yarmush, Martin/0000-0003-4986-8444; Stucky Hunter, Elizabeth/0000-0003-0797-9453	New Jersey Commission on Brain Injury Research [SNJ-DHSS-CBIR-CBIE12IPG019, 10-3215-BIR-E-0]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41EB002503]; Rutgers-UMDNJ Biotechnology Training Fellowship [T32GM00008339-21]; NSF Stem Cell IGERT Fellowship [0801620]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008339] Funding Source: NIH RePORTER	We would like to acknowledge Serom Lee, PhD, and Andrea Gray for their assistance and contribution to the statistical analyses, and Mehdi Ghodbane, PhD, for assistance with multiplex assay and analysis. This research was supported by the New Jersey Commission on Brain Injury Research (SNJ-DHSS-CBIR-CBIE12IPG019 and 10-3215-BIR-E-0), National Institute of Health Grant P41EB002503, Rutgers-UMDNJ Biotechnology Training Fellowship T32GM00008339-21 and NSF Stem Cell IGERT Fellowship 0801620. These funding agencies were not involved in the conduct of the research or preparation of the article.	Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Barminko J, 2011, BIOTECHNOL BIOENG, V108, P2747, DOI 10.1002/bit.23233; Barminko JA, 2014, BIOTECHNOL BIOENG, V111, P2239, DOI 10.1002/bit.25282; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Bernardino L, 2008, J NEUROCHEM, V106, P271, DOI 10.1111/j.1471-4159.2008.05387.x; Buchser E, 1996, ANESTHESIOLOGY, V85, P1005, DOI 10.1097/00000542-199611000-00007; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; CHUNG IY, 1990, J IMMUNOL, V144, P2999; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Detante O, 2009, CELL TRANSPLANT, V18, P1369, DOI 10.3727/096368909X474230; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dolle JP, 2013, NANO LIFE, V3, DOI 10.1142/S1793984413500049; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Foraker JE, 2011, J NEUROCHEM, V119, P1052, DOI 10.1111/j.1471-4159.2011.07511.x; Gilroy DW, 2003, FASEB J, V17, P2269, DOI 10.1096/fj.02-1162fje; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Haudenschild AK, 2009, ANN BIOMED ENG, V37, P492, DOI 10.1007/s10439-008-9629-2; Heile AMB, 2009, NEUROSCI LETT, V463, P176, DOI 10.1016/j.neulet.2009.07.071; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Liu D, 2005, ANN NEUROL, V57, P758, DOI 10.1002/ana.20461; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Maguire T, 2006, BIOTECHNOL BIOENG, V93, P581, DOI 10.1002/bit.20748; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; Marklein RA, 2012, SOFT MATTER, V8, P8113, DOI 10.1039/c2sm25501d; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010; Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Paredes-Juarez GA, 2013, J CONTROL RELEASE, V172, P983, DOI 10.1016/j.jconrel.2013.09.009; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Read TA, 1999, INT J DEV NEUROSCI, V17, P653, DOI 10.1016/S0736-5748(99)00052-0; Ross CJD, 1999, HUM GENE THER, V10, P49, DOI 10.1089/10430349950019183; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Sakata D, 2010, J PHARMACOL SCI, V112, P1, DOI 10.1254/jphs.09R03CP; Schafer S, 2012, J NEUROIMMUNOL, V249, P40, DOI 10.1016/j.jneuroim.2012.04.018; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Silva NA, 2013, BIOCHIMIE, V95, P2314, DOI 10.1016/j.biochi.2013.08.016; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Szczepanik AM, 1996, NEUROSCIENCE, V70, P57, DOI 10.1016/0306-4522(95)00296-U; Thanos CG, 2007, J BIOMED MATER RES A, V83A, P216, DOI 10.1002/jbm.a.31472; Thanos CG, 2006, BIOMATERIALS, V27, P3570, DOI 10.1016/j.biomaterials.2006.01.042; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou C, 2009, BRAIN RES, V1269, P23, DOI 10.1016/j.brainres.2009.02.049; Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x	58	36	36	0	19	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	OCT	2015	17	10					1353	1364		10.1016/j.jcyt.2015.05.002			12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	CR5XX	WOS:000361418800004	26210574	Green Accepted			2022-02-06	
J	Jovanovic, B; Milan, Z; Markovic-Denic, L; Djuric, O; Radinovic, K; Doklestic, K; Velickovi, J; Ivancevic, N; Gregoric, P; Pandurovic, M; Bajec, D; Bumbasirevic, V				Jovanovic, Bojan; Milan, Zoka; Markovic-Denic, Ljiljana; Djuric, Olivera; Radinovic, Kristina; Doklestic, Krstina; Velickovi, Jelena; Ivancevic, Nenad; Gregoric, Pavle; Pandurovic, Milena; Bajec, Djordje; Bumbasirevic, Vesna			Risk factors for ventilator-associated pneumonia in patients with severe traumatic brain injury in a Serbian trauma centre	INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES			English	Article						Injury; Neurotrauma; Pneumonia; Predictors	HEAD-INJURY; EARLY-ONSET; SCALE; SCORE; CARE; ASPIRATION	Introduction: The aims of this study were (1) to assess the incidence of ventilator-associated pneumonia (VAP) in patients with traumatic brain injury (TBI), (2) to identify risk factors for developing VAP, and (3) to assess the prevalence of the pathogens responsible. Patients and methods: The following data were collected prospectively from patients admitted to a 24bed intensive care unit (ICU) during 2013/14: the mechanism of injury, trauma distribution by system, the Acute Physiology and Chronic Health Evaluation (APACHE) II score, the Abbreviated Injury Scale (AIS) score, the Injury Severity Score (ISS), underlying diseases, Glasgow Coma Scale (GCS) score, use of vasopressors, need for intubation or cardiopulmonary resuscitation upon admission, and presence of pulmonary contusions. All patients were managed with a standardized protocol if VAP was suspected. The Sequential Organ Failure Assessment (SOFA) score and the Clinical Pulmonary Infection Score (CPIS) were measured on the day of VAP diagnosis. Results: Of the 144 patients with TBI who underwent mechanical ventilation for >48 h, 49.3% did not develop VAP, 24.3% developed early-onset VAP, and 26.4% developed late-onset VAP. Factors independently associated with early-onset VAP included thoracic injury (odds ratio (OR) 8.56, 95% confidence interval (CI) 2.05-35.70; p = 0.003), ISS (OR 1.09, 95% CI 1.03-1.15; p = 0.002), and coma upon admission (OR 13.40, 95% CI 3.12-57.66; p < 0.001). Age (OR 1.04, 95% CI 1.02-1.07; p = 0.002), ISS (OR 1.09, 95% CI 1.04-1.13; p < 0.001), and coma upon admission (OR 3.84, 95% CI 1.44-10.28; p = 0.007) were independently associated with late-onset VAP (Nagelkerke r(2) = 0.371, area under the curve (AUC) 0.815, 95% CI 0.733-0.897; p < 0.001). The 28-day survival rate was 69% in the non-VAP group, 45.7% in the early-onset VAP group, and 31.6% in the late-onset VAP group. Acinetobacter spp was the most common pathogen in patients with early-and late-onset VAP. Conclusions: These results suggest that the extent of TBI and trauma of other organs influences the development of early VAP, while the extent of TBI and age influences the development of late VAP. Patients with early-and late-onset VAP harboured the same pathogens. (C) 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.	[Jovanovic, Bojan; Doklestic, Krstina; Velickovi, Jelena; Ivancevic, Nenad; Gregoric, Pavle; Pandurovic, Milena; Bajec, Djordje; Bumbasirevic, Vesna] Univ Belgrade, Fac Med, Belgrade, Serbia; [Jovanovic, Bojan; Radinovic, Kristina; Velickovi, Jelena; Pandurovic, Milena; Bumbasirevic, Vesna] Clin Ctr Serbia, Ctr Anaesthesiol, Belgrade, Serbia; [Milan, Zoka] Kings Coll Hosp London, London SE5 9RS, England; [Markovic-Denic, Ljiljana; Djuric, Olivera] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia; [Doklestic, Krstina; Ivancevic, Nenad; Gregoric, Pavle] Clin Ctr Serbia, Clin Emergency Surg, Belgrade, Serbia; [Pandurovic, Milena] Medigrp Hosp, Belgrade, Serbia; [Bajec, Djordje] Clin Ctr Serbia, Clin Digest Surg, Belgrade, Serbia		Milan, Z (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	zoka.milan@kcl.ac.uk	Djuric, Olivera/H-8580-2019	Djuric, Olivera/0000-0002-8574-5938; Velickovic, Jelena/0000-0001-7862-5420	Ministry of Science and Technological Development of SerbiaMinistry of Education, Science & Technological Development, Serbia [175046]	This work was supported by the Ministry of Science and Technological Development of Serbia (contract number 175046, 2011-2014).	Adnet F, 1996, LANCET, V348, P123, DOI 10.1016/S0140-6736(05)64630-2; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Browne E, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000066; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Garnacho-Montero J, 2005, INTENS CARE MED, V31, P649, DOI 10.1007/s00134-005-2598-0; Garnacho-Montero Jose, 2014, BMC Infect Dis, V14, P135, DOI 10.1186/1471-2334-14-135; Gastmeier P, 2009, ANTIMICROB AGENTS CH, V53, P2714, DOI 10.1128/AAC.01070-08; Giantsou E, 2005, INTENS CARE MED, V31, P1488, DOI 10.1007/s00134-005-2697-y; Hedrick TL, 2008, J TRAUMA, V64, P714, DOI 10.1097/TA.0b013e31811ec18e; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Hui X, 2013, J SURG RES, V184, P438, DOI 10.1016/j.jss.2013.05.072; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Kalanuria AA, 2014, CRIT CARE, V18, DOI 10.1186/cc13775; Lockey DJ, 1999, ANAESTHESIA, V54, P1097, DOI 10.1046/j.1365-2044.1999.00754.x; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; Mannick JA, 2001, J AM COLL SURGEONS, V193, P237, DOI 10.1016/S1072-7515(01)01011-0; Martin-Loeches I, 2013, INTENS CARE MED, V39, P672, DOI 10.1007/s00134-012-2808-5; Morris AC, 2011, CRIT CARE MED, V39, P2218, DOI 10.1097/CCM.0b013e3182227d52; Nair GB, 2015, INTENS CARE MED, V41, P34, DOI 10.1007/s00134-014-3564-5; Plurad DS, 2013, J SURG RES, V183, P371, DOI 10.1016/j.jss.2013.01.036; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tilahun B, 2015, AM J CRIT CARE, V24, P8, DOI 10.4037/ajcc2015102; Zarzaur BL, 2013, J TRAUMA ACUTE CARE, V75, P234, DOI 10.1097/TA.0b013e3182924c18; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	30	36	48	1	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1201-9712	1878-3511		INT J INFECT DIS	Int. J. Infect. Dis.	SEP	2015	38						46	51		10.1016/j.ijid.2015.07.005			6	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	CV0OJ	WOS:000363949900010	26166697	gold			2022-02-06	
J	Kennis, M; van Rooij, SJH; Tromp, DPM; Fox, AS; Rademaker, AR; Kahn, RS; Kalin, NH; Geuze, E				Kennis, Mitzy; van Rooij, Sanne J. H.; Tromp, Do P. M.; Fox, Andrew S.; Rademaker, Arthur R.; Kahn, Rene S.; Kalin, Ned H.; Geuze, Elbert			Treatment Outcome-Related White Matter Differences in Veterans with Posttraumatic Stress Disorder	NEUROPSYCHOPHARMACOLOGY			English	Article							DEFAULT NETWORK CONNECTIVITY; PREDICTS TREATMENT RESPONSE; TRAUMATIC BRAIN-INJURY; ANTERIOR CINGULATE; INTEGRITY; THERAPY; NEUROCIRCUITRY; PSYCHOTHERAPY; AFGHANISTAN; SYMPTOMS	Posttraumatic stress disorder (PTSD) is a debilitating disorder that has been associated with brain abnormalities, including white matter alterations. However, little is known about the effect of treatment on these brain alterations. To investigate the course of white matter alterations in PTSD, we used a longitudinal design investigating treatment effects on white matter integrity using diffusion tensor imaging (DTI). Diffusion tensor and magnetization transfer images were obtained pre- and posttreatment from veterans with (n=39) and without PTSD (n=22). After treatment, 16 PTSD patients were remitted, and 23 had persistent PTSD based on PTSD diagnosis. The dorsal and hippocampal cingulum bundle, stria terminalis, and fornix were investigated as regions of interest. Exploratory whole-brain analyses were also performed. Groups were compared with repeated-measures ANOVA for fractional anisotropy (FA), and magnetization transfer ratio. Persistently symptomatic PTSD patients had increasing FA of the dorsal cingulum over time, and at reassessment these FA values were higher than both combat controls and the remitted PTSD group. Group-by-time interactions for FA were found in the hippocampal cingulum, fornix, and stria terminalis, posterior corona radiata, and superior longitudinal fasciculus. Our results indicate that higher FA of the dorsal cingulum bundle may be an acquired feature of persistent PTSD that develops over time. Furthermore, treatment might have differential effects on the hippocampal cingulum, fornix, stria terminalis, posterior corona radiata, and superior longitudinal fasciculus in remitted vs persistent PTSD patients. This study contributes to a better understanding of the neural underpinnings of PTSD treatment outcome.	[Kennis, Mitzy; van Rooij, Sanne J. H.; Rademaker, Arthur R.; Kahn, Rene S.; Geuze, Elbert] Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, NL-3584 CX Utrecht, Netherlands; [Kennis, Mitzy; van Rooij, Sanne J. H.; Rademaker, Arthur R.; Geuze, Elbert] Minist Def, Res Ctr Mil Mental Healthcare, Utrecht, Netherlands; [Tromp, Do P. M.; Fox, Andrew S.; Kalin, Ned H.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA		Kennis, M (corresponding author), Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, 100 HPN A01-1-46, NL-3584 CX Utrecht, Netherlands.	M.Kennis@umcutrecht.nl		van Rooij, Sanne J.H./0000-0002-0160-7248	Dutch Ministry of Defence	This research was funded by the Dutch Ministry of Defence. Dr Kalin has served on scientific advisory boards for Corcept Therapeutics, Neuronetics, CeNeRx BioPharma, and Skyland Trail; is a stockholder with equity options in Corcept Therapeutics and CeNeRx BioPharma; owned Promoter Neurosciences; and holds patents for promoter sequences for corticotropin-releasing factor CRF2 alpha and a method of identifying agents that alter the activity of the promoter sequences, promoter sequences for urocortin II and the use thereof, and promoter sequences for corticotropin-releasing factor binding protein and the use thereof. The authors declare no conflict of interest.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Aupperle RL, 2013, PSYCHIAT RES-NEUROIM, V214, P48, DOI 10.1016/j.pscychresns.2013.05.001; Avery SN, 2014, NEUROIMAGE, V91, P311, DOI 10.1016/j.neuroimage.2014.01.017; Balkom AV, 2013, RICHTLIJN DIAGNOSTIE; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Brady K, 2000, JAMA-J AM MED ASSOC, V283, P1837, DOI 10.1001/jama.283.14.1837; Bryant RA, 2008, PSYCHOL MED, V38, P555, DOI 10.1017/S0033291707002231; Bryant RA, 2008, J PSYCHIATR NEUROSCI, V33, P142; Concha L, 2014, NEUROSCIENCE, V276, P14, DOI 10.1016/j.neuroscience.2013.09.004; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Dickie EW, 2013, PSYCHOL MED, V43, P645, DOI 10.1017/S0033291712001328; Ding AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051704; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fani N, 2011, NEUROSCI LETT, V491, P196, DOI 10.1016/j.neulet.2011.01.037; First M., 1997, STRUCTURED CLIN INTE; Foa EB, 1997, ANNU REV PSYCHOL, V48, P449, DOI 10.1146/annurev.psych.48.1.449; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Gray J. A., 1982, NEUROPSYCHOL ANXIETY; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kennis M, 2015, HUM BRAIN MAPP, V36, P99, DOI 10.1002/hbm.22615; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; Lindauer RJL, 2005, PSYCHOL MED, V35, P1421, DOI 10.1017/S0033291705005246; Linden DEJ, 2006, MOL PSYCHIATR, V11, P528, DOI 10.1038/sj.mp.4001816; Mori S, 2005, MRI ATLAS HUMAN WHIT; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Morina N, 2013, J CLIN PSYCHIAT, V74, pE212, DOI 10.4088/JCP.12m07844; Philip NS, 2013, EUR NEUROPSYCHOPHARM, V23, P24, DOI 10.1016/j.euroneuro.2012.10.008; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reijnen A, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.05.003; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Roy MJ, 2010, ANN NY ACAD SCI, V1208, P142, DOI 10.1111/j.1749-6632.2010.05689.x; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Sekiguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083967; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; van Rooij SJH, 2015, NEUROPSYCHOPHARMACOL, V40, P667, DOI 10.1038/npp.2014.220; van Rooij SJH, 2015, PREDICTING PER UNPUB; van Wingen GA, 2012, P NATL ACAD SCI USA, V109, P15508, DOI 10.1073/pnas.1206330109; Wang S, 2014, NEUROSCIENCE, V276, P148, DOI 10.1016/j.neuroscience.2013.10.018; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zhang L, 2012, ACTA NEUROPSYCHIATR, V24, P34, DOI 10.1111/j.1601-5215.2011.00580.x; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	53	36	36	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	SEP	2015	40	10					2434	2442		10.1038/npp.2015.94			9	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CO9KE	WOS:000359493700016	25837284	Bronze, Green Published			2022-02-06	
J	Ochs, AL; Ross, DE; Zannoni, MD; Abildskov, TJ; Bigler, ED				Ochs, Alfred L.; Ross, David E.; Zannoni, Megan D.; Abildskov, Tracy J.; Bigler, Erin D.		Alzheimer's Dis Neuroimaging	Comparison of Automated Brain Volume Measures obtained with NeuroQuant (R) and FreeSurfer	JOURNAL OF NEUROIMAGING			English	Article						Brain morphometry; freesurfer; neuroquant((R)); reliability; pallidum	NEUROIMAGING INITIATIVE ADNI; VOXEL-BASED MORPHOMETRY; ALZHEIMERS-DISEASE; HIPPOCAMPAL VOLUME; STRUCTURAL MRI; RELIABILITY; SEGMENTATION; INJURY; ATROPHY; PHANTOM	PURPOSETo examine intermethod reliabilities and differences between FreeSurfer and the FDA-cleared congener, NeuroQuant (R), both fully automated methods for structural brain MRI measurements. MATERIALS AND METHODSMRI scans from 20 normal control subjects, 20 Alzheimer's disease patients, and 20 mild traumatically brain-injured patients were analyzed with NeuroQuant (R) and with FreeSurfer. Intermethod reliability was evaluated. RESULTSPairwise correlation coefficients, intraclass correlation coefficients, and effect size differences were computed. NeuroQuant (R) versus FreeSurfer measures showed excellent to good intermethod reliability for the 21 regions evaluated (r: .63 to .99/ICC: .62 to .99/ES: -.33 to 2.08) except for the pallidum (r/ICC/ES = .31/.29/-2.2) and cerebellar white matter (r/ICC/ES = .31/.31/.08). Volumes reported by NeuroQuant were generally larger than those reported by FreeSurfer with the whole brain parenchyma volume reported by NeuroQuant 6.50% larger than the volume reported by FreeSurfer. There was no systematic difference in results between the 3 subgroups. CONCLUSIONNeuroQuant (R) and FreeSurfer showed good to excellent intermethod reliability in volumetric measurements for all brain regions examined with the only exceptions being the pallidum and cerebellar white matter. This finding was robust for normal individuals, patients with Alzheimer's disease, and patients with mild traumatic brain injury.	[Ochs, Alfred L.; Ross, David E.; Zannoni, Megan D.] Virginia Inst Neuropsychiat, Midlothian, VA 23114 USA; [Ochs, Alfred L.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA; [Ross, David E.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Abildskov, Tracy J.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Abildskov, Tracy J.; Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Brain Inst Utah, Salt Lake City, UT USA		Ochs, AL (corresponding author), Virginia Inst Neuropsychiat, 364 Browns Hill Court, Midlothian, VA 23114 USA.	aochs@VaNeuropsychiatry.org		Ochs, Alfred/0000-0003-3932-876X	ADNI (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.Biogen; Bristol-Myers Squibb CompanyBristol-Myers Squibb; Eisai Inc.Eisai Co Ltd; Elan Pharmaceuticals, Inc.; Eli Lilly and CompanyEli Lilly; F. Hoffmann-La Roche Ltd., Genentech, Inc.Hoffmann-La RocheRoche HoldingGenentech; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); GE HealthcareGeneral ElectricGE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.Johnson & JohnsonJohnson & Johnson USA; Medpace, Inc.; Merck Co., Inc.Merck & Company; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals CorporationNovartis; Pfizer Inc.Pfizer; Piramal Imaging; Servier; Synarc Inc.; Takeda Pharmaceutical CompanyTakeda Pharmaceutical Company Ltd; Northern California Institute for Research and Education; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG024904] Funding Source: NIH RePORTER	Data collection and sharing for this project was funded by the ADNI (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (http://www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuroimaging at the University of Southern California.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Birk S, 2009, INTERN MED NEWS, V9, P12; Brewer JB, 2009, BEHAV NEUROL, V21, P21, DOI [10.1155/2009/616581, 10.3233/BEN-2009-0226]; Brewer JB, 2009, AM J NEURORADIOL, V30, P578, DOI 10.3174/ajnr.A1402; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Carmichael OT, 2005, NEUROIMAGE, V27, P979, DOI 10.1016/j.neuroimage.2005.05.005; Coe R., 2002, ITS EFFECT SIZE STUP; Cohen J., 2013, STAT POWER ANAL BEHA; Davids M, 2014, MAGN RESON IMAGING, V32, P771, DOI 10.1016/j.mri.2014.01.017; Desikan RS, 2013, AM J NEURORADIOL, V34, P2075, DOI 10.3174/ajnr.A3644; Farid N, 2012, RADIOLOGY, V264, P542, DOI 10.1148/radiol.12112638; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Heister D, 2011, NEUROLOGY, V77, P1619, DOI 10.1212/WNL.0b013e3182343314; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jatzko A, 2006, J AFFECT DISORDERS, V94, P121, DOI 10.1016/j.jad.2006.03.010; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kovacevic S, 2009, ALZ DIS ASSOC DIS, V23, P139, DOI 10.1097/WAD.0b013e318192e745; McEvoy Linda K, 2012, Imaging Med, V4, P343; McEvoy LK, 2010, EXPERT REV NEUROTHER, V10, P1675, DOI [10.1586/ern.10.162, 10.1586/ERN.10.162]; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mulder ER, 2014, NEUROIMAGE, V92, P169, DOI 10.1016/j.neuroimage.2014.01.058; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Ross DE, 2015, J NEUROPSYCH CLIN N, V27, P147, DOI 10.1176/appi.neuropsych.13040088; Ross DE, 2014, NEUROIMAGE, V102, P565, DOI 10.1016/j.neuroimage.2014.07.043; Ross DE, 2013, PSYCHOL INJ LAW, V6, P75, DOI 10.1007/s12207-012-9140-9; Ross DE, 2013, BRAIN INJURY, V27, P634, DOI 10.3109/02699052.2013.767939; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2013, J NEUROPSYCHIATRY CL, V25, P1, DOI DOI 10.1176/appi.neuropsych.12120401; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Testa C, 2004, J MAGN RESON IMAGING, V19, P274, DOI 10.1002/jmri.20001; Voets NL, 2008, NEUROIMAGE, V43, P665, DOI 10.1016/j.neuroimage.2008.08.013; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037	46	36	36	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	SEP-OCT	2015	25	5					721	727		10.1111/jon.12229			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CP3MO	WOS:000359783900004	25727700				2022-02-06	
J	Cepeda, S; Gomez, PA; Castano-Leon, AM; Martinez-Perez, R; Munarriz, PM; Lagares, A				Cepeda, Santiago; Gomez, Pedro A.; Castano-Leon, Ana Maria; Martinez-Perez, Rafael; Munarriz, Pablo M.; Lagares, Alfonso			Traumatic Intracerebral Hemorrhage: Risk Factors Associated with Progression	JOURNAL OF NEUROTRAUMA			English	Article						contusion; intracerebral hematoma; progressive hemorrhagic injury; TBI; TICH	SEVERE HEAD-INJURY; BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; COMPUTERIZED-TOMOGRAPHY; CONTUSIONS; COAGULOPATHY; HEMATOMA; LESION; THROMBOCYTOPENIA; PREDICTORS	The increase in the volume of a traumatic intracerebral hemorrhage (TICH) is a widely studied phenomenon that has a direct impact on the prognosis of patients. The objective of this study was to identify the risk factors associated with the progression of TICH. We retrospectively analyzed the records of 1970 adult patients >15 years of age who were consecutively admitted after sustaining a closed severe traumatic brain injury (TBI) between January 1987 and November 2013 at a single center. Beginning in 2007, patients with moderate TBIs were also included. A total of 782 patients exhibited one or more TICH on the initial CT scan, and met the selection criteria. The main outcome variable was the presence or absence of progression of the TICH. Univariate and multivariate statistical analyses were performed. Factors independently associated with the growth of TICH obtained through logistic regression included the following: an initial volume <5cc (odds ratio [OR] 2.42, p<0.001), cisternal compression (OR 1.95, p<0.001), decompressive craniectomy (OR 2.18, p<0.001), age (mean 37.67 vs. 42.95 years; OR 1.01, p<0.001), falls as mechanism of trauma (OR 1.72, p=0.001), multiple TICHs (OR 1.56, p=0.007), and hypoxia (OR 1.56, p=0.02). TICH progression occurred with a frequency of 63% in our study. We showed that there was a correlation between TICH growth and some variables, such as multiple TICHs, a lower initial volume, acute subdural hematoma, cisternal compression, older patient age, hypoxia, falls, and decompressive craniectomy.	[Cepeda, Santiago; Gomez, Pedro A.; Castano-Leon, Ana Maria; Martinez-Perez, Rafael; Munarriz, Pablo M.; Lagares, Alfonso] Univ Complutense Madrid, Hosp 12 Octubre, Dept Neurosurg, Madrid, Spain		Cepeda, S (corresponding author), Hosp 12 Octubre, Dept Neurosurg, Avda Cordoba S-N, E-28041 Madrid, Spain.	cepeda_santiago@hotmail.com	Lagares, Alfonso/B-2969-2011; MARTINEZ-PEREZ, Rafael/AAR-5874-2020; Munarriz, Pablo M/S-3398-2018; Martinez-Perez, Rafael/E-2408-2014; Gomez, Pedro/N-5051-2019; Castano-Leon, Ana M/ABF-6322-2020; Cepeda, Santiago/AAE-3200-2021; MARTINEZ-PEREZ, Rafael/AAO-7328-2020	Lagares, Alfonso/0000-0003-3996-0554; MARTINEZ-PEREZ, Rafael/0000-0002-2896-2346; Munarriz, Pablo M/0000-0002-9888-7046; Martinez-Perez, Rafael/0000-0002-2896-2346; Gomez, Pedro/0000-0002-4185-5238; Castano-Leon, Ana M/0000-0002-7918-5049; Cepeda, Santiago/0000-0003-1667-8548; 	Mutua Madrilena Foundation (Spain) [2010-007]	This study was funded by grant no. 2010-007 from the Mutua Madrilena Foundation (Spain) to Pedro A. Gomez.	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; Gean AD, 1994, IMAGING HEAD TRAUMA; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gomez PA, 1999, NEUROCIRUGIA, V10, P297; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Singounas E G, 1992, J Neurosurg Sci, V36, P201; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; Sturiale CL, 2012, J NEUROTRAUM, V29, P2723, DOI 10.1089/neu.2012.2556; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Wu JJ, 1999, J TRAUMA, V47, P39, DOI 10.1097/00005373-199907000-00009; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109	44	36	41	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1246	1253		10.1089/neu.2014.3808			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400009	25752340				2022-02-06	
J	Ahn, SY; Chang, YS; Sung, DK; Sung, SI; Yoo, HS; Im, GH; Choi, SJ; Park, WS				Ahn, So Yoon; Chang, Yun Sil; Sung, Dong Kyung; Sung, Se In; Yoo, Hye Soo; Im, Geun Ho; Choi, Soo Jin; Park, Won Soon			Optimal Route for Mesenchymal Stem Cells Transplantation after Severe Intraventricular Hemorrhage in Newborn Rats	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; MARROW STROMAL CELLS; TRAUMATIC BRAIN INJURY; BONE-MARROW; AGE; HYDROCEPHALUS; RECOVERY; OUTCOMES; THERAPY; INFANTS	Recently, we showed that intracerebroventricular (IC) transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) significantly attenuates post-hemorrhagic hydrocephalus (PHH) and brain damage after severe IVH in newborn rats. This study was performed to determine the optimal route for transplanting MSCs for severe IVH by comparing IC transplantation, intravenous (IV) transplantation, and IV transplantation plus mannitol infusion. Severe IVH was induced by injecting 100 uL of blood into each ventricle of Sprague-Dawley rats on postnatal day 4 (P4). After confirming severe IVH with brain magnetic resonance imaging (MRI) at P5, human UCB-derived MSCs were transplanted at P6 by an IC route (1x10(5)), an IV route (5x10(5)), or an IV route with mannitol infused. Follow-up brain MRIs and rotarod tests were performed. At P32, brain tissue samples were obtained for biochemical and histological analyses. Although more MSCs localized to the brain after IC than after IV delivery, both methods were equally effective in preventing PHH; attenuating impaired rotarod test; increasing the number of TUNEL-positive cells, inflammatory cytokines, and astrogliosis; and reducing corpus callosal thickness and myelin basic protein expression after severe IVH regardless of mannitol co-infusion. Despite the superior delivery efficacy with IC than with the IV route, both IC and IV transplantation of MSCs had equal therapeutic efficacy in protecting against severe IVH. These findings suggest that the less invasive IV route might be a good alternative for clinically unstable, very preterm infants that cannot tolerate a more invasive IC delivery of MSCs.	[Ahn, So Yoon; Chang, Yun Sil; Sung, Dong Kyung; Sung, Se In; Yoo, Hye Soo; Park, Won Soon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Im, Geun Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Choi, Soo Jin] MEDIPOST Co Ltd, Biomed Res Inst, Seoul, South Korea		Park, WS (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Pediat, Seoul, South Korea.	ws123.park@samsung.com			Korean Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A110445]; Samsung Biomedical Research Institute grantSamsung [SMX1131761, SMX1132321]	This work was supported by a grant from the Korean Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Number; A110445, Author; Won Soon Park) (https://www.htdream.kr/) and by a Samsung Biomedical Research Institute grant (Number; SMX1131761, Author; Won Soon Park, SMX1132321, Author; So Yoon Ahn) (http://www.skkusm.ac.kr/academics/ri.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and do not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Ahn SY, 2013, STROKE, V44, P497, DOI 10.1161/STROKEAHA.112.679092; AMTORP O, 1974, J PHYSIOL-LONDON, V243, P387, DOI 10.1113/jphysiol.1974.sp010759; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; BRAUN LD, 1980, J NEUROCHEM, V34, P147, DOI 10.1111/j.1471-4159.1980.tb04633.x; Chang YS, 2014, J PEDIATR-US, V164, P966, DOI 10.1016/j.jpeds.2013.12.011; Chang YS, 2009, CELL TRANSPLANT, V18, P869, DOI 10.3727/096368909X471189; Choi YJ, 2010, J NEUROL SCI, V298, P28, DOI 10.1016/j.jns.2010.09.003; Delo DM, 2008, STEM CELLS DEV, V17, P1185, DOI 10.1089/scd.2008.0028; Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Hudgins RJ, 1997, PEDIATR NEUROSURG, V26, P281, DOI 10.1159/000121207; Jang YK, 2006, ANN HEMATOL, V85, P212, DOI 10.1007/s00277-005-0047-3; Kawabori M, 2012, NEUROPATHOLOGY, V32, P217, DOI 10.1111/j.1440-1789.2011.01260.x; Kennedy C, 1998, LANCET, V352, P433; Kim ES, 2012, PEDIATR RES, V72, P277, DOI 10.1038/pr.2012.71; Kingham PJ, 2014, STEM CELLS DEV, V23, P741, DOI 10.1089/scd.2013.0396; Kuchroo P, 2015, STEM CELLS DEV, V24, P437, DOI 10.1089/scd.2014.0184; LARROCHE JC, 1972, BIOL NEONATE, V20, P287; Lee JK, 2007, CELL TRANSPLANT, V16, P849, DOI 10.3727/000000007783465271; LEVENE MI, 1982, ARCH DIS CHILD, V57, P410, DOI 10.1136/adc.57.6.410; Liu R, 2013, STEM CELLS DEV, V22, P1053, DOI 10.1089/scd.2012.0463; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; MUJSCE DJ, 1990, STROKE, V21, P1210, DOI 10.1161/01.STR.21.8.1210; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Payne AH, 2013, JAMA PEDIATR, V167, P451, DOI 10.1001/jamapediatrics.2013.866; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P299, DOI 10.1089/scd.2009.0403; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Thorp JA, 2001, AM J OBSTET GYNECOL, V185, P859, DOI 10.1067/mob.2001.117355; Tomasoni S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0266; van Velthoven CTJ, 2009, BRAIN RES REV, V61, P1, DOI 10.1016/j.brainresrev.2009.03.003; Vinukonda G, 2010, BRAIN, V133, P2264, DOI 10.1093/brain/awq107; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Yang SE, 2004, CYTOTHERAPY, V6, P476, DOI 10.1080/14653240410005041; Yasuhara T, 2010, J CELL MOL MED, V14, P914, DOI 10.1111/j.1582-4934.2008.00671.x; Zawadzka M, 2009, ACTA NEUROBIOL EXP, V69, P46; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479; 1990, ARCH DIS CHILDHOOD, V65, P3	40	36	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2015	10	7							e0132919	10.1371/journal.pone.0132919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN7NT	WOS:000358622000046	26208299	gold, Green Published, Green Submitted			2022-02-06	
J	Robertson, K; Schmitter-Edgecombe, M				Robertson, Kayela; Schmitter-Edgecombe, Maureen			Self-awareness and traumatic brain injury outcome	BRAIN INJURY			English	Article						Awareness; community integration; outcome; rehabilitation; self-awareness; traumatic brain injury	EPISODIC MEMORY; POSTTRAUMATIC AMNESIA; REHABILITATION; DEFICITS; PREDICTIONS; PERFORMANCE; METAMEMORY; IMPAIRMENT; ACCURACY; FLUENCY	Primary objective: Impaired self-awareness following a traumatic brain injury (TBI) can reduce the effectiveness of rehabilitation, resulting in poorer outcomes. However, little is understood about how the multi-dimensional aspects of self-awareness may differentially change with recovery and impact outcome. Thus, this study examined four self-awareness variables represented in the Dynamic Comprehensive Model of Awareness: metacognitive awareness, anticipatory awareness, error-monitoring and self-regulation. Research design: This study evaluated change of the self-awareness measures with recovery from TBI and whether the self-awareness measures predicted community re-integration at follow-up. Methods and procedures: Participants were 90 individuals with moderate-to-severe TBI who were tested acutely following injury and 90 age-matched controls. Forty-nine of the TBI participants and 49 controls were re-tested after 6 months. Main outcome and results: Results revealed that the TBI group's error-monitoring performance was significantly poorer than controls at both baseline and follow-up. Regression analyses revealed that the self-awareness variables at follow-up were predictive of community re-integration, with error-monitoring being a unique predictor. Conclusions: The results highlight the importance of error-monitoring and suggest that interventions targeted at improving error-monitoring may be particularly beneficial. Understanding the multi-dimensional nature of self-awareness will further improve rehabilitation efforts and understanding of the theoretical basis of self-awareness.	[Robertson, Kayela; Schmitter-Edgecombe, Maureen] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Robertson, K (corresponding author), Washington State Univ, Dept Psychol, POB 644820, Pullman, WA 99164 USA.	k.robertson@email.wsu.edu			NINSD [R01-N5047690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This work was supported by a grant from NINSD R01-N5047690.	Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; Anderson JW, 2010, J CLIN EXP NEUROPSYC, V32, P505, DOI 10.1080/13803390903224944; Anderson JW, 2009, J CLIN EXP NEUROPSYC, V31, P425, DOI 10.1080/13803390802232667; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Barco PP, 1991, TRAINING AWARENESS C; Beatty WW, 1998, MULT SCLER, V4, P40; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DEVOLDER PA, 1990, PSYCHOL AGING, V5, P291, DOI 10.1037/0882-7974.5.2.291; Faul M, 2010, TRAUMATIC BRAIN INJU; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; FitzGerald M. C., 2012, IRISH J PSYCHOL, V33, P78, DOI [10.1080/03033910.2012.708898, DOI 10.1080/03033910.2012.708898]; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming JM, 1996, BRAIN INJURY, V10, P1; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Hartman-Maeir A, 2002, J REHABIL MED, V34, P158, DOI 10.1080/16501970213236; HERTZOG C, 1990, PSYCHOL AGING, V5, P215, DOI 10.1037/0882-7974.5.2.215; Hoerold D, 2013, NEUROPSYCHOLOGIA, V51, P385, DOI 10.1016/j.neuropsychologia.2012.11.019; Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Leung DPK, 2011, INT J REHABIL RES, V34, P187, DOI 10.1097/MRR.0b013e3283487f31; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Majdan A, 1996, J CLIN EXP NEUROPSYC, V18, P416, DOI 10.1080/01688639608408998; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ownsworth T, 2004, NEUROPSYCHOL REHABIL, V14, P535, DOI 10.1080/09602010343000538; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Pigatano GP, 1991, AWARENESS DEFICIT BR; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmitter-Edgecombe M, 2004, BRAIN INJURY, V18, P997, DOI 10.1080/02699050410001719934; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; Schmitter-Edgecombe M, 2011, J CLIN EXP NEUROPSYC, V33, P218, DOI 10.1080/13803395.2010.507184; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Simmond M., 2003, OCCUP THER J RES, V66, P447, DOI [10.1177/030802260306601003, DOI 10.1177/030802260306601003]; TEASDALE G, 1974, LANCET, V2, P81; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4	51	36	36	0	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					848	858		10.3109/02699052.2015.1005135			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800009	25915097	Green Accepted			2022-02-06	
J	Lopez-Rodriguez, AB; Acaz-Fonseca, E; Giatti, S; Caruso, D; Viveros, MP; Melcangi, RC; Garcia-Segura, LM				Belen Lopez-Rodriguez, Ana; Acaz-Fonseca, Estefania; Giatti, Silvia; Caruso, Donatella; Viveros, Maria-Paz; Melcangi, Roberto C.; Garcia-Segura, Luis M.			Correlation of brain levels of progesterone and dehydroepiandrosterone with neurological recovery after traumatic brain injury in female mice	PSYCHONEUROENDOCRINOLOGY			English	Article						Tetrahydroprogesterone; 17 beta-Estradiol; Dehydroepiandrosterone; lsopregnanolone; Progesterone; Testosterone	NEUROACTIVE STEROID-LEVELS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ACUTE REGULATORY PROTEIN; SEX-DIMORPHIC CHANGES; CLOSED-HEAD INJURY; CEREBROSPINAL-FLUID; RAT HIPPOCAMPUS; NERVOUS-SYSTEM; CLINICAL-TRIAL; IN-VIVO	Traumatic brain injury (TBI) is an important cause of disability in humans. Neuroactive steroids, such as progesterone and dehydroepiandrosterone (DHEA), are neuroprotective in TBI models. However in order to design potential neuroprotective strategies based on neuroactive steroids it is important to determine whether its brain levels are altered by TBI. In this study we have used a weight-drop model of TBI in young adult female mice to determine the levels of neuroactive steroids in the brain and plasma at 24h, 72h and 2 weeks after injury. We have also analyzed whether the levels of neuroactive steroids after TBI correlated with the neurological score of the animals. TBI caused neurological deficit detectable at 24 and 72 h, which recovered by 2 weeks after injury. Brain levels of progesterone, tetrahydroprogesterone (THP), isopregnanolone and 17 beta-estradiol were decreased 24 h, 72 h and 2 weeks after TBI. DHEA and brain testosterone levels presented a transient decrease at 24 h after lesion. Brain levels of progesterone and DHEA showed a positive correlation with neurological recovery. Plasma analyses showed that progesterone was decreased 72 h after lesion but, in contrast with brain progesterone, its levels did not correlate with neurological deficit. These findings indicate that TBI alters the levels of neuroactive steroids in the brain with independence of its plasma levels and suggest that the pharmacological increase in the brain of the levels of. progesterone and DHEA may result in the improvement of neurological recovery after TBI. (C) 2015 Elsevier Ltd. All rights reserved.	[Belen Lopez-Rodriguez, Ana; Acaz-Fonseca, Estefania; Garcia-Segura, Luis M.] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Belen Lopez-Rodriguez, Ana; Viveros, Maria-Paz] Univ Complutense Madrid, Fac Biol, Dept Anim Physiol Anim Physiol 2, Madrid, Spain; [Giatti, Silvia; Caruso, Donatella; Melcangi, Roberto C.] Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol & Biomol Sci, I-20133 Milan, Italy		Lopez-Rodriguez, AB (corresponding author), CSIC, Inst Cajal, Avenida Doctor Arce 37, E-28002 Madrid, Spain.	lranabelen@gmail.com	Acaz-Fonseca, Estefania/S-5884-2016; Giatti, Silvia/G-9334-2016; Garcia-Segura, Luis M/U-3711-2017; Melcangi, Roberto Cosimo/AAA-6534-2022; Lopez-Rodriguez, Ana Belen/H-3631-2017; Viveros, Maria-Paz/S-6855-2016	Acaz-Fonseca, Estefania/0000-0003-2549-6420; Giatti, Silvia/0000-0001-7741-826X; Garcia-Segura, Luis M/0000-0002-2450-2916; Lopez-Rodriguez, Ana Belen/0000-0002-0747-7966; MELCANGI, COSIMO ROBERTO/0000-0003-0861-8967; Viveros, Maria-Paz/0000-0002-4119-4636	Ministerio de Economia y Competitividad, Spain [BFU2011-30217-C03-01, BFU2012-38144]; Institut de Salud Carlos III, Redes tematicas de Investigacion Cooperativa en Salud, Red de Trastornos Adictivos [RD2012/0028/0021]; GRUPO UCM [951579]; Fondazione CariploFondazione Cariplo [2012-0547]	We acknowledge financial support from the Ministerio de Economia y Competitividad, Spain to L.M.G.S. (BFU2011-30217-C03-01) and M.P.V. (BFU2012-38144), Institut de Salud Carlos III, Redes tematicas de Investigacion Cooperativa en Salud, Red de Trastornos Adictivos to M.P.V. (RD2012/0028/0021), GRUPO UCM to M.RV. (951579) and Fondazione Cariplo to R.C.M. (grant number 2012-0547).	Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Azcoitia I, 2001, J NEUROBIOL, V47, P318, DOI 10.1002/neu.1038; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Borowicz Kinga K, 2011, Front Endocrinol (Lausanne), V2, P50, DOI 10.3389/fendo.2011.00050; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caruso D, 2014, J NEUROCHEM, V130, P591, DOI 10.1111/jnc.12745; Caruso D, 2013, PSYCHONEUROENDOCRINO, V38, P2278, DOI 10.1016/j.psyneuen.2013.04.016; Caruso D, 2013, NEUROBIOL AGING, V34, P1080, DOI 10.1016/j.neurobiolaging.2012.10.007; Caruso D, 2010, J NEUROCHEM, V114, P921, DOI 10.1111/j.1471-4159.2010.06825.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Giatti S, 2010, NEUROCHEM INT, V56, P118, DOI 10.1016/j.neuint.2009.09.009; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hoffman SW, 2003, J NEUROTRAUM, V20, P859, DOI 10.1089/089771503322385791; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Juhasz-Vedres G, 2006, ENDOCRINOLOGY, V147, P683, DOI 10.1210/en.2005-0693; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Lavaque E, 2006, J NEUROBIOL, V66, P308, DOI 10.1002/neu.20221; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114173; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Lorenzo Monica, 2005, Pituitary, V8, P233, DOI 10.1007/s11102-006-6046-0; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Melcangi RC, 2008, CELL MOL LIFE SCI, V65, P777, DOI 10.1007/s00018-007-7403-5; Melcangi RC, 2014, PROG NEUROBIOL, V113, P56, DOI 10.1016/j.pneurobio.2013.07.006; Melcangi RC, 2012, J MOL NEUROSCI, V46, P177, DOI 10.1007/s12031-011-9570-y; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Mirzatoni A, 2010, J NEUROTRAUM, V27, P1875, DOI 10.1089/neu.2010.1330; Mitro N, 2012, NEUROCHEM INT, V60, P616, DOI 10.1016/j.neuint.2012.02.025; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Papadopoulos V, 2012, BEST PRACT RES CL EN, V26, P771, DOI 10.1016/j.beem.2012.05.002; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Pesaresi M, 2010, HORM BEHAV, V57, P46, DOI 10.1016/j.yhbeh.2009.04.008; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Sierra A, 2003, EUR J NEUROSCI, V18, P1458, DOI 10.1046/j.1460-9568.2003.02872.x; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang QG, 2014, MOL CELL ENDOCRINOL, V389, P84, DOI 10.1016/j.mce.2013.12.019	58	36	37	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4530			PSYCHONEUROENDOCRINO	Psychoneuroendocrinology	JUN	2015	56						1	11		10.1016/j.psyneuen.2015.02.018			11	Endocrinology & Metabolism; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry	CH6JE	WOS:000354142100001	25770855				2022-02-06	
J	Mychasiuk, R; Hehar, H; Esser, MJ				Mychasiuk, Richelle; Hehar, Harleen; Esser, Michael J.			A mild traumatic brain injury (mTBI) induces secondary attention-deficit hyperactivity disorder-like symptomology in young rats	BEHAVIOURAL BRAIN RESEARCH			English	Article						Go/No-Go; Executive function; Impulsive; Secondary ADHD; Weight-drop	PROBLEM-SOLVING SKILLS; REACTION-TIME-TASK; DEFICIT/HYPERACTIVITY DISORDER; EXECUTIVE FUNCTION; INHIBITORY CONTROL; SEX-DIFFERENCES; HEAD-INJURY; SHORT-TERM; CONCUSSION; CHILDREN	Although attention-deficit hyperactivity disorder (ADHD) is commonly reported after moderate and severe traumatic brain injury (TBI), research is struggling to find a strong link between mild TBI or concussion and ADHD. Epidemiological studies often generate conflicting results which may be related to the difficulty identifying the lingering symptoms of mTBI, the lack of baseline knowledge and the possible exacerbation of pre-existing ADHD symptomology, and/or differential diagnostic criteria for secondary ADHD. The purpose of this study was to determine if a mild TBI/concussion in the juvenile period (postnatal day 30) could induce ADHD-like symptoms in young rodents. Using the Go/No-Go paradigm of the 5-choice serial reaction task, sustained attention, impulsivity, and response inhibition was measured. The open field was also used to measure activity levels at two time points. Animals that experienced an mTBI in the juvenile period exhibited ADHD symptomology, with sex-differences present on one of the tasks. Significant deficits were identified in sustained attention, response inhibition, and impulsivity. Immediately after the mTBI, all rats were hypoactive in the open field, and while male animals exhibited a trend toward hyperactivity in the long-term, females continued to trend toward hypoactivity for the duration of the experiment. These findings provide a unique platform upon which preventative and therapeutic strategies can be implemented and tested in an effort to improve ADHD-like symptoms following mTBI. (C) 2015 Elsevier B.V. All rights reserved.	[Mychasiuk, Richelle; Hehar, Harleen; Esser, Michael J.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB T2N 1N4, Canada		Mychasiuk, R (corresponding author), Univ Calgary, Alberta Childrens Hosp, Res Inst, Room 274,Heritage Med Res Bldg,3330 Hosp Dr NW, Calgary, AB T2N 1N4, Canada.	rmmychas@ucalgary.ca			Alberta Children's Hospital Research Institute; Alberta Children's Hospital Foundation; Canadian Institute for Health ResearchCanadian Institutes of Health Research (CIHR); Markin USRP for Health and Wellness	The authors would like to thank Irene Ma, Simon Spanswick, and Rose Tobias for their technical assistance. They would also like to thank the Alberta Children's Hospital Research Institute, the Alberta Children's Hospital Foundation, the Canadian Institute for Health Research, and the Markin USRP for Health and Wellness, for their financial contributions.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Centers for Disease Control and Prevention, 2014, ATT DEF HYP DIS ADHD; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chudasama Y, 2003, BEHAV BRAIN RES, V146, P105, DOI 10.1016/j.bbr.2003.09.020; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Faul M, 2010, TRAUMATIC BRAIN INJU; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Golmirzaei J, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/953103; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kolb B., 2008, FUNDAMENTALS HUMAN N; Konrad KN, 2000, BRAIN INJURY, V14, P859; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, BRAIN INJURY, V12, P41; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Pellis SM, 2010, AM J PLAY, V2, P278; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sagvolden T, 2005, BIOL PSYCHIAT, V57, P1239, DOI 10.1016/j.biopsych.2005.02.002; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; White RD, 2014, SPORTS HEALTH, V6, P149, DOI 10.1177/1941738113484679; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Wodka EL, 2007, J CLIN EXP NEUROPSYC, V29, P345, DOI 10.1080/13803390600678046; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zang YF, 2005, BRAIN DEV-JPN, V27, P544, DOI 10.1016/j.braindev.2004.11.009	44	36	37	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUN 1	2015	286						285	292		10.1016/j.bbr.2015.03.010			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	CG8XS	WOS:000353599600038	25771208				2022-02-06	
J	List, J; Ott, S; Bukowski, M; Lindenberg, R; Floel, A				List, Jonathan; Ott, Stefanie; Bukowski, Martin; Lindenberg, Robert; Floeel, Agnes			Cognitive function and brain structure after recurrent mild traumatic brain injuries in young-to-middle-aged adults	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						concussion; cortical thickness; MRI; cognition; traumatic brain injury	HUMAN CEREBRAL-CORTEX; ALZHEIMERS-DISEASE; FOOTBALL PLAYERS; CONCUSSION; DEMENTIA; ENCEPHALOPATHY; COLLEGIATE; HISTORY; MRI; ABNORMALITIES	Recurrent mild traumatic brain injuries (mTBIs) are regarded as an independent risk factor for developing dementia in later life. We here aimed to evaluate associations between recurrent mTBIs, cognition, and gray matter volume and microstructure as revealed by structural magnetic resonance imaging (MRI) in the chronic phase after mTBIs in young adulthood. We enrolled 20 young-to-middle-aged subjects, who reported two or more sports-related mTBIs, with the last mTBI > 6 months prior to study enrolment (mTBI group), and 21 age-, sex- and education matched controls with no history of mTBI (control group). All participants received comprehensive neuropsychological testing, and high resolution T1-weighted and diffusion tensor MRI in order to assess cortical thickness (CT) and microstructure, hippocampal volume, and ventricle size. Compared to the control group, subjects of the mTBI group presented with lower CT within the right temporal lobe and left insula using an a priori region of interest approach. Higher number of mTBIs was associated with lower CT in bilateral insula, right middle temporal gyrus and right entorhinal area. Our results suggest persistent detrimental effects of recurrent mTBIs on CT already in young-to-middle-aged adults. If additional structural deterioration occurs during aging, subtle neuropsychological decline may progress to clinically overt dementia earlier than in age-matched controls, a hypothesis to be assessed in future prospective trials.	[List, Jonathan; Ott, Stefanie; Bukowski, Martin; Lindenberg, Robert; Floeel, Agnes] Charite, Dept Neurol, D-10117 Berlin, Germany; [Lindenberg, Robert; Floeel, Agnes] Charite, Ctr Stroke Res Berlin, D-10117 Berlin, Germany; [Floeel, Agnes] Charite, NeuroCure Cluster Excellence, D-10117 Berlin, Germany		List, J (corresponding author), Charite, Dept Neurol, Charitepl 1, D-10117 Berlin, Germany.	jonathan.list@charite.de; agnes.floeel@charite.de	Meijer, Anna/K-5118-2016; Floel, Agnes/A-9426-2017		Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [F1-379-8/1, 379-10/1, 379-11/1, DFG-Exc-257]; Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [FKZ0315673A, 01EO0801, 01GY1144]; Else-Kroner Fresenius Stiftung [2011_119]; Charite Universitatsmedizin Berlin; Berlin Institute of Health	This work was supported by grants from the Deutsche Forschungsgemeinschaft (AF: F1-379-8/1; 379-10/1; 379-11/1; DFG-Exc-257), Bundesministerium fur Bildung und Forschung (AF: FKZ0315673A; 01EO0801; 01GY1144) and Else-Kroner Fresenius Stiftung (RL: 2011_119). JL is participant in the Charite Clinical Scientist Program funded by the Charite Universitatsmedizin Berlin and the Berlin Institute of Health.	Albert Marilyn, 2008, Handb Clin Neurol, V88, P511, DOI 10.1016/S0072-9752(07)88027-4; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2014, CEREB CORTEX, V24, P919, DOI 10.1093/cercor/bhs379; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Helmstaedter C., 2001, VLMT VERBALER LERN U; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Juottonen K, 1998, NEUROBIOL AGING, V19, P15, DOI 10.1016/S0197-4580(98)00007-4; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kelly JP, 1997, NEUROLOGY, V48, P581; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mielke MM, 2014, NEUROLOGY, V82, P70, DOI 10.1212/01.wnl.0000438229.56094.54; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Nestor SM, 2008, BRAIN, V131, P2443, DOI 10.1093/brain/awn146; Pressley JC, 2003, J CLIN EPIDEMIOL, V56, P896, DOI 10.1016/S0895-4356(03)00133-1; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	51	36	36	3	28	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAY 21	2015	9								228	10.3389/fnhum.2015.00228			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	CK2TA	WOS:000356064200001	26052275	Green Published, gold			2022-02-06	
J	Agrawal, R; Noble, E; Tyagi, E; Zhuang, YM; Ying, Z; Gomez-Pinilla, F				Agrawal, Rahul; Noble, Emily; Tyagi, Ethika; Zhuang, Yumei; Ying, Zhe; Gomez-Pinilla, Fernando			Flavonoid derivative 7,8-DHF attenuates TBI pathology via TrkB activation	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Cognition; 7,8-Dihydroxyflavone; Metabolism; Plasticity; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL TRANSCRIPTION FACTOR; NEUROTROPHIC FACTOR; MEMORY DEFICITS; COPY NUMBER; MOUSE MODEL; PGC-1-ALPHA; 7,8-DIHYDROXYFLAVONE; BDNF; PLASTICITY	Traumatic brain injury (TBI) is followed by a state of metabolic dysfunction, affecting the ability of neurons to use energy and support brain plasticity: there is no effective therapy to counteract the TBI pathology. Brain-derived neurotrophic factor (BDNF) has an exceptional capacity to support metabolism and plasticity, which highly contrasts with its poor pharmacological profile. We evaluated the action of a flavonoid derivative 7,8-dihydroxyflavone (7,8-DHF), a BDNF receptor (TrkB) agonist with the pharmacological profile congruent for potential human therapies. Treatment with 7,8-DHF (5 mg/kg, ip, daily for 7 days) was effective to ameliorate the effects of TBI on plasticity markers (CREB phosphorylation, GAP-43 and syntaxin-3 levels) and memory function in Barnes maze test. Treatment with 7,8-DHF restored the decrease in protein and phenotypic expression of TrkB phosphorylation after TBI. In turn, intrahippocampal injections of K252a, a TrkB antagonist, counteracted the 7,8-DHF induced TrkB signaling activation and memory improvement in TBI, suggesting the pivotal role of TrkB signaling in cognitive performance after brain injury. A potential action of 7,8-DHF on cell energy homeostasis was corroborated by the normalization in levels of PGC-1 alpha, TFAM, COII AMPK and SIRT1 in animals subjected to TBI. Results suggest a potential mechanism by which 7,8-DHF counteracts TBI pathology via activation of the TrkB receptor and engaging the interplay between cell energy management and synaptic plasticity. Since metabolic dysfunction is an important risk factor for the development of neurological and psychiatric disorders, these results set a precedent for the therapeutic use of 7,8-DHF in a larger context.. (C) 2015 Elsevier B.V. All rights reserved.	[Agrawal, Rahul; Noble, Emily; Tyagi, Ethika; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Zhuang, Yumei; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Agrawal, Rahul/F-6412-2015	Agrawal, Rahul/0000-0001-8128-3724; Noble, Emily/0000-0002-7483-031X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050465]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA037689] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant NS050465. There is no conflict of interest for any of the contributing authors.	Alonso M, 2002, CELL MOL NEUROBIOL, V22, P663, DOI 10.1023/A:1021848706159; Andero R, 2012, HIPPOCAMPUS, V22, P399, DOI 10.1002/hipo.20906; Anglin RE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.107; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Burkhalter J, 2003, J NEUROSCI, V23, P8212; Campbell CT, 2012, BBA-GENE REGUL MECH, V1819, P921, DOI 10.1016/j.bbagrm.2012.03.002; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chen J, 2011, NEUROSCI LETT, V499, P181, DOI 10.1016/j.neulet.2011.05.054; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Eakins James, 2009, J Diabetes Sci Technol, V3, P1373; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Gupta SK, 2009, CELL DEATH DIFFER, V16, P624, DOI 10.1038/cdd.2008.188; Gupta VK, 2013, INT J MOL SCI, V14, P10122, DOI 10.3390/ijms140510122; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Liu X, 2010, J MED CHEM, V53, P8274, DOI 10.1021/jm101206p; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Markham A, 2004, EUR J NEUROSCI, V20, P1189, DOI 10.1111/j.1460-9568.2004.03578.x; Martin-Martin B, 1999, J LEUKOCYTE BIOL, V65, P397, DOI 10.1002/jlb.65.3.397; Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200; Real CC, 2013, NEUROSCIENCE, V237, P118, DOI 10.1016/j.neuroscience.2013.01.060; Riddle DR, 1997, BIOTECHNIQUES, V23, P928, DOI 10.2144/97235rr02; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]	46	36	38	2	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	MAY	2015	1852	5					862	872		10.1016/j.bbadis.2015.01.018			11	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CG3JJ	WOS:000353176200016	25661191	Bronze, Green Accepted			2022-02-06	
J	Brody, DL; Benetatos, J; Bennett, RE; Klemenhagen, KC; Mac Donald, CL				Brody, David L.; Benetatos, Joseph; Bennett, Rachel E.; Klemenhagen, Kristen C.; Mac Donald, Christine L.			The pathophysiology of repetitive concussive traumatic brain injury in experimental models; new developments and open questions	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Concussion; Traumatic brain injury; Traumatic axonal injury; Amyloid-beta; Tau; Microglia; Depression; Social behavior; Mouse; Sertraline	AMYLOID PROTEIN DEPOSITION; AXONAL INJURY; MOUSE MODEL; ALZHEIMERS-DISEASE; DENDRITIC SPINES; TAU OLIGOMERS; COGNITIVE IMPAIRMENT; PRECURSOR PROTEIN; HEAD-INJURY; RAT MODEL	In recent years, there has been an increasing interest in the pathophysiology of repetitive concussive traumatic brain injury (rcTBI) in large part due to the association with dramatic cases of progressive neurological deterioration in professional athletes, military personnel, and others. However, our understanding of the pathophysiology of rcTBI is less advanced than for more severe brain injuries. Most prominently, the mechanisms underlying traumatic axonal injury, microglial activation, amyloid-beta accumulation, and progressive tau pathology are not yet known. In addition, the role of injury to dendritic spine cytoskeletal structures, vascular reactivity impairments, and microthrombi are intriguing and subjects of ongoing inquiry. Methods for quantitative analysis of axonal injury, dendritic injury, and synaptic loss need to be refined for the field to move forward in a rigorous fashion. We and others are attempting to develop translational approaches to assess these specific pathophysiological events in both animals and humans to facilitate clinically relevant pharmacodynamic assessments of candidate therapeutics. In this article, we review and discuss several of the recent experimental results from our lab and others. We include new initial data describing the difficulty in modeling progressive tau pathology in experimental rcTBI, and results demonstrating that sertraline can alleviate social interaction deficits and depressive-like behaviors following experimental rcTBI plus foot shock stress. Furthermore, we propose a discrete set of open, experimentally tractable questions that may serve as a framework for future investigations. In addition, we also raise several important questions that are less experimentally tractable at this time, in hopes that they may stimulate future methodological developments to address them. This article is part of a Special Issue entitled "Traumatic Brain Injury". (C) 2015 Elsevier Inc All rights reserved.	[Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Hope Ctr Neurol Disorders, St Louis, MO USA		Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu	Bennett, Rachel/AAU-6949-2020	Bennett, Rachel/0000-0001-9640-0575	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065069] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS065069] Funding Source: Medline		Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bennett RE, 2014, J NEUROTRAUM, V31, P1647, DOI 10.1089/neu.2013.3320; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Conte V, 2004, J NEUROCHEM, V90, P758, DOI 10.1111/j.1471-4159.2004.02560.x; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Kleffner I, 2008, STROKE, V39, P1333, DOI 10.1161/STROKEAHA.107.500785; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lasagna-Reeves CA, 2011, CURR ALZHEIMER RES, V8, P659; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Opdal SH, 2010, PEDIATR RES, V68, P48, DOI [10.1203/PDR.0b013e3181df4e7c, 10.1203/00006450-201011001-00091]; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Sorani MD, 2008, HUM MOL GENET, V17, P2379, DOI 10.1093/hmg/ddn138; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960	63	36	37	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	MAY	2015	66		B		SI		91	98		10.1016/j.mcn.2015.02.005			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK7FT	WOS:000356398900004	25684677	Green Accepted			2022-02-06	
J	Goddeyne, C; Nichols, J; Wu, C; Anderson, T				Goddeyne, Corey; Nichols, Joshua; Wu, Chen; Anderson, Trent			Repetitive mild traumatic brain injury induces ventriculomegaly and cortical thinning in juvenile rats	JOURNAL OF NEUROPHYSIOLOGY			English	Article						concussion; electrophysiology; MRI; pediatrics; traumatic brain injury	COLLEGIATE FOOTBALL PLAYERS; MOTOR CORTEX; HIGH-SCHOOL; LONG-TERM; PROFESSIONAL FOOTBALL; ANIMAL-MODELS; MOUSE MODEL; NEUROPSYCHOLOGICAL OUTCOMES; RECURRENT CONCUSSION; CELLULAR MECHANISMS	Traumatic brain injury (TBI) most frequently occurs in pediatric patients and remains a leading cause of childhood death and disability. Mild TBI (mTBI) accounts for nearly 75% of all TBI cases, yet its neuropathophysiology is still poorly understood. While even a single mTBI injury can lead to persistent deficits, repeat injuries increase the severity and duration of both acute symptoms and long-term deficits. In this study, to model pediatric repetitive mTBI (rmTBI) we subjected unrestrained juvenile animals (postnatal day 20) to repeat weight-drop impacts. Animals were anesthetized and subjected to sham injury or rmTBI once per day for 5 days. Magnetic resonance imaging (MRI) performed 14 days after injury revealed marked cortical atrophy and ventriculomegaly in rmTBI animals. Specifically, beneath the impact zone the thickness of the cortex was reduced by up to 46% and the area of the ventricles increased by up to 970%. Immunostaining with the neuron-specific marker NeuN revealed an overall loss of neurons within the motor cortex but no change in neuronal density. Examination of intrinsic and synaptic properties of layer II/III pyramidal neurons revealed no significant difference between sham-injured and rmTBI animals at rest or under convulsant challenge with the potassium channel blocker 4-aminopyridine. Overall, our findings indicate that the neuropathological changes reported after pediatric rmTBI can be effectively modeled by repeat weight drop in juvenile animals. Developing a better understanding of how rmTBI alters the pediatric brain may help improve patient care and direct "return to game" decision making in adolescents.	[Goddeyne, Corey; Nichols, Joshua; Wu, Chen; Anderson, Trent] Univ Arizona, Coll Med Phoenix, Phoenix, AZ 85004 USA; [Goddeyne, Corey; Nichols, Joshua] Arizona State Univ, Sch Life Sci, Tempe, AZ USA		Anderson, T (corresponding author), Univ Arizona, Coll Med Phoenix, 425 N 5th St, Phoenix, AZ 85004 USA.	andersot@email.arizona.edu			University of Arizona College of Medicine-Phoenix; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087031] Funding Source: NIH RePORTER	Support for this project was provided by the University of Arizona College of Medicine-Phoenix.	Adelson PD, 1999, EXP TOXICOL PATHOL, V51, P130; Akbik FV, 2013, NEURON, V77, P859, DOI 10.1016/j.neuron.2012.12.027; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Anderson TR, 2010, J PHYSIOL-LONDON, V588, P4401, DOI 10.1113/jphysiol.2010.191858; Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Boudkkazi S, 2011, J PHYSIOL-LONDON, V589, P1117, DOI 10.1113/jphysiol.2010.199653; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BUCKLE PJ, 1982, J PHYSIOL-LONDON, V326, P109, DOI 10.1113/jphysiol.1982.sp014180; Bush PC, 1999, J NEUROPHYSIOL, V82, P1748, DOI 10.1152/jn.1999.82.4.1748; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Faul MXL., 2010, TRAUMATIC BRAIN INJU, P2002; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; FRIEDMAN WJ, 1991, EUR J NEUROSCI, V3, P688, DOI 10.1111/j.1460-9568.1991.tb00854.x; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Giza CC, 2006, INDIAN J NEUROTRAUM, V3, P19; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gregg CT, 2001, EXPTL BIOL REV, P1; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; GUATTEO E, 1994, NEUROSCI LETT, V175, P117, DOI 10.1016/0304-3940(94)91093-6; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Higgs MH, 2011, J PHYSIOL-LONDON, V589, P5125, DOI 10.1113/jphysiol.2011.216721; Holbourn AHS, 1943, LANCET, V2, P438; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; INSEL TR, 1990, NEUROSCIENCE, V35, P31, DOI 10.1016/0306-4522(90)90117-M; Iremonger KJ, 2006, J NEUROPHYSIOL, V96, P613, DOI 10.1152/jn.00105.2006; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402; Kolb Bryan, 2011, J Can Acad Child Adolesc Psychiatry, V20, P265; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li HL, 2011, J NEUROPHYSIOL, V105, P1963, DOI 10.1152/jn.01104.2010; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Minino AM, 2006, NATL VITAL STAT REP, V54, P1; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Ommaya A.K., 1967, 11 STAPP CAR CRASH C, DOI [10.4271/670906, DOI 10.4271/670906]; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prince D A, 1986, Adv Neurol, V44, P275; Prinz A, 2013, EXP NEUROL, V248, P236, DOI 10.1016/j.expneurol.2013.06.015; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Selemon LD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.7; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; van Zundert B, 2012, J CELL BIOCHEM, V113, P3301, DOI 10.1002/jcb.24234; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang L, 2007, J NEUROPHYSIOL, V97, P178, DOI 10.1152/jn.01374.2005; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Zecharia AY, 2012, J NEUROSCI, V32, P13062, DOI 10.1523/JNEUROSCI.2931-12.2012; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	112	36	36	0	18	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	MAY 1	2015	113	9					3268	3280		10.1152/jn.00970.2014			13	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	CL1LM	WOS:000356704800022	25695652	Green Submitted, Green Published			2022-02-06	
J	Liu, H; Wang, WM; Cheng, F; Yuan, Q; Yang, J; Hu, J; Ren, GH				Liu, Hua; Wang, Wenming; Cheng, Feng; Yuan, Qiang; Yang, Jian; Hu, Jin; Ren, Guanghui			External Ventricular Drains versus Intraparenchymal Intracranial Pressure Monitors in Traumatic Brain Injury: A Prospective Observational Study	WORLD NEUROSURGERY			English	Article						Intracranial pressure monitoring type; Neurological outcome; Traumatic brain injury	GUIDELINES; MANAGEMENT; PLACEMENT; OUTCOMES; CARE	BACKGROUND: Intracranial pressure (ICP) monitoring is the standard of care for patients with traumatic brain injury (TBI) and is used frequently. However, the efficacy of treatment based on the type of ICP monitor used for improving patient outcome has not been assessed prospectively. This study explores whether the type of ICP monitoring device used affects the neurologic outcomes of patients with TBI. METHODS: A prospective, observational study was conducted in 122 patients with TBI >= 13 years old with indications for monitoring who were being treated in neurosurgical intensive care units between January 2009 and December 2012. All enrolled patients required monitoring randomly using an external ventricular drain (EVD) or intraparenchymal fiberoptic monitor (IPM). Patients were placed into 2 groups depending on the type of monitoring device. Clinically relevant outcomes, refractory intracranial hypertension, survival rates, and devicerelated complications were compared between the 2 groups. RESULTS: There was a significant between-group difference in the Glasgow Outcome Scale score 6 months after injury, which was the primary outcome. Refractory intracranial hypertension was diagnosed in 44 of 122 patients, and patients monitored using IPM had a higher percentage of refractory intracranial hypertension (51.7% vs. 21.0%, P < 0.001). The 1-month survival rate was 90.3% in the EVD group and 76.7% in the IPM group (log-rank test, P = 0.04), and patients managed with EVDs had a significantly higher 6-month postinjury survival rate compared with patients treated with IPMs (88.7% vs. 68.3%, log-rank test, P = 0.006). There was no statistically significant difference between the groups in device-related complications (P = 0.448). CONCLUSIONS: Device selection for ICP monitoring provides prognostic discrimination, and use of EVDs may have a bigger advantage in controlling refractory intracranial hypertension. Based on our findings, we recommend routine placement of an EVD in patients with TBI, unless only parenchymal-type monitoring is available.	[Liu, Hua; Wang, Wenming; Cheng, Feng; Yang, Jian; Ren, Guanghui] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China; [Yuan, Qiang; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China		Liu, H (corresponding author), Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China.	wacilii@163.com					Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Camacho EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050708; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Guyot LL, 1998, ACT NEUR S, V71, P47; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Khan SH, 1998, ACT NEUR S, V71, P50; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; NORTH B, 1986, NEUROSURGERY, V18, P730, DOI 10.1227/00006123-198606000-00009; O'Neill BR, 2008, SURG NEUROL, V70, P268, DOI 10.1016/j.surneu.2007.05.007; Park YG, 2011, J KOREAN NEUROSURG S, V50, P317, DOI 10.3340/jkns.2011.50.4.317; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; TEASDALE G, 1974, LANCET, V2, P81; van Mourik MSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022846; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	23	36	39	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2015	83	5					794	800		10.1016/j.wneu.2014.12.040			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CI2FS	WOS:000354561500034	25541084				2022-02-06	
J	Purushothurnan, S; Johnstone, DM; Nandasena, C; van Eersel, J; Ittner, LM; Mitrofanis, J; Stone, J				Purushothurnan, Sivaraman; Johnstone, Daniel M.; Nandasena, Charith; van Eersel, Janet; Ittner, Lars M.; Mitrofanis, John; Stone, Jonathan			Near infrared light mitigates cerebellar pathology in transgenic mouse models of dementia	NEUROSCIENCE LETTERS			English	Article							LEVEL LASER THERAPY; MIDBRAIN DOPAMINERGIC CELLS; TERM NEUROLOGICAL DEFICITS; TRAUMATIC BRAIN-INJURY; MPTP-TREATED MICE; ALZHEIMERS-DISEASE; PHOTOBIOMODULATION; DEPOSITION; SURVIVAL; NEUROPROTECTION		[Purushothurnan, Sivaraman; Johnstone, Daniel M.; Nandasena, Charith; Mitrofanis, John; Stone, Jonathan] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Purushothurnan, Sivaraman; Johnstone, Daniel M.; Nandasena, Charith; Stone, Jonathan] Univ Sydney, Discipline Physiol, Sydney, NSW 2006, Australia; [Purushothurnan, Sivaraman; Johnstone, Daniel M.; Nandasena, Charith; Stone, Jonathan] Univ Sydney, Save Sight Inst, Sydney, NSW 2000, Australia; [Purushothurnan, Sivaraman; Johnstone, Daniel M.; Nandasena, Charith; Stone, Jonathan] Univ Sydney, Clin Ophthalmol, Sydney, NSW 2000, Australia; [Purushothurnan, Sivaraman; Johnstone, Daniel M.; Nandasena, Charith; Stone, Jonathan] Sydney Eye Hosp, Sydney, NSW 2000, Australia; [van Eersel, Janet; Ittner, Lars M.] Univ New S Wales, Sch Med Sci, Dementia Res Unit, Sydney, NSW 2052, Australia; [Ittner, Lars M.] Neurosci Res Australia, Sydney, NSW 2031, Australia; [Mitrofanis, John] Univ Sydney, Discipline Anat & Histol, Sydney, NSW 2006, Australia		Johnstone, DM (corresponding author), Univ Sydney, Discipline Physiol, Anderson Stuart Bldg F13, Sydney, NSW 2006, Australia.	Daniel.Johnstone@sydney.edu.au	Johnstone, Daniel/E-9929-2013; van Eersel, Janet/AAZ-4197-2020	Johnstone, Daniel/0000-0003-2876-3299; van Eersel, Janet/0000-0002-1354-6171; Ittner, Lars/0000-0001-6738-3825; Purushothuman, Sivaraman/0000-0002-0880-5060			Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BRAAK H, 1989, J NEUROL SCI, V93, P277, DOI 10.1016/0022-510X(89)90197-4; Bruck W, 1997, ANN NEUROL, V42, P783, DOI 10.1002/ana.410420515; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Franklin K., 2007, MOUSE BRAIN STEREOTA, VThird; Grillo SL, 2013, J PHOTOCH PHOTOBIO B, V123, P13, DOI 10.1016/j.jphotobiol.2013.02.015; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ivandic BT, 2008, PHOTOMED LASER SURG, V26, P241, DOI 10.1089/pho.2007.2132; JOACHIM CL, 1989, AM J PATHOL, V135, P309; Johnstone DM, 2014, NEUROSCIENCE, V274, P93, DOI 10.1016/j.neuroscience.2014.05.023; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; Moro C, 2014, J NEUROSURG, V120, P670, DOI 10.3171/2013.9.JNS13423; Moro C, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-40; Natoli R, 2010, MOL VIS, V16, P1801; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Peoples C, 2012, PARKINSONISM RELAT D, V18, P469, DOI 10.1016/j.parkreldis.2012.01.005; Purushothuman S, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt232; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; Shaw VE, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/296875; Shaw VE, 2010, J COMP NEUROL, V518, P25, DOI 10.1002/cne.22207; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Tuby H, 2013, PHOTOMED LASER SURG, V31, P269, DOI 10.1089/pho.2012.3395; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Wallace BA, 2007, BRAIN, V130, P2129, DOI 10.1093/brain/awm137; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xuan WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053454; Yan Q, 2003, J NEUROSCI, V23, P7504	32	36	37	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 30	2015	591						155	159		10.1016/j.neulet.2015.02.037			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4FO	WOS:000351786700029	25703226				2022-02-06	
J	Yerry, JA; Kuehn, D; Finkel, AG				Yerry, Juanita A.; Kuehn, Devon; Finkel, Alan G.			Onabotulinum Toxin A for the Treatment of Headache in Service Members With a History of Mild Traumatic Brain Injury: A Cohort Study	HEADACHE			English	Article						traumatic brain injury; botulinum toxin; military; headache; migraine; chronic migraine	CHRONIC POSTTRAUMATIC HEADACHES; BOTULINUM TOXIN; CHRONIC MIGRAINE; DOUBLE-BLIND; US SOLDIERS; PROPHYLACTIC TREATMENT; CERVICOGENIC HEADACHE; INTERNATIONAL BURDEN; STRESS-DISORDER; PREVALENCE	ObjectivePost-traumatic headache (PTH) of the migraine type is a common complication of mild traumatic brain injury (including blast injuries) in active duty service members. Persistent and near-daily headache occur. Usual preventive medications may have unacceptable side effects. Anecdotal reports suggest that onabotulinum toxin A (OBA) might be an effective treatment in these patients. MethodsThis study is a real-time retrospective consecutive case series of all patients treated with OBA at the Concussion Care Clinic of Womack Army Medical Center, Ft. Bragg, NC, between August 2008 and August 2012. Clinical treatment and pharmacy records were corroborated with the electronic medical records in the Armed Forces Health Longitudinal Technology Application to determine demographics, current headache and treatment characteristics, and clinical and occupational outcomes. ResultsSixty-four subjects (63 male) with mean age of 31.3 +/- 7.5 (range 20-59) years were evaluated and treated. Blast injuries were most common (n=36; 56.3%) and 7 patients (11%) reported a prior history of headache. Most patients (36; 56.3%) described more than 1 headache type and 48 (75%) patients had continuous pain. The most prevalent treating diagnosis was mixed continuous headache with migraine features on more than 15 days per month (n=26; 40.6%). The mean time from injury to the first injections was 10.8 +/- 21.9 (1-96) months. Forty (62.5%) patients received the Food and Drug Administration-approved chronic migraine injection protocol. Forty-one (64%) patients reported being better. Two patients discontinued for side effects. Twenty-seven (41%) remained on active duty. ConclusionsWe demonstrate that active duty military patients with headaches related to concussions may benefit from treatment with OBA. Further studies are indicated.	[Yerry, Juanita A.; Kuehn, Devon; Finkel, Alan G.] Womack Army Med Ctr, Dept Brain Injury Med, Ft Bragg, NC USA; [Finkel, Alan G.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Finkel, Alan G.] Carolina Headache Inst, Chapel Hill, NC USA		Finkel, AG (corresponding author), Carolina Headache Inst, Headache Med, 6114 Fayetteville Rd, Durham, NC 27713 USA.	finkela@chi09.com			Defense and Veteran Brain Injury Centers	One of the authors (AF) received salary support from the Defense and Veteran Brain Injury Centers in the conduct of this study and preparation of the manuscript. The views expressed herein are those of the presenters and do not reflect the official policy of the Department of the Army, Department of Defense, or the U.S. Government.	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2013, MSMR, V20, P9; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Becker WJ, 2011, CEPHALALGIA, V31, P979, DOI 10.1177/0333102411410086; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2011, CLIN NEUROPSYCHOL, V1, P1; Bloudek LM, 2012, J HEADACHE PAIN, V13, P361, DOI 10.1007/s10194-012-0460-7; Blumenfeld AM, 2011, CEPHALALGIA, V31, P301, DOI 10.1177/0333102410381145; Bryan CJ, 2011, HEADACHE, V51, P945, DOI 10.1111/j.1526-4610.2011.01887.x; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; Diener HC, 2010, CEPHALALGIA, V30, P804, DOI 10.1177/0333102410364677; Diener HC, 2012, NAT REV NEUROL, V8, P162, DOI 10.1038/nrneurol.2012.13; Dusitanond P, 2008, HEADACHE, V48, P1379, DOI 10.1111/j.1526-4610.2008.01245.x; Emanuelson I, 2009, BRAIN INJURY, V23, P612, DOI 10.1080/02699050902973913; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Eross EJ, 2005, HEADACHE, V45, P308, DOI 10.1111/j.1526-4610.2005.05067.x; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; Finkel AG, 2011, HEADACHE, V51, P1565, DOI 10.1111/j.1526-4610.2011.02021.x; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; He MW, 2009, CHINESE MED J-PEKING, V122, P427, DOI 10.3760/cma.j.issn.0366-6999.2009.04.0013; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2010, ARCH PHYS MED REHAB, V91, P963, DOI 10.1016/j.apmr.2010.02.005; International Headache Society, 2004, CEPHALALGIA S1, V24, P86; Kapural Leonardo, 2007, Pain Pract, V7, P337, DOI 10.1111/j.1533-2500.2007.00150.x; Kosaras B, 2009, J COMP NEUROL, V515, P331, DOI 10.1002/cne.22049; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Linde M, 2011, CEPHALALGIA, V31, P797, DOI 10.1177/0333102411398402; Lippert-Gruner M, 2012, NEUROL NEUROCHIR POL, V46, P591, DOI 10.5114/ninp.2012.32109; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Mathew NT, 2008, HEADACHE, V48, P442, DOI 10.1111/j.1526-4610.2007.00960.x; Mathew NT, 2005, HEADACHE, V45, P293, DOI 10.1111/j.1526-4610.2005.05066.x; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Moon J, 2010, CEPHALALGIA, V30, P1527, DOI 10.1177/0333102410368445; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Negro A, 2011, EUR REV MED PHARMACO, V15, P1401; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Rapp PE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00091; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Scher AI, 2011, 63 ANN M AM AC NEUR; Scher AI, 2014, CEPHALALGIA, V34, P83, DOI 10.1177/0333102413499644; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Serrano D, 2013, VALUE HEALTH, V16, P31, DOI 10.1016/j.jval.2012.08.2212; Silberstein SD, 2006, CEPHALALGIA, V26, P790, DOI 10.1111/j.1468-2982.2006.01114.x; Smitherman TA, 2013, HEADACHE, V53, P427, DOI 10.1111/head.12074; Sycha T, 2004, J NEUROL, V251, P19, DOI 10.1007/s00415-004-1106-8; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Theeler BJ, 2012, CEPHALALGIA, V32, P589, DOI 10.1177/0333102412445220; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vargas BB, 2009, CURR PAIN HEADACHE R, V13, P64, DOI 10.1007/s11916-009-0013-1; Walcott BP, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wilson J, 2009, AM J EPIDEMIOL, V169, P1362, DOI 10.1093/aje/kwp044; Yamazaki Y, 2011, J HEADACHE PAIN, V12, P661, DOI 10.1007/s10194-011-0382-9; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	71	36	36	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	MAR	2015	55	3					395	406		10.1111/head.12495			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CD6AS	WOS:000351171200004	25644249				2022-02-06	
J	Vaccari, JCD; Brand, FJ; Berti, AF; Alonso, OF; Bullock, MR; Vaccari, JPD				Vaccari, Juan Carlos de Rivero; Brand, Frank J., III; Berti, Aldo F.; Alonso, Ofelia F.; Bullock, M. Ross; Vaccari, Juan Pablo de Rivero			Mincle Signaling in the Innate Immune Response after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						innate immunity; neuroinflammation; traumatic brain injury; mincle; neurons	TUMOR-NECROSIS-FACTOR; CLOSED-HEAD INJURY; NEURONAL CELL-DEATH; TOLL-LIKE RECEPTORS; SPINAL-CORD-INJURY; FACTOR-ALPHA; RAT-BRAIN; KAPPA-B; TNF; INFLAMMASOME	The innate immune response contributes to the inflammatory activity after traumatic brain injury (TBI). In the present study we identify macrophage-inducible C-type lectin (mincle) as a pattern recognition receptor that contributes to innate immunity in neurons after TBI. Here we report that mincle is activated by SAP130 in cortical neurons in culture, resulting in production of the inflammatory cytokine TNF. In addition, mincle and SAP130 are elevated in the brain and cerebrospinal fluid of humans after TBI and the brain of rodents after fluid percussion brain injury. Thus, these findings suggest the involvement of mincle to the pathology of TBI. Importantly, blocking mincle with a neutralizing antibody against mincle in cortical neurons in culture treated with SAP130 resulted in inhibition of mincle signaling and decreased TNF production. Therefore, our findings identify mincle as a contributor to the inflammatory response after TBI.	[Vaccari, Juan Carlos de Rivero] Louisiana State Univ, Ochsner Med Ctr, Sch Med, Dept Ophthalmol, New Orleans, LA USA; [Brand, Frank J., III; Berti, Aldo F.; Alonso, Ofelia F.; Bullock, M. Ross; Vaccari, Juan Pablo de Rivero] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA		Vaccari, JPD (corresponding author), Lois Pope LIFE Ctr, Dept Neurol Surg, 1095 NW 14th Terrace,3-25, Miami, FL 33136 USA.	JdeRivero@med.miami.edu	de Rivero Vaccari, Juan Pablo/ABE-3248-2020; de Rivero Vaccari, Juan Pablo/H-5718-2019	de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834; 	Miami Project to Cure Paralysis	This project was supported by The Miami Project to Cure Paralysis.	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Adamczak SE, 2012, THESIS; Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Breen K, 2012, REPROD SCI, V19, P839, DOI 10.1177/1933719112438439; Cambi A, 2009, CURR BIOL, V19, pR375, DOI 10.1016/j.cub.2009.03.032; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Dubyak GR, 2012, CELL MICROBIOL, V14, P1697, DOI 10.1111/cmi.12001; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Kaltsonoudis E, 2014, AUTOIMMUN REV, V13, P54, DOI 10.1016/j.autrev.2013.09.002; Leung PY, 2012, STROKE, V43, P1383, DOI 10.1161/STROKEAHA.111.641522; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Matsunaga I, 2009, J EXP MED, V206, P2865, DOI 10.1084/jem.20092533; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Menon Suchithra, 2008, BMC Biochemistry, V9, P1, DOI 10.1186/1471-2091-9-1; Moots RJ, 2012, RHEUMATOLOGY, V51, P2252, DOI 10.1093/rheumatology/kes217; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; Schwenzer R, 1999, J BIOL CHEM, V274, P19368, DOI 10.1074/jbc.274.27.19368; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Sholkina Margarita N, 2002, Russ J Immunol, V7, P365; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sriram K, 2007, J NEUROIMMUNE PHARM, V2, P140, DOI 10.1007/s11481-007-9070-6; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stocker BL, 2014, CHEMBIOCHEM, V15, P382, DOI 10.1002/cbic.201300674; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2012, DERMATOL SURG, V38, P1033, DOI 10.1111/j.1524-4725.2012.02378.x; Vaccari JPD, 2012, J NEUROSCI, V32, P3058, DOI 10.1523/JNEUROSCI.4930-11.2012; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wang YC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-134; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yu WH, 2012, PHYTOTHER RES, V26, P1838, DOI 10.1002/ptr.4662; Zhang ZR, 2012, NEUROIMMUNOMODULAT, V19, P10, DOI 10.1159/000326771	47	36	37	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2015	32	4					228	236		10.1089/neu.2014.3436			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CB0KN	WOS:000349314900003	25111533				2022-02-06	
J	Briggs, A; Gates, JD; Kaufman, RM; Calahan, C; Gormley, WB; Havens, JM				Briggs, Alexandra; Gates, Jonathan D.; Kaufman, Richard M.; Calahan, Christopher; Gormley, William B.; Havens, Joaquim M.			Platelet dysfunction and platelet transfusion in traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Aspirin; Platelet transfusion; Multiplate aggregometry	INTRACRANIAL HEMORRHAGE; ANTIPLATELET THERAPY; COAGULOPATHY; CLOPIDOGREL; ACTIVATION; ASPIRIN; REVERSAL; MODEL	Background: Both aspirin therapy and trauma impair platelet function. Platelet dysfunction is associated with worse outcomes in patients with traumatic intracranial hemorrhage (ICH). Platelet transfusion is often used to limit progression of ICH in patients on aspirin, but has not been shown to improve platelet function or outcomes. We hypothesized that platelet transfusion would improve aspirin-induced, but not trauma-induced, platelet dysfunction. Materials and methods: In this prospective trial, blood samples were collected from patients evaluated in our level 1 trauma center with traumatic ICH, at the time of arrival and at the next clinical laboratory draw after admission. Patients on aspirin therapy were transfused one apheresis unit of platelets. Platelet function was assessed using a Multiplate multiple electrode aggregometer. Platelet activation was induced by collagen (COL) and arachidonic acid (AA). Agonist responses are reported as area under the aggregation curve in units (U). Reference ranges for agonist response were provided by the manufacturer, based on studies of healthy controls. Results: Seventeen patients with isolated ICH were enrolled, twelve taking aspirin and five not taking aspirin. All patients on aspirin received platelet transfusion. Median admission platelet function in patients taking aspirin was abnormal in response to both agonists. After transfusion, median platelet function in response to AA improved from 19.0 U to 26.0 U (P = 0.012), whereas there was no improvement in the COL response. In patients not on aspirin, platelet response to COL was abnormal at both time points. Conclusions: Patients with isolated ICH have trauma-induced platelet dysfunction. In addition, patients on aspirin have drug-induced abnormalities in platelet response to AA. Platelet transfusion improves aspirin-induced, but not trauma-induced, platelet dysfunction. (C) 2015 Elsevier Inc. All rights reserved.	[Briggs, Alexandra; Gates, Jonathan D.; Kaufman, Richard M.; Calahan, Christopher; Gormley, William B.; Havens, Joaquim M.] Brigham & Womens Hosp, Boston, MA 02115 USA		Havens, JM (corresponding author), Brigham & Womens Hosp, Div Trauma Burn & Surg Crit Care, 75 Francis St, Boston, MA 02115 USA.	jhavens@partners.org	Kaufman, Richard M/E-8890-2018	Kaufman, Richard M/0000-0003-1520-4535; Calahan, Christopher/0000-0002-9631-8966			Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Campbell PG, 2010, WORLD NEUROSURG, V74, P279, DOI 10.1016/j.wneu.2010.05.030; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; Farndale RW, 2006, BLOOD CELL MOL DIS, V36, P162, DOI 10.1016/j.bcmd.2005.12.016; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Surin WR, 2008, THROMB RES, V122, P786, DOI 10.1016/j.thromres.2007.10.005; Taylor G, 2013, J TRAUMA ACUTE CARE, V74, P1367, DOI 10.1097/TA.0b013e31828cca61; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	16	36	38	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2015	193	2					802	806		10.1016/j.jss.2014.08.016			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AW4IK	WOS:000346244300039	25218281				2022-02-06	
J	Sheriff, FG; Hinson, HE				Sheriff, Faheem G.; Hinson, Holly E.			Pathophysiology and Clinical Management of Moderate and Severe Traumatic Brain Injury in the ICU	SEMINARS IN NEUROLOGY			English	Article						severe traumatic brain injury; pathophysiology; multimodality monitoring; intensive care unit	CEREBRAL PERFUSION-PRESSURE; PAROXYSMAL SYMPATHETIC HYPERACTIVITY; WHITE-MATTER INJURY; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; TISSUE OXYGEN; DECOMPRESSIVE CRANIECTOMY; THERAPEUTIC HYPOTHERMIA; RISK-FACTORS; 4 SCORE	Moderate and severe traumatic brain injury (TBI) is the leading cause of morbidity and mortality among young individuals in high-income countries. Its pathophysiology is divided into two major phases: the initial neuronal injury (or primary injury) followed by secondary insults (secondary injury). Multimodality monitoring now offers neurointensivists the ability to monitor multiple physiologic parameters that act as surrogates of brain ischemia and hypoxia, the major driving forces behind secondary brain injury. The heterogeneity of the pathophysiology of TBI makes it necessary to take into consideration these interacting physiologic factors when recommending for or against any therapies; it may also account for the failure of all the neuroprotective therapies studied so far. In this review, the authors focus on neuroclinicians and neurointensivists, and discuss the developments in therapeutic strategies aimed at optimizing intracranial pressure and cerebral perfusion pressure, and minimizing cerebral hypoxia. The management of moderate to severe TBI in the intensive care unit is moving away from a pure "threshold-based" treatment approach toward consideration of patient-specific characteristics, including the state of cerebral autoregulation. The authors also include a concise discussion on the management of medical and neurologic complications peculiar to TBI as well as an overview of prognostication.	[Sheriff, Faheem G.; Hinson, Holly E.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR USA; [Hinson, Holly E.] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR USA		Hinson, HE (corresponding author), 3181 SW Sam Jackson Pk Rd,CR-127, Portland, OR 97239 USA.	hinson@ohsu.edu	Hinson, Holly/Q-2268-2019; Sheriff, Faheem/ABH-2434-2020	Hinson, Holly/0000-0003-1598-9782; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12HL108974] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K12 HL108974] Funding Source: Medline		Adamides AA, 2009, J AM COLL SURGEONS, V209, P531, DOI 10.1016/j.jamcollsurg.2009.05.028; Alyagari V, 2007, J NEUROL SCI, V261, P39, DOI 10.1016/j.jns.2007.04.030; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bohman LE, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0392-x; Bouzat P, 2013, ANN FR ANESTH, V32, P787, DOI 10.1016/j.annfar.2013.09.004; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; JENNETT B, 1976, LANCET, V1, P1031; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Kirmani BF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00170; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Le Roux P, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0331-2; Li J, 2012, J NEUROTRAUM, V29, P96, DOI 10.1089/neu.2011.1753; Ling Geoffrey S F, 2010, Continuum (Minneap Minn), V16, P27, DOI 10.1212/01.CON.0000391451.30299.bc; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, NEUROSURGERY, P1173; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Mangat Halinder S, 2012, Continuum (Minneap Minn), V18, P532, DOI 10.1212/01.CON.0000415426.76524.e1; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nakamura A, 1995, No To Shinkei, V47, P1170; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Oddo Mauro, 2009, Rev Med Suisse, V5, P2506; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Purins K, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00064; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salim A, 2009, AM SURGEON, V75, P25; Santarsieri M, 2014, BRAIN BEHAV IMMUN; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; Shahlaie K, 2009, NEUROCRIT CARE, V10, P61, DOI 10.1007/s12028-008-9138-z; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Wijdicks EFM, 2011, NEUROLOGY, V77, P84, DOI 10.1212/WNL.0b013e318220ac06	77	36	39	0	11	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					42	49		10.1055/s-0035-1544238			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC4AP	WOS:000350293300007	25714866	Green Accepted			2022-02-06	
J	DeRight, J; Jorgensen, RS				DeRight, Jonathan; Jorgensen, Randall S.			I Just Want My Research Credit: Frequency of Suboptimal Effort in a Non-Clinical Healthy Undergraduate Sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						Performance validity testing; Effort testing.; College students	SYMPTOM VALIDITY TEST; CNS VITAL SIGNS; TEST-PERFORMANCE; BRAIN-DAMAGE; TEST BATTERY; IMPACT; TESTS; PARTICIPANTS; CONCUSSION; CHILDREN	Although performance validity testing is becoming fairly routine in clinical settings, research protocols involving neuropsychological tests infrequently include assessments of performance validity. The current study utilized an embedded measure of effort over two administrations of CNS Vital Signs to determine the frequency of poor effort in non-clinical healthy undergraduate students participating in a research study for course credit. Results indicate that more than 1 in 10 college students participating in a cognitive test battery for research showed test scores consistent with inadequate effort, which was associated with poor performance on testing across many domains. This conclusion was supported by poor performance on many other subtests. Healthy college students with suboptimal effort (n = 11) had an overall score in the 15th percentile on average compared to the 48th percentile in the rest of the students (n = 66). Those who failed validity indicators on the baseline administration were more likely to fail validity indicators on the repeat administration. Those who were tested in the morning were also more likely to fail validity indicators. The current study provides evidence for the potential limitations of conducting research using neuropsychological tests with healthy college student volunteers in the absence of performance validity testing. Revised college-level cutoffs are proposed.	[DeRight, Jonathan; Jorgensen, Randall S.] Syracuse Univ, Dept Psychol, Syracuse, NY USA		DeRight, J (corresponding author), 600 N Wolfe St,Meyer 218, Baltimore, MD 21287 USA.	jderight@gmail.com			CNS Vital Signs	We would like to thank CNS Vital Signs for allowing us to use their program for research. There were no conditions attached to the use of their program and we do not receive any financial compensation from CNS Vital Signs. We would also like to thank Paul Hoskinson for his work in adapting the Brain Workshop program to the specifications of our study.	An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Armistead-Jehle P, 2011, ARCH CLIN NEUROPSYCH, V26, P592, DOI 10.1093/arclin/acr049; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Boone K. B., 2002, DOT COUNTING TEST MA; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P422, DOI 10.1093/arclin/acu029; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P858, DOI 10.1093/arclin/acs087; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Delis D.C., 2000, CALIFORNIA VERBAL LE; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Forbey JD, 2013, ASSESSMENT, V20, P448, DOI 10.1177/1073191113478154; Forbey JD, 2011, J PERS ASSESS, V93, P556, DOI 10.1080/00223891.2011.608757; Green P, 2013, MILD TRAUMATIC BRAIN, P73; Green P., 2005, WORD MEMORY TEST WIN; Green P, 2004, GREENS MED SYMPTOM V; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Gualtieri C. T., 2008, INT C ALZH DIS CHIC; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Halstead W.C., 1947, BRAIN INTELLIGENCE; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoskinson P, 2009, BRAIN WORKSHOP DUAL; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Letz R, 2003, NEUROTOXICOLOGY, V24, P479, DOI 10.1016/S0161-813X(03)00047-0; Lovell M. R, 2004, IMPACT VERSION 2 0 C; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Santos OA, 2014, ARCH CLIN NEUROPSYCH, V29, P609, DOI 10.1093/arclin/acu039; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Silk-Eglit GM, 2014, ARCH CLIN NEUROPSYCH, V29, P415, DOI 10.1093/arclin/acu028; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Stanczak EM, 2000, ARCH CLIN NEUROPSYCH, V15, P587; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Wintre MG, 2001, CAN PSYCHOL, V42, P216; Wolfson, 1993, HALSTEAD REITAN NEUR	38	36	36	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2015	29	1					101	117		10.1080/13854046.2014.989267			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CC4CS	WOS:000350299000008	25494327				2022-02-06	
J	Czorlich, P; Skevas, C; Knospe, V; Vettorazzi, E; Richard, G; Wagenfeld, L; Westphal, M; Regelsberger, J				Czorlich, Patrick; Skevas, Christos; Knospe, Volker; Vettorazzi, Eik; Richard, Gisbert; Wagenfeld, Lars; Westphal, Manfred; Regelsberger, Jan			Terson syndrome in subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic brain injury	NEUROSURGICAL REVIEW			English	Article						Terson syndrome; Intraocular hemorrhage; Subarachnoid hemorrhage; Traumatic brain injury; Intracerebral hemorrhage	NERVE SHEATH HEMORRHAGE; 60 CONSECUTIVE PATIENTS; VITREOUS HEMORRHAGE; INTRAOCULAR HEMORRHAGES; INTRACRANIAL-PRESSURE; MOYAMOYA-DISEASE; VITRECTOMY; INJECTION; ANEURYSMS	This prospective trial was designed to evaluate the incidence of Terson syndrome in patients suffering from subarachnoid hemorrhage, intracerebral hemorrhage, or traumatic brain injury and whether consequences necessarily derive from the intraocular hemorrhage itself. Two ophthalmologic examinations were performed to identify patients with Terson syndrome. Data on initial Glasgow Coma Scale, Hunt and Hess and Fisher grades, aneurysm site and diameter, and volume of hemorrhage in intracerebral hemorrhage patients were correlated to the location and course of Terson syndrome. Follow-up was performed after 3 months, including clinical and ophthalmologic investigations. The data showed that 16 of 83 subarachnoid hemorrhage patients (19.3 %), 2 of 22 intracerebral hemorrhage patients (9.1 %), and 1 of 32 traumatic brain injury patients (3.1 %) suffered from Terson syndrome. Low Glasgow Coma Scale (p = 0.002), high Hunt and Hess grade (p < 0.001), and high Fisher grade (p = 0.002) were found to be associated with a higher incidence of Terson syndrome. The neurological outcome in subarachnoid hemorrhage patients suffering from Terson syndrome was worse compared with that of subarachnoid hemorrhage patients without Terson syndrome (p = 0.005), and vitrectomy was performed in seven eyes of six patients due to poor visual acuity. Terson syndrome is underestimated in patients with subarachnoid hemorrhage and a rare pathology in intracerebral hemorrhage as well as in traumatic brain injury patients. Spontaneous regression of the intraocular hemorrhage may be seen, but in half of the patients, vitrectomy is necessary to prevent permanent visual deterioration.	[Czorlich, Patrick; Westphal, Manfred; Regelsberger, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, D-20246 Hamburg, Germany; [Skevas, Christos; Knospe, Volker; Richard, Gisbert; Wagenfeld, Lars] Univ Med Ctr Hamburg Eppendorf, Dept Ophthalmol, D-20246 Hamburg, Germany; [Vettorazzi, Eik] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, D-20246 Hamburg, Germany		Czorlich, P (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Martinistr 52, D-20246 Hamburg, Germany.	p.czorlich@uke.de	Vettorazzi, Eik/B-8130-2019; Czorlich, Patrick/H-8934-2019	Vettorazzi, Eik/0000-0002-3737-6402; 			Arakawa Y, 2000, NEUROL MED-CHIR, V40, P480, DOI 10.2176/nmc.40.480; Augsten R, 2007, KLIN MONATSBL AUGENH, V224, P674, DOI 10.1055/s-2007-963325; Baker ML, 2008, J CLIN NEUROSCI, V15, P313, DOI 10.1016/j.jocn.2006.09.011; CASTREN JA, 1963, ACTA OPHTHALMOL, V41, P430; FAHMY JA, 1973, ACTA OPHTHALMOL, V51, P289; Fountas KN, 2008, J NEUROSURG, V109, P439, DOI 10.3171/JNS/2008/109/9/0439; Frizzel RT, 1997, NEUROSURGERY, V41, P33; Frizzell RT, 1997, NEUROSURGERY, V41, P529, DOI 10.1097/00006123-199709000-00004; GARFINKLE AM, 1992, J NEUROSURG, V76, P766, DOI 10.3171/jns.1992.76.5.0766; Gauntt CD, 2007, J NEURO-OPHTHALMOL, V27, P193, DOI 10.1097/WNO.0b013e31814b22dc; Gibran S, 2002, BRIT J OPHTHALMOL, V86, P353, DOI 10.1136/bjo.86.3.353; Hoving EW, 2009, J NEUROSURG, V110, P858, DOI 10.3171/2008.6.17610; Jr Hegdes TR, 1955, AMA ARCH OPHTHALMOL, V54, P425; Kim HS, 2012, J KOREAN NEUROSURG S, V51, P367, DOI 10.3340/jkns.2012.51.6.367; Kuhn F, 1998, OPHTHALMOLOGY, V105, P472, DOI 10.1016/S0161-6420(98)93030-5; Litten M., 1881, BERL KLIN WOCHENSCHR, V18, P23; MANSCHOT WA, 1954, AM J OPHTHALMOL, V38, P501, DOI 10.1016/0002-9394(54)90700-X; Medele RJ, 1998, J NEUROSURG, V88, P851, DOI 10.3171/jns.1998.88.5.0851; Mena OJ, 2011, AM J FOREN MED PATH, V32, P55, DOI 10.1097/PAF.0b013e3181edee5b; MULLER PJ, 1974, J NEUROSURG, V41, P160, DOI 10.3171/jns.1974.41.2.0160; Naseri A, 2001, NEUROLOGY, V57, P364, DOI 10.1212/WNL.57.2.364; Ogawa T, 2001, OPHTHALMOLOGY, V108, P1654, DOI 10.1016/S0161-6420(01)00673-X; Pfausler B, 1996, J NEUROSURG, V85, P392, DOI 10.3171/jns.1996.85.3.0392; SHAW HE, 1975, AM J OPHTHALMOL, V80, P207, DOI 10.1016/0002-9394(75)90134-8; SHAW HE, 1977, ANN OPHTHALMOL, V9, P1403; Stiebel-Kalish H, 2004, RETINA-J RET VIT DIS, V24, P36, DOI 10.1097/00006982-200402000-00006; Stienen MN, 2012, CLIN NEUROL NEUROSUR, V114, P535, DOI 10.1016/j.clineuro.2011.10.034; Sung W, 2011, ACTA OPHTHALMOL, V89, P544, DOI 10.1111/j.1755-3768.2009.01735.x; Swallow CE, 1998, AM J NEURORADIOL, V19, P743; Takkar A, 2013, NEUROLOGY, V81, pE40, DOI 10.1212/WNL.0b013e31829e6f13; Terson A, 1900, CLIN OPHTHALMOL, V6, P309; TOOSI SH, 1987, ANN OPHTHALMOL, V19, P7; VANDERLINDEN RG, 1974, J NEUROSURG, V41, P167, DOI 10.3171/jns.1974.41.2.0167; WALSH FB, 1951, AM J OPHTHALMOL, V34, P509, DOI 10.1016/0002-9394(51)90294-2; WEAVER RG, 1961, AM J OPHTHALMOL, V52, P257, DOI 10.1016/0002-9394(61)91122-9; Wietholter S, 1998, ZBL NEUROCHIR, V59, P166	36	36	38	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607	1437-2320		NEUROSURG REV	Neurosurg. Rev.	JAN	2015	38	1					129	136		10.1007/s10143-014-0564-4			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AX8MD	WOS:000347162600023	25173620				2022-02-06	
J	Glang, AE; Koester, MC; Chesnutt, JC; Gioia, GA; McAvoy, K; Marshall, S; Gau, JM				Glang, Ann E.; Koester, Michael C.; Chesnutt, James C.; Gioia, Gerard A.; McAvoy, Karen; Marshall, Sondra; Gau, Jeff M.			The Effectiveness of a Web-Based Resource in Improving Postconcussion Management in High Schools	JOURNAL OF ADOLESCENT HEALTH			English	Article						Concussion; High school; Web-based training; School-based health care	POSITIVE BEHAVIOR SUPPORT; CONCUSSION EDUCATION; SPORT; KNOWLEDGE; MISCONCEPTIONS; COACHES; INJURY; HEADS	Purpose: Because many sports concussions happen during school-sponsored sports events, most state concussion laws specifically hold schools accountable for coach training and effective concussion management practices. Brain 101: The Concussion Playbook is a Web-based intervention that includes training in sports concussion for each member of the school community, presents guidelines on creating a concussion management team, and includes strategies for supporting students in the classroom. Methods: The group randomized controlled trial examined the efficacy of Brain 101 in managing sports concussion. Participating high schools (N = 25) were randomly assigned to the Brain 101 intervention or control. Fall athletes and their parents completed online training, and Brain 101 school administrators were directed to create concussion management policy and procedures. Results: Student athletes and parents at Brain 101 schools significantly outperformed those at control schools on sports concussion knowledge, knowledge application, and behavioral intention to implement effective concussion management practices. Students who had concussions in Brain 101 schools received more varied academic accommodations than students in control schools. Conclusions: Brain 101 can help schools create a comprehensive schoolwide concussion management program. It requires minimal expenditures and offers engaging and effective education for teachers, coaches, parents, and students. (C) 2015 Society for Adolescent Health and Medicine. All rights reserved.	[Glang, Ann E.] Univ Oregon, Ctr Brain Injury Res & Training, Eugene, OR 97401 USA; [Glang, Ann E.] ORCAS, Eugene, OR USA; [Koester, Michael C.] Slocum Ctr Orthoped & Sports Med, Sports Concuss Program, Eugene, OR USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Gioia, Gerard A.] Childrens Natl Med Ctr, Rockville, MD USA; [McAvoy, Karen] Rocky Mt Hosp Children, Centennial, CO USA; [Marshall, Sondra] St Charles Hlth Syst, Bend, OR USA; [Gau, Jeff M.] Oregon Res Inst, Eugene, OR 97403 USA		Glang, AE (corresponding author), Univ Oregon, Ctr Brain Injury Res & Training, 99 W 10th St,Suite 370, Eugene, OR 97401 USA.	aglang@uoregon.edu		Glang, Ann/0000-0002-3057-1977	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD056610]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R43HD056610, R44HD056610] Funding Source: NIH RePORTER	This project was completed with funding from the National Institute of Child Health and Human Development (grant number HD056610).	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2011, BASIC APPL SOC PSYCH, V33, P101, DOI 10.1080/01973533.2011.568834; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; BECKER MH, 1974, HLTH ED MONOGR, V2, P342; *CDCP, 1996, TEENS HAZ WE FAC WOR; *CDCP, 2013, HEADS ONL TRAIN COUR; Centers for Disease Control and Prevention, 2010, PAR AR KEY SAF TEEN; *CHILDR SAF NETW, 2012, IMPLEMENTATION OF ST; Cohen R, 2007, J POSIT BEHAV INTERV, V9, P203, DOI 10.1177/10983007070090040301; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Handler MW, 2007, PSYCHOL SCHOOLS, V44, P29, DOI 10.1002/pits.20203; Institute of Medicine (IOM) and National Research Council (NRC), 2014, SPORTS REL CONC YOUT; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; McLeod TCV, 2013, J ATHL TRAINING, V48, P483, DOI 10.4085/1062-6050-48.4.04; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Murray D. M., 1998, DESIGN ANAL GROUP RA; *NAT FED STAT HIGH, 2010, CONC SPORTS ONL COUR; *NAT FOOTB LEAG, 2014, ZACK LYST LAW; National Athletic Trainers' Association, 2009, ATHL TRAIN FILL NEC; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P	39	36	36	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	JAN	2015	56	1					91	97		10.1016/j.jadohealth.2014.08.011			7	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	AW9OM	WOS:000346586900016	25438964	Green Accepted			2022-02-06	
J	Heidari, K; Asadollahi, S; Jamshidian, M; Abrishamchi, SN; Nouroozi, M				Heidari, Kamran; Asadollahi, Shadi; Jamshidian, Morteza; Abrishamchi, Shohreh Nasiri; Nouroozi, Mahdi			Prediction of neuropsychological outcome after mild traumatic brain injury using clinical parameters, serum S100B protein and findings on computed tomography	BRAIN INJURY			English	Article						Computed tomography; outcome; post-concussion syndrome; prognosis; S100 protein; traumatic brain injury	MINOR HEAD-INJURY; NEURON-SPECIFIC ENOLASE; POST-CONCUSSION SYMPTOMS; NEW-ORLEANS CRITERIA; BIOCHEMICAL MARKERS; S-100B PROTEIN; DAMAGE; MANAGEMENT; RULE	Primary objective: To identify if demographics, clinical and computed tomographic (CT) characteristics at first presentation and S100B concentrations at 3 and 6 hours after mild traumatic brain injury (MTBI) predict the development of post-concussion syndrome (PCS) after 1 month. Research design and methods: All consecutive MTBI patients (Glasgow Coma Scale [GCS] score 13-15) admitted to the Emergency Department aged older than 15 were included in this prospective, observational study. Outcome was assessed using a Rivermead Post-Concussion Symptoms Questionnaire to identify the patients with and without PCS 1 month after the injury. Main outcomes and results: A total of 176 patients with isolated MTBI were included in the study. After multivariate analysis of the demographics, clinical variables, and CT abnormalities, headache (OR = 2.09, 95% CI = 1.04-4.21, p = 0.038), seizure (OR = 5.64, 95% CI = 1.55-20.54, p = 0.009), the presence of subarachnoid haemorrhage on CT (OR = 3.67, 95% CI = 1.46-9.24, p = 0.006) and 6-hour S100B concentration (OR = 2.22, 95% CI = 1.15-4.28, p = 0.017) were independently significant predictors of the outcome. Conclusions: Outcome prediction using baseline characteristics (post-traumatic headache and seizure), CT and laboratory findings (6-hour S100B) were valuable factors for identification of the individual MTBI patient at risk for developing PCS 1 month after the injury.	[Heidari, Kamran] Shahid Beheshti Univ Med Sci, Loghman Hakim Hosp, Dept Emergency Med, Tehran, Iran; [Asadollahi, Shadi] Shahid Beheshti Univ Med Sci, Sch Med, Tehran, Iran; [Jamshidian, Morteza; Abrishamchi, Shohreh Nasiri; Nouroozi, Mahdi] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Dept Emergency Med, Tehran, Iran		Asadollahi, S (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Daneshju Blv,Chamran Hwy, Tehran, Iran.	asadollahi.shadi@yahoo.com	VAFAEI, ALI/AAU-9473-2021; Eley, Rob/A-8121-2011	VAFAEI, ALI/0000-0002-7129-6457; Eley, Rob/0000-0003-0856-4313; Sinnott, Michael/0000-0002-2338-3126	Sina Trauma; Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran (Iran)Tehran University of Medical Sciences	The authors thank the people who took part in this study. The study was financially supported by a grant from Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran (Iran).	*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P704; [Anonymous], 1999, JAMA, V282, P974; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Heizmann CW, 2007, FRONTIERS BIOSCIENCE, V7, P1356; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus J, 1996, NEUROTRAUMA, P13; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Meerhoff S R, 2000, Ned Tijdschr Geneeskd, V144, P1915; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Savola O, 2005, EUROPEAN J NEUROLOGY, V10, P175; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	40	36	37	1	18	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					33	40		10.3109/02699052.2014.948068			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000005	25207823				2022-02-06	
J	Khan, M; Dhammu, TS; Matsuda, F; Baarine, M; Dhindsa, TS; Singh, I; Singh, AK				Khan, Mushfiquddin; Dhammu, Tajinder S.; Matsuda, Fumiyo; Baarine, Mauhammad; Dhindsa, Tejbir Singh; Singh, Inderjit; Singh, Avtar K.			Promoting endothelial function by S-nitrosoglutathione through the HIF-1 alpha/VEGF pathway stimulates neurorepair and functional recovery following experimental stroke in rats	DRUG DESIGN DEVELOPMENT AND THERAPY			English	Article						GSNO; IR; HIF-1 alpha; VEGF; motor function; subtle behavior; neuroprotection; neurorepair; angiogenesis; S-nitrosylation; stroke	TRAUMATIC BRAIN-INJURY; INDUCIBLE FACTOR-I; NITRIC-OXIDE DONORS; CEREBRAL-ISCHEMIA; LIQUID-CHROMATOGRAPHY; COGNITIVE IMPAIRMENT; NEUROVASCULAR UNIT; PROTECTS BRAIN; CELL MIGRATION; ACTIVATION	Background: For stroke patients, stimulating neurorepair mechanisms is necessary to reduce morbidity and disability. Our previous studies on brain and spinal cord trauma show that exogenous treatment with the S-nitrosylating agent S-nitrosoglutathione (GSNO) - a nitric oxide and glutathione metabolite of the human body - stimulates neurorepair and aids functional recovery. Using a rat model of cerebral ischemia and reperfusion (IR) in this study, we tested the hypothesis that GSNO invokes the neurorepair process and improves neurobehavioral functions through the angiogenic HIF-1 alpha/VEGF pathway. Methods: Stroke was induced by middle cerebral artery occlusion for 60 minutes followed by reperfusion in adult male rats. The injured animals were treated with saline (IR group, n=7), GSNO (0.25 mg/kg, GSNO group, n=7), and GSNO plus the HIF-1 alpha inhibitor 2-methoxyestradiol (2-ME) (0.25 mg/kg GSNO + 5.0 mg/kg 2-ME, GSNO + 2-ME group, n=7). The groups were studied for either 7 or 14 days to determine neurorepair mediators and functional recovery. Brain capillary endothelial cells were used to show that GSNO promotes angiogenesis and that GSNO-mediated induction of VEGF and the stimulation of angiogenesis are dependent on HIF-1 alpha activity. Results: IR injury increased the expression of neurorepair mediators HIF-1 alpha, VEGF, and PECAM-1 and vessel markers to a limited degree that correlate well with significantly compromised neurobehavioral functions compared with sham animals. GSNO treatment of IR not only remarkably enhanced further the expression of HIF-1 alpha, VEGF, and PECAM-1 but also improved functioning compared with IR. The GSNO group also had a higher degree of vessel density than the IR group. Increased expression of VEGF and the degree of tube formation (angiogenesis) by GSNO were reduced after the inhibition of HIF-1 alpha by 2-ME in an endothelial cell culture model. 2-ME treatment of the GSNO group also blocked not only GSNO's effect of reduced infarct volume, decreased neuronal loss, and enhanced expression of PECAM-1 (P<0.001), but also its improvement of motor and neurological functions (P<0.001). Conclusion: GSNO stimulates the process of neurorepair, promotes angiogenesis, and aids functional recovery through the HIF-1 alpha-dependent pathway, showing therapeutic and translational promise for stroke.	[Khan, Mushfiquddin; Dhammu, Tajinder S.; Matsuda, Fumiyo; Dhindsa, Tejbir Singh; Singh, Inderjit] Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; [Matsuda, Fumiyo] Kagoshima Univ, Sch Hlth Sci, Kagoshima 890, Japan; [Baarine, Mauhammad; Singh, Avtar K.] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Singh, Avtar K.] Ralph H Johnson VA Med Ctr, Charleston, SC USA		Singh, AK (corresponding author), Med Univ S Carolina, Dept Pathol & Lab Med, 513 Childrens Res Inst,173 Ashley Ave, Charleston, SC 29425 USA.	khanm@musc.edu; singha@musc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-72511]; VA merit awardUS Department of Veterans Affairs [BX001062]; NIH from the Extramural Research Facilities Program of the National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [C06 RR018823, C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR015455, C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072511] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001062] Funding Source: NIH RePORTER	This work was supported by grants from NIH (NS-72511) and VA merit award (BX001062). This work was also supported by the NIH, Grants C06 RR018823 and No C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources. We thank Ms Joyce Bryan and Ms Terry Hope for their technical help and secretarial assistance. We are grateful to Dr Harutoshi Sakakima and Dr Yoshihiro Yoshida for their valuable input. We also acknowledge Dr Tom Smith and Dr Lisa Kerr from the MUSC Writing Center for their valuable editing of the manuscript.	Aggarwal A, J NEUROCHEM; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Bove PF, 2008, J BIOL CHEM, V283, P17919, DOI 10.1074/jbc.M709914200; Bryan NS, 2004, P NATL ACAD SCI USA, V101, P4308, DOI 10.1073/pnas.0306706101; Carver DJ, 2007, AM J RESP CELL MOL, V37, P255, DOI 10.1165/rcmb.2006-0289SM; Chen JL, 2007, ANN NEUROL, V62, P49, DOI 10.1002/ana.21160; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen QM, 2013, J APPL PHYSIOL, V114, P752, DOI 10.1152/japplphysiol.01302.2012; Chou PCT, 2011, J MAGN RESON IMAGING, V33, P1301, DOI 10.1002/jmri.22574; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Harten SK, 2010, ANTIOXID REDOX SIGN, V12, P459, DOI 10.1089/ars.2009.2870; He P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088143; Heiss C, 2006, J AM COLL CARDIOL, V47, P573, DOI 10.1016/j.jacc.2005.06.089; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jatana M, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-12; Ju TC, 2005, FREE RADICAL BIO MED, V38, P938, DOI 10.1016/j.freeradbiomed.2004.12.019; Kasivisvanathan V, 2011, CURR VASC PHARMACOL, V9, P333, DOI 10.2174/157016111795495602; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Ke XJ, 2013, J HUAZHONG U SCI-MED, V33, P433, DOI 10.1007/s11596-013-1137-4; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Khan M, 2006, NITRIC OXIDE-BIOL CH, V15, P114, DOI 10.1016/j.niox.2006.01.008; Khan M, 2012, J NEUROCHEM, V123, P86, DOI 10.1111/j.1471-4159.2012.07947.x; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kimura H, 2002, BIOCHEM BIOPH RES CO, V296, P976, DOI 10.1016/S0006-291X(02)02029-6; Kluge I, 1997, J NEUROCHEM, V69, P2599; KONOREV EA, 1995, J PHARMACOL EXP THER, V274, P200; Lee CHZ, 2007, STROKE, V38, P2563, DOI 10.1161/STROKEAHA.106.481515; Lee CZ, 2009, STROKE, V40, P2879, DOI 10.1161/STROKEAHA.109.552059; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Liu DH, 2013, NEUROSCIENCE, V229, P36, DOI 10.1016/j.neuroscience.2012.10.055; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Maki T, 2013, CNS NEUROL DISORD-DR, V12, P302, DOI 10.2174/1871527311312030004; Matsuda F, 2011, ACTA PHYSIOL, V201, P275, DOI [10.1111/j.1748-1716.2010.02174.x, 10.1111/j.1748-1708.2010.02174.x]; Matsumoto A, 2011, NITRIC OXIDE-BIOL CH, V25, P102, DOI 10.1016/j.niox.2011.02.006; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.E02-12-0791; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Mooberry SL, 2003, DRUG RESIST UPDATE, V6, P355, DOI 10.1016/j.drup.2003.10.001; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Pluta RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014504; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x; Rashid Parveen A, 2003, J Stroke Cerebrovasc Dis, V12, P82, DOI 10.1053/jscd.2003.9; Rassaf T, 2006, EUR HEART J, V27, P1699, DOI 10.1093/eurheartj/ehl096; Rauhala P, 1996, SYNAPSE, V23, P58, DOI 10.1002/(SICI)1098-2396(199605)23:1<58::AID-SYN7>3.0.CO;2-G; Roberts BW, 2013, SHOCK, V39, P229, DOI 10.1097/SHK.0b013e31827f565b; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Sakakima H, 2012, RESTOR NEUROL NEUROS, V30, P383, DOI 10.3233/RNN-2012-110209; Savidge TC, 2007, GASTROENTEROLOGY, V132, P1344, DOI 10.1053/j.gastro.2007.01.051; Schonhoff CM, 2006, P NATL ACAD SCI USA, V103, P2404, DOI 10.1073/pnas.0507243103; Singh SP, 1996, P NATL ACAD SCI USA, V93, P14428, DOI 10.1073/pnas.93.25.14428; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Terpolilli NA, 2012, J CEREBR BLOOD F MET, V32, P1332, DOI 10.1038/jcbfm.2012.12; Tsikas D, 1999, ANAL BIOCHEM, V273, P32, DOI 10.1006/abio.1999.4209; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Wang ZF, 2012, STROKE, V43, P2430, DOI 10.1161/STROKEAHA.112.652545; Wei L, 2001, STROKE, V32, P2179, DOI 10.1161/hs0901.094282; Wellman TL, 2003, FASEB J, V17, P379, DOI 10.1096/fj.03-0143fje; Won JS, 2013, J ALZHEIMERS DIS, V34, P621, DOI 10.3233/JAD-121786; Yasinska IM, 2003, FEBS LETT, V549, P105, DOI 10.1016/S0014-5793(03)00807-X; Yin XH, 2013, NEUROSCIENCE, V248, P290, DOI 10.1016/j.neuroscience.2013.06.012; Zhang RL, 2013, EXPERT OPIN INV DRUG, V22, P843, DOI 10.1517/13543784.2013.793672; Zhang ZY, 2014, FREE RADICAL BIO MED, V68, P8, DOI 10.1016/j.freeradbiomed.2013.11.007; Zhou DC, 2008, NEUROL RES, V30, P268, DOI 10.1179/016164107X229920; Zhu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093334	76	36	36	0	10	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-8881			DRUG DES DEV THER	Drug Des. Dev. Ther.		2015	9						2233	2247		10.2147/DDDT.S77115			15	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CG1SN	WOS:000353054400001	25945035	gold, Green Published			2022-02-06	
J	Billeter, AT; Hellmann, J; Roberts, H; Druen, D; Gardner, SA; Sarojini, H; Galandiuk, S; Chien, SF; Bhatnagar, A; Spite, M; Polk, HC				Billeter, Adrian T.; Hellmann, Jason; Roberts, Henry; Druen, Devin; Gardner, Sarah A.; Sarojini, Harshini; Galandiuk, Susan; Chien, Sufan; Bhatnagar, Aruni; Spite, Matthew; Polk, Hiram C., Jr.			MicroRNA-155 potentiates the inflammatory response in hypothermia by suppressing IL-10 production	FASEB JOURNAL			English	Article						sepsis; peritonitis; cold exposure	RANDOMIZED CLINICAL-TRIAL; TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; THERAPEUTIC HYPOTHERMIA; INTRAOPERATIVE HYPOTHERMIA; PERIOPERATIVE HYPOTHERMIA; DENDRITIC CELLS; WOUND-INFECTION; IN-VIVO; MIR-155	Therapeutic hypothermia is commonly used to improve neurological outcomes in patients after cardiac arrest. However, therapeutic hypothermia increases sepsis risk and unintentional hypothermia in surgical patients increases infectious complications. Nonetheless, the molecular mechanisms by which hypothermia dysregulates innate immunity are incompletely understood. We found that exposure of human monocytes to cold (32 degrees C) potentiated LPS-induced production of TNF and IL-6, while blunting IL-10 production. This dysregulation was associated with increased expression of microRNA-155 (miR-155), which potentiates Toll-like receptor (TLR) signaling by negatively regulating Ship1 and Socs1. Indeed, Ship1 and Socs1 were suppressed at 32 degrees C and miR-155 antagomirs increased Ship1 and Socs1 and reversed the alterations in cytokine production in cold-exposed monocytes. In contrast, miR-155 mimics phenocopied the effects of cold exposure, reducing Ship1 and Socs1 and altering TNF and IL-10 production. In a murine model of LPS-induced peritonitis, cold exposure potentiated hypothermia and decreased survival (10 vs. 50%; P < 0.05), effects that were associated with increased miR-155, suppression of Ship1 and Socs1, and alterations in TNF and IL-10. Importantly, miR-155-deficiency reduced hypothermia and improved survival (78 vs. 32%, P < 0.05), which was associated with increased Ship1, Socs1, and IL-10. These results establish a causal role of miR-155 in the dysregulation of the inflammatory response to hypothermia.	[Billeter, Adrian T.; Roberts, Henry; Druen, Devin; Gardner, Sarah A.; Sarojini, Harshini; Galandiuk, Susan; Chien, Sufan; Polk, Hiram C., Jr.] Univ Louisville, Sch Med, Dept Surg, Price Inst Surg Res, Louisville, KY 40292 USA; [Hellmann, Jason; Bhatnagar, Aruni; Spite, Matthew] Univ Louisville, Sch Med, Diabet & Obes Ctr, Inst Mol Cardiol, Louisville, KY 40292 USA		Billeter, AT (corresponding author), Univ Louisville, Sch Med, Dept Surg, Price Inst Surg Res, Louisville, KY 40292 USA.	adrianbilleter@bluewin.ch; mspite@partners.org	Hellmann, Jason/B-9360-2012; Sarojini, Harshini/AAD-4870-2019; Billeter, Adrian/O-2185-2019	Sarojini, Harshini/0000-0002-3103-9712; Billeter, Adrian/0000-0001-8724-4793	Price Trust Fund; Joint Royal College of Surgeons of Edinburgh (RCSEd)/James and Emmeline Ferguson Research Fellowship Trust; U. S. National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL-106173, GM-103492, HL-116186]; Joint RCSEd/James and Emmeline Ferguson Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [F32HL116186, R01HL106173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103492] Funding Source: NIH RePORTER	The authors thank Donald E. Fry for insight, advice, and productive discussions and Dr. James McCracken for help with the FACS analysis of the peritoneal exudate cells. This work was funded by the Price Trust Fund, by the Joint Royal College of Surgeons of Edinburgh (RCSEd)/James and Emmeline Ferguson Research Fellowship Trust and by U. S. National Institutes of Health grants HL-106173 (to M. S.) and GM-103492 (to M. S. and A. B.). A. T. B. holds the Joint RCSEd/James and Emmeline Ferguson Research Fellowship and currently works at the Department of Surgery at the University of Heidelberg (Heidelberg, Germany). J.H. is the recipient of a National Research Service Award from the U. S. National Institutes of Health (grant HL-116186). The funding sources had no role in the production of the manuscript.	Ahmad FU, 2014, WORLD NEUROSURG, V82, P207, DOI 10.1016/j.wneu.2013.01.008; Ajuebor MN, 1999, J IMMUNOL, V162, P1685; AKRIOTIS V, 1985, J LEUKOCYTE BIOL, V37, P51, DOI 10.1002/jlb.37.1.51; Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; Arons MM, 1999, CRIT CARE MED, V27, P699, DOI 10.1097/00003246-199904000-00020; Arrich J, 2012, COCHRANE DB SYST REV, V4, P9; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Beilman GJ, 2009, ANN SURG, V249, P845, DOI 10.1097/SLA.0b013e3181a41f6f; Billeter AT, 2014, SURGERY, V156, P1245, DOI 10.1016/j.surg.2014.04.024; Billeter AT, 2012, SURGERY, V151, P1, DOI 10.1016/j.surg.2011.08.006; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Brock M, 2014, EUR HEART J, V35, P3203, DOI 10.1093/eurheartj/ehs060; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Clark N, 2007, FASEB J, V21, P3747, DOI 10.1096/fj.06-7460com; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Fairchild KD, 2005, AM J PHYSIOL-CELL PH, V289, pC1114, DOI 10.1152/ajpcell.00152.2005; Fairchild KD, 2004, AM J PHYSIOL-CELL PH, V287, pC422, DOI 10.1152/ajpcell.00507.2003; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; Fernandes ES, 2012, J IMMUNOL, V188, P5741, DOI 10.4049/jimmunol.1102147; Flores-Maldonado A, 2001, ARCH MED RES, V32, P227, DOI 10.1016/S0188-4409(01)00272-7; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Fries M, 2009, J CRIT CARE, V24, P453, DOI 10.1016/j.jcrc.2008.10.012; Geurts M, 2014, CRIT CARE MED, V42, P231, DOI 10.1097/CCM.0b013e3182a276e8; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Hammarfjord O, 2010, J LEUKOCYTE BIOL, V88, P747, DOI 10.1189/jlb.0310155; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Inaba K, 2012, J TRAUMA ACUTE CARE, V73, P1478, DOI 10.1097/TA.0b013e3182781db3; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jiang SY, 2013, CRIT CARE, V17, DOI 10.1186/cc12559; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Li RC, 2013, CIRC RES, V112, P601, DOI 10.1161/CIRCRESAHA.112.300806; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui T, 2014, NEUROCRIT CARE, V20, P301, DOI 10.1007/s12028-013-9911-5; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Meybohm P, 2010, CRIT CARE, V14, DOI 10.1186/cc8879; Monk CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013669; Mourvillier B, 2013, JAMA-J AM MED ASSOC, V310, P2174, DOI 10.1001/jama.2013.280506; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Perbet S, 2011, AM J RESP CRIT CARE, V184, P1048, DOI 10.1164/rccm.201102-0331OC; Pu J, 2012, BIOCHEM BIOPH RES CO, V428, P210, DOI 10.1016/j.bbrc.2012.09.126; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Seamon MJ, 2012, ANN SURG, V255, P789, DOI 10.1097/SLA.0b013e31824b7e35; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Tian DH, 2013, ANN CARDIOTHORAC SUR, V2, P148, DOI 10.3978/j.issn.2225-319X.2013.03.13; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Trotta R, 2012, BLOOD, V119, P3478, DOI 10.1182/blood-2011-12-398099; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; van Der Poll Tom, 1997, Clin Microbiol Infect, V3, P605, DOI 10.1111/j.1469-0691.1997.tb00465.x; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wenisch C, 1996, ANESTH ANALG, V82, P810, DOI 10.1097/00000539-199604000-00023; Xiao HY, 2005, CRIT CARE MED, V33, P161, DOI 10.1097/01.CCM.0000151049.19253.54; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	60	36	42	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5322	5336		10.1096/fj.14-258335			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	WOS:000345894500026	25231976	Green Published			2022-02-06	
J	Hofler, J; Unterberger, I; Dobesberger, J; Kuchukhidze, G; Walser, G; Trinka, E				Hoefler, Julia; Unterberger, Iris; Dobesberger, Judith; Kuchukhidze, Giorgi; Walser, Gerald; Trinka, Eugen			Seizure outcome in 175 patients with juvenile myoclonic epilepsy - A long-term observational study	EPILEPSY RESEARCH			English	Article						Juvenile myoclonic epilepsy; Seizure-freedom; Generalized epilepsy; Prognosis	PSYCHIATRIC COMORBIDITY; ANTIEPILEPTIC DRUGS; POLYCYSTIC OVARIES; VALPROATE; PROGNOSIS; PHOTOSENSITIVITY; POPULATION; RESISTANCE; DISORDERS; WOMEN	Introduction: Juvenile myoclonic epilepsy (JME) is a genetic generalized epilepsy syndrome. Under appropriate antiepileptic drugs (AED) up to 85% of patients become seizure-free, but many may have a relapse after AED withdrawal. Methods: We retrospectively studied 242 patients with JME at the Department of Neurology, Medical University Innsbruck, Austria (1975-2006). We analyzed age at seizure onset, age at last follow up, seizure types, photosensitivity, seizure outcome and neuroimaging findings; inclusion criterion was a medical treatment period of >2 years; exclusion criteria were traumatic or infectious brain injury before the onset of JME and/or gross structural pathology on neuroimaging. Results: We identified 175 patients (111 women) with a median age at seizure onset of 15 years, (range 3-46) and a median age at follow-up (FU) of 38 years (range 14-87; median FU 8 years, range 2-38). Fourteen percent showed (24/175) photosensitivity on routine EEG. Seizure outcome: 62% (109/175) were seizure-free of myoclonic seizures (MS), generalized tonic clonic seizures (GTCS) and absence seizures (AS) for >1 year, and 53% (94/175) for >2 years, including 16 patients (9%) without AEDs. Thirty-one percent (54/175) were seizure-free between 2and 5 years, 15% (26/175) between 6 and 10, and 8% (14/175) >10 years; 38% (66/175) were not seizure-free. Not seizure-free patients had more often MS, AS and GTCS within the first year of epilepsy than those who were seizure-free at last FU (11% vs. 3%, Chi(2) =4.679, df = 1, p = 0.043). Seizure-free patients had more often M GTCS as last seizure types in the year before becoming seizure-free (37% vs. 15%, p = 0.003), whereas in not seizure-free group MS only and GTCS only persisted. Conclusions: JME does not always need lifelong treatment, as a substantial minority of patients remain seizure-free without AEDs. AS, MS and GTCS at onset of the disease are indicators of poor long-term seizure control. (C) 2014 The Authors. Published by Elsevier B.V.	[Hoefler, Julia; Dobesberger, Judith; Kuchukhidze, Giorgi; Trinka, Eugen] Paracelsus Med Univ Salzburg, Dept Neurol, Christian Doppler Klin, Salzburg, Austria; [Hoefler, Julia; Unterberger, Iris; Dobesberger, Judith; Kuchukhidze, Giorgi; Walser, Gerald; Trinka, Eugen] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria		Trinka, E (corresponding author), Paracelsus Med Univ, Univ Klin Neurol, Christian Doppler Klin, Ignaz Harrer Str 79, A-5020 Salzburg, Austria.	E.Trinka@salk.at		Trinka, Eugen/0000-0002-5950-2692; Kuchukhidze, Giorgi/0000-0001-6899-8506	UCBUCB Pharma SA; Biogen-IdecBiogen; Sanofi-AventisSanofi-Aventis; FWFAustrian Science Fund (FWF) [KLI12-B00]; Jubilaumsfond der Oster-reichischen Nationalbank [14201]; Red Bull; EisaiEisai Co Ltd; Ever Neuropharma; Biogen IdecBiogen; Medtronics; BialBial Group	E. Trinka has acted as a paid consultant to Eisai, Ever Neuropharma, Biogen Idec, Medtronics, Bial, and UCB. He has received research funding from UCB, Biogen-Idec, Sanofi-Aventis, FWF (KLI12-B00), Jubilaumsfond der Oster-reichischen Nationalbank (14201) and Red Bull. He has received speakers' honoraria from Bial, Eisai, GL Lannacher, Glaxo Smith Kline, Bohringer, Viropharma, Actavis and UCB.	[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Appleton R, 2000, SEIZURE-EUR J EPILEP, V9, P108, DOI 10.1053/seiz.1999.0376; Baykan B, 2008, NEUROLOGY, V70, P2123, DOI 10.1212/01.wnl.0000313148.34629.1d; Camfield CS, 2009, NEUROLOGY, V73, P1041, DOI 10.1212/WNL.0b013e3181b9c86f; Canevini M P, 1992, Seizure, V1, P291, DOI 10.1016/1059-1311(92)90039-4; Chakravarty A, 2007, SEIZURE-EUR J EPILEP, V16, P134, DOI 10.1016/j.seizure.2006.10.012; de Araujo GM, 2008, EPILEPSY BEHAV, V13, P196, DOI 10.1016/j.yebeh.2008.01.008; Delgado-Escueta A. V., 1997, TREATMENT EPILEPSY P, P484; DELGADOESCUETA AV, 1984, NEUROLOGY, V34, P285, DOI 10.1212/WNL.34.3.285; DREIFUSS FE, 1989, EPILEPSIA, V30, pS1, DOI 10.1111/j.1528-1157.1989.tb05832.x; Geithner J, 2012, EPILEPSIA, V53, P1379, DOI 10.1111/j.1528-1167.2012.03526.x; Gelisse P, 2001, J NEUROL NEUROSUR PS, V70, P240, DOI 10.1136/jnnp.70.2.240; Gelisse P, 2007, EPILEPSIA, V48, P1032, DOI 10.1111/j.1528-1167.2007.01009_4.x; Genton P, 2001, EPILEPSIA, V42, P295, DOI 10.1046/j.1528-1157.2001.28899.x; GRUNEWALD RA, 1993, ARCH NEUROL-CHICAGO, V50, P594, DOI 10.1001/archneur.1993.00540060034013; Guaranha MSB, 2011, SEIZURE-EUR J EPILEP, V20, P42, DOI 10.1016/j.seizure.2010.10.004; Hirsch E, 2003, ACTA NEUROL SCAND, V108, P23, DOI 10.1034/j.1600-0404.108.s180.4.x; ISOJARVI JIT, 1993, NEW ENGL J MED, V329, P1383, DOI 10.1056/NEJM199311043291904; Jain S, 1997, ACTA NEUROL SCAND, V95, P263, DOI 10.1111/j.1600-0404.1997.tb00207.x; JANZ D, 1985, ACTA NEUROL SCAND, V72, P449; Janz D., 1969, DIE EPILEPSIEN; Janz D., 1957, DTSCH Z NERVENHEILKD, V176, P346, DOI [10.1007/BF00242439, DOI 10.1007/BF00242439]; Kasteleijn-Nolst Trenite D G, 1989, Acta Neurol Scand Suppl, V125, P3; Kleveland G, 1998, SEIZURE-EUR J EPILEP, V7, P31, DOI 10.1016/S1059-1311(98)90005-X; Labate A, 2007, EPILEPSY RES, V77, P17, DOI 10.1016/j.eplepsyres.2007.07.010; Luef G, 2002, J NEUROL, V249, P835, DOI 10.1007/S00415-002-0731-3; Luef GJ, 2004, ANN NEUROL, V55, P729, DOI 10.1002/ana.20074; Martinez-Juarez IE, 2006, BRAIN, V129, P1269, DOI 10.1093/brain/awl048; Meador Kimford J, 2008, Epilepsy Curr, V8, P90, DOI 10.1111/j.1535-7511.2008.00250.x; PANAYIOTOPOULOS CP, 1994, EPILEPSIA, V35, P285, DOI 10.1111/j.1528-1157.1994.tb02432.x; PENRY JK, 1989, EPILEPSIA, V30, pS19, DOI 10.1111/j.1528-1157.1989.tb05833.x; Perini GI, 1996, J NEUROL NEUROSUR PS, V61, P601, DOI 10.1136/jnnp.61.6.601; Rinnerthaler M, 2005, EPILEPSIA, V46, P320, DOI 10.1111/j.0013-9580.2005.36204.x; SCOLLOLAVIZZARI G, 1974, EUR NEUROL, V11, P1, DOI 10.1159/000114301; Senf P, 2013, NEUROLOGY, V81, P2128, DOI 10.1212/01.wnl.0000437303.36064.f8; SHINNAR S, 1994, ANN NEUROL, V35, P534, DOI 10.1002/ana.410350506; Teich M, 2004, EPILEPSIA, V45, P187, DOI 10.1111/j.0013-9580.2004.28302.x; Trenite DGAKN, 2013, EPILEPSY BEHAV, V28, pS25, DOI 10.1016/j.yebeh.2012.11.045; Trinka E, 2006, EPILEPSIA, V47, P2086, DOI 10.1111/j.1528-1167.2006.00828.x	39	36	36	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	DEC	2014	108	10					1817	1824		10.1016/j.eplepsyres.2014.09.008			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AY3RP	WOS:000347500600016	25443450	hybrid			2022-02-06	
J	Powell, MR; Powden, CJ; Houston, MN; Hoch, MC				Powell, Meaghan R.; Powden, Cameron J.; Houston, Megan N.; Hoch, Matthew C.			Plantar Cutaneous Sensitivity and Balance in Individuals With and Without Chronic Ankle Instability	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						ankle sprain; somatosensory; balance	TO-BOUNDARY MEASURES; POSTURAL CONTROL; DEFICITS; INJURIES; TIME; OSTEOARTHRITIS; RELIABILITY; AFFERENTS; OUTCOMES; SPRAINS	Objective: To determine if plantar cutaneous sensation and postural control differ between individuals with and without chronic ankle instability (CAI). Design: Case-control. Setting: Laboratory. Participants: Ten subjects with CAI and 10 subjects with no ankle sprain history participated. Interventions: Light touch was evaluated at 3 sites (heel, base of fifth metatarsal, and head of first metatarsal) on the plantar aspect of the foot using Semmes-Weinstein Monofilaments (SWMs). Postural control was assessed using the single leg firm and foam conditions of the Balance Error Scoring System (BESS) and during eyes open and eyes closed static postural control on a force plate. Main Outcome Measures: Semmes-Weinstein Monofilament detection thresholds, BESS errors, and the mean of time-to-boundary (TTB) minima (TTB-mean) and the SD of TTB minima (TTB-SD) in the anterior-posterior (AP) and medial-lateral directions were evaluated for each subject. Results: Subjects with CAI demonstrated increased SWM detection thresholds at the heel (P = 0.009), head of the first (P = 0.01), and base of the fifth metatarsal (P < 0.001) and postural control deficits on the BESS firm (P = 0.04) and foam (P = 0.001) conditions and with eyes open TTB-mean AP (P = 0.007) and TTB-SD AP (P = 0.02). When combining groups, a negative moderate correlation was observed between the base of the fifth metatarsal detection threshold and eyes open TTB-mean AP (r = -0.50; P = 0.03). Conclusions: Light touch and postural control deficits were observed in individuals with CAI. The correlation between light touch over the base of the fifth metatarsal and eyes open TTB-mean AP suggests that there may be a relevant relationship between these measures. Clinical Relevance: Individuals with CAI demonstrated deficits in light touch over the plantar aspect of the foot. The relationship between base of the fifth metatarsal sensation and TTB-mean AP may provide a starting point to link plantar cutaneous sensory deficits to changes in other aspects of sensorimotor function.	[Powell, Meaghan R.; Houston, Megan N.] Old Dominion Univ, Coll Educ, Dept Human Movement Sci, Norfolk, VA 23529 USA; [Powden, Cameron J.; Hoch, Matthew C.] Old Dominion Univ, Sch Phys Therapy & Athlet Training, Coll Hlth Sci, Norfolk, VA 23529 USA		Hoch, MC (corresponding author), Old Dominion Univ, Sch Phys Therapy & Athlet Training, Coll Hlth Sci, 102 Hlth Sci Annex, Norfolk, VA 23529 USA.	mhoch@odu.edu					Anandacoomarasamy A, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.011676; Arnold BL, 2009, MED SCI SPORT EXER, V41, P1048, DOI 10.1249/MSS.0b013e318192d044; Collins S, 2010, DISABIL REHABIL, V32, P2019, DOI 10.3109/09638281003797406; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Docherty CL, 2006, J ATHL TRAINING, V41, P154; DYCK PJ, 1993, NEUROLOGY, V43, P1508, DOI 10.1212/WNL.43.8.1508; Freeman M A, 1965, J Bone Joint Surg Br, V47, P678; Freeman M A, 1965, J Bone Joint Surg Br, V47, P669; Hertel J, 2002, J ATHL TRAINING, V37, P364; Hertel J, 2008, CLIN SPORT MED, V27, P353, DOI 10.1016/j.csm.2008.03.006; Hertel J, 2007, GAIT POSTURE, V25, P33, DOI 10.1016/j.gaitpost.2005.12.009; Hoch MC, 2014, MED SCI SPORT EXER, V46, P546, DOI 10.1249/MSS.0b013e3182a6a93b; Hoch MC, 2012, MED SCI SPORT EXER, V44, P666, DOI 10.1249/MSS.0b013e3182390212; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Jenkins ME, 2009, PARKINSONISM RELAT D, V15, P697, DOI 10.1016/j.parkreldis.2009.04.004; Knikou M, 2010, J NEUROPHYSIOL, V103, P1304, DOI 10.1152/jn.00880.2009; Liu W, 2002, ARCH PHYS MED REHAB, V83, P171, DOI 10.1053/apmr.2002.28025; McKeon JMM, 2012, J ATHL TRAINING, V47, P444, DOI 10.4085/1062-6050-47.4.15; McKeon PO, 2010, GAIT POSTURE, V32, P374, DOI 10.1016/j.gaitpost.2010.06.016; McKeon PO, 2007, SOMATOSENS MOT RES, V24, P171, DOI 10.1080/08990220701637224; McKeon PO, 2012, J SPORT REHABIL, V21, P1, DOI 10.1123/jsr.21.1.1; McKeon PO, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-76; McKeon PO, 2008, MED SCI SPORT EXER, V40, P1810, DOI 10.1249/MSS.0b013e31817e0f92; McVey ED, 2005, FOOT ANKLE INT, V26, P1055, DOI 10.1177/107110070502601210; Meyer PF, 2004, EXP BRAIN RES, V157, P526, DOI 10.1007/s00221-004-1868-3; Needle AR, 2013, J ATHL TRAINING, V48, P192, DOI 10.4085/1062-6050-48.1.09; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Palluel E, 2008, AGE, V30, P53, DOI 10.1007/s11357-008-9047-2; Perry SD, 2008, J GERONTOL A-BIOL, V63, P595, DOI 10.1093/gerona/63.6.595; Plante JE, 2013, PHYS THER SPORT, V14, P221, DOI 10.1016/j.ptsp.2012.09.005; Pope M, 2011, GAIT POSTURE, V34, P154, DOI 10.1016/j.gaitpost.2011.04.012; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Roll R, 2002, NEUROREPORT, V13, P1957, DOI 10.1097/00001756-200210280-00025; Rosenbaum D, 2006, RHEUMATOLOGY, V45, P212, DOI 10.1093/rheumatology/kei137; Sedory EJ, 2007, J ATHL TRAINING, V42, P355; Sefton JM, 2009, CLIN BIOMECH, V24, P451, DOI 10.1016/j.clinbiomech.2009.03.003; Shakoor N, 2008, ARTHRIT RHEUM-ARTHR, V59, P1237, DOI 10.1002/art.24004; Shakoor N, 2008, ARTHRIT RHEUM-ARTHR, V59, P117, DOI 10.1002/art.23241; van Rijn RM, 2008, AM J MED, V121, P324, DOI 10.1016/j.amjmed.2007.11.018; VERHAGEN RAW, 1995, ARCH ORTHOP TRAUM SU, V114, P92, DOI 10.1007/BF00422833; Wikstrom, 2012, ATHL TRAIN SPORT HLT, V4, P213, DOI DOI 10.3928/19425864-20120731-02; Wikstrom EA, 2010, GAIT POSTURE, V32, P82, DOI 10.1016/j.gaitpost.2010.03.015	42	36	36	0	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2014	24	6					490	496					7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	AT2AM	WOS:000344733000012	24451692				2022-02-06	
J	Gupta, A; Ip, IK; Raja, AS; Andruchow, JE; Sodickson, A; Khorasani, R				Gupta, Anurag; Ip, Ivan K.; Raja, Ali S.; Andruchow, James E.; Sodickson, Aaron; Khorasani, Ramin			Effect of clinical decision support on documented guideline adherence for head CT in emergency department patients with mild traumatic brain injury	JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION			English	Article							NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; MEANINGFUL USE; RULE; QUALITY; INFORMATION; RADIOLOGY; OUTCOMES; ENTRY	Imaging utilization in emergency departments (EDs) has increased significantly. More than half of the 1.2 million patients with mild traumatic brain injury (MTBI) presenting to US EDs receive head CT. While evidence-based guidelines can help emergency clinicians decide whether to obtain head CT in these patients, adoption of these guidelines has been highly variable. Promulgation of imaging efficiency guidelines by the National Quality Forum has intensified the need for performance reporting, but measuring adherence to these imaging guidelines currently requires labor-intensive and potentially inaccurate manual chart review. We implemented clinical decision support (CDS) based on published evidence to guide emergency clinicians towards appropriate head CT use in patients with MTBI and automated data capture needed for unambiguous guideline adherence metrics. Implementation of the CDS was associated with a 56% relative increase in documented adherence to evidence-based guidelines for imaging in ED patients with MTBI.	[Gupta, Anurag; Ip, Ivan K.; Raja, Ali S.; Andruchow, James E.; Sodickson, Aaron; Khorasani, Ramin] Brigham & Womens Hosp, Ctr Evidence Based Imaging, Brookline, MA 02445 USA; [Gupta, Anurag; Ip, Ivan K.; Raja, Ali S.; Andruchow, James E.; Sodickson, Aaron; Khorasani, Ramin] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Gupta, Anurag; Raja, Ali S.; Andruchow, James E.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Gupta, Anurag; Ip, Ivan K.; Raja, Ali S.; Sodickson, Aaron; Khorasani, Ramin] Harvard Univ, Sch Med, Boston, MA USA; [Ip, Ivan K.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA		Gupta, A (corresponding author), Brigham & Womens Hosp, Ctr Evidence Based Imaging, 20 Kent St,2nd Floor, Brookline, MA 02445 USA.	agupta15@partners.org	Khorasani, Ramin/AAM-8526-2021; Raja, Ali S./AAE-5103-2019	Sodickson, Aaron/0000-0003-1275-681X; Gupta, Anurag/0000-0003-1566-1656	National Library of MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15LM007092]; National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [1UC4EB012952-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [UC4EB012952] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15LM007092] Funding Source: NIH RePORTER	This study was funded in part by Grant T15LM007092 from the National Library of Medicine and by Grant 1UC4EB012952-01 from the National Institute of Biomedical Imaging and Bioengineering.	Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Congress of Rehabilitation Medicine Head Injury Interdisciplinary American Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86; De Haan GG, 2008, IMAGING MINOR HEAD I, V146, P55; Eagles D, 2008, ACAD EMERG MED, V15, P1256, DOI 10.1111/j.1553-2712.2008.00265.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Federal Register, 2012, HLTH INF TECHN STAND, V77, P54163; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Gupta A, 2014, J AM MED INFORM ASSN, V21, P23, DOI 10.1136/amiajnl-2013-001617; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hedner C, 2013, ACAD RADIOL, V20, P1115, DOI 10.1016/j.acra.2013.05.010; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Ip IK, 2012, J AM COLL RADIOL, V9, P129, DOI 10.1016/j.jacr.2011.10.010; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jha AK, 2010, JAMA-J AM MED ASSOC, V304, P1709, DOI 10.1001/jama.2010.1497; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Linder JA, 2012, J AM MED INFORM ASSN, V19, P1019, DOI [10.1136/amiajnl-2011-000788, 10.1136/amiajnl-2011-00078]; Lugtenberg M, 2009, QUAL SAF HEALTH CARE, V18, P385, DOI 10.1136/qshc.2008.028043; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; NQF, NAT VOL CONS STAND I; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Rosenbloom ST, 2011, J AM MED INFORM ASSN, V18, P181, DOI 10.1136/jamia.2010.007237; Schuur JD, 2012, ANN EMERG MED, V60, P280, DOI 10.1016/j.annemergmed.2011.12.025; Shinagare A, 2013, AJR AM J RO IN PRESS; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Sox HC, 2012, ANN EMERG MED, V60, P291, DOI 10.1016/j.annemergmed.2012.05.032; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Tierney WM, 2001, INT J MED INFORM, V62, P1, DOI 10.1016/S1386-5056(01)00127-7	32	36	36	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1067-5027	1527-974X		J AM MED INFORM ASSN	J. Am. Med. Inf. Assoc.	OCT	2014	21	E2					E347	E351		10.1136/amiajnl-2013-002536			5	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Health Care Sciences & Services; Information Science & Library Science; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Health Care Sciences & Services; Information Science & Library Science; Medical Informatics	AP1UV	WOS:000341858100024	24534635	Green Published, Bronze			2022-02-06	
J	Mackelprang, JL; Harpin, SB; Grubenhoff, JA; Rivara, FP				Mackelprang, Jessica L.; Harpin, Scott B.; Grubenhoff, Joseph A.; Rivara, Frederick P.			Adverse Outcomes Among Homeless Adolescents and Young Adults Who Report a History of Traumatic Brain Injury	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							POSTCONCUSSION SYNDROME; STREET YOUTH; HEALTH; PEOPLE; CARE; INTERVENTION; EXPERIENCES; CHALLENGES; MORTALITY; CHILDREN	Objectives. We examined the prevalence of self-reported traumatic brain injury (TBI) among homeless young people and explored whether sociodemographic characteristics, mental health diagnoses, substance use, exposure to violence, or difficulties with activities of daily living (ADLs) were associated with TBI. Methods. We analyzed data from the Wilder Homelessness Study, in which participants were recruited in 2006 and 2009 from streets, shelters, and locations in Minnesota that provide services to homeless individuals. Participants completed 30-minute interviews to collect information about history of TBI, homelessness, health status, exposure to violence (e. g., childhood abuse, assault), and other aspects of functioning. Results. Of the 2732 participating adolescents and young adults, 43% reported a history of TBI. Participants with TBI became homeless at a younger age and were more likely to report mental health diagnoses, substance use, suicidality, victimization, and difficulties with ADLs. The majority of participants (51%) reported sustaining their first injury prior to becoming homeless or at the same age of their first homeless episode (10%). Conclusions. TBI occurs frequently among homeless young people and is a marker of adverse outcomes such as mental health difficulties, suicidal behavior, substance use, and victimization.	[Mackelprang, Jessica L.; Rivara, Frederick P.] Univ Washington, Sch Med, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Mackelprang, Jessica L.; Rivara, Frederick P.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98104 USA; [Harpin, Scott B.] Univ Colorado, Anschutz Med Ctr, Coll Nursing, Aurora, CO USA; [Grubenhoff, Joseph A.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Grubenhoff, Joseph A.] Childrens Hosp Colorado, Aurora, CO USA		Mackelprang, JL (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Pediat, 401 Broadway,Suite 4075,Patricia Bracelin Steel, Seattle, WA 98104 USA.	jlmack11@uw.edu	Grubenhoff, Joseph A/H-9994-2019; Mackelprang, Jessica L./AAT-4283-2021	Grubenhoff, Joseph A/0000-0001-5072-4064; Mackelprang, Jessica L./0000-0001-9135-7811	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32-HD057822]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER	Jessica L. Mackelprang received fellowship support from the National Institute of Child Health and Human Development (grant T32-HD057822) during the preparation of this article.	[Anonymous], 2013 ANN HOM ASS REP; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Backer Thomas Earl, 2007, J Prim Prev, V28, P375, DOI 10.1007/s10935-007-0100-1; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barry Paul J, 2002, J Transcult Nurs, V13, P145, DOI 10.1177/104365960201300208; Carlson JL, 2006, J ADOLESCENT HEALTH, V38, P624, DOI 10.1016/j.jadohealth.2005.10.009; Cauce AM, 2000, J EMOT BEHAV DISORD, V8, P230, DOI 10.1177/106342660000800403; Cleverley K, 2011, J ADOLESCENCE, V34, P1049, DOI 10.1016/j.adolescence.2010.11.003; Cochran BN, 2002, AM J PUBLIC HEALTH, V92, P773, DOI 10.2105/AJPH.92.5.773; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dworsky A, 2013, AM J PUBLIC HEALTH, V103, pS318, DOI 10.2105/AJPH.2013.301455; Edidin JP, 2012, CHILD PSYCHIAT HUM D, V43, P354, DOI 10.1007/s10578-011-0270-1; Ensign J, 2004, QUAL HEALTH RES, V14, P1239, DOI 10.1177/1049732304268795; Ensign J, 1998, SOC SCI MED, V47, P2087, DOI 10.1016/S0277-9536(98)00273-1; Ensign J, 1998, ARCH PEDIAT ADOL MED, V152, P20; Ferguson KM, 2009, J INTERPERS VIOLENCE, V24, P1875, DOI 10.1177/0886260508325490; Hadland SE, 2012, J AFFECT DISORDERS, V136, P377, DOI 10.1016/j.jad.2011.11.019; Hodgson KJ, 2013, AM J PUBLIC HEALTH, V103, pE24, DOI 10.2105/AJPH.2013.301318; Hudson AL, 2010, NURS RES, V59, P212, DOI 10.1097/NNR.0b013e3181d1a8a9; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Kidd SA, 2007, J ADOLESCENCE, V30, P283, DOI 10.1016/j.adolescence.2006.03.002; Montauk SL, 2006, AM FAM PHYSICIAN, V74, P1132; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Parks RW, 2007, J ROY SOC MED, V100, P46, DOI 10.1258/jrsm.100.1.46; Roy E, 2004, JAMA-J AM MED ASSOC, V292, P569, DOI 10.1001/jama.292.5.569; Roy E, 2010, J URBAN HEALTH, V87, P95, DOI 10.1007/s11524-009-9397-9; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Thompson SJ, 2013, YOUTH SOC; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; Tsai M, 2005, J HEALTH CARE POOR U, V16, P297, DOI 10.1353/hpu.2005.0042; Walls NE, 2011, J SEX RES, V48, P423, DOI 10.1080/00224499.2010.501916; Walton MA, 2010, JAMA-J AM MED ASSOC, V304, P527, DOI 10.1001/jama.2010.1066; Zatzick D, 2014, JAMA PEDIATR, V168, P532, DOI 10.1001/jamapediatrics.2013.4784	35	36	36	1	17	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	OCT	2014	104	10					1986	1992		10.2105/AJPH.2014.302087			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AP1XG	WOS:000341865000046	25122029	Green Published			2022-02-06	
J	Lowrey, KM; Morain, SR				Lowrey, Kerri McGowan; Morain, Stephanie R.			State Experiences Implementing Youth Sports Concussion Laws: Challenges, Successes, and Lessons for Evaluating Impact	JOURNAL OF LAW MEDICINE & ETHICS			English	Article							INJURY; RETURN	While provisions of youth sports concussion laws are very similar, little is known as to how they are being implemented, factors that promote or impede implementation, or the level of compliance in each jurisdiction. We aimed to describe state experiences with implementation in order to inform ongoing efforts to reduce the harm of sports-related traumatic brain injury and to guide future evaluations of the laws' impacts and the development of future public health laws. We conducted key-informant interviews in 35 states with recently enacted concussion legislation. States varied considerably in their readiness and capacity for implementation. Factors facilitating implementation included existing partnerships, procedures, and resources; centralized implementation authority; prior related efforts; and involvement in the policymaking process by those now charged with implementation. Inhibitors included ambiguous statutory language, unclear delegation of authority, and compliance difficulties. Ongoing challenges persist, including primary prevention; determining which providers are qualified to make return-to-play assessments and contents of those assessments; compliance difficulties in rural and under-served areas; and unclear responsibility for enforcement. Despite the similarity of youth sports concussion laws, early evidence suggests there is considerable variation in their implementation. These findings are critical for ongoing empirical investigations to accurately evaluate the laws' provisions and to identify successful legal approaches to protecting young athletes.	[Lowrey, Kerri McGowan] Eastern Reg, Wyndmoor, PA 19038 USA; [Morain, Stephanie R.] Johns Hopkins Bloomberg Sch Publ Hlth, Berman Inst, Baltimore, MD USA		Lowrey, KM (corresponding author), Eastern Reg, Wyndmoor, PA 19038 USA.			Morain, Stephanie/0000-0001-7278-7517	Network for Public Health Law; Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health) [8UL1TR000170-05]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000170] Funding Source: NIH RePORTER	This work, performed under the auspices of the Network for Public Health Law, was made possible by the generous support of the Robert Wood Johnson Foundation and Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 8UL1TR000170-05, and financial contributions from Harvard University and its affiliated academic health care centers. The authors would like to thank Allison Bogsted for her assistance conducting interviews, Joanne Lucas and Blair Inniss for their research support, and Lainie Rutkow for her review of an earlier draft. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Robert Wood Johnson Foundation, Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health.	Bey T, 2009, WEST J EMERG MED, V10, P6; Burris S, 2010, MILBANK Q, V88, P169, DOI 10.1111/j.1468-0009.2010.00595.x; Carroll L J, 2011, CONCUSSION CRISIS AN; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Covassin T., 2012, AM J SPORTS MED, V20, P1; Gilchrist J., 2011, 60 CDC MORB MORT WEE, V60; GOLDING D, 1992, RISK ANAL, V12, P27, DOI 10.1111/j.1539-6924.1992.tb01304.x; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Lowrey K. M., 2011, SUMMARY MATRIX STATE; Matheson GO, 2011, CLIN J SPORT MED, V21, P25, DOI 10.1097/JSM.0b013e3182095f92; Nansel TR, 2002, PATIENT EDUC COUNS, V46, P175, DOI 10.1016/S0738-3991(01)00211-7; Robert Wood Johnson Foundation, STRENGTH ENF PUBL HL; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Shrier I, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-092492; Wood J, 2013, PUBLIC HLTH LAW THEO, P325; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	18	36	36	0	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics	FAL	2014	42	3			SI		290	296		10.1111/jlme.12146			7	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	AQ4ED	WOS:000342745000004	25264087				2022-02-06	
J	Jerusalem, A; Garcia-Grajales, JA; Merchan-Perez, A; Pena, JM				Jerusalem, Antoine; Garcia-Grajales, Julian A.; Merchan-Perez, Angel; Pena, Jose M.			A computational model coupling mechanics and electrophysiology in spinal cord injury	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Computational model; Axon; Electrophysiology; Mechanics; Spinal cord injury	WHITE-MATTER; MYELIN; AXONS; CONDUCTION; ELONGATION; CHANNELS; DEFICITS	Traumatic brain injury and spinal cord injury have recently been put under the spotlight as major causes of death and disability in the developed world. Despite the important ongoing experimental and modeling campaigns aimed at understanding the mechanics of tissue and cell damage typically observed in such events, the differentiated roles of strain, stress and their corresponding loading rates on the damage level itself remain unclear. More specifically, the direct relations between brain and spinal cord tissue or cell damage, and electrophysiological functions are still to be unraveled. Whereas mechanical modeling efforts are focusing mainly on stress distribution and mechanistic-based damage criteria, simulated function-based damage criteria are still missing. Here, we propose a new multiscale model of myelinated axon associating electrophysiological impairment to structural damage as a function of strain and strain rate. This multiscale approach provides a new framework for damage evaluation directly relating neuron mechanics and electrophysiological properties, thus providing a link between mechanical trauma and subsequent functional deficits.	[Jerusalem, Antoine] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Garcia-Grajales, Julian A.] Univ Politecn Madrid, Madrid, Spain; [Garcia-Grajales, Julian A.] IMDEA Mat Inst, Madrid, Spain; [Merchan-Perez, Angel] Univ Politecn Madrid, Lab Circuitos Cort, Ctr Tecnol Biomed, Madrid, Spain; [Merchan-Perez, Angel; Pena, Jose M.] Univ Politecn Madrid, DATSI, Madrid, Spain		Jerusalem, A (corresponding author), Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England.	antoine.jerusalem@eng.ox.ac.uk	Merchan-Perez, Angel/D-7417-2014; Merchan-Perez, Angel/AAY-8947-2020	Merchan-Perez, Angel/0000-0002-7228-5821; Merchan-Perez, Angel/0000-0002-7228-5821; Pena, Jose Maria/0000-0002-3303-0455; Jerusalem, Antoine/0000-0001-5026-8038	European Research Council under the European UnionEuropean Research Council (ERC) [306587]; Spanish Ministry of ScienceSpanish Government [TIN2010-21289-C02-02]; Cajal Blue Brain Project, the Spanish partner of the Blue Brain Project	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP72007-2013)/ERC Grant Agreement No. 306587, from the Spanish Ministry of Science (TIN2010-21289-C02-02), and the Cajal Blue Brain Project, the Spanish partner of the Blue Brain Project. The authors gratefully acknowledge the computer resources, technical expertise and assistance provided by the Supercomputing and Visualization Center of Madrid (CeSViMa).	Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Babbs CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067767; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2011, THESIS EINDHOVEN U T; Coggan JS, 2010, P NATL ACAD SCI USA, V107, P20602, DOI 10.1073/pnas.1013798107; Connell S, 2011, J NEUROTRAUM, V28, P1229, DOI 10.1089/neu.2011.1832; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; DENNERLL TJ, 1989, J CELL BIOL, V109, P3073, DOI 10.1083/jcb.109.6.3073; Garcia JA, 2012, CMES-COMP MODEL ENG, V87, P411; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gupta RS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00217; Hains BC, 2004, EXP NEUROL, V188, P365, DOI 10.1016/j.expneurol.2004.04.001; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; HILDEBRAND C, 1978, J NEUROL SCI, V38, P421, DOI 10.1016/0022-510X(78)90147-8; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; IBRAHIM M, 1995, J NEUROL SCI, V133, P119, DOI 10.1016/0022-510X(95)00174-Z; Ichimura H, 2005, J ORTHOP SCI, V10, P214, DOI 10.1007/s00776-004-0870-8; JACOBS JM, 1969, J ANAT, V105, P295; Jensen TH, 2011, NEUROIMAGE, V57, P124, DOI 10.1016/j.neuroimage.2011.04.013; Jerusalem A, 2012, ACTA BIOMATER, V8, P3360, DOI 10.1016/j.actbio.2012.04.039; Koch Christof, 1999, P1; Markin VS, 1999, BIOPHYS J, V76, P2852, DOI 10.1016/S0006-3495(99)77439-4; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; OCHS S, 1994, NEUROSCIENCE, V61, P361, DOI 10.1016/0306-4522(94)90237-2; Ouyang H, 2010, J NEUROTRAUM, V27, P1109, DOI 10.1089/neu.2010.1271; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shreiber DI, 2009, BIOMECH MODEL MECHAN, V8, P311, DOI 10.1007/s10237-008-0137-y; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; WAXMAN SG, 1978, J NEUROL NEUROSUR PS, V41, P408, DOI 10.1136/jnnp.41.5.408; Wu L, 2013, ENG FRACT MECH, V104, P162, DOI 10.1016/j.engfracmech.2013.03.018	39	36	36	1	17	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	AUG	2014	13	4					883	896		10.1007/s10237-013-0543-7			14	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	AL5EN	WOS:000339156400015	24337934	Green Accepted			2022-02-06	
J	Jia, F; Yin, YH; Gao, GY; Wang, Y; Cen, L; Jiang, JY				Jia, Feng; Yin, Yu Hua; Gao, Guo Yi; Wang, Yu; Cen, Lian; Jiang, Ji-yao			MMP-9 Inhibitor SB-3CT Attenuates Behavioral Impairments and Hippocampal Loss after Traumatic Brain Injury in Rat	JOURNAL OF NEUROTRAUMA			English	Article						hippocampus; neuroprotection; SB-3CT; traumatic brain injury	MATRIX-METALLOPROTEINASE ACTIVITY; MATRIX-METALLOPROTEINASE-9; EXPRESSION; ISCHEMIA; DEFICITS; BLOOD; FLUID; PROTEOLYSIS; HYPOTHERMIA; APOPTOSIS	The aim of this study was to evaluate the potential efficacy of SB-3CT, a matrix metallopeptidase 9 inhibitor, on behavioral and histological outcomes after traumatic brain injury (TBI) in rats. Adult male Sprague-Dawley rats were randomly divided into three groups (n = 15/group): TBI with SB-3CT treatment, TBI with saline, and sham injury. The TBI model was induced by a fluid percussion TBI device. SB-3CT (50 mg/kg in 10% dimethyl sulfoxide) was administered intraperitoneally at 30 min, 6 h, and 12 h after the TBI. Motor function (beam-balance/beam-walk tests) and spatial learning/memory (Morris water maze) were assessed on post-operative Days 1-5 and 11-15, respectively. Fluoro-Jade staining, immunofluorescence, and cresyl violet-staining were carried out for histopathological evaluation at 24 h, 72 h, and 15 days after TBI, respectively. It was shown that TBI can result in significant behavioral deficit induced by acute neurodegeneration, increased expression of cleaved caspase-3, and long-term neuronal loss. SB-3CT intervention via the current regime provides robust behavioral protection and hippocampal neurons preservation from the deleterious effects of TBI. Hence, the efficacy of SB-3CT on TBI prognosis could be ascertained. It is believed that the current study adds to the growing literature in identifying SB-3CT as a potential therapy for human brain injury.	[Jia, Feng; Yin, Yu Hua; Gao, Guo Yi; Wang, Yu; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Dept Neurosurg, Shanghai 200127, Peoples R China; [Cen, Lian] E China Univ Sci & Technol, Sch Chem Engn, Shanghai 20237, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, RenJi Hosp, Dept Neurosurg, Sch Med, Shanghai 200127, Peoples R China.	cenlian@hotmail.com; jiangjyb@126.com			973 projectNational Basic Research Program of China [2012CB518100, 2010CB944804]; National Key Basic Research ProjectNational Basic Research Program of China [81271381]; National Science and Nature Grant [81000829]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [11QB1402200]	This work was supported by grants from 973 project (No. 2012CB518100, No. 2010CB944804), National Key Basic Research Project (No. 81271381), National Science and Nature Grant (No. 81000829), and the Fundamental Research Funds for the Central Universities (No. 11QB1402200).	Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cui J., 2012, MOL NEURODEGENER, V15, P1186; Demestre M, 2004, NEUROSCIENCE, V124, P767, DOI 10.1016/j.neuroscience.2003.12.037; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Faden AI, 1996, JAMA-J AM MED ASSOC, V276, P569, DOI 10.1001/jama.276.7.569; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feng JF, 2011, BRAIN RES, V1395, P62, DOI 10.1016/j.brainres.2011.04.022; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Jia F, 2014, J NEUROTRAUM, V31, P387, DOI 10.1089/neu.2008.0814; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Kang SW, 2011, BRAIN RES, V1371, P121, DOI 10.1016/j.brainres.2010.11.057; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Liedtke W, 1998, ANN NEUROL, V44, P35, DOI 10.1002/ana.410440110; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Matyszak MK, 1996, J NEUROIMMUNOL, V69, P141; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Noble LJ, 2002, J NEUROSCI, V22, P7526; Ralay R. H., 2011, J NEUROTRAUM, V28, P1757, DOI DOI 10.1089/NEU.2011.1799; Ranasinghe HS, 2012, DEV NEUROSCI-BASEL, V34, P417, DOI 10.1159/000343257; Rau TF, 2012, J TRAUMA ACUTE CARE, V73, pS165, DOI 10.1097/TA.0b013e318260896a; Redford EJ, 1997, BRAIN, V120, P1895, DOI 10.1093/brain/120.10.1895; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Rosenberg GA, 1997, NEUROLOGY, V48, P921, DOI 10.1212/WNL.48.4.921; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Sood RR, 2008, J CEREBR BLOOD F MET, V28, P431, DOI 10.1038/sj.jcbfm.9600534; Steinmann-Niggli K, 1998, J AM SOC NEPHROL, V9, P397; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Vyavahare N, 2000, AM J PATHOL, V157, P885, DOI 10.1016/S0002-9440(10)64602-0; Wang J, 2005, NEUROCRIT CARE, V3, P77, DOI 10.1385/NCC:3:1:077; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Xiong Y, 2012, J NEUROSURG, V116, P1081, DOI 10.3171/2012.1.JNS111729; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Yu F, 2008, J NEUROTRAUM, V25, P184, DOI 10.1089/neu.2007.0438; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	53	36	36	2	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2014	31	13					1225	1234		10.1089/neu.2013.3230			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AL2VK	WOS:000338983500011	24661104	Green Published			2022-02-06	
J	Miller, DM; Wang, JA; Buchanan, AK; Hall, ED				Miller, Darren M.; Wang, Juan A.; Buchanan, Ashley K.; Hall, Edward D.			Temporal and Spatial Dynamics of Nrf2-Antioxidant Response Elements Mediated Gene Targets in Cortex and Hippocampus after Controlled Cortical Impact Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						4-hydroxy-2-nonenal; gene expression; lipid peroxidation; Nrf2; oxidative damage; traumatic brain injury	AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSCRIPTION FACTOR NRF2; COMPLEX-II INHIBITION; OXIDATIVE STRESS; CEREBRAL-ISCHEMIA; SYNAPTIC PROTEINS; CARNOSIC ACID; SPINAL-CORD; MOUSE MODEL; HEAD-INJURY	The pathophysiological importance of oxidative damage after traumatic brain injury (TBI) has been extensively demonstrated. The transcription factor nuclear factor erythoid related factor 2 (Nrf2) mediates antioxidant and cytoprotective genes by binding to antioxidant response elements (ARE) present in nuclear DNA. In this study, we characterized the time course of Nrf2-ARE-mediated expression in the cortex and hippocampus using a unilateral controlled cortical impact model of focal TBI. Ipsilateral hippocampal and cortical tissue was collected for Western-blot protein analysis (n = 6/group) or quantitative reverse transcription-polymerase chain reaction for mRNA (n = 3/group) at 3, 6, 12, 24, 48, and 72 h or 1 week post-injury. Multiple genes mediated by Nrf2-ARE were altered post-TBI. Specifically, Nrf2 mRNA increased significantly post-TBI at 48 and 72 h in the cortex and at 48 and 72 h and 1 week in the hippocampus with a coincident increase in glial fibrillary acidic protein mRNA, thereby implying this response is likely occurring in astrocytes. Presumably linked to Nrf2 activation, heme-oxygenase-1, nicotinamide adenine dinucleotide phosphate-quinone-oxidoreductase 1, glutathione reductase, and catalase mRNA overlap throughout the post-injury time course. This study demonstrates the first evidence of such changes during the first week after focal TBI and that increases in expression of some Nrf2-AREmediated cytoprotective genes are not observed until 24-48 h post-injury. Unfortunately, this does not precede, but rather coincides with, the occurrence of lipid peroxidative damage. This is the first known comparison between the time course of peroxidative damage and that of Nrf2-ARE activation during the first week post-TBI. These results underscore the necessity to discover pharmacological agents to accelerate and amplify Nrf2-ARE-mediated expression early post-TBI.	[Miller, Darren M.; Wang, Juan A.; Buchanan, Ashley K.; Hall, Edward D.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Miller, Darren M.; Hall, Edward D.] Univ Kentucky, Dept Anat & Neurobiol, Coll Med, Lexington, KY 40536 USA		Hall, ED (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Spinal Cord & Brain Injury Res Ctr, Coll Med, 741 S Limestone St BBSRB Room B477, Lexington, KY 40536 USA.	edhall@uky.edu	Hall, Edward D/F-8930-2013		NIH-NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [1T32 DA022738]; NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1T32 NS077889, 2P30 NS051220-01]; Kentucky Spinal Cord & Head Injury Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS051220, T32NS077889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA022738] Funding Source: NIH RePORTER	The authors would like to thank Kimberly M. Carrico for expert technical assistance. This work was supported by grants NIH-NIDA 1T32 DA022738, NIH-NINDS 1T32 NS077889, NIH-NINDS 2P30 NS051220-01, and funds from the Kentucky Spinal Cord & Head Injury Research Trust.	Andrus PK, 1998, J NEUROCHEM, V71, P2041; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11366, DOI 10.1073/pnas.90.23.11366; Cheng ZG, 2013, ASIAN PAC J TROP MED, V6, P305, DOI 10.1016/S1995-7645(13)60061-9; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Dowell JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070163; Hall E D, 1994, Adv Pharmacol, V28, P221, DOI 10.1016/S1054-3589(08)60497-4; HALL ED, 1994, ANN NY ACAD SCI, V738, P15; HALL ED, 1993, RES P ARNMD, V71, P81; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Innamorato NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011838; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jin W, 2009, EXP BIOL MED, V234, P181, DOI 10.3181/0807-RM-232; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kraft AD, 2007, EXP NEUROL, V207, P107, DOI 10.1016/j.expneurol.2007.05.026; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Miller DM, 2013, FREE RADICAL BIO MED, V57, P1, DOI 10.1016/j.freeradbiomed.2012.12.011; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Rojo AI, 2010, GLIA, V58, P588, DOI 10.1002/glia.20947; Satoh T, 2008, J NEUROCHEM, V104, P1116, DOI 10.1111/j.1471-4159.2007.05039.x; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Son TG, 2010, J NEUROCHEM, V112, P1316, DOI 10.1111/j.1471-4159.2009.06552.x; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	46	36	38	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2014	31	13					1194	1201		10.1089/neu.2013.3218			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AL2VK	WOS:000338983500008	24628668	Green Published			2022-02-06	
J	Salazar, D; Golz, A; Israel, H; Marra, G				Salazar, Dane; Golz, Andrew; Israel, Heidi; Marra, Guido			Heterotopic Ossification of the Elbow Treated With Surgical Resection: Risk Factors, Bony Ankylosis, and Complications	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							RADIATION-THERAPY; EARLY EXCISION; EXPERIENCE; FIXATION; RELEASE; INJURY; BURNS	Heterotopic ossification is the most common extrinsic cause of elbow contracture and may lead to clinically important stiffness, and rarely, complete bony ankylosis. Surgery sometimes is performed to treat this problem, and published reports differ regarding the factors that are associated with success or failure after this operation and whether the procedure is effective for patients with elbow ankylosis. We wished (1) to identify potential patient characteristics and modifiable risk factors that are associated with improvements in ROM after surgery for heterotopic ossification of the elbow; (2) to compare ROM gains between patients with complete ankylosis and partially restricted ROM; and (3) to characterize the complications of elbows treated by surgical release and excision of heterotopic ossification followed by a standardized rehabilitation program. We reviewed the records of all patients treated operatively for heterotopic ossification of the elbow from September 1999 to February 2012 at one institution by one surgeon. General indications for the surgery were clinically symptomatic or debilitating heterotopic ossification of the elbow. Each patient received prophylaxis postoperatively consisting of indomethacin (or single-shot radiation for patients with sensitivity to antiinflammatory medications). All patients received a physical therapy regimen and used a continuous passive motion machine for 6 weeks. Patient demographics, mechanism of injury, time between injury and surgery, and medical history were reviewed for comparison. Followup was at a mean of 13 months (range, 3-106 months); no patients were lost to followup. Thirty-nine patients (46 elbows) with heterotopic ossification treated with excision were identified: 10 patients (16 elbows) had burns, 28 patients (29 elbows) had trauma, and one patient (one elbow) had a closed head injury. Eight of the 39 patients (12 of 46 elbows [26%]) had complete ankylosis at the time of surgery. Hypertension, obesity, and absence of intraoperative anterior ulnar nerve transposition were associated with an adverse effect on change from preoperative to final arc of motion. The group with ankylosis had greater preoperative to postoperative gain in arc compared with the group with partial restriction (96A degrees, 95% CI, 84A degrees-107A degrees and 59A degrees, 95% CI, 46A degrees-72A degrees, respectively). For the entire cohort there was an overall improvement in mean flexion-extension arc of motion from 35A degrees to 103A degrees at final followup (p < 0.001; 95% CI, 57A degrees-80A degrees), with a 17% rate of complications (three patients [three elbows] with heterotopic ossification, three patients [three elbows] with nerve palsies, one patient [one elbow] with deep wound infection, and one patient [one elbow] with an unstable elbow). Patients with partially and completely restricted ROM showed substantial improvement in postoperative ROM. Hypertension, obesity, and absence of intraoperative anterior ulnar nerve transposition were negative predictors of outcome in our series. Surgery combined with postoperative prophylaxis and a regimented rehabilitation program are feasible modalities to treat patients with heterotopic ossification of the elbow. Level IV, therapeutic study. See the Instructions for Authors for a complete description of levels of evidence.	[Salazar, Dane; Golz, Andrew] Loyola Univ Hlth Syst, Dept Orthopaed Surg & Rehabil, Maywood, IL 60153 USA; [Israel, Heidi] St Louis Univ, Dept Orthopaed Surg, St Louis, MO 63103 USA; [Marra, Guido] Northwestern Univ, Dept Orthopaed Surg, Feinberg Sch Med, Chicago, IL 60611 USA		Salazar, D (corresponding author), Loyola Univ Hlth Syst, Dept Orthopaed Surg & Rehabil, 2160 South First Ave, Maywood, IL 60153 USA.	dsalazar@post.com			Zimmer Inc (Warsaw, IN, USA)	One of the authors certifies that he (GM), or a member of his or her immediate family, has or may receive payments or benefits, during the study period, an amount of less than 10,000 USD from Zimmer Inc (Warsaw, IN, USA).	Abrams GD, 2012, J SHOULDER ELB SURG, V21, P1550, DOI 10.1016/j.jse.2012.05.040; Akman S, 2010, ACTA ORTHOP TRAUMATO, V44, P206, DOI 10.3944/AOTT.2010.2441; Baldwin K, 2011, J HAND SURG-AM, V36A, P798, DOI 10.1016/j.jhsa.2011.01.015; Brouwer KM, 2010, J HAND SURG-AM, V35A, P1115, DOI 10.1016/j.jhsa.2010.03.040; Chao EK, 2002, J TRAUMA, V53, P928, DOI 10.1097/00005373-200211000-00019; Chapleau J, 2011, CLIN ORTHOP RELAT R, V469, P3134, DOI 10.1007/s11999-011-1986-8; COHEN RB, 1993, J BONE JOINT SURG AM, V75A, P215, DOI 10.2106/00004623-199302000-00008; GARDNER RJM, 1988, J MED GENET, V25, P113, DOI 10.1136/jmg.25.2.113; Garland DE, 1998, J BONE JOINT SURG AM, V80A, P453, DOI 10.2106/00004623-199803000-00023; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Gaur A, 2003, J BONE JOINT SURG AM, V85A, P1538, DOI 10.2106/00004623-200308000-00016; HASTINGS H, 1994, HAND CLIN, V10, P417; Hunt JL, 2006, J BURN CARE RES, V27, P535, DOI 10.1097/01.BCR.0000226023.58438.14; Keschner MT, 2007, BULL HOSP JT DIS, V65, P24; Koh KH, 2013, J SHOULDER ELB SURG, V22, P1128, DOI 10.1016/j.jse.2013.04.019; Lee EK, 2013, J SHOULDER ELB SURG, V22, P716, DOI 10.1016/j.jse.2012.11.020; Maender C, 2010, J SHOULDER ELB SURG, V19, P1269, DOI 10.1016/j.jse.2010.05.029; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; MORREY BF, 1981, J BONE JOINT SURG AM, V63, P872, DOI 10.2106/00004623-198163060-00002; Park MJ, 2010, J BONE JOINT SURG AM, V92A, P2692, DOI 10.2106/JBJS.I.01367; Ring D, 2003, J BONE JOINT SURG AM, V85A, P849, DOI 10.2106/00004623-200305000-00012; Ring David, 2004, Tech Hand Up Extrem Surg, V8, P25, DOI 10.1097/00130911-200403000-00007; Ruan HJ, 2013, ARCH ORTHOP TRAUM SU, V133, P179, DOI 10.1007/s00402-012-1659-4; Summerfield SL, 1997, J SHOULDER ELB SURG, V6, P321, DOI 10.1016/S1058-2746(97)90025-2; Tsionos I, 2004, J BONE JOINT SURG BR, V86B, P396, DOI 10.1302/0301-620X.86B3.14480	26	36	43	1	38	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUL	2014	472	7					2269	2275		10.1007/s11999-014-3591-0			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	AI6XP	WOS:000337021300041	24711127	Green Published, Bronze			2022-02-06	
J	Simpson, JR				Simpson, Joseph R.			DSM-5 and Neurocognitive Disorders	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							TRAUMATIC BRAIN-INJURY; OPERATION IRAQI FREEDOM	The newest edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) introduces several changes in the diagnostic criteria for dementia and other cognitive disorders. Some of these changes may prove helpful for clinical and forensic practitioners, particularly when evaluating less severe cognitive impairments. The most substantial change is that the cognitive disorder-not otherwise specified category found in prior editions has been eliminated. Those disorders that do not cause sufficient impairment to qualify for a diagnosis of dementia are now defined as neurocognitive disorders and placed on a spectrum with the more severe conditions. The concept of social cognition is also introduced as one of the core functional domains that can be affected by a neurocognitive disorder. This concept may be particularly significant in the evaluation of patients with non-Alzheimer's dementias, such as frontotemporal dementia. With the aging of the population and the increasing recognition of the possibility of long-lasting cognitive deficits after traumatic brain injury, the need for assessment of cognitive disorders in medicolegal contexts is certain to increase. Forensic psychiatrists who perform these evaluations should understand the conceptualization of Neurocognitive Disorders as presented in DSM-5 and how it differs from prior diagnostic systems.	[Simpson, Joseph R.] Univ So Calif, Keck Sch Med, Los Angeles Cty Jail Mental Hlth Serv, Los Angeles, CA 90033 USA; [Simpson, Joseph R.] Univ So Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA		Simpson, JR (corresponding author), POB 818, Hermosa Beach, CA 90254 USA.	jrsimpsonmd@gmail.com					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Faul M, 2010, TRAUMATIC BRAIN INJU; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gordon C, 2013, EXPERT REV NEUROTHER, V13, P1247, DOI 10.1586/14737175.2013.856265; Korngold C, 2013, J AM ACAD PSYCHIATRY, V41, P430; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mendez MF, 2010, J AM ACAD PSYCHIATRY, V38, P318; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679	12	36	39	0	2	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law	JUN 1	2014	42	2					159	164					6	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	AN8LW	WOS:000340856700005	24986342				2022-02-06	
J	Dubrovsky, AS; Friedman, D; Kocilowicz, H				Dubrovsky, Alexander Sasha; Friedman, Debbie; Kocilowicz, Helen			Pediatric Post-Traumatic Headaches and Peripheral Nerve Blocks of the Scalp: A Case Series and Patient Satisfaction Survey	HEADACHE			English	Article						post-concussion syndrome; post-traumatic headache; nerve block	TRAUMATIC BRAIN-INJURY; GREATER OCCIPITAL NERVE; POSTCONCUSSION SYNDROME; SUBOCCIPITAL REGION; DOUBLE-BLIND; CHILDREN; MANAGEMENT; MIGRAINE; ADOLESCENTS; LANDMARKS	Objective This study's objective is to characterize the therapeutic effect of peripheral nerve blocks of the scalp for children and adolescents with post-traumatic headaches. Background Headaches are the most frequently reported persistent symptoms following a pediatric mild traumatic brain injury, may be challenging to treat, and can transform into debilitating chronic headaches. The beneficial use of peripheral nerve blocks of the scalp has been reported for adults with post-traumatic headaches. Methods Retrospective case series on all patients January 2012 and June 2013 in the mild traumatic brain injury clinic with a nerve block. The main outcome measure was the proportion of patients with a good therapeutic effect, defined by the duration of the block being >24 hours and/or repeat blocks requested. A data extractor blinded to main outcome measures performed the chart review. A patient satisfaction survey was also sent to all patients to assess the recalled experience with the interventions received. Results A total of 62 nerve blocks were performed on 28 patients for 30 injuries that led to post-traumatic headaches. The mean (standard deviation) age was 14.6 (1.7) years. The first nerve blocks were performed a mean (standard deviation) of 70 (54.2) days post-injury. The therapeutic effect was good in 93% of patients with 71% reporting immediate complete relief of their headaches; the mean percent headache reduction was 94%. Most (91%) would recommend a nerve block for post-traumatic headaches. Conclusion The ease with which peripheral nerve blocks of the scalp can be performed combined with the immediate relief experienced by patients makes them a potential addition to the armamentarium of headache management strategies for children and adolescent with post-traumatic headaches.	[Dubrovsky, Alexander Sasha] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Div Pediat Emergency Med, Montreal, PQ, Canada; [Friedman, Debbie; Kocilowicz, Helen] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Montreal, PQ, Canada; [Dubrovsky, Alexander Sasha; Friedman, Debbie] McGill Univ, Fac Med, Montreal, PQ, Canada		Dubrovsky, AS (corresponding author), 2300 Tupper St,Room T-132, Montreal, PQ H3H 1P3, Canada.	sasha.dubrovsky@mcgill.ca					Ashkenazi A, 2010, HEADACHE, V50, P943, DOI 10.1111/j.1526-4610.2010.01675.x; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bartsch T, 2003, BRAIN, V126, P1801, DOI 10.1093/brain/awg190; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blumenfeld A, 2013, HEADACHE, V53, P437, DOI 10.1111/head.12053; Busch V, 2006, CEPHALALGIA, V26, P50, DOI 10.1111/j.1468-2982.2005.00992.x; COPPOLA M, 1995, ANN EMERG MED, V26, P541, DOI 10.1016/S0196-0644(95)70001-3; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; GAWEL MJ, 1992, CEPHALALGIA, V12, P9, DOI 10.1046/j.1468-2982.1992.1201009.x; Guvencer M, 2011, CLIN NEUROL NEUROSUR, V113, P289, DOI 10.1016/j.clineuro.2010.11.021; Hamalainen ML, 1997, NEUROLOGY, V48, P103, DOI 10.1212/WNL.48.1.103; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hecht JS, 2004, J HEAD TRAUMA REHAB, V19, P58, DOI 10.1097/00001199-200401000-00006; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lewis DW, 2002, HEADACHE, V42, P780, DOI 10.1046/j.1526-4610.2002.02180.x; Loukas M., 2006, Folia Morphologica, V65, P337; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Natsis K, 2006, CLIN ANAT, V19, P332, DOI 10.1002/ca.20190; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; SAADAH HA, 1987, HEADACHE, V27, P201, DOI 10.1111/j.1526-4610.1987.hed2704201.x; Tobin JA, 2009, HEADACHE, V49, P1479, DOI 10.1111/j.1526-4610.2009.01549.x; Ward JB, 2003, SEMIN NEUROL, V23, P59; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Winner P, 2002, HEADACHE, V42, P49, DOI 10.1046/j.1526-4610.2002.02013.x	28	36	36	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	MAY	2014	54	5					878	887		10.1111/head.12334			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AG8IW	WOS:000335663000008	24697265				2022-02-06	
J	Fon, D; Al-Abboodi, A; Chan, PPY; Zhou, K; Crack, P; Finkelstein, DI; Forsythe, JS				Fon, Deniece; Al-Abboodi, Aswan; Chan, Peggy P. Y.; Zhou, Kun; Crack, Peter; Finkelstein, David I.; Forsythe, John S.			Effects of GDNF-Loaded Injectable Gelatin-Based Hydrogels on Endogenous Neural Progenitor Cell Migration	ADVANCED HEALTHCARE MATERIALS			English	Article						gelatin; hydrogels; neuroblast migration	TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; STEM-CELLS; NEURONAL DEATH; ADULT BRAIN; CNS INJURY; PORE-SIZE; EXPRESSION; IMPLANTATION; ASTROCYTES	Brain repair following disease and injury is very limited due to difficulties in recruiting and mobilizing stem cells towards the lesion. More importantly, there is a lack of structural and trophic support to maintain viability of the limited stem/progenitor cells present. This study investigates the effectiveness of an injectable gelatin-based hydrogel in attracting neural progenitor cells (NPCs) from the subventricular zone (SVZ) towards the implant. Glial cell-line-derived neurotrophic factor (GDNF) encapsulated within the hydrogel and porosity within the hydrogel prevents glial scar formation. By directly targeting the hydrogel implant towards the SVZ, neuroblasts can actively migrate towards and along the implant tract. Significantly more doublecortin (DCX)-positive neuroblasts surround implants at 7 d post-implantation (dpi) compared with lesion alone controls, an effect that is enhanced when GDNF is incorporated into the hydrogels. Neuroblasts are not observed at the implant boundary at 21 dpi, indicating that neuroblast migration has halted, and neuroblasts have either matured or have not survived. The development of an injectable gelatin-based hydrogel has significant implications for the treatment of some neurodegenerative diseases and brain injuries. The ability of GDNF and porosity to effectively prevent glial scar formation will allow better integration and interaction between the implant and surrounding neural tissue.	[Fon, Deniece; Zhou, Kun; Forsythe, John S.] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia; [Al-Abboodi, Aswan] Monash Univ, Dept Chem Engn, Clayton, Vic 3800, Australia; [Al-Abboodi, Aswan; Chan, Peggy P. Y.] RMIT Univ, Micro Nanophys Res Lab, Melbourne, Vic 3000, Australia; [Chan, Peggy P. Y.] Melbourne Ctr Nanofabricat, Clayton, Vic 3168, Australia; [Crack, Peter] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia; [Finkelstein, David I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia		Forsythe, JS (corresponding author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.	john.forsythe@monash.edu	Finkelstein, David/B-9617-2009; Crack, Peter/ABE-2065-2020	Finkelstein, David/0000-0002-8167-4917; Crack, Peter/0000-0002-5030-0330; Al-Abboodi, Aswan/0000-0003-1063-9900; Chan, Peggy Pui Yik/0000-0001-6676-9769; Forsythe, John/0000-0003-2849-229X	Australian Research CouncilAustralian Research Council [DP120102570, DP0985433]; ARCAustralian Research Council; MCN Technology Fellowship	Funding for this work was partly provided through Australian Research Council Discovery Project Grants DP120102570 and DP0985433. P.J.C. is supported by the ARC Future Fellowship scheme. This work was performed in part at the Melbourne Centre for Nanofabrication. P.P.Y.C. is grateful for an MCN Technology Fellowship that supported this work, and a RMIT University Senior Research Fellowship.	Al-Abboodi A, 2013, BIOTECHNOL BIOENG, V110, P318, DOI 10.1002/bit.24612; Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5; Appel E, 1997, NEUROREPORT, V8, P3309, DOI 10.1097/00001756-199710200-00023; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Arvidsson A, 2003, NEUROBIOL DIS, V14, P542, DOI 10.1016/j.nbd.2003.08.002; Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Bryant SJ, 2007, BIOMATERIALS, V28, P2978, DOI 10.1016/j.biomaterials.2006.11.033; Cheng K, 2012, BIOMATERIALS, V33, P5317, DOI 10.1016/j.biomaterials.2012.04.006; Consales C, 2007, BRAIN RES, V1159, P28, DOI 10.1016/j.brainres.2007.04.071; Cunningham JJ, 2012, NAT BIOTECHNOL, V30, P849, DOI 10.1038/nbt.2329; Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275; Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001; Duarte EP, 2012, GROWTH FACTORS, V30, P242, DOI 10.3109/08977194.2012.691478; Elias PZ, 2012, J NEUROTRAUM, V29, P2086, DOI 10.1089/neu.2011.2181; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gorgieva S, 2011, BIOMATERIALS APPL NA; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Heile Anna, 2011, Dialogues Clin Neurosci, V13, P279; Hernandez-Ortega K, 2011, NEUROSCI BULL, V27, P185, DOI 10.1007/s12264-011-1002-z; Huang KF, 2012, BIOMATERIALS, V33, P2067, DOI 10.1016/j.biomaterials.2011.11.040; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; KRISTT DA, 1987, J NEUROPATH EXP NEUR, V46, P668, DOI 10.1097/00005072-198711000-00006; Lapchak PA, 1997, BRAIN RES, V747, P92, DOI 10.1016/S0006-8993(96)01265-6; Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028; Lim TC, 2012, BIOMATERIALS, V33, P3446, DOI 10.1016/j.biomaterials.2012.01.037; Lin CH, 2006, EXP NEUROL, V201, P225, DOI 10.1016/j.expneurol.2006.04.014; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nisbet DR, 2010, TISSUE ENG PT A, V16, P2833, DOI [10.1089/ten.tea.2009.0677, 10.1089/ten.TEA.2009.0677]; O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052; Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Powell HM, 2009, TISSUE ENG PT A, V15, P2177, DOI 10.1089/ten.tea.2008.0473; Ratner BD, 2007, POLYM INT, V56, P1183, DOI 10.1002/pi.2319; Rocha SM, 2012, NEUROBIOL DIS, V47, P407, DOI 10.1016/j.nbd.2012.04.014; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sandhu JK, 2009, NEUROBIOL DIS, V33, P405, DOI 10.1016/j.nbd.2008.11.016; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Toh WS, 2012, BIOMATERIALS, V33, P3835, DOI 10.1016/j.biomaterials.2012.01.065; TOMAC A, 1995, P NATL ACAD SCI USA, V92, P8274, DOI 10.1073/pnas.92.18.8274; Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075; Wang LS, 2010, BIOMATERIALS, V31, P1148, DOI 10.1016/j.biomaterials.2009.10.042; Wang W, 2004, BRAIN RES, V1023, P92, DOI 10.1016/j.brainres.2004.07.034; Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715; Yang CY, 2009, BIOMATERIALS, V30, P2881, DOI 10.1016/j.biomaterials.2009.01.056; Zhang WR, 2001, BRAIN RES, V903, P253, DOI 10.1016/S0006-8993(01)02364-2; Zhao ZQ, 2004, EXP NEUROL, V190, P356, DOI 10.1016/j.expneurol.2004.06.015	55	36	36	0	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2192-2640	2192-2659		ADV HEALTHC MATER	Adv. Healthc. Mater.	MAY	2014	3	5					761	774		10.1002/adhm.201300287			14	Engineering, Biomedical; Nanoscience & Nanotechnology; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics; Materials Science	AG9HO	WOS:000335730200013	24596339				2022-02-06	
J	Garcia-Ovejero, D; Gonzalez, S; Paniagua-Torija, B; Lima, A; Molina-Holgado, E; De Nicola, AF; Labombarda, F				Garcia-Ovejero, Daniel; Gonzalez, Susana; Paniagua-Torija, Beatriz; Lima, Analia; Molina-Holgado, Eduardo; De Nicola, Alejandro F.; Labombarda, Florencia			Progesterone Reduces Secondary Damage, Preserves White Matter, and Improves Locomotor Outcome after Spinal Cord Contusion	JOURNAL OF NEUROTRAUMA			English	Article						oligodendrocytes; spinal cord injury; spare white matter; progesterone; CatWalk	TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; GAIT ANALYSIS; SCIATIC-NERVE; RAT; OLIGODENDROCYTE; MOTOR; EXPRESSION; INCREASES; NEURONS	Progesterone is an anti-inflammatory and promyelinating agent after spinal cord injury, but its effectiveness on functional recovery is still controversial. In the current study, we tested the effects of chronic progesterone administration on tissue preservation and functional recovery in a clinically relevant model of spinal cord lesion (thoracic contusion). Using magnetic resonance imaging, we observed that progesterone reduced both volume and rostrocaudal extension of the lesion at 60 days post-injury. In addition, progesterone increased the number of total mature oligodendrocytes, myelin basic protein immunoreactivity, and the number of axonal profiles at the epicenter of the lesion. Further, progesterone treatment significantly improved motor outcome as assessed using the Basso-Bresnahan-Beattie scale for locomotion and CatWalk gait analysis. These data suggest that progesterone could be considered a promising therapeutical candidate for spinal cord injury.	[Garcia-Ovejero, Daniel; Paniagua-Torija, Beatriz; Molina-Holgado, Eduardo] Hosp Nacl Paraplej, Lab Neuroinflamac, Toledo, Spain; [Gonzalez, Susana] Inst Biol & Med Expt, Lab Nocicepc & Dolor Neuropat, RA-1428 Buenos Aires, DF, Argentina; [Lima, Analia; De Nicola, Alejandro F.; Labombarda, Florencia] Inst Biol & Med Expt, Lab Bioquim Neuroendocrina, RA-1428 Buenos Aires, DF, Argentina; [Gonzalez, Susana; De Nicola, Alejandro F.; Labombarda, Florencia] Univ Buenos Aires, Dept Human Biochem, Sch Med, Buenos Aires, DF, Argentina		Labombarda, F (corresponding author), Inst Biol & Med Expt CONICET, Lab Bioquim Neuroendocrina, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	florlabombarda@gmail.com	Molina-Holgado, Eduardo/C-2714-2008; Garcia-Ovejero, Daniel/H-9090-2019	Molina-Holgado, Eduardo/0000-0001-6693-1682; Garcia-Ovejero, Daniel/0000-0002-7479-5104	University of Buenos AiresUniversity of Buenos Aires [UBACyT 2011-2014: 20020100200053, UBACyT 2011-2014: 20020100100089]; Wings for Life Foundation	We thank Dr. Angel Arevalo-Martin for his generous assistance with MRI interpretation and his contribution to the development of some quantification procedures. We also are grateful to Dr. Jorge Collazos-Castro for his selfless help and generosity in sharing his knowledge. We thank Javier Mazario for his generous assistance with thermical and mechanical sensitivity tests. We thank Marien Fernandez, David Castejon, and Palmira Villa (CAI de Resonancia Magnetica, Instituto Pluridisciplinar, Universidad Complutense de Madrid) for technical assistance with the MRI. This work was supported by the University of Buenos Aires (UBACyT 2011-2014: 20020100200053 - / UBACyT 2011-2014: 20020100100089). B. Paniagua was partially funded by Wings for Life Foundation.	Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Ambrozaitis Kazys Vytautas, 2006, Medicina (Kaunas), V42, P255; Arevalo-Martin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049057; Arevalo-Martin A, 2010, NEUROBIOL DIS, V38, P304, DOI 10.1016/j.nbd.2010.02.002; Azcoitia I, 2003, NEUROBIOL AGING, V24, P853, DOI 10.1016/S0197-4580(02)00234-8; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Barriere G, 2008, J NEUROSCI, V28, P3976, DOI 10.1523/JNEUROSCI.5692-07.2008; Basso DM, 2004, J NEUROTRAUM, V21, P395, DOI 10.1089/089771504323004548; Basso DM, 2002, RESTOR NEUROL NEUROS, V20, P189; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 2000, PHYS THER, V80, P808, DOI 10.1093/ptj/80.8.808; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Bodley R, 2002, EUR J RADIOL, V42, P135, DOI 10.1016/S0720-048X(02)00046-3; BRACKEN MB, 1990, MED J AUSTRALIA, V153, P368, DOI 10.5694/j.1326-5377.1990.tb136976.x; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Clarac F, 2008, BRAIN RES REV, V57, P13, DOI 10.1016/j.brainresrev.2007.07.015; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Deumens R, 2006, EXP NEUROL, V200, P89, DOI 10.1016/j.expneurol.2006.01.030; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Dolan S, 2007, EUR J PAIN, V11, P644, DOI 10.1016/j.ejpain.2006.10.002; Fee DB, 2007, BRAIN RES, V1137, P146, DOI 10.1016/j.brainres.2006.12.024; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gago N, 2001, GLIA, V36, P295, DOI 10.1002/glia.1117; Garay L, 2011, NEUROSCIENCE, V192, P588, DOI 10.1016/j.neuroscience.2011.06.065; Garay LI, 2012, NEUROSCIENCE, V226, P40, DOI 10.1016/j.neuroscience.2012.09.032; Garcia-Ovejero D, 2013, J COMP NEUROL, V521, P233, DOI 10.1002/cne.23184; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Giatti S, 2012, J NEUROENDOCRINOL, V24, P851, DOI 10.1111/j.1365-2826.2012.02284.x; GOLDBERG AL, 1990, CLIN IMAG, V14, P11, DOI 10.1016/0899-7071(90)90111-N; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guertin PA, 2009, BRAIN RES REV, V62, P45, DOI 10.1016/j.brainresrev.2009.08.002; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hendriks WTJ, 2006, J NEUROTRAUM, V23, P18, DOI 10.1089/neu.2006.23.18; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Joosten EAJ, 2004, J NEUROSCI RES, V77, P127, DOI 10.1002/jnr.20088; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; Koopmans GC, 2006, EUR J NEUROSCI, V23, P1035, DOI 10.1111/j.1460-9568.2006.04627.x; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Labombarda F, 2002, J NEUROTRAUM, V19, P343, DOI 10.1089/089771502753594918; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Lammertse DP, 2013, SPINAL CORD, V51, P2, DOI 10.1038/sc.2012.137; Lankhorst AJ, 2001, J NEUROTRAUM, V18, P203, DOI 10.1089/08977150150502622; Leonelli E, 2006, J MOL NEUROSCI, V28, P65, DOI 10.1385/JMN:28:1:65; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; Magnuson DSK, 1999, EXP NEUROL, V156, P191, DOI 10.1006/exnr.1999.7016; Nguyen T, 2009, J NEUROSCI, V29, P630, DOI 10.1523/JNEUROSCI.5204-08.2009; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Parashari UC, 2011, J CRANIOVERTEBRAL JU, V2, P17, DOI 10.4103/0974-8237.85309; PEARSON KG, 1991, J NEUROPHYSIOL, V66, P1874, DOI 10.1152/jn.1991.66.6.1874; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Rabchevsky AG, 2007, GLIA, V55, P831, DOI 10.1002/glia.20508; Rabchevsky AG, 2011, PHARMACOL THERAPEUT, V132, P15, DOI 10.1016/j.pharmthera.2011.05.001; Raineteau O, 2002, EUR J NEUROSCI, V16, P1761, DOI 10.1046/j.1460-9568.2002.02243.x; Reier PJ, 2002, PROG BRAIN RES, V137, P49; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Schumacher M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00010; Singh A, 2011, NEUROREHAB NEURAL RE, V25, P24, DOI 10.1177/1545968310378510; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Van Meeteren NLU, 2003, J NEUROTRAUM, V20, P1029, DOI 10.1089/089771503770195876; Vlamings R, 2007, NEUROSCIENCE, V148, P815, DOI 10.1016/j.neuroscience.2007.06.043; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	89	36	37	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2014	31	9					857	871		10.1089/neu.2013.3162			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AF6TQ	WOS:000334847900007	24460450	Green Published			2022-02-06	
J	Santarsieri, M; Niyonkuru, C; McCullough, EH; Dobos, JA; Dixon, CE; Berga, SL; Wagner, AK				Santarsieri, Martina; Niyonkuru, Christian; McCullough, Emily H.; Dobos, Julie A.; Dixon, C. Edward; Berga, Sarah L.; Wagner, Amy K.			Cerebrospinal Fluid Cortisol and Progesterone Profiles and Outcomes Prognostication after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cortisol; outcome; group based trajectory analysis; progesterone; traumatic brain injury	SPINAL-CORD-INJURY; P-GLYCOPROTEIN; 11-BETA-HYDROXYSTEROID DEHYDROGENASES; NEUROSTEROID BIOSYNTHESIS; STEROIDOGENIC ENZYMES; GENE-EXPRESSION; NERVOUS-SYSTEM; HORMONE-LEVELS; CSF CORTISOL; RAT-BRAIN	Despite significant advances in the management of head trauma, there remains a lack of pharmacological treatment options for traumatic brain injury (TBI). While progesterone clinical trials have shown promise, corticosteroid trials have failed. The purpose of this study was to (1) characterize endogenous cerebrospinal fluid (CSF) progesterone and cortisol levels after TBI, (2) determine relationships between CSF and serum profiles, and (3) assess the utility of these hormones as predictors of long-term outcomes. We evaluated 130 adults with severe TBI. Serum samples (n=538) and CSF samples (n=746) were collected for 6 days post-injury, analyzed for cortisol and progesterone, and compared with healthy controls (n=13). Hormone data were linked with clinical data, including Glasgow Outcome Scale (GOS) scores at 6 and 12 months. Group based trajectory (TRAJ) analysis was used to develop temporal hormone profiles delineating distinct subpopulations. Compared with controls, CSF cortisol levels were significantly and persistently elevated during the first week after TBI, and high CSF cortisol levels were associated with poor outcome. As a precursor to cortisol, progesterone mediated these effects. Serum and CSF levels for both cortisol and progesterone were strongly correlated after TBI relative to controls, possibly because of blood-brain barrier disruption. Also, differentially impaired hormone transport and metabolism mechanisms after TBI, potential de novo synthesis of steroids within the brain, and the complex interplay of cortisol and pro-inflammatory cytokines may explain these acute hormone profiles and, when taken together, may help shed light on why corticosteroid trials have previously failed and why progesterone treatment after TBI may be beneficial.	[Santarsieri, Martina; Niyonkuru, Christian; McCullough, Emily H.; Dobos, Julie A.; Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; [Santarsieri, Martina; Niyonkuru, Christian; McCullough, Emily H.; Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Dixon, C. Edward; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Berga, Sarah L.] Wake Forest Univ, Dept Obstet Gynecol, Winston Salem, NC 27109 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR323155]; Department of DefenseUnited States Department of Defense [W81XWH-071-0701]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P01NS030318]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318] Funding Source: NIH RePORTER	The authors would like to thank Tammy Loucks, Ph D., for her assistance with hormone measurements. This work was supported by the Centers for Disease Control and Prevention (R49 CCR323155), the Department of Defense (W81XWH-071-0701), and the National Institutes of Health (5P01NS030318).	Alderson P., 2005, COCHRANE DATABASE SY, V1; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Baker DG, 2005, AM J PSYCHIAT, V162, P992, DOI 10.1176/appi.ajp.162.5.992; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; BARBER AE, 1993, J IMMUNOL, V150, P1999; Barnes C, 2004, ARCH PHYS MED REHAB, V85, P1602, DOI 10.1016/j.apmr.2004.02.025; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Boles J. A., 2013, J NEUROTRAUM, V30; Boles JA, 2012, J NEUROTRAUM, V29, pA44; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Caso JR, 2007, EUR NEUROPSYCHOPHARM, V17, P600, DOI 10.1016/j.euroneuro.2007.02.009; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Cooke PS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00108; Czech C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031501; De Kloet ER, 2004, ANN NY ACAD SCI, V1018, P1, DOI 10.1196/annals.1296.001; Dinkel K, 2003, J NEUROCHEM, V84, P705, DOI 10.1046/j.1471-4159.2003.01604.x; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Erkut ZA, 2002, MULT SCLER J, V8, P229, DOI 10.1191/1352458502ms797oa; Farrell RJ, 2002, ALIMENT PHARM THERAP, V16, P1021, DOI 10.1046/j.1365-2036.2002.01238.x; Faupel G, 1976, DYNAMICS BRAIN EDEMA, P337; GALICICH JH, 1961, AM PRACT DIG TREAT, V12, P169; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; GERNER RH, 1983, AM J PSYCHIAT, V140, P92; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Guo WZ, 2013, NEUROSCI LETT, V547, P53, DOI 10.1016/j.neulet.2013.05.014; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Heffelfinger AK, 2001, DEV PSYCHOPATHOL, V13, P491, DOI 10.1017/S0954579401003054; Ho JT, 2006, J CLIN ENDOCR METAB, V91, P105, DOI 10.1210/jc.2005-0265; Holub M, 2007, CRIT CARE, V11, DOI 10.1186/cc5729; JENNETT B, 1975, LANCET, V1, P480; Johnson JD, 2002, BRAIN BEHAV IMMUN, V16, P461, DOI 10.1006/brbi.2001.0638; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Karssen AM, 2001, ENDOCRINOLOGY, V142, P2686, DOI 10.1210/en.142.6.2686; King SR, 2002, J NEUROSCI, V22, P10613; Lamontagne F, 2013, CAN J ANESTH, V60, P652, DOI 10.1007/s12630-013-9929-3; Lin JH, 2008, CURR DRUG METAB, V9, P46, DOI 10.2174/138920008783331077; Liu XR, 2006, DRUG METAB DISPOS, V34, P1443, DOI 10.1124/dmd.105.008201; Liu XR, 2009, DRUG METAB DISPOS, V37, P787, DOI 10.1124/dmd.108.024125; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; MacKenzie SM, 2000, J MOL ENDOCRINOL, V24, P321, DOI 10.1677/jme.0.0240321; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Meffre D, 2007, J STEROID BIOCHEM, V104, P293, DOI 10.1016/j.jsbmb.2007.03.003; MELLON SH, 1993, BRAIN RES, V629, P283, DOI 10.1016/0006-8993(93)91332-M; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nagin D.S., 2005, GROUP BASED MODELING; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; PARDRIDGE WM, 1979, J CLIN INVEST, V64, P145, DOI 10.1172/JCI109433; Patte-Mensah C, 2004, CELL MOL LIFE SCI, V61, P2274, DOI 10.1007/s00018-004-4235-4; Pluchino N, 2013, CLIMACTERIC, V16, P8, DOI 10.3109/13697137.2013.809647; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Roberts DJ, 2008, EXPERT OPIN DRUG MET, V4, P1245, DOI 10.1517/17425255.4.10.1245 ; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Schumacher M, 2000, J NEUROCYTOL, V29, P307, DOI 10.1023/A:1007152904926; Schumacher M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00010; Sorrells SF, 2013, J NEUROSCI, V33, P7877, DOI 10.1523/JNEUROSCI.4705-12.2013; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stoffel-Wagner B, 2003, ANN NY ACAD SCI, V1007, P64, DOI 10.1196/annals.1286.007; STROMSTEDT M, 1995, MOL BRAIN RES, V34, P75, DOI 10.1016/0169-328X(95)00140-N; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Torpy DJ, 2007, HORM METAB RES, V39, P439, DOI 10.1055/s-2007-980200; Uhr M, 2002, J NEUROENDOCRINOL, V14, P753, DOI 10.1046/j.1365-2826.2002.00836.x; VANKALKEN CK, 1993, BRIT J CANCER, V67, P284, DOI 10.1038/bjc.1993.54; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Walf AA, 2009, PSYCHONEUROENDOCRINO, V34, P909, DOI [10.1016/j.psyneuen.2009.01.004, 10.1016/j.psyneuen.2009.07.005]; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wyrwoll CS, 2011, FRONT NEUROENDOCRIN, V32, P265, DOI 10.1016/j.yfrne.2010.12.001; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yu L, 2002, MOL CELL ENDOCRINOL, V190, P9, DOI 10.1016/S0303-7207(02)00041-2; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015	89	36	37	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2014	31	8					699	712		10.1089/neu.2013.3177			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AD7PX	WOS:000333457200001	24354775	Green Published			2022-02-06	
J	Du, W; Yang, J; Powis, B; Zheng, XY; Ozanne-Smith, J; Bilston, L; He, JL; Ma, T; Wang, XF; Wu, M				Du, Wei; Yang, Jie; Powis, Brent; Zheng, Xiaoying; Ozanne-Smith, Joan; Bilston, Lynne; He, JingLin; Ma, Ting; Wang, Xiaofei; Wu, Ming			Epidemiological profile of hospitalised injuries among electric bicycle riders admitted to a rural hospital in Suzhou: a cross-sectional study	INJURY PREVENTION			English	Article							CHINA	Police reports indicate an increasing burden of electric bike (E-bike) casualties in China; however, hospitalised injury data have not been reported. The aim of the present work was to describe hospitalised injury patterns for E-bikers involved in road crashes and explore injury risk disparities among them. For the period October 2010 to April 2011, this cross-sectional study retrospectively collected information for hospitalised E-bikers involved in road crashes from hospital records, in Suzhou China, using the International Classification of Diseases, 10th revision (ICD-10) injury diagnosis codes. Injury nature and body region were further categorised using ICD-10 codes. Multivariate logistic regression was used to assess the risk of specific injury types. We found that hospitalised E-biker injuries (n=323) accounted for 57.2% of road traffic hospitalisations over the 6-month study period. The average age, length of stay and hospitalisation cost were 43.8years, 10.0days and yen8229 (US$1286), respectively. Fractures and head injuries were common. The odds of traumatic brain injuries were significantly elevated for night-time E-bike crashes and incidents other than colliding with motor vehicles. These findings confirm E-bike injuries as an important population health problem and identify elevated injury odds in different E-biker groups. Future injury prevention initiatives should include encouraging helmet use among E-bikers.	[Du, Wei; Zheng, Xiaoying] Peking Univ, Inst Populat Res, Beijing 100871, Peoples R China; [Du, Wei; Bilston, Lynne] Univ New S Wales, Neurosci Res Australia, Randwick, NSW, Australia; [Yang, Jie; Wu, Ming] Jiangsu Prov Ctr Dis Control, Nanjing, Jiangsu, Peoples R China; [Powis, Brent] Int Med Univ, Sch Postgrad Studies & Res, Kuala Lumpur 57000, Malaysia; [Ozanne-Smith, Joan] Monash Univ, Dept Forens Med, Melbourne, Vic 3004, Australia; [He, JingLin] World Hlth Org Beijing Off, Beijing, Peoples R China; [Ma, Ting; Wang, Xiaofei] Third Municipal Hosp Zhangjiagang, Suzhou, Peoples R China		Du, W (corresponding author), Peking Univ, Inst Populat Res WHO Collaborating Ctr Reprod Hlt, Beijing 100871, Peoples R China.	kelvindu@gmail.com; jswuming@vip.sina.com	Bilston, Lynne E/C-9665-2011; Du, Wei/H-5376-2012	Bilston, Lynne E/0000-0001-8250-9019; Du, Wei/0000-0003-3622-2265	Bloomberg Philanthropies as part of the Road Safety in 10 Countries Project in China	This project received funding support from Bloomberg Philanthropies as part of the Road Safety in 10 Countries Project in China.	Barros Aluísio J. D., 2003, Cad. Saúde Pública, V19, P979, DOI 10.1590/S0102-311X2003000400021; China National People's Congress, 2004, LAW PEOPL REP CHIN R; Duan L, 2010, J PUBLIC HLTH PREVEN, V21, P10; Feng ZY, 2010, INJURY PREV, V16, DOI 10.1136/ip.2009.024646; Horan JM, 2003, EPIDEMIOL REV, V25, P24, DOI 10.1093/epirev/mxg010; Hu GQ, 2011, B WORLD HEALTH ORGAN, V89, P41, DOI 10.2471/BLT.10.080317; Hurst D., 2010, ELECT 2 WHEEL VEHICL; Larson K, 2012, TRAFFIC INJ PREV, V13, P3, DOI 10.1080/15389588.2012.671737; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Peden M, WORLD REPORT ON ROAD; Research In China, 2011, IND REP EL BIC CHIN; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; Weinert J, 2007, TRANSPORTATION, V34, P301, DOI 10.1007/s11116-007-9118-8; WHO, 2004, WORLD REPORT ROAD TR; WHO, 2011, GLOB PLAN DEC ACT RO; Wu C, 2012, TRANSPORTATION RES R; Yang CJ, 2010, TECHNOL FORECAST SOC, V77, P831, DOI 10.1016/j.techfore.2010.01.010	19	36	40	2	37	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	APR	2014	20	2					128	133		10.1136/injuryprev-2012-040618			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AD2AJ	WOS:000333034500010	23728530				2022-02-06	
J	Estraneo, A; Moretta, P; Loreto, V; Santoro, L; Trojano, L				Estraneo, Anna; Moretta, Pasquale; Loreto, Vincenzo; Santoro, Lucio; Trojano, Luigi			Clinical and Neuropsychological Long-Term Outcomes After Late Recovery of Responsiveness: A Case Series	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Outcome assessment (health care); Persistent vegetative state; Rehabilitation	MINIMALLY CONSCIOUS STATE; TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; FOLLOW-UP; UNRESPONSIVE WAKEFULNESS; COGNITIVE REHABILITATION; DISORDERS; SCALE; COMA; PROGRAM	Objective: To report clinical conditions and neuropsychological functioning of patients with late recovery of responsiveness at least 5 years after injury. Design: Patient series. Setting: Patients discharged from an inpatient rehabilitation unit. Participants: Patients (N=13) who recovered from a vegetative state 1 year after severe traumatic brain injury or 6 months after nontraumatic brain injury. Interventions: Not applicable. Main Outcome Measures: Coma Recovery Scale-Revised, Disability Rating Scale, and FIM. For patients who recovered full consciousness, neuropsychological tests specifically adapted for patients with very severe disabilities were used. Results: After regaining responsiveness, 2 patients died because of severe clinical complications. Among the remaining 11 patients, 5 were still in a minimally conscious state at their last. assessment, but 4 of them had recovered some complex behavioral responses to the environment (eg, they could follow simple commands, albeit inconsistently). Six patients had emerged from a minimally conscious state at the last evaluation. Severe functional disability was present in both patients who were conscious and patients who were minimally conscious. No patient was autonomous in common daily life activities or in transfers. All patients who were conscious showed variable cognitive impairments, and some of them also developed behavioral and psychological symptoms. However, such disturbances did not impede the patients' interaction with relatives and caregivers. Conclusions: This study provides systematic data about the course of the disease in a cohort of patients that was previously considered as exceptional. Patients with late recovery show a variable degree of functional recovery, although they experience marked residual motor and cognitive disabilities. The present findings contribute to enhance the understanding of the course of the disease in patients with late recovery. and might help clinicians optimize the levels of care and provide the patients' families with correct information. (C) 2014 by the American Congress of Rehabilitation Medicine	[Estraneo, Anna; Moretta, Pasquale; Loreto, Vincenzo] Salvatore Maugeri Fdn, IRCCS, Sci Inst Telese Terme, Telese Terme, Italy; [Santoro, Lucio] Univ Naples Federico II, Dept Neurol Sci, Naples, Italy; [Trojano, Luigi] Univ Naples 2, Dept Psychol, Neuropsychol Lab, I-81100 Caserta, Italy		Trojano, L (corresponding author), Univ Naples 2, Dept Psychol, Viale Ellitt 31, I-81100 Caserta, Italy.	luigi.trojano@unina2.it	Moretta, Pasquale/AAE-5162-2021; Trojano, Luigi/F-2396-2016	Moretta, Pasquale/0000-0003-2244-254X; Trojano, Luigi/0000-0002-0328-9642; Santoro, Lucio/0000-0001-9507-2303	Salvatore Maugeri Foundation	Supported by the Salvatore Maugeri Foundation.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; DEVOLDER AG, 1994, ACTA NEUROL BELG, V94, P183; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Elliott L, 2005, NEUROPSYCHOL REHABIL, V15, P480, DOI 10.1080/09602010443000506; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Fischer C, 2010, CLIN NEUROPHYSIOL, V121, P1032, DOI 10.1016/j.clinph.2010.02.005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sancisi E, 2009, BRAIN INJURY, V23, P163, DOI 10.1080/02699050802660446; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Trojano L, 2011, FUNCT NEUROL, V26, P55; Trojano L, 2010, ARCH PHYS MED REHAB, V91, P498, DOI 10.1016/j.apmr.2009.10.033; *UNIF DATA SYST ME, 1992, RICERCHE RIABILITAZI, V2, pS1; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021	28	36	36	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2014	95	4					711	716		10.1016/j.apmr.2013.11.004			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AF3YJ	WOS:000334648300019	24275063				2022-02-06	
J	Zhang, C; Zhu, J; Zhang, J; Li, HY; Zhao, ZJ; Liao, YW; Wang, XY; Su, J; Sang, SS; Yuan, XR; Liu, Q				Zhang, Chi; Zhu, Jie; Zhang, Jing; Li, Haoyu; Zhao, Zijin; Liao, Yiwei; Wang, Xiangyu; Su, Jun; Sang, Shushan; Yuan, Xianrui; Liu, Qing			Neuroprotective and anti-apoptotic effects of valproic acid on adult rat cerebral cortex through ERK and Akt signaling pathway at acute phase of traumatic brain injury	BRAIN RESEARCH			English	Article						Valproic acid; Neuroprotective effect; Traumatic brain injury; Extracellular signal-regulated kinase; Akt; Rat	HISTONE DEACETYLASE INHIBITION; CELL-DEATH; REGULATED KINASE; CORTICAL-NEURONS; SODIUM VALPROATE; ACTIVATION; PROTECTS; DAMAGE; PHOSPHORYLATION; ANTICONVULSANTS	Mood stabilizer valproic acid (VPA), a widely used antiepileptic drug that has been demonstrated neuroprotective effect against various insults through multiple signaling pathways. The role of VPA in traumatic brain injury (TBI) remains unclear. In the present study, we investigated the neuroprotective potency of VPA for protection against TBI in adult rats, focusing on studying signaling mediators of two well characterized pro-survival molecules, extracellular signal-regulated protein kinase (ERK) and Akt. We found that treatment of VPA after TBI significantly attenuated brain edema, reduced contusion volume and the rate of neuronal apoptosis. The treatment also partly blocked an increase in capase-3 activity. VPA markedly up-regulated the activity of ERK and Akt expression. Moreover, treatment with either PD98059, an ERIC inhibitor and/or LY294002, an Akt inhibitor, attenuated the neuroprotection of VPA against TBI to varying degrees. Taken together, these results demonstrated that treatment with VPA after TBI could be neuroprotective via activation of ERK and Akt signaling pathways (c) 2014 Elsevier B.V. All rights reserved.	[Zhang, Chi; Li, Haoyu; Zhao, Zijin; Liao, Yiwei; Wang, Xiangyu; Su, Jun; Sang, Shushan; Yuan, Xianrui; Liu, Qing] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China; [Zhu, Jie] 101th Hosp PLA, Dept Neurosurg, Rescue Ctr Craniocerebral Injuries PLA, Wuxi 214044, Jiangsu, Peoples R China; [Zhang, Jing] Lanzhou Gen Hosp Lanzhou Mil Command, Dept Otorhinolaryngol Head & Neck Surg, Lanzhou 730050, Gansu, Peoples R China		Yuan, XR (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha 410008, Hunan, Peoples R China.	yuanxianruicsu@hotmail.com; liuqcsu@hotmail.com		li, haoyu/0000-0002-0722-6809	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30901539]	This work was supported by the National Natural Science Foundation of China (30901539).	Adachi M, 2002, CELL DEATH DIFFER, V9, P1240, DOI 10.1038/sj.cdd.4401097; Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Boeckeler K, 2006, EUR J CELL BIOL, V85, P1047, DOI 10.1016/j.ejcb.2006.04.013; Bowden CL, 2006, AUST NZ J PSYCHIAT, V40, P386, DOI 10.1111/j.1440-1614.2006.01815.x; Brandt C, 2006, NEUROPHARMACOLOGY, V51, P789, DOI 10.1016/j.neuropharm.2006.05.021; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Clausen F, 2004, J NEUROTRAUM, V21, P1168, DOI 10.1089/neu.2004.21.1168; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Faissner A, 2006, ADV EXP MED BIOL, V557, P25; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOTOH O, 1985, STROKE, V16, P101, DOI 10.1161/01.STR.16.1.101; Guerra B, 2004, J NEUROCHEM, V91, P99, DOI 10.1111/j.1471-4159.2004.02695.x; Guo H, 2013, J NEUROSCI, V33, P6181, DOI 10.1523/JNEUROSCI.4491-12.2013; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Jeong MR, 2003, FEBS LETT, V542, P74, DOI 10.1016/S0014-5793(03)00350-8; Johannessen CU, 2000, NEUROCHEM INT, V37, P103, DOI 10.1016/S0197-0186(00)00013-9; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kanai H, 2004, PHARMACOGENOMICS J, V4, P336, DOI 10.1038/sj.tpj.6500269; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kuroki Y, 2001, EUR J NEUROSCI, V13, P472, DOI 10.1046/j.0953-816x.2000.01409.x; Li YQ, 2008, SURGERY, V144, P217, DOI 10.1016/j.surg.2008.03.037; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Lu KT, 2005, NEUROSCI LETT, V386, P40, DOI 10.1016/j.neulet.2005.05.057; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Miller JS, 2009, NEUROPHARMACOLOGY, V56, P1116, DOI 10.1016/j.neuropharm.2009.03.006; Miller Laura C, 2008, Expert Rev Neurother, V8, P1817, DOI 10.1586/14737175.8.12.1817; Park H. J., 2011, J MOL NEUROSCI; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Tunnicliff G, 1999, J PHYSIOL PHARMACOL, V50, P347; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018	45	36	39	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 25	2014	1555						1	9		10.1016/j.brainres.2014.01.051			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF1LS	WOS:000334476000001	24508577				2022-02-06	
J	Schroeppel, TJ; Sharpe, JP; Magnotti, LJ; Weinberg, JA; Clement, LP; Croce, MA; Fabian, TC				Schroeppel, Thomas J.; Sharpe, John P.; Magnotti, Louis J.; Weinberg, Jordan A.; Clement, L. Paige; Croce, Martin A.; Fabian, Timothy C.			Traumatic brain injury and beta-blockers: Not all drugs are created equal	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Trauma; propranolol; dysautonomia	BLUNT HEAD-INJURY; SUBARACHNOID HEMORRHAGE; IMPROVED OUTCOMES; NERVOUS-SYSTEM; CATECHOLAMINES; BLOCKADE; PROPRANOLOL; EPIDEMIOLOGY; MODULATION; EXPOSURE	BACKGROUND: Dysautonomia in traumatic brain injury patients may contribute to secondary injury. We hypothesize that propranolol is the best beta-blocker (BB) to block the excess catecholamines and improve mortality in this patient population. METHODS: Patients with traumatic brain injury admitted during a 48-month period who received BB were compared with those who did not after excluding patients who received preinjury BB, deaths within 48 hours, and head Abbreviated Injury Scale (AIS) score of less than 3 or greater than 5. In addition, propranolol was also compared with all other BBs. RESULTS: A total of 1,755 patients with traumatic brain injury were identified during the study period after exclusions. Patients who received BB (427) were older (49 years vs. 40 years; p < 0.0001), were more severely injured (Injury Severity Score [ISS], 30 vs. 24; p < 0.001), and had a more severe head injury (head AIS score, 4.2 vs. 4.0; p < 0.001). By univariate analysis, BB patients had a higher mortality (13% vs. 6%; p < 0.001); after adjusted analysis, no difference was identified (adjusted odds ratio, 0.850; 95% confidence interval, 0.536-1.348). Seventy-eight patients (18%) received propranolol during the study period. Propranolol patients were younger (30 years vs. 53 years; p G 0.001) but more severely injured (ISS, 33 vs. 29; p = 0.01; head AIS, 4.5 vs. 4.2; p < 0.001), with longer stay (44 days vs. 26 days, p G 0.001). Mortality was less in the propranolol group (3% vs. 15%, p = 0.002). Adjusted analysis confirmed the protective effect of propranolol (adjusted odds ratio, 0.199; 95% confidence interval, 0.043-0.920). CONCLUSION: Propranolol is the best BB to limit secondary injury and decrease mortality in patients with traumatic brain injury. Copyright (C) 2014 by Lippincott Williams & Wilkins	Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; Reg Med Ctr Memphis, Dept Pharm, Memphis, TN USA		Schroeppel, TJ (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Surg, 910 Madison Bldg,Ste 220, Memphis, TN 38163 USA.	tschroep@uthsc.edu		Schroeppel, Thomas/0000-0001-9164-5004			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; [Anonymous], TBI STAT; Arbabi S, 2004, J TRAUMA, V56, P265, DOI 10.1097/01.TA.0000109859.91202.C8; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Bukur M, 2012, J TRAUMA ACUTE CARE, V72, P1013, DOI 10.1097/TA.0b013e318241bc5b; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Deng JP, 2004, AM J PHYSIOL-CELL PH, V287, pC730, DOI 10.1152/ajpcell.00562.2003; ELENKOV IJ, 1995, J NEUROIMMUNOL, V61, P123, DOI 10.1016/0165-5728(95)00080-L; Freibel JH, 1981, ANN NEUROL, V9, P340; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HAWKINS WE, 1971, CARDIOVASC RES, V5, P524, DOI 10.1093/cvr/5.4.524; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; JAATTELA A, 1975, BRIT J SURG, V62, P177, DOI 10.1002/bjs.1800620303; Kalinichenko VV, 1999, J IMMUNOL, V163, P2492; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; MCLEOD AA, 1982, BRIT HEART J, V47, P221; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; NEILDWYER G, 1981, BRIT J CLIN PHARMACO, V11, P549, DOI 10.1111/j.1365-2125.1981.tb01169.x; NEILDWYER G, 1978, BRIT MED J, V2, P990, DOI 10.1136/bmj.2.6143.990; NEILDWYER G, 1985, EUR J CLIN PHARMACOL, V28, P25, DOI 10.1007/BF00543706; POLLICK C, 1988, J AM COLL CARDIOL, V12, P600, DOI 10.1016/S0735-1097(88)80044-5; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Randell T, 1999, J NEUROSURG ANESTH, V11, P163, DOI 10.1097/00008506-199907000-00001; Riordan WP, 2007, J TRAUMA, V63, P503, DOI 10.1097/TA.0b013e3181271c34; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; WEIR BK, 1978, J NEUROSURG, V49, P502, DOI 10.3171/jns.1978.49.4.0502; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899	39	36	37	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2014	76	2					504	509		10.1097/TA.0000000000000104			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AH8KG	WOS:000336386100038	24458058				2022-02-06	
J	van der Eerden, AW; Khalilzadeh, O; Perlbarg, V; Dinkel, J; Sanchez, P; Vos, PE; Luyt, CE; Stevens, RD; de Champfleur, NM; Delmaire, C; Tollard, E; Gupta, R; Dormont, D; Laureys, S; Benali, H; Vanhaudenhuyse, A; Galanaud, D; Puybasset, L				van der Eerden, Anke W.; Khalilzadeh, Omid; Perlbarg, Vincent; Dinkel, Julien; Sanchez, Paola; Vos, Pieter E.; Luyt, Charles-Edouard; Stevens, Robert D.; de Champfleur, Nicolas Menjot; Delmaire, Christine; Tollard, Eleonore; Gupta, Rajiv; Dormont, Didier; Laureys, Steven; Benali, Habib; Vanhaudenhuyse, Audrey; Galanaud, Damien; Puybasset, Louis		NICER Neuro Imaging Coma Emergence	White Matter Changes in Comatose Survivors of Anoxic Ischemic Encephalopathy and Traumatic Brain Injury: Comparative Diffusion-Tensor Imaging Study	RADIOLOGY			English	Article							AXONAL INJURY; CORPUS-CALLOSUM; CIRCULATORY ARREST; DEMYELINATION; PROTEIN; MYELIN; DAMAGE; NEUROPATHOLOGY; ANISOTROPY; BARRIER	To analyze white matter pathologic abnormalities by using diffusion-tensor (DT) imaging in a multicenter prospective cohort of comatose patients following cardiac arrest or traumatic brain injury (TBI). Institutional review board approval and informed consent from proxies and control subjects were obtained. DT imaging was performed 5-57 days after insult in 49 cardiac arrest and 40 TBI patients. To control for DT imaging-processing variability, patients' values were normalized to those of 111 control subjects. Automated segmentation software calculated normalized axial diffusivity (lambda(perpendicular to)) and radial diffusivity (lambda(perpendicular to)) in 19 predefined white matter regions of interest (ROIs). DT imaging variables were compared by using general linear modeling, and side-to- side Pearson correlation coefficients were calculated. P values were corrected for multiple testing (Bonferroni). In central white matter, lambda(perpendicular to) differed from that in control subjects in six of seven TBI ROIs and five of seven cardiac arrest ROIs (all P < .01). The lambda(perpendicular to) differed from that in control subjects in all ROIs in both patient groups (P < .01). In hemispheres, lambda(perpendicular to) was decreased compared with that in control subjects in three of 12 TBI ROIs (P < .05) and nine of 12 cardiac arrest ROIs (P < .01). The lambda(perpendicular to) was increased in all TBI ROIs (P < .01) and in seven of 12 cardiac arrest ROIs (P < .05). Cerebral hemisphere lambda(perpendicular to) was lower in cardiac arrest than in TBI in six of 12 ROIs (P < .01), while l. was higher in TBI than in cardiac arrest in eight of 12 ROIs (P,.01). Diffusivity values were symmetrically distributed in cardiac arrest (P < .001 for side-to-side correlation) but not in TBI patients. DT imaging findings are consistent with the known predominance of cerebral hemisphere axonal injury in cardiac arrest and chiefly central myelin injury in TBI. This consistency supports the validity of DT imaging for differentiating axon and myelin damage in vivo in humans.	[van der Eerden, Anke W.; Dormont, Didier; Galanaud, Damien] Hop La Pitie Salpetriere, AP HP, Dept Neuroradiol, F-75651 Paris 13, France; [Sanchez, Paola; Puybasset, Louis] Hop La Pitie Salpetriere, AP HP, Neurosurg ICU, F-75651 Paris 13, France; [Luyt, Charles-Edouard] Hop La Pitie Salpetriere, AP HP, Med ICU, F-75651 Paris 13, France; [van der Eerden, Anke W.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [Vos, Pieter E.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Perlbarg, Vincent; Benali, Habib] Univ Paris 06, INSERM, UMRS 678, Paris, France; [Khalilzadeh, Omid; Dinkel, Julien; Gupta, Rajiv] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol Crit Care Med, Div Neurosci Crit Care, Baltimore, MD USA; [de Champfleur, Nicolas Menjot] Guy de Chauliac Hosp, Dept Neuroradiol, Montpellier, France; [Delmaire, Christine] Roger Salengro Hosp, Dept Neuroradiol, Lille, France; [Tollard, Eleonore] Ctr Hosp Univ, Dept Neuroradiol, Rouen, France; [Laureys, Steven; Vanhaudenhuyse, Audrey] Univ Liege, Cyclotron Res Ctr, Liege, Belgium		Galanaud, D (corresponding author), Hop La Pitie Salpetriere, AP HP, Dept Neuroradiol, 47-83 Blvd Hop, F-75651 Paris 13, France.	galanaud@gmail.com	Vanhaudenhuyse, Audrey/AAP-2455-2020; Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011; van der Eerden, Anke/H-9413-2017	Laureys, Steven/0000-0002-3096-3807; van der Eerden, Anke/0000-0002-9182-9089			Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Busl KM, 2010, NEUROREHABILITATION, V26, P5, DOI 10.3233/NRE-2010-0531; Elovic E, 2004, PHYS MED REHABILITAT; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; GINSBERG MD, 1972, NEUROLOGY, V22, P998, DOI 10.1212/WNL.22.9.998; GINSBERG MD, 1976, ARCH NEUROL-CHICAGO, V33, P5, DOI 10.1001/archneur.1976.00500010007002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JENNETT B, 1975, LANCET, V1, P480; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kumar R, 2011, J NEUROL SCI, V307, P106, DOI 10.1016/j.jns.2011.04.028; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; LENNON VA, 1971, J IMMUNOL, V107, P56; Lovblad KO, 2006, MED RAD DIA IMG, P239, DOI 10.1007/3-540-27738-2_16; Luyt CE, 2012, ANESTHESIOLOGY, V117, P1311, DOI 10.1097/ALN.0b013e318275148c; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MILLER JR, 1972, NEUROLOGY, V22, P888, DOI 10.1212/WNL.22.8.888; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Okamura T, 2010, ANN THORAC SURG, V90, P2001, DOI 10.1016/j.athoracsur.2010.06.118; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Ringelstein EB, 2001, STROKE SYNDROMES, P564; Sharma HS, 2011, J NEURAL TRANSM, V118, P87, DOI 10.1007/s00702-010-0486-4; SHARMA HS, 1993, ACTA NEUROPATHOL, V86, P422; SHARMA HS, 1992, NEUROSCIENCE, V48, P889, DOI 10.1016/0306-4522(92)90277-9; SHARMA HS, 1992, PROG BRAIN RES, V91, P189; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Takahashi M, 2000, RADIOLOGY, V216, P881, DOI 10.1148/radiology.216.3.r00se41881; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90	42	36	36	0	8	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	FEB	2014	270	2					506	516		10.1148/radiol.13122720			11	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	AG0WB	WOS:000335135300023	24471392	Green Submitted, Bronze			2022-02-06	
J	Tartaglia, MC; Hazrati, LN; Davis, KD; Green, REA; Wennberg, R; Mikulis, D; Ezerins, LJ; Keightley, M; Tator, C				Tartaglia, Maria Carmela; Hazrati, Lili-Naz; Davis, Karen D.; Green, Robin E. A.; Wennberg, Richard; Mikulis, David; Ezerins, Leo J.; Keightley, Michelle; Tator, Charles			Chronic traumatic encephalopathy and other neurodegenerative	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						concussions; chronic traumatic encephalopathy; neurodegenerative disease; Alzheimer's disease; frontotempora I lobar degeneration; tau	FOOTBALL-LEAGUE PLAYER; BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; CEREBROSPINAL-FLUID; UNMYELINATED AXONS; PARKINSON DISEASE; CORPUS-CALLOSUM; FRONTAL LOBES; DEMENTIA	"Chronic traumatic encephalopathy" (CTE) is described as a slowly progressive neurodegenerative disease believed to result from multiple concussions. Traditionally, concussions were considered benign events and although most people recover fully, about 10% develop a post-concussive syndrome with persisting neurological, cognitive and neuropsychiatric symptoms. CTE was once thought to be unique to boxers, but it has now been observed in many different athletes having suffered multiple concussions as well as in military personal after repeated blast injuries. Much remains unknown about the development of CTE but its pathological substrate is usually tau, similar to that seen in Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD). The aim of this "perspective" is to compare and contrast clinical and pathological CTE with the other neurodegenerative proteinopathies and highlight that there is an urgent need for understanding the relationship between concussion and the development of CTE as it may provide a window into the development of a proteinopathy and thus new avenues for treatment.	[Tartaglia, Maria Carmela; Wennberg, Richard] Toronto Hosp, Univ Hlth Network, Krembil Neurosci Ctr, Div Neurol, Toronto, ON M5T 2S8, Canada; [Tartaglia, Maria Carmela; Hazrati, Lili-Naz] Toronto Hosp, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5T 2S8, Canada; [Tartaglia, Maria Carmela; Hazrati, Lili-Naz; Davis, Karen D.; Green, Robin E. A.; Wennberg, Richard; Mikulis, David; Ezerins, Leo J.; Keightley, Michelle; Tator, Charles] Canadian Sports Concussion Project, Toronto, ON, Canada; [Hazrati, Lili-Naz] Toronto Hosp, Dept Lab Med & Pathol, Toronto, ON M5T 2S8, Canada; [Davis, Karen D.] Toronto Hosp, Univ Hlth Network, Dept Neurosurg, Toronto, ON M5T 2S8, Canada; [Davis, Karen D.] Univ Hlth Network, Toronto Western Res Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada; [Davis, Karen D.] Toronto Hosp, Dept Surg, Toronto, ON M5T 2S8, Canada; [Davis, Karen D.] Toronto Hosp, Inst Med Sci, Toronto, ON M5T 2S8, Canada; [Green, Robin E. A.; Keightley, Michelle] Toronto Rehabil Inst, Toronto, ON, Canada; [Mikulis, David] Toronto Hosp, Joint Dept Med Imaging, Toronto Western Hosp, Div Neuroradiol, Toronto, ON M5T 2S8, Canada; [Ezerins, Leo J.] Canadian Football League Alumni Assoc, Toronto, ON, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Keightley, Michelle] Toronto Hosp, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5T 2S8, Canada; [Keightley, Michelle] Toronto Hosp, Grad Dept Rehabil Sci, Toronto, ON M5T 2S8, Canada; [Keightley, Michelle] Toronto Hosp, Dept Psychol, Toronto, ON M5T 2S8, Canada; [Keightley, Michelle; Tator, Charles] Toronto Hosp, Krembil Neurosci Ctr, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada		Tartaglia, MC (corresponding author), Toronto Hosp, Tanz Ctr Res Neurodegenerat Dis, Toronto Western Hosp, Memory Clin, West Wing 5-449,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	carmela.tartaglia@uhn.on.ca	hazrati, lili-naz/AAE-7785-2020; Mikulis, David J/H-5167-2019	hazrati, lili-naz/0000-0003-2715-1485; Mikulis, David/0000-0003-3956-0892; Green, Robin/0000-0001-9451-3963			Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Braak H, 1997, Int Psychogeriatr, V9 Suppl 1, P257, DOI 10.1017/S1041610297004973; Braak H, 1997, INT PSYCHOGERIATR S, V9, P269, DOI DOI 10.1017/S1041610297004973; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; BRUN A, 1993, DEMENTIA, V4, P126, DOI 10.1159/000107311; Brunden KR, 2010, EXP NEUROL, V223, P304, DOI 10.1016/j.expneurol.2009.08.031; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714, DOI 10.1192/bjp.105.440.714; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Green Robin, 2010, Neuropsychol Rehabil, V20, P471, DOI 10.1080/09602011003693298; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hu WT, 2010, NEUROLOGY, V75, P2079, DOI 10.1212/WNL.0b013e318200d78d; Hu WT, 2013, NEUROLOGY, V81, P1945, DOI 10.1212/01.wnl.0000436625.63650.27; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parnetti L, 2013, NAT REV NEUROL, V9, P131, DOI 10.1038/nrneurol.2013.10; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Schapira AHV, 2013, CURR OPIN NEUROL, V26, P395, DOI 10.1097/WCO.0b013e3283633741; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sperling Reisa, 2013, Continuum (Minneap Minn), V19, P325, DOI 10.1212/01.CON.0000429181.60095.99; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Whitwell JL, 2012, NAT REV NEUROL, V8, P131, DOI 10.1038/nrneurol.2012.7; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Wortzel H. S., 2013, BEHAV SCI LAW, DOI [10.1002/bsl.2079, DOI 10.1002/BSL.2079.[]; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	65	36	36	3	30	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	JAN 31	2014	8								30	10.3389/fnhum.2014.00030			6	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	302WY	WOS:000330637000001	24550810	gold, Green Published			2022-02-06	
J	Broughton, E; Pobereskin, L; Whitfield, PC				Broughton, Ellie; Pobereskin, Louis; Whitfield, Peter C.			Seven years of cranioplasty in a regional neurosurgical centre	BRITISH JOURNAL OF NEUROSURGERY			English	Article						cranioplasty; craniectomy; complications; outcomes; trauma	DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; MULTICENTER; INFECTION	Introduction. In recent years craniectomy has been widely used in the management of traumatic brain injury and ischaemic stroke. The objective of this study was to evaluate the indications, techniques and outcomes for patients undergoing cranioplasty over a recent 7-year period in a geographically distinct population. Materials and methods. An observational study was performed retrospectively, with review of case records from 2004 to 2011. Demographic, clinical and outcome data were collected, and complications were classified as major and minor. A multi-variant analysis was performed to identify patient and management factors that influenced outcome. Results. Data were collected on a total of 87 cranioplasty patients with a median age of 42 and a mean follow-up time of 3 years and 10 months. The main indications for craniectomy were trauma (46%), infection (19%) intracranial haemorrhage (15%), tumour (13%) and ischaemic stroke (6%). Eight percent of patients had a synchronous craniectomy and cranioplasty, 14% had cranioplasty within 3 months of craniectomy, 21% within 3-6 months, 35% within 6-12 months, 14% over 1 year and 8% over 2 years later. The most frequently implanted cranioplasty material was titanium (53%), followed by autologous bone (26%) and acrylic (15%). Administration of prophylactic antibiotics was recorded in 97% of cases. Major complications occurred in 20% of patients, including 2 deaths (2%), 5 extradural haemorrhages (6%) and 9 infections (10%). A further 10% of cases experienced minor or cosmetic complications. Conclusions. Cranioplasty is often considered as a low-risk procedure following craniectomy. In our cohort, a 20% risk of major complications, including death, was identified. These findings contribute to the literature,emphasising that cranioplasty is a high-risk procedure. Whilst compelling reasons may guide the undertaking of craniectomy, it is essential that consideration is given to the significant subsequent risks of cranioplasty.	[Broughton, Ellie; Pobereskin, Louis; Whitfield, Peter C.] Derriford Hosp, South West Neurosurg Ctr, Plymouth PL6 8DH, Devon, England		Broughton, E (corresponding author), Derriford Hosp, South West Neurosurg Ctr, Plymouth PL6 8DH, Devon, England.	ebroughton@doctors.org.uk	Whitfield, Peter/ABA-4471-2020	Whitfield, Peter/0000-0003-0566-1820			Al-Tamimi YZ, 2012, BRIT J NEUROSURG, V26, P510, DOI 10.3109/02688697.2011.633640; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2011, BRIT J NEUROSURG, V25, P343, DOI 10.3109/02688697.2011.568643; Joffe J, 1999, BRIT J NEUROSURG, V13, P576, DOI 10.1080/02688699943088; Lee SC, 2009, J CLIN NEUROSCI, V16, P56, DOI 10.1016/j.jocn.2008.04.001; Morina Arsim, 2011, Surg Neurol Int, V2, P72, DOI 10.4103/2152-7806.81735; National Collaborating Centre for Chronic Conditions, 2008, STROK NAT CLIN GUID; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Thavarajah D, 2012, BRIT J NEUROSURG, V26, P78, DOI 10.3109/02688697.2011.603850; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470	15	36	37	0	9	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JAN	2014	28	1					34	39		10.3109/02688697.2013.815319			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	304FB	WOS:000330731400008	23875882				2022-02-06	
J	de Guise, E; Alturki, AY; LeBlanc, J; Champoux, MC; Couturier, C; Lamoureux, J; Desjardins, M; Marcoux, J; Maleki, M; Feyz, M				de Guise, Elaine; Alturki, Abdulrahman Yaqub; LeBlanc, Joanne; Champoux, Marie-Claude; Couturier, Celine; Lamoureux, Julie; Desjardins, Monique; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			The Montreal Cognitive Assessment in Persons with Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Level 1 trauma center; Montreal Cognitive Assessment; outcome; traumatic brain injury	MENTAL-STATE-EXAMINATION; HEAD-INJURY; AXONAL INJURY; STROKE PATIENTS; IMPAIRMENT; REHABILITATION; MOCA; TBI; PREDICTORS; ADMISSION	The objective of this study was to examine the performance of patients with traumatic brain injury (TBI) on the Montreal Cognitive Assessment (MoCA). The MoCA was administered to 214 patients with TBI during their acute care hospitalization in a Level 1 trauma center. The results showed that patients with severe TBI had lower scores on the MoCA compared with patients with mild and moderate TBI, F(2, 211) 10.35, p=.0001. This difference was found for visuospatial/executive, attention, and orientation subtests (p<.05). Linear regression demonstrated that age, education, TBI severity, and the presence of neurological antecedents were the best predictors of cognitive impairments explaining 42% of the total variability of the MoCA. This information can enable clinicians to predict early cognitive impairments and plan cognitive rehabilitation earlier in the recovery process.	[de Guise, Elaine; LeBlanc, Joanne; Champoux, Marie-Claude; Couturier, Celine; Feyz, Mitra] McGill Univ, Traumat Brain Injury Program, Ctr Hlth, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine; Alturki, Abdulrahman Yaqub; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Neurosurg Dept, Ctr Hlth, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Alturki, Abdulrahman Yaqub] Natl Neurosci Inst, Riyadh, Saudi Arabia; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada; [Desjardins, Monique] McGill Univ, Dept Psychiat, Ctr Hlth, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada		de Guise, E (corresponding author), McGill Univ, Traumat Brain Injury Program, Ctr Hlth, Montreal Gen Hosp Site,Room D13-124,1650 Cedar, Montreal, PQ H3G 1A4, Canada.	elainedeguise@hotmail.ca					Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Copersino ML, 2009, EXP CLIN PSYCHOPHARM, V17, P337, DOI 10.1037/a0017260; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Freitas S, 2012, ARCH CLIN NEUROPSYCH, V27, P165, DOI 10.1093/arclin/acr116; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Heruti RJ, 2002, ARCH PHYS MED REHAB, V83, P742, DOI 10.1053/apmr.2002.32739; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Lezak M. D, 2012, NEUROPSYCHOLOGICAL A, P158; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Marshall LF, 1991, J NEUROSURG S, V75, P14; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mazeaux J. M., 1997, ARCH PHYS MED REHAB, V78, P1316; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nazem S, 2009, J AM GERIATR SOC, V57, P304, DOI 10.1111/j.1532-5415.2008.02096.x; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Novack TA, 2000, BRAIN INJURY, V14, P987; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Paul R, 2011, ARCH CLIN NEUROPSYCH, V26, P454, DOI 10.1093/arclin/acr017; Rabadi MH, 2008, ARCH PHYS MED REHAB, V89, P441, DOI 10.1016/j.apmr.2007.11.014; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Toglia J, 2011, ARCH PHYS MED REHAB, V92, P792, DOI 10.1016/j.apmr.2010.12.034; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641	40	36	36	1	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2014	21	2					128	135		10.1080/09084282.2013.778260			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	AM9VL	WOS:000340229000007	24826506				2022-02-06	
J	Elliott, M; Parente, F				Elliott, Madison; Parente, Frederick			Efficacy of memory rehabilitation therapy: A meta-analysis of TBI and stroke cognitive rehabilitation literature	BRAIN INJURY			English	Article						Cognitive rehabilitation; memory; meta-analysis; neurorehabilitation; remediation; stroke; TBI; working memory	TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; MODERATE; REMEDIATION; PERFORMANCE	Objective: To examine the efficacy of cognitive rehabilitation strategies specifically designed to improve memory after traumatic brain injury (TBI) and stroke vs. memory improvement with the passage of time. Design and methods: A meta-analysis was performed on 26 studies of memory retraining and recovery that were published between the years of 1985 and 2013. Effect sizes (ESs) from each study were calculated and converted to Pearson's r and then analysed to assess the overall effect size and the relationship among the ESs, patient demographics and treatment interventions. Results: Results indicated a significant average ES (r = 0.51) in the treatment intervention conditions, as well as a significant average ES (r = 0.31) in the control conditions, in which participants did not receive any treatment. The largest ESs occurred in studies of stroke patients and studies concerning working memory rehabilitation. Conclusions: Results showed that memory rehabilitation was an effective therapeutic intervention, especially for stroke patients and for working memory as a treatment domain. However, the results also indicated that significant memory improvement occurred spontaneously over time.	[Elliott, Madison; Parente, Frederick] Towson Univ, Towson, MD 21252 USA		Elliott, M (corresponding author), Towson Univ, Dept Psychol, 8000 York Rd, Towson, MD 21252 USA.	mellio4@students.towson.edu	Parente, Frederick/W-2570-2019	Parente, Frederick/0000-0002-2784-3433			Anderson JW, 2009, J CLIN EXP NEUROPSYC, V31, P425, DOI 10.1080/13803390802232667; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; [Anonymous], SEV BRAIN INJ; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cohen J., 2013, STAT POWER ANAL BEHA; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Evans J, 1996, CLIN REHABIL, V6, P75; FREEMAN M R, 1992, Brain Injury, V6, P65, DOI 10.3109/02699059209008124; Goldstein G, 1996, CLIN NEUROPSYCHOL, V10, P66, DOI 10.1080/13854049608406664; Goldstein G, 1998, CLIN NEUROPSYCHOL, V2, P251; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Hedges LV., 1994, HDB RES SYNTHESIS; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hildebrandt H, 2011, J CLIN EXP NEUROPSYC, V33, P257, DOI 10.1080/13803395.2010.511471; Katz I, 2006, COGNITIVE REHABILITA; Kay T, 2003, J HEAD TRAUMA REHAB, V8, P74; Kerner MJ, 1985, COGNITIVE REHABILITA, V1, P26; Kim D, 2006, EUROPEAN J PHARM, V542, P29; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krause M, 2009, BRAIN INJURY, V23, P965, DOI 10.3109/02699050903373485; Livengood M, 2010, BRAIN INJURY, V24, P598, DOI 10.3109/02699051003652815; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Mar J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-46; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Milders M, 1998, MEMORY, V6, P21, DOI 10.1080/741941597; Nadar MS, 2008, CLIN REHABIL, V22, P847, DOI 10.1177/0269215508091874; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Planas AM, 2012, TRANSLATIONAL MED, V44, P318; Robey RR, 1998, J SPEECH LANG HEAR R, V41, P172, DOI 10.1044/jslhr.4101.172; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Smania N, 2011, J HEAD TRAUMA REHAB, V15, P45; Stringer AY, 2011, BRAIN INJURY, V25, P169, DOI 10.3109/02699052.2010.541894; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	51	36	36	2	27	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	12					1610	1616		10.3109/02699052.2014.934921			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AR6UD	WOS:000343717700013	25058353	Green Submitted			2022-02-06	
J	Gould, KR; Ponsford, JL; Spitz, G				Gould, Kate Rachel; Ponsford, Jennie Louise; Spitz, Gershon			Association between cognitive impairments and anxiety disorders following traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Craniocerebral trauma; Mental processes; Executive function; Attention; Mental disorders	POSTTRAUMATIC-STRESS-DISORDER; TIME PRESSURE MANAGEMENT; PSYCHIATRIC-DISORDERS; BEHAVIOR THERAPY; PROCESSING SPEED; PREDICTORS; DEPRESSION; SYMPTOMS; STRATEGY; REHABILITATION	This study examined the association between cognitive impairment and anxiety disorders following traumatic brain injury (TBI). Sixty-six participants recruited from a rehabilitation hospital completed the Structured Clinical Interview for the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition) and cognitive tests at one year post injury. Prevalence of anxiety disorder was 27.3%. Logistic regression analyses revealed that the attention/working memory, information processing, and executive functions models were significantly associated with anxiety disorder. The memory model was not significant. Processing speed emerged as the strongest model associated with anxiety disorder. The role of cognitive impairment in the etiology of anxiety disorders after TBI is discussed, and treatment implications are explored.	[Gould, Kate Rachel; Ponsford, Jennie Louise; Spitz, Gershon] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [Gould, Kate Rachel; Ponsford, Jennie Louise; Spitz, Gershon] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Gould, Kate Rachel; Ponsford, Jennie Louise] Alfred Hosp, Natl Trauma Res Inst, Ctr Excellence Traumat Brain Injury Res, Melbourne, Vic, Australia		Gould, KR (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Hoddle St, Richmond, Vic 3121, Australia.	kate.gould@monash.edu	Spitz, Gershon/H-7755-2014; Gould, Kate Rachel/AAA-5511-2020	Spitz, Gershon/0000-0002-7810-1480; Gould, Kate Rachel/0000-0002-3564-7408	Transport Accident Commission; Centre of Excellence in Traumatic Brain Injury Research Rehabilitation Fellowship	This research was supported by the Transport Accident Commission. Kate Gould was the 2012 to 2013 recipient of the Centre of Excellence in Traumatic Brain Injury Research Rehabilitation Fellowship.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anderson D.R., 2002, MODEL SELECTION MULT; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Australian Psychological Society, 2010, EV BAS PSYCH INT TRE; Baddeley AD, 1994, DOORS PEOPLE TEST VI; Beck AT, 1997, BEHAV RES THER, V35, P49, DOI 10.1016/S0005-7967(96)00069-1; Benton AL, 1994, MULTILINGUAL APHASIA; Berthier ML, 2001, NEUROPSY NEUROPSY BE, V14, P23; Boals A, 2012, COGNITION EMOTION, V26, P1335, DOI 10.1080/02699931.2011.651100; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Coughlan A. K., 2007, BIRT MEMORY INFORM P; DePrince AP, 2004, PSYCHOL SCI, V15, P488, DOI 10.1111/j.0956-7976.2004.00706.x; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Engels AS, 2007, PSYCHOPHYSIOLOGY, V44, P352, DOI 10.1111/j.1469-8986.2007.00518.x; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Ghinassi C. W., 2010, ANXIETY; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Gray J A, 1996, Nebr Symp Motiv, V43, P61; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Hsieh MY, 2012, DISABIL REHABIL, V34, P408, DOI 10.3109/09638288.2011.607219; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Massana G, 2003, NEUROIMAGE, V19, P80, DOI 10.1016/S1053-8119(03)00036-3; McNally RJ, 1998, COGNITION EMOTION, V12, P479, DOI 10.1080/026999398379682; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; Ponsford J, 2004, SCI PRACT NEUROPSYCH, P59; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Qin LD, 2012, BRAIN RES, V1484, P50, DOI 10.1016/j.brainres.2012.09.029; Reitan R, 1985, HALSTEAD REITAN NEUR; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Smith, 1973, SYMBOL DIGIT MODALIT; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; SPITZER RL, 1983, COMPR PSYCHIAT, V24, P399, DOI 10.1016/0010-440X(83)90032-9; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; VANZOMEREN AH, 1984, CLOSED HEAD INJURY P; Victorian Neurotrauma Initiative, 2009, EC COST SPIN CORD IN; Wechsler D., 1997, WECHSLER MEMORY SCAL; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Winkens I, 2009, CLIN REHABIL, V23, P79, DOI 10.1177/0269215508097855; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	70	36	37	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2014	36	1					1	14		10.1080/13803395.2013.863832			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AI4KT	WOS:000336834800001	24303952				2022-02-06	
J	Hudak, AM; Peng, LF; de la Plata, CM; Thottakara, J; Moore, C; Harper, C; McColl, R; Babcock, E; Diaz-Arrastia, R				Hudak, Anne M.; Peng, Lifang; de la Plata, Carlos Marquez; Thottakara, John; Moore, Carol; Harper, Caryn; McColl, Roderick; Babcock, Evelyn; Diaz-Arrastia, Ramon			Cytotoxic and vasogenic cerebral oedema in traumatic brain injury: Assessment with FLAIR and DWI imaging	BRAIN INJURY			English	Article						Traumatic brain injury; MRI scan; outcome	APPARENT DIFFUSION-COEFFICIENT; FUNCTIONAL STATUS EXAMINATION; IMPROVES OUTCOME PREDICTION; MAGNETIC-RESONANCE; WHITE-MATTER; T2-WEIGHTED MRI; CELLULAR EDEMA; AXONAL INJURY; ISCHEMIA; ATROPHY	Primary objective: Cerebral oedema is a common complication of traumatic brain injury (TBI). The use of Fluid-Attenuated Inversion Recovery (FLAIR) imaging in combination with Diffusion Weighted Imaging (DWI) has the potential to distinguish between cytotoxic and vasogenic oedema. This study hypothesized a significant relationship between cytotoxic lesion volume and outcome. Research design: This observational study reports on a convenience sample where MRI was obtained for clinical purposes. Methods and procedures: Clinical post-TBI FLAIR and DWI images were analysed. For this study, lesions were defined as primarily cytotoxic oedema if the ratio of FLAIR to DWI lesion volume was comparable, defined as a ratio <2. If the ratio of FLAIR to DWI lesion volume was >= 2, oedema was considered predominantly of vasogenic origin. Main outcomes and results: The sample consisted primarily of males with TBIs whose injury severity ranged from complicated mild to severe. Analysis revealed that both oedema types are common after TBI and both are associated with functional deficits 6 months after injury. Conclusions: Acute MRI may be useful to assess pathology at the tissue after traumatic brain injury. Clinical trials targeting cytotoxic and vasogenic mechanisms of oedema formation may benefit from using DWI and FLAIR MRI as a means to differentiate the predominant oedema type after TBI.	[Hudak, Anne M.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Hudak, Anne M.] Hunter Holmes McGuire VA Med Ctr, Dept PM&R, Richmond, VA 23224 USA; [Peng, Lifang] Univ Texas Rio Grande Valley, Edinburg, TX USA; [de la Plata, Carlos Marquez] Pate Rehabil, Dallas, TX USA; [de la Plata, Carlos Marquez] Univ Texas Dallas, Ctr BrainHlth, Sch Behav & Brain Sci, Dallas, TX 75230 USA; [Thottakara, John] Univ Texas SW Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Moore, Carol; Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Harper, Caryn] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [McColl, Roderick; Babcock, Evelyn] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA		Hudak, AM (corresponding author), Hunter Holmes McGuire VA Med Ctr, Dept PM&R, 1201 Broad Rock Blvd, Richmond, VA 23224 USA.	Anne.Hudak@va.gov		McColl, Roderick/0000-0001-7022-100X; Diaz-Arrastia, Ramon/0000-0001-6051-3594	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 HD067553, K23 N5060827, R01 HD48179, U01 HD42652]; Mike Winters Fund; NIDRR [H133A070027]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD067553, U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048179] Funding Source: NIH RePORTER	The authors report no conflicts of interest. The present study was supported by NIH K23 HD067553 (Hudak), The Mike Winters Fund (Hudak), NIH K23 N5060827 (Marquez de la Plata), NIH R01 HD48179 (Diaz-Arrastia), NIH U01 HD42652 (Diaz-Arrastia), NIDRR H133A070027 (Diaz-Arrastia).	[Anonymous], MATLAB 7 1 STAT TOOL; [Anonymous], 2008, SAS WIND VERS 9 2 ST; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BENVENISTE H, 1992, STROKE, V23, P746, DOI 10.1161/01.STR.23.5.746; BULLOCK R, 1990, ACT NEUR S, V51, P286; Burdette JH, 1999, RADIOLOGY, V212, P333, DOI 10.1148/radiology.212.2.r99au36333; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Doelken M, 2007, DIAGN INTERV RADIOL, V13, P125; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kirkness Catherine J, 2002, J Neurosci Nurs, V34, P134; Kuroiwa T, 1998, STROKE, V29, P859, DOI 10.1161/01.STR.29.4.859; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MINTOROVITCH J, 1991, MAGNET RESON MED, V18, P39, DOI 10.1002/mrm.1910180106; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rumpel H, 1997, PEDIATR RES, V42, P54, DOI 10.1203/00006450-199707000-00009; Schlaug G, 1997, NEUROLOGY, V49, P113, DOI 10.1212/WNL.49.1.113; Schneider JP, 2006, ROFO-FORTSCHR RONTG, V178, P618, DOI 10.1055/s-2006-926631; SEVICK RJ, 1992, RADIOLOGY, V185, P687, DOI 10.1148/radiology.185.3.1438745; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stroop R, 1998, ACT NEUR S, V71, P303; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yankah A C, 1995, J Heart Valve Dis, V4, P40	39	36	38	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	12					1602	1609		10.3109/02699052.2014.936039			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AR6UD	WOS:000343717700012	25058428				2022-02-06	
J	Simpson, JR				Simpson, Joseph R.			DSM-5 and Neurocognitive Disorders	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							TRAUMATIC BRAIN-INJURY; OPERATION IRAQI FREEDOM	The newest edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) introduces several changes in the diagnostic criteria for dementia and other cognitive disorders. Some of these changes may prove helpful for clinical and forensic practitioners, particularly when evaluating less severe cognitive impairments. The most substantial change is that the cognitive disorder-not otherwise specified category found in prior editions has been eliminated. Those disorders that do not cause sufficient impairment to qualify for a diagnosis of dementia are now defined as neurocognitive disorders and placed on a spectrum with the more severe conditions. The concept of social cognition is also introduced as one of the core functional domains that can be affected by a neurocognitive disorder. This concept may be particularly significant in the evaluation of patients with non-Alzheimer's dementias, such as frontotemporal dementia. With the aging of the population and the increasing recognition of the possibility of long-lasting cognitive deficits after traumatic brain injury, the need for assessment of cognitive disorders in medicolegal contexts is certain to increase. Forensic psychiatrists who perform these evaluations should understand the conceptualization of Neurocognitive Disorders as presented in DSM-5 and how it differs from prior diagnostic systems.	[Simpson, Joseph R.] Los Angeles Cty Jail Mental Hlth Serv, Los Angeles, CA USA; [Simpson, Joseph R.] Univ So Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA		Simpson, JR (corresponding author), POB 818, Hermosa Beach, CA 90254 USA.	jrsimpsonmd@gmail.com					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Faul M, 2010, TRAUMATIC BRAIN INJU; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gordon C, 2013, EXPERT REV NEUROTHER, V13, P1247, DOI 10.1586/14737175.2013.856265; Korngold C, 2013, J AM ACAD PSYCHIATRY, V41, P430; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mendez MF, 2010, J AM ACAD PSYCHIATRY, V38, P318; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679	12	36	39	0	2	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2014	42	2					159	164					6	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	AL6GA	WOS:000339229400005	24986342				2022-02-06	
J	Kapoor, S; Kim, SM; Farook, JM; Mir, S; Saha, R; Sen, N				Kapoor, Suraj; Kim, Seon-Myung; Farook, Justin M.; Mir, Sajad; Saha, Rahul; Sen, Nilkantha			Foxo3a Transcriptionally Upregulates AQP4 and Induces Cerebral Edema Following Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE			English	Article							AQUAPORIN-4; EXPRESSION; PROTEIN; STRESS; RATS; MICE; SUPPRESSION; ASTROCYTES; CYTOKINE	Increased cranial pressure due to development of edema contributes significantly to the pathology of traumatic brain injury (TBI). Induction of an astrocytic water channel protein, Aquaporin 4 (AQP4), is known to predominantly contribute to cytotoxic edema following TBI. However, the mechanism for the increase in AQP4 following 24 h of TBI is poorly understood. Here we show that transcriptional activation of a ubiquitously expressed mammalian forkhead transcription factor, Foxo3a, induces cerebral edema by increasing the AQP4 level in the controlled cortical impact model of TBI in mice. TBI stimulates nuclear translocation of Foxo3a in astrocytes and subsequently augments its binding to AQP4 promoter in pericontusional cortex. Nuclear accumulation of Foxo3a is augmented by a decrease in phosphorylation at its Ser256 residue due to inactivation of Akt after TBI. Depletion of Foxo3a in mice rescues cytotoxic edema by preventing induction of AQP4 as well as attenuates memory impairment after TBI in mice.	[Sen, Nilkantha] Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA; Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA		Sen, N (corresponding author), Georgia Regents Univ, Inst Mol Med & Genet, 1120 15th St,CA 2018, Augusta, GA 30912 USA.	nsen@gru.edu	Sen, Nilkantha/AAW-9788-2020		Georgia Regents University	S.K., S.M., J.F., R.S., and N.S. were supported by a startup package provided by Georgia Regents University. We thank Dr. Lin Mei for his advice and technical support.	ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Bloch Orin, 2007, Neurosurg Focus, V22, pE3; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Das S, 2011, J BIOL CHEM, V286, P29806, DOI 10.1074/jbc.M111.271460; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hewett SJ, 2006, J PHARMACOL EXP THER, V319, P1219, DOI 10.1124/jpet.106.109876; Hu Hua, 2005, J Zhejiang Univ Sci B, V6, P33, DOI 10.1631/jzus.2005.B0033; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; KATAYAMA Y, 1990, ACT NEUR S, V51, P308; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P393; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vallee M, 1997, J NEUROSCI, V17, P2626; Vizuete ML, 1999, NEUROBIOL DIS, V6, P245, DOI 10.1006/nbdi.1999.0246; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570	32	36	37	0	7	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 30	2013	33	44					17398	17403		10.1523/JNEUROSCI.2756-13.2013			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	246BB	WOS:000326509800017	24174672	Green Published, Bronze			2022-02-06	
J	Egea-Guerrero, JJ; Murillo-Cabezas, F; Gordillo-Escobar, E; Rodriguez-Rodriguez, A; Enamorado-Enamorado, J; Revuelto-Rey, J; Pacheco-Sanchez, M; Leon-Justel, A; Dominguez-Roldan, JM; Vilches-Arenas, A				Egea-Guerrero, Juan J.; Murillo-Cabezas, Francisco; Gordillo-Escobar, Elena; Rodriguez-Rodriguez, Ana; Enamorado-Enamorado, Judy; Revuelto-Rey, Jaume; Pacheco-Sanchez, Maria; Leon-Justel, Antonio; Dominguez-Roldan, Jose M.; Vilches-Arenas, Angel			S100B Protein May Detect Brain Death Development after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						BD; biomarkers; S100B protein; TBI	SEVERE HEAD-INJURY; SERUM S-100B PROTEIN; INTRACRANIAL-PRESSURE; S100-BETA PROTEIN; TISSUE OXYGENATION; EARLY PREDICTOR; MARKER; ACTIVATION; EXPRESSION; MORTALITY	Despite improvements in the process of organ donation and transplants, the number of organ donors is progressively declining in developed countries. Therefore, the early detection of patients at risk for brain death (BD) is a priority for transplant teams seeking more efficient identification of potential donors. In the extensive literature on S100B as a biomarker for traumatic brain injury (TBI), no evidence appears to exist on its prognostic capacity as a predictor of BD after severe TBI. The objective of this study is to assess the value of including acute S100B levels in standard clinical data as an early screening tool for BD after severe TBI. This prospective study included patients with severe TBI (Glasgow Coma Scale score [GCS] 8) admitted to our Neurocritical Care Unit over a 30 month period. We collected the following clinical variables: age, gender, GCS score, pupillary alterations at admission, hypotension and pre-hospital desaturation, CT scan results, isolated TBI or other related injuries, Injury Severity Score (ISS), serum S100B levels at admission and 24h post-admission, and a final diagnosis regarding BD. Of the 140 patients studied, 11.4% developed BD and showed significantly higher S100B concentrations (p<0.001). Multivariate analysis showed that bilateral unresponsive mydriasis at admission and serum S100B at 24h post-admission had odds ratios (ORs) of 21.35 (p=0.005) and 4.9 (p=0.010), respectively. The same analysis on patients with photomotor reflex in one pupil at admission left only the 24h S100B sample in the model (OR=15.5; p=0.009). Receiver operating characteristics (ROC) curve analysis on this group showed the highest area under the curve (AUC) (0.86; p=0.001) for 24h S100B determinations. The cut off was set at 0.372g/L (85.7% sensitivity, 79.3% specificity, positive predictive value [PPV]=18.7% and negative predictive value [NPV]=98.9%). This study shows that pupillary responsiveness at admission, as well as 24h serum S100B levels, could serve as screening tools for the early detection of patients at risk for BD after severe TBI.	[Egea-Guerrero, Juan J.; Murillo-Cabezas, Francisco; Gordillo-Escobar, Elena; Enamorado-Enamorado, Judy; Revuelto-Rey, Jaume; Pacheco-Sanchez, Maria; Dominguez-Roldan, Jose M.] Univ Seville, NeuroCrit Care Unit, Seville, Spain; [Rodriguez-Rodriguez, Ana; Leon-Justel, Antonio] Univ Seville, Dept Clin Biochem, Virgen del Rocio Univ Hosp, Seville, Spain; [Vilches-Arenas, Angel] Univ Seville, CSIC, IBIS, Dept Prevent Med & Publ Hlth, Seville, Spain		Egea-Guerrero, JJ (corresponding author), Univ Seville, CSIC, IBIS, NeuroCrit Care Unit,Virgen del Rocio Univ Hosp, Avda Manuel Siurot S-N,PC 41013, Seville, Spain.	juanjoegea@hotmail.com	Vilches-Arenas, Angel/C-1167-2015; IBIS, NEUROCRITICOS/C-1805-2016; Dominguez-Roldan, Jose-Maria/M-1728-2016; Murillo-Cabezas, Francisco/AAO-3348-2021; Egea-Guerrero, Juan Jose JJ/P-5080-2014; IBIS, NEUROINMUNO/O-9306-2015; Rodriguez-Rodriguez, Ana/F-4718-2016	Vilches-Arenas, Angel/0000-0003-2197-3760; Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478; Egea-Guerrero, Juan Jose JJ/0000-0002-4166-313X; Rodriguez-Rodriguez, Ana/0000-0002-6854-9695; Revuelto-Rey, Jaume/0000-0001-8350-9555	Junta de Andalucia Health Department [S0430]; Roche Diagnostics, Mannheim, Germany [S100B]	This research was made possible by funding from the Junta de Andalucia Health Department 2010 Grant Fund (cod. S0430), and through the generous donation of Protein S100B Electrochemiluminescence Assay Kits from Roche Diagnostics, Mannheim, Germany. We thank the nursing staff at the Virgen del Rocio University Hospital for their collaboration with blood sample extractions related to this study.	*AM EL SOC, 1994, J CLIN NEUROPHYSIOL, V11, P10; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; [Anonymous], 2007, J NEUROTRAUMA S1, V24, pS1, DOI DOI 10.1089/NEU.2006.0209; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Dominguez-Roldan JM, 2009, MED INTENSIVA, V33, P434, DOI 10.1016/j.medin.2009.03.008; Dominguez-Roldan J.M., 2010, INTENS CARE MED, V36, P205; Dominguez-Roldan J.M., 1994, REV ESPANOLA TRASPLA, V3, P30; Dominguez-Roldan J.M., 1999, TRANSPL P, V31, P2957; Egea-Guerrero JJ, 2012, TRANSPL P, V44, P2050, DOI 10.1016/j.transproceed.2012.07.070; Egea-Guerrero JJ, 2012, NEUROLOGIA, V27, P377, DOI 10.1016/j.nrl.2011.07.013; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Escudero D, 2009, MED INTENSIVA, V33, P185, DOI 10.1016/S0210-5691(09)71215-X; Figaji AA, 2010, NEUROCRIT CARE, V12, P56, DOI 10.1007/s12028-009-9298-5; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Iznerowicz A, 2011, TRANSPL P, V43, P2887, DOI 10.1016/j.transproceed.2011.08.013; JENSEN R, 1985, J NEUROCHEM, V45, P700, DOI 10.1111/j.1471-4159.1985.tb04048.x; Egea-Guerrero JJ, 2011, NEUROLOGY, V76, P489, DOI 10.1212/WNL.0b013e3181fe77fa; Kompanje EJO, 2011, TRANSPLANTATION, V91, P1177, DOI 10.1097/TP.0b013e3182180567; Korfias S, 2006, BRAIN INJURY, V20, P867, DOI 10.1080/02699050600832395; Koudstaal LG, 2008, TRANSPLANTATION, V86, P148, DOI 10.1097/TP.0b013e31817ba53a; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; Marin-Caballos AJ, 2008, MED INTENSIVA, V32, P81, DOI 10.1016/S0210-5691(08)70912-4; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Meers C, 2009, TRANSPL P, V41, P572, DOI 10.1016/j.transproceed.2008.12.029; Murillo-Cabezas F, 2010, BRAIN INJURY, V24, P609, DOI 10.3109/02699051003652823; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Nijboer WN, 2004, TRANSPLANTATION, V78, P978, DOI 10.1097/01.TP.0000135565.49535.60; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; R Donato, 2010, CARDIOVASC PSYCHIAT, V92, P87; Raabe A, 2000, NEUROSURG REV, V23, P136, DOI 10.1007/PL00011944; Raabe A, 1999, J NEUROSURG, V91, P875, DOI 10.3171/jns.1999.91.5.0875; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Regner A, 2001, NEUROREPORT, V12, P691, DOI 10.1097/00001756-200103260-00015; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Salim A, 2011, J TRAUMA, V71, P733, DOI 10.1097/TA.0b013e31820500e6; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Siminoff L.A., 2011, JAMA-J AM MED ASSOC, V1, P71; van der Hoeven JAB, 2000, ANN SURG, V232, P804, DOI 10.1097/00000658-200012000-00009; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606; Wilhelm MJ, 2000, CIRCULATION, V102, P2426, DOI 10.1161/01.CIR.102.19.2426	49	36	38	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2013	30	20					1762	1769		10.1089/neu.2012.2606			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	232JW	WOS:000325491000009	23710646	Green Published			2022-02-06	
J	Dawson, DR; Binns, MA; Hunt, A; Lemsky, C; Polatajko, HJ				Dawson, Deirdre R.; Binns, Malcolm A.; Hunt, Anne; Lemsky, Carolyn; Polatajko, Helene J.			Occupation-Based Strategy Training for Adults With Traumatic Brain Injury: A Pilot Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Cognition therapy; Executive function; Rehabilitation; Rehabilitation outcome	COGNITIVE REHABILITATION	Objective: To evaluate, before undertaking a larger trial, feasibility of the study processes to determine the effectiveness of occupation-based strategy training for producing changes on trained real-world behaviors, and to determine whether far transfer of training effects to measures of real-world impact, including participation in everyday life, could be achieved. Design: Partially randomized controlled trial with pre- and postintervention assessments done by assessors masked to the treatment arm. Setting: Testing occurred at a research institute, interventions at participants' homes. Participants: People (N=13) with chronic traumatic brain injury (TBI), 7 in the experimental group (mean age, 42.6y; mean time post-TBI, 9.8y; 4 men) and 6 in the control arm (mean age, 40.5y; mean time post-TBI, 10.8y; 3 men), were assessed immediately before and after the intervention phase. Intervention: Occupation-based strategy training, an adapted version of the Cognitive Orientation to daily Occupational Performance (CO-OP), was provided in two 1-hour sessions per week for 10 weeks. Main Outcome Measures: Canadian Occupational Performance Measure, Dysexecutive Questionnaire, Mayo-Portland Adaptability Inventory-4 Participation Index, and Assessment of Motor and Process Skills. Results: The study processes (testing and intervention) were acceptable to all participants. Evidence of far transfer was found as the experimental group improved significantly more than the control group on performance and satisfaction with performance ratings on untrained goals (P<05), and reported increased levels of participation (P<.01). Conclusions: Findings must be interpreted with caution since the sample is small and comparisons are made with a no-treatment control. Nevertheless, they suggest that the training is feasible and a larger trial warranted. (c) 2013 by the American Congress of Rehabilitation Medicine	[Dawson, Deirdre R.; Binns, Malcolm A.] Baycrest, RRI, Toronto, ON M6A 2E1, Canada; [Dawson, Deirdre R.; Polatajko, Helene J.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Dawson, Deirdre R.; Hunt, Anne; Polatajko, Helene J.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Lemsky, Carolyn] Community Head Injury Resource Serv, West Toronto, ON, Canada		Dawson, DR (corresponding author), Baycrest, RRI, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	ddawson@research.baycrest.org	Binns, Malcolm/AAQ-9195-2020; Dawson, Deirdre R/I-8882-2014	Binns, Malcolm/0000-0001-9998-6612; Dawson, Deirdre R/0000-0001-7517-6121	Ontario Neurotrauma Foundation; Quebec Rehabilitation Research Network [2005-ABI-POP-363, 2007-ONF-REPAR-582]	Supported by the Ontario Neurotrauma Foundation and the Quebec Rehabilitation Research Network (grant nos. 2005-ABI-POP-363, 2007-ONF-REPAR-582).	Burgess P.W., 2005, EFFECTIVENESS REHABI, P211, DOI DOI 10.1093/ACPROF:OSO/9780198526544.001.0001; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J., 2013, STAT POWER ANAL BEHA; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Fisher A. G., 2010, ASSESSMENT MOTOR PRO, V1; Haskins E.C., 2012, COGNITIVE REHABILITA; Kuipers P., 2004, BRAIN IMPAIR, V5, P30, DOI DOI 10.1375/BRIM.5.1.30.35404; Law M, 1991, CANADIAN OCCUPATIONA; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Mandich, 2004, ENABLING OCCUPATION; Sidani S, ADV DESIGNS METHODS; Skidmore ER, 2011, NEUROPSYCHOL REHABIL, V21, P208, DOI 10.1080/09602011.2011.552559; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Zelinski EM, 2009, RESTOR NEUROL NEUROS, V27, P455, DOI 10.3233/RNN-2009-0495	15	36	37	1	33	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2013	94	10					1959	1963		10.1016/j.apmr.2013.05.021			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	231TU	WOS:000325442100014	23796683				2022-02-06	
J	Moreau, JF; Fink, EL; Hartman, ME; Angus, DC; Bell, MJ; Linde-Zwirble, WT; Watson, RS				Moreau, Jacqueline F.; Fink, Ericka L.; Hartman, Mary E.; Angus, Derek C.; Bell, Michael J.; Linde-Zwirble, Walter T.; Watson, R. Scott			Hospitalizations of Children With Neurologic Disorders in the United States	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						epidemiology; hospitalization; intensive care; neurologic outcome; pediatric; pediatric neurocritical care	PEDIATRIC-INTENSIVE-CARE; STROKE; TRENDS; RISK	Objectives: Although neurologic disorders are among the most serious acute pediatric illnesses, epidemiologic data are scarce. We sought to determine the scope and outcomes of children with these disorders in the United States. Design: Retrospective cohort study. Setting: All nonfederal hospitals in 11 states encompassing 38% of the U. S. pediatric population. Patients: Children 29 days to 19 years old hospitalized in 2005. Interventions: None. Measurements and Main Results: Using International Classification of Diseases, 9th Revision, Clinical Modification, codes, we identified admissions with neurologic diagnoses, analyzed patient and hospitalization characteristics, and generated age-and sex-adjusted national estimates. Of 960,020 admissions in the 11 states, 10.7% (103,140) included a neurologic diagnosis, which yields a national estimate of 273,900 admissions of children with neurologic diagnoses. The most common were seizures (53.9%) and traumatic brain injury (17.3%). Children with neuro-logic diagnoses had nearly three times greater ICU use than other hospitalized children (30.6% vs 10.6%, p < 0.001). Neurologic diagnoses were associated with nearly half of deaths (46.2%, n = 1,790). Among ICU patients, children with neurologic diagnoses had more than three times the mortality of other patients (4.8% vs1.5%, p < 0.001). Children with neurologic diagnoses had a significantly longer median hospital length of stay than other children (3 d [1, 5] vs 2 d [2, 4], p < 0.001) and greater median hospital costs ($4,630 [$2,380, $9,730] vs $2,840 [$1,520, $5,550], p < 0.001). Conclusions: Children with neurologic diagnoses account for a disproportionate amount of ICU stays and deaths compared with children hospitalized for other reasons.	[Moreau, Jacqueline F.; Fink, Ericka L.; Angus, Derek C.; Watson, R. Scott] Univ Pittsburgh, Dept Crit Care Med, CRISMA Ctr Clin Res Invest & Syst Modeling Acute, Pittsburgh, PA 15260 USA; [Fink, Ericka L.; Bell, Michael J.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Safar Ctr Resuscitat Res,Med Ctr, Pittsburgh, PA USA; [Hartman, Mary E.] Washington Univ, Sch Med, Dept Pediat, Div Crit Care Med, St Louis, MO 63110 USA; [Linde-Zwirble, Walter T.] ZD Associates LLC, Perkasie, PA USA		Watson, RS (corresponding author), Univ Pittsburgh, Dept Crit Care Med, CRISMA Ctr Clin Res Invest & Syst Modeling Acute, Pittsburgh, PA 15260 USA.	watsonrs@upmc.edu	Fink, Ericka/AAU-9792-2021; Angus, Derek C/E-9671-2012; Viani, Rafael/V-1196-2018	Watson, R. Scott/0000-0002-2581-7186; , Jacqueline/0000-0001-9250-3972; Fink, Ericka/0000-0002-3683-4571	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5TL1RR024155]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000145] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [TL1RR024155] Funding Source: NIH RePORTER	Ms. Moreau received funding from the National Institutes of Health (NIH) T-35 Start-Up Program (#5TL1RR024155). Dr. Fink received funding from NIH. Dr. Angus received funding from NIH (NIH T-35 Start-up training grant). Dr. Watson received funding from NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.	American College of Surgeons, 1999, TRAUM PROGR RES OPT; [Anonymous], 2011, INT CLASSIFICATION D; [Anonymous], 2005, PUBL US FIL PUF1 PAT; Au AK, 2011, PEDIATR CRIT CARE ME, V12, P566, DOI 10.1097/PCC.0b013e3181fe3420; Faul M, 2010, TRAUMATIC BRAIN INJU; Feudtner C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e99; Fullerton HJ, 2003, NEUROLOGY, V61, P189, DOI 10.1212/01.WNL.0000078894.79866.95; Healthcare Cost and Utilization Project (HCUP), 2005, STAT INP DAT SID; Kochanek PM, 2009, PEDIATR CRIT CARE ME, V10, P517, DOI 10.1097/PCC.0b013e3181ab88cd; Lo W, 2009, J CHILD NEUROL, V24, P194, DOI 10.1177/0883073808322665; Perkins E, 2009, STROKE, V40, P2820, DOI 10.1161/STROKEAHA.109.548156; Ramnarayan P, 2007, J MED ETHICS, V33, P255, DOI 10.1136/jme.2005.015768; Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; *TX DEP STAT HLTH, 2005, TEX HOSP INP DISCH P; United States Census Bureau, METH SUMM INT POP PR	16	36	36	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	OCT	2013	14	8					801	810		10.1097/PCC.0b013e31828aa71f			10	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	AI0EF	WOS:000336518300014	23842588	Green Accepted			2022-02-06	
J	Rogan, C; Fortune, DG; Prentice, G				Rogan, Carol; Fortune, Donal G.; Prentice, Garry			Post-traumatic growth, illness perceptions and coping in people with acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Post-traumatic growth; Acquired brain injury; Illness perceptions; Coping	2-COMPONENT MODEL; HEAD-INJURY; LIFE; REHABILITATION; LONG; PREDICTORS; PSYCHOLOGY; STRATEGIES; RESOURCES; HIV/AIDS	Post-traumatic growth is a process by which an individual who has faced a significantly adverse and life-altering event, can show evidence of an ability meaningfully to construe benefits from such adversity. The purpose of this study was to investigate, in a sample of people with acquired brain injury (ABI), the contribution of illness perceptions, distress, disability, and coping strategies and health to post-traumatic growth. Seventy people with an ABI took part in this cross-sectional investigation, comprising 70% males and 30% females. Traumatic brain injury accounted for the majority of brain injuries (56%), with 31% arising from a cerebrovascular accident and the remaining 13% arising from hypoxia, brain tumours, brain abcesses and encephalitis. The average time since injury was 70.43 months (SD=55.30, range=7-350). Participants completed assessments comprising post-traumatic growth (Post-traumatic Growth Inventory), beliefs about their condition (Illness Perception Questionnaire Revised), coping strategies (Brief COPE), anxiety and depression (Hospital Anxiety and Depression Scale) and functional disability (Functional Independence Measure and Functional Assessment Measure). All participants were accessing post-acute brain injury rehabilitation and support services. Results showed that greater levels of post-traumatic growth were associated with greater use of adaptive coping strategies (r=.597), lower levels of distress (r=-.241) and stronger beliefs about treatment-induced controllability of the effects arising from brain injury (r=.263). Greater use of adaptive coping strategies accounted for the greater proportion of the variance in post-traumatic growth (sr(2)=0.287) and was the only variable found to make a unique and statistically significant contribution to the prediction of growth. Illness perceptions more generally were not significantly associated with growth experiences. This study provides additional evidence of the factors associated with the process of post-traumatic growth, in particular adaptive coping strategies that may help to facilitate growth, although the direction of this relationship requires further empirical investigation. The findings of this study may have implications for professionals providing neurorehabilitation services.	[Rogan, Carol; Fortune, Donal G.] Acquired Brain Injury Ireland, Limerick, Ireland; [Fortune, Donal G.] Univ Limerick, Dept Psychol, Limerick, Ireland; [Prentice, Garry] Dublin Business Sch, Dublin, Ireland		Fortune, DG (corresponding author), Acquired Brain Injury Ireland, OMeara House,Ballinacurra Rd, Limerick, Ireland.	dfortune@abiireland.ie		Rogan, Carol/0000-0003-1510-5334			Ackroyd K, 2011, J CLIN PSYCHOL MED S, V18, P372, DOI 10.1007/s10880-011-9265-0; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Danoff-Burg S, 2005, J BEHAV MED, V28, P91, DOI 10.1007/s10865-005-2720-3; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Farhall J, 2007, CLIN PSYCHOL REV, V27, P476, DOI 10.1016/j.cpr.2006.12.002; FORTUNE DG, 2005, PSYCHOL HLTH MED, V0010, P00044; Frazier P, 2001, J CONSULT CLIN PSYCH, V69, P1048, DOI 10.1037//0022-006X.69.6.1048; Frostholm L, 2005, PSYCHOSOM MED, V67, P997, DOI 10.1097/01.psy.0000189164.85653.bc; Gangstad B, 2009, REHABIL PSYCHOL, V54, P69, DOI 10.1037/a0014639; Gillen G, 2006, AM J OCCUP THER, V60, P136, DOI 10.5014/ajot.60.2.136; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Hefferon K, 2009, BRIT J HEALTH PSYCH, V14, P343, DOI 10.1348/135910708X332936; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; JOSEPH S, 1993, J TRAUMA STRESS, V6, P271, DOI 10.1002/jts.2490060209; Joseph S., 2011, WHAT DOESNT KILL US; Katz RC, 2001, J BEHAV MED, V24, P561, DOI 10.1023/A:1012939310459; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; Leventhal H., 1980, CONTRIB MED PSYCHOL, V2, P7; Leventhal H, 1997, PERCEPTIONS HLTH ILL, P19; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Maercker A, 2004, PSYCHOL INQ, V15, P41; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; McGrath JC, 2011, BRAIN IMPAIR, V12, P82, DOI 10.1375/brim.12.2.82; *MED DIS SOC, 1988, MAN TRAUM BRAIN INJ; Milam JE, 2004, J APPL SOC PSYCHOL, V34, P2353, DOI 10.1111/j.1559-1816.2004.tb01981.x; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Park CL, 2006, J CONSULT CLIN PSYCH, V74, P791, DOI 10.1037/0022-006X.74.5.791; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Powell T, 2012, DISABIL REHABIL, V34, P1461, DOI 10.3109/09638288.2011.644384; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Seel RT, 2007, J HEAD TRAUMA REHAB, V22, P267, DOI 10.1097/01.HTR.0000290971.56130.c8; Siegel K, 2005, J BEHAV MED, V28, P403, DOI 10.1007/s10865-005-9015-6; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Taylor SE, 2000, AM PSYCHOL, V55, P99, DOI 10.1037//0003-066X.55.1.99; Tedeschi R.G., 1998, POSTTRAUMATIC GROWTH; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Thompson RJ, 2010, BEHAV RES THER, V48, P459, DOI 10.1016/j.brat.2010.01.007; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Updegraff JA, 2002, PERS SOC PSYCHOL B, V28, P382, DOI 10.1177/0146167202286009; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	53	36	38	1	55	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	OCT 1	2013	23	5					639	657		10.1080/09602011.2013.799076			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	220UE	WOS:000324611600002	23701407				2022-02-06	
J	Vlajkovic, SM; Lin, SCY; Wong, ACY; Wackrow, B; Thorne, PR				Vlajkovic, Srdjan M.; Lin, Shelly Ching-yu; Wong, Ann Chi Yan; Wackrow, Brad; Thorne, Peter R.			Noise-induced changes in expression levels of NADPH oxidases in the cochlea	HEARING RESEARCH			English	Article							INDUCED HEARING-LOSS; NOX FAMILY; CISPLATIN; ROLES; BRAIN; RAT; SUPEROXIDE; GENERATION; INHIBITORS; MUTATIONS	NADPH oxidases are enzymes that transport electrons across the plasma membrane and generate superoxide radical from molecular oxygen. The current study investigated the expression and distribution of NOX/DUOX members of the NADPH oxidase family (NOX1-5 and DUOX1-2) in the rat cochlea and their regulation in response to noise. Wistar rats (8-10 weeks) were exposed for 24 h to band noise (8-12 kHz) at moderate (100 dB) or traumatic (110 dB) sound pressure levels (SPL). Animals exposed to ambient noise (45-55 dB SPL) served as controls. Immunohistochemistly demonstrated predominant expression of all NOX/DUOX isoforms in the sensory and supporting cells of the organ of Corti, with very limited immunoexpression in the lateral wall tissues and spiral ganglion neurons. Noise exposure induced up-regulation of NOX1 and DUOX2 in the cochlea, whereas NOX3 was down-regulated. A significant reduction in the intensity of NOX3 immunolabeling was observed in the inner sulcus region of the cochlea after exposure to noise. Post-exposure inhibition of NADPH oxidases by Diphenyleneiodonium (DPI), a broadly selective NADPH oxidase inhibitor, mitigated noise-induced hearing loss. Conclusion: Noise-induced up-regulation of NOX1 and DUOX2 could be linked to cochlear injury. In contrast, down-regulation of NOX3 may represent an endogenous protective mechanism to reduce oxidative stress in the noise-exposed cochlea. Inhibition of NADPH oxidases is potentially a novel pathway for therapeutic management of noise-induced hearing loss. (C) 2013 Elsevier B.V. All rights reserved.	[Vlajkovic, Srdjan M.; Lin, Shelly Ching-yu; Wackrow, Brad; Thorne, Peter R.] Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland 1142, New Zealand; [Thorne, Peter R.] Univ Auckland, Discipline Audiol, Fac Med & Hlth Sci, Auckland 1142, New Zealand; [Wong, Ann Chi Yan] Univ New S Wales, Sch Med Sci, Translat Neurosci Facil, Sydney, NSW, Australia		Vlajkovic, SM (corresponding author), Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Private Bag 92019, Auckland 1142, New Zealand.	s.vlajkovic@auckland.ac.nz		Vlajkovic, Srdjan/0000-0001-8548-6844; Wong, Ann CY/0000-0001-7011-0369; Thorne, Peter/0000-0003-0214-0210	University of Auckland Faculty Research Development Fund	This study was supported by the University of Auckland Faculty Research Development Fund.	Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; Cross R.A., 1986, BIOCHEM J, V237, P111; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; HAMERNIK RP, 1984, HEARING RES, V16, P143, DOI 10.1016/0378-5955(84)90004-2; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Kim JA, 2011, EXPERT OPIN THER PAT, V21, P1147, DOI 10.1517/13543776.2011.584870; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mukherjea D, 2006, NEUROSCIENCE, V139, P733, DOI 10.1016/j.neuroscience.2005.12.044; Mukherjea D, 2010, ANTIOXID REDOX SIGN, V13, P589, DOI 10.1089/ars.2010.3110; Nakano Y, 2007, BIOCHEM J, V403, P97, DOI 10.1042/BJ20060819; Oishi N, 2011, EXPERT OPIN EMERG DR, V16, P235, DOI 10.1517/14728214.2011.552427; Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504; Rybak LP, 2012, CELL MOL LIFE SCI, V69, P2429, DOI 10.1007/s00018-012-1016-3; Schramm A, 2012, VASC PHARMACOL, V56, P216, DOI 10.1016/j.vph.2012.02.012; Thorne PR, 2008, NEW ZEAL MED J, V121, P33; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wong ACY, 2012, HISTOCHEM CELL BIOL, V137, P599, DOI 10.1007/s00418-012-0922-7; Wong ACY, 2010, HEARING RES, V260, P81, DOI 10.1016/j.heares.2009.12.004; Yamashita D, 2005, NEUROSCIENCE, V134, P633, DOI 10.1016/j.neuroscience.2005.04.015; Yamashita D, 2004, BRAIN RES, V1019, P201, DOI 10.1016/j.brainres.2004.05.104	31	36	36	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5955			HEARING RES	Hear. Res.	OCT	2013	304						145	152		10.1016/j.heares.2013.07.012			8	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	225PM	WOS:000324974800015	23899412				2022-02-06	
J	Wu, A; Ying, Z; Gomez-Pinilla, F				Wu, A.; Ying, Z.; Gomez-Pinilla, F.			EXERCISE FACILITATES THE ACTION OF DIETARY DHA ON FUNCTIONAL RECOVERY AFTER BRAIN TRAUMA	NEUROSCIENCE			English	Article						DHA; exercise; BDNF; omega-3 fatty acids; cognition	ALPHA-LINOLENIC ACID; DOCOSAHEXAENOIC ACID; MEMBRANE HOMEOSTASIS; SYNAPTIC PLASTICITY; FATTY-ACIDS; PROTEIN; INJURY; SUPPLEMENTATION; DAMAGE; BDNF	The abilities of docosahexaenoic acid (DHA) and exercise to counteract cognitive decay after traumatic brain injury (TBI) is getting increasing recognition; however, the possibility that these actions can be complementary remains just as an intriguing possibility. Here we have examined the likelihood that the combination of diet and exercise has the added potential to facilitate functional recovery following TBI. Rats received mild fluid percussion injury (mFPI) or sham injury and then were maintained on a diet high in DHA (1.2% DHA) with or without voluntary exercise for 12 days. We found that FPI reduced DHA content in the brain, which was accompanied by increased levels of lipid peroxidation assessed using 4-hydroxy-2-hexenal (4-HHE). FPI reduced the enzymes acyl-CoA oxidase 1 (Acox1) and 17 beta-hydroxysteroid dehydrogenase type 4 (17 beta-HSD4), and the calcium-independent phospholipases A2 (iPLA(2)), which are involved in metabolism of membrane phospholipids. FPI reduced levels of syntaxin-3 (STX-3), involved in the action of membrane DHA on synaptic membrane expansion, and also reduced brain-derived neurotrophic factor (BDNF) signaling through its tyrosine kinase B (TrkB) receptor. These effects of FPI were optimally counteracted by the combination of DHA and exercise. Our results support the possibility that the complementary action of exercise is exerted on restoring membrane homeostasis after TBI, which is necessary for supporting synaptic plasticity and cognition. It is our contention that strategies that take advantage of the combined applications of diet and exercise may have additional effects to the injured brain. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.	[Wu, A.; Ying, Z.; Gomez-Pinilla, F.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Gomez-Pinilla, F.] Univ Calif Los Angeles, Dept Neurosurg, Brain Injury Res Ctr, Los Angeles, CA 90095 USA		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 621 Charles E Young Dr, Los Angeles, CA 90095 USA.	agwu@ucla.edu; lying@physci.ucla.edu; fgomezpi@ucla.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS50465]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050465] Funding Source: NIH RePORTER	This study was supported by NIH award NS50465.	Adasme T, 2011, P NATL ACAD SCI USA, V108, P3029, DOI 10.1073/pnas.1013580108; Allyson J, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/569149; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Astarita G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012538; Biegon A, 2004, CURR PHARM DESIGN, V10, P2177, DOI 10.2174/1381612043384196; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; Cansev M, 2007, NEUROSCIENCE, V148, P421, DOI 10.1016/j.neuroscience.2007.06.016; Chytrova G, 2010, BRAIN RES, V1341, P32, DOI 10.1016/j.brainres.2009.05.018; Crawford MA, 2009, ANN NUTR METAB, V55, P202, DOI 10.1159/000229003; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Huyghe S, 2006, ENDOCRINOLOGY, V147, P2228, DOI 10.1210/en.2005-1571; Igarashi M, 2007, J LIPID RES, V48, P1150, DOI 10.1194/jlr.M600549-JLR200; Joseph MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041288; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Long EK, 2008, J NEUROCHEM, V105, P714, DOI 10.1111/j.1471-4159.2007.05175.x; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Menzies KJ, 2013, J BIOL CHEM, V288, P6968, DOI 10.1074/jbc.M112.431155; Merenda A, 2008, J NEUROTRAUM, V25, P527, DOI 10.1089/neu.2007.0359; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Sajikumar S, 2011, P NATL ACAD SCI USA, V108, P2551, DOI 10.1073/pnas.1016849108; Schaeffer EL, 2009, PSYCHOPHARMACOLOGY, V202, P37, DOI 10.1007/s00213-008-1351-0; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Stillwell W, 2005, REPROD NUTR DEV, V45, P559, DOI 10.1051/rnd:2005046; Su HM, 2001, J BIOL CHEM, V276, P38115; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Vaynman S, 2007, NEUROSCIENCE, V144, P825, DOI 10.1016/j.neuroscience.2006.10.005; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872	39	36	36	1	22	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 17	2013	248						655	663		10.1016/j.neuroscience.2013.06.041			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	299UV	WOS:000330422100058	23811071	Green Accepted			2022-02-06	
J	Kinnaman, KA; Mannix, RC; Comstock, RD; Meehan, WP				Kinnaman, Karen A.; Mannix, Rebekah C.; Comstock, R. Dawn; Meehan, William P., III			Management strategies and medication use for treating paediatric patients with concussions	ACTA PAEDIATRICA			English	Article						Concussion; Medication management; Paediatric patient	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION; SPORT; PHYSICIANS; KNOWLEDGE; PROVIDERS; MEDICINE	Aim: To assess management strategies for paediatric patients suffering from concussions. Methods: A 17-item questionnaire was distributed to 1305 section members of the American Academy of Pediatrics Sections on Adolescent Health, Sports Medicine and Fitness, Community Pediatrics and School Health. The use of medications, neuropsychological testing, neuroimaging and published guidelines in concussion management was queried. Results: Two hundred and twenty respondents (17%) completed the questionnaire, of which 64% had been an attending for greater than 10 years. A majority of respondents (92%) managed patients with concussions, with 26% treating more than 24 patients per year. Most paediatricians (84%) reported using a published guideline. The majority of respondents (89%) manage the symptoms of concussed patients with medications, most commonly acetaminophen (62%) or nonsteroidal anti-inflammatory medications (54%). The use of prescriptions medications such as tricyclic antidepressants (23%), amantadine (10%) and methylphenidate (8%) was also commonly reported. Paediatricians treating > 16 patients per year with concussion were more likely to prescribe tricyclic antidepressants, stimulants and agents used for sleep disturbance. Conclusion: Paediatricians nationwide routinely use medications when managing patients with concussions. The pharmacological agents used differ according to number of patients treated per year. In addition, most paediatricians use published guidelines in concussion management.	[Kinnaman, Karen A.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Kinnaman, Karen A.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Mannix, Rebekah C.; Meehan, William P., III] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Mannix, Rebekah C.] Harvard Univ, Sch Med, Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Comstock, R. Dawn] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Meehan, William P., III] Harvard Univ, Sch Med, Div Sports Med, Boston Childrens Hosp, Boston, MA USA; [Meehan, William P., III] Harvard Univ, Sch Med, Sports Concuss Clin, Boston Childrens Hosp, Boston, MA USA; [Meehan, William P., III] Micheli Ctr Sports Injury & Prevent, Waltham, MA USA		Kinnaman, KA (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St,Neville House 2nd Floor, Boston, MA 02115 USA.	kkinnaman@partners.org	Mannix, Rebekah/AAD-8702-2020				Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; Ferrara Michael S., 2001, J Athl Train, V36, P145; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCarthy Mark, 2010, Conn Med, V74, P485; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Reddy CC, 2012, J HEAD; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Williams SE, 2007, BRAIN INJURY, V21, P885, DOI 10.1080/02699050701553213; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	22	36	36	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0803-5253	1651-2227		ACTA PAEDIATR	Acta Paediatr.	SEP	2013	102	9					E424	E428		10.1111/apa.12315			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	193YV	WOS:000322598300010	23750873				2022-02-06	
J	Bonfield, CM; Lam, S; Lin, YM; Greene, S				Bonfield, Christopher M.; Lam, Sandi; Lin, Yimo; Greene, Stephanie			The impact of attention deficit hyperactivity disorder on recovery from mild traumatic brain injury Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						attention deficit hyperactivity disorder; traumatic brain injury; closed head injury; trauma; disability	CHILDREN; ADOLESCENTS; SCALE	Object. Attention deficit hyperactivity disorder (ADHD) and traumatic brain injury (TBI) are significant independent public health concerns in the pediatric population. This study explores the impact of a premorbid diagnosis of ADHD on outcome following mild TBI. Methods. The charts of all patients with a diagnosis of mild closed head injury (CHI) and ADHD who were admitted to Children's Hospital of Pittsburgh between January 2003 and December 2010 were retrospectively reviewed after institutional review board approval was granted. Patient demographics, initial Glasgow Coma Scale (GCS) score, hospital course, and King's Outcome Scale for Childhood Head Injury (KOSCHI) score were recorded. The results were compared with a sample of age-matched controls admitted with a diagnosis of CHI without ADHD. Results. Forty-eight patients with mild CHI and ADHD, and 45 patients with mild CHI without ADHD were included in the statistical analysis. Mild TBI due to CHI was defined as an initial GCS score of 13-15. The ADHD group had a mean age of 12.2 years (range 6-17 years), and the control group had a mean age of 11.14 years (range 5-16 years). For patients with mild TBI who had ADHD, 25% were moderately disabled (KOSCHI Score 4b), and 56% had completely recovered (KOSCHI Score 5b) at follow-up. For patients with mild TBI without ADHD, 2% were moderately disabled and 84% had completely recovered at follow-up (p < 0.01). Patients with ADHD were statistically significantly more disabled after mild TBI than were control patients without ADHD, even when controlling for age, sex, initial GCS score, hospital length of stay, length of follow-up, mechanism of injury, and presence of other (extracranial) injury. Conclusions. Patients who sustain mild TBIs in the setting of a premorbid diagnosis of ADHD are more likely to be moderately disabled by the injury than are patients without ADHD.	[Bonfield, Christopher M.; Greene, Stephanie] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15224 USA; [Lam, Sandi; Lin, Yimo] Univ Chicago, Neurosurg Sect, Chicago, IL 60637 USA		Bonfield, CM (corresponding author), Univ Pittsburgh, Dept Neurosurg, 4th Floor Fac Pavilion,4401 Penn Ave, Pittsburgh, PA 15224 USA.	bonfieldcm@upmc.edu		Lam, Sandi/0000-0003-3294-6637; Greene, Stephanie/0000-0002-5858-4032			Barkley Russell Alan, 2006, ATTENTION DEFICIT HY, V3rd; BIEDERMAN J, 1991, AM J PSYCHIAT, V148, P564; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P842; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; FAIGEL HC, 1995, J ADOLESCENT HEALTH, V16, P174, DOI 10.1016/1054-139X(94)00049-K; Hoare P, 2003, EUR J EMERG MED, V10, P98, DOI 10.1097/01.mej.0000072631.17469.71; JENNETT B, 1975, LANCET, V1, P480; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Kupper T, 2012, INT ARCH OCC ENV HEA, V85, P837, DOI 10.1007/s00420-012-0794-0; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; *NAT CTR INJ PREV, 2006, TRAUM BRAIN INJ US A; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Spencer TJ, 2002, J CLIN PSYCHIAT, V63, P3; TEASDALE G, 1974, LANCET, V2, P81; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	18	36	36	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2013	12	2					97	102		10.3171/2013.5.PEDS12424			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	187CM	WOS:000322094500001	23905842	Bronze			2022-02-06	
J	Imam, AM; Jin, G; Duggan, M; Sillesen, M; Hwabejire, JO; Jepsen, CH; DePeralta, D; Liu, BL; Lu, J; deMoya, MA; Socrate, S; Alam, HB				Imam, Ayesha M.; Jin, Guang; Duggan, Michael; Sillesen, Martin; Hwabejire, John O.; Jepsen, Cecilie H.; DePeralta, Danielle; Liu, Baoling; Lu, Jennifer; deMoya, Marc A.; Socrate, Simona; Alam, Hasan B.			Synergistic effects of fresh frozen plasma and valproic acid treatment in a combined model of traumatic brain injury and hemorrhagic shock	SURGERY			English	Article							DIFFERENT RESUSCITATION STRATEGIES; SEVERE HEAD-INJURY; HISTONE DEACETYLASE; FLUID RESUSCITATION; INTRACRANIAL-PRESSURE; OXYGEN DELIVERY; RODENT MODEL; BLOOD-LOSS; DEATH; AGE	Introduction. Traumatic brain injury (TBI) and hemorrhagic shock (HS) are major causes of trauma-related deaths and are especially lethal as a combined insult. Previously, we showed that early administration of fresh frozen plasma (FFP) decreased the size of the brain lesion and associated swelling in a swine model of combined TBI+HS. We have also shown separately that addition of valproic acid (VPA) to the resuscitation protocol attenuates inflammatory markers in the brain as well as the degree of TBI. The current study was performed to determine whether a combined FFP+VPA treatment strategy would exert a synergistic effect. Methods. Yorkshire swine (42-50 kg) were instrumented to measure hemodynamic parameters, intracranial pressure, and brain tissue oxygenation. TBI was created through a 20-mm craniotomy using a computer-controlled cortical impactor: 15-mm cylindrical tip impactor at 4 m/s velocity, 100 ms dwell time, and 12-mm penetration depth. The TBI was synchronized with the initiation of volume-controlled hemorrhage (40 +/- 5% of total blood volume). After a 2-hour period of shock, animals were randomized to 1 of 3 resuscitation groups (n = 5 per group): (1) 0.9% saline (NS); (2) FFP; and (3) FFP and VPA 300 mg/kg (FFP+VPA). The resuscitative volume for FFP was equivalent to the shed blood, whereas NS was 3 times this volume. VPA treatment was started 1 hour after hemorrhage. Animals were monitored for 6 hours post-resuscitation. At this time the brains were harvested, sectioned into 5-mm slices, and stained with 2,3,5-triphenyltetrazolium chloride to quantify the lesion size (mm(3)) and brain swelling (percent change compared with the uninjured side). Results. The combined TBI+HS model resulted in a highly reproducible brain injury. Lesion size and brain swelling (mean value +/- standard error of the mean) in the FFP+VPA group (1,459 +/- 218 mm(3) and 13 +/- 1%, respectively) were less than the NS group (3,285 +/- 131 mm(3) [P < .001] and 37 +/- 2% [P < .001], respectively), and the FFP alone group (2,160 +/- 203 mm(3) [P < .05] and 22 +/- 1% [P < .001], respectively). Conclusion. In a large animal model of TBI+HS, early treatment with a combination of FFP and VPA decreases the size of brain lesion and the associated swelling.	[Imam, Ayesha M.; Jin, Guang; Duggan, Michael; Sillesen, Martin; Hwabejire, John O.; Jepsen, Cecilie H.; DePeralta, Danielle; Liu, Baoling; Lu, Jennifer; deMoya, Marc A.; Alam, Hasan B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg,Div Trauma Emergency Surg & Surg Crit C, Boston, MA USA; [Socrate, Simona] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Jin, Guang; Liu, Baoling; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Sillesen, Martin/0000-0001-9494-5475	US Army Medical Research Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [GRANTT00521959]	Funded by a grant from the US Army Medical Research Material Command GRANTT00521959 (to HBA).	Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Atmaca A, 2007, BRIT J CANCER, V97, P177, DOI 10.1038/sj.bjc.6603851; Aucar John A, 2009, Am J Surg, V198, P900, DOI 10.1016/j.amjsurg.2009.05.034; Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Bilotta F, 2007, NEW ENGL J MED, V357, P2635; Bourguignon PR, 1998, ARCH SURG-CHICAGO, V133, P390, DOI 10.1001/archsurg.133.4.390; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention, INJ LEAD CAUS DEATH, P1; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; Fukudome EY, 2010, J SURG RES, V163, P118, DOI 10.1016/j.jss.2010.04.013; Gonzales ER, 2008, J TRAUMA, V65, P554, DOI 10.1097/TA.0b013e31818233ef; GUNNAR W, 1988, SURGERY, V103, P398; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; Ichiyama T, 2000, BRAIN RES, V857, P246, DOI 10.1016/S0006-8993(99)02439-7; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Jin G, 2010, TRANSL STROKE RES, V1, P65, DOI 10.1007/s12975-009-0009-5; Jin G, 2009, EXP NEUROL, V217, P165, DOI 10.1016/j.expneurol.2009.02.004; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kim K, 2012, RESUSCITATION, V83, P243, DOI 10.1016/j.resuscitation.2011.07.029; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lheureux PER, 2005, CRIT CARE, V9, P431, DOI 10.1186/cc3742; Li YQ, 2008, J TRAUMA, V64, P863, DOI 10.1097/TA.0b013e318166b822; Lin T, 2006, SURGERY, V139, P365, DOI 10.1016/j.surg.2005.08.022; Lin T, 2007, SURGERY, V141, P784, DOI 10.1016/j.surg.2007.01.014; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Myburgh J, 2007, NEW ENGL J MED, V357, P874; O'Connell KM, 2013, BIOL RES NURS; Offner PJ, 2004, CRIT CARE, V8, pS24, DOI 10.1186/cc2405; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Purdy FR, 1997, CAN J ANAESTH, V44, P1256, DOI 10.1007/BF03012772; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; Shults C, 2008, J TRAUMA, V64, P629, DOI 10.1097/TA.0b013e3181650ff3; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Sondeen JL, 2011, TRANSFUSION, V51, P779, DOI 10.1111/j.1537-2995.2010.02928.x; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; Takano K, 1997, STROKE, V28, P1255, DOI 10.1161/01.STR.28.6.1255; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; Zacharias N, 2011, RESUSCITATION, V82, P105, DOI 10.1016/j.resuscitation.2010.09.469; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1	47	36	37	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	AUG	2013	154	2					388	396		10.1016/j.surg.2013.05.008			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	196UB	WOS:000322801800031	23889966				2022-02-06	
J	Fraser, CD; Brady, KM; Rhee, CJ; Easley, RB; Kibler, K; Smielewski, P; Czosnyka, M; Kaczka, DW; Andropoulos, DB; Rusin, C				Fraser, Charles D., III; Brady, Ken M.; Rhee, Christopher J.; Easley, R. Blaine; Kibler, Kathleen; Smielewski, Peter; Czosnyka, Marek; Kaczka, David W.; Andropoulos, Dean B.; Rusin, Craig			The frequency response of cerebral autoregulation	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						cerebrovascular autoregulation; neonatal; frequency	TRAUMATIC BRAIN-INJURY; NEAR-INFRARED SPECTROSCOPY; BLOOD-FLOW AUTOREGULATION; CEREBROVASCULAR AUTOREGULATION; PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; PHASE RELATIONSHIP; REACTIVITY; ISOFLURANE; VELOCITY	The frequency-response of pressure autoregulation is not well delineated; therefore, the optimal frequency of arterial blood pressure (ABP) modulation for measuring autoregulation is unknown. We hypothesized that cerebrovascular autoregulation is band-limited and delineated by a cutoff frequency for which ABP variations induce cerebrovascular reactivity. Neonatal swine (n = 8) were anesthetized using constant minute ventilation while positive end-expiratory pressure (PEEP) was modulated between 6 and 0.75 cycles/min (min(-1)). The animals were hemorrhaged until ABP was below the lower limit of autoregulation (LLA), and PEEP modulations were repeated. Vascular reactivity was quantified at each frequency according to the phase lag between ABP and intracranial pressure (ICP) above and below the LLA. Phase differences between ABP and ICP were small for frequencies of >2 min(-1), with no ability to differentiate cerebrovascular reactivity between ABPs above or below the LLA. For frequencies of <2 min(-1), ABP and intracranial pressure (ICP) showed phase shift when measured above LLA and no phase shift when measured below LLA [above vs. below LLA at 1 min(-1): 156 degrees (139-174 degrees) vs. 30 degrees (22-50 degrees); P < 0.001 by two-way ANOVA for both frequency and state of autoregulation]. Data taken above LLA fit a Butterworth high-pass filter model with a cutoff frequency at 1.8 min(-1) (95% confidence interval: 1.5-2.2). Cerebrovascular reactivity occurs for sustained ABP changes lasting 30 s or longer. The ability to distinguish intact and impaired autoregulation was maximized by a 60-s wave (1 min(-1)), which was 100% sensitive and 100% specific in this model.	[Fraser, Charles D., III] Univ Texas Houston, Sch Med, Houston, TX USA; [Brady, Ken M.; Easley, R. Blaine; Kibler, Kathleen; Andropoulos, Dean B.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Brady, Ken M.; Easley, R. Blaine; Kibler, Kathleen; Andropoulos, Dean B.] Texas Childrens Hosp, Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; [Rhee, Christopher J.] Texas Childrens Hosp, Baylor Coll Med, Dept Neonatol, Houston, TX 77030 USA; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Cambridge CB2 2QQ, England; [Kaczka, David W.] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA; [Rusin, Craig] Texas Childrens Hosp, Baylor Coll Med, Dept Cardiol, Houston, TX 77030 USA		Brady, KM (corresponding author), Texas Childrens Hosp, 6621 Fannin,WT 17-417B, Houston, TX 77030 USA.	kmbrady@texaschildrens.org	Kaczka, David W./U-2580-2018; Kaczka, David W./A-2984-2008	Kaczka, David W./0000-0003-4378-5242; Kaczka, David W./0000-0003-4378-5242; Smielewski, Peter/0000-0001-5096-3938; Rusin, Craig/0000-0003-3812-8133	FAER Medical Student Summer Research Fellowship; American Association of Thoracic Surgery Student Research Fellowship	Charles Fraser was sponsored by both the FAER Medical Student Summer Research Fellowship and the American Association of Thoracic Surgery Student Research Fellowship during the time of these studies. Blaine Easley, Ken Brady, and Craig Rusin are co-inventors of the PEEP-modulation technology used to measure autoregulation in this study, and the method has been submitted for patent protection. ICM+ software used in this study is licensed by the University of Cambridge (Cambridge Enterprise). Marek Czosnyka and Peter Smielewski have a financial interest in a part of its licensing fee.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; Brady KM, 2010, ANESTH ANALG, V111, P191, DOI 10.1213/ANE.0b013e3181e054ba; Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Diedler J, 2011, ANESTH ANALG, V113, P849, DOI 10.1213/ANE.0b013e3182285dc0; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; LAPTOOK AR, 1983, PEDIATR RES, V17, P77, DOI 10.1203/00006450-198301000-00015; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lewis PM, 2008, ACTA NEUROCHIR, V150, P139, DOI 10.1007/s00701-007-1447-z; MCPHERSON RW, 1988, ANESTHESIOLOGY, V69, P493, DOI 10.1097/00000542-198810000-00008; Mertineit C, 2000, CAN J PHYSIOL PHARM, V78, P217, DOI 10.1139/cjpp-78-3-217; Pedersen TF, 2003, AM J PHYSIOL-HEART C, V285, pH1097, DOI 10.1152/ajpheart.00098.2003; Ragauskas A, 2005, ACTA NEUROCHIR SUPPL, V95, P367; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	22	36	36	0	6	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587			J APPL PHYSIOL	J. Appl. Physiol.	JUL	2013	115	1					52	56		10.1152/japplphysiol.00068.2013			5	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	174ZW	WOS:000321199200006	23681909				2022-02-06	
J	Immonen, R; Kharatishvili, I; Grohn, O; Pitkanen, A				Immonen, Riikka; Kharatishvili, Irina; Grohn, Olli; Pitkanen, Asla			MRI Biomarkers for Post-Traumatic Epileptogenesis	JOURNAL OF NEUROTRAUMA			English	Article						epilepsy; magnetic resonance imaging; traumatic brain injury	BRAIN-INJURY; SEIZURE SUSCEPTIBILITY; EPILEPSY; HIPPOCAMPUS; MODELS; RATS	The present study tested a hypothesis that early identification of injury severity with quantitative magnetic resonance imaging (MRI) provides biomarkers for predicting increased seizure susceptibility and epileptogenesis after traumatic brain injury (TBI). TBI was induced by lateral fluid percussion injury (FPI) in adult rats. Quantitative T2, T1 rho, and diffusion were assessed with MRI at 9 days, 23 days, or 2 months post-TBI in the perilesional cortex, thalamus, and hippocampus. Seizure susceptibility was assessed at 12 months after TBI using the pentylenetetrazol seizure-susceptibility test. At 9 and 23 days post-TBI, a change in T1 rho of the perilesional cortex showed the greatest predictive value for increased seizure susceptibility at 12 months post-TBI [area under the curve (AUC), 0.929 and 0.952, respectively; p < 0.01]. At 2 months post-TBI, Dav in the thalamus was the best of the biomarkers analyzed (AUC, 0.988; p < 0.05). The highest predictive value of all biomarkers was achieved by combining the measurement of Dav in the perilesional cortex and the thalamus at 2 months post-TBI (AUC, 1.000; p < 0.01). Our results provide proof-of-concept evidence that clinically relevant MRI biomarkers predict increased seizure susceptibility after experimental TBI.	[Immonen, Riikka; Grohn, Olli; Pitkanen, Asla] Univ Eastern Finland, Dept Neurobiol, AI Virtanen Inst Mol Sci, FI-70211 Kuopio, Finland; [Pitkanen, Asla] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Kharatishvili, Irina] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia		Pitkanen, A (corresponding author), Univ Eastern Finland, Dept Neurobiol, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi			Academy of FinlandAcademy of FinlandEuropean Commission; Sigrid Juselius FoundationSigrid Juselius Foundation	This study was supported by the Academy of Finland (to R.I., O.G., and A.P.) and the Sigrid Juselius Foundation (to A.P.).	Airaksinen AM, 2012, ISMRM 20 ANN M MELB; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Baulac M., 2009, EPILEPSIA, V50, P571; Blanco MM, 2009, EPILEPSIA, V50, P824, DOI 10.1111/j.1528-1167.2008.01797.x; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Engel J, 2011, BIOMARK MED, V5, P537, DOI [10.2217/BMM.11.62, 10.2217/bmm.11.62]; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Kelley Melinda S, 2009, Epilepsia, V50, P579, DOI 10.1111/j.1528-1167.2008.01813.x; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Pitkanen A., 2012, JASPERS BASIC MECH E, V4th; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; Rattka M, 2011, NEUROPHARMACOLOGY, V60, P505, DOI 10.1016/j.neuropharm.2010.11.005; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; VEZZANI A, 1994, BRAIN RES, V660, P138, DOI 10.1016/0006-8993(94)90847-8; Yue L, 2011, EPILEPSY BEHAV, V22, P692, DOI 10.1016/j.yebeh.2011.08.022	17	36	36	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	14					1305	1309		10.1089/neu.2012.2815			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	183MV	WOS:000321821100011	23469770	Green Published			2022-02-06	
J	Nielsen, TH; Olsen, NV; Toft, P; Nordstrom, CH				Nielsen, T. H.; Olsen, N. V.; Toft, P.; Nordstrom, C. H.			Cerebral energy metabolism during mitochondrial dysfunction induced by cyanide in piglets	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							TRAUMATIC BRAIN-INJURY; CYCLOSPORINE-A; SUBARACHNOID HEMORRHAGE; CYTOCHROME-OXIDASE; CELL-DEATH; ISCHEMIA; RATS; MICRODIALYSIS; MECHANISMS; FAILURE	Background Mitochondrial dysfunction is an important factor contributing to tissue damage in both severe traumatic brain injury and ischemic stroke. This experimental study explores the possibility to diagnose the condition bedside by utilising intracerebral microdialysis and analysis of chemical variables related to energy metabolism. Methods Mitochondrial dysfunction was induced in piglets and evaluated by monitoring brain tissue oxygen tension (PbtO2) and cerebral levels of glucose, lactate, pyruvate, glutamate, and glycerol bilaterally. The biochemical variables were obtained by microdialysis and immediate enzymatic analysis. Mitochondrial function was blocked by unilateral infusion of NaCN/KCN (0.5mol/L) through the microdialysis catheter (N=5). As a reference, NaCl (0.5mol/L) was infused by intracerebral microdialysis in one group of animals (N=3). Results PbtO2 increased during cyanide infusion and returned to baseline afterwards. The lactate/pyruvate (LP) ratio increased significantly following cyanide infusion because of a marked increase in lactate level while pyruvate remained within normal limits. Glutamate and glycerol increased after cyanide infusion indicating insufficient energy metabolism and degradation of cellular membranes, respectively. Conclusion Mitochondrial dysfunction is characterised by an increased LP ratio signifying a shift in cytoplasmatic redox state at normal or elevated PbtO2. The condition is biochemically characterised by a marked increase in cerebral lactate with a normal or elevated pyruvate level. The metabolic pattern is different from cerebral ischemia, which is characterised by simultaneous decreases in intracerebral pyruvate and PbtO2. The study supports the hypothesis that cerebral ischemia and mitochondrial dysfunction may be identified and separated at the bedside by utilising intracerebral microdialysis.	Odense Univ Hosp, Dept Anaesthesiol, DK-5000 Odense C, Denmark; [Nielsen, T. H.] Odense Univ Hosp, Dept Neurosurg, DK-5000 Odense C, Denmark; Univ Southern Denmark, Biomed Lab, DK-5000 Odense C, Denmark		Nielsen, TH (corresponding author), Odense Univ Hosp, Dept Neurosurg, Sdr Blvd 29, DK-5000 Odense C, Denmark.	troels.nielsen@ouh.regionsyddanmark.dk	Nielsen, Troels Halfeld/G-3456-2015	Nielsen, Troels Halfeld/0000-0002-3943-8128; Toft, Palle/0000-0002-3188-449X	Odense University Hospital; A.P. Moller foundation	The project was supported by grants from Odense University Hospital and the A.P. Moller foundation.	Akdemir G, 2005, NEUROL RES, V27, P827, DOI 10.1179/016164105X63610; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; CAMERINO PW, 1966, J BIOL CHEM, V241, P970; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Gardenfors A, 2002, ACTA NEUROCHIR, V144, P601, DOI 10.1007/s00701-002-0954-1; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hwang JH, 2010, BRAIN RES, V1359, P208, DOI 10.1016/j.brainres.2010.08.047; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kopterides P, 2011, INTENS CARE MED, V37, P1756, DOI 10.1007/s00134-011-2336-8; Lawson-Smith P, 2011, UNDERSEA HYPERBAR M, V38, P223; Levy B, 2005, LANCET, V365, P871, DOI 10.1016/S0140-6736(05)71045-X; MACMILLAN VH, 1989, J CEREBR BLOOD F MET, V9, P156, DOI 10.1038/jcbfm.1989.23; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P229, DOI 10.1111/j.1399-6576.2012.02783.x; Nielsen TH, 2011, NEUROCRIT CARE, V15, P585, DOI 10.1007/s12028-011-9563-2; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Nordstrom C H, 1977, Acta Neurol Scand Suppl, V64, P146; NORDSTROM CH, 1978, J NEUROCHEM, V30, P479, DOI 10.1111/j.1471-4159.1978.tb06553.x; PETTERSEN JC, 1993, J APPL TOXICOL, V13, P9, DOI 10.1002/jat.2550130104; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Siesjo BK, 1999, ACTA NEUROCHIR SUPPL, V73, P7; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Ungerstedt U, 1997, PHYSIOLOGY, STRESS, AND MALNUTRITION, P361; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	33	36	37	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	JUL	2013	57	6					793	801		10.1111/aas.12092			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	160JW	WOS:000320116800017	23495747				2022-02-06	
J	Snell, DL; Hay-Smith, EJC; Surgenor, LJ; Siegert, RJ				Snell, Deborah L.; Hay-Smith, E. Jean C.; Surgenor, Lois J.; Siegert, Richard J.			Examination of outcome after mild traumatic brain injury: The contribution of injury beliefs and Leventhal's Common Sense Model	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Mild traumatic brain injury; Illness perceptions; Outcome	POST-CONCUSSION SYMPTOMS; ILLNESS PERCEPTIONS; HEAD-INJURY; POSTCONCUSSION SYNDROME; MYOCARDIAL-INFARCTION; MISERABLE MINORITY; DEPRESSION SCALE; HOSPITAL ANXIETY; SELF-REGULATION; QUESTIONNAIRE	Associations between components of Leventhal's common sense model of health behaviour (injury beliefs, coping, distress) and outcome after mild traumatic brain injury (MTBI) were examined. Participants (n=147) were recruited within three months following MTBI and assessed six months later, completing study questionnaires at both visits (Illness Perceptions Questionnaire Revised, Brief COPE, Hospital Anxiety and Depression Scale). Outcome measures included the Rivermead Post-Concussion Symptoms Questionnaire and Rivermead Head Injury Follow-Up Questionnaire. Univariate and multivariate (logistic regression) analyses examined associations between injury beliefs, coping and distress at baseline, and later outcome. Participants endorsing stronger injury identity beliefs (p<.01), expectations of lasting severe consequences (p<.01), and distress (p<.01) at time one, had greater odds of poor outcome at time two. Coping styles were also associated with later outcome although variability in findings limited interpretability. Associations between psychological variables and outcome were examined and 76.5% of cases were correctly classified by the model. Consistent with Leventhal's model, participant beliefs about their injury and recovery had significant associations with outcome over time. Coping also appeared to have important associations with outcome but more research is required to examine these. Current reassurance-based interventions may be improved by targeting variables such as injury beliefs, coping and adjustment soon after injury.	[Snell, Deborah L.; Hay-Smith, E. Jean C.] Univ Otago, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Surgenor, Lois J.] Univ Otago, Dept Psychol Med, Christchurch, New Zealand; [Siegert, Richard J.] AUT Univ, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [Siegert, Richard J.] AUT Univ, Sch Rehabil & Occupat Studies, Auckland, New Zealand; [Snell, Deborah L.] Canterbury Dist Hlth Board, Burwood Hosp, Concuss Clin, Brain Injury Rehabil Serv, Christchurch, New Zealand		Snell, DL (corresponding author), Burwood Hosp, Brain Injury Rehabil Serv, Private Bag 4708, Christchurch, New Zealand.	deborah.snell@cdhb.govt.nz	Siegert, Richard J./K-2030-2019	Siegert, Richard/0000-0002-3074-0929	Neurological Foundation of New Zealand [0728-SPG]	This research has been support by a Small Project Grant from the Neurological Foundation of New Zealand (Grant no: 0728-SPG).	Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Cameron LD., 2003, SELF REGULATION HLTH; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen J., 2013, STAT POWER ANAL BEHA; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Deary V, 2007, CLIN PSYCHOL REV, V27, P781, DOI 10.1016/j.cpr.2007.07.002; Foster NE, 2008, PAIN, V136, P177, DOI 10.1016/j.pain.2007.12.007; French DP, 2006, J PSYCHOSOM RES, V61, P757, DOI 10.1016/j.jpsychores.2006.07.029; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hagger MS, 2005, J APPL SOC PSYCHOL, V35, P2345, DOI 10.1111/j.1559-1816.2005.tb02106.x; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kaptein AA, 2006, PSYCHOL HEALTH, V21, P431, DOI 10.1080/14768320500456947; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Leventhal H, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P19; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Leventhal H, 2008, ANNU REV PSYCHOL, V59, P477, DOI 10.1146/annurev.psych.59.103006.093643; Llewellyn CD, 2007, J PSYCHOSOM RES, V63, P17, DOI 10.1016/j.jpsychores.2007.01.013; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; Macleod AD, 2010, MED HYPOTHESES, V74, P1033, DOI 10.1016/j.mehy.2010.01.002; Maxwell S., 2008, ANNU REV PSYCHOL, V59, P1; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Mittenberg W., 1992, J NEUROL NEUROSUR PS, V41, P611; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Munro BH, 2005, STAT METHODS HLTH CA, V5th; NZGG, 2006, TRAUM BRAIN INJ DIAG; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; PETRIE K, 1995, J PSYCHOSOM RES, V39, P31, DOI 10.1016/0022-3999(94)00071-C; Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rose JM, 2005, BRAIN INJURY, V19, P29, DOI 10.1080/02699050310001617361; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff R., 2003, YOUMANS NEUROLOGICAL, P5181; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Siegert RJ, 2005, DISABIL REHABIL, V27, P1493, DOI 10.1080/09638280500288401; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell DL, 2011, J HEAD TRAUMA REHAB, V26, P468, DOI 10.1097/HTR.0b013e3181fc5e1e; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; SNELL DL, 2006, NZ MED J, V119, P1231; Stanton AL, 2007, ANNU REV PSYCHOL, V58, P565, DOI 10.1146/annurev.psych.58.110405.085615; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; TEASDALE G, 1974, LANCET, V2, P81; Van Ittersum MW, 2009, PATIENT EDUC COUNS, V74, P53, DOI 10.1016/j.pec.2008.07.041; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	74	36	36	1	28	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUN 1	2013	23	3					333	362		10.1080/09658211.2012.758419			30	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	145UT	WOS:000319044500003	23336822				2022-02-06	
J	Tajiri, N; Dailey, T; Metcalf, C; Mosley, YI; Lau, T; Staples, M; van Loveren, H; Kim, SU; Yamashima, T; Yasuhara, T; Date, I; Kaneko, Y; Borlongan, CV				Tajiri, Naoki; Dailey, Travis; Metcalf, Christopher; Mosley, Yusef I.; Lau, Tsz; Staples, Meaghan; van Loveren, Harry; Kim, Seung U.; Yamashima, Tetsumori; Yasuhara, Takao; Date, Isao; Kaneko, Yuji; Borlongan, Cesario V.			In Vivo Animal Stroke Models A Rationale for Rodent and Non-Human Primate Models	TRANSLATIONAL STROKE RESEARCH			English	Article						Cerebral ischemia; Animals; Basic research; Translational; Clinical application	CEREBRAL-ARTERY OCCLUSION; MARROW STROMAL CELLS; ACUTE ISCHEMIC-STROKE; ENDURING MEMORY IMPAIRMENT; INTRALUMINAL THREAD TECHNIQUE; TISSUE-PLASMINOGEN ACTIVATOR; TRANSIENT FOREBRAIN ISCHEMIA; TRAUMATIC BRAIN-INJURY; DELAYED NEURONAL DEATH; BONE-MARROW	On average, every 4 min an individual dies from a stroke, accounting for one out of every 18 deaths in the United States. Approximately 795,000 Americans have a new or recurrent stroke each year, with just over 600,000 of these being first attack Roger et al. (Circulation, 125(1): 188-197, 2012). There have been multiple animal models of stroke demonstrating that novel therapeutics can help improve the clinical outcome. However, these results have failed to show the same outcomes when tested in human clinical trials. This review will discuss the current in vivo animal models of stroke, advantages and limitations, and the rationale for employing these animal models to satisfy translational gating items for examination of neuroprotective, as well as neurorestorative strategies in stroke patients. An emphasis in the present discussion of therapeutics development is given to stem cell therapy for stroke.	[Tajiri, Naoki; Dailey, Travis; Metcalf, Christopher; Mosley, Yusef I.; Lau, Tsz; Staples, Meaghan; van Loveren, Harry; Kaneko, Yuji; Borlongan, Cesario V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA; [Kim, Seung U.] Univ British Columbia, Dept Neurol, Vancouver, BC V5Z 1M9, Canada; [Yamashima, Tetsumori] Kanazawa Univ, Dept Restorat Neurosurg, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Yasuhara, Takao; Date, Isao] Okayama Univ, Dept Neurol Surg, Grad Sch Med, Okayama, Japan		Borlongan, CV (corresponding author), Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012; Kaneko, Yuji/J-6447-2012	Borlongan, Cesar/0000-0002-2966-9782; 	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [UO15U01NS055914-04, R01NS071956-01]; James and Esther King Foundation for Biomedical Research Program; USF Signature Program in Interdisciplinary Neuroscience; SanBio Inc.; Celgene Cellular TherapeuticsBristol-Myers SquibbCelgene Corporation; KMPHC; NeuralStem Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956, U01NS055914] Funding Source: NIH RePORTER	The Borlongan Laboratory is supported by NIH NINDS UO15U01NS055914-04, NIH NINDS R01NS071956-01, James and Esther King Foundation for Biomedical Research Program, USF Signature Program in Interdisciplinary Neuroscience, SanBio Inc., Celgene Cellular Therapeutics, KMPHC, and NeuralStem Inc. CVB has patents and pending patents on cell therapy.	Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Borlongan CV, 2008, REGEN MED, V3, P249, DOI 10.2217/17460751.3.3.249; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Borlongan CV, 2006, FRONT BIOSCI-LANDMRK, V11, P1090, DOI 10.2741/1865; BRANSTON NM, 1974, EXP NEUROL, V45, P195, DOI 10.1016/0014-4886(74)90112-5; BRIERLEY JB, 1969, BRAIN RES, V13, P68, DOI 10.1016/0006-8993(69)90144-9; Bruno A, 2002, NEUROLOGY, V59, P669, DOI 10.1212/WNL.59.5.669; Busch E, 1997, BRAIN RES, V778, P16, DOI 10.1016/S0006-8993(97)01008-1; Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chopp M, 2009, CELL TRANSPLANT, V18, P691, DOI 10.3727/096368909X470883; CROWELL RM, 1981, NEUROLOGY, V31, P1295, DOI 10.1212/WNL.31.10.1295; Crowell RM, 1970, STROKE, V1, P439, DOI 10.1161/01.STR.1.6.439; Davenport R, 2000, J NEUROL NEUROSUR PS, V68, P277, DOI 10.1136/jnnp.68.3.277; de Crespigny Alex J, 2005, J Stroke Cerebrovasc Dis, V14, P80, DOI 10.1016/j.jstrokecerebrovasdis.2004.12.005; DELZOPPO GJ, 1986, STROKE, V17, P1254, DOI 10.1161/01.STR.17.6.1254; DUVERGER D, 1988, J CEREBR BLOOD F MET, V8, P449, DOI 10.1038/jcbfm.1988.86; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; EKLOF B, 1972, ACTA PHYSIOL SCAND, V86, P155, DOI 10.1111/j.1748-1716.1972.tb05322.x; EKLOF B, 1972, ACTA PHYSIOL SCAND, V86, P528, DOI 10.1111/j.1748-1716.1972.tb05354.x; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Fagan SC, 1998, NEUROLOGY, V50, P883, DOI 10.1212/WNL.50.4.883; Fagan SC, 2004, EXP NEUROL, V186, P248, DOI 10.1016/j.expneurol.2003.12.006; Fan X, 2012, STROKE, V43, P567, DOI 10.1161/STROKEAHA.111.635250; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Ferrari A, 2000, FEBS LETT, V486, P121, DOI 10.1016/S0014-5793(00)02251-1; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fisher Marc, 2008, Am J Manag Care, V14, pS204; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Fujioka M, 2000, CEREBROVASC DIS, V10, P2, DOI 10.1159/000016018; Fukuda S, 2003, ILAR J, V44, P96, DOI 10.1093/ilar.44.2.96; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Garcia JH, 1995, STROKE, V26, P635; Gerriets T, 2003, J NEUROSCI METH, V122, P201, DOI 10.1016/S0165-0270(02)00322-9; Ginsberg MD BR, 1998, CEREBROVASCULAR DIS; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; GLOBUS MYT, 1988, NEUROSCI LETT, V91, P36, DOI 10.1016/0304-3940(88)90245-5; Glover LE, 2012, TRANSL STROKE RES, V3, P90, DOI 10.1007/s12975-011-0127-8; Hara K, 2007, BRAIN RES BULL, V74, P164, DOI 10.1016/j.brainresbull.2007.06.014; Hattiangady B, 2008, AGING CELL, V7, P207, DOI 10.1111/j.1474-9726.2007.00363.x; Hess DC, 2005, STROKE, V36, P2018, DOI 10.1161/01.STR.0000177534.02969.e4; Hess DC, 2002, STROKE, V33, P1362, DOI 10.1161/01.STR.0000014925.09415.C3; Hurn PD, 2005, STROKE, V36, P193, DOI 10.1161/01.STR.0000153064.41332.f6; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; KAWAMURA S, 1991, ACTA NEUROCHIR, V109, P126, DOI 10.1007/BF01403007; KAWAMURA S, 1994, SURG NEUROL, V41, P368, DOI 10.1016/0090-3019(94)90029-9; Kim E, 2012, ANN NEUROL, V71, P753, DOI 10.1002/ana.23569; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lapchak Paul A, 2012, J Neurol Neurophysiol, V3; Lees JS, 2012, INT J STROKE, V7, P582, DOI 10.1111/j.1747-4949.2012.00797.x; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Lindner MD, 2003, J NEUROSCI, V23, P10913; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; MARKGRAF CG, 1993, STROKE, V24, P286, DOI 10.1161/01.STR.24.2.286; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marshall JWB, 2003, ILAR J, V44, P153, DOI 10.1093/ilar.44.2.153; Martini SR, 2007, J CEREBR BLOOD F MET, V27, P435, DOI 10.1038/sj.jcbfm.9600355; Matsukawa N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-126; Matsumoto Y, 2009, J IMMUNOL, V183, P4773, DOI 10.4049/jimmunol.0900871; MEMEZAWA H, 1992, STROKE, V23, P552, DOI 10.1161/01.STR.23.4.552; Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0; MOLINARI GF, 1974, STROKE, V5, P334, DOI 10.1161/01.STR.5.3.334; Munoz-Elias G, 2004, J NEUROSCI, V24, P4585, DOI 10.1523/JNEUROSCI.5060-03.2004; NEMOTO EM, 1977, STROKE, V8, P558, DOI 10.1161/01.STR.8.5.558; Nemoto EM, 2005, ADV EXP MED BIOL, V566, P83; NEUBUERGER KT, 1954, J NEUROPATH EXP NEUR, V13, P144; Nudo RJ, 2003, ILAR J, V44, P161, DOI 10.1093/ilar.44.2.161; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; PETITO CK, 1986, LAB INVEST, V55, P696; PULSINELLI WA, 1988, STROKE, V19, P913, DOI 10.1161/01.STR.19.7.913; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rewell SSJ, 2010, J CEREBR BLOOD F MET, V30, P729, DOI 10.1038/jcbfm.2009.273; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Rink C, 2008, P NATL ACAD SCI USA, V105, P14100, DOI 10.1073/pnas.0806678105; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Roitberg B, 2003, NEUROL RES, V25, P68, DOI 10.1179/016164103101200950; Romero-Perez D, 2008, J AM COLL CARDIOL, V52, P1086, DOI 10.1016/j.jacc.2008.06.028; Sasaki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026577; Schmahmann JD, 2004, ANN NEUROL, V55, P585, DOI 10.1002/ana.20060; Schmid-Elsaesser R, 1998, STROKE, V29, P2162, DOI 10.1161/01.STR.29.10.2162; Shi S, 2008, EUR J CLIN PHARMACOL, V64, P183, DOI 10.1007/s00228-007-0422-1; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; SMITH ML, 1984, ACTA NEUROL SCAND, V69, P385, DOI 10.1111/j.1600-0404.1984.tb07822.x; SPETZLER RF, 1980, SURG NEUROL, V13, P317; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; Symon L, 1975, Adv Neurol, V10, P199; TABUCHI E, 1992, BRAIN RES BULL, V29, P685, DOI 10.1016/0361-9230(92)90139-O; TABUCHI E, 1995, BRAIN RES BULL, V37, P73, DOI 10.1016/0361-9230(94)00262-2; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; Toda H, 2001, NEUROSCI LETT, V316, P9, DOI 10.1016/S0304-3940(01)02331-X; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Tsukada T, 2001, J NEUROCHEM, V79, P1196, DOI 10.1046/j.1471-4159.2001.00679.x; Vaitkevicius PV, 2001, P NATL ACAD SCI USA, V98, P1171, DOI 10.1073/pnas.98.3.1171; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Wang S, 2004, STROKE, V35, P1763, DOI 10.1161/01.STR.0000131858.63829.6e; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; WOLIN LR, 1971, EXP NEUROL, V30, P103, DOI 10.1016/0014-4886(71)90225-1; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-7; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yamashima T, 2003, HIPPOCAMPUS, V13, P791, DOI 10.1002/hipo.10127; Yamashima T, 1996, EUR J NEUROSCI, V8, P1932, DOI 10.1111/j.1460-9568.1996.tb01337.x; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; YONAS H, 1990, J NEUROSURG, V73, P266, DOI 10.3171/jns.1990.73.2.0266; Yoshida M, 2002, ACTA NEUROPATHOL, V104, P267, DOI 10.1007/s00401-002-0554-4; Yukie M, 2006, REV NEUROSCIENCE, V17, P201; Zhang AG, 1997, J CEREBR BLOOD F MET, V17, P123, DOI 10.1097/00004647-199702000-00001; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; ZOLAMORGAN S, 1992, J NEUROSCI, V12, P2582; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	127	36	37	0	19	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	JUN	2013	4	3					308	321		10.1007/s12975-012-0241-2			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	136XU	WOS:000318397800004	23682299	Green Accepted			2022-02-06	
J	Ishihara, Y; Kawami, T; Ishida, A; Yamazaki, T				Ishihara, Yasuhiro; Kawami, Tomohito; Ishida, Atsuhiko; Yamazaki, Takeshi			Allopregnanolone-mediated protective effects of progesterone on tributyltin-induced neuronal injury in rat hippocampal slices	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Neuroprotection; Progesterone; Allopregnanolone; Tributyltin; Hippocampal slices; GABA(A) receptor	OXYGEN-GLUCOSE DEPRIVATION; TRAUMATIC BRAIN-INJURY; ACUTE EXPOSURE; CELL-DEATH; SIGNAL-TRANSDUCTION; GABA(A) RECEPTOR; NEUROSTEROIDS; CULTURES; SYNAPTOGENESIS; EXCITOTOXICITY	Increasing evidence shows that progesterone, a neuroactive steroid, has protective actions in central nervous system, but there is little evidence to show the protective mechanism of progesterone on neurotoxicity induced by environmental chemicals. In this study, we examined the effects of progesterone on neuronal injury induced by tributyltin (TBT) in rat hippocampal slices. Treatment with progesterone dose-dependently suppressed hippocampal neuronal injury induced by TBT. The neuroprotective action of progesterone was completely canceled with pretreatment by finasteride, a 5 alpha-reductase inhibitor, but it was not affected by mifepristone, a progesterone receptor antagonist, or by SU-10603, a cytochrome P450 17 alpha. inhibitor. The content of allopregnanolone in the slices was significantly increased by treatment with progesterone, and this increment was greatly suppressed with a pretreatment of finasteride. Treatment with allopregnanolone attenuated neuronal injury induced by TBT in a dose-dependent manner. The neuroprotective effects not only of progesterone but also of allopregnanolone were canceled by bicuculline, a potent gamma-aminobutyric acid A (GABA(A)) receptor antagonist. Pretreatment with muscimol, a GABA(A) receptor agonist, attenuated hippocampal neuronal injury elicited by TBT. Taken together, allopregnanolone converted from progesterone in hippocampal slices could protect neurons from TBT-induced neurotoxicity due to a GABA(A) receptor-dependent mechanism. One of the physiological roles of neuroactive steroids might be neuroprotection from environmental chemicals. (C) 2012 Elsevier Ltd. All rights reserved.	[Ishihara, Yasuhiro; Kawami, Tomohito; Ishida, Atsuhiko; Yamazaki, Takeshi] Hiroshima Univ, Lab Mol Brain Sci, Grad Sch Integrated Arts & Sci, Higashihiroshima 724, Japan		Yamazaki, T (corresponding author), Hiroshima Univ, Lab Mol Brain Sci, Grad Sch Integrated Arts & Sci, 1-7-1 Kagamiyama, Hiroshima 7398521, Japan.	takey@hiroshima-u.ac.jp	Ishihara, Yasuhiro/U-6511-2017	Ishihara, Yasuhiro/0000-0001-9751-7660	Ministry of Education, Culture, Sports, Science, and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	We thank Dr. Eiji Munetsuna, Fujita Health University for technical contributions to the hippocampal slice cultures. This work was supported by Grants-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Brinton Roberta Diaz, 2006, Current Alzheimer Research, V3, P185; Casalbore P, 2010, J CELL PHYSIOL, V224, P710, DOI 10.1002/jcp.22170; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; EMA M, 1991, DRUG CHEM TOXICOL, V14, P161, DOI 10.3109/01480549109017874; EMA M, 1991, NEUROTOXICOL TERATOL, V13, P489, DOI 10.1016/0892-0362(91)90054-Z; Gasior M, 1999, TRENDS PHARMACOL SCI, V20, P107, DOI 10.1016/S0165-6147(99)01318-8; Higashi T, 2007, J CHROMATOGR B, V848, P188, DOI 10.1016/j.jchromb.2006.10.036; Ishihara Y, 2012, NEUROCHEM INT, V60, P782, DOI 10.1016/j.neuint.2012.03.004; Kawato S, 2003, ADV BIOPHYS, V37, P1, DOI 10.1016/S0065-227X(03)80002-3; Koczyk D, 1996, ACTA NEUROBIOL EXP, V56, P237; Le Goascogne C, 2000, GLIA, V29, P14, DOI 10.1002/(SICI)1098-1136(20000101)29:1<14::AID-GLIA2>3.3.CO;2-E; Lee BY, 2005, NEUROSCI RES, V52, P347, DOI 10.1016/j.neures.2005.04.008; Munetsuna E, 2009, ENDOCRINOLOGY, V150, P4260, DOI 10.1210/en.2008-1644; Nakatsu Y, 2006, TOXICOL SCI, V89, P235, DOI 10.1093/toxsci/kfj007; OCALLAGHAN JP, 1988, J PHARMACOL EXP THER, V246, P394; Radley E, 2012, NEUROSCI LETT, V506, P131, DOI 10.1016/j.neulet.2011.10.065; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Romer W, 1997, STEROIDS, V62, P688, DOI 10.1016/S0039-128X(97)00068-8; Sakamoto H, 2001, J NEUROSCI, V21, P6221, DOI 10.1523/JNEUROSCI.21-16-06221.2001; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Shibuya K, 2003, BBA-GEN SUBJECTS, V1619, P301, DOI 10.1016/S0304-4165(02)00489-0; Tsuda T, 1995, J AOAC INT, V78, P941; Whalen MM, 1999, ENVIRON RES, V81, P108, DOI 10.1006/enrs.1999.3968	28	36	39	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	MAY	2013	135						1	6		10.1016/j.jsbmb.2012.12.013			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	117AL	WOS:000316924400001	23280249				2022-02-06	
J	Jeter, CB; Hergenroeder, GW; Ward, NH; Moore, AN; Dash, PK				Jeter, Cameron B.; Hergenroeder, Georgene W.; Ward, Norman H., III; Moore, Anthony N.; Dash, Pramod K.			Human Mild Traumatic Brain Injury Decreases Circulating Branched-Chain Amino Acids and Their Metabolite Levels	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; dietary supplementation; intracranial pressure; metabolism; mild traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; CEREBRAL-BLOOD-FLOW; GLUCOSE-UTILIZATION; POSSIBLE LINK; LEUCINE; DOPAMINE; INSULIN; CONSCIOUSNESS; PHENYLALANINE; ISOLEUCINE	The pathophysiology of traumatic brain injury (TBI) is complex and not well understood. Because pathophysiology has ramifications for injury progression and outcome, we sought to identify metabolic cascades that are altered after acute human mild and severe TBI. Because catabolism of branched-chain amino acids (BCAAs; i.e., valine, isoleucine, and leucine) leads to glucose and energy metabolism, and neurotransmitter synthesis and availability, we investigated BCAA metabolites in plasma samples collected within 24 h of injury from mild TBI (Glasgow Coma Scale [GCS] score > 12), severe TBI (GCS <= 8), orthopedic injury, and healthy volunteers. We report decreased levels of all three BCAAs in patients with mild TBI relative to healthy volunteers, while these BCAAs levels in patients with severe TBI were further reduced compared with all groups. Orthopedic patients exhibited reductions in BCAA comparable to those in patients with mild TBI. The decrease in patients with mild and severe TBI persisted for derivatives of BCAA catabolic intermediates. Only plasma levels of methylglutarylcarnitine, a derivative of a leucine metabolite, were increased in patients with severe TBI compared with all other groups. Notably, logistic regression combination of three BCAA metabolites whose levels were changed by 24 h post-injury provided prognostic value (area under the curve = 0.92) in identifying patients with severe TBI in whom elevated intracranial pressure (>= 25mm Hg) developed. These changes suggest alteration of BCAA metabolism after TBI may contribute to decreased energy production and neurotransmitter synthesis and may contribute to TBI pathophysiology. Supplementation of BCAAs and/or their metabolites may reduce TBI pathology and improve outcome.	[Jeter, Cameron B.] Univ Texas Houston, Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77225 USA; [Hergenroeder, Georgene W.; Ward, Norman H., III] Univ Texas Houston, Sch Med, Vivian L Smith Dept Neurosurg, Houston, TX 77225 USA; [Moore, Anthony N.; Dash, Pramod K.] Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas Houston, Sch Med, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu	Jeter, Cameron B./AAO-1797-2021	Jeter, Cameron B./0000-0001-5303-5897; Hergenroeder, Georgene/0000-0002-6170-2191	Health Resources and Services AdministrationUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [R38OT10585]; Mission Connect/TIRR Foundation; Vivian L. Smith Foundation; Gilson-Longenbaugh Foundation	We would like to thank the nurses at Memorial Hermann Hospital-Texas Medical Center and Elizabeth B. Jones, MD, Toby T. Thomas, MD, and Brad Jacobson, MD, for assistance with recruiting patients. This study was supported by the Health Resources and Services Administration (R38OT10585), Mission Connect/TIRR Foundation, The Vivian L. Smith Foundation, and the Gilson-Longenbaugh Foundation.	American Association for Automotive Medicine, 2001, ABBR INJ SCAL AIS; Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Aquilani R, 2008, ARCH PHYS MED REHAB, V89, P1642, DOI 10.1016/j.apmr.2008.02.023; Banks WA, 1998, PEPTIDES, V19, P883, DOI 10.1016/S0196-9781(98)00018-7; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BERRY HK, 1990, AM J DIS CHILD, V144, P539, DOI 10.1001/archpedi.1990.02150290033020; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Cousins DA, 2009, BIPOLAR DISORD, V11, P787, DOI 10.1111/j.1399-5618.2009.00760.x; Davis JM, 2000, AM J CLIN NUTR, V72, p573S, DOI 10.1093/ajcn/72.2.573S; de Groot MJ, 2010, MOL GENET METAB, V99, pS86, DOI 10.1016/j.ymgme.2009.10.016; Fernstrom JD, 2005, J NUTR, V135, p1539S, DOI 10.1093/jn/135.6.1539S; FERNSTROM JD, 1990, J NUTR BIOCHEM, V1, P508, DOI 10.1016/0955-2863(90)90033-H; Gijsman HJ, 2002, PSYCHOPHARMACOLOGY, V160, P192, DOI 10.1007/s00213-001-0970-5; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Jeter CB, 2012, J NEUROTRAUM, V29, P119, DOI 10.1089/neu.2011.2029; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Mochel F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000647; Montgomery AJ, 2003, AM J PSYCHIAT, V160, P1887, DOI 10.1176/appi.ajp.160.10.1887; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Murphy MG, 2007, CHEMOSPHERE, V68, P1692, DOI 10.1016/j.chemosphere.2007.03.049; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; PALOVCIK RA, 1984, BRAIN RES, V309, P187, DOI 10.1016/0006-8993(84)91028-X; PARDRIDGE WM, 1986, FASEB J, V45, P2073; Piscopo P, 2011, J NEUROSCI RES, V89, P1276, DOI 10.1002/jnr.22655; Richardson MA, 2003, AM J PSYCHIAT, V160, P1117, DOI 10.1176/appi.ajp.160.6.1117; ROE CR, 1986, J CLIN INVEST, V77, P1391, DOI 10.1172/JCI112446; Sakai R, 2004, J NEUROCHEM, V88, P612, DOI 10.1111/j.1471-4159.2004.02179.x; Scarna A, 2003, BRIT J PSYCHIAT, V182, P210, DOI 10.1192/bjp.182.3.210; Schadewaldt P, 2001, PEDIATR RES, V49, P627, DOI 10.1203/00006450-200105000-00004; SHIBATA S, 1986, PHYSIOL BEHAV, V36, P79, DOI 10.1016/0031-9384(86)90077-6; SMITH QR, 1987, J NEUROCHEM, V49, P1651, DOI 10.1111/j.1471-4159.1987.tb01039.x; TEASDALE G, 1974, LANCET, V2, P81; van Calcar Sandra C, 2007, WMJ, V106, P12; van Os J, 2009, LANCET, V374, P635, DOI 10.1016/S0140-6736(09)60995-8; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vuille-Dit-Bille RN, 2012, AMINO ACIDS, V43, P1287, DOI 10.1007/s00726-011-1202-x; Xu G, 1998, J BIOL CHEM, V273, P28178, DOI 10.1074/jbc.273.43.28178; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	42	36	38	0	21	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2013	30	8			SI		671	679		10.1089/neu.2012.2491			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	133PO	WOS:000318151500009	23560894				2022-02-06	
J	Levin, HS; Robertson, CS				Levin, Harvey S.; Robertson, Claudia S.			Mild Traumatic Brain Injury in Translation	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; military injury; traumatic brain injury	FLUID PERCUSSION INJURY; DIFFUSE AXONAL INJURY; HEAD-INJURY; MOUSE MODEL; IMPACT; ENCEPHALOPATHY; RATS; PATHOPHYSIOLOGY; MAGNITUDE; PATHOLOGY	This Introduction to a Special Issue on Mild Traumatic Brain Injury (mTBI) highlights the methodological challenges in outcome studies and clinical trials involving patients who sustain mTBI. Recent advances in brain imaging and portable, computerized cognitive tasks have contributed to protocols that are sensitive to the effects of mTBI and efficient in time for completion. Investigation of civilian mTBI has been extended to single and repeated injuries in athletes and blast-related mTBI in service members and veterans. Despite differences in mechanism of injury, there is evidence for similar effects of acceleration-deceleration and blast mechanisms of mTBI on cognition. Investigation of repetitive mTBI suggests that the effects may be cumulative and that repeated mTBI and repeated subconcussive head trauma may lead to neurodegenerative conditions. Although animal models of mTBI using cortical impact and fluid percussion injury in rodents have been able to reproduce some of the cognitive deficits frequently exhibited by patients after mTBI, modeling post-concussion symptoms is difficult. Recent use of closed head and blast injury animal models may more closely approximate clinical mTBI. Translation of interventions that are developed in animal models to patients with mTBI is a priority for the research agenda. This Special Issue on mTBI integrates basic neuroscience studies using animal models with studies of human mTBI, including the cognitive sequelae, persisting symptoms, brain imaging, and host factors that facilitate recovery.	[Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Dept Vet Affairs, Neurorehabil Neurons Networks Traumat Brain Injur, Houston, TX USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Levin, HS (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	hlevin@bcm.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5P01NS056202]; Department of Defense (Post-Traumatic Stress Disorder and Traumatic Brain Injury (PTSD/TBI) Research Program) [W81XWH-08-2-0133 PT074693P2]; Center of Excellence for Traumatic Brain Injury Award from the Department of Veterans Affairs [26244]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202] Funding Source: NIH RePORTER	This research was supported by Grant 5P01NS056202 from the National Institute of Neurological Disorders and Stroke, by award W81XWH-08-2-0133 PT074693P2 from the Department of Defense (Post-Traumatic Stress Disorder and Traumatic Brain Injury (PTSD/TBI) Research Program), and award 26244 from The Center of Excellence for Traumatic Brain Injury Award from the Department of Veterans Affairs. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke, the National Institutes of Health, the Department of Veterans Affairs, or the Department of Defense.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Faul M, 2010, TRAUMATIC BRAIN INJU; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; GRONWALL D, 1975, LANCET, V2, P995; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; IOM (Institute of Medicine), 2009, LONG TERM CONS TRAUM, V7; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Morey R.A., 2012, HUM BRAIN MAPP; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stern Sarah, 2011, Emerg Nurse, V18, P28; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Walsh JM, 2005, ACCIDENT ANAL PREV, V37, P894, DOI 10.1016/j.aap.2005.04.013; Wang ZQ, 2012, EUR J RADIOL, V81, P277, DOI 10.1016/j.ejrad.2010.12.044; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36; Zouridakis G, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400064	66	36	38	12	45	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2013	30	8			SI		610	617		10.1089/neu.2012.2394			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	133PO	WOS:000318151500002	23046349	Green Published			2022-02-06	
J	Valiyaveettil, M; Alamneh, YA; Miller, SA; Hammamieh, R; Arun, P; Wang, Y; Wei, YL; Oguntayo, S; Long, JB; Nambiar, MP				Valiyaveettil, Manojkumar; Alamneh, Yonas A.; Miller, Stacey-Ann; Hammamieh, Rasha; Arun, Peethambaran; Wang, Ying; Wei, Yanling; Oguntayo, Samuel; Long, Joseph B.; Nambiar, Madhusoodana P.			Modulation of cholinergic pathways and inflammatory mediators in blast-induced traumatic brain injury	CHEMICO-BIOLOGICAL INTERACTIONS			English	Article; Proceedings Paper	International Meeting on Cholinesterases	JUN 04-09, 2012	Kazan, RUSSIA			Repeated blast exposure; Cholinergic pathway; Inflammation; Acetylcholinisterase; Micro RNA; Traumatic brain injury	ANTIINFLAMMATORY PATHWAY; ACETYLCHOLINESTERASE ACTIVITY; LUNG TRAUMA; STRESS; MODEL; BLOOD; MICRORNAS; EXPOSURE; MOUSE; RATS	Cholinergic activity has been recognized as a major regulatory component of stress responses after traumatic brain injury (TB!). Centrally acting acetylcholinesterase (AChE) inhibitors are also being considered as potential therapeutic candidates against TBI mediated cognitive impairments. We have evaluated the expression of molecules involved in cholinergic and inflammatory pathways in various regions of brain after repeated blast exposures in mice. Isoflurane anesthetized C57BL/6J mice were restrained and placed in a prone position transverse to the direction of the shockwaves and exposed to three 20.6 psi blast overpressures with 1-30 min intervals. Brains were collected at the 6 h time point after the last blast exposure and subjected to cDNA microarray and microRNA analysis. cDNA microarray analysis showed significant changes in the expression of cholinergic (muscarinic and nicotinic) and gammaaminobutyric acid and glutamate receptors in the midbrain region along with significant changes in multiple genes involved in inflammatory pathways in various regions of the brain. MicroRNA analysis of cerebellum revealed differential expression of miR-132 and 183, which are linked to cholinergic anti-inflammatory signaling, after blast exposure. Changes in the expression of myeloperoxidase in the cerebellum were confirmed by Western blotting. These results indicate that early pathologic progression of blast TBI involves dysregulation of cholinergic and inflammatory pathways related genes. Acute changes in molecules involved in the modulation of cholinergic and inflammatory pathways after blast TBI can cause long-term central and peripheral pathophysiological changes. (C) 2012 Published by Elsevier Ireland Ltd.	[Valiyaveettil, Manojkumar; Alamneh, Yonas A.; Arun, Peethambaran; Wang, Ying; Wei, Yanling; Oguntayo, Samuel; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Miller, Stacey-Ann; Hammamieh, Rasha] USA, Ctr Environm Hlth Res, Med Res & Mat Command, Ft Detrick, MD 21702 USA		Valiyaveettil, M (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	m.valiyaveettil@amedd.army.mil; madhu-soodana.nambiar@amedd.army.mil					AUGUSTINSSON KB, 1978, CLIN CHIM ACTA, V89, P239, DOI 10.1016/0009-8981(78)90322-4; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Czura CJ, 2003, J ENDOTOXIN RES, V9, P409, DOI 10.1179/096805103225002755; Dalle Lucca Jurandir J, 2012, J Neurol Sci, V318, P146, DOI 10.1016/j.jns.2012.02.002; DONOVAN DA, 1994, J WILDLIFE DIS, V30, P234, DOI 10.7589/0090-3558-30.2.234; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gorbunov NV, 2006, EXP MOL PATHOL, V80, P11, DOI 10.1016/j.yexmp.2005.06.007; Gorbunov NV, 2005, INT J IMMUNOPATH PH, V18, P547, DOI 10.1177/039463200501800315; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Martinez N, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-44; Meerson A, 2010, J MOL NEUROSCI, V40, P47, DOI 10.1007/s12031-009-9252-1; Meshorer E, 2005, MOL PSYCHIATR, V10, P985, DOI 10.1038/sj.mp.4001735; Meshorer E, 2006, TRENDS NEUROSCI, V29, P216, DOI 10.1016/j.tins.2006.02.005; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Soreq H, 2011, TRENDS MOL MED, V17, P548, DOI 10.1016/j.molmed.2011.06.009; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990	31	36	39	0	20	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0009-2797	1872-7786		CHEM-BIOL INTERACT	Chem.-Biol. Interact.	MAR 25	2013	203	1			SI		371	375		10.1016/j.cbi.2012.10.022			5	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	134HU	WOS:000318201800074	23159883				2022-02-06	
J	Sibley, KM; Straus, SE; Inness, EL; Salbach, NM; Jaglal, SB				Sibley, Kathryn M.; Straus, Sharon E.; Inness, Elizabeth L.; Salbach, Nancy M.; Jaglal, Susan B.			Clinical balance assessment: perceptions of commonly-used standardized measures and current practices among physiotherapists in Ontario, Canada	IMPLEMENTATION SCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; PHYSICAL-THERAPISTS; BEHAVIOR-CHANGE; KNOWLEDGE TRANSLATION; OLDER-PEOPLE; STROKE; CONSENSUS; EXERCISE; MOBILITY; FALLS	Background: Balance impairment is common in multiple clinical populations, and comprehensive assessment is important for identifying impairments, planning individualized treatment programs, and evaluating change over time. However, little information is available regarding whether clinicians who treat balance are satisfied with existing assessment tools. In 2010 we conducted a cross-sectional survey of balance assessment practices among physiotherapists in Ontario, Canada, and reported on the use of standardized balance measures (Sibley et al. 2011 Physical Therapy; 91: 1583-91). The purpose of this study was to analyse additional survey data and i) evaluate satisfaction with current balance assessment practices and standardized measures among physiotherapists who treat adult or geriatric populations with balance impairment, and ii) identify factors associated with satisfaction. Methods: The questionnaire was distributed to 1000 practicing physiotherapists. This analysis focuses on questions in which respondents were asked to rate their general perceptions about balance assessment, the perceived utility of individual standardized balance measures, whether they wanted to improve balance assessment practices, and why. Data were summarized with descriptive statistics and utility of individual measures was compared across clinical practice areas (orthopaedic, neurological, geriatric or general rehabilitation). Results: The questionnaire was completed by 369 respondents, of which 43.4% of respondents agreed that existing standardized measures of balance meet their needs. In ratings of individual measures, the Single Leg Stance test and Berg Balance Scale were perceived as useful for clinical decision-making and evaluating change over time by over 70% of respondents, and the Timed Up-and-Go test was perceived as useful for decision-making by 56.9% of respondents and useful for evaluating change over time by 62.9% of respondents, but there were significant differences across practice groups. Seventy-nine percent of respondents wanted to improve their assessments, identifying individual, environmental and measure-specific barriers. The most common barriers were lack of time and knowledge. Conclusions: This study offers new information on issues affecting the evaluation of balance in clinical settings from a broad sample of physiotherapists. Continued work to address barriers by specific practice area will be critical for the success of any intervention attempting to implement optimal balance assessment practices in the clinical setting.	[Sibley, Kathryn M.; Inness, Elizabeth L.; Salbach, Nancy M.; Jaglal, Susan B.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Sibley, Kathryn M.; Salbach, Nancy M.; Jaglal, Susan B.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Straus, Sharon E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Straus, Sharon E.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Inness, Elizabeth L.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada		Jaglal, SB (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada.	susan.jaglal@utoronto.ca		Jaglal, Susan/0000-0002-2930-1443; Inness, Elizabeth L./0000-0002-9217-4619	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Toronto Rehabilitation Institute-University Health Network; Provincial Rehabilitation Research Program from the Ministry of Health and Long Term Care in Ontario	KMS is supported by a Fellowship from the Canadian Institutes of Health Research and the Toronto Rehabilitation Institute-University Health Network. SBJ holds the Toronto Rehabilitation Institute Chair in Rehabilitation Research at the University of Toronto. SES holds a Canada Research Chair in Knowledge Translation and Quality of Care. We thank the College of Physiotherapists of Ontario for providing the mailing list. We acknowledge the support of the Toronto Rehabilitation Institute-University Health Network who receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and Long Term Care in Ontario.	An MJ, 2011, J NEUROSCI NURS, V43, P298, DOI 10.1097/JNN.0b013e318234ea24; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BERG K, 1989, Physiotherapy Canada, V41, P304; Birken SA, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-28; Dillman DA., 2000, MAIL INTERNET SURVEY; Flansbjer UB, 2012, PM&R, V4, P165, DOI 10.1016/j.pmrj.2011.11.004; FREGLY AR, 1968, AEROSPACE MED, V39, P277; French SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-38; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD14007146.pub14651853, DOI 10.1002/14651858.CD14007146.PUB14651853]; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Grimshaw JM, 2001, MED CARE, V39, pII2; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Howe TE, 2011, COCHRANE DB SYST REV, V11, DOI [10.1002/14651858.CD14004963.pub14651853, DOI 10.1002/14651858.CD14004963.PUB14651853]; Howe TE, 2011, AGE AGEING, V40, P532, DOI 10.1093/ageing/afr082; Jacobs JV, 2006, J NEUROL, V253, P1404, DOI 10.1007/s00415-006-0224-x; Kay T., 2001, PHYSIOTHER CAN, V53, P268; Kay TM, 2001, PHYSIOTHER CAN, V53, P281; Maki BE, 1997, PHYS THER, V77, P488, DOI 10.1093/ptj/77.5.488; Maki BE, 2001, CONTROL POSTURE GAIT, P126; McGinnis Patricia Q., 2010, Physiotherapy Theory and Practice, V26, P358, DOI 10.3109/09593980903219050; McGinnis PQ, 2009, PHYS THER, V89, P233, DOI 10.2522/ptj.20080131; McGlynn M, 2007, PHYSIOTHER CAN, V59, P241, DOI DOI 10.3138/ptc.59.4.241; Menon A, 2009, J REHABIL MED, V41, P1024, DOI 10.2340/16501977-0451; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Nilsen P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-53; Pardasaney PK, 2012, PHYS THER, V92, P388, DOI 10.2522/ptj.20100398; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pollock CL, 2011, CLIN REHABIL, V25, P693, DOI 10.1177/0269215510397394; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Rose DJ, 2006, ARCH PHYS MED REHAB, V87, P1478, DOI 10.1016/j.apmr.2006.07.263; Salbach NM, 2007, PHYS THER, V87, P1284, DOI 10.2522/ptj.20070040; Salbach NM, 2011, J REHABIL MED, V43, P543, DOI 10.2340/16501977-0820; Salbach NM, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-77; Scott SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-70; Sherrington Catherine, 2011, N S W Public Health Bull, V22, P78, DOI 10.1071/NB10056; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Sibley KM, 2011, PHYS THER, V91, P1583, DOI 10.2522/ptj.20110063; Silva A, 2012, BRAZ J PHYS THER, V16, P1; STRAUS S, 2009, KNOWLEDGE TRANSLATIO; Straus SE, 2005, EVIDENCE BASED MEDIC; Sturnieks DL, 2004, J RHEUMATOL, V31, P2272; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Tyson SF, 2006, PHYS THER, V86, P30, DOI 10.1093/ptj/86.1.30; Woollacott, 2007, MOTOR CONTROL TRANSL	47	36	36	0	16	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1748-5908			IMPLEMENT SCI	Implement. Sci.	MAR 20	2013	8								33	10.1186/1748-5908-8-33			8	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	137EQ	WOS:000318418700001	23510277	Green Published, gold			2022-02-06	
J	Lim, SN; Gladman, SJ; Dyall, SC; Patel, U; Virani, N; Kang, JX; Priestley, JV; Michael-Titus, AT				Lim, Siew-Na; Gladman, Stacy J.; Dyall, Simon C.; Patel, Urva; Virani, Nabeel; Kang, Jing X.; Priestley, John V.; Michael-Titus, Adina T.			Transgenic mice with high endogenous omega-3 fatty acids are protected from spinal cord injury	NEUROBIOLOGY OF DISEASE			English	Article						Transgenic fat-1 mice; Spinal cord injury; Omega-3 fatty acids; Neuroprotection	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; FATTY-ACIDS; DOCOSAHEXAENOIC ACID; LEUKOCYTE MOBILIZATION; FUNCTIONAL RECOVERY; FAT-1 MICE; RAT; NEUROTOXICITY; METABOLISM	Omega-3 polyunsaturated fatty acids have been shown to have therapeutic potential in a variety of neurological disorders, including acute traumatic injury of the spinal cord. We addressed the question whether the neuroprotective effect of these compounds after spinal cord injury could also be seen when their level is raised in tissues prophylactically, prior to injury. In this study we used transgenic fat-1 mice to examine whether enriching spinal cord tissue in endogenous omega-3 polyunsaturated fatty acids has an effect on the outcome after compression spinal cord injury. The results demonstrate that after thoracic compression spinal cord injury, fat-1 mice display better locomotor recovery compared with the wild-type mice on a high omega-6 diet (high omega-6 polyunsaturated fatty acids in tissues), and wild-type mice on a normal diet (controls). This is associated with a significant increase in neuronal and oligodendrocyte survival and a decrease in non-phosphorylated neurofilament loss. The protection from spinal cord injury in fat-1 mice was also correlated with a reduction in microglia/macrophage activation and in pro-inflammatory mediators. In vitro experiments in dorsal root ganglia primary sensory neurons further demonstrated that a fat-1 tissue background confers robust neuroprotection against a combined mechanical stretch and hypoxic injury. In conclusion, our studies support the hypothesis that a raised omega-3 polyunsaturated fatty acid level and an altered tissue omega-6/omega-3 ratio prior to injury leads to a much improved outcome after spinal cord injury. (C) 2012 Elsevier Inc. All rights reserved.	[Lim, Siew-Na; Gladman, Stacy J.; Dyall, Simon C.; Patel, Urva; Virani, Nabeel; Priestley, John V.; Michael-Titus, Adina T.] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, Ctr Neurosci & Trauma, London, England; [Lim, Siew-Na] Chang Gung Mem Hosp, Dept Neurol, Taipei 10591, Taiwan; [Lim, Siew-Na] Chang Gung Univ, Coll Med, Taipei, Taiwan; [Dyall, Simon C.] Roehampton Univ, Whitelands Coll, Dept Life Sci, London, England; [Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Lab Lipid Med & Technol, Boston, MA 02114 USA; [Kang, Jing X.] Harvard Univ, Sch Med, Boston, MA 02114 USA		Michael-Titus, AT (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Neurosci & Trauma, 4 Newark St, London, England.	a.t.michael-titus@qmul.ac.uk		Dyall, Simon/0000-0001-7591-4219; Gladman, Stacy/0000-0002-7112-4516	Chang Gung Memorial Hospital, TaiwanChang Gung Memorial Hospital [CMRPG360622]	This work was supported by Chang Gung Memorial Hospital, Taiwan (CMRPG360622). We gratefully acknowledge the assistance of Patrick Pallier, Laura Poddighe and Rasall Choudhury with preparatory staining for the Abercrombie correction.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Benes FM, 2001, TRENDS NEUROSCI, V24, P11, DOI 10.1016/S0166-2236(00)01660-X; Berquin IM, 2007, J CLIN INVEST, V117, P1866, DOI 10.1172/JCI31494; Bousquet M, 2011, J LIPID RES, V52, P263, DOI 10.1194/jlr.M011692; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Cao DH, 2004, PHARMACOL BIOCHEM BE, V79, P651, DOI 10.1016/j.pbb.2004.09.016; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Davis AEM, 2005, EUR J NEUROSCI, V22, P2441, DOI 10.1111/j.1460-9568.2005.04447.x; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Dyall SC, 2007, NEUROBIOL AGING, V28, P424, DOI 10.1016/j.neurobiolaging.2006.01.002; Dyall SC, 2008, NEUROMOL MED, V10, P219, DOI 10.1007/s12017-008-8036-z; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; Gladman SJ, 2010, NEUROSCIENCE, V171, P577, DOI 10.1016/j.neuroscience.2010.07.009; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; He CW, 2009, P NATL ACAD SCI USA, V106, P11370, DOI 10.1073/pnas.0904835106; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kaur G, 2010, BRIT J NUTR, V103, P32, DOI 10.1017/S0007114509991334; Kawasaki A, 2002, INVEST OPHTH VIS SCI, V43, P1835; Kelly L, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.001; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lim SN, 2010, PROSTAG LEUKOTR ESS, V83, P193, DOI 10.1016/j.plefa.2010.08.003; MANKU MS, 1983, LIPIDS, V18, P906, DOI 10.1007/BF02534572; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; MURPHY EJ, 1994, MOL CHEM NEUROPATHOL, V23, P13, DOI 10.1007/BF02858504; Okada S, 2004, J NEUROSCI RES, V76, P265, DOI 10.1002/jnr.20044; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Pearse DD, 2005, J NEUROTRAUM, V22, P680, DOI 10.1089/neu.2005.22.680; Pilitsis JG, 2003, BRAIN RES, V985, P198, DOI 10.1016/S0006-8993(03)03044-0; Popovich P, 2009, NAT MED, V15, P736, DOI 10.1038/nm0709-736; Rice T, 2007, J NEUROPATH EXP NEUR, V66, P184, DOI 10.1097/01.jnen.0000248552.07338.7f; Robins-Steele S, 2012, J NEUROTRAUM, V29, P1586, DOI 10.1089/neu.2011.2005; Schmocker C, 2007, HEPATOLOGY, V45, P864, DOI 10.1002/hep.21626; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Tsai MC, 2008, SURG NEUROL, V70, P19, DOI 10.1016/j.surneu.2007.09.033; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103	46	36	36	0	22	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961			NEUROBIOL DIS	Neurobiol. Dis.	MAR	2013	51				SI		104	112		10.1016/j.nbd.2012.10.021			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085PQ	WOS:000314627100012	23123586				2022-02-06	
J	Darrah, SD; Miller, MA; Ren, DX; Hoh, NZ; Scanlon, JM; Conley, YP; Wagner, AK				Darrah, Shaun D.; Miller, Megan A.; Ren, Dianxu; Hoh, Nichole Z.; Scanlon, Joelle M.; Conley, Yvette P.; Wagner, Amy K.			Genetic variability in glutamic acid decarboxylase genes: Associations with post-traumatic seizures after severe TBI	EPILEPSY RESEARCH			English	Article						Traumatic brain injury; Seizures; GABA; Glutamic acid decarboxylase; Promoter; Single nucleotide polymorphism	TRAUMATIC BRAIN-INJURY; GAMMA-AMINOBUTYRIC-ACID; GABA(A) RECEPTOR; CEREBROSPINAL-FLUID; STATUS EPILEPTICUS; GRANULE CELLS; CLEFT-PALATE; MICE LACKING; RISK-FACTORS; AMINO-ACIDS	Post traumatic seizures (PTS) occur frequently after traumatic brain injury (TBI). Since gamma-amino butyric acid (GABA) neurotransmission is central to excitotoxicity and seizure development across multiple models, we investigated how genetic variability for glutamic acid decarboxylase (GAD) influences risk for PTS. Using both a tagging and functional single nucleotide polymorphism (SNP) approach, we genotyped the GAD1 and GAD2 genes and Linked them with PTS data, regarding time to first seizure, obtained for 257 adult subjects with severe TBI. No significant associations were found for GAD2. In the GAD1 gene, the tagging SNP (tSNP) rs3828275 was associated with an increased risk for PTS occurring <1 wk. The tSNP rs769391and the functional SNP rs3791878 in the GAD1 gene were associated with increased PTS risk occurring 1 wk-6 mo post-injury. Both risk variants conferred an increased susceptibility to PTS compared to subjects with 0-1 risk variant. Also, those with haplotypes having both risk variants had a higher PTS risk 1 wk-6 mo post-injury than those without these haplotypes. Similarly, diplotype analysis showed those with 2 copies of the haplotype containing both risk alleles were at the highest PTS risk. These results implicate genetic variability within the GABA system in modulating the development of PTS. (c) 2012 Elsevier B.V. All rights reserved.	[Darrah, Shaun D.; Miller, Megan A.; Scanlon, Joelle M.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Ren, Dianxu; Hoh, Nichole Z.; Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Conley, Yvette P.; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	Darrah.shaun@medstudent.pitt.edu; mam187@pitt.edu; dir8@pitt.edu; nmzst1@pitt.edu; scanjm2@upmc.edu; yconley@pitt.edu; wagnerak@upmc.edu		Conley, Yvette/0000-0002-1784-6067	DODUnited States Department of Defense [W81XWH-07-1-0701]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NR008424];  [R01HD048162]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	This work was supported, in part, by R01HD048162 and DOD W81XWH-07-1-0701 to AKW, NIH R01NR008424, and DOD W81XWH-07-1-0701 to YPC. Thanks to the Brain Trauma Research Center for assistance with some pieces of data collection 5P01NS030318-16. Thanks to Sandra Deslouche for support with genotyping as well as the subjects and their families for their generous participation.	Allen NJ, 2004, PFLUG ARCH EUR J PHY, V449, P132, DOI 10.1007/s00424-004-1318-x; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; BU DF, 1994, GENOMICS, V21, P222, DOI 10.1006/geno.1994.1246; BU DF, 1992, P NATL ACAD SCI USA, V89, P2115, DOI 10.1073/pnas.89.6.2115; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Buxbaum JD, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-6; Cavalleri GL, 2007, EPILEPSIA, V48, P706, DOI 10.1111/j.1528-1167.2007.00977.x; Chen JWY, 2006, LANCET NEUROL, V5, P246, DOI 10.1016/S1474-4422(06)70374-X; Covic M, 2010, HEREDITY, V105, P122, DOI 10.1038/hdy.2010.27; Crestani F, 2000, BRIT J PHARMACOL, V131, P1251, DOI 10.1038/sj.bjp.0703717; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Du J, 2008, J NEURAL TRANSM, V115, P513, DOI 10.1007/s00702-007-0844-z; Ellenberger C, 2004, AM J VET RES, V65, P1108, DOI 10.2460/ajvr.2004.65.1108; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hasegawa D, 2004, J VET MED SCI, V66, P1555, DOI 10.1292/jvms.66.1555; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Hsu CC, 2000, J BIOL CHEM, V275, P20822, DOI 10.1074/jbc.M001403200; Hung CC, 2005, PHARMACOGENOMICS, V6, P411, DOI 10.1517/14622416.6.4.411; Jamali S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012740; JENNETT B, 1975, LANCET, V1, P480; KANTHAN R, 1995, J NEUROL NEUROSUR PS, V59, P326, DOI 10.1136/jnnp.59.3.326; Kao CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018696; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Kralic JE, 2002, J PHARMACOL EXP THER, V302, P1037, DOI 10.1124/jpet.102.036665; Kuo PH, 2009, DRUG ALCOHOL DEPEN, V101, P80, DOI 10.1016/j.drugalcdep.2008.11.009; Kwan P, 2007, EPILEPSY BEHAV, V11, P112, DOI 10.1016/j.yebeh.2007.04.013; Laje G, 2011, PROG NEURO-PSYCHOPH, V35, P1553, DOI 10.1016/j.pnpbp.2010.11.031; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Lin CM, 2009, SURG NEUROL, V72, P50, DOI 10.1016/j.wneu.2009.09.004; Liu SY, 2011, CHIN J TRAUMATOL, V14, P100, DOI 10.3760/cma.j.issn.1008-1275.2011.02.007; MELDRUM BS, 1989, BRIT J CLIN PHARMACO, V27, pS3, DOI 10.1111/j.1365-2125.1989.tb03454.x; Miller MA, 2010, BRAIN INJURY, V24, P1468, DOI 10.3109/02699052.2010.520299; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ebid AHI, 2007, THER DRUG MONIT, V29, P305; Motsinger AA, 2007, J INFECT DIS, V195, P1737, DOI 10.1086/518247; Muir JK, 1996, J CEREBR BLOOD F MET, V16, P1211, DOI 10.1097/00004647-199611000-00015; NATHAN B, 1994, J BIOL CHEM, V269, P7249; NATHAN B, 1994, BRAIN RES, V642, P297, DOI 10.1016/0006-8993(94)90934-2; National Center for Biotechnology Information U.S. National Library of Medicine, DBSNP SHORT GEN VAR; Neese SL, 2007, BRAIN RES, V1128, P157, DOI 10.1016/j.brainres.2006.09.073; Newton-Cheh C, 2005, MUTAT RES-FUND MOL M, V573, P54, DOI 10.1016/j.mrfmmm.2005.01.006; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Patel AB, 2006, J NEUROCHEM, V97, P385, DOI 10.1111/j.1471-4159.2006.03741.x; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Rootsweb, 2012, SOC SEC DEATH IND SS; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Ruegg J, 2008, MOL ENDOCRINOL, V22, P304, DOI 10.1210/me.2007-0128; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Scher AI, 2011, J NEUROTRAUM, V28, P1739, DOI 10.1089/neu.2011.1982; SCHWARZER C, 1995, NEUROSCIENCE, V69, P705, DOI 10.1016/0306-4522(95)00348-M; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Sperk G, 2003, HIPPOCAMPUS, V13, P806, DOI 10.1002/hipo.10133; Sperk G., 2011, HIPPOCAMPUS; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sur C, 2001, J NEUROSCI, V21, P3409, DOI 10.1523/JNEUROSCI.21-10-03409.2001; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Sweatt JD, 2009, BIOL PSYCHIAT, V65, P191, DOI 10.1016/j.biopsych.2008.09.002; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Waziri A, 2009, ANN NEUROL, V66, P366, DOI 10.1002/ana.21721; Yablon S. A., 2001, PHYS MED REHABIL STA, V15, P301; Yoshida H, 2006, CELL STRUCT FUNCT, V31, P117, DOI 10.1247/csf.06016; Young GB, 1996, NEUROLOGY, V47, P83; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061	78	36	39	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	FEB	2013	103	2-3					180	194		10.1016/j.eplepsyres.2012.07.006			15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	095ZD	WOS:000315372600007	22840783	Green Published, Green Accepted			2022-02-06	
J	Vlahou, CH; Kosmidis, MH; Dardagani, A; Tsotsi, S; Giannakou, M; Giazkoulidou, A; Zervoudakis, E; Pontikakis, N				Vlahou, Christina H.; Kosmidis, Mary H.; Dardagani, Aikaterini; Tsotsi, Stella; Giannakou, Maria; Giazkoulidou, Aikaterini; Zervoudakis, Emmanuel; Pontikakis, Nikolaos			Development of the Greek Verbal Learning Test: Reliability, Construct Validity, and Normative Standards	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Cross-cultural neuropsychology; Verbal learning; Verbal memory; Regression-based norms; Schizophrenia; Traumatic brain injury	TEST-PERFORMANCE; OLDER-ADULTS; IMPACT; LITERACY; NORMS	We developed a multiple-form list learning test appropriate for use with the Greek population and generated norms for clinical and research use. This task, the Greek Verbal Learning Test (GVLT), was based on the California Verbal Learning Test. We administered the standard version (Form A) to a sample of 354 healthy individuals, as well as two alternative forms (B and C) to a subgroup of the initial sample. Performance on the three forms was equivalent, and each test presented excellent internal consistency. We found good sensitivity and specificity in the testas (Form A) utility in differentiating individuals with schizophrenia (n 50) and individuals with traumatic brain injury (n 53) from healthy adults. A multiple regression analysis indicated that age, education and sex predicted performance. Regression-based norms are also provided. Taken together, these data provide preliminary support for the reliability and construct validity of the GVLT.	[Vlahou, Christina H.; Kosmidis, Mary H.; Dardagani, Aikaterini; Tsotsi, Stella; Giannakou, Maria; Giazkoulidou, Aikaterini; Pontikakis, Nikolaos] Aristotle Univ Thessaloniki, Sch Psychol, Thessaloniki 54124, Greece; [Zervoudakis, Emmanuel] Vrije Univ, Fac Psychol & Pedag, Leiden, Netherlands; [Giazkoulidou, Aikaterini] Papageorgiou Gen Hosp, Thessaloniki, Greece		Kosmidis, MH (corresponding author), Aristotle Univ Thessaloniki, Sch Psychol, Thessaloniki 54124, Greece.	kosmidis@psy.auth.gr	Kosmidis, Mary H/AAN-2104-2021	Vlahou, Christina Helen/0000-0002-9222-8269; Kosmidis, Mary/0000-0001-8790-1220	Marie Curie International ReintegrationEuropean Commission [FP7-PEOPLE-2007-4-3-IRG]	This work was supported by a Marie Curie International Reintegration Grant (FP7-PEOPLE-2007-4-3-IRG) awarded by the European Commission to the first author with the scientific coordination of the second.	Barker-Collo S, 2002, CLIN NEUROPSYCHOL, V16, P290, DOI 10.1076/clin.16.3.290.13856; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; Brooks BL, 2006, CLIN NEUROPSYCHOL, V20, P230, DOI 10.1080/13854040590947461; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Cherner M, 2007, ARCH CLIN NEUROPSYCH, V22, P343, DOI 10.1016/j.acn.2007.01.009; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Field A., 2017, DISCOVERING STAT USI, V5th; Folia V, 2003, CLIN NEUROPSYCHOL, V17, P143, DOI 10.1076/clin.17.2.143.16505; Fountoulakis KN, 1998, DEMENT GERIATR COGN, V9, P329, DOI 10.1159/000017085; Giaglis G., 2010, J INT NEUROPSYCHO S1, V16, P159; Giaglis G., 2008, 12 C EUR FED NEUR SO; Hiou K, 2004, PSYCHOL, V11, P388; Kosmidis M. H., 2008, CLIN NEUROPSYCHOLOGI; Kosmidis MH, 2006, CORTEX, V42, P1021, DOI 10.1016/S0010-9452(08)70208-9; Kosmidis MH, 2011, ARCH CLIN NEUROPSYCH, V26, P575, DOI 10.1093/arclin/acr063; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P818, DOI 10.1017/S1355617704106036; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014; Kramer JH, 2003, J INT NEUROPSYCH SOC, V9, P97, DOI 10.1017/S1355617703910113; Lacritz L H, 2001, Appl Neuropsychol, V8, P180, DOI 10.1207/S15324826AN0803_8; Malloy-Diniz LF, 2007, REV BRAS PSIQUIATR, V29, P324, DOI 10.1590/S1516-44462006005000053; McDowell BD, 2004, ARCH CLIN NEUROPSYCH, V19, P319, DOI 10.1016/S0887-6177(03)00023-4; Messinis L, 2007, ARCH CLIN NEUROPSYCH, V22, P739, DOI 10.1016/j.acn.2007.06.002; Muller H, 1997, J CLIN PSYCHOL, V53, P663, DOI 10.1002/(SICI)1097-4679(199711)53:7<663::AID-JCLP4>3.0.CO;2-J; Nell V., 2000, CROSS CULTURAL NEURO; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P68, DOI 10.1097/00001199-200601000-00007; Parmenter BA, 2010, J INT NEUROPSYCH SOC, V16, P6, DOI 10.1017/S1355617709990750; Puente A. E., 2000, HDB MULTICULTURAL ME, P419; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ribeiro F, 2007, J CLIN EXP NEUROPSYC, V29, P187, DOI 10.1080/13803390600629775; Rieu D, 2006, REV NEUROL-FRANCE, V162, P721, DOI 10.1016/S0035-3787(06)75069-X; Rosselli M, 2001, DEV NEUROPSYCHOL, V20, P355, DOI 10.1207/S15326942DN2001_3; Smerbeck AM, 2011, CLIN NEUROPSYCHOL, V25, P402, DOI 10.1080/13854046.2011.554445; SPSS Inc, 2009, IBM PASW STAT 18 SPS, V18; Testa SM, 2009, J INT NEUROPSYCH SOC, V15, P1012, DOI 10.1017/S1355617709990713; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Uzzell B.P., 2007, INT HDB CROSS CULTUR; Vlahou C. H., 2011, 3 M FED EUR SOC NEUR; Weible JA, 2002, AGING NEUROPSYCHOL C, V9, P38, DOI 10.1076/anec.9.1.38.834; WIENS AN, 1994, CLIN NEUROPSYCHOL, V8, P75, DOI 10.1080/13854049408401545; Woods SP, 2005, NEUROPSYCHOLOGY, V19, P35, DOI 10.1037/0894-4105.19.1.35; Yassuda MS, 2009, ARCH CLIN NEUROPSYCH, V24, P71, DOI 10.1093/arclin/acp009	43	36	37	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2013	28	1					52	64		10.1093/arclin/acs099			13	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	073EP	WOS:000313726600006	23179043	Bronze			2022-02-06	
J	Jourdan, C; Bayen, E; Bosserelle, V; Azerad, S; Genet, F; Fermanian, C; Aegerter, P; Pradat-Diehl, P; Weiss, JJ; Azouvi, P				Jourdan, Claire; Bayen, Eleonore; Bosserelle, Vanessa; Azerad, Sylvie; Genet, Francois; Fermanian, Christophe; Aegerter, Philippe; Pradat-Diehl, Pascale; Weiss, Jean-Jacques; Azouvi, Philippe		Steering Comm Paris TBi Study	Referral to Rehabilitation After Severe Traumatic Brain Injury: Results From the PariS-TBI Study	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury rehabilitation; traumatic brain injury epidemiology; treatment guidelines; outcomes	CLINICAL DECISION-MAKING; MULTIDISCIPLINARY REHABILITATION; STROKE REHABILITATION; DISCHARGE DISPOSITION; PRACTICAL SCALE; HEALTH-CARE; ACCESS; PLACEMENT; MODERATE; OUTCOMES	Background. After a severe traumatic brain injury (TBI), some patients are discharged home without rehabilitation, although rehabilitation is assumed to improve outcome. Objective. To assess factors that predict referral to rehabilitation following acute care. This study is part of a larger inception cohort study assessing the care network in the Parisian area (France). Methods. Between July 2005 and April 2007, 504 adults with severe TBI (Glasgow Coma Scale score acurrency <= 8) were prospectively recruited by mobile emergency services. This study included 254 acute care survivors (80% male, median age 32 years). Data regarding demographics, injury severity, and acute care pathway were collected. The first analysis compared patients referred to a rehabilitation facility with patients discharged to a living place. The second analysis compared patients referred to a specialized neurorehabilitation (NR) facility with patients referred to nonspecialized rehabilitation. Univariate and multivariate statistics were computed. Results. In all, 162 patients (64%) were referred to rehabilitation, 115 (45%) of which were referred to NR and 47 (19%) to nonspecialized rehabilitation. The following factors were significantly predictive of nonreferral to rehabilitation: living alone, a lower income professional category, pretraumatic alcohol abuse, lower TBI severity, and transfer through a nonspecialized medical ward before discharge. Patients referred to specialized NR were significantly younger and from a higher income professional category. Conclusions. These results raise concern regarding care pathways because many patients were discharged to living places, probably without adequate assessment and management of rehabilitation needs. Injury severity and social characteristics influenced discharge destination.	[Jourdan, Claire; Genet, Francois; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, F-92380 Garches, France; [Jourdan, Claire; Aegerter, Philippe; Azouvi, Philippe] Univ Versailles St Quentin, UFR Med, Guyancourt, France; [Jourdan, Claire; Bayen, Eleonore; Pradat-Diehl, Pascale; Azouvi, Philippe] Univ Paris 06, Unite ER 6, Paris, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Grp Hosp Pitie Salpetriere, AP HP, Serv Med Phys & Readaptat, F-75634 Paris, France; [Bosserelle, Vanessa; Azerad, Sylvie; Weiss, Jean-Jacques] Ctr Ressources Francilien Traumatisme Cranien, Paris, France; [Bosserelle, Vanessa; Azerad, Sylvie; Fermanian, Christophe; Aegerter, Philippe] Hop Ambroise Pare, AP HP, Unite Rech Clin Paris Ouest, Boulogne, France		Azouvi, P (corresponding author), Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, 104 Bd Raymond Poincare, F-92380 Garches, France.	philippe.azouvi@rpc.aphp.fr	AEGERTER, Philippe/AAY-6003-2021	AEGERTER, Philippe/0000-0002-9156-5028	French Ministry of Health (Programme Hospitalier de Recherche Clinique) [AOM04084]; AP-HP (Departement de la Recherche Clinique et du Developpement); Unite de Recherche Clinique Paris-Ouest	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by a grant of French Ministry of Health (Programme Hospitalier de Recherche Clinique 2004, AOM04084) and supported by AP-HP (Departement de la Recherche Clinique et du Developpement) and carried out with the support of Unite de Recherche Clinique Paris-Ouest.	Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Cavestri R, 1997, ITAL J NEUROL SCI, V18, P9, DOI 10.1007/BF02106224; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; CLARK JA, 1991, SOC SCI MED, V32, P853, DOI 10.1016/0277-9536(91)90241-4; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; EISENBERG JM, 1979, ANN INTERN MED, V90, P957, DOI 10.7326/0003-4819-90-6-957; Esselman PC, 2004, ARCH PHYS MED REHAB, V85, P1445, DOI 10.1016/j.apmr.2003.10.018; Foster M, 2004, SOC SCI MED, V59, P1867, DOI 10.1016/j.socscimed.2004.02.017; Foster M, 2003, SOC SCI MED, V56, P2201, DOI 10.1016/S0277-9536(02)00236-8; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Hughes D, 1997, SOC SCI MED, V44, P589, DOI 10.1016/S0277-9536(96)00207-9; Hurst SA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-137; INSEE, NOM PROF CAT SOC; INSEE, FRENCH POP IL DE FRA; JENNETT B, 1975, LANCET, V1, P480; Jette DU, 2003, PHYS THER, V83, P224, DOI 10.1093/ptj/83.3.224; LITTLE JP, 1995, ANAESTHESIA, V50, P658; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Miyai I, 2000, NEUROREHAB NEURAL RE, V25, P540; Putman K, 2007, J REHABIL MED, V39, P21, DOI 10.2340/16501977-0006; Putman K, 2009, TOP STROKE REHABIL, V16, P20, DOI 10.1310/tsr1601-20; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Sample PL, 2005, J HEAD TRAUMA REHAB, V20, P270, DOI 10.1097/00001199-200505000-00009; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Worthington AD, 2006, CLIN REHABIL, V20, P79, DOI 10.1191/0269215506cr881oa; WRIGLEY JM, 1994, ARCH PHYS MED REHAB, V75, P149	39	36	36	0	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JAN	2013	27	1					35	44		10.1177/1545968312440744			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	047PQ	WOS:000311853400004	22460612				2022-02-06	
J	Kammersgaard, LP; Linnemann, M; Tibaek, M				Kammersgaard, Lars Peter; Linnemann, Mia; Tibaek, Maiken			Hydrocephalus following severe traumatic brain injury in adults. Incidence, timing, and clinical predictors during rehabilitation	NEUROREHABILITATION			English	Article						Brain injury; traumatic; hydrocephalus; rehabilitation; prediction	POSTTRAUMATIC HYDROCEPHALUS; PRACTICAL SCALE; RISK-FACTORS; HEAD-INJURY	OBJECTIVE: To investigate timing and clinical predictors that might predict hydrocephalus emerging during rehabilitation until 1 year following severe traumatic brain injury (TBI). BACKGROUND: Posttraumatic hydrocephalus (PTH) may lead to clinical deterioration and poor outcome if untreated. However, PTH can be successfully treated if detected. Nevertheless, PTH is easily overlooked during rehabilitation, particularly in severe cases. METHOD: We prospectively followed all patients (n = 444) in Eastern Denmark (population 2.5 mill) sustaining severe TBI, who required lengthy rehabilitation between 2000 and 2010. All patients with PTH were tracked retrospectively. Demographics, surgery, injury severity, consciousness level, and disability were compared for patients with versus without PTH. Independent predictors of PTH during rehabilitation were identified through multiple logistic regression models. RESULTS: PTH occurred in 14.2% and 3/4 emerged during rehabilitation. Patients with PTH were older, had more severe brain injuries, were more frequently in vegetative state, and needed longer rehabilitation stays. After adjusted analyses, however, only older age and low level of consciousness were independently associated with PTH. CONCLUSION: Most cases of PTH emerge during rehabilitation. Therefore, attention towards this complication should be present also beyond the acute stage after TBI, particularly among older patients and patients with severe disordered consciousness.	[Kammersgaard, Lars Peter; Linnemann, Mia; Tibaek, Maiken] Copenhagen RUBRIC, Res Unit Brain Injury Rehabil, Copenhagen, Denmark; [Kammersgaard, Lars Peter; Linnemann, Mia; Tibaek, Maiken] Univ Copenhagen, Dept Neurorehabil, TBI Unit, Copenhagen, Denmark; [Kammersgaard, Lars Peter; Linnemann, Mia; Tibaek, Maiken] Glostrup Cty Hosp, Glostrup, Denmark		Kammersgaard, LP (corresponding author), Copenhagen Univ Hosp, TBI Unit, Dept Neurorehabil, Res Unit Brain Injury Rehabil,Copenhagen RUBRIC, Kettegard Alle 30, DK-2650 Hvidovre, Denmark.	kammersgaard@dadlnet.dk					ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; [Anonymous], 1999, JAMA, V282, P974; Bauer DF, 2011, NEUROSURGERY, V68, P85, DOI 10.1227/NEU.0b013e3181fd85f4; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Giacino JT, 1997, J HEAD TRAUMA REHABI, V12; Groswasser Z, 1988, Brain Inj, V2, P267, DOI 10.3109/02699058809150897; Guyot LL, 2000, NEUROL RES, V22, P25; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Licata C, 2001, J Neurosurg Sci, V45, P141; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Phuenpathom Nakornchai, 1999, Journal of the Medical Association of Thailand, V82, P46; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032	22	36	40	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	33	3					473	480		10.3233/NRE-130980			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	252DY	WOS:000326986400014	23949078				2022-02-06	
J	Parri, N; Crosby, BJ; Glass, C; Mannelli, F; Sforzi, I; Schiavone, R; Ban, KM				Parri, Niccolo; Crosby, Bradley J.; Glass, Casey; Mannelli, Francesco; Sforzi, Idanna; Schiavone, Raffaele; Ban, Kevin Michael			ABILITY OF EMERGENCY ULTRASONOGRAPHY TO DETECT PEDIATRIC SKULL FRACTURES: A PROSPECTIVE, OBSERVATIONAL STUDY	JOURNAL OF EMERGENCY MEDICINE			English	Article						ultrasound; computed tomography; Emergency Physician; skull fractures; pediatric head trauma	MINOR HEAD TRAUMA; INTRACRANIAL INJURY; CHILDREN YOUNGER; COMPUTED-TOMOGRAPHY; BEDSIDE ULTRASOUND; DIAGNOSIS; MANAGEMENT; RADIOGRAPHY; SONOGRAPHY; INFANTS	Background: Blunt head trauma is a common reason for medical evaluation in the pediatric Emergency Department (ED). The diagnostic work-up for skull fracture, as well as for traumatic brain injury, often involves computed tomography (CT) scanning, which may require sedation and exposes children to often-unnecessary ionizing radiation. Objectives: Our objective was to determine if bedside ED ultrasound is an accurate diagnostic tool for identifying skull fractures when compared to head CT. Methods: We present a prospective study of bedside ultrasound for diagnosing skull fractures in head-injured pediatric patients. A consecutive series of children presenting with head trauma requiring CT scan was enrolled. Cranial bedside ultrasound imaging was performed by an emergency physician and compared to the results of the CT scan. The primary outcome was to identify the sensitivity, specificity, and predictive values of ultrasound for skull fractures when compared to head CT. Results: Bedside emergency ultrasound performs with 100% sensitivity (95% confidence interval [CI] 88.2-100%) and 95% specificity (95% CI 75.0-99.9%) when compared to CT scan for the diagnosis of skull fractures. Positive and negative predictive values were 97.2% (95% CI 84.6-99.9%) and 100% (95% CI 80.2-100%), respectively. Conclusions: Compared to CT scan, bedside ultrasound may accurately diagnose pediatric skull fractures. Considering the simplicity of this examination, the minimal experience needed for an Emergency Physician to provide an accurate diagnosis and the lack of ionizing radiation, Emergency Physicians should consider this modality in the evaluation of pediatric head trauma. We believe this may be a useful tool to incorporate in minor head injury prediction rules, and warrants further investigation. (C) 2013 Elsevier Inc.	[Parri, Niccolo; Mannelli, Francesco; Sforzi, Idanna] Anna Meyer Pediat Hosp, Dept Pediat Emergency Med, I-50129 Florence, Italy; [Crosby, Bradley J.; Ban, Kevin Michael] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Glass, Casey] Wake Forest Univ, Dept Emergency Med, Winston Salem, NC 27109 USA; [Schiavone, Raffaele] Anna Meyer Pediat Hosp, Dept Emergency Radiol, I-50129 Florence, Italy; [Ban, Kevin Michael] Harvard Univ, Sch Med, Boston, MA USA		Parri, N (corresponding author), Anna Meyer Pediat Hosp, Dept Pediat Emergency Med, Viale Pieraccini 24, I-50129 Florence, Italy.			Parri, Niccolo/0000-0002-8098-2504			*AM COLL EM PHYS, 2008, POL STAT EM ULTR GUI; American Institute of Ultrasound in Medicine, 2007, OFF STAT PRUD US CLI; Bergman DA, 1999, PEDIATRICS, V104, P1407; Chen L, 2007, PEDIATR EMERG CARE, V23, P528, DOI 10.1097/PEC.0b013e318128f85d; Chung S, 2004, ANN EMERG MED, V43, P718, DOI 10.1016/j.annemergmed.2003.09.020; Cross KP, 2010, ACAD EMERG MED, V17, P687, DOI 10.1111/j.1553-2712.2010.00788.x; Da Dalt L, 2007, J PEDIATR-US, V150, P274, DOI 10.1016/j.jpeds.2006.11.060; Decarie JC, 1999, CHILD NERV SYST, V15, P740, DOI 10.1007/s003810050463; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Gurkov R, 2008, AM J RHINOL, V22, P613, DOI 10.2500/ajr.2008.22.3239; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Johnson JN, 2009, WEST J EMERG MED, V10, P303; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee MH, 2009, J ULTRAS MED, V28, P717, DOI 10.7863/jum.2009.28.6.717; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Nezafati S, 2010, DENTOMAXILLOFAC RAD, V39, P11, DOI 10.1259/dmfr/97056817; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Rainer TH, 2004, J TRAUMA, V56, P1211, DOI 10.1097/01.TA.0000075800.65485.48; Ramirez-Schrempp D, 2011, PEDIATR EMERG CARE, V27, P312, DOI 10.1097/PEC.0b013e3182131579; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Simanovsky N, 2009, J PEDIATR ORTHOPED, V29, P142, DOI 10.1097/BPO.0b013e318198452e; Sun BC, 2007, ANN EMERG MED, V49, P325, DOI 10.1016/j.annemergmed.2006.08.032; Torloni MR, 2009, ULTRASOUND OBST GYN, V33, P599, DOI 10.1002/uog.6328; Trenchs V, 2009, EUR J EMERG MED, V16, P150, DOI 10.1097/MEJ.0b013e328321b7b5; Williams H, 2008, ARCH DIS CHILDHOOD-E, V93, P120, DOI 10.1136/adc.2008.145532; You JS, 2010, J CLIN ULTRASOUND, V38, P135, DOI 10.1002/jcu.20669	35	36	36	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	JAN	2013	44	1					135	141		10.1016/j.jemermed.2012.02.038			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	073PO	WOS:000313755200073	22579023				2022-02-06	
J	Lopez, NE; Gaston, L; Lopez, KR; Coimbra, RC; Hageny, A; Putnam, J; Eliceiri, B; Coimbra, R; Bansal, V				Lopez, N. E.; Gaston, L.; Lopez, K. R.; Coimbra, R. C.; Hageny, A.; Putnam, J.; Eliceiri, B.; Coimbra, R.; Bansal, V.			Early ghrelin treatment attenuates disruption of the blood brain barrier and apoptosis after traumatic brain injury through a UCP-2 mechanism	BRAIN RESEARCH			English	Article						Traumatic brain injury; Ghrelin; Apoptosis; UCP-2; Caspase-3	OXYGEN-GLUCOSE DEPRIVATION; PREVENTS NEURONAL DEATH; UNCOUPLING PROTEIN-2; CELL-DEATH; HIPPOCAMPAL-NEURONS; PARKINSONS-DISEASE; CEREBRAL EDEMA; MOUSE MODEL; FOOD-INTAKE; TIME-COURSE	Ghrelin has been shown to be anti-inflammatory and neuroprotective in models of neurologic injury. We hypothesize that treatment with ghrelin will attenuate breakdown of the blood brain barrier (BBB) and apoptosis 24 h following traumatic brain injury (TB!). We believe this protection is at least in part mediated by up-regulation of UCP-2, thereby stabilizing mitochondria and preventing up-regulation of caspase-3. A weight drop model was used to create severe TBI. Balb/c mice were divided into 3 groups. Sham: no TBI or ghrelin treatment; TB!: TB! only; TBI/ghrelin: 20 mu g (IP) ghrelin at the time of TBI. BBB permeability to 70 kDa FITC-Dextran was measured 24 h following injury and quantified in arbitrary integrated fluorescence (afu). Brain tissue was subjected to TUNEL staining and TUNEL positive cells were quantified. Immunohistochemistry was performed on injured tissue to reveal patterns of caspase-3 and UCP-2 expression. TBI increased cerebral vascular permeability by three-fold compared to sham. Ghrelin treatment restored vascular permeability to the level of shams. TUNEL staining showed that ghrelin mitigated the significant increase in apoptosis that follows TBI. TBI increased both caspase-3 compared to sham. Treatment with ghrelin significantly increased UCP-2 compared to TBI alone and this increase in UCP-2 expression was associated with a decrease in expression of caspase-3. Early ghrelin treatment prevents TBI induced BBB disruption and TBI mediated apoptosis 24 h following injury. These results demonstrate the neuroprotective potential of ghrelin as a therapy in TBI. (C) 2012 Elsevier B.V. All rights reserved.	[Lopez, N. E.; Gaston, L.; Lopez, K. R.; Coimbra, R. C.; Hageny, A.; Putnam, J.; Eliceiri, B.; Coimbra, R.; Bansal, V.] Univ Calif San Diego, Dept Surg, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103 USA		Bansal, V (corresponding author), Univ Calif San Diego, Dept Surg, Div Trauma Surg Crit Care & Burns, 200W Arbor Dr 8896, San Diego, CA 92103 USA.	n1lopez@ucsd.edu; Lindsey.Gaston@kzoo.edu; karinal@email.arizona.edu; ahageny@ucsd.edu; jgputnam@ucsd.edu; beliceiri@ucsd.edu; rcoimbra@ucsd.edu; v3bansal@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; Eliceiri, Brian/0000-0003-1811-1916	American Surgical Association Foundation Award	The authors would like to acknowledge the generous support of the American Surgical Association Foundation Award.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005; Baldanzi G, 2002, J CELL BIOL, V159, P1029, DOI 10.1083/jcb.200207165; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bansal V., 2009, J NEUROTRAUMA; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Chung H, 2008, J ENDOCRINOL, V198, P511, DOI 10.1677/JOE-08-0160; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Degasperi GR, 2008, FEBS LETT, V582, P3103, DOI 10.1016/j.febslet.2008.08.006; Diano S, 2003, ENDOCRINOLOGY, V144, P5014, DOI 10.1210/en.2003-0667; Ersahin M, 2010, J NEUROTRAUM, V27, P1143, DOI 10.1089/neu.2009.1210; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; Frago LM, 2011, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmo1.2011.00023, 10.3389/fnmol.2011.00023]; Friedman A, 2009, EPILEPSY RES, V85, P142, DOI 10.1016/j.eplepsyres.2009.03.005; Hooper C, 2005, J NEUROCHEM, V92, P1363, DOI 10.1111/j.1471-4159.2005.02982.x; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Johnstone B, 1998, BRAIN INJURY, V12, P569, DOI 10.1080/026990598122331; KIM KS, 1992, LYMPHOKINE CYTOK RES, V11, P293; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Lee JY, 2010, ENDOCRINOLOGY, V151, P3815, DOI 10.1210/en.2009-1416; Lee J, 2010, J ENDOCRINOL, V205, P262, DOI 10.1677/JOE-10-0040; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu YJ, 2006, CHINESE J PHYSIOL, V49, P244; Liu Yajun, 2009, BMC Physiology, V9, P17, DOI 10.1186/1472-6793-9-17; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Lorberboym M, 2006, BRAIN RES, V1103, P13, DOI 10.1016/j.brainres.2006.05.073; Mailloux RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013289; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; Moon M, 2009, NEUROTOX RES, V15, P332, DOI 10.1007/s12640-009-9037-x; Moon M, 2009, ENDOCR J, V56, P525, DOI 10.1507/endocrj.K09E-089; Murakami N, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740283; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; Pan WH, 2006, PEPTIDES, V27, P911, DOI 10.1016/j.peptides.2005.12.014; Paradis E, 2003, TRENDS MOL MED, V9, P522, DOI 10.1016/j.molmed.2003.10.009; Qi L, 2012, MOL MED, V18, P186, DOI 10.2119/molmed.2011.00390; Qiu WC, 2008, WORLD J GASTROENTERO, V14, P2572, DOI 10.3748/wjg.14.2572; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Si QS, 1997, GLIA, V21, P413, DOI 10.1002/(SICI)1098-1136(199712)21:4<413::AID-GLIA9>3.0.CO;2-3; SIESJO BK, 1995, J NEUROTRAUM, V12, P943, DOI 10.1089/neu.1995.12.943; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Xu JJ, 2009, NEUROSCI LETT, V453, P58, DOI 10.1016/j.neulet.2009.01.067; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	65	36	39	0	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 13	2012	1489						140	148		10.1016/j.brainres.2012.10.031			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	054PZ	WOS:000312357000016	23099053				2022-02-06	
J	Gosselin, N; Bottari, C; Chen, JK; Huntgeburth, SC; De Beaumont, L; Petrides, M; Cheung, B; Ptito, A				Gosselin, Nadia; Bottari, Carolina; Chen, Jen-Kai; Huntgeburth, Sonja Christina; De Beaumont, Louis; Petrides, Michael; Cheung, Bob; Ptito, Alain			Evaluating the cognitive consequences of mild traumatic brain injury and concussion by using electrophysiology	NEUROSURGICAL FOCUS			English	Article						concussion; mild traumatic brain injury; event-related potential; working memory; electroencephalography	SPORTS-RELATED CONCUSSION; EVENT-RELATED POTENTIALS; POSTCONCUSSIVE SYNDROME; PREFRONTAL CORTEX; FRONTAL-CORTEX; RISK-FACTORS; SYMPTOMS; ABNORMALITIES; DEFICITS; MRI	Object. Mild traumatic brain injury (MTBI), often referred to as concussion when it occurs in sports, produces persistent cognitive problems in at least 15% of patients. Unfortunately, conventional neuropsychological tests usually yield results within normal limits in this population. The main objective of this event-related potential (ERP) study was to understand brain functioning during the performance of a working memory (WM) task in patients who have sustained an MTBI, mostly due to motor vehicle accident or sports concussion. This study also aimed for a better understanding of the association between brain functioning as measured with ERP, behavioral performance on the WM task, postconcussion symptoms, type of injury (that is, sports concussion vs other types), and time since the injury. Methods. Forty-four patients with MTBI (7.6 +/- 8.4 months postinjury) were tested on a visual WM task with simultaneous recording of ERP, and were compared with 40 control volunteers who were their equivalent for age and sex. Amplitude and latency of frontal (N200 and N350) and parietal (P200 and P300) ERP waves were measured and were compared between groups. Correlation analyses were also performed between ERP characteristics, clinical variables, and behavioral performance. Results. A significant group difference was found for behavioral performance on the WM task, in which the MTBI group had a lower percentage of correct answers than the control group (p < 0.05). The patients with MTBI also had smaller amplitudes of both frontal N350 and parietal P300 ERP components when compared with control volunteers (p < 0.05). No changes were found for latency of ERP components. Smaller ERP amplitudes were associated with slower reaction times and worse accuracy on the WM task among patients with MTBI (p < 0.05). Types of injury (that is, sports concussion vs other mechanisms) were not associated with different ERP characteristics. Conclusions. Abnormal ERP results are observed in patients after MTBI or sports concussion, even for those in the nonacute stage after their injury. Current standard clinical evaluations most often fail to detect cerebral dysfunction after MTBI, even when patients or athletes report symptoms. Clinicians should be aware that patients with MTBI, including sports concussion, probably have underlying mild but persistent cerebral dysfunctions that require further investigation. (http://thejns.org/doi/abs/10.3171/2012.10.FOCUS12253)	[Gosselin, Nadia; De Beaumont, Louis] Hop Sacre Coeur, Res Ctr, Montreal, PQ H4J 1C5, Canada; [Gosselin, Nadia] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Bottari, Carolina] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Chen, Jen-Kai; Huntgeburth, Sonja Christina; Petrides, Michael; Ptito, Alain] Montreal Neurol Hosp & Inst, Cognit Neurosci Unit, Montreal, PQ H3A 2B4, Canada; [Huntgeburth, Sonja Christina; Petrides, Michael; Ptito, Alain] McGill Univ, Dept Psychol, Montreal, PQ H3A 2B4, Canada; [Ptito, Alain] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3A 2B4, Canada; [De Beaumont, Louis] Univ Quebec Trois Rivieres, Dept Psychol, Toronto, ON, Canada; [Cheung, Bob] Def Res & Dev Canada, Toronto, ON, Canada		Ptito, A (corresponding author), McGill Univ, Montreal Neurol Inst, Cognit Neurosci Unit, Neuropsychol Dept, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	alain.ptito@mcgill.ca			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP-64271]; Defence Research & Development Canada (DRDC-CR) [DRDC-CR W7711-088134/001/TOR]; Fonds pour la Recherche du Quebec-Sante	This study was supported by the Canadian Institutes of Health Research (CIHR operating grant MOP-64271 to A. P. and M. P., and fellowships to N.G. and C. B.); by the Defence Research & Development Canada (DRDC-CR W7711-088134/001/TOR-contract to A. P.); and by the Fonds pour la Recherche du Quebec-Sante (fellowship to N.G. and J.K.C.). No competing financial interests exist.	Ally BA, 2007, NEUROIMAGE, V35, P378, DOI [10.1016/j.neuroimage.2006.11.023, 10.1016/j.neuroimage.2006.12.023]; Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bigler ED, 2009, J HEAD TRAUMA REHAB, V24, P76, DOI 10.1097/HTR.0b013e31819c2190; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bottari C, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/837301; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Champod AS, 2007, P NATL ACAD SCI USA, V104, P14837, DOI 10.1073/pnas.0607101104; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Gosselin N, 2012, J NEUROTRAUMA; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; PETRIDES M, 1991, P ROY SOC B-BIOL SCI, V246, P293, DOI 10.1098/rspb.1991.0157; PETRIDES M, 1995, J NEUROSCI, V15, P359; Polich John, 2004, Phys Med Rehabil Clin N Am, V15, P133, DOI 10.1016/S1047-9651(03)00109-8; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Tremblay S, 2012, CEREB CORTEX; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298	49	36	36	0	54	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2012	33	6							E7	10.3171/2012.10.FOCUS12253			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	048GI	WOS:000311898500008	23199430				2022-02-06	
J	Li, HY; Huang, JB; Du, WL; Jia, CX; Yao, HL; Wang, YZ				Li, Hongyu; Huang, Junbo; Du, Wanlu; Jia, Caixia; Yao, Hailan; Wang, Yizheng			TRPC6 inhibited NMDA receptor activities and protected neurons from ischemic excitotoxicity	JOURNAL OF NEUROCHEMISTRY			English	Article						excitotoxicity; focal ischemia; neuroprotection; transgenic mice; TRPC6	TRAUMATIC BRAIN-INJURY; TYROSINE PHOSPHORYLATION; GLUCOSE DEPRIVATION; CORTICAL CULTURES; CEREBRAL-ISCHEMIA; CHANNELS; MECHANISMS; CALCIUM; STROKE; RATS	Excitotoxicity induced by NMDA receptor-mediated intracellular Ca2+ ([Ca2+]i) overload is a major cause of delayed neuronal death in cerebral ischemia. Transient receptor potential canonical (TRPC) 6 protects neurons from ischemic brain damage. However, the mechanisms by which TRPC6 protects neurons are largely unknown. Here, we reported that TRPC6 suppressed the [Ca2+]i elevation induced by NMDA and protected neurons from excitotoxicity. Over-expressing or down-regulating TRPC6 suppressed or aggravated Ca2+ overload under excitotoxicity, respectively. TRPC6 protected cultured neurons from damage caused by NMDA toxicity or oxygen glucose deprivation (OGD). Moreover, the infarct volume in TRPC6 transgenic (Tg) mice was smaller than that in wild-type (WT) littermates. The TRPC6 Tg mice had better behavior performance and lower mortality than their WT littermates. Thus, TRPC6 inhibited NMDA receptor-triggered neurotoxicity and protected neurons from ischemic brain damage. Increase in TRPC6 activity could be a potential strategy for stroke prevention and therapy.	[Li, Hongyu; Huang, Junbo; Du, Wanlu; Jia, Caixia; Yao, Hailan; Wang, Yizheng] Chinese Acad Sci, Lab Neural Signal Transduct, Inst Neurosci, SIBS,State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Li, Hongyu; Huang, Junbo] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China		Wang, YZ (corresponding author), Chinese Acad Sci, Lab Neural Signal Transduct, Inst Neurosci, SIBS,State Key Lab Neurosci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	yzwang@ion.ac.cn		Du, Wanlu/0000-0003-2612-7846	NNSF of ChinaNational Natural Science Foundation of China (NSFC) [81130081]	This work was supported by a grant (81130081) from NNSF of China. We thank Q. Hu and ZJ. Fan for technical assistance. The authors have no conflict of interest to declare.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ashwal S, 1998, STROKE, V29, P1037, DOI 10.1161/01.STR.29.5.1037; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Du WL, 2010, J CLIN INVEST, V120, P3480, DOI 10.1172/JCI43165; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Jia YC, 2007, NAT NEUROSCI, V10, P559, DOI 10.1038/nn1870; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Lei ZG, 2006, NEUROSCI LETT, V407, P224, DOI 10.1016/j.neulet.2006.06.019; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Liu Y, 2003, BRAIN RES, V972, P142, DOI 10.1016/S0006-8993(03)02519-8; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; Pei L, 2000, ACTA PHARMACOL SIN, V21, P695; Riccio A, 2002, MOL BRAIN RES, V109, P95, DOI 10.1016/S0169-328X(02)00527-2; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Sattler R, 1998, J NEUROCHEM, V71, P2349; Smith Paul F, 2003, Curr Opin Investig Drugs, V4, P826; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Tao YM, 2006, MOL CELL BIOL, V26, P1038, DOI 10.1128/MCB.26.3.1038-1050.2006; Vazquez G, 2004, BBA-MOL CELL RES, V1742, P21, DOI 10.1016/j.bbamcr.2004.08.015; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Zhou J, 2008, NAT NEUROSCI, V11, P741, DOI 10.1038/nn.2127; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	36	36	40	2	14	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042			J NEUROCHEM	J. Neurochem.	DEC	2012	123	6					1010	1018		10.1111/jnc.12045			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	051WK	WOS:000312158500012	23043486				2022-02-06	
J	Mondello, S; Gabrielli, A; Catani, S; D'Ippolito, M; Jeromin, A; Ciaramella, A; Bossu, P; Schmid, K; Tortella, F; Wang, KKW; Hayes, RL; Formisano, R				Mondello, Stefania; Gabrielli, Andrea; Catani, Sheila; D'Ippolito, Mariagrazia; Jeromin, Andreas; Ciaramella, Antonio; Bossu, Paola; Schmid, Kara; Tortella, Frank; Wang, Kevin K. W.; Hayes, Ronald L.; Formisano, Rita			Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury	BRAIN INJURY			English	Article						MAP2; traumatic brain injury; biomarkers; outcome; cognitive functioning	MICROTUBULE-ASSOCIATED PROTEIN-2; VEGETATIVE STATE; CONSCIOUSNESS; DISORDERS; MARKER; ACTIN	Objective: To evaluate microtubule-associated proteins (MAP-2), a dendritic marker of both acute damage and chronic neuronal regeneration after injury, in serum of survivors after severe TBI and examine the association with long-term outcome. Methods: Serum concentrations of MAP-2 were evaluated in 16 patients with severe TBI (Glasgow Coma Scale score [GCS] <= 8) 6 months post-injury and in 16 controls. Physical and cognitive outcomes were assessed, using the Glasgow Outcome Scale Extended (GOSE) and Levels of Cognitive Functioning Scale (LCFS), respectively. Results: Severe TBI patients had significantly higher serum MAP-2 concentrations than normal controls with no history of TBI (p = 0.008) at 6 months post-injury. MAP-2 levels correlated with the GOSE (r = 0.58, p = 0.02) and LCFS (r = 0.65, p = 0.007) at month 6. Significantly lower serum levels of MAP-2 were observed in patients in a vegetative state (VS) compared to non-VS patients (p < 0.05). A trend tracking the level of consciousness was observed. Conclusions: Severe TBI results in a chronic release of MAP-2 into the peripheral circulation in patients with higher levels of consciousness, suggesting that remodelling of synaptic junctions and neuroplasticity processes occur several months after injury. The data indicate MAP-2 as a potential marker for emergence to higher levels of cognitive function.	[Mondello, Stefania; Jeromin, Andreas; Wang, Kevin K. W.; Hayes, Ronald L.] Univ Florida, Dept Anesthesiol, Gainesville, FL USA; [Mondello, Stefania; Gabrielli, Andrea; Wang, Kevin K. W.; Hayes, Ronald L.] Banyan Biomarkers Inc, Clin Dept, Banyan Labs, Alachua, FL 32615 USA; [Catani, Sheila; D'Ippolito, Mariagrazia; Ciaramella, Antonio; Bossu, Paola; Formisano, Rita] Santa Lucia Fdn, Rome, Italy; [Schmid, Kara; Tortella, Frank] Walter Reed Army Inst Res, Silver Spring, MD USA		Mondello, S (corresponding author), Banyan Biomarkers Inc, Dept Clin Programs, 13400 Progress Blvd, Alachua, FL 32615 USA.	stm_mondello@hotmail.com	D'Ippolito, Mariagrazia/K-4010-2016; ciaramella, antonio/P-9009-2019; Mondello, Stefania/A-1813-2012; Bosso, Paola/E-4832-2014; Nacmias, Benedetta/J-5084-2018; Ciaramella, Antonio/F-1170-2011	D'Ippolito, Mariagrazia/0000-0001-7818-7352; Mondello, Stefania/0000-0002-8587-3614; Bosso, Paola/0000-0002-1432-0078; Nacmias, Benedetta/0000-0001-9338-9040; Ciaramella, Antonio/0000-0001-9888-8156; Wang, Kevin/0000-0002-9343-6473	Banyan Biomarkers Inc.; Department of DefenseUnited States Department of Defense [DAMD17-03-1-0772, DAMD17-03-1-0066]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS049175-01, R01-NS052831-01, R01 NS051431-01]; Navy [N00014-06-1-1029]; Italian Ministry of HealthMinistry of Health, Italy [RF2008, n.31]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS051431, R01NS052831, R01NS049175] Funding Source: NIH RePORTER	Dr Mondello is a consultant of Banyan Biomarkers, Inc.; Dr Jeromin is an employee of Banyan Biomarkers; Dr Wang and Dr Hayes own stock, receive royalties and salaries from, and are officers of Banyan Biomarkers Inc. Drs Gabrielli, Tortella, Schmid, Catani, D'Ippolito, Ciaramella, Bossu and Formisano report no conflicts of interest.; This study was primarily sponsored by Department of Defense Award numbers DAMD17-03-1-0772 and DAMD17-03-1-0066; but we also acknowledge additional fund support from NIH (R01 NS049175-01, R01-NS052831-01 and R01 NS051431-01) and Navy grant number N00014-06-1-1029 (University of Florida). The collection of data in Santa Lucia Foundation was partially supported by the Italian Ministry of Health (grant RF2008, n.31).	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; AVILA J, 1992, LIFE SCI, V50, P327, DOI 10.1016/0024-3205(92)90433-P; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CACERES A, 1983, P NATL ACAD SCI-BIOL, V80, P1738, DOI 10.1073/pnas.80.6.1738; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DECAMILLI P, 1984, NEUROSCIENCE, V11, P819, DOI 10.1016/0306-4522(84)90194-5; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gosseries O, 2011, NEUROREHABILITATION, V28, P3, DOI 10.3233/NRE-2011-0625; GREENOUGH WT, 1988, TRENDS NEUROSCI, V11, P142, DOI 10.1016/0166-2236(88)90139-7; Hagen C, 1979, REHABILITATION HEAD; HUBER G, 1984, J NEUROSCI, V4, P151; JOHNSON GVW, 1992, J NEUROSCI RES, V33, P505, DOI 10.1002/jnr.490330402; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; MASLIAH E, 1993, BRAIN PATHOL, V3, P77, DOI 10.1111/j.1750-3639.1993.tb00728.x; MORALES M, 1989, CELL TISSUE RES, V256, P447; Park D, 2012, J NEUROSCI RES, V90, P461, DOI 10.1002/jnr.22769; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Strens LHA, 2004, BRAIN INJURY, V18, P213, DOI 10.1080/0269905031000149533; TEASDALE G, 1974, LANCET, V2, P81; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wagner AK, 2012, PATHOPHYSIOLOGY; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	34	36	39	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1629	1635		10.3109/02699052.2012.700083			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700009	22794497				2022-02-06	
J	Sukumari-Ramesh, S; Alleyne, CH; Dhandapani, KM				Sukumari-Ramesh, Sangeetha; Alleyne, Cargill H., Jr.; Dhandapani, Krishnan M.			Astrocyte-Specific Expression of Survivin after Intracerebral Hemorrhage in Mice: A Possible Role in Reactive Gliosis?	JOURNAL OF NEUROTRAUMA			English	Article						astrogliosis; Inhibitor of Apoptosis protein family; proliferation; repair; stroke	TRAUMATIC BRAIN-INJURY; GLIOBLASTOMA CELLS; BARRIER PROPERTIES; ENDOTHELIAL-CELLS; APOPTOSIS; CANCER; GLIA; STROKE; REPAIR; S100B	Intracerebral hemorrhage (ICH), the most common form of hemorrhagic stroke, accounts for up to 15% of all strokes. Despite maximal surgical intervention and supportive care, ICH is associated with significant morbidity and mortality, in part due to a lack of viable treatment options. Astrogliosis, a key feature of secondary injury that is characterized by glial proliferation, is a poorly-defined process that may produce both beneficial and detrimental outcomes after brain injury. Using a pre-clinical murine model of collagenase-induced ICH, we demonstrate a delayed upregulation of survivin, a key molecule involved in tumor cell proliferation and survival, by 72 h post-ICH. Notably, this increase in survivin expression was prominent in GFAP-positive astrocytes, but absent in neurons. Survivin was not expressed at detectable levels in the striatum of sham-operated mice. The expression of survivin after ICH was temporally and spatially associated with the expression of proliferating cell nuclear antigen (PCNA), an established marker of cellular proliferation. Moreover, the survivin expression was co-localized in proliferating astrocytes as evidenced by triple-label immunohistochemistry. Finally, shRNA-mediated silencing of survivin expression attenuated PCNA expression and reduced cellular proliferation in human glial cells. Together, these data suggest a potentially novel role for survivin in functionally promoting astrocytic proliferation after ICH.	[Sukumari-Ramesh, Sangeetha; Alleyne, Cargill H., Jr.; Dhandapani, Krishnan M.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA 30912 USA		Sukumari-Ramesh, S (corresponding author), Georgia Hlth Sci Univ, Dept Neurosurg, 1120 15th St, Augusta, GA 30912 USA.	sramesh@georgiahealth.edu		Dhandapani, Krishnan/0000-0001-7044-1117	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS065172, R21NS075774]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065172, R21NS075774] Funding Source: NIH RePORTER	This work was supported by grants from the National Institute of Health (R01NS065172, R21NS075774) to KMD.	ABBOTT NJ, 1992, NEUROPATH APPL NEURO, V18, P424, DOI 10.1111/j.1365-2990.1992.tb00808.x; Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 1999, LAB INVEST, V79, P1327; Blum R, 2006, MOL CANCER THER, V5, P2337, DOI 10.1158/1535-7163.MCT-06-0193; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Chakravarti A, 2004, ONCOGENE, V23, P7494, DOI 10.1038/sj.onc.1208049; Clem RJ, 1996, CELL DEATH DIFFER, V3, P9; Das A, 2002, J CANCER RES CLIN, V128, P302, DOI 10.1007/s00432-002-0343-4; Delgado P, 2006, STROKE, V37, P2837, DOI 10.1161/01.STR.0000245085.58807.ad; Dowlatshahi D, 2011, NEUROLOGY, V76, P1238, DOI 10.1212/WNL.0b013e3182143317; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.0.CO;2-B; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; James ML, 2009, BIOMARKERS, V14, P388, DOI 10.1080/13547500903015784; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Johnson EA, 2004, J NEUROTRAUM, V21, P1183, DOI 10.1089/neu.2004.21.1183; King MD, 2011, J NEUROSURG, V115, P116, DOI 10.3171/2011.2.JNS10784; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Mahesh VB, 2006, MOL CELL ENDOCRINOL, V246, P1, DOI 10.1016/j.mce.2005.11.017; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Moon WS, 2003, HUM PATHOL, V34, P1119, DOI 10.1053/j.humpath.2003.07.016; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Ribo M, 2006, CURR NEUROL NEUROSCI, V6, P17, DOI 10.1007/s11910-996-0004-0; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Sukumari-Ramesh S, 2011, J NEUROSURG, V114, P1681, DOI 10.3171/2010.12.JNS10588; Sukumari-Ramesh S, 2010, GLIA, V58, P1858, DOI 10.1002/glia.21055; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Villapol S, 2008, NEUROSCIENCE, V153, P108, DOI 10.1016/j.neuroscience.2008.01.054; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580	43	36	39	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2012	29	18					2798	2804		10.1089/neu.2011.2243			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	050ZE	WOS:000312092800009	22862734	Green Published			2022-02-06	
J	Matthews, SC; Spadoni, AD; Lohr, JB; Strigo, IA; Simmons, AN				Matthews, Scott C.; Spadoni, Andrea D.; Lohr, James B.; Strigo, Irma A.; Simmons, Alan N.			Diffusion tensor imaging evidence of white matter disruption associated with loss versus alteration of consciousness in warfighters exposed to combat in Operations Enduring and Iraqi Freedom	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						Diffusion tensor imaging; Concussion; Loss of consciousness; Depression; PTSD; White matter	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SPATIAL STATISTICS; VOXELWISE ANALYSIS; INTEGRITY; DEPRESSION; MRI; AFGHANISTAN; DISTORTION; SEQUELAE	The effects on the human brain of mild traumatic brain injury (mTBI), which is defined as a brief alteration (AOC) or loss of consciousness (LOC), are incompletely understood. Major psychiatric illnesses such as major depressive disorder (MDD) and posttraumatic stress disorder (PTSD) are common after mTBI. Prior research suggests that individuals who develop MOD after blast-related mTBI versus those who do not show significant white matter disruption and higher rates of LOC, suggesting that LOC might be uniquely associated with brain changes that increase the risk of developing mental illness after neurotrauma. Therefore, the objective of this study was to examine the effects of LOC, MDD, and PTSD on white matter integrity in individuals who reported experiencing mTBI during combat in Operations Enduring and Iraqi Freedom. We hypothesized that LOC would be associated with significant disruption of white matter, above and beyond putative effects of MOD and PTSD. To test this hypothesis, 46 individuals who experienced blast-related mTBI underwent a detailed clinical assessment and diffusion tensor imaging. As hypothesized, LOC versus AOC individuals displayed significantly lower fractional anisotropy (FA) in 14 regions, which included the superior longitudinal fasciculus and corpus callosum. No regions of significant FA difference were identified between individuals with and without PTSD, or between individuals with and without MDD. These preliminary results show that LOC is associated with detectable alterations in brain microstructure and may suggest a brain basis for psychiatric symptoms and mental illness after mTBI. Published by Elsevier Ireland Ltd.	[Matthews, Scott C.; Spadoni, Andrea D.; Lohr, James B.; Strigo, Irma A.; Simmons, Alan N.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Matthews, Scott C.; Spadoni, Andrea D.; Strigo, Irma A.; Simmons, Alan N.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Matthews, Scott C.; Lohr, James B.; Strigo, Irma A.; Simmons, Alan N.] VA Ctr Excellence Stress & Mental Hlth, La Jolla, CA USA; [Matthews, Scott C.] VA Mental Illness Res Educ & Clin Ctr, La Jolla, CA USA		Matthews, SC (corresponding author), Vet Affairs San Diego Healthcare Syst, 3350 La Jolla Village Dr,Mail Code 116-A, La Jolla, CA 92093 USA.	scmatthews@ucsd.edu	Simmons, Alan N/A-9815-2008; strigo, irina A/L-9882-2016	Simmons, Alan N/0000-0003-3963-2112; strigo, irina A/0000-0002-8799-716X; Spadoni, Andrea/0000-0002-8367-6406	Veterans AdministrationUS Department of Veterans Affairs; Congressionally Directed Medical Research ProgramUnited States Department of Defense; VA Mental Illness Research, Education and Clinical Center; VA Center of Excellence for Stress and Mental Health; VA Clinical Science Research and Development; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH018399] Funding Source: NIH RePORTER	We thank Ryan O'Connell, Elena Kosheleva, Martin Paulus, Dean Delis, and Larry Frank for their contributions to this research, which was funded by grants from the Veterans Administration and the Congressionally Directed Medical Research Program and was supported by the VA Mental Illness Research, Education and Clinical Center and the VA Center of Excellence for Stress and Mental Health. Dr. Matthews' VA salary is supported by a CDA-2 from VA Clinical Science Research and Development.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; First M., 1997, STRUCTURED CLIN INTE; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lange R. T., 2011, J HEAD TRAUMA REHABI; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mollica RF, 2009, ARCH GEN PSYCHIAT, V66, P1221, DOI 10.1001/archgenpsychiatry.2009.127; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Schwab K, 2006, NEUROLOGY, V66; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Zou K, 2008, J PSYCHIATR NEUROSCI, V33, P525	43	36	36	0	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	NOV 30	2012	204	2-3					149	154		10.1016/j.pscychresns.2012.04.018			6	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	081NP	WOS:000314329200012	23149025	Green Accepted			2022-02-06	
J	Mak, CHK; Wong, SKH; Ng, GKWS; Wang, KKW; Lam, PK; Poon, WS				Mak, Calvin H. K.; Wong, Stephen K. H.; Ng, George K. Wong Stephanie; Wang, Kevin K. W.; Lam, Ping Kuen; Poon, Wai Sang			Traumatic Brain Injury in the Elderly: Is it as Bad as we Think?	CURRENT GERIATRICS REPORTS			English	Article						Traumatic brain injury; Elderly; Geriatric; Aging; Review; Animal studies; Stem cell; Drugs; Anticoagulation; Antiplatelet; Warfarin; Aspirin; Clopidogrel; Epidemiology; Outcome; Cognitive; Craniotomy; Decompressive craniectomy		Traumatic brain injury in elderly patients is a neglected global disease burden. The main cause is fall, followed by motor vehicle accidents. This review article summarizes different aspects of geriatric traumatic brain injury, including epidemiology, pathology, and effects of comorbidities and pre-injury medications such as antiplatelets and anticoagulants. Functional outcome with or without surgical intervention, cognitive outcome, and psychiatric complications are discussed. Animal models are also reviewed in attempt to explain the relationship of aging and outcome, together with advances in stem cell research. Though elderly people in general did fare worse after traumatic brain injury, certain "younger elderly" people, aged 6575 years, could have a comparable outcome to younger adults after minor to moderate head injury.	[Mak, Calvin H. K.; Wong, Stephen K. H.; Ng, George K. Wong Stephanie; Wang, Kevin K. W.; Poon, Wai Sang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Neurosurg, Shatin, Hong Kong, Peoples R China; [Wang, Kevin K. W.] Univ Florida, Ctr Neuroprote & Biomarkers Res, McKnight Brain Inst, Dept Psychiat & Neurosci, Gainesville, FL 32611 USA; [Lam, Ping Kuen] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Chow Tai Fook Cheung Yu Tung Surg Stem Cell Res C, Shatin, Hong Kong, Peoples R China		Poon, WS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Neurosurg, Shatin, Hong Kong, Peoples R China.	wpoon@surgery.cuhk.edu.hk	Poon, Wai Sang/F-1558-2011; Mak, Calvin/ABA-5717-2021	Mak, Calvin/0000-0002-1443-2109; Wang, Kevin/0000-0002-9343-6473			Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Bhang SH, 2007, BIOCHEM BIOPH RES CO, V359, P40, DOI 10.1016/j.bbrc.2007.05.046; Bhullar IS, 2010, AM SURGEON, V76, P966; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Cameron PA, 2004, J TRAUMA, V56, P890, DOI 10.1097/01.TA.0000053398.40463.51; Chan LYL, 2009, ANAESTH INTENS CARE, V37, P773, DOI 10.1177/0310057X0903700511; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Colak T, 2012, INJURY; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; Downey DM, 2009, AM SURGEON, V75, P1100; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Fortier LA, 2005, VET SURG, V34, P415, DOI 10.1111/j.1532-950X.2005.00063.x; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Garber ST, 2012, J NEUROSURG; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Helmes E, 2011, BRAIN INJURY, V25, P338, DOI 10.3109/02699052.2011.556104; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Jagnoor J, 2011, INJURY; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; JENNETT B, 1976, LANCET, V1, P1031; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Karni A, 2001, AM SURGEON, V67, P1098; Karon SL, 2007, J HEAD TRAUMA REHAB, V22, P350, DOI 10.1097/01.HTR.0000300230.13490.11; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Lam P K, 2012, J CLIN NEUR IN PRESS; Lam PK, 2011, TRANSPLANTATION, V92, pE9, DOI 10.1097/TP.0b013e318221d3b7; Lau D, 2012, J NEUROSURG, V116, P234, DOI 10.3171/2011.7.JNS11396; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lin JW, 2006, SURG NEUROL, V66, pS20, DOI 10.1016/j.surneu.2006.04.005; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mehan N. D., 2011, NEUROBIOL AGING; Menzel JC, 2008, BRAIN INJURY, V22, P375, DOI 10.1080/02699050802001492; Mitra B, 2008, ANZ J SURG, V78, P588, DOI 10.1111/j.1445-2197.2008.04579.x; Mohindra S, 2008, SURG NEUROL, V69, P474, DOI 10.1016/j.surneu.2007.02.031; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Neideen T, 2008, J TRAUMA, V65, P1016, DOI 10.1097/TA.0b013e3181897eac; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Peschman J, 2011, J TRAUMA, V70, P1331, DOI 10.1097/TA.0b013e31821693e2; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Ramanathan D M, 2011, J NEUROTRAUMA; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P231, DOI 10.1176/appi.neuropsych.22.2.231; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P166, DOI 10.1176/appi.neuropsych.22.2.166; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Schneider EB, 2011, J TRAUMA, V71, P815, DOI 10.1097/TA.0b013e3182319de5; Schouten JW, 2004, J NEUROTRAUM, V21, P1501, DOI 10.1089/neu.2004.21.1501; Sinha VD, 2008, INDIAN J NEUROTRAUM, V5, P69; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Ushewokunze S, 2004, BRIT J NEUROSURG, V18, P604, DOI 10.1080/02688690400022763; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Wong GK, 2009, BRIT J NEUROSURG, V23, P601, DOI 10.3109/02688690902948184; Wong George K C, 2011, J Emerg Trauma Shock, V4, P346, DOI 10.4103/0974-2700.83861; Wong GKC, 2012, ACTA NEUROCHIR, V154, P105, DOI 10.1007/s00701-011-1198-8; WU X, 2004, J TRAUMA ACUTE CARE, V64, P1313; Yap SGM, 2008, J HEAD TRAUMA REHAB, V23, P158, DOI 10.1097/01.HTR.0000319932.15085.fe	87	36	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2196-7865			CURR GERIATR REP	Curr. Geriatr. Rep.	SEP	2012	1	3					171	178		10.1007/s13670-012-0017-2			8	Geriatrics & Gerontology	Emerging Sources Citation Index (ESCI)	Geriatrics & Gerontology	V3S8Y	WOS:000218556700007	24014175	hybrid, Green Published			2022-02-06	
J	Li, L; Zhang, W; Cheng, SW; Cao, DF; Parent, M				Li, Ling; Zhang, Wei; Cheng, Shaowu; Cao, Dongfeng; Parent, Marc			Isoprenoids and Related Pharmacological Interventions: Potential Application in Alzheimer's Disease	MOLECULAR NEUROBIOLOGY			English	Article						Isoprenoids; Protein prenylation; Statins; Bisphosphonates; Prenyltransferase inhibitors; Alzheimer's disease	HMG-COA REDUCTASE; AMYLOID PRECURSOR PROTEIN; TRAUMATIC BRAIN-INJURY; GERANYLGERANYLTRANSFERASE-I INHIBITOR; NITROGEN-CONTAINING BISPHOSPHONATES; BIPOLAR SPINDLE FORMATION; LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; FARNESYLTRANSFERASE INHIBITOR; MOUSE MODEL	Two major isoprenoids, farnesyl pyrophosphate and geranylgeranyl pyrophosphate, serve as lipid donors for the posttranslational modification (known as prenylation) of proteins that possess a characteristic C-terminal motif. The prenylation reaction is catalyzed by prenyltransferases. The lipid prenyl group facilitates to anchor the proteins in cell membranes and mediates protein-protein interactions. A variety of important intracellular proteins undergo prenylation, including almost all members of small GTPase superfamilies as well as heterotrimeric G protein subunits and nuclear lamins. These prenylated proteins are involved in regulating a wide range of cellular processes and functions, such as cell growth, differentiation, cytoskeletal organization, and vesicle trafficking. Prenylated proteins are also implicated in the pathogenesis of different types of diseases. Consequently, isoprenoids and/or prenyltransferases have emerged as attractive therapeutic targets for combating various disorders. This review attempts to summarize the pharmacological agents currently available or under development that control isoprenoid availability and/or the process of prenylation, mainly focusing on statins, bisphosphonates, and prenyltransferase inhibitors. Whereas statins and bisphosphonates deplete the production of isoprenoids by inhibiting the activity of upstream enzymes, prenyltransferase inhibitors directly block the prenylation of proteins. As the importance of isoprenoids and prenylated proteins in health and disease continues to emerge, the therapeutic potential of these pharmacological agents has expanded across multiple disciplines. This review mainly discusses their potential application in Alzheimer's disease.	[Li, Ling; Zhang, Wei; Cheng, Shaowu; Cao, Dongfeng; Parent, Marc] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA		Li, L (corresponding author), Univ Minnesota, Dept Expt & Clin Pharmacol, 2001 6th St SE,MTRF 4-208, Minneapolis, MN 55455 USA.	lil@umn.edu	cheng, shaowu/C-1622-2013	cheng, shaowu/0000-0001-6148-9565; Li, Ling/0000-0002-9245-7387	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG031846]; Alzheimer's AssociationAlzheimer's Association [IIRG-09-131791]; American Health Assistance FoundationBrightFocus Foundation [A2010328]; Academic Health Center of the University of MinnesotaUniversity of Minnesota System; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG031846] Funding Source: NIH RePORTER	This work was supported in part by grants from the National Institutes of Health (AG031846), the Alzheimer's Association (IIRG-09-131791, the American Health Assistance Foundation (A2010328), and the Academic Health Center of the University of Minnesota.	ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Barrington RE, 1998, MOL CELL BIOL, V18, P85, DOI 10.1128/MCB.18.1.85; BAUER J, 1991, FEBS LETT, V285, P111, DOI 10.1016/0014-5793(91)80737-N; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Bordier BB, 2003, J CLIN INVEST, V112, P407, DOI 10.1172/JCI200317704; Bosel J, 2005, J NEUROCHEM, V92, P1386, DOI 10.1111/j.1471-4159.2004.02980.x; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; Carrico D, 2004, BIOORGAN MED CHEM, V12, P6517, DOI 10.1016/j.bmc.2004.09.020; Cespedes-Rubio A, 2010, J NEUROSCI RES, V88, P3621, DOI 10.1002/jnr.22511; Chan LN, 2009, ELECTROPHORESIS, V30, P3598, DOI 10.1002/elps.200900259; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Cibickova L, 2007, PHYSIOL RES, V56, P765, DOI 10.33549/physiolres.931121; Clarke R, 2007, SIGHT SOUND, V17, P52; Clezardin P, 2005, CANCER RES, V65, P4971, DOI 10.1158/0008-5472.CAN-05-0264; Cohen-Jonathan E, 2001, CANCER RES, V61, P2289; Cole SL, 2005, J BIOL CHEM, V280, P18755, DOI 10.1074/jbc.M413895200; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Cordle A, 2005, J NEUROSCI, V25, P299, DOI 10.1523/JNEUROSCI.2544-04.2005; CORIA F, 1988, LAB INVEST, V58, P454; Costa RM, 2002, NATURE, V415, P526, DOI 10.1038/nature711; Coxon FP, 2000, J BONE MINER RES, V15, P1467, DOI 10.1359/jbmr.2000.15.8.1467; Cremers S, 2011, BONE, V49, P42, DOI 10.1016/j.bone.2011.01.014; Crespo NC, 2001, J BIOL CHEM, V276, P16161, DOI 10.1074/jbc.M006213200; Crespo NC, 2002, CELL DEATH DIFFER, V9, P702, DOI 10.1038/sj.cdd.4401023; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; DeGraw AJ, 2010, CHEM BIOL DRUG DES, V76, P460, DOI 10.1111/j.1747-0285.2010.01037.x; Douma TN, 2011, PSYCHOPHARMACOLOGY, V216, P537, DOI 10.1007/s00213-011-2245-0; Dunford JE, 2001, J PHARMACOL EXP THER, V296, P235; Eastman RT, 2006, J LIPID RES, V47, P233, DOI 10.1194/jlr.R500016-JLR200; Eckert GP, 2009, NEUROBIOL DIS, V35, P251, DOI 10.1016/j.nbd.2009.05.005; Eikelenboom P, 2011, CURR ALZHEIMER RES, V8, P142, DOI 10.2174/156720511795256080; EIKELENBOOM P, 1982, ACTA NEUROPATHOL, V57, P239, DOI 10.1007/BF00685397; Essig M, 1998, CIRC RES, V83, P683, DOI 10.1161/01.RES.83.7.683; Famer D, 2004, NEUROSCI LETT, V371, P209, DOI 10.1016/j.neulet.2004.08.069; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fawcett JR, 2002, BRAIN RES, V950, P10, DOI 10.1016/S0006-8993(02)02981-5; Martinez MF, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-39; Finder JD, 1997, J BIOL CHEM, V272, P13484, DOI 10.1074/jbc.272.21.13484; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; FLEISCH H, 1969, SCIENCE, V165, P1262, DOI 10.1126/science.165.3899.1262; FLEISCH H, 1969, NATURE, V223, P211, DOI 10.1038/223211a0; FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0; Fong LG, 2006, SCIENCE, V311, P1621, DOI 10.1126/science.1124875; Franke C, 2007, NEUROBIOL DIS, V25, P438, DOI 10.1016/j.nbd.2006.10.004; Fuller S, 2010, MUTAT RES-FUND MOL M, V690, P40, DOI 10.1016/j.mrfmmm.2009.08.016; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Govek EE, 2011, DEV NEUROBIOL, V71, P528, DOI 10.1002/dneu.20850; Holmberg E, 2006, J NEUROTRAUM, V23, P1366, DOI 10.1089/neu.2006.23.1366; Hooff GP, 2010, MOL NEUROBIOL, V41, P341, DOI 10.1007/s12035-010-8117-5; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jahnke W, 2010, NAT CHEM BIOL, V6, P660, DOI [10.1038/NCHEMBIO.421, 10.1038/nchembio.421]; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Johnson-Anuna LN, 2005, J PHARMACOL EXP THER, V312, P786, DOI 10.1124/jpet.104.075028; Jones PH, 2003, CLIN CARDIOL, V26, pI15; Kannan M, 2010, NEUROBIOL AGING, V31, P1543, DOI 10.1016/j.neurobiolaging.2008.09.004; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Kieran MW, 2007, PEDIATRICS, V120, P834, DOI 10.1542/peds.2007-1356; Kim CK, 2010, MOL PHARMACOL, V78, P142, DOI 10.1124/mol.110.063586; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kotti T, 2008, P NATL ACAD SCI USA, V105, P11394, DOI 10.1073/pnas.0805556105; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Kou JH, 2010, BRAIN RES, V1356, P102, DOI 10.1016/j.brainres.2010.07.102; Kretz A, 2006, NEUROBIOL DIS, V21, P421, DOI 10.1016/j.nbd.2005.08.003; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Lapchak PA, 2010, BRAIN RES, V1344, P217, DOI 10.1016/j.brainres.2010.05.035; Lerner EC, 1997, ONCOGENE, V15, P1283, DOI 10.1038/sj.onc.1201296; Leu CT, 2006, BONE, V38, P628, DOI 10.1016/j.bone.2005.07.023; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Lindberg C, 2005, J NEUROSCI RES, V82, P10, DOI 10.1002/jnr.20615; Liu M, 2010, P NATL ACAD SCI USA, V107, P6471, DOI 10.1073/pnas.0908396107; Liu ZH, 2009, P NATL ACAD SCI USA, V106, P4635, DOI 10.1073/pnas.0806474106; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Luckman SP, 1998, J BONE MINER RES, V13, P1668, DOI 10.1359/jbmr.1998.13.11.1668; Magrane J, 2005, J NEUROSCI, V25, P10960, DOI 10.1523/JNEUROSCI.1723-05.2005; Manabe T, 2000, J NEUROSCI, V20, P2504; Mans RA, 2012, NEUROSCIENCE, V202, P1, DOI 10.1016/j.neuroscience.2011.12.007; Mans RA, 2010, NEUROSCIENCE, V166, P435, DOI 10.1016/j.neuroscience.2009.12.062; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Mehta IS, 2010, BIOCHEM SOC T, V38, P287, DOI 10.1042/BST0380287; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Menge T, 2005, NAT REV NEUROSCI, V6, P325, DOI 10.1038/nrn1652; Meske V, 2003, EUR J NEUROSCI, V17, P93, DOI 10.1046/j.1460-9568.2003.02433.x; Morgan K, 2011, NEUROPATH APPL NEURO, V37, P353, DOI 10.1111/j.1365-2990.2011.01181.x; Nallan L, 2005, J MED CHEM, V48, P3704, DOI 10.1021/jm0491039; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; O'Dwyer PJ, 2010, ANN ONCOL, V21, P42; ODELL TJ, 1994, SCIENCE, V265, P542, DOI 10.1126/science.7518615; Onono FO, 2010, MOL CELL PROTEOMICS, V9, P742, DOI 10.1074/mcp.M900597-MCP200; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Paintlia AS, 2008, MOL PHARMACOL, V73, P1381, DOI 10.1124/mol.107.044230; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pappolla MA, 2003, NEUROLOGY, V61, P199, DOI 10.1212/01.WNL.0000070182.02537.84; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Perez-Sala D, 2007, FRONT BIOSCI-LANDMRK, V12, P4456, DOI 10.2741/2401; Pooler AM, 2006, J NEUROCHEM, V97, P716, DOI 10.1111/j.1471-4159.2006.03763.x; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Reuveni H, 2003, EUR J BIOCHEM, V270, P2759, DOI 10.1046/j.1432-1033.2003.03647.x; Rodriguez-Vita J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003959; Roelofs AJ, 2010, CURR PHARM DESIGN, V16, P2950; Rogers Maurice, 2011, Scottish Forestry, V65, P34; Rondeau JM, 2006, CHEMMEDCHEM, V1, P267, DOI 10.1002/cmdc.200500059; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Salins P, 2007, NEUROSCI LETT, V412, P211, DOI 10.1016/j.neulet.2006.07.045; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Schulz JG, 2004, J NEUROCHEM, V89, P24, DOI 10.1046/j.1471-4159.2003.02305.x; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shepardson NE, 2011, ARCH NEUROL-CHICAGO, V68, P1385, DOI 10.1001/archneurol.2011.242; Shepardson NE, 2011, ARCH NEUROL-CHICAGO, V68, P1239, DOI 10.1001/archneurol.2011.203; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shinohara M, 2010, J BIOL CHEM, V285, P22091, DOI 10.1074/jbc.M110.102277; Shitara Y, 2006, PHARMACOL THERAPEUT, V112, P71, DOI 10.1016/j.pharmthera.2006.03.003; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Sun YX, 2003, PHARMACOL RES, V47, P119, DOI 10.1016/S1043-6618(02)00288-8; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thornton C, 2003, J BIOL CHEM, V278, P23823, DOI 10.1074/jbc.M302389200; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Townsend KP, 2004, J NEUROSCI RES, V78, P167, DOI 10.1002/jnr.20234; Tsimberidou AM, 2010, EXPERT OPIN INV DRUG, V19, P1569, DOI 10.1517/13543784.2010.535516; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Vaughan CJ, 2003, AM J CARDIOL, V91, p23B, DOI 10.1016/S0002-9149(02)03270-8; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Vural K, 2011, EUR REV MED PHARMACO, V15, P985; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Wolazin B, 2006, ACTA NEUROL SCAND, V114, P63; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xu RX, 2008, J CELL BIOCHEM, V103, P256, DOI 10.1002/jcb.21402; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Ye XJ, 2010, NEURON, V68, P340, DOI 10.1016/j.neuron.2010.09.013; Yee LL, 2011, CLIN THER, V33, P1023, DOI 10.1016/j.clinthera.2011.07.011; Young SG, 2006, J BIOL CHEM, V281, P39741, DOI 10.1074/jbc.R600033200; Zacco A, 2003, J NEUROSCI, V23, P11104; Zhang B, 2002, CANCER RES, V62, P450; Zhou Y, 2008, FASEB J, V22, P47, DOI 10.1096/fj.07-8175com; Zuckerbraun BS, 2005, J SURG RES, V124, P256, DOI 10.1016/j.jss.2004.10.022	163	36	36	2	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2012	46	1			SI		64	77		10.1007/s12035-012-8253-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007FE	WOS:000308873400008	22418893	Green Accepted			2022-02-06	
J	Pearson, WS; Sugerman, DE; McGuire, LC; Coronado, VG				Pearson, William S.; Sugerman, David E.; McGuire, Lisa C.; Coronado, Victor G.			Emergency Department Visits for Traumatic Brain Injury in Older Adults in the United States: 2006-08	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article								Introduction: Traumatic brain injury (TBI) can be complicated among older adults due to age-related frailty, a greater prevalence of chronic conditions and the use of anticoagulants. We conducted this study using the latest available, nationally-representative emergency department (ED)data to characterize visits for TBI among older adults. Methods: We used the 2006-2008 National Hospital Ambulatory Medical Care - Emergency Department (NHAMCS-ED) data to examine ED visits for TBI among older adults. Population-level estimates of triage immediacy, receipt of a head computed tomography (CT) and/or head magnetic resonance imaging (MRI), and hospital admission by type were used to characterize 1,561 sample visits, stratified by age <65 and >= 65 years of age. Results: Of ED visits made by persons >= 65 years of age, 29.1% required attention from a physician within 15 minutes of arrival; 82.1% required a head CT, and 20.9% required hospitalization. Persons >= 65 years of age were 3 times more likely to receive a head CT or MRI compared to younger patients presenting with TBI (adjusted odds ratio [aOR] 3.2; 95% confidence interval [CI], 1.8-5.8), and were 4 times more likely to be admitted to an intensive care unit, step-down unit, or surgery (aOR 4.1; 95% CI 2.1-8.0) compared to younger patients presenting with TBI, while controlling for sex and race. Conclusion: Results demonstrate increased emergent service delivery for older persons presenting with TBI. As the United States population ages and continues to grow, TBI will become an even more important public health issue that will place a greater demand on the healthcare system.	[Pearson, William S.; Sugerman, David E.; McGuire, Lisa C.; Coronado, Victor G.] Natl Ctr Injury Prevent & Control, Ctr Dis Control & Prevent, Div Injury Response, Atlanta, GA USA		Pearson, WS (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,NE,Mailstop D-28, Atlanta, GA 30333 USA.	Wpearson@cdc.gov					Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dossett LA, 2011, ARCH SURG; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010	21	36	36	0	1	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	AUG	2012	13	3					289	293		10.5811/westjem.2012.3.11559			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V9W7U	WOS:000422594900013	22928058	Green Published, gold			2022-02-06	
J	Rau, TF; Kothiwal, AS; Rova, AR; Brooks, DM; Poulsen, DJ				Rau, Thomas F.; Kothiwal, Aakriti S.; Rova, Annela R.; Brooks, Diane M.; Poulsen, David J.			Treatment with low-dose methamphetamine improves behavioral and cognitive function after severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	Advanced Technology Applications for Combat Casualty Care Conference (ATACCC)	AUG 15-18, 2011	Fort Lauderdale, FL			Traumatic brain injury; neuroprotection; methamphetamine	SURVIVAL PATHWAY; CELL-DEATH; AKT; RECEPTOR; RATS	BACKGROUND: Methamphetamine increases the release and blocks the reuptake of dopamine. The moderate activation of dopamine receptors may elicit neuroprotective effects. We have recently demonstrated that low doses of methamphetamine reduce neuronal loss after ischemic injury. On the basis of this finding, we hypothesized that methamphetamine could also prevent neuronal loss and improve functional behavior after severe traumatic brain injury (TBI). METHODS: The rat lateral fluid percussion injury model was used to generate severe TBI. Three hours after injury, animals were treated with saline or methamphetamine. Neurological severity scores and foot fault assessments were used to determine whether treatment enhanced recovery after injury. The potential for methamphetamine treatment to improve cognitive function was assessed using the Morris water maze. Forty-eight hours after injury, paraffin-embedded brain sections were TUNEL stained to measure apoptotic cell death. Sections were also stained with antibody to doublecortin to quantify immature neurons within the dentate gyrus. RESULTS: Treatment with low-dose methamphetamine significantly reduced both behavioral and cognitive dysfunction after severe TBI. Methamphetamine-treated animals scored significantly lower on neurological severity scores and had significantly less foot faults after TBI compared with saline-treated control rats. Furthermore, methamphetamine treatment restored learning and memory function to near normal ability after TBI. At 48 hours after injury, apoptotic cell death within the hippocampus was significantly reduced, and the presence of immature neurons was significantly increased in methamphetamine-treated rats compared with saline-treated controls. CONCLUSION: Treatment with low-dose methamphetamine after severe TBI elicits a robust neuroprotective response resulting in significant improvements in behavioral and cognitive functions. (J Trauma Acute Care Surg. 2012; 73: S165-S172. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Rau, Thomas F.; Kothiwal, Aakriti S.; Rova, Annela R.; Brooks, Diane M.; Poulsen, David J.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA		Poulsen, DJ (corresponding author), Univ Montana, Dept Biomed & Pharmaceut Sci, 32 Campus Dr, Missoula, MT 59812 USA.	david.poulsen@umontana.edu					Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Brown JM, 2005, J NEUROCHEM, V95, P429, DOI 10.1111/j.1471-4159.2005.03379.x; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Doll H, 2009, J NEUROTRAUM, V26, P235, DOI 10.1089/neu.2008.0741; Kihara T, 2002, J NEUROSCI RES, V70, P274, DOI 10.1002/jnr.10426; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Rau TF, 2011, NEUROPHARMACOLOGY, V61, P677, DOI 10.1016/j.neuropharm.2011.05.010; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; Wang LL, 2005, MOL PHARMACOL, V67, P489, DOI 10.1124/mol.104.005595; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Writer BW, 2009, J NEUROPSYCH CLIN N, V21, P362, DOI 10.1176/appi.neuropsych.21.4.362; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zou SW, 2005, J NEUROSCI, V25, P4385, DOI 10.1523/JNEUROSCI.5099-04.2005	23	36	36	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2012	73			1			S165	S172		10.1097/TA.0b013e318260896a			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	992VP	WOS:000307808500028	22847088				2022-02-06	
J	Thompson, HJ; Weir, S; Rivara, FP; Wang, J; Sullivan, SD; Salkever, D; MacKenzie, EJ				Thompson, Hilaire J.; Weir, Sharada; Rivara, Frederick P.; Wang, Jin; Sullivan, Sean D.; Salkever, David; MacKenzie, Ellen J.			Utilization and Costs of Health Care after Geriatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						head injury; health services; informal care outcome	OLDER-ADULTS; OUTCOMES; MORTALITY; SEVERITY; DISORDER; PATIENT; RISK	Despite the growing number of older adults experiencing traumatic brain injury (TBI), little information exists regarding their utilization and cost of health care services. Identifying patterns in the type of care received and determining their costs is an important first step toward understanding the return on investment and potential areas for improvement. We performed a health care utilization and cost analysis using the National Study on the Costs and Outcomes of Trauma (NSCOT) dataset. Subjects were persons 55-84 years of age with TBI treated in 69 U. S. hospitals located in 14 states (n = 414, weighted n = 1038). Health outcomes, health care utilization, and 1-year costs of care following TBI in 2005 U. S. dollars were estimated from hospital bills, patient surveys, medical records, and Medicare claims data. The subjects were further analyzed in three subgroups (55-64, 65-74, and 75-84 years of age). Unadjusted cost models were built, followed by a second set of models adjusting for demographic and pre-injury health status. Those in the oldest category (75-84 years) had significantly higher numbers of re-hospitalizations, home health care visits, and hours per week of unpaid care, and significantly lower numbers of physician and mental health professional visits than younger age groups (age 55-64 and 65-74 years). Significant age-related differences were seen in all health outcomes tested at 12 months post-injury except for incidence of depressive symptoms. One-year total treatment costs did not differ significantly across age categories for brain-injured older adults in either the unadjusted or adjusted models. The unadjusted total mean 1-year cost of care was $77,872 in persons aged 55-64 years, $76,903 in persons aged 65-74 years, and $72,733 in persons aged 75-84 years. There were significant differences in cost drivers among the age groups. In the unadjusted model index hospitalization costs and inpatient rehabilitation costs were significantly lower in the oldest age category, while outpatient care costs and nursing home stays were lower in the younger age categories. In the adjusted model, in addition to these cost drivers, re-hospitalization costs were significantly higher among those 75-84 years of age, and receipt of informal care from friends and family was significantly different, being lowest among those aged 65-74 years, and highest among those aged 75-84 years. Identifying variations in care that these patients are receiving and determining the costs versus benefits is an important next step in understanding potential areas for improvement.	[Thompson, Hilaire J.; Rivara, Frederick P.; Wang, Jin] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Weir, Sharada] Univ Massachusetts, Ctr Hlth Policy & Res, Shrewsbury, MA USA; [Sullivan, Sean D.] Univ Washington, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Salkever, David] Univ Maryland Baltimore Cty, Dept Publ Policy, Baltimore, MD 21228 USA; [MacKenzie, Ellen J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA		Thompson, HJ (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Box 357266, Seattle, WA 98195 USA.	hilairet@uw.edu			National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CCR316840]; National Center for Research Resources, a component of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025015]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025015] Funding Source: NIH RePORTER	This work was supported in part by grant number R49/CCR316840 from the National Center for Injury Prevention and Control, and grant number KL2RR025015 from the National Center for Research Resources, a component of the National Institutes of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the granting agencies.	Aitken LM, 2010, J AM GERIATR SOC, V58, P442, DOI 10.1111/j.1532-5415.2010.02728.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Blough DK., 2000, HLTH SERV OUTCOMES R, V1, P185, DOI [10.1023/A:1012597123667, DOI 10.1023/A:1012597123667]; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Carter MW, 2011, J AM GERIATR SOC, V59, P406, DOI 10.1111/j.1532-5415.2010.03283.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Eaton W. W., 2004, USE PSYCHOL TESTING, P363; Faul M, 2010, TRAUMATIC BRAIN INJU; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Jacoby SF, 2006, J NURS SCHOLARSHIP, V38, P133, DOI 10.1111/j.1547-5069.2006.00090.x; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McKevitt EC, 2003, CAN J SURG, V46, P211; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Mullins RJ, 1998, JAMA-J AM MED ASSOC, V279, P1727, DOI 10.1001/jama.279.21.1727; Newell MA, 2009, J TRAUMA, V67, P337, DOI 10.1097/TA.0b013e3181add08b; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; Rochette LM, 2009, J SAFETY RES, V40, P353, DOI 10.1016/j.jsr.2009.08.003; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2010, ANN SURG, V252, P370, DOI 10.1097/SLA.0b013e3181df03d6; Weir S, 2010, EXPERT REV PHARM OUT, V10, P187, DOI [10.1586/erp.10.8, 10.1586/ERP.10.8]; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8	32	36	36	1	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	10					1864	1871		10.1089/neu.2011.2284			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	971YV	WOS:000306244400390	22435729	Green Published			2022-02-06	
J	Verrier, JD; Jackson, TC; Bansal, R; Kochanek, PM; Puccio, AM; Okonkwo, DO; Jackson, EK				Verrier, Jonathan D.; Jackson, Travis C.; Bansal, Rashmi; Kochanek, Patrick M.; Puccio, Ava M.; Okonkwo, David O.; Jackson, Edwin K.			The brain in vivo expresses the 2 ',3 '-cAMP-adenosine pathway	JOURNAL OF NEUROCHEMISTRY			English	Article						2'; 3'-cAMP; 3'; 5'-cAMP; adenosine; AMPs; brain	EXTRACELLULAR ADENOSINE ACCUMULATION; MYELIN-ASSOCIATED ENZYME; SMOOTH-MUSCLE-CELL; CEREBRAL-CORTEX; CYCLIC-AMP; DISRUPTION; ASTROCYTES; INJURY	J. Neurochem. (2012) 122, 115125. Abstract Although multiple biochemical pathways produce adenosine, studies suggest that the 2',3'-cAMP-adenosine pathway (2',3'-cAMP?2'-AMP/3'-AMP?adenosine) contributes to adenosine production in some cells/tissues/organs. To determine whether the 2',3'-cAMP-adenosine pathway exists in vivo in the brain, we delivered to the brain (gray matter and white matter separately) via the inflow perfusate of a microdialysis probe either 2',3'-cAMP, 3',5'-cAMP, 2'-AMP, 3'-AMP, or 5'-AMP and measured the recovered metabolites in the microdialysis outflow perfusate with mass spectrometry. In both gray and white matter, 2',3'-cAMP increased 2'-AMP, 3'-AMP and adenosine, and 3',5'-cAMP increased 5'-AMP and adenosine. In both brain regions, 2'-AMP, 3-AMP and 5'-AMP were converted to adenosine. Microdialysis experiments in 2',3'-cyclic nucleotide-3'-phosphodiesterase (CNPase) wild-type mice demonstrated that traumatic brain injury (controlled cortical impact model) activated the brain 2',3'-cAMP-adenosine pathway; similar experiments in CNPase knockout mice indicated that CNPase was involved in the metabolism of endogenous 2',3'-cAMP to 2'-AMP and to adenosine. In CSF from traumatic brain injury patients, 2',3'-cAMP was significantly increased in the initial 12 h after injury and strongly correlated with CSF levels of 2'-AMP, 3'-AMP, adenosine and inosine. We conclude that in vivo, 2',3'-cAMP is converted to 2'-AMP/3'-AMP, and these AMPs are metabolized to adenosine. This pathway exists endogenously in both mice and humans.	[Verrier, Jonathan D.; Jackson, Edwin K.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15219 USA; [Jackson, Travis C.; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Sch Med, Pittsburgh, PA 15219 USA; [Jackson, Travis C.; Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Sch Med, Pittsburgh, PA 15219 USA; [Bansal, Rashmi] Univ Connecticut, Sch Med, Dept Neurosci, New Haven, CT USA; [Puccio, Ava M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Sch Med, Pittsburgh, PA 15219 USA		Jackson, EK (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, 100 Technol Dr,Room 514, Pittsburgh, PA 15219 USA.	edj@pitt.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Jackson, Edwin/0000-0002-8101-6009	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS070003, DK068575, DK079307, NS38087, NS30318, NS38878, NS41078]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK068575, P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, R21NS070003, R01NS041078, R37NS038878, P20NS030318, R01NS038087, P01NS030318, R01NS038878] Funding Source: NIH RePORTER	This work was supported by NIH grants NS070003 (PMK/EKJ), DK068575 (EKJ), DK079307 (EKJ), NS38087 (PMK), NS30318 (PMK, DOO), NS38878 (RB) and NS41078 (RB). No author had a conflict of interest.	Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009; BANIK NL, 1979, ANN NEUROL, V5, P539, DOI 10.1002/ana.410050608; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care AANS/CNS, 2007, J NEUROTRAUMA S, V24, pS1, DOI DOI 10.1089/NEU.2007.9976; Brundege JM, 1997, NEUROPHARMACOLOGY, V36, P1201, DOI 10.1016/S0028-3908(97)00102-0; Dare E, 2007, PHYSIOL BEHAV, V92, P15, DOI 10.1016/j.physbeh.2007.05.031; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Jackson EK, 2011, AM J PHYSIOL-RENAL, V301, pF565, DOI 10.1152/ajprenal.00094.2011; Jackson EK, 2011, AM J PHYSIOL-HEART C, V301, pH391, DOI 10.1152/ajpheart.00336.2011; Jackson EK, 2011, J PHARMACOL EXP THER, V337, P444, DOI 10.1124/jpet.110.178137; Jackson EK, 2010, HYPERTENSION, V56, P151, DOI 10.1161/HYPERTENSIONAHA.110.152454; Jackson EK, 2009, J BIOL CHEM, V284, P33097, DOI 10.1074/jbc.M109.053876; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lauro C, 2008, J IMMUNOL, V180, P7590, DOI 10.4049/jimmunol.180.11.7590; Rao F, 2010, BIOCHEM BIOPH RES CO, V398, P500, DOI 10.1016/j.bbrc.2010.06.107; Ren J, 2009, J PHARMACOL EXP THER, V328, P855, DOI 10.1124/jpet.108.146712; Rosenberg PA, 1996, NEUROSCI LETT, V211, P49, DOI 10.1016/0304-3940(96)12718-X; ROSENBERG PA, 1989, J NEUROSCI, V9, P2654; ROSENBERG PA, 1994, J NEUROSCI, V14, P2953; ROSENBERG PA, 1995, BRAIN RES, V692, P227, DOI 10.1016/0006-8993(95)00668-G; Schmidt S, 1999, MULT SCLER J, V5, P147, DOI 10.1177/135245859900500303; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Stone Trevor W, 2009, Handb Exp Pharmacol, P535, DOI 10.1007/978-3-540-89615-9_17; SUDA H, 1984, NEUROCHEM PATHOL, V2, P85, DOI 10.1007/BF02834248; THOMPSON JE, 1994, BIOCHEMISTRY-US, V33, P7408, DOI 10.1021/bi00189a047; THOMPSON RJ, 1992, BIOCHEM SOC T, V20, P621, DOI 10.1042/bst0200621; Verrier JD, 2011, J NEUROCHEM, V118, P979, DOI 10.1111/j.1471-4159.2011.07392.x; VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x	29	36	36	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUL	2012	122	1					115	125		10.1111/j.1471-4159.2012.07705.x			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	956BG	WOS:000305064100012	22360621	Green Accepted			2022-02-06	
J	Ravin, R; Blank, PS; Steinkamp, A; Rappaport, SM; Ravin, N; Bezrukov, L; Guerrero-Cazares, H; Quinones-Hinojosa, A; Bezrukov, SM; Zimmerberg, J				Ravin, Rea; Blank, Paul S.; Steinkamp, Alex; Rappaport, Shay M.; Ravin, Nitay; Bezrukov, Ludmila; Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo; Bezrukov, Sergey M.; Zimmerberg, Joshua			Shear Forces during Blast, Not Abrupt Changes in Pressure Alone, Generate Calcium Activity in Human Brain Cells	PLOS ONE			English	Article							IN-VITRO; INJURY; MODEL; MECHANISMS; WAVE; RESPONSES	Blast-Induced Traumatic Brain Injury (bTBI) describes a spectrum of injuries caused by an explosive force that results in changes in brain function. The mechanism responsible for primary bTBI following a blast shockwave remains unknown. We have developed a pneumatic device that delivers shockwaves, similar to those known to induce bTBI, within a chamber optimal for fluorescence microscopy. Abrupt changes in pressure can be created with and without the presence of shear forces at the surface of cells. In primary cultures of human central nervous system cells, the cellular calcium response to shockwaves alone was negligible. Even when the applied pressure reached 15 atm, there was no damage or excitation, unless concomitant shear forces, peaking between 0.3 to 0.7 Pa, were present at the cell surface. The probability of cellular injury in response to a shockwave was low and cell survival was unaffected 20 hours after shockwave exposure.	[Ravin, Rea; Blank, Paul S.; Steinkamp, Alex; Rappaport, Shay M.; Ravin, Nitay; Bezrukov, Ludmila; Bezrukov, Sergey M.; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA; [Blank, Paul S.; Rappaport, Shay M.; Bezrukov, Sergey M.; Zimmerberg, Joshua] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Guerrero-Cazares, Hugo; Quinones-Hinojosa, Alfredo] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA		Ravin, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA.	zimmerbj@mail.nih.gov	Blank, Paul/Q-9673-2019	Guerrero-Cazares, Hugo/0000-0003-1307-719X	Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM); Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [ZIAHD000072, ZIAHD001409] Funding Source: NIH RePORTER	Support for this work included funding from Department of Defense in the Center for Neuroscience and Regenerative Medicine (CNRM) and the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BOWEN IG, 1968, ANN NY ACAD SCI, V152, P122, DOI 10.1111/j.1749-6632.1968.tb11971.x; BRODE HL, 1959, PHYS FLUIDS, V2, P217, DOI 10.1063/1.1705911; Center DaVBI, 2011, DEP DEF NUMB TRAUM B; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; LaPlaca Michelle C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2384; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Prado GR, 2005, J NEURAL ENG, V2, P148, DOI 10.1088/1741-2560/2/4/011; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Shin HS, 2009, J NANOSCI NANOTECHNO, V9, P7330, DOI 10.1166/jnn.2009.1769; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; WHITTAKER VP, 1993, J NEUROCYTOL, V22, P735, DOI 10.1007/BF01181319; Zhang JY, 2009, STAPP CAR CRASH JO, V53, P215	27	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2012	7	6							e39421	10.1371/journal.pone.0039421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	967FO	WOS:000305892100049	22768078	Green Published, gold			2022-02-06	
J	Rasouli, J; Lekhraj, R; White, NM; Flamm, ES; Pilla, AA; Strauch, B; Casper, D				Rasouli, Jonathan; Lekhraj, Rukmani; White, Nicholas M.; Flamm, Eugene S.; Pilla, Arthur A.; Strauch, Berish; Casper, Diana			Attenuation of interleukin-1beta by pulsed electromagnetic fields after traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Pulsed electromagnetic fields; PEMF; Inflammation; Interleukin-1beta; IL-1 beta; Traumatic brain injury; TBI	HEAD-INJURY; ADENOSINE RECEPTORS; CEREBROSPINAL-FLUID; NITRIC-OXIDE; INFLAMMATION; PATHOPHYSIOLOGY; EXPRESSION; INDUCTION; CYTOKINES; DAMAGE	Traumatic Brain Injury (TBI) is a major cause of morbidity and mortality in civilian and military populations. Interleukin-1beta (IL-1 beta) is a pro-inflammatory cytokine with a key role in the inflammatory response following TBI and studies indicate that attenuation of this cytokine improves behavioral outcomes. Pulsed electromagnetic fields (PEMF) can reduce inflammation after soft tissue injuries in animals and humans. Therefore, we explored whether PEMF signals could alter the course of IL-1 beta production in rats subjected to closed-head contusive weight-drop injuries (Marmarou method) and penetrating needle-stick brain injuries. Protein levels, measured by the Biorad assay, were not altered by injuries or PEMF treatment. In addition, we verified that IL-1 beta levels in cerebrospinal fluid (CSF) were proportional to injury severity in the contusion model. Results demonstrate that PEMF treatment attenuated IL-1 beta levels up to 10-fold in CSF within 6 h after contusive injury and also significantly suppressed IL-1 beta within 17-24h after penetrating injury. In contrast, no differences in IL-1 beta were seen between PEMF-treated and control groups in brain homogenates. To the authors' knowledge, this is the first report of the use of PEMF to modulate an inflammatory cytokine after TBI. These results warrant further studies to assess the effects of PEMF on other inflammatory markers and functional outcomes. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Casper, Diana] Montefiore Med Ctr, Neurosurg Lab, Bronx, NY 10467 USA; [Rasouli, Jonathan; Lekhraj, Rukmani; White, Nicholas M.; Flamm, Eugene S.; Casper, Diana] Albert Einstein Coll Med, Dept Neurosurg, Bronx, NY 10467 USA; [Pilla, Arthur A.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Strauch, Berish] Albert Einstein Coll Med, Dept Plast & Reconstruct Surg, Bronx, NY 10467 USA		Casper, D (corresponding author), Montefiore Med Ctr, Neurosurg Lab, Moses 3,111 E 210th St, Bronx, NY 10467 USA.	diana.casper@einstein.yu.edu	Rasouli, Jonathan/AAF-2742-2020	Rasouli, Jonathan/0000-0002-5085-8422	Ivivi Health Sciences; Ivivi Health Sciences, LLB, San Francisco	A.A.P. receives compensation as a scientific consultant to Ivivi Health Sciences. A.A.P., D.C. and B.S. may receive a small royalty from Ivivi Health Sciences if a recent TBI patent disclosure issues and Ivivi is able to commercialize a TBI product.; The authors would like to thank Don Pang, Valerie Lartchenko, Shahla Powell, and Lily Rasouli for excellent technical assistance and Parviz Lalezari for valuable discussions about this work. This study was funded in part by Ivivi Health Sciences, LLB, San Francisco.	BLACK RA, 1988, J BIOL CHEM, V263, P9437; Brydon L, 2005, BRAIN BEHAV IMMUN, V19, P540, DOI 10.1016/j.bbi.2004.12.003; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Edwards P, 2005, LANCET, V365, P1957; EPUAP 2002 European Pressure Ulcer Advisory Panel, 2002, DECUBITUS, V4, P49; Faul M, 2010, TRAUMATIC BRAIN INJU; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GOSSLING HR, 1992, ORTHOPEDICS, V15, P711; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Itoh M, 1991, DECUBITUS, V4, P29; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kim YM, 1998, J IMMUNOL, V161, P4122; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McColl BW, 2008, J NEUROSCI, V28, P9451, DOI 10.1523/JNEUROSCI.2674-08.2008; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Nirogi R, 2009, J NEUROSCI METH, V178, P116, DOI 10.1016/j.jneumeth.2008.12.001; PENNINGTON GM, 1993, MIL MED, V158, P101, DOI 10.1093/milmed/158.2.101; Pilla A, 2011, BBA-GEN SUBJECTS, V1810, P1236, DOI 10.1016/j.bbagen.2011.10.001; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Rohde C, 2010, PLAST RECONSTR SURG, V125, P1620, DOI 10.1097/PRS.0b013e3181c9f6d3; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Varani K, 2002, BRIT J PHARMACOL, V136, P57, DOI 10.1038/sj.bjp.0704695; Varani K, 2012, BIOELECTROMAGNETICS, V33, P279, DOI 10.1002/bem.20704; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	36	36	38	1	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 21	2012	519	1					4	8		10.1016/j.neulet.2012.03.089			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	965MX	WOS:000305773000002	22503903				2022-02-06	
J	LeBlanc, LA; Heinicke, MR; Baker, JC				LeBlanc, Linda A.; Heinicke, Megan R.; Baker, Jonathan C.			Expanding the Consumer Base for Behavior-Analytic Services: Meeting the Needs of Consumers in the 21st Century	BEHAVIOR ANALYSIS IN PRACTICE			English	Article						aging; behavior analysis; brain injury; consumers; dementia; funding; practitioner; retraining		A growing workforce of behavior analysts provides services to individuals with autism and intellectual disabilities as legislative initiatives have spurred a growth of funding options to support these services. Though many opportunities currently exist for serving individuals with autism, the growing demand for these services may wane or, at some point, the growth in service providers will meet that demand. Other consumer groups could benefit from behavior analytic services, but typically have limited access to qualified providers. Individuals with dementia and traumatic brain injury are used as example consumer groups to illustrate the necessary tasks for a behavior analyst to expand their scope of practice to a new population. This paper provides strategies for developing competence and creating employment opportunities with new consumer groups.	[LeBlanc, Linda A.] Trumpet Behav Hlth, Pear Land, TX USA; [Heinicke, Megan R.] Auburn Univ, Auburn, AL 36849 USA; [Baker, Jonathan C.] Southern Illinois Univ, Carbondale, IL USA		LeBlanc, LA (corresponding author), Trumpet Behav Hlth, Pear Land, TX USA.	lleblanc@tbh.com	Heinicke, Megan/AAI-6250-2020				Adkins V. K., 1999, J CLIN GEROPSYCHOLOG, V5, P39; Allen R., 2011, S 37 ANN CONV ASS BE; Austin J, 2000, HDB APPL BEHAV ANAL; BAER DM, 1968, J APPL BEHAV ANAL, V1, P91, DOI 10.1901/jaba.1968.1-91; Bailey J. S., 2010, 25 ESSENTIAL SKILLS; Baker J. C., 2010, BEHAV GERONTOLOGY SE; Baker J. C., 2011, S 37 ANN ASS BEH AN; Baker JC, 2011, BEHAV THER, V42, P30, DOI 10.1016/j.beth.2010.04.005; Baker JC, 2011, BEHAV THER, V42, P135, DOI 10.1016/j.beth.2010.02.006; Baker JC, 2006, J APPL BEHAV ANAL, V39, P469, DOI 10.1901/jaba.2006.80-05; BOURGEOIS MS, 1990, J APPL BEHAV ANAL, V23, P29, DOI 10.1901/jaba.1990.23-29; Bourgeois MS, 1996, BEHAV INTERVENT, V11, P3; Buchanan JA, 2002, J APPL BEHAV ANAL, V35, P99, DOI 10.1901/jaba.2002.35-99; Burgio LD, 2001, GERONTOLOGIST, V41, P449, DOI 10.1093/geront/41.4.449; Carr J. E., 2011, 29 ANN W REG C CAL A; Carr JE, 2010, BEHAV ANAL PRACT, V3, P13; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Conyers C, 2002, J APPL BEHAV ANAL, V35, P49, DOI 10.1901/jaba.2002.35-49; COWLEY BJ, 1992, J APPL BEHAV ANAL, V25, P461, DOI 10.1901/jaba.1992.25-461; Dolezal DN, 2010, J APPL BEHAV ANAL, V43, P309, DOI 10.1901/jaba.2010.43-309; Dwyer-Moore KJ, 2007, J APPL BEHAV ANAL, V40, P679, DOI 10.1901/jaba.2007.679-683; Eldevik S, 2009, J CLIN CHILD ADOLESC, V38, P439, DOI 10.1080/15374410902851739; Fisher WW., 2011, HDB APPL BEHAV ANAL; Friman P. C., 2010, INSIDE BEHAV ANAL, V2, P6; Friman PC, 2010, BEHAV ANALYST, V33, P19, DOI 10.1007/BF03392201; Fyffe CE, 2004, J APPL BEHAV ANAL, V37, P401, DOI 10.1901/jaba.2004.37-401; Higbee TS, 1999, RES DEV DISABIL, V20, P63, DOI 10.1016/S0891-4222(98)00032-8; Horner RH, 2005, EXCEPT CHILDREN, V71, P165, DOI 10.1177/001440290507100203; Houlihan D, 2011, BEHAV THER, V42, P1, DOI 10.1016/j.beth.2010.08.001; Johnston J., 2009, APBA 2009 PROFESSION; Kazdin A.E., 2003, RES DESIGN CLIN PSYC; Kirk R. E., 1999, STAT INTRO, V4th; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lash M., 2007, ESSENTIAL BRAIN INJU; LeBlanc L. A., 2011, HDB APPL BEHAV ANAL, P472; LeBlanc LA, 2010, BEHAV MODIF, V34, P443, DOI 10.1177/0145445510383528; LeBlanc Linda A, 2006, Am J Alzheimers Dis Other Demen, V21, P318, DOI 10.1177/1533317506292183; LeBlanc LA, 2008, BEHAV INTERVENT, V23, P213, DOI 10.1002/bin.266; Malott M. E., 2010, INSIDE BEHAV ANAL, V2, P6; Martella R. C., 1999, RES METHODS; McCurry SM, 2011, TREATING DEMENTIA CO; Mozzoni M. P., 2000, BEHAV INTERVENTIONS, V15; Mozzoni M. P, 2008, BRAIN INJURY PROFESS, V5, P29; Mozzoni MP, 2005, BEHAV INTERVENT, V20, P1, DOI 10.1002/bin.186; Olshansky SJ, 2009, MILBANK Q, V87, P842, DOI 10.1111/j.1468-0009.2009.00581.x; Pace G, 2011, 1 ANN ASS PROF BEH A; Reichow B, 2009, J AUTISM DEV DISORD, V39, P23, DOI 10.1007/s10803-008-0596-0; REID DH, 1991, J APPL BEHAV ANAL, V24, P437, DOI 10.1901/jaba.1991.24-437; Sidman M, 1994, EQUIVALENCE RELATION, P266; Silverman K, 2008, J APPL BEHAV ANAL, V41, P471, DOI 10.1901/jaba.2008.41-471; Slifer KJ, 2009, DEV DISABIL RES REV, V15, P144, DOI 10.1002/ddrr.60; Stewart I, 2010, BRAIN INJURY, V24, P1616, DOI 10.3109/02699052.2010.523050; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Trahan MA, 2011, J APPL BEHAV ANAL, V44, P687, DOI 10.1901/jaba.2011.44-687; Travis R, 2010, J APPL BEHAV ANAL, V43, P745, DOI 10.1901/jaba.2010.43-745; U. S. Census Bureau, 2010, NCEST200902 US CENS; UPDATE: Board of psychologists withdraws autism rule change, 2011, WSAZ NEWS CHANN 0928	57	36	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1998-1929	2196-8934		BEHAV ANAL PRACT	Behav. Anal. Pract.	JUN	2012	5	1					4	14					11	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VC4EO	WOS:000433739000002	23326626				2022-02-06	
J	Magnoni, S; Tedesco, C; Carbonara, M; Pluderi, M; Colombo, A; Stocchetti, N				Magnoni, Sandra; Tedesco, Cecilia; Carbonara, Marco; Pluderi, Mauro; Colombo, Angelo; Stocchetti, Nino			Relationship between systemic glucose and cerebral glucose is preserved in patients with severe traumatic brain injury, but glucose delivery to the brain may become limited when oxidative metabolism is impaired: Implications for glycemic control	CRITICAL CARE MEDICINE			English	Article						brain injury; brain ischemia; glucose; glucose transport; microdialysis; neurochemistry	SUBCUTANEOUS ADIPOSE-TISSUE; LACTATE/PYRUVATE RATIO; COMBINED MICRODIALYSIS; SUBSTRATE DELIVERY; ENERGY-METABOLISM; HEAD-INJURY; BLOOD-FLOW; ISCHEMIA; TRANSPORT; LACTATE	Objective: To clarify the dynamics of glucose delivery to the brain and the effects of changes in blood glucose after severe traumatic brain injury. Design: Retrospective analysis of a prospective observational cohort study. Setting: Neurosurgical intensive care unit of a university hospital. Patients: Seventeen patients with acute traumatic brain injury monitored with cerebral and subcutaneous microdialysis. Interventions: None. Measurements and Main Results: For continuous, accurate systemic monitoring, glucose was measured in the interstitial space of subcutaneous adipose tissue using microdialysis, and 39 specific episodes of spontaneous rises in glucose were identified. During these episodes, there was a significant positive linear relationship between systemic glucose levels and brain glucose concentrations measured by microdialysis (p < .0001). The basal lactate/pyruvate ratio, with a threshold of 25, was adopted to distinguish between disturbed and presumably preserved cerebral oxidative metabolism. Using normal vs. elevated lactate/pyruvate ratio as variable factor, the relationship between brain and systemic glucose during the episodes could be described by two significantly distinct parallel lines (p = .0001), which indicates a strong additive effect of subcutaneous glucose and lactate/pyruvate ratio in determining brain glucose. The line describing the relationship under disturbed metabolic conditions was lower than in presumably intact metabolic conditions, with a significant difference of 0.648 +/- 0.192 mM (p = .002). This let us to accurately predict that in this situation systemic glucose concentrations in the lower range of normality would result in critical brain glucose levels. Conclusions: The linear relationship between systemic and brain glucose in healthy subjects is preserved in traumatic brain-injured patients. As a consequence, in brain tissue where oxidative metabolism is disturbed, brain glucose concentrations might possibly drop below the critical threshold of 0.8 mM to 1.0 mM when there is a reduction in systemic glucose toward the lower limits of the "normal" range. (Crit Care Med 2012; 40:1785-1791)	[Magnoni, Sandra; Tedesco, Cecilia; Carbonara, Marco; Colombo, Angelo; Stocchetti, Nino] Univ Milan, Dept Anesthesia & Intens Care, Milan, Italy; [Pluderi, Mauro] Univ Milan, Dept Neurosurg, Milan, Italy; [Stocchetti, Nino] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy		Magnoni, S (corresponding author), Univ Milan, Dept Anesthesia & Intens Care, Milan, Italy.	smagnoni@policlinico.mi.it	Carbonara, Marco/N-3793-2015; Stocchetti, Nino/O-7444-2017; Magnoni, Sandra/AAC-7479-2022	Carbonara, Marco/0000-0002-1431-8322; Stocchetti, Nino/0000-0003-3250-6834; Magnoni, Sandra/0000-0002-1723-0844; Pluderi, Mauro/0000-0002-2981-9277	Fondazione IRCCS Ca Granda-Ospedale Maggiore Policlinico, Milan, Italy	Supported, in part, by the departmental fund of the Fondazione IRCCS Ca Granda-Ospedale Maggiore Policlinico, Milan, Italy.	Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOLINDER J, 1993, LANCET, V342, P1080, DOI 10.1016/0140-6736(93)92063-Y; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Choi IY, 2001, J CEREBR BLOOD F MET, V21, P653, DOI 10.1097/00004647-200106000-00003; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; CRONE C, 1965, J PHYSIOL-LONDON, V181, P103, DOI 10.1113/jphysiol.1965.sp007748; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gruetter R, 1998, J NEUROCHEM, V70, P397; GRUETTER R, 1992, P NATL ACAD SCI USA, V89, P1109, DOI 10.1073/pnas.89.3.1109; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Hutchinson PJA, 1999, ACT NEUR S, V75, P57; Hutchinson PJA, 2000, ACT NEUR S, V76, P431; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Lonjon M, 2001, NEUROSCI LETT, V304, P21, DOI 10.1016/S0304-3940(01)01739-6; Lourido J, 2002, SCAND J CLIN LAB INV, V62, P285, DOI 10.1080/003655102760145843; LUNDANDERSEN H, 1979, PHYSIOL REV, V59, P305, DOI 10.1152/physrev.1979.59.2.305; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nielsen JK, 2005, DIABETES, V54, P1635, DOI 10.2337/diabetes.54.6.1635; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Poca MA, 2006, J NEUROTRAUM, V23, P1510, DOI 10.1089/neu.2006.23.1510; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Schlenk F, 2008, INTENS CARE MED, V34, P1200, DOI 10.1007/s00134-008-1044-5; Sehba FA, 2006, NEUROL RES, V28, P381, DOI 10.1179/016164106X114991; Strong AJ, 2008, INTENS CARE MED, V34, P1169, DOI 10.1007/s00134-008-1045-4; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Zetterling M, 2011, J NEUROSURG, V115, P66, DOI 10.3171/2011.3.JNS10899	40	36	40	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUN	2012	40	6					1785	1791		10.1097/CCM.0b013e318246bd45			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946EZ	WOS:000304335600013	22610183				2022-02-06	
J	Pandya, NK; Behrends, D; Hosalkar, HS				Pandya, Nirav K.; Behrends, Dominque; Hosalkar, Harish S.			Open reduction of proximal humerus fractures in the adolescent population	JOURNAL OF CHILDRENS ORTHOPAEDICS			English	Article						Proximal humerus; Pediatric; Adolescent; Open reduction; Operative		Purpose Proximal humerus fractures in the pediatric population are a relatively uncommon injury, with the majority of injuries treated in a closed fashion due to the tremendous remodeling potential of the proximal humerus in the skeletally immature. Yet, in adolescent patients, open treatment is, at times, necessary due to unsatisfactory alignment following a closed reduction, loss of previously achieved closed reduction, and limited remodeling when close to skeletal maturity. The purpose of our study was to examine the open reduction of adolescent proximal humerus fractures. Methods A retrospective review of the outcomes of proximal humerus fractures in the adolescent population which were consecutively treated at our institution with open reduction was performed. Results Ten children met the inclusion criteria, with a mean age of 14.3 years (+/- 1.3) and a mean weight of 60.7 kg (+/- 14.9) at the time of injury. There were seven Salter-Harris 2 fractures and three Salter-Harris 1 fractures. The largest mean angulation was 55.0 degrees (+/- 33.9) and the largest mean displacement was 87.0 % (+/- 22.8). Intra-operatively, impediments to closed reduction within the fracture site which were found included: periosteum (90.0 %), biceps tendon (90.0 %), deltoid muscle (70.0 %), and comminuted bone (10.0 %). K-wire fixation was most commonly used (70.0 %), followed by flexible nails (20.0 %) and cannulated screws (10.0 %) for fixation. All patients achieved radiographic union at a mean of 4.0 weeks (+/- 0.7), had non-painful full shoulder range of motion and rotator cuff strength at final follow-up (mean 7.7 +/- 4.6 months), and returned to pre-injury sporting activities. Conclusions The operative treatment of proximal humerus fracture, particularly in adolescents with severe displacement/angulation having failed closed methods of treatment, is increasingly considered to be an acceptable modality of treatment. In addition to the long head of the biceps, periosteum, deltoid muscle, and bone fragments in combination can prevent fracture reduction. Surgeon preference and skill should dictate implant choice, and the risk of physeal damage utilizing these implants in this age group is low.	[Pandya, Nirav K.] Childrens Hosp & Res Ctr Oakland, Dept Pediat Orthopaed Surg, Oakland, CA 94609 USA; [Behrends, Dominque; Hosalkar, Harish S.] Rady Childrens Hosp San Diego, Dept Pediat Orthopaed Surg, 3030 Childrens Way,Suite 410, San Diego, CA 92103 USA; [Behrends, Dominque; Hosalkar, Harish S.] Univ Calif San Diego, San Diego, CA 92103 USA		Hosalkar, HS (corresponding author), Rady Childrens Hosp San Diego, Dept Pediat Orthopaed Surg, 3030 Childrens Way,Suite 410, San Diego, CA 92103 USA.	hhosalkar@rchsd.org					Bahrs C, 2009, J PEDIATR ORTHOPED, V29, P238, DOI 10.1097/BPO.0b013e31819bd9a7; BAXTER MP, 1986, J BONE JOINT SURG BR, V68, P570, DOI 10.1302/0301-620X.68B4.3733832; Beringer DC, 1998, J PEDIATR ORTHOPED, V18, P31, DOI 10.1097/00004694-199801000-00007; BURGOSFLORES J, 1993, INT ORTHOP, V17, P16; Carey TP, 2005, CAN ORTH RES SOC CAN; Dameron T.B., 1984, FRACTURES CHILDREN, P577; DAMERON TB, 1969, J BONE JOINT SURG AM, VA 51, P289, DOI 10.2106/00004623-196951020-00008; David S, 2006, CHIRURG, V77, P827, DOI 10.1007/s00104-006-1191-6; Di Gennaro Giovanni Luigi, 2008, Chir Organi Mov, V92, P89, DOI 10.1007/s12306-008-0050-7; Dobbs MB, 2003, J PEDIATR ORTHOPED, V23, P208, DOI 10.1097/00004694-200303000-00015; Fernandez FF, 2008, INJURY, V39, P1453, DOI 10.1016/j.injury.2008.04.001; KOHLER R, 1983, J PEDIATR ORTHOPED, V3, P326, DOI 10.1097/01241398-198307000-00010; LARSEN CF, 1990, ACTA ORTHOP SCAND, V61, P255, DOI 10.3109/17453679008993512; Neer C S 2nd, 1965, Clin Orthop Relat Res, V41, P24; Nilsson S, 1965, Acta Chir Scand, V130, P433; Pahlavan S, 2011, J CHILD ORTHOP, V5, P187, DOI 10.1007/s11832-011-0328-4; PETERSON CA, 1972, J TRAUM, V12, P275, DOI 10.1097/00005373-197204000-00002; PRITCHETT JW, 1988, J BONE JOINT SURG AM, V70A, P520, DOI 10.2106/00004623-198870040-00007; Rajan RA, 2008, J CHILD ORTHOP, V2, P15, DOI 10.1007/s11832-007-0070-0; ROSE SH, 1982, CLIN ORTHOP RELAT R, V168, P24; Schwendenwein E, 2004, EUR J PEDIATR SURG, V14, P51, DOI 10.1055/s-2004-815781; Shrader MW, 2007, HAND CLIN, V23, P431, DOI 10.1016/j.hcl.2007.09.002; Siebler G, 1984, Unfallchirurgie, V10, P237, DOI 10.1007/BF02585779; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; Tachdjian MO, 1990, PEDIAT ORTHOPEDICS, P3046; VISSER JD, 1980, NETH J SURG, V32, P12	26	36	39	0	0	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	1863-2521	1863-2548		J CHILD ORTHOP	J. Child. Orthop.	JUN	2012	6	2					111	118		10.1007/s11832-012-0398-y			8	Orthopedics; Pediatrics	Emerging Sources Citation Index (ESCI)	Orthopedics; Pediatrics	V28EB	WOS:000215409600003	23730341	Green Published			2022-02-06	
J	Betz, J; Zhuo, JC; Roy, A; Shanmuganathan, K; Gullapalli, RP				Betz, Joshua; Zhuo, Jiachen; Roy, Anindya; Shanmuganathan, Kathirkamanthan; Gullapalli, Rao P.			Prognostic Value of Diffusion Tensor Imaging Parameters in Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; Glasgow Coma Scale; magnetic resonance imaging; prognosis; severe traumatic brain injury	WHITE-MATTER INJURY; AXONAL INJURY; HEAD-INJURY; CORPUS-CALLOSUM; UNITED-STATES; MILD; MODERATE; ADULTS; SCALE; ABNORMALITIES	Diffusion tensor imaging (DTI) has recently emerged as a useful tool for assessing traumatic brain injury (TBI). In this study, the prognostic value of the relationship between DTI measures and the clinical status of severe TBI patients, both at the time of magnetic resonance imaging (MRI), and their discharge to acute TBI rehabilitation, was assessed. Patients (n = 59) admitted to the trauma center with severe closed head injuries were retrospectively evaluated after approval from the institution's institutional review board, to determine the prognostic value of DTI measures. The relationship of DTI measures, including apparent diffusion coefficient (ADC), fractional anisotropy (FA), axial (lambda(parallel to)) and radial diffusivity (lambda(perpendicular to)) from the whole brain white matter, internal capsule, genu, splenium, and body of the corpus callosum, were compared with neurological status at MRI and at discharge to acute TBI rehabilitation. Whole brain white matter averages of ADC, lambda(parallel to), and lambda(perpendicular to), and their coefficient of variation (CV) were significantly correlated with the Glasgow Coma Scale (GCS) score on the day of MRI. The average lambda(parallel to) was significantly correlated with GCS scores on the day of MRI in all measured brain regions. Outcomes were associated with whole brain white matter averages of ADC and lambda(parallel to), and the CVs of FA, ADC, lambda(parallel to), and lambda(perpendicular to); and the averages and CVs of FA and lambda(parallel to) in all corpus callosum regions. The inclusion of regional and global DTI measures improved the accuracy of prognostic models, when adjusted for admission GCS score and age (p < 0.05). Whole brain white matter and regional DTI measures are sensitive markers of TBI, and correlate with neurological status both at MRI and discharge to rehabilitation. The addition of DTI measures adjusted for age, gender, and admission GCS score significantly improved prognostic models.	[Betz, Joshua; Zhuo, Jiachen; Shanmuganathan, Kathirkamanthan; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Betz, Joshua; Zhuo, Jiachen; Gullapalli, Rao P.] Univ Maryland, Sch Med, Magnet Resonance Res Ctr, Baltimore, MD 21201 USA; [Betz, Joshua; Roy, Anindya] Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD 21228 USA		Gullapalli, RP (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 S Greene St, Baltimore, MD 21201 USA.	rgullapalli@umm.edu	See, Kye Yak/A-5118-2011	Betz, Joshua/0000-0003-4488-9799	U.S. Army [W81XWH-08-1-0725]	The authors thank Brigitte Pocta for reviewing the manuscript. This work was partly supported by a grant from the U.S. Army (W81XWH-08-1-0725).	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Avesani R., 2011, EUR J PHYS REHAB MED, P471; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Papadakis NG, 2000, MAGN RESON IMAGING, V18, P671, DOI 10.1016/S0730-725X(00)00151-X; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	52	36	37	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2012	29	7					1292	1305		10.1089/neu.2011.2215			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	933TC	WOS:000303384600002	22364596				2022-02-06	
J	Clayson, PE; Larson, MJ				Clayson, Peter E.; Larson, Michael J.			Cognitive performance and electrophysiological indices of cognitive control: A validation study of conflict adaptation	PSYCHOPHYSIOLOGY			English	Article						N2; Cognitive control; Neuropsychology; Attention; Executive function; Anterior cingulate; ACC; Event-related potentials (ERPs)	TRAUMATIC BRAIN-INJURY; MEDIAL FRONTAL-CORTEX; ANTERIOR CINGULATE; PARAMETRIC MANIPULATION; RESPONSE-INHIBITION; NEURAL MECHANISMS; ADJUSTMENTS; TASK; SCHIZOPHRENIA; ANXIETY	Psychiatric and neurologic disorders are associated with deficits in the postconflict recruitment of cognitive control. The primary aim of this study was to validate the relationship between cognitive functioning and indices of conflict adaptation. Event-related potentials were obtained from 89 healthy individuals who completed an Eriksen flanker task. Neuropsychological domains tested included memory, verbal fluency, and attention/executive functioning. Behavioral measures and N2 amplitudes showed significant conflict adaptation (i.e., previous-trial congruencies influenced current-trial measures). Higher scores on the attention/executive functioning and verbal fluency domains were associated with larger incongruent-trial N2 conflict adaptation; measures of cognitive functioning were not related to behavioral indices. This study provides initial validation of N2 conflict adaptation effects as cognitive function-related aspects of cognitive control.	[Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Clayson, Peter E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA		Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA.	michael_larson@byu.edu	Clayson, Peter/AAC-4028-2022; Clayson, Peter/AAC-9207-2019; Clayson, Peter E/F-5438-2011; Larson, Michael J/C-8543-2012	Clayson, Peter/0000-0003-4437-6598; Clayson, Peter E/0000-0003-4437-6598; Larson, Michael J/0000-0002-8199-8065	Brigham Young University College of Family, Home, and Social Sciences	We gratefully acknowledge the assistance of Joseph Fair, Isaac Prows, Ann Clawson, and William David Walker in data collection. This study was supported by funds from the Brigham Young University College of Family, Home, and Social Sciences.	Amstadter A, 2008, J ANXIETY DISORD, V22, P211, DOI 10.1016/j.janxdis.2007.02.004; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benton A., 1976, MULTILINGUAL APHASIA; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Bonnin CA, 2010, NEUROPSYCHOLOGY, V24, P542, DOI 10.1037/a0018384; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bugg JM, 2008, MEM COGNITION, V36, P1217, DOI 10.3758/MC.36.7.1217; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Clayson PE, 2011, PSYCHOPHYSIOLOGY, V48, P1621, DOI 10.1111/j.1469-8986.2011.01265.x; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; Clayson PE, 2011, BIOL PSYCHOL, V87, P282, DOI 10.1016/j.biopsycho.2011.03.011; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Danielmeier C, 2009, PSYCHOPHYSIOLOGY, V46, P1288, DOI 10.1111/j.1469-8986.2009.00860.x; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Durston S, 2002, NEUROIMAGE, V16, P449, DOI 10.1006/nimg.2002.1074; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Egner T, 2011, J COGNITIVE NEUROSCI, V23, P3903, DOI 10.1162/jocn_a_00064; Eichele H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00065; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Enticott PG, 2008, PSYCHIAT RES, V157, P251, DOI 10.1016/j.psychres.2007.04.007; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Fernandez-Duque D, 2008, J EXP PSYCHOL HUMAN, V34, P340, DOI 10.1037/0096-1523.34.2.340; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Forster SE, 2011, J COGNITIVE NEUROSCI, V23, P923, DOI 10.1162/jocn.2010.21458; Funes MJ, 2010, COGN NEUROPSYCHOL, V27, P360, DOI 10.1080/02643294.2010.532618; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Kerns JG, 2005, AM J PSYCHIAT, V162, P1833, DOI 10.1176/appi.ajp.162.10.1833; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kerns JG, 2006, NEUROIMAGE, V33, P399, DOI 10.1016/j.neuroimage.2006.06.012; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Ladouceur CD, 2007, DEVELOPMENTAL SCI, V10, P874, DOI 10.1111/j.1467-7687.2007.00639.x; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2011, COGN AFFECT BEHAV NE, V11, P159, DOI 10.3758/s13415-010-0018-6; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Laws K R, 1999, Cogn Neuropsychiatry, V4, P1, DOI 10.1080/135468099396025; Laws KR, 1999, COGN NEUROPSYCHIATRY, V4, P31, DOI DOI 10.1080/135468099396025; Logan GD, 2007, J EXP PSYCHOL HUMAN, V33, P978, DOI 10.1037/0096-1523.33.4.978; Ma XH, 2007, AM J MED GENET B, V144B, P407, DOI 10.1002/ajmg.b.30330; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Melcher T, 2008, BRAIN RES REV, V59, P96, DOI 10.1016/j.brainresrev.2008.06.003; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Notebaert W, 2005, EUR J COGN PSYCHOL, V17, P642, DOI 10.1080/09541440540000095; Osinsky R, 2010, COGN AFFECT BEHAV NE, V10, P372, DOI 10.3758/CABN.10.3.372; Pacheco-Unguetti AP, 2011, J ANXIETY DISORD, V25, P888, DOI 10.1016/j.janxdis.2011.04.010; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rund BR, 2006, ACTA PSYCHIAT SCAND, V113, P350, DOI 10.1111/j.1600-0447.2005.00626.x; Rushe TM, 1999, SCHIZOPHR RES, V37, P21, DOI 10.1016/S0920-9964(98)00129-7; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Thoma P, 2007, SCHIZOPHR RES, V92, P168, DOI 10.1016/j.schres.2007.02.004; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; van Steenbergen H, 2010, PSYCHOL SCI, V21, P1629, DOI 10.1177/0956797610385951; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Verbruggen F, 2006, PSYCHON B REV, V13, P328, DOI 10.3758/BF03193852; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Yeung N, 2007, COGN AFFECT BEHAV NE, V7, P347, DOI 10.3758/CABN.7.4.347; Yun DY, 2011, PROG NEURO-PSYCHOPH, V35, P1148, DOI 10.1016/j.pnpbp.2011.03.018; Zgaljardic DJ, 2006, J CLIN EXP NEUROPSYC, V28, P1127, DOI 10.1080/13803390500246910	80	36	37	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	MAY	2012	49	5					627	637		10.1111/j.1469-8986.2011.01345.x			11	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	923LM	WOS:000302620800005	22292850				2022-02-06	
J	Chambers, AR; Hancock, KE; Maison, SF; Liberman, MC; Polley, DB				Chambers, Anna R.; Hancock, Kenneth E.; Maison, Stephane F.; Liberman, M. Charles; Polley, Daniel B.			Sound-Evoked Olivocochlear Activation in Unanesthetized Mice	JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY			English	Article						olivocochlear; corticofugal; arousal; attention; anesthesia; contralateral reflex; outer hair cell	PRODUCT OTOACOUSTIC EMISSIONS; AWAKE GUINEA-PIGS; INFERIOR COLLICULUS; AUDITORY-CORTEX; FINE-STRUCTURE; EFFERENT ACTIVATION; DISTORTION PRODUCTS; COCHLEAR EFFERENT; ACOUSTIC INJURY; BRAIN-STEM	Genetic tools available for the mouse make it a powerful model to study the modulation of cochlear function by descending control systems. Suppression of distortion product otoacoustic emission (DPOAE) amplitude by contralateral acoustic stimulation (CAS) provides a robust tool for noninvasively monitoring the strength of descending modulation, yet investigations in mice have been performed infrequently and only under anesthesia, a condition likely to reduce olivocochlear activation. Here, we characterize the contralateral olivocochlear reflex in the alert, unanesthetized mouse. Head-fixed mice were restrained between two closed acoustic systems, while an artifact rejection protocol minimized contamination from self-generated sounds and movements. In mice anesthetized with pentobarbital, ketamine or urethane, CAS at 80 dB SPL evoked, on average, a <1-dB change in DPOAE amplitude. In contrast, the mean CAS-induced DPOAE suppression in unanesthetized mice was nearly 8 dB. Experiments in mice with targeted deletion of the alpha 9 subunit of the nicotinic acetylcholine receptor confirmed the contribution of the medial olivocochlear efferents to this phenomenon. These findings demonstrate the utility of the CAS assay in the unanesthetized mouse and highlight the adverse effects of anesthesia when probing the functional status of descending control pathways within the auditory system.	[Chambers, Anna R.; Hancock, Kenneth E.; Maison, Stephane F.; Liberman, M. Charles; Polley, Daniel B.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Chambers, Anna R.; Polley, Daniel B.] Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; [Hancock, Kenneth E.; Maison, Stephane F.; Liberman, M. Charles; Polley, Daniel B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02114 USA		Chambers, AR (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, 243 Charles St, Boston, MA 02114 USA.	Anna_Chambers@meei.harvard.edu		Polley, Daniel/0000-0002-5120-2409	NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [P30 DC5029, R01 DC0188, R01 DC09836, R03 DC09488]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC000188, R01DC009836, P30DC005209, R03DC009488] Funding Source: NIH RePORTER	We are grateful to Dr. Douglas Vetter for generously sharing his alpha 9-null and wild-type mice with us, to Drs. John Guinan, Jeremiah Cohen and Nao Uchida for helpful advice, and to Sara Anastas and John Thompson for animal care and technical assistance. Financial support was provided by NIDCD grants: P30 DC5029 (MCL), R01 DC0188 (MCL), R01 DC09836 (DBP), and R03 DC09488 (DBP).	Abdala C, 2009, J ACOUST SOC AM, V125, P1584, DOI 10.1121/1.3068442; Avan P, 1996, EXP BRAIN RES, V109, P9, DOI 10.1007/BF00228621; Bauerle P, 2011, J NEUROSCI, V31, P9708, DOI 10.1523/JNEUROSCI.5814-10.2011; Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; Boyev KP, 2002, JARO, V3, P362, DOI 10.1007/s101620020044; BROWN MC, 1993, J COMP NEUROL, V337, P600, DOI 10.1002/cne.903370406; Coomes DL, 2004, EUR J NEUROSCI, V19, P2188, DOI 10.1111/j.0953-816X.2004.03317.x; de Boer J, 2008, J NEUROSCI, V28, P4929, DOI 10.1523/JNEUROSCI.0902-08.2008; DEWSON JH, 1968, J NEUROPHYSIOL, V31, P122, DOI 10.1152/jn.1968.31.1.122; Doucet JR, 2003, EXP BRAIN RES, V153, P461, DOI 10.1007/s00221-003-1604-4; FELICIANO M, 1995, J NEUROCHEM, V65, P1348; Frisina RD, 2007, J ACOUST SOC AM, V121, pEL29, DOI 10.1121/1.2401226; FUCHS PA, 1992, P ROY SOC B-BIOL SCI, V248, P35, DOI 10.1098/rspb.1992.0039; Groff JA, 2003, J NEUROPHYSIOL, V90, P3178, DOI 10.1152/jn.00537.2003; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Guitton MJ, 2004, NEUROREPORT, V15, P1379, DOI 10.1097/01.wnr.0000131672.15566.64; Harkrider AW, 2009, J AM ACAD AUDIOL, V20, P208, DOI 10.3766/jaaa.20.3.7; Harrison RV, 2008, ACTA OTO-LARYNGOL, V128, P404, DOI 10.1080/00016480701784965; Henin S, 2011, J ACOUST SOC AM, V129, P2068, DOI 10.1121/1.3543945; Irving S, 2011, J NEUROSCI, V31, P2493, DOI 10.1523/JNEUROSCI.2679-10.2011; Kalluri R, 2001, J ACOUST SOC AM, V109, P622, DOI 10.1121/1.1334597; Kujawa SG, 2001, JARO, V2, P268, DOI 10.1007/s101620010047; Kumar UA, 2004, EAR HEARING, V25, P142, DOI 10.1097/01.AUD.0000120363.56591.E6; Lauer AM, 2011, JARO-J ASSOC RES OTO, V12, P329, DOI 10.1007/s10162-011-0262-7; LIBERMAN MC, 1988, HEARING RES, V34, P179, DOI 10.1016/0378-5955(88)90105-0; LIBERMAN MC, 1986, HEARING RES, V24, P17, DOI 10.1016/0378-5955(86)90003-1; Maison SF, 2002, J NEUROSCI, V22, P10838; Maison SF, 2000, J NEUROSCI, V20, P4701, DOI 10.1523/JNEUROSCI.20-12-04701.2000; Maison SF, 2003, J COMP NEUROL, V455, P406, DOI 10.1002/cne.10490; MAISON SF, 2011, ANESTHETIZED MICE CO; Maison SF, 2007, J NEUROPHYSIOL, V97, P3269, DOI 10.1152/jn.00067.2007; May BJ, 2004, ARCH OTOLARYNGOL, V130, P660, DOI 10.1001/archotol.130.5.660; Messing DP, 2009, SPEECH COMMUN, V51, P668, DOI 10.1016/j.specom.2009.02.002; Micheyl C, 1996, J ACOUST SOC AM, V99, P1604, DOI 10.1121/1.414734; MOULIN A, 1993, HEARING RES, V65, P193, DOI 10.1016/0378-5955(93)90213-K; Mukerji S, 2010, TRENDS AMPLIF, V14, P170, DOI 10.1177/1084713810381771; Mulders WHA, 2000, HEARING RES, V149, P11, DOI 10.1016/S0378-5955(00)00157-X; Puria S, 1996, J ACOUST SOC AM, V99, P500, DOI 10.1121/1.414508; Rossel M, 2005, DEVELOPMENT, V132, P1175, DOI 10.1242/dev.01683; Scates KW, 1999, HEARING RES, V128, P51, DOI 10.1016/S0378-5955(98)00198-1; Schofield BR, 2005, HEARING RES, V206, P3, DOI 10.1016/j.heares.2005.03.005; SMITH DW, 1994, BRAIN RES, V652, P243, DOI 10.1016/0006-8993(94)90233-X; SRIDHAR TS, 1995, J NEUROSCI, V15, P3667; Suga N, 2002, NEURON, V36, P9, DOI 10.1016/S0896-6273(02)00933-9; Taranda J, 2009, PLOS BIOL, V7, P71, DOI 10.1371/journal.pbio.1000018; THOMPSON AM, 1993, J COMP NEUROL, V335, P402, DOI 10.1002/cne.903350309; VETTER DE, 1993, HEARING RES, V70, P173, DOI 10.1016/0378-5955(93)90156-U; Vetter DE, 1999, NEURON, V23, P93, DOI 10.1016/S0896-6273(00)80756-4; Vetter DE, 2007, P NATL ACAD SCI USA, V104, P20594, DOI 10.1073/pnas.0708545105; Wagner W, 2007, HEARING RES, V223, P83, DOI 10.1016/j.heares.2006.10.001; WHITEHEAD ML, 1991, HEARING RES, V51, P55, DOI 10.1016/0378-5955(91)90007-V; WIEDERHOLD ML, 1970, J ACOUST SOC AM, V48, P950, DOI 10.1121/1.1912234; WIENISCH M, 2011, 2 PHOTON IMAGING NEU; Winer JA, 2006, HEARING RES, V212, P1, DOI 10.1016/j.heares.2005.06.014; Yan J, 2005, J NEUROPHYSIOL, V93, P71, DOI 10.1152/jn.00348.2004; Zhu XX, 2007, J COMP NEUROL, V503, P593, DOI 10.1002/cne.21402	56	36	37	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1525-3961			JARO-J ASSOC RES OTO	JARO	APR	2012	13	2					209	217		10.1007/s10162-011-0306-z			9	Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	940MH	WOS:000303893200005	22160753	Green Published, Bronze			2022-02-06	
J	Zhao, J; Pati, S; Redell, JB; Zhang, M; Moore, AN; Dash, PK				Zhao, Jing; Pati, Shibani; Redell, John B.; Zhang, Min; Moore, Anthony N.; Dash, Pramod K.			Caffeic Acid Phenethyl Ester Protects Blood-Brain Barrier Integrity and Reduces Contusion Volume in Rodent Models of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						claudin-5; neurovascular function; reactive oxygen species; tight junction; vascular permeability	CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; CELL-DEATH MECHANISMS; COGNITIVE DEFICITS; ACUTE-INFLAMMATION; OXIDATIVE STRESS; CHLOROGENIC ACID; MEMORY DEFICITS; MOUSE-BRAIN; HEAD-INJURY	A number of studies have established a deleterious role for inflammatory molecules and reactive oxygen species (ROS) in the pathology of traumatic brain injury (TBI). Caffeic acid phenethyl ester (CAPE) has been shown to exert both antioxidant and anti-inflammatory effects. The primary objective of the present study was to examine if CAPE could be used to reduce some of the pathological consequences of TBI using rodent models. Male Sprague-Dawley rats and C57BL/6 mice were subjected to controlled cortical impact (CCI) injury. Blood-brain barrier (BBB) integrity was assessed by examining claudin-5 expression and the extravasation of Evans blue dye. The effect of post-injury CAPE administration on neurobehavioral function was assessed using vestibulomotor, motor, and two hippocampus-dependent learning and memory tasks. We report that post-TBI administration of CAPE reduces Evans blue extravasation both in rats and mice. This improvement was associated with preservation of the levels of the tight junction protein claudin-5. CAPE treatment did not improve performance in either vestibulomotor/motor function (tested using beam balance and foot-fault tests), or in learning and memory function (tested using the Morris water maze and associative fear memory tasks). However, animals treated with CAPE were found to have significantly less cortical tissue loss than vehicle-treated controls. These findings suggest that CAPE may provide benefit in the treatment of vascular compromise following central nervous system injury.	[Zhao, Jing; Redell, John B.; Zhang, Min; Moore, Anthony N.; Dash, Pramod K.] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77225 USA; [Pati, Shibani] Univ Texas Med Sch Houston, Ctr Translat Injury Res, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas Med Sch Houston, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu		Dash, Pramod/0000-0001-6746-1002	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS049160]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049160] Funding Source: NIH RePORTER	The authors thank Cameron Jeter for her critical reading of the manuscript. The studies were made possible by funds from the NIH (NS049160).	Adelson PD, 1998, ACT NEUR S, V71, P104; Babikian T, 2010, DEV NEUROSCI-BASEL, V32, P431, DOI 10.1159/000320667; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Celik S, 2008, MOL CELL BIOCHEM, V312, P39, DOI 10.1007/s11010-008-9719-3; CHAN WS, 1995, ANTICANCER RES, V15, P703; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Dash PK, 2004, J NEUROTRAUM, V21, P1573, DOI 10.1089/0897715042441828; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; FESEN MR, 1993, P NATL ACAD SCI USA, V90, P2399, DOI 10.1073/pnas.90.6.2399; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Hall Edward D., 1993, Journal of Emergency Medicine, V11, P31; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Hayes RL, 2009, METHODS MOL BIOL, V566, P303, DOI 10.1007/978-1-59745-562-6_20; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hishikawa K, 2005, ARTERIOSCL THROM VAS, V25, P442, DOI 10.1161/01.ATV.0000148404.24271.fc; Honda M, 2006, CELL MOL NEUROBIOL, V26, P109, DOI 10.1007/s10571-006-9028-x; Huh Jimmy W, 2009, Anesthesiol Clin, V27, P213, DOI 10.1016/j.anclin.2009.05.006; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Ilhan A, 2004, FREE RADICAL BIO MED, V37, P386, DOI 10.1016/j.freeradbiomed.2004.04.022; Irmak MK, 2003, CELL BIOCHEM FUNCT, V21, P283, DOI 10.1002/cbf.1024; Kalonia Harikesh, 2009, Inflammopharmacology, V17, P211, DOI 10.1007/s10787-009-0012-1; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Khan M, 2007, J NEUROCHEM, V102, P365, DOI 10.1111/j.1471-4159.2007.04526.x; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; Kono Y, 1997, BBA-GEN SUBJECTS, V1335, P335, DOI 10.1016/S0304-4165(96)00151-1; KOSHIHARA Y, 1984, BIOCHIM BIOPHYS ACTA, V792, P92; Liao HF, 2003, J AGR FOOD CHEM, V51, P7907, DOI 10.1021/jf034729d; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Michaluart P, 1999, CANCER RES, V59, P2347; Mirzoeva OK, 1996, PROSTAG LEUKOTR ESS, V55, P441, DOI 10.1016/S0952-3278(96)90129-5; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Orban Z, 2000, NEUROIMMUNOMODULAT, V7, P99, DOI 10.1159/000026427; Orsoilc N, 2005, BIOL PHARM BULL, V28, P1928, DOI 10.1248/bpb.28.1928; Ottens AK, 2010, J NEUROTRAUM, V27, P1837, DOI 10.1089/neu.2010.1374; Park EH, 1999, ARCH PHARM RES, V22, P554, DOI 10.1007/BF02975325; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Povlishock J T, 1992, Hum Cell, V5, P345; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Smith C.M., 2010, NEUROBIOL DIS; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; SONDHEIMER E, 1958, ARCH BIOCHEM BIOPHYS, V74, P131, DOI 10.1016/0003-9861(58)90207-8; Stewart LR, 2001, J NEUROSCI RES, V65, P565, DOI 10.1002/jnr.1186; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; SUDINA GF, 1993, FEBS LETT, V329, P21, DOI 10.1016/0014-5793(93)80184-V; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Uz T, 1998, FASEB J, V12, P439, DOI 10.1096/fasebj.12.6.439; Vink R, 2010, NEUROTHERAPEUTICS, V7, P1, DOI 10.1016/j.nurt.2009.12.001; Wei X, 2004, BRAIN, V127, P2629, DOI 10.1093/brain/awh316; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whalen MJ, 1998, ACT NEUR S, V71, P212; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yang JQ, 2008, CNS NEUROSCI THER, V14, P10, DOI 10.1111/j.1527-3458.2007.00031.x; Zhang L, 2007, LIFE SCI, V80, P530, DOI 10.1016/j.lfs.2006.09.039; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhou Y, 2006, ACTA PHARMACOL SIN, V27, P1103, DOI 10.1111/j.1745-7254.2006.00406.x	84	36	38	2	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2012	29	6					1209	1218		10.1089/neu.2011.1858			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	927ZL	WOS:000302949100021	22150135	Green Published			2022-02-06	
J	Li, SH; Wei, M; Zhou, ZW; Wang, B; Zhao, XL; Zhang, JN				Li, Shenghui; Wei, Ming; Zhou, Ziwei; Wang, Bin; Zhao, Xinliang; Zhang, Jianning			SDF-1 alpha induces angiogenesis after traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Angiogenesis; Functional recovery; Stromal cell derived factor	UMBILICAL-CORD BLOOD; MARROW-DERIVED CELLS; MESENCHYMAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; CD34(+) CELLS; ISCHEMIC CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; CHEMOKINE RECEPTOR; FACTOR-I; TISSUE REGENERATION	This study aimed to investigate the effects of SDF-1 alpha on brain angiogenesis and neurological functional recovery in rats after traumatic brain injury (TB!) and the potentially involved mechanisms. Youth male Wistar rats were injured via lateral fluid percussion injury and then randomly divided into one of 3 groups: I. vehicle treated group; II. SDF-1 alpha neutralizing antibody treated group and III. rhSDF-1 alpha treated group. rhSDF-1 alpha and its neutralizing antibody or normal saline were administered to the brain penumbra via stereotactic injection 30 min after TBI. Modified neurological severity score (mNSS) and Morris water maze (MWM) test were used to assess the neurologic functional recovery (n=6/group). 14 days after injury, animals were euthanized and brain tissues were collected for quantitative real time polymerase chain reaction (qRT-PCR) (n=6/group) and immunohistochemistry (n=6/group) analysis. mNSS and MWM test indicated distinct amelioration of neurological disability in rhSDF-1 alpha group(P<0.05). Microvessel density (MVD) of rhSDF-1 alpha treated animals was remarkably increased around the injured area. On the contrary, MVD of the SDF-1 alpha antibody administrated group was significantly decreased compared to that of vehicle treated animals (P<0.05). The mNSS and MVD had significant negative correlation as tested by Spearman rank correlation coefficient. Immunofluorescence staining showed that CD34 and CXCR4 co-expressed on microvessels. The rhSDF-1 alpha treated animals had greater, contrarily, the SDF-1 alpha antibody treated animals had lesser number of double positive microvessels compared to that of vehicle treated animals. The mRNA expression of CD34 and CXCR4 was obviously elevated in the rhSDF-1 alpha administration group, conversely, declined in SDF-1 alpha antibody treated animals around the injured area compared with that of the vehicle treatment group (P<0.05). These data indicated that SDF-1 alpha could induce angiogenesis after TB!, potentially via SDF-1/CXCR4 axis. (C) 2012 Elsevier B.V. All rights reserved.	[Li, Shenghui; Zhou, Ziwei; Wang, Bin; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Wei, Ming] Tianjin Med Univ, Hosp 2, Dept Neurosurg, Tianjin 300211, Peoples R China; [Zhao, Xinliang] Tianjin Yongjiu Hosp, Dept Neurosurg, Binhai New Area, Tianjin 300450, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin Neurol Inst, 154 Anshan Rd, Tianjin 300052, Peoples R China.	lishenghui2000@gmail.com; neurowei@yahoo.com.cn; 1985zhouziwei@163.com; tianjinwangb@163.com; zxl6869@126.com; jianningzhang@hotmail.com			National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30772229]; National 973 ProjectNational Basic Research Program of China [2005CB522605]	We acknowledge Li Liu, Fanglian Chen, Weiyun Cui, Yue Wang for excellent technical support and Jieli Chen, Joshua Marks for careful manuscript revision. This work was supported by the National Science Foundation of China (30772229) and National 973 Project (2005CB522605).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Barresi V, 2007, ACTA NEUROPATHOL, V114, P147, DOI 10.1007/s00401-007-0251-4; Beck H, 2003, J CEREBR BLOOD F MET, V23, P709, DOI 10.1097/01.WCB.0000065940.18332.8D; Belmadani A, 2005, J NEUROSCI, V25, P3995, DOI 10.1523/JNEUROSCI.4631-04.2005; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Dabusti M, 2003, J HEMATOTH STEM CELL, V12, P425, DOI 10.1089/152581603322286051; Dai SJ, 2010, J MOL CELL CARDIOL, V49, P587, DOI 10.1016/j.yjmcc.2010.07.010; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Floege J, 2009, J AM SOC NEPHROL, V20, P1659, DOI 10.1681/ASN.2009060621; Franz WM, 2003, LANCET, V362, P675, DOI 10.1016/S0140-6736(03)14240-7; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jie W, 2010, INT J EXP PATHOL, V91, P436, DOI 10.1111/j.1365-2613.2010.00720.x; Kao CH, 2008, SHOCK, V29, P49, DOI 10.1097/shk.0b013c31805cddce; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Laughlin MJ, 2001, NEW ENGL J MED, V344, P1815, DOI 10.1056/NEJM200106143442402; Lazarini F, 2003, GLIA, V42, P139, DOI 10.1002/glia.10139; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ni G, 2011, EUR J NEUROL, V18, P1304, DOI 10.1111/j.1468-1331.2011.03393.x; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peterson DA, 2004, J CLIN INVEST, V114, P312, DOI 10.1172/jc1200422540; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Rosenkranz K, 2010, J NEUROSCI RES, V88, P1223, DOI 10.1002/jnr.22292; Rouhl RPW, 2008, STROKE, V39, P2158, DOI 10.1161/STROKEAHA.107.507251; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schonemeier B, 2008, J NEUROIMMUNOL, V198, P39, DOI 10.1016/j.jneuroim.2008.04.010; Semenza GL, 2007, J CELL BIOCHEM, V102, P840, DOI 10.1002/jcb.21523; Sharma M, 2011, STEM CELLS DEV, V20, P933, DOI 10.1089/scd.2010.0263; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Shyu WC, 2006, J NEUROSCI, V26, P3444, DOI 10.1523/JNEUROSCI.5165-05.2006; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Tysseling VM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-16; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang SH, 2010, CARDIOLOGY, V117, P140, DOI 10.1159/000320217; Ward NL, 2004, NEUROL RES, V26, P870, DOI 10.1179/016164104X3798; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Zaruba MM, 2010, EXPERT OPIN BIOL TH, V10, P321, DOI 10.1517/14712590903460286; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zhuang Y, 2009, CHINESE MED J-PEKING, V122, P183, DOI 10.3760/cma.j.issn.0366-6999.2009.02.014	64	36	40	1	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAR 20	2012	1444						76	86		10.1016/j.brainres.2011.12.055			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	914PD	WOS:000301962600009	22330724				2022-02-06	
J	Huang, KF; Hsu, WC; Chiu, WT; Wang, JY				Huang, Kuo-Feng; Hsu, Wei-Cherng; Chiu, Wen-Ta; Wang, Jia-Yi			Functional improvement and neurogenesis after collagen-GAG matrix implantation into surgical brain trauma	BIOMATERIALS			English	Article						Brain; Cell proliferation; Collagen-GAG; Neurotrophic factor; Scaffold; Functional recovery	NEURAL STEM-CELLS; HYALURONIC-ACID HYDROGELS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; EXTRACELLULAR-MATRIX; NEUROTROPHIC FACTOR; IN-VITRO; SUBVENTRICULAR ZONE; TISSUE REGENERATION; ADULT NEUROGENESIS	Surgical or traumatic brain injury often leads to loss of cerebral parenchyma but there is as yet no clinically effective strategy for neural regeneration. Collagen glycosaminoglycan (collagen-GAG, CG) scaffolds have previously been used in many tissues in vivo but have never been utilized in the brain. Using an animal model, we investigated the effects of the implantation of CG scaffold matrix following surgical brain trauma. Results indicated that implantation of CG scaffold could significantly promote functional recovery following surgical brain trauma. The CG scaffold was found to facilitate proliferation, differentiation and migration of endogenous neural precursor cells (NPCs) both in the intra-matrix zone (IMZ) and lesion boundary zone (LBZ). The tissue concentration of brain-derived neurotrophic factor (BDNF) and glia-derived neurotrophic factor (GDNF) in the cortex demonstrated a sustained increase after implantation of CG scaffold following surgical brain trauma. These results suggest that the utilization of CG scaffolds can be considered as a potential clinical strategy for tissue regeneration and functional recovery after brain injury. (C) 2011 Elsevier Ltd. All rights reserved.	[Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan; [Huang, Kuo-Feng; Wang, Jia-Yi] Natl Def Med Ctr, Grad Inst Med Sci, Taipei 114, Taiwan; [Huang, Kuo-Feng] Buddhist Tzu Chi Gen Hosp, Div Neurosurg, Dept Surg, Taipei Branch, New Taipei City 23143, Taiwan; [Hsu, Wei-Cherng] Buddhist Tzu Chi Gen Hosp, Dept Ophthamol, Taipei Branch, New Taipei City 23143, Taiwan; [Hsu, Wei-Cherng] Tzu Chi Univ, Sch Med, Hualien 97004, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei 110, Taiwan; [Wang, Jia-Yi] Natl Def Med Ctr, Dept Physiol, Taipei 114, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, 250 Wu Xing St, Taipei 110, Taiwan.	jywang2010@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351	National Science Council (NSC)Ministry of Science and Technology, Taiwan [99-2320-B-038-006-MY3]; Buddhist Tzu-Chi General Hospital Taipei branch at Taipei, Taiwan [TCRD-TPE-100-35]	This study was supported in part by a grant from the National Science Council (NSC 99-2320-B-038-006-MY3 to JY Wang) and from the Buddhist Tzu-Chi General Hospital Taipei branch (TCRD-TPE-100-35 to KF Huang) at Taipei, Taiwan, without conflict of interest. We would like to thank Ms. Jia-Hsun Lee and Dr. Shun-Yuan Jiang for data collection and analysis.	Bath KG, 2010, DEV NEUROBIOL, V70, P339, DOI 10.1002/dneu.20781; BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Crooks Carol Y, 2008, Mo Med, V105, P140; Crooks CY, 2000, MO MED, V105, P4; Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hallbergson AF, 2003, J CLIN INVEST, V112, P1128, DOI 10.1172/JCI200320098; Han QQ, 2011, BIOMATERIALS, V32, P5077, DOI 10.1016/j.biomaterials.2011.03.072; Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.actbio.2006.12.009; Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598; Harley BAC, 2008, CHEM ENG J, V137, P102, DOI 10.1016/j.cej.2007.09.009; Hejcl A, 2008, PHYSIOL RES, V57, pS121, DOI 10.33549/physiolres.931606; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Hsu WC, 2000, INVEST OPHTH VIS SCI, V41, P2404; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; Nielsen J, 2009, J NEUROSCI, V29, P11360, DOI 10.1523/JNEUROSCI.3239-09.2009; Novak U, 2000, J CLIN NEUROSCI, V7, P280, DOI 10.1054/jocn.1999.0212; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Tenovuo O, 2006, CURR OPIN NEUROL, V19, P528, DOI 10.1097/WCO.0b013e328010944f; Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; vanderLaan LJW, 1997, J NEUROSCI RES, V50, P539, DOI 10.1002/(SICI)1097-4547(19971115)50:4<539::AID-JNR5>3.0.CO;2-F; Viapiano MS, 2006, TRENDS MOL MED, V12, P488, DOI 10.1016/j.molmed.2006.08.007; Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11; Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715; Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015; YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933; YANNAS IV, 1994, J CELL BIOCHEM, V56, P188, DOI 10.1002/jcb.240560212; Zhang HZ, 2007, BRAIN RES, V1132, P29, DOI 10.1016/j.brainres.2006.09.117; Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	47	36	36	1	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612			BIOMATERIALS	Biomaterials	MAR	2012	33	7					2067	2075		10.1016/j.biomaterials.2011.11.040			9	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	895CN	WOS:000300473900013	22169139				2022-02-06	
J	Brooks, BL; Sherman, EMS; Krol, AL				Brooks, Brian L.; Sherman, Elisabeth M. S.; Krol, Andrea L.			Utility of TOMM Trial 1 as an Indicator of Effort in Children and Adolescents	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Effort; Malingering; Symptom validity; Malingered neurocognitive disorder; Pediatrics; Children	WORD MEMORY TEST; SYMPTOM VALIDITY TESTS; TRAUMATIC BRAIN-INJURY; MALINGERING TOMM; INSUFFICIENT EFFORT; TEST-PERFORMANCE; RECOGNITION; SAMPLE; ADULTS	Although measuring test compliance in a pediatric neuropsychological evaluation is important, increasing demands on clinicians' time and the need for efficiency during assessments may make it difficult to routinely include effort testing. This study investigated whether performance on Trial 1 of the Test of Memory Malingering (TOMM) is predictive of overall performance in children and adolescents with neurological disorders. Participants included 53 children and adolescents between six and 19 years (mean age = 12.4, SD = 4.1) who were followed through a neurology clinic at a tertiary care hospital. Several cutoff scores were examined, with the goal of maximizing positive predictive (accurate detection of failure on the TOMM) and negative predictive (accurate detection of passing the TOMM) values. Every participant who scored >= 36 on Trial 1 (n = 50) went on to pass the TOMM. This study is the first step in providing evidence that performance on Trial I might be used as a quick screening measure of overall performance on the TOMM in children and adolescents. Further research on this topic is warranted.	[Brooks, Brian L.; Sherman, Elisabeth M. S.] Alberta Childrens Prov Gen Hosp, Neurosci Program, Calgary, AB T3B 6A8, Canada; [Brooks, Brian L.; Sherman, Elisabeth M. S.] Univ Calgary, Calgary, AB, Canada; [Krol, Andrea L.] Univ Alberta, Edmonton, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca			Psychological Assessment Resources, Inc.	Drs Brooks and Sherman receive funding from Psychological Assessment Resources, Inc. and book royalities from Oxford University Press.	Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Bruininks R.H., 1996, SIB R SCALES INDEPEN; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Courtney JC, 2003, CHILD NEUROPSYCHOL, V9, P109, DOI 10.1076/chin.9.2.109.14507; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 1994, CALIFORNIA VERBAL LE; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Frazier TW, 2008, ARCH CLIN NEUROPSYCH, V23, P501, DOI 10.1016/j.acn.2008.04.001; Gavett BE, 2005, APPL NEUROPSYCHOL, V12, P1, DOI 10.1207/s15324826an1201_1; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Gunn D, 2010, CHILD NEUROPSYCHOL, V16, P105, DOI 10.1080/09297040903352564; Horner MD, 2006, INT J NEUROSCI, V116, P1181, DOI 10.1080/00207450500514029; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood M. W., PEDIAT FORE IN PRESS; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Nagle AM, 2006, ARCH CLIN NEUROPSYCH, V21, P777, DOI 10.1016/j.acn.2006.06.011; O'Bryant SE, 2008, APPL NEUROPSYCHOL, V15, P113, DOI 10.1080/09084280802083921; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; Rienstra A, 2010, ARCH CLIN NEUROPSYCH, V25, P371, DOI 10.1093/arclin/acq035; SEIDEL WT, 1991, CLIN NEUROPSYCHOL, V5, P53; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL	33	36	36	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2012	27	1					23	29		10.1093/arclin/acr086			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	885TE	WOS:000299802900003	22044946	Bronze, Green Published			2022-02-06	
J	Bryan, C; Hernandez, M				Bryan, Craig; Hernandez, Marie			Magnitudes of Decline on Automated Neuropsychological Assessment Metrics Subtest Scores Relative to Predeployment Baseline Performance Among Service Members Evaluated for Traumatic Brain Injury in Iraq	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						ANAM; military; traumatic brain injury	SPORTS CONCUSSION; AFGHANISTAN; SAMPLE	Objective: Identify the proportion of service members demonstrating declines in Automated Neuropsychological Assessment Metrics (ANAM) scores as part of a traumatic brain injury (TBI) evaluation conducted while deployed to Iraq. Background: Although TBI has been associated with poorer performance on cognitive test in the general population and military combatants, little is known about the proportion of service members demonstrating declines in ANAM scores after TBI. Methods: Military personnel (N = 116) referred to a combat support hospital for TBI evaluation in Iraq underwent a standardized intake evaluation including computerized neurocognitive testing, psychological and physical health questionnaires, a clinical interview, and a physical examination by a physician. Predeployment and postinjury cognitive performance among service members with and without a TBI diagnosis was compared. Results: A significantly larger proportion of patients with TBI demonstrated greater declines in speed across all ANAM subtests compared with patients with no TBI. Differences in accuracy scores among patients with TBI relative to patients without TBI were nonsignificant. Patients with TBI also demonstrated greater than minimal declines on throughput Simple Reaction Time, Procedural Reaction Time, Code Substitution-Learning, and Spatial Memory scores, with no significant differences on Code Substitution-Delayed or Mathematical Processing (MATH). A similar pattern was seen among individuals examined within 72 hours of index injury. Conclusion: Assessment of cognitive impairment following TBI in a combat zone may assist providers in making treatment recommendations for service members with mild TBI.	[Bryan, Craig; Hernandez, Marie] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA		Bryan, C (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, 7550 West IH-10,Ste 1325, San Antonio, TX 78229 USA.	bryanc3@uthscsa.edu		Bryan, Craig/0000-0002-9714-0733; huaxia, li/0000-0001-7346-6600			[Anonymous], 2007, AUT NEUR ASS METR CO; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jaycox, 2008, INVISIBLE WOUNDS WAR; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Traumatic Brain Injury (TBI) Task Force, 2008, TRAUM BRAIN INJ TASK; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa	14	36	36	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2012	27	1					45	54		10.1097/HTR.0b013e318238f146			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	879JV	WOS:000299326400005	22218202				2022-02-06	
B	Green, P; Flaro, L; Brockhaus, R; Montijo, J		Reynolds, CR; Horton, AM		Green, Paul; Flaro, Lloyd; Brockhaus, Robbi; Montijo, Jorge			Performance on the WMT, MSVT, and NV-MSVT in Children with Developmental Disabilities and in Adults with Mild Traumatic Brain Injury	DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION			English	Article; Book Chapter							WORD MEMORY TEST; SYMPTOM VALIDITY TESTS; MALINGERED NEUROCOGNITIVE DYSFUNCTION; EXTERNAL INCENTIVES; EXAGGERATION; VALIDATION; SEVERITY; FAILURE; DAMAGE		[Brockhaus, Robbi] Alexianer Krankenhaus, Krefeld, Germany			paulgreen@shaw.ca					Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Astner K., 1996, MANUAL WORD MEMORY T; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Brockhaus R, 2004, NERVENARZT, V75, P882, DOI 10.1007/s00115-003-1592-4; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Doane BM, 2009, LAW HUMAN BEHAV, V33, P329, DOI 10.1007/s10979-008-9157-5; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 2005, MANUAL WORD MEMORY T; Green P., 2009, 1 EUR C SYMPT VAL TE; Green P., 2004, MANUAL MED SYMPTOM V; Green P, 1995, MANUAL ORAL WORD MEM; Green P.J.E., 2008, MANUAL NONVERBAL MED; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry M., 2009, J CLIN EXPT NEUROPSY, V8, P1; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Rohling ML, 2010, CLIN NEUROPSYCHOL, V24, P119, DOI 10.1080/13854040903307243; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh T.N., 1996, TEST MEMORY MALINGER; [No title captured]	35	36	36	0	0	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4614-0441-5				2012							201	219		10.1007/978-1-4614-0442-2_6	10.1007/978-1-4614-0442-2		19	Psychology, Clinical; Neurosciences	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Neurosciences & Neurology	BAD69	WOS:000303852000006					2022-02-06	
J	Hosie, KA; King, AE; Blizzard, CA; Vickers, JC; Dickson, TC				Hosie, Katherine A.; King, Anna E.; Blizzard, Catherine A.; Vickers, James C.; Dickson, Tracey C.			Chronic excitotoxin-induced axon degeneration in a compartmented neuronal culture model	ASN NEURO			English	Article						alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA); distal axons; microfluidic; NMDA	NMDA RECEPTORS; GLUTAMATE RECEPTORS; DEPENDENT NEURODEGENERATION; MOLECULAR-MECHANISMS; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; AMPA RECEPTORS; INJURY; DAMAGE; EXOCYTOSIS	Glutamate excitotoxicity is a major pathogenic process implicated in many neurodegenerative conditions, including AD (Alzheimer's disease) and following traumatic brain injury. Occurring predominantly from over-stimulation of ionotropic glutamate receptors located along dendrites, excitotoxic axonal degeneration may also occur in white matter tracts. Recent identification of axonal glutamate receptor subunits within axonal nanocomplexes raises the possibility of direct excitotoxic effects on axons. Individual neuronal responses to excitotoxicity are highly dependent on the complement of glutamate receptors expressed by the cell, and the localization of the functional receptors. To enable isolation of distal axons and targeted excitotoxicity, murine cortical neuron cultures were prepared in compartmented microfluidic devices, such that distal axons were isolated from neuronal cell bodies. Within the compartmented culture system, cortical neurons developed to relative maturity at 11 DIV (days in vitro) as demonstrated by the formation of dendritic spines and clustering of the presynaptic protein synaptophysin. The isolated distal axons retained growth cone structures in the absence of synaptic targets, and expressed glutamate receptor subunits. Glutamate treatment (100 mu M) to the cell body chamber resulted in widespread degeneration within this chamber and degeneration of distal axons in the other chamber. Glutamate application to the distal axon chamber triggered a lesser degree of axonal degeneration without degenerative changes in the untreated somal chamber. These data indicate that in addition to current mechanisms of indirect axonal excitotoxicity, the distal axon may be a primary target for excitotoxicity in neurodegenerative conditions.	[Hosie, Katherine A.; King, Anna E.; Blizzard, Catherine A.; Vickers, James C.; Dickson, Tracey C.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia		Dickson, TC (corresponding author), Univ Tasmania, Wicking Dementia Res & Educ Ctr, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia.	Tracey.Dickson@utas.edu.au	King, Anna/J-7927-2014; Vickers, James C/J-7464-2014	King, Anna/0000-0003-1792-0965; Vickers, James C/0000-0001-5671-4879; Blizzard, Catherine/0000-0002-8683-2937; Dickson, Tracey/0000-0002-9196-1661	Wicking Dementia Research and Education Centre; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP10039]; Tasmanian Masonic Centenary Medical Research Foundation; Alzheimer's Association AustraliaAlzheimer's Association; Motor Neuron Disease Research Institute of Australia; University of Tasmania	The work was supported by the Wicking Dementia Research and Education Centre, National Health and Medical Research Council [grant number APP10039], Tasmanian Masonic Centenary Medical Research Foundation, and Alzheimer's Association Australia, Motor Neuron Disease Research Institute of Australia, University of Tasmania.	Andrasfalvy BK, 2001, J NEUROSCI, V21, P9151, DOI 10.1523/JNEUROSCI.21-23-09151.2001; Araque A, 2004, GLIA, V47, P241, DOI 10.1002/glia.20026; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bannerman P, 2007, J NEUROCHEM, V102, P1064, DOI 10.1111/j.1471-4159.2007.04612.x; Bardoni R, 2004, J NEUROSCI, V24, P2774, DOI 10.1523/JNEUROSCI.4637-03.2004; Carriedo SG, 1996, J NEUROSCI, V16, P4069; CHOI DW, 1987, J NEUROSCI, V7, P357; Chung RS, 2005, EXP NEUROL, V193, P481, DOI 10.1016/j.expneurol.2005.01.005; DeLima AD, 1997, J COMP NEUROL, V382, P230, DOI 10.1002/(SICI)1096-9861(19970602)382:2<230::AID-CNE7>3.0.CO;2-4; Diamond JS, 2000, J NEUROPHYSIOL, V83, P2835, DOI 10.1152/jn.2000.83.5.2835; Dickson TC, 2000, J NEUROTRAUM, V17, P1095, DOI 10.1089/neu.2000.17.1095; Doble A, 1996, NEUROLOGY, V47, pS233, DOI 10.1212/WNL.47.6_Suppl_4.233S; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fowler JH, 2006, J NEUROSCI RES, V84, P68, DOI 10.1002/jnr.20859; Fowler JH, 2003, BRAIN RES, V991, P104, DOI 10.1016/j.brainres.2003.08.004; GALLO V, 1995, J NEUROSCI RES, V42, P1, DOI 10.1002/jnr.490420102; Haas MA, 2004, EUR J NEUROSCI, V20, P1436, DOI 10.1111/j.1460-9568.2004.03620.x; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kane-Jackson R, 2003, NEUROSCIENCE, V122, P285, DOI 10.1016/S0306-4522(03)00596-7; King AE, 2007, EUR J NEUROSCI, V26, P2151, DOI 10.1111/j.1460-9568.2007.05845.x; King AE, 2006, J COMP NEUROL, V498, P277, DOI 10.1002/cne.21053; King AE, 2011, NEUROBIOL AGING, V32, P459, DOI 10.1016/j.neurobiolaging.2009.04.004; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Liu Z, 1996, DEV BRAIN RES, V97, P178, DOI 10.1016/S0165-3806(96)00141-1; Matute C, 1998, P NATL ACAD SCI USA, V95, P10229, DOI 10.1073/pnas.95.17.10229; Matute C, 2007, NEURON GLIA BIOL, V3, P281, DOI 10.1017/S1740925X08000033; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Ouardouz M, 2009, ANN NEUROL, V65, P151, DOI 10.1002/ana.21533; Ouardouz M, 2009, ANN NEUROL, V65, P160, DOI 10.1002/ana.21539; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Pitt D, 2003, NEUROLOGY, V61, P1113, DOI 10.1212/01.WNL.0000090564.88719.37; Pitt D, 2010, BRAIN RES, V1309, P146, DOI 10.1016/j.brainres.2009.10.066; Rao A, 1998, J NEUROSCI, V18, P1217; Saggu SK, 2008, EXP NEUROL, V211, P52, DOI 10.1016/j.expneurol.2007.12.022; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Smith B, 2011, ASN NEURO, V3, P213, DOI 10.1042/AN20110019; Stys PK, 2000, NEUROSCIENTIST, V6, P230, DOI 10.1177/107385840000600405; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Tovar KR, 2002, NEURON, V34, P253; Underhill SM, 2007, NEUROBIOL DIS, V25, P284, DOI 10.1016/j.nbd.2006.09.011; van Damme P, 2005, NEURODEGENER DIS, V2, P147, DOI 10.1159/000089620; Van Den Bosch L, 2000, J NEUROL SCI, V180, P29, DOI 10.1016/S0022-510X(00)00414-7; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Verkhratsky A, 2007, NEUROSCIENTIST, V13, P28, DOI 10.1177/1073858406294270; YOSHIOKA A, 1995, J NEUROCHEM, V64, P2442; Zheng JQ, 1996, J NEUROSCI, V16, P1140	56	36	37	0	11	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro		2012	4	1					47	57	e00076	10.1042/AN20110031			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	925NI	WOS:000302767600005	22356284	gold, Green Published, Green Submitted			2022-02-06	
J	Lopez, V; Galano, GJ; Black, CM; Gupta, AT; James, DE; Kelleher, KM; Allen, AA				Lopez, Victor, Jr.; Galano, Gregory J.; Black, Christopher M.; Gupta, Arun T.; James, Douglas E.; Kelleher, Kristen M.; Allen, Answorth A.			Profile of an American Amateur Rugby Union Sevens Series	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						rugby sevens; rugby union; sports injuries; epidemiology	DATA-COLLECTION PROCEDURES; CONSENSUS STATEMENT; INJURY DEFINITIONS; EPIDEMIOLOGY; PLAYERS; JUNIOR	Background: Rugby union will enter the Olympic arena as Rugby Sevens in 2016. Purpose: To investigate the injury rate, injury type, and nature of injuries sustained in an amateur American rugby union sevens tournament series. Study Design: Descriptive epidemiology study. Methods: The rate, demographics, and characteristics of injury were evaluated in 1536 rugby union sevens players, from 128 sides, competing in 4 amateur 1-day tournaments in a USA Rugby local area rugby union. Results: Forty-eight injuries occurred over 4 tournaments, for an injury rate of 55.4 injuries per 1000 playing hours. Head and neck injuries were most common (33.3% of injuries), followed by upper extremity (31.3%), trunk (18.8%), lower extremity (14.6%), and physiologic injuries (2.1%). The most common type of injury was ligament sprain (25.0%); followed by concussion (14.6%), hematoma/ contusion (12.5%), muscle strain (10.4%), and abrasion (8.3%). Tackling was the most common mechanism of injury (74.5%). Males were injured at a significantly higher rate than females (RR, 7.5, P < .01), but no significant difference was observed based on player position (P = .08). Conclusion: Injuries are common among American amateur rugby athletes, with a substantial proportion involving the head and neck region. Clinical Relevance: Understanding injury patterns in an American rugby union will be important for formulating future injury prevention, assessment, and treatment protocols.	[Lopez, Victor, Jr.; Galano, Gregory J.; Black, Christopher M.; Gupta, Arun T.; James, Douglas E.; Kelleher, Kristen M.; Allen, Answorth A.] Hosp Special Surg, New York, NY 10021 USA		Allen, AA (corresponding author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.	allena@hss.edu		Black, Christopher/0000-0003-2934-108X			Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2007, CLIN J SPORT MED, V17, P177, DOI 10.1097/JSM.0b013e31803220b3; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2010, CLIN J SPORT MED, V20, P179, DOI 10.1097/JSM.0b013e3181df1eea; Fuller CW, 2010, J SCI MED SPORT, V13, P36, DOI 10.1016/j.jsams.2008.09.008; Gabbett TJ, 2008, J SCI MED SPORT, V11, P323, DOI 10.1016/j.jsams.2007.06.003; Gabbett TJ, 2004, SPORTS MED, V34, P849, DOI 10.2165/00007256-200434120-00004; Gabbett TJ, 2002, BRIT J SPORT MED, V36, P23, DOI 10.1136/bjsm.36.1.23; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P36, DOI 10.1136/bjsm.37.1.36; Gabbett TJ, 2003, BRIT J SPORT MED, V37, P43; Haseler CM, 2010, BRIT J SPORT MED, V44, P1093, DOI 10.1136/bjsm.2010.074021; Headey J, 2007, AM J SPORT MED, V35, P1537, DOI 10.1177/0363546507300691; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; Kjaer M., 2003, TXB SPORTS MED BASIC; Schick DM, 2008, BRIT J SPORT MED, V42, P447, DOI 10.1136/bjsm.2008.046672; Targett SGR, 1998, CLIN J SPORT MED, V8, P280, DOI 10.1097/00042752-199810000-00005	22	36	37	2	23	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JAN	2012	40	1					179	184		10.1177/0363546511427124			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	873CA	WOS:000298857200023	22102102				2022-02-06	
J	Leitgeb, J; Mauritz, W; Brazinova, A; Janciak, I; Majdan, M; Wilbacher, I; Rusnak, M				Leitgeb, Johannes; Mauritz, Walter; Brazinova, Alexandra; Janciak, Ivan; Majdan, Marek; Wilbacher, Ingrid; Rusnak, Martin			Effects of Gender on Outcomes After Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic brain injury; Gender; Outcome	PROGNOSTIC VALUE; HEAD-INJURIES; IMPACT; MANAGEMENT; MORTALITY; SCALE; AGE	Background: It has been reported that female gender may be an independent risk factor for poor outcome after traumatic brain injury (TBI). The goal of this study was to investigate gender differences in outcome after TBI. Methods: Between February 2002 and April 2010, 17 Austrian centers prospectively enrolled 863 patients with moderate and severe TBI into observational studies. Data on crash, treatment, and outcomes were collected. Data sets from patients who had isolated TBI were selected. Six-month outcomes were classified as "favorable" if Glasgow Outcome Scale scores were 5 or 4 and were classified as "unfavorable" if Glasgow Outcome Scale scores were 3 or less. The Rotterdam score was used to classify computed tomography (CT) findings. Univariate statistics (Fisher's exact test, t test, chi(2) test) and logistic regression were used to identify factors associated with hospital mortality and favorable outcome. Results: There were 134 female and 305 male patients. Hospital mortality was 39.6% for females and 32.5% for males (p = 0.16). Rates of unfavorable outcome were 58.7% for females and 53.4% for males (p = 0.09). There were no significant mortality differences between females and males for factors such as age groups, trauma mechanisms, Glasgow Coma Scale scores, lesions on the CT scan, or treatment factors. Logistic regression revealed that gender had no significant influence on mortality of unfavorable outcome. The differences in outcome were due to the higher mean age of females (61.4 vs. 50.4, p < 0.001) and possibly because of small differences in Glasgow Coma Scale scores and in CT scores. Conclusions: Female gender is not an independent risk factor for in-hospital mortality after TBI.	[Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria; [Mauritz, Walter; Brazinova, Alexandra; Janciak, Ivan; Majdan, Marek; Wilbacher, Ingrid; Rusnak, Martin] INRO, Vienna, Austria; [Mauritz, Walter] Trauma Hosp Lorenz Boehler, Dept Anesthesiol & Intens Care Med, Vienna, Austria; [Brazinova, Alexandra; Majdan, Marek; Rusnak, Martin] Trnava Univ, Fac Hlth & Social Serv, Dept Publ Hlth, Trnava, Slovakia		Leitgeb, J (corresponding author), Med Univ Vienna, Dept Traumatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	johannes.leitgeb@meduniwien.ac.at	Rusnak, Martin/K-9349-2016; Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012	Rusnak, Martin/0000-0003-3321-1042; Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X; Mauritz, Walter/0000-0001-9043-3712	Austrian Worker's Compensation Board (AUVA) [FK 33/2003]; Austrian National Bank [8987]; Ministry of Health; AUVA [FK 11/2008, FK 11/2010]	Supported by the Austrian Worker's Compensation Board (AUVA; FK 33/2003) and by the "Jubilee Fund" of the Austrian National Bank (Project 8987), and for a project funded by the Ministry of Health (Contract October 15, 2008) and the AUVA (FK 11/2008 and FK 11/2010).	Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Farace E, 2000, Neurosurg Focus, V8, pe6; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	22	36	38	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1620	1626		10.1097/TA.0b013e318226ea0e			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	869RT	WOS:000298616400032	21808209				2022-02-06	
J	Boyko, M; Zlotnik, A; Gruenbaum, BF; Gruenbaum, SE; Ohayon, S; Kuts, R; Melamed, I; Regev, A; Shapira, Y; Teichberg, VI				Boyko, Matthew; Zlotnik, Alexander; Gruenbaum, Benjamin F.; Gruenbaum, Shaun E.; Ohayon, Sharon; Kuts, Ruslan; Melamed, Israel; Regev, Adi; Shapira, Yoram; Teichberg, Vivian I.			Pyruvate's blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						glutamate-pyruvate transaminase; middle cerebral artery occlusion; neuroprotection; pyruvate; stroke; traumatic brain injury	CEREBRAL-ARTERY OCCLUSION; OXALOACETATE TRANSAMINASE; CEREBROSPINAL-FLUID; ISCHEMIC-STROKE; AMINO-ACIDS; BRAIN; RELEASE; METABOLISM; TRANSIENT; PROTECTS	In previous studies, we have shown that by increasing the brain-to-blood glutamate efflux upon scavenging blood glutamate with either oxaloacetate or pyruvate, one achieves highly significant neuroprotection particularly in the context of traumatic brain injury. The current study examines, for the first time, how the blood glutamate scavenging properties of glutamatepyruvate transaminase (GPT), alone or in combination with pyruvate, may contribute to the spectrum of its neuroprotective mechanisms and improve the outcome of rats exposed to brain ischemia, as they do after head trauma. Rats that were exposed to permanent middle cerebral artery occlusion (MCAO) and treated with intravenous 250 mg/kg pyruvate had a smaller volume of infarction and reduced brain edema, resulting in an improved neurological outcome and reduced mortality compared to control rats treated with saline. Intravenous pyruvate at the low dose of 31.3 mg/kg did not demonstrate any neuroprotection. However, when combined with 0.6 mg/kg of GPT there was a similar neuroprotection observed as seen with pyruvate at 250 mg/kg. Animals treated with 1.69 g/kg glutamate had a worse neurological outcome and a larger extent of brain edema. The decrease in mortality, infarcted brain volume and edema, as well as the improved neurological outcome following MCAO, was correlated with a decrease in blood glutamate levels. We therefore suggest that the blood glutamate scavenging activity of GPT and pyruvate contributes to the spectrum of their neuroprotective mechanisms and may serve as a new neuroprotective strategy for the treatment of ischemic stroke.	[Boyko, Matthew; Zlotnik, Alexander; Gruenbaum, Benjamin F.; Ohayon, Sharon; Kuts, Ruslan; Shapira, Yoram] Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol & Crit Care, IL-84833 Beer Sheva, Israel; [Gruenbaum, Shaun E.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Melamed, Israel] Soroka Med Ctr, Dept Neurosurg, IL-84101 Beer Sheva, Israel; [Regev, Adi] Soroka Med Ctr, Clin Res Ctr, IL-84101 Beer Sheva, Israel; [Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel		Boyko, M (corresponding author), Ben Gurion Univ Negev, Soroka Med Ctr, Div Anesthesiol & Crit Care, 36 Hanoch Albek Str, IL-84833 Beer Sheva, Israel.	matthewboykoresearch@gmail.com		Boyko, Matthew/0000-0003-3116-1643	Nella and Leon Benoziyo Center for Neurological Diseases; Irwin Green Alzheimer's Research Fund; Carl and Micaela Einhorn-Dominic Institute for Brain Research; estate of Lola Asseof	The authors gratefully acknowledge Dr M. Dubilet, Resident, Division of Anesthesiology, Soroka Medical Center, for his help in the laboratory as well as in the histology analysis. The authors further want to thank Valeria Frishman, lab assistant at the Department of Clinical Biochemistry, Soroka Medical Center, Ben-Gurion University of the Negev, for her outstanding help with the biochemical analysis. The help of Shira Ovadia, Director of Animal Resources Unit, is also gratefully acknowledged. Many thanks to A. Alir and to the staff at the Critical Care Unit, Soroka Medical Center, for their support and helpful discussions. The data obtained are part of M.B.'s PhD thesis. This work was supported in part by grants to V.I.T. from the Nella and Leon Benoziyo Center for Neurological Diseases; the Irwin Green Alzheimer's Research Fund, the Carl and Micaela Einhorn-Dominic Institute for Brain Research and the estate of Lola Asseof. V.I.T. is the incumbent of the Louis and Florence Katz Cohen Professorial Chair of Neuropharmacology.	BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; BERL S, 1962, J BIOL CHEM, V237, P2562; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; Desagher S, 1997, J NEUROSCI, V17, P9060; GOODWIN TW, 1952, BIOCHEM J, V51, P708, DOI 10.1042/bj0510708; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Guyot LL, 2001, NEUROSCI LETT, V299, P37, DOI 10.1016/S0304-3940(01)01510-5; Han F, 2008, NEUROSCI LETT, V430, P275, DOI 10.1016/j.neulet.2007.11.021; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; KAPLAN B, 1991, STROKE, V22, P1032, DOI 10.1161/01.STR.22.8.1032; Kim JB, 2005, BRAIN RES, V1060, P188, DOI 10.1016/j.brainres.2005.08.029; Koura SS, 1998, ACT NEUR S, V71, P244; Lee JY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0002.2001; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MENZIES SA, 1992, NEUROSURGERY, V31, P100, DOI 10.1227/00006123-199207000-00014; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI 10.1084/jem.165.2.500; Sharma P, 2003, BRAIN RES, V992, P104, DOI 10.1016/j.brainres.2003.08.043; Stover JF, 2005, ACTA NEUROCHIR, V147, P847, DOI 10.1007/s00701-005-0562-y; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wang Q, 2009, NEUROBIOL DIS, V36, P223, DOI 10.1016/j.nbd.2009.07.018; Warlow CP, 1998, LANCET S3, V352, pS1; Xu XH, 2006, LIFE SCI, V78, P704, DOI 10.1016/j.lfs.2005.05.080; Yi JS, 2007, NEUROBIOL DIS, V26, P94, DOI 10.1016/j.nbd.2006.12.007; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	41	36	37	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	NOV	2011	34	9					1432	1441		10.1111/j.1460-9568.2011.07864.x			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849TD	WOS:000297147200009	21936878				2022-02-06	
J	Hutchison, M; Comper, P; Mainwaring, L; Richards, D				Hutchison, Michael; Comper, Paul; Mainwaring, Lynda; Richards, Doug			The Influence of Musculoskeletal Injury on Cognition Implications for Concussion Research	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; musculoskeletal injury; sport; neuropsychological testing	MILD HEAD-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; FOOTBALL PLAYERS; HIGH-SCHOOL; SPORTS; RECOVERY; RELIABILITY; PERFORMANCE; IMPAIRMENT; DEFICITS	Background: Safe return-to-play decisions after concussion can be challenging for sports medicine specialists. Neuropsychological testing is recommended to objectively measure concussion-related cognitive impairments. Purpose: The objective of this study was to measure cognitive functioning among 3 specific athletic groups: (1) athletes with no injuries (n = 36), (2) athletes with musculoskeletal injuries (n = 18), and (3) athletes with concussion (n = 18). Study Design: Case-control study; Level of evidence, 3. Methods: Seventy-two intercollegiate athletes completed preseason baseline cognitive testing and follow-up assessment using the Automated Neuropsychological Assessment Metrics (ANAM) test battery. Injured athletes were tested within 72 hours of injury. A 1-way analysis of covariance adjusted for baseline scores was performed to determine if differences existed in cognitive test scores among the 3 groups. Results: A group of athletes with concussion performed significantly worse than a group of athletes with no injuries on the following subtests of the ANAM at follow-up: Code Substitution Learning, Match to Sample, and Simple Reaction. Athletes with musculoskeletal injuries performed significantly worse than those with no injury on the Match to Sample subtest. No significant differences between athletes with concussion and athletes with musculoskeletal injuries were found on all ANAM subtests. Conclusion: Concussion produces cognitive impairment in the acute recovery period. Interestingly, athletes with musculoskeletal injuries also display a degree of cognitive impairment as measured by computerized tests. Clinical Relevance: Although these findings support previous research that neuropsychological tests can effectively measure concussion-related cognitive impairment, this study provides evidence that athletic injury, in general, also may produce a degree of cognitive disruption. Therefore, a narrow interpretation of scores of neuropsychological tests in a sports concussion context should be avoided.	[Hutchison, Michael] Univ Toronto, Grad Dept Rehabil Sci, Fac Med, Toronto, ON M5G 1V7, Canada		Hutchison, M (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, Fac Med, 500 Univ Ave, Toronto, ON M5G 1V7, Canada.	michael.hutchison@utoronto.ca			Faculty of Physical Education and Health, University of TorontoUniversity of Toronto; Varsity Blues athletic teams; Physicians Incorporated Services (PSI)	The authors thank the Faculty of Physical Education and Health, University of Toronto, and the coaches and athletes of the Varsity Blues athletic teams for their support and contribution. They also thank the research assistants of the University of Toronto Concussion Program, particularly Sam Esfandiari and Sandra Sokoloff, for their assistance in the preparation and review of the article. Finally, the research team is grateful to Physicians Incorporated Services (PSI) for financial support during the study period.	Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Holmes AJ, 2007, EMOTION, V7, P68, DOI 10.1037/1528-3542.7.1.68; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Jones WP, 2008, CLIN NEUROPSYCHOL, V22, P305, DOI 10.1080/13854040701281483; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; RICHARDS D, 2009, BRIT J SPORT MED, V43, P98, DOI DOI 10.1136/BJSM.2008.046680; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; Woodard J., 2002, J INT NEUROPSYCHOLOG, V8, P175	35	36	36	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	NOV	2011	39	11					2331	2337		10.1177/0363546511413375			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	838KG	WOS:000296287900007	21768531				2022-02-06	
J	Hand, CC; Brines, M				Hand, Carla Cerami; Brines, Michael			Promises and Pitfalls in Erythopoietin-Mediated Tissue Protection: Are Nonerythropoietic Derivatives a Way Forward?	JOURNAL OF INVESTIGATIVE MEDICINE			English	Article						inflammation; cytoprotection; apoptosis; cytokines; innate immune response	RECOMBINANT-HUMAN-ERYTHROPOIETIN; ISCHEMIA-REPERFUSION INJURY; FOCAL CEREBRAL-ISCHEMIA; SQUAMOUS-CELL CARCINOMA; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; NEURONS IN-VITRO; CARBAMYLATED ERYTHROPOIETIN; RECEPTOR EXPRESSION; PLATELET REACTIVITY	The essential biological role of erythropoietin (EPO) in maintaining erythrocyte mass has been well understood for many years. Although EPO is required for the maturation of red cells, it also has strong procoagulant effects on the vascular endothelium and platelets, which limit erythrocyte losses after hemorrhage. Like other members of the type 1 cytokine superfamily, EPO has multiple biological activities. For the past 10 years, multiple investigators have shown that EPO acts as a locally produced antagonist of proinflammatory cytokines that are generated by the innate immune response in response to infection, trauma, or metabolic stress. Specifically, EPO inhibits apoptosis of cells surrounding a locus of injury, reduces the influx of inflammatory cells, and recruits tissue-specific stem cells and endothelial progenitor cells. Available evidence suggests that these multiple, nonerythropoietic effects of EPO are mediated by a tissue protective receptor (TPR) that is distinct from the homodimeric receptor responsible for erythropoiesis. Notably, activation of the TPR requires a higher concentration of EPO than is needed for maximal erythropoiesis. Unfortunately, these higher concentrations of EPO also stimulate hematopoietic and procoagulant pathways, which can cause adverse effects and, therefore, potentially limit the clinical use of EPO for tissue protection. To circumvent these problems, the EPO molecule has been successfully modified in a variety of ways to interact only with the TPR. Early clinical experience has shown that these compounds appear to be safe, and proof of concept trials are ready to begin.	[Brines, Michael] Warren Pharmaceut, Ossining, NY 10562 USA; [Hand, Carla Cerami] Univ N Carolina, Chapel Hill, NC USA		Brines, M (corresponding author), Warren Pharmaceut, 712 Kitchawan Rd, Ossining, NY 10562 USA.	mbrines@warrenpharma.com	Brinesd, Michael/AAE-6072-2020	Cerami, Carla/0000-0002-7634-0955; Brines, Michael/0000-0003-4151-4449	National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R13 RR023236]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [R13RR023236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R56AI085201] Funding Source: NIH RePORTER	Supported in part by a grant from the National Center for Research Resources (R13 RR023236).	Abdelrahman M, 2004, SHOCK, V22, P63, DOI 10.1097/01.shk.00001276869.21260.9d; Acs G, 2003, AM J PATHOL, V162, P1789, DOI 10.1016/S0002-9440(10)64314-3; Acs G, 2001, CANCER RES, V61, P3561; Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; ANAGNOSTOU A, 1990, P NATL ACAD SCI USA, V87, P5978, DOI 10.1073/pnas.87.15.5978; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Baker JE, 2005, VASC PHARMACOL, V42, P233, DOI 10.1016/j.vph.2005.02.004; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Binbrek AS, 2009, AM J CARDIOL, V104, P1035, DOI 10.1016/j.amjcard.2009.05.050; Bohlius J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007303.pub2; Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; BOISSEL JP, 1993, J BIOL CHEM, V268, P15983; Brines M, 2008, J INTERN MED, V264, P405, DOI 10.1111/j.1365-2796.2008.02024.x; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines M, 2008, P NATL ACAD SCI USA, V105, P10925, DOI 10.1073/pnas.0805594105; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Byts N, 2008, CELL DEATH DIFFER, V15, P783, DOI 10.1038/cdd.2008.1; Cai ZQ, 2004, CIRCULATION, V109, P2050, DOI 10.1161/01.CIR.0000127954.98131.23; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Casals-Pascual C, 2008, P NATL ACAD SCI USA, V105, P2634, DOI 10.1073/pnas.0709715105; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Cheetham JC, 1998, NAT STRUCT BIOL, V5, P861, DOI 10.1038/2302; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Chin K, 2000, MOL BRAIN RES, V81, P29, DOI 10.1016/S0169-328X(00)00157-1; Coleman TR, 2006, P NATL ACAD SCI USA, V103, P5965, DOI 10.1073/pnas.0601377103; Depping R, 2005, J THORAC CARDIOV SUR, V130, P877, DOI 10.1016/j.jtcvs.2004.12.041; Diskin CJ, 2008, SEMIN DIALYSIS, V21, P447, DOI 10.1111/j.1525-139X.2008.00443.x; Ehrenreich H, 2007, MOL PSYCHIATR, V12, P206, DOI 10.1038/sj.mp.4001907; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ehrenreich H, 2007, BRAIN, V130, P2577, DOI 10.1093/brain/awm203; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Elliott S, 1997, BLOOD, V89, P493, DOI 10.1182/blood.V89.2.493; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Erbayraktar S, 2006, MOL MED, V12, P74, DOI 10.2119/2006-00042.Erbayraktar; Fandrey J, 2009, ONCOLOGIST, V14, P34, DOI 10.1634/theoncologist.2009-S1-34; Fantacci M, 2006, P NATL ACAD SCI USA, V103, P17531, DOI 10.1073/pnas.0608814103; FERRARIO M, 2009, INT J CARDIOL; Fiordaliso F, 2005, P NATL ACAD SCI USA, V102, P2046, DOI 10.1073/pnas.0409329102; Fisher JW, 2003, EXP BIOL MED, V228, P1; Fu P, 2009, BIOCHEM BIOPH RES CO, V379, P696, DOI 10.1016/j.bbrc.2008.12.146; Fu ZQ, 2010, J NEUROIMMUNOL, V221, P15, DOI 10.1016/j.jneuroim.2010.01.016; Gorio A, 2005, P NATL ACAD SCI USA, V102, P16379, DOI 10.1073/pnas.0508479102; Grasso G, 2006, J NEUROSURG-SPINE, V4, P310, DOI 10.3171/spi.2006.4.4.310; Grasso G, 2001, J Neurosurg Sci, V45, P7; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Gunnarson E, 2009, P NATL ACAD SCI USA, V106, P1602, DOI 10.1073/pnas.0812708106; Haiden N, 2005, THROMB HAEMOSTASIS, V93, P118, DOI 10.1160/TH04-02-0093; Hardee ME, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000549; Haroon ZSA, 2003, AM J PATHOL, V163, P993, DOI 10.1016/S0002-9440(10)63459-1; Imamura R, 2008, CELL TRANSPLANT, V17, P135, DOI 10.3727/000000008783907044; Jerndal M, 2010, J CEREBR BLOOD F MET, V30, P961, DOI 10.1038/jcbfm.2009.267; Jubinsky PT, 1997, BLOOD, V90, P1867, DOI 10.1182/blood.V90.5.1867; Kaiser K, 2006, J INFECT DIS, V193, P987, DOI 10.1086/500844; Kato S, 2010, J PHARMACOL SCI, V112, P167, DOI 10.1254/jphs.09262FP; Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025; Kim KH, 2008, J PHARMACOL EXP THER, V324, P160, DOI 10.1124/jpet.107.125773; King VR, 2007, EUR J NEUROSCI, V26, P90, DOI 10.1111/j.1460-9568.2007.05635.x; Kirkeby A, 2008, THROMB HAEMOSTASIS, V99, P720, DOI 10.1160/TH07-03-0208; KONISHI Y, 1993, BRAIN RES, V609, P29, DOI 10.1016/0006-8993(93)90850-M; Kumar SM, 2006, MELANOMA RES, V16, P275, DOI 10.1097/01.cmr.0000222594.60611.c3; Lauria G, 2009, AMYOTROPH LATERAL SC, V10, P410, DOI 10.3109/17482960902995246; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Liu WM, 2004, ONCOGENE, V23, P981, DOI 10.1038/sj.onc.1207294; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Mancini DM, 2003, CIRCULATION, V107, P294, DOI 10.1161/01.CIR.0000044914.42696.6A; Masuda S, 2000, AM J PHYSIOL-ENDOC M, V278, pE1038, DOI 10.1152/ajpendo.2000.278.6.E1038; MASUDA S, 1993, J BIOL CHEM, V268, P11208; Mennini T, 2006, MOL MED, V12, P153, DOI 10.2119/2006-00045.Mennini; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; Miskowiak K, 2007, BIOL PSYCHIAT, V62, P1244, DOI 10.1016/j.biopsych.2007.01.011; Miskowiak KW, 2009, PSYCHOPHARMACOLOGY, V207, P133, DOI 10.1007/s00213-009-1641-1; Mohyeldin A, 2005, NEOPLASIA, V7, P537, DOI 10.1593/neo.04685; Napolitano LM, 2008, J TRAUMA, V65, P285, DOI 10.1097/TA.0b013e31817f2c6e; Paragh G, 2009, AM J PATHOL, V174, P1504, DOI 10.2353/ajpath.2009.080592; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Rafiee P, 2005, BASIC RES CARDIOL, V100, P187, DOI 10.1007/s00395-004-0508-1; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; ROSTI V, 1993, HAEMATOLOGICA, V78, P208; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Santhanam AVR, 2006, ACTA PHARMACOL SIN, V27, P1389, DOI 10.1111/j.1745-7254.2006.00441.x; Sautina L, 2010, BLOOD, V115, P896, DOI 10.1182/blood-2009-04-216432; Savino C, 2006, J NEUROIMMUNOL, V172, P27, DOI 10.1016/j.jneuroim.2005.10.016; Sinclair AM, 2008, BRIT J CANCER, V98, P1059, DOI 10.1038/sj.bjc.6604220; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Stasko J, 2007, CLIN APPL THROMB-HEM, V13, P410, DOI 10.1177/1076029607303348; Stohlawetz PJ, 2000, BLOOD, V95, P2983, DOI 10.1182/blood.V95.9.2983.009k27_2983_2989; Swift S, 2010, BLOOD, V115, P4254, DOI 10.1182/blood-2009-10-248674; TABIRA T, 1995, INT J DEV NEUROSCI, V13, P241, DOI 10.1016/0736-5748(94)00020-4; Tramontano AF, 2003, BIOCHEM BIOPH RES CO, V308, P990, DOI 10.1016/S0006-291X(03)01503-1; Um M, 2007, CELL SIGNAL, V19, P634, DOI 10.1016/j.cellsig.2006.08.014; van der Meer P, 2009, HEART, V95, P1309, DOI 10.1136/hrt.2008.161091; Vitellaro-Zuccarello L, 2008, NEUROSCIENCE, V151, P452, DOI 10.1016/j.neuroscience.2007.11.004; Viviani B, 2005, J NEUROCHEM, V93, P412, DOI 10.1111/j.1471-4159.2005.03033.x; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; WEN DY, 1994, J BIOL CHEM, V269, P22839; Westenfelder C, 2000, KIDNEY INT, V58, P647, DOI 10.1046/j.1523-1755.2000.00211.x; Wiese L, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-3; Wojchowski DM, 1999, EXP CELL RES, V253, P143, DOI 10.1006/excr.1999.4673; Wolf RF, 1997, THROMB HAEMOSTASIS, V78, P1505; Wolf RF, 1997, THROMB HAEMOSTASIS, V77, P1020; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje; Xu X, 2009, SURGERY, V146, P506, DOI 10.1016/j.surg.2009.03.022; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; Yasuda Y, 2001, BRIT J CANCER, V84, P836, DOI 10.1054/bjoc.2000.1666; Yasuda Y, 1998, J BIOL CHEM, V273, P25381, DOI 10.1074/jbc.273.39.25381; Yoo JY, 2009, J NEUROSCI RES, V87, P150, DOI 10.1002/jnr.21832; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924; Zechariah A, 2010, STROKE, V41, P1008, DOI 10.1161/STROKEAHA.109.574418; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077; Zhu CL, 2009, PEDIATRICS, V124, pE218, DOI 10.1542/peds.2008-3553	118	36	38	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1081-5589	1708-8267		J INVEST MED	J. Invest. Med.	OCT	2011	59	7					1073	1082					10	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	823JH	WOS:000295117800014	20683348	Green Accepted			2022-02-06	
J	Rigg, JL; Mooney, SR				Rigg, John L.; Mooney, Scott R.			Concussions and the Military: Issues Specific to Service Members	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; BODY SKILLS GROUPS; POSTCONCUSSIVE SYMPTOMS; BASE RATES; RANDOMIZED-TRIAL; DEPRESSION; INTERVENTIONS; ASSOCIATION; AFGHANISTAN	Since October 2001, more than 1.6 million American military service members have deployed to Iraq and Afghanistan in the Global War on Terrorism. It is estimated that between 5% and 35% of them have sustained a concussion, also called mild traumatic brain injury (mTBI), during their deployment. Up to 80% of the concussions experienced in theater are secondary to blast exposures. The unique circumstances and consequences of sustaining a concussion in combat demands a unique understanding and treatment plan. The current literature was reviewed and revealed a paucity of pathophysiological explanations on the nature of the injury and informed treatment plans. However, through observation and experience, a theoretical but scientifically plausible model for why and how blast injuries experienced in combat give rise to the symptoms that affect day-to-day function of service members who have been concussed has been developed. We also are able to offer treatment strategies based on our evaluation of the current literature and experience to help palliate postconcussive symptoms. The purpose of this review is to elucidate common physical, cognitive, emotional, and situational challenges, and possible solutions for this special population of patients who will be transitioning into the civilian sector and interfacing with health professionals. There is a need for further investigation and testing of these strategies. PM R 2011;3:S380-S386	[Rigg, John L.; Mooney, Scott R.] Dwight D Eisenhower Army Med Ctr, Traumat Brain Injury Program, Neurosci & Rehabil Ctr, Ft Gordon, GA USA		Rigg, JL (corresponding author), Dwight D Eisenhower Army Med Ctr, Traumat Brain Injury Program, Neurosci & Rehabil Ctr, Ft Gordon, GA USA.	john.l.rigg@us.army.mil					Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bolton P, 2007, JAMA-J AM MED ASSOC, V298, P519, DOI 10.1001/jama.298.5.519; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Farag E, 2011, MINERVA ANESTESIOL, V77, P366; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Finkel MF, 2006, J NEUROL SCI, V249, P63, DOI 10.1016/j.jns.2006.06.005; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Gordon JS, 2008, J CLIN PSYCHIAT, V69, P1469, DOI 10.4088/JCP.v69n0915; Gordon JS, 2004, J TRAUMA STRESS, V17, P143, DOI 10.1023/B:JOTS.0000022620.13209.a0; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hosek J, 2006, MG432RC RAND CORP; Hovda D, DIRECTOR UCLA BRAIN; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; Lange RT, 2008, CLIN NEUROPSYCHOL, V22, P209, DOI 10.1080/13854040701290062; Larabee GP, 2005, ASSESSMENT MALINGERE; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Ness D, 2010, J NEUROL PHYS THER, V31, P30; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Paniak C, 2000, BRAIN INJURY, V14, P219; Sacho RH, 2010, J NEUROTRAUM, V27, P2157, DOI 10.1089/neu.2010.1384; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shapiro AP, 2004, BRIT J PSYCHIAT, V185, P140, DOI 10.1192/bjp.185.2.140; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Silver FW, 1996, AM J PHYS MED REHAB, V75, P134, DOI 10.1097/00002060-199603000-00013; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Staples JK, 2005, ALTERN THER HEALTH M, V11, P36; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	50	36	37	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S380	S386		10.1016/j.pmrj.2011.08.005			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	966YK	WOS:000305873100005	22035680				2022-02-06	
J	Barlow, M; Schlabach, D; Peiffer, J; Cook, C				Barlow, Michael; Schlabach, Drew; Peiffer, Jeffery; Cook, Chad			DIFFERENCES IN CHANGE SCORES AND THE PREDICTIVE VALIDITY OF THREE COMMONLY USED MEASURES FOLLOWING CONCUSSION IN THE MIDDLE SCHOOL AND HIGH SCHOOL AGED POPULATION	INTERNATIONAL JOURNAL OF SPORTS PHYSICAL THERAPY			English	Article						Concussion; Diagnostic accuracy; Post-concussion syndrome; Validity		Background: A battery of tests is commonly used to measure disability with and recovery from concussion. A number of different concussion-oriented assessment tests exist and each is considered useful. To the authors' knowledge, no study has compared the scores of these tests during recovery in the middle school and high school aged population to see how each change over time. Purpose: The purposes of this study were to analyze clinical data of concussed middle school and high school aged athletes to determine the concurrent and predictive validity for post-concussion syndrome (PCS) of the Post-Concussion Symptom Scale (PCSS), Balance Error Scoring System (BESS), and the five subscales of the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT). Methods: The study was a retrospective chart review performed on middle school and high school aged individuals with a diagnosis of concussion from the years 2008-2010 within the Akron Children's Hospital Sports Medicine system. To be eligible for inclusion in the dataset, each subject required a baseline measurement for each of the three tests (and all five subscales of the ImPACT) and a post-test measure. The mean age of the population was 15.38 years (SD= 1.7) and ranged from 11 to 19 years. Pearson product correlation tests (correlation matrix) were used to analyze the concurrent validity of the test items during recovery following a concussion. Receiver operating characteristics (ROC) curves were used to determine the predictive validity of initial scores for developing PCS. Results: The correlation matrix captured five statistically significant findings; however, these suggested only weak to mild correlations. Five test items yielded an area under the curve (AUC) greater than 0.50 but only one was statistically significant. After qualitative evaluation, only one of the three tests (including the five subscales of the ImPACT) was useful in predicting post-concussion syndrome. Conclusion: This study suggests that there is poor concurrent validity among three commonly used concussion tests and there is no baseline score that predicts whether post-concussion syndrome will occur.	[Barlow, Michael; Schlabach, Drew] Walsh Univ, Div Phys Therapy, North Canton, OH USA; [Peiffer, Jeffery] Akron Childrens Hosp, Akron, OH USA; [Cook, Chad] Walsh Univ, 2020 East Maple, North Canton, OH 44720 USA		Cook, C (corresponding author), Walsh Univ, 2020 East Maple, North Canton, OH 44720 USA.	ccook@walsh.edu					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cantu RC, 2009, NEUROSURGERY, V64, P786, DOI 10.1227/01.NEU.0000348539.13887.D3; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P785; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Faul M, 2010, TRAUMATIC BRAIN INJU; Finnoff JT, 2010, AM J SPORTS MED, V38, P47; Foy K, 2009, BRIT J HOSP MED, V70, P440, DOI 10.12968/hmed.2009.70.8.43536; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Howard B., 2009, HIGH SCH SPORTS PART; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kissick J, 2005, CLIN J SPORT MED, V15, P426, DOI 10.1097/01.jsm.0000186683.59158.8b; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	42	36	36	0	1	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	2159-2896			INT J SPORTS PHYS TH	Int. J. Sports Phys. Ther.	SEP	2011	6	3					150	157					8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VA0PI	WOS:000409609000001	21904694				2022-02-06	
J	Izzetoglu, K; Ayaz, H; Merzagora, A; Izzetoglu, M; Shewokis, PA; Bunce, SC; Pourrezaei, K; Rosen, A; Onaral, B				Izzetoglu, Kurtulus; Ayaz, Hasan; Merzagora, Anna; Izzetoglu, Meltem; Shewokis, Patricia A.; Bunce, Scott C.; Pourrezaei, Kambiz; Rosen, Arye; Onaral, Banu			THE EVOLUTION OF FIELD DEPLOYABLE fNIR SPECTROSCOPY FROM BENCH TO CLINICAL SETTINGS	JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES			English	Article						Functional near-infrared spectroscopy; fNIR; TBI; anesthesia; BCI; pediatric pain	NEAR-INFRARED SPECTROSCOPY; CEREBRAL-BLOOD; HEMODYNAMIC-RESPONSE; BRAIN ACTIVITY; ACTIVATION; STIMULATION; OXYGENATION; TISSUE; SEVOFLURANE; PROPOFOL	In the late 1980s and early 1990s, Dr. Britton Chance and his colleagues, using picosecond-long laser pulses, spearheaded the development of time-resolved spectroscopy techniques in an effort to obtain quantitative information about the optical characteristics of the tissue. These efforts by Chance and colleagues expedited the translation of near-infrared spectroscopy (NIRS)-based techniques into a neuroimaging modality for various cognitive studies. Beginning in the early 2000s, Dr. Britton Chance guided and steered the collaboration with the Optical Brain Imaging team at Drexel University toward the development and application of a field deployable continuous wave functional near-infrared spectroscopy (fNIR) system as a means to monitor cognitive functions, particularly during attention and working memory tasks as well as for complex tasks such as war games and air traffic control scenarios performed by healthy volunteers under operational conditions. Further, these collaborative efforts led to various clinical applications, including traumatic brain injury, depth of anesthesia monitoring, pediatric pain assessment, and brain-computer interface in neurology. In this paper, we introduce how these collaborative studies have made fNIR an excellent candidate for specified clinical and research applications, including repeated cortical neuroimaging, bedside or home monitoring, the elicitation of a positive effect, and protocols requiring ecological validity. This paper represents a token of our gratitude to Dr. Britton Chance for his influence and leadership. Through this manuscript we show our appreciation by contributing to his commemoration and through our work we will strive to advance the field of optical brain imaging and promote his legacy.	[Izzetoglu, Kurtulus; Ayaz, Hasan; Merzagora, Anna; Izzetoglu, Meltem; Shewokis, Patricia A.; Pourrezaei, Kambiz; Rosen, Arye; Onaral, Banu] Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Shewokis, Patricia A.] Drexel Univ, Coll Nursing & Hlth Profess, Philadelphia, PA 19104 USA; [Bunce, Scott C.] Penn State Coll Med, Ctr Emerging Neurotechnol & Imaging, Hershey, PA USA; [Bunce, Scott C.] Penn State Coll Med, Dept Psychiat, Hershey, PA USA		Izzetoglu, K (corresponding author), Sch Biomed Engn Sci & Hlth Syst, 3141 Chestnut St, Philadelphia, PA 19104 USA.	ki25@drexel.edu	Ayaz, Hasan/A-3274-2008; Izzetoglu, Kurtulus/AAB-6402-2020; Shewokis, Patricia A./C-5201-2014	Izzetoglu, Kurtulus/0000-0001-5304-7361; Shewokis, Patricia A./0000-0001-9246-9495; Ayaz, Hasan/0000-0001-5514-2741	Defense Advanced Research Projects Agency (DARPA) Augmented Cognition ProgramUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); Office of Naval Research (ONR)Office of Naval Research [N00014-02-1-0524, N00014-01-1-0986]; Wallace H. Coulter Foundation; U.S. Army Medical Research Acquisition Activity [W81XWH-08-2-0573]	We acknowledge with thanks Dr. Shoko Nioka for her support and guidance throughout the development of technology; Drs. George Mychaskiw, Harel Rosen, Jay Horrow, Jose Leon-Carrion, and Maria Schultheis for their leadership, support, and guidance during the clinical studies; Ajit Devaraj, Alper Bozkurt, Frank Kepics, Gunay Yurtsever, and Mauricio Rodriguez for their hardware support in helping to develop various fNIR systems. These studies have been sponsored in part by funds from the Defense Advanced Research Projects Agency (DARPA) Augmented Cognition Program and the Office of Naval Research (ONR), under agreement numbers N00014-02-1-0524 and N00014-01-1-0986; Wallace H. Coulter Foundation, U.S. Army Medical Research Acquisition Activity; Cooperative Agreement W81XWH-08-2-0573.	Abdelnour AF, 2009, NEUROIMAGE, V46, P133, DOI 10.1016/j.neuroimage.2009.01.033; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; Ang KK, 2010, IEEE IJCNN; Ayaz H., 2010, ADV UNDERSTANDING HU, P21, DOI DOI 10.1201/EBK1439835012-C3; Ayaz H, 2007, 2007 3RD INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, VOLS 1 AND 2, P342, DOI 10.1109/CNE.2007.369680; Ayaz H, 2011, JOVE-J VIS EXP, DOI 10.3791/3443; Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Ayaz H, 2009, LECT NOTES ARTIF INT, V5638, P699, DOI 10.1007/978-3-642-02812-0_79; Bartocci M, 2006, PAIN, V122, P109, DOI 10.1016/j.pain.2006.01.015; Bauernfeind G, 2008, BIOMED TECH, V53, P36, DOI 10.1515/BMT.2008.005; Bedforth NM, 2000, ANESTH ANALG, V91, P152, DOI 10.1097/00000539-200007000-00028; Birbaumer N, 2006, CLIN NEUROPHYSIOL, V117, P479, DOI 10.1016/j.clinph.2005.11.002; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Boas DA, 2002, METH NE FRO NEUROSCI, P193; Bozkurt A, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-29; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Chance B, 1998, OPT EXPRESS, V2, P411, DOI 10.1364/OE.2.000411; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Coyle S, 2004, PHYSIOL MEAS, V25, P815, DOI 10.1088/0967-3334/25/4/003; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; DELPY DT, 1987, SCAND J CLIN LAB INV, V47, P9; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Dubroff JG, 2008, SEMIN NEUROL, V28, P548, DOI 10.1055/s-0028-1083698; Eschweiler GW, 2000, PSYCHIAT RES-NEUROIM, V99, P161, DOI 10.1016/S0925-4927(00)00062-7; Fallgatter AJ, 2000, SCHIZOPHRENIA BULL, V26, P913, DOI 10.1093/oxfordjournals.schbul.a033505; FISHKIN JB, 1993, J OPT SOC AM A, V10, P127, DOI 10.1364/JOSAA.10.000127; Heinke W, 2005, CURR OPIN ANESTHESIO, V18, P625, DOI 10.1097/01.aco.0000189879.67092.12; Hock C, 1996, ANN NY ACAD SCI, V777, P22, DOI 10.1111/j.1749-6632.1996.tb34397.x; Hummel P, 2006, SEMIN FETAL NEONAT M, V11, P237, DOI 10.1016/j.siny.2006.02.004; Izzetoglu K, 2004, INT J HUM-COMPUT INT, V17, P211, DOI 10.1207/s15327590ijhc1702_6; Izzetoglu M, 2005, IEEE T NEUR SYS REH, V13, P153, DOI 10.1109/TNSRE.2005.847377; Izzetoglu M., 2010, SOC NEUROSCIEN UNPUB; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Limongi T., 2009, INT J BIOELECTROMAG, V11, P86; Luu S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016003; Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019; Matthews F., 2008, C P ANN INT C IEEE E, V2008, P4840; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; Meek JH, 1998, PEDIATR RES, V43, P840, DOI 10.1203/00006450-199806000-00019; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Obrig H, 1997, ADV EXP MED BIOL, V413, P113; Okada F, 1996, J AFFECT DISORDERS, V37, P13, DOI 10.1016/0165-0327(95)00040-2; OKADA F, 1994, EUR ARCH PSY CLIN N, V244, P17, DOI 10.1007/BF02279807; Oum K., 2010, 2010 2 INT IEEE CONS, P1; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; Pitetti RD, 2005, CAN MED ASSOC J, V172, P1699, DOI 10.1503/cmaj.050537; Platek SM, 2005, SCHIZOPHR RES, V73, P125, DOI 10.1016/j.schres.2004.09.024; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; Ranganath S, 2005, PROC SPIE, V5852, P434, DOI 10.1117/12.621536; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Sakatani K, 1999, J NEUROL NEUROSUR PS, V67, P769, DOI 10.1136/jnnp.67.6.769; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Sitaram R., 2009, NEURAL NETW; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Strangman G, 2005, AM J PHYS MED REHAB, V84, P62, DOI 10.1097/01.PHM.0000150787.26860.12; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Watanabe E, 2000, J BIOMED OPT, V5, P287, DOI 10.1117/1.429998; Wolpaw J. R., 2007, J PHYSL 3, V579, P619; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Zaramella P, 2001, PEDIATR RES, V49, P213, DOI 10.1203/00006450-200102000-00014	63	36	37	0	7	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1793-5458	1793-7205		J INNOV OPT HEAL SCI	J. Innov. Opt. Health Sci.	JUL	2011	4	3					239	250		10.1142/S1793545811001587			12	Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Optics; Radiology, Nuclear Medicine & Medical Imaging	V27YK	WOS:000208648300006					2022-02-06	
J	Zhao, TT; Li, YQ; Tang, LS; Li, YH; Fan, F; Jiang, B				Zhao, Tantai; Li, Yunqin; Tang, Luosheng; Li, Yuehua; Fan, Fang; Jiang, Bing			Protective effects of human umbilical cord blood stem cell intravitreal transplantation against optic nerve injury in rats	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Human umbilical cord blood stem cells (hUCBSCs); Traumatic optic neuropathy (TON); Brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF); Neural regeneration	RETINAL GANGLION-CELLS; NEUROTROPHIC FACTOR; BONE-MARROW; NEUROPATHY; THERAPY; DIFFERENTIATION; SURVIVAL; MODEL; STATE	The majority of studies addressing traumatic optic neuropathy (TON) have focused on drugs, proteins, cytokines, and various surgical techniques. A recent study reported that transplantation of human umbilical cord blood stem cells (hUCBSCs) achieved therapeutic effects on TON, but the exact effects on optic nerve injury are still unknown, and the mechanisms underlying nerve protection remain poorly understood. A total of 135 healthy Sprague-Dawley adult rats were randomly assigned to three groups: sham-surgery, model and transplantation, with 45 rats in each group. TON was induced in the model and transplantation groups via optic nerve crush injury. The crush injury was not performed in the sham-surgery group. Seven days after the injury, 10(6) hUCBSCs were injected into the rat vitreous cavity of transplantation group, and an equal volume of physiological saline was administered to the model and sham-surgery groups. Pathological observation of rat retina tissues was performed by hematoxylin-eosin (H&E) staining at days 3, 7, 14, 21 and 28 post-surgery. The number of retinal ganglion cells (RGCs) and mRNA expression levels of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) were assessed by the Fluorogold (FG) retrograde labeling and reverse transcriptase-polymerase chain reaction (RT-PCR) methods, respectively. The number of labeled RGCs and the expression of BDNF and GDNF mRNA obviously increased, and pathological injury was significantly ameliorated in the transplantation group compared to the model group (P < 0.05). Via intravitreal transplantation, the hUCBSCs resulted in a significant increase in the survival of the RGCs, and improved pathological changes in the rat retina, following TON. The protective mechanism is correlated with the continuous secretion of BDNF and GDNF in vivo of retina in optic nerve injury rats by the transplanted hUCBSCs.	[Zhao, Tantai; Tang, Luosheng; Li, Yuehua; Fan, Fang; Jiang, Bing] Cent S Univ, Dept Ophthalmol, Xiang Ya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Li, Yunqin] Second Peoples Hosp Yunnan Prov, Dept Ophthalmol, Kunming 650021, Yunnan Province, Peoples R China		Tang, LS (corresponding author), Cent S Univ, Dept Ophthalmol, Xiang Ya Hosp 2, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China.	welovetls57@126.com		fan, fang/0000-0002-0958-9996			BACIGALUPO A, 1988, BONE MARROW TRANSPL, V3, P531; Bjugstad KB, 2005, CELL TRANSPLANT, V14, P183, DOI 10.3727/000000005783983098; Bojanic Ines, 2006, Acta Med Croatica, V60, P215; Canque B, 2000, BLOOD, V96, P3748, DOI 10.1182/blood.V96.12.3748.h8003748_3748_3756; Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garbuzova-Davis S, 2006, PROG BRAIN RES, V157, P207, DOI 10.1016/S0079-6123(06)57014-1; Haas S, 2005, CURR OPIN NEUROL, V18, P59, DOI 10.1097/00019052-200502000-00012; HAO QL, 1995, BLOOD, V86, P3745, DOI 10.1182/blood.V86.10.3745.bloodjournal86103745; Kao CH, 2008, SHOCK, V29, P49, DOI 10.1097/shk.0b013c31805cddce; KNUDTZON S, 1974, BLOOD, V43, P357, DOI 10.1182/blood.V43.3.357.357; Lagreze W, 2009, KLIN MONATSBL AUGENH, V226, P875, DOI 10.1055/s-0028-1109728; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Lee AG, 2000, OPHTHALMOLOGY, V107, P814, DOI 10.1016/S0161-6420(99)00164-5; Li H, 2008, J LARYNGOL OTOL, V122, P1325, DOI 10.1017/S0022215108002296; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Mattson M P, 2001, Expert Rev Neurother, V1, P267, DOI 10.1586/14737175.1.2.267; Newcomb JD, 2007, CELL TRANSPLANT, V16, P151; Osborne NN, 2004, EYE, V18, P1075, DOI 10.1038/sj.eye.6701588; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; Selhorst JB, 2009, SEMIN NEUROL, V29, P29, DOI 10.1055/s-0028-1124020; Sieskiewicz Andrzej, 2008, Klin Oczna, V110, P155; Slater BJ, 2008, INVEST OPHTH VIS SCI, V49, P3671, DOI 10.1167/iovs.07-0504; Steinsapir K D, 1999, Curr Opin Ophthalmol, V10, P340, DOI 10.1097/00055735-199910000-00011; Van Adel BA, 2003, HUM GENE THER, V14, P103, DOI 10.1089/104303403321070801; Wilhelm H, 2004, KLIN MONATSBL AUGENH, V221, P702, DOI 10.1055/s-2004-813268; Wittekind D, 2003, BIOTECH HISTOCHEM, V78, P261, DOI 10.1080/10520290310001633725; Wu N, 2008, J INT MED RES, V36, P883, DOI 10.1177/147323000803600503; Zapala Jan, 2005, Klin Oczna, V107, P263; Zuo Ke-Jun, 2009, Zhonghua Yi Xue Za Zhi, V89, P389	31	36	41	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	JUL	2011	249	7					1021	1028		10.1007/s00417-011-1635-7			8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	784NG	WOS:000292163400009	21360302				2022-02-06	
J	McAllister, TW; Flashman, LA; McDonald, BC; Ferrell, RB; Tosteson, TD; Yanofsky, NN; Grove, MR; Saykin, AJ				McAllister, Thomas W.; Flashman, Laura A.; McDonald, Brenna C.; Ferrell, Richard B.; Tosteson, Tor D.; Yanofsky, Norman N.; Grove, Margaret R.; Saykin, Andrew J.			Dopaminergic Challenge With Bromocriptine One Month After Mild Traumatic Brain Injury: Altered Working Memory and BOLD Response	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							COGNITIVE FUNCTION; MECHANISMS; MODULATION; EXPRESSION; DEFICITS; TASK; LOAD	Catecholamines, particularly dopamine, modulate working memory (WM). Altered sensitivity to dopamine might play a role in WM changes observed after traumatic brain injury (TBI). Thirty-one healthy controls (HC) and 26 individuals with mild TBI (MTBI) 1 month after injury were challenged with bromocriptine versus placebo before administration of a verbal WM functional MRI task. Bromocriptine was associated with improved WM performance in the HC but not the MTBI group. On bromocriptine, the MTBI group showed increased activation outside of a task-specific region of interest. Findings are consistent with the hypothesis that individuals with MTBI have altered responsivity to dopamine. (The Journal of Neuropsychiatry and Clinical Neurosciences 2011; 23:277-286)	Dartmouth Med Sch, Dept Psychiat, Sect Neuropsychiat, Lebanon, NH USA; Indiana Univ Sch Med, Ctr Neuroimaging, Dept Radiol & Imaging Sci, Indianapolis, IN USA; Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA; Dartmouth Med Sch, Sect Emergency Med, Lebanon, NH USA		McAllister, TW (corresponding author), Dartmouth Hitchcock Med Ctr, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	thomas.w.mcallister@dartmouth.edu	Saykin, Andrew/A-1318-2007	Saykin, Andrew/0000-0002-1376-8532; Ferrell, Richard/0000-0002-7492-210X	NIDRR [H133G70031, H133000136]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS40472-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048176, R01HD047242] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW000018] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG010133, R01AG019771] Funding Source: NIH RePORTER	This research was supported in part by NIDRR Grants H133G70031 and H133000136, and NIH Grant R01 NS40472-01.	Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Arnsten A F, 1998, Adv Pharmacol, V42, P764; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; ARNSTEN AFT, 1994, PSYCHOPHARMACOLOGY, V116, P143, DOI 10.1007/BF02245056; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Cai JX, 1997, J PHARMACOL EXP THER, V283, P183; Chen KW, 2004, NEUROIMAGE, V22, P134, DOI 10.1016/j.neuroimage.2004.01.002; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; DELLIS DC, 2001, DELISKAPLAN EXECUTIV; First M., 1997, STRUCTURED CLIN INTE; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gordon M., 1986, GORDON DIAGNOSTIC SY; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kimberg DY, 1997, NEUROREPORT, V8, P3581, DOI 10.1097/00001756-199711100-00032; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PIZZOLATO G, 1985, BRAIN RES, V341, P303, DOI 10.1016/0006-8993(85)91069-8; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; *PSYCH CORP, 1997, WAIS 3 WAIS WMS 3 WE; Seamans JK, 1998, J NEUROSCI, V18, P1613; Strauss E., 1998, COMPENDIUM NEUROPSYC, P447; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; Whyte J, 2008, AM J PHYS MED REHAB, V87, P85, DOI 10.1097/PHM.0b013e3181619609; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; Wolfson, 1993, HALSTEAD REITAN NEUR	45	36	38	0	3	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2011	23	3					277	286					10	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	822BI	WOS:000295018300004	21948888	Green Accepted			2022-02-06	
J	McCauley, SR; Wilde, EA; Bigler, ED; Chu, ZL; Yallampalli, R; Oni, MB; Wu, TC; Ramos, MA; Pedroza, C; Vasquez, AC; Hunter, JV; Levin, HS				McCauley, Stephen R.; Wilde, Elisabeth A.; Bigler, Erin D.; Chu, Zili; Yallampalli, Ragini; Oni, Margaret B.; Wu, Trevor C.; Ramos, Marco A.; Pedroza, Claudia; Vasquez, Ana C.; Hunter, Jill V.; Levin, Harvey S.			Diffusion Tensor Imaging of Incentive Effects in Prospective Memory after Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cingulum bundles; diffusion tensor imaging; event-based prospective memory; incentive; motivation; pediatrics orbitofrontal white matter; traumatic brain injury; uncinate fasciculus	WHITE-MATTER ABNORMALITIES; VISUAL ASSOCIATION CORTEX; ANTERIOR CINGULATE CORTEX; WORKING-MEMORY; TEMPORAL-LOBE; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; UNCINATE FASCICULUS; FINANCIAL REWARD; EPISODIC MEMORY	Few studies exist investigating the brain-behavior relations of event-based prospective memory (EB-PM) impairments following traumatic brain injury (TBI). To address this, children with moderate-to-severe TBI performed an EB-PM test with two motivational enhancement conditions and underwent concurrent diffusion tensor imaging (DTI) at 3 months post-injury. Children with orthopedic injuries (OI; n = 37) or moderate-to-severe TBI (n = 40) were contrasted. Significant group differences were found for fractional anisotropy (FA) and apparent diffusion coefficient for orbitofrontal white matter (WM), cingulum bundles, and uncinate fasciculi. The FA of these WM structures in children with TBI significantly correlated with EB-PM performance in the high, but not the low motivation condition. Regression analyses within the TBI group indicated that the FA of the left cingulum bundle (p = 0.003), left orbitofrontal WM (p < 0.02), and left (p < 0.02) and right (p < 0.008) uncinate fasciculi significantly predicted EB-PM performance in the high motivation condition. We infer that the cingulum bundles, orbitofrontal WM, and uncinate fasciculi are important WM structures mediating motivation-based EB-PM responses following moderate-to-severe TBI in children.	[McCauley, Stephen R.] Baylor Coll Med, Cognit Neurosci Lab, Dept Neurol, Houston, TX 77030 USA; [McCauley, Stephen R.; Wilde, Elisabeth A.; Yallampalli, Ragini; Oni, Margaret B.; Ramos, Marco A.; Vasquez, Ana C.; Levin, Harvey S.] Univ Texas Houston, Sch Med, Houston, TX USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Chu, Zili; Hunter, Jill V.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [McCauley, Stephen R.; Wilde, Elisabeth A.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Bigler, Erin D.; Wu, Trevor C.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.; Wu, Trevor C.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Utah Brain Inst, Salt Lake City, UT USA; [Chu, Zili; Hunter, Jill V.] Texas Childrens Hosp, EB Singleton Dept Diagnost Imaging, Houston, TX 77030 USA; [Pedroza, Claudia] Univ Texas Houston, Sch Med, Ctr Clin Res & Evidence Based Med, Houston, TX USA		McCauley, SR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Neurol, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	mccauley@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282; Ramos, Marco/0000-0002-1649-7547	National Center for Medical Rehabilitation Research [K23 HD-40896]; National Institute Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD040896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by the National Center for Medical Rehabilitation Research (grant no. K23 HD-40896 to S. R. M) and the National Institute Neurological Disorders and Stroke (grant no. NS-21889 to H. S. L). The information in this article has never been published before, either electronically or in print. I would like to extend my personal appreciation to Drs. Mark McDaniel and Harvey Levin, who graciously served as mentors on a K-23 mentored patient-oriented research career development award. We also thank the participants and their families for their interest and willingness to take part in this research.	Akitsuki Y, 2003, NEUROIMAGE, V19, P1674, DOI 10.1016/S1053-8119(03)00250-7; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; Barbas H, 2007, ANN NY ACAD SCI, V1121, P10, DOI 10.1196/annals.1401.015; Barbas H, 2007, J ANAT, V211, P237, DOI 10.1111/j.1469-7580.2007.00777.x; Bracht T, 2009, PSYCHIAT RES-NEUROIM, V174, P217, DOI 10.1016/j.pscychresns.2009.05.001; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burianova H, 2010, NEUROIMAGE, V49, P865, DOI 10.1016/j.neuroimage.2009.08.066; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Catroppa C, 2008, J CHILD NEUROL, V23, P486, DOI 10.1177/0883073807309773; Charlton RA, 2010, CORTEX, V46, P474, DOI 10.1016/j.cortex.2009.07.005; Cheng HD, 2008, BRAIN INJURY, V22, P697, DOI 10.1080/02699050802263035; Clark L, 2009, NEURON, V61, P481, DOI 10.1016/j.neuron.2008.12.031; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; DAUM I, 1994, INT J NEUROSCI, V77, P187, DOI 10.3109/00207459408986030; Daum I, 2000, BEHAV NEUROL, V12, P161, DOI 10.1155/2000/327304; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Diehl B, 2008, EPILEPSIA, V49, P1409, DOI 10.1111/j.1528-1167.2008.01596.x; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Driscoll I, 2005, NEUROPSYCHOLOGY, V19, P28, DOI 10.1037/0894-4105.19.1.28; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Eddington KM, 2009, SOC COGN AFFECT NEUR, V4, P238, DOI 10.1093/scan/nsp016; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Elliott R, 2003, J NEUROSCI, V23, P303; Eschen A, 2007, INT J PSYCHOPHYSIOL, V64, P259, DOI 10.1016/j.ijpsycho.2006.09.005; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Fujiwara J, 2009, J NEUROPHYSIOL, V101, P3284, DOI 10.1152/jn.90909.2008; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Gilbert Alison M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P540, DOI 10.3758/CABN.4.4.540; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guajardo NR, 2000, COGNITIVE DEV, V15, P75, DOI 10.1016/S0885-2014(00)00016-2; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Harris J. E., 1984, EVERYDAY MEMORY ACTI, P71; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; Highley JR, 2002, CEREB CORTEX, V12, P1218, DOI 10.1093/cercor/12.11.1218; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Hoogenraad F., 2002, MULTICENTER EVALUATI; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kerns KA, 2001, CHILD NEUROPSYCHOL, V7, P162, DOI 10.1076/chin.7.3.162.8744; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kim JH, 2007, J CLIN NEUROL, V3, P62, DOI 10.3988/jcn.2007.3.1.62; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Kobayashi Y, 2007, J COMP NEUROL, V502, P810, DOI 10.1002/cne.21346; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krawczyk DC, 2007, BRAIN RES, V1141, P168, DOI 10.1016/j.brainres.2007.01.052; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Lazar M, 2006, AM J NEURORADIOL, V27, P1258; Lee ZI, 2003, AM J PHYS MED REHAB, V82, P556, DOI 10.1097/01.PHM.0000073830.15643.6A; Leube DT, 2008, INT J GERIATR PSYCH, V23, P1114, DOI 10.1002/gps.2036; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Linke J, 2010, NEUROIMAGE, V49, P2618, DOI 10.1016/j.neuroimage.2009.09.013; Louda J., 2007, Z NEUROPSYCHOL, V18, P91, DOI [10.1080/09602010600831004, DOI 10.1080/09602010600831004]; Lowther JL, 2004, ARCH CLIN NEUROPSYCH, V19, P105, DOI 10.1016/S0887-6177(02)00222-6; Mabbott DJ, 2009, BRAIN RES, V1294, P80, DOI 10.1016/j.brainres.2009.07.046; Maddock RJ, 1997, PSYCHIAT RES-NEUROIM, V75, P1, DOI 10.1016/S0925-4927(97)00018-8; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; MAYLOR EA, 1990, Q J EXP PSYCHOL-A, V42, P471, DOI 10.1080/14640749008401233; Maylor EA, 2002, MEM COGNITION, V30, P871, DOI 10.3758/BF03195773; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; MCCAULEY SR, J CLIN EXP IN PRESS; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; McCauley SR, 2010, CHILD NEUROPSYCHOL, V16, P293, DOI 10.1080/09297041003601470; McCauley SR, 2010, J INT NEUROPSYCH SOC, V16, P335, DOI 10.1017/S135561770999138X; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McDonald CR, 2008, NEUROLOGY, V71, P1869, DOI 10.1212/01.wnl.0000327824.05348.3b; McDonald CR, 2001, NEUROCASE, V7, P407, DOI 10.1076/neur.7.5.407.16250; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; MEACHAM JA, 1976, PROSPECTIVE REMEMBER; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nakamura M, 2005, BIOL PSYCHIAT, V58, P468, DOI 10.1016/j.biopsych.2005.04.016; Nestor PG, 2008, NEUROPSYCHOLOGY, V22, P246, DOI 10.1037/0894-4105.22.2.246; Nestor PG, 2004, NEUROPSYCHOLOGY, V18, P629, DOI 10.1037/0894-4105.18.4.629; Netsch T, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P718, DOI 10.1109/ICCV.2001.937595; Nielson KA, 2005, NEUROBIOL LEARN MEM, V84, P42, DOI 10.1016/j.nlm.2005.03.004; Nieuwenhuis S, 2005, EUR J NEUROSCI, V21, P3161, DOI 10.1111/j.1460-9568.2005.04152.x; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Nyberg L, 2003, NEUROPSYCHOLOGIA, V41, P371, DOI 10.1016/S0028-3932(02)00168-9; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Ogai M, 2005, ACTA PSYCHIAT SCAND, V111, P74, DOI 10.1111/j.1600-0447.2004.00395.x; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Palmer HM, 2000, BRAIN COGNITION, V44, P103; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Pearson JM, 2009, CURR BIOL, V19, P1532, DOI 10.1016/j.cub.2009.07.048; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Riha PD, 2008, NEUROBIOL LEARN MEM, V90, P112, DOI 10.1016/j.nlm.2008.01.011; Risinger RC, 2005, NEUROIMAGE, V26, P1097, DOI 10.1016/j.neuroimage.2005.03.030; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; RUTHER NM, 1993, M SE PSYCH ASS ATL; Salorio CF, 2005, J INT NEUROPSYCH SOC, V11, P686, DOI 10.1017/S1355617705050885; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; Sasson E, 2010, NEUROIMAGE, V50, P1231, DOI 10.1016/j.neuroimage.2009.12.079; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schultz W, 1998, NEUROPHARMACOLOGY, V37, P421, DOI 10.1016/S0028-3908(98)00071-9; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Schutter DJLG, 2006, J PSYCHIATR NEUROSCI, V31, P101; SEDAT J, 1990, J NEURORADIOLOGY, V17, P26; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Simoes-Franklin C, 2010, HUM BRAIN MAPP, V31, P458, DOI 10.1002/hbm.20879; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Staudinger MR, 2009, NEUROIMAGE, V47, P713, DOI 10.1016/j.neuroimage.2009.04.095; Szatkowska I, 2008, NEUROBIOL LEARN MEM, V90, P475, DOI 10.1016/j.nlm.2008.06.001; Szeszko PR, 2008, NEUROPSYCHOPHARMACOL, V33, P976, DOI 10.1038/sj.npp.1301480; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; UNGERLEIDER LG, 1989, EXP BRAIN RES, V76, P473, DOI 10.1007/BF00248903; VALENSTEIN E, 1987, BRAIN, V110, P1631, DOI 10.1093/brain/110.6.1631; Voineskos AN, 2010, NEUROBIOL AGING; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Ward H, 2004, BRAIN INJURY, V18, P471, DOI 10.1080/02699050310001646107; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; Weisskoff RM, 1996, MAGNET RESON MED, V36, P643, DOI 10.1002/mrm.1910360422; West R, 2001, PSYCHOL AGING, V16, P682, DOI 10.1037//0882-7974.16.4.682; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Winograd E., 1988, PRACTICAL ASPECTS ME, V1, P348; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Yung A, 2007, PEDIATR RES, V61, P732, DOI 10.1203/pdr.0b013e31805365db	175	36	37	1	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2011	28	4					503	516		10.1089/neu.2010.1555			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	746IW	WOS:000289240200002	21250917	Green Published			2022-02-06	
J	Hsieh, CT; Chen, GJ; Ma, HI; Chang, CF; Cheng, CM; Su, YH; Ju, DT; Hsia, CC; Chen, YH; Wu, HY; Liu, MY				Hsieh, Cheng-Ta; Chen, Guann-Juh; Ma, Hsin-I; Chang, Cheng-Fu; Cheng, Cheng-Ma; Su, Yih-Huei; Ju, Da-Tong; Hsia, Chung-Ching; Chen, Yuan-Hao; Wu, Hao-Yiang; Liu, Ming-Ying			The misplacement of external ventricular drain by freehand method in emergent neurosurgery	ACTA NEUROLOGICA BELGICA			English	Article						Hydrocephalus; traumatic brain injury; ventriculostomy; subarachnoid hemorrhages; stroke	PLACEMENT; GUIDE	External ventricular drain (EVD) placement is one of the most basic and common neurosurgical procedure which most was performed by young neurosurgical trainees. This study is conducted to determinate the safe and accuracy of Er VD placement by freehand method. About 129 EVD placements were evaluated in this study. Eighty-three catheters (64.3%) were located in the ipsilateral frontal horn or third ventricle. The functional accuracy was 86%. Of eighteen misplaced catheters, only 4 (3.1%) catheters were nonfunctional, requiring a replacement or reposition. The higher misplaced rate was significantly observed in patients whose head CT scans revealed the lower hydrocephalus ratio (28.85%) and the smaller ventricular size (5.6mm). Twenty-one (16.2%) new hemorrhages associated with EVD placements were observed. Using the freehand method, EVD placement is a safe and effective procedure in management of these emergent neurosurgical diseases.	[Hsieh, Cheng-Ta; Chen, Guann-Juh; Ma, Hsin-I; Chang, Cheng-Fu; Cheng, Cheng-Ma; Su, Yih-Huei; Ju, Da-Tong; Hsia, Chung-Ching; Chen, Yuan-Hao; Wu, Hao-Yiang; Liu, Ming-Ying] Tri Serv Gen Hosp, Dept Neurol Surg, Natl Def Med Ctr, Taipei, Taiwan; [Hsieh, Cheng-Ta] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan		Liu, MY (corresponding author), Tri Serv Gen Hosp, Dept Neurol Surg, Natl Def Med Ctr, 325,Sec 2,Cheng Kung Rd, Taipei, Taiwan.	nogor@mail2000.com.tw					Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; BOGDAHN U, 1992, NEUROSURGERY, V31, P898, DOI 10.1227/00006123-199211000-00011; Gardner PA, 2009, J NEUROSURG, V110, P1021, DOI 10.3171/2008.9.JNS17661; GHAJAR JBG, 1985, J NEUROSURG, V63, P985, DOI 10.3171/jns.1985.63.6.0985; Huyette DR, 2008, J NEUROSURG, V108, P88, DOI 10.3171/JNS/2008/108/01/0088; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Khan SH, 1998, ACT NEUR S, V71, P50; KHANNA RK, 1995, J NEUROSURG, V83, P791, DOI 10.3171/jns.1995.83.5.0791; Krotz M, 2004, EUR RADIOL, V14, P227, DOI 10.1007/s00330-003-2134-y; Lind CRP, 2008, J CLIN NEUROSCI, V15, P886, DOI 10.1016/j.jocn.2007.05.013; Lind CRP, 2009, J CLIN NEUROSCI, V16, P918, DOI 10.1016/j.jocn.2008.09.015; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; O'Leary ST, 2000, J NEUROSURG, V92, P801, DOI 10.3171/jns.2000.92.5.0801; Prat R, 2009, CLIN NEUROL NEUROSUR, V111, P579, DOI 10.1016/j.clineuro.2009.04.008; Roitberg BZ, 2001, BRIT J NEUROSURG, V15, P324; Saladino A, 2009, NEUROCRIT CARE, V10, P248, DOI 10.1007/s12028-008-9154-z; Stangl AP, 1998, SURG NEUROL, V50, P77, DOI 10.1016/S0090-3019(97)00301-7	17	36	36	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	MAR	2011	111	1					22	28					7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	743HR	WOS:000289009500005	21510229				2022-02-06	
J	Shellington, DK; Du, LN; Wu, XR; Exo, J; Vagni, V; Ma, L; Janesko-Feldman, K; Clark, RSB; Bayir, H; Dixon, CE; Jenkins, LW; Hsia, CJC; Kochanek, PM				Shellington, David K.; Du, Lina; Wu, Xianren; Exo, Jennifer; Vagni, Vincent; Ma, Li; Janesko-Feldman, Keri; Clark, Robert S. B.; Bayir, Huelya; Dixon, C. Edward; Jenkins, Larry W.; Hsia, Carleton J. C.; Kochanek, Patrick M.			Polynitroxylated pegylated hemoglobin: A novel neuroprotective hemoglobin for acute volume-limited fluid resuscitation after combined traumatic brain injury and hemorrhagic hypotension in mice	CRITICAL CARE MEDICINE			English	Article						head injury; hemoglobin based oxygen carrier; nitroxide; oxidative stress; nitric oxide; polyethylene glycol; hemorrhagic shock; blast injury; polytrauma; blood substitute; polynitroxylation; superoxide	FOCAL CEREBRAL-ISCHEMIA; CORTICAL CELL-CULTURE; OXYGEN CARRIERS; BLOOD SUBSTITUTES; CARBON-MONOXIDE; SWINE MODEL; ALBUMIN; TEMPOL; RATS; SHOCK	Objective: Resuscitation of hemorrhagic hypotension after traumatic brain injury is challenging. A hemoglobin-based oxygen carrier may offer advantages. The novel therapeutic hemoglobin-based oxygen carrier, polynitroxylated pegylated hemoglobin (PNPH), may represent a neuroprotective hemoglobin-based oxygen carrier for traumatic brain injury resuscitation. Hypotheses: 1) PNPH is a unique non-neurotoxic hemoglobin-based oxygen carrier in neuronal culture and is neuroprotective in in vitro neuronal injury models. 2) Resuscitation with PNPH would require less volume to restore mean arterial blood pressure than lactated Ringer's or Hextend and confer neuroprotection in a mouse model of traumatic brain injury plus hemorrhagic hypotension. Design: Prospective randomized, controlled experimental study. Setting: University center. Measurements and Main Results: In rat primary cortical neuron cultures, control bovine hemoglobin was neurotoxic (lactate dehydrogenase release; 3-[4,5-dimethylthiazol-2-yl-]-2,5-diphenyltetrazolium bromide assay) at concentrations from 12.5 to 0.625 mu M, whereas polyethylene glycol-conjugated hemoglobin showed intermediate toxicity. PNPH was not neurotoxic (p < .05 vs. bovine hemoglobin and polyethylene glycol hemoglobin; all concentrations). PNPH conferred neuroprotection in in vitro neuronal injury (glutamate/glycine exposure and neuronal stretch), as assessed via lactate dehydrogenase and 3-[4,5-dimethylthiazol-2- yl-]-2,5-diphenyltetrazolium bromide (all p < .05 vs. control). C57BL6 mice received controlled cortical impact followed by hemorrhagic hypotension (2 mL/100 g, mean arterial blood pressure similar to 35-40 mm Hg) for 90 min. Mice were resuscitated (mean arterial blood pressure >50 mm Hg for 30 min) with lactated Ringer's, Hextend, or PNPH, and then shed blood was reinfused. Mean arterial blood pressures, resuscitation volumes, blood gasses, glucose, and lactate were recorded. Brain sections at 7 days were examined via hematoxylin and eosin and Fluoro-Jade C (identifying dying neurons) staining in CA1 and CA3 hippocampus. Resuscitation with PNPH or Hextend required less volume than lactated Ringer's (both p < .05). PNPH but not Hextend improved mean arterial blood pressure vs. lactated Ringer's (p < .05). Mice resuscitated with PNPH had fewer Fluoro-Jade C positive neurons in CA1 vs. Hextend and lactated Ringer's, and CA3 vs. Hextend (p < .05). Conclusions: PNPH is a novel neuroprotective hemoglobin-based oxygen carrier in vitro and in vivo that may offer unique advantages for traumatic brain injury resuscitation. (Crit Care Med 2011; 39: 494 -505)	[Shellington, David K.; Du, Lina; Wu, Xianren; Exo, Jennifer; Vagni, Vincent; Janesko-Feldman, Keri; Clark, Robert S. B.; Bayir, Huelya; Dixon, C. Edward; Jenkins, Larry W.; Kochanek, Patrick M.] Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Shellington, David K.; Du, Lina; Clark, Robert S. B.; Bayir, Huelya; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Clark, Robert S. B.; Bayir, Huelya; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Dixon, C. Edward; Jenkins, Larry W.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Wu, Xianren] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Ma, Li; Hsia, Carleton J. C.] SynZyme Technol, Irvine, CA USA; [Ma, Li] Georgia So Univ, Dept Phys, Statesboro, GA 30460 USA		Shellington, DK (corresponding author), Safar Ctr Resuscitat Res, Pittsburgh, PA USA.	kochanekpm@ccm.upmc; kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Shellington, David/0000-0001-6708-6978	U.S. ArmyUnited States Department of Defense [PR054755 W81XWH-06-1-0247]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32HD040686, NS30318]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P01NS030318, P50NS030318] Funding Source: NIH RePORTER	Supported, in part, by grant PR054755 W81XWH-06-1-0247 from the U.S. Army (PMK), T32HD040686 from the National Institutes of Health (JE, PMK), and NS30318 from the National Institutes of Health (CED).	Abuchowski A, 2009, P 12 INT S BLOOD SUB, P49; AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; Alayash AI, 1999, NAT BIOTECHNOL, V17, P545, DOI 10.1038/9849; Beaulieu C, 1998, J CEREBR BLOOD F MET, V18, P1022, DOI 10.1097/00004647-199809000-00012; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; CHAPMAN KW, 1992, BIOMAT ARTIF CELL IM, V20, P415, DOI 10.3109/10731199209119661; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chung HT, 2008, METHOD ENZYMOL, V441, P329, DOI 10.1016/S0076-6879(08)01218-4; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dudkiewicz M, 2008, CRIT CARE MED, V36, P2641, DOI 10.1097/CCM.0b013e3181847af3; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; GOLD MS, 1990, ANN SURG, V211, P482, DOI 10.1097/00000658-199004000-00016; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Kao LW, 2006, CLIN LAB MED, V26, P99, DOI 10.1016/j.cll.2006.01.005; Kentner R, 2002, J TRAUMA, V53, P968, DOI 10.1097/00005373-200211000-00025; Koehler RC, 2009, P 12 INT S BLOOD SUB, P68; Krishna MC, 1996, J BIOL CHEM, V271, P26018, DOI 10.1074/jbc.271.42.26018; Leker RR, 2002, EXP NEUROL, V176, P355, DOI 10.1006/exnr.2002.7910; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lui FE, 2008, BIOCHEMISTRY-US, V47, P10773, DOI 10.1021/bi801116k; MOGGIO RA, 1983, CRIT CARE MED, V11, P943, DOI 10.1097/00003246-198312000-00009; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; RAMMING S, 1994, J TRAUMA, V37, P705, DOI 10.1097/00005373-199411000-00003; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; Regan RF, 2003, J NEUROTRAUM, V20, P111, DOI 10.1089/08977150360517236; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; Rogers B, 2003, FREE RADICAL BIO MED, V35, P872, DOI 10.1016/S0891-5849(03)00431-3; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Saetzler RK, 1999, FREE RADICAL BIO MED, V27, P1, DOI 10.1016/S0891-5849(99)00037-4; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Stern S, 2009, SHOCK, V31, P64, DOI 10.1097/SHK.0b013e3181778dc3; Whalen MJ, 2000, CRIT CARE MED, V28, P3710, DOI 10.1097/00003246-200011000-00029; Winslow RM, 2005, ARTIF CELL BLOOD SUB, V33, P1, DOI 10.1081/BIO-200046634; Winslow RM, 2008, BBA-PROTEINS PROTEOM, V1784, P1382, DOI 10.1016/j.bbapap.2008.04.032; Yu B, 2008, CIRCULATION, V117, P1982, DOI 10.1161/CIRCULATIONAHA.107.729137; Zhang RL, 1998, FREE RADICAL BIO MED, V24, P332, DOI 10.1016/S0891-5849(97)00267-0; Zhang S, 2000, FREE RADICAL BIO MED, V29, P42, DOI 10.1016/S0891-5849(00)00295-1	47	36	37	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAR	2011	39	3					494	505		10.1097/CCM.0b013e318206b1fa			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	723BB	WOS:000287480000011	21169820	Green Accepted			2022-02-06	
J	Bao, YH; Bramlett, HM; Atkins, CM; Truettner, JS; Lotocki, G; Alonso, OF; Dietrich, WD				Bao, Ying-hui; Bramlett, Helen M.; Atkins, Coleen M.; Truettner, Jessie S.; Lotocki, George; Alonso, Ofelia F.; Dietrich, W. Dalton			Post-Traumatic Seizures Exacerbate Histopathological Damage after Fluid-Percussion Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						epilepsy; immunohistochemistry; neuronal cell death; traumatic brain injury	HEAD-INJURY; DENTATE GYRUS; INTRACEREBRAL HEMORRHAGE; BARRIER PERMEABILITY; HIPPOCAMPAL CA1; SMALL MOLECULES; EPILEPSY; HYPEREXCITABILITY; DISRUPTION; TRAUMA	The purpose of this study was to investigate the effects of an induced period of post-traumatic epilepsy (PTE) on the histopathological damage caused by traumatic brain injury (TBI). Male Sprague Dawley rats were given a moderate parasagittal fluid-percussion brain injury (1.9-2.1 atm) or sham surgery. At 2 weeks after surgery, seizures were induced by administration of a GABA(A) receptor antagonist, pentylenetetrazole (PTZ, 30 mg/kg). Seizures were then assessed over a 1-h period using the Racine clinical rating scale. To evaluate whether TBI-induced pathology was exacerbated by the seizures, contusion volume and cortical and hippocampal CA3 neuronal cell loss were measured 3 days after seizures. Nearly all TBI rats showed clinical signs of PTE following the decrease in inhibitory activity. In contrast, clinically evident seizures were not observed in TBI rats given saline or sham-operated rats given PTZ. Contusions in TBI-PTZ-treated rats were significantly increased compared to the TBI-saline-treated group (p < 0.001). In addition, the TBI-PTZ rats showed less NeuN-immunoreactive cells within the ipsilateral parietal cerebral cortex (p < 0.05) and there was a trend for decreased hippocampal CA3 neurons in TBI-PTZ rats compared with TBI-saline or sham-operated rats. These results demonstrate that an induced period of post-traumatic seizures significantly exacerbates the structural damage caused by TBI. These findings emphasize the need to control seizures after TBI to limit even further damage to the injured brain.	[Bao, Ying-hui; Bramlett, Helen M.; Atkins, Coleen M.; Truettner, Jessie S.; Lotocki, George; Alonso, Ofelia F.; Dietrich, W. Dalton] Univ Miami, Sch Med, Neurotrauma Res Ctr, Dept Neurol Surg, Miami, FL 33136 USA; [Bao, Ying-hui; Bramlett, Helen M.; Atkins, Coleen M.; Truettner, Jessie S.; Lotocki, George; Alonso, Ofelia F.; Dietrich, W. Dalton] Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs Med Ctr, Miami, FL USA; [Bao, Ying-hui] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai, Peoples R China		Dietrich, WD (corresponding author), Univ Miami, Sch Med, Neurotrauma Res Ctr, Dept Neurol Surg, 1095 NW 14th Terrace,LPLC 2-30, Miami, FL 33136 USA.	ddietrich@miami.edu		Atkins, Coleen/0000-0003-4718-7493	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS030291, NS042133]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056072, R01NS042133, P50NS030291] Funding Source: NIH RePORTER	We thank Dr. Beata Frydel for assistance with the histopathological analysis and Jeremy Lytle for editorial assistance. This work was supported by NIH NS030291 and NS042133.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; ATKINS CM, 2010, EUR J NEURO IN PRESS; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Bautista RED, 2009, EPILEPSY BEHAV, V16, P325, DOI 10.1016/j.yebeh.2009.07.037; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; Loscher W, 2002, EPILEPSY RES, V50, P3, DOI 10.1016/S0920-1211(02)00063-3; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Statler KD, 2008, EPILEPSY RES, V80, P163, DOI 10.1016/j.eplepsyres.2008.04.001; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2001, DRUGS, V61, P1045, DOI 10.2165/00003495-200161080-00002; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wang HY, 2008, ACTA CRYSTALLOGR E, V64, pM26, DOI 10.1107/S1600536807061715; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	63	36	38	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2011	28	1					35	42		10.1089/neu.2010.1383			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	710DT	WOS:000286491800004	20836615	Green Published			2022-02-06	
J	Gumera, C; Rauck, B; Wang, YD				Gumera, Christiane; Rauck, Britta; Wang, Yadong			Materials for central nervous system regeneration: bioactive cues	JOURNAL OF MATERIALS CHEMISTRY			English	Article							SPINAL-CORD-INJURY; NEURAL STEM-CELLS; HYALURONIC-ACID HYDROGEL; OLIGODENDROCYTE PROGENITOR CELLS; ELECTRICALLY CONDUCTING POLYMER; TISSUE ENGINEERING APPLICATIONS; IN-VITRO BIOCOMPATIBILITY; NOGO-66 RECEPTOR ANTIBODY; GUIDE NEURITE OUTGROWTH; TRAUMATIC BRAIN-INJURY	Current clinical therapies have limited capacity to restore function in damaged nerves. Regeneration of axons in the injured central nervous system is inhibited by the presence of both physical and mechanical barriers. As such, neural tissue engineering strategies have received considerable attention in recent years. Materials-based approaches offer a way to blend synthetic and biological components in order to generate environments conducive to neural regeneration. While biomaterials themselves can facilitate regeneration simply by providing a substrate for cell growth, incorporation of "bioactive cues''-or molecules which interact with cells to elicit a specific response-has become increasingly necessary in order to promote nerve regeneration. This review attempts to outline the various biomaterials that are promising for central nerve applications, and discusses the array of bioactive cues that are valuable in promoting nerve repair.	[Rauck, Britta; Wang, Yadong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA; [Rauck, Britta; Wang, Yadong] Univ Pittsburgh, McGowan Inst, Pittsburgh, PA 15219 USA; [Gumera, Christiane] WL Gore & Associates, Elkton, MD 21922 USA		Wang, YD (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.	cgumera@wlgore.com; yaw20@pitt.edu	duan, hf/F-9166-2011; Wang, Yadong/AAC-3381-2020	Wang, Yadong/0000-0003-2067-382X			Ahmed I, 2006, J BIOMED MATER RES A, V76A, P851, DOI 10.1002/jbm.a.30587; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Aramakis VB, 1998, J NEUROSCI, V18, P8485; Armstrong SJ, 2007, TISSUE ENG, V13, P2863, DOI 10.1089/ten.2007.0055; Bamber NI, 2001, EUR J NEUROSCI, V13, P257, DOI 10.1046/j.1460-9568.2001.01387.x; Baumann MD, 2009, J CONTROL RELEASE, V138, P205, DOI 10.1016/j.jconrel.2009.05.009; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bechara SL, 2010, BIOMATERIALS, V31, P3492, DOI 10.1016/j.biomaterials.2010.01.084; Belachew S, 2000, EUR J NEUROSCI, V12, P1924, DOI 10.1046/j.1460-9568.2000.00085.x; Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031; BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409; Belluardo N, 2000, BEHAV BRAIN RES, V113, P21, DOI 10.1016/S0166-4328(00)00197-2; Berger F, 1998, J NEUROSCI, V18, P6871; Berkowitz M., 1998, SPINAL CORD INJURY A; Bernardini N, 2004, J NEUROCHEM, V88, P1533, DOI 10.1046/j.1471-4159.2003.02292.x; BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117; Bonner J, 2001, J NEUROSCI, V21, P9782, DOI 10.1523/JNEUROSCI.21-24-09782.2001; Borgens RB, 1999, NEUROSCIENCE, V91, P251, DOI 10.1016/S0306-4522(98)00584-3; Borgens RB, 1997, EXP NEUROL, V145, P376, DOI 10.1006/exnr.1997.6499; Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.3.CO;2-4; Borta A, 2007, J NEUROCHEM, V100, P587, DOI 10.1111/j.1471-4159.2006.04241.x; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Bryan DJ, 2004, J NEURAL ENG, V1, P91, DOI 10.1088/1741-2560/1/2/004; BYROM D, 1987, TRENDS BIOTECHNOL, V5, P246, DOI 10.1016/0167-7799(87)90100-4; Cai J, 2007, J BIOMED MATER RES A, V83A, P512, DOI 10.1002/jbm.a.31296; Chaudhry N, 2006, EXP NEUROL, V202, P238, DOI 10.1016/j.expneurol.2006.06.001; Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]; Cheng H, 2007, BIOCHEM BIOPH RES CO, V357, P938, DOI 10.1016/j.bbrc.2007.04.049; Cho Youngnam, 2010, J Biol Eng, V4, P2, DOI 10.1186/1754-1611-4-2; Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162; Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002; Clarke EC, 2009, J BIOMECH, V42, P1397, DOI 10.1016/j.jbiomech.2009.04.008; Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I; Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044; Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7; Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0; De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051; De Sarno P, 2003, J BIOL CHEM, V278, P11086, DOI 10.1074/jbc.M212157200; Deumens R, 2004, NEUROSCIENCE, V125, P591, DOI 10.1016/j.neuroscience.2004.02.010; Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]; Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103; Diaz J, 1997, J NEUROSCI, V17, P4282; Durgam H, 2010, J BIOMAT SCI-POLYM E, V21, P1265, DOI 10.1163/092050609X12481751806330; EDGAR D, 1984, EMBO J, V3, P1463, DOI 10.1002/j.1460-2075.1984.tb01997.x; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Fukushima Kazuyuki, 2008, J Med Dent Sci, V55, P71; Gao J, 2006, P NATL ACAD SCI USA, V103, P16681, DOI 10.1073/pnas.0606237103; Goraltchouk A, 2006, J CONTROL RELEASE, V110, P400, DOI 10.1016/j.jconrel.2005.10.019; GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012; Gumera CB, 2007, ADV MATER, V19, P4404, DOI 10.1002/adma.200701747; GUNDERSEN RW, 1987, DEV BIOL, V121, P423, DOI 10.1016/0012-1606(87)90179-5; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; Hamann MCJ, 2005, EXP NEUROL, V194, P106, DOI 10.1016/j.expneurol.2005.01.030; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; He LM, 2009, TISSUE ENG PART C-ME, V15, P243, DOI 10.1089/ten.tec.2008.0255; He QR, 2009, J MATER SCI-MATER M, V20, P1457, DOI 10.1007/s10856-009-3702-8; Hebb D. O., 1988, NEUROCOMPUTING FDN R, P43; Hejcl A, 2009, J MATER SCI-MATER M, V20, P1571, DOI 10.1007/s10856-009-3714-4; Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067; Heng JIT, 2007, EUR J NEUROSCI, V26, P537, DOI 10.1111/j.1460-9568.2007.05694.x; Hiramoto T, 2007, NEUROREPORT, V18, P659, DOI 10.1097/WNR.0b013e3280bef9d3; Honig MG, 2002, DEV BIOL, V243, P137, DOI 10.1006/dbio.2001.0556; Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133; Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Hu JG, 2009, J NEUROSCI RES, V87, P2854, DOI 10.1002/jnr.22111; Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004; HYNES RO, 1986, J NEUROSCI, V6, P867; Ichikawa N, 2005, BIOCHEMISTRY-US, V44, P5755, DOI 10.1021/bi0476228; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273; Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476; Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343; Ju YE, 2007, BIOMATERIALS, V28, P2097, DOI 10.1016/j.biomaterials.2007.01.008; JUCKER M, 1991, J NEUROSCI RES, V28, P507, DOI 10.1002/jnr.490280407; Kang CE, 2010, J CONTROL RELEASE, V144, P25, DOI 10.1016/j.jconrel.2010.01.029; Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349; Katz JS, 2009, WIRES NANOMED NANOBI, V1, P128, DOI 10.1002/wnan.10; Kenwrick S, 1998, BIOESSAYS, V20, P668, DOI 10.1002/(SICI)1521-1878(199808)20:8<668::AID-BIES10>3.0.CO;2-X; KERNS JM, 1991, NEUROSCIENCE, V40, P93, DOI 10.1016/0306-4522(91)90177-P; Kim DH, 2007, ADV FUNCT MATER, V17, P79, DOI 10.1002/adfm.200500594; Kim H, 2008, BIOTECHNOL PROGR, V24, P932, DOI 10.1021/bp070352a; Kim JW, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/1/017003; Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077; King VR, 2010, NEUROSCIENCE, V168, P523, DOI 10.1016/j.neuroscience.2010.03.040; Kirchhoff F, 1996, J NEUROCHEM, V66, P1383; Krewson CE, 1996, J BIOMAT SCI-POLYM E, V8, P103; Krsko P, 2009, BIOMATERIALS, V30, P721, DOI 10.1016/j.biomaterials.2008.10.011; Krych AJ, 2009, ACTA BIOMATER, V5, P2551, DOI 10.1016/j.actbio.2009.03.021; KUHN TB, 1995, NEURON, V14, P275, DOI 10.1016/0896-6273(95)90285-6; Kuhn TB, 1998, J NEUROSCI, V18, P184; Kwon BK, 2007, SPINE, V32, P1164, DOI 10.1097/BRS.0b013e318053ec35; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042; Lee SH, 2009, NEUROL RES, V31, P996, DOI 10.1179/174313209X385626; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; LETOURNEAU PC, 1975, DEV BIOL, V44, P77, DOI 10.1016/0012-1606(75)90378-4; Li XG, 2009, BIOMATERIALS, V30, P4978, DOI 10.1016/j.biomaterials.2009.05.047; Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063; LIESI P, 1989, FEBS LETT, V244, P141, DOI 10.1016/0014-5793(89)81180-9; LOFBERG J, 1980, DEV BIOL, V75, P148, DOI 10.1016/0012-1606(80)90151-7; LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6; Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005; Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; MATTSON MP, 1989, BRAIN RES, V478, P337, DOI 10.1016/0006-8993(89)91514-X; MCCOBB DP, 1988, NEURON, V1, P377, DOI 10.1016/0896-6273(88)90187-0; MCKINLEY M, 2006, HUMAN ANATOMY; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Meiners S, 2001, J NEUROSCI, V21, P7215, DOI 10.1523/JNEUROSCI.21-18-07215.2001; Mo LH, 2010, BIOMATERIALS, V31, P2184, DOI 10.1016/j.biomaterials.2009.11.078; Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267; Musoke-Zawedde P, 2006, BIOMED MATER, V1, P162, DOI 10.1088/1748-6041/1/3/011; Nguyen L, 2001, CELL TISSUE RES, V305, P187, DOI 10.1007/s004410000343; *NIH NAT I NEUR DI, 2008, SPIN CORD INJ HOP RE; Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652; Nisbet DR, 2007, J NEURAL ENG, V4, P35, DOI 10.1088/1741-2560/4/2/004; Nisbet DR, 2009, J BIOMED MATER RES A, V89A, P24, DOI 10.1002/jbm.a.31962; Nisbet DR, 2010, TISSUE ENG PT A, V16, P2833, DOI [10.1089/ten.tea.2009.0677, 10.1089/ten.TEA.2009.0677]; Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011; Nomura H, 2006, NEUROSURGERY, V59, P183, DOI 10.1227/01.NEU.0000219859.35349.EF; NORRIS CR, 1991, J NEUROSCI, V11, P3481; Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6; Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033; Olakowska E, 2010, FOLIA NEUROPATHOL, V48, P231; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364; Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519; Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9; Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x; Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020; Popolo M, 2004, DEV NEUROSCI-BASEL, V26, P229, DOI 10.1159/000082140; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153; Ragnarsson KT, 2008, SPINAL CORD, V46, P255, DOI 10.1038/sj.sc.3102091; Ramakers GJA, 1998, DEV BRAIN RES, V108, P205, DOI 10.1016/S0165-3806(98)00050-9; Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x; Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E; Roerig B, 1997, J NEUROSCI, V17, P8353; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rooney GE, 2008, TISSUE ENG PT A, V14, P681, DOI 10.1089/tea.2007.0260; Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5; Runge MB, 2010, BIOMATERIALS, V31, P5916, DOI 10.1016/j.biomaterials.2010.04.012; Saifuddin U, 2003, J BIOMED MATER RES A, V66A, P184, DOI 10.1002/jbm.a.10552; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7; Sayer FT, 2002, EXP NEUROL, V175, P282, DOI 10.1006/exnr.2002.7901; Schense JC, 2000, NAT BIOTECHNOL, V18, P415, DOI 10.1038/74473; Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948; Seidlits SK, 2008, NANOMEDICINE-UK, V3, P183, DOI 10.2217/17435889.3.2.183; Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125; Shen YX, 2010, CELL TRANSPLANT, V19, P147, DOI 10.3727/096368910X492616; Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Sorensen A, 2007, BIOMATERIALS, V28, P5498, DOI 10.1016/j.biomaterials.2007.08.034; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stabenfeldt SE, 2006, J BIOMED MATER RES A, V77A, P718, DOI 10.1002/jbm.a.30638; Stauffer WR, 2006, BIOMATERIALS, V27, P2405, DOI 10.1016/j.biomaterials.2005.10.024; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039; Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; Suisha F, 1998, INT J PHARM, V172, P27, DOI 10.1016/S0378-5173(98)00157-4; Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074; Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004; Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589; Tan EYM, 2007, PHARM RES-DORDR, V24, P2297, DOI 10.1007/s11095-007-9454-6; Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212; TASHIRO K, 1989, J BIOL CHEM, V264, P16174; Tata AM, 2003, J NEUROSCI RES, V73, P227, DOI 10.1002/jnr.10650; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Taylor L, 2006, J NEUROSCI, V26, P9713, DOI 10.1523/JNEUROSCI.0734-06.2006; Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005; Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005; Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003; Thid D, 2008, J BIOMED MATER RES A, V84A, P940, DOI 10.1002/jbm.a.31358; Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046; Thouas GA, 2008, IEEE ENG MED BIO, P1825, DOI 10.1109/IEMBS.2008.4649534; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025; Toborek M, 2007, J CELL BIOCHEM, V100, P279, DOI 10.1002/jcb.21013; TODD RD, 1992, BIOL PSYCHIAT, V31, P794, DOI 10.1016/0006-3223(92)90311-M; Tran PA, 2009, ADV DRUG DELIVER REV, V61, P1097, DOI 10.1016/j.addr.2009.07.010; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; Van Kampen JM, 2006, J NEUROSCI, V26, P7272, DOI 10.1523/JNEUROSCI.0837-06.2006; Van Kampen JM, 2005, NEUROSCIENCE, V136, P381, DOI 10.1016/j.neuroscience.2005.07.054; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Vernadakis A, 1996, PROG NEUROBIOL, V49, P185, DOI 10.1016/S0301-0082(96)00012-3; Vu TQ, 2005, BIOMATERIALS, V26, P1895, DOI 10.1016/j.biomaterials.2004.06.007; Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027; Wan Y, 2004, MACROMOL BIOSCI, V4, P882, DOI 10.1002/mabi.200400044; Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534; Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050; Wang YF, 2009, J CONTROL RELEASE, V140, P218, DOI 10.1016/j.jconrel.2009.05.025; Webb K, 2001, BIOMATERIALS, V22, P1017, DOI 10.1016/S0142-9612(00)00353-7; Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013; Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11; Wei YT, 2009, J BIOACT COMPAT POL, V24, P205, DOI 10.1177/0883911509102266; WHITAKERAZMITIA PM, 1990, ANN NY ACAD SCI, V600, P315, DOI 10.1111/j.1749-6632.1990.tb16892.x; Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028; Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844; Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Yao L, 2010, J BIOMED MATER RES A, V92A, P484, DOI 10.1002/jbm.a.32359; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yoshil S, 2009, J TISSUE ENG REGEN M, V3, P19, DOI 10.1002/term.130; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Yu D, 2009, STEM CELLS, V27, P1212, DOI 10.1002/stem.26; Yu LMY, 2008, J NEUROSCI METH, V171, P253, DOI 10.1016/j.jneumeth.2008.03.023; Yu LMY, 2007, J BIOMED MATER RES A, V82A, P243, DOI 10.1002/jbm.a.31069; Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887; Zelikin AN, 2002, ANGEW CHEM INT EDIT, V41, P141, DOI 10.1002/1521-3773(20020104)41:1<141::AID-ANIE141>3.0.CO;2-V; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071; SPINAL CORD INJURY F	229	36	36	2	71	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	0959-9428	1364-5501		J MATER CHEM	J. Mater. Chem.		2011	21	20					7033	7051		10.1039/c0jm04335d			19	Chemistry, Physical; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Materials Science	758LV	WOS:000290167200001					2022-02-06	
J	Radford, KA; Lah, S; Say, MJ; Miller, LA				Radford, Kylie A.; Lah, Suncica; Say, Miranda J.; Miller, Laurie A.			Validation of a New Measure of Prospective Memory: The Royal Prince Alfred Prospective Memory Test	CLINICAL NEUROPSYCHOLOGIST			English	Article						Reliability; Sensitivity; Everyday memory; Rehabilitation; Cognition	TRAUMATIC BRAIN-INJURY; EVERYDAY PROSPECTIVE MEMORY; INTENTIONS SCREENING-TEST; SELF-AWARENESS; PERFORMANCE; EVENT; ADULTS; TASKS; TIME; AGE	Prospective memory problems are common in patients with brain injury, but appropriate measures are limited. The reliability and validity of the newly designed Royal Prince Alfred Prospective Memory Test (RPA-ProMem), which has three alternate versions, was investigated in 20 healthy volunteers and 20 neurological patients with everyday prospective memory problems. The RPA-ProMem was found to be easy to score reliably (inter-rater reliability = .90) and its three versions were well matched (delayed alternate-form reliability = .71). Test validity and sensitivity to patient deficits were also supported. This new measure of prospective memory should be particularly useful in situations that require repeated assessments, such as evaluation of rehabilitation efforts.	[Miller, Laurie A.] Royal Prince Alfred Hosp, Neuropsychol Unit, Camperdown, NSW 2050, Australia; [Radford, Kylie A.; Lah, Suncica; Miller, Laurie A.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Say, Miranda J.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia		Miller, LA (corresponding author), Royal Prince Alfred Hosp, Neuropsychol Unit, Camperdown, NSW 2050, Australia.	lauriem@icn.usyd.edu.au	; Radford, Kylie/D-5338-2011	Lah, Suncica/0000-0003-2282-4812; Miller, Laurie/0000-0001-6329-2969; Radford, Kylie/0000-0001-8095-5314			Adda CC, 2008, NEUROPSYCHOLOGIA, V46, P1954, DOI 10.1016/j.neuropsychologia.2008.01.016; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Chau LT, 2007, NEUROPSYCHOL REHABIL, V17, P707, DOI 10.1080/09602010600923926; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Daum I, 2000, BEHAV NEUROL, V12, P161, DOI 10.1155/2000/327304; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fleming JM, 1996, BRAIN INJURY, V10, P1; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Howell D.C., 2007, STAT METHODS PSYCHOL; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Marsh RL, 1998, MEM COGNITION, V26, P633, DOI 10.3758/BF03211383; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Neulinger K., 2002, BRAIN IMPAIR, V3, P1, DOI [10.1375/brim.3.1.1, DOI 10.1375/BRIM.3.1.1]; Palmer HM, 2000, BRAIN COGNITION, V44, P103; RASKIN S, 2000, MEMORY INTENTI UNPUB; Raskin S, 2004, J INT NEUROPSYCHO S1, V10, P110, DOI DOI 10.1017/S1355617704040019; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; Shum D, 2004, SCHIZOPHRENIA BULL, V30, P693, DOI 10.1093/oxfordjournals.schbul.a007123; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; SHUM D, 2006, PSYCHOL TESTING ASSE; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; West R. L., 1988, PRACTICAL ASPECTS ME, V2, P119; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; WILSON BA, 2004, BRAIN IMPAIRMENT S, V5, P44; Wilson BA, 2003, RIVERMEAD BEHAV MEMO; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999	43	36	37	1	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	1					127	140		10.1080/13854046.2010.529463			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	722FM	WOS:000287417100009	21108144				2022-02-06	
J	Wali, B; Sayeed, I; Stein, DG				Wali, Bushra; Sayeed, Iqbal; Stein, Donald G.			Improved behavioral outcomes after progesterone administration in aged male rats with traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Aging; male rats; progesterone; recovery of function; traumatic brain injury	MORRIS WATER MAZE; INFLAMMATORY RESPONSE; CORTICAL CONTUSION; COGNITIVE RECOVERY; NERVOUS-SYSTEM; ISCHEMIC BRAIN; CNS INJURY; EDEMA; ALLOPREGNANOLONE; NEUROSTEROIDS	Twenty-month-old male Fischer 344 rats with bilateral contusions of the frontal cortex (n = 8/group) or sham operations received 16 mg/kg of progesterone or vehicle at 1 and 6 h post-injury, then once every 24 h for the next seven days, with tapering of the dose over the final two treatments. The rats' behavioral recovery was then evaluated on tests of locomotor activity and Morris water maze learning. All rats were sacrificed 21 days post-TBI and brains were perfused and cryoprotected for necrotic cavity measurements. The injury produced significant impairments in activity and spatial learning compared to sham controls. The progesterone-treated rats had better functional outcomes than vehicle-treated rats with similar cortical injuries. The neurosteroid treatment did not affect the size of the necrotic cavity.	[Stein, Donald G.] Emory Univ, Brain Res Lab, Dept Emergency Med, Sch Med, Atlanta, GA 30322 USA		Stein, DG (corresponding author), Emory Univ, Brain Res Lab, Dept Emergency Med, Sch Med, Suite 5100,1365B Clifton Rd NE, Atlanta, GA 30322 USA.	dstei04@emory.edu	Stein, Donald/AAJ-5139-2020		NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01 5R01NS048451-04S2]; BHR	We acknowledge Leslie McCann for her help in manuscript preparation. This work was supported by NIH/NINDS grants 1R01 5R01NS048451-04S2 to DGS. Dr. Donald Stein is entitled to royalty from products of BHR Pharma, Ltd. related to the research described in this presentation, and may receive research funding from BHR, which is developing products related to this research. In addition, the author serves as consultant to BHR and receives compensation for these services. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies.	BAGIELLA E, 2010, J HEAD TRAUMA REHABI; Bitran D, 1996, PSYCHOPHARMACOLOGY, V125, P65, DOI 10.1007/BF02247394; BITRAN D, 1993, PHARMACOL BIOCHEM BE, V45, P423, DOI 10.1016/0091-3057(93)90260-Z; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; BIXO M, 1990, PSYCHONEUROENDOCRINO, V15, P159, DOI 10.1016/0306-4530(90)90025-5; Cekic M, 2009, FRONT NEUROENDOCRIN, V30, P158, DOI 10.1016/j.yfrne.2009.04.002; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US E; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Faul M, 2010, TRAUMATIC BRAIN INJU; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2000, BEHAV BRAIN RES, V116, P141, DOI 10.1016/S0166-4328(00)00275-8; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0475, 10.3233/RNN-2009-0476]; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, pR8; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reddy DS, 1997, BRAIN RES, V752, P61, DOI 10.1016/S0006-8993(96)01447-3; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Singh M, 2008, FRONT BIOSCI-LANDMRK, V13, P1083, DOI 10.2741/2746; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; STUSS DT, 1999, COGNITIVE NEUROREHAB; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; UNTERBERG A, 1994, ACTA NEUROCHIR, P431; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; VanLandingham JW, 2008, J CEREBR BLOOD F MET, V28, P1786, DOI 10.1038/jcbfm.2008.73; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015; Wilson J A, 1987, Brain Inj, V1, P183, DOI 10.3109/02699058709034456; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; You JM, 2009, CAN J PHYSIOL PHARM, V87, P440, DOI [10.1139/Y09-027, 10.1139/y09-027]; Zinder O, 1999, ACTA PHYSIOL SCAND, V167, P181; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	60	36	37	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2011	29	1					61	71		10.3233/RNN-2011-0579			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	722ZZ	WOS:000287476200006	21335669				2022-02-06	
J	Widome, R; Kehle, SM; Carlson, KF; Laska, MN; Gulden, A; Lust, K				Widome, Rachel; Kehle, Shannon M.; Carlson, Kathleen F.; Laska, Melissa Nelson; Gulden, Ashley; Lust, Katherine			Post-traumatic Stress Disorder and Health Risk Behaviors Among Afghanistan and Iraq War Veterans Attending College	AMERICAN JOURNAL OF HEALTH BEHAVIOR			English	Article						veterans; tobacco; alcohol; health behaviors; OEF/OIF	TRAUMATIC BRAIN-INJURY; COMBAT DEPLOYMENT; AGGRESSION; DIAGNOSES; SYMPTOMS; STUDENTS; SMOKING; COHORT; PTSD; CARE	Objective: To determine if posttraumatic stress disorder (PTSD) is associated with health risk behaviors among Operations Enduring and Iraqi Freedom (OEF/OIF) veterans attending college. Method: Using 2008 Boynton College Student Health Survey data, we tested associations between self-reported PTSD diagnosis and self-reported risk behaviors (n=406). Results: We found PTSD diagnosis to be significantly associated with reporting involvement in a physical fight in the past year (ARR = 3.1; 95% CI: 2.2, 4.4) and marginally associated with high-risk drinking (ARR = 1.3; 95% CI: 1.1, 1.6). However, no association was seen between PTSD and the tobacco use and other safety behaviors that we examined. Conclusion: PTSD is likely a factor that contributes to the relationship between military service and certain health risk behaviors.	[Widome, Rachel; Kehle, Shannon M.; Gulden, Ashley] Univ Minnesota, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55455 USA; [Widome, Rachel] Univ Minnesota, Dept Med, Minneapolis, MN USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Portland VA Med Ctr, Portland Ctr Study Chron Comorbid Mental & Phys D, Portland, OR 97201 USA; [Carlson, Kathleen F.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Preventat Med, Portland, OR 97201 USA; [Laska, Melissa Nelson] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Lust, Katherine] Univ Minnesota, Boynton Hlth Serv, Minneapolis, MN USA		Widome, R (corresponding author), Univ Minnesota, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55455 USA.	chel@umn.edu		Laska, Melissa/0000-0002-3836-0269	NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U54 CA116849, U54CA116849] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [U54CA116849] Funding Source: NIH RePORTER		American College Health Association, AM COLL HLTH ASS NAT; Borsari B, 2008, J COLL STUD PSYCH, V22, P61, DOI 10.1080/87568220801960720; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Flood AM, 2009, J BEHAV MED, V32, P234, DOI 10.1007/s10865-008-9195-y; Fu SS, 2007, NICOTINE TOB RES, V9, P1071, DOI 10.1080/14622200701488418; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Karney B. R., 2008, INVISIBLE WOUNDS WAR, P119; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kirby AC, 2008, ADDICT BEHAV, V33, P1448, DOI 10.1016/j.addbeh.2008.05.007; Knight JR, 2002, J STUD ALCOHOL, V63, P263, DOI 10.15288/jsa.2002.63.263; LeardMann CA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1273; Maze R, 2009, ARMY TIMES, P7; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Raudenbush S.W., 2002, HIERACHICAL LINEAR M; Rheingold AA, 2004, TRAUMA HLTH PHYS HLT, P217, DOI DOI 10.1037/10723-009; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Substance Abuse and Mental Health Services Administration, 2009, NSDUH SER H; Taft CT, 2007, J ABNORM PSYCHOL, V116, P498, DOI 10.1037/0021-843X.116.3.498; United States Army, 2009, 700 SCH PARTN VA HEL; WIDOME R, AM J HLTH P IN PRESS	24	36	36	0	17	PNG PUBLICATIONS	OAK RIDGE	2205-K OAK RIDGE RD, #115, OAK RIDGE, NC 27310 USA	1945-7359			AM J HEALTH BEHAV	Am. J. Health Behav.		2011	35	4					387	392		10.5993/AJHB.35.4.1			6	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	909MA	WOS:000301567400001	22040585				2022-02-06	
J	Shahin, H; Gopinath, SP; Robertson, CS				Shahin, Hazem; Gopinath, Shankar P.; Robertson, Claudia S.			Influence of Alcohol on Early Glasgow Coma Scale in Head-Injured Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Alcohol; Intoxication; Traumatic brain injury; Glasgow Coma Scale	TRAUMATIC BRAIN-INJURY; ACUTE ETHANOL INTOXICATION; RATS; SEVERITY; POTENTIATION; DAMAGE; EXCITOTOXICITY; INGESTION; ISCHEMIA; STROKE	Background: To assess the depressant effects of alcohol on the level of consciousness of patients admitted with head injuries, this study examined the changes that occur in the Glasgow Coma Scale (GCS) of traumatic brain injury patients over time. Methods: The records of 269 head trauma patients consecutively admitted to the neurosurgery intensive care unit were examined retrospectively. Eighty-one patients were excluded because of incomplete data. The remaining 188 patients were further divided into an intoxicated group (blood alcohol concentration [BAC] >= 0.08%, n = 100 [53%]) and a nonintoxicated group (BAC <0.08%, n = 88 [47%]). The GCS in the prehospital setting, in the emergency department, and the highest GCS achieved during the first 24 hours postinjury were compared. Results: The change between emergency department-GCS and the best day 1 GCS in the intoxicated group was greater than the nonintoxicated group and deemed clinically and statistically significant; median change (3 vs. 0) p < 0.001. To assess whether these results were directly related to the BAC%, piecewise regression using a general linear model was used to assess the intercept and slope of alcohol on the changes of GCS with cutting point at BAC% = 0.08. The analysis showed that, in the nonintoxicated range, the effect of alcohol was not significantly related to the changes of GCS. But in the intoxicated range, BAC% was significantly positively related to the changes of GCS. Conclusion: This study concludes that the GCS increases significantly over time in alcohol intoxicated patients with traumatic brain injury.	[Shahin, Hazem] Baylor Coll Med, Dept Neurosurg, BCM 650, Houston, TX 77030 USA		Shahin, H (corresponding author), Baylor Coll Med, Dept Neurosurg, BCM 650, 1709 Dryden Rd,Suite 750, Houston, TX 77030 USA.	shahinhazem@yahoo.com			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01-NS38660]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	Data collection was funded in part by NIH Grant No P01-NS38660.	ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; ALTURA BM, 1983, SCIENCE, V220, P331, DOI 10.1126/science.6836278; BAUGHMAN VL, 1990, J NEUROSURG ANESTH, V2, P290, DOI 10.1097/00008506-199012000-00007; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; BRODNER RA, 1981, J TRAUMA, V21, P124, DOI 10.1097/00005373-198102000-00005; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; ChathamShowalter PE, 1996, PSYCHOSOMATICS, V37, P285, DOI 10.1016/S0033-3182(96)71567-0; Crews FT, 1998, PHARMACOL BIOCHEM BE, V59, P981, DOI 10.1016/S0091-3057(97)00538-8; Dash PK, 2004, J NEUROTRAUM, V21, P1573, DOI 10.1089/0897715042441828; DELANEY KA, 2000, HEAD INJURY; DEYKIN D, 1982, NEW ENGL J MED, V306, P852, DOI 10.1056/NEJM198204083061406; ELMER O, 1984, HAEMOSTASIS, V14, P223; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; Golan JD, 2007, J TRAUMA, V63, P365, DOI 10.1097/TA.0b013e31811ec178; HAUT MJ, 1974, AM J MED, V56, P22, DOI 10.1016/0002-9343(74)90747-5; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HOLT S, 1980, BRIT MED J, V281, P638, DOI 10.1136/bmj.281.6241.638; HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; INGLIS FM, 1990, ACT NEUR S, V51, P277; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; JENNETT B, 1977, LANCET, V1, P878; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; LAHAYE PA, 2000, TRAUMA, P377; Macewen William, 1879, Glasgow Med J, V11, P1; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MODELL JG, 1990, NEW ENGL J MED, V323, P455, DOI 10.1056/NEJM199008163230706; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Moskowitz H., 2000, HS809028 NAT HIGHW T; NATH FP, 1986, INJURY, V17, P150, DOI 10.1016/0020-1383(86)90320-7; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; PERSSON L, 1977, ACTA NEUROL SCAND, V56, P7; PIKAAR NA, 1987, METABOLISM, V36, P538, DOI 10.1016/0026-0495(87)90163-6; Piriyawat P, 2003, STROKE, V34, P1242, DOI 10.1161/01.STR.0000067706.23777.04; PORIES SE, 1992, J TRAUMA, V32, P60, DOI 10.1097/00005373-199201000-00013; SALCMAN M, 1981, NEUROSURGERY, V8, P15; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; SHAPIRA Y, 1994, STROKE, V25, P1637, DOI 10.1161/01.STR.25.8.1637; SLOAN EP, 1989, J TRAUMA, V29, P1647, DOI 10.1097/00005373-198912000-00011; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Strong R, 2000, NEUROPHARMACOLOGY, V39, P515, DOI 10.1016/S0028-3908(99)00156-2; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813	57	36	37	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2010	69	5					1176	1181		10.1097/TA.0b013e3181edbd47			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	678VK	WOS:000284110100041	21068620	Green Accepted			2022-02-06	
J	Deits, J; Yard, EE; Collins, CL; Fields, SK; Comstock, RD				Deits, Jeff; Yard, Ellen E.; Collins, Christy L.; Fields, Sarah K.; Comstock, R. Dawn			Patients With Ice Hockey Injuries Presenting to US Emergency Departments, 1990-2006	JOURNAL OF ATHLETIC TRAINING			English	Article						epidemiology; injury surveillance; face shields; mouth guards; body checking	NECK INJURIES; UNITED-STATES; DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; PLAYERS; HEAD; CONCUSSIONS; PROTECTION; SOCCER; RATES	Context: Although the number of US ice hockey participants doubled from 1990 to 2006, no nationally representative studies have examined US ice hockey injuries among participants of all ages during this period. Objective: To describe patients with ice hockey injuries presenting to a representative sample of US emergency departments (EDs) from 1990 through 2006. Design: Prospective injury surveillance study. Setting: The US Consumer Product Safety Commission collects data from 100 nationally representative EDs via the National Electronic Injury Surveillance System (NEISS). Patients or Other Participants: Individuals injured while playing ice hockey and presenting to a NEISS-affiliated ED from 1990 through 2006. Main Outcome Measure(s): Incidence and patterns of ice hockey-related injuries. Results: From 1990 through 2006, 8228 patients with ice hockey-related injuries presented to NEISS-affiliated EDs, representing an estimated 302 368 ice hockey-related injuries sustained nationally during this time. Injuries occurred predominantly among males (93.5%). More than half of the injured were aged 9 to 14 years (28.9%) or 1510 18 years (30.1%), and injury incidence in these age groups increased over the study period (P =.009 and P < .001, respectively). The most commonly injured body sites were the face (19.1%), wrist/hand/finger (14.1%), shoulder/upper arm (13.8%), and lower leg/ankle/foot (11.1%). Lacerations (27.0%), contusions/abrasions (23.6%), fractures (17.3%), and sprains/strains (16.9%) were the most common injuries. Falls (16.5%), contact with boards (13.6%), and contact with stick (13.0%) were the most common injury mechanisms. Compared with those aged 9 to 18 years, those aged 2 to 8 years and those older than 18 years sustained larger proportions of face (injury proportion ratio [IPR] = 2.66; 95% confidence interval [Cl] = 2.29, 3.08) and mouth (IPR = 4.34; 95% Cl = 2.87, 6.56) injuries. Concussions were more common among those aged 2 to 18 years (9.0%) than in those who were older than 18 years (3.7%) (IPR = 2.47; 95% Cl = 1.75, 3.49). Conclusions: Ice hockey injury patterns vary by age and sex. Our findings indicate that many trips to the ED might be prevented by using protective equipment appropriately.	[Yard, Ellen E.; Collins, Christy L.; Comstock, R. Dawn] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Deits, Jeff; Fields, Sarah K.] Ohio State Univ, Sch Phys Act & Educ Serv, Columbus, OH 43210 USA; [Yard, Ellen E.; Comstock, R. Dawn] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Yard, Ellen E.; Comstock, R. Dawn] Ohio State Univ, Coll Med, Columbus, OH 43210 USA		Collins, CL (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	christy.collins@nationwidechildrens.org					Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2007, J ATHL TRAINING, V42, P249; Anderson AJ, 2000, PEDIATRICS, V105, P657, DOI 10.1542/peds.105.3.640; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Berry DC, 2005, J PUBLIC HEALTH DENT, V65, P71, DOI 10.1111/j.1752-7325.2005.tb02789.x; Biasca N, 2002, BRIT J SPORT MED, V36, P410, DOI 10.1136/bjsm.36.6.410; *CONS PROD SAF COM, NEISS COD MAN; *CONS PROD SAF COM, NEISS SAMPL DES IMPL; Delaney JS, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.015735; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Dryden D M, 2000, J Sci Med Sport, V3, P140, DOI 10.1016/S1440-2440(00)80076-6; Dryden DM, 2000, MED SCI SPORT EXER, V32, P1378, DOI 10.1097/00005768-200008000-00004; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; Knox CL, 2006, BRIT J SPORT MED, V40, P268, DOI 10.1136/bjsm.2005.022855; Le Menestrel Suzanne, 2007, New Dir Youth Dev, P13; McKnight Cynthia M., 1992, Journal of Athletic Training, V27, P342; Molsa J, 2000, AM J SPORT MED, V28, P322; Molsa J, 2003, AM J SPORT MED, V31, P751; *NAT FED STAT HIGH, NFHS PART FIG SEARCH; Neussl Amy, 2008, J Dent Hyg, V82, P44; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; *US HOCK, 2009, MEMB STAT; *US HOCK, 2007 2009 OFF RUL IC; Wattie N, 2007, PEDIATRICS, V120, P142, DOI 10.1542/peds.2006-2672; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Woods SE, 2008, SOUTH MED J, V101, P991, DOI 10.1097/SMJ.0b013e3181830d42; Woods SE, 2007, FAM MED, V39, P473; Yard EE, 2006, J ATHL TRAINING, V41, P441	32	36	37	0	10	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2010	45	5					467	474		10.4085/1062-6050-45.5.467			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	654GZ	WOS:000282157800005	20831391	Green Published			2022-02-06	
J	Krawczyk, DC; Hanten, G; Wilde, EA; Li, XQ; Schnelle, KP; Merkley, TL; Vasquez, AC; Cook, LG; McClelland, M; Chapman, SB; Levin, HS				Krawczyk, Daniel C.; Hanten, Gerri; Wilde, Elisabeth A.; Li, Xiaoqi; Schnelle, Kathleen P.; Merkley, Tricia L.; Vasquez, Ana C.; Cook, Lori G.; McClelland, Michelle; Chapman, Sandra B.; Levin, Harvey S.			Deficits in analogical reasoning in adolescents with traumatic brain injury	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						analogy; reasoning; traumatic brain injury; gray matter; adolescent; distraction	CLOSED-HEAD INJURY; HUMAN CEREBRAL-CORTEX; ATTENTION DEFICIT/HYPERACTIVITY DISORDER; ROSTROLATERAL PREFRONTAL CORTEX; TYPICALLY DEVELOPING-CHILDREN; MAGNETIC-RESONANCE IMAGES; LONG-TERM OUTCOMES; INHIBITORY CONTROL; WORKING-MEMORY; EXECUTIVE FUNCTIONS	Individuals with traumatic brain injury (TBI) exhibit deficits in executive control, which may impact their reasoning abilities. Analogical reasoning requires working memory and inhibitory abilities. In this study, we tested adolescents with moderate to severe TBI and typically developing (TD) controls on a set of picture analogy problems. Three factors were varied: complexity (number of relations in the problems), distraction (distractor item present or absent), and animacy (living or non-living items in the problems). We found that TD adolescents performed significantly better overall than TBI adolescents. There was also an age effect present in the TBI group where older participants performed better than younger ones. This age effect was not observed in the TD group. Performance was affected by complexity and distraction. Further, TBI participants exhibited lower performance with distractors present than TD participants. The reasoning deficits exhibited by the TBI participants were correlated with measures of executive function that required working memory updating, attention, and attentional screening. Using MRI-derived measures of cortical thickness, correlations were carried out between task accuracy and cortical thickness. The TD adolescents showed negative correlations between thickness and task accuracy in frontal and temporal regions consistent with cortical maturation in these regions. This study demonstrates that adolescent TBI results in impairments in analogical reasoning ability. Further, TBI youth have difficulty effectively screening out distraction, which may lead to failures in comprehension of the relations among items in visual scenes. Lastly, TBI youth fail to show robust cortical-behavior correlations as observed in TD individuals.	[Krawczyk, Daniel C.; Cook, Lori G.; McClelland, Michelle; Chapman, Sandra B.] Univ Texas Dallas, Ctr Brain Hlth, Sch Behav & Brain Sci, Dallas, TX 75235 USA; [Krawczyk, Daniel C.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [Hanten, Gerri; Wilde, Elisabeth A.; Li, Xiaoqi; Schnelle, Kathleen P.; Vasquez, Ana C.; Levin, Harvey S.] Univ Texas Houston Med Sch, Houston, TX USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Merkley, Tricia L.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Krawczyk, DC (corresponding author), Univ Texas Dallas, Ctr Brain Hlth, Sch Behav & Brain Sci, 2200 Mockingbird Lane, Dallas, TX 75235 USA.	daniel.krawczyk@utdallas.edu	Merkley, Tricia L./AAN-2989-2020	Merkley, Tricia/0000-0002-0897-8391	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-21889]	We thank Lindsey Richland for assistance with the task materials and procedure. We thank Carrie McAdams, Kevin Murch, Ehsan Shokri, and Gloria Yang for helpful comments and suggestions. We also acknowledge the assistance of Drs. Jill V. Hunter and Zili Chu in image acquisition and pre-processing. This work was supported by NIH grant NS-21889 (Harvey S. Levin). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We would also like to acknowledge the generous support by Mission Connect of the TIRR Foundation.	Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; BROWN AL, 1989, SIMILARITY AND ANALOGICAL REASONING, P369, DOI 10.1017/CBO9780511529863.019; Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Bunge SA, 2009, NEUROIMAGE, V46, P338, DOI 10.1016/j.neuroimage.2009.01.064; Christoff K, 2009, BRAIN RES, V1286, P94, DOI 10.1016/j.brainres.2009.05.096; Colom R, 2006, NEUROIMAGE, V31, P1359, DOI 10.1016/j.neuroimage.2006.01.006; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P55, DOI 10.1111/j.1467-7687.2008.00743.x; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Geake JG, 2010, NEUROIMAGE, V49, P3489, DOI 10.1016/j.neuroimage.2009.09.008; GENTNER D, 1983, COGNITIVE SCI, V7, P155, DOI 10.1207/s15516709cog0702_3; GENTNER D, 1986, COGNITIVE SCI, V10, P277, DOI 10.1207/s15516709cog1003_2; Gentner D., 1991, PERSPECTIVES THOUGHT; Ghosh A, 2009, BRAIN INJURY, V23, P228, DOI 10.1080/02699050802672789; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; GOSWAMI U, 1990, COGNITION, V35, P69, DOI 10.1016/0010-0277(90)90037-K; Goswami U, 2001, BRIT J PSYCHOL, V92, P257, DOI 10.1348/000712601162068; Goswami U, 1998, BRIT J DEV PSYCHOL, V16, P553, DOI 10.1111/j.2044-835X.1998.tb00771.x; Green AE, 2006, BRAIN RES, V1096, P125, DOI 10.1016/j.brainres.2006.04.024; Green AE, 2010, CEREB CORTEX, V20, P70, DOI 10.1093/cercor/bhp081; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; HALFORD GS, 1994, CHILD DEV, V65, P1338, DOI 10.1111/j.1467-8624.1994.tb00820.x; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hiscock Merrill, 2002, Appl Neuropsychol, V9, P129, DOI 10.1207/S15324826AN0903_1; Holyoak KJ., 1996, MENTAL LEAPS ANALOGY; Hummel JE, 1997, PSYCHOL REV, V104, P427, DOI 10.1037/0033-295X.104.3.427; Hummel JE, 2003, PSYCHOL REV, V110, P220, DOI 10.1037/0033-295X.110.2.220; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kotovsky L, 1996, CHILD DEV, V67, P2797, DOI 10.2307/1131753; Krawczyk DC, 2008, NEUROPSYCHOLOGIA, V46, P2020, DOI 10.1016/j.neuropsychologia.2008.02.001; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Leblanc N, 2006, BRAIN COGNITION, V60, P208; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Luo Q, 2003, COGNITIVE BRAIN RES, V17, P527, DOI 10.1016/S0926-6410(03)00167-8; MARKMAN AB, 1993, COGNITIVE PSYCHOL, V25, P431, DOI 10.1006/cogp.1993.1011; McCauley SR, 2010, DEV NEUROPSYCHOL, V35, P318, DOI 10.1080/87565641003696866; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Morrison RG, 2004, J COGNITIVE NEUROSCI, V16, P260, DOI 10.1162/089892904322984553; Morrison RG, 2008, BEHAV BRAIN SCI, V31, P391, DOI 10.1017/S0140525X08004615; Morsanyi K, 2010, DEVELOPMENTAL SCI, V13, P578, DOI 10.1111/j.1467-7687.2009.00915.x; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; OHARE E, 2009, J COGNITIVE NEUROS S, V36, P46; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Penn DC, 2008, BEHAV BRAIN SCI, V31, P130; Penn DC, 2008, BEHAV BRAIN SCI, V31, P109, DOI 10.1017/S0140525X08003543; Rattermann MJ, 1998, COGNITIVE DEV, V13, P453, DOI 10.1016/S0885-2014(98)90003-X; Raven JC, 1938, PROGRESSIVE MATRICES; Richland LE, 2006, J EXP CHILD PSYCHOL, V94, P249, DOI 10.1016/j.jecp.2006.02.002; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Salvucci DD, 2001, COGNITIVE SCI, V25, P67; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Smith R, 2007, NEUROIMAGE, V36, P1387, DOI 10.1016/j.neuroimage.2007.04.032; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; STERNBERG RJ, 1979, J EXP CHILD PSYCHOL, V27, P195, DOI 10.1016/0022-0965(79)90044-4; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Tohill J.M., 2000, THINK REASON, V6, P27, DOI [10.1080/135467800393911, DOI 10.1080/135467800393911, 10.1080/135467800393911.]; Viskontas IV, 2004, PSYCHOL AGING, V19, P581, DOI 10.1037/0882-7974.19.4.581; Waltz JA, 1999, PSYCHOL SCI, V10, P119, DOI 10.1111/1467-9280.00118; Waltz JA, 2004, NEUROPSYCHOLOGY, V18, P296, DOI 10.1037/0894-4105.18.2.296; Waltz JA, 2000, MEM COGNITION, V28, P1205, DOI 10.3758/BF03211821; Wendelken C, 2008, J COGNITIVE NEUROSCI, V20, P682, DOI 10.1162/jocn.2008.20055; Wharton CM, 2000, COGNITIVE PSYCHOL, V40, P173, DOI 10.1006/cogp.1999.0726; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wright SB, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.008.2007; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; YNTEMA DB, 1967, ACTA PSYCHOL, V27, P325, DOI 10.1016/0001-6918(67)90075-3	99	36	37	0	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	AUG 19	2010	4								62	10.3389/fnhum.2010.00062			13	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	747FH	WOS:000289305200001	20844604	gold, Green Published			2022-02-06	
J	Ohsumi, A; Nawashiro, H; Otani, N; Ooigawa, H; Toyooka, T; Shima, K				Ohsumi, Atsushi; Nawashiro, Hiroshi; Otani, Naoki; Ooigawa, Hidetoshi; Toyooka, Terushige; Shima, Katsuji			Temporal and Spatial Profile of Phosphorylated Connexin43 after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						connexin43; fluid percussion injury; gap junction; traumatic brain injury	GAP-JUNCTIONAL COMMUNICATION; LATERAL FLUID-PERCUSSION; SELECTIVE VULNERABILITY; REACTIVE ASTROCYTES; ACTIVATION; EXPRESSION; INCREASES; NEURONS; PROTEIN; KINASE	Gap junctions are conductive channels formed by membrane proteins termed connexins (Cx), which permit the intercellular exchange of metabolites, ions, and small molecules. Junctional permeability is regulated by pH, membrane potential, and intracellular secondary messengers. The purpose of this study was to elucidate the expression and distribution of astrocytic gap junctions in the hippocampus and the cortex after traumatic brain injury (TBI) in vivo. Adult male Sprague-Dawley rats (300-400 g) were subjected to lateral fluid percussion injury (FPI) at moderate severity (2.6-2.8 atm, 12 msec) using a Dragonfly device model. Phosphorylated gap junction protein levels were quantified using Western blot analysis. Spatial distribution of immunoreactivity for phosphorylated Cx43 (p-Cx43) was analyzed by immunohistochemistry. Our findings showed that p-Cx43 expression in the ipsilateral hippocampus was significantly induced at 1 h after TBI, and remained at a high level until 24 h after injury. The p-Cx43 protein content reached a maximum level at 6 h after injury. In addition, the immunoreactivity for p-Cx43 was localized in the astrocytes surrounding ipsilateral CA3 pyramidal neurons. On the other hand, the protein level in the ipsilateral cortex was not significantly different at any time point after TBI. Double immunostaining using phosphorylated ERK (p-ERK) showed that p-Cx43 and p-ERK immunoreactivities were enhanced in the same astrocytes at 6 h after injury. These findings suggest that astrocytic gap junctions participate in pathophysiological processes in the hippocampus after TBI.	[Ohsumi, Atsushi; Nawashiro, Hiroshi; Otani, Naoki; Ooigawa, Hidetoshi; Toyooka, Terushige; Shima, Katsuji] Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 359, Japan		Ohsumi, A (corresponding author), Natl Def Med Coll, Dept Neurosurg, Namiki 3-2, Tokorozawa, Saitama 359, Japan.	atsuoh@ndmc.ac.jp					BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; Brandes RP, 2002, BRIT J PHARMACOL, V136, P709, DOI 10.1038/sj.bjp.0704776; Bruzzone R, 1997, EUR J NEUROSCI, V9, P1, DOI 10.1111/j.1460-9568.1997.tb01346.x; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cottrell GT, 2003, AM J PHYSIOL-CELL PH, V284, pC511, DOI 10.1152/ajpcell.00214.2002; Dermietzel R, 1998, BRAIN RES REV, V26, P176, DOI 10.1016/S0165-0173(97)00031-3; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; ENKVIST MOK, 1994, J NEUROCHEM, V62, P489; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; KATAYAMA Y, 1990, ACT NEUR S, V51, P271; LI W, 2005, J BIOL CHEM, V280, P7914; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mandell JW, 2001, GLIA, V34, P283, DOI 10.1002/glia.1062; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Muller T, 1995, INT REV NEUROBIOL, V38, P341, DOI 10.1016/S0074-7742(08)60530-9; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Rami A, 2000, EXP NEUROL, V170, P297, DOI 10.1006/exnr.2001.7712; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rouach N, 2000, J CELL BIOL, V149, P1513, DOI 10.1083/jcb.149.7.1513; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Siushansian R, 2001, J COMP NEUROL, V440, P387, DOI 10.1002/cne.1392; Teubner B, 2001, J NEUROSCI, V21, P1117; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zvalova D, 2004, GLIA, V46, P323, DOI 10.1002/glia.10334	38	36	39	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2010	27	7					1255	1263		10.1089/neu.2009.1234			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	631FD	WOS:000280331100010	20412010				2022-02-06	
J	Yang, FG; Fuller, J; Khodaparast, N; Krawczyk, DC				Yang, Fanpei Gloria; Fuller, Jerome; Khodaparast, Navid; Krawczyk, Daniel C.			Figurative language processing after traumatic brain injury in adults: A preliminary study	NEUROPSYCHOLOGIA			English	Article						Semantic; Memory; Control; Prefrontal cortex; Left inferior frontal gyrus; Abstraction; Traumatic brain injury; Metaphor; Figurative; Language; fMRI	PREFRONTAL CORTEX; METAPHOR; REGIONS; METAANALYSIS; ACTIVATION; KNOWLEDGE; FMRI	Figurative speech (e.g., proverb, irony, metaphor, and idiom) has been reported to be particularly sensitive to measurement of abstract thinking in patients who suffer from impaired abstraction and language abilities. Metaphor processing was investigated with fMRI in adults with moderate to severe post-acute traumatic brain injury (TBI) and healthy age-matched controls using a valence-judgment task. We hypothesized that TBI patients would display decreased activation of the left inferior frontal gyrus (LIFG), which is considered central to semantic memory retrieval and abstract thought, in comparison with healthy controls. We also predicted that decreased activation in TBI individuals would correlate with their behavioral response times. A whole-brain analysis across the two participant groups revealed that patients did not strongly engage frontal and temporal regions related to semantic processing for novel metaphor comprehension, whereas control participants exhibited more intensive and concentrated activation within frontal and temporal areas. A region of interest (ROI) analysis verified that the LIFG was underactivated in TBI patients compared to controls across all conditions. TBI patients' impaired abstraction of novel stimuli may stem from reduced prefrontal control of semantic memory as well as disrupted interconnectivity of prefrontal cortex with other regions. (C) 2010 Elsevier Ltd. All rights reserved.	[Yang, Fanpei Gloria] Univ Texas Dallas, Sch Brain & Behav Sci, Ctr Brain Hlth, Dallas, TX 75230 USA; [Krawczyk, Daniel C.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [Yang, Fanpei Gloria] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA		Yang, FG (corresponding author), Univ Texas Dallas, Sch Brain & Behav Sci, Ctr Brain Hlth, 2200 Mockingbird, Dallas, TX 75230 USA.	fbyang@gmail.com					Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bedny M, 2008, CEREB CORTEX, V18, P2574, DOI 10.1093/cercor/bhn018; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; BLUE CM, 1981, LANG SPEECH HEAR SER, V12, P120; Chee MWL, 1999, HUM BRAIN MAPP, V7, P15, DOI 10.1002/(SICI)1097-0193(1999)7:1<15::AID-HBM2>3.0.CO;2-6; Costafreda S, 2003, SCHIZOPHR RES, V60, P215, DOI 10.1016/S0920-9964(03)81173-8; De Carli D, 2007, MAGN RESON IMAGING, V25, P933, DOI 10.1016/j.mri.2007.03.031; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; ELMORE CM, 1957, J CLIN PSYCHOL, V13, P263, DOI 10.1002/1097-4679(195707)13:3<263::AID-JCLP2270130308>3.0.CO;2-C; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; Giora R, 1997, COGN LINGUIST, V8, P183, DOI 10.1515/cogl.1997.8.3.183; Giora R., 2000, METAPHOR SYMBOL, V15, P63, DOI [DOI 10.1080/10926488.2000.9678865, 10.1080/10926488.2000.9678865]; Giora R, 2007, BRAIN LANG, V100, P111, DOI 10.1016/j.bandl.2006.08.001; GROHER M, 1983, REHABILITATION HEAD; HAGEN C, 1984, LANGUAGE DISORDERS A; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Holland A., 1982, CLIN APH P C, P345; Levin HS., 1982, NEUROBEHAVIORAL CONS; Mashal N, 2007, BRAIN LANG, V100, P115, DOI 10.1016/j.bandl.2005.10.005; Mashal N, 2009, LATERALITY, V14, P30, DOI 10.1080/13576500802049433; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; NEARY D, 1988, J NEUROL NEUROSUR PS, V51, P353, DOI 10.1136/jnnp.51.3.353; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Pobric G, 2008, J COGNITIVE NEUROSCI, V20, P170, DOI 10.1162/jocn.2008.20005; Rapp AM, 2004, COGNITIVE BRAIN RES, V20, P395, DOI 10.1016/j.cogbrainres.2004.03.017; Stringaris AK, 2007, BRAIN LANG, V100, P150, DOI 10.1016/j.bandl.2005.08.001; Stringaris AK, 2006, NEUROIMAGE, V33, P784, DOI 10.1016/j.neuroimage.2006.06.057; Thompson-Schill SL, 1999, J EXP PSYCHOL LEARN, V25, P41, DOI 10.1037/0278-7393.25.1.41; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Towne R.L., 1993, LANG SPEECH HEAR SER, V24, P100; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; WIG E, 1984, LANGUAGE ASSESSMENT; Wigg E. H., 1988, NEUROPSYCHOLOGICAL S; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WINNER E, 1980, J EXP CHILD PSYCHOL, V30, P22, DOI 10.1016/0022-0965(80)90072-7; WINNER E, 1977, BRAIN, V100, P717, DOI 10.1093/brain/100.4.717; Yang FG, 2009, BRAIN LANG, V111, P114, DOI 10.1016/j.bandl.2009.08.006; [No title captured]	40	36	38	1	33	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JUN	2010	48	7					1923	1929		10.1016/j.neuropsychologia.2010.03.011			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	613ZD	WOS:000279023100006	20230844				2022-02-06	
J	Yang, JS; You, ZR; Kim, HH; Hwang, SK; Khuman, J; Guo, SZ; Lo, EH; Whalen, MJ				Yang, Jinsheng; You, Zerong; Kim, Hyung-Hwan; Hwang, Seo-Kyoung; Khuman, Jugta; Guo, Shuzhen; Lo, Eng H.; Whalen, Michael J.			Genetic Analysis of the Role of Tumor Necrosis Factor Receptors in Functional Outcome after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; gene knockout; inflammation; mice; tumor necrosis factor; traumatic brain injury	NF-KAPPA-B; CONTROLLED CORTICAL IMPACT; NONAPOPTOTIC CELL-DEATH; LACKING TNF RECEPTORS; FACTOR-ALPHA; ACTIVATION; EXPRESSION; DAMAGE; INHIBITOR; PATHWAY	We previously reported that tumor necrosis factor-alpha (TNF-alpha) and Fas receptor induce acute cellular injury, tissue damage, and motor and cognitive deficits after controlled cortical impact (CCI) in mice (Bermpohl et al. 2007); however, the TNF receptors (TNFR) involved are unknown. Using a CCI model and novel mutant mice deficient in TNFR1/Fas, TNFR2/Fas, or TNFR1/TNFR2/Fas, we tested the hypothesis that the combination of TNFR2/Fas is protective, whereas TNFR1/Fas is detrimental after CCI. Uninjured knockout (KO) mice showed no differences in baseline physiological variables or motor or cognitive function. Following CCI, mice deficient in TNFR2/Fas had worse post-injury motor and Morris water maze (MWM) performance than wild-type (WT) mice (p < 0.05 group effect for wire grip score and MWM performance by repeated measures ANOVA). No differences in motor or cognitive outcome were observed in TNFR1/Fas KO, or in TNFR2 or TNFR1 single KO mice, versus WT mice. Additionally, no differences in propidium iodide (PI)-positive cells (at 6 h) or lesion size (at 14 days) were observed between WT and TNFR1/Fas or TNFR2/Fas KO mice. Somewhat surprisingly, mice deficient in TNFR1/TNFR2/Fas also had PI-positive cells, lesion size, and motor and MWM deficits similar to those of WT mice. These data suggest a protective role for TNFR2/Fas in the pathogenesis of TBI. Further studies are needed to determine whether direct or indirect effects of TNFR1 deletion in TNFR2/Fas KO mice mediate improved functional outcome in TNFR1/TNFR2/Fas KO mice after CCI.	[Yang, Jinsheng; You, Zerong; Khuman, Jugta; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat, Charlestown, MA 02129 USA; [Khuman, Jugta; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Neurosci, Charlestown, MA 02129 USA; [Guo, Shuzhen; Lo, Eng H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Guo, Shuzhen; Lo, Eng H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA 02129 USA; [Kim, Hyung-Hwan; Hwang, Seo-Kyoung] Brigham & Womens Hosp, Vasc Med Res Unit, Boston, MA 02115 USA		Whalen, MJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat, Charlestown, MA 02129 USA.	mwhalen@partners.org			NIH/National Institute of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1NS47447]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047447] Funding Source: NIH RePORTER	This work was supported by NIH/National Institute of Neurological Diseases and Stroke grant RO1NS47447 to M.J.W.	Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Bruce-Keller AJ, 1999, J NEUROIMMUNOL, V93, P53, DOI 10.1016/S0165-5728(98)00190-8; Carpentier I, 2004, CURR MED CHEM, V11, P2205, DOI 10.2174/0929867043364694; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Costelli P, 2003, CELL DEATH DIFFER, V10, P997, DOI 10.1038/sj.cdd.4401281; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Kim GM, 2001, J NEUROSCI, V21, P6617, DOI 10.1523/JNEUROSCI.21-17-06617.2001; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Longhi L, 2008, ACTA NEUROCHIR SUPPL, V102, P409, DOI 10.1007/978-3-211-85578-2_80; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Marchetti L, 2004, J BIOL CHEM, V279, P32869, DOI 10.1074/jbc.M311766200; Martin-Villalba A, 2001, CELL DEATH DIFFER, V8, P679, DOI 10.1038/sj.cdd.4400882; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Pejovic V, 2004, PROTEOMICS, V4, P1461, DOI 10.1002/pmic.200300687; Raivich G, 2002, EXP NEUROL, V178, P186, DOI 10.1006/exnr.2002.8024; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Thompson C, 2004, MOL BRAIN RES, V123, P126, DOI 10.1016/j.molbrainres.2004.01.009; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44	39	36	36	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2010	27	6					1037	1046		10.1089/neu.2009.1229			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	612VO	WOS:000278933300007	20205514	Green Published			2022-02-06	
J	Gibson, CJ; Meyer, RC; Hamm, RJ				Gibson, Cynthia J.; Meyer, Rebecca C.; Hamm, Robert J.			Traumatic brain injury and the effects of diazepam, diltiazem, and MK-801 on GABA-A receptor subunit expression in rat hippocampus	JOURNAL OF BIOMEDICAL SCIENCE			English	Article							CALCIUM-CHANNEL BLOCKER; FLUID-PERCUSSION INJURY; EXCITATORY AMINO-ACIDS; TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; HUMAN NT-2 NEURONS; CORTICAL-NEURONS; DIFFERENTIAL EXPRESSION; SIGNAL-TRANSDUCTION	Background: Excitatory amino acid release and subsequent biochemical cascades following traumatic brain injury (TBI) have been well documented, especially glutamate-related excitotoxicity. The effects of TBI on the essential functions of inhibitory GABA-A receptors, however, are poorly understood. Methods: We used Western blot procedures to test whether in vivo TBI in rat altered the protein expression of hippocampal GABA-A receptor subunits alpha 1, alpha 2, alpha 3, alpha 5, beta 3, and gamma 2 at 3 h, 6 h, 24 h, and 7 days post-injuy. We then used pre-injury injections of MK-801 to block calcium influx through the NMDA receptor, diltiazem to block L-type voltage-gated calcium influx, or diazepam to enhance chloride conductance, and re-examined the protein expressions of alpha 1, alpha 2, alpha 3, and gamma 2, all of which were altered by TBI in the first study and all of which are important constituents in benzodiazepine-sensitive GABA-A receptors. Results: Western blot analysis revealed no injury-induced alterations in protein expression for GABA-A receptor alpha 2 or alpha 5 subunits at any time point post-injury. Significant time-dependent changes in alpha 1, alpha 3, alpha 3, and gamma 2 protein expression. The pattern of alterations to GABA-A subunits was nearly identical after diltiazem and diazepam treatment, and MK-801 normalized expression of all subunits 24 hours post-TBI. Conclusions: These studies are the first to demonstrate that GABA-A receptor subunit expression is altered by TBI in vivo, and these alterations may be driven by calcium-mediated cascades in hippocampal neurons. Changes in GABA-A receptors in the hippocampus after TBI may have far-reaching consequences considering their essential importance in maintaining inhibitory balance and their extensive impact on neuronal function.	[Gibson, Cynthia J.] Washington Coll, Dept Psychol, Chestertown, MD 21620 USA; [Meyer, Rebecca C.] Emory Univ, Neurosci Program, Atlanta, GA 30322 USA; [Hamm, Robert J.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA		Gibson, CJ (corresponding author), Washington Coll, Dept Psychol, Chestertown, MD 21620 USA.	cgibson2@washcoll.edu			NIH, National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20 RR016469]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016469] Funding Source: NIH RePORTER	This publication was made possible by NIH grant number P20 RR016469 from the INBRE Program of the National Center for Research Resources.	BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; Berman RF, 2000, J NEUROSURG, V93, P821, DOI 10.3171/jns.2000.93.5.0821; Brooks-Kayal AR, 2001, J NEUROCHEM, V77, P1266, DOI 10.1046/j.1471-4159.2001.00329.x; Chandra D, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-30; CHOI DW, 1987, J NEUROSCI, V7, P369; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Das P, 2004, NEUROSCIENCE, V124, P195, DOI 10.1016/j.neuroscience.2003.12.005; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Folkerts MM, 2007, J NEUROTRAUM, V24, P638, DOI 10.1089/neu.2006.0188; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Goda M, 2002, J NEUROTRAUM, V19, P1445, DOI 10.1089/089771502320914679; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Hamm RJ, 1993, BRAIN RES COGN BRAIN, V1, P223, DOI [10.1016/0926-6410(93)90006-Q, DOI 10.1016/0926-6410(93)90006-Q]; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Houlihan LM, 2000, NEUROPHARMACOLOGY, V39, P2533, DOI 10.1016/S0028-3908(00)00116-7; Huopaniemi L, 2004, J NEUROCHEM, V88, P1059, DOI 10.1046/j.1471-4159.2003.02216.x; Jensen ML, 2002, J BIOL CHEM, V277, P41438, DOI 10.1074/jbc.M205645200; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kim HS, 2000, BRAIN RES, V880, P28, DOI 10.1016/S0006-8993(00)02687-1; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Lavoie AM, 1997, BIOPHYS J, V73, P2518, DOI 10.1016/S0006-3495(97)78280-8; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Lyons HR, 2001, J NEUROCHEM, V78, P1114, DOI 10.1046/j.1471-4159.2001.00501.x; Marowsky A, 2004, EUR J NEUROSCI, V20, P1281, DOI 10.1111/j.1460-9568.2004.03574.x; MATLIB MA, 1983, LIFE SCI, V32, P2837, DOI 10.1016/0024-3205(83)90319-3; Matthews DB, 2000, J NEUROCHEM, V74, P1522, DOI 10.1046/j.1471-4159.2000.0741522.x; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3; MOHLER H, 1996, ION CHANNELS, V4; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; OBATA K, 1978, BRAIN RES, V144, P179, DOI 10.1016/0006-8993(78)90447-X; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Paquet-Durand F, 2004, BRAIN RES, V1011, P33, DOI 10.1016/j.brainres.2004.02.060; Paquet-Durand F, 2006, BRAIN RES, V1124, P45, DOI 10.1016/j.brainres.2006.09.077; Phillips LL, 1998, HIPPOCAMPUS, V8, P390, DOI 10.1002/(SICI)1098-1063(1998)8:4<390::AID-HIPO7>3.3.CO;2-9; Poulter MO, 1999, J NEUROSCI, V19, P4654; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Sarnowska A, 2009, NEUROCHEM INT, V55, P164, DOI 10.1016/j.neuint.2009.01.024; SCANLON JM, CELL CALCIUM, V28, P317; SCHURR A, 1995, BRAIN RES, V684, P233, DOI 10.1016/0006-8993(95)00466-4; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)01118-8; Sihver S, 2001, J NEUROCHEM, V78, P417, DOI 10.1046/j.1471-4159.2001.00428.x; SKEEN GA, 1994, J PHARMACOL EXP THER, V271, P30; Sotiriou E, 2005, J NEUROSCI RES, V82, P690, DOI 10.1002/jnr.20670; Sperk G, 1998, EPILEPSY RES, V32, P129, DOI 10.1016/S0920-1211(98)00046-1; Stein V, 2003, NEURON, V37, P375, DOI 10.1016/S0896-6273(03)00056-4; STELZER A, 1994, NEUROSCIENCE, V62, P813, DOI 10.1016/0306-4522(94)90479-0; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Thompson CL, 2000, J NEUROCHEM, V74, P920, DOI 10.1046/j.1471-4159.2000.0740920.x; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vaknin UA, 2006, J CELL BIOCHEM, V97, P1094, DOI 10.1002/jcb.20708; Vallazza-Deschamps G, 2005, DOC OPHTHALMOL, V110, P25, DOI 10.1007/s10633-005-7341-1; Wang L, 2009, NEUROPHARMACOLOGY, V56, P198, DOI 10.1016/j.neuropharm.2008.07.004; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x	72	36	39	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1021-7770			J BIOMED SCI	J. Biomed. Sci.	MAY 18	2010	17								38	10.1186/1423-0127-17-38			11	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	616MW	WOS:000279214500001	20482789	Green Published, gold			2022-02-06	
J	Xue, S; Zhang, HT; Zhang, P; Luo, J; Chen, ZZ; Jang, XD; Xu, RX				Xue, Sha; Zhang, Hong-tian; Zhang, Peng; Luo, Jie; Chen, Zhen-zhou; Jang, Xiao-dan; Xu, Ru-xiang			Functional endothelial progenitor cells derived from adipose tissue show beneficial effect on cell therapy of traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Adipose tissue; Endothelial progenitor cells; Traumatic brain injury	MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; HUMAN BONE-MARROW; CEREBRAL-ISCHEMIA; TRANSPLANTATION; RAT; NEOVASCULARIZATION; EXPRESSION; MICE	Endothelial progenitor cells (EPCs) are responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Adipose tissue (AT) is an abundant source of mesenchymal stem cells (MSCs), which have multipotent differentiation ability. We successfully derived EPCs from AT, which maintained a strong proliferative capacity and demonstrated the characteristic endothelial function of uptaking of acetylated low-density lipoprotein. They formed tube-like structures in vitro. Endothelial nitric oxide synthase (eNOS) gene expression in EPCs was similar to that in mature endothelial cells. Transplantation of EPCs derived from AT after the acute phase was applied in rats with traumatic brain injury (TBI). Transplanted EPCs participated in the neovascularization of injured brain. Improving functional recovery, reducement of deficiency volume of brain, host astrogliosis and inflammation were found. These results suggest that adult AT derived stem cells can be induced to functional EPCs and have beneficial effect on cell therapy. (C) 2010 Elsevier Ireland Ltd. All rights reserved.	[Xue, Sha; Zhang, Hong-tian; Zhang, Peng; Luo, Jie; Chen, Zhen-zhou; Jang, Xiao-dan; Xu, Ru-xiang] So Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou 510282, Guangdong, Peoples R China; [Xue, Sha; Zhang, Hong-tian; Zhang, Peng; Luo, Jie; Chen, Zhen-zhou; Jang, Xiao-dan; Xu, Ru-xiang] So Med Univ, Inst Neurosurg, Key Lab Brain Funct Repair & Regenerat Guangdong, Guangzhou 510282, Guangdong, Peoples R China; [Xu, Ru-xiang] Mil Gen Hosp Beijing PLA, Dept Neurosurg, Beijing 100700, Peoples R China		Jang, XD (corresponding author), So Med Univ, Zhujiang Hosp, Dept Neurosurg, 253 Gongye Rd, Guangzhou 510282, Guangdong, Peoples R China.	jiangxiao_dan@163.com; zjxuruxiang@163.com			Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [U0632008, 30772232, 30801184, 30500526]; Funds for Key Sci-Tech Research Projects of Guangdong Province [2006Z3-E522, YUE KEJIBAN (2007) 05/06-7005206, 05/06-7005213, YUECAIJIAO (2008) 258-2008A030201019]; Funds for Key Sci-Tech Research Projects of Guangzhou [YUEKETIAOZI (2008)3-2008A1-E4011-6, 09B52120112]	This research was supported by the Natural Science Foundation of China (NSFC) (U0632008, 30772232, 30801184, 30500526), Funds for Key Sci-Tech Research Projects of Guangdong Province [2006Z3-E522, YUE KEJIBAN (2007) 05/06-7005206, 05/06-7005213, YUECAIJIAO (2008) 258-2008A030201019], and Funds for Key Sci-Tech Research Projects of Guangzhou [YUEKETIAOZI (2008)3-2008A1-E4011-6, 09B52120112].	Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Becerra GD, 2007, BEHAV BRAIN RES, V179, P118, DOI 10.1016/j.bbr.2007.01.024; Chen ZZ, 2008, NEUROSCI LETT, V445, P36, DOI 10.1016/j.neulet.2008.08.039; Cheng J, 1996, BLOOD, V87, P479, DOI 10.1182/blood.V87.2.479.bloodjournal872479; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Kawamoto Atsuhiko, 2002, Cardiovasc Radiat Med, V3, P221, DOI 10.1016/S1522-1865(03)00082-9; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Loomans CJM, 2006, ARTERIOSCL THROM VAS, V26, P1760, DOI 10.1161/01.ATV.0000229243.49320.c9; Qian C, 2007, CARDIOVASC PATHOL, V16, P127, DOI 10.1016/j.carpath.2006.11.008; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shyu WC, 2006, J NEUROSCI, V26, P3444, DOI 10.1523/JNEUROSCI.5165-05.2006; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Yin T, 2008, CELL RES, V18, P792, DOI 10.1038/cr.2008.69; Zhang HT, 2009, NEUROSCI LETT, V458, P116, DOI 10.1016/j.neulet.2009.04.045; Zhang SJ, 2006, CELL RES, V16, P577, DOI 10.1038/sj.cr.7310075; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	21	36	41	1	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR 12	2010	473	3					186	191		10.1016/j.neulet.2010.02.035			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588ML	WOS:000277074300006	20178832				2022-02-06	
J	Babikian, T; Marion, SD; Copeland, S; Alger, JR; O'Neill, J; Cazalis, F; Mink, R; Giza, CC; Vu, JA; Hilleary, SM; Kernan, CL; Newman, N; Asarnow, RF				Babikian, Talin; Marion, Sarah DeBoard; Copeland, Sarah; Alger, Jeffry R.; O'Neill, Joseph; Cazalis, Fabienne; Mink, Richard; Giza, Christopher C.; Vu, Jennifer A.; Hilleary, Suzanne M.; Kernan, Claudia L.; Newman, Nina; Asarnow, Robert F.			Metabolic Levels in the Corpus Callosum and Their Structural and Behavioral Correlates after Moderate to Severe Pediatric TBI	JOURNAL OF NEUROTRAUMA			English	Article						corpus callosum; diffusion tensor imaging; evoked potentials; magnetic resonance spectroscopy; pediatric traumatic brain injury	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; DIFFUSE AXONAL INJURY; PROTON MR SPECTROSCOPY; HEAD TRAUMA; CHILDREN; FEATURES	Diffuse axonal injury (DAI) secondary to traumatic brain injury (TBI) contributes to long-term functional morbidity. The corpus callosum (CC) is particularly vulnerable to this type of injury. Magnetic resonance spectroscopy (MRS) was used to characterize the metabolic status of two CC regions of interest (ROIs) (anterior and posterior), and their structural (diffusion tensor imaging; DTI) and neurobehavioral (neurocognitive functioning, bimanual coordination, and interhemispheric transfer time [IHTT]) correlates. Two groups of moderate/severe TBI patients (ages 12-18 years) were studied: post-acute (5 months post-injury; n - 10), and chronic (14.7 months post-injury; n 8), in addition to 10 age-matched healthy controls. Creatine (energy metabolism) did not differ between groups across both ROIs and time points. In the TBI group, choline (membrane degeneration/in-inflammation) was elevated for both ROIs at the post-acute but not chronic period. N-acetyl aspartate (NAA) (neuronal/axonal integrity) was reduced initially for both ROIs, with partial normalization at the chronic time point. Posterior, not anterior, NAA was positively correlated with DTI fractional anisotropy (FA) (r = 0.88), and most domains of neurocognition (r range 0.22-0.65), and negatively correlated with IHTT (r = -0.89). Inverse corerlations were noted between creatine and posterior FA (r = -0.76), neurocognition (r range -0.22 to -0.71), and IHTT (r = 0.76). Multimodal studies at distinct time points in specific brain structures are necessary to delineate the course of the degenerative and reparative processes following TBI, which allows for preliminary hypotheses about the nature and course of the neural mechanisms of subsequent functional morbidity. This will help guide the future development of targeted therapeutic agents.	[Babikian, Talin] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Copeland, Sarah; Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Alger, Jeffry R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Alger, Jeffry R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Mink, Richard; Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Marion, Sarah DeBoard; Hilleary, Suzanne M.] Fuller Grad Sch Psychol, Dept Psychol, Pasadena, CA USA; [Mink, Richard] Harbor UCLA, Los Angeles Biomed Res Inst, Los Angeles, CA USA; [Vu, Jennifer A.] Univ Calif Los Angeles, Grad Sch Educ & Informat Studies, Los Angeles, CA 90095 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Grad Sch, Dept Psychol, Los Angeles, CA 90095 USA		Babikian, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza,Room C8-746, Los Angeles, CA 90095 USA.	tbabikian@mednet.ucla.edu			National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS053169, NS27544, NS057420]; UCLA Brain Injury Research Center (BIRC); Della Martin Foundation; Winokur Family Foundation/Child Neurology Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027544, F32NS053169, K02NS057420] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (F32NS053169, NS27544, and NS057420), the UCLA Brain Injury Research Center (BIRC), the Della Martin Foundation, and the Winokur Family Foundation/Child Neurology Foundation.	Akpinar E, 2007, J COMPUT ASSIST TOMO, V31, P657, DOI 10.1097/RCT.0b013e318033df1a; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Brown WS, 1999, NEUROPSYCHOLOGIA, V37, P1165, DOI 10.1016/S0028-3932(99)00011-1; BROWN WS, 1991, BIMANUAL COORD UNPUB; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Cohen M.J., 1997, CHILDRENS MEMORY SCA; COPELAND S, 2008, UC NEUR C CARM CA; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 1994, CALIFORNIA VERBAL LE; Ewing-Cobbs L, 2006, AM J NEURORADIOL, V27, P879; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gorrie C, 2002, J NEUROTRAUM, V19, P1171, DOI 10.1089/08977150260337976; Holshouser BA, 2000, J MAGN RESON IMAGING, V11, P9, DOI 10.1002/(SICI)1522-2586(200001)11:1<9::AID-JMRI2>3.3.CO;2-Y; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Hoon AH, 2000, J DEV BEHAV PEDIATR, V21, P291, DOI 10.1097/00004703-200008000-00007; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hunter JV, 2005, AM J NEURORADIOL, V26, P482; JEEVES MA, 1988, NEUROPSYCHOLOGIA, V26, P833, DOI 10.1016/0028-3932(88)90053-X; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; MARION SD, 2008, UC NEUR C CARM CA; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; O'Neill J, 2006, ISMRM WORKSH QUANT S; Parry L, 2004, CHILD NEUROPSYCHOL, V10, P248, DOI 10.1080/09297040490909279; PREILOWSKI BF, 1972, NEUROPSYCHOLOGIA, V10, P267, DOI 10.1016/0028-3932(72)90018-8; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; RUGG MD, 1985, J NEUROL NEUROSUR PS, V48, P367, DOI 10.1136/jnnp.48.4.367; SUTTON LN, 1995, PEDIATR NEUROSURG, V22, P81, DOI 10.1159/000120881; Tasker RC, 2006, EMERG MED J, V23, P519, DOI 10.1136/emj.2005.028779; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1977, WECHSLER MEMORY SCAL, VThird; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	46	36	39	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2010	27	3					473	481		10.1089/neu.2009.1058			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	575PJ	WOS:000276079100002	19925210	Green Published			2022-02-06	
J	Dalemans, RJ; de Witte, LP; Beurskens, AJ; van den Heuvel, WJ; Wade, DT				Dalemans, Ruth J.; de Witte, Luc P.; Beurskens, Anna J.; van den Heuvel, Wim J.; Wade, Derick T.			Psychometric Properties of the Community Integration Questionnaire Adjusted for People With Aphasia	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Aphasia; Feasibility studies; Outcome assessment (health care); Rehabilitation	TRAUMATIC BRAIN-INJURY; SOCIAL-PARTICIPATION; VALIDITY; REHABILITATION; RELIABILITY; INSTRUMENTS; STROKE; SCALE	Dalemans RJ, de Witte LP, Beurskens AJ, van den Heuvel WJ, Wade DT. Psychometric properties of the community integration questionnaire adjusted for people with aphasia. Arch Phys Med Rehabil 2010;91:395-9. Objectives: To describe the feasibility of the Community Integration Questionnaire (CIQ) adjusted for use in people with aphasia and to report its psychometric properties in people with aphasia (internal consistency, factor analysis, test-retest reliability, convergent validity). Design: A cross-sectional, interview-based psychometric study. Test-retest reliability was evaluated in 20 people (minimal to severe aphasia) by 2 different interviewers within a 2-week period. Setting: Community. Participants: In total 490 stroke survivors with (minimal to severe) aphasia were approached, of which 165 (34%) participants returned the answering letter. Participants (N=150) agreed to take part and were interviewed using a structured interview format. Interventions: Not applicable. Main Outcome Measures: Community Integration Questionnaire (CIQ), Frenchay Aphasia Screening Test, Barthel Index, Dartmouth Coop Functional Health Assessment Charts (COOP)-World Organisation of Family Doctors (WONCA) Charts, Life Satisfaction Questionnaire. Results: A total of 150 stroke survivors with aphasia completed the CIQ adjusted for people with aphasia. The CIQ adjusted for people with aphasia was a feasible instrument. Results showed good internal consistency for the CIQ total (standardized Cronbach alpha=.75), excellent test-retest reliability (intraclass correlation coefficient=.96), moderate correlations with the Barthel Index, the COOP-WONCA, and the Life Satisfaction Questionnaire with regard to construct validity. Significant relations were found with regard to age and aphasia severity. Conclusions: The CIQ adjusted for people with aphasia seems to he an adequate instrument to assess participation in people with aphasia.	[Dalemans, Ruth J.] Zuyd Univ, Dept Hlth & Tech, Heerlen, Netherlands; [Dalemans, Ruth J.; de Witte, Luc P.] Zuyd Univ, Res Ctr Technol Care, Heerlen, Netherlands; [Dalemans, Ruth J.; Beurskens, Anna J.] Zuyd Univ, Res Ctr Auton & Participat People Chron Illnesses, Heerlen, Netherlands; [van den Heuvel, Wim J.] Maastricht Univ, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Wade, Derick T.] Oxford Ctr Enablement, Oxford, England		Dalemans, RJ (corresponding author), Nieuw Eyckholt 300,Postbus 550, NL-6400 AN Heerlen, Netherlands.	r.dalemans@hszuyd.nl	van+den+Heuvel, Wim/AAI-9981-2020; De+Witte, Luc/AAI-3518-2020	De+Witte, Luc/0000-0002-3013-2640; Wade, Derick/0000-0002-1188-8442			Aleligay A, 2008, APHASIOLOGY, V22, P383, DOI 10.1080/02687030701415872; Charlifue S, 2004, NEUROREHABILITATION, V19, P91; Collin C, 1988, Int Disabil Stud, V10, P61; Dalemans R, 2008, CLIN REHABIL, V22, P542, DOI 10.1177/0269215507087462; Dalemans R, 2009, CLIN REHABIL, V23, P948, DOI 10.1177/0269215509337197; Dalemans RJP, 2008, APHASIOLOGY, V22, P1071, DOI 10.1080/02687030701632179; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Eadie TL, 2006, AM J SPEECH-LANG PAT, V15, P307, DOI 10.1044/1058-0360(2006/030); Enderby P M, 1987, Int Rehabil Med, V8, P166; Fleming J, 1999, BRAIN INJURY, V13, P417; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; Hansen NS, 1998, TOP SPINAL CORD INJ, V4, P56; Hilari K, 2003, STROKE, V34, P1944, DOI 10.1161/01.STR.0000081987.46660.ED; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; *ONT BRAIN INJ ASS, 2008, COMM INT QUEST SCOR; Reistetter TA, 2005, NEUROREHABILITATION, V20, P139; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Salter KL, 2007, INT J REHABIL RES, V30, P339, DOI 10.1097/MRR.0b013e3282f144b7; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; van Baalen B, 2006, CLIN REHABIL, V20, P686, DOI 10.1191/0269215506cre982oa; van de Ven L, 2005, DISABIL SOC, V20, P311, DOI 10.1080/09687590500060778; Van der Mei SF, 2007, DISABIL REHABIL, V29, P473, DOI 10.1080/09638280600841257; Van Weel C, 1993, Disabil Rehabil, V15, P96; Wade D T, 1988, Int Disabil Stud, V10, P64; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	30	36	37	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	2010	91	3					395	399		10.1016/j.apmr.2009.10.021			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	592YM	WOS:000277417900011	20298830				2022-02-06	
J	Ott, MM; Eriksson, E; Vanderkolk, W; Christianson, D; Davis, A; Scholten, D				Ott, Mickey Meilinger; Eriksson, Evert; Vanderkolk, Wayne; Christianson, David; Davis, Alan; Scholten, Donald			Antiplatelet and Anticoagulation Therapies Do Not Increase Mortality in the Absence of Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Anticoagulation; Antiplatelet; Blunt trauma; Outcomes; Clopidogrel; Warfarin	PREINJURY WARFARIN USE; INTRACRANIAL HEMORRHAGE; HEAD-INJURY; IMPACT; COMPLICATIONS; REVERSAL; OLDER	Background: As the population continues to age, the number of patients undergoing traumatic injury while on antiplatelet or anticoagulation therapies is increasing. Mortality has been shown to increase in traumatic brain injury patients on warfarin therapy. Whether this increased mortality is seen in trauma patients without traumatic brain injury remains controversial. We investigated whether patients on antiplatelet and/or anticoagulation therapy were at increased risk of death from blunt traumatic injury in the absence of head injury. Methods: A retrospective review of our Level I trauma center database was performed from 2002 to 2007. Inclusion criteria included all patients older than 60 years admitted to the trauma service. Only patients with a computed tomography scan negative for intracranial injury were analyzed. Results: Two hundred twelve patients were found, of which 67 were found to be taking aspirin, warfarin, clopidogrel, or a combination of the three. Injury Severity Score (21 vs. 21), length of stay (11 days vs. 9 days), intensive care unit days (5 days vs. 4 days), and deaths (13% vs. 10%) were similar between those patients on antiplatelet/anticoagulation therapy and those who were not. Conclusion: In the absence of traumatic brain injury, the use of preinjury antiplatelet and/or anticoagulation therapy does not significantly increase the risk of mortality in the trauma patient. As the number of active seniors rises, this patient population will continue to present to the trauma service. To the best of our knowledge, this study is one of the largest addressing this question, and the only study examining the addition of antiplatelet therapy.	[Ott, Mickey Meilinger; Eriksson, Evert; Vanderkolk, Wayne; Christianson, David; Davis, Alan; Scholten, Donald] Grand Rapids Michigan State Univ, Gen Surg Residency Program, Grand Rapids, MI USA		Ott, MM (corresponding author), Vanderbilt Univ, Med Ctr, Div Trauma & Surg Crit Care, 1211 21st Ave S,404 Med Arts Bldg, Nashville, TN 37212 USA.	meilingerott@hotmail.com		Eriksson, Evert/0000-0002-4099-325X			Ferrera PC, 1999, AM J EMERG MED, V17, P154, DOI 10.1016/S0735-6757(99)90050-5; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2006, J TRAUMA, V61, P318, DOI 10.1097/01.ta.0000223944.25922.91; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; STEIN J, 1995, ARCH PHYS MED REHAB, V76, P840, DOI 10.1016/S0003-9993(95)80549-4; Tharmarajah P, 2007, J ORTHOP TRAUMA, V21, P26, DOI 10.1097/BOT.0b013e31802c4f3c; U.S. Census Bureau, 2008, STAT ABSTR US; Wahl WL, 2001, J TRAUMA, V51, P1151; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	13	36	39	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2010	68	3					560	563		10.1097/TA.0b013e3181ad6600			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	567ZY	WOS:000275491200013	20065871				2022-02-06	
J	Choi, SC; Park, JH; Pae, A; Kim, JR				Choi, Sung Chul; Park, Jae Hong; Pae, Ahran; Kim, Jong Ryul			Retrospective study on traumatic dental injuries in preschool children at Kyung Hee Dental Hospital, Seoul, South Korea	DENTAL TRAUMATOLOGY			English	Article							OF-THE-LITERATURE; PRIMARY TEETH; TOOTH INJURIES; PEDIATRIC DENTISTRY; PERMANENT TEETH; EPIDEMIOLOGY; COUNTY; MEXICO	The purpose of this study was to analyse the traumatic dental injuries (TDI) of Korean preschoolers by investigating the occurrence, type, area, cause, injured region, seasonal variation and the interval between injury and treatment. In this study, data from 1856 preschoolers aged 4 months to 6 years and 11 months (mean age : 3.6 +/- 1.6) were used, out of a total of 2761 patients who attended the Department of Pediatric Dentistry, Kyung Hee Dental Hospital for TDI between January 1998 and December 2007. All the data were statistically analysed using the anovaand chi-square statics. Most of the patients were 1-2, 2-3 years old (24.5%, 25.4%) and boys were 1.67 times more likely to have TDI. The most common cause, location and seasonal variation of the trauma, were respectively falling (50.8%), at home (48.8%) and late spring. The treatment intervals usually occurred within a day. Most of the injuries involved single (47%) or double (38%) tooth/teeth. However, car accidents or sports trauma often involved multiple teeth. In both primary and permanent dentition, the most common teeth injured were maxillary central incisors (72.6%), and periodontal injury was caused by subluxation or concussion. Among the various types of hard tissue injuries, enamel fracture in the primary dentition (35.0%) and enamel-dentin fracture in the permanent dentition (45.8%) were the most common types.	[Choi, Sung Chul; Park, Jae Hong] Kyung Hee Univ, Dept Pediat Dent, Sch Dent, Seoul 130702, South Korea; [Choi, Sung Chul; Park, Jae Hong] Kyung Hee Univ, Inst Oral Biol, Sch Dent, Seoul 130702, South Korea; [Pae, Ahran] Kyung Hee Univ, Dept Prosthodont Dent, Sch Dent, Seoul 130702, South Korea; [Kim, Jong Ryul] Kyung Hee Univ, Dept Conservat Dent, Sch Dent, Seoul 130702, South Korea		Park, JH (corresponding author), Kyung Hee Univ, Dept Pediat Dent, Sch Dent, Seoul 130702, South Korea.	pedopjh@khu.ac.kr	CHOI, SUNG CHUL/B-4574-2019	CHOI, SUNG CHUL/0000-0001-7221-2000	Kyung Hee University Research Fund in 2008 [KHU-20080548]	This research was supported by the Kyung Hee University Research Fund in 2008 (KHU-20080548).	ANDREASEN J O, 1985, Endodontics and Dental Traumatology, V1, P45; Andreasen JO, 2007, TXB COLOR ATLAS TRAU; Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; DELROSARIO MEL, 1992, ENDOD DENT TRAUMATOL, V8, P213; Eyuboglu O, 2009, DENT TRAUMATOL, V25, P110, DOI 10.1111/j.1600-9657.2008.00668.x; Flores MT, 2007, DENT TRAUMATOL, V23, P196, DOI 10.1111/j.1600-9657.2007.00627.x; GARCIA-GODOY F, 1987, Endodontics and Dental Traumatology, V3, P126; Garcia-Godoy F, 2000, Dent Clin North Am, V44, P597; GARCIAGODOY F, 1983, COMMUNITY DENT ORAL, V11, P127, DOI 10.1111/j.1600-0528.1983.tb01370.x; Glendor U, 1996, SWED DENT J, V20, P15; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Hargreaves JA, 1999, ENDOD DENT TRAUMATOL, V15, P73; HARRINGTON MS, 1988, J DENT CHILD, V55, P334; Kramer PF, 2003, DENT TRAUMATOL, V19, P299, DOI 10.1046/j.1600-9657.2003.00203.x; OIKARINEN K, 1987, ENDOD DENT TRAUMATOL, V3, P172; Oliveira LB, 2007, DENT TRAUMATOL, V23, P76, DOI 10.1111/j.1600-9657.2005.00413.x; Otuyemi OD, 1996, E AFR MED J, V73, P604; Petersson EE, 1997, SWED DENT J, V21, P55; Rajab LD, 2003, DENT TRAUMATOL, V19, P6, DOI 10.1034/j.1600-9657.2003.00131.x; RAVN JJ, 1976, SCAND J DENT RES, V84, P137; Robson F, 2009, DENT TRAUMATOL, V25, P118, DOI 10.1111/j.1600-9657.2008.00725.x; Rocha MJD, 2001, DENT TRAUMATOL, V17, P245; Rodriguez JG, 2007, DENT TRAUMATOL, V23, P241, DOI 10.1111/j.1600-9657.2005.00428.x; SANCHEZ AV, 1990, ENDOD DENT TRAUMATOL, V6, P63; Skaare AB, 2005, DENT TRAUMATOL, V21, P315, DOI 10.1111/j.1600-9657.2005.00362.x; Soporowski Nancy Jo, 1994, Pediatric Dentistry, V16, P96; Zeng Yang, 1994, Pediatric Dentistry, V16, P419	27	36	36	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	FEB	2010	26	1					70	75		10.1111/j.1600-9657.2009.00840.x			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	541XE	WOS:000273453800013	20089062				2022-02-06	
J	Chun, KA; Manley, GT; Stiver, SI; Aiken, AH; Phan, N; Wang, V; Meeker, M; Cheng, SC; Gean, AD; Wintermark, M				Chun, Kimberly A.; Manley, Geoffrey T.; Stiver, Shirley I.; Aiken, Ashley H.; Phan, Nicholas; Wang, Vincent; Meeker, Michele; Cheng, Su-Chun; Gean, A. D.; Wintermark, Max			Interobserver Variability in the Assessment of CT Imaging Features of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						accuracy; computed tomography; imaging scores; interobserver agreement; traumatic brain injury	SEVERE HEAD-INJURY; SUBARACHNOID HEMORRHAGE; COMPUTERIZED-TOMOGRAPHY; OUTCOME PREDICTION; CLASSIFICATION; IMPACT; SCAN	The goal of our study was to determine the interobserver variability between observers with different backgrounds and experience when interpreting computed tomography (CT) imaging features of traumatic brain injury (TBI). We retrospectively identified a consecutive series of 50 adult patients admitted at our institution with a suspicion of TBI, and displaying a Glasgow Coma Scale score <= 12. Noncontrast CT (NCT) studies were anonymized and sent to five reviewers with different backgrounds and levels of experience, who independently reviewed each NCT scan. Each reviewer assessed multiple CT imaging features of TBI and assigned every NCT scan a Marshall and a Rotterdam grading score. The interobserver agreement and coefficient of variation were calculated for individual CT imaging features of TBI as well as for the two scores. Our results indicated that the imaging review by both neuroradiologists and neurosurgeons were consistent with each other. The kappa coefficient of agreement for all CT characteristics showed no significant difference in interpretation between the neurosurgeons and neuroradiologists. The average Bland and Altman coefficients of variation for the Marshall and Rotterdam classification systems were 12.7% and 21.9%, respectively, which indicates acceptable agreement among all five reviewers. In conclusion, there is good interobserver reproducibility between neuroradiologists and neurosurgeons in the interpretation of CT imaging features of TBI and calculation of Marshall and Rotterdam scores.	[Chun, Kimberly A.; Aiken, Ashley H.; Gean, A. D.; Wintermark, Max] Univ Calif San Francisco, Dept Radiol, Neuroradiol Sect, San Francisco, CA 94143 USA; [Manley, Geoffrey T.; Stiver, Shirley I.; Phan, Nicholas; Wang, Vincent; Meeker, Michele; Gean, A. D.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Cheng, Su-Chun] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Manley, Geoffrey T.; Stiver, Shirley I.; Phan, Nicholas; Wang, Vincent; Meeker, Michele] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Manley, Geoffrey T.; Stiver, Shirley I.; Phan, Nicholas; Wang, Vincent; Meeker, Michele] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA		Wintermark, M (corresponding author), Univ Calif San Francisco, Dept Radiol, Neuroradiol Sect, 505 Parnassus Ave,Box 0628, San Francisco, CA 94143 USA.	Max.Wintermark@radiology.ucsf.edu		Wintermark, Max/0000-0002-6726-3951	National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR024130]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024130] Funding Source: NIH RePORTER	Max Wintermark receives funding from the National Center for Research Resources (grant KL2 RR024130). The content of the article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke, the National Center for Research Resources, the National Institutes of Health, or the other sponsors.	ALTMAN DG, 1991, PRACTICAL STAT MED R, P404; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Doppenberg EMR, 1997, ANN NY ACAD SCI, V825, P305, DOI 10.1111/j.1749-6632.1997.tb48441.x; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Rosner B., 1995, FUNDAMENTALS BIOSTAT, V4th, P327; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Viera AJ, 2005, FAM MED, V37, P360	21	36	37	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2010	27	2					325	330		10.1089/neu.2009.1115			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	557JG	WOS:000274664800005	19895192	Green Published			2022-02-06	
J	Jin, W; Ni, HB; Dai, YX; Wang, HD; Lu, TY; Wu, J; Jiang, JA; Liang, WB				Jin, Wei; Ni, Hongbin; Dai, Yuxiang; Wang, Handong; Lu, Tianyu; Wu, Jun; Jiang, Jian; Liang, Weibang			Effects of Tert-Butylhydroquinone on Intestinal Inflammatory Response and Apoptosis following Traumatic Brain Injury in Mice	MEDIATORS OF INFLAMMATION			English	Article							NF-KAPPA-B; NRF2-DRIVEN ANTIOXIDANT RESPONSE; NRF2 ENHANCES SUSCEPTIBILITY; GLUTATHIONE-S-TRANSFERASE; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; NRF2-DEFICIENT MICE; PIVOTAL ROLE; INDUCTION; PROTECTION	Traumatic brain injury (TBI) can induce intestinal inflammatory response and mucosal injury. Antioxidant transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) has been shown in our previous studies to prevent oxidative stress and inflammatory response in gut after TBI. The objective of this study was to test whether tert-butylhydroquinone (tBHQ), an Nrf2 inducer, can protect against TBI-induced intestinal inflammatory response and mucosal injury in mice. Adult male ICR mice were randomly divided into three groups: (1) sham + vehicle group, (2) TBI + vehicle group, and (3) TBI + tBHQ group (n = 12 per group). Closed head injury was adopted using Hall's weight-dropping method. Intestinal mucosa apoptosis and inflammatory-related factors, such as nuclear factor kappa B (NF-kappa B), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6) and intercellular adhesion molecule-1 (ICAM-1), were investigated at 24 h after TBI. As a result, we found that oral treatment with 1% tBHQ prior to TBI for one week markedly decreased NF-kappa B activation, inflammatory cytokines production, and ICAM-1 expression in the gut. Administration of tBHQ also significantly attenuated TBI-induced intestinal mucosal apoptosis. The results of the present study suggest that tBHQ administration could suppress the intestinal inflammation and reduce the mucosal damage following TBI.	[Jin, Wei; Ni, Hongbin; Dai, Yuxiang; Lu, Tianyu; Wu, Jun; Jiang, Jian; Liang, Weibang] Nanjing Univ, Dept Neurosurg, Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Handong] Nanjing Univ, Dept Neurosurg, Jinling Hosp, Sch Med, Nanjing 210002, Jiangsu, Peoples R China		Liang, WB (corresponding author), Nanjing Univ, Dept Neurosurg, Drum Tower Hosp, Sch Med, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	njneurosurgery@yahoo.com.cn			Drum Tower Hospital of China	This work was supported by grants from Drum Tower Hospital of China. The authors thank Dr. Li-zhi Xu and Dr. Geng-bao Feng for their technical assistance. W. Jin, H. Ni, and Y. Dai have contributed equally to this work.	Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Chen F, 1999, CLIN CHEM, V45, P7; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Jin W, 2009, J SURG RES, V157, P251, DOI 10.1016/j.jss.2008.08.003; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Johnson DA, 2002, J NEUROCHEM, V81, P1233, DOI 10.1046/j.1471-4159.2002.00913.x; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Koh K, 2009, BIOCHEM BIOPH RES CO, V380, P449, DOI 10.1016/j.bbrc.2009.01.082; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Lamb JG, 2000, DRUG METAB DISPOS, V28, P1018; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Munday R, 2004, CARCINOGENESIS, V25, P1721, DOI 10.1093/carcin/bgh162; Munzel PA, 2003, BIOCHEM PHARMACOL, V66, P841, DOI 10.1016/S0006-2952(03)00389-7; Nakamura Y, 2003, BIOCHEMISTRY-US, V42, P4300, DOI 10.1021/bi0340090; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Nishizono S, 2000, BIOSCI BIOTECH BIOCH, V64, P1153, DOI 10.1271/bbb.64.1153; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Potten CS, 1997, STEM CELLS, V15, P82, DOI 10.1002/stem.150082; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Yan D, 2010, BIOCHEM PHARMACOL, V80, P144, DOI 10.1016/j.bcp.2010.03.004; Zhang C, 2002, BURNS, V28, P731, DOI 10.1016/S0305-4179(02)00210-3; 1999, WHO TECHNICAL REPORT, V884, P1	38	36	36	0	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.		2010	2010								502564	10.1155/2010/502564			7	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	728IX	WOS:000287868900001	21274455	gold, Green Submitted, Green Published			2022-02-06	
J	Leon-Carrion, J; Dominguez-Roldan, JM; Leon-Dominguez, U; Murillo-Cabezas, F				Leon-Carrion, Jose; Maria Dominguez-Roldan, Jose; Leon-Dominguez, Umberto; Murillo-Cabezas, Francisco			The Infrascanner, a handheld device for screening in situ for the presence of brain haematomas	BRAIN INJURY			English	Article						Critical care; emergency; neurotraumatology; traumatic brain injury; near-infrared spectroscopy; head injury	HEAD-INJURY; REHABILITATION; CONSEQUENCES; EPIDEMIOLOGY; PREDICTORS	Purpose: Early identification and treatment of intracranial haematomas in patients sustaining traumatic brain injury is fundamental to successful treatment. This pilot study evaluates the Infrascanner as a handheld medical screening tool for detection, in situ, of brain haematomas in patients with head injury. Methods: This study included 35 TBI patients aged 17-76 (M = 47.6), admitted to the neurosurgical intensive care unit and observation unit of a University Hospital in a Level 1 trauma centre. The Infrascanner(TM) NIRS device uses near infrared light measurements to calculate optical density in brain regions. Results: Results show Infrascanner sensitivity at 89.5% and specificity at 81.2%. PPV was 85% and NPV 86.7%. The device detected 90% of extra-axial, 88.9% of intra-axial and 93.3% of non-surgical haematomas (less than 25 mL). PPV for this classification was 82.3%; 87.5% sensitivity was found when the Infrascanner exam was performed within 12 hours post-trauma, whereas after 12 hours post-trauma, exams had 90.1% sensitivity. Conclusions: This study demonstrates that the Infrascanner is useful in initial examinations and screenings of patients with head injury as an adjunct to a CT scan or when it is not available and may allow earlier treatment and reduce secondary injury caused by present and delayed haematomas.	[Leon-Carrion, Jose] Univ Seville, Dept Expt Psychol, Human Neuropsychol Lab, Seville 41018, Spain; [Leon-Carrion, Jose; Leon-Dominguez, Umberto] Ctr Brain Injury Rehabil CRECER, Seville, Spain; [Maria Dominguez-Roldan, Jose; Murillo-Cabezas, Francisco] Univ Hosp Virgen del Rocio, Hosp Traumatol, Intens Care Unit, Seville, Spain		Leon-Carrion, J (corresponding author), Univ Seville, Dept Expt Psychol, Human Neuropsychol Lab, C Camilo Jose Cela S-N, Seville 41018, Spain.	leoncarrion@us.es	IBIS, NEUROCRITICOS/C-1805-2016; Dominguez-Roldan, Jose-Maria/M-1728-2016; Murillo-Cabezas, Francisco/AAO-3348-2021	Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478; Leon-Dominguez, Umberto/0000-0001-5170-2553			BARON EM, 2006, BRAIN INJURY MED PRI, P265; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CALZAVACCA P, 2003, INTENS CARE MED, V34, P2112; Davella D, 2000, J Neurosurg Sci, V44, P19; de Bruijn S F T M, 2004, Ned Tijdschr Geneeskd, V148, P2209; Esselman PC, 2004, ARCH PHYS MED REHAB, V85, P1445, DOI 10.1016/j.apmr.2003.10.018; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GOPINATH SP, 1995, J NEUROSURG, V83, P438, DOI 10.3171/jns.1995.83.3.0438; GOPINATH SP, 1993, J NEUROSURG, V79, P43, DOI 10.3171/jns.1993.79.1.0043; Gururaj G, 2004, J Indian Med Assoc, V102, P157; KLIMMEK R, 1988, ARCH TOXICOL, V62, P152, DOI 10.1007/BF00570133; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Leon-Carrion J, 2006, STUD NEUROPSYCH DEV, P117; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Santalucia P, 2008, NEUROL SCI, V29, pS271, DOI 10.1007/s10072-008-0961-y; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tang ME, 2009, MT SINAI J MED, V76, P119, DOI 10.1002/msj.20106; Tieves Kelly S, 2005, WMJ, V104, P22; Wright RO, 1999, ANN EMERG MED, V34, P646, DOI 10.1016/S0196-0644(99)70167-8; Xiang HY, 2005, J TRAUMA, V58, P112, DOI 10.1097/01.TA.0000151270.26634.DD; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	27	36	37	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	10					1193	1201		10.3109/02699052.2010.506636			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	667MJ	WOS:000283197100006	20715889				2022-02-06	
J	Lescot, T; Fulla-Oller, L; Po, C; Chen, XR; Puybasset, L; Gillet, B; Plotkine, M; Meric, P; Marchand-Leroux, C				Lescot, Thomas; Fulla-Oller, Lawrence; Po, Chrystelle; Chen, Xiao Ru; Puybasset, Louis; Gillet, Brigitte; Plotkine, Michel; Meric, Philippe; Marchand-Leroux, Catherine			Temporal and Regional Changes after Focal Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; nuclear magnetic resonance; nuclear magnetic resonance spectroscopy; traumatic brain injury		Magnetic resonance imaging (MRI) is widely used to evaluate the consequences of traumatic brain injury (TBI) in both experimental and clinical studies. Improved assessment of experimental TBI using the same methods as those used in clinical investigations would help to translate laboratory research into clinical advances. Here our goal was to characterize lateral fluid percussion-induced TBI, with special emphasis on differentiating the contused cortex from the pericontusional subcortical tissue. We used both in vivo MRI and proton magnetic resonance spectroscopy (H-1-MRS) to evaluate adult male Sprague-Dawley rats 24 h and 48 h and 7 days after TBI. T2 and apparent diffusion coefficient (ADC) maps were derived from T2-weighted and diffusion-weighted images, respectively. Ratios of N-acetylaspartate (NAA), choline compounds (Cho), and lactate (Lac) over creatine (Cr) were estimated by H-1-MRS. T2 values were high in the contused cortex 24 h after TBI, suggesting edema development; ADC was low, consistent with cytotoxic edema. At the same site, NAA/Cr was decreased and Lac/Cr elevated during the first week after TBI. In the ipsilateral subcortical area, NAA/Cr was markedly decreased and Lac/Cr was elevated during the first week, although MRI showed no evidence of edema, suggesting that H-1-MRS detected "invisible" damage. H-1-MRS combined with MRI may improve the detection of brain injury. Extensive assessments of animal models may increase the chances of developing successful neuroprotective strategies.	[Lescot, Thomas; Chen, Xiao Ru; Plotkine, Michel; Marchand-Leroux, Catherine] Univ Paris 05, Fac Sci Pharmaceut & Biol, EA 2510, Equipe Rech Pharmacol Circulat Cerebrale, F-75006 Paris, France; [Fulla-Oller, Lawrence; Puybasset, Louis] Grp Hosp Pitie Salpetriere, AP HP, Reanimat Neurochirurg Dept Anesthesie Reanimat, F-75634 Paris, France; [Fulla-Oller, Lawrence; Puybasset, Louis] Univ Paris 06, Paris, France; [Fulla-Oller, Lawrence; Po, Chrystelle; Gillet, Brigitte; Meric, Philippe] CNRS, Inst Chim Subst Nat, Lab Resonance Magnet Nucl Biol, Gif Sur Yvette, France		Lescot, T (corresponding author), Univ Paris 05, Fac Sci Pharmaceut & Biol, EA 2510, Equipe Rech Pharmacol Circulat Cerebrale, 4 Ave Observ, F-75006 Paris, France.	thomas.lescot@psl.aphp.fr	MARCHAND-LEROUX, Catherine/L-7453-2017	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; Po, Chrystelle/0000-0001-9785-9572	Fondation des Gueules Cassees	The authors are very grateful to Dr. Antoinette Wolfe for helping to prepare the manuscript, and to Dr. Yannick Le Manach for expert statistical assistance. This work was supported by the nonprofit organization Fondation des Gueules Cassees (grants to T. L. and L.F.O.).	Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Alessandri B, 2000, NEUROL RES, V22, P705; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BEDERSON JB, 1986, J NEUROSURG, V64, P795, DOI 10.3171/jns.1986.64.5.0795; BERRY I, 1986, ACTA RADIOL S, P338; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2001, J NEUROTRAUM, V18, P241, DOI 10.1089/08977150151070856; GUIMARAES AR, 1995, NEUROSCIENCE, V69, P1095, DOI 10.1016/0306-4522(95)00300-8; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; LEBIHAN D, 1988, MAGNET RESON MED, V7, P346, DOI 10.1002/mrm.1910070312; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MCINTOSH TK, 1990, ACTA NEUROCHIR S, P263; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Rubin Y, 1997, J NEUROTRAUM, V14, P441, DOI 10.1089/neu.1997.14.441; Rudkin TM, 1999, ARCH NEUROL-CHICAGO, V56, P919, DOI 10.1001/archneur.56.8.919; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; VIAN MR, 2005, NMR BIOMED, V8, P507; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	38	36	42	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2010	27	1					85	94		10.1089/neu.2009.0982			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	548RF	WOS:000273983200007	19705964				2022-02-06	
J	Han, RZ; Hu, JJ; Weng, YC; Li, DF; Huang, Y				Han, Rui-Zhang; Hu, Jin-Jia; Weng, Yuan-Chi; Li, Ding-Feng; Huang, Yi			NMDA receptor antagonist MK-801 reduces neuronal damage and preserves learning and memory in a rat model of traumatic brain injury	NEUROSCIENCE BULLETIN			English	Article						traumatic brain injury; MK-801; learning and memory; caspase-3; microglia; neuronal nitric oxide synthase		Objective NMDA receptor channel plays an important role in the pathophysiological process of traumatic brain injury (TBI). The present study aims to study the pathological mechanism of TBI and the impairment of learning and memory after TBI, and to investigate the mechanism of the protective effect of NMDA receptor antagonist MK-801 on learning and memory disorder after TBI. Methods Forty Sprague-Dawley rats (weighing approximately 200 g) were randomized into 5 groups (n = 8 in each group): control group, model group, low-dose group (MK-801 0.5 mg/kg), middle-dose group (MK-801 2 mg/kg), and high-dose group (MK-801 10 mg/kg). TBI model was established using a weight-drop head injury mode. After 2-month drug treatment, learning and memory ability was evaluated by using Morris water maze test. Then the animals were sacrificed, and brain tissues were taken out for morphological and immunohistochemical assays. Results The ability of learning and memory was significantly impaired in the TBI model animals. Besides, the neuronal caspase-3 expression, neuronal nitric oxide synthase (nNOS)-positive neurons and OX-42-positive microglia were all increased in TBI animals. Meanwhile, the number of neuron synapses was decreased, and vacuoles degeneration could be observed in mitochondria. After MK-801 treatment at 3 different dosages, the ability of learning and memory was markedly improved, as compared to that of the TBI model animals. Moreover, neuronal caspase-3 expression, OX-42-positive microglia and nNOS-positive neurons were all significantly decreased. Meanwhile, the mitochondria degeneration was greatly inhibited. Conclusion MK-801 could significantly inhibit the degeneration and apoptosis of neurons in damaged brain areas. It could also inhibit TBI-induced increase in nNOS-positive neurons and OX-42-positive microglia. Impairment in learning and memory in TBI animals could be repaired by treatment with MK-801.	[Hu, Jin-Jia; Weng, Yuan-Chi; Li, Ding-Feng; Huang, Yi] Shanghai Jiao Tong Univ, Coll Med, Shanghai 200025, Peoples R China; [Han, Rui-Zhang] 98th Hosp PLA, Dept Neurosurg, Huzhou 313000, Peoples R China		Hu, JJ (corresponding author), Shanghai Jiao Tong Univ, Coll Med, Shanghai 200025, Peoples R China.	jjhu2609@126.com			Nanjing Military Medical Science and Technology [08MA007]	This work was supported by the grants from Nanjing Military Medical Science and Technology Innovation Project (No. 08MA007).	Acarin L, 1996, J COMP NEUROL, V367, P361; Beray-Berthat V, 2003, EXP NEUROL, V182, P446, DOI 10.1016/S0014-4886(03)00106-7; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Celik SE, 2006, J NEUROTRAUM, V23, P1355, DOI 10.1089/neu.2006.23.1355; Chen Jian-Ye, 2006, Ai Zheng, V25, P170; Gilland E, 1998, J CEREBR BLOOD F MET, V18, P297, DOI 10.1097/00004647-199803000-00008; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Haga KK, 2003, BRAIN RES, V993, P42, DOI 10.1016/j.brainres.2003.08.063; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Heath D L, 1999, J Neurosci Nurs, V31, P97; Huang PL, 1999, BRAZ J MED BIOL RES, V32, P1353, DOI 10.1590/S0100-879X1999001100005; Ishida A, 2001, BRAIN DEV-JPN, V23, P349, DOI 10.1016/S0387-7604(01)00237-6; Kim JH, 2004, EXP NEUROL, V189, P122, DOI 10.1016/j.expneurol.2004.05.029; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Love S, 1999, BRAIN PATHOL, V9, P119; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Oehmichen M, 2000, J NEUROTRAUM, V17, P155, DOI 10.1089/neu.2000.17.155; Phillips LL, 1997, J NEUROSCI RES, V49, P197; Ravishankar S, 2001, BRAIN RES, V901, P23, DOI 10.1016/S0006-8993(01)02109-6; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Sairanen TR, 1997, J CEREBR BLOOD F MET, V17, P1107, DOI 10.1097/00004647-199710000-00013; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Stover JF, 2001, J NEUROSURG, V94, P782, DOI 10.3171/jns.2001.94.5.0782; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zhao XR, 2003, BRAIN RES, V966, P308, DOI 10.1016/S0006-8993(02)04223-3	28	36	42	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	DEC	2009	25	6					367	375		10.1007/s12264-009-0608-x			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V19RL	WOS:000208089400006	19927173	Green Published			2022-02-06	
J	Helling, TS; Kaswan, S; Miller, SL; Tretter, JF				Helling, Thomas S.; Kaswan, Sumesh; Miller, S. Lee; Tretter, James F.			Practice Patterns in the Use of Retrievable Inferior Vena Cava Filters in a Trauma Population: A Single-Center Experience	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Inferior vena cava filter; Anticoagulation; Trauma center	PULMONARY-EMBOLISM; VENOUS THROMBOEMBOLISM; DATA-BANK; PREVENTION; TERM	Background: The use of permanent inferior vena cava filters (IVCFs) offers protection against pulmonary embolism (PE) but increases the long-term risk of deep vein thrombosis (DVT) and does not affect long-term mortality. The use of retrievable IVCFs in trauma patients offers the dual advantage of protection against PE during the risk period and the option of filter removal thus avoiding complications of DVT. Despite the safety of removal, it is likely that many of these retrievable filters are not removed. Methods: This was a retrospective, single-center, observational cohort study at a rural level I trauma center. We sought to investigate the number of patients and the circumstances under which retrievable IVCFs were placed and removed. Results: During a 4-year period, 3,455 trauma patients were admitted and 125 patients had retrievable IVCFs placed (71 therapeutic and 54 prophylactic). The most common indications were traumatic brain and spinal cord injuries (66%). During in-hospital filter use, there were 36 new incidences (29%) of PE (1) and DVT (35). Nine patients died before removal. In 40 patients (32%), removal was attempted, and 32 (26%) retrievable IVCFs were successfully removed and in most patients (76%) within 180 days of insertion. Seventeen patients were transferred out of the area for extended care and lost to follow-Lip. In 55 patients, the filters were not removed. In 20 patients, the surgeon decided against removal. Thirty patients were transferred to extended care or rehabilitation within the community, but they did not return for removal. Thus, of 108/125 patients with follow-up, 76 patients (70%) did not have their IVCFs removed, and 50 patients did not have their IVCFs removed because of the choice of the surgeon, extended care, or rehabilitation. Conclusions: The use of retrievable IVCFs, when necessary, produced predictable protection against PE and DVT complications. Despite the opportunity for removal, most patients, in fact, did not have their filters removed, even when posthospital care could be tracked. The practices of the surgeon, the transfer to extended-care facilities, near or far, and the reluctance to remove long-standing IVCFs contributed to the high-retention rate.	[Helling, Thomas S.; Kaswan, Sumesh; Miller, S. Lee; Tretter, James F.] Conemaugh Mem Med Ctr, Dept Surg, Johnstown, PA USA		Helling, TS (corresponding author), Conemaugh Mem Med Ctr, Dept Surg, 1086 Franklin St, Johnstown, PA USA.	thelling@conemaugh.org					Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Berczi V, 2007, CARDIOVASC INTER RAD, V30, P820, DOI 10.1007/s00270-007-9153-z; Binkert CA, 2006, J VASC INTERV RADIOL, V17, P299, DOI 10.1097/01.RVI.0000195153.32491.37; COON WW, 1976, SURG GYNECOL OBSTET, V143, P385; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Fox MA, 2008, J VASC INTERV RADIOL, V19, P981, DOI 10.1016/j.jvir.2008.03.022; GREENFIELD LJ, 1988, SURGERY, V104, P706; Hoppe H, 2007, CHEST, V132, P31, DOI 10.1378/chest.06-2897; Johnson ON, 2009, J VASC SURG, V49, P410, DOI 10.1016/j.jvs.2008.09.004; Karmy-Jones R, 2007, J TRAUMA, V62, P17, DOI 10.1097/TA.0b013e31802dd72a; Knudson M Margaret, 2004, Curr Opin Crit Care, V10, P539, DOI 10.1097/01.ccx.0000144941.09650.9f; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Neuerburg JM, 2001, CARDIOVASC INTER RAD, V24, P418, DOI 10.1007/s00270-001-0066-y; Offner PJ, 2003, ARCH SURG-CHICAGO, V138, P591, DOI 10.1001/archsurg.138.6.591; Rogers FB, 2001, SURGERY, V130, P1, DOI 10.1067/msy.2001.114558; Shackford SR, 2007, J TRAUMA, V63, P764, DOI 10.1097/01.ta.0000240444.14664.5f; Stefanidis D, 2006, AM J SURG, V192, P789, DOI 10.1016/j.amjsurg.2006.08.046; Velmahos GC, 2000, J TRAUMA, V49, P132, DOI 10.1097/00005373-200007000-00020	18	36	36	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2009	67	6					1293	1296		10.1097/TA.0b013e3181b0637a			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	531IL	WOS:000272658100034	20009680				2022-02-06	
J	Novack, TA; Banos, JH; Brunner, R; Renfroe, S; Meythaler, JM				Novack, Thomas A.; Banos, James H.; Brunner, Robert; Renfroe, Sharon; Meythaler, Jay M.			Impact of Early Administration of Sertraline on Depressive Symptoms in the First Year after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; clinical trial; head trauma	QUALITY-OF-LIFE; HEAD-INJURY; RATING-SCALE; MODEL SYSTEMS; DISORDERS; MOOD; PARTICIPATION; MORBIDITY; SEROTONIN; COMA	The potential for sertraline administered in the first 3 months after moderate to severe traumatic brain injury (TBI) to decrease the incidence of depression in the first year after injury was assessed in a double-blinded randomized control trial. Subjects were enrolled an average of 21 days after injury (none > 8 weeks) followed by oral administration of placebo (50 subjects) or sertraline 50 mg (49 subjects) for 3 months. Subjects were not depressed at the time of study initiation. Outcome was assessed using the Hamilton Depression Rating Scale (HDRS) and the Depression Scale of the Neurobehavioral Functioning Inventory (NFI). Based on intent-to-treat and efficacy subset analyses, those receiving placebo exhibited significantly greater depressive symptoms than those receiving sertraline during the first 3 months after injury while receiving placebo/drug (10% of placebo group achieving a score of 6 or greater on the HDRS, 0% of the sertraline group; p < 0.023.). There was no significant difference in depressive symptoms during the remainder of the year between the two groups. Sertraline is effective in diminishing depressive symptoms even among those not clinically depressed while the medication is being taken. However, the results do not support the idea that administration early in recovery diminishes the expression of depressive symptoms after the drug is stopped. There is no basis from this study to assume that sertraline administered early in recovery after TBI, when neurotransmitter functioning is often altered, has ongoing effects on the serotonin system after sertraline is discontinued.	[Novack, Thomas A.; Banos, James H.; Brunner, Robert; Renfroe, Sharon] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35249 USA; [Meythaler, Jay M.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA		Novack, TA (corresponding author), Univ Alabama Birmingham, Dept Phys Med & Rehabil, SRC 530,619 19th St S, Birmingham, AL 35249 USA.	Novack@uab.edu			National Institute of Disability and Rehabilitation Research [H133A980010]	This project was supported by the National Institute of Disability and Rehabilitation Research Grant H133A980010 Traumatic Brain Injury Model System Project.	Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1056/NEJMra073096; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Bowen A, 1999, BRAIN INJURY, V13, P547; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; CASSIDY JW, 1989, J HEAD TRAUMA REHAB, V4, P67; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Faries D, 2000, J PSYCHIAT RES, V34, P3, DOI 10.1016/S0022-3956(99)00037-0; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Karakucuk EI, 1997, NEUROPEPTIDES, V31, P259, DOI 10.1016/S0143-4179(97)90057-3; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LINDEN M, 1995, ACTA PSYCHIAT SCAND, V92, P150, DOI 10.1111/j.1600-0447.1995.tb09559.x; MARKIANOS M, 1992, ACTA NEUROL SCAND, V86, P190, DOI 10.1111/j.1600-0404.1992.tb05064.x; Meythaler JM, 2001, BRAIN INJURY, V15, P321, DOI 10.1080/026990501750111274; Minderhoud JM., 1990, PHYS MED REHABILITAT, V4, P447; Moller HJ, 2001, EUR ARCH PSY CLIN N, V251, P13; NAYAK AK, 1980, J NEUROL SCI, V47, P211, DOI 10.1016/0022-510X(80)90005-2; O'Donnell ML, 2004, AM J PSYCHIAT, V161, P507, DOI 10.1176/appi.ajp.161.3.507; OSullivan RL, 1997, ACTA PSYCHIAT SCAND, V95, P379, DOI 10.1111/j.1600-0447.1997.tb09649.x; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; SALZMAN SK, 1987, J NEUROSURG, V66, P431, DOI 10.3171/jns.1987.66.3.0431; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SHARMA HS, 1989, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1988, P317; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; SIMON G, 2003, J PSYCHIATR RES, V27, P247; Snaith RP, 1996, BRIT J PSYCHIAT, V168, P594, DOI 10.1192/bjp.168.5.594; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stein PN, 1996, CLIN NEUROPSYCHOL, V10, P141, DOI 10.1080/13854049608406674; WHITAKERAZMITIA PM, 1990, ANN NY ACAD SCI, V600, P315, DOI 10.1111/j.1749-6632.1990.tb16892.x; Williams JBW, 2001, EUR ARCH PSY CLIN N, V251, P6, DOI 10.1007/BF03035120; Zauner A, 1996, TRAUMATIC BRAIN INJU, P97	51	36	36	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					1921	1928		10.1089/neu.2009.0895			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600007	19929217				2022-02-06	
J	Bechtel, K; Frasure, S; Marshall, C; Dziura, J; Simpson, C				Bechtel, Kirsten; Frasure, Sarah; Marshall, Clement; Dziura, James; Simpson, Christine			Relationship of Serum S100B Levels and Intracranial Injury in Children With Closed Head Trauma	PEDIATRICS			English	Article						closed head trauma; intracranial injury; pediatric emergency department; S100B	BIOCHEMICAL MARKERS; PROTEIN; CANCER; PREDICT; DAMAGE; RISKS	OBJECTIVE: To determine if serum levels of S100B are higher in children with CHT and ICI as detected by cranial CT and if long bone fractures affect the level of S100B in children with CHT and skeletal injury. METHODS: Children < 18 years of age who presented to an urban pediatric emergency department or were transferred from a referral hospital within 6 hours after accidental closed head trauma and who underwent cranial computed tomography were enrolled prospectively. Mean serum S100B levels for children with or without intracranial injury (ICI) and long-bone fractures were evaluated through analysis of covariance. RESULTS: One hundred fifty-two children, 24 with ICI and 128 without ICI, were enrolled prospectively. Twenty-five children had long-bone fractures. Children with ICI were significantly younger than those without ICI (6.9 vs 9.8 years; P = .01). The time of venipuncture after injury was significantly later in children with ICI (P = .03). Mean S100B levels were significantly greater for children with ICI (212.9 vs 84.4 ng/L; P = .001), children with long-bone fractures (P = .008), and non-white children (P = .03). After controlling for time of venipuncture, long-bone fractures, and race, mean S100B levels were still greater for children with ICI (409 vs 118 ng/L; P = .001). The ability of serum S100B measurements to detect ICI, determined as the area under the curve, was 0.67. CONCLUSIONS: After controlling for time of venipuncture, long-bone fractures, and race, S100B levels were still higher in children with ICI than in those without ICI. However, the ability of serum S100B measurements to detect ICI was poor. Pediatrics 2009; 124:e697-e704	[Bechtel, Kirsten] Yale Univ, Sch Med, Dept Pediat, Sect Pediat Emergency Med, New Haven, CT 06504 USA; [Dziura, James; Simpson, Christine] Yale Univ, Sch Med, Yale Ctr Clin Invest, New Haven, CT 06504 USA; [Marshall, Clement] Brown Univ, Sch Med, Dept Biochem, Providence, RI 02912 USA		Bechtel, K (corresponding author), Yale Univ, Sch Med, Dept Pediat, Sect Pediat Emergency Med, 840 Howard Ave,1st Floor, New Haven, CT 06504 USA.	kirsten.bechtel@yale.edu	Bechtel, Kirsten/K-2147-2019		National Center for Research Resources, a component of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR0249139]	Support for this study was through Clinical and Translational Science Awards grant UL1 RR0249139 from the National Center for Research Resources, a component of the National Institutes of Health.	Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Amer-Wahlin I, 2001, CLIN CHIM ACTA, V304, P57, DOI 10.1016/S0009-8981(00)00408-3; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Benz MG, 2004, PEDIATRICS, V114, P205, DOI 10.1542/peds.114.1.205; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Bergman DA, 1999, PEDIATRICS, V104, P1407; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hall EJ, 2002, PEDIATR RADIOL, V32, P700, DOI 10.1007/S00247-002-0774-8; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Listman DA, 2003, CURR OPIN PEDIATR, V15, P299, DOI 10.1097/00008480-200306000-00013; Luckl Jaaos, 2007, Ideggyogy Sz, V60, P284; Maschmann J, 2000, ACTA PAEDIATR, V89, P553, DOI 10.1080/080352500750027844; McAdory BS, 1998, BRAIN RES, V813, P211, DOI 10.1016/S0006-8993(98)01014-2; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Raabe A, 2004, NEUROL RES, V26, P440, DOI 10.1179/016164104225015958; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Zhu H, 2007, J NEUROSCI RES, V85, P2783, DOI 10.1002/jnr.21257	30	36	37	0	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	OCT	2009	124	4					E697	E704		10.1542/peds.2008-1493			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	500CI	WOS:000270274300052	19786430				2022-02-06	
J	Diedler, J; Sykora, M; Bast, T; Poli, S; Veltkamp, R; Mellado, P; Steiner, T; Rupp, A				Diedler, Jennifer; Sykora, Marek; Bast, Thomas; Poli, Sven; Veltkamp, Roland; Mellado, Patricio; Steiner, Thorsten; Rupp, Andre			Quantitative EEG Correlates of Low Cerebral Perfusion in Severe Stroke	NEUROCRITICAL CARE			English	Article						Continuous EEG; Multimodality brain monitoring; Cerebral perfusion pressure; Stroke	ACUTE ISCHEMIC-STROKE; GRADE SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; CAROTID-ENDARTERECTOMY; INTRACEREBRAL HEMORRHAGE; BLOOD-FLOW; BISPECTRAL INDEX; MALIGNANT COURSE; SYMMETRY-INDEX; PRESSURE	Continuous EEG provides the unique possibility to monitor neuronal function non-invasively. In our pilot study, we evaluated EEG spectral power during spontaneous drops in cerebral perfusion pressure (CPP) in deeply sedated and mechanically ventilated patients with severe stroke. We aimed to identify parameters that may be used for continuous monitoring even in patients with a burst-suppression baseline EEG pattern. Twenty ventilated and sedated patients with severe hemorrhagic or ischemic stroke underwent continuous EEG monitoring with synchronous CPP recording. EEG monitoring duration was 83.9 hours on average per patient. Spectral power of EEG during drops of CPP was compared with epochs during normal CPP under the same levels of sedation. We found a significant decrease in faster EEG activity (3.5-20.7 Hz) during phases of low CPP (unaffected hemisphere P < 0.01, affected hemisphere P < 0.01, both P < 0.01). Despite considerable changes in baseline activity due to deep sedation and severe brain injury, we found evidence for disturbed neuronal function during drops in CPP. Thus, continuous EEG monitoring may add clinically relevant information on neuronal function in the setting of multimodality brain monitoring. Further studies are needed to implement real-time data analysis in the ICU setting.	[Diedler, Jennifer; Sykora, Marek; Poli, Sven; Veltkamp, Roland; Mellado, Patricio; Steiner, Thorsten; Rupp, Andre] Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany; [Sykora, Marek] Comenius Univ, Dept Neurol, Bratislava 81369, Slovakia; [Bast, Thomas] Heidelberg Univ, Dept Pediat Neurol, D-69120 Heidelberg, Germany; [Mellado, Patricio] Pontificia Univ Catolica Chile, Dept Neurol, Santiago, Chile		Diedler, J (corresponding author), Heidelberg Univ, Dept Neurol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	jennifer.diedler@med.uni-heidelberg.de	Steiner, Thorsten/L-2868-2018; Steiner, Thorsten/A-7391-2014	Steiner, Thorsten/0000-0002-5080-8222; 			ADAMS DC, 1995, ANESTH ANALG, V81, P80, DOI 10.1097/00000539-199507000-00016; Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Berger C, 2005, STROKE, V36, pE4, DOI 10.1161/01.STR.0000151328.70519.e9; BERGER C, 2008, NEUROCRIT CARE; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Blume WT, 2006, J CLIN NEUROPHYSIOL, V23, P306, DOI 10.1097/01.wnp.0000229137.94384.fa; BLUME WT, 1986, STROKE, V17, P891, DOI 10.1161/01.STR.17.5.891; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Burghaus L, 2007, CLIN NEUROL NEUROSUR, V109, P45, DOI 10.1016/j.clineuro.2006.06.003; CHIAPPA KH, 1979, STROKE, V10, P381, DOI 10.1161/01.STR.10.4.381; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Claassen Jan, 2002, Curr Neurol Neurosci Rep, V2, P534, DOI 10.1007/s11910-002-0042-1; de Vos CC, 2008, J CLIN NEUROPHYSIOL, V25, P77, DOI 10.1097/WNP.0b013e31816ef725; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; El-Dawlatly Abdelazeem Ali, 2003, Middle East Journal of Anesthesiology, V17, P287; Finnigan SP, 2007, CLIN NEUROPHYSIOL, V118, P2525, DOI 10.1016/j.clinph.2007.07.021; Finnigan SP, 2006, CLIN NEUROPHYSIOL, V117, P2338, DOI 10.1016/j.clinph.2006.06.718; Finnigan SP, 2004, STROKE, V35, P899, DOI 10.1161/01.STR.0000122622.73916.d2; Hans SS, 2007, J VASC SURG, V45, P511, DOI 10.1016/j.jvs.2006.11.035; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; Merat S, 2001, CAN J ANAESTH, V48, P1066, DOI 10.1007/BF03020370; Morimoto Y, 2005, ANESTH ANALG, V100, P158, DOI 10.1213/01.ANE.0000139347.64944.95; NAGATA K, 1989, ELECTROEN CLIN NEURO, V72, P16, DOI 10.1016/0013-4694(89)90027-8; RAMPIL IJ, 1983, NEUROSURGERY, V13, P276, DOI 10.1227/00006123-198309000-00011; Scherg M, 2002, J CLIN NEUROPHYSIOL, V19, P91, DOI 10.1097/00004691-200203000-00001; Sharbrough FW, 1973, STROKE, V4, P674, DOI 10.1161/01.STR.4.4.674; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STEINER T, 2002, IMPORTANCE MONITORIN, V73, P501, DOI DOI 10.1007/S00115-002-1280-9; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; Stejskal L, 2007, ACTA NEUROCHIR, V149, P681, DOI 10.1007/s00701-007-1228-8; Sundt TM, 2007, J NEUROSURG, V107, P887, DOI 10.3171/JNS-0711010887; Theilen HJ, 2000, CRIT CARE MED, V28, P3522, DOI 10.1097/00003246-200010000-00029; Thomsen CE, 1996, BRIT J ANAESTH, V77, P172, DOI 10.1093/bja/77.2.172; TROJABOR.W, 1973, ELECTROEN CLIN NEURO, V34, P61, DOI 10.1016/0013-4694(73)90151-X; Umegaki N, 2003, J CLIN NEUROSCI, V10, P694, DOI 10.1016/j.jocn.2002.11.001; van Putten MJAM, 2004, STROKE, V35, P2489, DOI 10.1161/01.STR.0000144649.49861.1d; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Wartenberg KE, 2005, J CLIN NEUROPHYSIOL, V22, P124, DOI 10.1097/01.WNP.0000154918.51389.B6; WHITTEMORE AD, 1983, ANN SURG, V197, P707, DOI 10.1097/00000658-198306000-00009	46	36	38	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2009	11	2					210	216		10.1007/s12028-009-9236-6			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	495OG	WOS:000269902300012	19728178				2022-02-06	
J	Wang, M; Yoder, KK; Gao, MZ; Mock, BH; Xu, XM; Saykin, AJ; Hutchins, GD; Zheng, QH				Wang, Min; Yoder, Karmen K.; Gao, Mingzhang; Mock, Bruce H.; Xu, Xiao-Ming; Saykin, Andrew J.; Hutchins, Gary D.; Zheng, Qi-Huang			Fully automated synthesis and initial PET evaluation of [C-11]PBR28	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						Translocator protein (TSPO); [C-11]PBR28; Radiosynthesis; Positron emission tomography (PET); Traumatic brain injury (TBI); Brain imaging	PERIPHERAL BENZODIAZEPINE-RECEPTOR; PROTEIN 18 KDA; BINDING; DESIGN; RADIOSYNTHESIS; RADIOLIGAND; LIGANDS; MONKEY; AGENTS; BRAIN	Fully automated synthesis and initial PET evaluation of a TSPO radioligand, [C-11]PBR28 (N-(2[C-11]methoxybenzyl)-N-(4-phenoxypyridin-3-yl)acetamide), are reported. These results facilitate the potential preclinical and clinical PET studies of [C-11]PBR28 in animals and humans. (C) 2009 Elsevier Ltd. All rights reserved.	[Wang, Min; Yoder, Karmen K.; Gao, Mingzhang; Mock, Bruce H.; Saykin, Andrew J.; Hutchins, Gary D.; Zheng, Qi-Huang] Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN 46202 USA; [Xu, Xiao-Ming] Indiana Univ, Dept Neurosurg, Sch Med, Indianapolis, IN 46202 USA		Zheng, QH (corresponding author), Indiana Univ, Sch Med, Dept Radiol, 1345 W 16th St,Room 202, Indianapolis, IN 46202 USA.	qzheng@iupui.edu	Gao, Mingzhang/AAW-4383-2021; Gao, Mingzhang/AAW-4046-2021; Saykin, Andrew/A-1318-2007	Xu, Xiao-ming/0000-0002-7229-0081; Saykin, Andrew/0000-0002-1376-8532	Indiana Genomics Initiative (INGEN) of Indiana University; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01AG019771, 3P30AG010133-18S1, 5P50NS052606]; Indiana Economic Development Corporation [IEDC 87884]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS052606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG019771, P30AG010133] Funding Source: NIH RePORTER	This work was supported in part by the Indiana Genomics Initiative (INGEN) of Indiana University, as well as by grants from the NIH 5R01AG019771, 3P30AG010133-18S1, 5P50NS052606, and Indiana Economic Development Corporation (IEDC 87884). We gratefully acknowledge Dr. Robert B. Innis at the NIMH for his assistance. The referees' criticisms and editor's comments for the revision of the manuscript are greatly appreciated.	BENAVIDES J, 1987, BRAIN RES, V421, P167, DOI 10.1016/0006-8993(87)91287-X; Briard E, 2008, J MED CHEM, V51, P17, DOI 10.1021/jm0707370; Brown AK, 2007, J NUCL MED, V48, P2072, DOI 10.2967/jnumed.107.044842; Cheng TE, 2009, J NEUROSCI METH, V176, P24, DOI 10.1016/j.jneumeth.2008.08.031; ELSLAGER EF, 1972, J MED CHEM, V15, P827, DOI 10.1021/jm00278a008; Frese T, 2003, IEEE T MED IMAGING, V22, P258, DOI 10.1109/TMI.2002.808353; Fujimura Y, 2006, J NUCL MED, V47, P43; Imaizumi M, 2008, NEUROIMAGE, V39, P1289, DOI 10.1016/j.neuroimage.2007.09.063; Imaizumi M, 2007, NEUROSCI LETT, V411, P200, DOI 10.1016/j.neulet.2006.09.093; JEWETT DM, 1992, APPL RADIAT ISOTOPES, V43, P1383; Mock BH, 2005, J LABELLED COMPD RAD, V48, pS225; Mock BH, 2005, J LABELLED COMPD RAD, V48, pS224; Mock BH, 1999, NUCL MED BIOL, V26, P467, DOI 10.1016/S0969-8051(98)00087-0; Okubo T, 2004, BIOORGAN MED CHEM, V12, P3569, DOI 10.1016/j.bmc.2004.04.025; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Probst KC, 2007, NUCL MED BIOL, V34, P439, DOI 10.1016/j.nucmedbio.2007.02.009; Rouze NC, 2003, IEEE T NUCL SCI, V50, P1491, DOI 10.1109/TNS.2003.817378; Rouze NC, 2005, IEEE NUCL SCI CONF R, P2394; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Wang M, 2007, BIOORG MED CHEM LETT, V17, P332, DOI 10.1016/j.bmcl.2006.10.065; Wang M, 2009, EUR J MED CHEM, V44, P2748, DOI 10.1016/j.ejmech.2008.08.001; Wilson AA, 2008, NUCL MED BIOL, V35, P305, DOI 10.1016/j.nucmedbio.2007.12.009; Yasuno F, 2008, BIOL PSYCHIAT, V64, P835, DOI 10.1016/j.biopsych.2008.04.021; Zheng QH, 2005, BIOMED CHROMATOGR, V19, P671, DOI 10.1002/bmc.494; Zheng QH, 2003, NUCL MED BIOL, V30, P405, DOI 10.1016/S0969-8051(02)00447-X	25	36	36	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X	1464-3405		BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	OCT 1	2009	19	19					5636	5639		10.1016/j.bmcl.2009.08.051			4	Chemistry, Medicinal; Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Chemistry	498AH	WOS:000270106700025	19716298	Green Accepted			2022-02-06	
J	Gao, X; Chen, JH				Gao, Xiang; Chen, Jinhui			Conditional Knockout of Brain-Derived Neurotrophic Factor in the Hippocampus Increases Death of Adult-Born Immature Neurons following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain-derived neurotrophic factor; cell death; conditional knockout; postnatal-born neuron; traumatic brain injury	REDUCES INFARCT SIZE; SPINAL-CORD-INJURY; RAT HIPPOCAMPUS; CORTICAL IMPACT; NERVOUS-SYSTEM; DENTATE GYRUS; MELANOCORTIN SYSTEM; OXIDATIVE DAMAGE; MESSENGER-RNAS; POTENTIAL ROLE	It has been reported that the hippocampus is particularly vulnerable to traumatic brain injury (TBI), the consequence of which results in hippocampal-dependent cognitive impairment. In the previous study we found that adult-born immature neurons in the hippocampal dentate gyrus are the most vulnerable cell type to moderate TBI insult. However, the molecular mechanisms that regulate the survival of adult-born immature neurons in the hippocampus following TBI are still not well understood. Here, we conditionally knocked out brain-derived neurotrophic factor (BDNF) in the hippocampal dentate gyrus and examined the death of adult-born immature neurons following moderate TBI. The results showed that the amount of adult-born immature neuron death in the hippocampal dentate gyrus significantly increased in the BDNF conditional knockout mice. This result suggests that BDNF is involved in regulating the survival of adult-born immature neurons in the hippocampus following TBI, and potentially might be a useful target for preventing the adult-born immature neurons from death following TBI.	[Chen, Jinhui] Indiana Univ, Dept Neurosurg, Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA		Chen, JH (corresponding author), Indiana Univ, Dept Neurosurg, Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, 950 W Walnut St, Indianapolis, IN 46202 USA.	jchen@uky.edu	Chen, Jinhui/A-7138-2009	Chen, Jinhui/0000-0002-6864-7121	Indiana University.	This work was supported by startup funding provided by Indiana University.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Barde Y A, 1994, Prog Clin Biol Res, V390, P45; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; Cone RD, 1999, TRENDS ENDOCRIN MET, V10, P211, DOI 10.1016/S1043-2760(99)00153-8; Conover JC, 1997, REV NEUROSCIENCE, V8, P13; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; DEWIED D, 1987, ANN NY ACAD SCI, V512, P328, DOI 10.1111/j.1749-6632.1987.tb24971.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; GAO X, 2008, J NEUROSCI RES; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Goodfellow VS, 2003, CURR TOP MED CHEM, V3, P855, DOI 10.2174/1568026033452212; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Jagasia R, 2006, TRENDS MOL MED, V12, P400, DOI 10.1016/j.molmed.2006.07.006; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kim DH, 1996, NEUROREPORT, V7, P2221, DOI 10.1097/00001756-199609020-00033; Krude H, 2000, TRENDS ENDOCRIN MET, V11, P15, DOI 10.1016/S1043-2760(99)00213-1; Lu P, 2001, J COMP NEUROL, V436, P456, DOI 10.1002/cne.1080; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; MEMBERG SP, 1995, MOL CELL NEUROSCI, V6, P323, DOI 10.1006/mcne.1995.1025; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; RUBINSTEIN M, 1993, NEUROENDOCRINOLOGY, V58, P373, DOI 10.1159/000126566; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; SQUINTO SP, 1990, NEURON, V5, P757, DOI 10.1016/0896-6273(90)90334-C; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; TIMMUSK T, 1994, ANAL TRANSCRIPTIONAL, V199, P27; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Webster MJ, 2002, DEV BRAIN RES, V139, P139, DOI 10.1016/S0165-3806(02)00540-0; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Yamashita K, 1997, METAB BRAIN DIS, V12, P271, DOI 10.1007/BF02674671; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	65	36	36	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1325	1335		10.1089/neu.2008.0744			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900015	19203227				2022-02-06	
J	Goodrich-Hunsaker, NJ; Hopkins, RO				Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.			Word Memory Test Performance in Amnesic Patients With Hippocampal Damage	NEUROPSYCHOLOGY			English	Article						symptom validity test; amnesia; declarative memory; hippocampus	MEDIAL TEMPORAL-LOBE; TRAUMATIC BRAIN-INJURY; RECOGNITION MEMORY; EXTERNAL INCENTIVES; DECLARATIVE MEMORY; SPATIAL MEMORY; ITEM MEMORY; VALIDITY	Many symptom validity tests (SVTs) assess performance validity via declarative memory paradigms. One widely used SVT, the Word Memory Test (WMT), uses a variety of memory tests to assess performance. It is well known that declarative memory requires the hippocampus and related medial temporal lobe structures. In the present study, WMT performance was examined in nonlitigating amnesic subjects (n = 3) with well-documented focal bilateral hippocampal atrophy who were nondemented and otherwise cognitively unimpaired compared with matched controls. The amnesic subjects had no external incentives. Amnesic subjects performed significantly below the level of matched comparison subjects but above established cutoff scores on the immediate recognition and delay recognition subtests and consistency component. In contrast, the amnesic subjects were impaired relative to our comparison subjects on the multiple-choice, paired associate, free-recall, and long delay free-recall subtests and had extremely low performance on these measures. Thus, there was a differential effect of hippocampal damage on WMT performance where the recognition subtests were performed within the normal range, yet the free recall was profoundly impaired in amnesic subjects. Such an approach where SVT performance is assessed in populations with well-known cognitive impairments adds breadth to SVT clinical interpretations.	[Goodrich-Hunsaker, Naomi J.] Brigham Young Univ, Dept Physiol, Provo, UT 84602 USA; [Goodrich-Hunsaker, Naomi J.] Brigham Young Univ, Dev Biol & Neurosci Ctr, Provo, UT 84602 USA; [Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, Ramona O.] Intermt Med Ctr, Dept Crit Care Med, Murray, UT USA		Goodrich-Hunsaker, NJ (corresponding author), Brigham Young Univ, Dept Psychol, 1082 SWKT, Provo, UT 84602 USA.	naomihunsaker@mac.com					Aggleton JP, 2005, NEUROPSYCHOLOGIA, V43, P1810, DOI 10.1016/j.neuropsychologia.2005.01.019; Allen MD, 2007, BRAIN INJURY, V21, P1425, DOI 10.1080/02699050701769819; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Bowden SC, 2006, CLIN NEUROPSYCHOL, V20, P858, DOI 10.1080/13854040500246935; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Davachi L, 2008, CURR DIR PSYCHOL SCI, V17, P112, DOI 10.1111/j.1467-8721.2008.00559.x; Dickerson BC, 2007, HIPPOCAMPUS, V17, P1060, DOI 10.1002/hipo.20338; Dodrill CB, 2008, EPILEPSIA, V49, P691, DOI 10.1111/j.1528-1167.2007.01457.x; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Gold JJ, 2006, P NATL ACAD SCI USA, V103, P9351, DOI 10.1073/pnas.0602716103; Gold JJ, 2006, LEARN MEMORY, V13, P644, DOI 10.1101/lm.258406; Green P., 2003, WORD MEMORY TEST WIN; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P524, DOI 10.1016/j.neuropsychologia.2003.09.005; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Milner B, 2005, PSYCHIAT CLIN N AM, V28, P599, DOI 10.1016/j.psc.2005.06.002; Ofen N, 2007, NAT NEUROSCI, V10, P1198, DOI 10.1038/nn1950; Sarter M, 2006, BRAIN RES REV, V51, P145, DOI 10.1016/j.brainresrev.2005.11.002; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shrager Y, 2007, P NATL ACAD SCI USA, V104, P2961, DOI 10.1073/pnas.0611233104; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Vanderploeg RD, 2001, NEUROREHABILITATION, V16, P245; Wais PE, 2006, NEURON, V49, P459, DOI 10.1016/j.neuron.2005.12.020; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Westerberg CE, 2006, NEUROPSYCHOLOGY, V20, P193, DOI 10.1037/0894-4105.20.2.193	32	36	36	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2009	23	4					529	534		10.1037/a0015444			6	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	472IA	WOS:000268122600011	19586216				2022-02-06	
J	Gautschi, OP; Cadosch, D; Frey, SP; Skirving, AP; Filgueira, L; Zellweger, R				Gautschi, Oliver P.; Cadosch, Dieter; Frey, Soenke P.; Skirving, Allan P.; Filgueira, Luis; Zellweger, Rene			Serum-mediated osteogenic effect in traumatic brain-injured patients	ANZ JOURNAL OF SURGERY			English	Article						fracture healing; heterotopic ossification; osteogenic effect; traumatic brain injury	HETEROTOPIC OSSIFICATION; SPINAL-CORD; CALLUS FORMATION; HEAD-INJURY; ENHANCED OSTEOGENESIS; BONE; FRACTURE; DIFFERENTIATION	Background: Patients with a traumatic brain injury (TBI) and bone fractures often show an enhanced fracture healing, as well as an increased incidence of heterotopic ossifications (HO). It has been suggested that unknown osteoinductive factors may be released by the injured brain into the systemic blood circulation and act peripherally on the affected tissues. The aim of this study was to investigate whether serum from TBI patients is osteoinductive. Methods: Sixty-one consecutive patients were classified into four groups: TBI and long- bone fracture (group I, n = 12), isolated severe TBI (group II, n = 21), isolated long-bone fracture (group III, n = 19) and controls (group IV, n = 9). Blood samples were collected at 6, 24, 72 and 168 h post-injury. The osteogenic potential was determined by measuring the in vitro proliferation rate of the human fetal osteoblastic cell line hFOB1.19, and primary human osteoblasts. Additionally, serum induced osteoblastic differentiation was assessed by measuring the mRNA expression of specific osteoblastic markers, including alkaline phosphatase, runt-related transcription factor 2, cathepsin K and serine protease 7. Results: The sera of group I induced a higher mean proliferation rate of primary human osteoblasts at all time points of sampling than group III (P < 0.05). Group I had a higher mean proliferation rate of hFOB1.19 cells than all other groups at 6, 24 and 72 h post-injury (P < 0.05). The expression of alkaline phosphatase, cathepsin K and runt-related transcription factor 2 mRNA was increased in group I compared with group III and serine protease 7 was exclusively expressed in group I. Conclusion: The study results strongly support a humoral mechanism in enhanced fracture healing and the induction of HO after TBI. Increased proliferation of osteoblastic cells and an accelerated differentiation of osteoprogenitor cells may be responsible for increased osteogenesis in TBI.	[Gautschi, Oliver P.; Cadosch, Dieter; Frey, Soenke P.; Skirving, Allan P.; Zellweger, Rene] Royal Perth Hosp, Dept Orthopaed & Trauma Surg, Perth, WA, Australia; [Gautschi, Oliver P.; Cadosch, Dieter; Frey, Soenke P.; Skirving, Allan P.; Filgueira, Luis] Univ Western Australia, Sch Anat & Human Biol, Perth, WA 6009, Australia		Gautschi, OP (corresponding author), Kantonsspital, Dept Neurosurg, Rorschacher Str 95, CH-9007 St Gallen, Switzerland.	ogautschi@datacomm.ch	Filgueira, Luis/B-6492-2008	Filgueira, Luis/0000-0002-2266-6650	SUVA Stiftung, Switzerland	This study was supported by the SUVA Stiftung, Switzerland. The study has been approved by the RPH Research Ethics Committee (EC 2005/83).	Arosarena O, 2005, Orthod Craniofac Res, V8, P267, DOI 10.1111/j.1601-6343.2005.00349.x; Banovac K, 1997, SPINAL CORD, V35, P158, DOI 10.1038/sj.sc.3100380; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brighton CT, 1997, J ORTHOP TRAUMA, V11, P244, DOI 10.1097/00005131-199705000-00002; Camozzi V, 2007, J Endocrinol Invest, V30, P13; CANALIS E, 1985, CLIN ORTHOP RELAT R, P246; CHALMERS J, 1975, J BONE JOINT SURG BR, VB 57, P36, DOI 10.1302/0301-620X.57B1.36; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; DEJERINE MME, 1918, ANN MED, V5, P497; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Estrores IM, 2004, J SPINAL CORD MED, V27, P434, DOI 10.1080/10790268.2004.11752233; Filgueira L, 2005, BONE, V36, pS463; GARLAND DE, 1983, CLIN ORTHOP RELAT R, P190; GARLAND DE, 1980, CLIN ORTHOP RELAT R, P198; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; Gautschi OP, 2007, J NEUROTRAUM, V24, P154, DOI 10.1089/neu.2006.0166; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Hock JM, 2002, PRINCIPLES BONE BIOL, P463; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Klein BY, 1999, CALCIFIED TISSUE INT, V65, P217, DOI 10.1007/s002239900686; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; KURER MHJ, 1992, PARAPLEGIA, V30, P165, DOI 10.1038/sc.1992.48; Kushwaha V P, 1998, J Am Acad Orthop Surg, V6, P298; Mandelin J, 2006, BONE, V38, P769, DOI 10.1016/j.bone.2005.10.017; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Raisz L G, 1978, Recent Prog Horm Res, V34, P335; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; Shehab D, 2002, J NUCL MED, V43, P346; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Wang YH, 2007, AM J PHYSIOL-ENDOC M, V292, pE594, DOI 10.1152/ajpendo.00216.2006; Wildburger R, 1996, UNFALLCHIRURG, V99, P17; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295	40	36	44	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	JUN	2009	79	6					449	455		10.1111/j.1445-2197.2008.04803.x			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	463IL	WOS:000267425500009	19566868				2022-02-06	
J	Allahtavakoli, M; Moloudi, R; Arababadi, MK; Shamsizadeh, A; Javanmardi, K				Allahtavakoli, Mohammad; Moloudi, Roohollah; Arababadi, Mohammad Kazemi; Shamsizadeh, Ali; Javanmardi, Kazem			Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat	BRAIN RESEARCH			English	Article						Cerebral ischemia; Rosiglitazone; Neuroprotection; Delayed therapy	PROLIFERATOR-ACTIVATED RECEPTORS; CEREBRAL-ARTERY OCCLUSION; TRANSIENT FOCAL ISCHEMIA; PPAR-GAMMA AGONIST; BRAIN-INJURY; OXIDATIVE STRESS; INFLAMMATION; NEUROPROTECTION; STRATEGIES; PROTECTION	Rosiglitazone (RGZ), a peroxisome proliferator-activated receptor-gamma (PPAR-gamma), has been shown to provide neuroprotective and anti-inflammatory effects in the acute phase of cerebral ischemia, and traumatic or surgical brain injuries. However, the effect of delayed post ischemia administration of this compound is still unclear. This study was designed to evaluate the neuroprotective effects of RGZ when first administered at 24 h after the embolic model of stroke. Embolic focal cerebral ischemia was induced in rats by placing a preformed clot into the middle cerebral artery (MCA). RGZ (5 mg/kg, intraperitoneally) was injected at 24 and 48 h after MCA embolization. Neurological deficits were evaluated at 24, 48 and 72 h after stroke, and blood and brain tissues were then collected for differential blood cell counts and assessments of infarct volume and DNA fragmentation, respectively. Compared to the control group, the administration of RGZ, starting 24 h after cerebral ischemia, reduced infarct volume by 56% (P < 0.05) and decreased neurological deficits at 72 h after cerebral ischemia (P < 0.05). Also, delayed administration of RGZ prevented neutrophilia in blood (P < 0.005) and significantly decreased DNA fragmentation (P < 0.05), 72 h after MCA occlusion. Therefore, our data demonstrate that treatment with RGZ, starting 24 h after stroke, can reduce ischemic injury, improve neurological outcome, and prevent neutrophilia. These findings may support the idea that RGZ has an extended therapeutic window for the treatment of ischemic stroke, as it targets delayed pathways. Crown Copyright (C) 2009 Published by Elsevier B.V. All rights reserved.	[Allahtavakoli, Mohammad; Moloudi, Roohollah; Arababadi, Mohammad Kazemi; Shamsizadeh, Ali] Rafsanjan Univ Med Sci, Sch Med, Dept Physiol, Rafsanjan, Iran; [Javanmardi, Kazem] Fassa Univ Med Sci, Sch Med, Dept Physiol, Fassa, Iran		Allahtavakoli, M (corresponding author), Rafsanjan Univ Med Sci, Sch Med, Dept Physiol, Shariati St,POB 77175-835, Rafsanjan, Iran.	alahtavakoli@razi.tums.ac.ir	Kazemi Arababadi, Mohammad/H-5282-2017; javanmardi, kazem/M-8751-2017; Shamsizadeh, Ali/D-3807-2017; Moloudi, Mohammad Raman/C-3150-2016; Allahtavakoli, Mohammad/H-6764-2017	Kazemi Arababadi, Mohammad/0000-0002-4829-1586; javanmardi, kazem/0000-0003-0485-6722; Shamsizadeh, Ali/0000-0001-8329-9156; Moloudi, Mohammad Raman/0000-0003-2883-5213; Allahtavakoli, Mohammad/0000-0001-6612-9729; Kazemi Arababadi, Mohammad/0000-0002-4315-8153	Rafsanjan University of Medical Sciences, Iran [3365]	This study was financially supported by the grant no. 3365 from the Research Vice Chancellor of Rafsanjan University of Medical Sciences, Iran.	Ajmo CT, 2006, CURR NEUROVASC RES, V3, P89, DOI 10.2174/156720206776875849; Alexandrova ML, 2005, FREE RADICAL BIO MED, V39, P297, DOI 10.1016/j.freeradbiomed.2005.04.017; Alioglu B, 2008, PEDIATR INT, V50, P281, DOI 10.1111/j.1442-200X.2008.02570.x; Allahtavakoli M, 2006, CLIN EXP PHARMACOL P, V33, P1052, DOI 10.1111/j.1440-1681.2006.04486.x; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; Buck BH, 2008, STROKE, V39, P355, DOI 10.1161/STROKEAHA.107.490128; DiNapoli VA, 2006, J NEUROSCI METH, V154, P233, DOI 10.1016/j.jneumeth.2005.12.026; Dinkel K, 2004, P NATL ACAD SCI USA, V101, P331, DOI 10.1073/pnas.0303510101; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Giuliani D, 2006, EUR J PHARMACOL, V538, P48, DOI 10.1016/j.ejphar.2006.03.038; Green AR, 2006, DRUG DISCOV TODAY, V11, P681, DOI 10.1016/j.drudis.2006.06.001; Hartl R, 1996, J CEREBR BLOOD F MET, V16, P1108; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; Lee J, 2007, NEUROCHEM RES, V32, P635, DOI 10.1007/s11064-006-9138-3; Leonardo CC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-34; LOANE DJ, 2007, NEUROBIOL AGING, V18; Margaill I, 2005, FREE RADICAL BIO MED, V39, P429, DOI 10.1016/j.freeradbiomed.2005.05.003; Newcomb JD, 2006, CELL TRANSPLANT, V15, P213, DOI 10.3727/000000006783982043; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Schmerbach K, 2008, BRAIN RES, V1208, P225, DOI 10.1016/j.brainres.2008.02.032; Singhal PC, 2000, IMMUNOLOGY, V100, P57, DOI 10.1046/j.1365-2567.2000.00007.x; Stahel PF, 2008, PPAR RES, V2008, DOI 10.1155/2008/538141; Tolman Keith G, 2003, Clin Liver Dis, V7, P369, DOI 10.1016/S1089-3261(03)00020-5; Tureyen K, 2007, J NEUROCHEM, V101, P41, DOI 10.1111/j.1471-4159.2006.04376.x; Williams AJ, 2004, STROKE, V35, P1186, DOI 10.1161/01.STR.0000125721.10606.dc; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Zheng Z, 2003, CURR MOL MED, V3, P361, DOI 10.2174/1566524033479717	33	36	36	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 19	2009	1271						121	127		10.1016/j.brainres.2009.03.040			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	449SY	WOS:000266351500012	19332033				2022-02-06	
J	Brenner, LA; Ladley-O'Brien, SE; Harwood, JEF; Filley, CM; Kelly, JP; Homaifar, BY; Adler, LE				Brenner, Lisa A.; Ladley-O'Brien, Susan E.; Harwood, Jeri E. F.; Filley, Christopher M.; Kelly, James P.; Homaifar, Beeta Y.; Adler, Lawrence E.			An Exploratory Study of Neuroimaging, Neurologic, and Neuropsychological Findings in Veterans With Traumatic Brain Injury and/or Posttraumatic Stress Disorder	MILITARY MEDICINE			English	Article							VIETNAM VETERANS; COMBAT VETERANS; MILD; MEMORY; PTSD; IRAQ; AFGHANISTAN; DEFICITS	Seventy-two veterans with traumatic brain injury (TB!), posttraumatic stress disorder (PTSD), or both participated in assessment procedures to evaluate between group differences. Half the sample was randomly selected for magnetic resonance imaging (MRI). Neurologic examinations were conducted using the Neurologic Rating Scale (NRS). Neuropsychological measures included the Paced Auditory Serial Addition Test (PASAT), Rey Auditory Verbal Learning Test (RAVLT), Conners' Continuous Performance Test II (CPT II), and Halstead Impairment Index (HII) including the Booklet Category Test (BCT). Data were analyzed using linear regression. Participants with moderate/severe TBI were significantly more likely to have trauma-related imaging findings, and more severe TBI predicted lower scores on the NRS. No significant between-group differences were identified on the HI!, PASAT, RAVLT, or CPT II. TBI group performance was significantly better on the BCT. More severe TBI predicted abnormal imaging findings and lower NRS scores. Hypothesized between-group differences on neuropsychological measures were not supported.	[Brenner, Lisa A.; Homaifar, Beeta Y.; Adler, Lawrence E.] Educ & Clin Ctr MIRECC, VA VISN 19 Mental Illness Res, Denver, CO 80220 USA; [Brenner, Lisa A.; Filley, Christopher M.; Homaifar, Beeta Y.; Adler, Lawrence E.] Univ Colorado Denver, Dept Psychiat, Sch Med, Aurora, CO 80045 USA; [Brenner, Lisa A.; Ladley-O'Brien, Susan E.; Kelly, James P.] Univ Colorado Denver, Dept Phys Med & Rehabil, Sch Med, Aurora, CO 80045 USA; [Brenner, Lisa A.; Filley, Christopher M.] Univ Colorado Denver, Dept Neurol, Sch Med, Aurora, CO 80045 USA; [Harwood, Jeri E. F.] Univ Colorado Denver, Dept Pediat, Sch Med, Aurora, CO 80045 USA; [Kelly, James P.] Univ Colorado Denver, Dept Neurosurg, Sch Med, Aurora, CO 80045 USA		Brenner, LA (corresponding author), Educ & Clin Ctr MIRECC, VA VISN 19 Mental Illness Res, 1055 Clermont St, Denver, CO 80220 USA.		Brenner, Lisa A./AAG-2442-2019				Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bremner JD, 1995, PSYCHIAT RES, V59, P97; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; CONDER R, 1992, MANUAL COMPUTERIZED; Conners C. K., 2000, CONNERS CONTINUOUS P; Crowell TA, 2002, CLIN NEUROPSYCHOL, V16, P310, DOI 10.1076/clin.16.3.310.13851; Danckwerts A, 2003, NEUROPSYCHOL REV, V13, P221, DOI 10.1023/B:NERV.0000009485.76839.b7; DeFilippis N., 1997, BOOKLET CATEGORY TES, V2nd; *DEP VET AFF, 2004, VETEESA138 SP DEP VE, V138; Feinstein A, 2002, J NEUROPSYCH CLIN N, V14, P25, DOI 10.1176/appi.neuropsych.14.1.25; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gilbertson MW, 2007, BIOL PSYCHIAT, V62, P513, DOI 10.1016/j.biopsych.2006.12.023; GURVITS TV, 1993, J NEUROPSYCH CLIN N, V5, P183; Gurvits TV, 2006, ARCH GEN PSYCHIAT, V63, P571, DOI 10.1001/archpsyc.63.5.571; Heaton R. K., 2004, REVISED COMPREHENSIV; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McCullagh S, 2005, TXB TRAUMATIC BRAIN, P321; McMillan TM, 2003, NEUROPSYCHOL REHABIL, V13, P149, DOI 10.1080/09602010244000453; Reitan R.M., 1993, HALSTEADREITAN NEURO; SIPE JC, 1984, NEUROLOGY, V34, P1368, DOI 10.1212/WNL.34.10.1368; Spitzer R, 1995, STRUCTURED CLIN INTE; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Thurman DJ., 1995, GUIDELINES SURVEILLA; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Twamley EW, 2004, PSYCHIAT RES, V126, P265, DOI 10.1016/j.psychres.2004.01.008; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137	39	36	37	0	12	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	APR	2009	174	4					347	352		10.7205/MILMED-D-01-5808			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	601LB	WOS:000278059600005	19485102	Bronze			2022-02-06	
J	Muller, K; Ingebrigtsen, T; Wilsgaard, T; Wikran, G; Fagerheim, T; Romner, B; Waterloo, K				Muller, Kay; Ingebrigtsen, Tor; Wilsgaard, Tom; Wikran, Gry; Fagerheim, Toril; Romner, Bertil; Waterloo, Knut			PREDICTION OF TIME TRENDS IN RECOVERY OF COGNITIVE FUNCTION AFTER MILD HEAD INJURY	NEUROSURGERY			English	Article						Brain trauma; Neuropsychological assessment; Risk factors in epidemiology	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E; APOE GENOTYPE; NEUROPSYCHOLOGICAL FUNCTION; PROTEIN S-100B; EPSILON-4; SERUM; E4; ASSOCIATION; IMPAIRMENT	OBJECTIVE: To investigate relations between predictors and outcomes, and especially to identify predictors influencing the time trend in recovery after mild traumatic brain injury. METHODS: We included 59 patients with mild head injury in a prospective study. They underwent comprehensive assessment with neurological and neuroradiological examinations, serum S-100B analysis, and apolipoprotein E (APOE) genotyping. Neuropsychological testing was performed before and 6 months after discharge. Linear mixed models were used to assess associations between baseline predictors and neurocognitive performance and its change. RESULTS: A Glasgow Coma Scale score of less than 15, traumatic brain injury demonstrated with computed tomography, magnetic resonance imaging, and serum S-100B greater than 0.14 mu g/L predicted impaired cognitive performance both at baseline and after 6 months; APOE genotype did not. There was significant improvement of performance after 6 months. APOE-epsilon 4 genotype was the only independent factor significantly predicting less improvement. CONCLUSION: The presence of the APOE-epsilon A allele predicts less recovery of cognitive function after mild head injury.	[Muller, Kay] Univ Hosp N Norway, Dept Neurosurg, N-9038 Tromso, Norway; [Ingebrigtsen, Tor] Univ Tromso, Inst Clin Med, Tromso, Norway; [Wilsgaard, Tom] Univ Tromso, Inst Community Med, Tromso, Norway; [Wikran, Gry] Univ Hosp N Norway, Dept Radiol, N-9038 Tromso, Norway; [Fagerheim, Toril] Univ Hosp N Norway, Dept Med Genet, N-9038 Tromso, Norway; [Romner, Bertil] Univ Tromso, Inst Clin Med, Tromso, Norway		Muller, K (corresponding author), Univ Hosp N Norway, Dept Neurosurg, N-9038 Tromso, Norway.	kay.muller@unn.no		Ingebrigtsen, Tor/0000-0001-5966-9786			Aslanidis C, 1999, CLIN CHEM, V45, P1094; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; DELIS D, 1987, CALIFORNIA VERBAL LE; Egge A, 2005, ACTA NEUROL SCAND, V112, P76, DOI 10.1111/j.1600-0404.2005.00449.x; Golden CJ, 1978, STROOP COLOR WORD TE; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Houlden H, 2006, J NEUROL NEUROSUR PS, V77, P1106, DOI 10.1136/jnnp.2006.095513; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Muller K, 2006, CLIN CHEM LAB MED, V44, P1111, DOI 10.1515/CCLM.2006.211; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864; Wechsler D, 1987, MEMORY SCALE REVISED; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401; Wolfson, 1993, HALSTEAD REITAN NEUR; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; ZIMMERMANN P, 1999, TEST ATTENTIONAL PER	37	36	42	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	APR	2009	64	4					698	704		10.1227/01.NEU.0000340978.42892.78			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	427MN	WOS:000264783500030	19349827				2022-02-06	
J	Akiyama, Y; Miyata, K; Harada, K; Minamida, Y; Nonaka, T; Koyanagi, I; Asai, Y; Houkin, K				Akiyama, Yukinori; Miyata, Kei; Harada, Kuniaki; Minamida, Yoshihiro; Nonaka, Tadashi; Koyanagi, Izumi; Asai, Yasufumi; Houkin, Kiyohiro			Susceptibility-Weighted Magnetic Resonance Imaging for the Detection of Cerebral Microhemorrhage in Patients With Traumatic Brain Injury	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						susceptibility-weighted magnetic resonance imaging; cerebral microhemorrhage; brain injury	HYPERACUTE INTRACEREBRAL HEMORRHAGE	The sensitivity of susceptibility-weighted magnetic resonance (MR) imaging was compared with conventional MR sequences, including T-2*-weighted imaging, and computed tomography for the detection of cerebral hemorrhages in 15 patients with head injury. Susceptibility-weighted imaging detected a mean of 76 +/- 52 (total 1132) hypointense spotty lesions, compared to a mean of 21 +/- 19 (total 316) detected by T-2*-weighted imaging (p < 0.0001, paired t-test). Susceptibility-weighted imaging is extremely sensitive for the visualization and detection of microhemorrhages.	[Akiyama, Yukinori; Harada, Kuniaki; Minamida, Yoshihiro; Nonaka, Tadashi; Koyanagi, Izumi; Houkin, Kiyohiro] Sapporo Med Univ, Dept Neurosurg, Sapporo, Hokkaido 0608543, Japan; [Akiyama, Yukinori; Miyata, Kei; Asai, Yasufumi] Sapporo Med Univ, Dept Crit Care Med, Sapporo, Hokkaido 0608543, Japan		Akiyama, Y (corresponding author), Sapporo Med Univ, Dept Neurol Surg, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	akiyuki@sapmed.ac.jp	Houkin, Kiyohiro/G-5364-2012				Atlas SW, 1998, AM J NEURORADIOL, V19, P1471; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Fiebach JB, 2004, STROKE, V35, P502, DOI 10.1161/01.STR.0000114203.75678.88; Liang LX, 1999, AM J NEURORADIOL, V20, P1527; Linfante I, 1999, STROKE, V30, P2263, DOI 10.1161/01.STR.30.11.2263; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Patel MR, 1996, STROKE, V27, P2321, DOI 10.1161/01.STR.27.12.2321; Schellinger PD, 1999, STROKE, V30, P765, DOI 10.1161/01.STR.30.4.765	8	36	46	0	3	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAR	2009	49	3					97	99		10.2176/nmc.49.97			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	423SV	WOS:000264516900001	19318732	Bronze			2022-02-06	
J	McCauley, SR; McDaniel, MA; Pedroza, C; Chapman, SB; Levin, HS				McCauley, Stephen R.; McDaniel, Mark A.; Pedroza, Claudia; Chapman, Sandra B.; Levin, Harvey S.			Incentive Effects on Event-Based Prospective Memory Performance in Children and Adolescents With Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article; Proceedings Paper	32nd Annual Meeting of the International-Neuropsychological-Society	FEB 04-07, 2004	Baltimore, MD	Int Neuropsychol Soc		event-based prospective memory; traumatic brain injury; incentive; motivation; memory rehabilitation	CLOSED-HEAD-INJURY; ELECTRONIC MEMORY; ACADEMIC-ACHIEVEMENT; TASK INTERRUPTION; EVERYDAY MEMORY; POCKET MONEY; SHORT-TERM; AGE; ADULTS; IMPAIRMENT	Prospective memory (PM) is the formation of an intention and remembering to perform this intention at a future time or in response to specific cues. PM tasks are a ubiquitous part of daily life. Currently, there is a paucity of information regarding PM impairments in children with traumatic brain injury (TBI) and less empirical evidence regarding effective remediation strategies to mitigate these impairments. The present study employed two levels of a motivational enhancement (i.e., a monetary incentive) to determine whether event-based PM could be improved in children with severe TBI. In a crossover design, children with orthopedic injuries and mild or severe TBI were compared on two levels of incentive (dollars vs. pennies) given in response to accurate performance. All three groups performed significantly better under the high- versus low-motivation conditions. However, the severe TBI group's high-motivation condition performance remained significantly below the low-motivation condition performance of the orthopedic injury group. PM scores were positively and significantly related to age-at-test, but there were no age-at-injury or time-postinjury effects. Overall, these results suggest that event-based PM can be significantly improved in children with severe TBI.	[McCauley, Stephen R.; Levin, Harvey S.] Univ Texas Houston, Sch Med, Houston, TX USA; [McDaniel, Mark A.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Pedroza, Claudia] Univ Texas Houston, Sch Publ Hlth, Div Biostat, Houston, TX USA; [Chapman, Sandra B.] Univ Texas Dallas, Ctr Brainhlth, Inst Biomed Sci & Technol, Dallas, TX 75230 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Pediat Hematol Oncol, Houston, TX 77030 USA		McCauley, SR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 1709 Dryden Rd,Suite 725, Houston, TX 77030 USA.	mccauley@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD040896] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23-HD40896, K23 HD040896-04, K23 HD040896-01A1, K23 HD040896-03, K23 HD040896-02, K23 HD040896] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS21899] Funding Source: Medline		Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Baddeley A., 1990, HUMAN MEMORY; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Barnet-Verzat C, 2002, J ECON PSYCHOL, V23, P339, DOI 10.1016/S0167-4870(02)00080-6; Best D. L., 1992, MEMORY IMPROVEMENT I, P122; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Chapman S.B, 1995, TRAUMATIC HEAD INJUR, P95; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; CROVITZ HF, 1984, B PSYCHONOMIC SOC, V22, P413; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; DENNIS M, 2000, PATIENT BASED APPROA; Driscoll I, 2005, NEUROPSYCHOLOGY, V19, P28, DOI 10.1037/0894-4105.19.1.28; Einstein, 2007, PROSPECTIVE MEMORY O; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Flannery M A, 1997, Pediatr Rehabil, V1, P239; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Furnham A, 1999, BRIT J DEV PSYCHOL, V17, P585, DOI 10.1348/026151099165492; Furnham A, 2000, EUR PSYCHOL, V5, P202, DOI 10.1027//1016-9040.5.3.202; Furst C., 1986, COGNITIVE REHABILITA, V4, P24; GENTRY M, 1990, PERS SOC PSYCHOL B, V16, P241, DOI 10.1177/0146167290162005; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guajardo NR, 2000, COGNITIVE DEV, V15, P75, DOI 10.1016/S0885-2014(00)00016-2; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Harris J. E., 1984, EVERYDAY MEMORY ACTI, P71; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kerns KA, 2001, CHILD NEUROPSYCHOL, V7, P162, DOI 10.1076/chin.7.3.162.8744; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2001, MEMORY, V9, P1, DOI 10.1080/09658210042000003; Kliegel M, 2004, MEMORY, V12, P553, DOI 10.1080/09658210344000099; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; Louda J., 2007, Z NEUROPSYCHOL, V18, P91, DOI [10.1080/09602010600831004, DOI 10.1080/09602010600831004]; LYNCH WJ, 1995, J HEAD TRAUMA REHAB, V10, P94, DOI 10.1097/00001199-199502000-00011; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; MAYLOR EA, 1990, Q J EXP PSYCHOL-A, V42, P471, DOI 10.1080/14640749008401233; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McDaniel M. A., 2008, PROSPECTIVE MEMORY C, P141; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; MEACHAM JA, 1976, PROSPECTIVE REMEMBER; Neisser U., 1982, MEMORY OBSERVED REME, P327; Neul SKT, 2001, CHILD FAM BEHAV THER, V23, P37, DOI 10.1300/J019v23n04_03; PASTORE DR, 1992, COMPREHENSIVE ADOLES; Reason J.T., 1977, ADULT LEARNING PSYCH; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; RUTHER NM, 1993, M SE PSYCHOL ASS ATL; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; *SAS I INC, 2003, STAT AN SOFTW WIND V; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; SOMERVILLE SC, 1983, J GENET PSYCHOL, V143, P87, DOI 10.1080/00221325.1983.10533537; STOKES S, 2005, NAT C UND RES LEX VA; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; TERRY WS, 1988, PSYCHOL REP, V62, P299, DOI 10.2466/pr0.1988.62.1.299; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Ward H, 2004, BRAIN INJURY, V18, P471, DOI 10.1080/02699050310001646107; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; West R. L., 1984, M AM PSYCH ASS TOR; WILKINS AJ, 1978, PRACTICAL ASPECTS ME; WILSON B, 1987, REHABILITATION MEMOR; Winograd E., 1988, PRACTICAL ASPECTS ME, V1, P348; Yasuda K, 2002, NEUROPSYCHOL REHABIL, V12, P155, DOI 10.1080/09602010143000239; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; [No title captured]; [No title captured]	100	36	37	0	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2009	23	2					201	209		10.1037/a0014192			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychology; Neurosciences & Neurology	416VR	WOS:000264034100008	19254093	Green Accepted			2022-02-06	
J	Baker, F; Wigram, T; Stott, D; McFerran, K				Baker, Felicity; Wigram, Tony; Stott, David; McFerran, Katrina			Therapeutic songwriting in music therapy, Part II: Comparing the literature with practice across diverse clinical populations	NORDIC JOURNAL OF MUSIC THERAPY			English	Article						songwriting; music therapy methods; lyric creation	TRAUMATIC BRAIN-INJURY; SONGS WRITTEN; ADOLESCENTS; THEMES; PEOPLE	A growing body of literature on therapeutic songwriting with diverse clinical populations indicates that clinicians employ a wide range of approaches. The purpose of this research was to establish trends in the clinical practice of songwriting as implemented across a range of clinical populations. Responses to a 21-question online survey were obtained from 419 professional music therapists practicing in 29 countries which focused on approaches to songwriting within their practice with a single clinical population. Results suggest that, in general, the literature provides good representation for what is occurring in clinical practice. Generally, songs were composed with individual clients in single sessions, with lyrics created prior to the music. Clinicians had a significant role in creating the music with improvised and predetermined musical structures being equally employed. Chi-square or comparable Exact tests (Fisher-Freeman-Halton) were applied to the data and significant associations were found according to clinical populations, particularly with respect the number of sessions required to complete a song, approaches to composing lyrics and music, the context with which songwriting was employed, and the types of allied health professionals involved in the songwriting interventions. There is a distinct absence of songwriting literature as applied in developmental disability, autism spectrum disorder, and aged care contexts so the resulting practice trends offered here contribute to the increasing body of knowledge about songwriting practices.	[Baker, Felicity] Univ Queensland, Sch Mus, Brisbane, Qld, Australia; [Wigram, Tony] Univ Aalborg, Dept Humanities, Inst Commun & Psychol, Aalborg, Denmark; [Wigram, Tony] Anglia Ruskin Univ, Cambridge, England; [McFerran, Katrina] Univ Melbourne, Fac Mus, Melbourne, Vic 3010, Australia; [Stott, David] Univ Hertfordshire, E England RDSU Hertfordshire, Hatfield AL10 9AB, Herts, England; [Stott, David] Univ Bedfordshire, Bedford, England		Baker, F (corresponding author), Univ Queensland, Sch Mus, Brisbane, Qld, Australia.	f.baker1@uq.edu.au		McFerran, Katrina/0000-0003-0699-3683			Aasgaard T, 2001, J PALLIATIVE CARE, V17, P177; Aasgaard T., 2005, SONGWRITING METHODS, P154; Abad V., 2003, AUSTR J MUSIC THERAP, V14, P20; Baker F, 2005, J MUSIC THER, V42, P111, DOI 10.1093/jmt/42.2.111; Baker F., 2005, SONGWRITING METHODS, P116; Baker F., 2005, AUSTR J MUSIC THERAP, V16, P25; BAKER F, 2005, SONGWRITING METHODS; Baker F., 2005, SONGWRITING METHODS, P134; Baker FA, 2006, MUSIC THERAPY METHOD; BAKER FA, ARTS PSYCHO IN PRESS; Baker F, 2008, NORD J MUSIC THER, V17, P105, DOI 10.1080/08098130809478203; Bruscia K. E., 1987, IMPROVISATIONAL MODE; Dalton TA, 2005, ART PSYCHOTHER, V32, P131, DOI 10.1016/j.aip.2005.02.002; Dalton TA, 2006, MUSIC THER PERSPECT, V24, P94, DOI 10.1093/mtp/24.2.94; Davis E., 2005, SONGWRITING METHODS, P45; Day T., 2005, SONGWRITING METHODS; Derrington P, 2005, SONGWRITING METHODS; DILEO Cheryl, 2005, SONGWRITING METHODS, P226; Edgerton C. D., 1990, MUSIC THERAPY PERSPE, V8, P15; Edwards J., 1998, MUSIC THERAPY PERSPE, V16, P21, DOI DOI 10.1093/mtp/16.1.21; FICKEN T, 1976, J MUSIC THER, V13, P163, DOI 10.1093/jmt/13.4.163; Freed B. S., 1987, MUSIC THERAPY PERSPE, V4, P13, DOI [10.1093/mtp/4.1.13, DOI 10.1093/MTP/4.1.13]; Gallagher LM., 2002, MUSIC THER PERSPECT, V20, P117, DOI DOI 10.1093/MTP/20.2.117; Gfeller K., 1987, MUSIC THERAPY, V6, P28; GLASSMAN LR, 1991, ART PSYCHOTHER, V18, P149, DOI 10.1016/0197-4556(91)90022-3; GOLDSTEIN SL, 1990, ART PSYCHOTHER, V17, P117, DOI 10.1016/0197-4556(90)90021-H; Grocke D, 2007, RECEPTIVE METHODS MU; Hadley S., 1996, AUSTR J MUSIC THERAP, V7, P16; Jones JD, 2005, J MUSIC THER, V42, P94, DOI 10.1093/jmt/42.2.94; KENNELLY J, 1999, MUSIC MED, V3; Krout R., 2005, SONGWRITING METHODS, P206; Krout RE, 2005, MUSIC THER PERSPECT, V23, P118, DOI 10.1093/mtp/23.2.118; Ledger A., 2001, AUST J MUSIC THER, V12, P21; Lindberg K. A., 1995, MUSIC THERAPY, V13, P93; Mayers KS, 1995, ART PSYCHOTHER, V22, P495, DOI 10.1016/0197-4556(94)00050-6; O'Callaghan C.C., 1997, MUSIC THER PERSPECT, V15, P32, DOI [https://doi.org/10.1093/mtp/15.1.32, DOI 10.1093/MTP/15.1.32]; OBrien E., 2005, SONGWRITING METHODS, P180; OCALLAGHAN C, 1990, AUSTR J MUSIC THERAP, V1, P15; OCallaghan CC, 1996, J MUSIC THER, V33, P74, DOI 10.1093/jmt/33.2.74; Oldfield A., 2005, SONGWRITING METHODS, P24; Robb S. L., 1996, MUSIC THERAPY PERSPE, V14, P30, DOI DOI 10.1093/mtp/14.1.30; Roberts M, 2006, AUSTR J MUSIC THERAP, V17, P18; Rolvsjord Randi., 2005, SONGWRITING METHODS, P97; Silber F., 1995, MUSIC THERAPY PERSPE, V13, P31, DOI DOI 10.1093/MTP/13.1.31; Silverman MJ, 2003, ART PSYCHOTHER, V30, P25, DOI 10.1016/S0197-4556(02)00231-9; Slivka H. H., 1986, MUSIC THERAPY A, V6A, P30; Tamplin J., 2006, NORD J MUSIC THER, V15, P177, DOI [10.1080/08098130609478164, DOI 10.1080/08098130609478164]; TURRY A, 1999, CLIN APPL MUSIC THER, P13; WIGRAM T, 2005, SONGWRITING METHODS, P246; Wigram T., 2004, IMPROVISATION METHOD; Wigram T., 2005, SONGWRITING METHODS; Williams SL, 2006, NUTR REV, V64, P93, DOI [10.1301/nr.2006.mar.93-108, 10.1111/j.1753-4887.2006.tb00193.x]	52	36	36	1	24	GRIEG ACADEMY	BERGEN	UNIV BERGEN, DEPT MUSIC, LARS HILLES GATE 3, BERGEN, N-5015, NORWAY	0803-9828			NORD J MUSIC THER	Nord. J. Music Ther.		2009	18	1					32	56		10.1080/08098130802496373			25	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	442GQ	WOS:000265830100003					2022-02-06	
J	Griffin, JM; Friedemann-Sanchez, G; Hall, C; Phelan, S; van Ryn, M				Griffin, Joan M.; Friedemann-Sanchez, Greta; Hall, Carmen; Phelan, Sean; van Ryn, Michelle			Families of patients with polytrauma: Understanding the evidence and charting a new research agenda	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						caregiving; families; Family Care Map; information needs; polytrauma; rapid assessment process; recovery; rehabilitation; resilience; stress; traumatic brain injury	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; INTENSIVE-CARE-UNIT; DEMENTIA CAREGIVERS; HEALTH-CARE; NEEDS; REHABILITATION; PERSPECTIVES; INFORMATION; RESILIENCE	Although research shows that caring for a family member with chronic disease or disability can cause significant distress for caregivers, it also shows that families that function well and adequately support patients can improve the quality of life and health outcomes for their ill or disabled family member. Currently, little knowledge exists about how families function and cope after a loved one has sustained polytrauma, the multiple traumatic injuries that often include traumatic brain injury (TBI). We summarize the polytrauma and TBI research about family needs during rehabilitation and recovery, describe current efforts to improve family-centered care, and detail approaches for understanding family resilience and the long-term consequences of injuries on families. We conclude with recommendations for future research in inpatient and outpatient settings where evidence has been limited for families of patients with TBI and is nonexistent for families of patients with polytrauma. Understanding many of these issues will help to better inform families of policies for benefits and resources and help researchers and clinicians plan for appropriate interventions.	[Griffin, Joan M.; Hall, Carmen] Minneapolis VA Med Ctr, Ctr Chron Dis Outcomes Res, Dept Vet Affairs, VA Hlth Serv Res Ctr Excellence, Minneapolis, MN 55417 USA; [Griffin, Joan M.] Univ Minnesota, Sch Med, Dept Med, Div Gen Internal Med, Minneapolis, MN 55455 USA; [Friedemann-Sanchez, Greta] Univ Minnesota, Hubert H Humphrey Inst Publ Affairs, Minneapolis, MN 55455 USA; [Phelan, Sean] Univ Minnesota, Sch Publ Hlth, Dept Epidemiol & Community Med, Minneapolis, MN USA; [van Ryn, Michelle] Univ Minnesota, Sch Med, Dept Med, Div Family Med & Community Hlth, Minneapolis, MN 55455 USA		Griffin, JM (corresponding author), Minneapolis VA Med Ctr, Ctr Chron Dis Outcomes Res, Dept Vet Affairs, VA Hlth Serv Res Ctr Excellence, 1 Vet Dr, Minneapolis, MN 55417 USA.	joangriffin2@va.gov	Griffin, Jillian/F-9415-2010; VAN RYN, MICHELLE/B-1664-2010	Friedemann-Sanchez, Greta/0000-0002-0493-7218	VA Health Services Research and Development ServiceUS Department of Veterans Affairs [RRP 06149, SDR 07-044]; VA PT/BRI QUERI	This material was based on work supported by VA Health Services Research and Development Service (grants RRP 06149 and SDR 07-044) and the VA PT/BRI QUERI.	Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Armstrong Kira, 2002, Pediatr Rehabil, V5, P149, DOI 10.1080/1363849021000039353; Bamm EL, 2008, ARCH PHYS MED REHAB, V89, P1618, DOI 10.1016/j.apmr.2007.12.034; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Bensink M, 2006, J TELEMED TELECARE, V12, P8, DOI 10.1258/135763306779380174; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Buckley Kathleen M, 2004, Online J Issues Nurs, V9, P9; Burr G, 1998, Intensive Crit Care Nurs, V14, P161, DOI 10.1016/S0964-3397(98)80473-4; Caron W, 1999, PSYCHIATRY, V62, P347, DOI 10.1080/00332747.1999.11024882; Chin MH, 2007, MED CARE, V45, P1135, DOI 10.1097/MLR.0b013e31812da80e; Chiu YL, 2004, J CLIN NURS, V13, P655, DOI 10.1111/j.1365-2702.2004.00844.x; Coon DW, 2004, AGING MENT HEALTH, V8, P330, DOI 10.1080/13607860410001709683; Darkins A, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.03.0029; DAVISMARTIN S, 1994, HEART LUNG, V23, P515; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; *DEP DEF, 2009, DOD PRESS RES; Dunn MS, 2006, PEDIATRICS, V118, pS95, DOI 10.1542/peds.2006-0913F; Engli M, 1993, J Neurosci Nurs, V25, P78; EVANS RL, 1991, ARCH PHYS MED REHAB, V72, P144; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Friedemann-Sanchez G, 2008, REHABIL NURS, V33, P206, DOI 10.1002/j.2048-7940.2008.tb00229.x; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Futrell, 1999, DYNAMICS RESILIENT F; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Gottlieb BH, 2004, AGING MENT HEALTH, V8, P364, DOI 10.1080/13607860410001709719; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hawley DR, 1996, FAM PROCESS, V35, P283, DOI 10.1111/j.1545-5300.1996.00283.x; Holland D, 1998, BRAIN INJURY, V12, P993, DOI 10.1080/026990598121918; Holland Daniel, 2002, Issues Compr Pediatr Nurs, V25, P73, DOI 10.1080/01460860290042512; Horbar JD, 2004, BMJ-BRIT MED J, V329, P1004, DOI 10.1136/bmj.329.7473.1004; Horbar JD, 2003, PEDIATRICS, V111; Institute for Healthcare Improvement, 2003, BREAKTHR SER IHIS CO; Junque C, 1997, BRAIN INJURY, V11, P251, DOI 10.1080/026990597123557; King G, 2003, CHILD HEALTH CARE, V32, P191, DOI 10.1207/S15326888CHC3203_2; King S, 2004, CHILD HEALTH CARE, V33, P35, DOI 10.1207/s15326888chc3301_3; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Langley G., 1996, IMPROVEMENT GUIDE PR; Lesar TS, 2007, JT COMM J QUAL PATIE, V33, P73, DOI 10.1016/S1553-7250(07)33009-2; Levine C., 1998, ROUGH CROSSINGS FAMI; Luthar SS, 2000, DEV PSYCHOPATHOL, V12, P857, DOI 10.1017/S0954579400004156; McCubbin H. I., 1998, RESILIENCY AFRICAN A; McCubbin H.I., 1998, RESILIENCY NATIVE AM; McCubbin H.I., 1982, FAMILY STRESS COPING; McCubbin H.I., 1983, MARRIAGE FAM REV, V6, P7, DOI [10.1300/J002v06n01_02, DOI 10.1300/J002V06N01_02]; McCubbin H. I., 1987, FAMILY ASSESSMENT IN, P3; MCCUBBIN HI, 1988, FAM RELAT, V37, P247, DOI 10.2307/584557; McCubbin HI, 1980, FAMILY CHANGE, P89; MCCUBBIN HI, 1997, AM ASS FAM CONS SCI; MCCUBIN HI, 1975, J MARRIAGE FAM, V37, P471, DOI 10.2307/350511; Meade MA, 2004, REHABIL PSYCHOL, V49, P150, DOI 10.1037/0090-5550.49.2.150; Morris KC, 2001, BRAIN INJURY, V15, P239, DOI 10.1080/02699050010004068; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pargeon KL, 1999, J PAIN SYMPTOM MANAG, V18, P358, DOI 10.1016/S0885-3924(99)00097-4; Paterson B, 2001, Rehabil Nurs, V26, P48; Patterson JM, 2002, J MARRIAGE FAM, V64, P349, DOI 10.1111/j.1741-3737.2002.00349.x; Ramritu PL, 1999, INT J NURS STUD, V36, P209, DOI 10.1016/S0020-7489(99)00016-4; Rosenbaum P., 1998, PHYS OCCUP THER PEDI, V18, P1, DOI [DOI 10.1080/J006v18n01_01, 10.1080/J006v18n01_01]; Rotondi AJ, 2005, J HEAD TRAUMA REHAB, V20, P173, DOI 10.1097/00001199-200503000-00005; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Sorensen S, 2002, GERONTOLOGIST, V42, P356, DOI 10.1093/geront/42.3.356; Spatt L, 1986, QRB Qual Rev Bull, V12, P16; Stringer E. T., 1999, ACTION RES HDB PRACT; Taylor E J, 1993, Oncol Nurs Forum, V20, P919; TAYLOR HG, 1995, TRAUMATIC HEAD INJUR; Testani-Dufour L, 1992, J Neurosci Nurs, V24, P317; Vaccaro MJ, 2002, NEUROREHABILITATION, V17, P169; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Verhaeghe S, 2005, J CLIN NURS, V14, P501, DOI 10.1111/j.1365-2702.2004.01081.x; Veterans Health Administration, 2005, VHA HDB; Ward K, 2001, Pediatr Nurs, V27, P281; Warden DL, 2005, NEW ENGL J MED, V353, P633; Wearden AJ, 2000, CLIN PSYCHOL REV, V20, P633, DOI 10.1016/S0272-7358(99)00008-2	76	36	36	2	15	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2009	46	6					879	891		10.1682/JRRD.2008.08.0104			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	531BQ	WOS:000272638100017	20104409	Bronze			2022-02-06	
J	Jaffee, CMS; Meyer, KS				Jaffee, Col Michael S.; Meyer, Kimberly S.			A BRIEF OVERVIEW OF TRAUMATIC BRAIN INJURY (TBI) AND POST-TRAUMATIC STRESS DISORDER (PTSD) WITHIN THE DEPARTMENT OF DEFENSE	CLINICAL NEUROPSYCHOLOGIST			English	Article						Traumatic brain injury (TBI); Post-traumatic stress disorder (PTSD); Department of Defense	ENDURING-FREEDOM; IRAQI FREEDOM; US ARMY; EXPERIENCE; BLAST; TEAM	The current conflicts in the Middle East have yielded increasing awareness of the acute and chronic effect of traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). The increasing frequency of exposure to blast and multiple deployments potentially impact the probability that a service member may sustain one of these injuries. The 2008 International Conference on Behavioral Health and Traumatic Brain Injury united experts in the fields of behavioral health and traumatic brain injury to address these significant health concerns. This article summarizes current Department of Defense (DoD) initiatives related to TBI and PTSD.	[Jaffee, Col Michael S.; Meyer, Kimberly S.] Def & Vet Brain Injury Ctr, Washington, DC 20012 USA		Jaffee, CMS (corresponding author), Def & Vet Brain Injury Ctr, Washington, DC 20012 USA.	Michael.jaffee@amedd.army.mil	Meyer, Kimberly/L-5430-2019				Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; DEMITTENBERG W, 1996, ARCH CLIN NEUROPSYCH, V11, P139; *DEP DEF, 2006, 602521E DOD; *DEP DEF, 2008, EV MAN MTBI CONC DEP; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Grissom Thomas E, 2005, Crit Care Med, V33, pS13, DOI 10.1097/01.CCM.0000151063.85112.5A; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; *IOM, 2008, LONG TERM CONS TRAUM; Jaycox L. H., 2008, INVISIBLE WOUNDS WAR; *MAN CONC MILD TBI, 2009, VA DOD CLIN PRACT GU; McCrea M., 2000, STANDARDIZED ASSESSM; Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6; Patel TH, 2004, J TRAUMA, V57, P201, DOI 10.1097/01.TA.0000133638.30269.38; Peoples GE, 2005, MIL MED, V170, P451, DOI 10.7205/MILMED.170.6.451; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; REEVES D, 2004, ANN REPORT C FEDERAL; RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; TARIVERDI F, 2006, J CLIN ENDOCRINOLOGY, V91, P2105; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; WALILKO T, J HEAD TRAU IN PRESS	24	36	37	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	8					1291	1298		10.1080/13854040903307250			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	524KF	WOS:000272141500004	19882472				2022-02-06	
J	Kim, KT; Park, JK; Kang, SG; Cho, KS; Yoo, DS; Jang, DK; Huh, PW; Kim, DS				Kim, Ki-Tae; Park, Jin-Kyu; Kang, Seok-Gu; Cho, Kyung-Suck; Yoo, Do-Sung; Jang, Dong-Kyu; Huh, Pil-Woo; Kim, Dal-Soo			Comparison of the effect of decompressive craniectomy on different neurosurgical diseases	ACTA NEUROCHIRURGICA			English	Article						Decompressive craniectomy; Intracranial pressure; Traumatic brain injury; Cerebral infarction; Intracerebral haemorrhage	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; REFRACTORY INTRACRANIAL HYPERTENSION; SUPRATENTORIAL INTRACEREBRAL HEMORRHAGE; SEVERE HEAD-INJURIES; SURGICAL DECOMPRESSION; HEMISPHERIC INFARCTION; CEREBELLAR INFARCTION; FUNCTIONAL RECOVERY; PROGNOSTIC-FACTORS	Many previous studies have reported that decompressive craniectomy has improved clinical outcomes in patients with intractable increased intracranial pressure (ICP) caused by various neurosurgical diseases. However there is no report that compares the effectiveness of the procedure in the different conditions. The authors performed decompressive craniectomy following a constant surgical indication and compared the clinical outcomes in different neurosurgical diseases. Seventy five patients who underwent decompressive craniectomy were analysed retrospectively. There were 28 with severe traumatic brain injury (TBI), 24 cases with massive intracerebral haemorrhage (ICH), and 23 cases with major infarction (MI). The surgical indications were GCS score less than 8 and/or a midline shift more than 6 mm on CT. The clinical outcomes were assessed on the basis of mortality and Glasgow Outcome Scale (GOS) scores. The changes of ventricular pressure related to the surgical intervention were also compared between the different disease groups. Clinical outcomes were evaluated 6 months after decompressive craniectomy. The mortality was 21.4% in patients with TBI, 25% in those with ICH and 60.9% in MI. A favourable outcome, i.e. GOS 4-5 (moderate disability or better) was observed in 16 (57.1%) patients with TBI, 12 (50%) with ICH and 7 (30.4%) with MI. The change of ventricular pressure after craniectomy and was 53.2 (reductions of 17.4%) and further reduced by 14.9% (with dural opening) and (24.8%) after returning to its recovery room, regardless of the diseases group. According to the mortality and GOS scores, decompressive craniectomy with dural expansion was found to be more effective in patients with ICH or TBI than in the MI group. However, the ventricular pressure change during the decompressive craniectomy was similar in the different disease groups. The authors thought that decompressive craniectomy should be performed earlier for the major infarction patients.	[Yoo, Do-Sung] Uijeongbu St Marys Hosp, Dept Neurosurg, Uijeongbu City 480130, Gyeonggi Do, South Korea; [Park, Jin-Kyu; Kang, Seok-Gu; Cho, Kyung-Suck; Yoo, Do-Sung; Jang, Dong-Kyu; Huh, Pil-Woo; Kim, Dal-Soo] Catholic Univ Korea, Coll Med, Dept Neurosurg, Uijeongbu St Marys Hosp, Seoul, South Korea; [Kim, Ki-Tae] Catholic Univ Korea, Coll Med, Dept Radiol, Uijeongbu St Marys Hosp, Seoul, South Korea		Yoo, DS (corresponding author), Uijeongbu St Marys Hosp, Dept Neurosurg, 65-1 Kumoh Dong, Uijeongbu City 480130, Gyeonggi Do, South Korea.	yooman@catholic.ac.kr		Kang, Seok-Gu/0000-0001-5676-2037	Catholic Institute of Cell Therapy Basic Science Programs Foundation	The author wish to acknowledge the financial support of the Catholic Institute of Cell Therapy Basic Science Programs Foundation made in the program year of 2007.	Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Cho DY, 2003, SURG NEUROL, V60, P227, DOI 10.1016/S0090-3019(03)00266-0; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Coplin WM, 2001, NEUROL RES, V23, P277, DOI 10.1179/016164101101198433; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; DELASHAW JB, 1990, STROKE, V21, P874, DOI 10.1161/01.STR.21.6.874; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fandino Y, 2004, SWISS MED WKLY, V134, P423; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Georgiadis D, 2002, STROKE, V33, P1584, DOI 10.1161/01.STR.0000016970.51004.D9; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hofmeijer J, 2003, CRIT CARE MED, V31, P617, DOI 10.1097/01.CCM.0000050446.16158.80; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Hutchinson P J, 2004, Curr Opin Crit Care, V10, P101, DOI 10.1097/00075198-200404000-00004; IVAMOTO HS, 1974, STROKE, V5, P365, DOI 10.1161/01.STR.5.3.365; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; JUVELA S, 1989, J NEUROSURG, V70, P755, DOI 10.3171/jns.1989.70.5.0755; KERR FWL, 1963, MAYO CLIN P, V43, P852; Kilincer C, 2005, ACTA NEUROCHIR, V147, P587, DOI 10.1007/s00701-005-0493-7; KOBAYASHI S, 1994, NEUROSURGERY, V34, P246, DOI 10.1227/00006123-199402000-00006; Koh MS, 2000, SURG NEUROL, V53, P225, DOI 10.1016/S0090-3019(00)00163-4; KONDZIOLKA D, 1988, NEUROSURGERY, V23, P143, DOI 10.1227/00006123-198808000-00002; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; MACDONELL RAL, 1987, STROKE, V18, P849, DOI 10.1161/01.STR.18.5.849; Maira G, 2002, NEUROL RES, V24, P54, DOI 10.1179/016164102101199549; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; MARMAROU A, 2004, YOUMANS NEUROLOGICAL, V4, P175; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; Meier U, 2000, ACTA NEUROCHIR SUPPL, V76, P475; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Mori K, 2004, SURG NEUROL, V62, P420, DOI 10.1016/j.surneu.2003.12.017; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Ong YK, 2002, CHILD NERV SYST, V18, P340, DOI 10.1007/s00381-002-0597-9; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Raco A, 2003, NEUROSURGERY, V53, P1061, DOI 10.1227/01.NEU.0000088766.34559.3E; RENGACHARY SS, 1981, NEUROSURGERY, V8, P321, DOI 10.1227/00006123-198103000-00004; RIEKE K, 1995, CRIT CARE MED, V23, P1576, DOI 10.1097/00003246-199509000-00019; ROBERTSON C, 2004, YOUMANS NEUROLOGICAL, V4, P5103; Robertson SC, 2004, NEUROSURGERY, V55, P55, DOI 10.1227/01.NEU.0000126875.02630.36; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Sakai K, 1998, NEUROL MED-CHIR, V38, P131, DOI 10.2176/nmc.38.131; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Schwarz S, 1997, ACTA NEUROCHIR, V139, P897, DOI 10.1007/BF01411297; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Soukiasian HJ, 2002, AM SURGEON, V68, P1066; Stefini R, 1999, NEUROSURGERY, V45, P626, DOI 10.1097/00006123-199909000-00038; Steiner T, 2001, NEUROLOGY, V57, pS61, DOI 10.1212/WNL.57.suppl_2.S61; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Strege RJ, 2003, NEUROL RES, V25, P510, DOI 10.1179/016164103101201742; TABADDOR K, 1982, SURG NEUROL, V18, P212, DOI 10.1016/0090-3019(82)90395-0; TEITHMEIER T, 2005, CHILD NERV SYST, V21, P249; Uhl E, 2004, J NEUROL NEUROSUR PS, V75, P270; Unwin D H, 1992, Neurosurg Clin N Am, V3, P533; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002; Woertgen C, 2004, ACTA NEUROCHIR, V146, P691, DOI 10.1007/s00701-004-0280-x; Yao Y, 2005, SURG NEUROL, V64, P165, DOI 10.1016/j.surneu.2004.10.021; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; Ziai WC, 2003, J NEUROSURG ANESTH, V15, P25, DOI 10.1097/00008506-200301000-00005; Zuccarello M, 1999, STROKE, V30, P1833, DOI 10.1161/01.STR.30.9.1833	75	36	36	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2009	151	1					21	30		10.1007/s00701-008-0164-6			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	399EY	WOS:000262784400003	19096757				2022-02-06	
J	Thomas, ML; Youngjohn, JR				Thomas, Michael L.; Youngjohn, James R.			Let's Not Get Hysterical: Comparing the MMPI-2 Validity, Clinical, and RC Scales in TBI Litigants Tested for Effort	CLINICAL NEUROPSYCHOLOGIST			English	Article						RC scale; Traumatic brain injury; Symptom validity test; MMPI-2; Litigation	FAKE-BAD-SCALE; MULTIPHASIC PERSONALITY-INVENTORY; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; SYMPTOMATOLOGY; PROFILES; PATTERNS; IMPACT	The MMPI-2 restructured clinical (RC) scales replace the traditional clinical scales in the MMPI-2 restructured form (MMPI-2-RF). Few studies to date have examined the MMPI-2 RC scales in traumatic brain injury (TBI) litigants. We compared MMPI-2 validity, clinical, and RC scales profiles of 83 mild, complicated mild, and moderate/severe TBI litigants who were tested for effort. Past research shows that patients referred for neuropsychological evaluations with mild TBIs paradoxically have higher MMPI-2 clinical scale elevations than patients with moderate/severe TBIs. Failure on cognitive symptom validity tests (SVTs) has also been associated with elevated validity and clinical scales profiles. The oconversion Vo (elevated Hs and Hy, followed by D) is the most frequent elevated profile configuration in mild TBI and/or SVT failure. We sought to determine if these patterns of symptom reporting would replicate on the RC scales profile. Archival data from independent neuropsychological examinations were used to correlate TBI severity, cognitive test effort as indicated by SVTs, and MMPI-2 profiles. Results suggest that the validity, clinical, and RC scales profiles all correlate well with indices of cognitive test effort (namely that failure on SVTs is correlated with elevated symptom reporting). In addition, the validity scales profile, but not the clinical or RC scales profiles, was significantly inversely related to TBI severity. Discriminant function analyses suggest that the MMPI-2 RC scales can aid in the diagnosis of over-reported TBI symptomatology. However, RC3the RC equivalent of the Hy scaleno longer appears to serve as a marker of somatization and/or malingering.	[Thomas, Michael L.] Arizona State Univ, Scottsdale, AZ USA; [Youngjohn, James R.] Neuropsychol Clin, Scottsdale, AZ USA		Youngjohn, JR (corresponding author), 7533 E 1st St, Scottsdale, AZ 85251 USA.	drjyoungjohn@aol.com					Arbisi PA, 2008, J PERS ASSESS, V90, P122, DOI 10.1080/00223890701845146; BENPORATH YS, 2007, M NAT AC NEUR SCOTTS; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; BINDER LM, 1993, PORTLAND DIGIT RECOG; Boone KB, 1999, CLIN NEUROPSYCHOL, V13, P414; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; BURKE J M, 1990, Brain Injury, V4, P223, DOI 10.3109/02699059009026171; Butcher JN, 2006, J PERS ASSESS, V87, P186, DOI 10.1207/s15327752jpa8702_08; Butcher JN, 2001, MMPI 2 MANUAL ADM SC; Downing SK, 2008, CLIN NEUROPSYCHOL, V22, P680, DOI 10.1080/13854040701562825; Enders CK, 2003, MEAS EVAL COUNS DEV, V36, P40, DOI 10.1080/07481756.2003.12069079; Finn SE, 2006, J PERS ASSESS, V87, P202, DOI 10.1207/s15327752jpa8702_10; Forbey JD, 2008, J PERS ASSESS, V90, P136, DOI 10.1080/00223890701845161; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; Gough HG, 1946, J CLIN PSYCHOL, V2, P23, DOI 10.1002/1097-4679(194601)2:1<23::AID-JCLP2270020105>3.0.CO;2-Y; Graham J.R., 1990, MMPI 2 ASSESSING PER; Green P, 1995, MANUAL ORAL WORD MEM; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C, P210; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P919, DOI 10.1080/13854040701625853; Jackson D. N., 1970, CURRENT TOPICS CLIN, V2, P60; Kurtz JE, 2007, J PERS ASSESS, V88, P66, DOI 10.1207/s15327752jpa8801_09; Lanyon R. I., 1997, PERSONALITY ASSESSME; Lanyon RI, 2002, J AM ACAD PSYCHIATRY, V30, P400; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; LeesHaley PR, 1997, J CLIN PSYCHOL, V53, P745, DOI 10.1002/(SICI)1097-4679(199711)53:7<745::AID-JCLP13>3.3.CO;2-7; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; Maxwell S, 1992, ADV SOCIAL SCI METHO, V2, P137; McKinley JC, 1944, J APPL PSYCHOL, V28, P153, DOI 10.1037/h0059245; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Nichols DS, 2006, J PERS ASSESS, V87, P121, DOI 10.1207/s15327752jpa8702_02; Nitch S. R., 2007, ASSESSMENT FEIGNED C, P78; NOVACK TA, 1984, INT J CLIN NEUROPSYC, V6, P139; Osberg TM, 2008, J PERS ASSESS, V90, P81, DOI 10.1080/00223890701693801; Pope K.S., 1993, MMPI MMPI 2 MMPI A C; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rogers R, 2006, J PERS ASSESS, V87, P139, DOI 10.1207/s15327752jpa8702_03; Sellbom M, 2008, J PERS ASSESS, V90, P129, DOI 10.1080/00223890701845153; Smart CM, 2008, J INT NEUROPSYCH SOC, V14, P842, DOI 10.1017/S1355617708081034; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Tellegen A., 2003, MMPI 2 RESTRUCTURED; Tellegen A., 2008, MMPI 2 RF TECHNICAL; Tellegen A, 2006, J PERS ASSESS, V87, P148, DOI 10.1207/s15327752jpa8702_04; Wallace A, 2005, ASSESSMENT, V12, P290, DOI 10.1177/1073191105276250; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	51	36	36	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	6					1067	1084	PII 910192198	10.1080/13854040902795000			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	473BG	WOS:000268178000010	19343593				2022-02-06	
J	Yip, BCB; Man, DWK				Yip, Ben C. B.; Man, David W. K.			Virtual reality (VR)-based community living skills training for people with acquired brain injury: A pilot study	BRAIN INJURY			English	Article						Brain injury; rehabilitation; cognition; virtual reality; community-living	COGNITIVE STATUS EXAMINATION; LIFE SATISFACTION; INSTRUMENTAL ACTIVITIES; CHINESE VERSION; REHABILITATION; STROKE; INTEGRATION; PERFORMANCE; IMPAIRMENT; VALIDATION	Primary objective: The purpose of the present study was to test the usability and effectiveness of a newly-developed virtual reality (VR)-based community living skills training program for people with acquired brain injury (ABI). Method: A small-sample, pre- and post-quasi experimental design was adopted to initially study the efficacy of the VR-based training program. Its usability was also investigated through interviewing subjects. Outcomes were documented in terms of subjects' skills acquisition, self-efficacy in applying the learnt skills and the transfer ratio of the learnt skills to the real environment. Global cognitive ability and the functional independence level were also assessed. Results: Four subjects with ABI (one traumatic brain injury and three stroke subjects) were successfully recruited and received 10 sessions of VR-based community living skills training. All four subjects showed improvement in skills acquisition and memory performance, while three out of four also showed improvement in self-efficacy and demonstrated transfer of skills to the real environment. Usability was initially supported. Conclusions: Preliminary results suggested positive changes in ABI subjects. The proposed virtual reality (VR) community living skills training software will be further investigated in a randomized controlled trial.	[Yip, Ben C. B.; Man, David W. K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China		Man, DWK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	david.man@polyu.edu.hk			Research Grants Council of Hong KongHong Kong Research Grants Council [523205]	The project was funded by The Competitive Earmarked Research Grant (now known as the General Research Fund or GRF), of the Research Grants Council of Hong Kong (#523205).	Brooks BM, 2003, NEUROREHABILITATION, V18, P147; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; CERVELLI L, 1990, REHABILITATION ADULT, P463; Chan CCH, 2002, BRAIN INJURY, V16, P873, DOI 10.1080/02699050210131975; Chan CHC, 1999, ARCH CLIN NEUROPSYCH, V14, P71, DOI 10.1093/arclin/14.1.71; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Duncan PW, 2002, CLIN REHABIL, V16, P493, DOI 10.1191/0269215502cr510oa; Fisher WW, 2003, J APPL BEHAV ANAL, V36, P387, DOI 10.1901/jaba.2003.36-387; GLYSKY EL, 1987, NEUROPSYCHOLOGIA, V25, P839; GOUVIER W, 1997, NEUROPSYCHOLOGY HDB, P3; Gregg L, 2007, SOC PSYCH PSYCH EPID, V42, P343, DOI 10.1007/s00127-007-0173-4; Gurka JA, 1999, J HEAD TRAUMA REHAB, V14, P247, DOI 10.1097/00001199-199906000-00005; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Johnson DA, 1998, SCOT MED J, V43, P81, DOI 10.1177/003693309804300307; Katz N, 2005, DISABIL REHABIL, V27, P1235, DOI 10.1080/09638280500076079; Lam YS, 2006, NEUROREHABILITATION, V21, P245; Lee JH, 2003, CYBERPSYCHOL BEHAV, V6, P383, DOI 10.1089/109493103322278763; LEZAK MD, 1990, TRAUMATIC BRAIN INJU, P365; LOOMIS JM, 1992, J EXP PSYCHOL HUMAN, V18, P906, DOI 10.1037/0096-1523.18.4.906; Lynch B, 2002, J HEAD TRAUMA REHAB, V17, P446, DOI 10.1097/00001199-200210000-00006; LYNCH W, 1992, J HEAD TRAUMA REHAB, V7, P36; MALIA K, 2004, RECOMMENDATIONS BEST; Man DWK, 2006, BRAIN INJURY, V20, P981, DOI 10.1080/13561820600909852; Man DWK, 2006, BRAIN INJURY, V20, P205, DOI 10.1080/02699050500454621; Mariani E, 2008, INT J GERIATR PSYCH, V23, P523, DOI 10.1002/gps.1932; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; NEISTADT ME, 1990, AM J OCCUP THER, V44, P299, DOI 10.5014/ajot.44.4.299; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Rizzo AA, 2000, CYBERPSYCHOL BEHAV, V3, P483, DOI 10.1089/10949310050078940; Rizzo AA, 2001, PRESENCE-TELEOP VIRT, V10, P359, DOI 10.1162/1054746011470226; Rose FD, 2000, ERGONOMICS, V43, P494, DOI 10.1080/001401300184378; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; SCHWAMM LH, 1987, ANN INTERN MED, V107, P486, DOI 10.7326/0003-4819-107-4-486; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Sohlberg MM, 2005, BRAIN INJURY, V19, P1249, DOI 10.1080/02699050500309510; SOHLBERG MM, 2001, COGNITIVE REHABILITA, P4; Tam SF, 2005, REHABIL PSYCHOL, V50, P285, DOI 10.1037/0090-5550.50.3.285; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; Tong AYC, 2002, OTJR-OCCUP PART HEAL, V22, P132, DOI 10.1177/153944920202200402; Wallace JJ, 2000, BRAIN INJURY, V14, P63, DOI 10.1080/026990500120934; WATERS J, 1996, COGNITIVE REHABILITA, P425; Weiss Patrice L Tamar, 2003, Occup Ther Int, V10, P39, DOI 10.1002/oti.176; White O. R., 1980, EXCEPTIONAL TEACHING; You SH, 2005, STROKE, V36, P1166, DOI 10.1161/01.STR.0000162715.43417.91; Zencius AH, 1999, BRAIN INJURY, V13, P723	50	36	39	3	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	13-14					1017	1026		10.3109/02699050903379412			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	529YR	WOS:000272556000004	19891532				2022-02-06	
J	Fabbri, A; Servadei, F; Marchesini, G; Stein, SC; Vandelli, A				Fabbri, A.; Servadei, F.; Marchesini, G.; Stein, S. C.; Vandelli, A.			Observational approach to subjects with mild-to-moderate head injury and initial non-neurosurgical lesions	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; PROGNOSTIC-FACTORS; PROPENSITY SCORE; CARE; MANAGEMENT; PREDICTORS; DIAGNOSIS; PROPOSAL; ADULTS; SYSTEM	Background: The model of care for patients with mild-to-moderate head injury and CT-detected lesions that do not require an immediate intervention is a matter of debate. This study compared the effects on outcome of a model based either on observation in a neurosurgical unit (NSU) or in a peripheral hospital (PH), making use of neurosurgical expertise via a teleradiology system. Patients and methods: The investigation reviewed the data that was prospectively collected in 865 cases with mild-to-moderate head injury and positive CT scan, not needing immediate neurosurgical evacuation. Outcome was determined at 6 months. The predictive value of location of observation on outcome was evaluated by logistic regression, after adjustment for the propensity score to the type of observation (calculated on main entry variables). Findings: 700 subjects had a mild head injury, 105 had a moderate injury with GCS 13-11 and 60 with Glasgow Coma Scale (GCS) 10-9. Only 152/865 subjects (17.6%) were admitted to a NSU. During observation, neurosurgery was necessary in 117 cases (13.5%), 74/152 (48.7%) NSU-observed patients and 43/713 (6.0%; p, 0.001) PH-observed cases. The outcome was unfavourable in 18% of the NSU cases versus 10% of the PH cases (p=0.143). After correction for propensity, no significant differences were found between models of observation (NSU vs. PH; odds ratio, 0.92; 95% confidence interval, 0.49 to 1.75). Interpretation: A model of care based on observation in PH with neurosurgical consult by teleradiology system, repeat CT scanning and transfer time 30-60 min to a NSU is not detrimental for subjects with initial non-neurosurgical lesions after mild-to-moderate head injury.	[Fabbri, A.; Vandelli, A.] Azienda USL Forli, Presidio Osped Morgagni Pierantoni, Dipartimento Emergenza, I-47100 Forli, Italy; [Servadei, F.] Univ Parma, Azienda Osped, Unita Operat Neurochirurg, I-43100 Parma, Italy; [Marchesini, G.] Univ Bologna, I-40126 Bologna, Italy; [Stein, S. C.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA		Fabbri, A (corresponding author), Azienda USL Forli, Presidio Osped Morgagni Pierantoni, Dipartimento Emergenza, Via Forlanini 34, I-47100 Forli, Italy.	dr.andrea.fabbri@gmail.com	Fabbri, Andrea/K-9994-2016	Fabbri, Andrea/0000-0002-9837-4638; Servadei, Franco/0000-0002-3595-3464; Marchesini, Giulio/0000-0003-2407-9860	Emergency Medical System	We are grateful to the Emergency Medical System personnel for helpful support.	ASH AS, 1997, RISK ADJUSTMENT MEAS; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Cavuto S, 2006, DRUG DEVELOP RES, V67, P208, DOI 10.1002/ddr.20079; Chalrson ME, 1987, J CHRON DIS, V40, P373; Crimmins DW, 2000, J NEUROL NEUROSUR PS, V68, P8, DOI 10.1136/jnnp.68.1.8; D'Agostino RB, 2007, CIRCULATION, V115, P2340, DOI 10.1161/CIRCULATIONAHA.105.594952; DUBIN DB, 2007, STAT MED, V26, P20; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Fearnside M, 1998, AUST NZ J SURG, V68, P58, DOI 10.1111/j.1445-2197.1998.tb04638.x; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; MacKenzie EJ, 1999, J TRAUMA, V47, pS34, DOI 10.1097/00005373-199909001-00008; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; NORUSIS MJ, 2004, SPSS PC BASE SYSTEM; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 2002, BRIT J NEUROSURG, V16, P36, DOI 10.1080/02688690120114255; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; STEIN SC, 1996, NEUROTRAUMA, P755; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Visca A, 2006, BRIT J NEUROSURG, V20, P82, DOI 10.1080/02688690600682416	26	36	36	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	OCT	2008	79	10					1180	1185		10.1136/jnnp.2007.135178			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	348XG	WOS:000259242800021	18356255				2022-02-06	
J	Tallon, JM; Ackroyd-Stolarz, S; Karim, SA; Clarke, DB				Tallon, John M.; Ackroyd-Stolarz, Stacy; Karim, Saleema A.; Clarke, David B.			The epidemiology of surgically treated acute subdural and epidural hematomas in patients with head injuries: a population-based study	CANADIAN JOURNAL OF SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; NONOPERATIVE MANAGEMENT; PREHOSPITAL CARE; LIFE-SUPPORT; MORTALITY; INTUBATION; TRANSPORT; SYSTEM; IMPACT	Background: The purpose of this paper is to review the population-based epidemiology of surgically treated post-traumatic epidural hematomas (EDHs) and/or subdural hematomas (SDHs) among patients who presented to the single neurosurgical centre in Nova Scotia. Methods: We included all patients aged 16 years or older who presented to the tertiary care hospital with acute post-traumatic EDHs and/or SDHs between May 23, 1996, and May 22, 2005, and who were surgically treated. We generated an initial cohort from the provincial trauma registry and reviewed a total of 152 charts for possible inclusion; 70 (46%) patients met the study criteria. We performed a blinded, explicit chart review using a standardized data collection form, and we generated descriptive statistics. Results: Of the patients who had surgery, 34 (49%) presented with SDHs, 23 (33%) presented with EDHs and 13 (19%) presented with both conditions. The median age was 45 years, and 80% of the cohort was male. The major mechanisms of injury were falls (11%), motor vehicle collisions ( 30%) and assault (11%). More than half (61%) of patients were transferred from referring hospitals while the remainder (39%) arrived directly without an intermediate facility. There were 18 postoperative deaths ( 26%). Forty-four of 70 patients (63%) had associated good outcomes at 6 months (Glasgow Outcome Scale). Conclusion: Acute post-traumatic EDHs and/or SDHs are relatively rare (0.83/100 000 population per annum) and are generally associated with good outcomes. Death was more likely among older, more severely injured patients and among those who required surgery for SDH rather than EDH.	[Tallon, John M.; Ackroyd-Stolarz, Stacy] Dalhousie Univ, Dept Emergency Med, Halifax, NS, Canada; [Karim, Saleema A.] Dalhousie Univ, Capital Dist Hlth Author, Nova Scotia Trauma Program, Halifax, NS, Canada; [Clarke, David B.] Dalhousie Univ, Dept Surg, Div Neurosurg, Halifax, NS B3H 4H2, Canada		Clarke, DB (corresponding author), Halifax Infirm, Div Neurosurg, 1796 Summer St,Rm 3807, Halifax, NS B3H 3A7, Canada.	d.clarke@dal.ca		Karim, Saleema/0000-0002-8946-9897			Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BIROS MH, 2002, ROSENS EMERGENCY MED, V1, P286; Brazier H, 1999, J ACCID EMERG MED, V16, P18; Callaham M, 1997, ANN EMERG MED, V30, P785, DOI 10.1016/S0196-0644(97)70049-0; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coats TJ, 1999, J ACCID EMERG MED, V16, P182; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Davis DP, 2007, PREHOSP EMERG CARE, V11, P1, DOI 10.1080/10903120601021093; De Souza M, 2007, J TRAUMA, V63, P370, DOI 10.1097/TA.0b013e318124a95b; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hebb MO, 2007, CAN J SURG, V50, P187; HEDGES JR, 1982, J TRAUMA, V22, P989, DOI 10.1097/00005373-198212000-00003; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; JACOBS LM, 1984, J TRAUMA, V24, P8, DOI 10.1097/00005373-198401000-00002; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; Lind CRP, 2005, ANZ J SURG, V75, P858, DOI 10.1111/j.1445-2197.2005.03574.x; LOKKEBERG AR, 1984, J NEUROSURG, V61, P254, DOI 10.3171/jns.1984.61.2.0254; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McKhann GM, 1996, NEUROTRAUMA, P103; Meyer SH, 1996, PRACTICE NEUROSURGER, V2, P1443; Mitchell AD, 2007, CAN J SURG, V50, P129; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; *NAT TRAUM REG, 2008, CIHI ICIS; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; Offner PJ, 2006, AM J SURG, V192, P801, DOI 10.1016/j.amjsurg.2006.08.047; Pitts LH, 1998, J TRAUMA, V44, P989; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Sampalis JS, 1995, J TRAUMA, V39, P1029, DOI 10.1097/00005373-199512000-00002; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Tallon JM, 2006, J TRAUMA, V60, P548, DOI 10.1097/01.ta.0000209336.66283.ea; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; VALADKA AB, 1996, TRAUMA, P267; WALD SL, 1995, SURG CLIN N AM, V75, P225, DOI 10.1016/S0039-6109(16)46585-0; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Ward J D, 1991, Neurosurg Clin N Am, V2, P251; Wester T, 1999, J TRAUMA, V46, P914, DOI 10.1097/00005373-199905000-00023; *WHO, 2007, INT CLASS DIS ICD; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wu JJ, 1999, J TRAUMA, V47, P39, DOI 10.1097/00005373-199907000-00009; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; NOVA SCOTIA CANADA	56	36	37	0	4	CMA-CANADIAN MEDICAL ASSOC	OTTAWA	1867 ALTA VISTA DR, OTTAWA, ONTARIO K1G 5W8, CANADA	0008-428X	1488-2310		CAN J SURG	Can. J. Surg.	OCT	2008	51	5					339	345					7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	353CM	WOS:000259543700011	18841222				2022-02-06	
J	Chen, XR; Besson, VC; Beziaud, T; Plotkine, M; Marchand-Leroux, C				Chen, Xiao Ru; Besson, Valerie C.; Beziaud, Tiphaine; Plotkine, Michel; Marchand-Leroux, Catherine			Combination therapy with fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, and simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, on experimental traumatic brain injury	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							PPAR-ALPHA; COMBINED HYPERLIPIDEMIA; NEURONAL SURVIVAL; CEREBRAL EDEMA; ATORVASTATIN; STATINS; EXPRESSION; FIBRATE; RATS; CYCLOOXYGENASE-2	We and others have demonstrated that fibrates [peroxisome proliferator-activated receptor (PPAR)alpha agonists] and statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) exerted neuroprotective and pleiotropic effects in experimental models of traumatic brain injury (TBI). Because the combination of statins and fibrates synergistically enhanced PPAR alpha activation, we hypothesized that the combination of both drugs may exert more important and/or prolonged beneficial effects in TBI than each alone. In this study, we examined the combination of fenofibrate with simvastatin, administered 1 and 6 h after injury, on the consequences of TBI. First, our dose-effect study demonstrated that the most efficient dose of simvastatin (37.5 mg/kg) reduced post-traumatic neurological deficits and brain edema. Then, the effects of the combination of fenofibrate (50 mg/kg) and simvastatin (37.5 mg/kg), given p. o. at 1 and 6 h after TBI, were evaluated on the TBI consequences in the early and late phase after injury. The combination exerted more sustained neurological recovery-promoting and antiedematous effects than monotherapies, and it synergistically decreased the post-traumatic brain lesion. Furthermore, a delayed treatment given p. o. at 3 and 8 h after TBI with the combination was still efficient on neurological deficits induced by TBI, but it failed to reduce the brain edema at 48 h. The present data represent the first demonstration that the combination of fenofibrate and simvastatin exerts prolonged and synergistic neuroprotective effects than each drug alone. Thus, these results may have important therapeutic significance for the treatment of TBI.	[Chen, Xiao Ru; Besson, Valerie C.; Beziaud, Tiphaine; Plotkine, Michel; Marchand-Leroux, Catherine] Univ Paris 05, Fac Sci Pharmaceut & Biol, Equipe Rech Pharmacol Circulat Cerebrale EA 2510, F-75006 Paris, France		Besson, VC (corresponding author), Univ Paris 05, Pharmacol Lab, EA 2510, 4 Ave Observ, F-75006 Paris, France.	valerie.besson@univ-paris5.fr	besson, valerie C/L-7388-2017; MARCHAND-LEROUX, Catherine/L-7453-2017; BESSON, VALERIE/AAZ-9989-2020	besson, valerie C/0000-0002-1491-2380; MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; BESSON, VALERIE/0000-0002-1491-2380			Athyros VG, 2002, DIABETES CARE, V25, P1198, DOI 10.2337/diacare.25.7.1198; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Davidson MH, 2007, AM J CARDIOL, V99, p3C, DOI 10.1016/j.amjcard.2006.11.016; Fruchart JC, 1999, CURR OPIN LIPIDOL, V10, P245, DOI 10.1097/00041433-199906000-00007; GOLANOV EV, 1995, J CEREBR BLOOD F MET, V15, P172, DOI 10.1038/jcbfm.1995.19; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; Inoue I, 2000, LIFE SCI, V67, P863, DOI 10.1016/S0024-3205(00)00680-9; Inoue I, 2002, BIOCHEM BIOPH RES CO, V290, P131, DOI 10.1006/bbrc.2001.6141; Koh KK, 2005, J AM COLL CARDIOL, V45, P1649, DOI 10.1016/j.jacc.2005.02.052; Koh KK, 2004, INT J CARDIOL, V97, P239, DOI 10.1016/j.ijcard.2003.09.007; Koh KK, 2008, INT J CARDIOL, V124, P149, DOI 10.1016/j.ijcard.2007.04.080; Landrier JF, 2004, J BIOL CHEM, V279, P45512, DOI 10.1074/jbc.M407461200; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Millerot-Serrurot E, 2007, NEUROCHEM INT, V50, P328, DOI 10.1016/j.neuint.2006.08.016; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Musial J, 2001, INT J CARDIOL, V77, P247, DOI 10.1016/S0167-5273(00)00439-3; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Paumelle R, 2006, CIRC RES, V98, P361, DOI 10.1161/01.RES.0000202706.70992.95; Penn R, 2006, CLIN THER, V28, P45, DOI 10.1016/j.clinthera.2005.12.004; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Shabanzadeh AP, 2005, BRAIN RES, V1042, P1, DOI 10.1016/j.brainres.2005.01.105; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Stepien K, 2005, PHARMACOL REP, V57, P561; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vega GL, 2003, AM J CARDIOL, V91, P956, DOI 10.1016/S0002-9149(03)00111-5; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c; Zapolska-Downar D, 2004, LIFE SCI, V75, P1287, DOI 10.1016/j.lfs.2004.03.005	41	36	37	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	SEP	2008	326	3					966	974		10.1124/jpet.108.140368			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	338RB	WOS:000258524400033	18562561				2022-02-06	
J	Chiaretti, A; Antonelli, A; Genovese, O; Pezzotti, P; Di Rocco, C; Viola, L; Riccardi, R				Chiaretti, Antonio; Antonelli, Alessia; Genovese, Orazio; Pezzotti, Patrizio; Di Rocco, Concezio; Viola, Luigi; Riccardi, Riccardo			Nerve growth factor and doublecortin expression correlates with improved outcome in children with severe traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						doublecortin; nerve growth factor; neuroprotection; traumatic brain injury	NEURAL STEM-CELLS; NEURONAL DEATH; ADULT BRAIN; CEREBROSPINAL-FLUID; NEUROTROPHIC FACTOR; PROLIFERATION; DEFICITS; NEUROGENESIS; INCREASES; INFUSION	Background. In the adult brain, migrating neuroblasts can replace damaged neurons after severe traumatic brain injury (TBI). Little is known about which factors determine the magnitude and amplification of neurogenesis after TBI, but there are some evidences that the nerve growth factor (NGF) and the doublecortin (DCX) can influence neurogenesis and neuronal repair. Methods: This study investigates the NGF and DCX levels in the cerebrospinal fluid of 12 children with severe TBI and 12 matched controls, to determine the correlation between the expression of both these factors and the patients outcome. We collected cerebrospinal fluid samples 2 hours (Time T1) and 48 hours (Time T2) after brain injury. NGF levels were measured using a two-site immunoenzymatic assay, whereas the DCX expression by a Western blot analysis. Results: At time T1 and T2, children with the best outcomes had higher levels of NGF than children with poor outcomes. Evaluating the change of NGF levels from time T1 to time T2, we found that the NGF up-regulation in the early time after injury was significantly associated with good outcomes of patients. Concomitantly, the expression of DCX increased only in patients with NGF up-regulation from time T1 to time T2. In others patients and in controls the expression of DCX remained unchanged. Conclusion: Based on these results, we hypothesize that NGF and DCX contribute to the mechanisms of neuroprotection and neuronal connection reorganization after TBI, playing a key role in the outcome of these patients.	[Chiaretti, Antonio; Antonelli, Alessia; Genovese, Orazio; Viola, Luigi] Univ Cattolica Sacro Cuore, Sch Med, Pediatr Intens Care Unit, Policlin A Gemelli Largo Gemelli, I-00168 Rome, Italy; [Pezzotti, Patrizio] Univ Cattolica Sacro Cuore, Sch Med, Agcy Publ Hlth Lazio Reg, I-00168 Rome, Italy		Antonelli, A (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Pediatr Intens Care Unit, Policlin A Gemelli Largo Gemelli, I-00168 Rome, Italy.	antonelliales@yahoo.it		RICCARDI, RICCARDO/0000-0001-7515-6622; GENOVESE, Orazio/0000-0002-1989-1363			Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barde Y. A., 1994, PROG CLIN BIOL RES, V390, P1855; Calza L, 2003, P NATL ACAD SCI USA, V100, P7325, DOI 10.1073/pnas.1132092100; Chiaretti A, 2005, NEUROL RES, V27, P741, DOI 10.1179/016164105X35611; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Collin T, 2005, EXP NEUROL, V195, P71, DOI 10.1016/j.expneurol.2005.03.017; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Gu Q, 1995, REV NEUROSCIENCE, V6, P329; Gustafsson E, 2003, EUR J NEUROSCI, V17, P2667, DOI 10.1046/j.1460-9568.2003.02713.x; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; Karl C, 2005, J NEUROCHEM, V92, P264, DOI 10.1111/j.1471-4159.2004.02879.x; Krenz NR, 2000, J NEUROCHEM, V74, P730, DOI 10.1046/j.1471-4159.2000.740730.x; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; LONGO FM, 1984, EXP NEUROL, V84, P207, DOI 10.1016/0014-4886(84)90016-5; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; OLSON L, 1992, J NEURAL TRANSM-PARK, V4, P79, DOI 10.1007/BF02257624; Ong J, 2005, PEDIATR RES, V58, P600, DOI 10.1203/01.PDR.0000179381.86809.02; PATTERSON SL, 1993, BRAIN RES, V605, P43, DOI 10.1016/0006-8993(93)91354-U; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Wilde GJC, 2000, EUR J NEUROSCI, V12, P3863, DOI 10.1046/j.1460-9568.2000.00273.x; Zhou Zheng, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P217; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	30	36	37	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2008	65	1					80	85		10.1097/TA.0b013e31805f7036			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	327ZP	WOS:000257767300014	18580535				2022-02-06	
J	Sosnoff, JJ; Broglio, SP; Ferrara, MS				Sosnoff, Jacob J.; Broglio, Steven P.; Ferrara, Michael S.			Cognitive and motor function are associated following mild traumatic brain injury	EXPERIMENTAL BRAIN RESEARCH			English	Article						post-concussion; postural control; reaction time	COLLEGIATE FOOTBALL PLAYERS; POSTURAL STABILITY; CONCUSSION; ATTENTION; RECOVERY; DEFICITS; GAIT; SENSORIMOTOR; PERFORMANCE; SYMPTOMS	Mild traumatic brain injury (mTBI) causes deficits in motor and cognitive function. There is a dearth of research examining the association between these deficits. The purpose of this investigation was to examine the effect of mTBI on the association between cognitive and motor function. Thirty-six individuals completed a neurocognitive test battery and postural control assessment at baseline and were retested 24-h post mTBI. Reaction time and accuracy to various cognitive tasks was assessed. Postural control was indexed with the somatosenory organization test. This test allows for the decomposition of postural control resulting from the integration of visual, somatosensory and vestibular information. The association between cognitive and motor function was assessed with correlational analyses. Overall, it was found that mTBI resulted in increased simple and choice reaction time as well as deficits in verbal and visual memory. mTBI was also found to reduce overall postural control, especially when visual information was utilized. Prior to injury there was no association between cognitive and motor function-indicating minimal association between cognitive and motor function. After injury there were significant positive correlations between cognitive and motor function. The findings suggest that transient neural insults resulting from mTBI lead to increased cognitive-motor association. It is speculated that a shared neural process, such as visuospatial attention is damaged resulting in similar deficits in cognitive and motor function.	[Sosnoff, Jacob J.; Broglio, Steven P.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Sosnoff, Jacob J.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Ferrara, Michael S.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Sosnoff, JJ (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, 906 Goodwin Ave, Urbana, IL 61801 USA.	jsosnoff@uiuc.edu	Sosnoff, Jacob/P-3397-2019	Sosnoff, Jacob/0000-0002-0286-9207			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bowen A, 2001, AGE AGEING, V30, P319, DOI 10.1093/ageing/30.4.319; BROGLIO SP, 2007, J ATHL TRAINING, V42, P502; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; ERLANGER DM, 2002, HEADMINDER CONCUSSIO; Finkelstein E., 2006, INCIDENCE EC BURDEN; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Holtzer R, 2006, NEUROPSYCHOLOGY, V20, P215, DOI 10.1037/0894-4105.20.2.215; Holtzer R, 2007, NEUROPSYCHOLOGY, V21, P540, DOI 10.1037/0894-4105.21.5.540; Kahneman D., 1973, ATTENTION EFFORT; Kelly JP, 1997, NEUROLOGY, V48, P581; KERR B, 1985, J EXP PSYCHOL HUMAN, V11, P617, DOI 10.1037/0096-1523.11.5.617; Konczak J, 2007, NEUROSCI BIOBEHAV R, V31, P1101, DOI 10.1016/j.neubiorev.2007.04.014; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li SC, 2001, GERONTOLOGY, V47, P100, DOI 10.1159/000052782; LOVELL MR, 2005, IMPACT 2005 4 0 CLIN; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Nashner L.M., 1997, HDB BALANCE FUNCTION, P280; Nesselroade JR, 2004, J GERONTOL B-PSYCHOL, V59, pP49, DOI 10.1093/geronb/59.2.P49; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Pugh KG, 2002, NEUROBIOL AGING, V23, P421, DOI 10.1016/S0197-4580(01)00319-0; Rosenbaum DA, 2005, AM PSYCHOL, V60, P308, DOI 10.1037/0003-066X.60.4.308; Serrien DJ, 2007, PROG NEUROBIOL, V82, P95, DOI 10.1016/j.pneurobio.2007.02.003; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; van Donkelaar P, 2006, EXERC SPORT SCI REV, V34, P77, DOI 10.1249/00003677-200604000-00007; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	49	36	36	0	18	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	JUN	2008	187	4					563	571		10.1007/s00221-008-1324-x			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	304BM	WOS:000256085000006	18301883				2022-02-06	
J	Mayer, NH; Whyte, J; Wannstedt, G; Ellis, CA				Mayer, Nathaniel H.; Whyte, John; Wannstedt, Gunillia; Ellis, Colin A.			Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						botulinum toxins; brain injuries; injections; muscle hypertonia; rehabilitation	UPPER-LIMB SPASTICITY; DOUBLE-BLIND; HEMIPLEGIC PATIENTS; MUSCLE SPASTICITY; ASHWORTH SCALE; MOTOR CONTROL; BRAIN-INJURY; STROKE; EFFICACY; TRIAL	Objective: To compare 2 techniques of botulinum toxin injection for elbow flexor hypertonia. Design: Parallel-group, randomized, controlled trial with blinded outcome assessment. Setting: Laboratory, tertiary rehabilitation hospital. Participants: Adults (N=31) with acquired brain injury (21 with traumatic brain injury, 8 with stroke, 2 with hypoxic encephalopathy) provided 36 sets of elbow flexors with Ash-worth Scale scores equal to 3. Intervention: Botulinum toxin type A (BTX-A) was injected with a motor point or a multisite injection technique after obtaining 2 baseline evaluations of the main outcome measures. Motor point technique involved decremental electric stimulation with delivery of 60U of BTX-A (Botox) in 2.4mL or 30U BTX-A in 1.2mL of preservative-free saline at single biceps and brachioradialis motor points, respectively. Distributed injection was performed using, electromyographic feedback. Fifteen units in 0.6mL were delivered to each of 4 biceps sites and 2 brachioradialis sites. Total dose (90U) and total injection volume (3.6mL) were identical across groups. Only sites and injection techniques varied. The brachialis was not injected in either group. Main Outcome Measures: Ashworth Scale, Tardieu Catch angle, and root mean square surface electromyographic activity of the biceps, brachialis, and brachioradialis. Results: Postintervention testing at 3 weeks showed no significant differences between groups (P range, 3 1-82 across 3 outcome measures). However, within each group, significant treatment effects were observed on all outcome measures (all P <.01). For the uninjected brachialis muscle, electromyographic reduction was greater for the distributed group. Conclusions: In 31 adults with acquired brain injury, single motor point and multisite distributed injections of low-dose. high-volume BTX-A had similar impact. Findings suggest that low-dose, high-volume strategies may have a potential role in reducing drug cost and helping clinicians stay within accepted limits for total body dose in patients With upper motoneuron syndrome requiring many injections.	[Mayer, Nathaniel H.] Temple Univ, Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19122 USA; [Mayer, Nathaniel H.; Whyte, John; Ellis, Colin A.] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Philadelphia, PA USA; [Whyte, John] Thomas Jefferson Univ, Dept Rehabil Med, Philadelphia, PA 19107 USA; [Mayer, Nathaniel H.; Wannstedt, Gunillia] MossRehab, Motor Control Anal Lab, Elkins Pk, PA 19027 USA		Mayer, NH (corresponding author), MossRehab, Motor Control Anal Lab, 60 E Township Line Rd, Elkins Pk, PA 19027 USA.	nmayer@einstein.edu		Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research [H133AO20505]	Supported in part by the National Institute on Disability and Rehabilitation Research (grant no. H133AO20505) and an educational grant front Allergan Inc.	Abbruzzese G, 2006, NEUROTOX RES, V9, P109, DOI 10.1007/BF03033927; AQUILONIUS SM, 1984, MUSCLE NERVE, V7, P287, DOI 10.1002/mus.880070406; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Bakheit AMO, 2003, J NEUROL NEUROSUR PS, V74, P646, DOI 10.1136/jnnp.74.5.646; Bakheit AMO, 2001, EUR J NEUROL, V8, P559, DOI 10.1046/j.1468-1331.2001.00277.x; Banks RW, 2006, J ANAT, V208, P753, DOI 10.1111/j.1469-7580.2006.00558.x; Bergfeldt U, 2006, J REHABIL MED, V38, P166, DOI 10.1080/16501970500415348; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BORODIC GE, 1990, HEAD NECK-J SCI SPEC, V12, P392, DOI 10.1002/hed.2880120504; Boyd RN, 1999, EUR J NEUROL, V6, pS23, DOI 10.1111/j.1468-1331.1999.tb00031.x; BOYD RN, 1998, DEV MED CHILD NEUROL, V40, P7; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; Brin M F, 1997, Muscle Nerve Suppl, V6, pS208; Childers MK, 1996, AM J PHYS MED REHAB, V75, P462, DOI 10.1097/00002060-199611000-00013; Childers MK, 2004, ARCH PHYS MED REHAB, V85, P1063, DOI 10.1016/j.apmr.2003.10.015; Childers MK, 1998, MUSCLE NERVE, V21, P653, DOI 10.1002/(SICI)1097-4598(199805)21:5<653::AID-MUS15>3.0.CO;2-W; COERS C, 1959, Am J Phys Med, V38, P166; Coers C., 1959, INNERVATION MUSCLE B; De Luca C.J., 2002, SURFACE ELECTROMYOGR; Deshpande S, 2006, NEUROTOX RES, V9, P115, DOI 10.1007/BF03033928; Francisco GE, 2002, AM J PHYS MED REHAB, V81, P355, DOI 10.1097/00002060-200205000-00007; Gracies JM, 2002, ANN NEUROL, V52, pS87; Gracies JM, 2001, NEUROLOGY, V56, pA3; Gracies JM, 2000, ARCH PHYS MED REHAB, V81, P1547, DOI 10.1053/apmr.2000.16346; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; Kokkorogiannis T, 2004, J THEOR BIOL, V229, P263, DOI 10.1016/j.jtbi.2004.03.019; LESLIE GC, 1992, CLIN REHABIL, V0006, P00041, DOI DOI 10.1177/026921559200600106; LEVIN MF, 1994, BRAIN RES, V657, P23, DOI 10.1016/0006-8993(94)90949-0; Levin MF, 2000, BRAIN RES, V853, P352, DOI 10.1016/S0006-8993(99)02298-2; Mayer NH, 2004, J HEAD TRAUMA REHAB, V19, P119, DOI 10.1097/00001199-200403000-00005; Mayer NH, 2002, SPASTICITY ETIOLOGY, P154; Pandyan AD, 2002, CLIN REHABIL, V16, P654, DOI 10.1191/0269215502cr536oa; Rousseaux M, 2002, J NEUROL, V249, P76, DOI 10.1007/PL00007851; Sanger TD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e89; SHAARI CM, 1991, LARYNGOSCOPE, V101, P960; SHAARI CM, 1993, MUSCLE NERVE, V16, P964, DOI 10.1002/mus.880160913; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; Smith SJ, 2000, CLIN REHABIL, V14, P5, DOI 10.1191/026921500666642221; Warfel J.H., 1985, EXTREMITIES MUSCLES, V5th; [No title captured]	40	36	36	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2008	89	5					982	987		10.1016/j.apmr.2007.10.022			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	341ST	WOS:000258735900026	18452749				2022-02-06	
J	Merenda, A; Gugliotta, M; Holloway, R; Levasseur, JE; Alessandri, B; Sun, D; Bullock, MR				Merenda, Amedeo; Gugliotta, Marinella; Holloway, Rebecca; Levasseur, Joseph E.; Alessandri, Beht; Sun, Dong; Bullock, M. Ross			Validation of brain extracellular glycerol as an indicator of cellular membrane damage due to free radical activity after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; axonal injury; head trauma; metabolism; microdialysis	SEVERE HEAD-INJURY; CEREBRAL-ARTERY OCCLUSION; NERVOUS-SYSTEM TRAUMA; LIPID-PEROXIDATION; INTERSTITIAL GLYCEROL; RAT-BRAIN; PHOSPHOLIPID DEGRADATION; SALICYLATE HYDROXYLATION; SUBDURAL-HEMATOMA; HYPERBARIC-OXYGEN	Following severe traumatic brain injury (TBI), increasing oxygen delivery to the brain has been advocated as a useful strategy to reverse mitochondrial dysfunction and improve neurological outcome. However, this might also promote overproduction of free radicals, responsible for lipid peroxidation and hence brain cell damage. Therefore, a method for monitoring this potential adverse effect in humans is desirable. Glycerol, an end product of phospholipid breakdown, easily detectable in the human brain by means of microdialysis, might represent a reliable indicator of free radical induced cell membrane damage. Brain microdialysates were collected from 24 adult male Sprague-Dawley rats over a 3-hour period following sham operation (n = 6), chemical brain injury via administration of Fenton's reagent (n = 6), a powerful hydroxyl radical generator, and lateral fluid percussion injury (FPI; n = 12). In the FPI animals, post-traumatic i.v. administration of either normal saline or the free radical scavenger Tempol (10 mg/kg, followed by an infusion of 30 mg/kg/h over 3 h) was carried out to evaluate the effect of blockade of free radical generation. Samples were analyzed for the presence of glycerol and the marker of hydroxyl radical (OH center dot) by generation of 2,3-DHBA (dihydroxybenzoic acid). Brain tissue staining with TTC (2,3,5-triphenyltetrazoium chloride) was performed for lesion size assessment. Rats subjected to either Fenton's reagent administration or FPI exhibited significantly higher levels of glycerol as compared with shams (p = 0.05). However, when the FPI was followed by Tempol administration, concentration of both glycerol and 2,3-DHBA decreased significantly (p = 0.05). Furthermore, TCC staining revealed a significant reduction of secondary brain tissue damage in Tempol-treated animals (p = 0.05). Our data suggest that injury-induced increases in microdialysate glycerol levels are a valid indicator of free radical activity, and their amelioration following Tempol treatment accords with less histological damage in response to FPI.	[Merenda, Amedeo; Holloway, Rebecca; Levasseur, Joseph E.; Sun, Dong; Bullock, M. Ross] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Merenda, Amedeo] Univ Messina, Dept Neurosurg, Messina, Italy; [Gugliotta, Marinella] Kantonsspital, Dept Neurosurg, Aarau, Switzerland; [Alessandri, Beht] Johannes Gutenberg Univ Mainz, Dept Neurosurg, Inst Neurosurg Pathophysiol, Mainz, Germany		Bullock, MR (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Room 3-20,1095 NW 14th Terrace, Miami, FL 33136 USA.	rbullock@med.miami.edu		MERENDA, AMEDEO/0000-0002-9270-7470	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587] Funding Source: Medline		Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BERTRAND N, 1992, NEUROSCI LETT, V148, P81, DOI 10.1016/0304-3940(92)90809-L; Bonini MG, 2002, CHEM RES TOXICOL, V15, P506, DOI 10.1021/tx015571z; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Bremer YA, 2005, PEDIATR RES, V57, P22, DOI 10.1203/01.PDR.0000147736.27672.15; Carroll RT, 2000, CHEM RES TOXICOL, V13, P294, DOI 10.1021/tx990159t; Chatterjee PK, 2000, KIDNEY INT, V58, P658, DOI 10.1046/j.1523-1755.2000.00212.x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Daugherty WP, 2004, NEUROSURGERY, V54, P1223, DOI 10.1227/01.NEU.0000119238.68938.5D; Dhillon HS, 1999, NEUROCHEM RES, V24, P751, DOI 10.1023/A:1020779413122; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doppenberg EMR, 1998, J NEUROTRAUM, V15, P337, DOI 10.1089/neu.1998.15.337; DUCKROW RB, 1981, J NEUROSURG, V54, P607, DOI 10.3171/jns.1981.54.5.0607; Elayan IM, 2000, J NEUROPHYSIOL, V83, P2022, DOI 10.1152/jn.2000.83.4.2022; FLOYD RA, 1984, J BIOCHEM BIOPH METH, V10, P221, DOI 10.1016/0165-022X(84)90042-3; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; GELVAN D, 1991, P NATL ACAD SCI USA, V88, P4680, DOI 10.1073/pnas.88.11.4680; GERCKEN G, 1973, PFLUG ARCH EUR J PHY, V344, P207, DOI 10.1007/BF00588461; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GRAHAM DI, 1985, BRIT J ANAESTH, V57, P3, DOI 10.1093/bja/57.1.3; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALLIWELL B, 1991, FREE RADICAL BIO MED, V10, P439, DOI 10.1016/0891-5849(91)90052-5; HALLIWELL B, 1985, TRENDS NEUROSCI, V8, P22, DOI 10.1016/0166-2236(85)90010-4; Halliwell B, 1981, AGE PIGMENTS, P1; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hutchinson PJA, 2000, ZBL NEUROCHIR, V61, P88, DOI 10.1055/s-2000-8265; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Kwon TH, 2003, J NEUROTRAUM, V20, P337, DOI 10.1089/089771503765172291; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; LEWEN A, 1996, J NEUROTRAUM, V13, P600; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; MINK RB, 1995, CRIT CARE MED, V23, P1398, DOI 10.1097/00003246-199508000-00014; Morimoto T, 1996, J CEREBR BLOOD F MET, V16, P92, DOI 10.1097/00004647-199601000-00011; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; Nishio S, 1997, ACT NEUR S, V70, P84; OLIVER CN, 1990, J NEUROSCI, V10, P1035; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Rak R, 2000, J NEUROSURG, V92, P646, DOI 10.3171/jns.2000.92.4.0646; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; WILSON JT, 1995, J TRAUMA, V39, P473; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	47	36	37	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2008	25	5					527	537		10.1089/neu.2007.0359			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	303PY	WOS:000256054100009	18363507				2022-02-06	
J	Thornton, AE; Cox, DN; Whitfield, K; Fouladi, RT				Thornton, Allen E.; Cox, David N.; Whitfield, Kevin; Fouladi, Rachel T.			Cumulative concussion exposure in rugby players: Neurocognitive and symptomatic outcomes	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; COLLEGIATE FOOTBALL PLAYERS; RECURRENT CONCUSSION; WORKING MEMORY; RECOVERY; EXPECTATION; IMPAIRMENT	A total of 111 rugby players underwent comprehensive testing to determine the impact of self-reported concussion exposure. Reliable estimates of concussion exposure were associated with an increase in postconcussion symptoms (PCS), but not diminished neurocognitive functioning. Importantly, the effects of concussion exposure on PCS varied as a function of player status. More specifically, extent of concussion exposure was associated with increased memory complaints and overall PCS endorsements in a dose-dependent manner for retired and older recreational players, but not for those who were younger and playing at more competitive levels. Future work should systematically evaluate the constituent participant factors that may influence differential concussion outcomes.	[Thornton, Allen E.; Cox, David N.; Whitfield, Kevin; Fouladi, Rachel T.] Simon Fraser Univ, Dept Psychol, Human Neuropsychol Lab, Burnaby, BC V5A 1S6, Canada		Thornton, AE (corresponding author), Simon Fraser Univ, Dept Psychol, Human Neuropsychol Lab, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	aethornt@sfu.ca		Thornton, Allen/0000-0002-9942-0122			Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; CATTELL RB, 1973, HDB INDIVIDUAL GROUP; Chan RCK, 2005, BRAIN INJURY, V19, P1117, DOI 10.1080/026990500150088; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Ekstrom RB., 1976, MANUAL KIT FACTOR RE; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GRONWALL D, 1975, LANCET, V2, P995; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heaton R.K., 1981, WISCONSIN CARD SORTI; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kelly JP, 1997, NEUROLOGY, V48, P581; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Ponsford J, 2005, CURR OPIN NEUROL, V18, P692, DOI 10.1097/01.wco.0000186840.61431.44; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; SALTHOUSE TA, 1989, J EXP PSYCHOL LEARN, V15, P507, DOI 10.1037/0278-7393.15.3.507; Schmidt M., 1996, REY AUDITORY VERBAL; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; THORNTON A, 2002, J INT NEUROPSYCH SOC, V8, P172; War Department Adjutant General's Office, 1994, ARM IND TEST BATT MA; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	44	36	38	0	23	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY	2008	30	4					398	409		10.1080/13803390701443662			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	303FM	WOS:000256026400002	18938678				2022-02-06	
J	Currier, BL; Maus, TP; Eck, JC; Larson, DR; Yaszemski, MJ				Currier, Bradford L.; Maus, Tim P.; Eck, Jason C.; Larson, Dirk R.; Yaszemski, Michael J.			Relationship of the internal carotid artery to the anterior aspect of the C1 vertebra	SPINE			English	Article						internal carotid artery; atlas; C1 lateral mass screw; C1-C2 transarticular screw	TRANSARTICULAR SCREW FIXATION; COMPUTED-TOMOGRAPHY; ACCURACY; INJURY; FUSION	Study Design. Anatomic study of the internal carotid artery ( ICA) location with respect to C1 based on computed tomography ( CT) scans with contrast medium. Objective. To measure the location of the ICA relative to the anterior aspect of C1 to assess the risk of placing C1 - C2 transarticular or C1 lateral mass screws. Summary of Background Data. Vertebral artery injury is a known risk from placement of screws in C1. A previous case report revealed an ideally placed C1 - C2 transarticular screw abutting and narrowing the ICA. The risk of ICA injury from C1 screws is unknown. Methods. Fifty random head and neck CT scans with contrast medium were retrospectively analyzed. Measurements were taken bilaterally including the closest distance from the ICA lumen to C1 and the distance from the medial edge of the ICA to a line drawn along the medial border of the foramen transversarium. The risk of inserting bicortical C1 - C2 transarticular and C1 lateral mass screws was estimated based on these measurements. Results. The mean distance from the ICA to C1 was 2.88 mm on the left and 2.89 mm on the right. The ICA lumen was medial to the foramen transversarium in 42 ( 84%) of 50 cases ( mean: 2.78 mm on the left and 3.00 mm on the right). The proximity of the ICA to C1 posed moderate risk in 46% of cases and high risk in 12% ( on at least one side). Conclusion. Because of the risk of ICA injury from a drill bit or the tip of a bicortical screw, we recommend preoperative CT scan with contrast medium in all cases in which a screw is to be placed into C1. If the ICA is in close proximity to the anterior border of C1, unicortical fixation or a different fusion technique should be considered.	[Currier, Bradford L.; Eck, Jason C.; Yaszemski, Michael J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Maus, Tim P.] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA; [Larson, Dirk R.] Mayo Clin, Dept Biostat, Rochester, MN 55905 USA		Currier, BL (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 1st St SW, Rochester, MN 55905 USA.	currier.bradford@mayo.edu					Aota Y, 2006, J NEUROSURG-SPINE, V5, P554, DOI 10.3171/spi.2006.5.6.554; Bloch O, 2001, J NEUROSURG, V95, P74, DOI 10.3171/spi.2001.95.1.0074; Currier BL, 2003, SPINE, V28, pE461, DOI 10.1097/01.BRS.0000092385.19307.9E; CURRIER BL, 2004, CURR OPIN ORTHOP, V15, P184; CYR SJ, 2007, SPINE J; Ebraheim NA, 2000, SURG NEUROL, V53, P208, DOI 10.1016/S0090-3019(00)00160-9; Eck JC, 2007, J SPINAL DISORD TECH, V20, P505, DOI 10.1097/BSD.0b013e318031af8b; Gebhard JS, 1998, SPINE, V23, P2185, DOI 10.1097/00007632-199810150-00008; GOEL A, 1994, ACTA NEUROCHIR, V129, P47, DOI 10.1007/BF01400872; GROB D, 1991, J BONE JOINT SURG BR, V73, P972, DOI 10.1302/0301-620X.73B6.1955447; Harms J, 2001, SPINE, V26, P2467, DOI 10.1097/00007632-200111150-00014; Heller JG, 1996, J BONE JOINT SURG AM, V78A, P1315, DOI 10.2106/00004623-199609000-00004; Kelleher MO, 2006, INT J MED ROBOT COMP, V2, P154, DOI 10.1002/rcs.92; Lambert CC, 2007, BIOMED SCI INSTRUM, V43, P330; Madawi AA, 1997, J NEUROSURG, V86, P961, DOI 10.3171/jns.1997.86.6.0961; Magerl F, 1987, CERVICAL SPINE, P322; Nogueira-Barbosa MH, 2005, EUR SPINE J, V14, P493, DOI 10.1007/s00586-004-0838-6; Paramore CG, 1996, J NEUROSURG, V85, P221, DOI 10.3171/jns.1996.85.2.0221; Reilly TM, 2003, J SPINAL DISORD TECH, V16, P248, DOI 10.1097/00024720-200306000-00004; Weidner A, 2000, SPINE, V25, P2668, DOI 10.1097/00007632-200010150-00020; Wright NM, 1998, J NEUROSURG, V88, P634, DOI 10.3171/jns.1998.88.4.0634; Yamazaki M, 2005, SPINE, V30, P2452, DOI 10.1097/01.brs.0000184306.19870.a8	22	36	42	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0362-2436			SPINE	SPINE	MAR 15	2008	33	6					635	639		10.1097/BRS.0b013e318166e083			5	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	283QP	WOS:000254651900010	18344857				2022-02-06	
J	Byrne, RW; Bagan, BT; Slavin, KV; Curry, D; Koski, TR; Origitano, TC				Byrne, Richard W.; Bagan, Bradley T.; Slavin, Konstantin V.; Curry, Daniel; Koski, Tyler R.; Origitano, Thomas C.			Neurosurgical emergency transfers to academic centers in Cook County: A prospective multicenter study	NEUROSURGERY			English	Article						Cook County; Emergency Medical Treatment and Active Labor Act; emergency room coverage; neurosurgical transfers	TRAUMATIC BRAIN-INJURY; ACUTE-CARE SURGERY; SYSTEM; TRANSPORT; MORTALITY	OBJECTIVE: The absence of surgical subspecialty emergency care in the United States is a growing public health concern. Neurosurgery is a field lacking coverage ill many areas of the country; however, this is generally thought to be of greater concern in rural areas. Because of decreasing numbers of neurosurgeons, medical malpractice, and liability concerns, neurosurgery coverage is becoming a public health crisis in urban areas. Our objective was to quantify neurosurgical emergency transfers to academic medical centers in Cook County, IL, including patient demographics, reasons for transfer, time lapse in transfer, and effects on patient condition. METHODS: Data on neurosurgery emergency transfers was gathered prospectively by all five of the academic neurosurgery departments in Cook County, IL, over a 2-month period. Patient demographics devoid of identifiers, diagnosis, transfer origin, time lapse of transfer, and patient condition at the time of transfer and at the receiving hospital were recorded. RESULTS: Two-hundred thirty emergent neurosurgical transfers occurred during the study period. The most common diagnoses were parenchymal intracerebral hemorrhage (33%) and subarachnoid hemorrhage (28%). Sixty-six percent of neurosurgical transfers to academic medical facilities originated at hospitals without full-time neurosurgery coverage. The mean time to transfer for all patients was 5 hours 10 minutes (standard deviation, 3 h 42 min; range, 1-20 h 12 min). A decline in Glasgow Coma Scale score was seen in 29 patients. A shortage of neurosurgical intensive care unit beds occurred on 55% of the days in the study. Only 19% of the emergency cases were related to cranial trauma, and only 3% of transfers came from Level 1 trauma centers. CONCLUSION: A combination of factors has led to decreases in availability of neurosurgical coverage in Cook County community hospital emergency departments. This has placed an increased burden on neurosurgical departments at academic centers, and, in some cases, delays led to a decline in patient condition. Eighty-one percent of the cases were not related to cranial trauma; thus, acute care trauma surgeons would be of little use. Coordinated efforts among local governments, medical centers, and emergency medical services to regionalize subspecialty services will be necessary to manage this problem.	[Byrne, Richard W.; Bagan, Bradley T.] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA; [Curry, Daniel] Univ Illinois, Dept Surg, Div Neurosurg, Chicago, IL 60680 USA; [Koski, Tyler R.] Northwestern Univ, Dept Neurosurg, Chicago, IL 60611 USA; [Origitano, Thomas C.] Loyola Univ, Dept Neurosurg, Chicago, IL 60611 USA		Byrne, RW (corresponding author), Rush Univ, Med Ctr, Dept Neurosurg, 1725 W Harrison,Suite 1115, Chicago, IL 60612 USA.	rbyrne37@aol.com	Slavin, Konstantin/H-3269-2019; Byrne, Richard/Q-9644-2019	Slavin, Konstantin/0000-0002-7946-8639; 			*AM ASS NEUR SURG, 2001, EM ROOM COV WHAT EV; *AM COLL EM PHYS, 2004, ON CALL SPEC COV US; *AM MED ASS, 2006, PHYS CHAR DISTR US 2; ANSELL DA, 1987, JAMA-J AM MED ASSOC, V257, P1500, DOI 10.1001/jama.257.11.1500; BYRNE R, 2004, AANS B, V13, P14; Dunn LT, 1997, INJURY, V28, P427, DOI 10.1016/S0020-1383(97)00051-X; ELJAMEL MS, 1992, BRIT J NEUROSURG, V6, P559, DOI 10.3109/02688699209002373; *GEN ACC OFF, 2003, GAO03836; GENTLEMAN D, 1992, INJURY, V23, P471, DOI 10.1016/0020-1383(92)90066-2; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Holmen CD, 2002, J TRAUMA, V53, P345, DOI 10.1097/00005373-200208000-00026; *I MED, 2006, FUT EM CAR KEY FIND; Lind CRP, 2005, ANZ J SURG, V75, P858, DOI 10.1111/j.1445-2197.2005.03574.x; Moore EE, 2006, J AM COLL SURGEONS, V202, P698, DOI 10.1016/j.jamcollsurg.2005.12.007; SCHIFF RL, 1986, NEW ENGL J MED, V314, P552, DOI 10.1056/NEJM198602273140905; SEAVER M, 2006, AANS B, V15, P8; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sklar D, 2002, ANN EMERG MED, V39, P456, DOI 10.1067/mem.2002.122782; VALADKA AB, 2004, AM ASS NEUROLOGICAL, V13, P6; Valadka AB, 2007, SURGERY, V141, P321, DOI 10.1016/j.surg.2007.01.009; Valadka AB, 2006, J AM COLL SURGEONS, V203, P962, DOI 10.1016/j.jamcollsurg.2006.08.014; Williams JM, 2001, ANN EMERG MED, V38, P323, DOI 10.1067/mem.2001.115217; Wyatt SM, 1997, ACAD MED, V72, P922	24	36	36	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAR	2008	62	3					709	715		10.1227/01.neu.0000317320.79106.7e			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	292LV	WOS:000255268500037	18425017				2022-02-06	
J	Morris, LGT; Ziff, DJS; DeLacure, MD				Morris, Luc G. T.; Ziff, David J. S.; DeLacure, Mark D.			Malpractice litigation after surgical injury of the spinal accessory nerve - An evidence-based analysis	ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY			English	Article							CLOSED CLAIMS ANALYSIS; MEDICAL-MALPRACTICE; MEDICOLEGAL ANALYSIS; INFORMED CONSENT; NECK DISSECTIONS; ADVERSE EVENTS; SURGERY; MANAGEMENT; PAYMENTS; ERRORS	Objective: To review the background, case characteristics, and outcomes of malpractice litigation resulting from surgical injury of the spinal accessory nerve. Design: Retrospective review of indemnity insurance cases (part 1) and court trials (part 2) between January 1, 1985, and January 1, 2007. In part 1, records of the Medical Liability Mutual Insurance Company identified 41 lawsuits in New York State; part 2 was a review of a national legal database (WestLaw) that identified 81 court trials. Case details were analyzed, and awards were adjusted for inflation. Results: For part 1, of 41 indemnity insurance cases, 39 (95%) involved a posterior triangle lymph node biopsy. Defendants were mainly general surgeons and otolaryngologists. Most lawsuits against surgeons (22 of 34 [65%]) were settled before trial, and only 4 of 34 (12%) were discontinued. Of these 34 cases, 28 (82%) ultimately compensated the plaintiff. The mean inflation-adjusted pretrial settlement was $264 395, and the mean settlement at trial was $443 538. Cases reaching trial received significantly higher settlements (P=.01). For part 2, 81 cases of alleged surgical injury to the spinal accessory nerve were identified. Defendant physicians were mainly general surgeons and otolaryngologists. Most operations were cervical lymph node biopsies (55 [68%]), followed by sebaceous cyst excisions (6 [7%]), neck dissections (4 [5%]), and other procedures (12 [15%]). Morbidity included weakness (81 patients [100%]), pain (30 patients [37%]), inability to work (20 patients [25%]), need for a nerve repair procedure (16 patients [20%]), deformity (9 patients [11%]), and numbness (4 patients [5%]). Types of malpractice alleged included negligent surgical technique (79 cases [98%]), lack of informed consent (17 cases [21%]), and failure to diagnose the injury (16 cases [20%]). Thirty-seven cases (46%) were decided for the defendant, 32 (40%) were decided for the plaintiff, and 12 (15%) were settled (percentages do not total 100 because of rounding). The mean inflation-adjusted settlement was $356 132, and the mean jury award was $515968. Jury awards were significantly higher than settlements (P=.003). Conclusions: Unintended injury to the spinal accessory nerve after head and neck surgery is a significant source of malpractice litigation. Timely diagnosis and treatment of this complication are essential. Regardless of whether the medical community considers careful surgical technique and nerve preservation to be the standard of care, the legal system clearly treats it as such, awarding compensation in 82% of cases. Strategies for optimal surgical care and litigation risk reduction are discussed.	[Morris, Luc G. T.; DeLacure, Mark D.] NYU, Sch Med, Head & Neck Surg Serv,Dept Otolaryngol, New York Univ Canc Inst, New York, NY 10016 USA; [Ziff, David J. S.] US Court Appeals Second Circuit, New York, NY USA		Morris, LGT (corresponding author), NYU, Sch Med, Head & Neck Surg Serv,Dept Otolaryngol, New York Univ Canc Inst, 550 1st Ave,NBV 5E5, New York, NY 10016 USA.	luc.morris@med.nyu.edu					BAKER T, 2005, MED MALPRACTICE MYTH; Bhananker SM, 2006, ANESTHESIOLOGY, V104, P228, DOI 10.1097/00000542-200602000-00005; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; BROWN H, 1988, ANN SURG, V208, P654, DOI 10.1097/00000658-198811000-00019; Cappiello J, 2005, LARYNGOSCOPE, V115, P259, DOI 10.1097/01.mlg.0000154729.31281.da; Chandawarkar RY, 2003, PLAST RECONSTR SURG, V111, P611, DOI 10.1097/01.PRS.0000041943.47622.EB; Cheney FW, 2006, ANESTHESIOLOGY, V105, P1081, DOI 10.1097/00000542-200612000-00007; DONNER TR, 1993, NEUROSURGERY, V32, P907, DOI 10.1227/00006123-199306000-00004; FRANZ SI, 1907, ARCH PSYCHOL, V2, P1; Hekkenberg RJ, 1997, J OTOLARYNGOL, V26, P155; HUTSON MM, 1991, J BONE JOINT SURG AM, V73A, P160, DOI 10.2106/00004623-199173020-00002; KERN KA, 1994, AM J SURG, V168, P217, DOI 10.1016/S0002-9610(05)80189-8; KING RJ, 1983, ANN ROY COLL SURG, V65, P35; Koybasioglu A, 2000, LARYNGOSCOPE, V110, P73; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; Lydiatt DD, 2003, ARCH OTOLARYNGOL, V129, P50, DOI 10.1001/archotol.129.1.50; Lydiatt DD, 2003, HEAD NECK-J SCI SPEC, V25, P429, DOI 10.1002/hed.10254; Lynn-Macrae AG, 2004, LARYNGOSCOPE, V114, P1492, DOI 10.1097/00005537-200408000-00032; Nason RW, 2000, AM J SURG, V180, P241, DOI 10.1016/S0002-9610(00)00449-9; OSGAARD O, 1987, ACTA CHIR SCAND, V153, P171; Peterson GN, 2005, ANESTHESIOLOGY, V103, P33, DOI 10.1097/00000542-200507000-00009; Rogers SO, 2006, SURGERY, V140, P25, DOI 10.1016/j.surg.2006.01.008; SLOAN FA, 1990, LAW SOC REV, V24, P997, DOI 10.2307/3053617; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; TARAGIN MI, 1992, ANN INTERN MED, V117, P780, DOI 10.7326/0003-4819-117-9-780; VALTONEN J, 1974, ACTA CHIR SCAND, V140, P453; WRIGHT TA, 1975, CLIN ORTHOP RELAT R, P15	27	36	36	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0886-4470			ARCH OTOLARYNGOL	Arch. Otolaryngol. Head Neck Surg.	JAN	2008	134	1					102	107		10.1001/archotol.134.1.102			6	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	250PU	WOS:000252313300018	18209145				2022-02-06	
J	Singh, R; Mcdonald, C; Dawson, K; Lewis, S; Pringle, AM; Smith, S; Pentland, B				Singh, Rajiv; Mcdonald, Clare; Dawson, Kirstin; Lewis, Sarah; Pringle, Anne-Marie; Smith, Stephen; Pentland, Brian			Zolpidem in a minimally conscious state	BRAIN INJURY			English	Article						minimally conscious state; zolpidem	SEMI-COMATOSE STATE; TRANSIENT IMPROVEMENT; VEGETATIVE STATE; BRAIN-INJURY; AROUSAL	Background: Case reports of the use of zolpidem in Permanent Vegetative States (PVS) have led to interest by the media and court judgements defining treatment with such drugs. It is uncertain whether this paradoxical effect of zolpidem in raising consciousness may be evident in other low awareness states such as Minimally Conscious State (MCS). Case study: This study treated a 44 year old male with MCS some 4 years after his traumatic brain injury with zolpidem for 1 week on and 1 week off treatment. Assessment with a number of tests by blinded therapists showed that his scores were no better on zolpidem and in some cases were worse on treatment. Conclusions: Ideally a series of individuals is required to assess the effect of zolpidem, but in the light of positive spin stories in the media, negative case reports should also be highlighted. It is imperative that medical treatment in all instances and certainly in low awareness states and end of life decisions is always based on firm evidence.	[Singh, Rajiv; Mcdonald, Clare; Dawson, Kirstin; Lewis, Sarah; Pringle, Anne-Marie; Smith, Stephen; Pentland, Brian] Astley Ainslie Hosp, Dept Rehabil Med, Edinburgh EH9 2HL, Midlothian, Scotland		Singh, R (corresponding author), Astley Ainslie Hosp, Dept Rehabil Med, 133 Grange Loan, Edinburgh EH9 2HL, Midlothian, Scotland.	rajiv.singh@lpct.scot.nhs.uk		singh, rajiv/0000-0002-3173-9591			Clauss P, 2001, SAMJ S AFR MED J, V91, P788; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Clauss R, 2004, NEW ENGL J MED, V351, P511, DOI 10.1056/NEJM200407293510522; Clauss RP, 2004, ARZNEIMITTELFORSCH, V54, P641; Clauss RP, 2000, S AFR MED J, V90, P68; Cohen L, 2004, NEW ENGL J MED, V350, P949, DOI 10.1056/NEJM200402263500922; Crestani F, 2000, BRIT J PHARMACOL, V131, P1251, DOI 10.1038/sj.bjp.0703717; ENNA SJ, 1977, ARCH NEUROL-CHICAGO, V34, P683, DOI 10.1001/archneur.1977.00500230053008; Feldman R. S, 1997, PRINCIPLES NEUROPSYC, P417; Garretto NS, 2004, MOVEMENT DISORD, V19, P967, DOI 10.1002/mds.20085; GillThwaites H, 1997, BRAIN INJURY, V11, P723, DOI 10.1080/026990597123098; Kang-Park MH, 2004, NEUROPHARMACOLOGY, V46, P1, DOI 10.1016/S0028-3908(03)00340-X; Kertesz A., 1982, W APHASIA BATTERY; MASTAIN B, 1995, REV NEUROL, V151, P52; MASTAIN B, 1998, MOVEMENT DISORD, V13, P46; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; Sanger DJ, 1999, PHARMACOL BIOCHEM BE, V64, P269, DOI 10.1016/S0091-3057(99)00081-7; 2006, GUARDIAN        1207, P4	19	36	37	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2008	22	1					103	106		10.1080/02699050701829704			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	250QF	WOS:000252314400012	18183514				2022-02-06	
J	Stokely, ME; Orr, EL				Stokely, Martha E.; Orr, Edward L.			Acute effects of calvarial damage on dural mast cells, pial vascular permeability, and cerebral cortical histamine levels in rats and mice	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; blood-brain barrier dysfunction; head trauma; inflammation; neurotransmitters	BLOOD-BRAIN-BARRIER; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INFLAMMATORY MEDIATORS; MIGRAINE HEADACHE; EDEMA FORMATION; MOUSE-BRAIN; LEWIS RATS; STRESS; MATER; DEGRANULATION	Neurological complications after mild head injury can include vasogenic edema and/or subsequent development of epilepsy, conditions associated with elevated histamine. In the present study we assessed the potential of mast cells located in the dura mater to contribute to elevated cortical histamine and breakdown of the blood-brain barrier after minor head injury, modeled by either a parietal craniectomy or producing a groove in (scoring) the parietal bone surface to model a grazing head injury. We measured the following effects at 5-20 min after a unilateral parietal craniectomy (rats) or unilateral scoring of the parietal bone (mice): (1) mast cell integrity in subjacent dura mater; (2) subjacent vs. contralateral histamine in dura mater and cerebral cortex; (3) vascular permeability of cerebral cortical blood vessels subjacent to the injury, and; (4) the effects of an H-2-receptor antagonist on cerebral cortical vascular permeability. Results. Dural mast cells subjacent to the craniectomy became activated (degranulated) concomitant with (1) decreased histamine in dura mater subjacent to the craniectomy; (2) increased histamine in the subjacent cerebral cortex; and (3) extravasation of Evans blue-albumin which stained the subjacent cerebral cortex, indicating a localized breakdown of the blood-brain barrier. Similar results were observed in mice after scoring the parietal bone surface and, additionally, pretreatment with the histamine H-2-receptor antagonist zolantadine (1 h before injury) dose-dependently inhibited extravasation of Evans blue-albumin. We conclude that even a minor grazing injury of the skull, in the absence of penetrating brain injury or concussion, can activate dural mast cells and elevate cortical histamine, a novel mechanism with potential contributions to neurotraumatic complications arising from a relatively minor or grazing head wound.	[Orr, Edward L.] Barry Univ, Sch Nat & Hlth Sci, Grad Program Biomed Sci, Miami Shores, FL 33161 USA; [Stokely, Martha E.] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Stokely, Martha E.] Univ N Texas, Hlth Sci Ctr, N Texas Eye Res Inst, Ft Worth, TX USA		Orr, EL (corresponding author), Barry Univ, Sch Nat & Hlth Sci, Grad Program Biomed Sci, 11300 NE 2nd Ave, Miami Shores, FL 33161 USA.	eorr@mail.barry.edu					Bebo BF, 1996, J NEUROSCI RES, V45, P340; BUTT AM, 1992, BRAIN RES, V569, P100, DOI 10.1016/0006-8993(92)90374-I; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; DIMLICH RVW, 1991, J NEUROCYTOL, V20, P485, DOI 10.1007/BF01252276; DVORAK AM, 1992, INT ARCH ALLERGY IMM, V99, P74, DOI 10.1159/000236338; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; GELLER HM, 1984, CAN J PHYSIOL PHARM, V62, P715, DOI 10.1139/y84-118; Gregory GD, 2005, EUR J IMMUNOL, V35, P3478, DOI 10.1002/eji.200535271; Gregory Greg D, 2005, Novartis Found Symp, V271, P215; Janigro Damir, 2007, Epilepsy Curr, V7, P105, DOI 10.1111/j.1535-7511.2007.00190.x; JOO F, 1994, ACT NEUR S, V60, P76; Kandere-Grzybowska K, 2003, BRAIN RES, V980, P213, DOI 10.1016/S0006-8993(03)02975-5; KELLER JT, 1989, J COMP NEUROL, V290, P310, DOI 10.1002/cne.902900210; Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012; Levy D, 2006, HEADACHE, V46, pS13, DOI 10.1111/j.1526-4610.2006.00485.x; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Lozada A, 2005, NEUROPATH APPL NEURO, V31, P150, DOI 10.1111/j.1365-2990.2004.00622.x; MARKOWITZ S, 1989, BRAIN RES, V477, P157, DOI 10.1016/0006-8993(89)91403-0; MARTINS AN, 1980, STROKE, V11, P469, DOI 10.1161/01.STR.11.5.469; MOHANTY S, 1989, J NEUROL SCI, V90, P87, DOI 10.1016/0022-510X(89)90048-8; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; OLESEN SP, 1987, ACTA PHYSIOL SCAND, V130, P63, DOI 10.1111/j.1748-1716.1987.tb08112.x; Orr E L, 1988, Ann N Y Acad Sci, V540, P723, DOI 10.1111/j.1749-6632.1988.tb27226.x; ORR EL, 1984, J NEUROCHEM, V43, P1497, DOI 10.1111/j.1471-4159.1984.tb05416.x; ORR EL, 1984, J NEUROCHEM, V42, P727, DOI 10.1111/j.1471-4159.1984.tb02743.x; ORR EL, 1988, NEUROCHEM PATHOL, V8, P43; ORR EL, 1989, J NEUROCHEM, V53, P111, DOI 10.1111/j.1471-4159.1989.tb07301.x; Patnaik R, 2000, ACTA NEUROCHIR SUPPL, V76, P535; Powell HC, 1999, BRAIN PATHOL, V9, P219; Rozniecki JJ, 1999, BRAIN RES, V849, P1, DOI 10.1016/S0006-8993(99)01855-7; Sakas DE, 1997, NEUROSURGERY, V41, P661, DOI 10.1097/00006123-199709000-00031; Sarker MH, 2002, J PHYSIOL-LONDON, V540, P209, DOI 10.1113/jphysiol.2001.012912; Sarker MH, 1998, J PHYSIOL-LONDON, V507, P909, DOI 10.1111/j.1469-7793.1998.909bs.x; SHAFF RE, 1979, ANAL BIOCHEM, V94, P425, DOI 10.1016/0003-2697(79)90385-3; SHARMA HS, 1992, NEUROSCIENCE, V50, P445, DOI 10.1016/0306-4522(92)90436-6; STANLEY NC, 1990, J NEUROIMMUNOL, V29, P223, DOI 10.1016/0165-5728(90)90165-J; Theoharides TC, 2002, J CLIN PSYCHOPHARM, V22, P103, DOI 10.1097/00004714-200204000-00001; THEOHARIDES TC, 1995, ENDOCRINOLOGY, V136, P5745, DOI 10.1210/en.136.12.5745; TOSAKI A, 1994, EUR J PHARMACOL, V264, P455, DOI 10.1016/0014-2999(94)00546-X; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; YONG T, 1994, J NEUROTRAUM, V11, P161, DOI 10.1089/neu.1994.11.161	42	36	36	0	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	2008	25	1					52	61		10.1089/neu.2007.0397			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	258IJ	WOS:000252861300005	18355158				2022-02-06	
J	Marklund, N; Bayre, FM; Royo, NC; Thompson, HJ; Mir, AK; Grady, MS; Schwab, ME; McIntosh, TK				Marklund, Niklas; Bayre, Florence M.; Royo, Nicolas C.; Thompson, Hilaire J.; Mir, Anis K.; Grady, M. Sean; Schwab, Martin E.; McIntosh, Tracy K.			Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression	JOURNAL OF NEUROSURGERY			English	Article						cognition; GAP-43; neurological motor deficits; Nogo-A; regeneration; traumatic brain injury	MONOCLONAL-ANTIBODY IN-1; CENTRAL-NERVOUS-SYSTEM; MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL-CORD REPAIR; NEURITE GROWTH; FUNCTIONAL RECOVERY; AXONAL REGENERATION; ADULT-RAT; CORTICAL LESION; HEAD-INJURY	Object. Central nervous system axons regenerate poorly after traumatic brain injury (TBI), partly due to inhibitors such as the protein Nogo-A present in myelin. The authors evaluated the efficacy of anti-Nogo-A monoclonal antibody (mAb) 7B 12 administration on the neurobehavioral and cognitive outcome of rats following lateral fluid-percussion brain injury, characterized the penetration of the 7B 12 or control antibodies into target brain regions, and evaluated the effects of Nogo-A inhibition on hemispheric tissue loss and sprouting of uninjured motor tracts in the cervical cord. To elucidate a potential molecular response to Nogo-A inhibition, we evaluated the effects of 7B 12 on hippocampal GAP-43 expression. Methods. Beginning 24 hours after lateral fluid-percussion brain injury or sham injury in rats, the mAb 7B 12 or control antibody was infused intracerebroventricularly over 14 days, and behavior was assessed over 4 weeks. Results. Immunoreactivity for 7B 12 or immunoglobulin G was detected in widespread brain regions at 1 and 3 weeks postinjury. The brain-injured animals treated with 7B 12 showed improvement in cognitive function (p < 0.05) at 4 weeks but no improvement in neurological motor function from 1 to 4 weeks postinjury compared with brain-injured, vehicle-treated controls. The enhanced cognitive function following inhibition of Nogo-A was correlated with an attenuated postinjury downregulation of hippocampal GAP-43 expression (p < 0.05). Conclusions. Increased GAP-43 expression may be a novel molecular mechanism of the enhanced cognitive recovery mediated by Nogo-A inhibition after TBI in rats.	Univ Uppsala Hosp, Dept Neurosurg, SE-75185 Uppsala, Sweden; Univ Penn, Dept Neurosurg, Traumat Brain Injury Lab, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA; Univ Zurich, Brain Res Inst, Zurich, Switzerland; Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; Novartis Inst Biomed Res, Basel, Switzerland		Marklund, N (corresponding author), Univ Uppsala Hosp, Dept Neurosurg, SE-75185 Uppsala, Sweden.	niklas.marklund@neurokir.uu.se	Schwab, Martin E/B-6818-2016	Marklund, Niklas/0000-0002-9797-5626	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [L30 DC008284-01, L30 DC008284] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS R01-40978, R01 NS040978-04, NS P50-08803, P50 NS008803-27] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, R01NS040978] Funding Source: NIH RePORTER		Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bomze HM, 2001, NAT NEUROSCI, V4, P38, DOI 10.1038/82881; Buchli AD, 2005, ANN MED, V37, P556, DOI 10.1080/07853890500407520; CADELLI D, 1991, EUR J NEUROSCI, V3, P825, DOI 10.1111/j.1460-9568.1991.tb00093.x; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; David S, 2003, ANNU REV NEUROSCI, V26, P411, DOI 10.1146/annurev.neuro.26.043002.094946; Dergham P, 2002, J NEUROSCI, V22, P6570; Emerick AJ, 2003, J NEUROSCI, V23, P4826; Emery DL, 2000, J COMP NEUROL, V424, P521; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Fiedler M, 2002, PROTEIN ENG, V15, P931, DOI 10.1093/protein/15.11.931; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fischer D, 2004, J NEUROSCI, V24, P1646, DOI 10.1523/JNEUROSCI.5119-03.2004; Fouad K, 2004, EUR J NEUROSCI, V20, P2479, DOI 10.1111/j.1460-9568.2004.03716.x; Fournier AE, 2002, PROG BRAIN RES, V137, P361; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Gianola S, 2004, EUR J NEUROSCI, V19, P819, DOI 10.1111/j.0953-816X.2004.03190.x; Grados-Munro EM, 2003, J NEUROSCI RES, V74, P479, DOI 10.1002/jnr.10803; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Hulo S, 2002, EUR J NEUROSCI, V15, P1976, DOI 10.1046/j.1460-9568.2002.02026.x; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Kartje GL, 1999, ANN NEUROL, V45, P778, DOI 10.1002/1531-8249(199906)45:6<778::AID-ANA12>3.0.CO;2-B; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lee DHS, 2003, NAT REV DRUG DISCOV, V2, P872, DOI 10.1038/nrd1228; Lenzlinger PM, 2005, NEUROSCIENCE, V134, P1047, DOI 10.1016/j.neuroscience.2005.04.048; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Marklund N, 2005, RESTOR NEUROL NEUROS, V23, P31; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meier S, 2003, FASEB J, V17, P1153, DOI 10.1096/fj.02-0453fje; Mingorance A, 2004, MOL CELL NEUROSCI, V26, P34, DOI 10.1016/j.mcn.2004.01.001; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; *NAT RES COUNC, 1996, GUID CAR US LAB; Oertle T, 2003, J NEUROSCI, V23, P5393; Oudega M, 2000, NEUROSCIENCE, V100, P873, DOI 10.1016/S0306-4522(00)00350-X; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; PAXIOS G, 1986, RAT BRAIN STEREOTAXI; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rekart JL, 2005, HIPPOCAMPUS, V15, P1, DOI 10.1002/hipo.20045; Riedel G, 2001, PROG NEURO-PSYCHOPH, V25, P835, DOI 10.1016/S0278-5846(01)00153-1; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; SchmidtKastner R, 1997, CELL TISSUE RES, V288, P225, DOI 10.1007/s004410050808; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Thompson HJ, 2006, EUR J NEUROSCI, V24, P3063, DOI 10.1111/j.1460-9568.2006.05197.x; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Weinmann O, 2006, MOL CELL NEUROSCI, V32, P161, DOI 10.1016/j.mcn.2006.03.007; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8	66	36	36	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	2007	107	4					844	853		10.3171/JNS-07/10/0844			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	214NY	WOS:000249746500021	17937233	Green Accepted			2022-02-06	
J	Soustiel, JF; Sviri, GE				Soustiel, Jean F.; Sviri, Gill E.			Monitoring of cerebral metabolism: non-ischemic impairment of oxidative metabolism following severe traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						traumatic brain injury; cerebral blood flow; cerebral metabolism	SEVERE HEAD-INJURY; POSITRON-EMISSION-TOMOGRAPHY; BLOOD-FLOW; GLUCOSE-UTILIZATION; PREDICTOR; OXYGEN; CONSCIOUSNESS; DYSFUNCTION; ASTROCYTES; PRESSURE	Objective: To investigate and compare the respective dynamics of cerebral blood flow (CBF) and metabolism in response to changes in neurological condition and intracranial pressure (ICP) in severe traumatic brain injury (TBI). Methods: Eight-four patients with severe TBI were prospectively enrolled in this study. CBF was measured daily and global cerebral metabolic rates of oxygen (CMRO2), glucose (CMRGlc) and lactate (CMRLct) were calculated using arterial jugular differences. In addition, 33 patients had a second evaluation shortly after a significant change (>5 mmHg) in their ICP. Results: Eight hundred and ninety-four evaluations were collected during a period ranging between 1 and 12 days (mean: 5.1 +/- 2.6 days). CBF was moderately but significantly decreased. Oppositely, CMRO2 was profoundly reduced with evidence for critical metabolic failure (<1.2 ml/100 g/min) in 30.5% whereas only 8.5% of CBF measurements were lower than 20 ml/100 g/min. Furthermore, in 78 instances of a dynamic assessment performed following ICP increase (n = 20) or decrease (n = 58), CMRO2 but not CBF proved to be significantly and inversely affected by ICP fluctuations. Finally, CMRO2 and CMRLct correlated with GCS score in contrast with CBF. Both CBF and metabolic indices, however, correlated with neurological outcome. Conclusion: This study shows that cerebral metabolic failure following TBI is a common finding that is not of ischemic origin in most instances. Unlike frequently assumed, cerebral metabolism is not constrained within the narrow range of a static depression sustained for weeks but rather subject to significant variations in response to changes in ICP or neurological condition.	Technion Israel Inst Technol, Fac Med, Rambam Med Ctr, Dept Neurosurg, IL-31096 Haifa, Israel		Soustiel, JF (corresponding author), Rambam Med Ctr, Dept Neurosurg, PO Box 9602, IL-31096 Haifa, Israel.	lj_soustiel@rambam.health.gov.il					Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; POWERS WJ, 1985, J CEREBR BLOOD F MET, V5, P600, DOI 10.1038/jcbfm.1985.89; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Soustiel JF, 2006, ACTA NEUROCHIR, V148, P845, DOI 10.1007/s00701-006-0792-7; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Soustiel JF, 2003, STROKE, V34, P1876, DOI 10.1161/01.STR.0000080942.32331.39; Soustiel JF, 2002, J ULTRAS MED, V21, P1405, DOI 10.7863/jum.2002.21.12.1405; TEASDALE G, 1974, LANCET, V2, P81; VALADKA B, 2000, NEUROSURG FOCUS, V9, pE3; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; WALZ W, 1988, NEUROSCI LETT, V86, P296, DOI 10.1016/0304-3940(88)90499-5; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	29	36	37	0	4	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	OCT	2007	29	7					654	660		10.1179/016164107X240017			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234MJ	WOS:000251167900004	18173902				2022-02-06	
J	Rothman, MS; Arciniegas, DB; Filley, CM; Wierman, ME				Rothman, Micol S.; Arciniegas, David B.; Filley, Christopher M.; Wierman, Margaret E.			The neuroendocrine effects of traumatic brain injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							GROWTH-HORMONE DEFICIENCY; COGNITIVE FUNCTION; TESTOSTERONE REPLACEMENT; SUBARACHNOID HEMORRHAGE; PITUITARY DYSFUNCTION; CRITICAL ILLNESS; HYPOGONADAL MEN; SEPTIC SHOCK; SEX-HORMONES; HEAD TRAUMA	Neuroendocrine dysfunction after traumatic brain injury (TBI) is under-diagnosed, under-treated, and may adversely affect the rate of recovery. Single or multiple pituitary-target hormone disruption occurs in up to two-thirds of persons with TBI, most commonly affecting the gonadal and growth hormone axes. The time course of decline in and recovery of pituitary function in relation to cognitive dysfunction and rehabilitation progress are not well described. This article reviews the clinical spectrum Of neuroendocrine deficits after TBI and their underlying mechanisms. Future studies of the effects of hormonal replacement on recovery are recommended.	Univ Colorado, Dept Med, Denver, CO USA; Ctr Hlth Sci, Aurora, CO USA; Univ Colorado, Dept Psychiat & Neurol, Denver, CO USA; Univ Colorado, Dept Med, Denver, CO USA; Vet Affairs Med Ctr, Res Serv, Denver, CO USA; Healthone Spalding Rehabil Hosp, Brain Injury Rehabil Unit, Aurora, CO USA		Wierman, ME (corresponding author), VAMC, 111H Endocrinol, 1055 Clermont St, Denver, CO 80220 USA.	margaret.wierman@uchsc.edu	Arciniegas, David/A-3792-2009				Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Azad N, 2003, J CLIN ENDOCR METAB, V88, P3064, DOI 10.1210/jc.2002-020632; Azcoitia I, 2003, ANN NY ACAD SCI, V1007, P298, DOI 10.1196/annals.1286.028; BECKER RA, 1982, CRIT CARE MED, V10, P870, DOI 10.1097/00003246-198212000-00014; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bhasin S, 1998, J CLIN ENDOCR METAB, V83, P3155, DOI 10.1210/jc.83.9.3155; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P407, DOI 10.1210/jc.82.2.407; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; BRENT GA, 1986, J CLIN ENDOCR METAB, V63, P1; Butler TL, 2003, BRAIN RES BULL, V59, P339, DOI 10.1016/S0361-9230(02)00926-7; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Cernak I, 1999, BRAIN INJURY, V13, P1005; Childers MK, 1998, BRAIN INJURY, V12, P517, DOI 10.1080/026990598122476; Chinga-Alayo E, 2005, INTENS CARE MED, V31, P1356, DOI 10.1007/s00134-005-2719-9; CLARK JDA, 1992, CLIN ENDOCRINOL, V36, P481, DOI 10.1111/j.1365-2265.1992.tb02249.x; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Dutton Richard P, 2003, Curr Opin Crit Care, V9, P503, DOI 10.1097/00075198-200312000-00007; Ferrando AA, 2001, CRIT CARE MED, V29, P1936, DOI 10.1097/00003246-200110000-00015; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; GREENSPAN FS, 2004, BASIC CLIN ENDOCRINO; Grinspoon S, 2000, ANN INTERN MED, V133, P348, DOI 10.7326/0003-4819-133-5-200009050-00010; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; JIANG ZM, 1989, ANN SURG, V210, P513, DOI 10.1097/00000658-198910000-00012; JORGENSEN JOL, 1989, LANCET, V1, P1221; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Knox JB, 1996, AM J SURG, V171, P576, DOI 10.1016/S0002-9610(96)00033-5; Ko YH, 2006, NEUROPSYCHOBIOLOGY, V53, P169, DOI 10.1159/000093780; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; LEE SC, 1994, BRAIN INJURY, V8, P571; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Marik PE, 2003, CRIT CARE MED, V31, P141, DOI 10.1097/00003246-200301000-00022; Maruff P, 2005, HORM RES, V64, P100, DOI 10.1159/000089325; MAY ME, 1985, AM J MED, V79, P679, DOI 10.1016/0002-9343(85)90517-0; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McEwen BS, 1999, J CLIN ENDOCR METAB, V84, P1790, DOI 10.1210/jc.84.6.1790; Mechanick JI, 2006, CRIT CARE CLIN, V22, P87, DOI 10.1016/j.ccc.2005.08.005; Moffat SD, 2002, J CLIN ENDOCR METAB, V87, P5001, DOI 10.1210/jc.2002-020419; Nierman DM, 1999, CRIT CARE MED, V27, P2418, DOI 10.1097/00003246-199911000-00016; O'Connor DB, 2001, NEUROPSYCHOLOGIA, V39, P1385, DOI 10.1016/S0028-3932(01)00067-7; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rasmuson S, 1996, CLIN ENDOCRINOL, V44, P151, DOI 10.1046/j.1365-2265.1996.600482.x; REICHLIN S, 1992, NEUROENDOCRINOLOGY W, P174; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; Savaridas T, 2004, INTENS CARE MED, V30, P1479, DOI 10.1007/s00134-004-2306-5; Scheepens A, 2001, NEUROSCIENCE, V104, P677, DOI 10.1016/S0306-4522(01)00109-9; SPRATT DI, 1993, J CLIN ENDOCR METAB, V76, P1548, DOI 10.1210/jc.76.6.1548; SPRATT DI, 1992, J CLIN ENDOCR METAB, V75, P1562, DOI 10.1210/jc.75.6.1562; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; WHITEHEAD HM, 1992, CLIN ENDOCRINOL, V36, P45, DOI 10.1111/j.1365-2265.1992.tb02901.x; Wolf OT, 2002, HORM BEHAV, V41, P259, DOI 10.1006/hbeh.2002.1770; WOOLF PD, 1985, J CLIN ENDOCR METAB, V60, P444, DOI 10.1210/jcem-60-3-444; Yaffe K, 2002, J AM GERIATR SOC, V50, P707, DOI 10.1046/j.1532-5415.2002.50166.x; Yaffe K, 2000, LANCET, V356, P708, DOI 10.1016/S0140-6736(00)02628-3	71	36	40	0	6	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2007	19	4					363	372		10.1176/appi.neuropsych.19.4.363			10	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	235EQ	WOS:000251216700002	18070838				2022-02-06	
J	Maegele, M; Sauerland, S; Bouillon, B; Schafer, U; Trubel, H; Riess, P; Neugebauer, EAM				Maegele, M.; Sauerland, S.; Bouillon, B.; Schaefer, U.; Truebel, H.; Riess, P.; Neugebauer, E. A. M.			Differential immunoresponses following experimental traumatic brain injury, bone fracture and "two-hit"-combined neurotrauma	INFLAMMATION RESEARCH			English	Article						cytokines; traumatic brain injury; tibia fracture; combined neurotrauma; inflammatory response	TUMOR-NECROSIS-FACTOR; MULTIPLE ORGAN FAILURE; INTERLEUKIN 6 IL-6; CIRCULATING LEVELS; HEMORRHAGIC-SHOCK; BURNED PATIENTS; SOLUBLE RECEPTORS; MAJOR SURGERY; FACTOR-ALPHA; HEAD-INJURY	Cytokine-mediated immunoresponses are consequences of isolated traumatic brain injury (TBI) and muskuloskeletal trauma but little is known when both impacts occur simulanteously in combined neurotrauma (CNT), i. e. TBI + muskuloskeletal trauma (bone fracture). A "two-hit"-experimental model of CNT (TBI + tibia fracture) was used to investigate circulating cytokine interleukin-1-beta, -6, -10 and sTNF-R1 concentrations following peripheral bone fracture only, TBI only and CNT. Blood samples were drawn at 30 min, 6 h, 24 h, 48 h, and 7 days following trauma and circulating cytokine concentrations were determined via immunoassay. Circulating cytokines were increased after trauma (p < 0.001 vs. controls), but peaked at different time points. sTNF R1 peaked first at 30 min, followed by IL-6 at 6 h after trauma. IL-10 levels were highest at 24 h, and those for IL-1beta at 48 h after trauma. Circulating IL-6 and IL-10 levels were highest in CNT at 8/10 time points studied (p < 0.001). Circulating cytokine IL-1-beta, -6, -10 and sTNF-R1 concentrations are increased after trauma (TBI, fracture and CNT) but peak at different time points. Pronounced IL-6 and IL-10 responses after CNT may contribute to the increased susceptibility for complications in CNT versus monotrauma.	Univ Witten Herdecke, Inst Res Operat Med, D-51109 Cologne, Germany; Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Traumat & Orthoped Surg, D-51109 Cologne, Germany		Maegele, M (corresponding author), Univ Witten Herdecke, Inst Res Operat Med, Ostmerheimerstr 200, D-51109 Cologne, Germany.	Marc.Maegele@t-online.de		Sauerland, Stefan/0000-0003-1048-796X			BAIGRIE RJ, 1991, LYMPHOKINE CYTOK RES, V10, P253; BAIGRIE RJ, 1992, BRIT J SURG, V79, P757, DOI 10.1002/bjs.1800790813; Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; Biffl WL, 1996, ANN SURG, V224, P647, DOI 10.1097/00000658-199611000-00009; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; BOURQUE WT, 1992, LAB ANIM SCI, V42, P369; CANNON JG, 1992, CRIT CARE MED, V20, P1414, DOI 10.1097/00003246-199210000-00009; Chuang D, 2005, ANZ J SURG, V75, P813, DOI 10.1111/j.1445-2197.2005.03530.x; CROZIER TA, 1993, ANAESTHESIST, V42, P343; ERTEL W, 1995, J TRAUMA, V39, P879, DOI 10.1097/00005373-199511000-00011; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GUO Y, 1990, CLIN IMMUNOL IMMUNOP, V54, P361, DOI 10.1016/0090-1229(90)90050-Z; Hauser CJ, 1997, J TRAUMA, V42, P895, DOI 10.1097/00005373-199705000-00021; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; HOCH RC, 1993, CRIT CARE MED, V21, P839, DOI 10.1097/00003246-199306000-00010; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; Maegele M, 2005, SHOCK, V23, P476, DOI 10.1097/01.shk.0000159929.87737.5c; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Meixensberger J, 1998, LANGENBECK ARCH SURG, V383, P214, DOI 10.1007/s004230050121; Menger MD, 2004, LANGENBECK ARCH SURG, V389, P475, DOI 10.1007/s00423-004-0472-0; Neely AN, 1996, BURNS, V22, P524, DOI 10.1016/0305-4179(96)00029-0; Neidhardt R, 1997, J TRAUMA, V42, P863, DOI 10.1097/00005373-199705000-00017; Neugebauer E, 2000, UNFALLCHIRURG, V103, P122, DOI 10.1007/s001130050023; Partrick DA, 1996, AM J SURG, V172, P425, DOI 10.1016/S0002-9610(96)00252-8; Pasquale MD, 1996, CRIT CARE MED, V24, P1238, DOI 10.1097/00003246-199607000-00029; PULLICINO EA, 1990, LYMPHOKINE RES, V9, P231; REICHLIN S, 1993, NEW ENGL J MED, V329, P1246; Ribeiro CA, 2002, INTENS CARE MED, V28, P472, DOI 10.1007/s00134-001-1190-5; RODRIGUEZ JL, 1991, J TRAUMA, V31, P907, DOI 10.1097/00005373-199107000-00005; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Segal JL, 1997, ARCH PHYS MED REHAB, V78, P44, DOI 10.1016/S0003-9993(97)90008-3; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; TAN LR, 1993, J TRAUMA, V34, P634, DOI 10.1097/00005373-199305000-00004; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; Vindenes HA, 1998, EUR J SURG, V164, P647; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Yeh FL, 1999, BURNS, V25, P131, DOI 10.1016/S0305-4179(98)00150-8; Yeh FL, 2000, BURNS, V26, P454, DOI 10.1016/S0305-4179(99)00174-6; Yokoyama Y, 2004, AM J PHYSIOL-GASTR L, V286, pG942, DOI 10.1152/ajpgi.00502.2003; Zhang B, 1998, BURNS, V24, P599, DOI 10.1016/S0305-4179(98)00091-6	49	36	39	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	AUG	2007	56	8					318	323		10.1007/s00011-007-6141-3			6	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	201DC	WOS:000248810700002	17687516				2022-02-06	
J	O'Keeffe, FM; Dockree, PM; Moloney, P; Carton, S; Robertson, IH				O'Keeffe, F. M.; Dockree, P. M.; Moloney, P.; Carton, S.; Robertson, I. H.			Characterising error-awareness of attentional lapses and inhibitory control failures in patients with traumatic brain injury	EXPERIMENTAL BRAIN RESEARCH			English	Article						traumatic brain injury; errors; attention; response inhibition; frontal dysfunction	SUSTAINED ATTENTION; SELF-AWARENESS; EXECUTIVE FUNCTIONS; IMPAIRED AWARENESS; HEAD-INJURY; ADULTS; SENSITIVITY; DYSFUNCTION; RELATIVES; BEHAVIOR	Awareness deficits are a significant problem following traumatic brain injury (TBI). This study examined error processing as candidate marker of awareness and compared the performance of 18 TBI participants and 18 controls using an online error-monitoring task while participants performed simple go/no-go tasks. Error-monitoring performance was compared where the no-go target was part of (a) a predictive sequence, (b) predictive sequence plus a dual-task element and (c) a random sequence. Results showed that the TBI participants, in contrast to control participants, were significantly impaired at monitoring their errors during both predictive sequence tasks but were not impaired on the random sequence task. These findings suggest that following TBI, when an error is more impulsive it may be more easily monitored, whereas when an error is characterised by attentional drift, subsequent error-processing mechanisms may fail to engage. Higher levels of online error-awareness were also associated with lower levels of anxiety, fewer symptoms of frontal dysfunction and greater competence in everyday functioning.	Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland; Univ Dublin Trinity Coll, Dept Psychol, Dublin 2, Ireland; Natl Rehabil Hosp, Dept Clin Neuropsychol, Dun Laoghaire, Co Dublin, Ireland		Robertson, IH (corresponding author), Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland.	iroberts@tcd.ie		Robertson, Ian H/0000-0001-8637-561X			Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Barco PP, 1991, COGNITIVE REHABILITA, P129; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2005, NEUROIMAGE, V27, P587, DOI 10.1016/j.neuroimage.2005.05.044; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Malloy PF., 2002, FRONTAL SYSTEMS BEHA; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Markova IS, 2006, NEUROPSYCHOL REHABIL, V16, P439, DOI 10.1080/09602010500373396; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; OKEEFE F, IN PRESS BRAIN; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Richardson JTE., 2000, CLIN NEUROPSYCHOLOGI; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sturm W, 2004, NEUROPSYCHOLOGIA, V42, P563, DOI 10.1016/j.neuropsychologia.2003.11.004; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; STUSS DT, 1998, NEUROBEHAVIOURAL REC; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	36	36	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	JUN	2007	180	1					59	67		10.1007/s00221-006-0832-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	181SO	WOS:000247456600006	17216412				2022-02-06	
J	Prilloff, S; Noblejas, MI; Chedhomme, V; Sabel, BA				Prilloff, S.; Noblejas, M. I.; Chedhomme, V.; Sabel, B. A.			Two faces of calcium activation after optic nerve trauma: life or death of retinal ganglion cells in vivo depends on calcium dynamics	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						calcium imaging; ICON-microscopy; light stimulation; optic nerve crush; Oregon Green BAPTA-dextran	VISUAL-CORTEX; NEURONAL-ACTIVITY; GRADED CRUSH; BRAIN INJURY; ADULT-RATS; VISION; RESTORATION; RECOVERY; GROWTH; PLASTICITY	Calcium elevations after neurotrauma are not only implicated in cell death but may contribute to adaptive plasticity. We now wished to resolve this contradiction by following calcium dynamics after optic nerve crush in vivo. Adult rats received no injury (n = 5), unilateral mild (n = 10) or moderate optic nerve crush (n = 10) (ONC), or axotomy (n = 5). Before surgery, retinal ganglion cells (RGCs) were retrogradely labelled with Oregon Green BAPTA-dextran, a fluorescent calcium marker. Calcium-related fluorescence intensity (FI) was repeatedly measured in individual RGCs in vivo using the in vivo confocal neuroimaging (ICON) method. Four different RGC types were found. Normal RGCs without FI change were found in sham rats and also in both ONC groups. RGCs with mild damage were seen only after mild ONC, showing an initial calcium depression of 26% at day 4 followed by a 169% increase 15 days after ONC. RGCs with moderate damage were found only after moderate ONC and showed calcium hypoactivation followed by a slower return toward baseline and a delayed calcium increase of 72% above baseline. Sixty to sixty-five per cent of the RGCs in both ONC groups and all RGCs in the axotomy group died within 6 days following a fast and massive calcium increase of 316% with a concomitant 156% soma size increase. In conclusion rapid calcium elevation leads to cell death, while an initial calcium depression followed by a delayed and moderate calcium hyperactivation is associated with cell survival. We propose that immediate, massive calcium activation is maladaptive whereas delayed and moderate hyperactivation of surviving cells is adaptive. Implications for pharmacotherapy are discussed.	Univ Magdeburg, Med Fac, Inst Med Psychol, D-39120 Magdeburg, Germany		Sabel, BA (corresponding author), Univ Magdeburg, Med Fac, Inst Med Psychol, Leipziger Str 44, D-39120 Magdeburg, Germany.	Bernhard.Sabel@medizin.uni-magdeburg.de	Sabel, Bernhard A./E-6579-2013	Sabel, Bernhard/0000-0002-4472-5543			Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Barmashenko G, 2001, NEUROREPORT, V12, P3023, DOI 10.1097/00001756-200110080-00009; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bootman MD, 2001, J CELL SCI, V114, P2213; Chino YM, 1999, RESTOR NEUROL NEUROS, V15, P165; CHOI DW, 1988, J NEUROSCI, V8, P185; COHAN CS, 1986, SCIENCE, V232, P1638, DOI 10.1126/science.3715470; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DUVDEVANI R, 1990, RESTOR NEUROL NEUROS, V2, P31, DOI 10.3233/RNN-1990-2104; Eysel UT, 1999, RESTOR NEUROL NEUROS, V15, P153; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Hanke J, 2004, ACT NEUR S, V89, P75; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Hyrc K, 1997, J NEUROSCI, V17, P6669; Kasten E, 1998, NAT MED, V4, P1083, DOI 10.1038/2079; Kasten E, 1999, RESTOR NEUROL NEUROS, V15, P273; KATER SB, 1990, PROG BRAIN RES, V86, P117; KIMLEE MH, 1993, BRAIN RES, V613, P156, DOI 10.1016/0006-8993(93)90467-2; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; MATTSON MP, 1988, BRAIN RES REV, V13, P179, DOI 10.1016/0165-0173(88)90020-3; MCCAIG CD, 1991, EXP PHYSIOL, V76, P473, DOI 10.1113/expphysiol.1991.sp003514; MCCLELLAN AD, 1994, BRAIN RES, V663, P61, DOI 10.1016/0006-8993(94)90462-6; McPherson DR, 1997, BRAIN RES PROTOC, V1, P157, DOI 10.1016/S1385-299X(96)00024-4; Mittmann T, 2001, NEUROREPORT, V12, P3341, DOI 10.1097/00001756-200110290-00039; Mohr JP, 1998, CEREBROVASC DIS, V8, P17, DOI 10.1159/000047499; Nicotera P, 2003, TOXICOL SCI, V74, P4, DOI 10.1093/toxsci/kfg109; RASMUSSEN H, 1989, SCI AM, V261, P66, DOI 10.1038/scientificamerican1089-66; Rousseau V, 2001, RESTOR NEUROL NEUROS, V18, P177; Rousseau V, 1999, NEUROREPORT, V10, P3387, DOI 10.1097/00001756-199911080-00024; Sabel BA, 1999, RESTOR NEUROL NEUROS, V15, P177; Sabel BA, 1999, RESTOR NEUROL NEUROS, V15, P73; Sabel BA, 1997, NAT MED, V3, P244, DOI 10.1038/nm0297-244; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; SAUTTER J, 1991, BRAIN RES, V565, P23, DOI 10.1016/0006-8993(91)91732-G; Schiefer U, 1999, RESTOR NEUROL NEUROS, V15, P201; Schwab BL, 2002, CELL DEATH DIFFER, V9, P818, DOI 10.1038/sj.cdd.4401042; SILVEIRA LCL, 1994, J NEUROCYTOL, V23, P75, DOI 10.1007/BF01183863; Spitzer NC, 2000, BIOESSAYS, V22, P811; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; VANHUIZEN F, 1987, DEV BRAIN RES, V31, P1, DOI 10.1016/0165-3806(87)90077-0; VANHUIZEN F, 1987, EXP NEUROL, V97, P280, DOI 10.1016/0014-4886(87)90089-6; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Walker SA, 2003, FEBS LETT, V546, P6, DOI 10.1016/S0014-5793(03)00412-5; Werth R, 1999, RESTOR NEUROL NEUROS, V15, P229; Yoles E, 1998, ARCH OPHTHALMOL-CHIC, V116, P906, DOI 10.1001/archopht.116.7.906	48	36	36	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUN	2007	25	11					3339	3346		10.1111/j.1460-9568.2007.05550.x			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	176WL	WOS:000247115500014	17553002				2022-02-06	
J	Chaytor, N; Temkin, N; Machamer, J; Dikmen, S				Chaytor, Naomi; Temkin, Nancy; Machamer, Joan; Dikmen, Sureyya			The ecological validity of neuropsychological assessment and the role of depressive symptoms in moderate to severe traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						activities of daily living; everyday functioning; cognition; self-report; depressed mood; validation studies	MAJOR DEPRESSION; CES-D; TESTS; IMPAIRMENT; MEMORY; MILD; SCALE	Evaluating the ecological validity of neuropsychological tests has become an increasingly important topic. Previous research suggests that neuropsychological tests have a moderate level of ecological validity when predicting everyday functioning. The presence of depressive symptoms, however, may impact the relationship between neuropsychological tests and real world performance. The current study empirically tests this hypothesis in a sample of 216 participants with moderate to severe traumatic brain injury (TBI) who completed neuropsychological testing, self-report of mood symptoms, and report of everyday functioning six months post-injury. Contrary to some previous research and clinical lore, results indicated that depression was weakly related to neuropsychological test performance, although it was more strongly related to everyday functioning. Neuropsychological test performance was also significantly related to everyday functioning. The ecological validity of the neuropsychological tests together was not impacted by depressive symptoms, when predicting significant other ratings of functional status. However, patient self-report seems somewhat less related to neuropsychological performance in those with significant depressive symptoms. Neuropsychological test performance was equally related to self and other report of everyday functioning in patients without significant depressive symptoms.	Harborview Med Ctr, Reg Epilepsy Ctr, Seattle, WA 98104 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Chaytor, N (corresponding author), Harborview Med Ctr, Reg Epilepsy Ctr, POB 359745,325 9th Ave, Seattle, WA 98104 USA.	chaytor@u.washington.edu	Chaytor, Naomi/L-4315-2019	Chaytor, Naomi/0000-0001-8821-289X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS19643] Funding Source: Medline		Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Bush BA, 2004, J CLIN PSYCHOL MED S, V11, P195, DOI 10.1023/B:JOCS.0000037613.69367.d4; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; CHOI SC, 1977, BIOMETRIKA, V64, P645, DOI 10.1093/biomet/64.3.645; Christodoulou C, 2005, J INT NEUROPSYCH SOC, V11, P614, DOI 10.1017/S1355617705050733; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Franzen MD, 1997, BIOL NEUROPSYCHOLOGI; Goldstein G., 1995, INT J REHABILITATION, V1, DOI [10.1007/BF02214959, DOI 10.1007/BF02214959]; GRANT I, 1993, NEUROPSYCHOLOGY, V7, P53; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; HEINRICHS RW, 1990, PROF PSYCHOL-RES PR, V21, P171, DOI 10.1037/0735-7028.21.3.171; Jones JE, 2005, EPILEPSIA, V46, P731, DOI 10.1111/j.1528-1167.2005.49704.x; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Long, 1996, ECOLOGICAL VALIDITY, P15; Long C.J., 1995, ADV MED PSYCHOTHERAP, V8, P59; LONG CJ, 1997, CRIT ISS NE, P153; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; PARIKH RM, 1988, INT J PSYCHIAT MED, V18, P169, DOI 10.2190/BH75-EUYA-4FM1-J7QA; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Sbordone RJ, 1999, STUD NEUROPSYCHOL DE, P227; SBORDONE RJ, 1997, NEUROPSYCHOL HDB, V1; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Veiel HOF, 1997, J CLIN EXP NEUROPSYC, V19, P587, DOI 10.1080/01688639708403745; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wolfson, 1988, TRAUMATIC BRAIN INJU, VII	42	36	37	1	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2007	13	3					377	385		10.1017/S1355617707070592			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	162WZ	WOS:000246121500001	17445285				2022-02-06	
J	Eriksson, PO; Haggman-Henrikson, B; Zafar, H				Eriksson, Per-Olof; Haggman-Henrikson, Birgitta; Zafar, Hamayun			Jaw-neck dysfunction in whiplash-associated disorders	ARCHIVES OF ORAL BIOLOGY			English	Article; Proceedings Paper	International Mastication Symposium 2006	JUN, 2006	Univ Queensland, St Lucia, Brisbane, AUSTRALIA	Int Assoc Dent Res, Neurosci Grp, Univ Adelaide	Univ Queensland, St Lucia	dysfunction; endurance; head; human; jaw; neck; whiplash	WIRELESS OPTOELECTRONIC RECORDINGS; OPENING-CLOSING TASKS; HEAD MOVEMENTS; MARKERS; INPUTS; RATS	This paper reports data from recent studies on integrative jaw-neck motor control in healthy subjects and disturbed jaw-neck behaviour in whiplash-associated disorders (WAD). The results show that neck function is an integral part of natural jaw behaviour, and that neck injury can impair jaw function and therefore disturb eating behaviour. We also show preliminary results from implementation of a new approach for rehabilitation of jaw-neck dysfunction and pain in WAD. (c) 2007 Elsevier Ltd. All rights reserved.	Umea Univ, Fac Med, Dept Odontol, Muscle & Motor Control & MotoRehab Lab, SE-90187 Umea, Sweden		Eriksson, PO (corresponding author), Umea Univ, Fac Med, Dept Odontol, Muscle & Motor Control & MotoRehab Lab, SE-90187 Umea, Sweden.	per-olof.eriksson@odont.umu.se	Haggman-Henrikson, Birgitta/C-6998-2008	Haggman-Henrikson, Birgitta/0000-0001-6088-3739; Zafar, Hamayun/0000-0001-9318-3691			Eriksson PO, 2000, J DENT RES, V79, P1378, DOI 10.1177/00220345000790060501; Eriksson PO, 2004, EUR J ORAL SCI, V112, P25, DOI 10.1111/j.0909-8836.2004.00098.x; Eriksson PO, 1998, J ORAL REHABIL, V25, P859, DOI 10.1046/j.1365-2842.1998.00333.x; ERIKSSON PO, 1993, SWED DENT J, V17, pA93; ERIKSSON PO, 2005, CONNS CURRENT THERAP, P1128; Haggman-Henrikson B, 2004, J DENT RES, V83, P864, DOI 10.1177/154405910408301108; Haggman-Henrikson B, 1998, J ORAL REHABIL, V25, P527, DOI 10.1046/j.1365-2842.1998.00292.x; Haggman-Henrikson B, 2002, J DENT RES, V81, P747, DOI 10.1177/154405910208101105; Haggman-Henrikson B, 2004, J DENT RES, V83, P946, DOI 10.1177/154405910408301211; HENRIKSON BH, 2006, J DENT RES, V85, P1001; Igarashi N, 2000, BRAIN RES, V871, P151, DOI 10.1016/S0006-8993(00)02433-1; Josefsson T, 1996, COMPUT METH PROG BIO, V49, P119, DOI 10.1016/0169-2607(96)01715-4; LUND J P, 1991, Critical Reviews in Oral Biology and Medicine, V2, P33; SEPULVEDA W, 1995, ULTRASOUND OBST GYN, V5, P57, DOI 10.1046/j.1469-0705.1995.05010057.x; Zafar H, 2006, SWED DENT J, V30, P9; Zafar H, 2000, ARCH ORAL BIOL, V45, P675, DOI 10.1016/S0003-9969(00)00032-7; Zafar H, 1995, ALPHA AND GAMMA MOTOR SYSTEMS, P502; Zafar H, 2000, J ORAL REHABIL, V27, P227, DOI 10.1046/j.1365-2842.2000.00505.x; Zafar H, 2002, EXP BRAIN RES, V146, P70, DOI 10.1007/s00221-002-1157-y; Zeredo JL, 2003, J DENT RES, V82, P402, DOI 10.1177/154405910308200515; Zeredo JL, 2002, J DENT RES, V81, P39, DOI 10.1177/154405910208100109	21	36	39	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969			ARCH ORAL BIOL	Arch. Oral Biol.	APR	2007	52	4					404	408		10.1016/j.archoralbio.2006.12.016			5	Dentistry, Oral Surgery & Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	152FU	WOS:000245347400028	17274944				2022-02-06	
J	Fee, DB; Swartz, KR; Joy, KM; Roberts, KN; Scheff, NN; Scheff, SW				Fee, Dominic B.; Swartz, Karin R.; Joy, Kelly M.; Roberts, Kelly N.; Scheff, Nicole N.; Scheff, Stephen W.			Effects of progesterone on experimental spinal cord injury	BRAIN RESEARCH			English	Article						progesterone; spinal cord injury; contusion; neurotrauma; gender; BBB	FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; BRAIN; RAT; EXPRESSION; CONTUSION; PROTEIN; NEUROPROTECTION; STEROIDS; RECEPTOR	Progesterone has been proposed to be protective to the central nervous system following injury. This study assessed progesterone supplementation in the setting of contusional spinal cord injury in male and female rats. Short-term (S days of either 4 or 8 mg/kg progesterone) and long-term (14 days of either 8 or 16 mg/kg progesterone) therapy failed to show any significant alteration in locomotor functioning and injury morphometrics after 21 days. This study does not support progesterone as a potential therapeutic agent in spinal cord injury. (c) 2006 Elsevier B.V. All rights reserved.	Univ Kentucky, Albert B Chandler Med Ctr, Dept Neurol, Lexington, KY 40536 USA; Univ Kentucky, Albert B Chandler Med Ctr, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; Univ Kentucky, Albert B Chandler Med Ctr, Div Neurosurg, Lexington, KY 40536 USA; Univ Kentucky, Albert B Chandler Med Ctr, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Fee, DB (corresponding author), KY Clin, Dept Neurol, Rm L-55, Lexington, KY 40536 USA.	dbfee2@email.uky.edu					Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; di Michele F, 2000, NEUROSCI LETT, V284, P65, DOI 10.1016/S0304-3940(00)00965-4; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Gintzler A R, 2001, Prog Brain Res, V133, P83; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; GUTH L, 1994, P NATL ACAD SCI USA, V91, P12308, DOI 10.1073/pnas.91.25.12308; Ibanez C, 2003, PROG NEUROBIOL, V71, P49, DOI 10.1016/j.pneurobio.2003.09.002; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Labombarda F, 2002, J NEUROTRAUM, V19, P343, DOI 10.1089/089771502753594918; Labombarda F, 2000, J STEROID BIOCHEM, V73, P159, DOI 10.1016/S0960-0760(00)00064-9; MACLUSKY NJ, 1978, NATURE, V274, P276, DOI 10.1038/274276a0; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Rabchevsky AG, 2003, J NEUROTRAUM, V20, P659, DOI 10.1089/089771503322144572; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Robel P, 1995, CRIT REV NEUROBIOL, V9, P383; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Scheff SW, 2002, J NEUROTRAUM, V19, P1251, DOI 10.1089/08977150260338038; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; YU WHA, 1989, BRAIN RES, V491, P379, DOI 10.1016/0006-8993(89)90075-9	29	36	37	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 16	2007	1137	1					146	152		10.1016/j.brainres.2006.12.024			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	145EY	WOS:000244849300017	17204255				2022-02-06	
J	Mitra, B; Cameron, P; Butt, W				Mitra, Biswadev; Cameron, Peter; Butt, Warwick			Population-based study of paediatric head injury	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						craniocerebral trauma; Emergency Medicine; Epidemiology; Neurosurgery	TRAUMATIC BRAIN-INJURY; CHILDREN; MORTALITY	Aim: There is a paucity of population-based studies regarding the spectrum of paediatric head injury from mild through serious to fatal paediatric head injury. The aims of the present study were to determine the incidence, demographics and outcome of significant head injury in a state-wide population of children aged 0-15 years. A secondary aim was to determine if any serious head injuries were being missed under the current management protocols of the state-wide trauma system. Methods: A retrospective review of significant head injury in all paediatric patients over a period of 2 years was undertaken. Data were collected from the Victorian State Trauma Outcome Registry and Monitoring database, the Victorian Emergency Minimum Dataset and from the Victorian Institute of Forensic Medicine. Results: The incidence of paediatric head injury in Victoria over the 2-year period was 765 per 100 000 per year. The incidence of admitted head injuries was 75 per 100 000 per year and the incidence of significant head injury was seven per 100 000 or 151 children. Forty-one per cent of these injuries required surgical intervention. Mortality was 1.6 children per 100 000. All patients who died presented with a Glasgow Coma Score (GCS) of 3 and had multiple other risk factors. There were no deaths in patients discharged from hospital. Demographic and clinical factors associated with higher mortality and morbidity was determined. Conclusion: The incidence of significant paediatric head injury was low. Deaths occurred early and were always associated with significant early clinical features of severe head injury. This highlights the importance of strategies for the prevention of head injuries. There appeared to be no serious head injuries missed during the study period.	Monash Univ, Alfred Emergency & Trauma Ctr, Melbourne, Vic 3004, Australia; Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; Royal Childrens Hosp, Intens Care Unit, Melbourne, Vic, Australia; Alfred Hosp, Intens Care Unit, Melbourne, Vic, Australia; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia		Mitra, B (corresponding author), Monash Univ, Alfred Emergency & Trauma Ctr, Commercial Rd, Melbourne, Vic 3004, Australia.	b.mitra@alfred.org.au	Mitra, Biswadev/AAC-3724-2019	Mitra, Biswadev/0000-0002-0508-2450; Cameron, Peter/0000-0002-1443-557X			Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BROOKES M, 1990, J EPIDEMIOL COMMUN H, V44, P147, DOI 10.1136/jech.44.2.147; Brown L, 2003, AM J EMERG MED, V21, P467, DOI 10.1016/S0735-6757(03)00174-8; Cameron P, 1995, AUST NZ J SURG, V65, P848, DOI 10.1111/j.1445-2197.1995.tb00574.x; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; COOKSLEY D, 2006, TXB PAEDIAT EMERGENC, P63; COOKSLEY D, 2006, TXB PAEDIAT EMERGENC, P62; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Gabbe BJ, 2005, ANZ J SURG, V75, P650, DOI 10.1111/j.1445-2197.2005.03484.x; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hirsch W, 2002, PAEDIATR ANAESTH, V12, P337, DOI 10.1046/j.1460-9592.2002.00837.x; INABA A, 1991, EMERG MED CLIN N AM, V9, P290; International Liaison Committee on Resuscitation, 2005, Resuscitation, V67, P271; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; MULLICK P, 2004, INDIAN J ANAEST, V48, P111; Pickett W, 2001, CAN MED ASSOC J, V165, P288; Ratan Simmi K., 2002, Indian Journal of Pediatrics, V69, P573, DOI 10.1007/BF02722680; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Sanchez JI, 1999, SURG CLIN N AM, V79, P1503, DOI 10.1016/S0039-6109(05)70090-6; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Sharma M, 1994, Indian Pediatr, V31, P733; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; Williamson LM, 2002, J EPIDEMIOL COMMUN H, V56, P285, DOI 10.1136/jech.56.4.285	25	36	36	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1034-4810	1440-1754		J PAEDIATR CHILD H	J. Paediatr. Child Health	MAR	2007	43	3					154	159		10.1111/j.1440-1754.2007.01035.x			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	132WT	WOS:000243974300012	17316189				2022-02-06	
J	Rusnak, M; Janciak, I; Majdan, M; Wilbacher, I; Mauritz, W				Rusnak, Martin; Janciak, Ivan; Majdan, Marek; Wilbacher, Ingrid; Mauritz, Walter		Austrian Severe TBI Study Investig	Severe traumatic brain injury in Austria VI: Effects of guideline-based management	WIENER KLINISCHE WOCHENSCHRIFT			English	Article						brain injury; traumatic; guidelines; compliance; resuscitation; mannitol; ICP; barbiturates; corticosteroids; hyperventilation; lengths of stay; monitoring; outcome	SEVERE HEAD-INJURY; CARE MANAGEMENT; UNITED-STATES; SCALE; PROTOCOL; OUTCOMES; SCORE	OBJECTIVES: The goal of this paper is to report relations between health outcomes and implementation of individual recommendations of the guidelines. PATIENTS AND METHODS: Data sets from 405 patients included by 5 Austrian hospitals were available. The analysis focused on the compliance of treatment modalities to TBI guidelines recommendations. Compliance was evaluated based on scores developed specifically for this purpose. To evaluate the relations between the TBI guidelines compliance and outcomes the estimation of odds ratios was computed using multiple as well as logistic regression with age, ISS and initial GCS used to control confounding. RESULTS: The option on prehospital resuscitation was followed in 84%, the guideline on early resuscitation was followed in 79%. The guideline on intracranial pressure treatment threshold was the most closely followed one (89%). The option on cerebral perfusion pressure was followed in less than 30% of patients. Only the scores on resuscitation of blood pressure and oxygenation and on cerebral perfusion pressure were positively and statistically significantly related to ICU survival. Positive relations were also found for adherence to the recommendations on the type of monitoring, hyperventilation (guideline), prophylactic use of anti-seizure drugs, and the total of scores. The other recommendations were negatively related to ICU survival, but computed odds ratios were statistically not significant. Analysis of relations between compliance scores and length of ICU and hospitals stay in survivors showed that adherence to the recommendations on type of monitoring was related to a reduction of length of stay in ICU and hospital, adherence to the hyperventilation guideline was related to shortened ICU, but increased hospital stay, and adherence to the guideline on mannitol was related to reduced days in hospital, but not to days in ICU. Implementing the standard on corticosteroid use was related to a reduction of days both in hospital and ICU. Using the standard on prophylactic use of anti-seizure drugs was related to a reduction in ICU days. If all the recommendations were closely followed an increase of days in ICU would be observed, while the length of stay in hospital would be reduced. CONCLUSIONS: The relatively strong relation between initial resuscitation in the hospital and ICU survival provides a firm basis for future efforts of emergency teams. The positive influence of some of the recommendations on reduction of ICU or hospital days may provide economic incentives to promote guidelines implementation.	INRO, Med Advisory Board, Vienna, Austria; Trauma Hosp Lorenz Boehler, Dept Anaesthesia & Crit Care Med, Vienna, Austria		Rusnak, M (corresponding author), INRO, Med Advisory Board, Vienna, Austria.		Majdan, Marek/K-5017-2012; Rusnak, Martin/K-9349-2016	Majdan, Marek/0000-0001-8037-742X; Rusnak, Martin/0000-0003-3321-1042; Mauritz, Walter/0000-0001-9043-3712			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Clayton TJ, 2004, BRIT J ANAESTH, V93, P761, DOI 10.1093/bja/aeh249; Drobetz H, 2000, ANASTH INTENSIV NOTF, V35, P630, DOI 10.1055/s-2000-7365; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hurwitz B, 1999, BRIT MED J, V318, P661, DOI 10.1136/bmj.318.7184.661; JENNETT B, 1975, LANCET, V1, P480; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Mauritz W, 2003, CLIN RES REGUL AFF, V20, P81, DOI 10.1081/CRP-120018744; Mcilvoy L, 2001, J Neurosci Nurs, V33, P72; Miller KJ, 2005, J NEUROSURG, V103, P239, DOI 10.3171/jns.2005.103.2.0239; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; ROSENBERG J, 1992, NEUROLOGY, V42, P1110, DOI 10.1212/WNL.42.5.1110; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Scottish Intercollegiate Guidelines Network (SIGN), GUID DEV HDB; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; WALTERS BC, 1998, NEUROSURGERY TRANSIT, P99	23	36	39	0	10	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	FEB	2007	119	1-2					64	71		10.1007/s00508-006-0765-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	142GQ	WOS:000244637800012	17318752				2022-02-06	
J	Cormio, M; Citerio, G				Cormio, Manuela; Citerio, Giuseppe			Continuous low dose diclofenac sodium infusion to control fever in neurosurgical critical care	NEUROCRITICAL CARE			English	Article						fever; antipyretic therapy; diclofenac sodium; cerebral perfusion pressure; intracranial pressure; traumatic brain injury; subarachnoid hemorrhage	INTENSIVE-CARE; BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; ANTIPYRETIC THERAPY; CEREBRAL-ISCHEMIA; BODY-TEMPERATURE; FEBRILE PATIENTS; CLINICAL-TRIAL; STROKE; HYPERTHERMIA	Introduction: Aim of this randomized prospective clinical trial is to compare two methods of antipyretics and evaluate their efficacy in controlling fever during the acute phase of brain damage. Methods: Twenty-two febrile comatose patients: 12 severe traumatic brain injury and 10 subarachnoid hemorrhage divided in 2 groups: Diclofenac low-dose infusion (10 patients) and extemporaneous boluses of NSAIDs (CTRL, 12 patients). The primary outcome measure was length of time with temperature > 38 degrees C. Secondary outcome measures were: 1) to assess the effects of each antipyretic strategy on intracranial pressure (ICP), cerebral perfusion pressure (CPP), mean arterial pressure (MAP) and heart rate; 2) to monitor adverse effects of each antipyretic strategy. The baseline characteristics in the two treatment groups were similar. Results: Primary findings: percentage of time per patient with temperature > 38 degrees C was significantly lower (P < 0.0001) in the DCF group, 4% (0-22%), vs. 34% (8-56%) in CTRL group. In addition, mean T degrees, max T degrees were lower in DCF than in CTRL (P < 0.05). Secondary findings: CPP and MAP were significantly higher in DCF group (P < 0.05) while ICP was not different (NS). However, if ICP pre randomization was < 25 mmHg, CTRL suffered a worst ICP (24 +/- 11 vs. +/- 16 +/- 7 P = 0.01), MAP (89 +/- 10 vs. 104 +/- 10 P = 0.01) and CPP (75 +/- 10 vs. 94 +/- 17 P = 0.01) compared to DCF. No differences between the two treatment were recorded when ICP +/- 25 mmHg before randomization. There was no gastrointestinal or intracranial bleeding. Conclusions: Low dose DCF infusion is a potential useful strategy for a successful control temperature better than intermittent NSAIDs dosing, minimizing potentially brain-damaging effects of fever.	Osped San Gerardo, Dipartimento Med Perioperatoria & Terapie Intens, I-20052 Monza, MI, Italy		Citerio, G (corresponding author), Osped San Gerardo, Dipartimento Med Perioperatoria & Terapie Intens, Via Pergolesi 33, I-20052 Monza, MI, Italy.	g.citerio@hsgerardo.org	Citerio, Giuseppe/B-1839-2015	Citerio, Giuseppe/0000-0002-5374-3161			Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; BETTINI R, 1986, J INT MED RES, V14, P95, DOI 10.1177/030006058601400208; Boyle M, 1997, Aust Crit Care, V10, P120, DOI 10.1016/S1036-7314(97)70414-4; Brown G, 1996, HEART LUNG, V25, P137, DOI 10.1016/S0147-9563(96)80116-6; Cairns Chris J S, 2002, Curr Opin Crit Care, V8, P106, DOI 10.1097/00075198-200204000-00003; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Corbett D, 2000, BRAIN PATHOL, V10, P145; Cormio M, 2000, INTENS CARE MED, V26, P552, DOI 10.1007/s001340051203; DIETRICH WD, 1992, J NEUROTRAUMA, V9, P475; GARNER JS, 1996, APIC INFECT CONTROL; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Henker R, 2001, Am J Crit Care, V10, P276; HETHERINGTON JW, 1986, BRIT MED J, V292, P237, DOI 10.1136/bmj.292.6515.237; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Klein NC, 1996, INFECT DIS CLIN N AM, V10, P211, DOI 10.1016/S0891-5520(05)70295-6; Lenhardt R, 1999, AM J MED, V106, P550, DOI 10.1016/S0002-9343(99)00068-6; LUNDSTAM SOA, 1982, LANCET, V1, P1096; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Mackenzie I, 2000, INTENS CARE MED, V26, P1408, DOI 10.1007/s001340000614; MALKINSON TJ, 1990, AM J PHYSIOL, V258, pR783, DOI 10.1152/ajpregu.1990.258.3.R783; MAYBERG MR, 1994, STROKE, V25, P2315, DOI 10.1161/01.STR.25.11.2315; Mayer SA, 2001, NEUROLOGY, V56, P292, DOI 10.1212/WNL.56.3.292; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Oborilova A, 2002, J PAIN SYMPTOM MANAG, V24, P608; ODonnell J, 1997, CLIN INFECT DIS, V24, P1208, DOI 10.1086/513660; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; PESENTI A, 1986, INTENS CARE MED, V12, P370, DOI 10.1007/BF00292928; Poblete B, 1997, BRIT J ANAESTH, V78, P123, DOI 10.1093/bja/78.2.123; POCOCK SJ, 1992, BMJ-BRIT MED J, V305, P235, DOI 10.1136/bmj.305.6847.235; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Thornhill J, 2001, CAN J PHYSIOL PHARM, V79, P254, DOI 10.1139/cjpp-79-3-254; Wang Y, 2000, STROKE, V31, P404, DOI 10.1161/01.STR.31.2.404; WASS CT, 1995, ANESTHESIOLOGY, V83, P325, DOI 10.1097/00000542-199508000-00013; Yu CG, 2001, NEUROSURGERY, V49, P152, DOI 10.1097/00006123-200107000-00023; ZANDSTRA DF, 1983, INTENS CARE MED, V9, P21, DOI 10.1007/BF01693701	40	36	36	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care		2007	6	2					82	89		10.1007/s12028-007-0002-3			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	179DW	WOS:000247270700002	17522789				2022-02-06	
J	Stapleton, S; Adams, M; Atterton, L				Stapleton, Sally; Adams, Malcolm; Atterton, Linda			A mobile phone as a memory aid for individuals with traumatic brain injury: A preliminary investigation	BRAIN INJURY			English	Article						memory aid; memory rehabilitation; cognitive rehabilitation; traumatic brain injury; single case series	COGNITIVE REHABILITATION; PAGING SYSTEM	Primary objective: To investigate the use of a 'reminders' function on a mobile phone as a compensatory memory aid for five individuals with traumatic brain injury ( TBI). Research design: A series of five single case ABAB reversal design. Methods and procedure: A mobile phone was given to each participant during two intervention phases. Target behaviours were recorded for the length of the study. Experimental intervention: The phone was programmed to prompt a number of identified target behaviours. Main outcomes and results: For two participants, there was an increase in the target behaviours achieved when the phone was used, with percentages rising from 51% to 95% for Participant 1 ( P1) and 58% to 88% for Participant 5 ( P5). The percentage of target behaviours achieved did not return to initial baseline levels when the phone was removed, indicating that the intervention may have facilitated P1 and, in particular, P5 in the learning of their routines. The participants who did not benefit from the mobile phone differed from P1 and P5 as they fell in the category of 'severe memory impairment' on the RBMT, were significantly impaired on an assessment of executive functioning ( Tower Test) and required 24- hour care. Conclusions: The preliminary investigation with five participants suggests that this system may be of best use with individuals who do not require 24- hour care and do not experience severe memory and executive functioning difficulties. However, further research with a larger sample is highly recommended.	Julian Hosp, So Team, Norwich NR2 3TD, Norfolk, England; Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Colman Hosp, Colman Ctr Specialist Rehabil, Dept Psychol, Norwich, Norfolk, England		Stapleton, S (corresponding author), Julian Hosp, So Team, Bowthorpe Rd, Norwich NR2 3TD, Norfolk, England.	sally.stapleton@nwmhp.nhs.uk					BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Baddeley A., 1992, SPEED CAPACITY LANGU; Barlow DH, 1984, SINGLE CASE EXPT DES; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; DELIS DC, 2001, DKEFS EXECUTIVE FUNC; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Evans JJ, 2006, J NEUROL, V253, P520, DOI 10.1007/s00415-006-0014-5; Huitema B. E., 2004, Understanding Statistics, V3, P27, DOI 10.1207/s15328031us0301_2; Hunkin NM, 1998, NEUROPSYCHOLOGIA, V36, P25, DOI 10.1016/S0028-3932(97)00106-1; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P1; MORLEY S, 1991, BRIT J CLIN PSYCHOL, V30, P97, DOI 10.1111/j.2044-8260.1991.tb00926.x; MORLEY S, 1989, BRIT J CLIN PSYCHOL, V28, P1, DOI 10.1111/j.2044-8260.1989.tb00807.x; Robertson I., 1994, TEST EVERYDAY ATTENT; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; WILSON BA, 1991, NEUROPSYCHOL REHABIL, V1, P117, DOI DOI 10.1080/09602019108401386; World Health Organization, 2007, INT CLASS FUNCT DIS	24	36	36	0	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	4					401	411		10.1080/02699050701252030			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	168IY	WOS:000246518600006	17487638				2022-02-06	
J	Trokel, M; Discala, C; Terrin, NC; Sege, RD				Trokel, Matthew; Discala, Carla; Terrin, Norma C.; Sege, Robert D.			Patient and injury characteristics in abusive abdominal injuries	PEDIATRIC EMERGENCY CARE			English	Article						child abuse; blunt abdominal injury	TRAUMATIC BRAIN-INJURY; CHILD-ABUSE; YOUNG-CHILDREN; BLUNT TRAUMA; HEAD-INJURY; FRACTURES; INFANTS; MECHANISMS; HOSPITALS; ACCIDENT	Objective: To identify patient and injury characteristics associated with suspected child abuse in the setting of blunt abdominal trauma. Patients: We extracted from the National Pediatric Trauma Registry phases 2 and 3 (October 1995 to April 2001; N = 106,135) all-cases of blunt abdominal injury, excluding motor vehicle injuries, in patients aged 0 to 4 years. Main Outcome Measures: Independent variables included age, mortality, nutritional status, and injury type. The dependent variable was suspected child abuse. Results: Six hundred sixty-four cases were analyzed. The median age of patients was 2.6 years; 11.4% were undernourished. The 3 most common mechanisms of injury were suspected child abuse (40.5%), fall (36.6%), and struck-not child abuse (9.7%). Hepatic injury (46.1%) was the most common intra-abdominal injury, followed by splenic (26%), hollow viscous (17.9%), and pancreatic (8.6%) injuries. Eighty-four percent of deaths were related to suspected child abuse. There was a greater proportion of children with suspected child abuse in every patient and injury characteristics studied than all other mechanisms combined. In a regression model including age, undernourishment, pancreatic injury, hollow viscous injury, traumatic brain injury, and mortality, all variables were significantly associated with suspected abuse. Hollow viscous injury had the highest odds ratio (OR, 9.5; confidence limits, 5.7, 15.8), whereas traumatic brain injury had the lowest (OR, 3.6; confidence limits, 2.4, 5.6). Conclusions: Young children with severe pancreatic or hollow viscous injuries or severe abdominal injuries in the context of either brain injury or undernourishment should be evaluated for the possibility that these injuries resulted from abuse. Increasing the awareness of the possibility of child abuse associated with a set of injury characteristics may allow for more consistent and complete medical evaluation.	Boston Med Ctr, Dept Pediat, Boston, MA USA; Floating Hosp, Pediat & Adolescent Hlth Res Ctr, Boston, MA USA; Tufts New England Med Ctr, Biostat Res Ctr, Boston, MA USA; Tufts New England Med Ctr, Div Clin Care Res, Boston, MA USA		Sege, RD (corresponding author), Tufts Univ New England Med Ctr, Pediat & Adolescent Hlth Res Ctr, Box 351,750 Washington St, Boston, MA 02111 USA.	rsege@tufts-nemc.org		Sege, Robert/0000-0003-1260-4787	AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [T32 HS0060-09] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR1186-03] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [T32HS000060] Funding Source: NIH RePORTER		Arkovitz MS, 1997, J TRAUMA, V42, P49, DOI 10.1097/00005373-199701000-00009; Athey J, 2001, PEDIATR EMERG CARE, V17, P170, DOI 10.1097/00006565-200106000-00005; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; CANIANO DA, 1986, ANN SURG, V203, P219, DOI 10.1097/00000658-198602000-00017; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; *CHILD WELF INF GA, CHILD AB NEGL FAT ST; COBB LM, 1986, J TRAUMA, V26, P461, DOI 10.1097/00005373-198605000-00009; COOPER A, 1994, J PEDIATR SURG, V29, P33, DOI 10.1016/0022-3468(94)90518-5; COOPER A, 1988, J TRAUMA, V28, P1483, DOI 10.1097/00005373-198810000-00015; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; GORNALL P, 1972, ARCH DIS CHILD, V47, P211, DOI 10.1136/adc.47.252.211; HAMPTON RL, 1985, AM J PUBLIC HEALTH, V75, P56, DOI 10.2105/AJPH.75.1.56; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; KARP RJ, 1989, CLIN PEDIATR, V28, P317, DOI 10.1177/000992288902800704; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; LEDBETTER DJ, 1988, ARCH SURG-CHICAGO, V123, P1101; NAKAYAMA DK, 1992, J PEDIATR SURG, V27, P427, DOI 10.1016/0022-3468(92)90328-5; Nance ML, 2000, J PEDIATR SURG, V35, P1300, DOI 10.1053/jpsu.2000.9301; *NAT CTR HLTH STAT, CDC GROWTH CHARTS US; ONEILL JA, 1973, J TRAUMA, V13, P332, DOI 10.1097/00005373-197304000-00012; PENA SDJ, 1973, J PEDIATR-US, V83, P1026, DOI 10.1016/S0022-3476(73)80542-6; Rex C, 2000, J PEDIATR ORTHOPED, V20, P411; Scherl SA, 2000, CLIN ORTHOP RELAT R, P96; Shaw BA, 1997, J PEDIATR ORTHOPED, V17, P293, DOI 10.1097/00004694-199705000-00005; Skuse D H, 1995, J Med Screen, V2, P145; Tepas Joseph J. Iii, 1993, Current Opinion in Pediatrics, V5, P317	30	36	37	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	2006	22	10					700	704		10.1097/01.pec.0000238734.76413.d0			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Pediatrics	096HQ	WOS:000241368600002	17047468				2022-02-06	
J	Bond, CE; Patel, P; Crouch, L; Tetlow, N; Day, T; Abu-Hayyeh, S; Williamson, C; Greenfield, SA				Bond, C. E.; Patel, P.; Crouch, L.; Tetlow, N.; Day, T.; Abu-Hayyeh, S.; Williamson, C.; Greenfield, S. A.			Astroglia up-regulate transcription and secretion of 'readthrough' acetylcholinesterase following oxidative stress	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						astrocyte; degeneration; hypoxia; neurotoxicity; rat; RNA	ALZHEIMERS-DISEASE; BUTYRYLCHOLINESTERASE; ASTROCYTES; EXPRESSION; VARIANTS; NEURONS; ROLES; BRAIN	Novel and diverse functions of glial cells are currently the focus of much attention [A. Volterra and J. Meldolesi (2005)Nature Rev. 6, 626-640]. Here we present evidence that rat astroglia release acetylcholinesterase (AChE) as part of their response to hypoxic damage. Exposure of astroglia to tert-butyl hydroperoxide, and hence oxidative stress, subsequently leads to a switching in mRNA from the classical membrane-bound T-AChE to a preferential increase in the splice variant for a soluble form, R-AChE, This change in expression is reflected in increased perinuclear and reduced cytoplasmic AChE staining of the insulted glial cells, with a concomitant and marked increase in extracellular secretion that peaks at 1 h post-treatment. An analogous increase in R-AChE, over a similar time scale, occurs in response to psychological stress [D. Kaufer et al. (1998)Nature 93, 373-377], as well as to head injury and stroke [E. Shohami et al. (1999)J. Neurotrauma 6, 365-76]. The data presented here suggest that glial cells may be key chemical intermediaries in such situations and, perhaps more generally in pathological conditions involving oxidative stress, such as neurodegeneration.	Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London W12 0NN, England		Bond, CE (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	cherie.bond@pharm.ox.ac.uk		Williamson, Catherine/0000-0002-6226-7611			Allen Matthew, 1994, Clinical Materials, V16, P189; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; Coleman BA, 1996, J BIOL CHEM, V271, P4410; Day T, 2002, NEUROSCIENCE, V111, P649, DOI 10.1016/S0306-4522(02)00031-3; Desagher S, 1996, J NEUROSCI, V16, P2553; Dori A, 2005, CEREB CORTEX, V15, P419, DOI 10.1093/cercor/bhh145; Dringen R, 1998, GLIA, V23, P139, DOI 10.1002/(SICI)1098-1136(199806)23:2<139::AID-GLIA5>3.0.CO;2-1; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Eriksson M, 2000, J BIOL CHEM, V275, P19964, DOI 10.1074/jbc.M001592200; Greenfield S, 2002, NEUROSCIENCE, V113, P485, DOI 10.1016/S0306-4522(02)00194-X; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; HEDREEN JC, 1985, J HISTOCHEM CYTOCHEM, V33, P134, DOI 10.1177/33.2.2578498; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Keymer JE, 1999, EUR J NEUROSCI, V11, P1049, DOI 10.1046/j.1460-9568.1999.00510.x; Marchetti B, 2005, BRAIN RES REV, V48, P129, DOI 10.1016/j.brainresrev.2004.12.002; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Patel P, 2003, PLACENTA, V24, P39, DOI 10.1053/plac.2002.0879; Pick M, 2004, ANN NY ACAD SCI, V1018, P85, DOI 10.1196/annals.1296.010; Saez-Valero J, 2003, NEUROSCI LETT, V348, P123, DOI 10.1016/S0304-3940(03)00790-0; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Toiber D, 2005, NEUROCHEM RES, V30, P909, DOI 10.1007/s11064-005-6963-8; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Whyte KA, 2003, EXP NEUROL, V184, P496, DOI 10.1016/S0014-4886(03)00386-8	24	36	38	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUL	2006	24	2					381	386		10.1111/j.1460-9568.2006.04898.x			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	065IH	WOS:000239152900006	16903848				2022-02-06	
J	Kurpius, D; Wilson, N; Fuller, L; Hoffman, A; Dailey, ME				Kurpius, Dana; Wilson, Nicholas; Fuller, Leah; Hoffman, Amara; Dailey, Michael E.			Early activation, motility, and homing of neonatal microglia to injured neurons does not require protein synthesis	GLIA			English	Article						brain slice; time-lapse; motility; migration; anisomycin; CNS trauma; LFA-1; ED1	HIPPOCAMPAL SLICE CULTURES; NF-KAPPA-B; ADHESION MOLECULE EXPRESSION; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; FACIAL MOTOR NUCLEUS; IN-VITRO; EXTRACELLULAR-MATRIX; RAT-BRAIN; CELLS	Neuronal injury in CNS tissues induces a rapid activation and mobilization of resident microglia (MG). It is widely assumed that changes in gene expression drive the morphological transformation of MG and regulate their mobilization during activation. Here, we used acutely excised neonatal rat brain slices to test whether the morphological transformation and homing of MG to injured neurons requires gene expression and de novo protein synthesis. Traumatic injury during excision of live brain tissue slices induces a rapid and transient translocation of a transcription factor, NF-kappa B, to nuclei in MG. This is followed within 4-8 h by an increase in immunolabeling for cell adhesion molecules and lysosomal proteins, accompanied by changes in cell morphology. Application of anisomycin, a protein synthesis inhibitor, prevents the increase in immunolabeling for markers of MG activation but not the morphological transformation. Confocal time-lapse imaging in live tissue slices indicates that MG cell motility (branch extension and retraction) and locomotion are unaffected by anisomycin at early postinjury time-points (< 4 h), while at later timepoints (4-8 h postinjury) MG locomotion but not motility is inhibited. Thus, activated MG rapidly localize to injure pyramidal neuron cell bodies by 4-h postinjury, even in the presence of anisomycin. Moreover, this early MG activation and homing to injured neurons is unaffected in tissue slices from beta 2 integrin deficient mice. These results indicate that gene activation and new protein synthesis coincide with, but are not necessary for, the rapid morphological transformation and early migration-dependent homing of activated MG to injured neurons in CNS tissues. (c) 2006 Wiley-Liss, Inc.	Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA		Dailey, ME (corresponding author), Univ Iowa, Dept Biol Sci, 369 Biol Bldg, Iowa City, IA 52242 USA.	Michael-e-dailey@uiowa.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR017941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS043468] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10 RR017941] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS43468, R01 NS043468] Funding Source: Medline		Abd-El-Basset EM, 2004, MED PRIN PRACT, V13, P325, DOI 10.1159/000080469; AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Bellander BM, 2004, J NEUROTRAUM, V21, P605, DOI 10.1089/089771504774129937; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Bianco F, 2005, BRAIN RES REV, V48, P144, DOI 10.1016/j.brainresrev.2004.12.004; Boucsein C, 2000, EUR J NEUROSCI, V12, P2049, DOI 10.1046/j.1460-9568.2000.00100.x; Brauer AU, 2004, FEBS LETT, V563, P41, DOI 10.1016/S0014-5793(04)00244-3; Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO;2-E; Carbonell WS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-5; Carbonell WS, 2005, J NEUROSCI, V25, P7040, DOI 10.1523/JNEUROSCI.5171-04.2005; DAILEY ME, 2005, IMAGING NEUROSCIENCE; Dalmau I, 1998, HIPPOCAMPUS, V8, P458, DOI 10.1002/(SICI)1098-1063(1998)8:5<458::AID-HIPO6>3.0.CO;2-N; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dong JH, 2004, GLIA, V47, P102, DOI 10.1002/glia.10355; Elkabes S, 1996, J NEUROSCI, V16, P2508; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; GRAEBER MB, 1990, J NEUROIMMUNOL, V27, P121, DOI 10.1016/0165-5728(90)90061-Q; Grossmann R, 2002, GLIA, V37, P229, DOI 10.1002/glia.10031; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; Hailer NP, 1997, HIPPOCAMPUS, V7, P341, DOI 10.1002/(SICI)1098-1063(1997)7:3<341::AID-HIPO8>3.0.CO;2-N; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Heppner FL, 1998, EUR J NEUROSCI, V10, P3284, DOI 10.1046/j.1460-9568.1998.00379.x; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kalla R, 2001, J COMP NEUROL, V436, P182; KALTSCHMIDT C, 1994, J NEUROIMMUNOL, V55, P99, DOI 10.1016/0165-5728(94)90151-1; Kloss CUA, 1999, J COMP NEUROL, V411, P162, DOI 10.1002/(SICI)1096-9861(19990816)411:1<162::AID-CNE12>3.0.CO;2-W; Kloss CUA, 2001, EXP NEUROL, V168, P32, DOI 10.1006/exnr.2000.7575; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; KURPIUS D, 2005, IMAGING NEUROSCIENCE; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2002, J NEUROSCI, V22, P1562, DOI 10.1523/JNEUROSCI.22-05-01562.2002; MONETA ME, 1993, J NEUROIMMUNOL, V45, P203, DOI 10.1016/0165-5728(93)90181-W; NAKAJIMA K, 2005, NEUROGLIA; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Olsen IM, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-25; Origasa M, 2001, MOL BRAIN RES, V88, P1, DOI 10.1016/S0169-328X(01)00005-5; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rappert A, 2002, J IMMUNOL, V168, P3221, DOI 10.4049/jimmunol.168.7.3221; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sanz O, 2002, J NEUROSCI RES, V67, P772, DOI 10.1002/jnr.10140; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Schiefer J, 1999, J NEUROCYTOL, V28, P439, DOI 10.1023/A:1007048903862; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; STREIT WJ, 1993, GLIA, V7, P68, DOI 10.1002/glia.440070112; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; WILSON RW, 1993, J IMMUNOL, V151, P1571; Witting A, 2000, J NEUROCHEM, V75, P1060, DOI 10.1046/j.1471-4159.2000.0751060.x; Yu NC, 1998, NEUROIMMUNOMODULAT, V5, P42, DOI 10.1159/000026325; Zuckerman SH, 1998, INFLAMMATION, V22, P95, DOI 10.1023/A:1022351908951	59	36	39	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JUL	2006	54	1					58	70		10.1002/glia.20355			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	050JZ	WOS:000238084900006	16715500				2022-02-06	
J	Richardson, RM; Holloway, KL; Bullock, MR; Broaddus, WC; Fillmore, HL				Richardson, RM; Holloway, KL; Bullock, MR; Broaddus, WC; Fillmore, HL			Isolation of neuronal progenitor cells from the adult human neocortex	ACTA NEUROCHIRURGICA			English	Article						adult human brain; neuronal progenitor cell; autologous transplantation; traumatic brain injury	NEURAL STEM-CELLS; HUMAN BRAIN; ZONE; NEUROGENESIS; HIPPOCAMPUS; PRECURSORS; FOREBRAIN; PRIMATES; REGIONS; CULTURE	Background. The reliability of harvesting neuronal progenitor cells (NPCs) from the adult human neocortex has not been established, with respect to preparing autologous cell cultures for transplantation in stroke and traumatic brain injured patients. Method. Enriched NPC cultures have been generated from nonneurogenic regions of the adult rodent brain by buoyancy-dependent fractionation, but the feasibility of using such a method to isolate NPCs from the adult human cortex has not been reported previously. To determine if a starter population of human adult cortical NPCs could be isolated for in vitro expansion using this method, tissue samples from five patients undergoing cortical resection for either epilepsy or trauma were assayed. Findings. Cultured cells generated from all patients predominately expressed both the NPC marker nestin and neuron-specific beta-tubulin III. The presence of NPCs was verified by in vitro BrdU/beta-tubulin III co-labeling and increasing beta-tubulin expression in differentiating conditions. Despite the formation of aggregates in monolayer culture, cell proliferation as measured by BrdU incorporation was not as prevalent as that reported from rodent cultures generated by this protocol. Conclusions. NPCs isolated from the adult human neocortex using this method expressed beta-tubulin III in larger percentages than has been previously reported for NPCs isolated using other methods. As such, these data suggest the possibility of culturing dividing neuroblasts from the adult neocortex for further manipulation as transplantable cells.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Virginia Commonwealth Univ, Med Coll Virginia Hosp, Dept Neurosurg, Richmond, VA USA; McGuire Dept Vet Affairs Med Ctr, Neurosurg Serv, Richmond, VA USA; McGuire Dept Vet Affairs Med Ctr, Parkinsons Dis Res Educ & Clin Ctr, Richmond, VA USA		Richardson, RM (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,Rm M779, San Francisco, CA 94143 USA.	robertmark.richardson@ucsfmedctr.org	Broaddus, William/ABF-8984-2020; Richardson, R Mark/C-6819-2016; Messier, Claude/A-2322-2008	Broaddus, William/0000-0001-9614-8162; Richardson, R Mark/0000-0003-2620-7387; Messier, Claude/0000-0002-4791-1763; Fillmore, Helen/0000-0003-4131-579X; Holloway, Kathryn/0000-0003-3777-0060	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, F31NS042420, P50NS012587] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA16059] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31 NS042420-04, F31 NS042420-03, F31NS42420, F31 NS042420, F31 NS042420-01, NS12587, F31 NS042420-02] Funding Source: Medline		Arsenijevic Y, 2001, EXP NEUROL, V170, P48, DOI 10.1006/exnr.2001.7691; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2001, P NATL ACAD SCI USA, V98, P10910, DOI 10.1073/pnas.181354698; Gritti A, 1999, J NEUROSCI, V19, P3287; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Lie DC, 2002, J NEUROSCI, V22, P6639; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Richardson RM, 2005, MOL CELL NEUROSCI, V28, P674, DOI 10.1016/j.mcn.2004.11.013; Richardson RM, 2005, BRAIN RES, V1032, P11, DOI 10.1016/j.brainres.2004.10.043; Richardson RM, 2004, J NEUROSURG, V100, P659, DOI 10.3171/jns.2004.100.4.0659; Roy NS, 2000, J NEUROSCI RES, V59, P321, DOI 10.1002/(SICI)1097-4547(20000201)59:3<321::AID-JNR5>3.0.CO;2-9; Roy NS, 2000, NAT MED, V6, P271; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X	24	36	37	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JUL	2006	148	7					773	777		10.1007/s00701-006-0778-5			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	058SR	WOS:000238685400013	16708171				2022-02-06	
J	Tate, RL; Pfaff, A; Baguley, IJ; Marosszeky, JE; Gurka, JA; Hodgkinson, AE; King, C; T Lane-Brown, A; Hanna, J				Tate, R. L.; Pfaff, A.; Baguley, I. J.; Marosszeky, J. E.; Gurka, J. A.; Hodgkinson, A. E.; King, C.; T Lane-Brown, A.; Hanna, J.			A multicentre, randomised trial examining the effect of test procedures measuring emergence from post-traumatic amnesia	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CLOSED-HEAD INJURY; TRAUMATIC BRAIN-INJURY; GALVESTON ORIENTATION; RECOVERY; MEMORY; SCALE; RETENTION; DURATION; STATE; PTA	Background: Post-traumatic amnesia (PTA) tests that record different PTA durations in the same patient, thereby raising measurement accuracy issues, have been reported previously. A major problem lies in determining the end point of PTA. Aims: To delineate areas of discrepancy in PTA tests and to provide independent verification for a criterion signalling emergence from PTA. Methods: In a randomised design, two related PTA procedures were compared, one purportedly more difficult (Westmead PTA Scale, WPTAS) than the other (Modified Oxford PTA Scale, MOPTAS). Eighty two patients in the early stages of PTA were examined daily until emergence, by using the Galveston Orientation and Amnesia Test (GOAT) and the WPTAS/MOPTAS. A short battery of cognitive and behavioural measurements was made on three occasions: at the early stage of PTA (time 1), towards the end of PTA when the maximum score (12/12) was first obtained (time 2) and at the traditional criterion for emergence (scoring 12/12 for 3 consecutive days; time 3). Results: No significant difference was recorded in PTA duration between the MOPTAS and WPTAS. Both scales recorded longer PTA durations than the GOAT. By using Kaplan-Meier survival analyses, the WPTAS was found to show a more protracted pattern of emergence at the end stage of PTA than the MOPTAS. A time lag of >= 1 week in the resolution of disorientation as compared with amnesia was observed in 59% cases. Significant improvements occurred on all independent measurements between time 1 and time 2, but on only 2 of 5 cognitive measurements between time 2 and time 3. Conclusions: Although no significant differences in the duration of PTA on the MOPTAS/WPTAS were recorded, emergence from the late stages of PTA occurred more promptly with the MOPTAS. The need for inclusion of both orientation and memory items in PTA tests is highlighted by the frequency of disorientation-amnesia dissociations. The patterns of results on the independent measures suggest that patients who are in PTA for. 4 weeks have probably emerged from PTA when they first score 12/12 on the MOPTAS/WPTAS, and this criterion can replace the traditional criterion.	Univ Sydney, Fac Med, Rehabil Studies Unit, No Clin Sch, Sydney, NSW 2006, Australia; Liverpool Hosp, Brain Injury Rehabil Serv, Sydney, NSW, Australia; Westmead Hosp, Brain Injury Rehabil Serv, Sydney, NSW, Australia; Royal Rehabil Ctr, Brain Injury Rehabil Serv, Sydney, NSW, Australia		Tate, RL (corresponding author), Rehabil Studies Unit, POB 6, Ryde, NSW, Australia.	rtate@med.usyd.edu.au	Baguley, Ian/AAM-5828-2021; Baguley, Ian J/K-6878-2013	Baguley, Ian J/0000-0001-5650-3705			Ahmed S, 2000, BRAIN INJURY, V14, P765; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Borgdorff MW, 2001, LANCET, V357, P1532, DOI 10.1016/S0140-6736(00)04690-0; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; HUNKIN NM, 1993, CORTEX, V29, P485, DOI 10.1016/S0010-9452(13)80255-9; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kennedy RE, 2003, PSYCHOSOMATICS, V44, P283, DOI 10.1176/appi.psy.44.4.283; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MILLER EN, 1990, CALIFORNIA COMPUTERI; Mysiw WJ., 1990, J HEAD TRAUMA REHAB, V5, P65; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; PARKIN AJ, 1990, CORTEX, V26, P373, DOI 10.1016/S0010-9452(13)80087-1; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Reynolds C.R., 1994, TEST MEMORY LEARNING; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Strub R, 2000, MENTAL STATUS EXAMIN; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; THORNDIKE EI, 1944, TEACHERS WORLD BOOK; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Wilson BA., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [DOI 10.1080/09602019208401410, 10.1080/09602019208401410]	35	36	38	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUL	2006	77	7							841	10.1136/jnnp.2005.074989			9	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	054ZL	WOS:000238417900011	16574735	Green Published			2022-02-06	
J	Greenspan, AI; Stringer, AY; Phillips, VL; Hammond, FM; Goldstein, FC				Greenspan, Arlene I.; Stringer, Anthony Y.; Phillips, V. L.; Hammond, Flora M.; Goldstein, Felicia C.			Symptoms of post-traumatic stress: Intrusion and avoidance 6 and 12 months after TBI	BRAIN INJURY			English	Article						post-traumatic stress symptoms; impact of events scale; amnesia; traumatic brain injury; risk factors; follow-up studies	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; DISORDER SYMPTOMS; MAJOR TRAUMA; EVENT SCALE; PSYCHIATRIC CONSEQUENCES; CONVERGENT VALIDITY; RECOVERY PROJECT; PTSD; PREDICTORS	Primary objectives: (1) To examine survivors with traumatic brain injury (TBI) for symptoms of avoidance and intrusion, two dimensions of post-traumatic stress (PTS) at 6 and 12 months post-injury. (2) To identify risk factors associated with these symptoms. Research design: Prospective follow-up study. Methods and procedures: Georgia and North Carolina Model Brain Injury Systems participants (n = 198) with mild (19%), moderate (21%) and severe (60%) TBI were interviewed by telephone at 6 and 12 months post-injury. The Impact of Event Scale (IES) was used to identify intrusion and avoidance symptoms. Results: Symptoms consistent with severe PTS increased from 11% at 6 months to 16% 12 months post-injury (p < 0.003). African-Americans (p < 0.01) and women (p < 0.05) reported greater symptomatology at 12 months compared to their counterparts. TBI severity and memory of the event were not associated with PTS-like symptoms. Symptoms increased over time when examined by race, injury intent, gender and age (p < 0.05). Conclusions: Regardless of severity, survivors with TBI are at risk for developing symptoms consistent with PTS. Amnesia for the injury event was not protective against developing these symptoms. African-Americans appear to be at greatest risk.	Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; Emory Univ, Dept Rehabil Med, Atlanta, GA 30322 USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Charlotte Inst Rehabil, Charlotte, NC USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA		Greenspan, AI (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, 4770 Buford Highway NE,Mailstop K-63, Atlanta, GA 30341 USA.	agreenspan@cdc.gov					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Blanchard E. B., 1997, CRASH ASSESSMENT TRE; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; BRESLAU N, 1995, AM J PSYCHIAT, V152, P529; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Corneil W, 1999, J Occup Health Psychol, V4, P131, DOI 10.1037/1076-8998.4.2.131; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Greenspan AI, 2002, J TRAUMA, V53, P709, DOI 10.1097/00005373-200210000-00015; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Harvey AG, 2001, J TRAUMA STRESS, V14, P277, DOI 10.1023/A:1011108816888; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kornblith AB, 1996, HEAD NECK-J SCI SPEC, V18, P323, DOI 10.1002/(SICI)1097-0347(199607/08)18:4<323::AID-HED3>3.3.CO;2-1; KORNBLITH AB, 1992, CANCER, V70, P2508, DOI 10.1002/1097-0142(19921115)70:10<2508::AID-CNCR2820701020>3.0.CO;2-V; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; MALT U, 1988, BRIT J PSYCHIAT, V153, P810, DOI 10.1192/bjp.153.6.810; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702005470; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MCFALL ME, 1990, AM J PSYCHIAT, V147, P645; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; McMillan TM, 2001, BRAIN INJURY, V15, P39, DOI 10.1080/02699050118030; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NEAL LA, 1994, J TRAUMA STRESS, V7, P447, DOI 10.1007/BF02102789; O'Donnell ML, 2003, CLIN PSYCHOL REV, V23, P587, DOI 10.1016/S0272-7358(03)00036-9; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; Richmond TS, 1998, J TRAUMA, V44, P635, DOI 10.1097/00005373-199804000-00012; Ruchkin VV, 1998, CHILD ABUSE NEGLECT, V22, P889, DOI 10.1016/S0145-2134(98)00064-7; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Shalev AY, 1997, BRIT J PSYCHIAT, V170, P558, DOI 10.1192/bjp.170.6.558; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; Sundin EC, 2003, PSYCHOSOM MED, V65, P870, DOI 10.1097/01.PSY.0000084835.46074.F0; TEASDALE G, 1974, LANCET, V2, P81; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861; ZILBERG NJ, 1982, J CONSULT CLIN PSYCH, V50, P407, DOI 10.1037/0022-006X.50.3.407; Zlotnick C, 2004, J NERV MENT DIS, V192, P153, DOI 10.1097/01.nmd.0000110287.16635.8e; Zlotnick C, 2001, J NERV MENT DIS, V189, P404, DOI 10.1097/00005053-200106000-00011; 1999, J HEAD TRAUMA REHABI, V14, P189	55	36	36	0	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2006	20	7					733	742		10.1080/02699050600773276			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	062LV	WOS:000238947200008	16809206				2022-02-06	
J	Cox, AL; Coles, AJ; Nortje, J; Bradley, PG; Chatfield, DA; Thompson, SJ; Menon, DK				Cox, A. L.; Coles, A. J.; Nortje, J.; Bradley, P. G.; Chatfield, D. A.; Thompson, S. J.; Menon, D. K.			An investigation of auto-reactivity after head injury	JOURNAL OF NEUROIMMUNOLOGY			English	Article						autoimmunity; T lymphocytes; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; REGULATORY T-CELLS; SPINAL-CORD-INJURY; PRACTICAL SCALE; AUTOIMMUNITY; DAMAGE	Murine models of CNS injury show auto-reactive T cell responses directed at myelin antigens, associated with improved neuronal survival and functional recovery. This pilot study shows, for the first time, that similar immune responses against myelin occur in human traumatic brain injury (TBI), with an expansion of lymphocytes recognising myelin basic protein observed in 40% of patients studied. "Reactive" patients did not have greater contusion volume on imaging, but were younger than the "unreactive" subgroup and tended towards a more favorable outcome. These findings are consistent with the concept of "beneficial autoimmunity". (c) 2006 Elsevier B.V. All rights reserved.	Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England		Coles, AJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Hills Rd, Cambridge CB2 2QQ, England.	ajc1020@medschl.cam.ac.uk		Coles, Alasdair/0000-0003-4738-0760	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0001237] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0600986, G9439390] Funding Source: Medline		Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Givan AL, 1999, J IMMUNOL METHODS, V230, P99, DOI 10.1016/S0022-1759(99)00136-2; Hauben E, 2000, LANCET, V355, P286, DOI 10.1016/S0140-6736(99)05140-5; Ibarra A, 2004, EUR J NEUROSCI, V19, P2984, DOI 10.1111/j.0953-816X.2004.03402.x; JENNETT B, 1975, LANCET, V1, P480; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2002, J NEUROIMMUNOL, V130, P78, DOI 10.1016/S0165-5728(02)00219-9; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Lyons AB, 2001, METHOD CELL BIOL, V63, P375; MCKENZIE JF, 1992, SOFTWARE LJ, V5, P1; Meinl E, 1997, AM J PATHOL, V150, P445; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; PETTE M, 1990, NEUROLOGY, V40, P1770, DOI 10.1212/WNL.40.11.1770; TEASDALE G, 1974, LANCET, V2, P81	15	36	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	MAY	2006	174	1-2					180	186		10.1016/j.jneuroim.2006.01.007			7	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	045QA	WOS:000237755600021	16519951				2022-02-06	
J	Rassovsky, Y; Satz, P; Alfano, MS; Light, RK; Zaucha, K; McArthur, DL; Hovda, D				Rassovsky, Y; Satz, P; Alfano, MS; Light, RK; Zaucha, K; McArthur, DL; Hovda, D			Functional outcome in TBI I: Neuropsychological, emotional, and behavioral mediators	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; MILD HEAD; PSYCHOSOCIAL ADJUSTMENT; HIV-1 INFECTION; SCALE; SCHIZOPHRENIA; RETURN; WORK; ADOLESCENTS	Literature exists to suggest that the severity of traumatic brain injury (TBI) is positively associated with the severity of functional impairment. However, potential mediators of this relationship have not been studied systematically. In the present study, we evaluated a model hypothesized to explain the relationship between TBI severity and functional impairment in 87 patients with moderate-to-severe TBI, studied longitudinally. Using structural equation modeling, we found that only neuropsychological status (but not emotional or behavioral difficulties) consistently mediated the relationship between TBI severity and functional outcome at 12-months post-injury. These findings suggest that, of the factors examined here, neurocognitive compromise plays the most prominent role in mediating post-TBI adaptive functioning in moderate-to-severe TBI, which has important implications for post-injury interventions.	Univ Calif Los Angeles, Neuropsychiat Inst & Hosp, Neuropsychol Div, Los Angeles, CA 90024 USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Daniel Freeman Mem Hosp, Inglewood, CA USA; Univ Calif Los Angeles, Neuropsychiat Inst & Hosp, Dept Child Psychiat, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Sch Med, Div Neurosurg, Los Angeles, CA 90024 USA		Rassovsky, Y (corresponding author), Univ Calif Los Angeles, Neuropsychiat Inst & Hosp, Neuropsychol Div, Room C8-747,760 Westwood Plaza, Los Angeles, CA 90024 USA.	yurir@ucla.edu	McArthur, David/E-6442-2013	McArthur, David/0000-0003-3385-1314; Rassovsky, Yuri/0000-0002-6362-9944			ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BENTLER PM, 1996, EQS STRUCTURAL EQUAT; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Brekke JS, 1997, SCHIZOPHRENIA BULL, V23, P19, DOI 10.1093/schbul/23.1.19; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; DELIA LF, 1996, COLOR TRAILS TEST AD; DEROGATIS LR, 1983, SYMPTOM CHECKLIST 90, V2; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; FRANKOWSKI RF, 1985, CENTRAL NERVOUS SYST; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; GENNARELLI T, 1984, ALMANAC         1009, P6; GIACINO JT, 1999, J HEAT TRAUMA REHABI, V14, P277; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; GOLDSTEIN FC, 1990, TRAUMATIC BRAIN INJU; Goodkin K, 2001, PSYCHIAT ANN, V31, P37, DOI 10.3928/0048-5713-20010101-09; Green MF, 1999, SCHIZOPHRENIA BULL, V25, P309, DOI 10.1093/oxfordjournals.schbul.a033380; Green MF, 1996, AM J PSYCHIAT, V153, P321; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; KlOve H, 1963, MED CLIN N AM; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; KURTZKE JF, 1984, ANN NEUROL, V16, P265, DOI 10.1002/ana.410160302; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; ODDY M, 1984, CLOSED HEAD INJURY; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; Rey A., 1964, EXAMEN CLIN PSYCHOL; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Sohlberg M., 2001, COGNITIVE REHABILITA; *STAT U NEW YORK, 1993, AD FUNCT IND MEAS VE; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; Ullman JB., 2001, USING MULTIVARIATE S, V4, P653; Vogenthaler D R, 1987, Brain Inj, V1, P113; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Wilkie FL, 1998, J NEUROPSYCH CLIN N, V10, P125, DOI 10.1176/jnp.10.2.125	57	36	36	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY	2006	28	4					567	580		10.1080/13803390500434466			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	033MX	WOS:000236853600008	16624784				2022-02-06	
J	Sanui, M; King, DR; Feinstein, AJ; Varon, AJ; Cohn, SM; Proctor, KG				Sanui, M; King, DR; Feinstein, AJ; Varon, AJ; Cohn, SM; Proctor, KG			Effects of arginine vasopressin during resuscitation from hemorrhagic hypotension after traumatic brain injury	CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the American-Society-of-Anesthesiologists	OCT 23-27, 2004	Las Vegas, NV	Amer Soc Anesthesiologists		shock; intracranial pressure; brain tissue Po-2; CO2 reactivity; cerebral perfusion pressure; swine	CEREBRAL PERFUSION-PRESSURE; ARTERIAL-HYPERTENSION; FLUID RESUSCITATION; VASODILATORY SHOCK; BISPECTRAL INDEX; LIVER TRAUMA; BLOOD-FLOW; OXYGEN; AUTOREGULATION; PATIENT	Objective: Two series of experiments were designed to evaluate whether early arginine vasopressin improves acute outcome following resuscitation from traumatic brain injury and severe hemorrhagic hypotension Design: Prospective randomized, blinded animal study. Setting. University laboratory. Subjects: Thirty-three swine. Interventions. In series 1 (n = 19), after traumatic brain injury with hemorrhage and 12 mins of shock (mean arterial pressure approximate to 20 mm Hg), survivors (n = 16) were initially resuscitated with 10 mL/kg crystalloid. After 30 mins, crystalloid and blood with either 0.1 unit.kg(-1).hr(-1) arginine vasopressin or placebo was titrated to a mean arterial pressure target >= 60 mm Hg. After 90 mins, all received mannitol and the target was cerebral perfusion pressure >= 60 mm Hg. To test cerebrovascular function, 7.5% inhaled CO2 was administered periodically. In series 2 (n = 14), the identical protocol was followed except the shock period was 20 mins and survivors (n = 10) received a bolus of either arginine vasopressin (0.2 units/kg) or placebo during the initial fluid resuscitation. Measurements and Main Results: In series 1, by 300 mins after traumatic brain injury with arginine vasopressin (n = 8) vs. placebo (n = 8), the fluid and transfusion requirements were reduced (both p <.01), intracranial pressure was improved (11 +/- 1 vs. 23 +/- 2 mmHg; p <.0001), and the CO2-evoked intracranial pressure elevation was reduced (7 +/- 2 vs. 26 +/- 3 mm Hg, p <.001), suggesting improved compliance. In series 2, with arginine vasopressin vs. placebo, cerebral perfusion pressure was more rapidly corrected (p <.05). With arginine vasopressin, five of five animals survived 300 mins, whereas three of five placebo animals died. The survival time with placebo was 54 +/- 4 mins (p <.05 vs. arginine vasopressin). Conclusions. Early supplemental arginine vasopressin rapidly corrected cerebral perfusion pressure, improved cerebrovascular compliance, and prevented circulatory collapse during fluid resuscitation of hemorrhagic shock after traumatic brain injury.	Univ Miami, Div Surg Crit Care, Daughtry Family Dept Surg, Miller Sch Med,Ryder Trauma Ctr, Miami, FL 33136 USA; Univ Miami, Dept Anesthesiol, Div Trauma Anesthesia & Crit Care, Miller Sch Med, Miami, FL 33136 USA; Univ Miami, Dept Surg, Div Trauma & Surg Crit Care, Miller Sch Med, Miami, FL 33136 USA		Proctor, KG (corresponding author), Univ Miami, Div Trauma, Daughtry Family Dept Surg, Miller Sch Med,Ryder Trauma Ctr, 1800 NW 10th Ave, Miami, FL 33136 USA.	sanui@omiya.jichi.ac.jp; cohn@uthscsa.edu; kproctor@miami.edu	Proctor, Kenneth/AAA-2199-2022	Proctor, Kenneth/0000-0003-1326-6628; Feinstein, Ara/0000-0001-6214-5334; King, David/0000-0003-1028-1478	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM08749-01] Funding Source: Medline		Argenziano M, 1997, CIRCULATION, V96, P286; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P493; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; Chieregato A, 2003, ACTA NEUROCHIR SUPPL, V86, P361; Crookes BA, 2004, J TRAUMA, V57, P547, DOI 10.1097/01.TA.0000135162.85859.4C; DeWitt DS, 2000, CRIT CARE MED, V28, P3933, DOI 10.1097/00003246-200012000-00036; Dunser MW, 2003, CRIT CARE MED, V31, P1394, DOI 10.1097/01.CCM.0000059722.94182.79; Fowler R, 2002, EMERG MED CLIN N AM, V20, P953, DOI 10.1016/S0733-8627(02)00038-X; Hayashida M, 2003, BRIT J ANAESTH, V90, P694, DOI 10.1093/bja/aeg107; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Holmes CL, 2001, CHEST, V120, P989, DOI 10.1378/chest.120.3.989; Holtzer S, 2001, CRIT CARE MED, V29, P1609, DOI 10.1097/00003246-200108000-00018; Huang Wei-dong, 2003, Chin J Traumatol, V6, P139; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Krismer AC, 2005, ANAESTHESIST, V54, P220, DOI 10.1007/s00101-004-0793-y; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Kroppenstedt SN, 2000, CRIT CARE MED, V28, P3792, DOI 10.1097/00003246-200012000-00004; Landry DW, 1997, CIRCULATION, V95, P1122; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Malay MB, 2004, CRIT CARE MED, V32, P1327, DOI 10.1097/01.CCM.0000128578.37822.F1; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; MARSHALL WJ, 1969, ARCH NEUROL-CHICAGO, V21, P545, DOI 10.1001/archneur.1969.00480170117012; Masamoto K, 2003, BRAIN RES, V979, P104, DOI 10.1016/S0006-8993(03)02882-8; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Morales D, 1999, CIRCULATION, V100, P226, DOI 10.1161/01.CIR.100.3.226; Myles PS, 2004, ANESTH ANALG, V98, P706; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahuquillo J, 1996, ACTA NEUROCHIR, V138, P435, DOI 10.1007/BF01420306; Stadlbauer KH, 2003, ANESTHESIOLOGY, V98, P699, DOI 10.1097/00000542-200303000-00018; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P521; Voelckel WG, 2003, CRIT CARE MED, V31, P1160, DOI 10.1097/01.CCM.0000060014.75282.69; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Westphal M, 2003, CRIT CARE MED, V31, P1502, DOI 10.1097/01.CCM.0000063042.15272.84; Yeh CC, 2003, ANESTH ANALG, V97, P577, DOI 10.1213/01.ANE.0000070231.16378.A6; Zhao LX, 2004, J NEUROSCI, V24, P2226, DOI 10.1523/JNEUROSCI.4922-03.2004; Zhu Yan-xiang, 2003, Chin J Traumatol, V6, P152	41	36	37	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	FEB	2006	34	2					433	438		10.1097/01.CCM.0000196206.83534.39			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	008UF	WOS:000235065500021	16424725				2022-02-06	
J	De Guise, E; Leblanc, J; Feyz, M; Lamoureux, J				De Guise, E; Leblanc, J; Feyz, M; Lamoureux, J			Prediction of the level of cognitive functional independence in acute care following traumatic brain injury	BRAIN INJURY			English	Article						functional independence measure; traumatic brain injury; acute care	SEVERE HEAD-INJURY; GLASGOW COMA SCALE; INTERRATER RELIABILITY; POSTTRAUMATIC AMNESIA; OUTCOME PREDICTION; REHABILITATION; MORTALITY; AGE; PERFORMANCE; RECOVERY	Primary objective: To determine a predictive model for cognitive functional outcome of patients with traumatic brain injury (TBI) at discharge from acute care. Methods and procedure: Three hundred and thirty-five patients were included in this analysis. Variables considered were age, education, initial score on the Glasgow Coma Scale (GCS), duration of post-traumatic amnesia ( PTA), cerebral imaging results and the need for neurosurgical intervention. Experimental interventions: Functional Independence Measure (FIM). Main outcomes and results: Results of this analysis indicated better cognitive FIM at discharge from acute care settings for patients with TBI when PTA was less than 24 hours, when level of education was higher, when no parietal lesion was identified, when no neurosurgical intervention was required, for patients with TBI who were younger and who presented with a higher GCS score upon admission. Conclusions: This model will help to plan resource allocation for treatment and discharge planning within the first weeks following TBI.	McGill Univ, Montreal Gen Hosp, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada		De Guise, E (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Traumat Brain Injury Program, Local D13-124,1650 Av Cedar, Montreal, PQ H3G 1A4, Canada.	elaine.deguise@muhc.mcgill.ca					Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Caille S, 2000, BRAIN COGNITION, V44, P30; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; Chesnut R M, 1995, New Horiz, V3, P366; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; HETHERINGTON H, 1995, INJURY, V26, P97, DOI 10.1016/0020-1383(95)92185-D; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Lane PL, 2000, CAN J SURG, V43, P442; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Stineman MG, 1997, ARCH PHYS MED REHAB, V78, P636, DOI 10.1016/S0003-9993(97)90430-5; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Toschlog EA, 2003, AM SURGEON, V69, P491; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Vath A, 2001, NEUROL RES, V23, P315, DOI 10.1179/016164101101198677; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	66	36	37	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2005	19	13					1087	1093		10.1080/02699050500149882			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983ZD	WOS:000233270000003	16286322				2022-02-06	
J	Prado, GR; Ross, JD; DeWeerth, SP; LaPlaca, MC				Prado, Gustavo R.; Ross, James D.; DeWeerth, Stephen P.; LaPlaca, Michelle C.			Mechanical trauma induces immediate changes in neuronal network activity	JOURNAL OF NEURAL ENGINEERING			English	Article								During a traumatic insult to the brain, tissue is subjected to large stresses at high rates which often surpass cellular thresholds leading to cell dysfunction or death. The acute response of neurons to a mechanical trauma, however, is poorly understood. Plasma membrane disruption may be the earliest cellular outcome from a mechanical trauma. The increase in membrane permeability due to such disruptions may therefore play an important role in the initiation of deleterious cascades following brain injury. The immediate consequences of an increase in plasma membrane permeability on the electrophysiological behavior of a neuronal network exposed to the trauma have not been elucidated. We have developed an in vitro model of traumatic brain injury (TBI) that utilizes a novel device capable of applying stress at high rates to neuronal cells cultured on a microelectrode array. The mechanical insult produced by the device caused a transient increase in neuronal plasma membrane permeability, which subsided after 10 min. We were able to monitor acute spontaneous electrophysiological activity of injured cultures for at least 10 min following the insult. Firing frequency, average burst interval and spikes within burst were assessed before and after injury. The electrophysiological responses to the insult were heterogeneous, although an increase in burst intervals and in the variability of the assessed parameters were common. This study provides a multi-faceted approach to elucidate the role of neuronal plasma membrane disruptions in TBI and its functional consequences.	[Prado, Gustavo R.; Ross, James D.; DeWeerth, Stephen P.; LaPlaca, Michelle C.] Georgia Inst Technol, Emory Coulter Dept Biomed Engn, Georgia Tech, Lab Neuroengn, 313 Ferst Dr, Atlanta, GA 30332 USA		Prado, GR (corresponding author), Georgia Inst Technol, Emory Coulter Dept Biomed Engn, Georgia Tech, Lab Neuroengn, 313 Ferst Dr, Atlanta, GA 30332 USA.	michelle.laplaca@bme.gatech.edu			NIBIB/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [EB00786]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB000786] Funding Source: NIH RePORTER	Funding was provided through NIBIB/NINDS (EB00786).	Blackman BR, 2000, ANN BIOMED ENG, V28, P363, DOI 10.1114/1.286; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Doebler JA, 2000, TOXICOL LETT, V114, P27, DOI 10.1016/S0378-4274(99)00193-9; GALLANT PE, 1992, J NEUROPATH EXP NEUR, V51, P220, DOI 10.1097/00005072-199203000-00011; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; MILLS LR, 1990, NEURON, V4, P149, DOI 10.1016/0896-6273(90)90451-K; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; SAWYER DB, 1989, BIOCHEMISTRY-US, V28, P6571, DOI 10.1021/bi00442a007; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Smith DH, 1999, J NEUROSCI, V19, P4263; Tateno T, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051924; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	18	36	37	1	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	DEC	2005	2	4					148	158	PMID 16317239	10.1088/1741-2560/2/4/011			11	Engineering, Biomedical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	V43HN	WOS:000209672600017	16317239				2022-02-06	
J	Henninger, N; Dutzmann, S; Sicard, KM; Kollmar, R; Bardutzky, J; Schwab, S				Henninger, N; Dutzmann, S; Sicard, KM; Kollmar, R; Bardutzky, J; Schwab, S			Impaired spatial learning in a novel rat model of mild cerebral concussion injury	EXPERIMENTAL NEUROLOGY			English	Article						ADC; animal model; beta APP; diffuse axonal injury; DWI; histology; MAP-2; Morris water maze; MRI; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; CONTROLLED CORTICAL IMPACT; MORRIS WATER MAZE; COGNITIVE DEFICITS; NEUROPSYCHOLOGICAL DEFICITS; NEURONAL APOPTOSIS; MEMORY IMPAIRMENT; FUNCTIONAL MRI; ANIMAL-MODELS	The aim of the present study was to develop a model of mild traumatic brain injury in the rat that mimics human concussive brain injury suitable to study pathophysiology and potential treatments. 34 male Wistar rats received a closed head trauma (TBI) and 30 animals served as controls (CON). Immediately following trauma, animals lost their muscle tone and righting reflex response, recovering from the latter within 11.4 +/- 8.2 min. Corneal reflex and whisker responses returned within 4.5 +/- 3.0 min and 6.1 +/- 2.9 min, respectively. The impact resulted in a short transient decrease of pO(2) (P < 0.001), increase in mean arterial blood pressure (P = 0.026), and a reduction of heart rate (P < 0.01). Serial MRI did not show any abnormalities across the entire cerebrum on diffusion, T1, T2, and T2*-weighted images at all investigated time points. TBI animals needed significantly longer to locate the hidden platform in a Morris water maze and spent less time in the training quadrant than controls. TBI led to a significant neuronal loss in frontal cortex (P < 0.001), as well as hippocampal CA3 (P = 0.017) and CA1 (P = 0.002) at 9 days after the trauma; however, cytoskeletal architecture was preserved as indicated by normal beta APP- and MAP-2 staining. We present a unique, noninvasive rat model of mild closed head trauma with characteristics of human concussion injury, including brief loss of consciousness, cognitive impairment, and minor brain injury. (c) 2005 Elsevier Inc. All rights reserved.	Univ Massachusetts, Sch Med, Ctr Comparat Neuroimaging, Dept Psychiat, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany		Henninger, N (corresponding author), Univ Massachusetts, Sch Med, Ctr Comparat Neuroimaging, Dept Psychiat, 303 Belmont St, Worcester, MA 01655 USA.	nils.henninger@umassmed.edu		Henninger, Nils/0000-0002-3883-5623			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BOHNEN N, 1993, ACTA NEUROL BELG, V93, P23; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Caner H, 2004, ACTA NEUROCHIR, V146, P611, DOI 10.1007/s00701-003-0209-9; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Davis KL, 1998, J NEUROTRAUM, V15, P615, DOI 10.1089/neu.1998.15.615; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Finset A, 1999, PSYCHOSOM MED, V61, P576, DOI 10.1097/00006842-199907000-00024; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gluck MA, 1997, ANNU REV PSYCHOL, V48, P481, DOI 10.1146/annurev.psych.48.1.481; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Heiland S, 1999, ROFO-FORTSCHR RONTG, V171, P3, DOI 10.1055/s-1999-9889; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoiland S, 1997, JMRI-J MAGN RESON IM, V7, P1109, DOI 10.1002/jmri.1880070625; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Isaksson J, 2001, ACTA NEUROPATHOL, V102, P246; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Jarrard LE, 1995, BEHAV BRAIN RES, V71, P1, DOI 10.1016/0166-4328(95)00034-8; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; KRAUS JF, 1989, MILD HEAD INJURY, P8; Lado WE, 2003, PERCEPT MOTOR SKILL, V97, P1115, DOI 10.2466/PMS.97.7.1115-1127; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lukoyanov NV, 2000, ALCOHOL, V20, P139, DOI 10.1016/S0741-8329(99)00069-5; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Lythgoe MF, 2003, BRIT MED BULL, V65, P235, DOI 10.1093/bmb/65.1.235; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tang SL, 1997, J CHART INST WATER E, V11, P14; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	70	36	36	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	OCT	2005	195	2					447	457		10.1016/j.expneurol.2005.06.013			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968VI	WOS:000232190600019	16084512				2022-02-06	
J	Hoane, MR; Wolyniak, JG; Akstulewicz, SL				Hoane, MR; Wolyniak, JG; Akstulewicz, SL			Administration of riboflavin improves behavioral outcome and reduces edema formation and glial fibrillary acidic protein expression after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						vitamin B-2; Recovery of Function; GFAP; Rat; sensorimotor behavior; antioxidant	FOCAL CEREBRAL-ISCHEMIA; MAGNESIUM THERAPY; OXIDATIVE INJURY; WISTAR RATS; NICOTINAMIDE; INFARCTION; APOPTOSIS; RADICALS; RECOVERY; DEFICITS	Previous studies have shown that administration of riboflavin, vitamin B-2, significantly reduced edema formation following experimental stroke. The present study evaluated the ability of B-2 to improve behavioral function, reduce edema formation, and limit glial fibrillary acidic protein (GFAP) expression following frontal cortex contusion injury. Groups of rats were assigned to B-2 (7.5 mg/kg) or saline (1.0 ml/kg) treatment conditions and received contusion injuries or sham procedures. Drug treatment was administered 15 min and 24 h following injury. Rats were examined on a variety of tests to measure sensorimotor performance (bilateral tactile removal test), and cognitive ability (acquisition of reference and working memory) in the Morris water maze. Administration of B-2 following injury significantly reduced the behavioral impairments observed on the bilateral tactile removal test and improved the acquisition of both reference and working memory tests compared to saline-treated rats. The lesion analysis showed that B-2 reduced the size of the lesion. Examination of GFAP expression around the lesion revealed that B-2 significantly reduced the number of GFAP(+) astrocytes. Edema formation following injury was also significantly reduced by B-2 administration. These findings are the first to show that B-2 administration significantly improved behavioral outcome and reduced lesion volume, edema formation, and the expression of GFAP following traumatic brain injury. These findings suggest that B-2 may have therapeutic potential for the treatment of TBI.	So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Brain & Cognit Sci Program, Carbondale, IL 62901 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Brain & Cognit Sci Program, MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R15NS045647-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS045647] Funding Source: NIH RePORTER		Atlante A, 2001, FEBS LETT, V497, P1, DOI 10.1016/S0014-5793(01)02437-1; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; Ayoub IA, 2002, NEUROREPORT, V13, P213, DOI 10.1097/00001756-200202110-00008; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; BETZ AL, 1994, ACTA NEUROCHIR, P314; CHRISTENSEN HN, 1993, NUTR REV, V51, P149; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; HALL ED, 1993, RES P ARNMD, V71, P81; Hausmann ON, 2002, SPINAL CORD, V40, P449, DOI 10.1038/sj.sc.3101330; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Heath DL, 1999, MAGNESIUM RES, V12, P269; Hoane Michael R, 2004, Clin Calcium, V14, P65; Hoane MR, 2005, RESTOR NEUROL NEUROS, V23, P67; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Hoane MR, 1997, RESTOR NEUROL NEUROS, V11, P71, DOI 10.3233/RNN-1997-111208; Hoane MR, 2002, PHYSIOL BEHAV, V76, P271, DOI 10.1016/S0031-9384(02)00714-X; HULTQUIST DE, 1993, AM J HEMATOL, V42, P13, DOI 10.1002/ajh.2830420105; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Klaidman LK, 1996, NEUROSCI LETT, V206, P5, DOI 10.1016/0304-3940(96)12446-0; Ksendzova GA, 2004, FREE RADICAL RES, V38, P1183, DOI 10.1080/10715760400016162; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Lin YP, 2004, NEUROREPORT, V15, P2241, DOI 10.1097/00001756-200410050-00020; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Maynard KI, 2001, ANN NY ACAD SCI, V939, P416; McCord JM, 2004, J NUTR, V134, p3171S, DOI 10.1093/jn/134.11.3171S; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MODUDAI T, 2000, STROKE, V31, P1679; Mukherjee SK, 1997, MOL CHEM NEUROPATHOL, V32, P59, DOI 10.1007/BF02815167; Paxinos G., 1997, RAT BRAIN STEROTAXIC, VThird; Sakakibara Y, 2000, NEUROSCI LETT, V281, P111, DOI 10.1016/S0304-3940(00)00854-5; Sakakibara Y, 2002, BRAIN RES, V931, P68, DOI 10.1016/S0006-8993(02)02263-1; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; van den Heuvel Corinna, 2004, Clin Calcium, V14, P9; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; WASE AW, 1956, ARCH BIOCHEM BIOPHYS, V61, P174, DOI 10.1016/0003-9861(56)90329-0	41	36	40	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2005	22	10					1112	1122		10.1089/neu.2005.22.1112			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	977ZS	WOS:000232842600007	16238487				2022-02-06	
J	Willer, B; Kroetsch, B; Darling, S; Hutson, A; Leddy, J				Willer, B; Kroetsch, B; Darling, S; Hutson, A; Leddy, J			Injury rates in house league, select, and representative youth ice hockey	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						injury prevention; injury severity; concussion; sports	HIGH-SCHOOL; SPORTS	Purpose: The purpose of this study was to determine injury rates in a youth ice hockey program over two seasons (2002-2004). Injury rates for age groups (4-18 yr) and for different levels of competition were compared. Another purpose was to determine the effect of body checking on injury rates among these youths. Methods: A prospective injury report form was completed by a volunteer trainer for each injury that caused a loss of player time and resulted in evaluation by a physician. The injury form documented age group, type of injury, length of time that the player missed action due to the injury, location of the injury, and circumstances that led to the injury. Participants included 2632 boys aged 4-18 who played in the 2002-2003 season and 2639 boys who played in the 2003-2004 season. Results: Injuries were four times more likely to occur in games than practices. Boys who played in the most advanced levels of competition are 6.1 times more likely to be injured than boys playing in house leagues. Injury rates during games showed a trend toward increasing with the age of the player. Injury rates spiked the first year that body checking was introduced in two different competition levels. Injury rates also spiked with the onset of adolescence (age 13). Conclusion: The study findings suggest that the introduction of body checking at age 9 to competitive youth hockey causes an immediate but relatively short-term increase in injury rates. The period of adjustment that accompanies body checking should be taken into account when determining the age at which body checking is introduced.	SUNY Buffalo, Dept Psychiat, Buffalo, NY 14214 USA; Joseph Brant Mem Hosp, Rehabil Serv, Burlington, ON, Canada		Willer, B (corresponding author), SUNY Buffalo, Dept Psychiat, G96 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	willer@vaxxine.com					*AAP, 2000, PEDIATRICS, V105, P657; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Cantu RC, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.08.945; DAFFNER RH, 1977, J FAM PRACTICE, V4, P225; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Roberts WO, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.11.1102; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; ROY MA, 1989, PHYSICIAN SPORTSMED, V17, P119, DOI 10.1080/00913847.1989.11709735; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Stuart MJ, 2000, AM SOC TEST MATER, V1341, P19, DOI 10.1520/STP15224S; Sutherland G W, 1976, Am J Sports Med, V4, P264, DOI 10.1177/036354657600400605	13	36	36	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	OCT	2005	37	10					1658	1663		10.1249/01.mss.0000181839.86170.06			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	980XM	WOS:000233051500003	16260964				2022-02-06	
J	Poggi, G; Liscio, M; Adduci, A; Galbiati, S; Massimino, M; Sommovigo, M; Zettin, M; Figini, E; Castelli, E				Poggi, G; Liscio, M; Adduci, A; Galbiati, S; Massimino, M; Sommovigo, M; Zettin, M; Figini, E; Castelli, E			Psychological and adjustment problems due to acquired brain lesions in childhood: A comparison between post-traumatic patients and brain tumour survivors	BRAIN INJURY			English	Article						brain injury; brain tumours; psychological problems; social adjustment	CLOSED-HEAD-INJURY; PRACTICAL SCALE; CHILDREN; MEDULLOBLASTOMA; DEPRESSION; DISORDERS; SEQUELAE; ADHD	Objective: To define and differentiate psychological and adjustment problems due to brain injury or brain tumour in children and adolescents. Methods: Two groups of patients with acquired brain lesions (24 post-traumatic patients and 22 brain tumour survivors), ranging in age between 8-15 years, received a psychological evaluation, including the Child Behaviour Checklist for Ages 4-18 (CBCL) and the Vineland Behaviour Adaptive Scales (VABS). Results: Both groups showed psychological and social adjustment problems. Post-traumatic patients were more impaired than brain tumour survivors. Social adjustment problems were associated to externalizing problems in post-traumatic patients and internalizing problems in brain tumour surviving patients. Conclusions: These differences in psychological and behavioural disorders between the two groups must necessarily be considered when developing psychological treatment, rehabilitation plan and social re-entry.	IRCCS Eugenio Medea, I-23842 Bosisio Parini, LC, Italy; Natl Tumour Inst, Milan, Italy; Univ Turin, I-10124 Turin, Italy		Poggi, G (corresponding author), IRCCS Eugenio Medea, Via Don Luigi Monza 20, I-23842 Bosisio Parini, LC, Italy.	gpoggi@bp.lnf.it	Castelli, Enrico/J-1887-2012; massimino, maura/K-7310-2016; Poggi, Geraldina/K-4490-2016; Galbiati, Sara/AAA-7115-2020	massimino, maura/0000-0002-5506-2001; Poggi, Geraldina/0000-0003-0589-6347; Galbiati, Sara/0000-0001-6810-359X			Achenbach TM, 1991, MANUAL CHILD BEHAV C; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Bell K R, 2001, Phys Med Rehabil Clin N Am, V12, P169; BIEDERMAN J, 1993, J CHILD PSYCHOL PSYC, V34, P1241, DOI 10.1111/j.1469-7610.1993.tb01785.x; BLOOM HJG, 1969, AMER J ROENTGENOL RA, V105, P43, DOI 10.2214/ajr.105.1.43; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Ciccetti D., 1984, VINELAND ADAPTIVE BE; DANOFF BF, 1982, CANCER, V48, P1580, DOI 10.1002/1097-0142(19820415)49:8<1580::AID-CNCR2820490810>3.0.CO;2-7; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fossen A, 1998, PEDIATR HEMAT ONCOL, V15, P479, DOI 10.3109/08880019809018309; Fuemmeler BF, 2002, CLIN PSYCHOL REV, V22, P547, DOI 10.1016/S0272-7358(01)00120-9; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; Green ML, 1998, J PEDIATR PSYCHOL, V23, P289, DOI 10.1093/jpepsy/23.5.289; HIRSCH JF, 1979, ACTA NEUROCHIR, V48, P1, DOI 10.1007/BF01406016; JENNETT B, 1975, LANCET, V1, P480; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, BRAIN INJURY, V12, P41; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; MULHERN RK, 1993, J PEDIATR PSYCHOL, V18, P339, DOI 10.1093/jpepsy/18.3.339; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; RIS MD, 2002, J CLIN EXPT NEUROPSY, V16, P21; ROBIN AH, 1999, ARCH PHYS MED REHAB, V80, P991; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Sherwin ED, 2000, BRAIN INJURY, V14, P267; Siffert J, 1999, CHILD ADOL PSYCH CL, V8, P879; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 1974, WECHSLER INTELLIGENC	33	36	36	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2005	19	10					777	785		10.1080/0269905500110132			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	945EI	WOS:000230484800004	16175838				2022-02-06	
J	Motin, M; Keren, O; Groswasser, Z; Gordon, CR				Motin, M; Keren, O; Groswasser, Z; Gordon, CR			Benign paroxysmal positional vertigo as the cause of dizziness in patients after severe traumatic brain injury: diagnosis and treatment	BRAIN INJURY			English	Article; Proceedings Paper	2nd World Congress of the International-Society-of-Physical-and-Rehabilitation-Medicine (ISPRM)	MAY 18-23, 2003	Prague, CZECH REPUBLIC	Int Soc Phys & Rehabilitat Med		traumatic brain injury; rehabilitation; benign paroxysmal positional vertigo; particle repositioning maneouvre	FEATURES	Objectives: To identify patients with benign paroxysmal positional vertigo (BPPV) among patients with severe traumatic brain injury (TBI) and to evaluate the effectiveness of the Particle Repositioning Maneouvre (PRM). Design and methods: Eighteen months prospective study of 150 consecutive patients with severe TBI referred to an in-patients rehabilitation department. Interventions: A structured interview emphasizing the possible presence of vertigo followed by a detailed neuro-otological examination. Patients diagnosed with BPPV were immediately treated with the PRM. Main outcomes and results: BPPV diagnosis was based on a positive Dix-Hallpike positional test. PRM efficacy was determined by repeating the positional test 1 or 2 weeks after treatment. Twenty out of 150 (13.3%) patients complained about positional vertigo. The diagnosis of BPPV was confirmed in 10 patients. Signs and symptoms were completely relieved in six patients after a single PRM, while the other four patients needed repeated treatment for complete resolution of BPPV. Conclusions: About half of the patients with severe TBI who complain about positional vertigo suffer from BPPV. These patients can be efficiently treated by physical maneouvres improving the rehabilitation outcome.	Meir Hosp, Dept Neurol, IL-44281 Kefar Sava, Israel; Loewenstein Rahabil Hosp, Raanana, Israel; Tel Aviv Univ, Tel Aviv, Israel		Gordon, CR (corresponding author), Meir Hosp, Dept Neurol, IL-44281 Kefar Sava, Israel.	cgordon@post.tau.ac.il		Gordon, Carlos/0000-0003-1576-214X			BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Baloh RW, 1998, LANCET, V352, P1841, DOI 10.1016/S0140-6736(98)05430-0; BRANDT T, 1994, NEUROLOGY, V44, P796, DOI 10.1212/WNL.44.5.796; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; DIX MR, 1952, P ROY SOC MED, V45, P341, DOI 10.1177/003591575204500604; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399, DOI 10.1177/019459989210700310; Furman JM, 1999, NEW ENGL J MED, V341, P1590, DOI 10.1056/NEJM199911183412107; Gordon Carlos R, 2002, Harefuah, V141, P944; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; GYO K, 1988, LARYNGOSCOPE, V98, P332; HERDMAN SJ, 1993, ARCH OTOLARYNGOL, V119, P450; Honrubia V, 1999, AM J OTOL, V20, P465; Hughes CA, 1997, LARYNGOSCOPE, V107, P607, DOI 10.1097/00005537-199705000-00010; KATSARKAS A, 1978, J OTOLARYNGOL, V7, P320; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; LEMPERT T, 1995, BRIT MED J, V311, P489, DOI 10.1136/bmj.311.7003.489; Longridge N., 1978, CANADIAN J OTOLOGY, V7; Nuti D, 1996, J VESTIBUL RES-EQUIL, V6, P173; PARNES LS, 1993, ANN OTO RHINOL LARYN, V102, P325, DOI 10.1177/000348949310200501; Semont A, 1988, Adv Otorhinolaryngol, V42, P290; ZEE DS, 1996, DISORDERS VESTIBULAR, P178	22	36	40	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2005	19	9					693	697		10.1080/02699050400013600			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Rehabilitation	945EH	WOS:000230484600007	16195183				2022-02-06	
J	Shore, AD; Mccarthy, ML; Serpi, T; Gertner, M				Shore, AD; Mccarthy, ML; Serpi, T; Gertner, M			Validity of administrative data for characterizing traumatic brain injury-related hospitalizations	BRAIN INJURY			English	Article						traumatic brain injury; administrative data sources; injury epidemiology	ACCURACY	Primary objective: To examine the validity of Maryland Hospital Discharge (MHD) data for identifying and characterizing traumatic brain injury (TBI)-related hospitalizations. Methods: All TBI-related hospitalizations in 1999 were identified using MHD and Maryland Trauma Registry (MTR) data. In addition, a sample of records were abstracted to compare agreement between MHD and chart data. Results: The MHD file identified fewer TBI cases (61%) compared to the MTR (95%). Overall, TBI-related hospitalization rates based on MHD were significantly fewer ( 95; 95% CI 92, 98) vs MHD and MTR ( 144; 95% CI 140, 147). There was good agreement between the MHD and chart data regarding skull fractures or intracranial lesions (kappa = 0.73 and 0.83, respectively), but poor agreement for neurologic abnormalities or amnesia. The MHD significantly underestimated TBI severity. Conclusions: TBI cases, especially mild ones, were under-reported by MHD data. MHD data are better at detecting anatomic injuries compared to TBI symptoms and sequella.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; Maryland Inst Emergency Med Serv Syst, Baltimore, MD 21201 USA		Shore, AD (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 624 N Broadway,Room 637, Baltimore, MD 21205 USA.	ashore@jhsph.edu			ODCDC CDC HHS [U17/CCU314059-04] Funding Source: Medline		*CDCP, 2001, RR1350 US DEP HHS CD; Committee on Injury Scaling, 1990, ABBR INJ SCAL 1990 R; Hunt JP, 2000, J TRAUMA, V49, P679, DOI 10.1097/00005373-200010000-00016; Hunt JP, 1999, SURGERY, V126, P191, DOI 10.1067/msy.1999.98749; Johnson RL, 1997, AM J EPIDEMIOL, V146, P266; LANGLOIS JA, 2003, 52SS04 CDCP; Lilienfeld A.M., 1980, FDN EPIDEMIOLOGY; MACKENZIE EJ, 1984, AM J EMERG MED, V2, P537, DOI 10.1016/0735-6757(84)90081-0; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MCCARTHY ML, 2004, IN PRESS J TRAUMA; MULLINS RJ, 1995, J TRAUMA, V39, P941, DOI 10.1097/00005373-199511000-00020; *NAT CTR INJ PREV, 1999, TRAUM BRAIN INJ US R; PETRUCELLI E, 1981, ACCIDENT ANAL PREV, V13, P25; *SAS I, 1998, SAS SYST WIND REL 7; Sox HC, 1996, ANNU REV MED, V47, P463; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ., 1995, GUIDELINES SURVEILLA; Wynn A, 2001, J TRAUMA, V51, P464, DOI 10.1097/00005373-200109000-00007	18	36	37	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2005	19	8					613	621		10.1080/02699050400013568			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	933IS	WOS:000229622700006	16175815				2022-02-06	
J	Alves, OL; Bullock, R; Clausen, T; Reinert, M; Reeves, TM				Alves, OL; Bullock, R; Clausen, T; Reinert, M; Reeves, TM			Concurrent monitoring of cerebral electrophysiology and metabolism after traumatic brain injury: An experimental and clinical study	JOURNAL OF NEUROTRAUMA			English	Article						cerebral monitoring; electrophysiology; extracellular glutamate; metabolic dysfunction; microdialysis; traumatic brain injury	SINGLE-UNIT ACTIVITY; HUMAN HEAD-INJURY; SPREADING DEPRESSION; EXTRACELLULAR GLUTAMATE; NEUROSURGICAL PATIENTS; SUBSTRATE DELIVERY; NEURONS; RAT; MECHANISMS; ISCHEMIA	Multiparameter cerebral monitoring has been widely applied in traumatic brain injury to study posttramnatic pathophysiology and to manage head-injured patients (e.g., combining 02 and pH sensors with cerebral microdialysis). Because a comprehensive approach towards understanding injury processes will also require functional measures, we have added electrophysiology to these monitoring modalities by attaching a recording electrode to the microdialysis probe. These dual-function (microdialysis/electrophysiology) probes were placed in rats following experimental fluid percussion brain injuries, and in a series of severely head-injured human patients. Electrical activity (cell firing, EEG) was monitored concurrently with microdialysis sampling of extracellular glutamate, glucose and lactate. Electrophysiological parameters (firing rate, serial correlation, field potential occurrences) were analyzed offline and compared to dialysate concentrations. In rats, these probes demonstrated an injury-induced suppression of neuronal firing (from a control level of 2.87 to 0.41 spikes/sec postinjury), which was associated with increases in extracellular glutamate and lactate, and decreases in glucose levels. When placed in human patients, the probes detected sparse and slowly firing cells (mean = 0.21 spike/sec), with most units (70%) exhibiting a lack of serial correlation in the spike train. In some patients, spontaneous field potentials were observed, suggesting synchronously firing neuronal populations. In both the experimental and clinical application, the addition of the recording electrode did not appreciably affect the performance of the microdialysis probe. The results suggest that this technique provides a functional monitoring capability which cannot be obtained when electrophysiology is measured with surface or epidural EEG alone.	Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; Univ Porto, Fac Med, P-4100 Oporto, Portugal; Univ Halle Wittenberg, Dept Anesthesiol & Intens Care Med, Halle An Der Saale, Saale, Germany; Univ Bern, Inselspital, Dept Neurosurg, CH-3012 Bern, Switzerland		Reeves, TM (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	tmreeves@hsc.vcu.edu	Reinert, Michael/AAA-3929-2019; Reinert, Michael/E-4964-2011	Reinert, Michael/0000-0002-0971-9543; 	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER		Alessandri B, 2000, ACTA NEUROCHIR SUPPL, V76, P425; ANDERSEN BJ, 1992, BRAIN RES, V585, P190, DOI 10.1016/0006-8993(92)91206-T; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; CREUTZFELDT OD, 1974, HDB ELECTROENCEPHALO, V20, P5; Detari L, 1997, BRAIN RES, V759, P112, DOI 10.1016/S0006-8993(97)00252-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DURING MJ, 1993, LANCET, V341, P1607; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; GRAHN DA, 1989, AM J PHYSIOL, V256, pR840, DOI 10.1152/ajpregu.1989.256.4.R840; Grenier F, 2003, NEUROSCIENCE, V119, P277, DOI 10.1016/S0306-4522(03)00101-5; Hillered L, 1999, SCAND J CLIN LAB INV, V59, P9, DOI 10.1080/00365519950185904; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KOSTOPOULOS G, 1984, ELECTROEN CLIN NEURO, V57, P69, DOI 10.1016/0013-4694(84)90009-9; Lebedev MA, 2000, EXP BRAIN RES, V130, P195, DOI 10.1007/s002210050022; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lewis P.A.W., 1966, STAT ANAL SERIES EVE; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Ludvig N, 2001, BRAIN RES, V900, P252, DOI 10.1016/S0006-8993(01)02319-8; MACGREGOR RJ, 1997, NEURAL MODELING ELEC; Matz P G, 1997, Clin Neurosurg, V44, P267; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Nunez P, 1981, ELECT FIELDS BRAIN; OBRENOVITCH TP, 1995, J NEUROPHYSIOL, V73, P2107, DOI 10.1152/jn.1995.73.5.2107; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Rogatsky G, 1996, J Basic Clin Physiol Pharmacol, V7, P23; Rose ME, 2002, BRAIN RES, V935, P40, DOI 10.1016/S0006-8993(02)02445-9; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Velasco AL, 2000, NEURAL PLAST, V7, P49, DOI 10.1155/NP.2000.49; WINDHORST U, 1982, PFLUG ARCH EUR J PHY, V393, P148, DOI 10.1007/BF00582938; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011; Zhang FY, 2002, J NEUROSURG, V97, P963, DOI 10.3171/jns.2002.97.4.0963	49	36	39	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2005	22	7					733	749		10.1089/neu.2005.22.733			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	945VQ	WOS:000230530800002	16004577				2022-02-06	
J	Graham, DI; Adams, JH; Murray, LS; Jennett, B				Graham, DI; Adams, JH; Murray, LS; Jennett, B			Neuropathology of the vegetative state after head injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Proceedings Paper	Joint Conference of the International-Neuropsychological-Society/German-Society-for-Neuropsychology	JUL 16-19, 2003	Berlin, GERMANY	Int Neuropsychol Soc, German Soc Neuropsychol			CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; WHITE-MATTER; DAMAGE; DEATH; PATHOLOGY; SURVIVAL	A detailed neuropathological study of patients identified clinically after head injury as either severely disabled (SD, n = 30) or vegetative (VS, n = 35) has been carried out to determine the nature and frequency of the various pathologies that form the basis of these clinical states. Patients who were SD were older (SD median 49.5 yrs vs. VS median 38 yrs, p = .04), more likely to have a lucid interval (SD 31% vs. VS 9%, p = .03), and to have had an acute intracranial haematoma (SD 70% vs. VS 26%, p < .001). SD patients less often had severe, Grades (2 or 3) of traumatic diffuse axonal injury (SD 30% vs. VS 71%, p = .001) and less often had thalamic damage (SD 37% vs. VS 80%, p < .001). Similar features of both focal and diffuse damage were present in some SD and VS cases with both groups having considerable damage to white matter and to the thalamus. It is concluded that the principal structural basis of both SD and VS is diffuse traumatic axonal injury (DAI) with widespread damage to white matter and changes in the thalami. However, both ischaemic brain damage and the vascular complications of raised intracranial pressure contributed to the clinical signs and symptoms.	Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland		Graham, DI (corresponding author), So Gen Hosp, Inst Neurol Sci, Acad Univ Neuropathol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	d.graham@clinmed.gla.ac.uk					ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1966, BRAIN, V89, P235, DOI 10.1093/brain/89.2.235; Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; [Anonymous], 2003, Clin Med (Lond), V3, P249; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Auer RN, 2002, GREENFIELDS NEUROPAT, V7th, P233; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BRIERLEY JB, 1971, LANCET, V2, P560; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; COLE G, 1987, CLIN NEUROPATHOL, V6, P104; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DOUGHERTY JH, 1981, NEUROLOGY, V31, P991, DOI 10.1212/WNL.31.8.991; FRENCH JD, 1952, AMA ARCH NEUROL PSY, V68, P727, DOI 10.1001/archneurpsyc.1952.02320240002001; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1995, BRAIN PATHOL, V5, P117; HAVTON LA, 1994, NEW ENGL J MED, V331, P1378; Ingvar D H, 1978, Ann N Y Acad Sci, V315, P184; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jennett B., 2002, VEGETATIVE STATE; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; REILLY PL, 1975, LANCET, V2, P375; RELKIN NR, 1990, ANN NEUROL, V28, P221; RINK A, 1995, AM J PATHOL, V147, P1575; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Wilson S, 2004, J NEUROTRAUM, V21, P239, DOI 10.1089/089771504322972031; [No title captured]; [No title captured]; [No title captured]	43	36	37	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-SEP	2005	15	3-4					198	213		10.1080/09602010443000452			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychology	965PE	WOS:000231961900007	16350963	Green Submitted			2022-02-06	
J	Sawchyn, JM; Mateer, CA; Suffield, JB				Sawchyn, JM; Mateer, CA; Suffield, JB			Awareness, emotional adjustment, and injury severity in postacute brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						awareness; emotional adjustment; severity; traumatic brain injury	CLOSED-HEAD-INJURY; COMPETENCE RATING-SCALE; SELF-AWARENESS; IMPAIRED AWARENESS; SOCIAL-BEHAVIOR; DEFICITS; INDIVIDUALS; LIMITATIONS; ANOSOGNOSIA; DISABILITY	Objective: Relationships among awareness of deficits, injury severity, and emotional adjustment in patients with traumatic brain injury were explored. Participants: One hundred sixty-six individuals were referred for postacute neurocognitive assessment. Design: Retrospective file analysis identified injury severity, and data from the Patient Competency Rating Scale and Katz Adjustment Scale-Revised, utilizing self-ratings and significant others' ratings, were gathered. Results: Significant others described emotional adjustment difficulties, regardless of the severity of injury. A positive association was noted between patients' acknowledgment of neurobehavioral problems and ratings of their emotional adjustment. Conclusions: Severity of TBI appeared less important than emotional adjustment in the awareness of deficit; mildly injured patients were more likely to report neurobehavioral deficits than were moderately and severely injured patients, relative to the reports of significant others.	AT Malcolm & Associates, Victoria, BC V8R 1T2, Canada; Univ Victoria, Dept Psychol, Victoria, BC V8R 1T2, Canada; Columbia Rehabil Ctr, Calgary, AB, Canada		Sawchyn, JM (corresponding author), AT Malcolm & Associates, 216-284 Helmcken Rd, Victoria, BC V8R 1T2, Canada.	jsawchyn@island.net					ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; Benson D.F., 1986, FRONTAL LOBES; BENYISHAY Y, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P194; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Coetzer BR, 2001, J COGN REHABIL, V19, P8; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GORAN DA, 1993, BRAIN INJURY, V7, P219, DOI 10.3109/02699059309029674; Heilbronner R L, 1989, Brain Inj, V3, P387, DOI 10.3109/02699058909004562; HEILBRONNER RL, 1993, J CLIN EXP NEUROPSYC, V15, P67; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Kortte KB, 2003, REHABIL PSYCHOL, V48, P131, DOI 10.1037/0090-5550.48.3.131; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P799; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Prigozhin L, 1996, FREE BOUNDARY PROBLE, V10, P2; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; Ryan LM, 1998, ARCH CLIN NEUROPSYCH, V13, P147; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wallace CA, 2000, BRAIN INJURY, V14, P549	45	36	36	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2005	20	4					301	314		10.1097/00001199-200507000-00003			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941MV	WOS:000230219800003	16030438				2022-02-06	
J	Jones, C; Harvey, AG; Brewin, CR				Jones, C; Harvey, AG; Brewin, CR			Traumatic brain injury, dissociation, and posttraumatic stress disorder in road traffic accident survivors	JOURNAL OF TRAUMATIC STRESS			English	Article							MOTOR-VEHICLE ACCIDENTS; CLOSED HEAD-INJURY; SYMPTOMS; MEMORY; PTSD	This study investigated the symptom profiles of acute stress disorder (ASD) and posttraumatic stress disorder (PTSD) in participants who did and did not sustain traumatic brain injury (TBI), following a road traffic accident. The participants were assessed at three time points: as soon as possible posttrauma as well as at 6 weeks and 3 months posttrauma. At the first assessment, fewer participants from the TBI group recalled feeling fear and helplessness at the time of the trauma, fewer TBI participants reported recurrent intrusive thoughts and images, and more TBI participants reported dissociation since the trauma, relative to the non-TBI group. At the second assessment, fewer participants from the TBI group recalled feeling intense helplessness at the time of the trauma. Fewer TBI participants also reported reliving and physiological reactions on trauma reminders relative to the non-TBI group. At 3 months posttrauma, there was no difference in PTSD symptom profile between non-TBI and TBI groups. Our findings indicate that the presence of TBI is likely to influence the distribution of certain symptoms, but need not be a significant barrier to diagnosing ASD and PTSD.	Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Oxford, Dept Expt Psychol, Oxford OX1 2JD, England; UCL, Subdept Clin Hlth Psychol, London, England		Harvey, AG (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall 1650, Berkeley, CA 94720 USA.	aharvey@berkeley.edu	Brewin, Chris R/C-4566-2008	Brewin, Chris R/0000-0002-7462-4460			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bohnen N., 1992, J NERV MENT DIS, V180, P183; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; BREWIN CR, 2003, POSTTRAUMATICAL STRE; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1998, APPL COGNITIVE PSYCH, V12, P81, DOI 10.1002/(SICI)1099-0720(199802)12:1<81::AID-ACP507>3.0.CO;2-8; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Bryant RA., 2000, ACUTE STRESS DISORDE; Creamer M, 2004, BEHAV RES THER, V42, P315, DOI 10.1016/S0005-7967(03)00141-4; DAVIDOFF DA, 1988, COGNITIVE REHABI MAR, P8; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; GRIGSBY J, 1993, BRAIN INJURY, V7, P507, DOI 10.3109/02699059309008178; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Halligan SL, 2003, J CONSULT CLIN PSYCH, V71, P419, DOI 10.1037/0022-006X.71.3.419; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Harvey AG, 2000, J NERV MENT DIS, V188, P602, DOI 10.1097/00005053-200009000-00007; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Hyman IE, 1998, CLIN PSYCHOL REV, V18, P933, DOI 10.1016/S0272-7358(98)00041-5; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Kato H, 1996, ACTA PSYCHIAT SCAND, V93, P477, DOI 10.1111/j.1600-0447.1996.tb10680.x; KRAUS JF, 1996, NEUROLOGY TRAUMA, P3; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; MARMAR CR, 1997, ASSESSING PSYCHOL TR; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; Middelboe T., 1992, European Psychiatry, V7, P183; Murray J, 2002, BRIT J PSYCHIAT, V180, P363, DOI 10.1192/bjp.180.4.363; Panasetis P, 2003, J TRAUMA STRESS, V16, P563, DOI 10.1023/B:JOTS.0000004079.74606.ba; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; Symonds CP, 1943, LANCET, V1, P7; Ursano RJ, 1999, AM J PSYCHIAT, V156, P1808; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018	45	36	37	0	9	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0894-9867			J TRAUMA STRESS	J. Trauma Stress	JUN	2005	18	3					181	191		10.1002/jts.20031			11	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	986JQ	WOS:000233446300001	16281212				2022-02-06	
J	Basta, D; Todt, I; Scherer, H; Clarke, A; Ernst, A				Basta, D; Todt, I; Scherer, H; Clarke, A; Ernst, A			Postural control in otolith disorders	HUMAN MOVEMENT SCIENCE			English	Article						otolith disorder; trunk sway; minor head trauma; postural control	CLINICAL BALANCE TESTS; TRUNK SWAY MEASURES; HEAD TRAUMA; DIFFERENTIAL-DIAGNOSIS; SPATIAL ORIENTATION; VESTIBULAR DEFICIT; SUPPORT-SURFACE; STABILITY; INJURY; POSTUROGRAPHY	It was the aim of the present paper to investigate the influence of otolith disorders on human postural control by different methods. The 33 patients of our study had undergone a minor head injury and suffered subsequently from an utricular or sacculo-utricular disorder as evidenced by vestibular evoked myogenic potential recordings and eccentric rotation recordings of the otolith-ocular responses. Postural control was assessed by performing stance/gait tests (standard balance deficit test, SBDT) and by evaluating trunk sway (using angular velocity sensors). Moreover, classical tests of the posterior column of the spinal tract (Romberg/Unterberger) and the dynamic posturography (sensory organization test, SOT) were included. It could be shown that SBDT tasks with reduced proprioceptive and visual cues (e.g. standing on foam, eyes closed) are most sensitive for an otolith disorder. The patients showed an increased trunk sway in the pitch plane (i.e. linear motion as adequate utricular stimulus) and an increase in sway velocities (i.e. tilting movements as adequate saccular stimulus) compared to controls. The SOT was most sensitive for combined (sacculo-utricular) otolith disorders (78%) while vestibulospinal tests are not enough sensitive. In essence, otolith disorders evidently impair human postural control and have been possibly underestimated as a source of posttraumatic postural imbalance as yet. (c) 2005 Elsevier B.V. All rights reserved.	Ukb, Dept Otolaryngol, Charite Med Sch, D-12683 Berlin, Germany; Benjamin Franklin Med Ctr, Charite Med Sch, Dept Otolaryngol, Vestibular Res Lab, Berlin, Germany		Ernst, A (corresponding author), Ukb, Dept Otolaryngol, Charite Med Sch, Warener Str 7, D-12683 Berlin, Germany.	arneborge@ukb.de					Akin F W, 2001, J Am Acad Audiol, V12, P445; Allum JHJ, 2003, AUDIOL NEURO-OTOL, V8, P286, DOI 10.1159/000071999; Allum JHJ, 2002, GAIT POSTURE, V16, P264, DOI 10.1016/S0966-6362(02)00011-5; Allum JHJ, 2001, GAIT POSTURE, V14, P227, DOI 10.1016/S0966-6362(01)00132-1; Allum JHJ, 2001, GAIT POSTURE, V14, P217, DOI 10.1016/S0966-6362(01)00142-4; Allum JHJ, 1999, J VESTIBUL RES-EQUIL, V9, P223; Allum JHJ, 1998, GAIT POSTURE, V8, P214, DOI 10.1016/S0966-6362(98)00027-7; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BLACK FO, 1984, ACTA OTO-LARYNGOL, P110; Bronstein AM, 2002, BRIT MED BULL, V63, P213, DOI 10.1093/bmb/63.1.213; BUCHELE W, 1979, AGRESSOLOGIE, V20, P221; Carpenter MG, 2001, EXP BRAIN RES, V140, P95, DOI 10.1007/s002210100802; Choy NL, 2003, J GERONTOL A-BIOL, V58, P525; Clarke AH, 2003, J VESTIBUL RES-EQUIL, V13, P215; Clarke AH, 1998, EXP BRAIN RES, V121, P457, DOI 10.1007/s002210050481; Colebatch JG, 2002, ADV EXP MED BIOL, V508, P105; COLEBATCH JG, 1994, J NEUROL NEUROSUR PS, V57, P190, DOI 10.1136/jnnp.57.2.190; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; ERNST A, 1998, AUDIOLOGY NEUROTOLOG; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Guyot JP, 2001, ANN OTO RHINOL LARYN, V110, P562, DOI 10.1177/000348940111000611; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; Kaufman GD, 2001, EXP BRAIN RES, V137, P397; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Lahat E, 1996, PEDIATR NEUROL, V15, P299, DOI 10.1016/S0887-8994(96)00221-4; Mergner T, 2003, ANN NY ACAD SCI, V1004, P303, DOI 10.1196/annals.1303.028; Paige GD, 2002, ANN NY ACAD SCI, V956, P314, DOI 10.1111/j.1749-6632.2002.tb02830.x; PETERSEN H, 1995, ACTA OTO-LARYNGOL, P443; RUBIN AM, 1995, AM J OTOL, V16, P216; Sans A, 2001, ADV OTO-RHINO-LARYNG, V58, P1; Sjostrom H, 2003, SPINE, V28, P1725, DOI 10.1097/00007632-200308010-00018; Welgampola MS, 2003, J NEUROL NEUROSUR PS, V74, P771, DOI 10.1136/jnnp.74.6.771; ZAMANI F, 2005, KLINISCHE ANWENDUNG	34	36	39	1	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	APR	2005	24	2					268	279		10.1016/j.humov.2005.04.002			12	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	964GZ	WOS:000231868600009	15953652				2022-02-06	
J	Yi, JH; Hazell, AS				Yi, JH; Hazell, AS			N-acetylcysteine attenuates early induction of heme oxygenase-1 following traumatic brain injury	BRAIN RESEARCH			English	Article						heme oxygenase; traumatic brain injury; astrocyte; oxidative stress; fluid percussion; antioxidant	OXIDATIVE STRESS; RAT; EXPRESSION; HO-1; CYSTEINE; HYPOXIA; VOLUME; GENE; GLIA	Traumatic brain injury (TBI) results in a cascade of events that includes the production of reactive oxygen species. Heme oxygenase-1 (HO-1) is induced in glial cells following head trauma, suggestive of oxidative stress. We have studied the temporal and spatial effects of the antioxidant N-acetylcysteine (NAC) on HO-1 levels following lateral fluid-percussion injury by immunoblotting and immunohistochemistry. In the injured cerebral cortex, maximal HO-1 induction was seen 6 h post-TBI and was maintained for up to 24 h following the insult, while the ipsilateral hippocampus and thalamus showed marked induction at 24 h postinjury. In all three brain regions, little or no HO-1 immunoreactivity was observed on the contralateral side. Astrocytes exhibited positive immunoreactivity for HO-1 in the injured cerebral cortex, hippocampus, and thalamus, while some neurons and microglia were also immunoreactive in the injured cortex. The administration of NAC 5 min following TBI resulted in a marked reduction in this widespread induction of HO-1, concomitant with a decrease in the volume of injury in all three brain regions. Together, these findings indicate that HO-1 induction is related to both oxidative and injury characteristics of the affected tissue, suggesting that protein expression of this gene is a credible marker of oxidative damage in this model of TBI. (C) 2004 Elsevier B.V All rights reserved.	Univ Montreal, Dept Med, Hop St Luc, CHUM, Montreal, PQ H2X 3J4, Canada		Hazell, AS (corresponding author), Univ Montreal, Dept Med, Hop St Luc, CHUM, 1058 St Denis St, Montreal, PQ H2X 3J4, Canada.	alan.stewart.hazell@umontreal.ca					ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Bergeron M, 1997, J CEREBR BLOOD F MET, V17, P647; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; Garnier P, 2001, BRAIN RES, V893, P301, DOI 10.1016/S0006-8993(01)02009-1; Hazell AS, 2001, J NEUROCHEM, V78, P560, DOI 10.1046/j.1471-4159.2001.00436.x; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kelly G S, 1998, Altern Med Rev, V3, P114; Kweon MH, 2004, FREE RADICAL BIO MED, V36, P40, DOI 10.1016/j.freeradbiomed.2003.09.023; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; OTTERBEIN L, 1995, AM J RESP CELL MOL, V13, P595, DOI 10.1165/ajrcmb.13.5.7576696; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; RATAN RR, 1994, J NEUROSCI, V14, P4385; Regan RF, 2003, J NEUROTRAUM, V20, P111, DOI 10.1089/08977150360517236; Scapagnini G, 2002, BRAIN RES, V954, P51, DOI 10.1016/S0006-8993(02)03338-3; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; SHAN Y, 2004, IN PRESS J BIOL CHEM; Turner CP, 1999, MOL BRAIN RES, V65, P87, DOI 10.1016/S0169-328X(98)00340-4; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; VINCENT SR, 1994, NEUROSCIENCE, V63, P223, DOI 10.1016/0306-4522(94)90018-3; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067	28	36	37	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 1	2005	1033	1					13	19		10.1016/j.brainres.2004.10.055			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899GZ	WOS:000227134200002	15680334				2022-02-06	
J	Hepp, U; Moergeli, H; Buchi, S; Wittmann, L; Schnyder, U				Hepp, U; Moergeli, H; Buchi, S; Wittmann, L; Schnyder, U			Coping with serious accidental injury: A one-year follow-up study	PSYCHOTHERAPY AND PSYCHOSOMATICS			English	Article						posttraumatic stress disorder; coping, accidents; sense of coherence; intensive care unit	POSTTRAUMATIC-STRESS-DISORDER; MOTOR-VEHICLE ACCIDENTS; TRAUMATIC BRAIN-INJURY; ADMINISTERED PTSD SCALE; COHERENCE; SENSE; SYMPTOMS; RESPONSIBILITY; SEVERITY; VICTIMS	Background: The aim of this study was to analyze changes of coping strategies in severely injured accident victims over time and to compare patients with high and low posttraumatic stress disorder (PTSD) symptom levels with regard to their coping patterns and accident-related cognitions. Methods: 106 consecutive patients with severe accidental injuries admitted to a trauma surgery intensive care unit (ICU) were assessed within 1 month after the trauma and 6 and 12 months later. Assessments included a clinical interview, the Freiburg Questionnaire of Coping with Illness, the patients' accident-related cognitions, the Clinician-Administered PTSD Scale, the 90-item revised Symptom Checklist (SCL- 90-R), and the Sense of Coherence Questionnaire (SOC). Patients who met the criteria for either full or subsyndromal PTSD at least once over the observation period (36 subjects; 34.0%) were assigned to a highly symptomatic group HSG), the remainder (70 subjects; 66.0%) to a less symptomatic group. Results: Overall, active problem-focused coping was predominant immediately after the accident and declined over time, with a stronger decrease in the HSG. Patients in the HSG scored higher on the SCL Global Severity Index and lower on the SOC. The patients' subjective appraisal of accident severity was higher in the HSG, whereas there was no group difference with regard to accident-related variables such as type of accident, injury severity and mild to moderate traumatic brain injury. Conclusions: Active problem- focused coping, although utilized most frequently and often regarded as protective, might be an inadequate strategy in face of acute stress following a severe accident. Clinicians should not expect their patients to cope very actively in the acute ICU phase. In the subsequent rehabilitation, active coping seems to be more adaptive. Copyright (c) 2005 S. Karger AG, Basel.	Univ Zurich Hosp, Dept Psychiat, CH-8091 Zurich, Switzerland		Hepp, U (corresponding author), Univ Zurich Hosp, Dept Psychiat, Culmannstr 8, CH-8091 Zurich, Switzerland.	Urs.Hepp@usz.ch		Schnyder, Ulrich/0000-0003-3556-7990			American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Antonovsky A., 1987, UNRAVELING MYSTERY H; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLAKE DD, 1990, BEHAV THERAPIST, V8, P187; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Buchi S, 1998, J RHEUMATOL, V25, P869; Chung MC, 2001, AUST NZ J PSYCHIAT, V35, P528, DOI 10.1046/j.1440-1614.2001.00922.x; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Delahanty DL, 1997, J CONSULT CLIN PSYCH, V65, P560, DOI 10.1037/0022-006X.65.4.560; Derogatis L.R, 1986, SCL 90 R ADM SCORING; Folkman S., 1984, STRESS; Franke G, 1995, SCL 90 R SYMPTOMCHEC; Frommberger U, 1999, J PSYCHOSOM RES, V46, P343, DOI 10.1016/S0022-3999(98)00117-2; Fuglsang AK, 2002, PSYCHOTHER PSYCHOSOM, V71, P214; Geyer S, 1997, SOC SCI MED, V44, P1771, DOI 10.1016/S0277-9536(96)00286-9; Ginzburg K, 2002, PSYCHOSOM MED, V64, P748, DOI 10.1097/01.PSY.0000021949.04969.2E; GREEN MM, 1993, MED J AUSTRALIA, V159, P529, DOI 10.5694/j.1326-5377.1993.tb138006.x; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Heim E, 1998, PSYCHOTHER PSYCH MED, V48, P321; Hickling EJ, 1999, J TRAUMA STRESS, V12, P345, DOI 10.1023/A:1024784711484; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Malt U F, 1992, Psychiatr Med, V10, P135; Malt U F, 1992, Psychiatr Med, V10, P117; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Moore A D, 1994, Int J Rehabil Res, V17, P39, DOI 10.1097/00004356-199403000-00004; Muthny F.A., 1989, FREIBURGER FRAGEBOGE, V1st ed.; Nilsson B, 2003, SCAND J PUBLIC HEALT, V31, P297, DOI 10.1080/14034940210164920; Roesch SC, 2001, J PSYCHOSOM RES, V50, P205, DOI 10.1016/S0022-3999(01)00188-X; Schnyder U, 2000, PSYCHOTHER PSYCHOSOM, V69, P296, DOI 10.1159/000012411; Schnyder U, 2003, AM J PSYCHIAT, V160, P2025, DOI 10.1176/appi.ajp.160.11.2025; Schnyder U, 2002, J TRAUMA STRESS, V15, P487, DOI 10.1023/A:1020922023090; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Sharkansky EJ, 2000, J ABNORM PSYCHOL, V109, P188, DOI 10.1037/0021-843X.109.2.188; SOLOMON Z, 1988, J PERS SOC PSYCHOL, V55, P279, DOI 10.1037/0022-3514.55.2.279; SPURRELL MT, 1993, SOC PSYCH PSYCH EPID, V28, P194, DOI 10.1007/BF00797323; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; TEASDALE G, 1974, LANCET, V2, P81	45	36	37	0	9	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0033-3190			PSYCHOTHER PSYCHOSOM	Psychother. Psychosom.		2005	74	6					379	386		10.1159/000087786			8	Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	975LU	WOS:000232664800008	16244515				2022-02-06	
J	Ownsworth, T; McFarland, K				Ownsworth, T; McFarland, K			Investigation of psychological and neuropsychological factors associated with clinical outcome following a group rehabilitation programme	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; IMPAIRED SELF-AWARENESS; HEAD-INJURY; DEFICITS; SCALE; PSYCHOTHERAPY; UNAWARENESS; DISABILITY; DEPRESSION; SYMPTOMS	The present study investigated neuropsychological and psychological factors associated with successful treatment outcome following a group intervention for individuals with acquired brain injury (ABI). Participants were classified into two groups ("Clinically Improved" and "Not Improved") based upon the findings of a previous study (Ownsworth, McFarland, & Young, 2000a). A discriminant analysis was used to predict group membership on three outcome measures (Awareness and Strategy Behaviour indices of the Self-Regulation Skills Interview and the Psychosocial Dimension of the Sickness Impact Profile) between pre-assessment and post-assessment, and between pre-assessment and 6 months follow-up. Neuropsychological factors involved measures of executive functioning and psychological factors were assessed using measures of personality-related denial and coping-related denial. Overall, the results indicated that individuals with impaired executive functioning were most likely to be classified as Clinically Improved on measures of awareness, strategy behaviour and psychosocial functioning. Individuals who deny or minimise their ABI symptoms were less likely to improve their psychosocial functioning following the group intervention. Future research needs to evaluate interventions for enhancing self-regulation skills and improving psychosocial functioning for individuals who employ denial as a main strategy for coping following ABI.	Univ Queensland, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, St Lucia, Qld 4072, Australia		Ownsworth, T (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, St Lucia, Qld 4072, Australia.	t.ownsworth@shrs.uq.edu.au	Ownsworth, Tamara/ABB-6961-2021	Ownsworth, Tamara/0000-0003-1835-7094			Armengol CG, 1999, J HEAD TRAUMA REHAB, V14, P233, DOI 10.1097/00001199-199906000-00004; Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Barco PP, 1991, COGNITIVE REHABILITA, P129; BAYLESS JD, 1989, J CLIN EXP NEUROPSYC, V11, P913, DOI 10.1080/01688638908400944; Bennett T L, 1997, Appl Neuropsychol, V4, P55, DOI 10.1207/s15324826an0401_7; Benson D.F., 1986, FRONTAL LOBES; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; CICERONE KD, 2000, TRAUMATIC BRAIN INJU, P95; Cramer P, 1998, J PERS, V66, P919, DOI 10.1111/1467-6494.00037; Crisp R, 1992, Aust Occup Ther J, V39, P15, DOI 10.1111/j.1440-1630.1992.tb01730.x; CRONBACH LJ, 1959, J EDUC PSYCHOL, V50, P230, DOI 10.1037/h0042848; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; DEATON AV, 1991, COGNITIVE REHABILITA, P191; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; EVANS RG, 1982, J PERS ASSESS, V46, P415, DOI 10.1207/s15327752jpa4604_14; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Feinberg TE, 1997, NEUROCASE, V3, P73, DOI 10.1080/13554799708404037; Finset A, 2000, BRAIN INJURY, V14, P887; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Fleming JM, 1997, J HEAD TRAUMA REHAB, V12, P27, DOI 10.1097/00001199-199706000-00004; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Hageman WJJM, 1999, BEHAV RES THER, V37, P1169; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kelly AE, 1998, J COUNS PSYCHOL, V45, P50, DOI 10.1037/0022-0167.45.1.50; KENDALL E, 1998, THESIS U QUEENSLAND; Kolb B., 1999, COGNITIVE NEUROREHAB, P9; LANE RD, 1990, AM J PSYCHIAT, V147, P573; Langer KG., 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI [DOI 10.1080/09602019208401395, 10.1080/09602019208401395]; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Loeb, 1996, INDEPENDENT LIVING S; MALCOLM CD, 1993, LEZAKS TINKER TOY TE; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; OWNSWORTH TL, 2002, 25 ANN C AUSTR SOC S; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Prigatano GP, 1996, NEUROPSYCHOL REHABIL, V6, P305, DOI 10.1080/713755515; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; SHAW RE, 1985, PSYCHOSOM MED, V47, P262, DOI 10.1097/00006842-198505000-00004; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Smith H.E., 1992, CLIN REHABIL, V6, P31; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; Stuss D. T., 1999, COGNITIVE NEUROREHAB, P188; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TUPPER DE, 1989, ANN M NAT AC NEUR WA; Weinstein E.A., 1955, DENIAL ILLNESS SYMBO; Williams WH, 1999, NEUROPSYCHOL REHABIL, V9, P421, DOI 10.1080/096020199389482; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026; Wilson BA, 1996, MEMORY, V4, P465, DOI 10.1080/741940776; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; [No title captured]	67	36	36	0	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	DEC	2004	14	5					535	562		10.1080/09602010343000538			28	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	863AY	WOS:000224533800004					2022-02-06	
J	Kamineni, S; Ankem, H; Sanghavi, S				Kamineni, S; Ankem, H; Sanghavi, S			Anatomical considerations for percutaneous proximal humeral fracture fixation	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						proximal humerus; fracture; percutaneous pin fixation; neurovascular injury	4-PART FRACTURES; 3-PART; NECK; HEAD	Purpose: To investigate the hypothesis that percutaneous wire fixation of proximal humeral fractures is prone to regional neurovascular injury. Materials and Methods: 40 cadaveric shoulders had percutaneous wires inserted from anterior and lateral humeral shaft entry points into the humeral head. The shoulders were then dissected to identify the neurovascular structures in this area. Results: The axillary nerve trunk and posterior circumflex humeral artery were found to be within the field of dissection. The axillary nerve was damaged on three occasions by the lateral wires, two of which were direct nerve penetrations. The anterior wires caused a single perineural injury of a terminal branch. The main neurovascular leash was 57 mm (range 35-70 mm) from the acromion tip laterally and 51 mm (range 35-85 mm) anteriorly, with a width of 6 mm (range 4-13 mm) laterally, and 12 mm (range 7-15 mm) anteriorly. Conclusions: Percutaneous wire stabilisation is an attractive fixation option but this study highlights the close proximity of the important neurovasculature. Such fixation should be performed utilising a limited open approach, with dissection to bone under direct vision, with the subsequent use of a drill-sleeve for soft-tissue protection. (C) 2003 Elsevier Ltd. All rights reserved.	Univ London Imperial Coll Sci Technol & Med, Dept Orthopaed Surg, London W6 8RF, England; Hillingdon Gen Hosp, Dept Orthopaed, Uxbridge UB8 3NN, Middx, England		Kamineni, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Orthopaed Surg, Charing Cross Campus, London W6 8RF, England.						BROOKS CH, 1993, J BONE JOINT SURG BR, V75, P132, DOI 10.1302/0301-620X.75B1.8421010; Burkhart SS, 1996, ARTHROSCOPY, V12, P634, DOI 10.1016/S0749-8063(96)90206-6; Burkhead W Z Jr, 1992, J Shoulder Elbow Surg, V1, P31, DOI 10.1016/S1058-2746(09)80014-1; CLIFFORD PC, 1980, INJURY, V12, P91, DOI 10.1016/0020-1383(80)90129-1; GERBER C, 1990, J BONE JOINT SURG AM, V72A, P1486, DOI 10.2106/00004623-199072100-00009; HAGG O, 1984, SURG SHOULDER, P354; JABERG H, 1992, J BONE JOINT SURG AM, V74A, P508, DOI 10.2106/00004623-199274040-00006; MUNST P, 1992, ORTHOPADE, V21, P121; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; Resch H, 1997, J BONE JOINT SURG BR, V79B, P295, DOI 10.1302/0301-620X.79B2.6958; STABLEFORTH PG, 1984, J BONE JOINT SURG BR, V66, P104, DOI 10.1302/0301-620X.66B1.6693466	11	36	40	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	NOV	2004	35	11					1133	1136		10.1016/j.injury.2003.08.008			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	866QG	WOS:000224787400009	15488504				2022-02-06	
J	Kunihara, T; Matsuzaki, K; Shiiya, N; Saijo, Y; Yasuda, K				Kunihara, T; Matsuzaki, K; Shiiya, N; Saijo, Y; Yasuda, K			Naloxone lowers cerebrospinal fluid levels of excitatory amino acids after thoracoabdominal aortic surgery	JOURNAL OF VASCULAR SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD ISCHEMIA; CEREBRAL-ISCHEMIA; EXTRACELLULAR GLUTAMATE; ANEURYSM REPAIR; ASPARTIC ACID; RELEASE; CSF; RECEPTOR; STROKE	Objective: Although naloxone has been used to prevent ischemic spinal cord injury (SCI), its effect on excitatory amino acids (EAAs) has not been understood. We investigated the clinical significance of naloxone by measuring EAAs in the cerebrospinal fluid (CSF) in patients undergoing thoracoabdominal aortic surgery. Methods and subjects: Twenty-seven patients (15 men and 12 women; mean age, 66 +/- 12 years) undergoing prosthetic replacement of the thoracoabdominal aorta (n = 19) or the descending thoracic aorta (n = 8) from April 1997 to June 2003 under distal perfusion and mild hypothermia were enrolled in this cohort study with historical controls. Their etiology was 7 dissections and 20 nondissections. In 16 patients (naloxone group), intravenous infusion of naloxone (1 mug/kg/h) was continued until the patients became alert. In the remaining 11 patients (control group) naloxone was not given. CSF drainage was used in all patients. CSF levels of EAAs, glutamate, aspartate, and glycine were measured at 6 points in time until 72 hours postoperatively, using a high-performance liquid chromatography method. Results: In 5 patients with SCI (2 patients in control group, 3 in naloxone group), CSF levels of glutamate and glycine continued to increase even at 72 hours postoperatively, and were significantly more elevated than those in patients without SCI (P <.0001, glutamate; P =.0006, glycine). Postoperative maximum levels of CSF glutamate and glycine were also significantly higher in patients with postoperative SCI than in patients without SCI (glutamate: 215.3% +/- 158.6% vs 32.9% +/- 37.3% increase from baseline, P <.0001; glycine: 309.1% +/- 218.2% vs 89.2% +/- 103.1% increase from baseline, P =.0036). CSF levels of glutamate and aspartate in naloxone group were significantly lower than those in control group (P =.0161, glutamate; P <.0001, aspartate). Postoperative maximum level of CSF aspartate was also significantly lower in the naloxone group than in the control group (8.3% +/- 75.5% vs 119.7% +/- 120.6% increase from baseline, P =.0077). In multivariate logistic regression analysis, postoperative maximum CSF glutamate > 100% from baseline (P <.001) and postoperative maximum level of CSF glycine (P =.005) were identified as the independent risk factors for SCI. Both SCI (P <.001) and postoperative maximum level of CSF glycine (P =.005) were the independent predictors for postoperative maximum level of CSF glutamate > 100% from baseline. Conclusions: CSF levels of EA.As are elevated in patients with SCI. CSF glutamate is the strongest independent predictor of SCL Naloxone is effective in lowering CSF levels of EAAs.	Hokkaido Univ Hosp, Dept Cardiovasc Surg, Kita Ku, Sapporo, Hokkaido 0608648, Japan; Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan		Kunihara, T (corresponding author), Hokkaido Univ Hosp, Dept Cardiovasc Surg, Kita Ku, N14,W5, Sapporo, Hokkaido 0608648, Japan.	kunihara@med.hokudai.ac.jp	Saijo, Yasuaki/J-3796-2019	Saijo, Yasuaki/0000-0002-6211-8202			ACHER CW, 1994, J VASC SURG, V19, P236, DOI 10.1016/S0741-5214(94)70099-0; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BAKER CJ, 1995, NEUROSURGERY, V36, P994, DOI 10.1227/00006123-199505000-00016; BASKIN DS, 1981, LANCET, V2, P272; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BLIN O, 1994, J NEUROL NEUROSUR PS, V57, P119, DOI 10.1136/jnnp.57.1.119-a; Brock MV, 1997, ANN THORAC SURG, V64, P999, DOI 10.1016/S0003-4975(97)00621-8; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; COLLIER HOJ, 1974, NATURE, V248, P24, DOI 10.1038/248024a0; Coselli JS, 2002, J VASC SURG, V35, P631, DOI 10.1067/mva.2002.122024; Csernansky JG, 1996, NEUROLOGY, V46, P1715, DOI 10.1212/WNL.46.6.1715; FADEN AI, 1982, NEUROLOGY, V32, P1083, DOI 10.1212/WNL.32.10.1083; FADEN AI, 1981, ANN NEUROL, V10, P326, DOI 10.1002/ana.410100403; GRAHAM LT, 1967, J NEUROCHEM, V14, P465, DOI 10.1111/j.1471-4159.1967.tb09545.x; GUERREROMUNOZ F, 1979, SCIENCE, V206, P89, DOI 10.1126/science.39340; HONEY CR, 1985, NEUROSCI LETT, V61, P135, DOI 10.1016/0304-3940(85)90414-8; HOSOBUCHI Y, 1982, SCIENCE, V215, P69, DOI 10.1126/science.6274019; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KASHIWAGI S, 1994, J NEUROL NEUROSUR PS, V57, P1442, DOI 10.1136/jnnp.57.11.1442; KIM JP, 1987, EUR J PHARMACOL, V138, P133, DOI 10.1016/0014-2999(87)90349-9; MARZULLO G, 1981, SCIENCE, V208, P1171; MATSUMOTO K, 1993, J CEREBR BLOOD F MET, V13, P586, DOI 10.1038/jcbfm.1993.76; MENDELSOHN LG, 1985, J PHARMACOL EXP THER, V233, P597; NAKAMURA R, 1994, BRAIN RES, V654, P279, DOI 10.1016/0006-8993(94)90490-1; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; PETEL J, 1990, J NEUROCHEM, V54, P849; REDMOND JM, 1995, ANN THORAC SURG, V59, P579; ROKKAS CK, 1995, J THORAC CARDIOV SUR, V110, P27, DOI 10.1016/S0022-5223(05)80006-6; ROKKAS CK, 1994, ANN THORAC SURG, V58, P312, DOI 10.1016/0003-4975(94)92200-4; SHIMADA N, 1989, J CEREBR BLOOD F MET, V9, P603, DOI 10.1038/jcbfm.1989.86; UEDA Y, 1992, STROKE, V23, P253, DOI 10.1161/01.STR.23.2.253; WAHL F, 1994, J NEUROCHEM, V63, P1003; XUE D, 1994, J CEREBR BLOOD F MET, V14, P251, DOI 10.1038/jcbfm.1994.32	36	36	37	0	3	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	OCT	2004	40	4					681	690		10.1016/j.jvs.2004.07.005			10	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	902WZ	WOS:000227388700014	15472595	Bronze			2022-02-06	
J	Bryant, RA; Marosszeky, JE; Crooks, J; Gurka, JA				Bryant, RA; Marosszeky, JE; Crooks, J; Gurka, JA			Elevated resting heart rate as a predictor of posttraumatic stress disorder after severe traumatic brain injury	PSYCHOSOMATIC MEDICINE			English	Article						posttraumatic stress disorder; traumatic brain injury; heart rate; fear conditioning	ANXIETY; PTSD; FEAR	Objective: This study indexed the relationship between resting heart rates (HRs) after injury and subsequent posttraumatic stress disorder (PTSD) in patients who sustained severe traumatic brain injury (TBI). Methods: Patients who sustained a severe TBI (N = 68) had their resting HR assessed 1 week and 1 month after injury, and they were assessed for PTSD 6 months after injury with the PTSD Inter-view, a structured clinical interview based on the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, Revised. Results: PTSD was diagnosed in 23% of patients. PTSD participants had higher HRs at 1 week but not at 1 month after trauma than non-PTSD participants. This difference remained significant when the effect of posttraumatic amnesia was controlled, but it was not significant when the effect of Glasgow Coma Scale was controlled. Conclusion: These findings accord with the proposal that fear conditioning can occur outside the level of awareness and contribute to PTSD development.	Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; Westmead Hosp, Dept Rehabil Med, Sydney, NSW, Australia		Bryant, RA (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	r.bryant@unsw.edu.au	Bryant, Richard/AAA-6479-2019	Bryant, Richard/0000-0002-9607-819X			Blanchard EB, 2002, J TRAUMA STRESS, V15, P199, DOI 10.1023/A:1015299126858; Bryant RA, 2000, J ABNORM PSYCHOL, V109, P341, DOI 10.1037/0021-843X.109.2.341; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Pitman R. K., 2000, NEW COGNITIVE NEUROS; PITMAN RK, 1990, J ABNORM PSYCHOL, V99, P49, DOI 10.1037/0021-843X.99.1.49; Shalev AY, 1998, ARCH GEN PSYCHIAT, V55, P553, DOI 10.1001/archpsyc.55.6.553; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; WATSON CG, 1991, J CLIN PSYCHOL, V47, P179, DOI 10.1002/1097-4679(199103)47:2<179::AID-JCLP2270470202>3.0.CO;2-P	12	36	36	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0033-3174			PSYCHOSOM MED	Psychosom. Med.	SEP-OCT	2004	66	5					760	761		10.1097/01.psy.0000138121.13198.84			2	Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	856UJ	WOS:000224070300021	15385703				2022-02-06	
J	Chen, SF; Richards, HK; Smielewski, T; Johnstrom, P; Salvador, R; Pickard, JD; Harris, TG				Chen, SF; Richards, HK; Smielewski, T; Johnstrom, P; Salvador, R; Pickard, JD; Harris, TG			Relationship between flow-metabolism uncoupling and evolving axonal injury after experimental traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						uncoupling; autoradiography; blood flow; glucose metabolism; cortical contusion injury	CEREBRAL-BLOOD-FLOW; CONTROLLED CORTICAL IMPACT; POSITRON EMISSION TOMOGRAPHY; FLUID-PERCUSSION INJURY; GLUCOSE-UTILIZATION; HEAD-INJURY; WHITE-MATTER; QUANTITATIVE ASSESSMENT; ARTERY OCCLUSION; ISCHEMIC-INJURY	Blood flow-metabolism uncoupling is a well-documented phenomenon after traumatic brain injury, but little is known about the direct consequences for white matter. The aim of this study was to quantitatively assess the topographic interrelationship between local cerebral blood flow (LCBF) and glucose metabolism (LCMRglc) after controlled cortical impact injury and to determine the degree of correspondence with the evolving axonal injury. LCMRglc and LCBF measurements were obtained at 3 hours in the same rat from F-18-fluorodeoxyglucose and C-14-iodoantipyrine coregistered autoradiographic images, and compared to the density of damaged axonal profiles in adjacent sections and in an additional group at 24 hours using beta-amyloid precursor protein (beta-APP) immunohistochemistry. LCBF was significantly reduced over the ipsilateral hemisphere by 48 +/- 15% compared with shamcontrols, whereas LCMRglc was unaffected, apart from foci of elevated LCMRglc in the contusion margin. Flow-metabolism was uncoupled, indicated by a significant 2-fold elevation in the LCMRglc/LCBF ratio within most ipsilateral structures. There was a significant increase in beta-APP-stained axons from 3 to 24 hours, which was negatively correlated with LCBF and positively correlated with the LCMRglc/LCBF ratio at 3 hours in the cingulum and corpus callosum. Our study indicates a possible dependence of axonal outcome on flow-metabolism in the acute injury stage.	Univ Cambridge, Acad Neurosurg, Ctr Brain Repair, Cambridge, England; Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; Univ Cambridge, Clin Pharmacol Unit, Cambridge, England		Harris, TG (corresponding author), Univ Calif Los Angeles, Sch Med, Div Neurosurg, 100 UCLA Medplaza Suite 219,Box 718424, Los Angeles, CA 90095 USA.	ngharris@mednet.ucla.edu	Chen, Szu-Fu/K-5040-2012	Harris, Neil/0000-0002-1965-6750; Salvador, Raymond/0000-0001-5557-1562; Smielewski, Peter/0000-0001-5096-3938	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0001237] Funding Source: Medline		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Belayev L, 1997, J CEREBR BLOOD F MET, V17, P1266, DOI 10.1097/00004647-199712000-00002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GINSBERG MD, 1987, NEUROLOGY, V37, P11, DOI 10.1212/WNL.37.1.11; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Graham DI, 1996, NEUROPATH APPL NEURO, V22, P505, DOI 10.1111/j.1365-2990.1996.tb01125.x; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; INGVAR M, 1991, J CEREBR BLOOD F MET, V11, P926, DOI 10.1038/jcbfm.1991.157; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KIRINO T, 1985, PROG BRAIN RES, V63, P39; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; LEAR JL, 1989, METAB BRAIN DIS, V4, P95, DOI 10.1007/BF00999387; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Lythgoe MF, 2003, BRIT MED BULL, V65, P235, DOI 10.1093/bmb/65.1.235; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MIES G, 1991, J CEREBR BLOOD F MET, V11, P753, DOI 10.1038/jcbfm.1991.132; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; NAKAI H, 1987, STROKE, V18, P158, DOI 10.1161/01.STR.18.1.158; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SOKOLOFF L, 1981, FED PROC, V40, P2311; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; STUDHOLME C, 1997, MED PHYS, V6, P334; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; SUTTON RL, 1994, ACTA NEUROCHIR, P446; TOMIMOTO H, 1994, J CEREBR BLOOD F MET, V14, P565, DOI 10.1038/jcbfm.1994.70; Valeriani V, 2000, J CEREBR BLOOD F MET, V20, P765, DOI 10.1097/00004647-200005000-00002; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; WAXMAN SG, 1992, BRAIN RES, V574, P105, DOI 10.1016/0006-8993(92)90806-K; Whalen MJ, 1998, ACT NEUR S, V71, P212; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yam PS, 1998, J NEUROTRAUM, V15, P441, DOI 10.1089/neu.1998.15.441; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAO H, 1995, J CEREBR BLOOD F MET, V15, P398, DOI 10.1038/jcbfm.1995.50; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	70	36	36	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	2004	24	9					1025	1036		10.1097/01.WCB.0000129415.34520.47			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	853CO	WOS:000223804100008	15356423	Bronze			2022-02-06	
J	Juttler, E; Potrovita, I; Tarabin, V; Prinz, S; Tuan, DS; Fink, G; Schwaninger, M				Juttler, E; Potrovita, I; Tarabin, V; Prinz, S; Tuan, DS; Fink, G; Schwaninger, M			The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-kappa B)	NEUROPHARMACOLOGY			English	Article						cannabinoid; inflammation; dexanabinol; apoptosis; nuclear factor-kappa B	FOCAL CEREBRAL-ISCHEMIA; NECROSIS-FACTOR-ALPHA; RECEPTOR MESSENGER-RNA; CLOSED-HEAD INJURY; RAT-BRAIN; NEUROPROTECTIVE ANTIOXIDANTS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CB1 RECEPTOR; CELL-DEATH	Exogenous and endogenous cannabinoids have been shown to have neuroprotective effects in vitro and in vivo. Although many of the pharmacological effects of cannabinoids have been identified, the mechanism of neuroprotection still represents a controversy. Here we demonstrate for the first time protective effects of the synthetic cannabinoid dexanabinol by inhibiting apoptosis in a neuron-like cell line using nuclear staining and FACS analysis and in primary neurons. We provide further evidence of inhibition of nuclear factor-kappakappa B (NF-kappaB) by dexanabinol: Dexanabinol inhibits (1) phosphorylation and degradation of the inhibitor of NF-kappaB IkappaBalpha and translocation of NF-kappaB to the nucleus; dexanabinol reduces (2) the transcriptional activity of NF-kappaB and (3) mRNA accumulation of the NF-kappaB target genes tumor necrosis factor-alpha and interleukin-6 (TNF-alpha and IL-6). Dexanabinol does not bind to cannabinoid (CB) receptors I and 2. To investigate the mechanism of action, we employed the non-antioxidant CBI receptor agonist WIN 55,212-2 and the antioxidant cannabinol, which binds to CBI receptors only weakly. Both cannabinoids mimicked the effect of dexanabinol on NF-kappaB and apoptosis. This suggests that neither the antioxidant properties of cannabinoids nor binding to CB1 or CB2 receptors are responsible for the inhibition of NF-kappaB activity and apoptosis. Our results clearly demonstrate that dexanabinol inhibits NF-kappaB. NF-kappaB has been shown to be involved in brain damage and to promote neuronal cell death in vitro and in in vivo models of ischemic and neurodegenerative neurological diseases. (C) 2004 Elsevier Ltd. All rights reserved.	Univ Heidelberg, Dept Neurol, D-69120 Heidelberg, Germany; Pharmos Ltd Kiryat, Rehovot, Israel		Juttler, E (corresponding author), Univ Heidelberg, Dept Neurol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	eric_juettler@med.uni-heidelberg.de		Fink, George/0000-0002-0713-527X			Abood ME, 2001, NEUROSCI LETT, V309, P197, DOI 10.1016/S0304-3940(01)02065-1; Achiron A, 2000, J NEUROIMMUNOL, V102, P26, DOI 10.1016/S0165-5728(99)00149-6; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bass R, 1996, J INFECT DIS, V173, P735, DOI 10.1093/infdis/173.3.735; Bauerle PA, 1996, CELL, V87, P13; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; BELAYEV L, 1995, STROKE, V26, P2313, DOI 10.1161/01.STR.26.12.2313; BIEGON A, 1995, NEUROL RES, V17, P275, DOI 10.1080/01616412.1995.11740326; Breivogel CS, 1999, J NEUROCHEM, V73, P2447, DOI 10.1046/j.1471-4159.1999.0732447.x; BURNETTECURLEY D, 1995, P SOC EXP BIOL MED, V210, P64, DOI 10.3181/00379727-210-43926; Chan GCK, 1998, J NEUROSCI, V18, P5322, DOI 10.1523/JNEUROSCI.18-14-05322.1998; Chen YQ, 2000, J PHARMACOL EXP THER, V293, P807; Childers SR, 1998, DRUG ALCOHOL DEPEN, V51, P173, DOI 10.1016/S0376-8716(98)00075-1; Cowling RT, 2002, J BIOL CHEM, V277, P5719, DOI 10.1074/jbc.M107515200; Devin A, 2000, IMMUNITY, V12, P419, DOI 10.1016/S1074-7613(00)80194-6; Di Marzo V, 2000, FASEB J, V14, P1432, DOI 10.1096/fj.14.10.1432; DROUET C, 1991, J IMMUNOL, V147, P1694; ESHHAR N, 1995, EUR J PHARMACOL, V283, P19, DOI 10.1016/0014-2999(95)00271-L; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; Filbert MG, 1999, ANN NY ACAD SCI, V890, P505, DOI 10.1111/j.1749-6632.1999.tb08032.x; Gallily R, 1997, J PHARMACOL EXP THER, V283, P918; Gebremedhin D, 1999, AM J PHYSIOL-HEART C, V276, pH2085, DOI 10.1152/ajpheart.1999.276.6.H2085; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Guzman M, 2001, J MOL MED-JMM, V78, P613, DOI 10.1007/s001090000177; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Hampson AJ, 2000, ANN NY ACAD SCI, V899, P274, DOI 10.1111/j.1749-6632.2000.tb06193.x; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Herring AC, 1999, J PHARMACOL EXP THER, V291, P1156; Huang CJ, 2002, INT J DEV NEUROSCI, V20, P289, DOI 10.1016/S0736-5748(02)00022-9; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Jack DB, 1997, DRUG NEWS PERSPECT, V10, P440; Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x; Kittler JT, 2000, PHYSIOL GENOMICS, V3, P175, DOI 10.1152/physiolgenomics.2000.3.3.175; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lipton SA, 1997, NAT MED, V3, P20, DOI 10.1038/nm0197-20; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; Nagayama T, 1999, J NEUROSCI, V19, P2987; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Ouyang YL, 1998, MOL PHARMACOL, V53, P676, DOI 10.1124/mol.53.4.676; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Sancho R, 2003, MOL PHARMACOL, V63, P429, DOI 10.1124/mol.63.2.429; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHWANINGER M, 1993, J BIOL CHEM, V268, P23111; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; Shen MX, 1996, J NEUROSCI, V16, P4322; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Simpson CS, 2000, J BIOL CHEM, V275, P16879, DOI 10.1074/jbc.275.22.16879; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; van der Stelt M, 2001, J NEUROSCI, V21, P6475, DOI 10.1523/JNEUROSCI.21-17-06475.2001; van der Stelt M, 2001, J NEUROSCI, V21, P8765, DOI 10.1523/JNEUROSCI.21-22-08765.2001; Won SJ, 1999, NEUROSCIENCE, V94, P83, DOI 10.1016/S0306-4522(99)00196-7; Xu L, 2002, BIOCHEM BIOPH RES CO, V299, P14, DOI 10.1016/S0006-291X(02)02573-1; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	59	36	37	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	SEP	2004	47	4					580	592		10.1016/j.neuropharm.2004.05.009			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	858WU	WOS:000224223900009	15380375				2022-02-06	
J	Riley, GA; Brennan, AJ; Powell, T				Riley, GA; Brennan, AJ; Powell, T			Threat appraisal and avoidance after traumatic brain injury: why and how often are activities avoided?	BRAIN INJURY			English	Article							HEAD-INJURY; STRESS; MODEL	Objective: Goldstein emphasized the anxiety-related avoidance of activities after brain injury, but such avoidance has rarely been systematically investigated. This study aimed to compile a list of specific threat appraisals that may lead to avoidance and to obtain data on the frequency with which these appraisals and consequent avoidance occur. Design: Survey. Method: Qualitative methodology was used to obtain an account of threat appraisals. These data were then used to compile two questionnaires that asked about the experience of these appraisals and consequent avoidance. Fifty individuals with a TBI completed the questionnaires. Results: A varied list of threat appraisals was obtained. Appraisals and consequent avoidance were frequent in the sample. Males and those whose TBI resulted from an assault reported more avoidance. Conclusions: A core aim of rehabilitation is to facilitate participation in valued roles and activities. Threat appraisals and avoidance deserve more attention in research and practice because they may constitute a significant obstacle to achieving this.	Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England		Riley, GA (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	rileyga@bham.ac.uk	Riley, Gerard/A-4328-2008; Riley, Gerard Anthony/J-1646-2012; riley, gerard/AAP-1439-2020	Riley, Gerard Anthony/0000-0002-1167-8023; Powell, Theresa/0000-0002-3351-9453			BUCK M, 1963, J REHABIL, V29, P37; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dey I., 1993, QUALITATIVE DATA ANA; Finset A, 2000, BRAIN INJURY, V14, P887; FOLKMAN S, 1984, J PERS SOC PSYCHOL, V46, P839, DOI 10.1037/0022-3514.46.4.839; Folkman S., 1984, STRESS; FREEDMAN LR, 1987, DOCTORS GET SICK, P131; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Goldstein K., 1939, ORGANISM; Goldstein K, 1942, EFFECTS BRAIN INJURY; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; HINCKLEDAY NS, 1990, BRAIN INJURY, V47, P50; KAPUR N, 1998, INJURED BRAINS MED M; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kline P., 2000, PSYCHOMETRICS PRIMER; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LINGE FR, 1990, CAN J PSYCHOL, V44, P116, DOI 10.1037/h0084383; LINGE FR, 1980, CANADAS MENTAL HLTH, V28, P317; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; MOORE AD, 1994, CANADIAN J REHABILIT, V7, P193; NEWBORNE B, 1997, RETURN ITHACA; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; QUINN DA, 1998, CONQUERING DARKNESS; Rimel RW, 1990, REHABILITATION ADULT, P8; Syder D, 1993, SHEFFIELD SCREENING; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218	26	36	36	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2004	18	9					871	888		10.1080/02699050410001671829			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	831FG	WOS:000222178700003	15223740				2022-02-06	
J	Holmgren, EP; Dierks, EJ; Homer, LD; Potter, BE				Holmgren, EP; Dierks, EJ; Homer, LD; Potter, BE			Facial computed tomography use in trauma patients who require a head computed tomogram	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							FRACTURES; INJURIES; DIAGNOSIS	Purpose: Head-injured patients admitted to a trauma center may or may not have associated facial fractures. Most head-injured patients undergo head computed tomography (CT) scan early in their evaluation. The question of adding a facial CT at the time of the head CT can be unclear. The aims of our study are 1) to analyze how the facial CT is used in conjunction with the head CT in facial fracture trauma patients, 2) to recognize unique identifiers that would aid the surgeon's decision-making process to order a facial CT in continuity with a head CT, and 3) to examine what is characteristic of head trauma patients who receive a facial CT separately, at some point after the head CT. Materials and Methods: Data were retrospectively reviewed for a 5-year period at a level 1 trauma center in which all patients who present with craniomaxillofacial trauma are managed by the oral and maxillofacial surgery (OMFS) service. included patients must have obtained a head CT during initial resuscitation and be diagnosed with a facial fracture during the same hospital stay. These patients were divided into 3 groups: those who had a 1) head CT only, 2) head CT and facial CT at the same time, and 3) head CT with the facial CT performed at a later time. Results: A total of 9,871 patients were admitted to the trauma service during a 5-year period and 4,926 patients (49.9%) had head CT performed. Of this group, 12% had facial fractures, and the most common associated injury in this group was facial lacerations and concussions. The nasal fracture followed by the orbital fracture was the most common fracture type. Eighty-four percent of the time, the facial CT was used to help diagnose facial fractures in this patient population. The 3 different groups showed unique trends. Conclusion: Six points were identified in our study that can augment the physical examination in patients who require head CT. The following points can help prompt the clinician to order a combination head and facial CT: 1) 12% of trauma patients who require a head CT will have a facial fracture, whereas half of these patients will have multiple facial fractures. 2) Orbital fractures are commonly missed in this group and often require a secondary scan such as coronal views for accurate diagnosis. 3) Facial lacerations correlate with ordering a combination head and facial CT. 4) The most common facial fracture identified among patients receiving a trauma head CT is the nasal fracture. 5) The use of the facial CT in more severely injured patients tended to be delayed and was related to increased hospital and intensive care unit days. 6) Only 16% of facial fracture patients who had received an initial trauma head CT did not require further facial CT scanning. (C) 2004 American Association of Oral and Maxillofacial Surgeons.	Oregon Hlth & Sci Univ, Dept Oral & Maxillofacial Surg, Portland, OR 97203 USA; Legacy Hosp Syst, Portland, OR 97203 USA		Holmgren, EP (corresponding author), Oregon Hlth & Sci Univ, Dept Oral & Maxillofacial Surg, 7416 N Olin Ave, Portland, OR 97203 USA.	holmgren@ohsu.edu					ABUBAKER AO, 2001, ORAL MAXILLOFACIAL S, P203; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOOTH PW, 1999, MAXILLOFACIAL SURG, P21; Carroll SM, 1996, IRISH MED J, V89, P188; ENDERSON BL, 1991, SURG CLIN N AM, V71, P399; GAUTAM V, 1994, INJURY, V25, P47, DOI 10.1016/0020-1383(94)90184-8; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; McAuley Clyde E., 1992, Journal of Trauma, V33, P948; PRESS BH, 2000, INJURY, V31, P677; REHM CG, 1995, J ORAL MAXIL SURG, V53, P522, DOI 10.1016/0278-2391(95)90063-2; SINCLAIR D, 1988, Journal of Emergency Medicine, V6, P109, DOI 10.1016/0736-4679(88)90148-5; WHITAKER LA, 1990, ANN PLAS SURG, V25, P440, DOI 10.1097/00000637-199012000-00003	13	36	45	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	AUG	2004	62	8					913	918		10.1016/j.joms.2003.12.026			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	842RS	WOS:000223022300002	15278853				2022-02-06	
J	Wassenberg, R; Max, JE; Lindgren, SD; Schatz, A				Wassenberg, R; Max, JE; Lindgren, SD; Schatz, A			Sustained attention in children and adolescents after traumatic brain injury: relation to severity of injury, adaptive functioning, ADHD and social background	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; DEFICIT-HYPERACTIVITY DISORDER; FAMILY ASSESSMENT DEVICE; SCHOOL-AGE-CHILDREN; INHIBITORY CONTROL; PERFORMANCE; RELIABILITY; PREDICTORS; CHILDHOOD; BEHAVIOR	Primary objective: To examine the relationship of child and family psychosocial variables and traumatic brain injury (TBI) severity as it relates to sustained attention ( the Paediatric Assessment of Cognitive Efficiency, PACE). Research design: Forty-two children and adolescents were recruited and participated in a 2 year longitudinal study to evaluate sustained attention using the computerized testing metric, PACE. More specifically, errors of omission ( inattention) and commission ( impulsiveness) were measured. Main outcomes and results: Significant improvement on inattention and impulsiveness were observed over time. High pre-injury psychosocial adversity and low pre-injury adaptive functioning significantly predicted a greater number of inattention errors. Severity of injury predicted the reduction of impulsiveness. Moreover, omission errors immediately after TBI predicted later secondary attention-deficit/hyperactivity disorder (SADHD, ADHD that emerges after TBI). Conclusions: Based on these findings, it is important to consider pre-injury child and family psychosocial characteristics in addition to severity of injury when predicting outcome of TBI in children.	Childrens Hosp & Hlth Ctr, San Diego, CA 92123 USA; Univ Maastricht, Maastricht, Netherlands; Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; Univ Iowa Hosp & Clin, Dept Pediat, Ctr Disabil & Dev, Iowa City, IA 52242 USA		Max, JE (corresponding author), Childrens Hosp & Hlth Ctr, 3020 Childrens Way,MC 5033, San Diego, CA 92123 USA.	jmax@ucsd.edu			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001800] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH01800] Funding Source: Medline		American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Andreasen N.C., 1994, PSYCHAT EPIDEMIOLOGY, P349; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; ARMSTRONG K, 2001, J INT NEUROPSYCH SOC, V7, P238; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Berger A, 2000, NEUROSCI BIOBEHAV R, V24, P3, DOI 10.1016/S0149-7634(99)00046-9; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; CHAMBERS WJ, 1985, ARCH GEN PSYCHIAT, V42, P696; Chhabildas N, 2001, J ABNORM CHILD PSYCH, V29, P529, DOI 10.1023/A:1012281226028; Ciccetti D., 1984, VINELAND ADAPTIVE BE; CORKUM PV, 1993, J CHILD PSYCHOL PSYC, V34, P1217, DOI 10.1111/j.1469-7610.1993.tb01784.x; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; FISHER M, 1995, J CLIN CHILD PSYCHOL, V24, P427; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LINDGREN S, 1983, PEDIAT ASSESSMENT CO; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; PLISZKA SR, 1992, J AM ACAD CHILD PSY, V31, P197, DOI 10.1097/00004583-199203000-00003; Posner M., 1996, IMAGES MIND; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Robin DA, 1999, APHASIOLOGY, V13, P701, DOI 10.1080/026870399401812; RUTTER M, 1981, AM J PSYCHIAT, V48, P564; *SAS I INC, 1999, SAS PROPR SOFTW VERS; Swanson J, 1998, ATTENTIVE BRAIN, P445; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; TROMMER BL, 1988, J DEV BEHAV PEDIATR, V9, P339; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Vriezen ER, 2000, BRAIN COGNITION, V44, P67; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; WOLRAICH ML, 1994, NEW ENGL J MED, V330, P301, DOI 10.1056/NEJM199402033300501; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; [No title captured]	61	36	36	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2004	18	8					751	764		10.1080/02699050410001671775			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	826AN	WOS:000221801300002	15204316				2022-02-06	
J	Dimopoulou, I; Tsagarakis, S; Douka, E; Zervou, M; Kouyialis, AT; Dafni, U; Thalassinos, N; Roussos, C				Dimopoulou, I; Tsagarakis, S; Douka, E; Zervou, M; Kouyialis, AT; Dafni, U; Thalassinos, N; Roussos, C			The low-dose corticotropin stimulation test in acute traumatic and non-traumatic brain injury: incidence of hypo-responsiveness and relationship to outcome	INTENSIVE CARE MEDICINE			English	Article						head trauma; stroke; critical illness; cortisol; low-dose corticotropin stimulation test; outcome prediction	SEPTIC SHOCK; ADRENAL INSUFFICIENCY; CORTISOL RESPONSE	Objective. To investigate adrenal responses to the low-dose corticotropin (ACTH) stimulation test in acute traumatic or non-traumatic brain injury (BI) and to assess its value in predicting outcome. Design. Prospective study. Setting. Intensive care unit (ICU) in a university hospital. Patients and participants. Seventy-five patients with acute BI, with a median age of 45 years were investigated. BI was due to trauma (n=51), ischemic stroke (n=17), subarachnoid hemorrhage (n=4) or intracerebral hemorrhage (n=3). Interventions. Blood was taken on day 16 (median) after admission to the ICU to determine baseline cortisol and ACTH. Thereafter, a low-dose stimulation test (LDST) was performed: 1 mug of tetracosactrin was injected and 30 min later a second blood specimen was obtained to measure stimulated cortisol. Patients having a stimulated cortisol below 500 nmol/l were defined as non-responders to the LDST. Measurements and results. Median baseline and stimulated cortisol were 491 nmol/l and 690 nmol/l, respectively. The median increment in cortisol was 154 nmol/l (range 5-579 nmol/l). Mean ACTH was 46+/-21 pg/ml. Ten (13%) patients were non-responders to the LDST; these had a higher mortality rate compared to patients with adequate cortisol production (70 vs 32%, p=0.034). Logistic regression analysis revealed that APACHE II (p<0.001), Glasgow Coma Scale (GCS) (p=0.04) and age (p=0.02) were independent outcome predictors. In contrast, the increment in cortisol (p=0.26) did not add to outcome prediction. Conclusions. Adrenal hypo-responsiveness in the setting of acute traumatic or non-traumatic BI is not an independent outcome predictor in the presence of high APACHE II, low GCS and older age.	Natl & Kapodistrian Univ Athens, Dept Crit Care Med, Evangelismos Hosp, Sch Med, Athens 10675, Greece; Natl & Kapodistrian Univ Athens, Dept Endocrinol Diabet & Metab, Evangelismos Hosp, Sch Med, Athens 10675, Greece		Dimopoulou, I (corresponding author), Natl & Kapodistrian Univ Athens, Dept Crit Care Med, Evangelismos Hosp, Sch Med, Athens 10675, Greece.	idimo@otenet.gr	Dafni, Ourania/AAH-4453-2019	Dafni, Ourania/0000-0003-4367-4497			Ambrosi B, 1998, EUR J ENDOCRINOL, V139, P575, DOI 10.1530/eje.0.1390575; Beishuizen A, 2001, INTENS CARE MED, V27, P1584, DOI 10.1007/s001340101073; BOACHOUR G, 1995, INTENS CARE MED, V21, P57; Bourne RS, 2003, ANAESTHESIA, V58, P591, DOI 10.1046/j.1365-2044.2003.03183.x; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; DIMOPOULOU I, 2004, CRIT CARE MED, V32, P404; GRINSPOON SK, 1994, J CLIN ENDOCR METAB, V79, P923, DOI 10.1210/jc.79.4.923; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; LEDINGHAM IM, 1983, LANCET, V1, P1270; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; OLSSON T, 1992, STROKE, V23, P1573, DOI 10.1161/01.STR.23.11.1573; ROTHWELL PM, 1991, LANCET, V337, P582, DOI 10.1016/0140-6736(91)91641-7; SALEM M, 1994, ANN SURG, V219, P416, DOI 10.1097/00000658-199404000-00013; Tordjman K, 2000, CLIN ENDOCRINOL, V52, P633, DOI 10.1046/j.1365-2265.2000.00984.x	15	36	40	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JUN	2004	30	6					1216	1219		10.1007/s00134-004-2297-2			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825BF	WOS:000221730300033	15103462				2022-02-06	
J	Xiang, H; Stallones, L; Smith, GA				Xiang, H; Stallones, L; Smith, GA			Downhill skiing injury fatalities among children	INJURY PREVENTION			English	Article							HEAD-INJURIES	Objective: Young skiers are at increased risk for injury, however, epidemiological data on skiing related fatal injuries among child skiers are scarce. This study aimed to provide information needed to develop injury control and prevention programs. Design and setting: Study subjects came from Colorado, USA and were identified using a death certificate based surveillance system. Fatal injuries were limited to events that occurred at established commercial ski resorts in Colorado, and subjects were classified as child skiers (0-17 years) or adult skiers (greater than or equal to18 years). Main outcome measure: Type and external cause, time, and week day of injury, gender and residency of the decedents. Results: During the study period from 1980-2001, 149 fatal injuries associated with downhill skiing were identified; 21 (14.1%) occurred among child skiers aged less than or equal to17 years. The age of the youngest decedent was 7 years. In females the proportion of fatal Injuries among child skiers was nearly three times that of adults. Traumatic brain injuries were the leading cause of death (67% of all deaths) among children, while multiple internal injuries and traumatic brain injuries accounted for almost equal proportions of fatal injuries among adults. Collision was the leading external mechanism of fatal injuries, accounting for more than two thirds of fatal Injuries in both child and adult skiers. Conclusions: Traumatic brain injury was the leading cause and collision was the leading external injury mechanism of fatal injuries associated with downhill skiing among child skiers. This underscores the importance of brain injury prevention strategies, including the use of ski helmets and prevention of collisions on ski slopes.	Ohio State Univ, Columbus Childrens Res Inst, Ctr Injury Res & Policy, Columbus, OH 43210 USA; Ohio State Univ, Coll Med & Publ Hlth, Columbus Childrens Hosp, Columbus, OH 43210 USA; Colorado State Univ, Dept Psychol, Colorado Injury Control Res Ctr, Ft Collins, CO 80523 USA		Xiang, H (corresponding author), Columbus Childrens Hosp, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	xiangh@pediatrics.ohio-state.edu	Xiang, Huiyun/E-4335-2011; Stallones, Lorann/AAC-6248-2021	Stallones, Lorann/0000-0001-7616-582X	ODCDC CDC HHS [R49/CCR811509] Funding Source: Medline		BLITZER CM, 1984, AM J SPORT MED, V12, P142, DOI 10.1177/036354658401200210; BROWN JM, 1997, CONT PEDIAT, V14, P115; CDC Injury Research Agenda, 2002, CDC INJ RES AG; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; Deibert MC, 1998, J BONE JOINT SURG AM, V80A, P25, DOI 10.2106/00004623-199801000-00006; Ferrera PC, 1999, AM J EMERG MED, V17, P575, DOI 10.1016/S0735-6757(99)90199-7; FURRER M, 1995, J TRAUMA, V39, P737, DOI 10.1097/00005373-199510000-00024; Goulet C, 1999, AM J SPORT MED, V27, P644, DOI 10.1177/03635465990270051701; JAFFIN B, 1981, MT SINAI J MED, V48, P353; JENKINS R, 1983, P 5 INT S PHIL, P358; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Macnab A J, 1996, Inj Prev, V2, P286, DOI 10.1136/ip.2.4.286; MORROW PL, 1988, J TRAUMA, V28, P95, DOI 10.1097/00005373-198801000-00014; *NIH, 1992, SPORTS INJ YOUTH SUR; SAS INSTITUTE INC, 2000, SAS STAT US GUID VER; SHERRY E, 1988, MED J AUSTRALIA, V149, P615, DOI 10.5694/j.1326-5377.1988.tb120803.x; Shorter NA, 1996, J TRAUMA, V40, P997, DOI 10.1097/00005373-199606000-00024; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; TOUGH SC, 1993, AM J FOREN MED PATH, V14, P17, DOI 10.1097/00000433-199303000-00004; TOUGH SC, 1993, AM J FOREN MED PATH, V14, P12, DOI 10.1097/00000433-199303000-00003; US Consumer Product Safety Commission, 1999, SKIING HELM EV POT R; Weston J T, 1977, J Forensic Sci, V22, P222; Xiang HY, 2003, INJURY, V34, P892, DOI 10.1016/S0020-1383(03)00055-X	24	36	36	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	APR	2004	10	2					99	102		10.1136/ip.2003.004655			4	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	820AX	WOS:000221359900012	15066975	Bronze, Green Published			2022-02-06	
J	Korinthenberg, R; Schreck, J; Weser, J; Lehmkuhl, G				Korinthenberg, R; Schreck, J; Weser, J; Lehmkuhl, G			Post-traumatic syndrome after minor head injury cannot be predicted by neurological investigations	BRAIN & DEVELOPMENT			English	Article						minor head injury; childhood; prognosis; post-traumatic syndrome; electroencephalography; neurological examination	BEHAVIORAL SEQUELAE; PAROXYSMAL ACTIVITY; NORMAL CHILDREN; MILD; TRAUMA; ELECTROENCEPHALOGRAM; TERM; INTERVENTION; RECOVERY; FOLLOW	The aim of this study is to investigate predictive factors of post-traumatic syndrome in children with minor head injury. Prospective neurological, electroencephalographic and psychological investigations were performed in 98 children aged 3 - 13 years within 24 h after the trauma and 4-6 weeks later. Inclusion criteria for mild head injury were unconsciousness < 10 min or none at all, lack of overt neurological symptoms and other complications requiring intensive care. Twenty-six of the children had been unconscious for a short period. Ten had suffered a skull fracture. Within the first 24 h, nearly all children reported acute symptoms of concussion and 64 of 98 showed abnormal EEG findings. After 4-6 weeks, 23 of 98 still exhibited post-traumatic complaints with headache, fatigue, sleep disturbances, anxiety and affect instability. Such post-traumatic symptoms did not correlate with somatic, neurological or electroencephalographic findings observed immediately after the injury or at the follow-up investigation. As opposed to the situation in more severe head trauma, post-traumatic syndrome after minor head injury in children is apparently not due to central nervous injury detectable by neurological examination or electroencephalography. Irrespective of the necessity of neuroradiological investigations and repeated EEGs in more severe and complicated head trauma, we discourage the routine EEG examination in very slight head injury and instead rather recommend parent and patient counselling. (C) 2003 Elsevier B.V. All rights reserved.	Univ Hosp, Div Neuropaediat & Muscular Dis, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany; Univ Hosp, Dept Child & Adolescent Psychiatry, D-50931 Cologne, Germany		Korinthenberg, R (corresponding author), Univ Hosp, Div Neuropaediat & Muscular Dis, Dept Pediat & Adolescent Med, Mathildenstrassw 1, D-79106 Freiburg, Germany.	rudokori@kikli.ukl.uni-freiburg.de	Korinthenberg, Rudolf/A-9796-2009	Korinthenberg, Rudolf/0000-0002-4638-3460			BIJUR PE, 1990, PEDIATRICS, V86, P337; BLACK P, 1981, BRAIN DYSFUNCTION CH; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CASEY R, 1987, PEDIATRICS, V80, P159; DUSSER A, 1989, ELECTROEN CLIN NEURO, V73, P85, DOI 10.1016/0013-4694(89)90187-9; Edna T H, 1987, J Oslo City Hosp, V37, P101; EEGOLOFSSON O, 1971, NEUROPADIATRIE, V2, P375, DOI 10.1055/s-0028-1091791; ENOMOTO T, 1986, CHILD NERV SYST, V2, P72; Esser G., 1989, MANNHEIMER ELTERNINT; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; Fellick JM, 2001, ARCH DIS CHILD, V85, P371, DOI 10.1136/adc.85.5.371; HUGENHOLTZ H, 1987, CHILD NERV SYST, V3, P266, DOI 10.1007/BF00271820; JONES RK, 1974, SURG NEUROL, V2, P101; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; KOUFEN H, 1977, EEG-EMG-Z ELEK ELEKT, V8, P29; KOUFEN H, 1977, MED KLIN, V72, P739; KRAUS F, 1990, AM J DIS CHILD, V44, P684; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MASUZAWA H, 1988, CHILD NERV SYST, V4, P198, DOI 10.1007/BF00270914; PETERSEN I, 1971, NEUROPADIATRIE, V2, P247, DOI 10.1055/s-0028-1091786; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; RAEGRANT AD, 1991, ELECTROEN CLIN NEURO, V79, P349, DOI 10.1016/0013-4694(91)90199-E; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; RUIJS MBM, 1993, EUR J PEDIATR, V152, P844, DOI 10.1007/BF02073384; RUIJS MBM, 1994, NEUROPEDIATRICS, V25, P73, DOI 10.1055/s-2008-1071589; RUMPL E, 1999, ELECTROENCEPHALOGRAP, P393; RUTHERFORD WH, 1977, LANCET, V1, P1; SANFORD RA, 1988, SEMIN NEUROL, V8, P108, DOI 10.1055/s-2008-1041362; SILVERMAN D, 1962, NEUROLOGY, V12, P273, DOI 10.1212/WNL.12.4.273; SLATER EJ, 1989, J ADOLESCENT HEALTH, V10, P237, DOI 10.1016/0197-0070(89)90240-4; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Touwen B., 1979, EXAMINATION CHILD MI	34	36	39	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	MAR	2004	26	2					113	117		10.1016/S0387-7604(03)00110-4			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	801VH	WOS:000220122900007	15036430				2022-02-06	
J	Aare, M; Kleiven, S; Halldin, P				Aare, M; Kleiven, S; Halldin, P			Injury tolerances for oblique impact helmet testing	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						injury tolerances; oblique impacts; helmet; head injuries and FE (finite element)	DIFFUSE AXONAL INJURY; HUMAN HEAD	The most frequently sustained severe injuries in motorcycle crashes are injuries to the head, and many of these are caused by rotational force. Rotational force is most commonly the result of oblique impacts to the head. Good testing methods for evaluating the effects of such impacts are currently lacking. There is also a need for improving our understanding of the effects of oblique impacts on the human head. Helmet standards currently in use today do not measure rotational effects in test dummy heads. However rotational force to the head results in large shear strains arising in the brain, which has been proposed as a cause of traumatic brain injuries like diffuse axonal injuries (DAI). This paper investigates a number of well-defined impacts, simulated using a detailed finite element (FE) model of the human head, an FE model of the Hybrid III dummy head and an FE model of a helmet. The same simulations were performed on both the FE human head model and the FE Hybrid III head model, both fitted with helmets. Simulations on both these heads were performed to describe the relationship between load levels in the FE Hybrid III head model and strains in the brain tissue in the FE human head model. In this study, the change in rotational velocity and the head injury criterion (HIC) value were chosen as appropriate measurements. It was concluded that both rotational and translational effects are important when predicting the strain levels in the human brain.	CTV, Div Neuron Engn, Royal Inst Technol, SE-14157 Huddinge, Sweden; Karolinska Inst, S-10401 Stockholm, Sweden		Aare, M (corresponding author), CTV, Div Neuron Engn, Royal Inst Technol, Novum Res Pk, SE-14157 Huddinge, Sweden.	aare@kth.se					Aare M, 1999, INJ CONTR SAF PROMOT, V10, P131, DOI [DOI 10.1076/ICSP.10.3.131.14556, 10.1076/icsp.10.3.131.14556]; AARE M, 2003, NEW LAB RIG EVALUATI, V4, P240; BAIN BC, 1996, AGARD AMP; BAIN BC, 2000, J BIOMECH ENG, V16, P615; Beusenberg M, 2001, IRCOBI C 2001 ISL MA, P295; *BRIT STAND I, 1985, PROT HELM VEH US; DiMasi F. P., 1995, 952718 SAE; DONNELLY BR, 1998, P 26 INT WORKSH, P47; FREDRIKSSON LA, 1996, 447 DIV SOL MECH DEP; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gennarelli T.A., 1987, 872197 SAE, P49; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HALLQUIST JO, 1998, LSDYNA3D THEOR MAN L; HARDY WN, 2001, 45 STAPP CAR CRASH J, P337; Hering A., 2000, P IRCOBI C MONTP FRA, P307; Holbourn AHS, 1943, LANCET, V2, P438; KING AI, 2002, 4 WORLD C BIOM AUG 2; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; KLEIVEN S, 2002, 02S76 SAE; KLEIVEN S, 2003, P RTO SPEC M NATO CO; KLEIVEN S, 2001, IRCOBI C 2001 ISL MA, P161; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; NEWMAN JA, 2000, 200101SC16 SAE; *NHTSA DOT, 1972, OCC CRAST PROT HEAD; OTTE D, 1999, 327 COST; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; UENO K, 1995, J BIOMECH ENG-T ASME, V117, P319, DOI 10.1115/1.2794187; *UN EC COMM EUR, 1999, WORK PART WP29 CONST; YETTRAM AL, 1994, PLAST RUB COMPOS PRO, V22, P215; 2003, VISIBLE HUMAN PROJEC; 1997, FMV218	32	36	36	0	15	WOODHEAD PUBL LIMITED	LETCHWORTH	BLACKHORSE RD, LETCHWORTH SG6 1HN, HERTS, ENGLAND	1358-8265			INT J CRASHWORTHINES	Int. J. Crashworthiness		2004	9	1					15	23		10.1533/ijcr.2004.0268			9	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	771DF	WOS:000188769800002					2022-02-06	
J	Arundine, M; Chopra, GK; Wrong, A; Lei, SB; Aarts, MM; Macdonald, JF; Tymianski, M				Arundine, M; Chopra, GK; Wrong, A; Lei, SB; Aarts, MM; Macdonald, JF; Tymianski, M			Enhanced vulnerability to NMDA toxicity in sublethal traumatic neuronal injury in vitro	JOURNAL OF NEUROTRAUMA			English	Article						excitotoxicity; F-actin; in vitro model; microtubules; NMDA receptor; stretch injury; trauma	STRETCH-INDUCED INJURY; HIPPOCAMPAL-NEURONS; RECEPTOR ACTIVATION; GENE-EXPRESSION; ALPHA-ACTININ; BRAIN-INJURY; CALCIUM; NEUROTOXICITY; CHANNEL; DAMAGE	Traumatic brain injury causes neuronal disruption and triggers secondary events leading to additional neuronal death. To study injuries triggered by secondary events, we exposed cultured cortical neurons to sublethal mechanical stretch, thus eliminating confounding death from primary trauma. Sublethally stretched neurons maintained cell membrane integrity, viability, and electrophysiological function. However, stretching induced in the cells a heightened vulnerability to subsequent challenges with L-glutamate or NMDA. This heightened vulnerability was specifically mediated by NMDA receptors (NMDARs), as stretched neurons did not become more vulnerable to either kainate toxicity or to that induced by the Call ionophore A23187. Stretch-enhanced vulnerability to NMDA occurred independently of endogenous glutamate release, but required Ca2+ and Na+ influx through NMDARs. Stretch did not affect the electrophysiological properties of NMDARs nor excitatory synaptic activity, indicating that specificity of enhanced vulnerability to NMDA involves postsynaptic mechanisms downstream from NMDARs. To test whether this specificity requires physical interactions between NMDARs and cytoskeletal elements, we perturbed actin filaments and microtubules, both of which are linked to NMDARs. This had no effect on the stretch-induced vulnerability to NMDA, suggesting that sublethal stretch does not affect cell survival through the cytoskeleton. Our data illustrate that sublethal in vitro stretch injury triggers distinct signaling pathways that lead to secondary injury, rather than causing a generalized increase in vulnerability to secondary insults.	Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada		Tymianski, M (corresponding author), Toronto Western Hosp, Res Inst, Toronto, ON M5T 2S8, Canada.	mike_t@uhnres.utoronto.ca	Aarts, Michelle/C-5766-2008	Aarts, Michelle/0000-0002-9171-0571; Tymianski, Mike/0000-0002-6311-9565	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 39060] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039060] Funding Source: NIH RePORTER		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Allison DW, 1998, J NEUROSCI, V18, P2423; Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Brenman JE, 1998, J NEUROSCI, V18, P8805; Brocard JB, 2001, J PHYSIOL-LONDON, V531, P793, DOI 10.1111/j.1469-7793.2001.0793h.x; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; BRUNO VMG, 1994, J NEUROCHEM, V63, P1398; *CDCP, 2001, TRAUM INJ US INT REP; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1987, J NEUROSCI, V7, P357; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; David JC, 1996, J NEUROSCI, V16, P200; Di X, 1999, J NEUROTRAUM, V16, P195, DOI 10.1089/neu.1999.16.195; DUBINSKY JM, 1991, J NEUROSCI, V11, P2545; DUGAN LL, 1995, J NEUROSCI, V15, P6377; Ehlers MD, 1998, J NEUROSCI, V18, P720; EIMERL S, 1994, J NEUROCHEM, V62, P1223; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Faddis BT, 1997, J NEUROSCI, V17, P951; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GARTHWAITE G, 1986, NEUROSCIENCE, V18, P437, DOI 10.1016/0306-4522(86)90164-8; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Graham SH, 2000, J NEUROTRAUM, V17, P831, DOI 10.1089/neu.2000.17.831; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kaech S, 1997, J NEUROSCI, V17, P9565; Krupp JJ, 1999, J NEUROSCI, V19, P1165; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; Li S, 1999, J Neurosci, V19, pRC16; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MADDEN KP, 1990, BRAIN RES, V537, P256, DOI 10.1016/0006-8993(90)90366-J; MARCOUX FW, 1989, CEREBROVASC DIS, P135; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; *NAT CTR HLTH STAT, 1997, DAT FIL DOC NAT HOSP; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sattler R, 1998, J NEUROCHEM, V71, P2349; Sattler R, 2000, J NEUROSCI, V20, P22, DOI 10.1523/JNEUROSCI.20-01-00022.2000; Sattler R, 1997, J CEREBR BLOOD F MET, V17, P455, DOI 10.1097/00004647-199704000-00011; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Shorte SL, 1997, J NEUROPHYSIOL, V78, P1135, DOI 10.1152/jn.1997.78.2.1135; Smith DH, 1999, J NEUROSCI, V19, P4263; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; TANKE HJ, 1982, J IMMUNOL METHODS, V52, P91, DOI 10.1016/0022-1759(82)90353-2; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Tymianski M, 1996, ADV NEUROL, V71, P85; Tymianski M, 1996, NEUROSURGERY, V38, P1176; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; WEBER K, 1975, EXP CELL RES, V95, P111, DOI 10.1016/0014-4827(75)90615-1; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zwienenberg M, 2001, NEUROL RES, V23, P167, DOI 10.1179/016164101101198505	76	36	36	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2003	20	12					1377	1395		10.1089/089771503322686166			19	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	756XH	WOS:000187510700009	14748985				2022-02-06	
J	Rosenkranz, KA; Sheridan, RL				Rosenkranz, KA; Sheridan, RL			Trauma to adult bicyclists: a growing problem in the urban environment	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article							SAFETY HELMETS	The proportion of adults involved in serious bicycle accidents has increased in the last two decades. The majority of the bicycle injury prevention efforts, however, are directed toward child riders. The authors performed a retrospective review of injury statistics from the Massachusetts Hospital Discharge Data Set, 1994-1999, the Massachusetts Emergency Department Injury Surveillance System, 1999, and the trauma registry of an Urban Level I Trauma Centre, 1993-2000. Massachusetts's state-wide injury data reveals a 30% increase in hospital charges between 1994 and 1999 for adults following bicycle falls and collisions with concomitant stability in the charges for children. In the years 1993-2000, 60% of patients requiring inpatient care at the Study Centre for Bicycle Related Injuries were over 16 years of age. Fifty-one percent of patients were without a helmet. Positive blood alcohol tests were present in 35 (16%) of the 222 patients. Forty-six (75%) of patients suffering closed head injury were not helmeted. Adult bicycle trauma is a significant health and financial problem in the urban state of Massachusetts. Bicycle education and legislation emphasising safe bicycling practice, the protective effects of helmets, and the danger of cycling under the influence of alcohol may help alleviate this problem. (C) 2003 Elsevier Science Ltd. All rights reserved.	Massachusetts Gen Hosp, Dept Surg, Div Trauma & Burns, Clin 108, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Dartmouth Hitchcock Med Ctr, Dept Surg, Boston, MA 02114 USA		Sheridan, RL (corresponding author), Massachusetts Gen Hosp, Dept Surg, Div Trauma & Burns, Clin 108, Boston, MA 02114 USA.						FORESTER J, 1994, BICYCLE TRANSPORTER, P41; Li GH, 2001, JAMA-J AM MED ASSOC, V285, P893, DOI 10.1001/jama.285.7.893; STUTTS J, 1999, INJURIES PEDESTRIAN; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON DC, 2002, COCHRANE LIB; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101	6	36	37	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	NOV	2003	34	11					825	829	PII S0020-1383(02)00389-3	10.1016/S0020-1383(02)00389-3			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	745DJ	WOS:000186673400004	14580814				2022-02-06	
J	Kuhlow, CJ; Krady, JK; Basu, A; Levison, SW				Kuhlow, CJ; Krady, JK; Basu, A; Levison, SW			Astrocytic ceruloplasmin expression, which is induced by IL-1 beta and by traumatic brain injury, increases in the absence of the IL-1 type 1 receptor	GLIA			English	Article						interleukin 1; traumatic brain injury; ceruloplasmin; oxidative stress; metals; gliosis	NECROSIS-FACTOR-ALPHA; INTERLEUKIN-1-BETA CONVERTING-ENZYME; EXCITOTOXIC NEURONAL DAMAGE; CILIARY NEUROTROPHIC FACTOR; CENTRAL-NERVOUS-SYSTEM; FACTOR MESSENGER-RNA; NF-KAPPA-B; GENE-EXPRESSION; RAT-BRAIN; NEURODEGENERATIVE DISORDERS	IL-1alpha and IL-1beta are induced immediately after insults to the brain, and signaling through the type 1 IL-1 receptor is essential for a normal microglial and astroglial response to injury. To better understand which genes are induced in astrocytes by IL-1beta, we used the unbiased technique of differential display to analyze mouse astroglial gene expression after IL-1beta treatment. Two novel genes were induced, as well as the gene for ceruloplasmin, a ferroxidase with antioxidant properties. Ceruloplasmin was analyzed further by Northern and Western blot. RNA and protein levels of ceruloplasmin were increased when astrocytes were treated with IL-1beta. To determine whether the IL-1 type 1 receptor (IL-1R1) is essential for the injury-induced expression of ceruloplasmin, a Western blot analysis was performed after a traumatic brain injury on mice that were IL-1R1-deficient. Ceruloplasmin increased significantly above controls after injury; however, injury-induced levels of ceruloplasmin were lower in IL-1R1-deficient (2.7-fold increase) than in the wild-type animals (3.5-fold increase). These data indicate that while IL-1R1 deletion has a slight effect on ceruloplasmin expression, it is not essential for either the basal or the induced expression of ceruloplasmin in vivo. Since ceruloplasmin buffers free copper, oxidizes ferrous iron, and catalyzes the dismutation of free radicals, increased levels of ceruloplasmin likely protect neurons and glia from sustaining damage after injury. Furthermore, as the lL-1R1 has been proposed to be a target for achieving neuroprotection after injury, these data suggest that the protection afforded by ceruloplasmin will be retained even when the lL-1R1 is antagonized. (C) 2003 Wiley-Liss, Inc.	Penn State Coll Med, Dept Neurosci & Anat, Hershey, PA 17033 USA		Levison, SW (corresponding author), Penn State Coll Med, Dept Neurosci & Anat, H109,POB 850, Hershey, PA 17033 USA.		Levison, Steven W./Q-6903-2019	Levison, Steven W./0000-0002-1264-7309; Basu, Anirban/0000-0002-5200-2054			Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Albrecht PJ, 2002, EXP NEUROL, V173, P46, DOI 10.1006/exnr.2001.7834; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; ALOISI F, 1992, J IMMUNOL, V149, P2358; ARAUJO DM, 1992, J NEUROSCI, V12, P1668; BANDTLOW CE, 1990, J CELL BIOL, V111, P1701, DOI 10.1083/jcb.111.4.1701; BARTLETT PF, 1980, BRAIN RES, V204, P339; Basu A, 2002, J NEUROSCI, V22, P6071; BAUER J, 1993, J NEUROIMMUNOL, V48, P13, DOI 10.1016/0165-5728(93)90053-2; BENVENISTE EN, 1990, J NEUROIMMUNOL, V30, P201, DOI 10.1016/0165-5728(90)90104-U; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Chang JW, 2001, NEUROCHEM INT, V39, P349, DOI 10.1016/S0197-0186(01)00042-0; CHUNG IY, 1990, J IMMUNOL, V144, P2999; CONNOR JR, 1993, NEUROSCI LETT, V159, P88, DOI 10.1016/0304-3940(93)90805-U; DACUNHA A, 1992, J NEUROIMMUNOL, V36, P157; DECKERTSCHLUTER M, 1992, J NEUROL SCI, V113, P50, DOI 10.1016/0022-510X(92)90264-L; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Friedman WJ, 1996, J BIOL CHEM, V271, P31115, DOI 10.1074/jbc.271.49.31115; GADIENT RA, 1990, NEUROSCI LETT, V117, P335, DOI 10.1016/0304-3940(90)90687-5; GELMAN BB, 1995, J NEUROPATH EXP NEUR, V54, P477, DOI 10.1097/00005072-199507000-00001; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; GIULIAN D, 1988, J NEUROSCI, V8, P2485; GOLDSTEIN E, 1979, ARCH ENVIRON HEALTH, V34, P424, DOI 10.1080/00039896.1979.10667444; GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; HARTUNG HP, 1989, BRAIN RES, V489, P113, DOI 10.1016/0006-8993(89)90013-9; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Herx LM, 2000, J IMMUNOL, V165, P2232, DOI 10.4049/jimmunol.165.4.2232; Herx LM, 2001, J NEUROPATH EXP NEUR, V60, P961, DOI 10.1093/jnen/60.10.961; HOFMAN FM, 1986, J IMMUNOL, V136, P3239; Jacobson D R, 1991, PCR Methods Appl, V1, P146; JENNER P, 1994, LANCET, V344, P796, DOI 10.1016/S0140-6736(94)92347-7; Klomp LWJ, 1996, J CLIN INVEST, V98, P207, DOI 10.1172/JCI118768; LEE SC, 1995, J NEUROCHEM, V64, P1800; Legos JJ, 2000, NEUROSCI LETT, V282, P189, DOI 10.1016/S0304-3940(00)00907-1; Levison S., 1991, CULTURING NERVE CELL, P309; Liu XH, 1999, J CEREBR BLOOD F MET, V19, P1099, DOI 10.1097/00004647-199910000-00006; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; Loeffler DA, 1996, BRAIN RES, V738, P265, DOI 10.1016/S0006-8993(96)00782-2; MARTINEZ O. J., 1994, GLOBAL BOUNDARIES WO, V1, P1, DOI [10.1163/9789401204774_002, DOI 10.4324/9780203211960]; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; McGuinness MC, 1997, J NEUROIMMUNOL, V75, P174, DOI 10.1016/S0165-5728(97)00020-9; MINAMI M, 1992, J NEUROCHEM, V58, P390, DOI 10.1111/j.1471-4159.1992.tb09324.x; MIYAJIMA H, 1987, NEUROLOGY, V37, P761, DOI 10.1212/WNL.37.5.761; MORELL AG, 1958, SCIENCE, V127, P588, DOI 10.1126/science.127.3298.588-a; NORRIS JG, 1994, J IMMUNOL, V152, P841; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Qian ZM, 1998, BRAIN RES REV, V27, P257, DOI 10.1016/S0165-0173(98)00012-5; RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T; ROESER HP, 1970, J CLIN INVEST, V49, P2408, DOI 10.1172/JCI106460; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Salzer JL, 1998, J NEUROSCI RES, V54, P147, DOI 10.1002/(SICI)1097-4547(19981015)54:2<147::AID-JNR3>3.3.CO;2-Z; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; SPARACIO SM, 1992, J NEUROIMMUNOL, V39, P231, DOI 10.1016/0165-5728(92)90257-L; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P390, DOI 10.1073/pnas.81.2.390; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676	59	36	36	0	3	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0894-1491			GLIA	Glia	OCT	2003	44	1					76	84		10.1002/glia.10273			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	723QF	WOS:000185442500008	12951659				2022-02-06	
J	Hoffman, SW; Virmani, S; Simkins, RM; Stein, DG				Hoffman, SW; Virmani, S; Simkins, RM; Stein, DG			The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; controlled cortical impact injury; DHEAS; medical rehabilitation; neuroplasticity; neurosteroids; recovery of function	METHYL-D-ASPARTATE; INDUCED LEARNING IMPAIRMENT; CONTROLLED CORTICAL IMPACT; ENHANCE MEMORY RETENTION; FLUID-PERCUSSION INJURY; REDUCED EVOKED RELEASE; CLOSED-HEAD INJURY; LONG-TERM; PREFRONTAL CORTEX; CONTUSION INJURY	The goal of the current study was to test the hypothesis that dehydroepiandrosterone-sulfate (DHEAS), a pro-excitatory neurosteroid, could facilitate recovery of function in male rats after delayed treatment following TBI. DHEAS has been found to play a major role in brain development and aging by influencing the migration of neurons, arborization of dendrites, and formation of new synapses. These characteristics make it suitable as a potential treatment to enhance neural repair in response to CNS injury. In our study, behavioral tests were conducted concurrently with DHEAS administration (0, 5, 10, or 20 mg/kg) starting seven days post-injury (PI). These assays included 10 days of Morris Water Maze testing (MWM; 7d PI), 10 days of Greek-Cross (GC; 21d PI), Tactile Adhesive Removal task (TAR; PI days: 6, 13, 20, 27, 34), and spontaneous motor behavior testing (SMB; PI days: 2, 4, 6, 12, 19, 26, 33). Brain-injured rats showed an improvement in performance in all tasks after 5, 10, or 20 mg/kg DHEAS. The most effective dose of DHEAS in the MWM was 10 mg/kg, while in the GC it was 20 mg/kg, in TAR 5 mg/kg, and all doses, except for vehicle, were effective at reducing injury-induced SMB hyperactivity. In no task did DHEAS-treated animals perform worse than the injured controls. In addition, DHEAS had no significant effects on behavioral performance in the sham-operates. These results can be interpreted to demonstrate that after a 7-day delay, the chronic administration of DHEAS to injured rats significantly improves behavioral recovery on both sensorimotor and cognitive tasks.	Emory Univ, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA		Hoffman, SW (corresponding author), Emory Univ, Dept Emergency Med, Brain Res Lab, Atlanta, GA 30322 USA.	swhoffm@emory.edu	Stein, Donald/AAJ-5139-2020		NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5R03 HD 040295] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD040295] Funding Source: NIH RePORTER		BARTH TM, 1990, STROKE, V21, P153; Baulieu EE, 1998, PSYCHONEUROENDOCRINO, V23, P963, DOI 10.1016/S0306-4530(98)00071-7; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Bergeron R, 1996, J NEUROSCI, V16, P1193; BERGERON R, 1995, N-S ARCH PHARMACOL, V351, P252, DOI 10.1007/BF00233244; Borromei A, 1997, FUNCT NEUROL, V12, P89; BOYESON MG, 1994, AM J PHYS MED REHAB, V73, P76, DOI 10.1097/00002060-199404000-00002; CARBARY TJ, 2002, J NEUROTRAUM, V19, P1323; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Compagnone NA, 1998, P NATL ACAD SCI USA, V95, P4678, DOI 10.1073/pnas.95.8.4678; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Debonnel G, 1996, J ENDOCRINOL, V150, pS33; Devan BD, 1999, J NEUROSCI, V19, P2789; Diamond DM, 1996, NEUROSCI LETT, V202, P204, DOI 10.1016/0304-3940(95)12233-8; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Doppenberg EMR, 1997, ANN NY ACAD SCI, V825, P305, DOI 10.1111/j.1749-6632.1997.tb48441.x; Dorner G, 2001, NEUROENDOCRINOL LETT, V22, P403; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; Feeney DM, 1997, ADV NEUROL, V73, P383; FINGER S, 1985, BRAIN RES REV, V10, P177, DOI 10.1016/0165-0173(85)90023-2; Finger S., 1982, BRAIN DAMAGE RECOVER; FLOOD JF, 1988, BRAIN RES, V448, P178, DOI 10.1016/0006-8993(88)91116-X; FLOOD JF, 1988, BRAIN RES, V447, P269, DOI 10.1016/0006-8993(88)91129-8; Frye CA, 1999, PHYSIOL BEHAV, V66, P85, DOI 10.1016/S0031-9384(98)00256-X; FRYE CA, 1995, NEUROBIOL LEARN MEM, V64, P83, DOI 10.1006/nlme.1995.1046; Gladstone DJ, 2000, CAN J NEUROL SCI, V27, P97; Goodyer IM, 2001, BRIT J PSYCHIAT, V179, P243, DOI 10.1192/bjp.179.3.243; Hoffman S. W, 2001, ACAD EMERG MED, V8, P496; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Hoffman SW, 1997, RESTOR NEUROL NEUROS, V11, P1, DOI 10.3233/RNN-1997-111201; Jorgensen OS, 1997, EXP NEUROL, V144, P326, DOI 10.1006/exnr.1996.6372; KOLB B, 1982, BEHAV BRAIN RES, V6, P365, DOI 10.1016/0166-4328(82)90018-3; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Lee I, 2003, J NEUROSCI, V23, P1517, DOI 10.1523/JNEUROSCI.23-04-01517.2003; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Li SY, 1997, ENDOCRINE, V6, P265, DOI 10.1007/BF02820502; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; MAJEWSKA MD, 1990, BRAIN RES, V526, P143, DOI 10.1016/0006-8993(90)90261-9; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Marx CE, 2000, BRAIN RES, V871, P104, DOI 10.1016/S0006-8993(00)02452-5; Maurice T, 1999, JPN J PHARMACOL, V81, P125, DOI 10.1254/jjp.81.125; Maurice T, 2000, EUR J PHARMACOL, V390, P145, DOI 10.1016/S0014-2999(00)00015-7; MCDANIEL WF, 1995, BEHAV BRAIN RES, V70, P165, DOI 10.1016/0166-4328(95)80006-9; McIntosh TK, 1996, LAB INVEST, V74, P315; Melchior CL, 1996, PHARMACOL BIOCHEM BE, V53, P51, DOI 10.1016/0091-3057(95)00197-2; Migues PV, 2002, NEUROSCIENCE, V109, P243, DOI 10.1016/S0306-4522(01)00471-7; MONNET FP, 1995, P NATL ACAD SCI USA, V92, P3774, DOI 10.1073/pnas.92.9.3774; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MUIZELAAR JP, 1994, ADV EXP MED BIOL, V366, P389; Nieto-Escamez FA, 2002, BEHAV BRAIN RES, V134, P93, DOI 10.1016/S0166-4328(01)00458-2; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Pham J, 2000, PHYSIOL BEHAV, V70, P431, DOI 10.1016/S0031-9384(00)00286-9; Ragozzino ME, 2002, NEUROBIOL LEARN MEM, V77, P29, DOI 10.1006/nlme.2001.4003; Reddy DS, 1998, BRAIN RES, V799, P215, DOI 10.1016/S0006-8993(98)00419-3; Rhodes ME, 1997, BRAIN RES, V773, P28, DOI 10.1016/S0006-8993(97)00867-6; Rhodes ME, 1996, BRAIN RES, V733, P284, DOI 10.1016/0006-8993(96)00751-2; ROBERTS E, 1987, BRAIN RES, V406, P357, DOI 10.1016/0006-8993(87)90807-9; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; ROOF RL, 1994, SOC NEUR MIAM BEACH; ROOF RL, 1997, J NEUROTRAUM, V14, P760; Sanchez-Izquierdo-Riera JA, 1998, ANESTH ANALG, V86, P1219, DOI 10.1097/00000539-199806000-00016; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; SPIVAK CE, 1994, SYNAPSE, V16, P113, DOI 10.1002/syn.890160205; STEFFENSEN SC, 1995, HIPPOCAMPUS, V5, P320, DOI 10.1002/hipo.450050405; Sutton RL, 2000, NEURAL PLAST, V7, P109, DOI 10.1155/NP.2000.109; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; Urani A, 1998, BRAIN RES, V799, P64, DOI 10.1016/S0006-8993(98)00469-7; UYLINGS HBM, 1990, 16 INT SUMM SCH BRAI; Vallee M, 2001, BRAIN RES REV, V37, P301, DOI 10.1016/S0165-0173(01)00135-7; WALKERBATSON D, 1995, STROKE, V26, P2254, DOI 10.1161/01.STR.26.12.2254; Watson RR, 1996, DRUG AGING, V9, P274, DOI 10.2165/00002512-199609040-00005; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Wolf OT, 1999, BRAIN RES REV, V30, P264, DOI 10.1016/S0165-0173(99)00021-1; Yoo A, 1996, EXP NEUROL, V137, P151, DOI 10.1006/exnr.1996.0015	83	36	36	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2003	20	9					859	870		10.1089/089771503322385791			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	725BB	WOS:000185521800005	14577864				2022-02-06	
J	Tyack, ZF; Ziviani, J				Tyack, ZF; Ziviani, J			What influences the functional outcome of children at 6 months post-burn?	BURNS			English	Article						paediatric burn; functional outcome; functioning and disability; parents; children; burn injury; pre-morbid functioning	PEDIATRIC BURN SURVIVORS; TRAUMATIC BRAIN INJURY; SOCIAL SUPPORT; ADJUSTMENT; STRESS; FAMILY; SEQUELAE; QUESTIONNAIRE; PREDICTORS; 80-PERCENT	The contribution of demographic, injury, pre-morbid, and parent factors to a child's functional outcome at 6 months post-burn injury was examined. Sixty-eight children, aged 5-14 years with percent total body surface area (%TBSA) burns ranging from <1 to 35%, and their primary caregivers participated in the study. It was expected that pre-morbid and parent factors but not injury factors would have a significant impact on the functional outcome of children at 6 months post-burn. Injury factors included the percent of total body surface area burned, number of operative procedures, and source of the burn (i.e. flame burn, scald burn). Pre-morbid child factors included the presence or absence of behaviour problems. psychological or psychiatric problems, learning difficulty or developmental delay. Parent factors included anxiety. depression, coping processes, and social support. Whilst investigating the contribution of these factors to functional outcome, the effect of demographic factors (i.e. age, gender, family socioeconomic status, and the number of previous hospitalizations) was controlled for and investigated. Analyses included two hierarchical multiple regression analyses that supported the expected results. R was significantly different front zero at the end of each step in both hierarchical regression analyses, indicating that each group of factors added significantly to the fit of the model. After step 4 in the final regression model with all independent variables in the equation, R = 0.85, F(18, 49) = 6.89, P < 0.001. (C) 2003 Published by Elsevier Science Ltd and ISBI.	Univ Queensland, St Lucia, Qld, Australia		Ziviani, J (corresponding author), Univ Queensland, St Lucia, Qld, Australia.		Tyack, Zephanie/Z-4135-2019; Ziviani, Jenny M/C-1708-2010; tyack, zephanie/A-7810-2015	Tyack, Zephanie/0000-0003-3376-5731; tyack, zephanie/0000-0003-3376-5731			ATKINSON M, 1993, PSYCHOL REP, V72, P1159, DOI 10.2466/pr0.1993.72.3c.1159; Beck A. T., 1996, BDI 2 MANUAL; Blakeney P, 1998, J TRAUMA, V44, P625, DOI 10.1097/00005373-199804000-00011; Blakeney Patricia, 1993, Journal of Burn Care and Rehabilitation, V14, P65, DOI 10.1097/00004630-199301000-00015; Byrne C, 1986, J Burn Care Rehabil, V7, P247, DOI 10.1097/00004630-198605000-00011; CELLA DF, 1988, J PEDIATR PSYCHOL, V13, P87, DOI 10.1093/jpepsy/13.1.87; COHEN J, 1993, APPL MULTIPLE REGRES; COMPAS BE, 1990, AM J COMMUN PSYCHOL, V18, P525, DOI 10.1007/BF00938058; CROMES CF, 1998, J BURN CARE REHABI 2, V19, pS178; Davey RB, 1999, BURNS, V25, P62, DOI 10.1016/S0305-4179(98)00059-X; FLEMING JM, 1996, THESIS U QUEENSLAND; FOLKMAN S, 1987, PSYCHOL AGING, V2, P171, DOI 10.1037/0882-7974.2.2.171; Folkman S., 1988, WAYS COPING QUESTION; Gorga D, 1999, J BURN CARE REHABIL, V20, P171; HALEY SM, 1991, PHYS MED REH CLIN N, V2, P689; HARTFORD CE, 1996, TOTAL BURN CARE, P78; Heaman D J, 1995, J Pediatr Nurs, V10, P311, DOI 10.1016/S0882-5963(05)80049-1; HU XH, 1994, J TRAUMA, V37, P209, DOI 10.1097/00005373-199408000-00010; JOHNSTON MV, 1993, REHABILITATION MED P, P240; Kent L, 2000, BURNS, V26, P317, DOI 10.1016/S0305-4179(99)00172-2; KOWALSKE K, 1998, J BURN CARE REHABIL, V19, pS150; LAMONTAGNE LL, 1990, HEART LUNG, V19, P416; LIBBER SM, 1984, J TRAUMA, V24, P245, DOI 10.1097/00005373-198403000-00011; Lund CC, 1944, SURG GYNECOL OBSTE, V79, P352; MAHER M, 2000, J BURN CARE REHABI 2, V21, pS251; MASON S, 1993, BURNS, V19, P507, DOI 10.1016/0305-4179(93)90008-V; MCCOLL MA, 1995, DISABIL REHABIL, V17, P24, DOI 10.3109/09638289509166624; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; Meyer W. J. Iii, 1995, Journal of Burn Care and Rehabilitation, V16, P511, DOI 10.1097/00004630-199509000-00009; Meyer Walter J., 1994, Journal of Burn Care and Rehabilitation, V15, P62, DOI 10.1097/00004630-199401000-00012; Meyer WJ, 2000, J BURN CARE REHABIL, V21, P179, DOI 10.1097/00004630-200021020-00019; Meyers-Paal R, 2000, J BURN CARE REHABIL, V21, P43, DOI 10.1097/00004630-200021010-00009; Ottenbacher KJ, 1999, AM J OCCUP THER, V53, P181, DOI 10.5014/ajot.53.2.181; PERRIN EC, 1993, J DEV BEHAV PEDIATR, V14, P94; Pruitt Basil A. Jr., 1996, P5; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; ROHE DE, 1993, REHABILITATION MED P, P131; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; SCHOR EL, 1995, PEDIATR CLIN N AM, V42, P89; SPARROW SS, 1984, INTERVIEW EDITION SU; SPIELBERGER CD, 1983, MANUAL STATE TRAIT A; Staley M, 1999, J BURN CARE REHABIL, V20, P91, DOI 10.1097/00004630-199901001-00023; Staley Marlys, 1996, Journal of Burn Care and Rehabilitation, V17, P362, DOI 10.1097/00004630-199607000-00014; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TARNOWSKI KJ, 1991, CLIN PSYCHOL REV, V11, P371, DOI 10.1016/0272-7358(91)90114-A; TARNOWSKI KJ, 1989, J PEDIATR PSYCHOL, V14, P607, DOI 10.1093/jpepsy/14.4.607; TYACK ZF, 2001, THESIS U QUEENSLAND; Warden Glenn D., 1996, P523; WESSON DE, 1992, J TRAUMA, V33, P252, DOI 10.1097/00005373-199208000-00015; WILLIAMSON GG, 1993, FRAMES REFERENCE PED, P395; World Health Organization, 2007, INT CLASS FUNCT DIS; Zeitlin REK, 1998, BURNS, V24, P3, DOI 10.1016/S0305-4179(97)00052-1; [No title captured]	53	36	39	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-4179			BURNS	Burns	AUG	2003	29	5					433	444		10.1016/S0305-4179(03)00045-7			12	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Dermatology; Surgery	709AU	WOS:000184603200005	12880722				2022-02-06	
J	Braverman, ER; Blum, K				Braverman, ER; Blum, K			P300 (latency) event-related potential: An accurate predictor of memory impairment	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article; Proceedings Paper	Conference of the American-Academy-of-Anti-Aging-Medicine	DEC 05-08, 2002	LAS VEGAS, NV	Amer Acad Anti Aging Med		aging; Alzheimer's disease; brain health; memory loss; mini-mental status exam; p300; QEEG; Wechsler memory scale	MINI-MENTAL-STATE; ACADEMY-OF-NEUROLOGY; CLINICAL-NEUROPHYSIOLOGY-SOCIETY; OBSESSIVE-COMPULSIVE DISORDER; MILD ALZHEIMERS-DISEASE; TRAUMATIC BRAIN INJURY; RECEPTOR A1 ALLELE; AUDITORY P300; PARKINSONS-DISEASE; COGNITIVE FUNCTION	To determine if P300 latency changes precede and correlate with memory and mental status, patients (N=1506 aged 20-100 years) who received medical and psychiatric diagnoses (from 1997 to 2002), were assessed for P300 (N=1496), WMS-III (N=694), and MMSE (N=456). Patient and control groups included, a) normal WMS-111 on all 4 subscales (N=36), b) normal WMS-111 and MMSE (N=189) with subjective memory/mental status complaints, and c) medical patients with normal WMS-111 and no memory complaints (N=205), and d) P300 control group without medical, psychiatric or memory problems for ROC. Patients with impaired/borderline memory had a prolonged P300 latency (P<0.02) compared to age matched non-impaired controls; in patients with normal WMS-III/MMSE, with subjective mild memory/mental status impairment, P300 latency was prolonged compared to controls (P=0.0004). The P300 latency increased by 0.72ms per year (P=7.9x10(-65)) and voltage decreased by 0.03dV per year (P=6.7x10(-10)), and both parameters were linearly correlated with the age of the subjects. Male subjects had an average voltage of 6.1 dV and female 6.8 dV(P=0.00009). Statistically, prolonged latency began at age range 41-50 (P=0.0002); reduced P300 volt age began at age range 51-60 (P=0.003). WMS-111 memory decline for all measures began in females at age range 61 70 (P value at least=0.02) and for males at age range 61 80 (P=0.02). Prolonged P300 latency (P<0.0001) and memory impairment (at least <0.02) were greater for females than males. MMSE memory decline, male and female, began at age range 81-90 (P value of at least 0.00007). In our logistic regression model P300 latency was more predictive of WMS-111 impairment than MMSE >24. In patients whose WMS-III score is impaired less than or equal to69, or borderline less than or equal to79 (P at least =0.004), a P300 latency more prolonged than the norm (greater than or equal to300 + 30 + Age) identifies these patients, whereas a MMSE >24 failed. With the ROC curve, we confirmed that P300 latency could accurately identify borderline/impaired memory.	Path Med Res Fdn, New York, NY 10016 USA; Univ N Texas, Dept Sci Biol, Denton, TX USA		Braverman, ER (corresponding author), Path Med Res Fdn, 185 Madison Ave,6th Floor, New York, NY 10016 USA.	Pathmedical@aol.com	Braverman, Eric new/ABC-1152-2021				Alberti A, 2001, HEADACHE, V41, P579, DOI 10.1046/j.1526-4610.2001.041006579.x; Ament P A, 1995, J Spinal Cord Med, V18, P208; Aminoff JC, 2001, J CLIN NEUROPHYSIOL, V18, P372, DOI 10.1097/00004691-200107000-00009; Anderer P, 1998, NEUROPSYCHOBIOLOGY, V37, P20, DOI 10.1159/000026472; Anokhin AP, 2000, PSYCHOPHARMACOLOGY, V149, P409, DOI 10.1007/s002130000387; [Anonymous], 1991, Am J Psychiatry, V148, P961; Attias J, 1996, BIOL PSYCHIAT, V40, P373, DOI 10.1016/0006-3223(95)00419-X; Bandini F, 2002, J NEURAL TRANSM, V109, P41, DOI 10.1007/s702-002-8235-5; BARAJAS JJ, 1991, ACTA OTO-LARYNGOL, P157; Barrett G, 1999, EEG CL N SU, V50, P469; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Bauer LO, 1999, BIOL PSYCHIAT, V46, P263, DOI 10.1016/S0006-3223(98)00335-7; Bauer LO, 2001, J STUD ALCOHOL, V62, P571, DOI 10.15288/jsa.2001.62.571; BLACKER D, 2000, COMPREHENSIVE TXB PS, V1, P776; BLEECKER ML, 1988, NEUROLOGY, V38, P1565, DOI 10.1212/WNL.38.10.1565; BLOM JL, 1982, ELECTROEN CLIN NEURO, V54, P591, DOI 10.1016/0013-4694(82)90046-3; BLUM K, 1994, PHARMACOGENETICS, V4, P313, DOI 10.1097/00008571-199412000-00004; BodisWollner I, 1997, CLIN ELECTROENCEPHAL, V28, P143, DOI 10.1177/155005949702800305; BOWSER A, 2002, CNS NEWS, V5, P1; Braverman ER, 1996, CLIN ELECTROENCEPHAL, V27, P5, DOI 10.1177/1550059496027S0402; Braverman ER, 2001, MOL PSYCHIATR, V6, pS5; BROWN WS, 1991, NEUROPSYCHOLOGIA, V29, P35, DOI 10.1016/0028-3932(91)90092-M; BUTLER RW, 1995, COMPREHENSIVE TXB PS, V1, P568; CAINE ED, 2000, COMPREHENSIVE TXB PS, V1, P894; Casey BJ, 2002, SCIENCE, V296, P1408, DOI 10.1126/science.1072684; Clark CR, 1996, BIOL PSYCHIAT, V39, P845; Coburn KL, 2003, J NEUROPSYCH CLIN N, V15, P175, DOI 10.1176/appi.neuropsych.15.2.175; d'Ardhuy XL, 1999, NEUROPSYCHOBIOLOGY, V40, P207, DOI 10.1159/000026621; De Jager CA, 2002, PSYCHOL MED, V32, P483, DOI 10.1017/S003329170200524X; DeFrance JF, 1996, INT J NEUROSCI, V86, P119, DOI 10.3109/00207459608986704; deGroot CM, 1997, CLIN ELECTROENCEPHAL, V28, P148, DOI 10.1177/155005949702800306; Deguchi K, 2001, J NEUROL SCI, V190, P61, DOI 10.1016/S0022-510X(01)00588-3; Derrer DS, 2001, J GERIATR PSYCH NEUR, V14, P1, DOI 10.1177/089198870101400102; DETOLEDOMORRELL L, 1991, ARCH NEUROL-CHICAGO, V48, P605, DOI 10.1001/archneur.1991.00530180061018; DIERKS T, 1994, PHARMACOPSYCHIATRY, V27, P72, DOI 10.1055/s-2007-1014282; DOLLINS AB, 1995, PHYSIOL BEHAV, V57, P223, DOI 10.1016/0031-9384(94)00278-D; Drake M E Jr, 1996, Electromyogr Clin Neurophysiol, V36, P457; DUFFY FH, 1994, CLIN ELECTROENCEPHAL, V25, pR6, DOI 10.1177/155005949402500403; Dufouil C, 2000, NEUROLOGY, V55, P1609, DOI 10.1212/WNL.55.11.1609; Enoch MA, 2001, ALCOHOL CLIN EXP RES, V25, P1293; Farrag AF, 2002, DEMENT GERIATR COGN, V13, P193, DOI 10.1159/000048652; Folmer RL, 1997, BRAIN LANG, V56, P306, DOI 10.1006/brln.1997.1828; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fontani G, 2000, NEUROPSYCHOBIOLOGY, V41, P158, DOI 10.1159/000026649; Ford JM, 2001, BIOL PSYCHIAT, V49, P848, DOI 10.1016/S0006-3223(00)01051-9; FOWLER B, 1993, AVIAT SPACE ENVIR MD, V64, P493; Frodl T, 2002, INT J PSYCHOPHYSIOL, V43, P237, DOI 10.1016/S0167-8760(01)00182-9; Frodl T, 2000, BRAIN TOPOGR, V13, P3, DOI 10.1023/A:1007831017318; Frodl-Bauch T, 1999, NEUROPSYCHOBIOLOGY, V40, P86, DOI 10.1159/000026603; Gaeta H, 2001, PSYCHOL AGING, V16, P55, DOI 10.1037//0882-7974.16.1.55; Gaetz M, 2000, BRAIN INJURY, V14, P815; Geerlings MI, 1999, AM J PSYCHIAT, V156, P531; GEISLER MW, 1992, PSYCHOPHYSIOLOGY, V29, P76, DOI 10.1111/j.1469-8986.1992.tb02017.x; Giger-Mateeva VI, 2000, METAB BRAIN DIS, V15, P179, DOI 10.1023/A:1011159624831; Glass I, 1998, CLIN ELECTROENCEPHAL, V29, P19, DOI 10.1177/155005949802900109; Goldman WP, 2001, ALZ DIS ASSOC DIS, V15, P72, DOI 10.1097/00002093-200104000-00006; Golob EJ, 2002, CLIN NEUROPHYSIOL, V113, P151, DOI 10.1016/S1388-2457(01)00713-1; Grigoletto F, 1999, NEUROLOGY, V53, P315, DOI 10.1212/WNL.53.2.315; Haaland KY, 2003, J INT NEUROPSYCH SOC, V9, P89, DOI 10.1017/S1355617703910101; HAMMOND EJ, 1987, NEUROLOGY, V37, P346, DOI 10.1212/WNL.37.2.346; Hansenne M, 2000, EUR PSYCHIAT, V15, P370, DOI 10.1016/S0924-9338(00)00505-8; HANSENNE M, 1995, EVOKED POTENTIAL, V96, P194, DOI 10.1016/0168-5597(94)00317-8; Hansenne M, 1999, EUR PSYCHIAT, V14, P143, DOI 10.1016/S0924-9338(99)80732-9; Hayakawa T, 2000, PSYCHIAT CLIN NEUROS, V54, P319, DOI 10.1046/j.1440-1819.2000.00695.x; HENDERSON AS, 2000, COMPREHENSIVE TXB PS, V2, P2990; Henderson RM, 2000, ACTA PAEDIATR, V89, P52, DOI 10.1080/080352500750029068; HENDERSON S, 1995, COMPREHENSIVE TXB PS, V2, P2514; Hill SY, 2000, BIOL PSYCHIAT, V48, P265, DOI 10.1016/S0006-3223(00)00841-6; Hill SY, 1999, BIOL PSYCHIAT, V46, P970, DOI 10.1016/S0006-3223(99)00032-3; Hill SY, 1998, BIOL PSYCHIAT, V43, P40, DOI 10.1016/S0006-3223(97)00203-5; Hill SY, 1999, BIOL PSYCHIAT, V45, P346, DOI 10.1016/S0006-3223(97)00525-8; Himani A, 1999, Indian J Physiol Pharmacol, V43, P367; Hoffman DA, 1999, J NEUROPSYCH CLIN N, V11, P401, DOI 10.1176/jnp.11.3.401; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; HOLSCHNEIDER DP, 2000, TXB GERIATRIC NEUROP, P293; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; Idiazabal MA, 2002, REV NEUROLOGIA, V34, P301, DOI 10.33588/rn.3404.2000501; Javitt DC, 1995, EEG CL N SU, P161; Jing H, 2001, J NEUROL, V248, P184, DOI 10.1007/s004150170224; JING H, 2000, CLIN NEUROPHYSIOL, V38, P109; Justus AN, 2001, ALCOHOL CLIN EXP RES, V25, P1457, DOI 10.1097/00000374-200110000-00008; Kalayam B, 1998, AM J PSYCHIAT, V155, P425, DOI 10.1176/ajp.155.3.425; Kazis A, 1996, NEUROPHYSIOL CLIN, V26, P75, DOI 10.1016/0987-7053(96)83148-0; Kiehl KA, 1999, BIOL PSYCHIAT, V45, P1498, DOI 10.1016/S0006-3223(98)00193-0; Kilo J, 2001, ANN THORAC SURG, V72, P1926, DOI 10.1016/S0003-4975(01)03199-X; Kilpelainen R, 1999, PSYCHOPHYSIOLOGY, V36, P343, DOI 10.1017/S0048577299981337; Kilpelainen R, 1999, NEUROREPORT, V10, P3405, DOI 10.1097/00001756-199911080-00027; KONISHI T, 1995, PEDIATR NEUROL, V12, P132, DOI 10.1016/0887-8994(95)00001-V; Korpelainen JT, 2000, ACTA NEUROL SCAND, V101, P202, DOI 10.1034/j.1600-0404.2000.101003202.x; Kotchoubey B, 2001, NEUROSCI LETT, V301, P37, DOI 10.1016/S0304-3940(01)01600-7; KUKULL WA, 1994, J CLIN EPIDEMIOL, V47, P1061, DOI 10.1016/0895-4356(94)90122-8; KURITA A, 1995, ACTA NEUROL SCAND, V92, P319; LACADENA CG, 1996, GAC MED MEX, V3, P267; Lagopoulos J, 1998, NEUROL RES, V20, P5; Legrain V, 2001, REV NEUROL-FRANCE, V157, P365; Lindgren M, 1997, J CLIN EXP NEUROPSYC, V19, P772, DOI 10.1080/01688639708403759; Lorberboym M, 2002, J TRAUMA, V52, P521, DOI 10.1097/00005373-200203000-00017; LYONS WL, 2002, GERIATRIC MED, V41, P55; Makatura TJ, 1999, BRAIN INJURY, V13, P355; Mannan MR, 2001, PSYCHIAT CLIN NEUROS, V55, P451, DOI 10.1046/j.1440-1819.2001.00889.x; Mathalon DH, 2000, BIOL PSYCHIAT, V47, P434, DOI 10.1016/S0006-3223(99)00277-2; MAZZOTTA G, 1995, HEADACHE, V35, P210, DOI 10.1111/j.1526-4610.1995.hed3504210.x; MCCARLEY RW, 1991, SCHIZOPHR RES, V4, P209, DOI 10.1016/0920-9964(91)90034-O; McEvoy LK, 2001, COGNITIVE BRAIN RES, V11, P363, DOI 10.1016/S0926-6410(01)00009-X; Mecklinger A, 1998, BRAIN, V121, P1919, DOI 10.1093/brain/121.10.1919; Meyer JS, 2001, INT J GERIATR PSYCH, V16, P430, DOI 10.1002/gps.359; MOCHIZUKI M, 1996, CLIN ELECTROENCEPHAL, V29, P1; Mochizuki Y, 2001, J CLIN NEUROSCI, V8, P407, DOI 10.1054/jocn.2000.0850; Mutschler V, 1996, NEUROPHYSIOL CLIN, V26, P158, DOI 10.1016/0987-7053(96)89626-2; Naganuma Y, 1997, BRAIN DEV-JPN, V19, P117, DOI 10.1016/S0387-7604(96)00489-5; Nakano Yoko, 2000, Hiroshima Journal of Medical Sciences, V49, P37; Naumann A, 2001, NEUROREPORT, V12, P2807, DOI 10.1097/00001756-200109170-00011; NESHIGE R, 1988, J NEUROL NEUROSUR PS, V51, P1120, DOI 10.1136/jnnp.51.9.1120; NOBLE EP, 1994, AM J HUM GENET, V54, P658; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; OSTERWEIL D, 1992, J AM GERIATR SOC, V40, P325, DOI 10.1111/j.1532-5415.1992.tb02130.x; Perry RJ, 2000, DEMENT GERIATR COGN, V11, P342, DOI 10.1159/000017264; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; PEWERSELL RC, 1999, ARCH NEUROL-CHICAGO, V56, P303; PFEFFERBAUM A, 1984, ELECTROEN CLIN NEURO, V59, P85, DOI 10.1016/0168-5597(84)90026-1; Pimenta MG, 1999, AVIAT SPACE ENVIR MD, V70, pA107; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P97, DOI 10.1016/S0167-8760(00)00133-1; POLICH J, 1991, ELECTROEN CLIN NEURO, P304; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; POLICH J, 1995, J CLIN NEUROPHYSIOL, V12, P186, DOI 10.1097/00004691-199503000-00009; Polich J, 1999, EEG CL N SU, V50, P281; Portin R, 2000, SCAND J PSYCHOL, V41, P31, DOI 10.1111/1467-9450.00168; Prabhakar S, 2000, NEUROL INDIA, V48, P239; RATCLIFF G, 2000, TXB GERIATRIC NEUROP, P174; RAY PG, 1992, J CLIN PSYCHOPHARM, V12, P415; Reeves RR, 1999, CLIN ELECTROENCEPHAL, V30, P122, DOI 10.1177/155005949903000310; REILLY EL, 2000, COMPREHENSIVE TXB PS, V1, P152; RODIN E, 1999, ELECTROENCEPHALOGRAP, P1207; Salamat M T, 1999, J Am Acad Audiol, V10, P379; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; Sangal RB, 1998, CLIN ELECTROENCEPHAL, V29, P1, DOI 10.1177/155005949802900105; Sangal RB, 1996, CLIN ELECTROENCEPHAL, V27, P46, DOI 10.1177/155005949602700108; Sangal RB, 1997, CLIN ELECTROENCEPHAL, V28, P16, DOI 10.1177/155005949702800104; Sanz M, 2001, PSYCHIAT RES, V101, P75, DOI 10.1016/S0165-1781(00)00250-X; Saxena N, 2001, J GASTROEN HEPATOL, V16, P322, DOI 10.1046/j.1440-1746.2001.02388.x; SEMLITSCH HV, 1993, INT CLIN PSYCHOPHARM, V8, P155, DOI 10.1097/00004850-199300830-00004; SHAW TG, 1984, NEUROLOGY, V34, P855, DOI 10.1212/WNL.34.7.855; SOLLIWAY BM, 1994, ELECTROENCEPHALOGR C, V92, P422; SOUZA VBN, 1995, BIOL PSYCHIAT, V37, P300, DOI 10.1016/0006-3223(94)00131-L; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Tachibana H, 1999, J NEUROL SCI, V168, P52, DOI 10.1016/S0022-510X(99)00182-3; Tasman A, 1999, BIOL PSYCHIAT, V45, P1516, DOI 10.1016/S0006-3223(98)00196-6; Thatcher RW, 1999, CLIN ELECTROENCEPHAL, V30, P94, DOI 10.1177/155005949903000304; Thomas A, 2001, CLIN NEUROPHARMACOL, V24, P31, DOI 10.1097/00002826-200101000-00007; TREIMAN DM, 1990, EPILEPSY RES, V5, P49, DOI 10.1016/0920-1211(90)90065-4; Tulsky DS, 2001, J INT NEUROPSYCH SOC, V7, P860, DOI 10.1017/S1355617701777089; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P29, DOI 10.1076/jcen.21.1.29.939; von Bierbrauer A, 1998, ACTA NEUROL BELG, V98, P21; Winker MA, 2002, JAMA-J AM MED ASSOC, V287, P1326, DOI 10.1001/jama.287.10.1326; Yagi Y, 1999, EUR J APPL PHYSIOL O, V80, P402, DOI 10.1007/s004210050611; Zhu JJ, 2001, J INT NEUROPSYCH SOC, V7, P862, DOI 10.1017/S1355617701777090	156	36	40	0	5	EEG & CLINICAL NEUROSCIENCE SOC (E C N S)	WHEATON	805 W LIBERTY DR, PO BOX 725, WHEATON, IL 60187 USA	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	JUL	2003	34	3					124	139		10.1177/155005940303400306			16	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Engineering; Neurosciences & Neurology	706WN	WOS:000184478200004	14521274				2022-02-06	
J	Inamasu, J; Nakamura, Y; Ichikizaki, K				Inamasu, J; Nakamura, Y; Ichikizaki, K			Induced hypothermia in experimental traumatic spinal cord injury: an update	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						hypothermia; local cooling; systemic cooling; temperature; traumatic spinal cord injury	SYSTEMIC HYPOTHERMIA; COMPRESSION INJURY; BRAIN INJURY; MILD HYPOTHERMIA; LOCOMOTOR FUNCTION; RAT; HYPERTHERMIA; TEMPERATURE; DAMAGE; IMMUNOHISTOCHEMISTRY	The use of induced hypothermia in the treatment of traumatic spinal cord injury (SCI) has been studied extensively between the 1960s and 1970s. Although the treatment showed some promise, it became less popular by the 1980s, mainly because of its adverse effects. However, a revival of hypothermia in the treatment of traumatic brain injury (TBI) in the last decade has encouraged neuroscientists to conduct experiments to reevaluate the potential benefits of hypothermia in traumatic SCI. All laboratory investigations studying the mechanisms of action and/or the efficacy of induced hypothermia in treating experimental traumatic SCI published in the last decade were reviewed. Although efficacy of hypothermia in improving functional outcome of mild to moderate traumatic SCI has been demonstrated, hypothermia may not be protective against severe traumatic SCI. At present, induced hypothermia has yet to be recognized or approved as a potential treatment having therapeutic value for traumatic SCI in humans. The continued search for a possible synergistic effect of induced hypothermia and pharmacological therapy may yield some promise. It has also been deduced from these laboratory studies that hyperthermia is deleterious and rigorous measures to prevent hyperthermia should be taken to minimize the propagation of secondary neuronal damage after traumatic SCI. (C) 2002 Elsevier Science B.V All rights reserved.	Natl Tokyo Med Ctr, Dept Neurosurg, Tokyo 1528902, Japan		Inamasu, J (corresponding author), Natl Tokyo Med Ctr, Dept Neurosurg, Higashigaoka 2-5-1, Tokyo 1528902, Japan.	GInamasu@aol.com	Inamasu, Joji/R-7314-2019				Amar AP, 1999, J AM COLL SURGEONS, V188, P550, DOI 10.1016/S1072-7515(99)00013-7; Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Bricolo A, 1976, Surg Neurol, V6, P101; Cambria R P, 2000, Semin Vasc Surg, V13, P315; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; CHEN H, 1991, NEUROLOGY, V41, P1133, DOI 10.1212/WNL.41.7.1133; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; Farooque M, 1997, J NEUROTRAUM, V14, P63, DOI 10.1089/neu.1997.14.63; Fijen J W, 1997, Ned Tijdschr Geneeskd, V141, P1390; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; HANSEBOUT RR, 1984, SPINE, V9, P508, DOI 10.1097/00007632-198407000-00020; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Hindman BJ, 1999, NEUROSURGERY, V44, P23, DOI 10.1097/00006123-199901000-00009; Inamasu J, 2002, ANN EMERG MED, V40, P220, DOI 10.1067/mem.2002.123697; JANSSEN L, 1989, SPINE, V14, P23, DOI 10.1097/00007632-198901000-00005; Jou IM, 2000, SPINE, V25, P1878, DOI 10.1097/00007632-200008010-00004; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kuchner E F, 1976, Surg Neurol, V6, P371; Kuchner EF, 2000, J SPINAL DISORD, V13, P391, DOI 10.1097/00002517-200010000-00004; LUNDGREN J, 1994, EXP BRAIN RES, V99, P43; Marsala M, 1997, J NEUROSCI METH, V74, P97, DOI 10.1016/S0165-0270(97)02270-X; MARTINEZARIZALA A, 1992, J NEUROTRAUM, V9, pS497; MENARD MR, 1991, ARCH PHYS MED REHAB, V72, P421; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Tator C H, 1973, Trans Am Neurol Assoc, V98, P107; Tuzgen S, 1998, SPINAL CORD, V36, P654, DOI 10.1038/sj.sc.3100660; Westergren H, 2000, ACTA NEUROCHIR, V142, P567, DOI 10.1007/s007010050471; Westergren H, 1999, SPINAL CORD, V37, P696, DOI 10.1038/sj.sc.3100920; Westergren H, 1998, J NEUROTRAUM, V15, P943, DOI 10.1089/neu.1998.15.943; Westergren H, 2001, SPINAL CORD, V39, P74, DOI 10.1038/sj.sc.3101127; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Yamamoto K, 1998, NEUROREPORT, V9, P1655, DOI 10.1097/00001756-199805110-00072; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; Yu CG, 2001, NEUROSURGERY, V49, P152, DOI 10.1097/00006123-200107000-00023; Yu WR, 1999, ACTA NEUROPATHOL, V98, P15, DOI 10.1007/s004010051046; Yu WR, 1999, NEUROPATHOLOGY, V19, P172, DOI 10.1046/j.1440-1789.1999.00227.x; Yu WR, 2000, ACTA NEUROPATHOL, V100, P546, DOI 10.1007/s004010000206	41	36	39	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAY 15	2003	209	1-2					55	60		10.1016/S0022-510X(02)00463-X			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672VN	WOS:000182543800009	12686402				2022-02-06	
J	Farmer, JE; Clark, MJ; Sherman, AK				Farmer, JE; Clark, MJ; Sherman, AK			Rural versus urban social support seeking as a moderating variable in traumatic brain injury outcome	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						community integration; rural; traumatic brain injury	QUALITY-OF-LIFE; DISCOURSE ABILITIES; DEPRESSION; INDIVIDUALS; INTEGRATION; ADJUSTMENT; IMPAIRMENT; COMPETENCE	Objective: To investigate personal beliefs about seeking social support following traumatic brain injury (TBI) and the relationship of these appraisals to demographic and injury variables, social integration, and quality of life ratings. Setting: The central region of a Midwest state. Participants: Fifty-six adults with TBI who were more than 6 months postinjury and living in the community. Main outcome measures: The Hesitation Scale, a 20-item survey that assesses reasons that people might hesitate to reach out to others in the community, and portions of the Living Life After Traumatic Brain Injury Scale. Results: Negative attitudes and beliefs about seeking social support were significantly related to lower perceptions of social support, lower ratings of quality of life, longer time since injury, being divorced or separated, and living in an urban area. Predictors of higher quality of fife ratings included more positive appraisals about seeking social support, living in a rural area, and the ability to engage in productive activity. Conclusions: Positive outcomes after TBI appear to be moderated by living in a rural area, which is associated with more openness to seeking social supports and contributes to better quality of life.	Univ Missouri, Columbia Sch Hlth Profess, Dept Hlth Psychol, Columbia, MO 65212 USA		Farmer, JE (corresponding author), Univ Missouri, Columbia Sch Hlth Profess, Dept Hlth Psychol, DCO46-46,1 Hosp Dr, Columbia, MO 65212 USA.	farmerje@health.missouri.edu					ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Andrews F. M., 1976, SOCIAL INDICATORS WE; Beck A.T., 1967, DEPRESSION CLIN; BIGELOW DA, 1990, PSYCHOSOC REHABIL, V14, P94; BOAKE C, 1991, COGNITIVE REHABILITA, P181; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Chwalisz K, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P537, DOI 10.1037/10361-025; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Condeluci A, 1999, Top Health Inf Manage, V19, P40; *CRAIG RES DEP, 2001, CRAIG HOSP INV ENV F; DUNST CJ, 1994, SUPPORTING STRENGTHE, P152; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Folkman S., 1984, STRESS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Gottlieb B., 2000, SOCIAL SUPPORT MEASU, P195, DOI DOI 10.1093/MED:PSYCH/9780195126709.003.0006; Gottlieb B.H., 2000, SOCIAL SUPPORT MEASU, P136, DOI [10.1093/med:psych/9780195126709.003.0005, DOI 10.1093/MED:PSYCH/9780195126709.003.0005]; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Johnson M, 1998, GENERATIONS, V22, P4; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; JOHNSTONE B, IN PRESS NEUROREHAB; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; KALPAKJIAN CZ, 2001, ANN M AM PSYCH ASS A; Karlovits T, 1999, BRAIN INJURY, V13, P845; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kruglanski, 1996, SOCIAL PSYCHOL HDB B, P597; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; MCKINLAY W, 1999, REHABILITATION ADULT, P74; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; *MT SIN MED CTR DE, 1999, LIV LIF TBI SURV MAN; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; OBRIEN J, 1992, NATURAL SUPPORTS SCH, P17; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; Prigatano GP, 1999, REHABILITATION ADULT, P271; Schaefer JA, 1998, LEA SER PER CLIN PSY, P99; SCHOOTMAN M, 1999, BRAIN INJURY, V13, P70; Schopp LH, 2000, J TELEMED TELECARE, V6, P146, DOI 10.1258/1357633001934474; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Taylor SE, 2000, AM PSYCHOL, V55, P99, DOI 10.1037//0003-066X.55.1.99; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Van Horn K R, 1992, Brain Inj, V6, P15, DOI 10.3109/02699059209008118; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; World Health Organization, 2007, INT CLASS FUNCT DIS	52	36	36	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2003	18	2					116	127		10.1097/00001199-200303000-00003			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	663DU	WOS:000181991600003	12802221				2022-02-06	
J	Sander, AM; Sherer, M; Malec, JF; High, WM; Thompson, RN; Moessner, AM; Josey, J				Sander, AM; Sherer, M; Malec, JF; High, WM; Thompson, RN; Moessner, AM; Josey, J			Preinjury emotional and family functioning in caregivers of persons with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; caregivers; family; rehabilitation	BLUNT HEAD-INJURY; RELATIVES; BURDEN; RELIABILITY; PREDICTORS; AWARENESS; DISTRESS	Objective: To characterize the preinjury family functioning, emotional distress, and social support of caregivers of persons with traumatic brain injury (TBI). Design: Inception cohort. Setting: Three Traumatic Brain Injury Model Systems centers' inpatient rehabilitation facilities. Participants: One hundred ninety-one caregivers, primarily white and female, of persons with TBI. Interventions: Not applicable. Main Outcome Measures: The Brief Symptom Inventory, Family Assessment Device, Multidimensional Scale of Perceived Social Support, and history of medical and psychiatric illness. Results: Thirty-seven percent of caregivers indicated symptoms of emotional distress consistent with psychiatric diagnoses for the month before injury, whereas 27% reported a history of psychiatric or psychologic treatment at some point in the past. Between 25% and 33% of caregivers reported unhealthy family functioning in 1 or more areas for the month before injury. Persons with an annual income less than $10,000 reported less healthy preinjury family functioning. Caregivers reported good satisfaction with preinjury social support, and very few caregivers reported a history of substance abuse. Conclusion: A substantial proportion of caregivers reported emotional distress and/or unhealthy family functioning before injury. Such difficulties may make them more vulnerable to the stress associated with injury and result in greater coping difficulties.	Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; TIRR, Houston, TX USA; Methodist Rehabil Ctr, Jackson, MS USA; Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Psychiat, Jackson, MS 39216 USA; Mayo Med Ctr & Med Sch, Dept Psychiat & Psychol, Rochester, MN USA; Mayo Med Ctr & Med Sch, Dept Phys Med & Rehabil, Rochester, MN USA		Sander, AM (corresponding author), Brain Injury Res Ctr, 2455 S Braeswood, Houston, TX 77030 USA.	sandea@tirr.tmc.edu					ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KAZARIAN SS, 1991, J COMMUNITY PSYCHOL, V19, P150, DOI 10.1002/1520-6629(199104)19:2<150::AID-JCOP2290190206>3.0.CO;2-J; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LIVINGSTON MG, 2001, BRAIN INJURY, V1, P33; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Panting A, 1972, REHABILITATION, V38, P33; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SIMON GE, 1995, J CLIN EPIDEMIOL, V48, P1109, DOI 10.1016/0895-4356(95)00010-2; TEASDALE G, 1974, LANCET, V2, P81; United States Department of Health and Human Services, 2001, MENT HLTH REP SURG G; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; ZARSKI J, 1988, J HEAD TRAUMA REHAB, V3, P31; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; [No title captured]; [No title captured]	40	36	36	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2003	84	2					197	203		10.1053/apmr.2003.50105			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	643QV	WOS:000180872700008	12601650				2022-02-06	
J	Ravdin, LD; Barr, WB; Jordan, B; Lathan, WE; Relkin, NR				Ravdin, LD; Barr, WB; Jordan, B; Lathan, WE; Relkin, NR			Assessment of cognitive head recovery following sports related trauma in boxers	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sports related head injury; neuropsychology; baseline assessment; return-to-play decisions	PROFESSIONAL BOXERS; BRAIN INJURY; REACTION-TIME; WEIGHT-LOSS; PERFORMANCE; CONSISTENCY; CONCUSSION; WRESTLERS; PLAYERS; BATTERY	Objective: To prospectively examine recovery of cognitive function within one month following subconcussive sports related head trauma. Design: A prospective study of New York State licensed professional boxers,who underwent testing of cognitive functioning before and after (within days, one week, and one month) a professional bout. Setting: Male professional athletes recruited from the New York State Athletic Commission and local boxing gyms. Participants: Twenty-six licensed professional boxers were enrolled in the protocol. Data is presented on the 18 participants who completed testing on at least three of the four time points. Interventions: Serial neuropsychological assessment before and after the athletes engaged in competition. Main Outcome Measures: Neuropsychological measures of cognitive functioning, including new learning and memory, information processing speed, and mental flexibility. Results: A series of repeated. measures MANOVAS revealed significant within subject differences across testing on complex information processing and verbal fluency. Post hoc analyses indicated significant differences between time 1 (baseline) and time 4 (one month post), with scores one month following the bout indicating significantly improved performance. Memory scores did not change significantly across testing; however, prior boxing exposure measured by total number of professional bouts was associated with poorer memory performance. Conclusions: Cognitive testing one month following participation in a professional boxing bout yielded scores suggestive of recovery to a level above the baseline. We conclude that baseline assessment taken during periods of intense training are likely confounded by other pre-bout conditions (i.e., sparring, rapid weight loss, pre-bout anxiety) and do not represent true baseline abilities. Instability of performance associated with mild head injury may complicate the interpretation of post-injury assessments. Practice effects may also confound the interpretation of serial assessments, leading to underestimation of the effects of sports related head trauma. Poorer cognitive performance was evident during the presumed recovery period in boxers with greater exposure to the sport (>12 professional bouts). This finding is consistent with reports of a cumulative effect of repetitive head trauma and the subsequent development of chronic traumatic brain injury. These data have implications for assessing recovery of function following head injury in players of other contact sports as well as determination of return-to-play following an injury.	Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York Presbyterian Hosp, New York, NY 10021 USA; NYU, Sch Med, New York, NY USA; Burke Rehabil Hosp, New York, NY USA		Ravdin, LD (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York Presbyterian Hosp, 525 E 68 St,Suite F 610, New York, NY 10021 USA.			Barr, William/0000-0001-7711-7758	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR00047] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08-NS02016] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS002016] Funding Source: NIH RePORTER		ALVES W, 1991, ATHLETIC INJURIES HE, P28; Barth JT, 1989, MILD HEAD INJURY, P257; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CASSON IR, 1982, J NEUROL NEUROSUR PS, V45, P170, DOI 10.1136/jnnp.45.2.170; Choma CW, 1998, MED SCI SPORT EXER, V30, P746, DOI 10.1097/00005768-199805000-00016; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Dicker G, 1993, Aust Fam Physician, V22, P750; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; DREW RH, 1986, J CLIN PSYCHOL, V42, P520, DOI 10.1002/1097-4679(198605)42:3<520::AID-JCLP2270420319>3.0.CO;2-6; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Houston M E, 1981, Phys Sportsmed, V9, P73, DOI 10.1080/00913847.1981.11711208; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JORDAN B, 1997, JAMA-J AM MED ASSOC, V276, P136; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; KASTE M, 1982, LANCET, V2, P1186; Kelly JP, 1997, NEUROLOGY, V48, P581; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCaffrey RJ, 1995, NEUROPSYCHOL REV, V5, P203, DOI 10.1007/BF02214762; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; MITRUSHINA M, 1991, J CLIN PSYCHOL, V47, P790, DOI 10.1002/1097-4679(199111)47:6<790::AID-JCLP2270470610>3.0.CO;2-C; MORRISON RG, 1986, JAMA-J AM MED ASSOC, V255, P2475, DOI 10.1001/jama.255.18.2475; ROSS RJ, 1987, CLIN SPORT MED, V6, P41; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; WEBSTER S, 1990, MED SCI SPORT EXER, V22, P229; Wechsler D, 1987, MEMORY SCALE REVISED; YOUNGJOHN JR, 1992, CLIN NEUROPSYCHOL, V6, P276, DOI DOI 10.1080/13854049208404129	37	36	41	0	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2003	13	1					21	27		10.1097/00042752-200301000-00005			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	639MG	WOS:000180632500005	12544160				2022-02-06	
J	Verbois, SL; Hopkins, DM; Scheff, SW; Pauly, JR				Verbois, SL; Hopkins, DM; Scheff, SW; Pauly, JR			Chronic intermittent nicotine administration attenuates traumatic brain injury-induced cognitive dysfunction	NEUROSCIENCE			English	Article						alpha 7(star) nicotinic receptor; neurotrauma; autoradiography; bungarotoxin; epibatidine; Morris water maze	MORRIS WATER MAZE; UP-REGULATION; BINDING-SITES; RECEPTOR SUBTYPES; RAT-BRAIN; HIPPOCAMPAL ALPHA-7; CONTINUOUS-INFUSION; CHRONIC EXPOSURE; HEAD-INJURY; AGED RATS	Traumatic brain injury (TBI) initiates immediate and secondary neuropathological cascades that can result in persistent neurological dysfunction. Previous studies from our laboratory have shown that experimental rat brain injury causes a rapid and persistent decrease in CNS alpha7* nicotinic cholinergic receptor (nAChr) expression. The purpose of this study was to investigate whether intermittent nicotine injections could improve cognitive performance in the Morris water maze (MWM) following experimental brain injury. Adult male rats were anesthetized and subjected to a 1.5 mm controlled cortical impact (CCI) injury of the somatosensory cortex. Animals received twice daily i.p. nicotine injections for 11 days prior to CCI, 11 days following CCI or during both pre- and post-surgical intervals. MWM training was initiated 12 days post-injury. In the training phase of cognitive testing, twice-daily nicotine treatment following injury attenuated trauma-induced deficits in the distance traveled to reach the escape platform. This group of animals also had improvements in several measures of the probe test, including time spent, distance traveled and total entries into the target quadrant. TBI caused significant deficits in alpha7* nAChr expression in several regions of the hippocampus and cerebral cortex, which were largely unaffected by intermittent nicotine treatment. However, nicotine treatment up-regulated [3H]-epibatidine binding to non-alpha7* nAChrs, attenuating TBI-induced deficits in receptor expression in several brain regions evaluated. These results suggest that nicotine is efficacious at attenuating CCl-induced cognitive deficits in a manner independent of changes in alpha7* nAChr expression, perhaps via up-regulation of non-alpha7* nAChrs. (C) 2003 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA		Pauly, JR (corresponding author), Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39828, NS42196] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042196, R01NS039828] Funding Source: NIH RePORTER		ABDULLA FA, 1993, PSYCHOPHARMACOLOGY, V111, P508, DOI 10.1007/BF02253544; Abdulla FA, 1996, PSYCHOPHARMACOLOGY, V124, P323, DOI 10.1007/BF02247437; Attaway CM, 1999, PHYSIOL BEHAV, V67, P421, DOI 10.1016/S0031-9384(99)00081-5; BARRANTES GE, 1995, BRAIN RES, V672, P228, DOI 10.1016/0006-8993(94)01386-V; Brown RW, 2000, PHARMACOL BIOCHEM BE, V67, P473, DOI 10.1016/S0091-3057(00)00398-1; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Collins AC, 1996, DRUG DEVELOP RES, V38, P231, DOI 10.1002/(SICI)1098-2299(199607/08)38:3/4<231::AID-DDR12>3.0.CO;2-1; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dani JA, 2001, BIOL PSYCHIAT, V49, P166, DOI 10.1016/S0006-3223(00)01011-8; Decker MW, 1997, J PHARMACOL EXP THER, V283, P247; DECKER MW, 1994, EUR J PHARMACOL, V261, P217, DOI 10.1016/0014-2999(94)90323-9; Delbono O, 1997, J PHARMACOL EXP THER, V280, P428; Fenster CP, 1999, J NEUROSCI, V19, P4804; Flores CM, 1997, J NEUROCHEM, V69, P2216; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; HODGES H, 1995, PSYCHOPHARMACOLOGY, V117, P318, DOI 10.1007/BF02246107; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kawai H, 2001, J NEUROCHEM, V78, P1367, DOI 10.1046/j.1471-4159.2001.00526.x; Ke L, 1998, J PHARMACOL EXP THER, V286, P825; Levin ED, 2002, NEUROSCIENCE, V109, P757, DOI 10.1016/S0306-4522(01)00538-3; LEVIN ED, 1992, BEHAV NEURAL BIOL, V58, P152, DOI 10.1016/0163-1047(92)90399-O; Levin ED, 2000, EUR J PHARMACOL, V393, P141, DOI 10.1016/S0014-2999(99)00885-7; Levin ED, 1998, PSYCHOPHARMACOLOGY, V140, P135, DOI 10.1007/s002130050750; MARKS MJ, 1987, PHARMACOL BIOCHEM BE, V27, P505, DOI 10.1016/0091-3057(87)90355-8; MARKS MJ, 1993, J PHARMACOL EXP THER, V266, P1268; MARKS MJ, 1992, J NEUROSCI, V12, P2765; McCallum SE, 2000, PSYCHOPHARMACOLOGY, V150, P1, DOI 10.1007/s002130000401; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; Meyer EM, 1997, BRAIN RES, V768, P49, DOI 10.1016/S0006-8993(97)00536-2; Molinari EJ, 1998, EUR J PHARMACOL, V347, P131, DOI 10.1016/S0014-2999(98)00084-3; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olale F, 1997, J PHARMACOL EXP THER, V283, P675; PAULY JR, 1991, J PHARMACOL EXP THER, V258, P1127; Pauly JR, 1996, J PHARMACOL EXP THER, V278, P361; Perry DC, 2002, J NEUROCHEM, V82, P468, DOI 10.1046/j.1471-4159.2002.00951.x; PERRY DC, 1995, J PHARMACOL EXP THER, V275, P1030; Perry EK, 2001, ALCOHOL, V24, P63, DOI 10.1016/S0741-8329(01)00130-6; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Riekkinen M, 1997, NEUROREPORT, V8, P699, DOI 10.1097/00001756-199702100-00024; Rusted JM, 2000, BEHAV BRAIN RES, V113, P121, DOI 10.1016/S0166-4328(00)00207-2; SANDERSON EM, 1993, BRAIN RES, V617, P349, DOI 10.1016/0006-8993(93)91104-Z; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Simosky JK, 2001, BIOL PSYCHIAT, V50, P493, DOI 10.1016/S0006-3223(01)01093-9; SOCCI DJ, 1995, NEUROBIOL AGING, V16, P857, DOI 10.1016/0197-4580(95)00091-R; Sparks JA, 1999, PSYCHOPHARMACOLOGY, V141, P145, DOI 10.1007/s002130050818; Taverni JP, 1998, BRAIN INJURY, V12, P77; Ulrich YM, 1997, NEUROPHARMACOLOGY, V36, P1119, DOI 10.1016/S0028-3908(97)00107-X; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Verbois SL, 2003, NEUROPHARMACOLOGY, V44, P224, DOI 10.1016/S0028-3908(02)00366-0; WELZL H, 1988, PSYCHOPHARMACOLOGY, V96, P317, DOI 10.1007/BF00216057; Whiteaker P, 2002, J NEUROSCI, V22, P2522, DOI 10.1523/JNEUROSCI.22-07-02522.2002; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X	57	36	37	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2003	119	4					1199	1208		10.1016/S0306-4522(03)00206-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	700HT	WOS:000184107100023	12831873				2022-02-06	
J	Otani, N; Nawashiro, H; Fukui, S; Nomura, N; Shima, K				Otani, N; Nawashiro, H; Fukui, S; Nomura, N; Shima, K			Temporal and spatial profile of phosphorylated mitogen activated protein kinase pathways after lateral fluid percussion injury in the cortex of the rat brain	JOURNAL OF NEUROTRAUMA			English	Article						c-Jun NH2-terminal kinase; double immunostaining; extracellular signal-regulated kinase; immunohistochemistry; mitogen-activated protein kinase; traumatic brain injury	CEREBRAL-ARTERY OCCLUSION; REACTIVE ASTROCYTES; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; ERK/MAP KINASE; MESSENGER-RNA; MOUSE-BRAIN; MAP KINASES; APOPTOSIS; SIGNAL	Mitogen-activated protein kinases (MAPK) play a crucial role in signal transduction that regulates gene expression through transcriptional factor activity. The purpose of this study was to investigate the temporal expression and topographic distribution of the activated MAPK pathways including extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38 MAPK following traumatic brain injury (TBI) in the cortex of the rat brain. Adult male Sprague-Dawley rats (300-400 g) were subjected to lateral fluid percussion injury of moderate severity (3.5-4.0 atm) using the Dragonfly device model (no. HPD-1700). Phosphorylated-MAPK protein levels were quantified using Western blot analysis. Topographic distribution of immunoreactivity for phosphorylated-MAPK was examined using immunohistochemistry. Our findings showed that TBI significantly increased the phosphorylated-ERK (p-ERK) and -JNK (p-JNK) levels, but not the -p38 (p-p38) protein levels in the cortex surrounding the injury site. The immunoreactivity for p-ERK and p-JNK immediately after TBI were localized in neurons. The immunoreactivity for p-JNK was uniformly but only transiently induced and returned to control levels I h after TBE The immunoreactivity for p-ERK was confirmed up until 30 min after TBI in the superficial neuronal layers. Double immunostaining using a glial-specific marker demonstrated that p-ERK was prominent in astrocytes 6 h after TBI. The current results suggest that the ERK and JNK pathways, but not the p38 MAPK pathways are involved in signal transduction in the cortex following TBI.	Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 3598513, Japan		Otani, N (corresponding author), Natl Def Med Coll, Dept Neurosurg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.						BALASINGAM V, 1994, J NEUROSCI, V14, P846; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Conti AC, 1998, J NEUROSCI, V18, P5663; Di X, 1999, J NEUROTRAUM, V16, P195, DOI 10.1089/neu.1999.16.195; DIETRICH DW, 1994, J NEUROTRAUM, V13, P289; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; Hayashi T, 2000, NEUROSCI LETT, V284, P195, DOI 10.1016/S0304-3940(00)01024-7; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Jander S, 2001, J CEREBR BLOOD F MET, V21, P218, DOI 10.1097/00004647-200103000-00005; JOHANSON SO, 1995, BRAIN RES, V690, P55, DOI 10.1016/0006-8993(95)00587-G; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; KURINO M, 1995, J NEUROCHEM, V65, P1282; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; LIEBERMAN AP, 1992, J BIOL CHEM, V267, P2123; Mandell JW, 1999, NEUROREPORT, V10, P3567, DOI 10.1097/00001756-199911260-00019; Mandell JW, 2001, GLIA, V34, P283, DOI 10.1002/glia.1062; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; McKeon RJ, 1997, EXP NEUROL, V148, P558, DOI 10.1006/exnr.1997.6698; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Nakahara S, 1999, J NEUROPATH EXP NEUR, V58, P442, DOI 10.1097/00005072-199905000-00003; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Skaper SD, 1998, MOL CELL NEUROSCI, V12, P179, DOI 10.1006/mcne.1998.0714; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Wu DC, 2000, J CEREBR BLOOD F MET, V20, P1320, DOI 10.1097/00004647-200009000-00007; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhang L, 2000, NEUROREPORT, V11, P409, DOI 10.1097/00001756-200002070-00037	40	36	40	0	4	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2002	19	12					1587	1596		10.1089/089771502762300247			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	629UY	WOS:000180070700006	12542859				2022-02-06	
J	Stein, TD; Fedynyshyn, JP; Kalil, RE				Stein, TD; Fedynyshyn, JP; Kalil, RE			Circulating autoantibodies recognize and bind dying neurons following injury to the brain	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						autoimmunity; blood-brain barrier; cortical lesion; immunoglobulins; neural cell death	CENTRAL-NERVOUS-SYSTEM; LIPID-PEROXIDATION; MULTIPLE-SCLEROSIS; CEREBRAL-ISCHEMIA; SPINAL-CORD; RAT-BRAIN; PHAGOCYTOSIS; BLOOD; IGG; DEATH	While it is known that autoimmune cells can protect against cell damage following traumatic injury of the brain, the role of autoantibodies in brain injury is less clear. Here we present evidence in adult rats that following a cortical lesion of the brain, circulating IgG autoantibodies bind to dying neurons in the vicinity of the lesion. At intervals that ranged from 4 h to 7 days after making a unilateral lesion of visual cortex, we observed neurons near the lesion that were immunopositive for rat IgG. Many of these IgG-positive neurons were in advanced stages of degeneration. The magnitude of the immunostaining observed was directly proportional to the percent reactivity to rat IgG of the antibodies that were used. Preadsorption of the antibodies with rat serum eliminated the immunostaining. In addition, immunostaining for serum albumin in sections through the cortical lesion was negative, supporting the conclusion that the positive staining for IgG does not result from the passive diffusion of serum proteins into injured cells. Instead, the evidence presented here strongly suggests that naturally occurring IgG autoantibodies bind specifically to dying neurons in the injured brain. We propose that this autoantibody binding may participate in the phagocytosis and removal of injured neurons.	Univ Wisconsin, Sch Med, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA		Kalil, RE (corresponding author), Univ Wisconsin, Sch Med, Dept Ophthalmol & Visual Sci, 1300 Univ Ave,173 Med Sci Bldg, Madison, WI 53706 USA.			Stein, Thor/0000-0001-6954-4477	VAUS Department of Veterans Affairs [5I01CX001038-04] Funding Source: Federal RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008692] Funding Source: Medline; CSRD VA [I01 CX001038] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008692] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001038] Funding Source: NIH RePORTER		AANDERUD S, 1983, INT ARCH ALLER A IMM, V70, P40, DOI 10.1159/000233271; ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Agarwala S, 1998, J COMP NEUROL, V392, P252, DOI 10.1002/(SICI)1096-9861(19980309)392:2<252::AID-CNE7>3.0.CO;2-1; AIHARA N, 1994, J COMP NEUROL, V342, P481, DOI 10.1002/cne.903420402; Albayrak S, 1997, ACTA NEUROPATHOL, V94, P158, DOI 10.1007/s004010050688; ANDERSON DK, 1994, NEUROBIOLOGY CENTRAL, P131; Asakura K, 1998, MULT SCLER, V4, P217, DOI 10.1177/135245859800400324; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; BALOYANNIS SJ, 1979, J NEUROPATH EXP NEUR, V38, P519, DOI 10.1097/00005072-197909000-00006; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; BERNEMAN A, 1992, EUR J IMMUNOL, V22, P625, DOI 10.1002/eji.1830220303; BERNSTEIN JJ, 1987, BRAIN RES, V426, P112, DOI 10.1016/0006-8993(87)90430-6; BRIGHTMA.MW, 1970, J NEUROL SCI, V10, P215, DOI 10.1016/0022-510X(70)90151-6; BROADWELL RD, 1976, J COMP NEUROL, V166, P257, DOI 10.1002/cne.901660302; Butler MH, 2000, NEURON, V26, P307, DOI 10.1016/S0896-6273(00)81165-4; Cover CC, 1996, LIFE SCI, V58, P655, DOI 10.1016/0024-3205(95)02334-8; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; DEMEDIUK P, 1985, P NATL ACAD SCI USA, V82, P7071, DOI 10.1073/pnas.82.20.7071; Denecker G, 2000, FEBS LETT, V465, P47, DOI 10.1016/S0014-5793(99)01702-0; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; GRABAR P, 1975, CLIN IMMUNOL IMMUNOP, V4, P453, DOI 10.1016/0090-1229(75)90087-2; Hanisch UK, 1996, SYNAPSE, V24, P104, DOI 10.1002/(SICI)1098-2396(199610)24:2<104::AID-SYN2>3.3.CO;2-V; HINTNER H, 1987, J INVEST DERMATOL, V88, P176, DOI 10.1111/1523-1747.ep12525322; Islekel H, 1999, BRAIN RES, V843, P18, DOI 10.1016/S0006-8993(99)01845-4; Janeway Jr C. A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Kalil R. E., 1996, Society for Neuroscience Abstracts, V22, P305; Kalil R. E., 1998, Society for Neuroscience Abstracts, V24, P1303; KAY MMB, 1994, ANN NY ACAD SCI, V719, P419, DOI 10.1111/j.1749-6632.1994.tb56847.x; KAY MMB, 1981, NATURE, V289, P491, DOI 10.1038/289491a0; Keller JN, 1998, REV NEUROSCIENCE, V9, P105; KERGONOU JF, 1988, BIOCHEM INT, V16, P835; KHANSARI N, 1983, CELL IMMUNOL, V78, P114, DOI 10.1016/0008-8749(83)90264-2; LAURSEN H, 1993, ACTA NEUROPATHOL, V86, P378, DOI 10.1007/BF00369451; Ling C., 1999, Society for Neuroscience Abstracts, V25, P759; Ling C., 1998, Society for Neuroscience Abstracts, V24, P1304; LUTZ HU, 1987, P NATL ACAD SCI USA, V84, P7368, DOI 10.1073/pnas.84.21.7368; MAEDA M, 1992, ACTA NEUROPATHOL, V84, P59, DOI 10.1007/BF00427216; MARTIN SE, 1975, P NATL ACAD SCI USA, V72, P1036, DOI 10.1073/pnas.72.3.1036; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; MRINI A, 1995, J HISTOCHEM CYTOCHEM, V43, P1285, DOI 10.1177/43.12.8537644; PERL A, 1982, ACTA PHYSIOL HUNG, V60, P53; Petersen A, 2000, BRAIN RES, V857, P20, DOI 10.1016/S0006-8993(99)02320-3; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; Remmers M, 1999, BRAIN RES, V827, P237, DOI 10.1016/S0006-8993(99)01304-9; ROITT I, 1998, IMMUNOLOGY; SCHMIDTKASTNER R, 1993, J NEUROSCI METH, V46, P121, DOI 10.1016/0165-0270(93)90147-J; Soares HD, 1995, J NEUROSCI, V15, P8223; UCHIDA K, 1992, P NATL ACAD SCI USA, V89, P4544, DOI 10.1073/pnas.89.10.4544; ULVESTAD E, 1994, J NEUROPATH EXP NEUR, V53, P27, DOI 10.1097/00005072-199401000-00004; Upender M. B., 1996, Society for Neuroscience Abstracts, V22, P1202; Upender MB, 1997, J COMP NEUROL, V384, P271; van Noort JM, 2000, J NEUROIMMUNOL, V105, P46, DOI 10.1016/S0165-5728(00)00181-8; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Yahya MD, 1996, J AUTOIMMUN, V9, P3, DOI 10.1006/jaut.1996.0002; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001; Yuki N, 1999, JPN J INFECT DIS, V52, P99	57	36	39	1	2	AMER ASSN NEUROPATHOLOGISTS INC	LAWRENCE	1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	DEC	2002	61	12					1100	1108		10.1093/jnen/61.12.1100			9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	624LY	WOS:000179762200009	12484573	Bronze			2022-02-06	
J	Cernak, I; Chapman, SM; Hamlin, GP; Vink, R				Cernak, I; Chapman, SM; Hamlin, GP; Vink, R			Temporal characterisation of pro- and anti-apoptotic mechanisms following diffuse traumatic brain injury in rats	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						apoptosis; diffuse axonal injury; neurotrauma; caspases	CEREBRAL-ARTERY OCCLUSION; HYPOXIA-INDUCED APOPTOSIS; CORTICAL IMPACT INJURY; PROGRAMMED CELL-DEATH; NEURONAL APOPTOSIS; BCL-X; CASPASE-3 ACTIVATION; ANTIOXIDANT PATHWAY; TRANSGENIC MICE; AXONAL INJURY	Few studies have characterised apoptosis in a brain injury model that causes a significant degree of diffuse axonal injury. Such characterisation is essential from a clinical viewpoint since diffuse axonal injury is a major component of human head injury. The present study therefore, examines the expression of active and proactive caspase-3, and the bax, bcl-2 and bcl-x members of the bcl-2 family, to characterise the temporal profile of apoptosis in a model of traumatic brain injury in rats that produces significant diffuse axonal injury. Pentobarbital anaesthetised male Sprague-Dawley rats were injured using the 2 m impact-acceleration model of diffuse traumatic brain injury. After injury, diffuse trauma resulted in an increased bax expression followed by induction of caspase-3. The increase in caspase-3 was simultaneous with an increase in anti-apoptotic bcl-2 expression. Bcl-x levels were increased after induction of caspase-3 and the increased levels of bcl-x were sustained to the end of the 5-day observation period. Increased active caspase-3 expression was associated with the appearance of TUNEL positive cells. These cells were detected in different brain regions at different times, with some regions showing no apoptotic cells until 3 days after injury. No TUNEL positive cells were detected at 7 and 14 days after injury. DNA electrophoresis confirmed that DNA fragmentation was maximal at 3 days after injury. Increased active caspase-3 levels were also significantly correlated with increased bcl-2 levels (r=0.80; P < 0.001) suggesting that the apoptotic cascade after diffuse traumatic brain injury is a carefully controlled cellular homeostatic response. Pharmacological manipulation of this balance may offer a therapeutic approach for preventing cell death and improving outcome after diffuse traumatic brain injury. (C) 2002 Elsevier Science Ltd. All rights reserved.	Univ Adelaide, Dept Pathol, Adelaide, SA 5005, Australia; James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia; Georgetown Univ, Dept Neurosci, Washington, DC USA		Vink, R (corresponding author), Univ Adelaide, Dept Pathol, Adelaide, SA 5005, Australia.	robert.vink@adelaide.edu.au	Cernak, Ibolja/A-6399-2008; Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Ibolja, Cernak/0000-0003-3214-698X			Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Antonawich FJ, 1998, J CEREBR BLOOD F MET, V18, P882, DOI 10.1097/00004647-199808000-00008; Banasiak KJ, 1999, MOL BRAIN RES, V72, P214, DOI 10.1016/S0169-328X(99)00189-8; Bossenmeyer-Pourie C, 1999, MOL BRAIN RES, V71, P225, DOI 10.1016/S0169-328X(99)00190-4; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Charriaut-Marlangue C., 1999, Annales Pharmaceutiques Francaises, V57, P309; CHIOU SK, 1994, MOL CELL BIOL, V14, P2556, DOI 10.1128/MCB.14.4.2556; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Conti AC, 1998, J NEUROSCI, V18, P5663; Cregan SP, 1999, J NEUROSCI, V19, P7860; Ellis RE, 1992, CURR OPIN GENET DEV, V2, P635, DOI 10.1016/S0959-437X(05)80184-4; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Gillardon F, 1996, MOL BRAIN RES, V40, P254, DOI 10.1016/0169-328X(96)00059-9; Gottron FJ, 1997, MOL CELL NEUROSCI, V9, P159, DOI 10.1006/mcne.1997.0618; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Isenmann S, 1998, BRAIN PATHOL, V8, P49; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Kitanaka C, 1997, ONCOGENE, V15, P1763, DOI 10.1038/sj.onc.1201349; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Krebs JF, 1999, J CELL BIOL, V144, P915, DOI 10.1083/jcb.144.5.915; Mancini M, 1998, J CELL BIOL, V140, P1485, DOI 10.1083/jcb.140.6.1485; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Michel PP, 1999, CLIN NEUROPHARMACOL, V22, P137; Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morita-Fujimura Y, 1999, J CEREBR BLOOD F MET, V19, P634, DOI 10.1097/00004647-199906000-00006; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Namura S, 1998, J NEUROSCI, V18, P3659; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Okuno S, 1998, J BIOL CHEM, V273, P34272, DOI 10.1074/jbc.273.51.34272; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Rao L, 1997, CURR OPIN GENET DEV, V7, P52, DOI 10.1016/S0959-437X(97)80109-8; Ravishankar S, 2001, BRAIN RES, V901, P23, DOI 10.1016/S0006-8993(01)02109-6; RINK A, 1995, AM J PATHOL, V147, P1575; Rudin CM, 1997, ANNU REV MED, V48, P267; Sastry PS, 2000, J NEUROCHEM, V74, P1, DOI 10.1046/j.1471-4159.2000.0740001.x; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; StClair EG, 1997, J BIOL CHEM, V272, P29347; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; Wiessner C, 1999, NEUROSCI LETT, V268, P119, DOI 10.1016/S0304-3940(99)00392-4; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yoshimura S, 1998, J BIOL CHEM, V273, P6921, DOI 10.1074/jbc.273.12.6921	55	36	41	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2002	9	5					565	572		10.1054/jocn.2002.1132			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609YL	WOS:000178933900016	12383417				2022-02-06	
J	Frazier, JL; Wang, PP; Patel, SH; Benson, JE; Cameron, DE; Hoon, AH; Avellino, AM				Frazier, JL; Wang, PP; Patel, SH; Benson, JE; Cameron, DE; Hoon, AH; Avellino, AM			Unusual migration of the distal catheter of a ventriculoperitoneal shunt into the heart: Case report	NEUROSURGERY			English	Article						heart; hydrocephalus; ventriculoperitoneal shunt	FOREIGN-BODIES; COMPLICATIONS; REMOVAL; CHEST	OBJECTIVE AND IMPORTANCE: Placement of a ventriculoperitoneal (VP) shunt is the most common form of treatment for hydrocephalus. Thoracic complications with VP shunts are rare, but we present the second documented case of the distal migration of the distal catheter of a VP shunt into the heart. CLINICAL PRESENTATION: A 14-year-old boy, who underwent placement of a right occipital VP shunt at another institution after closed-head injury, presented with hypertension. Plain chest x-rays and computed tomography revealed the distal catheter to be in the right ventricle of the heart. INTERVENTION: A joint surgical procedure was performed with the cardiac surgery team. The cardiac surgeons created a pericardial window through a subxyphoid incision. Simultaneously, a right occipital incision was made to access the distal catheter, which was then Slowly pulled out with the pericardium under direct visualization. No hemorrhage or change in the pericardium was observed, and, therefore, the need for a thoracotomy was eliminated. A new distal catheter was placed into the peritoneal cavity. CONCLUSION: The migration of the distal catheter probably occurred during the initial VP shunt placement. The internal jugular vein probably was perforated by the tunneler during the creation of the distal catheter tract. Slow venous flow and negative inspiratory pressure may have gradually pulled the catheter up into the right atria and ventricle. As demonstrated by our case report, the catheter can be extracted safely in a joint procedure with cardiac surgeons, and a thoracotomy is not always necessary. The patient did not experience postoperative complications, and his hypertension was alleviated.	Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Cardiac Surg, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA		Avellino, AM (corresponding author), Johns Hopkins Univ Hosp, Dept Neurosurg, Harvey 811,600 N Wolfe St, Baltimore, MD 21287 USA.	avellino@jhmi.edu					COOPER JR, 1978, J NEUROSURG, V48, P146, DOI 10.3171/jns.1978.48.1.0146; Fischer G, 1983, Zentralbl Neurochir, V44, P155; FISHER RG, 1978, AM J ROENTGENOL, V130, P541, DOI 10.2214/ajr.130.3.541; FUKAMACHI A, 1982, ACTA NEUROCHIR, V64, P159, DOI 10.1007/BF01405628; GAUDIO R, 1988, NEUROSURGERY, V23, P768, DOI 10.1227/00006123-198812000-00017; GRABENWOEGER F, 1988, BRIT J RADIOL, V61, P1014, DOI 10.1259/0007-1285-61-731-1014; GROSFELD JL, 1974, PEDIATRICS, V54, P791; Haralampopoulos F, 1996, SURG NEUROL, V46, P21, DOI 10.1016/0090-3019(96)00052-3; HLAVIN ML, 1990, NEUROSURGERY, V26, P526, DOI 10.1097/00006123-199003000-00024; James CA, 1997, PEDIATR RADIOL, V27, P330, DOI 10.1007/s002470050142; Kang JK, 1996, CHILD NERV SYST, V12, P176, DOI 10.1007/BF00266827; LOURIE H, 1985, NEUROSURGERY, V17, P324, DOI 10.1227/00006123-198508000-00014; Mori Takahisa, 1993, Neurologia Medico-Chirurgica, V33, P713, DOI 10.2176/nmc.33.713; NISHIJIMA M, 1980, Neurological Surgery, V8, P679; PATEL CD, 1973, J NEUROSURG, V38, P761, DOI 10.3171/jns.1973.38.6.0761; PORTNOY HD, 1974, CLIN J NEUROSURGERY, V39, P775; Schulhof L A, 1975, Surg Neurol, V3, P265; TAUB E, 1994, NEUROSURGERY, V34, P181; UFLACKER R, 1986, RADIOLOGY, V160, P731, DOI 10.1148/radiology.160.3.3737911	19	36	37	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2002	51	3					819	822		10.1097/00006123-200209000-00042			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	592FH	WOS:000177925700058	12188965				2022-02-06	
J	Davis, CH				Davis, CH			Self-perception in mild traumatic brain injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						mild traumatic brain injury; concussion; misattribution; postconcussive syndrome	POSTCONCUSSION SYMPTOMS; HEAD-INJURY	Objective: The objectives of this study were (1) to describe a procedure for measuring preinjury and postinjury symptoms, (2) to compare these symptoms with normal controls and individuals with non-head related traumas, (3) to describe patterns in persistent symptomatology after mild traumatic brain injury, and (4) to document trends in self-perception as measured by retrospective ratings of symptoms after trauma. Design: A total of 102 individuals with mild traumatic brain injury and 69 individuals with non-head-related traumas completed preinjury and postinjury symptom questionnaires 1 wk after trauma. Symptoms were compared with 115 normal controls. Three months after injury, a subgroup of the mild traumatic brain injury group completed symptom questionnaires again. A factor analysis and subsequent discriminant function analysis of the symptoms differentiated the groups. Results: Retrospective ratings of preinjury symptoms by the two trauma groups were significantly less than the normal controls, implying misattribution. Most symptoms were somatic at 1 wk postinjury in both trauma groups. At 3 mo, the mild traumatic brain injury group endorsed more recall symptoms. Conclusions: The procedure was useful in differentiating groups by symptom patterns and increasing our knowledge of persistent symptomatology after mild traumatic brain injury. Misattribution, the unrealistic self-perception of symptoms after the event of a trauma, was detected in both the head and non-head trauma groups.	Univ Calif Davis, Med Ctr, Phys Med & Rehabil Ambulatory Care Ctr, Sacramento, CA 95817 USA		Davis, CH (corresponding author), Univ Calif Davis, Med Ctr, Phys Med & Rehabil Ambulatory Care Ctr, 4860 Y St,Suite 1100, Sacramento, CA 95817 USA.						ALVES W, 1992, PHYSICAL MED REHABIL, P21; BARSKY AJ, 1983, AM J PSYCHIAT, V140, P273; BERROL S, 1992, REHABILITATION POST, P1; Davis CH, 1999, ARCH CLIN NEUROPSYCH, V14, P28, DOI 10.1093/arclin/14.1.28a; FERGUSON R, 1993, MILD HEAD INJURY SYM; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Gwin RD, 1998, ARCH CLIN NEUROPSYCH, V13, P133; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; Levin HS., 1982, NEUROBEHAVIORAL CONS; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; TAFOYA S, 2000, CALIFORNIA COUNTYS P, V1	17	36	36	3	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	AUG	2002	81	8					609	618	UNSP 0894-9115/02/8108-0609/0	10.1097/00002060-200208000-00009			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	577EE	WOS:000177047900009	12172071				2022-02-06	
J	Rudehill, A; Bellander, BM; Weitzberg, E; Bredbacka, S; Backheden, M; Gordon, E				Rudehill, A; Bellander, BM; Weitzberg, E; Bredbacka, S; Backheden, M; Gordon, E			Outcome of traumatic brain injuries in 1,508 patients: Impact of prehospital care	JOURNAL OF NEUROTRAUMA			English	Article						Glasgow Coma Scale; Glasgow Outcome Scale; prehospital care; traumatic brain injury	SEVERE HEAD-INJURY; PROGNOSTIC FACTORS; ADULT PATIENTS; MANAGEMENT; GUIDELINES; PREDICTION; HEMATOMAS	This article describes the outcome of 1,508 patients with traumatic brain injuries (TBI) treated in a single neurosurgical unit over an 8-year period. Our aim has been to compare those outcomes with our previous results and with other large patient series. Another important goal was to evaluate the effect of the introduction of a 4-year ongoing study initiated in January 1993 using a new strategy of prehospital care on postresuscitation Glasgow Coma Score (GCS) and Glasgow Outcome Score (GOS). Results from the 1,508 patients showed good recovery or moderate disability in 69%, severe disability or vegetative state in 11%, and a mortality rate of 20%. When outcome of the most severely injured patients (GCS less than or equal to 8) was compared with those of our previous and other large international patient series, more favorable outcome figures were shown in the present study. To evaluate the impact of the improved prehospital care after half of the study period, a logistic regression analysis showed after January 1993 a significantly increased expected odds/ratio for a postresuscitation GCS 8-15 rather than a GCS 3-4 (odds/ratio: 2.2; p < 0.001). For patients with postresuscitation GCS 5-7 and 8-15, the expected odds/ratio for a GOS 4-5 instead of GOS 1 increased significantly (odds/ratio: 2.2 and 1.7, respectively; p < 0.05-0.01). For patients with GCS 3-4, an increased expected odds/ratio (2.0; p < 0.05) for a GOS 2-3 rather than a GOS I was seen. The principal conclusion is that outcome for the severely injured patients in the present study is more favorable than in other large series of TBI. We posit that the introduction of effective prehospital care most likely contributed to the improved postresuscitation neurological status and consequently to the better outcome observed after January 1993.	Karolinska Hosp, Dept Anesthesiol & Intens Care, S-17176 Stockholm, Sweden; Karolinska Hosp, Dept Neurosurg, S-17176 Stockholm, Sweden; Karolinska Hosp, Dept Med Stat, S-17176 Stockholm, Sweden; Karolinska Inst, S-10401 Stockholm, Sweden		Rudehill, A (corresponding author), Karolinska Hosp, Dept Anesthesiol & Intens Care, S-17176 Stockholm, Sweden.						Alberts KA, 1999, EUR J SURG, V165, P426; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Bullock MR, 1996, J NEUROTRAUM, V13, P643; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; GORDON E, 1995, J NEUROSURG ANESTH, V7, P235, DOI 10.1097/00008506-199510000-00001; GORDON E, 1979, MANAGEMENT ACUTE INT, P188; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Marshall LF, 1991, J NEUROSURG S, V75, P14; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; TEASDALE G, 1974, LANCET, V2, P81; Vollmer DG, 1991, J NEUROSURG S, V75, P37	21	36	38	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2002	19	7					855	868		10.1089/08977150260190447			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	577JL	WOS:000177057700005	12184855				2022-02-06	
J	Adler, DE; Milhorat, TH				Adler, DE; Milhorat, TH			The tentorial notch: anatomical variation, morphometric analysis, and classification in 100 human autopsy cases	JOURNAL OF NEUROSURGERY			English	Article						tentorium cerebelli; oculomotor nerve; brainstem; brain herniation; brain concussion; morphometric study	MINOR HEAD-INJURY; CONCUSSION	Object. Variations in the structure of the tentorial notch may influence the degree of brainstem distortion in transtentorial herniation, concussion, and acceleration-deceleration injuries. The authors examined the anatomical relationships of the mesencephalon, cerebellum, and oculomotor nerves to the dimensions of the tentorial aperture. On the basis of numerical data collected from this study, the authors have developed the first classification system of the tentorial notch and present new neuroanatomical observations pertaining to the subarachnoid third cranial nerve and the brainstem. Methods. The mesencephalon was sectioned at the level of the tentorial edge in 100 human autopsy cases (specimens from 23 female and 77 male cadavers with a mean age, at time of death of 42.5 years [range 18-80 years]). The following measurements were determined: 1) anterior notch width, the width of the tentorial notch in the axial plane through the posterior aspect of the dorsum sellae; 2) maximum notch width (MNW), the maximum width of the notch in the axial plane; 3) notch length (NL), the length of the tentorial notch from the superoposterior edge of the dorsum sellae to the apex of the notch; 4) posterior tentorial length, the shortest distance between the apex of the notch and the most anterior part of the confluence of the sinuses; 5) interpedunculoclival (IC) distance, the distance from the interpeduncular fossa to the superoposterior edge of the dorsum sellae; 6) apicotectal (AT) distance, the distance from the tectum in the median plane to a perpendicular line dropped from the apex of the tentorial notch to the cerebellum; 7) cisternal third nerve distance, the distance covered by the cisternal portion of the third cranial nerve; and 8) inter-third nerve angle, the angle between the two third cranial nerves. The quartile distribution technique was applied to all measurements. Mean values are presented as the means +/- standard deviations. Quartile groups defined by NL (mean 57.7 +/- 5.6 mm) were labeled long, short, and midrange, and those defined by MNW (mean 29.6 +/- 3 mm) were labeled wide, narrow, and midrange. Combining these groups into a matrix formation resulted in the classification of the tentorial notch into the following eight types: 1) narrow (15% of specimens); 2) wide (12% of specimens); 3) short (8% of specimens); 4) long (15% of specimens); 5) typical (24% of specimens); 6) large (9% of specimens); 7) small (10% of specimens); and 8) mixed (7% of specimens). The IC distance (mean 20.4 +/- 3.2 mm) was used to characterize brainstem position as prefixed (28% of specimens), postfixed (36% of specimens), or midposition (36% of specimens). The IC distance was correlated with the left and right cisternal third nerve distances (means 26.7 +/- 2.9 mm and 26.1 +/- 3.2 mm, respectively) and the inter-third nerve angle (mean 57.3 +/- 7.3degrees). The exposed cerebellar parenchyma within the notch, the relationship between the brainstem and tentorial edge, and the brainstem position varied considerably among individuals. The cisternal third nerve distance, its trajectory, and its anatomical relation to the skull base also varied widely. Two anatomically distinct segments of the subarachnoid third cranial nerves were characterized with respect to the skull base as suspended and supported segments. Conclusions. The authors present a new classification system for the tentorial aperture to help explain variations in herniation syndromes in patients with otherwise similar intracranial pathological conditions, and responses to concussive and acceleration-deceleration injuries. The authors present observations not previously described regarding the position of the brainstem within the tentorial aperture and the cisternal portion of the third cranial nerves. A significant statistical correlation was discovered among specific morphometric parameters of the tentorial notch, brainstem, and oculomotor nerves. These findings may have neurosurgical implications in clinical situations that cause brainstem distortion. Additionally, this analysis provides baseline data for interpreting magnetic resonance and computerized tomography images of the tentorial notch and its regional anatomy.	Legacy Hlth Syst, Dept Neurosurg, Portland, OR USA; Dept Oregon State Police, Med Examiner Div, State Med Examiners Off, Portland, OR USA; SUNY Hlth Sci Ctr, Dept Neurosurg, Brooklyn, NY 11203 USA; Kings Cty Hosp, Off Chief Med Examiner, Brooklyn, NY USA		Adler, DE (corresponding author), Legacy Neurol Sci Ctr, 1040 NW 22nd Ave,Suite 200, Portland, OR 97210 USA.	DAdler@lhs.org					BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BROWN WJ, 1972, AM J PATHOL, V67, P41; BULL JWD, 1969, P ROY SOC MED, V62, P1301, DOI 10.1177/003591576906201242; CORSELLIS JAN, 1958, J NEUROL NEUROSUR PS, V21, P279, DOI 10.1136/jnnp.21.4.279; ECKER A, 1948, J NEUROSURG, V5, P51, DOI 10.3171/jns.1948.5.1.0051; FOLTZ EL, 1953, J NEUROSURG, V10, P342, DOI 10.3171/jns.1953.10.4.0342; FREEDMAN H, 1952, J NEUROSURG, V9, P52, DOI 10.3171/jns.1952.9.1.0052; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jefferson G, 1938, ARCH NEURO PSYCHIATR, V40, P857, DOI 10.1001/archneurpsyc.1938.02270110011001; Kernohan JW, 1929, ARCH NEURO PSYCHIATR, V21, P274, DOI 10.1001/archneurpsyc.1929.02210200030004; KLINTWORTH GK, 1968, ANAT RECORD, V160, P635, DOI 10.1002/ar.1091600312; LEBEAU J, 1938, OEDEME CERVEAU SON R; Meyer A, 1920, ARCH NEURO PSYCHIATR, V4, P387, DOI 10.1001/archneurpsyc.1920.02180220036003; MUNRO D, 1950, T AM NEUROL ASSOC, P62; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Reid WL, 1939, J AMER MED ASSOC, V112, P2030, DOI 10.1001/jama.1939.02800200028008; Reid WL, 1940, SURGERY, V8, P756; SCHEINKER M, 1945, ARCH NEURO PSYCHIATR, V53, P289; Schwarz GA, 1941, ARCH NEURO PSYCHIATR, V46, P297, DOI 10.1001/archneurpsyc.1941.02280200103005; SUNDERLAND S, 1958, BRIT J SURG, V45, P422, DOI 10.1002/bjs.18004519306; Vincent C, 1936, REV NEUROL-FRANCE, V65, P536; Ward A A Jr, 1964, Clin Neurosurg, V12, P95; WINDLE W. F., 1944, TRANS AMER NEUROL ASSOC, V70, P117; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561	27	36	41	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2002	96	6					1103	1112		10.3171/jns.2002.96.6.1103			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	559LD	WOS:000176026900027	12066913				2022-02-06	
J	Hicks, RR; Keeling, KL; Yang, MY; Smith, SA; Simons, AM; Kotwal, GJ				Hicks, RR; Keeling, KL; Yang, MY; Smith, SA; Simons, AM; Kotwal, GJ			Vaccinia virus complement control protein enhances functional recovery after traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; complement; fluid percussion injury; inflammation; memory loss; Morris Water Maze; vaccinia virus complement control protein	HEAD-INJURY; SYSTEM; INFLAMMATION; ACTIVATION; BINDING; RAT; PROTEOGLYCANS; ACCUMULATION; DYSFUNCTION; INHIBITION	Inflammation is a major contributor to the neuropathological consequences of traumatic brain injury (TBI). Previous studies have shown that proinflammatory complement activation fragments are present in the injured brain within the first 24 h after trauma. To investigate whether complement activation within the injured brain leads to the neuropathology and subsequent functional impairment associated with TBI, we examined what effect administration of a complement inhibitor, the vaccinia virus complement control protein (VCP), would have on spatial learning and memory in brain injured rats, as measured using the Morris Water Maze (MWM) procedure. Animals were subjected to a lateral fluid percussion brain injury of moderate severity and, 15 min later, received a 10-muL injection of either full-length VCP, a truncated version of VCP (VCPt), which lacks the complement inhibitory activity but retains the heparin binding activity of VCP, or saline directly into the cortex. Results of such intervention indicated that, at 2 weeks postinjury, both VCP and VCPt treatment attenuated impairments in spatial memory, but not neuropathological damage, as compared to the saline treated controls. These results were surprising and suggest that the neuroprotective effects following administration of VCP after acute brain injury are mediated by mechanisms other than complement inhibition. Potential mechanisms are discussed.	Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY USA		Kotwal, GJ (corresponding author), Univ Cape Town, Div Med Virol, ZA-7925 Cape Town, South Africa.	GJKOTW01@yahoo.com					Al-Mohanna F, 2001, TRANSPLANTATION, V71, P796, DOI 10.1097/00007890-200103270-00019; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Bovolenta P, 2000, PROG NEUROBIOL, V61, P113, DOI 10.1016/S0301-0082(99)00044-1; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Dunzendorfer S, 2001, BLOOD, V97, P1079, DOI 10.1182/blood.V97.4.1079; Farkas I, 1998, NEUROSCIENCE, V86, P903, DOI 10.1016/S0306-4522(98)00108-0; Fernaud-Espinosa I, 1998, J NEUROBIOL, V36, P16, DOI 10.1002/(SICI)1097-4695(199807)36:1<16::AID-NEU2>3.0.CO;2-D; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Harris JA, 2001, NEURON, V30, P315, DOI 10.1016/S0896-6273(01)00300-2; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kesner RP, 2000, HIPPOCAMPUS, V10, P483, DOI 10.1002/1098-1063(2000)10:4<483::AID-HIPO15>3.3.CO;2-Q; Kirschfink M, 1997, IMMUNOPHARMACOLOGY, V38, P51, DOI 10.1016/S0162-3109(97)00057-X; Kotwal G, 1998, 10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, P315; Kotwal GJ, 2000, IMMUNOL TODAY, V21, P242, DOI 10.1016/S0167-5699(00)01606-6; Kotwal GJ, 1998, MOL CELL BIOCHEM, V185, P39, DOI 10.1023/A:1006844624825; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; Kotwal GJ, 1997, J LEUKOCYTE BIOL, V62, P415, DOI 10.1002/jlb.62.4.415; Lalonde R, 1997, INT REV NEUROBIOL, V41, P191, DOI 10.1016/S0074-7742(08)60352-9; Leoni MJ, 2000, EXP NEUROL, V166, P442, DOI 10.1006/exnr.2000.7513; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MARTIN D, 1998, NEUROINFLAMMATION ME, P197; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCKENZIE R, 1992, J INFECT DIS, V166, P1245, DOI 10.1093/infdis/166.6.1245; Miller CG, 1997, VIROLOGY, V229, P126, DOI 10.1006/viro.1996.8396; Molinari M, 1997, INT REV NEUROBIOL, V41, P217, DOI 10.1016/S0074-7742(08)60353-0; Morgan BP, 1996, IMMUNOL TODAY, V17, P461, DOI 10.1016/0167-5699(96)20028-F; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murthy KHM, 2001, CELL, V104, P301, DOI 10.1016/S0092-8674(01)00214-8; Nieto-Sampedro M, 1999, ADV EXP MED BIOL, V468, P207; Osaka H, 1999, J CELL BIOCHEM, V73, P303, DOI 10.1002/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.3.CO;2-U; OTT L, 1998, CONTEMP NEUROSCI, P221; Paxinos G, 1996, RAT BRAIN STEREOTAXI; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; Rauvala H, 2000, MATRIX BIOL, V19, P377, DOI 10.1016/S0945-053X(00)00084-6; REYNOLDS DN, 1999, ADV ANIMAL VIROLOGY, P343; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Smith SA, 2000, J VIROL, V74, P5659, DOI 10.1128/JVI.74.12.5659-5666.2000; Soares HD, 1995, J NEUROSCI, V15, P8223; SPIEGEL K, 1998, NEUROINFLAMMATION ME, P129; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2000, J NEUROIMMUNOL, V109, P164, DOI 10.1016/S0165-5728(00)00304-0; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21	49	36	36	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2002	19	6					705	714		10.1089/08977150260139093			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	569EZ	WOS:000176588900003	12165132				2022-02-06	
J	Schneider, G; Fries, P; Wagner-Jochem, D; Thome, D; Laurer, H; Kramann, B; Mautes, A; Hagen, T				Schneider, G; Fries, P; Wagner-Jochem, D; Thome, D; Laurer, H; Kramann, B; Mautes, A; Hagen, T			Pathophysiological changes after traumatic brain injury: comparison of two experimental animal models by means of MRI	MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE			English	Article						traumatic brain injury; experimental animal model; MRI; pathophysiology	CEREBRAL BLOOD-FLOW; TIME-COURSE; RATS; EDEMA	In an experimental study MRI was used to compare the pathophysiological changes of brain tissue after lateral fluid percussion injury (FPI) versus cold injury (CI) as models of traumatic brain injury (TBI), Two groups of Sprague-Dawley rats (n = 23) were subjected to mild FPI, respectively, Cl localized over the right parietal cortex. MRI was performed at different time points including T1w, T2w and T1w-CE (Gd-DTPA 0.2 mmol/kg BW) sequences as well as perfusion-weighted imaging with calculation of regional cerebral blood volume (rCBV) and regional cerebral blood flow (rCBF). T2w and T1w-CE images showed hyperintense areas in the traumatised cortex demonstrating brain edema and blood-brain barrier (BBB)-breakdown increasing up to 12 h. Perfusion-weighted imaging demonstrated a significant decrease of rCBV and rCBF in the ipsilateral cortex of CI animals compared with the contralateral hemisphere, In contrast, rats of the FPI group showed only slight differences in rCBF and rCBV comparing the left and right cortex. The results of our study confirm that both mild FPI and CI produced focal brain edema with concomitant breakdown of the BBB as a model of TBI. Since differences regarding perfusion are much more pronounced in CI our results suggest that, this model more likely seems to reflect pathophysiological changes of brain ischemia, whereas FPI seems to be better suited to model the pathophysiological characteristics of TBI. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Hosp, Dept Diagnost Radiol, D-66421 Homburg, Germany; Univ Hosp, Neurosurg Res Lab, D-66421 Homburg, Germany; Univ Hosp, Dept Neuroradiol, D-66421 Homburg, Germany		Schneider, G (corresponding author), Univ Hosp, Dept Diagnost Radiol, Gebaude 49, D-66421 Homburg, Germany.	ragsne@uniklinik-saarland.de					Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Baethmann A, 1997, ZBL NEUROCHIR, V58, P20; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; EDELMAN RR, 1990, RADIOLOGY, V176, P211, DOI 10.1148/radiology.176.1.2353094; EVERETT NB, 1956, CIRC RES, V4, P419, DOI 10.1161/01.RES.4.4.419; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6; Hagen T, 1999, J COMPUT ASSIST TOMO, V23, P257, DOI 10.1097/00004728-199903000-00015; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hermann DM, 1999, NEUROREPORT, V10, P759, DOI 10.1097/00001756-199903170-00018; KUCHIWAKI H, 1990, ACT NEUR S, V51, P77; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; MATTHAEI D, 1986, Magnetic Resonance Imaging, V4, P381, DOI 10.1016/0730-725X(86)90043-3; MCINTOSH TK, 1990, ACT NEUR S, V51, P263; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; SCHNEIDER GH, 1994, ACTA NEUROCHIR, P437; SCHNEIDER GH, 1994, ACTA NEUROCHIR, P516	19	36	36	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0968-5243	1352-8661		MAGN RESON MATER PHY	Magn. Reson. Mat. Phys. Biol. Med.	JUN	2002	14	3					233	241	PII S1352-8661(02)00068-6	10.1016/S1352-8661(02)00068-6			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	578PD	WOS:000177126100003	12098566				2022-02-06	
J	Festoff, BW; SantaCruz, K; Arnold, PM; Sebastian, CT; Davies, PJA; Citron, BA				Festoff, BW; SantaCruz, K; Arnold, PM; Sebastian, CT; Davies, PJA; Citron, BA			Injury-induced 'switch' from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord	JOURNAL OF NEUROCHEMISTRY			English	Article						apoptosis; cross-linking; GTPase; motoneurons; spinal cord; transglutaminase	TUMOR-NECROSIS-FACTOR; INDUCED CROSS-LINKING; KAPPA-B ACTIVATION; ALZHEIMERS-DISEASE; MESSENGER-RNA; UP-REGULATION; CELL-DEATH; INTRANUCLEAR INCLUSIONS; NEURONAL DEGENERATION; GENE-EXPRESSION	We recently found that alternative transcripts of tissue transglutaminase (tTG or TG2) were present in hippocampal brain regions of Alzheimer's disease (AD), but not in control, non-demented, age-matched brains. Since antecedent non-severe trauma has been implicated in AD and other neurodegenerative diseases, such as Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), we were interested in whether alternative transcripts might be detected in a model of neurotrauma, controlled-contusion spinal cord injury (SCI) in the rat. Implicated in diverse roles from growth and differentiation to apoptotic cell death, only bifunctional tTG, of the nine member TG family, has dual catalytic activities: guanine trinucleotide (GTP) hydrolyzing activity (GTPase), as well as protein cross-linking. These functions imply two physiological functions: programmed cell life and death. These may have profound roles in the nervous system since studies in cultured astrocytes found tTG short (S) mRNA transcripts induced by treatment with injury-related cytokines. In the developing rat spinal cord, tTG activity is concentrated in ventral horn alpha motoneurons, but neither studies of spinal cord tTG gene expression, nor evaluation of the GTP-regulated isoforms in tissues, have been reported. We now report increased tTG protein and gene expression occurring rapidly after SCI. In parallel, novel appearance of a second, short form transcript, in addition to the normal long (L) isoform, occurs by 8 h of injury. Up-regulation of tTG message and activity following neural injury. with appearance of a truncated GTP-unregulated S form, may represent new approaches to drug targets in neurotrauma.	Univ Kansas, Med Ctr, Dept Vet Affairs Med Ctr, Neurobiol Res Lab, Kansas City, MO 64128 USA; Univ Kansas, Med Ctr, Dept Neurol, Kansas City, MO 64128 USA; Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, MO 64128 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, MO 64128 USA; Univ Kansas, Med Ctr, Dept Surg Neurosurg, Kansas City, MO 64128 USA; Univ Texas, Med Ctr, Dept Integrat Biol Pharmacol & Physiol, Houston, TX USA		Festoff, BW (corresponding author), Univ Kansas, Med Ctr, Dept Vet Affairs Med Ctr, Neurobiol Res Lab 151, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	bfestoff@kumc.edu					Aeschlimann D, 1998, J BIOL CHEM, V273, P3452, DOI 10.1074/jbc.273.6.3452; AESCHLIMANN D, 1991, J BIOL CHEM, V266, P15308; Appelt DM, 1996, J HISTOCHEM CYTOCHEM, V44, P1421, DOI 10.1177/44.12.8985134; Bethea JR, 1998, J NEUROSCI, V18, P3251; CARIELLO L, 1994, BIOCHEM BIOPH RES CO, V205, P565, DOI 10.1006/bbrc.1994.2702; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; Citron BA, 2001, J BIOL CHEM, V276, P3295, DOI 10.1074/jbc.M004776200; Citron BA, 2000, NEUROCHEM INT, V37, P337, DOI 10.1016/S0197-0186(00)00044-9; Citron BA, 2000, J NEUROTRAUM, V17, P1191, DOI 10.1089/neu.2000.17.1191; Cooper AJL, 1999, J NEUROCHEM, V72, P889, DOI 10.1046/j.1471-4159.1999.0720889.x; Crowe M. J., 1995, Society for Neuroscience Abstracts, V21, P232; EITAN S, 1994, SCIENCE, V264, P1764, DOI 10.1126/science.7911602; ELALAOUI S, 1991, INT J CANCER, V48, P221; Farlow DN, 2000, J CELL BIOCHEM, V80, P171; Feng JF, 1999, BIOCHEMISTRY-US, V38, P10743, DOI 10.1021/bi9905009; FRAIJ BM, 1992, J BIOL CHEM, V267, P22616; Fraij BM, 1996, BIOCHEM BIOPH RES CO, V218, P45, DOI 10.1006/bbrc.1996.0009; Fujita K, 1998, NEUROCHEM RES, V23, P557, DOI 10.1023/A:1022442904179; Fujita K, 1995, NEUROCHEM RES, V20, P1195, DOI 10.1007/BF00995383; Gentile V, 1998, ARCH BIOCHEM BIOPHYS, V352, P314, DOI 10.1006/abbi.1998.0592; GILAD GM, 1985, J NEUROCHEM, V44, P1385, DOI 10.1111/j.1471-4159.1985.tb08774.x; Gill LS, 1998, BRAIN RES, V788, P95, DOI 10.1016/S0006-8993(97)01526-6; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Holmes FE, 1996, NEUROSCI LETT, V213, P185; HWANG KC, 1995, J BIOL CHEM, V270, P27058, DOI 10.1074/jbc.270.45.27058; Iismaa SE, 2000, J BIOL CHEM, V275, P18259, DOI 10.1074/jbc.M000583200; Iismaa SE, 1997, BIOCHEMISTRY-US, V36, P11655, DOI 10.1021/bi970545e; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Johnson GVW, 1997, BRAIN RES, V751, P323, DOI 10.1016/S0006-8993(96)01431-X; Kahlem P, 1996, P NATL ACAD SCI USA, V93, P14580, DOI 10.1073/pnas.93.25.14580; Kahlem P, 1998, MOL CELL, V1, P595, DOI 10.1016/S1097-2765(00)80059-3; Kim SY, 1999, J BIOL CHEM, V274, P30715, DOI 10.1074/jbc.274.43.30715; Kim TW, 1998, NEURON, V21, P657, DOI 10.1016/S0896-6273(00)80581-4; Kuncio GS, 1998, AM J PHYSIOL-GASTR L, V274, pG240, DOI 10.1152/ajpgi.1998.274.2.G240; LEE KN, 1993, BIOCHIM BIOPHYS ACTA, V1202, P1, DOI 10.1016/0167-4838(93)90055-V; LEE KN, 1989, BIOCHEM BIOPH RES CO, V162, P1370, DOI 10.1016/0006-291X(89)90825-5; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lorand L, 1996, P NATL ACAD SCI USA, V93, P14310, DOI 10.1073/pnas.93.25.14310; Melino G, 2000, CELL MOL LIFE SCI, V57, P612, DOI 10.1007/PL00000723; Melino G, 1998, FEBS LETT, V430, P59, DOI 10.1016/S0014-5793(98)00521-3; Mey J, 2001, Z NATURFORSCH C, V56, P163; Mirza A, 1997, AM J PHYSIOL-GASTR L, V272, pG281, DOI 10.1152/ajpgi.1997.272.2.G281; Monsonego A, 1998, FASEB J, V12, P1163, DOI 10.1096/fasebj.12.12.1163; Monsonego A, 1998, J MOL BIOL, V282, P713, DOI 10.1006/jmbi.1998.2052; Monsonego A, 1997, J BIOL CHEM, V272, P3724, DOI 10.1074/jbc.272.6.3724; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Norlund MA, 1999, BRAIN RES, V851, P154, DOI 10.1016/S0006-8993(99)02179-4; Pabbathi VK, 1997, BRAIN RES, V760, P22, DOI 10.1016/S0006-8993(97)00272-2; Pan WH, 1999, J NEUROSCI, V19, P3649; PERRY MJM, 1993, INT J DEV NEUROSCI, V11, P325, DOI 10.1016/0736-5748(93)90004-W; Piredda L, 1999, FASEB J, V13, P355, DOI 10.1096/fasebj.13.2.355; Raghunath M, 1996, J CLIN INVEST, V98, P1174, DOI 10.1172/JCI118901; Ritter SJ, 1998, J BIOL CHEM, V273, P12798, DOI 10.1074/jbc.273.21.12798; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Sisodia SS, 1998, CELL, V95, P1, DOI 10.1016/S0092-8674(00)81743-2; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; SWINGLER S, 1994, BIOCHEM BIOPH RES CO, V203, P623, DOI 10.1006/bbrc.1994.2228; Tan J, 2000, J NEUROSCI, V20, P7587; TETZLAFF W, 1988, BRAIN RES, V445, P142, DOI 10.1016/0006-8993(88)91083-9; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459; Zemaitaitis MO, 2000, J NEUROPATH EXP NEUR, V59, P983, DOI 10.1093/jnen/59.11.983; Zhang HF, 1998, HUM PATHOL, V29, P965, DOI 10.1016/S0046-8177(98)90202-7; Zhang SR, 1996, INVEST OPHTH VIS SCI, V37, P1793; Zhang W, 1997, LIFE SCI, V60, P2323, DOI 10.1016/S0024-3205(97)00288-9; Zhang-Gouillon ZQ, 1998, HEPATOLOGY, V27, P116, DOI 10.1002/hep.510270119	72	36	36	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAY	2002	81	4					708	718		10.1046/j.1471-4159.2002.00850.x			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	549YL	WOS:000175475100005	12065630				2022-02-06	
J	Nielsen, AS; Mortensen, PB; O'Callaghan, E; Mors, O; Ewald, H				Nielsen, AS; Mortensen, PB; O'Callaghan, E; Mors, O; Ewald, H			Is head injury a risk factor for schizophrenia?	SCHIZOPHRENIA RESEARCH			English	Article						head injury; schizophrenia; concussion	FIRST-EPISODE SCHIZOPHRENIA; PSYCHOSIS; REGISTER; TRAUMA	Background: The few studies that have examined whether head injury is a risk factor for later schizophrenia have had important methodological problems. Method: We examined the rates of head injury among 8288 persons in the 15 years up to their first admission with schizophrenia and compared them with 82880 age- and gender-matched controls. We used hospitalization for concussion or severe head injury as a definition of head injury. We controlled for any generally altered accident proneness prior to schizophrenia by also comparing the groups with respect to exposition to fractures not involving the skull or spine. Results: Males with schizophrenia had significantly reduced exposure to concussion (OR = 0.864, p = 0.024), whereas females had significantly increased exposure (OR = 1.322, p = 0.025). No differences were found as regards severe head injury. Males had significantly reduced risk of other fractures (OR = 0.616, p < 0.0001). whereas the risk in females did not differ from controls (OR = 1.154 p = 0.189). After adjusting head injury with the risk for other fractures, both concussion and severe head injury were significantly increased in males (OR = 1.501, p < 0.001 and OR = 1.516, p < 0,001, respectively) but not in females (OR = 1. 15, p = 0.413 and OR = 0.819. p = 0.442, respectively). Conclusion: Our results do not exclude that for males. head injury may contribute to the risk for schizophrenia in a limited number of cases. This relation may also exist for females. but it is paralleled by an increased liability to traumas in general. Premorbid general accident proneness requires consideration when studying this association. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Aarhus, Natl Ctr Register Based Res, DK-8000 Aarhus C, Denmark; Psychiat Hosp Aarhus, Inst Basic Psychiat Res, Dept Psychiat Demog, DK-8240 Risskov, Denmark; Cluain Mhuire Family Care, Dublin, Ireland; Psychiat Hosp Aarhus, Dept Biol Psychiat, DK-8240 Risskov, Denmark		Mortensen, PB (corresponding author), Univ Aarhus, Natl Ctr Register Based Res, Taasingegade 1, DK-8000 Aarhus C, Denmark.		Mortensen, Preben B/D-2358-2015	Mortensen, Preben B/0000-0002-5230-9865; Mors, Ole/0000-0002-5660-0393			ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; AITA JA, 1948, AM J PSYCHIAT, V105, P161, DOI 10.1176/ajp.105.3.161; Andersen TF, 1999, DAN MED BULL, V46, P263; BALDWIN JA, 1978, BRIT J PSYCHIAT, V133, P445, DOI 10.1192/bjp.133.5.445; Clayton D., 1993, STAT MODELS EPIDEMIO; DAVISON D, 1969, SPECIAL PUBLICATION, V4, P113; Deb S, 1999, AM J PSYCHIAT, V156, P374; FLANDERS WD, 1986, AM J EPIDEMIOL, V124, P684, DOI 10.1093/oxfordjournals.aje.a114442; GREENLAND S, 1982, AM J EPIDEMIOL, V116, P547, DOI 10.1093/oxfordjournals.aje.a113439; GUREJE O, 1994, AM J PSYCHIAT, V151, P368; HAAS GL, 1992, SCHIZOPHRENIA BULL, V18, P373, DOI 10.1093/schbul/18.3.373; JOHANSSON E, 1958, ACTA PSYCHIAT SCAND, V125, P33; Larsen TK, 1996, SCHIZOPHRENIA BULL, V22, P241, DOI 10.1093/schbul/22.2.241; Larsen TK, 1996, SCHIZOPHRENIA BULL, V22, P257, DOI 10.1093/schbul/22.2.257; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; MUNKJORGENSEN P, 1995, THESIS AARHUS; NASRALLAH HA, 1981, PSYCHOSOMATICS, V22, P359; NEUSTADT R, 1931, DTSCH Z GESAMTE GERI, V18, P1; OCALLAGHAN E, 1988, BRIT J PSYCHIAT, V153, P394, DOI 10.1192/bjp.153.3.394; Siegel E, 1970, Psychiatr Neurol Med Psychol (Leipz), V22, P345; *SUNDH, 1986, KLASS SYGD, P8; *WHO, 1967, INT CLASS DIS MAN IN; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Yung AR, 1996, AUST NZ J PSYCHIAT, V30, P587, DOI 10.3109/00048679609062654	26	36	37	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964			SCHIZOPHR RES	Schizophr. Res.	MAY 1	2002	55	1-2					93	98	PII S0920-9964(01)00205-5	10.1016/S0920-9964(01)00205-5			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	546ZQ	WOS:000175307500011	11955968				2022-02-06	
J	Wiedemayer, H; Triesch, K; Schafer, H; Stolke, D				Wiedemayer, H; Triesch, K; Schafer, H; Stolke, D			Early seizures following non-penetrating traumatic brain injury in adults: risk factors and clinical significance	BRAIN INJURY			English	Article							POSTTRAUMATIC SEIZURES; CHILDREN	Background: In the literature dissenting data are obtained about risk factors for early post-traumatic seizures and their impact on outcome. This study was conducted to obtain more information about the clinical significance of early seizures and their possible impact on the treatment of traumatic brain injury. Methods and results: A consecutive series of 1868 adult patients with head injury were analysed retrospectively. Demographic data of the patients, characteristics of the injury, and findings on CT scan were recorded. Risk factors for early post-traumatic seizures were identified using univariate statistics. A multivariate logistic regression was performed to look for interaction of different variables. The impact of early post-traumatic seizures on outcome was examined in an analogous way. Chronic alcohol abuse, subdural haematoma and brain contusion were identified as independent risk factors for early post-traumatic seizures. A significant association of early post-traumatic seizures with an unfavourable outcome was observed, but this effect was small compared to other variables. Conclusions: Early post-traumatic seizures appear to be an acute reaction of the brain to cortical damage with little independent impact on the management of head injury.	Univ Essen Gesamthsch, Sch Med, Dept Neurosurg, Essen, Germany		Wiedemayer, H (corresponding author), Univ Essen Gesamthsch Klinikum, Neurochirurg Klin, Hufelandstr 55, D-45122 Essen, Germany.	helmut.wiedemayer@uni-essen.de					ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; BAUMHACKL U, 1994, EUROPEAN NEUROLOGY S, V1, P71; Dalmady-Israel Christina, 1993, Brain Injury, V7, P263, DOI 10.3109/02699059309029679; De Santis A, 1992, Acta Neurochir Suppl (Wien), V55, P64; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; Kollevold T, 1978, J Oslo City Hosp, V28, P77; KOLLEVOLD T, 1979, J OWLO CITY HOSP, V29, P36; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; Lee ST, 1997, CAN J NEUROL SCI, V24, P40, DOI 10.1017/S0317167100021077; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MAUGUIERE F, 1979, REV EEG NEUROPHYSIOL, V9, P149, DOI 10.1016/S0370-4475(79)80069-6; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; RUTHERFORD WH, 1977, LANCET, V1, P1021; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Schutze M, 1999, ZBL NEUROCHIR, V60, P163; TEASDALE G, 1974, LANCET, V2, P81; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37	23	36	37	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2002	16	4					323	330		10.1080/02699050110102077			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	541CM	WOS:000174967700004	11953003				2022-02-06	
J	Butterwick, DJ; Hagel, B; Nelson, DS; LeFave, MR; Meeuwisse, WH				Butterwick, DJ; Hagel, B; Nelson, DS; LeFave, MR; Meeuwisse, WH			Epidemiologic analysis of injury in five years of Canadian professional rodeo	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article								Longitudinal studies of rodeo injuries are rare. We prospectively investigated injuries in professional rodeo in Canada over a 5-year period. Our specific interests included injury incidence density in specific rodeo events, risk factors such as past injury, and the incidence of head injury. Of 323 professional rodeos from 1995 through 1999, 63 rodeos provided a convenience sample. These rodeos were selected because the Canadian Professional Rodeo Sport Medicine Team was in attendance at these events, thus providing both competitor health care and data collection. Four hundred fifty-one injuries were reported during 30,564 competitor-exposures. The greatest injury frequency and injury incidence density were in the rough stock events (bull riding, bareback riding, and saddle bronc). Bull riding accounted for the greatest injury frequency (141) and incidence density (32.2 injuries per 1000 competitor-exposures). Bull riding had a relative injury risk of 1.32 when compared with bareback riding; bareback riding had a relative injury risk of 1.39 when compared with saddle bronc riding. Concussions accounted for 8.6% of all reported injuries. Concussions and other head injuries (65) were second only to knee injuries (76) in frequency of injury to specific body parts. This concussion frequency is higher than has previously been reported.	Univ Calgary, Fac Kinesiol, Sport Med Ctr, Calgary, AB T2N 1N4, Canada; Mt Royal Coll, Calgary, AB, Canada; McGill Univ, Montreal, PQ, Canada		Butterwick, DJ (corresponding author), Univ Calgary, Fac Kinesiol, Sport Med Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.		Hagel, Brent/AAK-3319-2020				Brandenburg MA, 1998, ANN EMERG MED, V32, P118, DOI 10.1016/S0196-0644(98)70123-4; Butterwick DJ, 1996, CLIN J SPORT MED, V6, P171, DOI 10.1097/00042752-199607000-00006; GRIFFIN R, 1987, PHYSICIAN SPORTSMED, V15, P104, DOI 10.1080/00913847.1987.11709284; Griffin R, 1983, Phys Sportsmed, V11, P110, DOI 10.1080/00913847.1983.11708608; HARVEY J, 1995, SPORTS MED UPDATE, V10, P1; MEYERS MC, 1990, AM J SPORT MED, V18, P87, DOI 10.1177/036354659001800114; NEBERGALL R, 1996, EPIDEMIOLOGY SPORTS, P350; SEAGER SB, 1981, ANN EMERG MED, V10, P252, DOI 10.1016/S0196-0644(81)80050-9; Slawski D P, 1997, Am J Orthop (Belle Mead NJ), V26, P794; STOCK C, 2000, CALGARY HERALD  0529, pC16; TRIPP HF, 1995, MIL MED, V160, P422, DOI 10.1093/milmed/160.8.422; Warren WL, 1998, CLIN SPORT MED, V17, P13, DOI 10.1016/S0278-5919(05)70057-0; 1996, MMWR MORB MORTAL WKL, V45, P796	13	36	36	0	3	AMER ORTHOPAEDIC SOC SPORT MED	WALTHAM	230 CALVARY STREET, WALTHAM, MA 02154 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	MAR-APR	2002	30	2					193	198		10.1177/03635465020300020801			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	533FV	WOS:000174519500008	11912087				2022-02-06	
J	Otto, VI; Gloor, SM; Frentzel, S; Gilli, U; Ammann, E; Hein, AE; Folkers, G; Trentz, O; Kossmann, T; Morganti-Kossmann, MC				Otto, VI; Gloor, SM; Frentzel, S; Gilli, U; Ammann, E; Hein, AE; Folkers, G; Trentz, O; Kossmann, T; Morganti-Kossmann, MC			The production of macrophage inflammatory protein-2 induced by soluble intercellular adhesion molecule-1 in mouse astrocytes is mediated by src tyrosine kinases and p42/44 mitogen-activated protein kinase	JOURNAL OF NEUROCHEMISTRY			English	Article						astrocytes; macrophage inflammatory protein-2; p42/44 mitogen-activated protein kinase; soluble intercellular adhesion molecule-1; src tyrosine kinases	CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELLS; TNF-ALPHA; CHEMOTACTIC ACTIVITY; HELICOBACTER-PYLORI; CEREBROSPINAL-FLUID; SIGNALING PATHWAYS; CIRCULATING ICAM-1; EPITHELIAL-CELLS	Severe traumatic brain injury stimulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) into CSF. Studies in cultured mouse astrocytes suggest that sICAM-1 induces the production of macrophage inflammatory protein-2 (MIP-2). In the present study, we investigated the underlying mechanisms for MIP-2 induction. sICAM-1 induced MIP-2 in astrocytes lacking membrane-bound ICAM-1, indicating that its action is due to heterophilic binding to an undescribed receptor rather than homophilic binding to surface ICAM-1. Signal transduction may be mediated by src tyrosine kinases, as the src tyrosine kinase inhibitors herbimycin A and PP2 abolished MIP-2 induction by sICAM-1. Phosphorylation of p42/44 mitogen-activated protein kinase (MAPK), but not of p38 MAPK, occurred further downstream, as evidenced by western blot analysis combined with the use of herbimycin A and specific MAPK inhibitors. By contrast, induction of MIP-2 by tumour necrosis factor-alpha (TNF-alpha) involved both p42/44 MAPK and p38 MAPK. Following stimulation with either sICAM-1 or TNF-alpha, astrocyte supernatants promoted chemotaxis of human neutrophils and incubation of these supernatants with anti-MIP-2 antibodies more efficiently suppressed the migration induced by sICAM-1 than by TNF-alpha. These results show that sICAM-1 induces the production of biologically active MIP-2 in astrocytes by heterophilic binding to an undefined receptor and activation of src tyrosine kinases and p42/44 MAPK.	Univ Zurich Hosp, Div Res, Dept Surg, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Surg, Div Trauma Surg, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Internal Med, Lab Transplantat Immunol, CH-8091 Zurich, Switzerland; Swiss Fed Inst Technol, ETH, Inst Biochem, Zurich, Switzerland; Novartis Pharma Res, Basel, Switzerland; Swiss Fed Inst Technol, Dept Appl Biosci, ETH, Div Pharmaceut Sci, Zurich, Switzerland		Otto, VI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, BRC 417,975 NE 10th St, Oklahoma City, OK 73104 USA.			Folkers, Gerd/0000-0002-3620-705X; Morganti-Kossmann, Cristina/0000-0002-0807-2063; Otto, Vivianne/0000-0002-1157-0186			BAJAJ MS, 1992, INFLAMMATION, V16, P241, DOI 10.1007/BF00918813; Beales ILP, 1997, CYTOKINE, V9, P514, DOI 10.1006/cyto.1996.0195; Ding SZ, 1997, BIOCHEM BIOPH RES CO, V240, P561, DOI 10.1006/bbrc.1997.7699; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Etienne S, 1998, J IMMUNOL, V161, P5755; Etienne-Manneville S, 1999, J IMMUNOL, V163, P668; Franchini M, 1998, VET IMMUNOL IMMUNOP, V66, P53, DOI 10.1016/S0165-2427(98)00178-0; Gho YS, 1999, CANCER RES, V59, P5128; HASKARD D, 1986, J IMMUNOL, V137, P2901; Holland J, 1997, J BIOL CHEM, V272, P9108; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Janabi N, 1999, J IMMUNOL, V162, P1701; Keane MP, 2000, CRIT CARE MED, V28, pN13, DOI 10.1097/00003246-200004001-00003; KING PD, 1995, J IMMUNOL, V154, P6080; KUBY J, 1997, IMMUNOLOGY, P357; Kusterer K, 1998, AM J PHYSIOL-GASTR L, V275, pG377; Lacy P, 1999, BLOOD, V94, P23, DOI 10.1182/blood.V94.1.23.413k13_23_32; Lawson C, 1999, J IMMUNOL, V162, P2990; Lee SJ, 2000, J IMMUNOL, V165, P4658, DOI 10.4049/jimmunol.165.8.4658; LUKACS NW, 1994, BLOOD, V83, P1174; Matsumoto K, 1998, J ALLERGY CLIN IMMUN, V101, P825, DOI 10.1016/S0091-6749(98)70311-2; MCCABE SM, 1993, CELL IMMUNOL, V150, P364, DOI 10.1006/cimm.1993.1204; MEYER DM, 1995, J IMMUNOL, V155, P3578; MEYER JD, 1988, ARCH SURG-CHICAGO, V123, P1454; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; MORGANTI MC, 1990, EXP NEUROL, V109, P98, DOI 10.1016/S0014-4886(05)80012-3; MROWIETZ U, 1988, BIOCHEM BIOPH RES CO, V153, P1223, DOI 10.1016/S0006-291X(88)81358-5; Otto VI, 2000, J NEUROSCI RES, V60, P733, DOI 10.1002/1097-4547(20000615)60:6<733::AID-JNR5>3.0.CO;2-X; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; RIECKMANN P, 1995, J NEUROIMMUNOL, V60, P9, DOI 10.1016/0165-5728(95)00047-6; ROTHLEIN R, 1991, J IMMUNOL, V147, P3788; Sano H, 1998, BIOCHEM BIOPH RES CO, V250, P694, DOI 10.1006/bbrc.1998.9385; Saunders J, 1999, DRUG DISCOV TODAY, V4, P80, DOI 10.1016/S1359-6446(98)01280-X; Schmal H, 1998, J IMMUNOL, V161, P3685; SEEBACH J, 1995, J IMMUNOL, V155, P4367; SHARIEF MK, 1993, J NEUROIMMUNOL, V43, P15, DOI 10.1016/0165-5728(93)90070-F; Shrikant P, 1996, J IMMUNOL, V157, P1819; SOBEL RA, 1990, AM J PATHOL, V136, P1309; Su SB, 1996, J LEUKOCYTE BIOL, V59, P420, DOI 10.1002/jlb.59.3.420; VAN SG, 1990, J IMMUNOL, V144, P4579; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Wolff B, 1998, J EXP MED, V188, P1757, DOI 10.1084/jem.188.9.1757; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95; Zu YL, 1998, J IMMUNOL, V160, P1982	45	36	41	0	6	BLACKWELL PUBLISHING LTD	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	0022-3042			J NEUROCHEM	J. Neurochem.	MAR	2002	80	5					824	834		10.1046/j.0022-3042.2001.00748.x			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	527CY	WOS:000174169500013	11948246	Bronze			2022-02-06	
J	Fisk, GD; Novack, T; Mennemeier, M; Roenker, D				Fisk, GD; Novack, T; Mennemeier, M; Roenker, D			Useful field of view after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						divided attention; driving; peripheral vision; processing speed; selective attention	CLOSED-HEAD-INJURY; ATTENTIONAL DEFICITS; DRIVING PERFORMANCE; VISUAL-SEARCH; OLDER ADULTS; OF-VIEW; CRASHES; DRIVERS; AGE	Background: Traumatic brain injury (TBI) survivors often have sensory and cognitive impairments that may interfere with driving ability. The Useful Field of View (UFOV) is a measure of visual information processing that is a good predictor of vehicle crash risk in older adults. Objective: The objective of this study was to explore the possibility that UFOV is compromised after TBI Design: UFOV performance of 23 TBI survivors and 18 young adults without neurological impairment were compared, Conclusion: TBI survivors had higher UFOV scores than young adults, which indicated a greater functional loss of peripheral vision, The results suggest that the UFOV may be a valuable instrument for assessing driving readiness in TBI survivors.	Georgia SW State Univ, Dept Psychol & Sociol, Americus, GA 31709 USA; Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; Western Kentucky Univ, Dept Psychol, Bowling Green, KY 42101 USA		Fisk, GD (corresponding author), Georgia SW State Univ, Dept Psychol & Sociol, 800 Wheatley St, Americus, GA 31709 USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD07420-06] Funding Source: Medline		BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; Ball K., 1992, J AM OPTOM ASSOC, V64, P71; BALL K, 1999, USEFUL FIELD VIEW MA; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; BALL KK, 1990, DEV ATTENTION RES TH, P489, DOI DOI 10.1016/S0166-4115(08)60472-0; BROOKE MM, 1992, AM J PHYS MED REHAB, V71, P177, DOI 10.1097/00002060-199206000-00009; CREMONAMETEYARD SL, 1994, BRAIN INJURY, V8, P541, DOI 10.3109/02699059409151006; CROFT D, 1987, BRIT J OCCUPATIONAL, V50, P357; DELIS D, 1987, CALIFORNIA VERBAL LE; Fisk GD, 1998, BRAIN INJURY, V12, P683; FISK GD, 2002, ARCH PHYS MED REHABI, V83; Fox G K, 1992, Disabil Rehabil, V14, P140; GALSKI T, 1993, AM J OCCUP THER, V47, P391, DOI 10.5014/ajot.47.5.391; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; HANDLER BS, 1995, J REHABIL, V61, P43; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; Hibpshman T. L., 1991, SLOSSON INTELLIGENCE; Hills EC, 1998, BRAIN INJURY, V12, P69, DOI 10.1080/026990598122872; IKEDA M, 1975, PERCEPT PSYCHOPHYS, V18, P255, DOI 10.3758/BF03199371; Korner-Bitensky N, 2000, AM J PHYS MED REHAB, V79, P253, DOI 10.1097/00002060-200005000-00007; MATTHEWS CG, 1964, INSTRUCTION MANUAL A; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; Myers RS, 2000, PERCEPT MOTOR SKILL, V91, P279, DOI 10.2466/PMS.91.5.279-290; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; OWSLEY C, 1995, VISION RES, V35, P579, DOI 10.1016/0042-6989(94)00166-J; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; REITAN RM, 1985, HAISTAN REITAN NEURO; Rizzo M, 1997, ARCH NEUROL-CHICAGO, V54, P545, DOI 10.1001/archneur.1997.00550170027011; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; Seiple W, 1996, VISION RES, V36, P1859, DOI 10.1016/0042-6989(95)00288-X; Sekuler AB, 2000, EXP AGING RES, V26, P103, DOI 10.1080/036107300243588; SEKULER R, 1986, J OPTOM SOC AM, V3, P861; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Wechsler, 1997, WECHSLER ADULT INTEL; Whyte J, 1998, J INT NEUROPSYCH SOC, V4, P127, DOI 10.1017/S1355617798001271; ZACHARY RA, 1987, SHIPLEY I LIVING SCA; Zar, 1974, BIOSTATISTICAL ANAL	39	36	37	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	2002	17	1					16	25		10.1097/00001199-200202000-00004			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	519MM	WOS:000173730100005	11860326				2022-02-06	
J	Garnett, MR; Cadoux-Hudson, TAD; Styles, P				Garnett, MR; Cadoux-Hudson, TAD; Styles, P			How useful is magnetic resonance imaging in predicting severity and outcome in traumatic brain injury?	CURRENT OPINION IN NEUROLOGY			English	Article							CLOSED-HEAD-INJURY; SPECTROSCOPY; DIFFUSION; MILD; MRI; LESIONS	Major advances have been made in the ever-expanding field of magnetic resonance imaging and related technologies, such as magnetic resonance spectroscopy, haemodynamic and functional imaging. Although these magnetic resonance modalities are of great research interest, it is still questionable as to how useful these investigations are in the clinical setting. All of these modalities strive to define a few variables that might dominate the heterogeneous but common aetiopathology of traumatic brain injury. Recent studies have found that the use of various magnetic resonance imaging techniques at early and delayed time points can provide useful information with regard to the severity and clinical outcome of patients following traumatic brain injury. These new observations offer opportunities for improved clinical management in such patients. Curr Opin Neurol 14:753-757. (C) 2001 Lippincott Williams Wilkins.	Radcliffe Infirm, Dept Neurosurg, Oxford OX2 9DL, England; Univ Oxford, Dept Biochem, MRC, Biochem & Clin Magnet Resonance Unit, Oxford OX1 3QU, England		Cadoux-Hudson, TAD (corresponding author), Radcliffe Infirm, Dept Neurosurg, Oxford OX2 9DL, England.						Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Assaf Y, 1999, J NEUROTRAUM, V16, P1165, DOI 10.1089/neu.1999.16.1165; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bruce DA, 2000, CHILD NERV SYST, V16, P755, DOI 10.1007/PL00013720; CADOUXHUDSON TAD, 1998, P INT SOC MAGN RES M, P1383; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Condon B, 1998, J NEUROTRAUM, V15, P563, DOI 10.1089/neu.1998.15.563; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Henry-Feugeas MC, 2000, BRAIN INJURY, V14, P597; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kuzma BB, 2000, SURG NEUROL, V53, P400; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Takanashi Y, 2000, J NEUROTRAUM, V17, P359, DOI 10.1089/neu.2000.17.359; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Vinjamuri S, 2000, NUCL MED COMMUN, V21, P645, DOI 10.1097/00006231-200007000-00008	31	36	38	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1350-7540			CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	2001	14	6					753	757		10.1097/00019052-200112000-00012			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	510NG	WOS:000173213700012	11723384				2022-02-06	
J	Ferrari, R; Obelieniene, D; Russell, AS; Darlington, P; Gervais, R; Green, P				Ferrari, R; Obelieniene, D; Russell, AS; Darlington, P; Gervais, R; Green, P			Symptom expectation after minor head injury. A comparative study between Canada and Lithuania	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						minor head injury; mild traumatic brain injury; concussion; symptom expectation	SEQUELAE; WHIPLASH; TRAUMA	Objectives: The purpose of the present study is to compare the frequency and nature of expected symptoms in Lithuania (a country where the chronic post-concussive syndrome is largely unknown) with that in Canada. Methods: A symptom checklist was administered to two subject groups selected from local companies in Kaunas, Lithuania, and Edmonton, Canada, respectively. Subjects were asked to imagine having suffered head trauma with loss of consciousness in a motor vehicle accident, and to check off symptoms they expected might arise from the injury. For symptoms they anticipated, they were asked to select the period of time they expected those symptoms to persist. Results: In both the Lithuanian and Edmontonian groups,, the pattern or symptoms anticipated closely resembled the acute symptoms commonly reported by accident victims with minor head injury. Yet, while many, Edmontonians also anticipated symptoms to last months or years, very few Lithuanian subjects selected any symptoms as being likely to persist in a chronic manner. Conclusions: In Lithuania, despite the frequent experience of minor head injury in motor vehicle accidents, there is a very low rate of expectation of any chronic sequelae from such an injury, contrasting greatly with the response shown in Canada, where the prevalence of the chronic post-concussive syndrome is higher. Symptom expectation in some countries may be all important factor in the development of the chronic post-concussive syndrome. (C) 2001 Elsevier Science B.V. All rights reserved.			Ferrari, R (corresponding author), 12779-50 St, Edmonton, AB T5A 4L8, Canada.	rferrari@powersurfr.com		Obelieniene, Diana/0000-0002-7356-7150			AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; DADOLENE JH, 2001, 16 EULAR C PRAG CZEC; DADONLENE JH, 2001, 16 EULAR C PRAG CZEC; FERRARI R, IN PRESS ARTHRITIS C; FERRARI R, 1999, WHIPLASH ENCY FACTS; Hewlett S, 1995, Arthritis Care Res, V8, P4, DOI 10.1002/art.1790080104; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; KAY T, 1992, NEUROPSYCHOLOGY, V6, P341; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MADIANOS MG, 1993, PSYCHOTHER PSYCHOSOM, V60, P177, DOI 10.1159/000288691; McMillan TM, 1997, CURR OPIN NEUROL, V10, P479, DOI 10.1097/00019052-199712000-00008; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; Obelieniene D, 1998, CEPHALALGIA, V18, P559, DOI 10.1046/j.1468-2982.1998.1808559.x; PINCUS T, 1983, ARTHRITIS RHEUM-US, V26, P1346, DOI 10.1002/art.1780261107	19	36	36	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2001	103	3					184	190		10.1016/S0303-8467(01)00143-3			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	476YC	WOS:000171255500011	11532561				2022-02-06	
J	Forsman, L; Eriksson, A				Forsman, L; Eriksson, A			Skateboarding injuries of today	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						skateboard; injury; prevention	CHILDREN	Background-Skateboarding injuries have increased with the rise in popularity of the sport, and the injury pattern can be expected to have changed with the development of both skateboard tricks and the materials used for skateboard construction. Objective-To describe the injury pattern of today. Methods-The pattern of injuries, circumstances, and severity were investigated in a study of all 139 people injured in skateboarding accidents during the period 1995-1998 inclusive and admitted to the University Hospital of Umea. This is the only hospital in the area, serving a population of 135 000. Results-Three of the 139 injured were pedestrians hit by a skateboard rider; the rest were riders. The age range was 7-47 years (mean 16). The severity of the injuries was minor (AIS 1) to moderate (AIS 2); fractures were classified as moderate. The annual number of injuries increased during the study period. Fractures were found in 29% of the casualties, and four children had concussion. The most common fractures were of the ankle and wrist. Older patients had less severe injuries, mainly sprains and soft tissue injuries. Most children were injured while skateboarding on ramps and at arenas; only 12 (9%) were injured while skateboarding on roads. Some 37% of the injuries occurred because of a loss of balance, and 26% because of a failed trick attempt. Falls caused by surface irregularities resulted in the highest proportion of the moderate injuries. Conclusions-Skateboarding should be restricted to supervised skateboard parks, and skateboarders should be required to wear protective gear. These measures would reduce the number of skateboarders injured in motor vehicle collisions, reduce the personal injuries among skateboarders, and reduce the number of pedestrians injured in collisions with skateboarders.	Umea Univ, Sect Forens Med, Dept Community Hlth & Rehabil, SE-90712 Umea, Sweden		Forsman, L (corresponding author), Umea Univ, Sect Forens Med, Dept Community Hlth & Rehabil, POB 7642, SE-90712 Umea, Sweden.						ADAMS ID, 1979, NURS TIMES, V26, P707; ALLUM RL, 1978, INJURY, V10, P152; *ASS ADV AUT MED, ABBR INJ SCAL 1990 R; ATIENZA F, 1976, PEDIATRICS, V57, P793; Banas M P, 1992, J Orthop Trauma, V6, P301, DOI 10.1097/00005131-199209000-00006; BOYLE WE, 1995, PEDIATRICS, V95, P611; Brudvik C, 2001, Tidsskr Nor Laegeforen, V121, P19; CARRAGHER A M, 1990, Journal of Emergency Medicine, V8, P419, DOI 10.1016/0736-4679(90)90168-U; CASS DT, 1990, MED J AUSTRALIA, V153, P140, DOI 10.5694/j.1326-5377.1990.tb136832.x; Cassorla A., 1988, ULTIMATE SKATEBOARD, P17; Christian M S, 1980, Br J Sports Med, V14, P102; *COMM ACC POIS PRE, 1979, PEDIATRICS, V63, P924; Fountain JL, 1996, SPORTS MED, V22, P360, DOI 10.2165/00007256-199622060-00004; FYFE IS, 1979, J SPORT MED PHYS FIT, V19, P265; FYFE IS, 1978, INJURY, V10, P149; HAWKINS RW, 1981, AM J SPORT MED, V9, P99, DOI 10.1177/036354658100900205; HAWKINS RW, 1978, AM J DIS CHILD, V132, P751, DOI 10.1001/archpedi.1978.02120330023004; ILLINGWORTH CM, 1978, CLIN PEDIATR, V17, P781, DOI 10.1177/000992287801701012; JAKOBS RA, 1977, PEDIATRICS, V59, P939; KEMM I, 1978, BRIT MED J, V1, P894, DOI 10.1136/bmj.1.6117.894; Maddox D, 1976, PHYSICIAN SPORTSMED, V4, P24; MAITRA AK, 1979, BRIT J CLIN PRACT, V33, P281; MAITRA AK, 1979, BR J CLIN PRACT, V33, P288; MORGAN WJ, 1980, SCOT MED J, V25, P39, DOI 10.1177/003693308002500109; PENDERGRAST RA, 1990, J ADOLESCENT HEALTH, V11, P408, DOI 10.1016/0197-0070(90)90087-I; RETSKY J, 1991, AM J DIS CHILD, V145, P188, DOI 10.1001/archpedi.1991.02160020080022; SCHIEBER RA, 1994, JAMA-J AM MED ASSOC, V271, P1856, DOI 10.1001/jama.271.23.1856; SMITH RG, 1979, CAN MED ASSOC J, V121, P510; Tordai P, 1979, Lakartidningen, V76, P2781; WIDOME MD, 1989, PEDIATRICS, V83, P1070	30	36	38	4	19	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	OCT	2001	35	5					325	328		10.1136/bjsm.35.5.325			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	479FR	WOS:000171394800013	11579065	Bronze, Green Published			2022-02-06	
J	Pyne, GJ; Cadoux-Hudson, TAD; Clark, JF				Pyne, GJ; Cadoux-Hudson, TAD; Clark, JF			Magnesium protection against in vitro cerebral vasospasm after subarachnoid haemorrhage	BRITISH JOURNAL OF NEUROSURGERY			English	Article						cerebral vasospasm; magnesium; stroke; subarachnoid haemorrhage	INTRACELLULAR-FREE MAGNESIUM; TRAUMATIC BRAIN INJURY; SMOOTH-MUSCLE CELLS; GUINEA-PIG CECUM; HEMORRHAGE; CALCIUM; SULFATE; TAENIA; PHOSPHORYLATION; RELEASE	Mg2+ has recently been proposed for the treatment of cerebral vasospasm and is known to dilate vessels. In this study, we examine the effects of Mg2+ on in vitro vasospasm using CSF from vasospastic subarachnoid haemorrhage patients with vasospasm (CSFv). Oxygen consumption and isometric force measurements in the porcine carotid artery were used to assess the contractile and metabolic status of the vessels' responses to CSFv and the effect of Mg2+. Mg2+ caused a dose dependant decrease in tension following contraction by CSFv. Mg2+ (12 mM) caused a normalization of relaxation rate in tissue exposed to CSFv, caused a significant decrease in basal oxygen consumption, as well as significantly decreasing the rate of oxygen consumption of the porcine carotid artery when stimulated by CSF (0.70 +/- 0.12 versus. 0.46 +/- 0.1 mmol O-2 min(-1) g(-1)). Acute Mg2+ addition demonstrated the most effective protection using an assay based on CSFv contraction. These results suggest that Mg2+ can protect vascular smooth muscle exposed to CSFv by benefiting contractile behaviour and metabolism of the arteries.	Univ Oxford, Dept Biochem, MRC, Biochem & Clin Magnet Resonance Unit, Oxford OX1 3QU, England; MRC, Ctr Collaborat, London NW7 1AD, England		Clark, JF (corresponding author), Univ Cincinnati, Med Ctr, Dept Neurol, Cincinnati, OH 45267 USA.						Altura BT, 1997, NEUROSCI LETT, V230, P37, DOI 10.1016/S0304-3940(97)00471-0; ARHEDEN H, 1992, BIOPHYS J, V61, P1480, DOI 10.1016/S0006-3495(92)81954-9; BARANY K, 1985, J BIOL CHEM, V260, P7126; Bearchell MC, 1998, AM J OBSTET GYNECOL, V179, P1534, DOI 10.1016/S0002-9378(98)70020-1; Boet R, 2000, NEUROSURGERY, V47, P602, DOI 10.1097/00006123-200009000-00014; Cadoux-Hudson TAD, 2001, ACTA NEUROCHIR, V143, P65, DOI 10.1007/s007010170140; CADOUXHUDSON TAD, 1999, EMERGING THERAPEUTIC, V3, P439; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; DULEY L, 1995, LANCET, V345, P1455; ENDO S, 1977, STROKE, V8, P702, DOI 10.1161/01.STR.8.6.702; FORD GD, 1986, AM J PHYSIOL, V251, pC687, DOI 10.1152/ajpcell.1986.251.5.C687; HEALY M D, 1984, Magnesium, V3, P63; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1997, NEUROSCI LETT, V228, P175, DOI 10.1016/S0304-3940(97)00394-7; HORN E, 1906, MED REV, V32, P264; Lazard EM, 1933, AM J OBSTET GYNECOL, V26, P647, DOI 10.1016/S0002-9378(33)90285-9; MACDONALD RL, 1994, FREE RADICAL BIO MED, V16, P633; MCCLEAN RM, 1994, AM J MED, V96, P63; MORELAND RS, 1981, ARCH BIOCHEM BIOPHYS, V208, P325, DOI 10.1016/0003-9861(81)90516-6; MORELAND S, 1987, PFLUG ARCH EUR J PHY, V408, P139, DOI 10.1007/BF00581343; MUIR KW, 1995, STROKE, V26, P1183, DOI 10.1161/01.STR.26.7.1183; NAKAYAMA S, 1991, J PHYSIOL-LONDON, V435, P559, DOI 10.1113/jphysiol.1991.sp018525; NAKAYAMA S, 1994, J GEN PHYSIOL, V103, P833, DOI 10.1085/jgp.103.5.833; NAKAYAMA S, 1990, J PHYSIOL-LONDON, V421, P363, DOI 10.1113/jphysiol.1990.sp017949; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; POE M, 1969, ARCH BIOCHEM BIOPHYS, V132, P377, DOI 10.1016/0003-9861(69)90379-8; Pyne GJ, 2000, BBA-GEN SUBJECTS, V1474, P283, DOI 10.1016/S0304-4165(00)00030-1; Pyne GJ, 2001, ACTA NEUROCHIR, V143, P59, DOI 10.1007/s007010170139; RAM Z, 1991, STROKE, V22, P922, DOI 10.1161/01.STR.22.7.922; RUSSELL WE, 1973, EUR J BIOCHEM, V33, P459, DOI 10.1111/j.1432-1033.1973.tb02703.x; SJOGREN A, 1988, PHARMACOL TOXICOL, V62, P17; SLOANE BF, 1978, ARCH BIOCHEM BIOPHYS, V189, P409, DOI 10.1016/0003-9861(78)90228-X; STRAUSS JD, 1996, BIOCH SMOOTH MUSCLE, P345; STULL JT, 1986, ENZYMES, P113; TAYLOR JS, 1991, P NATL ACAD SCI USA, V88, P6810, DOI 10.1073/pnas.88.15.6810; VARSOS VG, 1983, J NEUROSURG, V58, P11, DOI 10.3171/jns.1983.58.1.0011; WEBER A, 1969, BIOCHEMISTRY-US, V8, P2266, DOI 10.1021/bi00834a005; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; WEIR B, 1995, BRIT J NEUROSURG, V9, P375, DOI 10.1080/02688699550041386; WHITE RE, 1989, BIOCHEM PHARMACOL, V38, P859, DOI 10.1016/0006-2952(89)90272-4; WINGARD CJ, 1995, J PHYSIOL-LONDON, V488, P729, DOI 10.1113/jphysiol.1995.sp021004; ZHANG A, 1992, BIOCHIM BIOPHYS ACTA, V1134, P25, DOI 10.1016/0167-4889(92)90024-6	42	36	37	0	0	CARFAX PUBLISHING	BASINGSTOKE	RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	OCT	2001	15	5					409	415		10.1080/02688690120082413			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	486MP	WOS:000171821800005	11708544				2022-02-06	
J	Kincaid, EH; Chang, MC; Letton, RW; Chen, JG; Meredith, JW				Kincaid, EH; Chang, MC; Letton, RW; Chen, JG; Meredith, JW			Admission base deficit in pediatric trauma: A study using the National Trauma Data Bank	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						base deficit; trauma; pediatric; shock; acidosis; children	ABDOMINAL INJURY; PREDICTORS; SEVERITY; MORTALITY; SHOCK; RISK	Background. The base deficit, an important indicator of physiologic derangement after severe injury in adults, has not been specifically examined in the pediatric trauma population. The purpose of this study was to assess the ability of the admission base deficit to predict injury severity and outcome in the pediatric trauma population. Methods. The study group included all patients in the National Trauma Data Bank over a 2-year period aged 0 to 12 years with a base deficit (0 to -30 mEq/L) recorded from the emergency depart-ment. Age, presence of a severe closed head injury, and base deficit were analyzed with respect to mortality and other indicators of injury severity. Results. A total of 515 patients constituted the study group. Base deficit less than -4 mEq/L (p < 0.001) and the presence of a closed head injury (odds ratio, 3.8; p < 0.05) were predictors of mortality. For the group, an admission base deficit of -8 mEq/L, corresponded to a probability of mortality of 25%. Significant correlations were found between base deficit and emergency department systolic blood pressure, Injury Severity Score, and Revised Trauma Score. There was no relationship between age and mortality. Conclusion In injured children, the admission base deficit reflects injury severity and predicts mortality. The probability of mortality increases precipitously in children with a base deficit less than -8 mEq/L, and should alert the clinician to the presence of potentially lethal injuries or uncompensated shock.	Wake Forest Univ, Sch Med, Med Ctr, Dept Gen Surg, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Med Ctr, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA		Chang, MC (corresponding author), Wake Forest Univ, Sch Med, Med Ctr, Dept Gen Surg, Med Ctr Blvd, Winston Salem, NC 27157 USA.						Botha AJ, 1997, INTENS CARE MED, V23, P504, DOI 10.1007/s001340050365; DAVIS JW, 1988, J TRAUMA, V28, P1464, DOI 10.1097/00005373-198810000-00010; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; DAVIS JW, 1991, ANN EMERG MED, V20, P842, DOI 10.1016/S0196-0644(05)81423-4; DUNHAM CM, 1991, CRIT CARE MED, V19, P231, DOI 10.1097/00003246-199102000-00020; Eichelberger M, 1993, PEDIAT TRAUMA PREVEN; Kincaid EH, 1998, J AM COLL SURGEONS, V187, P384, DOI 10.1016/S1072-7515(98)00202-6; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; MACKERSIE RC, 1989, ARCH SURG-CHICAGO, V124, P809; Rating the severity of tissue damage. I, 1971, JAMA-J AM MED ASSOC, V215, P277; RUTHERFORD EJ, 1992, J TRAUMA, V33, P417, DOI 10.1097/00005373-199209000-00014; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; SHOEMAKER WC, 1971, SURG GYNECOL OBSTETR, V132, P1033; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; SIGGAARD.O, 1971, SCAND J CLIN LAB INV, V27, P239, DOI 10.3109/00365517109080214	15	36	37	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2001	51	2					332	335		10.1097/00005373-200108000-00018			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	463DW	WOS:000170462400017	11493795				2022-02-06	
J	Stancin, T; Kaugars, AS; Thompson, GH; Taylor, HG; Yeates, KO; Wade, SL; Drotar, D				Stancin, T; Kaugars, AS; Thompson, GH; Taylor, HG; Yeates, KO; Wade, SL; Drotar, D			Child and family functioning 6 and 12 months after a serious pediatric fracture	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	60th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	OCT 11-15, 2000	SAN ANTONIO, TX	Amer Assoc Surg Trauma		injuries; fractures; child and family outcomes	TRAUMATIC BRAIN INJURY; ACQUIRED LIMB DEFICIENCIES; SEVERITY SCALE; HEAD-INJURY; MORBIDITY; BURDEN; STRESS; IMPACT	Background: Previous findings indicate that pediatric fractures can have adverse consequences for child adjustment and family functioning immediately after injury. However, longer term effects of the fractures are unknown. The purposes of the present prospective study were to examine the child and family outcomes of pediatric traumatic fractures at 6 months and 1 year after injury, and to identify injury and treatment factors associated with these outcomes. Methods: We evaluated 57 children 6 to 12 years of age with traumatic fractures requiring hospitalization. Using standardized measures and parent interview, we obtained measures of pre- and postinjury child and family functioning. Results: Although outcomes were primarily positive at 1 year after injury, child functional limitations and family stress were observed up to 6 months after injury. Lower extremity fractures had a more negative impact on families across all three assessment points. Children with fracture interventions that involved prolonged immobilization had more functional limitations at 6 months than children who were ambulatory. Family burden was higher at 1 month for the immobilized children, but not at later follow-up, Conclusion: some children and families experience adverse effects during the year after a serious pediatric fracture, especially if sustained in a lower extremity, Fracture stabilization that allows for greater ambulation may offer some benefits related to functional outcomes and family impact.	Metrohlth Med Ctr, Dept Pediat, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Psychol, Cleveland, OH 44106 USA; Univ Hosp, Dept Orthopaed, Cleveland, OH USA; Case Western Reserve Univ, Sch Med, Cleveland, OH USA; Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Childrens Hosp, Columbus, OH 43205 USA; Univ Cincinnati, Dept Phys Med & Rehabil Med, Cincinnati, OH USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA		Stancin, T (corresponding author), Metrohlth Med Ctr, Dept Pediat, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	tstancin@metrohealth.org	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ 390611] Funding Source: Medline		Achenbach TM, 1991, MANUAL CHILD BEHAV C; BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Ciccetti D., 1984, VINELAND ADAPTIVE BE; CRAMER KE, 1995, CLIN ORTHOP RELAT R, P125; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; EISEN M, 1980, RAND CORPORATION PUB; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GALLAGHER SS, 1984, AM J PUBLIC HEALTH, V74, P1340, DOI 10.2105/AJPH.74.12.1340; HARRIS BH, 1989, J PEDIATR SURG, V24, P103, DOI 10.1016/S0022-3468(89)80311-2; HUGHES BF, 1995, J PEDIATR ORTHOPED, V15, P457, DOI 10.1097/01241398-199507000-00009; Joy D, 2000, J TRAUMA, V48, P490, DOI 10.1097/00005373-200003000-00020; KASHANI JH, 1981, BRIT J PSYCHIAT, V138, P21, DOI 10.1192/bjp.138.1.21; Loder R T, 1987, J Orthop Trauma, V1, P48; LODER RT, 1995, J PEDIATR ORTHOPED, V15, P41, DOI 10.1097/01241398-199501000-00010; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; MAYER T, 1984, J TRAUMA, V24, P31, DOI 10.1097/00005373-198401000-00004; MOOS R, 1988, LIFE STRESSORS SOCIA; *NAT CTR HLTH STAT, 1980, US DEP HHS SER, V10; Shindi J, 1983, Int J Soc Psychiatry, V29, P292, DOI 10.1177/002076408302900409; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; Stein R, 1985, PACTS PAPERS AECOM T; STEVENS G, 1981, SOC SCI RES, V10, P364, DOI 10.1016/0049-089X(81)90011-9; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; VARNI JW, 1989, PEDIATRICS, V84, P323; VARNI JW, 1989, J DEV BEHAV PEDIATR, V10, P13; VARNI JW, 1989, J PEDIATR PSYCHOL, V14, P515, DOI 10.1093/jpepsy/14.4.515; WADE S, 1995, J PEDIATR PSYCHOL, V20, P737, DOI 10.1093/jpepsy/20.6.737; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; YEATES KO, 1977, J INT NEUROL SOC, V3, P617	36	36	36	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2001	51	1					69	76		10.1097/00005373-200107000-00011			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	453FL	WOS:000169905800012	11468470				2022-02-06	
J	Schoenberger, NE; Shiflett, SC; Esty, ML; Ochs, L; Matheis, RJ				Schoenberger, NE; Shiflett, SC; Esty, ML; Ochs, L; Matheis, RJ			Flexyx neurotherapy system in the treatment of traumatic brain injury: An initial evaluation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alternative medicine; biofeedback; brain injuries; neurotherapy	EEG BIOFEEDBACK; DISORDERS	Objective: To conduct a preliminary experimental evaluation of the potential efficacy of Flexyx Neurotherapy System (FNS), an innovative electroencephalography (EEG)-based therapy used clinically in the treatment of traumatic brain injury (TBI). Participants: Twelve people aged 21 to 53 who had experienced mild to moderately severe closed head injury at least 12 months previously and who reported substantial cognitive difficulties after injury which interfered with their functioning. Design: Participants were randomly assigned to an immediate treatment group or a wait-list control group and received 25 sessions of FNS treatment. They were assessed at pretreatment, posttreatment, and follow-up with standardized neuropsychological and mood measures. Results: Comparison of the two groups on outcome measures indicated improvement after treatment for participants' reports of depression, fatigue, and other problematic symptoms, as well as for some measures of cognitive functioning. Most participants experienced meaningful improvement in occupational and social functioning. Conclusion: On the basis of these results, FNS appears to be a promising new therapy for TBI and merits more extensive evaluation.	Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA; Beth Israel Med Ctr, Ctr Hlth & Healing, New York, NY 10003 USA; Neurotherapy Ctr Washington, Chevy Chase, MD USA; Flexyx LLC, Walnut Creek, CA USA		Schoenberger, NE (corresponding author), POB 18082, Memphis, TN 38181 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U24HD032994] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U24 HD32994] Funding Source: Medline		Alhambra M. A., 1995, J NEUROTHERAPY, V1, P39; AYERS ME, 1987, NATL HEAD INJURY SYL, P380; Byers AP., 1995, J NEUROTHERAPY, V1, P22; Carter J.L., 1993, TEXAS RES, V4, P65; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; DULEY JF, 1993, CLIN NEUROPSYCHOL, V7, P29, DOI DOI 10.1080/13854049308401885; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hoffman D. A., 1995, J NEUROTHERAPY, V1, P14, DOI [10.1300/ J184v01n01_03, DOI 10.1300/J184V01N01_03]; Kumano H, 1996, BIOFEEDBACK SELF-REG, V21, P323, DOI 10.1007/BF02214432; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Linden M, 1996, BIOFEEDBACK SELF-REG, V21, P35, DOI 10.1007/BF02214148; LUBAR JF, 1995, BIOFEEDBACK SELF-REG, V20, P83, DOI 10.1007/BF01712768; LUBAR JF, 1991, BIOFEEDBACK SELF-REG, V16, P201, DOI 10.1007/BF01000016; LUBAR JO, 1984, BIOFEEDBACK SELF-REG, V9, P1, DOI 10.1007/BF00998842; McDowell I., 1996, MEASURING HLTH GUIDE; OCHS L, 1994, EEG DRIV STIM MILD H; OCHS L, 1994, EEG DRIV STIM HET HE; Packard RC, 1997, HEADACHE Q-CURR TREA, V8, P348; Patrick G.J., 1996, J NEUROTHER, V1, P27, DOI DOI 10.1300/J184V01N04_04; Rossiter T. R., 1995, J NEUROTHERAPY, V1, P48, DOI [DOI 10.1300/J184V01N01_, DOI 10.1300/J184V01N0107]; Shapiro D M, 1990, Arch Clin Neuropsychol, V5, P405, DOI 10.1016/0887-6177(90)90018-K; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Thatcher RW, 2000, CLIN ELECTROENCEPHAL, V31, P38, DOI 10.1177/155005940003100110; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; WALTER VJ, 1949, ELECTROEN CLIN NEURO, V1, P57, DOI 10.1016/0013-4694(49)90011-5; WILSON BA, 1990, TRAUMATIC BRAIN INJU, P121	26	36	36	0	7	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	2001	16	3					260	274		10.1097/00001199-200106000-00005			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	442YY	WOS:000169313600005	11346448				2022-02-06	
J	Dunn, LT; Stewart, E; Murray, GD; Nicoll, JAR; Teasdale, GM				Dunn, LT; Stewart, E; Murray, GD; Nicoll, JAR; Teasdale, GM			The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: A preliminary study	NEUROSURGERY			English	Article						apolipoproteins; outcome; subarachnoid hemorrhage	CEREBRAL AMYLOID ANGIOPATHY; E EPSILON-2 ALLELE; HIGH-FREQUENCY; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; CEREBROVASCULAR-DISEASE; E POLYMORPHISM; APOE GENOTYPE; SCALE; STROKE	OBJECTIVE: Possession of an apolipoprotein E (APOE)epsilon4 allele has been shown to be associated with a poor outcome after closed head injury and spontaneous intracerebral hemorrhage but not after ischemic stroke. This study assessed the influence of the APOE genotype on outcome in patients admitted to a neurosurgical unit with spontaneous subarachnoid hemorrhage. METHODS: A total of 100 patients with spontaneous subarachnoid hemorrhage were studied. Four patients were excluded because the diagnosis of subarachnoid hemorrhage was not confirmed. The incidence of rehemorrhage and delayed ischemia and the outcome at 6 months were determined using the Glasgow Outcome Scale. APOE genotypes were determined by polymerase chain reaction and restriction enzyme digestion. RESULTS: Allele frequencies in this patient group were 0.04 for epsilon2, 0.86 for epsilon3, and 0.1 for epsilon4. Of 96 patients, 72 had an aneurysmal hemorrhage and 1 had a hemorrhage from an arteriovenous malformation. In 14 patients, the results of angiography were negative, and in 9, no angiogram was performed. Of the 96 patients, 20 had one or more epsilon4 allele. Outcome at 6 months was no worse in patients with one or more epsilon4 allele than in those with no epsilon4 allele (odds ratio, 0.98; 95% confidence interval, 0.35-2.74). None of the 12 patients who experienced delayed ischemic deterioration had an epsilon4 allele. Of the 20 patients with an epsilon4 allele, 3 had a rehemorrhage, as compared with 6 of 76 patients without an epsilon4 allele. CONCLUSION: There was underrepresentation of the epsilon4 allele in this group when compared with previously studied cases of subarachnoid hemorrhage with a fatal outcome and with the general population. This suggests that patients with the epsilon4 allele who have a subarachnoid hemorrhage are less likely to be admitted to a neurosurgical unit. This study does not support an association between possession of an epsilon4 allele and poor outcome in patients admitted to a neurosurgical unit with spontaneous subarachnoid hemorrhage, although the wide confidence interval does not preclude a clinically relevant association between APOE genotype and outcome. The findings indicate that an association between genotype and the development of delayed ischemic complications after subarachnoid hemorrhage may be possible.	Univ Glasgow, Dept Neurosurg, Glasgow, Lanark, Scotland; Univ Glasgow, Dept Neuropathol, Glasgow, Lanark, Scotland; Univ Edinburgh, Dept Community Hlth Sci, Edinburgh, Midlothian, Scotland		Dunn, LT (corresponding author), So Gen Hosp, Inst Neurol Sci, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland.		; Nicoll, James/I-9253-2017	Dunn, Laurence/0000-0002-8990-4334; Nicoll, James/0000-0002-9444-7246; Murray, Gordon/0000-0001-9866-4734			ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Basun H, 1996, STROKE, V27, P1310, DOI 10.1161/01.STR.27.8.1310; Corder EH, 1996, ARCH NEUROL-CHICAGO, V53, P418, DOI 10.1001/archneur.1996.00550050048022; CUMMING AM, 1984, CLIN GENET, V25, P310; DRAKE CG, 1988, J NEUROSURG, V68, P985; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GREENBERG SM, 1995, ANN NEUROL, V38, P254, DOI 10.1002/ana.410380219; Greenberg SM, 1996, STROKE, V27, P1333, DOI 10.1161/01.STR.27.8.1333; JENNETT B, 1975, LANCET, V1, P480; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; McCarron MO, 1999, NEUROLOGY, V53, P1308, DOI 10.1212/WNL.53.6.1308; McCarron MO, 2000, ARCH NEUROL-CHICAGO, V57, P1480, DOI 10.1001/archneur.57.10.1480; McCarron MO, 1998, STROKE, V29, P1882, DOI 10.1161/01.STR.29.9.1882; McCarron MO, 1998, NEUROSCI LETT, V247, P45, DOI 10.1016/S0304-3940(98)00286-9; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; Nicoll JAR, 1997, ANN NEUROL, V41, P716, DOI 10.1002/ana.410410607; Nicoll JAR, 1996, ANN NEUROL, V39, P682, DOI 10.1002/ana.410390521; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204	27	36	38	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	2001	48	5					1006	1010		10.1097/00006123-200105000-00007			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	424GB	WOS:000168223000017	11334266				2022-02-06	
J	Bara, BG; Cutica, I; Tirassa, M				Bara, BG; Cutica, I; Tirassa, M			Neuropragmatics: Extralinguistic communication after closed head injury	BRAIN AND LANGUAGE			English	Article						neuropragmatics; closed head injury; intentional communication; extralinguistic communication	LANGUAGE; DISCOURSE; ABILITY	This work is concerned with the decay of communicative abilities after head trauma. A protocol composed of 16 videotaped scenes was devised in order to investigate the comprehension of several types of communicative actions realized with extralinguistic means, like pointing or clapping. The protocol was administered to 30 closed-head-injured individuals. The results showed that performance decreased from simple standard acts to complex standard acts, deceits, and ironies. The subjects' performance was worse with the scenes reproducing failing, rather than successful, communicative actions. The results are compared with those we previously obtained with a linguistic protocol. A theory of the cognitive processes underlying intentional communication is outlined and used to explain the results. (C) 2001 Academic Press.	Univ Turin, Ctr Cognit Sci, I-10123 Turin, Italy		Bara, BG (corresponding author), Univ Turin, Ctr Cognit Sci, Via Lagrange 3, I-10123 Turin, Italy.	bara@psych.unito.it		CUTICA, ILARIA/0000-0003-2749-0719			AIRENTI G, 1993, COGNITIVE SCI, V17, P197, DOI 10.1207/s15516709cog1702_2; AIRENTI G, 1993, J PRAGMATICS, V20, P303, DOI 10.1016/0378-2166(93)90055-T; Austin JL., 1962, DO THINGS WORDS, V2; Bara BG, 2000, BRAIN COGNITION, V43, P21; Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; Bara BG, 1999, PROCEEDINGS OF THE TWENTY FIRST ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P55; Bara BG, 1999, P 3 EUR C COGN SCI E; BARA BG, 2000, IN PRESS BRAIN LANGU; Caplan D., 1992, LANGUAGE STRUCTURE P; Clark Herbert H., 1996, USING LANGUAGE; COLOMBETTI M, 1993, ARTIF INTELL, V62, P341, DOI 10.1016/0004-3702(93)90082-M; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; FEYEREISEN P, 1982, BRAIN LANG, V16, P191, DOI 10.1016/0093-934X(82)90083-9; Foldi N.S., 1983, LANGUAGE FUNCTIONS B; Grice P., 1989, STUDIES WAY WORDS; HOLLAND AL, 1982, J SPEECH HEAR DISORD, V47, P50, DOI 10.1044/jshd.4701.50; JOANETTE Y, 1991, DISCOURSE ABILITY BR; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; PAGE EB, 1963, J AM STAT ASSOC, V58, P216, DOI 10.2307/2282965; PETITTO LA, 1987, COGNITION, V27, P1, DOI 10.1016/0010-0277(87)90034-5; Poizner H., 1987, WHAT HANDS REVEAL BR; REITER R, 1980, ARTIF INTELL, V13, P81, DOI 10.1016/0004-3702(80)90014-4; Searle J.R., 1979, EXPRESSION MEANING; Searle John R., 1969, SPEECH ACTS ESSAY PH; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHERRATT SM, 1990, APHASIOLOGY, V4, P539, DOI 10.1080/02687039008248506; STEMMER B, 1994, BRAIN LANG, V46, P565, DOI 10.1006/brln.1994.1031; Tirassa M, 1999, BRAIN LANG, V68, P419, DOI 10.1006/brln.1999.2121; TIRASSA M, 1997, P 2 EUR C COGN SCI E, P103; Wilson D., 1986, RELEVANCE COMMUNICAT; WYCKOFF LH, 1984, THESIS U FLORIDA	33	36	36	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	APR	2001	77	1					72	94		10.1006/brln.2000.2430			23	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	416BP	WOS:000167760100006	11247657	Green Submitted			2022-02-06	
J	Morris, KC				Morris, KC			Psychological distress in carers of head injured individuals: the provision of written information	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; FAMILY NEEDS; FOLLOW-UP; RELATIVES; CAREGIVERS; QUESTIONNAIRE; HEALTH; STRESS; SCALE	Since the early 1970s, researchers have expressed concern about the emotional well- being of family members after traumatic brain injury (TBI), and it is now widely acknowledged that TBI has longterm effects on the patient and relatives alike. Researchers have found a substantial number of relatives caring for head injured patients to show significant levels of anxiety and depression, and have emphasized the need for information for relatives on the prognosis of head injury. There are, however, very few studies that have investigated the usefulness of giving literature to relatives. Using a longitudinal, mixed variable, within- and between- subject design, the present study investigated the effect of an information booklet on levels of distress in a group of 34 carers of individuals with TBI. These results are discussed, and the proposal made that an information booklet such as the one used in the present study should become an integral part of the discharge procedure for relatives of individuals who have sustained a head injury.	Tayside Area Clin Psychol Dept, Dundee, Scotland		Morris, KC (corresponding author), Tayside Area Clin Psychol Dept, Wedderburn House, Dundee, Scotland.						ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BRUMFITT S, 1994, APHASIOLOGY, V8, P583, DOI 10.1080/02687039408248683; Eisner J, 1989, Brain Inj, V3, P79, DOI 10.3109/02699058909008078; ELLIS DA, 1979, BRIT MED J, V1, P456, DOI 10.1136/bmj.1.6161.456; Frosch S, 1997, BRAIN INJURY, V11, P891; GENTLEMAN D, 1996, EUR J NEUROL S2, V3, P52; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; GRONWALL D, 1997, HEAD INJURY FACTS GU; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Junque C, 1997, BRAIN INJURY, V11, P251, DOI 10.1080/026990597123557; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; Leathem J, 1996, BRAIN INJURY, V10, P27; LEY P, 1990, COMMUNICATING PATIEN; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LIVINGSTON MG, 1986, BRIT MED J, V293, P742, DOI 10.1136/bmj.293.6549.742; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCKINLAY WW, 1990, QUESTIONNAIRE RELATI; MERRITT KL, 1990, PSYCHOL REP, V67, P129, DOI 10.2466/PR0.67.5.129-130; NOVACK TA, 1991, J HEAD TRAUMA REHAB, V6, P69, DOI DOI 10.1097/00001199-199112000-00014; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1995, TRAUMATIC BRAIN INJU, P167; Panting A, 1972, REHABILITATION, V38, P33; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; PONSFORD J, 1996, TRAUMATIC BRAIN INJU; ROSE FD, 1996, BRAIN INJURY IMPROVE; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; SINGER GHS, 1994, J HEAD TRAUMA REHAB, V9, P38, DOI DOI 10.1097/00001199-199412000-00006; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Toner H, 1987, BRIT J CLIN SOCIAL P, V5, P24; TURVEY T, 1985, NEW DEV CLIN PSYCHOL, P234; WALLACE LM, 1986, BRIT J CLIN PSYCHOL, V25, P111, DOI 10.1111/j.2044-8260.1986.tb00679.x; Wiles R, 1998, J ADV NURS, V28, P794, DOI 10.1046/j.1365-2648.1998.00709.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	36	38	0	5	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2001	15	3					239	254		10.1080/02699050010004068			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	407ZM	WOS:000167302100004	11260772				2022-02-06	
J	Togher, L				Togher, L			Discourse sampling in the 21st century	JOURNAL OF COMMUNICATION DISORDERS			English	Article						discourse; neurogenic communication disorder; linguistics; brain damage; functional therapy	CLOSED HEAD-INJURY; NARRATIVE DISCOURSE; INFORMATION; CHILDREN; ABILITY	This paper examines the importance of evaluating discourse in individuals with a neurogenic language disorder. Discourse analysis is acknowledged as an important tool for speech-language pathologists, although it is often not the assessment tool of choice due to its apparent time-consuming nature and the overwhelming number of options available. The wide range of analyses available to clinicians such as the number of T-units and total words produced or Pragmatic Protocol checklists make it difficult to choose assessment measures. Even more difficult is the decision of where to direct treatment efforts. This paper aims to show that there are a number of levels of discourse analysis available to clinicians and that it is possible to sample a number of different genres in a clinical setting. The significance of the communication partner's contribution is discussed, particularly with regard to the limitations of the therapeutic interaction and the need to assess clients with a range of communication partners. The discourse opportunities we make available to people with communication problems will influence what is possible for them. To achieve this, the benefits of a theory of linguistic analysis, namely, Systemic Functional Linguistics (SFL) [Halliday, M. A. K. (1994). An introduction to functional grammar (2nd ed.). London: Edward Arnold.] will be explored. (C) 2001 Elsevier Science Inc. All rights reserved.	Univ Sydney, Fac Hlth Sci, Sch Commun Sci & Disorders, Sydney, NSW 2141, Australia		Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, Sch Commun Sci & Disorders, POB 170, Sydney, NSW 2141, Australia.	l.tougher@cchs.usyd.edu.au	Togher, Leanne/AAC-7083-2019	Togher, Leanne/0000-0002-4518-6748			AMRTIN J, 2000, EVALUATION TEXT, P142; Armstrong E. M, 1993, APHASIA TREATMENT WO, P263; Atkinson J.Maxwell., 1984, STRUCTURES SOCIAL AC; BERRY M, 1981, STUDIES DISCOURSE AN, P120; Bloom R. L., 1994, DISCOURSE ANAL APPL; Boles L, 1998, APHASIOLOGY, V12, P547, DOI 10.1080/02687039808249557; BROWNELL HH, 1993, NARRATIVE DISCOURSE; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Cherney L. R., 1998, ANAL DISCOURSE COMMU; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; EGGINS S, 1997, ANAL CASUAL CONSERVA; Eggins S., 1994, INTRO SYSTEMIC FUNCT; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; Enderby P., 1997, THERAPY OUTCOME MEAS; Fairclough N., 1992, DISCOURSE SOCIAL CHA; FERGUSON A, 1994, APHASIOLOGY, V8, P143, DOI 10.1080/02687039408248647; FERGUSON A, 1998, COMMUNICATION; FERGUSON A, 1998, SPEECH PATH AUSTR NA; FRATTALI C, 1997, MEASURING OUTCOMES S; GALLARD L, UNPUB MAKING MOST ME; Gerot L., 1994, MAKING SENSE FUNCTIO; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Halliday M., 2004, INTRO FUNCTIONAL GRA; Halliday M. A. K., 1985, INTRO FUNCTIONAL GRA; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hymes D., 1974, FDN SOCIOLINGUISTICS; JOANETTE Y, 1990, DISCOURSE ABILITY BR; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LILES BZ, 1995, J SPEECH HEAR RES, V38, P415, DOI 10.1044/jshr.3802.415; Martin J. R, 1997, WORKING FUNCTIONAL G; Martin J. R., 1992, ENGLISH TEXT SYSTEM; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; MORTENSEN L, 1992, J NEUROLINGUIST, V7, P309, DOI 10.1016/0911-6044(92)90021-N; Penn C, 1988, Brain Inj, V2, P3, DOI 10.3109/02699058809150928; Perkins M. R., 1995, CASE STUDIES CLIN LI, P293; Poynton C., 1985, LANGUAGE GENDER MAKI; Prigatano G. P., 1985, LANG SCI, V7, P217, DOI [10.1016/S0388-0001(85)80020-6, DOI 10.1016/S0388-0001(85)80020-6]; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Rothery J., 1994, EXPLORING LIT SCH EN; SLADE D, 1994, AUSTR REV APPL LIN S, P47; Thompson Geoffrey., 1996, INTRO FUNCTIONAL GRA; THOMSON J, 1997, SPEECH PATH AUSTR NA; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1999, APHASIOLOGY, V13, P709, DOI 10.1080/026870399401821; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Togher L, 2000, APHASIOLOGY, V14, P365, DOI 10.1080/026870300401414; TOGHER L, 1999, BRAIN DAM B, P113; ULATOWSKA HK, 1981, BRAIN LANG, V13, P345, DOI 10.1016/0093-934X(81)90100-0; VENTOLA E, 1979, J PRAGMATICS, V3, P267, DOI 10.1016/0378-2166(79)90034-1; VENTOLA E, 1987, STRUCTURE SOCIAL INT; WECKERT C, UNPUB MAKING MOST ME; Wirz S.L, 1990, REVISED EDINBURGH FU	58	36	37	2	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	JAN-APR	2001	34	1-2					131	150		10.1016/S0021-9924(00)00045-9			20	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	416PZ	WOS:000167790500009	11322564	Green Submitted			2022-02-06	
J	Hoffman, SW; Rzigalinski, BA; Willoughby, KA; Ellis, EF				Hoffman, SW; Rzigalinski, BA; Willoughby, KA; Ellis, EF			Astrocytes generate isoprostanes in response to trauma or oxygen radicals	JOURNAL OF NEUROTRAUMA			English	Article						antioxidants; cultured astrocytes; deferoxamine; 8-epi-prostaglandin; hydroxyl radical; lipid peroxidation; trauma	STRETCH-INDUCED INJURY; BRAIN INJURY; SUPEROXIDE-DISMUTASE; ARACHIDONIC-ACID; PROSTAGLANDINS; CELLS; NONCYCLOOXYGENASE; METABOLISM; RECOVERY; F2-ALPHA	Previous studies have shown that oxygen radical scavengers prevent the reduced cerebral blood flow that occurs following experimental traumatic brain injury. The exact chemical species responsible for the posttraumatic reduction in flow is unknown. We tested whether isoprostanes, which are formed by non-cyclooxygenase-dependent free radical attack of arachidonic acid and are vasoconstrictors of the cerebral circulation, are increased in astrocytes following stretch-induced trauma or injury with a free radical generating system. Isoprostane (8-epi-prostaglandin F-2 alpha) was analyzed in cells and in media by immunoassay, Confluent rat cortical astrocytes in culture were injured by a hydroxyl radical generating system consisting of hydrogen peroxide and ferrous sulfate or by rapid stretch of astrocytes grown on a deformable silastic membrane. Some cells were treated with the iron chelator deferoxamine for 1 h before injury. The hydroxyl generating system caused free and cell-bound isoprostanes to increase to more than 400% of control. After trauma, free and membrane bound isoprostanes increased to 321 +/- 34% and 229 +/- 23% of control, respectively, and posttraumatic increases were prevented by deferoxamine. Since astrocytes are in close proximity to cerebral vessels, posttraumatic free radical formation may increase the formation of isoprostanes, which in turn produce vasoconstriction and decrease cerebral blood flow.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA		Ellis, EF (corresponding author), Box 980613,MCV Stn, Richmond, VA 23298 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-07288, NS-27214] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027214] Funding Source: NIH RePORTER		AHMED SM, 2000, IN PRESS J NEUROCHEM; AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; Aoshima H, 1997, BBA-LIPID LIPID MET, V1345, P35, DOI 10.1016/S0005-2760(96)00159-2; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; Ferrari R, 1996, J CARDIOVASC PHARM, V28, pS1; FUKUNAGA M, 1993, AM J PHYSIOL, V264, pC1619, DOI 10.1152/ajpcell.1993.264.6.C1619; Hall CB, 1993, CONT PEDIAT, V10, P92; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hoffman SW, 1996, J NEUROSCI METH, V68, P133; Hoffman SW, 1997, STROKE, V28, P844, DOI 10.1161/01.STR.28.4.844; KAYGANICHHARRISON KA, 1993, J LIPID RES, V34, P1229; Lamb RG, 1997, J NEUROCHEM, V68, P1904; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Mobert J, 1997, J CARDIOVASC PHARM, V29, P789, DOI 10.1097/00005344-199706000-00012; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; MORRIS HC, 1992, THEOR PSYCHOL, V2, P89, DOI 10.1177/0959354392021005; MORROW JD, 1991, ADV PROSTAG THROMB L, V21, P125; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; MORROW JD, 1990, ANAL BIOCHEM, V184, P1, DOI 10.1016/0003-2697(90)90002-Q; MUIR JK, 1995, J NEUROTRAUM, V12, P179, DOI 10.1089/neu.1995.12.179; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; PerezPinzon MA, 1997, BRAIN RES, V754, P163, DOI 10.1016/S0006-8993(97)00066-8; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Schapira AHV, 1996, CURR OPIN NEUROL, V9, P260, DOI 10.1097/00019052-199608000-00003; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95	29	36	38	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAY	2000	17	5					415	420		10.1089/neu.2000.17.415			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	316BB	WOS:000087146500004	10833060				2022-02-06	
J	Ylvisaker, M; Feeney, T				Ylvisaker, M; Feeney, T			Reflections on Dobermanns, poodles, and social rehabilitation for difficult-to-serve individuals with traumatic brain injury	APHASIOLOGY			English	Article							CLOSED-HEAD-INJURY; FOLLOW-UP; BEHAVIORAL MOMENTUM; FRONTAL-LOBE; CHILDREN; COMPREHENSION; DISABILITIES; METAPHOR; DAMAGE; INTERVENTIONS		Coll St Rose, Dept Commun Disorders, Albany, NY USA; Wildwood Inst, Wildwood TBI Behav Resource Project, Schenectady, NY USA		Ylvisaker, M (corresponding author), 1171 Van Antwerp Rd, Schenectady, NY 12309 USA.						ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Alderman N, 1996, NEUROPSYCHOL REHABIL, V6, P161, DOI 10.1080/713755505; Anderson, 1989, TRANSFER COGNITIVE S; BAER DM, 1987, J APPL BEHAV ANAL, V20, P313, DOI 10.1901/jaba.1987.20-313; BANNERMAN DJ, 1990, J APPL BEHAV ANAL, V23, P79, DOI 10.1901/jaba.1990.23-79; BARKLEY RA, 1987, DEFIANT CHILDREN CLI; Benson D.F., 1986, FRONTAL LOBES; BILLOW RM, 1975, DEV PSYCHOL, V11, P415, DOI 10.1037/h0076668; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; BOND MR, 1990, REHABILITATION ADULT; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROWN F, 1993, EDUC TRAIN MENT RET, V28, P318; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Carr EG, 1998, ANTECEDENT CONTROL, P3; CARR EG, 1994, COMMUNICATION BASED; CARR EG, 1997, POSITIVE BEHAV SUPPO, P403; CHILDS KE, 1994, J APPL BEHAV ANAL, V27, P7, DOI 10.1901/jaba.1994.27-7; CONGER JJ, 1984, ADOLESCENCE YOUTH; CZIKSZENTMILHAL.M, 1984, BEING ADOLESCENT; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DAMASIO AR, 1994, DESCARTESERROR; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; FEENEY TJ, 1997, CHILDREN ACQUIRED BR, P229; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; Fletcher JM, 1995, HDB PEDIAT PSYCHOL, P362; FOWLER R, 1996, OREGON C MONOGRAPH, V8, P137; Frankl V., 1984, MANS SEARCH MEANING; GARDNER H, 1974, CHILD DEV, V45, P84, DOI 10.1111/j.1467-8624.1974.tb00562.x; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HALLOWELL EM, 1994, DRIVEN DISTRACTION; Harchik A E, 1993, Ann Clin Psychiatry, V5, P151, DOI 10.3109/10401239309148979; HARLAN D, 1994, MAPPING MOTIVATIONAL; Johnson M., 1998, PHILOS FLESH EMBODIE; KAVALE K, 1983, J LEARN DISABIL, V16, P165, DOI 10.1177/002221948301600307; KENNEDY CH, 1995, J APPL BEHAV ANAL, V28, P97, DOI 10.1901/jaba.1995.28-97; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Lakoff G, 2008, METAPHORS WE LIVE; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; LEWIN J, 1998, COLLABORATIVE BRAIN; LEWIS L, 1990, J NERV MENT DIS, V178, P69, DOI 10.1097/00005053-199002000-00001; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; MACE FC, 1990, J EXP ANAL BEHAV, V54, P163, DOI 10.1901/jeab.1990.54-163; MACE FC, 1988, J APPL BEHAV ANAL, V21, P123, DOI 10.1901/jaba.1988.21-123; Mace FC, 1997, J APPL BEHAV ANAL, V30, P1, DOI 10.1901/jaba.1997.30-1; Mann L, 1979, TRAIL PROCESS HIST P; MCINTOSH R, 1991, J LEARN DISABIL, V24, P451, DOI 10.1177/002221949102400802; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Nippold M., 1998, LATER LANGUAGE DEV S; PEARSON BZ, 1990, J CHILD LANG, V17, P185, DOI 10.1017/S0305000900013179; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; POLLACK I, 1994, ED DIMENSIONS ACQUIR, P303; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Robinson TR, 1999, J EDUC PSYCHOL, V91, P195, DOI 10.1037/0022-0663.91.2.195; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; Skinner BF., 1938, BEHAV ORGANISMS EXPT; STUSS DT, IN PRESS MEMORY CONS; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; Thomsen I V, 1987, Brain Inj, V1, P131, DOI 10.3109/02699058709034452; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WAGGONER JE, 1985, CHILD DEV, V56, P1156, DOI 10.2307/1130230; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; *WHO, 1998, COMM LANG FUNCT DIS; WIENER J, 1998, LEARNING DISABILITIE, V12, P40; World Health Organization, 1980, INT CLASS IMP DIS HA; Ylvisaker M., 1998, COLLABORATIVE BRAIN; YVLISAKER M, 1999, CLIN PRACTICE MANAGE, P117; YVLISAKER M, 1995, SEMINARS SPEECH LANG, V16, P32; YVLISAKER M, 1998, TRAUMATIC BRAIN INJU, P271; YVLISAKER M, 1996, SEMINARS SPEECH LANG, V17, P217; YVLISAKER M, 1987, COMMUNITY REENTRY HE; YVLISAKER M, 1998, TRAUMATIC BRAIN INJU, P221; YVLISAKER M, 1985, CLIN MANAGEMENT NEUR, P243; YVLISAKER M, 1994, TOP LANG DISORD, V15, P37; ZARAGOZA P, 1991, 42ND ANN M EUR ASS A, V1, P260; [No title captured], DOI DOI 10.1097/00001199-198812000-00004; [No title captured]	82	36	38	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	APR	2000	14	4					407	431		10.1080/026870300401432			25	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	315AV	WOS:000087091200005					2022-02-06	
J	Grandas, OH; Klar, M; Goldman, MH; Filston, HC				Grandas, OH; Klar, M; Goldman, MH; Filston, HC			Deep venous thrombosis in the pediatric trauma population: an unusual event: Report of three cases	AMERICAN SURGEON			English	Article; Proceedings Paper	67th Annual Meeting of the Southeastern Surgical Congress	FEB 13-17, 1999	TAMPA, FLORIDA	SE Surg Congress			ACTIVATED PROTEIN-C; VEIN THROMBOSIS; PULMONARY-EMBOLISM; RISK-FACTORS; THROMBOEMBOLIC COMPLICATIONS; CHILDREN; RESISTANCE; DIAGNOSIS; ADOLESCENTS; PROPHYLAXIS	The incidence of deep venous thrombosis (DVT) in the pediatric population has been reported to be lower than in adults. Pediatric trauma patients have predisposing risk factors for DVT similar to those in the general trauma population, We reviewed the records of 2746 children under 16 years of age admitted to our Level I pediatric trauma service from 1989 to 1997. Only three cases of DVT were documented, all adolescents. DVT was located in the upper (n = 1) and lower (n = 1) extremity venous system. One patient presented with pulmonary embolism alone without identifiable DVT. Risk factors found were venous system manipulations, including atriocaval shunt, subclavian central line, and hyperinflated medical antishock trousers garment. Therapy consisted of heparin followed by warfarin anticoagulation, A vena cava filter was inserted in one patient for whom systemic anticoagulation was contraindicated, No DVT was seen in 1123 closed head injury patients or 29 spinal cord injury patients without associated risk factors, The thrombotic risk in pediatric trauma patients is low. Routine screening or prophylaxis is not indicated except for patients who are likely to remain immobile for an extended period of time and require prolonged rehabilitation, have venous manipulations, or present with clinical symptoms. Hematologic evaluation in patients with diagnosed DVT is necessary to identify individual risk factors.	Univ Tennessee, Med Ctr, Div Pediat Surg, Knoxville, TN 37920 USA; Univ Tennessee, Med Ctr, Dept Surg, Div Vasc Surg, Knoxville, TN 37920 USA; Univ Tennessee, Grad Sch Med, Dept Surg, Knoxville, TN USA		Grandas, OH (corresponding author), Univ Tennessee, Med Ctr, Dept Surg, Div Vasc Surg, Box U-11,1924 Alcoa Highway, Knoxville, TN 37920 USA.						ANDREW M, 1994, BLOOD, V83, P1251, DOI 10.1182/blood.V83.5.1251.1251; BERMAN D A, 1989, Pediatric Emergency Care, V5, P102; BERNSTEIN D, 1986, AM J DIS CHILD, V140, P667, DOI 10.1001/archpedi.1986.02140210065028; BLANCO A, 1994, AM J HEMATOL, V45, P330, DOI 10.1002/ajh.2830450411; Britt LD, 1996, AM J SURG, V172, P13, DOI 10.1016/S0002-9610(96)00079-7; BURNS GA, 1993, J TRAUMA, V35, P405, DOI 10.1097/00005373-199309000-00012; Criado E, 1997, SURGERY, V122, P578, DOI 10.1016/S0039-6060(97)90131-8; CROYLE PH, 1979, JAMA-J AM MED ASSOC, V241, P827, DOI 10.1001/jama.241.8.827; Dahlback B, 1996, HAEMOSTASIS, V26, P301; DAVID M, 1995, THROMB HAEMOSTASIS, V74, P791; DAVID M, 1993, J PEDIATR-US, V123, P337, DOI 10.1016/S0022-3476(05)81730-5; DENNIS JW, 1993, J TRAUMA, V35, P132, DOI 10.1097/00005373-199307000-00021; HORATTAS MC, 1988, SURGERY, V104, P561; Kahn SR, 1998, ARCH INTERN MED, V158, P2315, DOI 10.1001/archinte.158.21.2315; MancoJohnson MJ, 1997, THROMB HAEMOSTASIS, V78, P710; MCBRIDE WJ, 1994, J TRAUMA, V37, P913, DOI 10.1097/00005373-199412000-00007; MEYER CS, 1995, ANN VASC SURG, V9, P109, DOI 10.1007/BF02015324; NGUYEN LT, 1986, J PEDIATR SURG, V21, P640, DOI 10.1016/S0022-3468(86)80422-5; PETAJA J, 1995, J PEDIATR-US, V127, P103, DOI 10.1016/S0022-3476(95)70266-0; Petaja J, 1997, J CARDIOTHOR VASC AN, V11, P889, DOI 10.1016/S1053-0770(97)90129-4; RADECKI RT, 1994, ARCH PHYS MED REHAB, V75, P248, DOI 10.1016/0003-9993(94)90023-X; ROGERS FB, 1993, J TRAUMA, V35, P637, DOI 10.1097/00005373-199310000-00021; Rohrer MJ, 1996, J VASC SURG, V24, P46, DOI 10.1016/S0741-5214(96)70143-X; Rosendaal FR, 1997, THROMB HAEMOSTASIS, V78, P1; Satiani B, 1997, ANN VASC SURG, V11, P626, DOI 10.1007/s100169900101; Schulman S, 1997, THROMB HAEMOSTASIS, V78, P693; SOBUS KM, 1994, ARCH PHYS MED REHAB, V75, P362, DOI 10.1016/0003-9993(94)90044-2; SOBUS KM, 1993, ARCH PHYS MED REHAB, V74, P547, DOI 10.1016/0003-9993(93)90123-R; SVENSSON PJ, 1994, NEW ENGL J MED, V330, P517, DOI 10.1056/NEJM199402243300801; TRACY T, 1988, J PEDIATR SURG, V23, P529, DOI 10.1016/S0022-3468(88)80362-2; vonScheven E, 1996, J PEDIATR-US, V129, P339, DOI 10.1016/S0022-3476(96)70064-1; ZIONTS LE, 1983, J BONE JOINT SURG AM, V65, P839, DOI 10.2106/00004623-198365060-00018	32	36	36	0	1	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	MAR	2000	66	3					273	276					4	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	298EZ	WOS:000086127500013	10759198				2022-02-06	
J	Stout, CE; Yorkston, KM; Pimentel, JI				Stout, CE; Yorkston, KM; Pimentel, JI			Discourse production following mild, moderate, and severe traumatic brain injury: A comparison of two tasks	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							ADULTS; DEFICITS	The purpose of this study was to examine discourse production in adults with traumatic brain injury (TBI) using a picture description and a story retelling task. Our questions were: (1) do individuals with TBI perform differently from educationally compatible controls, and (2) what is the relationship between severity of initial injury and performance on these tasks? Ninety-four individuals with mild, moderate, or severe TBI and 38 control subjects participated. All subjects with TBI had been referred to speech pathology for treatment, but none had yet returned to his or her former employment. The samples were analyzed on a variety of measures that reflect quantity and efficiency of production. Results suggested some task differences that may be associated with varying cognitive demands. For the picture description task, subjects with TBI spoke more slowly, communicated content at a slower rate, and produced longer mazes than did control subjects. On the other hand, stories produced by individuals with TBI were shorter and contained less content than those produced by controls. There was Little relationship between the severity of the initial injury and performance on a variety of measures of spoken discourse. Implications are discussed for the diagnostic, prognostic, and treatment challenges in this population.	Oklahoma State Univ, Dept Commun Sci & Disorders, Stillwater, OK 74078 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; Eastern Washington Univ, Dept Commun Disorders, Cheney, WA 99004 USA		Stout, CE (corresponding author), Oklahoma State Univ, Dept Commun Sci & Disorders, 120 Hanner Hall, Stillwater, OK 74078 USA.						Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Cherney L. R., 1998, ANAL DISCOURSE COMMU, P1; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Goodglass H, 1983, ASSESSMENT APHASIA R; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Hagen C, 1979, LEVELS COGNITIVE FUN; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; HUNT KW, 1970, MONOGR SOC RES CHILD, V35, P1; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Loban Walter, 1976, LANGUAGE DEV KINDERG; MACLAY H, 1959, WORD, V15, P19, DOI 10.1080/00437956.1959.11659682; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; REEVES J, 1985, FABLES AESOP, P30; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow P, 1997, BRAIN INJURY, V11, P409; UOMOTO JM, 1990, COMMUNICATION DISORD; YORKSTON KM, 1980, J SPEECH HEAR DISORD, V45, P27, DOI 10.1044/jshd.4501.27	21	36	36	0	10	SINGULAR PUBLISHING GROUP INC	SAN DIEGO	401 WEST A ST, STE 325, SAN DIEGO, CA 92101-7904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	2000	8	1					15	25					11	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	290LH	WOS:000085677400003					2022-02-06	
J	Al-Noori, S; Swann, JW				Al-Noori, S; Swann, JW			A role for sodium and chloride in kainic acid-induced beading of inhibitory interneuron dendrites	NEUROSCIENCE			English	Article						varicose swellings; explant cultures; kainate; excitotoxicity; glutamate; sodium channels	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN INJURY; EXCITATORY AMINO-ACIDS; RAT HIPPOCAMPUS; RECEPTOR ACTIVATION; PYRAMIDAL NEURONS; IONIC DEPENDENCE; IN-VITRO; GLUTAMATE; NEUROTOXICITY	Excitotoxic injury of the dendrites of inhibitory interneurons could lead to decreases in their synaptic activation and explain subsequent local circuit hyperexcitability and epilepsy. A hallmark of dendrotoxicity, at least in principal neurons of the hippocampus and cortex, is focal or varicose swellings of dendritic arbors. In experiments reported here, transient (1 h) exposure of hippocampal explant cultures to kainic acid produced marked focal swellings of the dendrites of parvalbumin-immunoreactive pyramidal basket cells in a highly reproducible and dose-dependent manner. AL 5 mM kainic acid, more than half of the immunopositive apical dendrites in area CA, had a beaded appearance, However, the somal volumes of these cells were unaltered by the same treatment. The presence of focal swellings was reversible with kainate washout and was not accompanied by interneuronal cell death. In contrast, exposure to much higher concentrations (300 mM) of kainic acid resulted in the total loss of parvalbumin-positive interneurons from explants. Surprisingly, kainic acid-induced dendritic beading does not appear to be mediated by extracellular calcium. Beading was unaltered in the presence of N-methyl-D-aspartate receptor antagonists, the L-type calcium channel antagonist, nimodipine, cadmium, or by removing extracellular calcium. However, blockade of voltage-gated sodium channels by either tetrodotoxin or lidocaine abolished dendritic beading, while the activation of existing voltage-gated sodium channels by veratridine mimicked the kainic acid-induced dendritic beading. Finally, the removal of extracellular chloride prevented the kainic acid-induced dendritic beading. Thus, we suggest that the movement of Na+ and Cl-, rather than Ca2+, into cells underlies the focal swellings of interneuron dendrites in hippocampus, (C) 2000 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Baylor Coll Med, Cain Fdn Labs, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA		Swann, JW (corresponding author), Baylor Coll Med, Cain Fdn Labs, Houston, TX 77030 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS18309, NS37171] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037171, R01NS018309] Funding Source: NIH RePORTER		ALNOORI S, 1998, NEUR ABSTR, V24, P1933; ALNOORI S, 2000, IN PRESS NEUR ABSTR; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; BEKENSTEIN JW, 1993, SCIENCE, V259, P97, DOI 10.1126/science.8093417; Bernard C, 1998, EPILEPSY RES, V32, P93, DOI 10.1016/S0920-1211(98)00043-6; BEST N, 1993, NEUROSCI LETT, V155, P1, DOI 10.1016/0304-3940(93)90660-D; BINDOKAS VP, 1995, J NEUROSCI, V15, P6999; CHOI DW, 1987, J NEUROSCI, V7, P369; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Colbert CM, 1996, J NEUROSCI, V16, P6676; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; Faddis BT, 1997, J NEUROSCI, V17, P951; FALCONER MA, 1964, ARCH NEUROL-CHICAGO, V10, P233, DOI 10.1001/archneur.1964.00460150003001; FRANCK JE, 1985, BRAIN RES, V329, P309, DOI 10.1016/0006-8993(85)90540-2; FRANCK JE, 1988, J NEUROSCI, V8, P1991; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; FROTSCHER M, 1995, PROG NEUROBIOL, V45, P143, DOI 10.1016/0301-0082(94)00040-O; HAUSER WA, 1984, EPILEPSIA, V25, P666; HILLE B, 1984, CALCIUM CHANNELS ION; Inglefield JR, 1997, HIPPOCAMPUS, V7, P511, DOI 10.1002/(SICI)1098-1063(1997)7:5<511::AID-HIPO7>3.3.CO;2-V; Isokawa M, 1997, J NEUROPHYSIOL, V77, P3355, DOI 10.1152/jn.1997.77.6.3355; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; KATO K, 1991, J PHARMACOL EXP THER, V256, P402; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; MULTANI P, 1994, EPILEPSIA, V35, P728, DOI 10.1111/j.1528-1157.1994.tb02503.x; OBENAUS A, 1993, J NEUROSCI, V13, P4470; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Paul L A, 1986, Adv Neurol, V44, P775; PURPURA DP, 1982, DEV BRAIN RES, V5, P287, DOI 10.1016/0165-3806(82)90128-6; ROTHMAN SM, 1987, NEUROSCIENCE, V22, P471, DOI 10.1016/0306-4522(87)90347-2; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; SIMAN R, 1989, J NEUROSCI, V9, P1579; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; SLOVITER RS, 1985, BRAIN RES BULL, V15, P39, DOI 10.1016/0361-9230(85)90059-0; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; STARMER CF, 1984, BIOPHYS J, V46, P15, DOI 10.1016/S0006-3495(84)83994-6; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Zhang YL, 1999, J NEUROSCI, V19, P3307	46	36	36	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2000	101	2					337	348		10.1016/S0306-4522(00)00384-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	378BX	WOS:000165562800009	11074157				2022-02-06	
J	Baskaya, MK; Dogan, A; Temiz, C; Dempsey, RJ				Baskaya, MK; Dogan, A; Temiz, C; Dempsey, RJ			Application of 2,3,5-triphenyltetrazolium chloride staining to evaluate injury volume after controlled cortical impact brain injury: Role of brain edema in evolution of injury volume	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; brain injury; controlled cortical impact; injury volume; 2,3,5-triphenyltetrazolium chloride (TTC)	CLOSED-HEAD INJURY; CEREBRAL EDEMA; TIME-COURSE; RATS; BARRIER; QUANTIFICATION; ISCHEMIA	A reliable method for measuring injury volume after traumatic brain injury (TBI) is of great importance when studying pharmacological protective agents in the field of head trauma research. Utilization of 2,3,5-triphenyltetrazolium chloride (TTC) has gained extensive acceptance in stroke research and has recently been applied to injury volume measurement in the lateral fluid percussion model. The present study was undertaken to apply this method to the controlled cortical impact (CCI) model and to study the role of brain edema. Male Sprague-Dawley rats were subjected to CCI brain injury at a velocity of 3 m/sec and 1 mm (mild), 2 mm (moderate), and 3 mm (severe injury) deformation, while rats in the control group were subjected to the same surgical procedure but received no injury. Absolute and corrected injury volumes with TTC staining and brain edema measurements with the wet-dry method were evaluated at 1, 2, 3, 4, and 7 days after TBI. The most prominent injury volume in the moderate injury group (2 mm deformation) was seen at postinjury day 1 and 2 (day 1, absolute: 49.1 +/- 5.6, corrected: 40.5 +/- 7.9; day 2, absolute: 46 +/- 6.9, corrected: 40.2 +/- 10.5), whereas the smallest injury volume was found at postinjury day 7 (absolute: 24.9 +/- 7, corrected: 27.4 +/- 7.4). The time course of brain edema studies demonstrates that brain edema formation peaks at postinjury day 1. A statistically significant reduction of injury volume was observed after postinjury day 4. We also observed that due to the presence of brain edema absolute injury volume is more than corrected injury volume in the first 3 days after injury as opposed to injury volume at postinjury day 7. These results suggest that the measurement of injury volume with TTC staining should be corrected for brain edema in the CCI brain injury model.	Louisiana State Univ, Med Ctr, Dept Neurosurg, Shreveport, LA 71130 USA; Univ Wisconsin, Dept Neurol Surg, Madison, WI USA		Baskaya, MK (corresponding author), Louisiana State Univ, Dept Neurosurg, Ctr Hlth Sci, 1501 Kings Highway,POB 33932, Shreveport, LA 71130 USA.		Dogan, Aclan/AAF-8305-2019				Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Baskaya MK, 1997, NEUROSURGERY, V40, P364; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dogan A, 1999, J NEUROCHEM, V72, P765, DOI 10.1046/j.1471-4159.1999.0720765.x; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; Onal MZ, 1997, STROKE, V28, P1060, DOI 10.1161/01.STR.28.5.1060; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47	18	36	38	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	2000	17	1					93	99		10.1089/neu.2000.17.93			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	278WR	WOS:000085012400008	10674761				2022-02-06	
J	Connolly, JF; Mate-Kole, CC; Joyce, BM				Connolly, JF; Mate-Kole, CC; Joyce, BM			Global aphasia: An innovative assessment approach	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							RECEPTIVE VOCABULARY; BRAIN POTENTIALS; SPOKEN SENTENCES; COMPREHENSION; STROKE; WORDS	Objective: To provide an alternative language comprehension assessment strategy for patients unable to be tested with traditional verbally/behaviorally based methods. Design: Event-related brain potentials were recorded from three midline scalp locations to visually and aurally computer-presented sentences, 50% of which were semantically appropriate and 50% semantically incongruous. Setting: A rehabilitation hospital. Patient: A 21-year-old man with a traumatic brain injury. Results: The patient exhibited brain response patterns to aurally presented congruous and incongruous sentences indicative of intact semantic processing capabilities. These findings resulted in reinstatement of individualized rehabilitative intervention, with a successful outcome. Conclusions: This innovative technique provides new opportunities for assessing intellectual function in noncommunicative patients who were patients previously unable to be tested. (C) 1999 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	Dalhousie Univ, Life Sci Ctr, Dept Psychol, Cognit Clin Neurosci Unit, Halifax, NS B3H 4J1, Canada; Dalhousie Univ, Dept Med, Div Psychiat, Halifax, NS B3H 4J1, Canada; Dalhousie Univ, Div Phys Med & Rehabil, Halifax, NS B3H 4J1, Canada; Cent Connecticut State Univ, Dept Psychol, New Britain, CT 06050 USA		Connolly, JF (corresponding author), Dalhousie Univ, Life Sci Ctr, Dept Psychol, Cognit Clin Neurosci Unit, Halifax, NS B3H 4J1, Canada.			Connolly, John/0000-0001-8869-5369			ANDERSON JE, 1995, PSYCHOPHYSIOLOGY, V32, P177, DOI 10.1111/j.1469-8986.1995.tb03310.x; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BESSON M, 1992, J COGNITIVE NEUROSCI, V4, P132, DOI 10.1162/jocn.1992.4.2.132; Byrne JM, 1995, CHILD NEUROPSYCHOL, V1, P211, DOI 10.1080/09297049508400226; BYRNE JM, 1995, J CLIN EXP NEUROPSYC, V17, P9, DOI 10.1080/13803399508406576; CHIAPPA K, 1997, EVOKED POTENTIALS CL; COLTHEART M, 1985, ATTENTION PERFORM, V11, P3; CONNOLLY JF, 1992, BRAIN LANG, V43, P1, DOI 10.1016/0093-934X(92)90018-A; CONNOLLY JF, 1995, J CLIN EXP NEUROPSYC, V17, P548, DOI 10.1080/01688639508405145; CONNOLLY JF, 1990, BRAIN LANG, V39, P302, DOI 10.1016/0093-934X(90)90016-A; CONNOLLY JF, 1995, ELECTROEN CLIN NEURO, V94, P276, DOI 10.1016/0013-4694(95)98479-R; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; CONNOLLY JF, IN PRESS INT J PSYCH; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Dunn LM., 1981, PEABODY PICTURE VOCA; Enderby P, 1987, Int Rehabil Med, V8, P162; ENDERBY P, 1986, BRIT J DISORD COMMUN, V21, P151; Goodglass H., 1972, ASSESSMENT APHASIA R; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Ingles JL, 1996, CORTEX, V32, P199, DOI 10.1016/S0010-9452(96)80047-5; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; KIMURA D, 1986, NEUROPSYCHOLOGY TEST; Kutas M., 1988, ADV PSYCHOPHYSIOLOGY, V3, P139; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Marquardsen J, 1969, ACTA NEUROL SCAND  S, V38, P67; MATARAZZO JD, 1992, AM PSYCHOL, V47, P1007, DOI 10.1037/0003-066X.47.8.1007; MATEKOLE CC, 1994, ARCH PHYS MED REHAB, V75, P867; MCFIE J, 1952, J MENT SCI, V98, P299, DOI 10.1192/bjp.98.411.299; MCFIE J, 1975, ASSESSMENT ORGANIC I; MICHELL PF, 1993, PSYCHOPHYSIOLOGY, V30, P496; MORSE PA, 1992, CLIN SYNDROMES ADULT, P86; NAATANEN R, 1995, EAR HEARING, V16, P6; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Osterhout L, 1996, J COGNITIVE NEUROSCI, V8, P507, DOI 10.1162/jocn.1996.8.6.507; Patterson K., 1982, NORMALITY PATHOLOGY, P77; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; Picton T. W., 1995, HDB NEUROPSYCHOLOGY, V10, P3; Polich, 1993, CURRENT DIRECTIONS P, V2, P175, DOI [DOI 10.1111/1467-8721.EP10769728, 10.1111/1467-8721.ep10769728]; Rugg Michael D., 1995, P789; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Swaab T, 1997, J COGNITIVE NEUROSCI, V9, P39, DOI 10.1162/jocn.1997.9.1.39; WADE DT, 1986, J NEUROL NEUROSUR PS, V49, P11, DOI 10.1136/jnnp.49.1.11; Warrington E, 1984, RECOGNITION MEMORY T, V1; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; [No title captured]	47	36	37	0	7	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	1999	80	10					1309	1315		10.1016/S0003-9993(99)90035-7			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	244AW	WOS:000083030500018	10527093				2022-02-06	
J	Slavik, RS; Rhoney, DH				Slavik, RS; Rhoney, DH			Indomethacin: A review of its cerebral blood flow effects and potential use for controlling intracranial pressure in traumatic brain injury patients	NEUROLOGICAL RESEARCH			English	Article						indomethacin; intracranial pressure; traumatic brain injury; cerebral blood flow; cerebral perfusion pressure; non-steroidal anti-inflammatory agent	SEVERE HEAD-INJURY; CARBON-DIOXIDE REACTIVITY; PATENT DUCTUS-ARTERIOSUS; HEALTHY-VOLUNTEERS; INTENSIVE MANAGEMENT; AGGRESSIVE TREATMENT; PREMATURE-INFANTS; HYPERTENSION; METABOLISM; HYPOTHERMIA	Traumatic brain injury (TBI) causes about 75,000 deaths and leaves approximately 200,000 people disabled in USA each year. Brain swelling and increased intracranial pressure (ICP) contribute to this morbidity and mortality. Aggressive management protocols,including ICP control, have been shown to reduce the overall mortality from 50% to 36% following severe head injury. Despite these encouraging results, new and improved pharmacologic strategies to control ICP are required. Indomethacin (IND) is a non-steroidal anti-inflammatory agent with unique effects on cerebral blood flow physiology which may be of benefit in reducing elevated ICP in TBI patients. Data from animal models and randomized, controlled studies with pre-term infants have shown that i.v. IND produces rapid, significant reductions in cerebral blood flow (CBF). Controlled studies of i.v. IND in normal volunteers show a reduction in CBF from 26%-40%. Case series involving severe TBI patients suggest that IND i.v. boluses of 30-50 mg reduce ICP by 37%-52%, reduce CBF by 22%-26%, with a modest 14% increase in cerebral perfusion pressure (CPP). Despite these encouraging results, i.v. IND should only be considered an experimental treatment for control of refractory ICP in TBI patients. Larger, well-designed randomized trials in TBI patients will provide more efficacy and safety data and delineate the effects of IND alone or in combination with other proven, effective, or experimental therapies. Once these concerns have been addressed, larger outcome studies will ultimately be needed to determine the role of IND for ICP control in TBI patients.	Wayne State Univ, Detroit Receiving Hosp & Univ Hlth Ctr, Dept Pharm Serv, Coll Pharm, Detroit, MI 48201 USA; Wayne State Univ, Coll Pharm & Allied Hlth Profess, Dept Pharm Practice, Detroit, MI 48201 USA; Vancouver Hosp & Hlth Sci Ctr, Dept Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada		Rhoney, DH (corresponding author), Wayne State Univ, Detroit Receiving Hosp & Univ Hlth Ctr, Dept Pharm Serv, Coll Pharm, 4201 St Antoine, Detroit, MI 48201 USA.						Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BIESTRO AA, 1995, J NEUROSURG, V83, P627, DOI 10.3171/jns.1995.83.4.0627; BOREL C, 1990, CHEST, V98, P180, DOI 10.1378/chest.98.1.180; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Cold GE, 1996, ANESTHESIOLOGY, V85, P1499; COWAN F, 1986, J PEDIATR-US, V109, P341, DOI 10.1016/S0022-3476(86)80398-5; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Dahl B, 1996, ACTA NEUROCHIR, V138, P265, DOI 10.1007/BF01411736; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; ERIKSSON S, 1983, GEN PHARMACOL, V14, P179, DOI 10.1016/0306-3623(83)90096-4; EVANS DH, 1987, DEV MED CHILD NEUROL, V29, P776; FRIEDMAN PL, 1981, NEW ENGL J MED, V305, P1171, DOI 10.1056/NEJM198111123052002; HAMMERMAN C, 1995, PEDIATRICS, V95, P244; Jensen K, 1996, J NEUROSURG ANESTH, V8, P111, DOI 10.1097/00008506-199604000-00002; JENSEN K, 1993, ACTA NEUROCHIR, V124, P114, DOI 10.1007/BF01401132; JENSEN K, 1991, ACTA NEUROCHIR, V108, P116, DOI 10.1007/BF01418518; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; KRAAIER V, 1992, ELECTROEN CLIN NEURO, V82, P208, DOI 10.1016/0013-4694(92)90169-I; KRISCH JR, 1986, ARCH INTERN MED, V146, P1415; Luer MS, 1996, PHARMACOTHERAPY, V16, P830; MARDOUM R, 1991, J PEDIATR-US, V118, P112, DOI 10.1016/S0022-3476(05)81860-8; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARKUS HS, 1994, STROKE, V25, P1760, DOI 10.1161/01.STR.25.9.1760; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mathew P, 1996, J NEUROTRAUM, V13, P465, DOI 10.1089/neu.1996.13.465; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Monro A., 1783, OBSERVATIONS STRUCTU; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NITTER WH, 1995, PHARMACOLOGY, V51, P48, DOI 10.1159/000139316; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; PICKARD JD, 1973, NATURE-NEW BIOL, V245, P187, DOI 10.1038/newbio245187a0; PICKLES H, 1984, J NEUROL NEUROSUR PS, V47, P51, DOI 10.1136/jnnp.47.1.51; PRYDS O, 1988, EUR J PEDIATR, V147, P315, DOI 10.1007/BF00442705; QUANDT CM, 1984, DRUG INTEL CLIN PHAR, V18, P105, DOI 10.1177/106002808401800203; SAKABE T, 1979, ACTA PHYSIOL SCAND, V107, P283, DOI 10.1111/j.1748-1716.1979.tb06476.x; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Simko A, 1994, J Perinatol, V14, P29; THERKELSEN K, 1994, SCAND J CLIN LAB INV, V54, P441, DOI 10.3109/00365519409085468; WENNMALM A, 1981, CLIN PHYSIOL, V1, P227, DOI 10.1111/j.1475-097X.1981.tb00891.x; WENNMALM A, 1984, ARCH TOXICOL, P350	46	36	37	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUL	1999	21	5					491	499					9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	218JU	WOS:000081550100010	10439431				2022-02-06	
J	Schurr, MJ; Ebner, KA; Maser, AL; Sperling, KB; Helgerson, RB; Harms, B				Schurr, MJ; Ebner, KA; Maser, AL; Sperling, KB; Helgerson, RB; Harms, B			Formal swallowing evaluation and therapy after traumatic brain injury improves dysphagia outcomes	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	58th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma/Trauma-Association-of-Canada	SEP 24-26, 1998	BALTIMORE, MARYLAND	Amer Assoc Surg Trauma, Trauma Assoc Canada		speech pathology; aspiration pneumonia; videofluoroscopic swallow study; closed head injury		Background: The incidence of swallowing dysfunction after brain injury is unknown. The efficacy of dysphagia therapy is also unknown. We reviewed our experience to define the incidence of swallowing dysfunction and efficacy of therapeutic intervention, Methods: Patients with brain injury sustained between January of 1996 and December of 1997 were reviewed. All were screened with trials of oral intake. Abnormal findings were confirmed with a videofluoroscopic swallow study. Standard therapies included diet, posture, and behavior modifications. Results: A total of 47 patients were evaluated. Bedside evaluations were normal in 14 patients, 2 patients had overt aspiration and underwent gastrostomy, and 31 patients were referred for a videofluoroscopic swallow study (66%), The videofluoroscopic swallow study was abnormal in 22 of 31 patients (71%). Of these, 4 additional patients required gastrostomy, 13 patients had laryngeal penetration or minor aspiration responsive to dysphagia therapy and were fed. Five other patients had silent aspiration and were fed by means of nasogastric tube; these five patients responded to dysphagia therapy and were able to resume oral intake. Conclusion: Dysphagia is common after severe head injury. With formal swallowing service intervention, aspiration is avoided. Therapeutic interventions can be used to restore oral intake.	Univ Wisconsin Hosp, Dept Surg, Madison, WI 53792 USA; Univ Wisconsin Hosp, Swallowing Serv, Madison, WI 53792 USA; Univ Wisconsin Hosp, Dept Rehabil Med, Madison, WI 53792 USA		Schurr, MJ (corresponding author), Univ Wisconsin Hosp, Dept Surg, 600 Highland Ave, Madison, WI 53792 USA.						Cherney LR, 1996, SEMIN NEUROL, V16, P349, DOI 10.1055/s-2008-1040993; DELARMINAT V, 1995, CRIT CARE MED, V23, P486, DOI 10.1097/00003246-199503000-00012; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; Kaye GM, 1997, ANN OTO RHINOL LARYN, V106, P705, DOI 10.1177/000348949710600817; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Lazarus CL, 1989, J HEAD TRAUMA REHAB, V4, P34; Logemann JA, 1997, OTOLARYNG HEAD NECK, V116, P335, DOI 10.1016/S0194-5998(97)70269-9; LOGEMANN JA, 1989, J HEAD TRAUMA REHAB, V4, P24; Tolep K, 1996, CHEST, V109, P167, DOI 10.1378/chest.109.1.167	9	36	40	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	1999	46	5					817	821		10.1097/00005373-199905000-00009			5	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	196EA	WOS:000080295000017	10338398				2022-02-06	
J	Iverson, GL; Franzen, MD; Lovell, MR				Iverson, GL; Franzen, MD; Lovell, MR			Normative comparisons for the controlled Oral Word Association Test following acute traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							HEAD-INJURY; NEUROPSYCHOLOGICAL DEFICITS	The Controlled Oral Word Association Test (COWAT) is widely used in clinical neuropsychology as a measure of verbal fluency. It is important for psychologists to realize that using the recently published normative data will result in different clinical conclusions because the updated normative sample performed better than the original normative sample. The purpose of this study was to compare the original and updated norms in a large sample of patients with acute traumatic brain injuries (N=669). The percentages of patients who scored below the 5th centile in each system varied as a function of brain injury severity. Moreover, a substantially larger number of patients scored in the impaired range according to the updated normative data.	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B4, Canada; Riverview Hosp, Neuropsychiat Unit, Vancouver, BC, Canada; Allegheny Gen Hosp, Dept Psychiat, Pittsburgh, PA 15212 USA; Henry Ford Hosp, Div Behav Sci, Detroit, MI USA; Henry Ford Hosp, Neuropsychiat Unit, Detroit, MI USA; Allegheny Gen Hosp, Neuropsychiat Unit, Pittsburgh, PA 15212 USA		Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2B4, Canada.			Iverson, Grant/0000-0001-7348-9570			BEERS SR, 1994, J LEARN DISABIL, V27, P315, DOI 10.1177/002221949402700508; BENTON AL, 1994, MULTLINGUAL APHASIA; DLATON JE, 1986, VA PRACTITIONER, P37; Hart R P, 1988, Arch Clin Neuropsychol, V3, P313, DOI 10.1016/0887-6177(88)90044-3; JONES RD, 1992, NEUROPSYCHOLOGY, V6, P13, DOI DOI 10.1037/0894-4105.6.1.13; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; PEYSER JM, 1990, ARCH NEUROL-CHICAGO, V47, P94, DOI 10.1001/archneur.1990.00530010120030; RASKIN S A, 1990, Neuropsychology Review, V1, P185, DOI 10.1007/BF01112571; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; SKORASZEWSKI MJ, 1991, J CLIN EXP NEUROPSYC, V13, P278, DOI 10.1080/01688639108401043; Smith-Seemiller L, 1996, Appl Neuropsychol, V3, P41, DOI 10.1207/s15324826an0301_6; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tombaugh T., 1998, COMPENDIUM NEUROPSYC, P453; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y	16	36	36	0	3	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		1999	13	4					437	441		10.1076/1385-4046(199911)13:04;1-Y;FT437			5	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	310PP	WOS:000086836800007	10806456				2022-02-06	
J	Alexeeva, N; Broton, JG; Calancie, B				Alexeeva, N; Broton, JG; Calancie, B			Latency of changes in spinal motoneuron excitability evoked by transcranial magnetic brain stimulation in spinal cord injured individuals	ELECTROMYOGRAPHY AND MOTOR CONTROL-ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY			English	Article						H-reflex; transcranial magnetic stimulation; spinal cord injury; human; central motor conduction	MOTOR CORTEX STIMULATION; LOWER-LIMB MOTONEURONS; ELECTRICAL-STIMULATION; PRESYNAPTIC INHIBITION; MULTIPLE-SCLEROSIS; H-REFLEXES; INTACT MAN; CONDUCTION; MUSCLE; DEMYELINATION	Objectives: To examine the basis for delay in the excitatory effects of transcranial magnetic stimulation (TMS) of motor cortex on motoneuron pools of muscles left partially-paralyzed by traumatic spinal cord injury (SCI). Methods: The effect of subthreshold transcranial magnetic stimulation (TMS) on just-suprathreshold H-reflex amplitude was examined in subjects (n = 10) with incomplete cervical SCI, and in able-bodied (AB) subjects (n = 20) for comparison. EMG activity was recorded from the soleus and the abductor hallucis muscles, and H-reflex was elicited by stimulation of the tibial nerve behind the knee. Comparison of the peak-to-peak amplitude of the TMS-conditioned H-reflex to that of the H-reflex alone (i.e. unconditioned H-reflex) was made for different conditioning-test intervals with multivariate analysis of variance and (when called for) t testing. Results: The absolute latencies of motor responses to suprathreshold TMS delivered during a weak voluntary contraction of the soleus and abductor hallucis were significantly prolonged in the SCI group relative to AB subjects. For the TMS-conditioned H-reflex, the timecourse effect of TMS on the H-reflex amplitude in different AB subjects included an early effect (typically facilitation, but occasionally inhibition) seen between -5 and 0 ms, followed by a later period (i.e. >5 ms) of H-reflex facilitation. In contrast, the earliest indication of a TMS effect on H-reflex excitability in SCT subjects was between 5 and 10 ms after TMS. This difference between SCI and AB subjects of approximately 10 ms was similar to the prolongation of TMS-evoked response latencies in the soleus and the abductor hallucis muscles of the SCI subjects. Conclusions: The results suggest that motor conduction slowing after traumatic SCI most likely occurs across the population of the descending tract axons mediating the TMS-evoked motor responses. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.	Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA		Calancie, B (corresponding author), Univ Miami, Sch Med, Miami Project Cure Paralysis, 1600 NW 10th Ave,R-48, Miami, FL 33136 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036542] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS36542] Funding Source: Medline		ADVANI A, 1990, CAN J PHYSIOL PHARM, V68, P1231, DOI 10.1139/y90-185; Alexeeva N, 1997, EXP NEUROL, V148, P399, DOI 10.1006/exnr.1997.6689; ALEXEEVA N, 1997, P INT S BRAIN MOV ST, P21; BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7; BROUWER B, 1992, EXP BRAIN RES, V89, P649; BROUWER B, 1992, J NEUROL NEUROSUR PS, V55, P20, DOI 10.1136/jnnp.55.1.20; BUNGE RP, 1993, ADV NEUROL, V59, P75; BURKE D, 1993, J PHYSIOL-LONDON, V470, P383, DOI 10.1113/jphysiol.1993.sp019864; CALANCIE B, 1993, ELECTROEN CLIN NEURO, V89, P177, DOI 10.1016/0168-5597(93)90131-8; Calancie Blair, 1995, Journal of Neurotrauma, V12, P361; CHANG CW, 1991, MUSCLE NERVE, V14, P990, DOI 10.1002/mus.880141010; CLARKE CE, 1994, PARAPLEGIA, V32, P554, DOI 10.1038/sc.1994.87; COWAN JMA, 1986, J PHYSIOL-LONDON, V377, P333, DOI 10.1113/jphysiol.1986.sp016190; Dimitrijevic M R, 1983, Adv Neurol, V39, P915; GRIFFITHS IR, 1983, J NEUROL SCI, V58, P335, DOI 10.1016/0022-510X(83)90093-X; HAYES KC, 1992, ELECTROEN CLIN NEURO, V85, P102, DOI 10.1016/0168-5597(92)90075-M; ILES JF, 1992, J PHYSIOL-LONDON, V455, P425, DOI 10.1113/jphysiol.1992.sp019309; LEWKO JP, 1995, RESTOR NEUROL NEUROS, V7, P225, DOI 10.3233/RNN-1994-7405; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; NIELSEN J, 1995, J PHYSIOL-LONDON, V484, P777, DOI 10.1113/jphysiol.1995.sp020703; NIELSEN J, 1993, J PHYSIOL-LONDON, V471, P223, DOI 10.1113/jphysiol.1993.sp019899; NIELSEN J, 1995, J PHYSIOL-LONDON, V484, P791, DOI 10.1113/jphysiol.1995.sp020704; PRIORI A, 1993, ELECTROEN CLIN NEURO, V89, P131, DOI 10.1016/0168-5597(93)90095-7; QUENCER RM, 1992, NEURORADIOLOGY, V34, P85, DOI 10.1007/BF00588148; ROTHWELL JC, 1987, BRAIN, V110, P1173, DOI 10.1093/brain/110.5.1173; ROTHWELL JC, 1991, EXP PHYSIOL, V76, P159, DOI 10.1113/expphysiol.1991.sp003485; ROTHWELL JC, 1987, NEUROSURGERY, V20, P156; ROTHWELL JC, 1984, EXP BRAIN RES, V54, P382; THOMPSON PD, 1991, ELECTROEN CLIN NEURO, V81, P397, DOI 10.1016/0168-5597(91)90029-W; UGAWA Y, 1995, CAN J NEUROL SCI, V22, P36, DOI 10.1017/S0317167100040476; VALLSSOLE J, 1994, NEUROSCI LETT, V170, P149, DOI 10.1016/0304-3940(94)90261-5; VANDERKAMP W, 1991, ANN NEUROL, V29, P6, DOI 10.1002/ana.410290104; WAXMAN SG, 1994, PROG BRAIN RES, V100, P233; WAXMAN SG, 1989, J NEUROL SCI, V91, P1, DOI 10.1016/0022-510X(89)90072-5; Wolfe DL, 1996, J NEUROTRAUM, V13, P281, DOI 10.1089/neu.1996.13.281	35	36	37	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0924-980X			ELECTROMYOGR MOTOR C	Electromyogr. Mot. Control-Electroencephalogr. Clin. Neurophysiol.	AUG	1998	109	4					297	303		10.1016/S0924-980X(98)00021-6			7	Engineering, Biomedical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	116LA	WOS:000075725100003	9751291				2022-02-06	
J	Hilsabeck, RC; Gouvier, WD; Bolter, JE				Hilsabeck, RC; Gouvier, WD; Bolter, JE			Reconstructive memory bias in recall of neuropsychological symptomatology	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							SOCIAL SUPPORT; HEAD-INJURY; BASE RATES; DEPRESSION; SYMPTOMS; PERSPECTIVE; ETIOLOGY	Subjective recall of symptoms among nonlitigants with closed-head and back injuries and non-injured participants with high and low levels of life stressors was evaluated. All participants completed a demographic questionnaire, the Brief Symptom Inventory, and a symptom checklist. Recall of symptoms by participants with closed-head and back injuries was consistent with perceptions of being worse now than they were before their injuries. The results further suggest that these participants tend to overestimate the actual degree of change that has taken place by recalling fewer pre-injury symptoms than control participants. In addition, participants with closed-head injuries, but not with back injuries, showed significantly higher levels of symptom endorsement now than controls.	Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; Neuromed Ctr, Baton Rouge, LA USA		Gouvier, WD (corresponding author), Louisiana State Univ, Dept Psychol, 236 Audubon Hall, Baton Rouge, LA 70803 USA.		Hilsabeck, Robin/ABC-5093-2020				BAHRICK HP, 1984, PHYSIOL PSYCHOL, V12, P53; BARCLAY CR, 1988, PRACTICAL ASPECTS ME, V1, P289; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; BRESLOW R, 1981, AM J PSYCHIAT, V138, P227; CASSEL J, 1974, INT J HEALTH SERV, V4, P471, DOI 10.2190/WF7X-Y1L0-BFKH-9QU2; CONWAY M, 1984, J PERS SOC PSYCHOL, V47, P738, DOI 10.1037/0022-3514.47.4.738; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; DUNBAR GC, 1984, BRIT J PSYCHIAT, V144, P376, DOI 10.1192/bjp.144.4.376; FIENBERG SE, 1985, MILBANK FUND Q, V63, P582, DOI 10.2307/3349849; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; HARTLAGE LC, 1989, MANUAL BEHAV CHANGE; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; KRAUS JF, 1989, MILD HEAD INJURY, P8; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lees-Haley P.R., 1988, AM J FORENSIC PSYCHO, V6, P3; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LeesHaley PR, 1996, PSYCHOL REP, V79, P811, DOI 10.2466/pr0.1996.79.3.811; LEWINSOHN PM, 1980, J ABNORM PSYCHOL, V89, P203, DOI 10.1037/0021-843X.89.2.203; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LINDSAY DS, 1994, APPL COGNITIVE PSYCH, V8, P281, DOI 10.1002/acp.2350080403; Loftus E. F., 1982, GS HALL LECTURES, P119; LOFTUS EF, 1983, MEM COGNITION, V11, P114, DOI 10.3758/BF03213465; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; NADOLNE M, 1996, 16 ANN M NAT AC NEUR; NEISSER U, 1981, COGNITION, V9, P1, DOI 10.1016/0010-0277(81)90011-1; Rattan G, 1987, Arch Clin Neuropsychol, V2, P257, DOI 10.1016/0887-6177(87)90013-8; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; WEBSTER JD, 1993, DEV REV, V13, P54, DOI 10.1006/drev.1993.1003; YARROW MR, 1970, MONOGRAPH SOC RES CH, V5; [No title captured]; [No title captured]	34	36	36	0	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN	1998	20	3					328	338		10.1076/jcen.20.3.328.813			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	142MM	WOS:000077204300007	9845160				2022-02-06	
J	Keren, O; Ben-Dror, S; Stern, MJ; Goldberg, G; Groswasser, Z				Keren, O; Ben-Dror, S; Stern, MJ; Goldberg, G; Groswasser, Z			Event-related potentials as an index of cognitive function during recovery from severe closed head injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							P300 COMPONENT; STIMULI; LATENCY	Objective: To evaluate the utility and neuropsychological correlates of serially performed recordings of event-related potentials (ERPs) in patients recovering from a severe closed head injury (CHI). Design: Prospective longitudinal study. Setting: Brain injury rehabilitation unit based in a national rehabilitation hospital. Subjects: Sixteen patients with severe CHI (significant degree of impaired consciousness greater than 24 hours) subclassified into two severity groups according to initial Glasgow Coma Scale (GCS) score: those with initial GCS score < 9, consistent with a more severe injury; and those with initial GCS score > 8, indicating a less severe injury. Methods: ERPs were elicited using the standard auditory P300 "oddball" detection paradigm. ERP recordings were carried out three times: 2 months after injury, 1 month later, and 2.5 months or more after the initial study. Parameters analyzed included latencies and amplitudes of the P3, N2, P2, and N1 components of the ERPs. Correlations between changes in these ERP parameters and specific neuropsychological test results were evaluated. Results: Initial P3 latencies in the more severely injured group were significantly longer (P < .05) than those recorded in the less severely injured patients. In subsequent recordings, P3 latency was found to be significantly shorter compared with the initial P3 latency, and the difference in P3 latency between the two patient groups was no longer statistically significant by the time of the third recording. For the group as a whole, P3 latency decreased significantly on each repeated recording. N2 latency was found to be significantly shorter (P < .05) between the first and third recordings. Cognitive performance significantly improved between the first and third recordings. P3 latency shortening was correlated with improvement in neuropsychological test scores for short-term and long-term story recall and for word recall. N2 latency shortening was correlated with improvement in the neuropsychological test scores for word recall only. Conclusion: ERP recordings performed in the subacute stage after CHI may assist in evaluating injury severity. Moreover, serially performed recordings of P3 latency may be used as a physiologic index of brain activity that correlates with recovery from CHI.	Loewenstein Hosp, Rehabil Ctr, Dept Brain Injury Rehabil, IL-43100 Raanana, Israel; Loewenstein Rehabil Hosp, Sect Psychiat, IL-43100 Raanana, Israel; MossRehab Hosp, Drucker Brain Injury Ctr, Dept Psychotherapy, Philadelphia, PA USA; Tel Aviv Univ, Sackler Fac Med, Dept Phys Med & Rehabil, IL-69978 Tel Aviv, Israel		Groswasser, Z (corresponding author), Loewenstein Hosp, Rehabil Ctr, Dept Brain Injury Rehabil, POB 3, IL-43100 Raanana, Israel.						BADDELEY A, 1982, AGING, V19; BRECHER M, 1987, ELECTROEN CLIN NEURO, V66, P369; Buchwald JS., 1990, EVENT RELATED BRAIN; CAMPBELL K, 1986, CEREBRAL PSYCHOPHYSI; Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; CURRY SH, 1980, MOTIVATION MOTOR SEN; DEACONELLIOTT DL, 1987, CURRENT TRENDS EVENT; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; DRAKE ME, 1990, SEMIN NEUROL, V10, P196, DOI 10.1055/s-2008-1041269; Goldberg G, 1987, Electromyogr Clin Neurophysiol, V27, P455; GOODIN DS, 1978, BRAIN, V101, P635, DOI 10.1093/brain/101.4.635; HIRATA K, 1991, EUR ARCH PSY CLIN N, V240, P240, DOI 10.1007/BF02189533; HOFFMAN JE, 1990, EVENT RELATED BRAIN; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCCALLUM WC, 1968, ELECTROEN CLIN NEURO, V25, P319, DOI 10.1016/0013-4694(68)90172-7; MCCLELLAND JL, 1979, PSYCHOL REV, V86, P287, DOI 10.1037/0033-295X.86.4.287; OBERT AD, 1990, AM J OTOL, V11, P447; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; PAPANICOLAOU AC, 1984, NEUROSURGERY, V14, P676, DOI 10.1227/00006123-198406000-00005; PFEFFERBAUM A, 1984, ELECTROEN CLIN NEURO, V59, P85, DOI 10.1016/0168-5597(84)90026-1; PFEFFERBAUM A, 1984, ELECTROEN CLIN NEURO, V59, P104, DOI 10.1016/0168-5597(84)90027-3; Picton T., 1988, HUMAN EVENT RELATED; PICTON TW, 1990, CURRENT PRACTICE CLI; POLICH J, 1985, J GERONTOL, V40, P721, DOI 10.1093/geronj/40.6.721; Rappaport M, 1991, J Neuropsychiatry Clin Neurosci, V3, P180; Rappaport M, 1990, J Neuropsychiatry Clin Neurosci, V2, P399; RAPPAPORT M, 1996, MED REHABILITATION T; RAPPAPORT M, 1994, J HEAD TRAUMA REHAB, V9, P94; Raven J. C., 1960, GUIDE STANDARD PROGR; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; RIZZO PA, 1978, ELECTROEN CLIN NEURO, V45, P281, DOI 10.1016/0013-4694(78)90012-3; RUCHKIN DS, 1994, BRAIN, V117, P289, DOI 10.1093/brain/117.2.289; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; SKLARE DA, 1984, ELECTROEN CLIN NEURO, V59, P420, DOI 10.1016/0168-5597(84)90043-1; SQUIRES K, 1980, AGING 1980S; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WHYTE J, 1988, PRINCIPLES PRACTICE; [No title captured]; [No title captured]	41	36	39	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1998	13	3					15	30					16	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ZT046	WOS:000074042200003	9582176				2022-02-06	
J	Tateishi, A; Soejima, Y; Taira, Y; Nakashima, K; Fujisawa, H; Tsuchida, E; Maekawa, T; Ito, H				Tateishi, A; Soejima, Y; Taira, Y; Nakashima, K; Fujisawa, H; Tsuchida, E; Maekawa, T; Ito, H			Feasibility of the titration method of mild hypothermia in severely head-injured patients with intracranial hypertension	NEUROSURGERY			English	Article						body temperature; central nervous system injury; head injury; induced hypothermia; intracranial pressure	TRAUMATIC BRAIN INJURY; MODERATE HYPOTHERMIA; PROTECTION; ISOFLURANE; ISCHEMIA; RELEASE; RAT	OBJECTIVE: Clinical strategy to maximize effectiveness and to minimize adverse influences remains to be determined for mild hypothermia therapy for traumatic brain injury. This study was conducted to evaluate the clinical feasibility of the titration method of mild hypothermia in severely head-injured patients in whom a reduction in intracranial pressure was regarded as the target effect. METHODS: Nine consecutive patients with severe head injury were studied. Patient age ranged between 18 and 66 years, Glasgow Coma Scale scores were equal to or less than 8, and intracranial pressures were equal to or greater than 20 mm Hg despite removal of intracranial hematoma and drugs, including glycerol and thiopental. During a maximum of 6 days of hypothermia therapy, jugular venous blood or cerebrospinal fluid temperature was titrated to reduce intracranial pressure to less than 20 mm Hg by means of repeated intragastric cooling with our nasoduodenal tube and surface cooling. The feasibility and the effects on systemic complications of this titration method of mild hypothermia were evaluated. RESULTS: Intracranial pressure variably decreased from before to 3 hours after the beginning of all procedures of cooling. The mean intracranial pressure significantly decreased from 24 to 15 mm Hg with cooling, while temperature reduced an average of 2.0 degrees C. Four patients had systemic infection complications. Increased C-reactive protein and decreased platelet count were observed in all patients during hypothermia. The incidence of good recovery and moderate disability according to the Glasgow Outcome Scale was seven of nine patients. CONCLUSION: The titration method of mild hypothermia to control intracranial hypertension in severely head-injured patients is clinically feasible. However, the method failed to reduce the incidence of infectious and hematological complications.	Yamaguchi Univ Hosp, Div Intens Care Med, Ube, Yamaguchi 755, Japan; Yamaguchi Univ Hosp, Dept Anesthesiol, Ube, Yamaguchi 755, Japan; Yamaguchi Univ Hosp, Dept Neurosurg, Ube, Yamaguchi 755, Japan; Yamaguchi Univ Hosp, Dept Emergency Med, Ube, Yamaguchi 755, Japan; Yamaguchi Univ Hosp, Div Gen Med, Ube, Yamaguchi 755, Japan		Tateishi, A (corresponding author), Yamaguchi Univ Hosp, Div Gen Med, 1144 Kogushi, Ube, Yamaguchi 755, Japan.						BERNTMAN L, 1981, ANESTHESIOLOGY, V55, P495, DOI 10.1097/00000542-198111000-00003; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DAVSON H, 1962, EXP NEUROL, V6, P118, DOI 10.1016/0014-4886(62)90082-1; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HESSEL EA, 1980, J SURG RES, V28, P23, DOI 10.1016/0022-4804(80)90078-5; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MICHENFELDER JD, 1968, ANESTHESIOLOGY, V29, P1107, DOI 10.1097/00000542-196811000-00005; MOSS G, 1966, ARCH SURG-CHICAGO, V92, P80; Nakashima K, 1996, ANESTHESIOLOGY, V85, P161, DOI 10.1097/00000542-199607000-00022; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; ROSOMOFF HL, 1955, AM J PHYSIOL, V183, P19, DOI 10.1152/ajplegacy.1955.183.1.19; SANO T, 1992, ANESTHESIOLOGY, V76, P221, DOI 10.1097/00000542-199202000-00011; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; TATEISHI A, 1981, ANESTHESIOLOGY, V54, P335, DOI 10.1097/00000542-198104000-00016; YAMASHITA K, 1991, STROKE, V22, P1574, DOI 10.1161/01.STR.22.12.1574	20	36	36	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	1998	42	5					1065	1069		10.1097/00006123-199805000-00066			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ZK454	WOS:000073322500058	9588551				2022-02-06	
J	McCleary, C; Satz, P; Forney, D; Light, R; Zaucha, K; Asarnow, R; Namerow, N				McCleary, C; Satz, P; Forney, D; Light, R; Zaucha, K; Asarnow, R; Namerow, N			Depression after traumatic brain injury as a function of Glasgow outcome score	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							HEAD-INJURY; SCALE; MOOD	One hundred and five patients with traumatic brain injury (TBI) were assessed for depressive symptomatology at 6 months postinjury and 66 of those patients were examined again at 12 months postinjury. At 6 months, 42% of the patients with TBI and 20% of the Other Injury Control Group (OIC) were identified as depressed. Individuals with poor outcome las measured by Glasgow Outcome Score [GOS]) had a higher frequency of depressive symptomatology than those with good GOS outcome. At 12 months, 36% of the patients with TBI and 288 of the OIC group were identified as depressed. At 12 months, there was no difference in terms of frequency of depressive symptomatology among patients with TBI with poor, moderate, or good outcome.	Univ So Calif, Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90024 USA; Daniel Freeman Mem Hosp, Los Angeles, CA USA		McCleary, C (corresponding author), Univ So Calif, Sch Med, Dept Neurol, 1510 San Pablo St,Suite 268, Los Angeles, CA 90033 USA.						*ASS ADV AUT MED, 1990, ABBR INJ SCAL 1990; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Derogatis L. R., 1983, SCL 90 R; DICKSON WJ, 1983, INTRO STAT ANAL; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; JENNETT B, 1975, LANCET, V1, P480; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; ROBINSON RG, 1985, CRC CR REV CL NEUROB, V1, P285; SATZ P, IN PRESS BRAIN INJUR; TEASDALE G, 1974, LANCET, V2, P81; *U NY, 1993, GUID UN DAT SYST MED; WETZLER S, 1993, J PERS ASSESS, V60, P1, DOI 10.1207/s15327752jpa6001_1; [No title captured]	19	36	37	0	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1998	20	2					270	279		10.1076/jcen.20.2.270.1172			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	122GG	WOS:000076063100015	9777481				2022-02-06	
J	Hinchliffe, FJ; Murdoch, BE; Chenery, HJ				Hinchliffe, FJ; Murdoch, BE; Chenery, HJ			Towards a conceptualization of language and cognitive impairment in closed-head injury: use of clinical measures	BRAIN INJURY			English	Article							VERBAL IMPAIRMENT; MEMORY; COMPREHENSION; PERFORMANCE; SKILLS	Language deficits following closed-head injury (CHI) are widely considered as impairments secondary to the cognitive disruptions common to closed-head injury. In addition, the use of standardized measures to assess the functioning of the language: system in closed-head injury has mostly been limited to aphasia test batteries which examine primary language functions only. This has resulted in generalizations as to the integrity of the language system following dosed-head injury, and as a consequence, consideration of the contribution of the language system to the achievement of communicative competence in this population has been minimized. This paper presents a framework in which the functional language system is identified as a hierarchical system containing primary and higher-order language processes involved in reciprocal relationships with cognitive functions at each level. A group of 25 closed-head injury subjects and 23 demographically matched control subjects were examined for linguistic proficiency using a battery of standardized tests which investigated the language system across a hierarchy of complexity, structure and predicability. In addition, 23 of the closed-head subjects were administered a comprehensive neuropsychological test battery in order to determine the nature and extent of concomitant impairments in cognitive processes and their relationship with impairments in the language system. The language battery was found to consistently discriminate between the control and clinical groups indicating that the linguistic system is significantly impaired following CHI, with the lexical-semantic system being the most vulnerable to disruption. A strong influential relationship between language and cognitive processes was statistically confirmed and the nature of the relationship between aspects of language and cognition further delineated.	Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia		Hinchliffe, FJ (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia.		Murdoch, Bruce E/C-1397-2012; Chenery, Helen J/F-5194-2010				ADAMOVICH BB, 1990, FOLIA PHONIATR, V42, P11, DOI 10.1159/000266015; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; *ASLHA, 1987, AM SPEECH HEARING AS, P53; BAKER L, 1982, TOPICS LEARNING LEAR, V2, P26; BENJAMIN L, 1989, THEORY FUNCTION BRID, P57; Bloom L., 1978, LANGUAGE DEV LANGUAG; BRAUN CMJ, 1987, CLIN APHASIOLOGY, P326; BRYAN KL, 1989, RIGHT HEMISPHERE LAN; BUTLERHINZ S, 1990, J SPEECH HEAR RES, V33, P269, DOI 10.1044/jshr.3302.269; CHAPMAN S, 1992, BRAIN LANG, V43, P4; CHAPMAN SB, 1995, HDB NEUROLOGICAL SPE, P387; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; COPPENS P, 1995, BRAIN INJURY, V9, P195, DOI 10.3109/02699059509008192; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; GESCHWIND N, 1971, NEW ENGL J MED, V284, P654, DOI 10.1056/NEJM197103252841206; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Graham D. I., 1987, HEAD INJURY, P72; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HOLLAND AL, 1982, CLIN APHASIOLOGY, V12, P345; HOLM S, 1979, SCAND J STAT, V6, P65; Huisingh R, 1990, WORD TEST REVISED; Irvine L, 1986, S Afr J Commun Disord, V33, P49; Kaplan E, 1983, BOSTON NAMING TEST; KENNEDY MRT, 1991, COMMUNICATION DISORD, P123; Kertesz A., 1982, W APHASIA BATTERY; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEZAK M, 1996, NEUROPSCYHOLOGICAL A; MALKMUS D, 1989, COMMUNICATION DISORD, P123; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; McNeil MR, 1978, REVISED TOKEN TEST; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; Morse P, 1992, CLIN SYNDROMES ADULT, P85; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; NORUSIS MJ, 1990, SPSS PC PLUS STAT 4; PAIGET J, 1969, PSYCHOL CHILD; Pang D, 1985, HEAD INJURY REHABILI, P3; PARSONS C, 1989, AUSTR J HUMAN COMMUN, V17, P237; PAYNEJOHNSON JC, 1986, J COMMUN DISORD, V19, P237, DOI 10.1016/0021-9924(86)90030-4; PEACH RK, 1992, J SPEECH HEAR RES, V35, P810, DOI 10.1044/jshr.3504.810; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P18; Reitan R, 1985, HALSTEAD REITAN NEUR; REITAN RM, 1987, TRAUMATIC BRAIN INJU, pR2; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Spreen O, 1991, COMPENDIUM NEUROPSYC; Spreen O., 1969, NEUROSENSORY CTR COM; TABACHNICK BG, 1995, USING MULTIVARIATE S; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Vygotsky L. S., 1962, THOUGHT LANGUAGE; Wechsler D., 1981, WAIS R MANUAL; Wechsler D., 1987, WECHSLER MOMORY SCAL; Wiig E. H., 1989, TEST LANGUAGE COMPET; Wiig E. H., 1984, TOP LANG DISORD, V4, P1; WIIG EH, 1974, PERCEPT MOTOR SKILL, V38, P171, DOI 10.2466/pms.1974.38.1.171; WIIG EH, 1984, TOP LANG DISORD, V4, P41; Wiig EH., 1992, TEST WORD KNOWLEDGE; Yorkston K.M., 1981, ASSESSMENT INTELLIGI	72	36	36	1	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1998	12	2					109	132		10.1080/026990598122746			24	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YV073	WOS:000071786900002	9492959				2022-02-06	
J	Beringer, DC; Weiner, DS; Noble, JS; Bell, RH				Beringer, DC; Weiner, DS; Noble, JS; Bell, RH			Severely displaced proximal humeral epiphyseal fractures: A follow-up study	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						children's fractures; humeral epiphyseal fractures	CHILDREN; GROWTH	Forty-eight patients with severely displaced proximal, humeral epiphyseal fractures were reviewed. Twenty-one patients were followed up for an average of 9 years after injury with a personal interview, examination, and radiographs. Average age was 14.1 years, half of whom were age 15 years or older. Initial head-shaft displacement averaged 80%, and 31 fractures were displaced by greater than or equal to 80%. All underwent attempted closed reduction. Radiographs for all except three were sufficient to judge the adequacy of reduction. Twenty-six of 45 attempted closed reductions failed to improve displacement significantly. Nine patients underwent operative treatment, and the remainder had a closed reduction. In the operative group, complications occurred in three of nine patients. No complications occurred in the nonoperative group. No patients seen at late follow-up identified any activity or employment restrictions as a result of their injuries. Several patients incurred humeral shortening or imperfect radiographic remodeling, but this did not correlate with clinical outcome. Comparing the operative complications with the excellent late results after nonoperative treatment in this series supports previous recommendations to avoid operative intervention with few exceptions. The magnitude of displacement alone does not appear to justify operative treatment.	Childrens Hosp, Med Ctr, Dept Pediat Orthopaed Surg, Akron, OH 44308 USA		Weiner, DS (corresponding author), Childrens Hosp, Med Ctr, Dept Pediat Orthopaed Surg, 1 Perkins Sq,Ste 250,Locust Bldg, Akron, OH 44308 USA.						Aitken A., 1936, J BONE JOINT SURG, V18, P1036; BAXTER MP, 1986, J BONE JOINT SURG BR, V68, P570, DOI 10.1302/0301-620X.68B4.3733832; BLOUND WP, 1954, FRACTURES CHILDREN; BOURDILLON JF, 1950, J BONE JOINT SURG BR, V32, P35; Crenshaw A.H., 1992, CAMPBELLS OPERATIVE; CURTIS RJ, 1990, ORTHOP CLIN N AM, V21, P315; DAMERON TB, 1969, J BONE JOINT SURG AM, VA 51, P289, DOI 10.2106/00004623-196951020-00008; HOHL JC, 1976, ORTHOP CLIN N AM, V7, P557; JEFFERY CC, 1953, SURG GYNECOL OBSTET, V96, P205; KOHLER R, 1983, J PEDIATR ORTHOPED, V3, P326, DOI 10.1097/01241398-198307000-00010; LARSEN CF, 1990, ACTA ORTHOP SCAND, V61, P255, DOI 10.3109/17453679008993512; McBride E D, 1965, Clin Orthop Relat Res, V38, P143; Neer C S 2nd, 1965, Clin Orthop Relat Res, V41, P24; Nilsson S, 1965, Acta Chir Scand, V130, P433; PETERSON CA, 1972, J TRAUM, V12, P275, DOI 10.1097/00005373-197204000-00002; Rockwood C, 1991, FRACTURES CHILDREN; SMITH FM, 1956, AM J SURG, V91, P627, DOI 10.1016/0002-9610(56)90296-3	17	36	39	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0271-6798			J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JAN-FEB	1998	18	1					31	37		10.1097/00004694-199801000-00007			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	ZG845	WOS:000073045800007	9449098				2022-02-06	
J	Eng, DL; Lee, YL; Lal, PG				Eng, DL; Lee, YL; Lal, PG			Expression of glutamate uptake transporters after dibutyryl cyclic AMP differentiation and traumatic injury in cultured astrocytes	BRAIN RESEARCH			English	Article						cell injury; astrocyte; glutamate; uptake; transporter	AMINO-ACID TRANSPORTER; RAT-BRAIN; HIGH-AFFINITY; NEUROTRANSMITTER TRANSPORTERS; ASPARTATE TRANSPORTER; MESSENGER-RNA; CLONING; CELLS	Our findings indicate that differentiation of primary astrocytes by dibutyryl cyclic adenosine monophosphate (dBcAMP) and scratch injury together resulted in increased glutamate transporter gene expression. Confluent primary cultures were prepared from cerebral cortex of normal new born rat pups. The primary cultures were then divided into four groups each: control and scratch-injured, and dBcAMP-treated control and scratch-injured cultures. Total RNA was extracted at 0, 1, 2, 4, and 7 days after injury. Expression of the electrogenic glutamate transporters, GLAST, GLT-1, and EAAC-1, was quantitated by the reverse transcriptase-polymerase chain reaction method (RT-PCR) and slot blot hybridization followed by densitometric scanning. Triplicate cultures were analyzed for each time-point. Our studies indicate that all these astrocyte cultures expressed the two glial transporters, GLAST and GLT-1, while none of the cultures expressed the neuronal transporter, EAAC-1. The expression of the two transporters in the dBcAMP-treated primary cultures were markedly increased from the non-treated cultures. The dBcAMP-treated cultures had 2- to 4-times increase in levels of GLAST and GLT-1-mRNA expression both before and after scratch injury, as compared to untreated non-injured and injured primary cultures. All of the cultures expressed GLAST in greater proportion than GLT-1. (C) 1997 Elsevier Science B.V.	Vet Affairs Palo Alto Hlth Care Syst, Med Res Serv, Palo Alto, CA 94304 USA		Eng, DL (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Med Res Serv, 3801 Miranda Ave, Palo Alto, CA 94304 USA.						AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; BALCAR VJ, 1972, J NEUROCHEM, V19, P2657, DOI 10.1111/j.1471-4159.1972.tb01325.x; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLARK JA, 1993, BIOESSAYS, V15, P323, DOI 10.1002/bies.950150506; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DREJER J, 1982, EXP BRAIN RES, V47, P259; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FLOTT B, 1991, GLIA, V4, P293, DOI 10.1002/glia.440040307; KAKU DA, 1993, SCIENCE, V260, P1516, DOI 10.1126/science.8389056; KANAI Y, 1993, TRENDS NEUROSCI, V16, P365, DOI 10.1016/0166-2236(93)90094-3; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KONDO K, 1995, NEUROSCI LETT, V188, P140, DOI 10.1016/0304-3940(95)11408-O; LEHRE KP, 1995, J NEUROSCI, V15, P1835; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; MURPHY GM, 1993, J NEUROSCI RES, V35, P643, DOI 10.1002/jnr.490350607; OTORI Y, 1994, MOL BRAIN RES, V27, P310, DOI 10.1016/0169-328X(94)90014-0; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; RONG H, 1993, BRAIN RES, V618, P346, DOI 10.1016/0006-8993(93)91289-5; ROSENBERG PA, 1992, J NEUROSCI, V12, P56; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; SCHOUSBOE A, 1977, J NEUROCHEM, V29, P999, DOI 10.1111/j.1471-4159.1977.tb06503.x; SHER PK, 1990, GLIA, V3, P350, DOI 10.1002/glia.440030506; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; YU ACH, 1991, J NEUROSCI RES, V30, P72, DOI 10.1002/jnr.490300109; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	31	36	37	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 5	1997	778	1					215	221		10.1016/S0006-8993(97)01093-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YP069	WOS:000071238100024	9462894				2022-02-06	
J	Nagtegaal, JE; Kerkhof, GA; Smits, MG; Swart, ACW; van der Meer, YG				Nagtegaal, JE; Kerkhof, GA; Smits, MG; Swart, ACW; van der Meer, YG			Traumatic brain injury-associated delayed sleep phase syndrome	FUNCTIONAL NEUROLOGY			English	Article						brain injury; delayed sleep phase syndrome; melatonin	MELATONIN	A 15-year-old girl developed a prominent delayed sleep phase syndrome (DSPS) following traumatic brain injury. Several physiological markers of the sleep-wake rhythm: plasma melatonin, body temperature, wrist activity and sleep architecture (EEG) were delayed almost half a day, returning to normal after treatment with 5 mg melatonin. This report suggests an association between traumatic brain injury and DSPS. Awareness of this phenomenon may result in better possibilities for treatment of patients with brain injury.	Hosp Gelderse Vallei, Dept Clin Pharm, Bennekon, Netherlands; Hosp Gelderse Vallei, Dept Neurol, Bennekon, Netherlands; Hosp Gelderse Vallei, Dept Clin Chem, Bennekon, Netherlands; Acad Hosp Leiden, Dept Physiol, Leiden, Netherlands				Sanguansri, Luz/B-6630-2011	Sanguansri, Luz/0000-0003-1908-7604			Arendt J., 1995, MELATONIN MAMMALIAN, P161; DAHLITZ M, 1991, LANCET, V337, P1121, DOI 10.1016/0140-6736(91)92787-3; *DIAGN CLASS STEER, 1990, INT CLASS SLEEP DIS, P128; KNEISLEY LW, 1978, J NEURAL TRANSM, P311; LEWY AJ, 1992, CHRONOBIOL INT, V9, P380, DOI 10.3109/07420529209064550; Middleton BA, 1996, LANCET, V348, P551, DOI 10.1016/S0140-6736(05)64715-0; MINORS D S, 1984, Chronobiology International, V1, P205, DOI 10.3109/07420528409063897; NAGTEGAAL E, 1995, LANCET, V346, P1299, DOI 10.1016/S0140-6736(95)91901-5; NAGTEGAAL JE, 1995, BIOL RHYTHM RES, V26, P426; PATTEN SB, 1992, J AM ACAD CHILD PSY, V31, P100, DOI 10.1097/00004583-199201000-00015	10	36	37	0	3	C I C-EDIZIONI INTERNAZIONALI SRL	ROME	VIA L SPALLANZANI 11, 00161 ROME, ITALY	0393-5264			FUNCT NEUROL	Funct. Neurol.	NOV-DEC	1997	12	6					345	348					4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YT888	WOS:000071656300006	9503198				2022-02-06	
J	Cicerone, KD; Kalmar, K				Cicerone, KD; Kalmar, K			Does premorbid depression influence post-concussive symptoms and neuropsychological functioning?	BRAIN INJURY			English	Article							MINOR HEAD-INJURY; BRAIN INJURY; MEMORY; COMPLAINTS	We examined the contribution of premorbid affective disturbance to persistent post-concussive symptoms and neuropsychological functioning following a mild traumatic brain injury. No differences were observed on self-reported post-concussive symptoms, MMPI scales, or neuropsychological measures between two case-matched soups of patients with and without a history of pre-injury depression. Clinicians are urged to use caution in attributing post-concussive symptoms or neuropsychological deficits to the presence of a pre-existing affective disorder.			Cicerone, KD (corresponding author), JFK JOHNSON REHABIL INST,DEPT NEUROPSYCHOL,2048 OAK TREE RD,EDISON,NJ 08820, USA.						ALEXANDER MP, 1992, J HEAD TRAUMA REHABI, V7, P90; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; GUILMETTE TJ, 1995, NEUROPSYCHOLOGY, V9, P338, DOI 10.1037/0894-4105.9.3.338; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MASSMAN PJ, 1992, J CLIN EXP NEUROPSYC, V14, P687, DOI 10.1080/01688639208402856; OCONNOR DW, 1990, ARCH GEN PSYCHIAT, V47, P224; OTTO MW, 1994, ARCH CLIN NEUROPSYCH, V9, P81, DOI 10.1016/0887-6177(94)90016-7; PELCO L, 1992, Brain Injury, V6, P29, DOI 10.3109/02699059209008119; RADANOV BP, 1991, LANCET, V338, P712, DOI 10.1016/0140-6736(91)91441-V; ROBERTSON E, 1994, CLIN NEUROPSYCHOL, V8, P69; WILKINSON L, 1989, SYSTAT SYSTEM STAT; ZAPPALA G, 1992, ARCH CLIN NEUROPSYCH, V7, P145, DOI 10.1016/0887-6177(92)90008-B	14	36	38	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	SEP	1997	11	9					643	648		10.1080/026990597123197			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	XT726	WOS:A1997XT72600003	9376832				2022-02-06	
J	McCrory, PR				McCrory, PR			Were you knocked out? A team physician's approach to initial concussion management	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						concussion; mild head injury	CEREBRAL CONCUSSION; HEAD-INJURIES; CONTACT-SPORTS; 2ND IMPACT; GUIDELINES; PREVENTION; RECOVERY; MEMORY	To present an evidence-based approach reviewing the acute management of concussive brain injury in sport. All published articles on the acute management of sport-related brain injury were extracted using searches of computerised databases (Medline, Embase, Spelt Discus) as well as detailed literature reviews based upon the published bibliographies in this area. The review details the aspects where prospective scientific data is available upon which to base clinical management strategies. The first few minutes after an athlete receives a concussive injury provides a window of opportunity during which time the initial medical management forms a crucial and potentially lifesaving treatment. All clinicians involved in care of the concussed athlete need to have an understanding of the early management of the concussed athlete and a strategy by which they may manage such problems. An efficient and appropriate response to the immediate concussion management will help minimise the potential sequelae which may impact upon the athletes ability to return to sport.	AUSTIN & REPATRIAT MED CTR,DEPT NEUROL,HEIDELBERG,GERMANY		McCrory, PR (corresponding author), OLYMPIC PK SPORTS MED CTR,MELBOURNE,VIC,AUSTRALIA.		McCrory, Paul/Q-8688-2019				ALVES WM, 1987, CLIN SPORT MED, V6, P211; Barth JT, 1989, MILD HEAD INJURY, P257; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1984, BRIT MED J, V289, P715, DOI 10.1136/bmj.289.6447.715; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1992, PHYSICIAN SPORTSMED, V20, P55, DOI 10.1080/00913847.1992.11947483; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; GASTAUT H, 1957, LANCET, V2, P1018; GERSOFF W, 1991, SPORTS MED SCH AGE A, P45; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1976, Proceedings of the Australian Association of Neurologists, V13, P143; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1989, MILD HEAD INJURY, P153; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; JENNETT B, 1975, LANCET, V1, P480; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; KOBRINE AI, 1977, J NEUROSURG, V46, P256, DOI 10.3171/jns.1977.46.2.0256; KULUND D, 1982, INJURED ATHLETE, P225; LEMPERT T, 1994, ANN NEUROL, V36, P233, DOI 10.1002/ana.410360217; LENINGER B, 1990, J NEUROL NEUROSUR PS, V53, P293; LEVIN H, 1982, NEUROBEHAVIOURAL CON, P88; MADDOCKS D, 1989, SPORT HLTH S, V7, P6; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; MADDOCKS DL, 1991, J CLIN EXP NEUROPSYC, V13, P439; MADDOCKS DL, 1995, THESIS U MELBOURNE M; Maroon J C, 1980, Clin Neurosurg, V27, P414; McCrory P, 1997, PHYSICIAN SPORTSMED, V25, P33, DOI 10.3810/psm.1997.02.1133; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; NARAYAN R, 1996, NEUROTRAUMA, P913; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; OMMAYA A, 1990, SPORTS NEUROLOGY, P84; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PATEL MN, 1994, PHYSICIAN SPORTSMED, V22, P57, DOI 10.1080/00913847.1994.11947694; PICKLES W, 1950, NEW ENGL J MED, V242, P607, DOI 10.1056/NEJM195004202421602; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROBERTS WO, 1992, PHYSICIAN SPORTSMED, V20, P66, DOI 10.1080/00913847.1992.11710295; Roos R, 1996, PHYSICIAN SPORTSMED, V24, P67, DOI 10.3810/psm.1996.10.1327; Russell WR, 1935, LANCET, V2, P762; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; Rutherford W. H., 1989, MILD HEAD INJURY, P217; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; *SOC COL MED, 1991, REP SPORTS MED COMM; TORG JF, 1991, ATHLETIC INJURIES HE, P694; VANZOMEREN AH, 1981, REACTION TIME ATTENT, P15; Wechsler, 1997, WECHSLER ADULT INTEL; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; YARNELL PR, 1970, LANCET, V1, P863; [No title captured]	55	36	35	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0195-9131			MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUL	1997	29	7		S			S207	S212					6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	XM280	WOS:A1997XM28000001	9247917				2022-02-06	
J	Amirjamshidi, A; Abbassioun, K; Roosbeh, H				Amirjamshidi, A; Abbassioun, K; Roosbeh, H			Air-gun pellet injuries to the head and neck	SURGICAL NEUROLOGY			English	Article						air-gun pellet; brain abscess; brain injury; missile; traumatic aneurysm	CRANIOCEREBRAL GUNSHOT WOUNDS; INTERNAL CAROTID-ARTERY; TRAUMATIC ANEURYSMS; PENETRATING WOUNDS; LEBANESE CONFLICT; CIVILIAN PRACTICE; MISSILE INJURIES; BRAIN; MANAGEMENT; VIETNAM	BACKGROUND Air-gun pellet injuries (AgPI) of the central nervous system (CNS) are rare but catastrophic events. They occur mostly in children and young adults. The entrance is usually either through the orbit or through the neck and the entry wound is so small that it may be disregarded on physical examination in the emergency room. Early recognition and correct management of the possible complications of AgPIs is important and may prevent a poor outcome. METHODS We intend to present our experience with 16 cases of AgPIs of the head and neck referred to the department of neurosurgery during the last 15 years. The characteristic findings on physical examination of the cases and the imaging studies performed are described. Special management undertaken for the rare complications are mentioned and a short literature review is performed on each entity. RESULTS All our cases happened in the first and second decades of life and only in boys playing with toy guns. There were 12 head and face and four neck wounds. Damaged globe that had to be exenterated was the earliest complication, handled by ophthalmologists (four cases). Cerebrospinal fluid (CSF) leakage, meningitis, brain abscess formation, development of traumatic aneurysm (TA), carotid-cavernous sinus fistula (CCF), wandering intracerebral and intraventricular pellet, and splitting of the pellet after striking hard bone were the complications noted. In addition to plain X ray films, computed tomography (CT) scanning and angiography were diagnostic procedures of choice CONCLUSIONS The present series of patients is the largest collection of AgPIs to the head and neck reported in the literature in which nearly all the possible complications of such injuries have been reviewed. Early recognition and awareness of the possible cumbersome complications of such a minor penetrating wound can prevent major catastrophies in this young group of victims. (C) 1997 by Elsevier Science Inc.	UNIV TEHRAN, TEHRAN, IRAN		Amirjamshidi, A (corresponding author), SINA HOSP, DEPT NEUROSURG, IMAM AVE, TEHRAN, IRAN.						AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; APPLEGATE LJ, 1990, NEUROSURGERY, V20, P312; BISHOP EJ, 1967, NEUROSURGERY TRAUMA, P203; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; BYRNES DP, 1974, BRIT J SURG, V61, P169, DOI 10.1002/bjs.1800610302; Campbell E, 1942, ARCH SURG-CHICAGO, V44, P789, DOI 10.1001/archsurg.1942.01210230013002; CAREY ME, 1972, SURG GYNECOL OBSTETR, V135, P386; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CHAPMAN PH, 1985, CONCEPTS PEDIAT NEUR, V5, P1; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; DEYSINE M, 1969, SURGERY, V66, P1004; EICHLER A, 1969, J NEUROSURG, V31, P72, DOI 10.3171/jns.1969.31.1.0072; FURLOW LT, 1947, J NEUROSURG, V4, P380, DOI 10.3171/jns.1947.4.4.0380; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HAYNES WG, 1945, J NEUROSURG, V2, P365, DOI 10.3171/jns.1945.2.5.0365; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P199, DOI 10.1007/BF01808959; HUBSCHMANN O, 1979, J TRAUMA, V19, P6, DOI 10.1097/00005373-197901000-00002; KIRKPATRICK JB, 1978, J NEUROSURG, V49, P185, DOI 10.3171/jns.1978.49.2.0185; KOJIMA T, 1987, NEUROSURGERY, V20, P322, DOI 10.1227/00006123-198702000-00022; MALTBY GL, 1946, J NEUROSURG, V3, P239, DOI 10.3171/jns.1946.3.3.0239; MEIROWSKY AM, 1981, J NEUROSURG, V54, P44, DOI 10.3171/jns.1981.54.1.0044; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; PENECK TL, 1986, J NEUROSURG, V64, P813; POZZATI E, 1982, J NEUROSURG, V57, P418, DOI 10.3171/jns.1982.57.3.0418; RAHIMIZADEH A, 1987, ACTA NEUROCHIR, V84, P93, DOI 10.1007/BF01418831; RAHMAT H, 1984, J NEUROSURG, V60, P630, DOI 10.3171/jns.1984.60.3.0630; RAIMONDI AJ, 1970, J NEUROSURG, V32, P647, DOI 10.3171/jns.1970.32.6.0647; RICH NM, 1980, AM J SURG, V139, P414, DOI 10.1016/0002-9610(80)90304-9; ROSS DA, 1988, NEUROSURGERY, V22, P414, DOI 10.1227/00006123-198802000-00025; SADAR ES, 1973, SURG GYNECOL OBSTET, V137, P59; SHUMACKER HB, 1955, VASCULAR SURG WORLD, P361; Small JM, 1945, BRIT J SURG, V32, P414, DOI 10.1002/bjs.18003212715; TAHA JM, 1991, NEUROSURGERY, V29, P380, DOI 10.1227/00006123-199109000-00007; TEAL JS, 1973, J NEUROSURG, V38, P568, DOI 10.3171/jns.1973.38.5.0568; THOMAS JN, 1979, J LARYNGOL OTOL, V93, P383, DOI 10.1017/S0022215100087168; VAQUERO J, 1982, NEURORADIOLOGY, V23, P161; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	41	36	37	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	APR	1997	47	4					331	338		10.1016/S0090-3019(96)00357-6			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WR392	WOS:A1997WR39200016	9122835				2022-02-06	
J	Sander, AM; Witol, AD; Kreutzer, JS				Sander, AM; Witol, AD; Kreutzer, JS			Alcohol use after traumatic brain injury: Concordance of patients' and relatives' reports	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SELF-REPORTS; FOLLOW-UP; DRINKING; VALIDITY	Objective: To investigate bias and concurrent validity of patients' alcohol use reports by examining concordance with relatives' reports. Design: Using a quasiexperimental static group comparison design, alcohol use was examined at 1 year after injury. Chi-square analyses, t tests, and a Fisher exact probability test were conducted to investigate the relationship between patients' and caregivers' reports on measures of alcohol use. Setting: Medical center outpatient clinic Participants: 175 adult patients with traumatic brain injury and 175 family informants. Inclusion criteria were: patient older than 18 years of age and completion of self-report and family member versions of questionnaires. The full range of brain injury severity was represented. Main Outcome Measures: Quantity-Frequency-Variability Index (QFVI; Cahalan and Cisin, 1968); Brief Michigan Alcohol Screening Test (B-MAST; Porkorny et al, 1972). Results: A high rate of concordance, typically greater than 90%, was noted between patients' and relatives' reports on each of the alcohol use measures. Chi-square analyses revealed no significant differences (p > .05) between patients' and relatives' reports for the QFVI or the B-MAST. Inspection of the data found lesser rates of agreement for persons with severe injuries. Chi-square analyses revealed no differences based on family members' relationship to patients or whether they lived together or apart. However, a Fisher exact probability test (p < .03) for the QFVI indicated higher agreement rates for spouses relative to parents. Conclusions: The results do not support the hypothesis that patients underreport drinking and that their reports are inconsistent with those of caregivers. The high levels of concordance are consistent with those found in similar research studies involving alcoholic populations. Results suggest that patients' reports should be given higher credibility and should not be routinely dismissed in favor of information provided by families. However, more caution is necessary when collecting information from persons with severe injury. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT REHABIL MED,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV NEUROL SURG,RICHMOND,VA 23298								Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P642; CAHALAN D, 1968, Q J STUD ALCOHOL, V29, P130; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; HESSELBROCK M, 1983, INT J ADDICT, V18, P593, DOI 10.3109/10826088309027359; HOFFMANN NG, 1994, ALCOHOL CLIN EXP RES, V18, P231, DOI 10.1111/j.1530-0277.1994.tb00006.x; Kreutzer J., 1987, GEN HLTH HIST QUESTI; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer J.S., 1990, COMMUNITY INTEGR TRA, P249; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; MAISTO SA, 1979, J CONSULT CLIN PSYCH, V47, P106, DOI 10.1037/0022-006X.47.1.106; OFARRELL TJ, 1984, BEHAV ASSESS, V6, P263; POLICH JM, 1982, ADDICT BEHAV, V7, P123, DOI 10.1016/0306-4603(82)90037-5; PORKORNY AD, 1972, AM J PSYCHIAT, V129, P342; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; *SECR HLTH HUM SER, 1987, 6 SPEC REP US C ALC; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; SKINNER H, 1982, J STUD ALCOHOL, V40, P502; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WILKINSON DA, 1987, NEUROPSYCHOLOGY ALCO, P76; *WISC DEP HLTH SOC, 1985, ALC PERS DIS PREL RE; ZUNG BJ, 1975, J STUD ALCOHOL, V36, P127, DOI 10.15288/jsa.1975.36.127	29	36	36	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	1997	78	2					138	142		10.1016/S0003-9993(97)90254-9			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	WH072	WOS:A1997WH07200005	9041893				2022-02-06	
J	Perri, BR; Smith, DH; Murai, H; Sinson, G; Saatman, KE; Raghupathi, R; Bartus, RT; McIntosh, TK				Perri, BR; Smith, DH; Murai, H; Sinson, G; Saatman, KE; Raghupathi, R; Bartus, RT; McIntosh, TK			Metabolic quantification of lesion volume following experimental traumatic brain injury in the rat	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; histopathology; lateral fluid-percussion; lesion volume; metabolism; TTC	FOCAL CEREBRAL-ISCHEMIA; BLOOD-FLOW; CALPAIN INHIBITOR; ARTERY OCCLUSION; DAMAGE; EDEMA; CHLORIDE; MODEL; (S)-EMOPAMIL; REDUCTION	A reliable and rapid method for quantifying lesion volume following traumatic brain injury (TBI) has vast potential in brain injury research. Staining with 2,3,5-triphenyltetrazolium chloride (TTC) provides for demarcation of damaged or infarcted tissue from normal, viable cerebral tissue, in which a red formazan product is formed by reduction during cellular respiration of mitochondrial dehydrogenase enzymes. The present study evaluated the use of TTC staining to quantify the cortical lesion volume in rats undergoing fluid-percussion (FP) brain injury. Male Sprague-Dawley rats (350-450 g, n = 27) were anesthetized (sodium pentobarbital, 60 mg/kg, ip) and subjected to lateral FP brain injury of mild (1.1-1.3 atm, n = 5), moderate (2.0-2.3 atm, n = 9), or high (2.4-2.6 atm, n = 8) severity, while sham (noninjured) animals (n = 5) were anesthetized and surgically prepared without injury. Forty-eight hours after injury animals were sacrificed, brains were stained with TTC, and lesion volumes were calculated. A highly significant correlation was found between cerebral cortical lesion volume (mm(3)) and severity of brain injury (r = 0.85; p < 0.0001). The mean (+/- SD) lesion volumes were 12.1 (+/- 4.5) mm(3) following mild injury, 33.8 (+/- 8.6) mm(3) following moderate injury, and 45.1 (+/- 14.0) mm(3) following severe injury. A significant difference was observed between all injury groups using a t test with Bonferroni correction (p < 0.05). These results suggest that the TTC staining technique is a useful, rapid, and reproducible method for quantification of lesion volume following lateral FP brain injury.	UNIV PENN,DIV NEUROSURG,PHILADELPHIA,PA 19104; ALKERMES INC,CAMBRIDGE,MA 02139				Raghupathi, Ramesh/AAX-5538-2021; smith, douglas/A-1321-2007		NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01-AG12527] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS26818, R01-NS08803] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG012527] Funding Source: NIH RePORTER		BARTUS RT, 1994, J CEREBR BLOOD F MET, V14, P537, DOI 10.1038/jcbfm.1994.67; BARTUS RT, 1994, STROKE, V25, P2265, DOI 10.1161/01.STR.25.11.2265; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BOSE B, 1988, STROKE, V19, P28, DOI 10.1161/01.STR.19.1.28; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; COLE DJ, 1990, ACTA NEUROPATHOL, V80, P152, DOI 10.1007/BF00308918; COLE DJ, 1993, CAN J NEUROL SCI, V20, P30, DOI 10.1017/S0317167100047363; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; ELGER B, 1994, EUR J PHARMACOL, V254, P65, DOI 10.1016/0014-2999(94)90371-9; FADEN AI, 1993, J NEUROTRAUM, V10, P91, DOI 10.1089/neu.1993.10.91; HEINEL LA, 1994, BRAIN RES BULL, V34, P137, DOI 10.1016/0361-9230(94)90010-8; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; HOVDA DA, 1992, J NEUROTRAUMA, V9, P547; ISAYAMA K, 1991, STROKE, V22, P1394, DOI 10.1161/01.STR.22.11.1394; KIYOTA Y, 1993, EXP BRAIN RES, V95, P388; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; MARINOV M, 1991, Neurological Research, V13, P77; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEMEZAWA H, 1992, EXP BRAIN RES, V89, P67; MINEMATSU K, 1992, NEUROLOGY, V42, P235, DOI 10.1212/WNL.42.1.235; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; OKIYAMA K, 1994, J NEUROTRAUM, V11, P83, DOI 10.1089/neu.1994.11.83; PARK CK, 1988, NEUROPATH APPL NEURO, V14, P289, DOI 10.1111/j.1365-2990.1988.tb00889.x; PITTS L, 1990, HDB CLIN NEUROLOGY, P65; RANJAN A, 1993, ACTA NEUROCHIR, V123, P87, DOI 10.1007/BF01476291; SAEED D, 1993, PEDIATR NEUROL, V9, P263, DOI 10.1016/0887-8994(93)90061-G; Smith D. H., 1994, Society for Neuroscience Abstracts, V20, P424; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soares HD, 1995, J NEUROSCI, V15, P8223; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; VINK R, 1994, NEUROBIOLOGY CNS TRA, P68; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	42	36	37	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	1997	14	1					15	22		10.1089/neu.1997.14.15			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WK032	WOS:A1997WK03200002	9048307				2022-02-06	
J	Hawkins, ML; Lewis, FD; Medeiros, RS				Hawkins, ML; Lewis, FD; Medeiros, RS			Serious traumatic brain injury: An evaluation of functional outcomes	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	55th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 27-30, 1995	HALIFAX, CANADA	Amer Assoc Surg Trauma		serious traumatic brain injury; functional independence measure; Glasgow Coma Scale; injury severity score; outcomes measurement	REHABILITATION	Objectives: Evaluate independent living, productivity, and social outcomes of patients with serious traumatic brain injury (TBI) after inpatient rehabilitation, Methods: Fifty-five adults with serious TBI (Abbreviated Injury Scale score greater than or equal to 3) were admitted to a Level I trauma center and subsequently transferred to a comprehensive inpatient rehabilitation hospital (Walton Rehabilitation Hospital), Functional Independence Measures were obtained at admission (Adm), discharge (D/C), and at 3- (n = 52) and 1-year (n = 51) follow-up, Results: At 1 year, 90% of the patients were living at home. Eight (16%) required full-time supervision, while 41 (82%) were independent of supervision throughout most of the day, Thirteen (25%) patients had returned to work, eight full time and five with reduced responsibility and fewer hours than before injury, Nineteen shared household duties, while eight (16%) had primary responsibility. Fourteen (27%) patients demonstrated socially inappropriate or disruptive behavior at least weekly. [GRAPHICS] Conclusion: Although cognitive skills were diminished for the majority of patients, many achieved a substantial reduction in disability within 18 months after TBI.	WALTON REHABIL HOSP,AUGUSTA,GA		Hawkins, ML (corresponding author), MED COLL GEORGIA,1120 15TH ST,ROOM BA 4411,AUGUSTA,GA 30912, USA.						*AM COLL SURG, 1993, ATLS INSTR MAN, P9; COOK L, 1994, ARCH PHYS MED REHAB, V75, P390, DOI 10.1016/0003-9993(94)90160-0; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Di Donato B A, 1994, Rehabil Nurs, V19, P219; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Gronwall D, 1989, MILD HEAD INJURY, P153; Haffey W. J., 1990, NEUROPSYCHOLOGY EVER, P99; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; JOHNSTON MV, 1994, ARCH PHYS MED REHAB, V75, pSC2; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keith R A, 1987, Adv Clin Rehabil, V1, P6; LONG WB, 1994, ARCH PHYS MED REHAB, V75, P144; MALKMUS D, 1974, ASSESSMENT MANUAL; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1987, BNI Q, V31, P10; RHODES M, 1988, J TRAUMA, V28, P931, DOI 10.1097/00005373-198807000-00005; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; STRAX TE, 1994, ARCH PHYS MED REHAB, V75, pSC1; [No title captured]	19	36	36	0	3	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	1996	41	2					257	263		10.1097/00005373-199608000-00010			7	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	VC511	WOS:A1996VC51100015	8760533				2022-02-06	
J	Mathew, P; Bullock, R; Teasdale, G; McCulloch, J				Mathew, P; Bullock, R; Teasdale, G; McCulloch, J			Changes in local microvascular permeability and in the effect of intervention with 21-aminosteroid (Tirilazad) in a new experimental model of focal cortical injury in the rat	JOURNAL OF NEUROTRAUMA			English	Article						autoradiography; focal injury; microvascular permeability; rodent; 21-aminosteroid	BLOOD-BRAIN-BARRIER; OXYGEN-FREE-RADICALS; CEREBROVASCULAR PERMEABILITY; LIPID-PEROXIDATION; HEAD-INJURY; EDEMA; DISRUPTION; TRANSPORT; RESPONSES; SYSTEM	In a new, reproducible model of rodent focal cortical injury, we have shown that in the absence of early traumatic disruption of the microvasculature and subsequent hemorrhage, delayed perivascular protein leakage and polymorphonuclear leukocyte infiltration of the injured cortex occur. In this study we employed a sensitive quantitative autoradiographic technique (using alpha-aminoisobutyric acid as a tracer) to investigate the focal changes in microvascular permeability with time and to determine the effects of administration of a 21-aminosteroid (Tirilazad) initiated 5 min after induction of the cortical injury. At all time points studied, there was a significant increase in perilesional blood-brain barrier permeability in lesioned animals treated with vehicle, compared to sham-operated animals, with the most marked increase in blood-brain barrier permeability at 4 h postinjury (mean K-i +/- SE = 19.2 +/- 2.4/1000 min with cortical injury, 1.5 +/- 0.3/1000 min in shams) (mean volume +/- SE = 15.48 +/- 0.7 mm(3)). In animals with cortical injury treated with Tirilazad (10 mg/kg), there was a significant reduction in microvascular permeability at the site of injury (K-i = 3.1 +/- 0.5, p < 0.001) and a significant reduction in volume of increased permeability (4.86 +/- 0.7 mm(3), p < 0.01) at 4 h postinjury. In this model of cortical injury, a delayed increase in microvascular permeability occurs, which is significantly attenuated by postinjury treatment with Tirilazad.	SO GEN HOSP, INST NEUROL SCI, DEPT NEUROSURG, GLASGOW G51 4TF, LANARK, SCOTLAND; UNIV GLASGOW, WELLCOME SURG INST, GLASGOW G61 1QH, LANARK, SCOTLAND						Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Anderson DK, 1991, J NEUROTRAUM, V8, P187, DOI 10.1089/neu.1991.8.187; Blasberg R G, 1980, Adv Neurol, V28, P255; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; BROSNAN CF, 1989, J NEUROIMMUNOL, V25, P227, DOI 10.1016/0165-5728(89)90141-0; BULLOCK R, 1990, ACT NEUR S, V51, P286; CAO W, 1988, NEUROSCI LETT, V88, P233, DOI 10.1016/0304-3940(88)90132-2; COLTRAN RS, 1987, J IMMUNOL, V139, P1833; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DUMLICH RVW, 1990, ADV NEUROL, V52, P365; ELLISON MD, 1990, J NEUROIMMUNOL, V28, P249, DOI 10.1016/0165-5728(90)90018-I; HADLEY DM, 1991, NEURORADIOLOGY S, V33, P86; HALL ED, 1992, J NEUROTRAUM, V9, pS425; IKEDA Y, 1990, NEUROSURGERY, V27, P1; JOO F, 1994, ACT NEUR S, V60, P76; KLATZO I, 1994, ACTA NEUROCHIR, P3; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1989, INTRACRANIAL PRESSUR, V7, P787; LOSSINSKY AS, 1979, ACTA NEUROPATHOL, V47, P105, DOI 10.1007/BF00717032; MATHEW P, 1994, ACTA NEUROCHIR, P428; MATHEW P, 1993, J NEUROTRAUMA S1, V1, P80; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MITCHELL J, 1979, ACTA NEUROPATHOL, V46, P45, DOI 10.1007/BF00684803; OHNO K, 1978, AM J PHYSIOL, V235, pH299, DOI 10.1152/ajpheart.1978.235.3.H299; PERSSON L, 1976, ACTA NEUROPATHOL, V35, P333; PETITO CK, 1979, J NEUROPATH EXP NEUR, V38, P222, DOI 10.1097/00005072-197905000-00003; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; Smith SL, 1996, J NEUROSURG, V84, P229, DOI 10.3171/jns.1996.84.2.0229; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TODD NV, 1990, ACT NEUR S, V51, P296; TOMITA H, 1994, ACTA NEUROCHIR, P558; TORNHEIM PA, 1984, J NEUROSURG, V60, P473, DOI 10.3171/jns.1984.60.3.0473; TYSON GW, 1982, J NEUROSURG, V57, P186, DOI 10.3171/jns.1982.57.2.0186; VOLTERRA A, 1994, J NEUROSCI, V14, P2924; WEI EP, 1986, AM J PHYSIOL, V251, pH693, DOI 10.1152/ajpheart.1986.251.4.H693; ZALESKA MM, 1985, NEUROCHEM RES, V10, P397, DOI 10.1007/BF00964608; ZUCCARELLO M, 1989, STROKE, V20, P367, DOI 10.1161/01.STR.20.3.367	39	36	37	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	1996	13	8					465	472		10.1089/neu.1996.13.465			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	VH009	WOS:A1996VH00900004	8880610				2022-02-06	
J	Massagli, TL; Jaffe, KM; Fay, GC; Polissar, NL; Liao, SQ; Rivara, JB				Massagli, TL; Jaffe, KM; Fay, GC; Polissar, NL; Liao, SQ; Rivara, JB			Neurobehavioral sequelae of severe pediatric traumatic brain injury: A cohort study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SEVERE HEAD-INJURY; CHILDREN; ADOLESCENTS; RECOVERY; MEMORY	Objectives: To determine: (1) the magnitude of neurobehavioral deficits following severe traumatic brain injury (TBI) in children, 3 weeks and 1 year after resolution of post-traumatic amnesia (PTA); (2) the relationship between deficits and injury severity; (3) the performance of cases compared to population norms versus individually matched controls. Design: Prospective cohort study. Setting: Two regional university medical centers, Participants: Cases were 30 children 6 to 15 years old with severe TBI, measured by initial Glasgow Coma Scale (GCS) score and days to reach a GCS score of 15. Controls were individually matched for age, gender, and premorbid academic achievement. Main Outcome Measures: Subjects received the same neurobehavioral tests three weeks and one year after resolution of PTA, Outcomes included individual test scores and variables summarizing results in eight domains. Correlations were calculated between deficits, expressed as case-control differences, and injury severity. Results: Cases showed substantial deficits and performed significantly more poorly than controls at both initial and 1-year testing. At initial testing, cases had an overall score two standard deviations below controls, At I-year testing their overall score was one standard deviation below controls. Greater impairment was found in those who reached a GCS score of 15 after 1 month or who had an initial GCS of 3 to 5. The proportion of cases with deficits and the magnitude of deficits at both testing times was underestimated by using population norms instead of controls. Conclusions: Severe TBI results in significant, persistent deficits related to the level of severity, Comparisons with population norms instead of controls underestimates deficits. (C) 1996 by the American Congress of Rehabilitation Medicine	CHILDRENS HOSP & MED CTR,DEPT PEDIAT,SEATTLE,WA 98105; CHILDRENS HOSP & MED CTR,DEPT NEUROL SURG,SEATTLE,WA 98105; UNIV WASHINGTON,DEPT REHABIL MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT NEUROL SURG,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195; UNIV WASHINGTON,SCH SOCIAL WORK,SEATTLE,WA 98195; STAT & EPIDEMIOL RES CORP,SEATTLE,WA; NORTHWEST HOSP,SEATTLE,WA		Massagli, TL (corresponding author), CHILDRENS HOSP & MED CTR,DEPT REHABIL MED,CH-71,POB 5371,SEATTLE,WA 98105, USA.						BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bruininks R. H., 1984, SCALES INDEPENDENT B; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1984, J CLIN NEUROPSYCHOL, V6, P269; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; DELIS DC, 1989, CALIFORNIA VERBAL LE; DeMyer W, 1980, TECHNIQUE NEUROLOGIC; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; GOTTFRIED AW, 1985, MERRILL PALMER QUART, V31, P85; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; JENNET B, 1979, ADV NEUROLOGY, V22; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; SNEDECOR GW, 1967, STAT METHODS; Wechsler D., 1974, WECHSLER INTELLIGENC; Wilkinson, 1984, WIDE RANGE ACHIEVEME; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218	32	36	36	0	6	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1996	77	3					223	231		10.1016/S0003-9993(96)90102-1			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	TZ874	WOS:A1996TZ87400003	8600862				2022-02-06	
J	Kronisch, RL; Chow, TK; Simon, LM; Wong, PF				Kronisch, RL; Chow, TK; Simon, LM; Wong, PF			Acute injuries in off-road bicycle racing	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article							SEVERITY SCORE; CARE	A descriptive study was conducted to investigate injuries sustained at a major off-road bicycling race at Mammoth Mountain, California, July 6 to 10, 1994. A total of 4027 individual starts in five events during the race were reported. Overall, the total number of competitors in the 5 events was 3624, with some cyclists participating in multiple events. Injuries were considered significant if they occurred during competition and prevented the rider from completing the event. Sixteen cyclists had injuries that met these criteria for an overall injury rate of 0.40%. These 16 cyclists had 44 injuries. Abrasions were the most common injury, followed by contusions, lacerations, fractures, and concussions. The mean injury severity score was 3.0 (range, 1 to 5) with 81.2% of the injuries resulting from cyclists going downhill. Injuries were more severe when the riders were thrown from the bicycles (P = 0.03). We observed different mechanisms of injury in various events, suggesting that the risk factors for sustaining a traumatic injury may vary according to the type of competition involved.	LOMA LINDA UNIV,MED CTR,LOMA LINDA,CA		Kronisch, RL (corresponding author), SAN JOSE STATE UNIV,1 WASHINGTON SQ,SAN JOSE,CA 95192, USA.						[Anonymous], 1990, ABBREVIATED INJURY S; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brogger-Jensen T, 1990, Br J Sports Med, V24, P269; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHOW TK, 1993, WESTERN J MED, V159, P145; KRONISCH RL, 1994, CLIN J SPORT MED, V4, P240; Maslanka Alex M., 1993, Emergency Medicine Clinics of North America, V11, P15; MCLENNAN JG, 1988, AM J SPORT MED, V16, P266, DOI 10.1177/036354658801600312; PFEIFFER RP, 1994, CLIN SPORT MED, V13, P207; PFEIFFER RP, 1993, CYCLING SCI, V5, P21; Withers B F, 1984, Emerg Med Clin North Am, V2, P701	12	36	38	0	2	AMER ORTHOPAEDIC SOC SPORT MED	WALTHAM	230 CALVARY STREET, WALTHAM, MA 02154	0363-5465			AM J SPORT MED	Am. J. Sports Med.	JAN-FEB	1996	24	1					88	93		10.1177/036354659602400116			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	TR338	WOS:A1996TR33800016	8638760				2022-02-06	
J	Parker, RS; Rosenblum, A				Parker, RS; Rosenblum, A			IQ loss and emotional dysfunctions after mild head injury incurred in a motor vehicle accident	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							WHIPLASH INJURY; WAIS-R; CEREBRAL CONCUSSION; NECK; COMPENSATION; DEFICITS; SYMPTOMS; STRESS; IMPACT	Intelligence and personality dysfunctions after minor traumatic brain injury (TBI) (whiplash; slight head impact) incurred in a motor vehicle accident (MVA) were studied in adults after an average interval of 20 months. There was a mean loss of 14 points of Full Scale IQ from estimated preinjury baseline IQ determined from the standardization group (WAIS-R) without evidence for recovery. Personality dysfunctions included cerebral personality disorder, psychiatric diagnosis (30 of 33 patients), post-traumatic stress disorders, persistent altered consciousness, and psychodynamic reactions to impairment. Cognitive loss is caused by interaction of brain injury with distractions such as pain and emotional distress. Unreported head impact and altered consciousness at the time of accident contribute to the underestimation of brain trauma after minor TBI.	NATL DEV RES INST INC,NEW YORK,NY		Parker, RS (corresponding author), NYU,MED CTR,NEW YORK,NY 10012, USA.						Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; AUER RN, 1994, J NEUROL NEUROSUR PS, V57, P500, DOI 10.1136/jnnp.57.4.500; Becker DP, 1989, TXB HEAD INJURY, P1; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BOHNEN N, 1993, ACTA NEUROL BELG, V93, P23; BOONE DE, 1992, J CLIN PSYCHOL, V48, P72, DOI 10.1002/1097-4679(199201)48:1<72::AID-JCLP2270480111>3.0.CO;2-0; CARETTE S, 1994, NEW ENGL J MED, V330, P1083, DOI 10.1056/NEJM199404143301512; COLLUM CM, 1991, FORENSIC NEUROPSYCHO, P141; CORNES P, 1992, INJURY, V23, P256, DOI 10.1016/S0020-1383(05)80011-7; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FARR SP, 1986, HDB CLIN NEUROPSYCHO, V2, P213; GALASKO D, 1993, NEUROLOGY, V43, P1559, DOI 10.1212/WNL.43.8.1559; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; Gennarelli T, 1982, HEAD INJURY BASIC CL, V1982, P129; GLOVER H, 1992, J TRAUMA STRESS, V5, P643, DOI 10.1007/BF00979232; GOTTEN N, 1956, JAMA-J AM MED ASSOC, V162, P865, DOI 10.1001/jama.1956.02970260015005; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GREGORY R, 1987, ADULT INTELLECTUAL A; GURDJIAN ES, 1975, SURG GYNECOLOGY OBST, V146, P805; HIRSCH AD, 1968, 287 DEP NAV NAV SHIP, V19, P352; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; KHURANA RK, 1986, HEADACHE, V26, P183, DOI 10.1111/j.1526-4610.1986.hed2604183.x; Kirkpatrick J B, 1983, Acta Neurochir Suppl (Wien), V32, P115; LEE J, 1993, J PSYCHOSOM RES, V37, P105, DOI 10.1016/0022-3999(93)90076-R; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; LEVIN HS, 1985, CENTRAL NERVOUS SYST, P281; MATARAZZO JD, 1984, J CONSULT CLIN PSYCH, V52, P631, DOI 10.1037/0022-006X.52.4.631; MAYOU R, 1992, International Review of Psychiatry, V4, P45, DOI 10.3109/09540269209066301; MCCAFFREY RJ, 1992, CLIN NEUROPSYCHOL, V0006, P00032, DOI [DOI 10.1080/138540492084041_15, DOI 10.1080/13854049208404115]; MILLER L, 1994, PSYCHOTHERAPY, V31, P161, DOI 10.1037/0033-3204.31.1.161; MILLER L, 1993, J COGNITIVE REHA JUL, P18; Ommaya A. K., 1990, NEUROLOGICAL SURG, V3, P1877; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PARKER R, 1990, TRAUMATIC BRAIN INJU; PARKER RS, 1994, GUIDE ANAL UNDERSTAN, P79; PARKER RS, 1994, J NEUROL ORTH MED S, V15, P123; PARMAR HV, 1993, INJURY, V24, P75, DOI 10.1016/0020-1383(93)90191-8; PEARCE JMS, 1994, NEUROLOGY, V44, P1993, DOI 10.1212/WNL.44.11.1993; PEARCE JMS, 1992, HEADACHE Q-CURR TREA, V3, P45; PENNIE B, 1991, INJURY, V22, P57, DOI 10.1016/0020-1383(91)90166-C; PILOWSKY I, 1985, BRIT J PSYCHIAT, V147, P310, DOI 10.1192/bjp.147.3.310; PORTER KM, 1989, BRIT MED J, V298, P973, DOI 10.1136/bmj.298.6679.973; PRIGATANO GP, 1991, AWARENESS DEFICIT BR, P110; PUTNAM SH, 1992, PSYCHOL ASSESSMENT, V4, P312; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; RADANOV BP, 1994, BRIT J RHEUMATOL, V33, P442; ROSS ED, 1993, NEUROL CLIN, V11, P9, DOI 10.1016/S0733-8619(18)30168-3; RYAN JJ, 1991, J CLIN PSYCHOL, V47, P104, DOI 10.1002/1097-4679(199101)47:1<104::AID-JCLP2270470117>3.0.CO;2-2; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Van der Kolk Bessel A., 1988, J TRAUMA STRESS, V1, P273, DOI [10.1002/jts.2490010302, DOI 10.1002/JTS.2490010302]; Wechsler, 1997, WECHSLER ADULT INTEL	60	36	37	0	1	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	JAN	1996	52	1					32	43		10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.3.CO;2-1			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	TY363	WOS:A1996TY36300005	8682910				2022-02-06	
J	ALEXIS, NE; DIETRICH, WD; GREEN, EJ; PRADO, R; WATSON, BD				ALEXIS, NE; DIETRICH, WD; GREEN, EJ; PRADO, R; WATSON, BD			NONOCCLUSIVE COMMON CAROTID-ARTERY THROMBOSIS IN THE RAT RESULTS IN REVERSIBLE SENSORIMOTOR AND COGNITIVE-BEHAVIORAL DEFICITS	STROKE			English	Article						BEHAVIOR, ANIMAL; CEREBRAL ISCHEMIA; COGNITION; STROKE; RATS	MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN INJURY; DOPPLER ULTRASOUND; CORTEX INJURY; RECOVERY; CONSEQUENCES; INFARCTION; OCCLUSION; STROKE; MODEL	Background and Purpose Microemboli released during transient ischemic attack, stroke, and cardiac surgery are thought to cause a variety of functional deficits in humans. The purpose of this study was to characterize the type and extent of neurobehavioral deficits present after photochemically induced common carotid artery thrombosis (CCAT), a thromboembolic model of stroke in the rat that results In shower. Methods Thirty-two male Wistar rats were assigned to four groups 1 (n=8) and 3 (n=8) were long-term (6-week survival) and short-term (2-week survival) experimental groups subjected to right CCAT with the use of the photochemical technique. Groups 2 (n=8) and 4 (n=8) served as sham-operated controls for each experimental group. A battery of behavioral tests was applied daily beginning 24 hours after thrombosis; this consisted of elicited forelimb placing, postural reflex, beam balance, beam walking, and open Field activity. Cognitive testing with a water maze task was performed on post-CCAT days 30 to 33 fur groups 1 and 2 and on post-CCAT day 2 for groups 3 and 4. Ten-micrometer coronal brain sections were stained with hematoxylin and eosin, and infarct location and frequency were determined. Results Significant sensorimotor deficits were observed; which recovered within 2 weeks after CCAT. The data that follow are derived by combining the two experimental groups and comparing these with the two sham groups. The following tests showed significant effects after CCAT: contralateral elicited forelimb placing, ipsilateral elicited forelimb placing, beam balance, and beam walking score. Cognitive dysfunction was seen acutely (group 3 animals) at 2 days after CCAT; Morris water maze length and latency to target were significantly greater in the experimental group. No deficits were seen in postural reflex, open field activity, or delayed cognitive testing. Histopathological assessment revealed small infarcts in 11 of 16 thrombosed rats. However, a strong relationship between neurobehavioral deficits and infarct location was not consistently demonstrated. Conclusions CCAT produces consistent sensorimotor and cognitive behavioral deficits that recover within 2 weeks of injury. Behavioral outcome was not necessarily associated with overt histopathological damage, suggesting that reversible injury mechanisms, both vascular and neuronal, may be partly responsible for the temporary loss of function. These data strengthen the role of CCAT as a clinically relevant model of thromboembolic stroke.	UNIV MIAMI,DEPT PSYCHOL,CORAL GABLES,FL 33124; UNIV MIAMI,SCH MED,DEPT NEUROL,CEREBRAL VASC DIS RES CTR,CORAL GABLES,FL 33124						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-23244, NS-05820, NS-27127] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027127, P01NS005820, P50NS005820, R01NS023244] Funding Source: NIH RePORTER		ATTELLA MJ, 1992, BEHAV NEURAL BIOL, V57, P157, DOI 10.1016/0163-1047(92)90665-Q; BARBUT D, 1994, STROKE, V25, P2398, DOI 10.1161/01.STR.25.12.2398; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Betz A. Lorris, 1994, P681; BLAUTH CI, 1988, J THORAC CARDIOV SUR, V95, P668; Brierly J, 1984, GREENFIELDS NEUROPAT, P125; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; COYLE P, 1992, STROKE, V23, P697; DERYCK M, 1992, BRAIN RES, V573, P44; DIETRICH WD, 1994, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1994, P565; DIETRICH WD, 1995, STROKE, V26, P111, DOI 10.1161/01.STR.26.1.111; DIETRICH WD, 1993, J NEUROPATH EXP NEUR, V52, P351, DOI 10.1097/00005072-199307000-00002; DIETRICH WD, 1991, J CEREBR BLOOD F MET, V11, P957, DOI 10.1038/jcbfm.1991.161; DIETRICH WD, 1993, STROKE, V24, P1534, DOI 10.1161/01.STR.24.10.1534; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FUTRELL N, 1988, ANN NEUROL, V23, P251, DOI 10.1002/ana.410230307; FUTRELL N, 1993, STROKE, V24, P1983, DOI 10.1161/01.STR.24.12.1983; GAROFALO L, 1992, PHYSIOL BEHAV, V52, P971, DOI 10.1016/0031-9384(92)90379-G; GOLDSTEIN LB, 1990, BEHAV NEUROSCI, V104, P318; GRABOWSKI M, 1993, STROKE, V24, P83; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HENNERICI MG, 1993, STROKE, V24, P637, DOI 10.1161/01.STR.24.5.637; HURWITZ BE, 1991, STROKE, V22, P648, DOI 10.1161/01.STR.22.5.648; JARRARD LE, 1973, PSYCHOL BULL, V79, P1, DOI 10.1037/h0033792; JASPERS RMA, 1990, NEUROSCI LETT, V117, P149, DOI 10.1016/0304-3940(90)90135-V; JOHANSSON BB, 1994, BRAIN PATHOL, V4, P85; KIMBLE DP, 1963, J COMP PHYSIOL PSYCH, V56, P273, DOI 10.1037/h0048903; KOTILA M, 1984, STROKE, V15, P1039, DOI 10.1161/01.STR.15.6.1039; LYDEN PD, 1992, EXP NEUROL, V116, P122, DOI 10.1016/0014-4886(92)90160-R; MARKGRAF CG, 1994, STROKE, V25, P153, DOI 10.1161/01.STR.25.1.153; MARKGRAF CG, 1992, BRAIN RES, V575, P238, DOI 10.1016/0006-8993(92)90085-N; MILESON BE, 1991, NEUROSCI LETT, V128, P71, DOI 10.1016/0304-3940(91)90762-I; PADAYACHEE TS, 1987, ANN THORAC SURG, V44, P298, DOI 10.1016/S0003-4975(10)62077-2; PUGSLEY W, 1994, STROKE, V25, P1393, DOI 10.1161/01.STR.25.7.1393; ROBINSON RG, 1979, SCIENCE, V205, P707, DOI 10.1126/science.462179; RUSSELL D, 1991, STROKE, V22, P253, DOI 10.1161/01.STR.22.2.253; SCHVIER FJ, 1978, ARCH NEUROL-CHICAGO, V35, P264; SKILBECK CE, 1983, J NEUROL NEUROSUR PS, V46, P5, DOI 10.1136/jnnp.46.1.5; SPENCER MP, 1990, STROKE, V21, P415, DOI 10.1161/01.STR.21.3.415; TEGELER CH, 1991, J NEUROIMAGING, V1, P61; WATSON BD, 1987, J NEUROSURG, V66, P748, DOI 10.3171/jns.1987.66.5.0748; WESTER P, 1992, ROLE OF NEUROTRANSMITTERS IN BRAIN INJURY, P153; WESTER P, 1992, STROKE, V23, P870, DOI 10.1161/01.STR.23.6.870; Zilles K, 1985, CORTEX RAT; 1986, ARCH NEUROL-CHICAGO, V43, P71	46	36	38	0	7	AMER HEART ASSOC	DALLAS	7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596	0039-2499			STROKE	Stroke	DEC	1995	26	12					2338	2346		10.1161/01.STR.26.12.2338			9	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	TH075	WOS:A1995TH07500029	7491661				2022-02-06	
J	KRAUSS, JK; WAKHLOO, AK; NOBBE, F; TRANKLE, R; MUNDINGER, F; SEEGER, W				KRAUSS, JK; WAKHLOO, AK; NOBBE, F; TRANKLE, R; MUNDINGER, F; SEEGER, W			LESIONS OF DENTATOTHALAMIC PATHWAYS IN SEVERE POSTTRAUMATIC TREMOR	NEUROLOGICAL RESEARCH			English	Article						HEAD INJURY; MAGNETIC RESONANCE IMAGING; MOVEMENT DISORDER; OUTCOME; TREMOR	POSTTRAUMATIC CEREBELLAR SYNDROME; DIFFUSE AXONAL INJURY; HEAD-INJURY; STEREOTAXIC SURGERY; MOVEMENT-DISORDERS; MR; BRAIN; THALAMOTOMY; FERRITIN; IRON	The present study investigates evidence of dentatothalamic pathway lesions in nineteen patients with severe kinetic post-traumatic tremor retrospectively by magnetic resonance imaging (MRI). Kinetic tremor is thought to be characteristic of lesions of the cerebellar outflow While this hypothesis is supported by experimental data, neuropathological and neuroradiological findings have been limited. The appendicular tremors were unilateral in 13 patients and bilateral in 6, accounting for 25 instances of tremor. The tremor developed after severe head trauma in 18 patients. These patients had evidence of diffuse axonal injury on MRI. Postural and kinetic tremor was present in all patients, and was accompanied by tremor also present at rest in 14 instances. Multiplanar MRI studies were performed on a high-field MRI system operating at 2.0 T in 13 patients and on intermediate-field strength MRI systems in 6 patients according to a standardized protocol. To detect small deposits of hemosiderin after post-traumatic lesions, the protocol included a heavily T2-weighted spin-echo pulse sequence. Lesions of the dentatothalamic pathways were found in 22 instances. The lesions were classified into different types according to their distribution. A lesion of the dentate nucleus ipsilateral to the tremor (type I) was found in one instance (4%), lesions involving the ipsilateral predecussational dentatothalamic pathway (type II and III) were found in 14 instances (56%), and lesions involving the contralateral post-decussational course (type IV) in 7 instances (28%). One patient with a mild head trauma had a lesion of the contralateral thalamus. The lesions appeared as hypointense, hyperintense or mixed. Two of three patients with a parkinsonian-like rest tremor had type IV lesions involving the substantia nigra. The nosological concepts of tremors are discussed. 'Midbrain' tremor may have distinct pathoanatomical lesion sites.	UNIV FREIBURG,DEPT NEUROSURG,FREIBURG,GERMANY; UNIV FREIBURG,NEURORADIOL SECT,FREIBURG,GERMANY; ST JOSEFS HOSP,DEPT FUNCT & STEREOTACT NEUROSURG,FREIBURG,GERMANY								ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ANDREW J, 1982, J NEUROL NEUROSUR PS, V45, P815, DOI 10.1136/jnnp.45.9.815; BIRG W, 1982, APPL NEUROPHYSIOL, V45, P387; BIZZI A, 1990, RADIOLOGY, V177, P59, DOI 10.1148/radiology.177.1.2399339; BROGGI G, 1993, MOVEMENT DISORD, V8, P206, DOI 10.1002/mds.870080217; BULLARD DE, 1984, J NEUROSURG, V61, P316, DOI 10.3171/jns.1984.61.2.0316; BUZSAKI G, 1990, NEUROSCIENCE, V36, P1, DOI 10.1016/0306-4522(90)90345-5; Capildeo R., 1984, MOVEMENT DISORDERS T, P37; CARPENTER MB, 1956, J COMP NEUROL, V105, P195, DOI 10.1002/cne.901050204; CARREA RME, 1955, J COMP NEUROL, V102, P151, DOI 10.1002/cne.901020108; CHEN JC, 1989, RADIOLOGY, V173, P521, DOI 10.1148/radiology.173.2.2798884; COOPER IS, 1960, NEW ENGL J MED, V263, P441, DOI 10.1056/NEJM196009012630905; DECARO R, 1993, 2ND INT NEUR S GLASG, P38; DIENER HC, 1992, MOVEMENT DISORD, V7, P95, DOI 10.1002/mds.870070202; Fahn S, 1986, MOVEMENT DISORD, V1, P299; FERBERT A, 1993, MOVEMENT DISORD, V8, P179, DOI 10.1002/mds.870080211; FERRIER O, 1894, PHILOS T ROY SOC LON, V185, P719; FRIEDMAN JH, 1992, MOVEMENT DISORD, V7, P281, DOI 10.1002/mds.870070315; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GERSTENBRAND F, 1970, INT J NEUROL, V7, P271; GILMAN S, 1976, BRAIN, V99, P311, DOI 10.1093/brain/99.2.311; GOLDMAN MS, 1992, J NEUROSURG, V77, P223, DOI 10.3171/jns.1992.77.2.0223; HADLEY MDM, 1993, 2ND INT NEUR S GLASG, P180; HAGGARD P, 1995, J NEUROL NEUROSUR PS, V58, P433, DOI 10.1136/jnnp.58.4.433; HALLETT M, 1986, HDB CLIN NEUROLOGY, V49, P583; HARDY PA, 1989, MAGN RESON IMAGING, V12, P25; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; HORSTINK MWI, 1991, J NEUROL NEUROSUR PS, V55, P632; Huhn B, 1970, Nervenarzt, V41, P326; IWADATE Y, 1989, Neurosurgical Review, V12, P500, DOI 10.1007/BF01790695; JANKOVIC J, 1980, ANN INTERN MED, V93, P460, DOI 10.7326/0003-4819-93-3-460; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; JOHNSON SLJ, 1992, ARCH DIS CHILD, V67, P227, DOI 10.1136/adc.67.2.227; KOLLER WC, 1989, MOVEMENT DISORD, V4, P20, DOI 10.1002/mds.870040106; KRAUSS JK, 1994, J NEUROSURG, V80, P810, DOI 10.3171/jns.1994.80.5.0810; KRAUSS JK, 1992, MOVEMENT DISORD, V7, P263, DOI 10.1002/mds.870070313; KREMER M, 1947, J NEUROL NEUROSUR PS, V10, P49, DOI 10.1136/jnnp.10.2.49; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; Marks Paul V., 1993, Stereotactic and Functional Neurosurgery, V60, P157, DOI 10.1159/000100605; METTLER FA, 1966, ARCH NEUROL-CHICAGO, V15, P241, DOI 10.1001/archneur.1966.00470150019004; MUNDINGER F, 1963, Fortschr Neurol Psychiatr Grenzgeb, V31, P69; MUNDINGER F, 1965, CONFIN NEUROL, V26, P222; MUNDINGER F, 1963, Fortschr Neurol Psychiatr Grenzgeb, V31, P1; NAKAMURA R, 1993, MOVEMENT DISORD, V8, P209, DOI 10.1002/mds.870080218; OBESO JA, 1983, J NEUROL NEUROSUR PS, V46, P788, DOI 10.1136/jnnp.46.8.788; OHYE C, 1988, BEHAV BRAIN RES, V28, P241, DOI 10.1016/0166-4328(88)90102-7; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POIRIER LJ, 1960, J NEUROPHYSIOL, V23, P534, DOI 10.1152/jn.1960.23.5.534; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P61; SABRA AF, 1984, NEUROLOGY, V34, P151, DOI 10.1212/WNL.34.2.151; SAMIE MR, 1990, NEUROLOGY, V40, P62, DOI 10.1212/WNL.40.1.62; SANDYK R, 1989, INT J NEUROSCI, V47, P301, DOI 10.3109/00207458908987443; SOLOMON DH, 1994, NEUROLOGY, V44, P810, DOI 10.1212/WNL.44.5.810; Tomlinson B, 1970, J CLIN PATHOL S4, V23, P154; Walker AE, 1937, BRAIN, V60, P329, DOI 10.1093/brain/60.3.329; Walker AE, 1982, STEREOTAXY HUMAN BRA, P181; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; [No title captured]	62	36	37	0	1	FOREFRONT PUBL GROUP	LONDON	MONOMARK HOUSE 27 OLD GLOUCESTER STREET, LONDON, ENGLAND WC1N 3XX	0161-6412			NEUROL RES	Neurol. Res.	DEC	1995	17	6					409	416		10.1080/01616412.1995.11740353			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TJ818	WOS:A1995TJ81800002	8622792				2022-02-06	
J	YANG, K; MU, XS; XUE, JJ; PEREZPOLO, JR; HAYES, RL				YANG, K; MU, XS; XUE, JJ; PEREZPOLO, JR; HAYES, RL			REGIONAL AND TEMPORAL PROFILES OF C-FOS AND NERVE GROWTH-FACTOR MESSENGER-RNA EXPRESSION IN RAT-BRAIN AFTER LATERAL CORTICAL IMPACT INJURY	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						GENE EXPRESSION; IMMEDIATE EARLY GENE; C-FOS; NGF; BRAIN INJURY	FACTOR MESSENGER-RNA; DIFFERENTIAL REGULATION; NEUROTROPHIC FACTOR; CEREBRAL-ISCHEMIA; FACTOR GENE; HIPPOCAMPUS; TRANSCRIPTION; NGF; INDUCTION; INCREASE	Lesion-induced increases in NGF mRNA are thought to be mediated by c-fos gene expression. Conversely, NGF induction of c-fos expression has been reported following administration of exogenous NGF. However, the relationship between c-fos and NGF gene expression after traumatic injury to the intact brain is not known. Thus, we applied in situ hybridization and semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) methods to determine temporal profiles of c-fos and NGF mRNA expression in rat brains after controlled impact to the exposed cortex. Using alternate sections from the same rat brains, in situ hybridization studies showed that in neocortex, c-fos mRNA transiently increased at 30 min, 1 hr, and 3 hr after injury, while there were no increases of NGF mRNA at these postinjury time points. In the hippocampus, in situ hybridization showed that c-fos mRNA increased at 30 min, 1 hr and 3 hr postinjury, while NGF mRNA increased at 1 hr, 3 hr but not at 30 min after injury. RT-PCR studies in hippocampus confirmed that c-fos mRNA increased as early as 5 min after injury, peaked at 30 min postinjury, and remained elevated 5 hr postinjury, Levels of hippocampal NGF mRNA expression increased by 1 hr after injury and plateaued until 3 and 5 hr postinjury. These data are consistent with the possible regulatory role of endogenous c-fos on NGF expression following traumatic brain injury. (C) 1995 Wiley-Liss, Inc.	UNIV TEXAS,HLTH SCI CTR,DEPT NEUROSURG,HOUSTON,TX 77030; UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77550				Perez-Polo, Jose R./B-6250-2009		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS31998, R01 NS21458] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031998, R01NS021458] Funding Source: NIH RePORTER		BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; DASH PK, 1995, IN PRESS J NEUROSCI; DEKOSKY ST, 1995, IN PRESS EXP NEUROL; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DIXON CE, 1994, UNPUB REDUCED EVOKED; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; GALL C, 1991, EPILEPSY RES S, V4, P225; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GIORDANO T, 1992, MOL BRAIN RES, V16, P239, DOI 10.1016/0169-328X(92)90231-Y; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GWAG BJ, 1994, BRAIN RES, V647, P23, DOI 10.1016/0006-8993(94)91394-3; HASHIMOTO Y, 1992, NEUROSCI LETT, V139, P45, DOI 10.1016/0304-3940(92)90853-Y; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HENGERER B, 1990, P NATL ACAD SCI USA, V87, P3899, DOI 10.1073/pnas.87.10.3899; HERRERA DG, 1993, BRAIN RES, V602, P99, DOI 10.1016/0006-8993(93)90247-K; JEHAN F, 1993, J NEUROCHEM, V60, P1843, DOI 10.1111/j.1471-4159.1993.tb13411.x; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KAMINSKA B, 1993, NEUROSCI LETT, V153, P189, DOI 10.1016/0304-3940(93)90319-G; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; LADENHEIM RG, 1993, J NEUROCHEM, V60, P260, DOI 10.1111/j.1471-4159.1993.tb05846.x; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH B G, 1991, Society for Neuroscience Abstracts, V17, P165; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MOCCHETTI I, 1989, P NATL ACAD SCI USA, V86, P3891, DOI 10.1073/pnas.86.10.3891; MORGAN JI, 1991, TRENDS PHARMACOL SCI, V12, P343, DOI 10.1016/0165-6147(91)90594-I; PENG ZC, 1993, BRAIN RES, V632, P57, DOI 10.1016/0006-8993(93)91138-I; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; PRASAD MR, 1995, IN PRESS J NEUROCHEM; ROCAMORA N, 1992, MOL BRAIN RES, V13, P27, DOI 10.1016/0169-328X(92)90041-9; SHARP FR, 1989, NEUROSCI LETT, V100, P117, DOI 10.1016/0304-3940(89)90670-8; SHOZUHARA H, 1992, J NEUROCHEM, V59, P175, DOI 10.1111/j.1471-4159.1992.tb08888.x; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; SZEKELY AM, 1989, MOL PHARMACOL, V35, P401; VARON S, 1994, J NEUROTRAUM, V11, P473, DOI 10.1089/neu.1994.11.473; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; ZHENG M, 1988, MOL BRAIN RES, V3, P133, DOI 10.1016/0169-328X(88)90058-7	45	36	39	0	1	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	NOV 1	1995	42	4					571	578		10.1002/jnr.490420415			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TC837	WOS:A1995TC83700014	8568943				2022-02-06	
J	DIXON, CE; BAO, J; JOHNSON, KM; YANG, K; WHITSON, J; CLIFTON, GL; HAYES, RL				DIXON, CE; BAO, J; JOHNSON, KM; YANG, K; WHITSON, J; CLIFTON, GL; HAYES, RL			BASAL AND SCOPOLAMINE-EVOKED RELEASE OF HIPPOCAMPAL ACETYLCHOLINE FOLLOWING TRAUMATIC BRAIN INJURY IN RATS	NEUROSCIENCE LETTERS			English	Article						BRAIN INJURY; ACETYLCHOLINE; MICRODIALYSIS; SCOPOLAMINE; RAT	CONTROLLED CORTICAL IMPACT; DEAFFERENTATION	This study employed in vivo microdialysis in awake, freely-moving Sprague-Dawley rats to examine acetylcholine (ACh) release in the dorsal hippocampus at 14 days following lateral controlled cortical impact. Extracellular levels of ACh were measured prior to and after an intraperitoneal administration of scopolamine (1 mg/kg), which evokes ACh release by blocking autoreceptors. At 14 days post injury there were no differences in basal ACh levels. However, injury produced a significant reduction in scopolamine-evoked ACh release. The data suggest that cholinergic neurotransmission remains chronically compromised, and thus may contribute to previously documented post traumatic spatial memory deficits.	UNIV TEXAS, MED BRANCH, DEPT PHARMACOL & TOXICOL, GALVESTON, TX 77555 USA		DIXON, CE (corresponding author), UNIV TEXAS, HLTH SCI CTR, DEPT NEUROSURG, 6431 FANNIN ST, SUITE 7148, HOUSTON, TX 77030 USA.		Johnson, Kenneth/E-7944-2014		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS31998, NS21458] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49-CCR303547] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS031998, R01NS021458] Funding Source: NIH RePORTER		AMMASSARITEULE M, 1993, BEHAV BRAIN RES, V54, P145, DOI 10.1016/0166-4328(93)90073-Y; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; CARROLL PT, 1980, SCIENCE, V210, P641, DOI 10.1126/science.7433989; COLLERTON D, 1986, NEUROSCIENCE, V19, P1, DOI 10.1016/0306-4522(86)90002-3; Dixon C. E., 1995, Journal of Neurotrauma, V12, P491; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DIXON CE, 1995, IN PRESS BEHAV BIOCH; DIXON CE, 1995, IN PRESS BEHAV BRAIN; DUTAR P, 1986, BRAIN RES, V365, P325, DOI 10.1016/0006-8993(86)91644-6; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; LEANZA G, 1993, BRAIN RES, V615, P147, DOI 10.1016/0006-8993(93)91126-D; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN HS, 1985, CENTRAL NERVOUS SYST, P281; MORTIMER JA, 1991, INT J EPIDEMIOL S2, V20, P528; POSTMANTUR RM, UNPUB J NEUROPATHOL; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; STARKE K, 1989, PHYSIOL REV, V69, P864, DOI 10.1152/physrev.1989.69.3.864; SUNDERLAND T, 1987, ARCH GEN PSYCHIAT, V44, P418; VANDERZEE EA, 1994, BRAIN RES, V652, P263, DOI 10.1016/0006-8993(94)90236-4	20	36	37	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 29	1995	198	2					111	114		10.1016/0304-3940(95)11979-7			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TA406	WOS:A1995TA40600011	8592633				2022-02-06	
J	LIU, DX; YANG, JP; LI, LP; MCADOO, DJ				LIU, DX; YANG, JP; LI, LP; MCADOO, DJ			PARAQUAT - A SUPEROXIDE GENERATOR - KILLS NEURONS IN THE RAT SPINAL-CORD	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						MICRODIALYSIS; NEUROTRAUMA; PEROXIDATION; REACTIVE OXYGEN SPECIES; SPINAL CORD; SUPEROXIDE; FREE RADICALS	CENTRAL-NERVOUS-SYSTEM; LIPID-PEROXIDATION; NITRIC-OXIDE; OXYGEN RADICALS; HIPPOCAMPAL SLICES; PRIMARY AMINES; BRAIN-DAMAGE; INJURY; DISMUTASE; MICRODIALYSIS	Microdialysis was used to administer paraquat into the spinal cord of the anesthetized rat to determine the effects of the in vivo generation of the superoxide anion (O-2(.-)) on neurons. Exposure to paraquat caused blockage of axonal conduction, destruction of the cell bodies of neurons, and a general release of amino acids. Thus, paraquat is quite harmful to neuronal tissue. Similarities between paraquat-induced damage and that previously observed from the hydroxyl radical are consistent with paraquat, causing damage by generation of reactive oxygen species and the widespread belief that generation of O-2(.-) initiates the formation of destructive reactive oxygen species in a wide variety of traumas and other disorders.	UNIV TEXAS, MED BRANCH, DEPT HUMAN BIOL CHEM & GENET, GALVESTON, TX 77555 USA		LIU, DX (corresponding author), UNIV TEXAS, MED BRANCH, INST MARINE BIOMED, 200 UNIV BLVD, GALVESTON, TX 77555 USA.			liu, danxia/0000-0001-8172-2344	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS11255] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS011255] Funding Source: NIH RePORTER		AMSTAD P, 1991, BIOCHEMISTRY-US, V30, P9305, DOI 10.1021/bi00102a024; AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X; BAGETTA G, 1992, PHARMACOL TOXICOL, V71, P443, DOI 10.1111/j.1600-0773.1992.tb00575.x; BAUKNIGHT GC, 1992, STROKE, V23, P1512, DOI 10.1161/01.STR.23.10.1512; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BUS JS, 1974, BIOCHEM BIOPH RES CO, V58, P749, DOI 10.1016/S0006-291X(74)80481-X; Bus JS, 1977, BIOCH MECHANISMS PAR, P157; CAZEVIEILLE C, 1993, FREE RADICAL BIO MED, V14, P389, DOI 10.1016/0891-5849(93)90088-C; CHAN PH, 1982, J NEUROCHEM, V38, P525, DOI 10.1111/j.1471-4159.1982.tb08659.x; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; CORASANITI MT, 1992, HUM EXP TOXICOL, V11, P535, DOI 10.1177/096032719201100616; DEMONTIGNY P, 1987, ANAL CHEM, V59, P1096, DOI 10.1021/ac00135a007; DYKSTRA KH, 1992, J NEUROCHEM, V58, P931, DOI 10.1111/j.1471-4159.1992.tb09346.x; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; HAYASHIN, 1990, ACTA NEUROCHIR S, V51, P31; HIRAISHI H, 1992, J BIOL CHEM, V267, P14812; HUGHES JT, 1988, NEUROTOXICOLOGY, V9, P243; IMAIZUMI S, 1990, ACT NEUR S, V51, P236; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; KONTOS CD, 1992, AM J PHYSIOL, V263, pH1234, DOI 10.1152/ajpheart.1992.263.4.H1234; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1985, CIRC RES, V57, P142, DOI 10.1161/01.RES.57.1.142; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LIU D, 1990, Journal of Neurotrauma, V7, P219, DOI 10.1089/neu.1990.7.219; LIU D, IN PRES FREE RADIC B; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LIU DX, 1994, J NEUROCHEM, V62, P37; LIU DX, 1993, J BIOCHEM BIOPH METH, V27, P281, DOI 10.1016/0165-022X(93)90009-D; LIU DX, 1993, J NEUROTRAUM, V10, P349, DOI 10.1089/neu.1993.10.349; LIU DX, 1994, MOL CHEM NEUROPATHOL, V23, P77, DOI 10.1007/BF02815402; LIU TH, 1989, AM J PHYSIOL, V256, pH589, DOI 10.1152/ajpheart.1989.256.2.H589; MATUSZEWSKI BK, 1987, ANAL CHEM, V59, P1102, DOI 10.1021/ac00135a008; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; OURY TD, 1992, P NATL ACAD SCI USA, V89, P9715, DOI 10.1073/pnas.89.20.9715; PELLEGRINIGIAMPIETRO DE, 1988, J NEUROCHEM, V51, P1960, DOI 10.1111/j.1471-4159.1988.tb01187.x; PELLMAR TC, 1992, BRAIN RES, V569, P189, DOI 10.1016/0006-8993(92)90630-R; Pereira B M, 1990, Adv Neurol, V52, P97; SION A, 1989, BIOCHEM PHARMACOL, V38, P3903, DOI 10.1016/0006-2952(89)90666-7; THOMAS CE, 1985, J BIOL CHEM, V260, P3275; TOGASHI H, 1991, HEPATOLOGY, V14, P707, DOI 10.1002/hep.1840140422; TOMITA M, 1992, BIOCHIM BIOPHYS ACTA, V1128, P174, DOI 10.1016/0005-2760(92)90304-E	50	36	38	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	MAY	1995	18	5					861	867		10.1016/0891-5849(94)00214-5			7	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	QP569	WOS:A1995QP56900004	7797093				2022-02-06	
J	YOSHIHARA, M; BANDOH, K; MARMAROU, A				YOSHIHARA, M; BANDOH, K; MARMAROU, A			CEREBROVASCULAR CARBON-DIOXIDE REACTIVITY ASSESSED BY INTRACRANIAL-PRESSURE DYNAMICS IN SEVERELY BEAD INJURED PATIENTS	JOURNAL OF NEUROSURGERY			English	Article						CARBON DIOXIDE REACTIVITY; INTRACRANIAL PRESSURE; HEAD INJURY; CEREBROVASCULAR REACTIVITY; PRESSURE VOLUME INDEX; BLOOD VOLUME RESPONSIVITY	CEREBRAL BLOOD-FLOW; CLOSED HEAD-INJURY; TRANSCRANIAL DOPPLER; CO2 REACTIVITY; BRAIN INJURY; ACUTE PHASE; ULTRASOUND; VELOCITY; HEMODYNAMICS; CIRCULATION	Appropriate management of intracranial pressure (ICP) in severely head injured patients depends in part on the cerebral vessel reactivity to PCO2; loss of CO2 reactivity has been associated with poor outcome. This study describes a new method for evaluating vascular reactivity in head-injured patients by determining the sensitivity of ICP change to alterations in PCO2. This method was combined with measurements of the pressure volume index (PVI), which allowed calculation of blood volume change necessary to alter ICP. The objective of this study was to investigate the ICP response and the blood volume change corresponding to alterations in PCO2 and to examine the correlation of responsivity and outcome as measured on the Glasgow Outcome Scale. The PVI and ICP at different end-tidal PCO2 levels produced by mild hypo- and hyperventilation were obtained in 49 patients with Glasgow Coma Scale scores of less than 8 and over a wide range of PCO2 (25 to 40 mm Hg) in eight patients. Given the assumption that the PVI remained constant during alteration of PaCO2, the estimated blood volume change per torr change of PCO2 was calculated by the following equation: BVR = PVI X Delta log(ICP)/Delta PCO2, where BVR = blood volume reactivity. The data in this study showed that PVI remained stable with changes in PCO2, thus validating the assumption used in the blood volume estimates. Moreover, the response of ICP to PCO2 alterations followed an exponential curve that could be described in terms of the responsivity indices to capnic stimuli. It was found that responsivity to hypocapnia was reduced by 50% compared to responsivity to hypercapnia measured within 24 hours of injury (p < 0.01). The sensitivity of ICP to estimated blood volume changes in patients with a PVI of less than 15 ml was extremely high with only 4 ml of blood required to raise ICP by 10 mm Hg. The authors conclude from these data that, following traumatic injury, the resistance vessels are in a state of persistent vasoconstriction, possibly due to vasospasm or compression. Furthermore, BVR correlates with outcome on the Glasgow Coma Scale, indicating that assessment of cerebrovascular response within the first 24 hours of injury may be of prognostic value.			YOSHIHARA, M (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV NEUROSURG,POB 508,MCV STN,RICHMOND,VA 23298, USA.						BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BURKI NK, 1983, CHEST, V83, P666, DOI 10.1378/chest.83.4.666; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P359, DOI 10.1111/j.1399-6576.1977.tb01232.x; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P222; Compton J S, 1987, Br J Neurosurg, V1, P435, DOI 10.3109/02688698708999633; COMPTON JS, 1987, J NEUROL NEUROSUR PS, V50, P1499, DOI 10.1136/jnnp.50.11.1499; DALY C, 1962, BIOMETRICS, V18, P114, DOI 10.2307/2527714; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; GOMEZ CR, 1991, SURG NEUROL, V35, P30, DOI 10.1016/0090-3019(91)90198-I; GOTOH F, 1961, EXP NEUROL, V4, P48, DOI 10.1016/0014-4886(61)90077-2; GREENBERG JH, 1978, CIRC RES, V43, P324, DOI 10.1161/01.RES.43.2.324; Hayes T M, 1969, Surg Forum, V20, P421; JENNETT B, 1975, LANCET, V1, P480; Kindt G. W., 1972, INTRACRANIAL PRESSUR, P210; KONTOS HA, 1977, STROKE, V8, P226, DOI 10.1161/01.STR.8.2.226; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; LANGFITT TW, 1966, HEAD INJURY, P172; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; LUNDAR T, 1990, ACTA NEUROCHIR, V102, P85, DOI 10.1007/BF01405419; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARMAROU A, 1988, INTRACRANIAL PRESSUR, V7, P688; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; OBRIST WD, 1984, J NEUROSURG, V61, P251; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PAUL RL, 1972, J NEUROSURG, V36, P714, DOI 10.3171/jns.1972.36.6.0714; REIVICH M, 1964, AM J PHYSIOL, V206, P25, DOI 10.1152/ajplegacy.1964.206.1.25; ROUGHTON FJW, 1946, BIOCHEM J, V40, P319, DOI 10.1042/bj0400319; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SHIGEMORI M, 1990, ACTA NEUROCHIR, V107, P5, DOI 10.1007/BF01402605; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; Takagi H, 1980, INTRACRANIAL PRESSUR, VIV, P163; TEASDALE G, 1974, LANCET, V2, P81; TENJIN H, 1990, ACTA NEUROCHIR, V104, P121, DOI 10.1007/BF01842829; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	39	36	37	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	1995	82	3					386	393		10.3171/jns.1995.82.3.0386			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QJ311	WOS:A1995QJ31100002	7861215				2022-02-06	
J	PRAYER, L; WIMBERGER, D; ODER, W; KRAMER, J; SCHINDLER, E; PODREKA, I; IMHOF, H				PRAYER, L; WIMBERGER, D; ODER, W; KRAMER, J; SCHINDLER, E; PODREKA, I; IMHOF, H			CRANIAL MR-IMAGING AND CEREBRAL TC-99M HM-PAO-SPECT IN PATIENTS WITH SUBACUTE OR CHRONIC SEVERE CLOSED-HEAD INJURY AND NORMAL CT EXAMINATIONS	ACTA RADIOLOGICA			English	Article						HEAD INJURIES, CT; MR; EMISSION CT	TRAUMATIC BRAIN INJURY; MAGNETIC-RESONANCE; COMPUTERIZED-TOMOGRAPHY; TECHNETIUM-99M-HMPAO SPECT; INITIAL EXPERIENCE; BLOOD-FLOW; FIELD MR; IMAGES; PERFUSION; PET	Eighteen patients in the subacute or chronic state following severe closed head injury with normal cranial CT scans were examined by MR and Tc-99m HM-PAO SPECT. Correlations were sought between these 2 imaging modalities and the clinical outcome, as defined by the Glasgow Outcome Scale (GOS) score. Both MR and SPECT revealed cerebral damage in all patients examined but structural and functional alterations did not coincide topographically in 64.9% of lesions. Nevertheless, complementary injury patterns suggesting poor recovery were found; cortical contusions and diffuse axonal injury (MR) in conjunction with cortical and thalamic hypoperfusion (SPECT) were noticed in 8 out of 12 patients with unfavorable outcome (GOS=III and IV). The synthesis of MR and SPECT information clearly enhanced the ability both to accurately assess posttraumatic brain damage and to improve patients' outcome pre prediction.	UNIV VIENNA,ALLGEMEINES KRANKENHAUS,DEPT NEUROL,A-1010 VIENNA,AUSTRIA; UNIV VIENNA,ALLGEMEINES KRANKENHAUS,MR INST,A-1010 VIENNA,AUSTRIA		PRAYER, L (corresponding author), UNIV VIENNA,ALLGEMEINES KRANKENHAUS,DEPT RADIOL,DIV NEURORADIOL,WAHRINGER GURTEL 18-20,A-1097 VIENNA,AUSTRIA.						ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ADAMS JH, 1984, RECENT ADV HISTOPATH, P1; ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; CHEVENET TL, 1990, RADIOLOGY, V117, P401; CLARK JM, 1974, J NEUROL NEUROSUR PS, V37, P463, DOI 10.1136/jnnp.37.4.463; CROOKS DA, 1991, NEUROPATH APPL NEURO, V17, P421, DOI 10.1111/j.1365-2990.1991.tb00742.x; FUMEYA H, 1990, ACT NEUR S, V51, P283; GENARELLI TA, 1982, ANN NEUROL, V12, P564; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; GHETTI B, 1989, NEUROLOGY, V39, P1453, DOI 10.1212/WNL.39.11.1453; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GRAY BG, 1992, J NUCL MED, V33, P52; HESSELINK JR, 1988, AM J NEURORADIOL, V9, P269; HOLMAN BL, 1991, J NUCL MED, V32, P1478; JENNETT B, 1975, LANCET, V1, P480; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LEVIN DN, 1989, RADIOLOGY, V172, P783, DOI 10.1148/radiology.172.3.2788893; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; MILLER BL, 1991, NMR BIOMED, V4, P47, DOI 10.1002/nbm.1940040203; MURASE K, 1992, J NUCL MED, V33, P135; NADJMI M, 1981, KRANIELLE COMPUTERTO, P56; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; PELIZZARI CA, 1989, J COMPUT ASSIST TOMO, V13, P20, DOI 10.1097/00004728-198901000-00004; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; PODREKA I, 1987, J NUCL MED, V28, P1657; REID RH, 1990, CLIN NUCL MED, V15, P383, DOI 10.1097/00003072-199006000-00003; ROPER SN, 1991, J NUCL MED, V32, P1684; SKLAR EML, 1992, RADIOL CLIN N AM, V30, P353; WALDEMAR G, 1991, J CEREBR BLOOD F MET, V11, P508, DOI 10.1038/jcbfm.1991.95; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267; WOLFF SD, 1991, RADIOLOGY, V179, P133, DOI 10.1148/radiology.179.1.2006263; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	37	36	37	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0284-1851			ACTA RADIOL	Acta Radiol.	NOV	1993	34	6					593	599					7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	MJ632	WOS:A1993MJ63200012	8240895				2022-02-06	
J	WRENN, K; RODEWALD, L; LUMB, E; SLOVIS, C				WRENN, K; RODEWALD, L; LUMB, E; SLOVIS, C			THE USE OF STRUCTURED, COMPLAINT-SPECIFIC PATIENT ENCOUNTER FORMS IN THE EMERGENCY DEPARTMENT	ANNALS OF EMERGENCY MEDICINE			English	Article						PATIENT SATISFACTION		Study objective: To assess the effect of preprinted, structured, complaint-specific patient encounter forms on documentation, use of testing, and treatment compared with free-text record keeping. Design: Nonrandomized case-control trial. Setting: University-affiliated, tertiary referral hospital emergency department. Methods: The records of all patients with lacerations, pharyngitis, asthma, or isolated closed-head injury during an eight-month period were reviewed. Intervention: Use of structured complaint-specific patient encounter forms versus traditional free-text record keeping. Main outcome measure: The null hypothesis was that there would be no differences in documentation, test use, or practice when the structured forms were used compared with free-text record keeping. Results: Differences in documentation that favored the use of the structured forms for all four problems studied were seen consistently. Not only was documentation improved, but test use also was affected in a way that decreased use. In addition, in certain areas (eg, treatment of pharyngitis), clinical practice also was changed. Conclusion: Structured, problem-specific ED records improve documentation and affect both resource use and clinical practice. These forms may be useful for improving communication and reimbursement as well as for medicolegal documentation. They provide a method for standardized quality assurance review and clinical data abstraction. Finally, they provide a method for active dissemination of clinical standards.			WRENN, K (corresponding author), VANDERBILT UNIV,MED CTR,DEPT EMERGENCY MED,ROOM 1368,NASHVILLE,TN 37232, USA.		Wrenn, Keith/AAI-7651-2020	Rodewald, Lance/0000-0003-2593-542X				0	36	36	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	MAY	1993	22	5					805	812		10.1016/S0196-0644(05)80796-6			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	KZ091	WOS:A1993KZ09100007	8470837				2022-02-06	
J	JACOBSEN, EJ; VANDOORNIK, FJ; AYER, DE; BELONGA, KL; BRAUGHLER, JM; HALL, ED; HOUSER, DJ				JACOBSEN, EJ; VANDOORNIK, FJ; AYER, DE; BELONGA, KL; BRAUGHLER, JM; HALL, ED; HOUSER, DJ			2-(AMINOMETHYL)CHROMANS THAT INHIBIT IRON-DEPENDENT LIPID-PEROXIDATION AND PROTECT AGAINST CENTRAL-NERVOUS-SYSTEM TRAUMA AND ISCHEMIA	JOURNAL OF MEDICINAL CHEMISTRY			English	Article							SPINAL-CORD INJURY; EXPERIMENTAL BRAIN INJURY; VITAMIN-E; CEREBRAL-ISCHEMIA; ALPHA-TOCOPHEROL; OXYGEN RADICALS; 21-AMINOSTEROID U74006F; GLOBAL-ISCHEMIA; HUMAN-DISEASE; RAT-BRAIN	A series of 2-(aminomethyl)chromans was developed as potent inhibitors of iron-dependent lipid peroxidation. Compounds within this class are extremely effective at inhibiting lipid peroxidation with IC50's as low as 0.2 muM. Selected members were found to enhance early neurological recovery and survival in a mouse head injury model. In this assay, improvement in the 1-h post-head-injury neurological status (grip test score) by as much as 230 % of control was observed. One of the most efficacious compounds (35) was evaluated in two models of cerebral ischemia where significant neuroprotection was observed. These results provide further support for the importance of cerebroprotective antioxidants for the treatment of traumatic and ischemic injury as well as additional evidence for the role of oxygen radicals in postischemic brain damage.	UPJOHN CO,CHEM RES PREPARAT,KALAMAZOO,MI 49001; UPJOHN CO,CNS RES,KALAMAZOO,MI 49001		JACOBSEN, EJ (corresponding author), UPJOHN CO,MED CHEM RES,7246-209-719,301 HENRIETTA ST,KALAMAZOO,MI 49001, USA.		Hall, Edward D/F-8930-2013				Anderson D.K., 1983, NEUROCHEM PATHOL, V1, P249; ANDERSON DK, 1988, J NEUROSURG, V69, P562, DOI 10.3171/jns.1988.69.4.0562; ARDELT BK, 1989, TOXICOLOGY, V56, P147, DOI 10.1016/0300-483X(89)90129-7; Asano T, 1980, CEREBRAL ARTERIAL SP, P190; BOLKENIUS FN, 1991, FREE RADICAL RES COM, V14, P363, DOI 10.3109/10715769109093425; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRAUGHLER J M, 1989, Drugs of the Future, V14, P143; BRAUGHLER JM, 1986, J BIOL CHEM, V261, P282; BRAUGHLER JM, 1988, BIOCHEM PHARMACOL, V37, P3853, DOI 10.1016/0006-2952(88)90066-4; BRAUGHLER JM, 1987, J BIOL CHEM, V262, P10438; BRAUGHLER JM, 1988, J PHARMACOL EXP THER, V244, P423; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BURTON GW, 1986, ACCOUNTS CHEM RES, V19, P194, DOI 10.1021/ar00127a001; BURTON GW, 1981, J AM CHEM SOC, V103, P6472, DOI 10.1021/ja00411a035; COHEN G, 1982, PATHOLOGY OXYGEN, P115; COHEN N, 1982, SYNTHETIC COMMUN, V12, P57, DOI 10.1080/00397918208080067; CRAW MT, 1985, REV CHEM INTERMED, V6, P1, DOI 10.1007/BF03155990; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; DEMOPOULOS HB, 1982, CAN J PHYSIOL PHARM, V60, P1415, DOI 10.1139/y82-210; FANTONE JC, 1982, AM J PATHOL, V107, P397; FLOYD RA, 1982, FREE RADICALS CANCER; FUJIMOTO S, 1984, SURG NEUROL, V22, P449, DOI 10.1016/0090-3019(84)90301-X; GIROTTI AW, 1984, J BIOL CHEM, V259, P1744; Hall E., 1989, J CEREB BLOOD FLO S1, V19, pS561; Hall E D, 1987, Acta Anaesthesiol Belg, V38, P421; Hall E D, 1986, Cent Nerv Syst Trauma, V3, P281; HALL ED, 1982, INT REV NEUROBIOL, V23, P165, DOI 10.1016/S0074-7742(08)60625-X; HALL ED, 1982, SURG NEUROL, V18, P320, DOI 10.1016/0090-3019(82)90140-9; HALL ED, 1988, J NEUROSURG, V68, P462, DOI 10.3171/jns.1988.68.3.0462; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1990, STROKE, V21, P83; HALL ED, 1988, STROKE, V19, P997, DOI 10.1161/01.STR.19.8.997; HALL ED, 1988, EXP NEUROL, V102, P244, DOI 10.1016/0014-4886(88)90100-8; HALL ED, 1982, J NEUROSURG, V57, P247, DOI 10.3171/jns.1982.57.2.0247; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; HALL ED, Patent No. 78517; HALLIWELL B, 1985, TRENDS NEUROSCI, V8, P22, DOI 10.1016/0166-2236(85)90010-4; HARRIS RJ, 1981, J CEREBR BLOOD F MET, V1, P203, DOI 10.1038/jcbfm.1981.21; JACOBSEN EJ, 1990, J MED CHEM, V33, P1145, DOI 10.1021/jm00166a010; KANAMARU K, 1991, J NEUROSURG, V74, P454, DOI 10.3171/jns.1991.74.3.0454; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KURRARY, Patent No. 202580; MAKER HS, 1981, J NEUROCHEM, V36, P589, DOI 10.1111/j.1471-4159.1981.tb01631.x; McBrien D. C. H., 1982, FREE RADICALS LIPID; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P417; MCCAY PB, 1985, ANNU REV NUTR, V5, P323, DOI 10.1146/annurev.nu.05.070185.001543; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MUKAI K, 1982, CHEM PHYS LIPIDS, V30, P337, DOI 10.1016/0009-3084(82)90027-5; NISHIKIMI M, 1975, ARCH BIOCHEM BIOPHYS, V170, P684, DOI 10.1016/0003-9861(75)90165-4; OBRIEN PJ, 1969, CAN J BIOCHEM CELL B, V47, P485, DOI 10.1139/o69-076; PIETTE LH, 1983, OXYGEN RADICALS CHEM, P137; Pryor W.A., 1984, FREE RADICALS MOL BI, P13; Sano K, 1980, Neurol Res, V2, P253; SAUNDERS RD, 1987, J NEUROCHEM, V49, P24, DOI 10.1111/j.1471-4159.1987.tb03388.x; SCHUDEL P, 1972, VITAMINS, P168; SCOTT JW, 1974, J AM OIL CHEM SOC, V51, P200, DOI 10.1007/BF02632894; SCOTT ML, 1978, FAT SOLUBLE VITAMINS, P133; SLIVKA A, 1985, J BIOL CHEM, V260, P5466; SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P390, DOI 10.1016/S0025-6196(12)64862-9; STEINKE DE, 1989, NEUROSURGERY, V24, P179, DOI 10.1227/00006123-198902000-00005; TAYLOR MJ, 1981, J AM OIL CHEM SOC, V58, P622, DOI 10.1007/BF02672378; THOMAS CE, 1985, J BIOL CHEM, V260, P3275; WATSON BD, 1984, J NEUROCHEM, V42, P268, DOI 10.1111/j.1471-4159.1984.tb09728.x; WAUQUIER A, 1981, ARCH INT PHARMACOD T, V249, P330; YAMAMOTO M, 1983, STROKE, V14, P977, DOI 10.1161/01.STR.14.6.977; YAMAMOTO S, 1983, PROSTAGLANDINS RELAT, P171; 1977, Patent No. 4003919; [No title captured]	71	36	37	0	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0022-2623			J MED CHEM	J. Med. Chem.	NOV 13	1992	35	23					4464	4472		10.1021/jm00101a025			9	Chemistry, Medicinal	Index Chemicus (IC); Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	JY974	WOS:A1992JY97400025	1447746				2022-02-06	
J	BOHNEN, N; JOLLES, J; TWIJNSTRA, A; MELLINK, R; SULON, J				BOHNEN, N; JOLLES, J; TWIJNSTRA, A; MELLINK, R; SULON, J			COPING STYLES, CORTISOL REACTIVITY, AND PERFORMANCE IN A VIGILANCE TASK OF PATIENTS WITH PERSISTENT POSTCONCUSSIVE SYMPTOMS AFTER A MILD HEAD-INJURY	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						COGNITIVE IMPAIRMENT; CORTISOL; MILD HEAD INJURY; POSTCONCUSSIVE SYMPTOMS; STRESS	CONCUSSION		UNIV LIMBURG HOSP,DEPT NEUROL,MAASTRICHT,NETHERLANDS; CHU SART TILMAN,STEROIDES LAB,LIEGE,BELGIUM		BOHNEN, N (corresponding author), UNIV LIMBURG,DEPT NEUROPSYCHOL & PSYCHOBIOL,POB 616,6200 MD MAASTRICHT,NETHERLANDS.		Bohnen, Nicolaas/A-1312-2007				ANSSEAU M, 1984, PSYCHIAT RES, V13, P201; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOHNEN N, 1990, BIOL PSYCHOL, V31, P107, DOI 10.1016/0301-0511(90)90011-K; BOHNEN N, 1991, J PSYCHOSOM RES, V35, P141, DOI 10.1016/0022-3999(91)90068-Y; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; GRONWALL D, 1974, LANCET, V2, P605; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; Holroyd K.A., 1982, HDB STRESS THEORETIC; HUBERT W, 1989, Journal of Clinical Chemistry and Clinical Biochemistry, V27, P235; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Long C J, 1983, Psychiatr Med, V1, P35; Luteijn F., 1983, HANDLEIDING GRONINGE; MENAGHAN E, 1982, J HEALTH SOC BEHAV, V23, P220, DOI 10.2307/2136631; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; SCHIFFRIN RM, 1977, PSYCHOL REV, V84, P127; SCHREURS PJG, 1987, UTRECHTSE COPING LIJ; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VANZOMEREN AH, 1981, THESIS U GRONINGEN N; Verhage R., 1964, INTELLIGENTIE LEEFTI; VINING RF, 1986, CRIT REV CL LAB SCI, V23, P95, DOI 10.3109/10408368609165797; 1985, USERS GUIDE STATISTI	27	36	36	0	2	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1992	64	1-4					97	105		10.3109/00207459209000536			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JB934	WOS:A1992JB93400008	1342053				2022-02-06	
J	ASHRAF, J; CROCKARD, HA; RANSFORD, AO; STEVENS, JM				ASHRAF, J; CROCKARD, HA; RANSFORD, AO; STEVENS, JM			TRANSORAL DECOMPRESSION AND POSTERIOR STABILIZATION IN MORQUIOS-DISEASE	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article								A 3.5 year old boy with Morquio's disease was referred with a persisting left hemiparesis four months after a fall and was found to have craniocervical junction compression due to atlantoaxial subluxation and significant anterior soft tissue compression. Transient unconsciousness at the time of the fall was probably due to medullary concussion as a result of hyperextension, not a head injury. Spinal cord compression due to atlantoaxial subluxation at the craniovertebral junction is a major cause of disability and death in these patients. Once cervical myelopathy appears, early posterior occipitocervical fusion has been advocated in order to arrest the progression of neurological disability and this is successful in most cases. This conventional approach was considered unsafe because of the significant anterior compression. A combined anterior transoral decompression with posterior fusion to deal with this particularly difficult problem is described.	NATL HOSP NEUROL & NEUROSURG, QUEEN SQ, LONDON WC1N 3BG, ENGLAND; UNIV COLL HOSP LONDON, WC1 LONDON, ENGLAND								Beighton P, 1973, J Bone Joint Surg Br, V55, P478; BETHEM D, 1981, J BONE JOINT SURG AM, V63, P1412, DOI 10.2106/00004623-198163090-00007; Crockard H A, 1988, Clin Neurosurg, V34, P389; CROCKARD HA, 1990, J BONE JOINT SURG BR, V72, P682, DOI 10.1302/0301-620X.72B4.2380227; EDWARDS MK, 1982, AM J NEURORADIOL, V3, P666; GOLDBERG MJ, 1976, ORTHOP CLIN N AM, V7, P445; GREENBERG AD, 1968, BRAIN, V91, P655, DOI 10.1093/brain/91.4.655; JONES AEP, 1979, ANESTHESIOLOGY, V51, P261, DOI 10.1097/00000542-197909000-00018; KOPITS SE, 1972, J BONE JOINT SURG AM, V54, P1349; KOPITS SE, 1976, CLIN ORTHOP RELAT R, V114, P153; LIPSON SJ, 1977, J BONE JOINT SURG AM, V59, P340, DOI 10.2106/00004623-197759030-00008; MCKUSICK VA, 1972, HERITABLE DISORDERS, P596; MCKUSICK VA, 1983, METABOLIC BASIS INHE, P751; OGDEN JA, 1986, SKELETAL RADIOL, V15, P433, DOI 10.1007/BF00355100; STEVENS JM, 1991, J BONE JOINT SURG BR, V73, P851, DOI 10.1302/0301-620X.73B5.1910048	15	36	37	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	NOV	1991	66	11					1318	1321		10.1136/adc.66.11.1318			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	GQ327	WOS:A1991GQ32700015	1755646	Green Published, Bronze			2022-02-06	
J	EYSEL, UT; SCHMIDTKASTNER, R				EYSEL, UT; SCHMIDTKASTNER, R			NEURONAL DYSFUNCTION AT THE BORDER OF FOCAL LESIONS IN CAT VISUAL-CORTEX	NEUROSCIENCE LETTERS			English	Article						THERMOLESION; VISUAL CORTEX; SINGLE CELL RECORDING; HYPOACTIVITY; HYPEREXCITATION	TRAUMATIC BRAIN INJURY; NMDA RECEPTORS; STRIATE CORTEX; INHIBITION; GLUTAMATE; DAMAGE; ISCHEMIA; INACTIVATION; PARVALBUMIN; CONNECTIONS	Traditional concepts assume that traumatic or ischemic brain lesions are surrounded by regions with depressed neuronal function. More recently hyperactivity gained increasing attention as excitotoxic mechanisms become effective at certain stages of neuronal injury. Single cell recordings in the surrounding of small focal lesions in the cat visual cortex revealed both types of functional pathology 1-30 days after lesioning. A rim of suppressed neurons surrounded a completely silent core. Cells further away from the lesion showed bursts and long lasting hyperactivity with extremely high discharge rates. Consequently, the volume of disturbed tissue was considerably larger than the region of initial cell death. This halo of dysfunction may be important for neurological symptoms evoked by cortical lesions.			EYSEL, UT (corresponding author), RUHR UNIV BOCHUM,FAK MED,NEUROPHYSIOL ABT,GEBAUDE MA4-149,W-4630 BOCHUM 1,GERMANY.			Eysel, Ulf/0000-0001-6087-957X			ALBERS GW, 1989, ANN NEUROL, V25, P398, DOI 10.1002/ana.410250412; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; CELIO MR, 1988, CELL CALCIUM, V9, P81, DOI 10.1016/0143-4160(88)90027-9; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; EYSEL UT, 1988, J PHYSIOL-LONDON, V399, P657; EYSEL UT, 1990, EXP BRAIN RES, V80, P626; EYSEL UT, 1987, EXP BRAIN RES, V68, P606; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FINGER S, 1985, BRAIN RES REV, V10, P177, DOI 10.1016/0165-0173(85)90023-2; GERMANO IM, 1987, ANN NEUROL, V22, P730, DOI 10.1002/ana.410220609; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1963, J PHYSIOL-LONDON, V165, P559, DOI 10.1113/jphysiol.1963.sp007079; Klatzo I, 1980, Adv Neurol, V28, P359; LINDSBERG PJ, 1991, J CEREBR BLOOD F MET, V11, P88, DOI 10.1038/jcbfm.1991.10; MATSUBARA JA, 1987, BRAIN RES BULL, V18, P121, DOI 10.1016/0361-9230(87)90040-2; NOVELLI A, 1988, BRAIN RES, V451, P205, DOI 10.1016/0006-8993(88)90765-2; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SCHMIDTKASTNER R, 1988, ACTA NEUROPATHOL, V76, P411, DOI 10.1007/BF00686979; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; STICHEL CC, 1987, J COMP NEUROL, V262, P563, DOI 10.1002/cne.902620409; SUZUKI R, 1983, ACTA NEUROPATHOL, V60, P217, DOI 10.1007/BF00691869; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; WORGOTTER F, 1988, J NEUROSCI METH, V25, P135, DOI 10.1016/0165-0270(88)90150-1; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16	33	36	36	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	SEP 30	1991	131	1					45	48		10.1016/0304-3940(91)90333-O			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK153	WOS:A1991GK15300011	1791978				2022-02-06	
J	MARSH, NV; KNIGHT, RG				MARSH, NV; KNIGHT, RG			BEHAVIORAL-ASSESSMENT OF SOCIAL COMPETENCE FOLLOWING SEVERE HEAD-INJURY	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							SKILLS; REHABILITATION; ADJUSTMENT; DISORDERS	Eighteen community-dwelling adults who had suffered a very severe closed-head injury more than 18 months previously and required long-term rehabilitative support were compared with a closely matched control group on a number of behavioral measures of skill during social interaction. Results showed that during social interactions the head-injured patients exhibited impaired communication skills. They appeared disinterested, and thier speech was characterized as lacking in fluency and clarity due to their difficulty in finding appropriate words, use of inappropriate expressions and inability to express ideas clearly. Attempts to find a relationship between the patients' cognitive deficits and their impaired communication skills were unsuccessful. It is suggested that the often reported poor social adjustment of some head-injured patients is in part related to their inappropriate behavior during social interactions. This is particularly manifest in their poor language skills and speech delivery style.	UNIV OTAGO, DUNEDIN, NEW ZEALAND		MARSH, NV (corresponding author), UNIV WAIKATO, DEPT PSYCHOL, PRIVATE BAG 3105, HAMILTON, NEW ZEALAND.		Marsh, Nigel V./F-5433-2019; Marsh, Nigel/ABA-3609-2021	Marsh, Nigel V./0000-0002-4060-6432; Marsh, Nigel/0000-0002-4060-6432			BELLACK AS, 1983, BEHAV RES THER, V21, P29, DOI 10.1016/0005-7967(83)90123-7; Benson D.F., 1986, FRONTAL LOBES; Bond M R, 1979, Int Rehabil Med, V1, P155; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Cronbach L.J., 1972, DEPENDABILITY BEHAVI; CURRAN JP, 1984, RADICAL APPROACHES S, P16; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; FARRELL AD, 1985, BEHAV ASSESS, V7, P155; FARRELL AD, 1979, J CONSULT CLIN PSYCH, V47, P164; GLOSSER G, 1990, J CLIN EXP NEUROPSYC, V12, P485, DOI 10.1080/01688639008400995; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; HAGEN C, 1982, COGNITIVE REHABILITA, P131; Holland A., 1982, CLIN APH P C, P345; HOLLAND BS, 1988, PSYCHOL BULL, V104, P145, DOI 10.1037/0033-2909.104.1.145; HOLM S, 1979, SCAND J STAT, V6, P65; HORTON AM, 1981, PERCEPT MOTOR SKILL, V53, P349, DOI 10.2466/pms.1981.53.2.349; JOHNSON DA, 1987, BRIT J CLIN PSYCHOL, V26, P289, DOI 10.1111/j.2044-8260.1987.tb01362.x; LARZELERE RE, 1977, PSYCHOL BULL, V84, P557, DOI 10.1037/0033-2909.84.3.557; LAWSON MJ, 1989, J CLIN EXP NEUROPSYC, V11, P842, DOI 10.1080/01688638908400939; LEWIS FD, 1988, BEHAV THER, V19, P203, DOI 10.1016/S0005-7894(88)80043-1; Marsh NV, 1990, NEUROPSYCHOLOGY, V4, P13, DOI 10.1037/0894-4105.4.1.13; MARSHALL JC, 1984, J CLIN NEUROPSYCHOL, V6, P65, DOI 10.1080/01688638408401197; MURDOCH BE, 1987, BRAIN LANG, V31, P122, DOI 10.1016/0093-934X(87)90064-2; Nelson H. E, 1982, NATIONAL ADULT READI; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; PASHLER H, 1985, J EXP PSYCHOL HUMAN, V11, P105, DOI 10.1037/0096-1523.11.2.105; POWELL GE, 1980, BRIT J SOC CLIN PSYC, V19, P189, DOI 10.1111/j.2044-8260.1980.tb00947.x; RAVEN JC, 1977, MANUAL RAVENS PROGR; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SARNO MT, 1988, SCAND J REHABIL MED, P55; SCHLOSS PJ, 1985, APPL RES MENT RETARD, V6, P269, DOI 10.1016/0270-3092(85)90001-3; Sunderland A., 1990, CLIN REHABIL, V4, P181, DOI DOI 10.1177/026921559000400301; TURNER SM, 1978, J BEHAV THER EXP PSY, V9, P253, DOI 10.1016/0005-7916(78)90037-X; WALLANDER JL, 1985, BEHAV ASSESS, V7, P137; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wiig E. H., 1988, NEUROPSYCHOLOGICAL S, P186; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767	41	36	36	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	SEP	1991	13	5					729	740		10.1080/01688639108401086			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GK476	WOS:A1991GK47600008	1955528				2022-02-06	
J	GOMEZ, CR; BACKER, RJ; BUCHOLZ, RD				GOMEZ, CR; BACKER, RJ; BUCHOLZ, RD			TRANSCRANIAL DOPPLER ULTRASOUND FOLLOWING CLOSED HEAD-INJURY - VASOSPASM OR VASOPARALYSIS	SURGICAL NEUROLOGY			English	Article						DOPPLER ULTRASOUND; TRAUMA; VASOPARALYSIS	CEREBRAL VASOSPASM; SUBARACHNOID HEMORRHAGE; FLOW VELOCITY; SPASM	Nine patients suffering closed head injury were studied using transcranial Doppler ultrasound recording of the basal cerebral arteries. On admission, six patients had Glasgow Coma Scores of 7 or less, while three had initial scores of 8-10. Eight of the nine patients (82%) developed abnormally high mean velocities (greater-than-or-equal-to-110 cm/s) in one or more vessels. The onset, duration, and amplitude of the altered flow velocities were somewhat different from those that are seen with vasospasm after aneurysmal subarachnoid hemorrhage, which tend to occur later. Cerebral angiography in one of the study patients confirmed the presence of vasospasm. Multivariate regression analysis showed a definite correlation between the velocities recorded, even when abnormally elevated, and concurrent pH and P(CO2) measurements (p = 0.01, R2 = 0.23). Although these results suggest that the cerebral vasculature retains its vasoreactivity following head injury, arguing against vasoparalysis, inconsistencies found in some of the patients lead us to think that both vasospasm and vasoparalysis may occur following head trauma but that they may have different temporal profiles.	ST LOUIS UNIV,MED CTR,DEPT NEUROL,ST LOUIS,MO 63103; ST LOUIS UNIV,MED CTR,DIV NEUROL SURG,ST LOUIS,MO 63103								AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; ARNOLDS BJ, 1986, ULTRASOUND MED BIOL, V12, P115, DOI 10.1016/0301-5629(86)90016-5; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; HASSLER W, 1988, J NEUROSURG, V68, P745; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; MARSHALL LF, 1978, J NEUROSURG, V48, P560, DOI 10.3171/jns.1978.48.4.0560; PASQUALIN A, 1984, NEUROSURGERY, V15, P855, DOI 10.1227/00006123-198412000-00015; ROPPER AH, 1987, NEUROLOGY, V37, P1733, DOI 10.1212/WNL.37.11.1733; SAUNDERS FW, 1988, SURG NEUROL, V29, P401, DOI 10.1016/0090-3019(88)90049-3; SCHNEIDER PA, 1988, STROKE, V19, P589, DOI 10.1161/01.STR.19.5.589; SEILER RW, 1986, J NEUROSURG, V64, P594, DOI 10.3171/jns.1986.64.4.0594; SEKHAR LN, 1988, NEUROSURGERY, V22, P813, DOI 10.1227/00006123-198805000-00002; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626	15	36	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.	JAN	1991	35	1					30	35		10.1016/0090-3019(91)90198-I			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EP166	WOS:A1991EP16600005	1983879				2022-02-06	
J	EIDSON, M; LYBARGER, JA; PARSONS, JE; MACCORMACK, JN; FREEMAN, JI				EIDSON, M; LYBARGER, JA; PARSONS, JE; MACCORMACK, JN; FREEMAN, JI			RISK-FACTORS FOR TORNADO INJURIES	INTERNATIONAL JOURNAL OF EPIDEMIOLOGY			English	Article							DISASTERS	Tornadoes in North and South Carolina on 28 March 1984 caused 252 people to be injured seriously enough to require hospitalization and 59 to be killed. To evaluate risk factors, we gathered information on 238 (94%) of those hospitalized and 46 (78%) of those killed. Those hospitalized or decreased had statistically significantly more deep cuts, concussions, unconsciousness and broken bones than those with them at the time of the tornado who were not hospitalized or killed. People living in mobile homes were more likely to be hospitalized or die than people occupying conventional houses. Other risk factors for hospitalization or death included advanced age (60+ years), no physical protection (not having been covered with a blanket or other object), having been struck by broken window glass or other falling objects, home lifted off its foundation, collapsed ceiling or floor, or walls blown away. More awareness of the tornado risk before it strikes and better adherence to tornado protection guidelines could reduce injuries and deaths in the future.	N CAROLINA DEPT HUMAN RESOURCES,DIV HLTH SERV,RALEIGH,NC 27609; CTR DIS CONTROL,CTR ENVIRONM HLTH & INJURY CONTROL,DIV FIELD SERV,ATLANTA,GA 30333								AHEARN FL, 1984, 841311 NAT I MENT HL; BELVILLE JD, 1987, ANN EMERG MED, V16, P1078, DOI 10.1016/S0196-0644(87)80762-X; BINDER S, 1987, ANN EMERG MED, V16, P1081, DOI 10.1016/S0196-0644(87)80763-1; DYNES RR, 1977, B AM METEOROL SOC, V58, P689; FUJITA TT, 1981, J ATMOS SCI, V38, P1511, DOI 10.1175/1520-0469(1981)038<1511:TADITC>2.0.CO;2; GLASS RI, 1980, SCIENCE, V207, P734, DOI 10.1126/science.207.4432.734; GORDON P, 1982, SPECIAL STATISTICAL; Leibovich M, 1983, J Ark Med Soc, V80, P98; LINEHAN UJ, 1957, 30 US DEP COMM WEATH, P47; LUBIN JH, 1981, COMPUT BIOMED RES, V14, P138, DOI 10.1016/0010-4809(81)90031-8; LUBIN JH, 1981, COMPUTERS BIOMED RES; LUBIN JH, 1981, PARAMETER ESTIMATION; MACCONNON G, 1985, SELECTED BIBLIO EMER; MAHONEY LE, 1987, ANN EMERG MED, V16, P1085, DOI 10.1016/S0196-0644(87)80764-3; MANDELBAUM I, 1966, J TRAUM, V6, P353, DOI 10.1097/00005373-196605000-00005; SANDERS WW, 1975, 2ND P NAT C WIND ENG; SANDERSON LM, 1989, PUBLIC HLTH CONSEQUE, P39; SIMMS JH, 1972, SCIENCE, V176, P1386; WOLDETINSAE AM, 1985, J CLIM APPL METEOROL, V24, P699, DOI 10.1175/1520-0450(1985)024<0699:WAOTBO>2.0.CO;2; 1987, B AM METEOROL SOC, V68, P687; 1985, B AM METEOROL SOC, V66, P570; 1981, GUIDE EMERGENCY HLTH; 1985, B AM METEOROL SOC, V66, P857; 1988, MORB MORT WEEKLY REP, V37, P454; 1972, DISASTER PREPAREDNES, P35; 1985, MORB MORT WEEKLY REP, V34, P205; 1983, MED SUPPLY MANAGEMEN; 1988, B AM METEOROL SOC, V69, P422	28	36	37	0	2	OXFORD UNIV PRESS UNITED KINGDOM	OXFORD	WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP	0300-5771			INT J EPIDEMIOL	Int. J. Epidemiol.	DEC	1990	19	4					1051	1056		10.1093/ije/19.4.1051			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	ET595	WOS:A1990ET59500040	2083989				2022-02-06	
J	SARNO, MT				SARNO, MT			VERBAL IMPAIRMENT AFTER CLOSED HEAD-INJURY - REPORT OF A REPLICATION STUDY	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article											SARNO, MT (corresponding author), NYU MED CTR,DEPT REHABIL MED,NEW YORK,NY 10016, USA.			sarno, martha/0000-0001-7649-8691			Benson D. F., 1967, CORTEX MILANO, V3, P373, DOI DOI 10.1016/S0010-9452(67)80025-X; BOLLER F, 1966, BRAIN, V89, P815, DOI 10.1093/brain/89.4.815; BOLLER F, 1979, AUDITORY COMPREHENSI; GALLAHER AJ, 1979, BRAIN LANG, V7, P34, DOI 10.1016/0093-934X(79)90004-X; GESCHWIND N, 1971, NEW ENGL J MED, V284, P654, DOI 10.1056/NEJM197103252841206; Geschwind N, 1964, Int J Neurol, V4, P207; HARTJE W, 1973, NEUROPSYCHOLOGIA, V11, P119, DOI 10.1016/0028-3932(73)90072-9; Levin HS., 1982, NEUROBEHAVIORAL CONS; MARSHALL JC, 1975, CIBA F S, V34, P245; Norman Geschwind, 1967, CORTEX, V3, P97; Poeck K., 1966, CORTEX, V2, P222, DOI 10.1016/S0010-9452(66)80005-9; Sarno M. T., 1969, FUNCTIONAL COMMUNICA; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Spreen O., 1969, NEUROSENSORY CTR COM; TAYLORSARNO M, 1965, ARCH PHYS MED REHABI, V49, P101	15	36	37	1	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.		1984	172	8					475	479		10.1097/00005053-198408000-00006			5	Clinical Neurology; Psychiatry	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	TE542	WOS:A1984TE54200006	6747618				2022-02-06	
J	WEST, M; PARKINSON, D; HAVLICEK, V				WEST, M; PARKINSON, D; HAVLICEK, V			SPECTRAL-ANALYSIS OF THE ELECTROENCEPHALOGRAPHIC RESPONSE TO EXPERIMENTAL CONCUSSION IN THE RAT	ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY			English	Article									UNIV MANITOBA,FAC MED,DEPT NEUROSURG,WINNIPEG R3E 0W3,MANITOBA,CANADA		WEST, M (corresponding author), UNIV MANITOBA,FAC MED,DEPT PHYSIOL,WINNIPEG R3E 0W3,MANITOBA,CANADA.						BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; FOLTZ EL, 1956, J NEUROSURG, V13, P145, DOI 10.3171/jns.1956.13.2.0145; FRANTZEN E, 1958, ACTA PSYCH NEUROL, V33, P417, DOI 10.1111/j.1600-0447.1958.tb03529.x; HAVLICEK V, 1977, NEUROPADIATRIE, V8, P360, DOI 10.1055/s-0028-1091532; JOSEPH PD, 1971, BRAIN RES, V26, P15; LETCHER FS, 1973, J NEUROSURG, V39, P167, DOI 10.3171/jns.1973.39.2.0167; MEYER JS, 1955, ELECTROENCEPH CLIN N, V7, P520; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OLEARY JL, 1966, CLIN NEUROSURG, V12, P171; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PARKINSON D, 1977, MAYO CLIN PROC, V52, P492; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; PLUM F, 1972, DIAGNOSIS STUPOR COM, P286; POVISHOCK JT, 1978, BRAIN RES, V153, P223; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; ROTHMAN JE, 1968, 8143 DIG EQ CORP; ROWBOTHAM G. F., 1961, BRIT JOUR SURG, V48, P400, DOI 10.1002/bjs.18004821008; Shetter A G, 1979, Adv Neurol, V22, P5; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; SYMONDS C, 1962, LANCET, V1, P1; WARD AA, 1966, CLIN NEUROSURG, V12, P95; [No title captured]; [No title captured]	23	36	36	0	3	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0013-4694			ELECTROEN CLIN NEURO	Electroencephalogr. Clin. Neurophysiol.		1982	53	2					192	200		10.1016/0013-4694(82)90023-2			9	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	NE396	WOS:A1982NE39600006	6174291				2022-02-06	
J	FRIEDE, RL				FRIEDE, RL			EXPERIMENTAL CONCUSSION ACCELERATION - PATHOLOGY AND MECHANICS	ARCHIVES OF NEUROLOGY			English	Article																	BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; BRODAL A, 1954, J NEUROPHYSIOL, V17, P484, DOI 10.1152/jn.1954.17.5.484; Brodal A, 1956, RETICULAR FORMATION; CHASON JL, 1957, J NEUROPATH EXP NEUR, V16, P102, DOI 10.1097/00005072-195701000-00012; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; DOW S, 1945, J NEUROPHYSIOL, V8, P161; FRIEDE R, 1955, Monatsschr Unfallheilkd Versicherungsmed, V58, P361; FRIEDE R, 1955, Zentralbl Neurochir, V15, P73; FRIEDE RL, 1960, J NEUROPATH EXP NEUR, V19, P266, DOI 10.1097/00005072-196004000-00007; FRIEDE RL, 1959, EXP NEUROL, V1, P441, DOI 10.1016/0014-4886(59)90043-3; GERNANDT BE, 1960, J NEUROPHYSIOL, V23, P269, DOI 10.1152/jn.1960.23.3.269; GOVONS R, 1944, SURGERY, V1, P606; GROAT RA, 1944, J NEUROSURG, V2, P26; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; GROSS AG, 1958, AVIAT MED, P725; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Gurdjian ES, 1944, SURGERY, V16, P381; HALLERVORDEN J, 1957, DEUT MED WOCHENSCHR, V82, P129, DOI 10.1055/s-0028-1114649; HESSLER DC, UAFC; Holbourn AHS, 1944, J NEUROSURG, V1, P190, DOI 10.3171/jns.1944.1.3.0190; Holbourn AHS, 1943, LANCET, V2, P438; HOLLISTER NR, WADC TR 58-193; Jakob A., 1912, HISTOL HISTOPATH ARB, V5, P182; KOENIG H, 1945, STAIN TECHNOL, V20, P13, DOI 10.3109/10520294509107124; KREMS A. D., 1942, PROC SOC EXP BIOL AND MED, V49, P73; LIVINGSTON WK, 1939, WESTERN J SURG, V54, P131; LOMBARD CHARLES F., 1951, JOUR AVIATION MED, V22, P109; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; POLIS A, 1924, REV CHIR LY, P273; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; SCHARENBERG K, 1952, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V188, P430, DOI 10.1007/BF00353219; Shelden CH, 1944, J NEUROSURG, V1, P67, DOI 10.3171/jns.1944.1.1.0067; SPIEGEL EA, 1948, J NEUROPATH EXP NEUR, V7, P162, DOI 10.1097/00005072-194804000-00004; SPIEGELADOLF M, 1947, J NERV MENT DIS, V106, P359, DOI 10.1097/00005053-194710630-00011; WALKER EA, 1944, J NEUROSURG, V1, P103; WARD JW, 1948, SCIENCE, V107, P349, DOI 10.1126/science.107.2779.349; WARD JW, 1948, J NEUROPHYSIOL, V11, P59, DOI 10.1152/jn.1948.11.2.59; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; WINDLE W. F., 1944, TRANS AMER NEUROL ASSOC, V70, P117; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210; Witkowski L., 1877, ARCH PATH ANAT, V69, P498; WRIGHT DR, 1946, SURGERY, V19, P661; [No title captured]	46	36	36	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.		1961	4	4					449	&		10.1001/archneur.1961.00450100097012			0	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	5674A	WOS:A19615674A00005	13701949				2022-02-06	
J	Baksaas-Aasen, K; Gall, LS; Stensballe, J; Juffermans, NP; Curry, N; Maegele, M; Brooks, A; Rourke, C; Gillespie, S; Murphy, J; Maroni, R; Vulliamy, P; Henriksen, HH; Pedersen, KH; Kolstadbraaten, KM; Wirtz, MR; Kleinveld, DJB; Schafer, N; Chinna, S; Davenport, RA; Naess, PA; Goslings, JC; Eaglestone, S; Stanworth, S; Johansson, PI; Gaarder, C; Brohi, K				Baksaas-Aasen, K.; Gall, L. S.; Stensballe, J.; Juffermans, N. P.; Curry, N.; Maegele, M.; Brooks, A.; Rourke, C.; Gillespie, S.; Murphy, J.; Maroni, R.; Vulliamy, P.; Henriksen, H. H.; Pedersen, K. Holst; Kolstadbraaten, K. M.; Wirtz, M. R.; Kleinveld, D. J. B.; Schaefer, N.; Chinna, S.; Davenport, R. A.; Naess, P. A.; Goslings, J. C.; Eaglestone, S.; Stanworth, S.; Johansson, P. I.; Gaarder, C.; Brohi, K.			Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial	INTENSIVE CARE MEDICINE			English	Article						Trauma; Haemorrhage; Coagulopathy; Thrombelastography; Thromboelastometry	BRAIN-INJURY; RAPID THROMBELASTOGRAPHY; RESUSCITATION; COAGULOPATHY; TRANSFUSION; MORTALITY; DEFINITION; MANAGEMENT; PLASMA	Purpose Contemporary trauma resuscitation prioritizes control of bleeding and uses major haemorrhage protocols (MHPs) to prevent and treat coagulopathy. We aimed to determine whether augmenting MHPs with Viscoelastic Haemostatic Assays (VHA) would improve outcomes compared to Conventional Coagulation Tests (CCTs). Methods This was a multi-centre, randomized controlled trial comparing outcomes in trauma patients who received empiric MHPs, augmented by either VHA or CCT-guided interventions. Primary outcome was the proportion of subjects who, at 24 h after injury, were alive and free of massive transfusion (10 or more red cell transfusions). Secondary outcomes included 28-day mortality. Pre-specified subgroups included patients with severe traumatic brain injury (TBI). Results Of 396 patients in the intention to treat analysis, 201 were allocated to VHA and 195 to CCT-guided therapy. At 24 h, there was no difference in the proportion of patients who were alive and free of massive transfusion (VHA: 67%, CCT: 64%, OR 1.15, 95% CI 0.76-1.73). 28-day mortality was not different overall (VHA: 25%, CCT: 28%, OR 0.84, 95% CI 0.54-1.31), nor were there differences in other secondary outcomes or serious adverse events. In pre-specified subgroups, there were no differences in primary outcomes. In the pre-specified subgroup of 74 patients with TBI, 64% were alive and free of massive transfusion at 24 h compared to 46% in the CCT arm (OR 2.12, 95% CI 0.84-5.34). Conclusion There was no difference in overall outcomes between VHA- and CCT-augmented-major haemorrhage protocols.	[Baksaas-Aasen, K.; Kolstadbraaten, K. M.; Naess, P. A.; Gaarder, C.] Oslo Univ Hosp, Oslo, Norway; [Baksaas-Aasen, K.; Kolstadbraaten, K. M.; Naess, P. A.; Gaarder, C.] Univ Oslo, Oslo, Norway; [Gall, L. S.; Rourke, C.; Gillespie, S.; Vulliamy, P.; Davenport, R. A.; Eaglestone, S.; Brohi, K.] Queen Mary Univ London, Blizard Inst, Ctr Trauma Sci, 4 Newark St, London E1 2AT, England; [Stensballe, J.; Henriksen, H. H.; Pedersen, K. Holst; Johansson, P. I.] Rigshosp, Copenhagen Univ Hosp, Copenhagen, Denmark; [Juffermans, N. P.; Wirtz, M. R.; Kleinveld, D. J. B.; Goslings, J. C.] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Curry, N.; Stanworth, S.] Oxford Univ Hosp NHS Trust, Oxford, England; [Maegele, M.; Schaefer, N.] Univ Witten Herdecke, Cologne Merheim Med Ctr, Cologne, Germany; [Brooks, A.; Chinna, S.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Murphy, J.; Maroni, R.] Queen Mary Univ London, London, England; [Stanworth, S.] NHS Blood & Transplant, Bristol, Avon, England		Brohi, K (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Trauma Sci, 4 Newark St, London E1 2AT, England.	k.brohi@qmul.ac.uk	Baksaas-Aasen, Kjersti/AAP-4957-2021; Maroni, Roberta/K-7044-2019	Baksaas-Aasen, Kjersti/0000-0002-1140-8939; Maroni, Roberta/0000-0001-6420-2881; Hee Henriksen, Hanne/0000-0003-1323-9718; Johansson, Par Ingemar/0000-0001-9778-5964	European Commission under the FP7 framework [F3-2013-602771]	The study was part of the "Targeted Action for Curing Trauma-Induced Coagulopathy" (TACTIC) program, funded by the European Commission under the FP7 framework (Grant No. F3-2013-602771). Both TEM (R) International GmbH and Haemonetics (R) Corporation were collaborating organizations in the TACTIC program. For this ITACTIC study, they provided the ROTEM Sigma and TEG 6S analyzers and all reagents to the relevant participating institutions. Neither these organizations nor any of their representatives had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007871.pub2; [Anonymous], 2011, LANCET, V377, DOI DOI 10.1016/S0140-6736(11)60278-X; [Anonymous], 2016, NICE RECOMMENDATIONS; Asehnoune K, 2017, INTENS CARE MED, V43, P1340, DOI 10.1007/s00134-017-4895-9; Baksaas-Aasen K, 2019, ANN SURG, V270, P1178, DOI 10.1097/SLA.0000000000002825; Baksaas-Aasen K, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2224-9; Balvers K, 2017, BRIT J SURG, V104, P222, DOI 10.1002/bjs.10330; Brohi K, 2019, INTENS CARE MED, V45, P709, DOI 10.1007/s00134-019-05560-x; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Cole E, 2021, ANN SURG, V273, P1215, DOI 10.1097/SLA.0000000000003657; Da Luz LT, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0518-9; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Einersen PM, 2017, J TRAUMA ACUTE CARE, V82, P114, DOI 10.1097/TA.0000000000001270; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Hagemo JS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0823-y; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hunt H, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010438.pub2; Johansson PI, 2013, TRANSFUSION, V53, P3088, DOI 10.1111/trf.12214; Khan S, 2015, INTENS CARE MED, V41, P239, DOI 10.1007/s00134-014-3584-1; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Tapia NM, 2013, J TRAUMA ACUTE CARE, V74, P378, DOI 10.1097/TA.0b013e31827e20e0; Veigas PV, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0308-2; Winearls J, 2016, ANESTH ANALG, V123, P910, DOI 10.1213/ANE.0000000000001516	31	35	35	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JAN	2021	47	1					49	59		10.1007/s00134-020-06266-1		OCT 2020	11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PO2FJ	WOS:000578323800001	33048195	Green Published, hybrid			2022-02-06	
J	Barney, CW; Dougan, CE; McLeod, KR; Kazemi-Moridani, A; Zheng, Y; Ye, ZY; Tiwari, S; Sacligil, I; Riggleman, RA; Cai, SQ; Lee, JH; Peyton, SR; Tew, GN; Crosby, AJ				Barney, Christopher W.; Dougan, Carey E.; McLeod, Kelly R.; Kazemi-Moridani, Amir; Zheng, Yue; Ye, Ziyu; Tiwari, Sacchita; Sacligil, Ipek; Riggleman, Robert A.; Cai, Shengqiang; Lee, Jae-Hwang; Peyton, Shelly R.; Tew, Gregory N.; Crosby, Alfred J.			Cavitation in soft matter	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						soft solids; traumatic brain injury; TBI; rheology; bubble	LASER-INDUCED CAVITATION; TRAUMATIC BRAIN-INJURY; MECHANICAL-PROPERTIES; FRACTURE-MECHANICS; COVALENT BONDS; CAVITY GROWTH; BUBBLE; RUBBER; MODEL; DEFORMATION	Cavitation is the sudden, unstable expansion of a void or bubble within a liquid or solid subjected to a negative hydrostatic stress. Cavitation rheology is a field emerging from the development of a suite of materials characterization, damage quantification, and therapeutic techniques that exploit the physical principles of cavitation. Cavitation rheology is inherently complex and broad in scope with wide-ranging applications in the biology, chemistry, materials, and mechanics communities. This perspective aims to drive collaboration among these communities and guide discussion by defining a common core of high-priority goals while highlighting emerging opportunities in the field of cavitation rheology. A brief overview of the mechanics and dynamics of cavitation in soft matter is presented. This overview is followed by a discussion of the overarching goals of cavitation rheology and an overview of common experimental techniques. The larger unmet needs and challenges of cavitation in soft matter are then presented alongside specific opportunities for researchers from different disciplines to contribute to the field.	[Barney, Christopher W.; McLeod, Kelly R.; Sacligil, Ipek; Tew, Gregory N.; Crosby, Alfred J.] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; [Dougan, Carey E.; Peyton, Shelly R.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA; [Kazemi-Moridani, Amir; Tiwari, Sacchita; Lee, Jae-Hwang] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA; [Zheng, Yue; Cai, Shengqiang] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Ye, Ziyu] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Riggleman, Robert A.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA		Tew, GN; Crosby, AJ (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.; Peyton, SR (corresponding author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.; Lee, JH (corresponding author), Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA.; Cai, SQ (corresponding author), Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA.; Riggleman, RA (corresponding author), Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA.	rrig@seas.upenn.edu; shqcai@ucsd.edu; leejh@umass.edu; speyton@umass.edu; tew@mail.pse.umass.edu; acrosby@umass.edu	Lee, Jae-Hwang/F-7595-2014; Kazemi-Moridani, Amir/Z-2636-2019	Lee, Jae-Hwang/0000-0002-2546-1044; Kazemi-Moridani, Amir/0000-0003-4496-9553; zheng, yue/0000-0002-0492-5946; Crosby, Alfred/0000-0001-8850-8869; Tiwari, Sacchita/0000-0002-7572-0526; Barney, Christopher/0000-0002-1854-9523	Office of Naval ResearchOffice of Naval Research [ONR N00014-17-1-2056]	This work was funded by Office of Naval Research Grant ONR N00014-17-1-2056. We acknowledge helpful discussions with Prof. Robin C. Young from the Department of Mathematics and Statistics at the University of Massachusetts Amherst.	Adhikari U, 2016, PHYS CHEM CHEM PHYS, V18, P32638, DOI 10.1039/c6cp06704b; Ahn B, 2010, MED IMAGE ANAL, V14, P138, DOI 10.1016/j.media.2009.10.006; Archer LA, 1997, RHEOL ACTA, V36, P579; Arita Y, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016319; Arnal B, 2017, PHYS MED BIOL, V62, P843, DOI 10.1088/1361-6560/aa4fe8; Arvanitis CD, 2015, IEEE T MED IMAGING, V34, P1270, DOI 10.1109/TMI.2014.2383835; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; BALL JM, 1982, PHILOS T R SOC A, V306, P557, DOI 10.1098/rsta.1982.0095; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Barney CW, 2019, SOFT MATTER, V15, P7390, DOI 10.1039/c9sm01173k; Belayachi N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/2/025008; Bentz KC, 2018, SOFT MATTER, V14, P8395, DOI 10.1039/c8sm01560k; Bentz KC, 2016, SOFT MATTER, V12, P4991, DOI 10.1039/c6sm00431h; Brujan EA, 2006, J FLUID MECH, V558, P281, DOI 10.1017/S0022112006000115; BUNDY FP, 1955, NATURE, V176, P51, DOI 10.1038/176051a0; Busse WF, 1938, J APPL PHYS, V9, P438, DOI 10.1063/1.1710439; Canchi S, 2017, J MECH BEHAV BIOMED, V74, P261, DOI 10.1016/j.jmbbm.2017.06.018; Canchi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175396; Cao YL, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00010; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; CHO K, 1987, J MATER SCI, V22, P2899, DOI 10.1007/BF01086488; Colchester RJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4873678; Creton C, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/4/046601; Crosby AJ, 2000, J APPL PHYS, V88, P2956, DOI 10.1063/1.1288017; Cubuk ED, 2017, SCIENCE, V358, P1033, DOI 10.1126/science.aai8830; Cui J, 2012, MACROMOLECULES, V45, P6104, DOI 10.1021/ma300593g; Cui J, 2011, SOFT MATTER, V7, P7827, DOI 10.1039/c1sm05340j; Davis DA, 2009, NATURE, V459, P68, DOI 10.1038/nature07970; Delbos A, 2012, SOFT MATTER, V8, P8204, DOI 10.1039/c2sm25458a; Diani J, 2001, INT J FRACTURE, V112, P151, DOI 10.1023/A:1013311526076; Estrada JB, 2018, J MECH PHYS SOLIDS, V112, P291, DOI 10.1016/j.jmps.2017.12.006; Fakhouri S, 2015, SOFT MATTER, V11, P4723, DOI 10.1039/c5sm00230c; Fei PZ, 2015, LANGMUIR, V31, P492, DOI 10.1021/la503832r; Frieberg BR, 2018, SOFT MATTER, V14, P4696, DOI 10.1039/c8sm00722e; Fuentes-Caparros AM, 2019, SOFT MATTER, V15, P6340, DOI 10.1039/c9sm01023h; Gateau J, 2011, PHYS MED BIOL, V56, P7001, DOI 10.1088/0031-9155/56/22/001; Gaudron R, 2015, J FLUID MECH, V766, DOI 10.1017/jfm.2015.7; Gent A. N., 1970, RUBBER CHEM TECHNOL, V43, P873; GENT AN, 1991, J MATER SCI, V26, P3392, DOI 10.1007/BF01124691; GENT AN, 1959, PROC R SOC LON SER-A, V249, P195, DOI 10.1098/rspa.1959.0016; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gossweiler GR, 2014, ACS MACRO LETT, V3, P216, DOI 10.1021/mz500031q; Grindy SC, 2017, SOFT MATTER, V13, P4057, DOI 10.1039/c7sm00617a; Han TH, 2010, J APPL PHYS, V107, DOI 10.1063/1.3430989; Hashemnejad SM, 2019, SOFT MATTER, V15, P7852, DOI 10.1039/c9sm01039d; Hashemnejad SM, 2017, ACS OMEGA, V2, P1864, DOI 10.1021/acsomega.7b00108; Hashemnejad SM, 2015, SOFT MATTER, V11, P4315, DOI 10.1039/c5sm00330j; Holzapfel GA, 2010, P ROY SOC A-MATH PHY, V466, P1551, DOI 10.1098/rspa.2010.0058; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; HUANG Y, 1991, J MECH PHYS SOLIDS, V39, P223, DOI 10.1016/0022-5096(91)90004-8; Hui CY, 2003, P ROY SOC A-MATH PHY, V459, P1489, DOI 10.1098/rspa.2002.1057; Hutchens SB, 2016, SOFT MATTER, V12, P2557, DOI 10.1039/c5sm02055g; Hutchens SB, 2014, SOFT MATTER, V10, P3679, DOI 10.1039/c3sm52689e; HUTCHINSON JW, 1983, ACTA METALL MATER, V31, P1079, DOI 10.1016/0001-6160(83)90204-3; Ivancic RJS, 2019, SOFT MATTER, V15, P4548, DOI 10.1039/c8sm02423e; Jansen LE, 2015, J MECH BEHAV BIOMED, V50, P299, DOI 10.1016/j.jmbbm.2015.06.023; Johansen P, 2004, EXPERT REV MED DEVIC, V1, P95, DOI 10.1586/17434440.1.1.95; Kang JT, 2017, SOFT MATTER, V13, P6372, DOI 10.1039/c7sm01479a; Kang W, 2018, ACTA BIOMATER, V67, P295, DOI 10.1016/j.actbio.2017.11.030; Kawchuk GN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119470; Kim G, 2019, P NATL ACAD SCI USA, V116, P10214, DOI 10.1073/pnas.1901047116; Kumar A, 2017, J ELASTICITY, V126, P201, DOI 10.1007/s10659-016-9589-y; Kundu S, 2009, SOFT MATTER, V5, P3963, DOI 10.1039/b909237d; Kurosawa Y, 2009, IEEE ENG MED BIO, P7224, DOI 10.1109/IEMBS.2009.5335260; Kushner AM, 2007, J AM CHEM SOC, V129, P14110, DOI 10.1021/ja0742176; Kwasny MT, 2017, J MATER CHEM A, V5, P1400, DOI 10.1039/c6ta07990c; Lafond M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25913-8; Lakrout H, 1999, J ADHESION, V69, P307, DOI 10.1080/00218469908017233; Lefevre V, 2015, INT J FRACTURE, V192, P1, DOI 10.1007/s10704-014-9982-0; Lin ST, 2017, J MECH PHYS SOLIDS, V106, P229, DOI 10.1016/j.jmps.2017.05.011; Lin YY, 2004, INT J FRACTURE, V126, P205, DOI 10.1023/B:FRAC.0000026510.60747.3a; Liu YQ, 2011, MACROMOLECULES, V44, P8622, DOI 10.1021/ma201023v; Lopez-Pamies O, 2011, J MECH PHYS SOLIDS, V59, P1464, DOI 10.1016/j.jmps.2011.04.015; Lopez-Pamies O, 2009, J ELASTICITY, V94, P115, DOI 10.1007/s10659-008-9187-8; Luo H., 2015, J DYN BEHAV MAT, V2, P59; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Macoskey JJ, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaae3b; Madison MJ, 2017, BIOMASS BIOENERG, V98, P135, DOI 10.1016/j.biombioe.2017.01.007; Mancia L, 2017, ULTRASOUND MED BIOL, V43, P1421, DOI 10.1016/j.ultrasmedbio.2017.02.020; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Milner MP, 2019, EXTREME MECH LETT, V28, P69, DOI 10.1016/j.eml.2019.02.007; Mohammadzadeh M, 2017, J FLUID MECH, V823, DOI 10.1017/jfm.2017.358; Nakamura T, 2012, INT J NONLIN MECH, V47, P331, DOI 10.1016/j.ijnonlinmec.2011.07.007; Palanker D, 1997, LASER SURG MED, V21, P294, DOI 10.1002/(SICI)1096-9101(1997)21:3<294::AID-LSM10>3.0.CO;2-D; Parada GA, 2018, SOFT MATTER, V14, P5186, DOI 10.1039/c8sm00646f; Pardoen T, 2000, J MECH PHYS SOLIDS, V48, P2467, DOI 10.1016/S0022-5096(00)00019-3; Pavlovsky L, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896108; Peel CS, 2011, APPL PHYS A-MATER, V103, P1131, DOI 10.1007/s00339-010-6056-7; Polio S., 2018, PLOS ONE, V13, P1; Poulain X, 2017, INT J FRACTURE, V205, P1, DOI 10.1007/s10704-016-0176-9; Raayai-Ardakani S, 2019, SOFT MATTER, V15, P4999, DOI 10.1039/c9sm00570f; Raayai-Ardakani S, 2019, SOFT MATTER, V15, P381, DOI 10.1039/c8sm02142b; Rambod E, 1999, ANN BIOMED ENG, V27, P774, DOI 10.1114/1.231; Rana RK, 2002, ADV MATER, V14, P1414, DOI 10.1002/1521-4095(20021002)14:19<1414::AID-ADMA1414>3.0.CO;2-F; Rau KR, 2006, BIOPHYS J, V91, P317, DOI 10.1529/biophysj.105.079921; Rayleigh, 1917, PHILOS MAG, V34, P94, DOI 10.1080/14786440808635681; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; SACCHI CA, 1991, J OPT SOC AM B, V8, P337, DOI 10.1364/JOSAB.8.000337; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sankin GN, 2003, DOKL PHYS, V48, P665, DOI 10.1134/1.1639433; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Shavit A, 2014, PHYS CHEM CHEM PHYS, V16, P10301, DOI 10.1039/c3cp55330b; Shunmugam R, 2010, MACROMOL RAPID COMM, V31, P784, DOI 10.1002/marc.200900869; Sivaloganathan J, 2006, SIAM J APPL MATH, V66, P736, DOI 10.1137/040618965; Sivaloganathan J, 2002, P ROY SOC EDINB A, V132, P985, DOI 10.1017/S0308210500001979; Stride EP, 2010, P I MECH ENG H, V224, P171, DOI 10.1243/09544119JEIM622; Tang JD, 2017, EXTREME MECH LETT, V10, P24, DOI 10.1016/j.eml.2016.09.010; Tang SC, 2016, MACROMOLECULES, V49, P9163, DOI 10.1021/acs.macromol.6b01618; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Wang HM, 2015, J APPL PHYS, V117, DOI 10.1063/1.4918278; Wang HM, 2015, SOFT MATTER, V11, P1058, DOI 10.1039/c4sm02652g; Wang QM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2178; Wang WJ, 2017, FOOD RES INT, V102, P101, DOI 10.1016/j.foodres.2017.09.087; Wei CW, 2014, OPT LETT, V39, P2599, DOI 10.1364/OL.39.002599; Wilde GS, 2012, EXP EYE RES, V97, P36, DOI 10.1016/j.exer.2012.01.011; WILLIAMS ML, 1965, INT J FRACT MECH, V1, P64, DOI 10.1007/BF00184154; Yerzley FL, 1939, IND ENG CHEM, V31, P950, DOI 10.1021/ie50356a007; Zha YP, 2012, J AM CHEM SOC, V134, P4493, DOI 10.1021/ja211365r; Zhang K, 2011, LAB CHIP, V11, P1389, DOI 10.1039/c0lc00520g; Zhu J, 2011, J ADHESION, V87, P466, DOI 10.1080/00218464.2011.575332; Zimberlin JA, 2007, SOFT MATTER, V3, P763, DOI 10.1039/b617050a; Zimberlin JA, 2010, SOFT MATTER, V6, P3632, DOI 10.1039/b925407b; Zimberlin JA, 2010, J POLYM SCI POL PHYS, V48, P1423, DOI 10.1002/polb.21968	124	35	35	8	16	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	APR 28	2020	117	17					9157	9165		10.1073/pnas.1920168117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LJ3WV	WOS:000530099500009	32291337	Green Published, hybrid			2022-02-06	
J	Marcos-Contreras, OA; Greineder, CF; Kiseleva, RY; Parhiz, H; Walsh, LR; Zuluaga-Ramirez, V; Myerson, JW; Hood, ED; Villa, CH; Tombacz, I; Pardi, N; Seliga, A; Mui, BL; Tam, YK; Glassman, PM; Shuvaev, VV; Nong, J; Brenner, JS; Khoshnejad, M; Madden, T; Weissmann, D; Persidsky, Y; Muzykantov, VR				Marcos-Contreras, Oscar A.; Greineder, Colin F.; Kiseleva, Raisa Yu; Parhiz, Hamideh; Walsh, Landis R.; Zuluaga-Ramirez, Viviana; Myerson, Jacob W.; Hood, Elizabeth D.; Villa, Carlos H.; Tombacz, Istvan; Pardi, Norbert; Seliga, Alecia; Mui, Barbara L.; Tam, Ying K.; Glassman, Patrick M.; Shuvaev, Vladimir V.; Nong, Jia; Brenner, Jacob S.; Khoshnejad, Makan; Madden, Tom; Weissmann, Drew; Persidsky, Yuri; Muzykantov, Vladimir R.			Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						blood-brain barrier; cerebrovascular drug targeting; drug delivery to brain; mRNA therapy; VCAM-1	SENSITIVE MOLECULAR MRI; ENDOTHELIAL-CELLS; DRUG-DELIVERY; COLLABORATIVE ENHANCEMENT; MAGNETIC-RESONANCE; ADHESION MOLECULES; MOUSE MODEL; EXPRESSION; VCAM-1; NANOCARRIERS	Drug targeting to inflammatory brain pathologies such as stroke and traumatic brain injury remains an elusive goal. Using a mouse model of acute brain inflammation induced by local tumor necrosis factor alpha (TNF alpha), we found that uptake of intravenously injected antibody to vascular cell adhesion molecule 1 (anti-VCAM) in the inflamed brain is >10-fold greater than antibodies to transferrin receptor-1 and intercellular adhesion molecule 1 (TfR-1 and ICAM-1). Furthermore, uptake of anti-VCAM/liposomes exceeded that of anti-TfR and anti-ICAM counterparts by similar to 27- and similar to 8-fold, respectively, achieving brain/blood ratio >300-fold higher than that of immunoglobulin G/liposomes. Single-photon emission computed tomography imaging affirmed specific anti-VCAM/liposome targeting to inflamed brain in mice. Intravital microscopy via cranial window and flow cytometry showed that in the inflamed brain anti-VCAM/liposomes bind to endothelium, not to leukocytes. Anti-VCAM/LNP selectively accumulated in the inflamed brain, providing de novo expression of proteins encoded by cargo messenger RNA (mRNA). Anti-VCAM/LNP-mRNA mediated expression of thrombomodulin (a natural endothelial inhibitor of thrombosis, inflammation, and vascular leakage) and alleviated TNF alpha-induced brain edema. Thus VCAM-directed nanocarriers provide a platform for cerebrovascular targeting to inflamed brain, with the goal of normalizing the integrity of the blood-brain barrier, thus benefiting numerous brain pathologies.	[Marcos-Contreras, Oscar A.; Greineder, Colin F.; Kiseleva, Raisa Yu; Parhiz, Hamideh; Walsh, Landis R.; Myerson, Jacob W.; Hood, Elizabeth D.; Villa, Carlos H.; Glassman, Patrick M.; Shuvaev, Vladimir V.; Nong, Jia; Brenner, Jacob S.; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Zuluaga-Ramirez, Viviana; Seliga, Alecia; Persidsky, Yuri] Temple Univ, Dept Pathol, Lewis Katz Sch Med, Philadelphia, PA 19140 USA; [Tombacz, Istvan; Pardi, Norbert; Weissmann, Drew] Univ Penn, Perelman Sch Med, Infect Dis, Philadelphia, PA 19104 USA; [Mui, Barbara L.; Tam, Ying K.; Madden, Tom] Acuitas Therapeut, Vancouver, BC V6L 2A1, Canada; [Brenner, Jacob S.; Muzykantov, Vladimir R.] Univ Penn, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19140 USA; [Brenner, Jacob S.] Univ Penn, Perelman Sch Med, Pulm & Crit Care Med, Philadelphia, PA 19104 USA; [Khoshnejad, Makan] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Greineder, Colin F.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Greineder, Colin F.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA		Marcos-Contreras, OA; Greineder, CF; Muzykantov, VR (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Muzykantov, VR (corresponding author), Univ Penn, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19140 USA.	oscarmar@pennmedicine.upenn.edu; coling@med.umich.edu; muzykant@mail.med.upenn.edu		Tombacz, Istvan/0000-0001-6683-7223; Nong, Jia/0000-0002-9210-7707; Glassman, Patrick/0000-0003-3786-0437	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 HL128398-02, RO1 HL 143806-01, T32 HL 007971, K08 HL130430]; Acuitas (SRA); Cardiovascular Institute of the University of Pennsylvania; American Heart AssociationAmerican Heart Association [19CDA34590001]	V.R.M. received funding from NIH (Grants RO1 HL128398-02 and RO1 HL 143806-01) and Acuitas (SRA), V.R.M. and J.S.B. received funding from the Cardiovascular Institute of the University of Pennsylvania, O.A.M.-C. received funding from the American Heart Association (Grant 19CDA34590001), R.Yu.K. and P.M.G. received funding from NIH (Grant T32 HL 007971), and C.F.G. and L.R.W. received funding from NIH (Grant K08 HL130430). We acknowledge Kathleen LeForte for technical assistance in the preparation of this manuscript and Dr. Silvia Muro (University of Maryland) for the stimulating discussion of the manuscript.	Anraku Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00952-3; Anselmo AC, 2015, J CONTROL RELEASE, V199, P29, DOI 10.1016/j.jconrel.2014.11.027; Batrakova EV, 2007, BIOCONJUGATE CHEM, V18, P1498, DOI 10.1021/bc700184b; Bellavance MA, 2008, AAPS J, V10, P166, DOI 10.1208/s12248-008-9018-7; Boado RJ, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/296151; Bonavia AS, 2006, APPL RADIAT ISOTOPES, V64, P470, DOI 10.1016/j.apradiso.2005.11.004; Brenner JS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05079-7; Brenner Jacob S, 2017, Nanomedicine, V13, P1495, DOI 10.1016/j.nano.2016.12.019; Bruckman MA, 2014, NANO LETT, V14, P1551, DOI 10.1021/nl404816m; BurkeGaffney A, 1996, BRIT J PHARMACOL, V119, P1149, DOI 10.1111/j.1476-5381.1996.tb16017.x; Chacko AM, 2015, ACS NANO, V9, P6785, DOI 10.1021/nn505672x; Danielyan K, 2007, J PHARMACOL EXP THER, V321, P947, DOI 10.1124/jpet.107.120535; Demeule M, 2014, J CLIN INVEST, V124, P1199, DOI 10.1172/JCI70647; Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC; Dogbevia GK, 2017, ANN NEUROL, V82, P93, DOI 10.1002/ana.24981; Fournier AP, 2017, P NATL ACAD SCI USA, V114, P6116, DOI 10.1073/pnas.1619424114; Frechou M, 2013, CONTRAST MEDIA MOL I, V8, P157, DOI 10.1002/cmmi.1512; Gauberti M, 2013, STROKE, V44, P1988, DOI 10.1161/STROKEAHA.111.000544; Greineder CF, 2017, BLOOD ADV, V1, P1452, DOI 10.1182/bloodadvances.2017007229; Greineder CF, 2015, FASEB J, V29, P3483, DOI 10.1096/fj.15-271213; Greineder CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080110; Griffin JH, 2018, BLOOD, V132, P159, DOI 10.1182/blood-2018-02-769026; Hood ED, 2012, J CONTROL RELEASE, V163, P161, DOI 10.1016/j.jconrel.2012.08.031; Howard M, 2014, ACS NANO, V8, P4100, DOI 10.1021/nn500136z; Howard MD, 2014, MOL PHARMACEUT, V11, P2262, DOI 10.1021/mp400677y; Hsu J, 2014, PHARM RES-DORDR, V31, P1855, DOI 10.1007/s11095-013-1289-8; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Huynh GH, 2007, BRAIN RES, V1128, P181, DOI 10.1016/j.brainres.2006.10.041; Irani DN, 1996, J IMMUNOL, V156, P3850; ISHII H, 1986, BLOOD, V67, P362; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Johnsen KB, 2016, J CONTROL RELEASE, V222, P32, DOI 10.1016/j.jconrel.2015.11.032; Kanodia JS, 2016, CPT-PHARMACOMET SYST, V5, P283, DOI 10.1002/psp4.12081; Kiseleva R, 2018, DRUG DELIV TRANSL RE, V8, P883, DOI 10.1007/s13346-017-0464-6; Kiseleva RY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20027-7; Klyachko NL, 2017, BIOMATERIALS, V140, P79, DOI 10.1016/j.biomaterials.2017.06.017; Li RR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196976; Liu HL, 2016, THERANOSTICS, V6, P1588, DOI 10.7150/thno.15492; Llovera G, 2017, ACTA NEUROPATHOL, V134, P851, DOI 10.1007/s00401-017-1758-y; Loghmani H, 2018, BLOOD, V132, P148, DOI 10.1182/blood-2017-12-768994; MATTILA P, 1992, SCAND J IMMUNOL, V36, P159, DOI 10.1111/j.1365-3083.1992.tb03087.x; Mead BP, 2017, NANO LETT, V17, P3533, DOI 10.1021/acs.nanolett.7b00616; Montagne A, 2012, NEUROIMAGE, V63, P760, DOI 10.1016/j.neuroimage.2012.07.018; Muller K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04871; Murciano JC, 2003, BLOOD, V101, P3977, DOI 10.1182/blood-2002-09-2853; Muzykantov VR, 1996, P NATL ACAD SCI USA, V93, P5213, DOI 10.1073/pnas.93.11.5213; Myerson JW, 2018, ADV MATER, V30, DOI 10.1002/adma.201802373; Myerson JW, 2016, ADV DRUG DELIVER REV, V99, P97, DOI 10.1016/j.addr.2015.10.011; Nahrendorf M, 2009, JACC-CARDIOVASC IMAG, V2, P1213, DOI 10.1016/j.jcmg.2009.04.016; National Research Council, 2011, GUIDE CARE USE LAB A; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Papademetriou J, 2014, J CONTROL RELEASE, V188, P87, DOI 10.1016/j.jconrel.2014.06.008; Pardi N, 2015, J CONTROL RELEASE, V217, P345, DOI 10.1016/j.jconrel.2015.08.007; Patel N, 2015, BIOCONJUGATE CHEM, V26, P1542, DOI 10.1021/acs.bioconjchem.5b00380; Posel C, 2016, JOVE-J VIS EXP, DOI 10.3791/53658; Polfliet MMJ, 2001, J IMMUNOL, V167, P4644, DOI 10.4049/jimmunol.167.8.4644; Rom S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0729-x; Rossi B, 2011, J LEUKOCYTE BIOL, V89, P539, DOI 10.1189/jlb.0710432; Seo JW, 2015, J CONTROL RELEASE, V220, P51, DOI 10.1016/j.jconrel.2015.09.057; Sherman DG, 2001, NEUROLOGY, V57, P1428, DOI 10.1212/wnl.57.8.1428; Shi YJ, 2017, P NATL ACAD SCI USA, V114, pE1243, DOI 10.1073/pnas.1621174114; Shuvaev VV, 2015, J CONTROL RELEASE, V219, P576, DOI 10.1016/j.jconrel.2015.09.055; Sun T, 2017, P NATL ACAD SCI USA, V114, pE10281, DOI 10.1073/pnas.1713328114; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Tsourkas A, 2005, BIOCONJUGATE CHEM, V16, P576, DOI 10.1021/bc050002e; Voinea M, 2005, PHARM RES-DORDR, V22, P1906, DOI 10.1007/s11095-005-7247-3; Vuorte J, 1999, J IMMUNOL, V162, P2353; Weissman D, 2015, MOL THER, V23, P1416, DOI 10.1038/mt.2015.138; Wichert S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171205; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426; Yuan DF, 2017, BIOMATERIALS, V142, P1, DOI 10.1016/j.biomaterials.2017.07.011; Zhang C, 2017, THERANOSTICS, V7, P3260, DOI 10.7150/thno.19979	73	35	35	6	37	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	FEB 18	2020	117	7					3405	3414		10.1073/pnas.1912012117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KM4JX	WOS:000514096400017	32005712	Green Published, Bronze			2022-02-06	
J	Silverberg, ND; Iaccarino, MA; Panenka, WJ; Iverson, GL; McCulloch, KL; Dams-O'Connor, K; Reed, N; McCrea, M; Cogan, AM; Graf, MJP; Kajankova, M; McKinney, G; Jamora, CW				Silverberg, Noah D.; Iaccarino, Mary Alexis; Panenka, William J.; Iverson, Grant L.; McCulloch, Karen L.; Dams-O'Connor, Kristen; Reed, Nick; McCrea, Michael; Cogan, Alison M.; Graf, Min Jeong Park; Kajankova, Maria; McKinney, Gary; Jamora, Christina Weyer		Amer Congress Rehabil Med Brain In	Management of Concussion and Mild Traumatic Brain Injury: A Synthesis of Practice Guidelines	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Brain injuries; traumatic; Practice guidelines as topic; Rehabilitation; Review	PATIENT HEALTH QUESTIONNAIRE-9; CT HEAD RULE; COGNITIVE REHABILITATION; POSTCONCUSSION SYMPTOMS; CHILDREN; RISK; OUTCOMES; SPORT; RECOMMENDATIONS; TRENDS	At least 3 million Americans sustain a mild traumatic brain injury (mTBI) each year, and 1 in 5 have symptoms that persist beyond 1 month. Standards of mTBI care have evolved rapidly, with numerous expert consensus statements and clinical practice guidelines published in the last 5 years. This Special Communication synthesizes recent expert consensus statements and evidenced-based clinical practice guidelines for civilians, athletes, military, and pediatric populations for clinicians practicing outside of specialty mTBI clinics, including primary care providers. The article offers guidance on key clinical decisions in mTBI care and highlights priority interventions that can be initiated in primary care to prevent chronicity. (C) 2019 by the American Congress of Rehabilitation Medicine. Published by Elsevier Inc.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada; [Silverberg, Noah D.] GF Strong Rehabil Ctr, Rehabil Res Program, Vancouver, BC, Canada; [Iaccarino, Mary Alexis; Kajankova, Maria] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Iaccarino, Mary Alexis] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Iaccarino, Mary Alexis] Harvard Med Sch, Boston, MA 02115 USA; [Panenka, William J.] BC Mental Hlth & Addict Res Inst, Vancouver, BC, Canada; [Panenka, William J.] British Columbia Prov Neuropsychiat Program, Vancouver, BC, Canada; [Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] MassGen Hosp, Children Sport Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [McCulloch, Karen L.] Univ North Carolina Chapel Hill, Dept Allied Hlth Sci, Div Phys Therapy, Sch Med, Chapel Hill, NC USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [McCrea, Michael] Med Coll Wisconsin, Ctr Neurotrauma Res CNTR, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Cogan, Alison M.] Washington DC Vet Affairs Med Ctr, Washington, DC USA; [Graf, Min Jeong Park] Univ Minnesota, Med Sch, Minneapolis, MN 55455 USA; [Graf, Min Jeong Park] Hennepin Healthcare, Dept Phys Med & Rehabil, Minneapolis, MN USA; [Kajankova, Maria] Brain Injury Res Ctr, Houston, TX USA; [McKinney, Gary] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Jamora, Christina Weyer] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Jamora, Christina Weyer] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Psychiat, San Francisco, CA 94143 USA		Silverberg, ND (corresponding author), Univ British Columbia, Div Phys Med & Rehabil, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca	Cogan, Alison/AAS-3101-2021; McKinney, Gary/ABB-9894-2021	Panenka, William/0000-0001-7143-6512	American Congress of Rehabilitation Medicine Brain Injury Special Interest Group	The American Congress of Rehabilitation Medicine Brain Injury Special Interest Group provided administrative support for the activities of the Task Force and funded the open access fees for this article through a Task Force grant.	Ananthaharan A, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0193-2; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; [Anonymous], 2014, GUID DIAGN MAN PED C; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Bloom B, 2018, BRAIN INJURY, V32, P1623, DOI 10.1080/02699052.2018.1532111; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; CASSIDY JD, 2014, ARCH PHYS MED REHAB, V95, P132; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Cnossen MC, 2017, BRAIN INJURY, V31, P800; Collins MW, 2015, NEUROSURGERY, V2016, P1; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Diener HC, 2016, NAT REV NEUROL, V12, P575, DOI 10.1038/nrneurol.2016.124; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2015, BRAIN INJURY, V29, P185, DOI 10.3109/02699052.2014.965212; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kemp S, 2010, J NEUROPSYCHOL, V4, P231, DOI 10.1348/174866409X482614; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Keret A, 2017, J NEUROSURG-PEDIATR, V20, P64, DOI 10.3171/2017.2.PEDS16585; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kristman VL, 2014, ARCH PHYS MED REHAB, V95, P295; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuhl NO, 2018, PHYSICIAN SPORTSMED, V46, P1, DOI 10.1080/00913847.2018.1419775; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Leddy J, 2016, PM R S3, V8, P91; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Manea L, 2015, GEN HOSP PSYCHIAT, V37, P67, DOI 10.1016/j.genhosppsych.2014.09.009; Mann A, 2017, CAN FAM PHYSICIAN, V63, P460; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Minhas H, 2018, BRIT J HAEMATOL, V183, P119, DOI 10.1111/bjh.15509; Minkkinen M, 2019, J NEUROTRAUM, V36, P2904, DOI 10.1089/neu.2018.6351; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Morin M, 2016, J SPORTS MED, V2016, P1; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Ontario Neurotrauma Foundation, 2019, ONTARIO NEUROTRAUMA; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Rao DP, 2018, HEALTH PROMOT CHRON, V38, P147, DOI 10.24095/hpcdp.38.3.05; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Scheenen ME, 2016, J NEUROTRAUM, V33, P339, DOI 10.1089/neu.2015.3926; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Tepper SJ, 2010, CLEV CLIN J MED, V77, P236, DOI 10.3949/ccjm.77a.09147; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Ungprasert P, 2016, STROKE, V47, P356, DOI 10.1161/STROKEAHA.115.011678; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Veterans Affairs/Department of Defense, 2016, MAN CONC MILD TRAUM; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wennberg R, 2018, CAN J NEUROL SCI, V45, P275, DOI 10.1017/cjn.2017.300; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zetterberg H, 2016, CONCUSSION, V1	135	35	35	4	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2020	101	2					382	393		10.1016/j.apmr.2019.10.179			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	KM6CP	WOS:000514226500021	31654620	hybrid			2022-02-06	
J	Stemper, BD; Shah, AS; Harezlak, J; Rowson, S; Mihalik, JP; Duma, SM; Riggen, LD; Brooks, A; Cameron, KL; Campbell, D; DiFiori, JP; Giza, CC; Guskiewicz, KM; Jackson, J; McGinty, GT; Svoboda, SJ; McAllister, TW; Broglio, SP; McCrea, M; Hoy, AM; Hazzard, JB; Kelly, LA; Ortega, JD; Port, N; Putukian, M; Langford, TD; Tierney, R; Goldman, JT; Benjamin, HJ; Buckley, T; Kaminski, TW; Clugston, JR; Schmidt, JD; Feigenbaum, LA; Eckner, JT; Guskiewicz, K; Miles, JD; Anderson, S; Master, CL; Collins, M; Kontos, AP; Bazarian, JJ; Chrisman, SPO; McGinty, G; O'Donnell, P; Cameron, K; Susmarski, A; Duma, S; Rowson, S; Bullers, CT; Miles, CM; Dykhuizen, BH; Lintner, L				Stemper, Brian D.; Shah, Alok S.; Harezlak, Jaroslaw; Rowson, Steven; Mihalik, Jason P.; Duma, Stefan M.; Riggen, Larry D.; Brooks, Alison; Cameron, Kenneth L.; Campbell, Darren; DiFiori, John P.; Giza, Christopher C.; Guskiewicz, Kevin M.; Jackson, Jonathan; McGinty, Gerald T.; Svoboda, Steven J.; McAllister, Thomas W.; Broglio, Steven P.; McCrea, Michael; Hoy, April Marie (Reed); Hazzard, Joseph B., Jr.; Kelly, Louise A.; Ortega, Justus D.; Port, Nicholas; Putukian, Margot; Langford, T. Dianne; Tierney, Ryan; Goldman, Joshua T.; Benjamin, Holly J.; Buckley, Thomas; Kaminski, Thomas W.; Clugston, James R.; Schmidt, Julianne D.; Feigenbaum, Luis A.; Eckner, James T.; Guskiewicz, Kevin; Miles, Jessica Dysart; Anderson, Scott; Master, Christina L.; Collins, Micky; Kontos, Anthony P.; Bazarian, Jeffrey J.; Chrisman, Sara P. O.; McGinty, Gerald; O'Donnell, Patrick; Cameron, Kenneth; Susmarski, Adam; Duma, Stefan; Rowson, Steve; Bullers, Christopher Todd; Miles, Christopher M.; Dykhuizen, Brian H.; Lintner, Laura		CARE Consortium Investigators	Comparison of Head Impact Exposure Between Concussed Football Athletes and Matched Controls: Evidence for a Possible Second Mechanism of Sport-Related Concussion	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Repetitive head impact exposure; Subconcussive; Traumatic brain injury; Sport-related concussion	WHITE-MATTER INTEGRITY; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; CEREBRAL CONCUSSION; INJURY; PLAYERS; BIOMECHANICS; IMPAIRMENT; VALIDATION; KINEMATICS	Studies of football athletes have implicated repetitive head impact exposure in the onset of cognitive and brain structural changes, even in the absence of diagnosed concussion. Those studies imply accumulating damage from successive head impacts reduces tolerance and increases risk for concussion. Support for this premise is that biomechanics of head impacts resulting in concussion are often not remarkable when compared to impacts sustained by athletes without diagnosed concussion. Accordingly, this analysis quantified repetitive head impact exposure in a cohort of 50 concussed NCAA Division I FBS college football athletes compared to controls that were matched for team and position group. The analysis quantified the number of head impacts and risk weighted exposure both on the day of injury and for the season to the date of injury. 43% of concussed athletes had the most severe head impact exposure on the day of injury compared to their matched control group and 46% of concussed athletes had the most severe head impact exposure for the season to the date of injury compared to their matched control group. When accounting for date of injury or season to date of injury, 72% of all concussed athletes had the most or second most severe head impact exposure compared to their matched control group. These trends associating cumulative head impact exposure with concussion onset were stronger for athletes that participated in a greater number of contact activities. For example, 77% of athletes that participated in ten or more days of contact activities had greater head impact exposure than their matched control group. This unique analysis provided further evidence for the role of repetitive head impact exposure as a predisposing factor for the onset of concussion. The clinical implication of these findings supports contemporary trends of limiting head impact exposure for college football athletes during practice activities in an effort to also reduce risk of concussive injury.	[Stemper, Brian D.] Marquette Univ, Joint Dept Biomed Engn, Milwaukee, WI 53233 USA; [Stemper, Brian D.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Stemper, Brian D.; Shah, Alok S.; McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Stemper, Brian D.; Shah, Alok S.; McCrea, Michael] Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA; [Harezlak, Jaroslaw; Riggen, Larry D.] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Bloomington, IN USA; [Rowson, Steven; Duma, Stefan M.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Steve Tisch BrainSPORT Program, Dept Neurosurg, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Steve Tisch BrainSPORT Program, Dept Pediat, Los Angeles, CA 90095 USA; [DiFiori, John P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Family Med & Orthopaed, Div Sports Med & Nonoperat Orthopaed, Los Angeles, CA 90095 USA; [Brooks, Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped, Madison, WI USA; [Mihalik, Jason P.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Cameron, Kenneth L.; Svoboda, Steven J.] US Mil Acad, John A Feagin Jr Sports Med Fellowship, Keller Army Hosp, West Point, NY 10996 USA; [Campbell, Darren; Jackson, Jonathan; McGinty, Gerald T.] US Air Force Acad, Dept Sports Med, Colorado Springs, CO 80840 USA; [McAllister, Thomas W.] Indiana Sch Med, Dept Psychiat, Indianapolis, IN USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Hoy, April Marie (Reed)] Azusa Pacific Univ, Azusa, CA 91702 USA; [Hazzard, Joseph B., Jr.] Bloomsburg Univ, Bloomsburg, PA USA; [Kelly, Louise A.] Calif Lutheran Univ, Thousand Oaks, CA USA; [Ortega, Justus D.] Humboldt State Univ, Arcata, CA USA; [Port, Nicholas] Indiana Univ, Bloomington, IN 47405 USA; [Putukian, Margot] Princeton Univ, Princeton, NJ 08544 USA; [Langford, T. Dianne; Tierney, Ryan] Temple Univ, Philadelphia, PA 19122 USA; [Giza, Christopher C.; Goldman, Joshua T.] Univ Calif Los Angeles, Los Angeles, CA USA; [Benjamin, Holly J.] Univ Chicago, Chicago, IL 60637 USA; [Buckley, Thomas; Kaminski, Thomas W.] Univ Delaware, Newark, DE 19716 USA; [Clugston, James R.] Univ Florida, Gainesville, FL 32611 USA; [Schmidt, Julianne D.] Univ Georgia, Athens, GA 30602 USA; [Feigenbaum, Luis A.] Univ Miami, Coral Gables, FL 33124 USA; [Eckner, James T.] Univ Michigan, Ann Arbor, MI 48109 USA; [Mihalik, Jason P.; Guskiewicz, Kevin] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Miles, Jessica Dysart] Univ North Georgia, Dahlonega, GA USA; [Anderson, Scott] Univ Oklahoma, Norman, OK 73019 USA; [Master, Christina L.] Univ Penn, Philadelphia, PA 19104 USA; [Collins, Micky; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Bazarian, Jeffrey J.] Univ Rochester, Rochester, NY 14627 USA; [Chrisman, Sara P. O.] Univ Washington, Seattle, WA 98195 USA; [Brooks, Alison] Univ Wisconsin Madison, Madison, WI USA; [McGinty, Gerald] US Air Force Acad, Colorado Springs, CO 80840 USA; [O'Donnell, Patrick] US Coast Guard Acad, New London, CT USA; [Cameron, Kenneth] US Mil Acad, West Point, NY USA; [Susmarski, Adam] US Naval Acad, Annapolis, MD 21402 USA; [Duma, Stefan; Rowson, Steve] Virginia Tech, Blacksburg, VA USA; [Bullers, Christopher Todd; Miles, Christopher M.] Wake Forest Univ, Winston Salem, NC 27101 USA; [Dykhuizen, Brian H.] Wilmington Coll, Southwest, OH USA; [Lintner, Laura] Winston Salem Univ, Winston Salem, NC USA		Stemper, BD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.	bstemper@mcw.edu	Buckley, Thomas A/B-7525-2016; Rowson, Steven/B-1270-2012; Stemper, Brian/AAX-7611-2020; Harezlak, Jaroslaw/P-8557-2014	Buckley, Thomas A/0000-0002-0515-0150; Rowson, Steven/0000-0002-3227-0596; Cameron, Kenneth/0000-0002-6276-4482; Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - Department of Defense (DoD); U.S. Army Medical Research Acquisition Activity, Chandler Street, Ford Detrick MD; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; UCLA	This investigation was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Ford Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds). The authors have no other financial conflicts of interest to disclose. UCLA would like to acknowledge the Tisch BrainSPORT program which provided funds to purchase the HIT System for their team. The team would also like to acknowledge the HIT System operators that participated in this study: Julia Ford (UNC), Gus Hendricks (UCLA), Quinn Lukens (UW), Brett Griesemer (VT), Alex Black (VT), Lewis Young (VT), Dom Calhoun (USAFA), and Sean Roach (USMA). Results of this study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. Results of the present study do not constitute endorsement by ACSM. The conclusions herein are those of the authors. They do not represent official policy of the Department of the Air Force or the Department of Defense. CARE Consortium Investigators are listed alphabetically by institution: April Marie (Reed) Hoy, MS, ATC (Azusa Pacific University); Joseph B. Hazzard Jr, EdD, ATC (Bloomsburg University); Louise A. Kelly, PhD (California Lutheran University); Justus D. Ortega, PhD (Humboldt State University); Nicholas Port, PhD (Indiana University); Margot Putukian MD (Princeton University); T. Dianne Langford, PhD, and Ryan Tierney, PhD, ATC (Temple University); Christopher C. Giza, MD and Joshua T. Goldman, MD, MBA (University of California, Los Angeles); Holly J. Benjamin MD (University of Chicago); Thomas Buckley, EdD, ATC, and Thomas W. Kaminski, PhD, ATC (University of Delaware); James R. Clugston, MD, MS (University of Florida); Julianne D. Schmidt, PhD, ATC (University of Georgia); Luis A. Feigenbaum, DPT, ATC (University of Miami); James T. Eckner, MD, MS (University of Michigan); Kevin Guskiewicz, PhD, ATC, and Jason P. Mihalik, PhD, CAT(C), ATC (University of North Carolina at Chapel Hill); Jessica Dysart Miles, PhD, ATC (University of North Georgia); Scott Anderson, ATC (University of Oklahoma); Christina L. Master, MD (University of Pennsylvania); Micky Collins, PhD, and Anthony P. Kontos, PhD (University of Pittsburgh Medical Center); Jeffrey J. Bazarian, MD, MPH (University of Rochester); Sara P.O. Chrisman, MD, MPH (University of Washington); Alison Brooks, MD, MPH (University of Wisconsin-Madison); Jonathan Jackson, MD, and Gerald McGinty, DPT (United States Air Force Academy); Patrick O'Donnell, MHA (United States Coast Guard Academy); Kenneth Cameron, PhD, MPH, ATC (United States Military Academy); Adam Susmarski, MD (United States Naval Academy); Stefan Duma, PhD and Steve Rowson, PhD (Virginia Tech); Christopher Todd Bullers, MD, and Christopher M. Miles, MD (Wake Forest University); Brian H. Dykhuizen, MS, ATC (Wilmington College); Laura Lintner DO (Winston-Salem University).	Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Belson K, NY TIMES; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Holbourn AHS, 1943, LANCET, V2, P438; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P40; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	55	35	35	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2019	47	10			SI		2057	2072		10.1007/s10439-018-02136-6			16	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JQ0HT	WOS:000498636800003	30362082	hybrid, Green Published			2022-02-06	
J	Xiao, X; Jiang, YJ; Liang, WB; Wang, YY; Cao, SQ; Yan, H; Gao, LB; Zhang, L				Xiao, Xiao; Jiang, Youjing; Liang, Weibo; Wang, Yanyun; Cao, Shuqiang; Yan, He; Gao, Linbo; Zhang, Lin			miR-212-5p attenuates ferroptotic neuronal death after traumatic brain injury by targeting Ptgs2	MOLECULAR BRAIN			English	Article						Traumatic brain injury (TBI); Ferroptosis; miR-212-5p; Prostaglandin endoperoxide synthase-2 (Ptgs2)	DOWN-REGULATION; EXPRESSION; MECHANISMS; PROMOTES; INACTIVATION; METABOLISM; MONOCYTES; OXIDATION; RETENTION; MICRORNAS	Ferroptosis, a newly discovered form of iron-dependent regulated cell death, has been implicated in traumatic brain injury (TBI). MiR-212-5p has previously been reported to be downregulated in extracellular vesicles following TBI. To investigate whether miR-212-5p is involved in the ferroptotic neuronal death in TBI mice, we first examined the accumulation of malondialdehyde (MDA) and ferrous ion, and the expression of ferroptosis-related molecules at 6 h, 12 h, 24 h, 48 h and 72 h following controlled cortical impact (CCI) in mice. There was a significant upregulation in the expression of Gpx4 and Acsl4 at 6 h, Slc7a11 from 12 h to 72 h, and Nox2 and Sat1 from 6 h to 72 h post injury. Similarly, an upregulation in the expression of Gpx4 at 6 h, Nox2 from 6 h to 72 h, xCT from 12 h to 72 h, and Sat1 at 72 h after CCI was observed at the protein level. Interestingly, MDA and ferrous ion were increased whereas miR-212-5p was decreased in the CCI group compared to the sham group. Furthermore, we found that overexpression of miR-212-5p attenuated ferroptosis while downregulation of miR-212-5p promoted ferroptotic cell death partially by targeting prostaglandin-endoperoxide synthase-2 (Ptgs2) in HT-22 and Neuro-2a cell lines. In addition, administration of miR-212-5p in CCI mice significantly improved learning and spatial memory. Collectively, these findings indicate that miR-212-5p may protect against ferroptotic neuronal death in CCI mice partially by targeting Ptgs2.	[Xiao, Xiao; Jiang, Youjing; Liang, Weibo; Cao, Shuqiang; Zhang, Lin] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Forens Genet, Chengdu 610041, Sichuan, Peoples R China; [Wang, Yanyun; Gao, Linbo; Zhang, Lin] Sichuan Univ, Ctr Translat Med, Key Lab Birth Defects & Related Dis Women & Child, Lab Mol Translat Med,Minist Educ,West China Univ, Chengdu, Sichuan, Peoples R China; [Yan, He] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Forens Pathol, Chengdu, Sichuan, Peoples R China		Zhang, L (corresponding author), Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Forens Genet, Chengdu 610041, Sichuan, Peoples R China.; Gao, LB; Zhang, L (corresponding author), Sichuan Univ, Ctr Translat Med, Key Lab Birth Defects & Related Dis Women & Child, Lab Mol Translat Med,Minist Educ,West China Univ, Chengdu, Sichuan, Peoples R China.	gaolinboscu@163.com; zhanglin@scu.edu.cn	liang, weibo/G-8456-2011	liang, weibo/0000-0002-8487-3575	Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [2018SCUH0053]; Science and Technology Major Projects of Sichuan Province of China [2017SZDZX0013]; Science and Technology Support Program of Sichuan Province of China [2016SZ0013]	This work was supported by the Fundamental Research Funds for the Central Universities (No. 2018SCUH0053), the Science and Technology Major Projects of Sichuan Province of China (No.2017SZDZX0013), and the Science and Technology Support Program of Sichuan Province of China (No.2016SZ0013).	Amadio P, 2017, THROMB HAEMOSTASIS, V117, P1486, DOI 10.1160/TH16-12-0968; Aten S., 2016, RNA DIS, V3, P1375; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Becker RE, 2018, ALZHEIMERS DEMENT, V14, P431, DOI 10.1016/j.jalz.2017.11.007; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bretscher P, 2015, EMBO MOL MED, V7, P593, DOI 10.15252/emmm.201404702; Burek M, 2019, TRANSL STROKE RES, V10, P672, DOI 10.1007/s12975-018-0683-2; Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1; Chen W, 2019, BIOMATERIALS, V192, P590, DOI 10.1016/j.biomaterials.2018.11.035; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Dean Dana D, 2017, Curr Protoc Neurosci, V81, DOI 10.1002/cpns.37; del Rey MQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00238; Devos D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39739-5; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Fricker M, 2018, PHYSIOL REV, V98, P813, DOI 10.1152/physrev.00011.2017; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Garcia-Concejo A, 2018, BBA-GEN SUBJECTS, V1862, P2605, DOI 10.1016/j.bbagen.2018.07.001; Gaschler MM, 2018, ACS CHEM BIOL, V13, P1013, DOI 10.1021/acschembio.8b00199; Guiney SJ, 2017, NEUROCHEM INT, V104, P34, DOI 10.1016/j.neuint.2017.01.004; Guo YJ, 2017, J MOL ENDOCRINOL, V59, P205, DOI 10.1530/JME-16-0179; Hambright WS, 2017, REDOX BIOL, V12, P8, DOI 10.1016/j.redox.2017.01.021; Hansen KF, 2016, LEARN MEMORY, V23, P61, DOI 10.1101/lm.039578.115; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; He J, 2016, J ENVIRON SCI, V39, P97, DOI 10.1016/j.jes.2015.12.003; Hernandez-Rapp J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30953; Hernandez-Rapp J, 2015, BEHAV BRAIN RES, V287, P15, DOI 10.1016/j.bbr.2015.03.032; Hirschhorn T, 2019, FREE RADICAL BIO MED, V133, P130, DOI 10.1016/j.freeradbiomed.2018.09.043; Hu C, 2019, J CELL PHYSIOL, V234, P7090, DOI 10.1002/jcp.27463; Hua X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09636-w; Iaccarino C, 2018, J NEUROSURG SCI, V62, P765, DOI 10.23736/S0390-5616.16.03721-8; Ilmaniemi S, 2019, J EPIDEMIOL COMMUN H, V73, P451, DOI 10.1136/jech-2018-211960; Jiang Yi-na, 2018, Chinese Pharmacological Bulletin, V34, P166, DOI 10.3969/j.issn.1001-1978.2018.02.005; Kang R, 2017, CURR PATHOBIOL REP, V5, P153, DOI 10.1007/s40139-017-0139-5; Keller RF, 2017, IEEE T NANOBIOSCI, V16, P843, DOI 10.1109/TNB.2017.2776841; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kong ZY, 2019, BIOMED PHARMACOTHER, V109, P2043, DOI 10.1016/j.biopha.2018.11.030; Lane DJR, 2018, J ALZHEIMERS DIS, V64, pS379, DOI 10.3233/JAD-179944; Lee YS, 2018, MOL CANCER RES, V16, P1073, DOI 10.1158/1541-7786.MCR-18-0055; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu XP, 2016, CELL CHEM BIOL, V23, P1217, DOI 10.1016/j.chembiol.2016.08.009; Lu L, 2013, INT J BIOCHEM CELL B, V45, P2530, DOI 10.1016/j.biocel.2013.08.007; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Magtanong L, 2019, DEV NEUROSCI-BASEL, V40, P382, DOI 10.1159/000496922; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Mendoza-Viveros L, 2017, CELL REP, V19, P505, DOI 10.1016/j.celrep.2017.03.057; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Pichler S, 2017, NEUROBIOL AGING, V50, DOI 10.1016/j.neurobiolaging.2016.09.019; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Shang J, 2015, MOL ENDOCRINOL, V29, P1243, DOI 10.1210/me.2014-1335; Smith PY, 2015, HUM MOL GENET, V24, P6721, DOI 10.1093/hmg/ddv377; Sticht C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206239; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Sui XB, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01371; Sun DD, 2017, CELL MOL NEUROBIOL, V37, P1349, DOI 10.1007/s10571-017-0484-2; Sun SF, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00381; Ved R, 2018, J NEUROL, V265, P1241, DOI 10.1007/s00415-018-8855-2; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang CY, 2017, J NEUROCHEM, V143, P112, DOI 10.1111/jnc.14138; Wang Y, 2017, NEUROBIOL AGING, V51, P156, DOI 10.1016/j.neurobiolaging.2016.12.015; Weigelt K, 2013, BRAIN BEHAV IMMUN, V29, P147, DOI 10.1016/j.bbi.2012.12.018; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wu YN, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00115; Xiao JJ, 2016, J CELL MOL MED, V20, P204, DOI 10.1111/jcmm.12733; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Zhang ZL, 2018, AUTOPHAGY, V14, P2083, DOI 10.1080/15548627.2018.1503146	73	35	38	2	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1756-6606		MOL BRAIN	Mol. Brain	SEP 18	2019	12	1							78	10.1186/s13041-019-0501-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IZ3YM	WOS:000487021500001	31533781	Green Published, gold			2022-02-06	
J	Harris, TC; de Rooij, R; Kuhl, E				Harris, Taylor C.; de Rooij, Rijk; Kuhl, Ellen			The Shrinking Brain: Cerebral Atrophy Following Traumatic Brain Injury	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Cerebral atrophy; Neurodegeneration; Computational simulation; Finite element modeling	ALZHEIMERS-DISEASE; WHITE-MATTER; HEAD-INJURY; VOLUME; ENCEPHALOPATHY; PREDICTS; SEGMENTATION; MORPHOMETRY; DYSFUNCTION; CONCUSSION	Cerebral atrophy in response to traumatic brain injury is a well-documented phenomenon in both primary investigations and review articles. Recent atrophy studies focus on exploring the region-specific patterns of cerebral atrophy; yet, there is no study that analyzes and synthesizes the emerging atrophy patterns in a single comprehensive review. Here we attempt to fill this gap in our current knowledge by integrating the current literature into a cohesive theory of preferential brain tissue loss and by identifying common risk factors for accelerated atrophy progression. Our review reveals that observations for mild traumatic brain injury remain inconclusive, whereas observations for moderate-to-severe traumatic brain injury converge towards robust patterns: brain tissue loss is on the order of 5% per year, and occurs in the form of generalized atrophy, across the entire brain, or focal atrophy, in specific brain regions. The most common regions of focal atrophy are the thalamus, hippocampus, and cerebellum in gray matter and the corpus callosum, corona radiata, and brainstem in white matter. We illustrate the differences of generalized and focal gray and white matter atrophy on emerging deformation and stress profiles across the whole brain using computational simulation. The characteristic features of our atrophy simulations-a widening of the cortical sulci, a gradual enlargement of the ventricles, and a pronounced cortical thinning-agree well with clinical observations. Understanding region-specific atrophy patterns in response to traumatic brain injury has significant implications in modeling, simulating, and predicting injury outcomes. Computational modeling of brain atrophy could open new strategies for physicians to make informed decisions for whom, how, and when to administer pharmaceutical treatment to manage the chronic loss of brain structure and function.	[Harris, Taylor C.; de Rooij, Rijk; Kuhl, Ellen] Stanford Univ, Stanford, CA 94305 USA		Kuhl, E (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	ekuhl@stanford.edu	Kuhl, Ellen/G-4444-2011	Kuhl, Ellen/0000-0002-6283-935X	Stanford Graduate FellowshipStanford University; Bio-X IIP Seed Grant Molecular Mechanisms of Chronic Traumatic Encephalopathy; National Science Foundation GrantNational Science Foundation (NSF) [CMMI 1727268]	We acknowledge the support of Alexander Zollner and Johannes Weickenmeier for creating the finite element models and the illustration by Lucy Reading. This study was supported by the Stanford Graduate Fellowship to Rijk de Rooij and by the Bio-X IIP Seed Grant Molecular Mechanisms of Chronic Traumatic Encephalopathy and the National Science Foundation Grant CMMI 1727268 Understanding Neurodegeneration Across the Scales to Ellen Kuhl.	Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; BOWEN DM, 1983, J NEUROCHEM, V41, P266, DOI 10.1111/j.1471-4159.1983.tb11838.x; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05644; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALPAN GJ, 1992, NEUROLOGY, V42, P2125, DOI 10.1212/WNL.42.11.2125; de Rooij R, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00144; de Rooij R, 2018, J MECH PHYS SOLIDS, V112, P563, DOI 10.1016/j.jmps.2017.12.011; de Rooij R, 2018, BIOPHYS J, V114, P201, DOI 10.1016/j.bpj.2017.11.010; Deng XQ, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414400028; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Finkenstein EA, 2006, INCIDENCE EC BURDEN; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Horstemeyer M. F., 2018, PHYS MOTIVATED MECH; Horstemeyer MF, 1999, INT J SOLIDS STRUCT, V36, P5029, DOI 10.1016/S0020-7683(98)00239-X; Hua X, 2008, NEUROIMAGE, V43, P458, DOI 10.1016/j.neuroimage.2008.07.013; Irimia A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00530; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KUHL DE, 1982, ANN NEUROL, V12, P425, DOI 10.1002/ana.410120504; Kuo C, 2017, J NEUROTRAUM, V34, P3198, DOI 10.1089/neu.2016.4893; Ledig C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188152; Lehericy S, 2007, EUR RADIOL, V17, P347, DOI 10.1007/s00330-006-0341-z; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Losseff NA, 1996, BRAIN, V119, P2009, DOI 10.1093/brain/119.6.2009; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Purohit DP, 2011, J ALZHEIMERS DIS, V24, P187, DOI 10.3233/JAD-2010-101698; Ruet A, 2018, J NEUROTRAUM, V35, P1552, DOI 10.1089/neu.2017.5242; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor DA, 2013, MMWR-MORBID MORTAL W, V66, P1; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Turner RC, 2016, BRAIN INJURY, V30, P1279, DOI 10.1080/02699052.2016.1193631; van den Bedem H, 2017, CURR OPIN BIOMED ENG, V1, P23, DOI 10.1016/j.cobme.2017.02.003; Waller, 1850, PHILOS T R SOC LOND, VI, P423, DOI [10.1098/rspl.1843.0224, DOI 10.1098/RSTL.1850.0021]; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Weickenmeier J, 2018, J MECH BEHAV BIOMED, V84, P88, DOI 10.1016/j.jmbbm.2018.04.009; Weickenmeier J, 2017, COMPUT METHOD APPL M, V314, P180, DOI 10.1016/j.cma.2016.08.011; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Weickenmeier J, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.158101; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	69	35	36	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2019	47	9			SI		1941	1959		10.1007/s10439-018-02148-2			19	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JD1MH	WOS:000489738300008	30341741	Green Published, hybrid			2022-02-06	
J	Zeiler, FA; Ercole, A; Cabeleira, M; Zoerle, T; Stocchetti, N; Menon, DK; Smielewski, P; Czosnyka, M; Anke, A; Beer, R; Bellander, BM; Buki, A; Chevallard, G; Chieregato, A; Citerio, G; Czeiter, E; Depreitere, B; Eapen, G; Frisvold, S; Helbok, R; Jankowski, S; Kondziella, D; Koskinen, LO; Meyfroidt, G; Moeller, K; Nelson, D; Piippo-Karjalainen, A; Radoi, A; Ragauskas, A; Raj, R; Rhodes, J; Rocka, S; Rossaint, R; Sahuquillo, J; Sakowitz, O; Stevanovic, A; Sundstrom, N; Takala, R; Tamosuitis, T; Tenovuo, O; Vajkoczy, P; Vargiolu, A; Vilcinis, R; Wolf, S; Younsi, A				Zeiler, Frederick A.; Ercole, Ari; Cabeleira, Manuel; Zoerle, Tommaso; Stocchetti, Nino; Menon, David K.; Smielewski, Peter; Czosnyka, Marek; Anke, Audny; Beer, Ronny; Bellander, Bo-Michael; Buki, Andras; Chevallard, Giorgio; Chieregato, Arturo; Citerio, Giuseppe; Czeiter, Endre; Depreitere, Bart; Eapen, George; Frisvold, Shirin; Helbok, Raimund; Jankowski, Stefan; Kondziella, Daniel; Koskinen, Lars-Owe; Meyfroidt, Geert; Moeller, Kirsten; Nelson, David; Piippo-Karjalainen, Anna; Radoi, Andreea; Ragauskas, Arminas; Raj, Rahul; Rhodes, Jonathan; Rocka, Saulius; Rossaint, Rolf; Sahuquillo, Juan; Sakowitz, Oliver; Stevanovic, Ana; Sundstrom, Nina; Takala, Riikka; Tamosuitis, Tomas; Tenovuo, Olli; Vajkoczy, Peter; Vargiolu, Alessia; Vilcinis, Rimantas; Wolf, Stefa; Younsi, Alexander		CENTER-TBI High Resolution	Univariate comparison of performance of different cerebrovascular reactivity indices for outcome association in adult TBI: a CENTER-TBI study	ACTA NEUROCHIRURGICA			English	Article						Autoregulation; Cerebrovascular reactivity; ICP indices; Outcome analysis	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; AUTOREGULATION; MANAGEMENT; MODERATE	BackgroundMonitoring cerebrovascular reactivity in adult traumatic brain injury (TBI) has been linked to global patient outcome. Three intra-cranial pressure (ICP)-derived indices have been described. It is unknown which index is superior for outcome association in TBI outside previous single-center evaluations. The goal of this study is to evaluate indices for 6- to 12-month outcome association using uniform data harvested in multiple centers.MethodsUsing the prospectively collected data from the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study, the following indices of cerebrovascular reactivity were derived: PRx (correlation between ICP and mean arterial pressure (MAP)), PAx (correlation between pulse amplitude of ICP (AMP) and MAP), and RAC (correlation between AMP and cerebral perfusion pressure (CPP)). Univariate logistic regression models were created to assess the association between vascular reactivity indices with global dichotomized outcome at 6 to 12months, as assessed by Glasgow Outcome Score-Extended (GOSE). Models were compared via area under the receiver operating curve (AUC) and Delong's test.ResultsTwo separate patient groups from this cohort were assessed: the total population with available data (n=204) and only those without decompressive craniectomy (n=159), with identical results. PRx, PAx, and RAC perform similar in outcome association for both dichotomized outcomes, alive/dead and favorable/unfavorable, with RAC trending towards higher AUC values. There were statistically higher mean values for the index, % time above threshold, and hourly dose above threshold for each of PRx, PAx, and RAC in those patients with poor outcomes.ConclusionsPRx, PAx, and RAC appear similar in their associations with 6- to 12-month outcome in moderate/severe adult TBI, with RAC showing tendency to achieve stronger associations. Further work is required to determine the role for each of these cerebrovascular indices in monitoring of TBI patients.	[Zeiler, Frederick A.; Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Zeiler, Frederick A.; Cabeleira, Manuel; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab,Div Neurosurg, Cambridge, England; [Zoerle, Tommaso; Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuro ICU, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Menon, David K.] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Menon, David K.] Queens Coll, Cambridge, England; [Menon, David K.] Natl Inst Hlth Res, London, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Anke, Audny] Univ Hosp Northern Norway, Dept Phys Med & Rehabil, Tromso, Norway; [Beer, Ronny; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Bellander, Bo-Michael; Nelson, David] Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care Med, Stockholm, Sweden; [Buki, Andras; Czeiter, Endre] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, Hungarian Brain Res Program, Janos Szentagothai Res Ctr, Pecs, Hungary; [Chevallard, Giorgio; Chieregato, Arturo] Osped Niguarda Ca Granda, NeuroIntens Care, Milan, Italy; [Citerio, Giuseppe; Vargiolu, Alessia] ASST Monza, Dept Anesthesia & Intens Care, NeuroIntens Care Unit, Monza, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Depreitere, Bart] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [Frisvold, Shirin] Univ Hosp Northern Norway, Dept Anesthesiol & Intens Care, Tromso, Norway; [Jankowski, Stefan] Sheffield Teaching Hosp NHS Fdn Trust, Neurointens Care, Sheffield, S Yorkshire, England; [Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Neurol, Copenhagen, Denmark; [Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Neuroanesthesiol, Copenhagen, Denmark; [Koskinen, Lars-Owe] Umea Univ Hosp, Dept Clin Neurosci, Neurosurg, Umea, Sweden; [Meyfroidt, Geert] Univ Hosp Leuven, Intens Care Med, Leuven, Belgium; [Moeller, Kirsten] Reg Hovedstaden Rigshosp, Dept Neuroanesthesiol, Copenhagen, Denmark; [Piippo-Karjalainen, Anna; Raj, Rahul] Helsinki Univ Cent Hosp, Helsinki, Finland; [Radoi, Andreea; Sahuquillo, Juan] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Ragauskas, Arminas; Rocka, Saulius] Kaunas Univ Technol, Dept Neurosurg, Kaunas, Lithuania; [Ragauskas, Arminas; Rocka, Saulius] Vilnius Univ, Vilnius, Lithuania; [Rhodes, Jonathan] NHS Lothian, Dept Anesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland; [Rhodes, Jonathan] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Rossaint, Rolf; Stevanovic, Ana] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Sakowitz, Oliver] Klinikum Ludwigsburg, Klin Neurochirurg, Ludwigsburg, Germany; [Sakowitz, Oliver; Younsi, Alexander] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany; [Sundstrom, Nina] Umea Univ Hosp, Dept Radiat Sci, Biomed Engn, Umea, Sweden; [Takala, Riikka] Turku Univ Cent Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Takala, Riikka; Tenovuo, Olli] Univ Turku, Turku, Finland; [Tamosuitis, Tomas] Kaunas Univ Hlth Sci, Neurointens Care Unit, Kaunas, Lithuania; [Tenovuo, Olli] Turku Univ Cent Hosp, Rehabil & Brain Trauma, Turku, Finland; [Vajkoczy, Peter] Charite Univ Med Berlin, Neurol Neurochirurg & Psychiat, Berlin, Germany; [Vilcinis, Rimantas] Kaunas Univ Hlth Sci, Dept Neurosurg, Kaunas, Lithuania; [Wolf, Stefa] Charite Univ Med Berlin, Interdisciplinary Neuro Intens Care Unit, Berlin, Germany		Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab,Div Neurosurg, Cambridge, England.	umzeiler@myumanitoba.ca; ae105@cam.ac.uk; mc916@cam.ac.uk; tommaso.zoerle@policlinico.mi.it; nino.stocchetti@policlinico.mi.it; dkm13@cam.ac.uk; ps10011@cam.ac.uk; mc141@medschl.cam.ac.uk	Koskinen, Lars-Owe/AAQ-8957-2020; Citerio, Giuseppe/B-1839-2015; Sahuquillo, Juan/B-3577-2008; Helbok, Raimund/AAA-8361-2021; Raj, Rahul/K-7693-2012; Depreitere, Bart/AAA-9846-2020; Younsi, Alexander/AAW-7869-2020; Ercole, Ari/B-6288-2009; Moller, Kirsten/A-4751-2009	Citerio, Giuseppe/0000-0002-5374-3161; Sahuquillo, Juan/0000-0003-0713-5875; Raj, Rahul/0000-0003-4243-9591; Depreitere, Bart/0000-0002-7458-0648; Younsi, Alexander/0000-0002-8218-9243; Ercole, Ari/0000-0001-8350-8093; Zeiler, Frederick/0000-0003-1737-0510; Sakowitz, Oliver/0000-0003-3248-6335; Zoerle, Tommaso/0000-0001-8713-8085; Moller, Kirsten/0000-0003-3058-1072; Nelson, David/0000-0003-2530-8207; Radoi, Andreea/0000-0002-0677-3544; Kondziella, Daniel/0000-0001-5562-9808	European Union 7th Framework program (EC grant) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); National Institute for Health Research (NIHR, UK)National Institute for Health Research (NIHR); Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust; NIHR Clinical Research network	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). DKM was also supported by funding from the National Institute for Health Research (NIHR, UK) through a Senior Investigator award and the Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust. The study also received additional support from the NIHR Clinical Research network. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care, UK.; FAZ has received salary support for dedicated research time, during which this project was completed. Such salary support came from: the Cambridge Commonwealth Trust Scholarship, the University of Manitoba Clinician Investigator Program, and the Royal College of Surgeons of Canada-Harry S. Morton Traveling Fellowship in Surgery.	Aries MJH, 2016, CRIT CARE MED, V44, pE996, DOI 10.1097/CCM.0000000000001816; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Depreitere B, 2016, ACTA NEUROCHIR SUPPL, V122, P245, DOI 10.1007/978-3-319-22533-3_49; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Nourallah B, 2018, ACTA NEUROCHIR, V160, P1315, DOI 10.1007/s00701-018-3555-3; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Zeiler F.A., 2018, J NEUROTRAUM; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086	23	35	35	2	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2019	161	6					1217	1227		10.1007/s00701-019-03844-1			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HY6FJ	WOS:000468224800025	30877472	Green Submitted, Green Published, hybrid			2022-02-06	
J	Ge, XT; Li, WZ; Huang, S; Yin, ZY; Yang, MC; Han, ZY; Han, ZL; Chen, FL; Wang, HC; Lei, P; Zhang, JN				Ge, Xintong; Li, Wenzhu; Huang, Shan; Yin, Zhenyu; Yang, Mengchen; Han, Zhenying; Han, Zhaoli; Chen, Fanglian; Wang, Haichen; Lei, Ping; Zhang, Jianning			Increased miR-21-3p in Injured Brain Microvascular Endothelial Cells after Traumatic Brain Injury Aggravates Blood-Brain Barrier Damage by Promoting Cellular Apoptosis and Inflammation through Targeting MAT2B	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; blood-brain barrier; inflammation; miRNA; traumatic brain injury	MICRORNA EXPRESSION; SIGNALING PATHWAY; DOWN-REGULATION; IN-VITRO; NEUROINFLAMMATION; PROLIFERATION; CONTRIBUTES; HYPOTHERMIA; MIRNA-21; CORTEX	Our recent articles have reported that increased miR-21-5p in brain after traumatic brain injury (TBI) could improve the neurological outcome through alleviating blood-brain barrier (BBB) damage. miR-21-3p is another mature miRNA derived from pre-miR-21 after Dicer Procession other than miR-21-5p. Its roles in various diseases, such as tumors and myocardial disease, aroused great interest for research in recent years. To further explore the function and underlying mechanism of miR-21, especially miR-21-3p, in regulating the pathological development of BBB damage after TBI, we designed this research and focused on studying the impact of miR-21-3p on apoptosis and inflammation in brain microvascular endothelial cells (BMVECs), the major cellular component of BBB. We performed controlled cortical impact on mouse brain and employed the oxygen glucose deprivation/reoxygenation (OGD)-treated bEnd.3 cells injury model. We found that the miR-21-3p level in BMVECs from injured cerebral cortex of controlled cortical impact (CCI) mice and bEnd.3 cells with OGD treatment were both increased after injury. For in vitro experiments, downregulation on the miR-21-3p level by transfecting miR-21-3p antagomir in cultured cells alleviated OGD-induced BBB damage, characterized by decreased BBB leakage and increased expression of tight junction proteins. Besides, miR-21-3p antagomir could suppress cell death by anti-apoptosis and control inflammatory response by inhibiting the activity of NF-kappa B signaling. Using luciferase reporter assay and a MAT2B-silenced shRNA vector, we further proved that miR-21-3p exerted the above functions through targeting MAT2B. In addition, in vivo experiments also confirmed that intracerebroventricular infusion of miR-21-3p antagomir could alleviate BBB leakage after TBI. It reduced Evans Blue extravasation and promoted the expression of tight junction proteins, thus contributed to improve the neurological outcome of CCI mice. Taken together, increased miR-21-3p in BMVECs after TBI was bad for restoration of injured BBB. Downregulation on the miR-21-3p level in injured brain could be a promising therapeutic strategy for BBB damage after TBI.	[Ge, Xintong; Yang, Mengchen; Han, Zhenying; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Chen, Fanglian] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China; [Yang, Mengchen; Han, Zhenying; Chen, Fanglian; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Ge, Xintong; Li, Wenzhu; Huang, Shan; Yin, Zhenyu; Han, Zhaoli; Lei, Ping] Tianjin Med Univ, Gen Hosp, Tianjin Geriatr Inst, Lab Neurotrauma & Neurodegenerat Disorders, Tianjin, Peoples R China; [Li, Wenzhu; Huang, Shan; Yin, Zhenyu; Han, Zhaoli; Lei, Ping] Tianjin Med Univ, Gen Hosp, Dept Geriatr, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Wang, Haichen] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.; Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Geriatr, 154 Anshan Rd, Tianjin 300052, Peoples R China.	leiping1974@163.com; jianningzhang@hotmail.com	Ge, Xintong/X-4889-2019	Ge, Xintong/0000-0001-7153-952X			Baez-Vega PM, 2016, ONCOTARGET, V7, P36321, DOI 10.18632/oncotarget.9216; Cavallini A, 2017, ONCOTARGET, V8, P41866, DOI 10.18632/oncotarget.16383; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.135; Chen X, 2014, J NEUROL SCI, V342, P93, DOI 10.1016/j.jns.2014.04.032; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Chen XW, 2013, J MEMBRANE BIOL, V246, P7, DOI 10.1007/s00232-012-9495-6; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Degueurce G, 2016, EMBO MOL MED, V8, P919, DOI 10.15252/emmm.201505384; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Edwards P, 2005, LANCET, V365, P1957; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Frau M, 2013, J HEPATOL, V59, P830, DOI 10.1016/j.jhep.2013.04.031; Ge X., 2015, RNA DIS, V2, pe642; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Gordillo GM, 2014, J BIOL CHEM, V289, P9027, DOI 10.1074/jbc.M113.519264; Han ZL, 2015, DNA CELL BIOL, V34, P703, DOI 10.1089/dna.2015.2800; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Haseloff RF, 2015, SEMIN CELL DEV BIOL, V38, P16, DOI 10.1016/j.semcdb.2014.11.004; Huang S, 2018, FASEB J, V32, P512, DOI 10.1096/fj.201700673R; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lei Y, 2016, INT J ONCOL, V49, P981, DOI 10.3892/ijo.2016.3603; Levin H, 2013, LANCET NEUROL, V12, P15, DOI 10.1016/S1474-4422(12)70300-9; Lin L, 2018, MOL NEUROBIOL, V55, P3131, DOI 10.1007/s12035-017-0544-0; Lo TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075628; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Miao W, 2015, BRAZ J MED BIOL RES, V48, P433, DOI [10.1590/1414-431X20144012, 10.1590/1414-431x20144012]; Nasser M, 2016, CNS NEUROL DISORD-DR, V15, P1030, DOI 10.2174/1871527315666160815093525; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rizwan H, 2017, INT J NANOMED, V12, P5841, DOI 10.2147/IJN.S141839; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Ruck T, 2014, JOVE-J VIS EXP, DOI 10.3791/52204; Sandhir R, 2014, NEUROCHEM INT, V78, P117, DOI 10.1016/j.neuint.2014.09.009; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Temiz-Resitoglu M, 2017, EUR J PHARMACOL, V802, P7, DOI 10.1016/j.ejphar.2017.02.034; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Wang Q, 2008, WORLD J GASTROENTERO, V14, P4633, DOI 10.3748/wjg.14.4633; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yan MW, 2015, CARDIOVASC RES, V105, P340, DOI 10.1093/cvr/cvu254; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Yang HP, 2013, J BIOL CHEM, V288, P23161, DOI 10.1074/jbc.M113.487157; Yang Y, 2016, INT J BIOCHEM CELL B, V79, P222, DOI 10.1016/j.biocel.2016.08.040; Zacharek A, 2006, NEUROSCI LETT, V404, P28, DOI 10.1016/j.neulet.2006.05.027	58	35	38	1	33	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1291	1305		10.1089/neu.2018.5728			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000463812000008	29695199	Bronze			2022-02-06	
J	Samuels, JM; Moore, EE; Silliman, CC; Banerjee, A; Cohen, MJ; Ghasabyan, A; Chandler, J; Coleman, JR; Sauaia, A				Samuels, Jason M.; Moore, Ernest E.; Silliman, Christopher C.; Banerjee, Anirban; Cohen, Mitchell J.; Ghasabyan, Arsen; Chandler, James; Coleman, Julia R.; Sauaia, Angela			Severe traumatic brain injury is associated with a unique coagulopathy phenotype	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						TBI; hyperfibrinolysis; trauma-induced coagulopathy; thrombelastography	TISSUE FACTOR; VENOUS THROMBOEMBOLISM; FIBRINOLYSIS SHUTDOWN; PHYSIOLOGICAL FIBRINOLYSIS; POSTINJURY FIBRINOLYSIS; BLOOD-TRANSFUSION; AMERICAN-COLLEGE; TRANEXAMIC ACID; HYPOPERFUSION; HYPERFIBRINOLYSIS	BACKGROUND Traumatic brain injury (TBI) patients present on a spectrum from hypocoagulability to hypercoagulability, depending on the injury complexity, severity, and time since injury. Prior studies have found a unique coagulopathy associated with TBI using conventional coagulation assays such as INR; however, few studies have assessed the association of TBI and coagulopathy using viscoelastic assays that comprehensively evaluate the coagulation in whole blood. This study aims to reevaluate the TBI-specific trauma-induced coagulopathy using arrival thrombelastography. Because brain tissue is high in key procoagulant molecules, we hypothesize that isolated TBI is associated with procoagulant and hypofibrinolytic profiles compared with injuries of the torso, extremities, and polytrauma, including TBI. METHODS Data are from the prospective Trauma Activation Protocol study. Activated clotting time (ACT), angle, maximum amplitude (MA), 30-minute percent lysis after MA (LY30), and functional fibrinogen levels (FFLEV) were recorded. Patients were categorized into isolated severe TBI (I-TBI), severe TBI with torso and extremity injuries (TBI + TORSO/EXTREMITIES), and isolated torso and extremity injuries (I-TORSO/EXTREMITIES). Poisson regression was used to adjust for multiple confounders. RESULTS Overall, 572 patients (48 I-TBI, 45 TBI + TORSO/EXTREMITIES, 479 I-TORSO/EXTREMITIES) were included in this analysis. The groups differed in INR, ACT, angle, MA, and FFLEV but not in 30-minute percent lysis. When compared with I-Torso/Extremities, after adjustment for confounders, severe I-TBI was independently associated with ACT less than 128 seconds (relative risk [RR], 1.5; 95% confidence interval [CI], 1.1-2.2), angle less than 65 degrees (RR, 2.2; 95% CI, 1.4-3.6), FFLEV less than 356 (RR, 1.7; 95% CI, 1.2-2.4) but not MA less than 55 mm, hyperfibrinolysis, fibrinolysis shutdown, or partial thromboplastin time (PTT) greater than 30. CONCLUSION Severe I-TBI was independently associated with a distinct coagulopathy with delayed clot formation but did not appear to be associated with fibrinolysis abnormalities. Low fibrinogen and longer ACT values associated with I-TBI suggest that early coagulation factor replacement may be indicated in I-TBI patients over empiric antifibrinolytic therapy. Mechanisms triggering coagulopathy in TBI are unique and warrant further investigation.	[Samuels, Jason M.; Silliman, Christopher C.; Banerjee, Anirban; Coleman, Julia R.] Univ Colorado, Dept Surg, Denver, CO USA; [Moore, Ernest E.; Cohen, Mitchell J.; Ghasabyan, Arsen; Chandler, James] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Sauaia, Angela] Univ Colorado, Sch Publ Hlth, Dept Pediat, Aurora, CO USA		Sauaia, A (corresponding author), Univ Colorado, Sch Publ Hlth, 13001 E 17th Pl,B119 Bldg 500,E3309, Aurora, CO 80045 USA.	angela.sauaia@ucdenver.edu		Samuels, Jason/0000-0001-5427-3117	National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008315, P50 GM049222]; National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM 1HL 120877]; Department of Defense (USAMRAA)United States Department of Defense [W81XWH-12-2-0028]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008315, P50GM049222] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health (T32 GM008315 and P50 GM049222), The National Heart, Lung, and Blood Institute (UM 1HL 120877) and the Department of Defense (USAMRAA, W81XWH-12-2-0028). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (or other sponsors of the project).	[Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; BACH R, 1986, BIOCHEMISTRY-US, V25, P4007, DOI 10.1021/bi00362a005; Balvers- K, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00024; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Brandt MM, 2007, AM J SURG, V193, P383; Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P1395, DOI 10.1097/TA.0b013e31825b9f05; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; DEFOUW NJ, 1988, THROMB HAEMOSTASIS, V60, P328; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; DRAKE TA, 1989, AM J PATHOL, V134, P1087; EDDLESTON M, 1993, J CLIN INVEST, V92, P349, DOI 10.1172/JCI116573; Einersen PM, 2017, J TRAUMA ACUTE CARE, V82, P114, DOI 10.1097/TA.0000000000001270; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Gould MK, 2012, CHEST, V141, pE227S, DOI 10.1378/chest.11-2297; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harr JN, 2013, SHOCK, V39, P45, DOI 10.1097/SHK.0b013e3182787122; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Holcomb JB, 2013, J TRAUMA ACUTE CARE, V75, pS31, DOI 10.1097/TA.0b013e31828fa3ed; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Meizoso JP, 2017, J AM COLL SURGEONS, V224, P575, DOI 10.1016/j.jamcollsurg.2016.12.018; Moore FA, 1997, ARCH SURG-CHICAGO, V132, P620; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Morrison JJ, 2013, JAMA SURG, V148, P218, DOI 10.1001/jamasurg.2013.764; Oaxaca R., 1973, INT EC REV, V14, P693, DOI DOI 10.2307/2525981; Osterud B, 2006, SEMIN THROMB HEMOST, V32, P11, DOI 10.1055/s-2006-933336; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Schreiber MA, 2014, J TRAUMA ACUTE CARE, V77, P817; Schrieber M, 2007, J TRAUMA, V63, P1261; Shackford SR, 2004, ANN SURG, V240, P496; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Stettler GR, 2018, J TRAUMA ACUTE CARE; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Van Gent JM, 2014, J TRAUMA ACUTE CARE, V77, P238, DOI 10.1097/TA.0000000000000294	50	35	35	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2019	86	4					686	693		10.1097/TA.0000000000002173			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	HR5QD	WOS:000463201000017	30601456	Green Accepted			2022-02-06	
J	Erdodi, LA				Erdodi, Laszlo A.			Aggregating validity indicators: The salience of domain specificity and the indeterminate range in multivariate models of performance validity assessment	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Aggregating validity indicators; domain specificity hypothesis; Erdodi Index; indeterminate range; multivariate base rates; performance validity assessment	RECOGNITION MEMORY TEST; TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; FORCED-CHOICE RECOGNITION; VERBAL-LEARNING TEST; COMPLEX IDEATIONAL MATERIAL; ADULT INTELLIGENCE SCALE; RELIABLE DIGIT SPAN; SYMPTOM VALIDITY; CLASSIFICATION ACCURACY	This study was designed to examine the "domain specificity" hypothesis in performance validity tests (PVTs) and the epistemological status of an "indeterminate range" when evaluating the credibility of a neuropsychological profile using a multivariate model of performance validity assessment. While previous research suggests that aggregating PVTs produces superior classification accuracy compared to individual instruments, the effect of the congruence between the criterion and predictor variable on signal detection and the issue of classifying borderline cases remain understudied. Data from a mixed clinical sample of 234 adults referred for cognitive evaluation (M-Age = 46.6; M-Education = 13.5) were collected. Two validity composites were created: one based on five verbal PVTs (EI-5(VER)) and one based on five nonverbal PVTs (EI-5(NV)) and compared against several other PVTs. Overall, language-based tests of cognitive ability were more sensitive to elevations on the EI-5(VER) compared to visual-perceptual tests; whereas, the opposite was observed with the EI-5(NV). However, the match between predictor and criterion variable had a more complex relationship with classification accuracy, suggesting the confluence of multiple factors (sensory modality, cognitive domain, testing paradigm). An "indeterminate range" of performance validity emerged that was distinctly different from both the Pass and the Fail group. Trichotomized criterion PVTs (Pass-Borderline-Fail) had a negative linear relationship with performance on tests of cognitive ability, providing further support for an "in-between" category separating the unequivocal Pass and unequivocal Fail classification range. The choice of criterion variable can influence classification accuracy in PVT research. Establishing a Borderline range between Pass and Fail more accurately reflected the distribution of scores on multiple PVTs. The traditional binary classification system imposes an artificial dichotomy on PVTs that was not fully supported by the data. Accepting "indeterminate" as a legitimate third outcome of performance validity assessment has the potential to improve the clinical utility of PVTs and defuse debates regarding "near-Passes" and "soft Fails."	[Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Windsor, ON, Canada		Erdodi, LA (corresponding author), 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com					An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P675, DOI 10.1016/j.acn.2007.07.005; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Chafetz M, 2011, CLIN NEUROPSYCHOL, V25, P1239, DOI 10.1080/13854046.2011.586785; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, PSYCHOL INJ LAW, V10, P96, DOI 10.1007/s12207-017-9282-x; Erdodi LA, 2017, APPL NEUROPSYCH-CHIL, V6, P355, DOI 10.1080/21622965.2016.1198908; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Frederick RI, 2000, ARCH CLIN NEUROPSYCH, V15, P281, DOI 10.1016/S0887-6177(99)00002-5; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Hopwood CJ, 2007, J PERS ASSESS, V88, P43, DOI 10.1207/s15327752jpa8801_06; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; KANE R L, 1991, Neuropsychology Review, V2, P281, DOI 10.1007/BF01108849; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee G. J., 2012, FORENSIC NEUROPSYCHO, P117; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lippa SM, 2014, REHABIL PSYCHOL, V59, P306, DOI 10.1037/a0037217; Lu P. H., 2007, ASSESSMENT FEIGNED C, P178; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pearson, 2009, ADV CLIN SOL WAIS 4; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; ROGERS R, 1990, PROF PSYCHOL-RES PR, V21, P182; Rogers R., 1997, CLIN ASSESSMENT MALI, P398; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P18, DOI 10.1076/1385-4046(200002)14:1;1-8;FT018; Trueblood W., 1994, J CLIN EXPT NEUROPSY, V4, P697, DOI DOI 10.1080/01688639408402671; Vallabhajosula B, 2001, J AM ACAD PSYCHIATRY, V29, P207; Warrington E, 1984, RECOGNITION MEMORY T, V1; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4	93	35	35	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 4	2019	26	2					155	172		10.1080/23279095.2017.1384925			18	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HR3RD	WOS:000463056200006	29111772				2022-02-06	
J	Van Stan, JH; Dijkers, MP; Whyte, J; Hart, T; Turkstra, LS; Zanca, JM; Chen, C				Van Stan, Jarrad H.; Dijkers, Marcel. P.; Whyte, John; Hart, Tessa; Turkstra, Lyn S.; Zanca, Jeanne M.; Chen, Christine			The Rehabilitation Treatment Specification System: Implications for Improvements in Research Design, Reporting, Replication, and Synthesis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Meta-analysis as topic; Methods; Outcome assessment (health care); Rehabilitation; Therapeutics; Translational medical research	TRAUMATIC BRAIN-INJURY; VOICE DISORDERS; BLACK-BOX; STROKE; INTERVENTIONS; EXERCISE; THERAPY; EXPLANATION; OUTCOMES; ADULTS	Despite significant advances in measuring the outcomes of rehabilitation interventions, little progress has been made in specifying the therapeutic ingredients and processes that cause measured changes in patient functioning. The general approach to better clarifying the process of treatment has been to develop reporting checklists and guidelines that increase the amount of detail reported. However, without a framework instructing researchers in how to describe their treatment protocols in a manner useful to or even interpretable by others, requests for more detail will fail to improve our understanding of the therapeutic process. In this article, we describe how the Rehabilitation Treatment Specification System (RTSS) provides a theoretical framework that can improve research intervention reporting and enable testing and refinement of a protocol's underlying treatment theories. The RTSS framework provides guidance for researchers to explicitly state their hypothesized active ingredients and targets of treatment as well as for how the individual ingredients in their doses directly affect the treatment targets. We explain how theory-based treatment specification has advantages over checklist approaches for intervention design, reporting, replication, and synthesis of evidence in rehabilitation research. A complex rehabilitation intervention is used as a concrete example of the differences between an RTSS-based specification and the Template for Intervention Description and Replication checklist. The RTSS's potential to advance the rehabilitation field can be empirically tested through efforts to use the framework with existing and newly developed treatment protocols. (C) 2018 by the American Congress of Rehabilitation Medicine	[Van Stan, Jarrad H.] Harvard Med Sch, Boston, MA USA; [Van Stan, Jarrad H.] Massachusetts Gen Hosp, Ctr Laryngeal Surg & Voice Rehabil, 11th Fl,1 Bowdoin Sq, Boston, MA 02114 USA; [Van Stan, Jarrad H.] Massachusetts Gen Hosp, Inst Hlth Profess, Charlestown, MA USA; [Dijkers, Marcel. P.] Wayne State Univ, Detroit, MI USA; [Dijkers, Marcel. P.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Whyte, John; Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Turkstra, Lyn S.] McMaster Univ, Hamilton, ON, Canada; [Zanca, Jeanne M.] Kessler Fdn, W Orange, NJ USA; [Chen, Christine] Texas Womens Univ, Denton, TX USA		Van Stan, JH (corresponding author), Massachusetts Gen Hosp, Ctr Laryngeal Surg & Voice Rehabil, 11th Fl,1 Bowdoin Sq, Boston, MA 02114 USA.	jvanstan@mgh.harvard.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921; Whyte, John/0000-0002-4381-1474	Patient Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [ME-1403-14083]; National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders and Office of Behavioral and Social Sciences Research [R21 DC016124, OD016124]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R21DC016124] Funding Source: NIH RePORTER	We thank the members of our Advisory Board, Mary Ferraro, PhD, OTR/L and Andrew Packel, PT, NCS, who provided valuable feedback on the concepts presented here. The contents of this article were developed under contract number ME-1403-14083 from the Patient Centered Outcomes Research Institute awarded to John Whyte at Moss Rehabilitation Research Institute and grant numbers R21 DC016124 and OD016124 from the National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders and Office of Behavioral and Social Sciences Research awarded to Jarrad Van Stan at Massachusetts General Hospital. All statements in this report, including its findings and conclusions, are solely those of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee. The article's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Campbell KL, 2012, BRIT J SPORT MED, V46, P909, DOI [10.1136/bjsports-2010-082719, 10.1136/bjsm.2010.082719]; Carlaw C, 2012, DYSPHAGIA, V27, P297, DOI 10.1007/s00455-011-9366-9; Chang SM., 2012, METHODS GUIDE MED TE; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, pS35, DOI 10.1016/S0003-9993(99)90101-6; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; DeJong G, 2005, ARCH PHYS MED REHAB, V86, pS1, DOI 10.1016/j.apmr.2005.09.003; DeJong G, 2004, ARCH PHYS MED REHAB, V85, P678, DOI 10.1016/j.apmr.2003.06.033; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; Devan D, 2014, J HAND THER, V27, P325, DOI 10.1016/j.jht.2014.02.005; Dijkers M, 2002, AM J PHYS MED REHAB, V81, P21, DOI 10.1097/00002060-200201000-00005; Dijkers MP, 2015, ARCH PHYS MED REHAB, V96, P1170, DOI 10.1016/j.apmr.2015.01.017; Goedert KM, 2020, NEUROPSYCHOL REHABIL, V30, P32, DOI 10.1080/09602011.2018.1448287; Hart T, 2019, ARCH PHYS MED REHAB, V100, P172, DOI 10.1016/j.apmr.2018.09.109; Hart T, 2017, J HEAD TRAUMA REHAB, V32, P319, DOI 10.1097/HTR.0000000000000316; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Hayward KS, 2015, CLIN REHABIL, V29, P1234, DOI 10.1177/0269215514565395; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2015, ARCH PHYS MED REH S8, V96; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P563, DOI 10.1080/09602011.2012.676284; Jack K, 2010, MANUAL THER, V15, P220, DOI 10.1016/j.math.2009.12.004; JOHNSONLAIRD PN, 1980, COGNITIVE SCI, V4, P71, DOI 10.1207/s15516709cog0401_4; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kragel PA, 2018, NEURON, V99, P257, DOI 10.1016/j.neuron.2018.06.009; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Neil-Sztramko SE, 2019, BRIT J SPORT MED, V53, P504, DOI 10.1136/bjsports-2017-098389; Page P, 2017, INT J SPORTS PHYS TH, V12, P297; Patti F, 2010, PATIENT PREFER ADHER, V4, P1; Phillips AC, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0759-1; Powell LE, 2012, NEUROPSYCHOL REHABIL, V22, P85, DOI 10.1080/09602011.2011.640466; ROY N, 1993, J VOICE, V7, P242, DOI 10.1016/S0892-1997(05)80333-9; Roy N, 2003, J SPEECH LANG HEAR R, V46, P670, DOI 10.1044/1092-4388(2003/053); Roy N, 2012, INT J SPEECH-LANG PA, V14, P419, DOI 10.3109/17549507.2012.686119; Slade SC, 2016, BRIT J SPORT MED, V50, P1428, DOI 10.1136/bjsports-2016-096651; Sliwa JA, 2002, AM J PHYS MED REHAB, V81, P126, DOI 10.1097/00002060-200202000-00009; Sohlberg MM, 2007, J MED SPEECH-LANG PA, V15, pXV; Tiedemann A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1380-7; Wade DT, 2009, CLIN REHABIL, V23, P291, DOI 10.1177/0269215509103551; Waterschoot FPC, 2014, PAIN, V155, P179, DOI 10.1016/j.pain.2013.10.006; Whiteneck G, 2009, J SPINAL CORD MED, V32, P251, DOI 10.1080/10790268.2009.11760779; Whyte J, 2014, ARCH PHYS MED REHA S, V95; Whyte J, 2019, ARCH PHYS MED REHAB, V100, P156, DOI 10.1016/j.apmr.2018.09.111; Whyte J, 2014, ARCH PHYS MED REHAB, V95, pS17, DOI 10.1016/j.apmr.2013.02.029; Winstein CJ, 2003, NEUROREHAB NEURAL RE, V17, P137, DOI 10.1177/0888439003255511; Zbogar D, 2017, SPINAL CORD, V55, P172, DOI 10.1038/sc.2016.129	48	35	35	3	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2019	100	1					146	155		10.1016/j.apmr.2018.09.112			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HH8HP	WOS:000455972800019	30267666	Green Accepted			2022-02-06	
J	Hammond, FM; Giacino, JT; Richardson, RN; Sherer, M; Zafonte, RD; Whyte, J; Arciniegas, DB; Tang, XY				Hammond, Flora M.; Giacino, Joseph T.; Richardson, Risa Nakase; Sherer, Mark; Zafonte, Ross D.; Whyte, John; Arciniegas, David B.; Tang, Xinyu			Disorders of Consciousness due to Traumatic Brain Injury: Functional Status Ten Years Post-Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injuries; cognition; consciousness disorders; minimally conscious state; prognosis; rehabilitation outcome; vegetative state	RECOVERY; REHABILITATION; OUTCOMES; POPULATION; ADMISSION; HEALTH	Few studies have assessed the long-term functional outcomes of patients with a disorder of consciousness due to traumatic brain injury (TBI). This study examined functional status during the first 10 years after TBI among a cohort with disorders of consciousness (i.e., coma, vegetative state, minimally conscious state). The study sample included 110 individuals with TBI who were unable to follow commands prior to inpatient rehabilitation and for whom follow-up data were available at 1, 2, 5, and 10 years post-injury. The sample was subdivided into those who demonstrated command-following early (before 28 days post-injury) versus late ( 28 days post-injury or never). Functional Independence Measure (FIM) at 1, 2, 5, and 10 years following TBI was used to measure functional outcomes. Measureable functional recovery occurred throughout the 10-year period, with more than two thirds of the sample achieving independence in mobility and self-care, and about one quarter achieving independent cognitive function by 10 years. Following commands prior to 28 days was associated with greater functional independence at all outcome time-points. Multi-trajectory modeling of recovery of three FIM subscales (self-care, mobility, cognition) revealed four distinct prognostic groups with different temporal patterns of change on these subscales. More than half the sample achieved near-maximal recovery by 1 year post-injury, while the later command-following subgroups recovered over longer periods of time. Significant late functional decline was not observed in this cohort. Among a cohort of patients unable to follow commands at the time of inpatient rehabilitation, a substantial proportion achieved functional independence in self-care, mobility, and cognition. The proportion of participants achieving functional independence increased between 5 and 10 years post-injury. These findings suggest that individuals with disorders of consciousness may benefit from ongoing functional monitoring and updated care plans for at least the first decade after TBI.	[Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Richardson, Risa Nakase] Univ S Florida, Hlth Serv Res & Dev Serv, Ctr Innovat Disabil & Rehabil Res, Tampa, FL USA; [Richardson, Risa Nakase] Univ S Florida, Def & Vet Brain Injury Ctr, James A Haley Vet Hosp, Tampa, FL USA; [Sherer, Mark] Univ S Florida, Coll Med, Tampa, FL USA; [Zafonte, Ross D.] Harvard Med Sch, Spaulding Rehabil Hosp, Massachusetts Gen Hosp, Brigham & Womens Hosp,Dept Phys Med & Rehabil, Boston, MA USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Marcus Inst Brain Hlth, Dept Neurol,Ctr Mental Hlth, Gunnison, CO USA; [Arciniegas, David B.] Univ Colorado, Sch Med, Marcus Inst Brain Hlth, Dept Psychiat,Ctr Mental Hlth, Gunnison, CO USA; [Tang, Xinyu] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS) [DPTBI17000014, 90DP0036, 90DRTB0002, 90DPTB0011, 90DP0039]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research); VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]; U.S. Department of Veterans Affairs Health Services Research and Development COIN grantUS Department of Veterans Affairs [1 I50 HX001233-01]	The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR; grant numbers, DPTBI17000014; 90DP0036 and 90DRTB0002; 90DPTB0011, 90DP0039), which is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS).; The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Health and Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center within the Defense Health Agency, and U.S. Department of Veterans Affairs Health Services Research and Development COIN grant (1 I50 HX001233-01; CINDRR).	Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fins Joseph J, 2012, Virtual Mentor, V14, P221, DOI 10.1001/virtualmentor.2012.14.3.stas1-1203; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hammond F, 2009, J NEUROTRAUM, V26, pA83; Institute of Medicine, 2009, GULF WAR HLTH, V7; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Nagin DS, 2018, STAT METHODS MED RES, V27, P2015, DOI 10.1177/0962280216673085; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	23	35	35	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1136	1146		10.1089/neu.2018.5954		OCT 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR6CL	WOS:000447718700001	30226400	hybrid, Green Submitted			2022-02-06	
J	Fakhri, S; Dargahi, L; Abbaszadeh, F; Jorjani, M				Fakhri, Sajad; Dargahi, Leila; Abbaszadeh, Fatemeh; Jorjani, Masoumeh			Astaxanthin attenuates neuroinflammation contributed to the neuropathic pain and motor dysfunction following compression spinal cord injury	BRAIN RESEARCH BULLETIN			English	Article						Astaxanthin; Spinal cord injury; Neuroinflammation; Glutamate signaling; Sensory-motor function; Rat	GLUN2B-CONTAINING NMDA RECEPTORS; MIGRATION-INHIBITORY FACTOR; GLUTAMATE-INDUCED APOPTOSIS; OXIDATIVE STRESS; BRAIN-INJURY; IN-VITRO; HIPPOCAMPAL-NEURONS; DNA FRAGMENTATION; TRAUMATIC BRAIN; CELL APOPTOSIS	Spinal cord injury (SCI) is a debilitating condition in which inflammatory responses in the secondary phase of injury leads to long lasting sensory-motor dysfunction. The medicinal therapy of SCI complications is still a clinical challenge. Understanding the molecular pathways underlying the progress of damage will help to find new therapeutic candidates. Astaxanthin (AST) is a ketocarotenoid which has shown anti-inflammatory effects in models of traumatic brain injury. In the present study, we examined its potential in the elimination of SCI damage through glutamatergic-phospo p38 mitogen-activated protein kinase (p-p38MAPK) signaling pathway. Inflammatory response, histopathological changes and sensory-motor function were also investigated in a severe compression model of SCI in male rats. The results of acetone drop and inclined plane tests indicated the promising role of AST in improving sensory and motor function of SCI rats. AST decreased the expression of n-methyl-D-aspartate receptor subunit 2B (NR2B) and p-p38MAPK as inflammatory signaling mediators as well as tumor necrosis factor-alpha (TNF-alpha) as an inflammatory cytokine, following compression SCI. The histopathological study culminated in preserved white mater and motor neurons beyond the injury level in rostral and caudal parts. The results show the potential of AST to inhibit glutamate-initiated signaling pathway and inflammatory reactions in the secondary phase of SCI, and suggest it as a promising candidate to enhance functional recovery after SCI.	[Fakhri, Sajad; Jorjani, Masoumeh] Shahid Beheshti Univ Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran; [Dargahi, Leila] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Abbaszadeh, Fatemeh; Jorjani, Masoumeh] Shahid Beheshti Univ Med Sci, Neurobiol Res Ctr, Tehran, Iran		Jorjani, M (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran.; Jorjani, M (corresponding author), Shahid Beheshti Univ Med Sci, Sch Med, Neurobiol Res Ctr, Tehran, Iran.	msjorjani@sbmu.ac.ir	Jorjani, Masoumeh/AAV-5596-2021; fakhri, sajad/E-9333-2019; Dargahi, Leila/K-4693-2017	Dargahi, Leila/0000-0001-7777-5435	Neuroscience Research Center of Shahid Beheshti University of Medical Sciences, IRAN [S-N-56-1397]	The current research was performed as part of a Ph.D. thesis project of Sajad Fakhri and was supported by the Neuroscience Research Center (Grant No. S-N-56-1397) of Shahid Beheshti University of Medical Sciences, IRAN.	Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128; Araujo IM, 2010, NEUROCHEM RES, V35, P1966, DOI 10.1007/s11064-010-0323-z; Augusti PR, 2012, J CLIN BIOCHEM NUTR, V51, P42, DOI 10.3164/jcbn.11-74; Bachis A, 2001, J NEUROSCI, V21, P3104, DOI 10.1523/JNEUROSCI.21-09-03104.2001; Balietti M, 2016, J SCI FOOD AGR, V96, P615, DOI 10.1002/jsfa.7131; Bank M, 2015, ARCH PHYS MED REHAB, V96, P633, DOI 10.1016/j.apmr.2014.10.021; Baralic I, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/783761; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Borbely Z, 2017, BRAIN RES BULL, V131, P150, DOI 10.1016/j.brainresbull.2017.04.007; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Brecht S, 2001, MOL BRAIN RES, V94, P25, DOI 10.1016/S0006-8993(01)02767-6; Cheriyan T, 2014, SPINAL CORD, V52, P588, DOI 10.1038/sc.2014.91; Choi DC, 2012, EXP NEUROL, V236, P268, DOI 10.1016/j.expneurol.2012.05.014; Choi SK, 2008, J MICROBIOL BIOTECHN, V18, P1990, DOI 10.4014/jmb.0800.489; David BT, 2013, NEUROBIOL DIS, V54, P194, DOI 10.1016/j.nbd.2012.12.012; Dong LY, 2013, MAR DRUGS, V11, P960, DOI 10.3390/md11030960; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dowdall T, 2005, PHARMACOL BIOCHEM BE, V80, P93, DOI 10.1016/j.pbb.2004.10.016; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Elmarakby AA, 2012, CARDIOVASC THER, V30, P49, DOI 10.1111/j.1755-5922.2010.00218.x; Evans J, 2015, MICROVASC RES, V98, P145, DOI 10.1016/j.mvr.2014.04.011; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Gruener H, 2018, SPINAL CORD, V56, P176, DOI 10.1038/s41393-017-0014-6; Guo SX, 2015, MAR DRUGS, V13, P2105, DOI 10.3390/md13042105; Higuera-Ciapara I, 2006, CRIT REV FOOD SCI, V46, P185, DOI 10.1080/10408690590957188; Hook MA, 2017, J NEUROTRAUM, V34, P632, DOI 10.1089/neu.2016.4507; Hu Y, 2011, CARBON NANOTUBES - GROWTH AND APPLICATIONS, P3; Hui KY, 2014, CANCER LETT, V354, P189, DOI 10.1016/j.canlet.2014.08.009; Ikeda Y, 2008, J NEUROCHEM, V107, P1730, DOI 10.1111/j.1471-4159.2008.05743.x; Jiang Q, 2000, BRAIN RES, V857, P71, DOI 10.1016/S0006-8993(99)02364-1; Jiang X, 2018, NEUROSCI LETT, V662, P36, DOI 10.1016/j.neulet.2017.09.064; Kakulas BA, 1998, SPINAL CORD MONITORING, P395; Kauppila T, 2000, EXP NEUROL, V161, P740, DOI 10.1006/exnr.1999.7287; Khoei HH, 2019, TOXIN REV, V38, P223, DOI 10.1080/15569543.2018.1444641; Kidd P, 2011, ALTERN MED REV, V16, P355; Kim SY, 2002, NEUROREPORT, V13, P2483, DOI 10.1097/00001756-200212200-00021; Kiss JP, 2012, NEUROCHEM INT, V60, P170, DOI 10.1016/j.neuint.2011.12.005; Koda M, 2004, ACTA NEUROPATHOL, V108, P31, DOI 10.1007/s00401-004-0853-z; Kong XY, 2017, J CELL MOL MED, V21, P941, DOI 10.1111/jcmm.13034; Kuedo Z, 2016, MOLECULES, V21, DOI 10.3390/molecules21030382; Kwon BK, 2011, J NEUROTRAUM, V28, P1525, DOI 10.1089/neu.2010.1296; Kwon BK, 2011, J NEUROTRAUM, V28, P1589, DOI 10.1089/neu.2009.1150; Lancelot E, 1998, PROG BRAIN RES, V116, P331, DOI 10.1016/S0079-6123(08)60446-X; Lerch JK, 2014, SEMIN IMMUNOL, V26, P409, DOI 10.1016/j.smim.2014.03.004; Lin XT, 2017, EUR J PHARMACOL, V806, P43, DOI 10.1016/j.ejphar.2017.04.008; Luo Y, 2015, MOL MED REP, V12, P7132, DOI 10.3892/mmr.2015.4274; Masoudi A, 2017, BEHAV BRAIN RES, V329, P104, DOI 10.1016/j.bbr.2017.04.026; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Nakae A., 2011, BIOMED RES INT; Nakajima Y, 2008, J PHARM PHARMACOL, V60, P1365, DOI 10.1211/jpp/60.10.0013; Nakano M, 2008, J NUTR SCI VITAMINOL, V54, P329, DOI 10.3177/jnsv.54.329; Nakao R, 2010, ANTICANCER RES, V30, P2721; Naseri K, 2013, J MOL NEUROSCI, V49, P470, DOI 10.1007/s12031-012-9840-3; O'Shea TM, 2017, J CLIN INVEST, V127, P3265, DOI 10.1172/JCI90608; Ohgami K, 2003, INVEST OPHTH VIS SCI, V44, P2694, DOI 10.1167/iovs.02-0822; Pan L, 2017, BRAIN RES BULL, V130, P211, DOI 10.1016/j.brainresbull.2017.01.024; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Rami A, 2000, BRAIN RES, V866, P299, DOI 10.1016/S0006-8993(00)02301-5; Rao AR, 2010, J AGR FOOD CHEM, V58, P8553, DOI 10.1021/jf101187k; Ray SK, 2000, BRAIN RES, V852, P326, DOI 10.1016/S0006-8993(99)02148-4; Samini F, 2013, PHARMACOL BIOCHEM BE, V110, P238, DOI 10.1016/j.pbb.2013.07.019; Schelman WR, 2004, MOL BRAIN RES, V128, P160, DOI 10.1016/j.molbrainres.2004.06.011; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Sedy J, 2008, NEUROSCI BIOBEHAV R, V32, P550, DOI 10.1016/j.neubiorev.2007.10.001; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sharma K, 2018, NEUROSCI LETT, V674, P162, DOI 10.1016/j.neulet.2018.03.030; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shen H, 2009, FASEB J, V23, P1958, DOI 10.1096/fj.08-123281; Sifi N, 2016, INFLAMM RES, V65, P623, DOI 10.1007/s00011-016-0945-y; Song Xue-Song, 2005, Shengli Xuebao, V57, P139; Speranza L, 2012, MAR DRUGS, V10, P890, DOI 10.3390/md10040890; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Suzuki Y, 2006, EXP EYE RES, V82, P275, DOI 10.1016/j.exer.2005.06.023; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Vegh D, 2017, BRAIN RES BULL, V135, P157, DOI 10.1016/j.brainresbull.2017.10.011; Vizi ES, 2013, BRAIN RES BULL, V93, P32, DOI 10.1016/j.brainresbull.2012.10.005; Wu HJ, 2015, MAR DRUGS, V13, P5750, DOI 10.3390/md13095750; Xue Y, 2017, BRAIN RES BULL, V131, P221, DOI 10.1016/j.brainresbull.2017.04.019; Yan TT, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4512309; Ye QY, 2013, MAR DRUGS, V11, P1019, DOI 10.3390/md11041019; Zhang Fei-E, 2005, Shengli Xuebao, V57, P545; Zhang XS, 2014, MAR DRUGS, V12, P4291, DOI 10.3390/md12084291; Zhang YM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-49	83	35	36	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	OCT	2018	143						217	224		10.1016/j.brainresbull.2018.09.011			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HD8NL	WOS:000452813700023	30243665				2022-02-06	
J	Wu, YG; Liu, W; Zhou, Y; Hilton, T; Zhao, ZL; Liu, W; Wang, M; Yeon, J; Houck, K; Thiagarajan, P; Zhang, FY; Shi, FD; Wu, XP; Li, M; Dong, JF; Zhang, JN				Wu, Yingang; Liu, Wei; Zhou, Yuan; Hilton, Tristan; Zhao, Zilong; Liu, Wei; Wang, Min; Yeon, Jason; Houck, Katie; Thiagarajan, Perumal; Zhang, Fangyi; Shi, Fu-Dong; Wu, Xiaoping; Li, Min; Dong, Jing-fei; Zhang, Jianning			von Willebrand factor enhances microvesicle-induced vascular leakage and coagulopathy in mice with traumatic brain injury	BLOOD			English	Article							THROMBOTIC THROMBOCYTOPENIC PURPURA; WEIBEL-PALADE BODIES; VONWILLEBRAND-FACTOR; FACTOR MULTIMERS; IN-VITRO; COAGULATION; ADAMTS-13; PROTEOLYSIS; PROTEASE; SURFACE	von Willebrand factor (VWF) is an adhesive ligand, and its activity is proteolytically regulated by the metalloprotease ADAMTS-13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat 13). An elevated level of plasma VWF has been widely considered a marker for endothelial cell activation in trauma and inflammation, but its causal role in these pathological conditions remains poorly defined. Using a fluid percussion injury mouse model, we demonstrated that VWF released during acute traumatic brain injury (TBI) was activated and became microvesicle-bound. The VWF-bound microvesicles promoted vascular leakage and systemic coagulation. Recombinant ADAMTS-13 given either before or after TBI reduced the VWF reactivity with minimal influence on VWF secretion. rADAMTS-13 protected the integrity of endothelial cell barriers and prevented TBI-induced coagulopathy by enhancing VWF cleavage without impairing basal hemostasis. Promoting microvesicle clearance by lactadherin had efficacy similar to that of rADAMTS-13. This study uncovers a novel synergistic action between VWF and cellular microvesicles in TBI-induced vascular leakage and coagulopathy and demonstrates protective effects of rADAMTS-13.	[Wu, Yingang; Zhou, Yuan; Zhao, Zilong; Zhang, Jianning] Tianjin Inst Neurol, Dept Neurosurg, Tianjin, Peoples R China; [Wu, Yingang; Zhou, Yuan; Zhao, Zilong; Liu, Wei; Zhang, Jianning] Tianjin Med Univ Gen Hosp, Tianjin, Peoples R China; [Wu, Yingang; Hilton, Tristan; Yeon, Jason; Houck, Katie; Zhang, Jianning] Bloodworks Res Inst, 1551 Eastlake Ave East, Seattle, WA 98102 USA; [Liu, Wei; Wang, Min; Wu, Xiaoping; Dong, Jing-fei] Lanzhou Univ, Sch Med Sci, Inst Pathol, Lanzhou, Gansu, Peoples R China; [Liu, Wei; Wang, Min; Li, Min] Lanzhou Univ, Gansu Prov Key Lab Preclin Study New Drug Dev, Lanzhou, Gansu, Peoples R China; [Liu, Wei; Li, Min] Tianjin Inst Neurol, Dept Neurol, Tianjin, Peoples R China; [Thiagarajan, Perumal] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Thiagarajan, Perumal] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Thiagarajan, Perumal] Michael E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX USA; [Zhang, Fangyi] Univ Washington, Sch Med, Dept Neurosurg, Seattle, WA USA; [Shi, Fu-Dong] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Shi, Fu-Dong; Dong, Jing-fei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA		Dong, JF (corresponding author), Bloodworks Res Inst, 1551 Eastlake Ave East, Seattle, WA 98102 USA.; Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.; Li, M (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Inst Pathol, Lanzhou, Gansu, Peoples R China.	limin@lzu.edu.cn; jfdong@bloodworksnw.org; jianningzhang@hotmail.com	Zhao, Zilong/AAZ-2196-2020		National Institutes of Health, National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS087296]; National Institutes of Health, National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL119391, HL125957]; Natural Science Foundation of China State Key Program [81330029]; Veterans Administration Research ServiceUS Department of Veterans Affairs;  [81271361];  [81271359];  [16PTSTJC00180];  [81672399]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL125957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS087296] Funding Source: NIH RePORTER	This study is supported by National Institutes of Health, National Institute of Neurological Disorders and Stroke grant NS087296 (J.-f.D.), National Institutes of Health, National Heart, Lung, and Blood Institute grants HL119391 and HL125957 (J.-f.D.), Natural Science Foundation of China State Key Program Grant 81330029 (J.Z.), and research grants 81271361, 81271359, and 16PTSTJC00180 (J.Z.) and 81672399 (M.L.), and a grant from the Veterans Administration Research Service (P.T.).	Ayme G, 2017, ARTERIOSCL THROM VAS, V37, P1736, DOI 10.1161/ATVBAHA.117.309319; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Denorme F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179258; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Feys HB, 2006, J THROMB HAEMOST, V4, P955, DOI 10.1111/j.1538-7836.2006.01833.x; FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Habe K, 2012, THROMB RES, V129, P598, DOI 10.1016/j.thromres.2011.10.011; Hardaway RM, 2001, SEMIN THROMB HEMOST, V27, P577, DOI 10.1055/s-2001-18863; Huang J, 2009, BLOOD, V113, P1589, DOI 10.1182/blood-2008-05-158584; Hyun J, 2009, THROMB RES, V124, P75, DOI 10.1016/j.thromres.2008.11.020; KAPLAN JE, 1989, AM J PHYSIOL, V257, pH423, DOI 10.1152/ajpheart.1989.257.2.H423; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; MAYADAS TN, 1989, J BIOL CHEM, V264, P13497; Moake JL, 1998, J CLIN APHERESIS, V13, P126, DOI 10.1002/(SICI)1098-1101(1998)13:3<126::AID-JCA6>3.0.CO;2-U; Motto DG, 2005, J CLIN INVEST, V115, P2752, DOI 10.1172/JCI26007; Nakano T, 2015, BRAIN RES, V1624, P330, DOI 10.1016/j.brainres.2015.07.027; Nascimbene A, 2017, J HEART LUNG TRANSPL, V36, P477, DOI 10.1016/j.healun.2017.01.010; Padilla A, 2004, BLOOD, V103, P2150, DOI 10.1182/blood-2003-08-2956; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; SPORN LA, 1987, BLOOD, V69, P1531; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; Suidan GL, 2013, ARTERIOSCL THROM VAS, V33, P2112, DOI 10.1161/ATVBAHA.113.301362; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; VISCHER UM, 1994, BLOOD, V83, P3536; WAGNER DD, 1987, BLOOD, V69, P27; Wu X, 2012, PHARMACOL THERAPEUT, V134, P68, DOI 10.1016/j.pharmthera.2011.12.008; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929; Zhao ZL, 2016, BLOOD, V127, P2763, DOI [10.1182/blood-2015-12688838, 10.1182/blood-2015-12-688838]; Zhou Y, 2018, BLOOD, V131, P563, DOI 10.1182/blood-2017-08-801738	34	35	37	1	14	AMER SOC HEMATOLOGY	WASHINGTON	2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA	0006-4971	1528-0020		BLOOD	Blood	SEP 6	2018	132	10					1075	1084		10.1182/blood-2018-03-841932			10	Hematology	Science Citation Index Expanded (SCI-EXPANDED)	Hematology	GS6WH	WOS:000443840200014	29941674	Green Published, Bronze			2022-02-06	
J	Hunter, A; Eastwood, JD				Hunter, Andrew; Eastwood, John D.			Does state boredom cause failures of attention? Examining the relations between trait boredom, state boredom, and sustained attention	EXPERIMENTAL BRAIN RESEARCH			English	Article						State boredom; Trait boredom; Attention; Cognition	TRAUMATIC BRAIN-INJURY; ANXIETY STRESS SCALES; RISKY DECISION-MAKING; VIGILANCE DECREMENT; COGNITIVE FAILURES; WORKING-MEMORY; DEPRESSION; PRONENESS; PERFORMANCE; AROUSAL	Boredom is an important personal and social problem, but the phenomena itself remains poorly understood. Recent work has shown that boredom is highly related to attention, and that this relationship may be instrumental in revealing boredom's causes and consequences. In this paper, experimental findings on trait boredom, state boredom, and sustained attention performance are presented. We demonstrate that trait boredom uniquely predicts sustained attention performance, over and above depression and self-report attention problems. We also present exploratory findings consistent with the claim that attention failures may cause boredom and that sustained attention tasks may themselves be boring. Discussion of each of these findings, and potential ramifications for cognitive research as a whole, is included.	[Hunter, Andrew; Eastwood, John D.] York Univ, Toronto, ON, Canada		Eastwood, JD (corresponding author), York Univ, Toronto, ON, Canada.	johneast@yorku.ca					Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Barkley R. A., 2006, ATTENTION DEFICIT HY; Ben-Zeev D, 2012, PSYCHIAT RES, V197, P55, DOI 10.1016/j.psychres.2011.11.025; Berlyne D. E., 1960, CONFLICT AROUSAL CUR; BERNSTEIN HE, 1975, SOC RES, V42, P512; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Birnbaum MH, 2008, PSYCHOL REV, V115, P463, DOI 10.1037/0033-295X.115.2.463; BLASZCZYNSKI A, 1990, PSYCHOL REP, V67, P35, DOI 10.2466/PR0.67.5.35-42; Carriere JSA, 2008, CONSCIOUS COGN, V17, P835, DOI 10.1016/j.concog.2007.04.008; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; Crawford JR, 2003, BRIT J CLIN PSYCHOL, V42, P111, DOI 10.1348/014466503321903544; Csikszentmihalyi M., 1978, HIDDEN COSTS REWARD, P205; Cummings ML, 2016, HUM FACTORS, V58, P279, DOI 10.1177/0018720815609503; Dahlen ER, 2005, ACCIDENT ANAL PREV, V37, P341, DOI 10.1016/j.aap.2004.10.006; DAMRADFRYE R, 1989, J PERS SOC PSYCHOL, V57, P315; de Bont J, 1994, SPEED MOTION PICTURE; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Duque A, 2015, J BEHAV THER EXP PSY, V46, P107, DOI 10.1016/j.jbtep.2014.09.005; Dutilh G, 2012, ATTEN PERCEPT PSYCHO, V74, P454, DOI 10.3758/s13414-011-0243-2; Eastwood JD, 2012, PERSPECT PSYCHOL SCI, V7, P482, DOI 10.1177/1745691612456044; Fahlman SA, 2013, ASSESSMENT, V20, P68, DOI 10.1177/1073191111421303; Fahlman SA, 2009, J SOC CLIN PSYCHOL, V28, P307, DOI 10.1521/jscp.2009.28.3.307; FARMER R, 1986, J PERS ASSESS, V50, P4, DOI 10.1207/s15327752jpa5001_2; Fisher CD, 1998, J ORGAN BEHAV, V19, P503, DOI 10.1002/(SICI)1099-1379(199809)19:5<503::AID-JOB854>3.0.CO;2-9; FISHER CD, 1993, HUM RELAT, V46, P395, DOI 10.1177/001872679304600305; Gerritsen CJ, 2014, CONSCIOUS COGN, V27, P27, DOI 10.1016/j.concog.2013.10.001; Goldberg Y, 2013, BEHAV SCI-BASEL, V3, P434, DOI 10.3390/bs3030434; Goldberg YK, 2011, J SOC CLIN PSYCHOL, V30, P647, DOI 10.1521/jscp.2011.30.6.647; GRIFFIN JA, 1986, MOTIV EMOTION, V10, P195, DOI 10.1007/BF00992315; HAMILTON JA, 1984, PERS INDIV DIFFER, V5, P183, DOI 10.1016/0191-8869(84)90050-3; Helton WS, 2011, EXP BRAIN RES, V212, P429, DOI 10.1007/s00221-011-2749-1; HOLLENBECK JR, 1995, J APPL PSYCHOL, V80, P685, DOI 10.1037/0021-9010.80.6.685; Hunter JA, 2016, EUR J PSYCHOL ASSESS, V32, P241, DOI 10.1027/1015-5759/a000251; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Kass SJ, 2001, J BUS PSYCHOL, V16, P317, DOI 10.1023/A:1011121503118; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LEARY MR, 1986, J PERS SOC PSYCHOL, V51, P968, DOI 10.1037/0022-3514.51.5.968; Lee CM, 2007, ADDICT BEHAV, V32, P1384, DOI 10.1016/j.addbeh.2006.09.010; LePera N., 2011, NEW SCH PSYCHOL B, V8, P15, DOI DOI 10.1037/E741452011-003; Leventhal H., 1987, COGNITION EMOTION, V1, P3, DOI 10.1080/02699938708408361; Malkovsky E, 2012, EXP BRAIN RES, V221, P59, DOI 10.1007/s00221-012-3147-z; Martin M., 2006, QUAL RES PSYCHOL, V3, P193, DOI [10.1191/1478088706qrp066oa, DOI 10.1191/1478088706QRP0660A, DOI 10.1191/1478088706QRP066OA]; MATTHEWS G, 1998, VIEWING PSYCHOL WHOL, P113; Matthies S, 2012, J BEHAV THER EXP PSY, V43, P938, DOI 10.1016/j.jbtep.2012.02.002; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mercer-Lynn KB, 2013, J SOC CLIN PSYCHOL, V32, P897; Merrifield C, 2014, EXP BRAIN RES, V232, P481, DOI 10.1007/s00221-013-3755-2; Nisbett R., 1974, THOUGHT FEELING, P74; O'Connell RG, 2008, NEUROPSYCHOLOGIA, V46, P1379, DOI 10.1016/j.neuropsychologia.2007.12.018; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Robertson I., 1994, TEST EVERYDAY ATTENT; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rupp DE, 1997, J SOC BEHAV PERS, V12, P925; Sawin DA, 1995, HUM FACTORS, V37, P752, DOI 10.1518/001872095778995616; Scerbo M. W., 1998, VIEWING PSYCHOL WHOL, P145, DOI [DOI 10.1037/10290-006, 10.1037/10290-006]; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Thackray RI, 1977, VIGILANCE THEORY OPE, P203; TROUTWINE R, 1981, PERCEPT MOTOR SKILL, V52, P865, DOI 10.2466/pms.1981.52.3.865; van Tilburg WAP, 2011, PERS SOC PSYCHOL B, V37, P1679, DOI 10.1177/0146167211418530; Video Tutor Inc., 1995, EAS ENGL US NUMB MON; Vodanovich SJ, 2005, J PERS ASSESS, V85, P295, DOI 10.1207/s15327752jpa8503_05; Wallace JC, 2003, PERS INDIV DIFFER, V34, P635, DOI 10.1016/S0191-8869(02)00050-8; Watt JD, 2010, J BUS PSYCHOL, V25, P163, DOI 10.1007/s10869-009-9138-9; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	68	35	37	9	23	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	SEP	2018	236	9			SI		2483	2492		10.1007/s00221-016-4749-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GP4FV	WOS:000440815700005	27510405				2022-02-06	
J	Kerr, NA; Vaccari, JPD; Abbassi, S; Kaur, H; Zambrano, R; Wu, S; Dietrich, WD; Keane, RW				Kerr, Nadine A.; Vaccari, Juan Pablo de Rivero; Abbassi, Sam; Kaur, Harmanpreet; Zambrano, Ronald; Wu, Shu; Dietrich, W. Dalton; Keane, Robert W.			Traumatic Brain Injury-Induced Acute Lung Injury: Evidence for Activation and Inhibition of a Neural-Respiratory-Inflammasome Axis	JOURNAL OF NEUROTRAUMA			English	Article						acute lung injury; extracellular vesicles; inflammasome; innate immune response; traumatic brain injury	MOLECULAR-WEIGHT HEPARIN; DISTRESS-SYNDROME; EXTRACELLULAR VESICLES; IMPACT; HMGB1	Approximately 20-25% of traumatic brain injury (TBI) subjects develop acute lung injury (ALI), but the pathomechanisms of TBI-induced ALI remain poorly defined. Our previous work has shown that the inflammasome plays a critical role in TBI-induced secondary pathophysiology and that inflammasome proteins are released in extracellular vesicles (EV) after TBI. Here we investigated whether EV-mediated inflammasome signaling contributed to the etiology of TBI-induced ALI. C57/BL6 male mice were subjected to controlled cortical impact (CCI), and the brains and lungs were examined for inflammasome activation and ALI at 4 and 24 h after TBI. We show that TBI releases EV containing inflammasome proteins into serum that target the lung to cause ALI, supporting activation of a neural-respiratory-inflammasome axis. Administration of a low-molecular-weight heparin (enoxaparin, a blocker of EV uptake) or treatment with a monoclonal antibody against apoptosis speck-like staining protein containing a caspase recruitment domain (anti-ASC) after adoptive transfer of EV isolated from TBI-injured mice significantly inhibited inflammasome activation in the lungs of recipient mice resulting in improved ALI scores.This axis constitutes an important arm of the innate inflammatory response in lung pathology after TBI and targeting this axis represents a novel therapeutic treatment for TBI-induced ALI.	[Kerr, Nadine A.; Vaccari, Juan Pablo de Rivero; Kaur, Harmanpreet; Dietrich, W. Dalton; Keane, Robert W.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Kerr, Nadine A.; Vaccari, Juan Pablo de Rivero; Abbassi, Sam; Keane, Robert W.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, 1600 NW 10th Ave,RMSB 5058, Miami, FL 33136 USA; [Zambrano, Ronald; Wu, Shu] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA		Keane, RW (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, 1600 NW 10th Ave,RMSB 5058, Miami, FL 33136 USA.	rwkeane@med.miami.edu	de Rivero Vaccari, Juan Pablo/H-5718-2019; de Rivero Vaccari, Juan Pablo/ABE-3248-2020	de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R42NS086274, HL132425, R01 NS042133, NS089443]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042133] Funding Source: NIH RePORTER	We thank Dr. Tahir Ahmed for scientific discussions and for critically reading the manuscript and Ofelia E. Furones-Alonso for help with blood gas determinations. This project was supported in part with NIH grant R42NS086274 to RWK, NIH grant HL132425 to NK, and R01 NS042133 and NS089443 to WDD.	Andersson U, 2011, J INTERN MED, V270, P296, DOI 10.1111/j.1365-2796.2011.02430.x; Assis-Nascimento P, 2016, J NEUROSCI METH, V263, P57, DOI 10.1016/j.jneumeth.2016.01.025; Atai NA, 2013, J NEURO-ONCOL, V115, P343, DOI 10.1007/s11060-013-1235-y; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Campo C, 1999, J APPL PHYSIOL, V86, P549, DOI 10.1152/jappl.1999.86.2.549; Campolo M, 2018, METHODS MOL BIOL, V1727, P385, DOI 10.1007/978-1-4939-7571-6_30; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Cross LJM, 2011, CRIT CARE CLIN, V27, P355, DOI 10.1016/j.ccc.2010.12.005; Feldman P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-180; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kokiko-Cochran ON, 2018, J NEUROTRAUM, V35, P73, DOI 10.1089/neu.2017.5203; Liu LY, 2014, BIOCHEM BIOPH RES CO, V450, P851, DOI 10.1016/j.bbrc.2014.06.074; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Luan ZG, 2014, INFLAMMATION, V37, P924, DOI 10.1007/s10753-014-9812-6; Luh Shi-Ping, 2007, Journal of Zhejiang University-Science B, V8, P60, DOI 10.1631/jzus.2007.B0060; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Mrozek S, 2014, CRIT CARE, V18, DOI 10.1186/cc13841; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Newton K, 2012, COLD SPRING HARB PER, V4; Nicolls MR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010259; Ning FY, 2015, GENE, V557, P88, DOI 10.1016/j.gene.2014.12.018; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Ragaller Maximillian, 2010, J Emerg Trauma Shock, V3, P43, DOI 10.4103/0974-2700.58663; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Shomer E, 2016, THROMB RES, V137, P141, DOI 10.1016/j.thromres.2015.11.026; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Sun Q, 2017, HEPATOLOGY, V65, P253, DOI 10.1002/hep.28893; Sustar V, 2009, BLOOD CELL MOL DIS, V42, P223, DOI 10.1016/j.bcmd.2009.01.012; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weber DJ, 2014, SCI TRANSL MED, V6, P252; Wiklander OPB, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26316; Wu S, 2010, AM J RESP CELL MOL, V42, P552, DOI 10.1165/rcmb.2009-0068OC; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yadav H, 2016, CRIT CARE MED, V44, P1082, DOI 10.1097/CCM.0000000000001617; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	51	35	38	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	17					2067	2076		10.1089/neu.2017.5430		JUN 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ7LU	WOS:000434937100001	29648974	Green Published			2022-02-06	
J	Leung, A; Metzger-Smith, V; He, YF; Cordero, J; Ehlert, B; Song, D; Lin, L; Shahrokh, G; Tsai, A; Vaninetti, M; Rutledge, T; Polston, G; Sheu, R; Lee, R				Leung, Albert; Metzger-Smith, Valerie; He, Yifan; Cordero, James; Ehlert, Brandon; Song, David; Lin, Lisa; Shahrokh, Golshan; Tsai, Alice; Vaninetti, Michael; Rutledge, Thomas; Polston, Greg; Sheu, Robert; Lee, Roland			Left Dorsolateral Prefrontal Cortex rTMS in Alleviating MTBI Related Headaches and Depressive Symptoms	NEUROMODULATION			English	Article						Chronic posttraumatic headaches; MTBI; MTBI-HA; neuropathic pain; rTMS; transcranial magnetic stimulation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; ELECTRICAL-STIMULATION; YOUNG-PATIENTS; CENTRAL PAIN; CONNECTIVITY; VETERANS; NEUROPSYCHOLOGY; INTELLIGENCE; PREVALENCE	ObjectivePersistent mild traumatic brain injury related headache (MTBI-HA) represents a neuropathic pain state. This study tested the hypothesis that repetitive transcranial magnetic stimulation (rTMS) at the left prefrontal cortex can alleviate MTBI-HA and associated neuropsychological dysfunctions. Methods and MaterialsVeterans with MTBI-HA were randomized to receive four sessions of either real (REAL group) or sham (SHAM group) high frequency rTMS delivered at 10 Hz, 80% of resting motor threshold and 2000 pulses per session at >24 and <72 hours apart. Pre-treatment, post-treatment 1-week and 4-week headache and neuropsychological assessments were conducted. ResultsTwenty nine out of forty-four consented subjects completed the study. A two-factor (visit x treatment) repeated measures ANOVA showed a significant (p=0.002, F=11.63, df=1) interaction for the average daily persistent headache intensity with the REAL group exhibiting a significant (p<0.0001) average reduction (SD) of 25.3 +/- 16.8% and 23.0 +/- 17.7% reduction in their numerical rating scale at the one-week and four-week post-treatment assessments in comparison to <1 +/- 11.7% and 2.3 +/- 14.5% reduction found in the SHAM group. In addition, a significant (p<0.01) 50% and 57% reduction was found in the prevalence of persistent headache in the REAL group at the one-week and four-week assessments in comparison to 7% and 20% reduction found in the SHAM group. Furthermore, the REAL group demonstrated a significant (p=0.033) improvement (from 22.3 +/- 6.4 at pre-treatment to 19.0 +/- 5.0 at post-treatment one-week) in the Hamilton Rating Scale for Depression score, while the SHAM group's score remained largely unchanged (from 25.33 +/- 8.43 to 24.64 +/- 5.03) in the same time frame. This trend of improvement, although not statistically significant, continues to the post-treatment four-week assessment. ConclusionA short-course rTMS at the left DLPFC can alleviate MTBI-HA symptoms and provide a transient mood enhancing benefit. Further studies are required to establish a clinical protocol balancing both treatment efficacy and patient compliance.	[Leung, Albert; Vaninetti, Michael; Polston, Greg] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Leung, Albert; Metzger-Smith, Valerie; He, Yifan; Cordero, James; Ehlert, Brandon; Song, David; Lin, Lisa; Tsai, Alice; Vaninetti, Michael; Rutledge, Thomas; Polston, Greg] Vet Affairs San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Song, David] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Shahrokh, Golshan] Vet Med Res Fdn, San Diego, CA USA; [Rutledge, Thomas] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Sheu, Robert] Naval Med Ctr, San Diego, CA USA; [Lee, Roland] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA		Leung, A (corresponding author), Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA.; Leung, A (corresponding author), Vet Affairs San Diego Healthcare Syst, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ayleung@ucsd.edu			VA Rehabilitation and Research Development SPIRE Awards [21RX001359, 21RX002366]; Department of Defense Congressionally Directed Medical Research Program GrantUnited States Department of Defense [W81XWH-16-1-0754]	The authors thank the funding support from the following agencies: VA Rehabilitation and Research Development SPIRE Awards (21RX001359, 21RX002366) and Department of Defense Congressionally Directed Medical Research Program Grant (W81XWH-16-1-0754).	Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; de Oliveira RAA, 2014, J PAIN, V15, P1271, DOI 10.1016/j.jpain.2014.09.009; Bormann JE, 2014, MED CARE, V52, pS13, DOI 10.1097/MLR.0000000000000200; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Caeyenberghs K, 2015, BRAIN CONNECT, V5, P423, DOI 10.1089/brain.2014.0293; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; de Andrade DC, 2011, PAIN, V152, P320, DOI 10.1016/j.pain.2010.10.032; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Joubert Jacques, 2005, Aust Fam Physician, V34, P621; Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806; Klein MM, 2015, PAIN; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Leung A, 2014, HEADACHE, V54, P57; Leung A, 2015, NEUROMODULATION; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; Leung A, 2016, PAIN PHYSICIAN, V19, pE347; Leung A, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-18; Leung A, 2009, J PAIN, V10, P1205, DOI 10.1016/j.jpain.2009.03.010; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Ljubisavljevic M, 1996, ELECTROMYOGR MOTOR C, V101, P281, DOI 10.1016/0924-980X(96)95627-1; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lorenz J, 2002, NEURON, V35, P383, DOI 10.1016/S0896-6273(02)00767-5; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Misra UK, 2013, J NEUROL, V260, P2793, DOI 10.1007/s00415-013-7072-2; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; O'Neil-Pirozzi TM, 2012, BRAIN INJURY, V26, P1425, DOI 10.3109/02699052.2012.694561; Ohn SH, 2012, NEUROREHAB NEURAL RE, V26, P344, DOI 10.1177/1545968311423110; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pal D, 2012, CLIN NEUROL NEUROSUR, V114, P564, DOI 10.1016/j.clineuro.2011.12.002; Pal E, 2010, MOVEMENT DISORD, V25, P2311, DOI 10.1002/mds.23270; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; Peng HJ, 2012, J AFFECT DISORDERS, V136, P249, DOI 10.1016/j.jad.2011.12.006; PEYRON R, 1995, PAIN, V62, P275, DOI 10.1016/0304-3959(94)00211-V; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schmidt-Wilcke T, 2014, NEUROIMAGE-CLIN, V6, P252, DOI 10.1016/j.nicl.2014.09.007; Schmidt-Wilcke T, 2014, PAIN MED, V15, P1346, DOI 10.1111/pme.12460; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Taylor JJ, 2013, NEUROPSYCHOPHARMACOL, V38, P1189, DOI 10.1038/npp.2013.13; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wu E, 2015, J HEAD TRAUMA REHABI	56	35	35	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	JUN	2018	21	4					390	401		10.1111/ner.12615			12	Medicine, Research & Experimental; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	GL9WF	WOS:000437692500010	28557049				2022-02-06	
J	Moran, RN; Covassin, T; Elbin, RJ; Gould, D; Nogle, S				Moran, Ryan N.; Covassin, Tracey; Elbin, R. J.; Gould, Dan; Nogle, Sally			Reliability and Normative Reference Values for the Vestibular/Ocular Motor Screening (VOMS) Tool in Youth Athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; baseline testing; vestibular; ocular motor; athletes	CONCUSSION; OCULOMOTOR; PLAYERS; SPORTS	Background: The Vestibular/Ocular Motor Screening (VOMS) measure is a newly developed vestibular and ocular motor symptom provocation screening tool for sport-related concussions. Baseline data, psychometric properties, and reliability of the VOMS are needed to further understand the applications of this tool, especially in the youth population, where research is scarce. Purpose: To establish normative data and document the internal consistency and false-positive rate of the VOMS in a sample of nonconcussed youth athletes. Study Design: Cross-sectional study; Level of evidence, 3. Methods: A total of 423 youth athletes (male = 278, female = 145) between the ages of 8 and 14 years completed baseline VOMS screening before the start of their respective sport seasons. Internal consistency was measured with Cronbach alpha and inter-item correlations. Results: Approximately 60% of youth athletes reported no symptom provocation on baseline VOMS assessment, with 9% to 13% scoring over the cutoff levels (score of >= 2 for any individual VOMS symptom, near point convergence distance of >= 5 cm). The VOMS displayed a high internal consistency (Cronbach alpha = .97) at baseline among youth athletes. Conclusion: The current findings provide preliminary support for the implementation of VOMS baseline assessment into clinical practice, due to a high internal consistency, strong relationships between VOMS items, and a low false-positive rate at baseline in youth athletes.	[Moran, Ryan N.; Covassin, Tracey; Elbin, R. J.; Gould, Dan; Nogle, Sally] Michigan State Univ, E Lansing, MI 48824 USA; [Moran, Ryan N.] Univ Alabama, Dept Hlth Sci, Athlet Training Res Lab, 478 Russell Hall,Box 870311, Tuscaloosa, AL 35487 USA; [Covassin, Tracey; Nogle, Sally] Michigan State Univ, Dept Kinesiol, Sports Injury Res Lab, E Lansing, MI 48824 USA; [Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA; [Gould, Dan] Michigan State Univ, Inst Study Youth Sports, E Lansing, MI 48824 USA		Moran, RN (corresponding author), Univ Alabama, Dept Hlth Sci, Athlet Training Res Lab, 478 Russell Hall,Box 870311, Tuscaloosa, AL 35487 USA.	rnmoran@ches.ua.edu			Michigan State University College of Education; Michigan State University Graduate School	This study was funded by the Michigan State University College of Education and Graduate School dissertation award. The funding was used for participant reimbursement for participation.	Broglio S, 2004, J ATHL TRAINING, V49, P245; CAMPBELL JP, 1995, ANN EMERG MED, V26, P590, DOI 10.1016/S0196-0644(95)70009-9; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Li C, 2006, J PEDIAT, V171, P240; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moore D. S., 2013, BASIC PRACTICE STAT, V6th; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; O'Reilly RC, 2010, OTOL NEUROTOL, V31, P1441, DOI 10.1097/MAO.0b013e3181f20673; Riina N, 2005, ARCH OTOLARYNGOL, V131, P996, DOI 10.1001/archotol.131.11.996; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	22	35	35	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2018	46	6					1475	1480		10.1177/0363546518756979			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	GF7IB	WOS:000432140700025	29513549				2022-02-06	
J	Oravec, CS; Motiwala, M; Reed, K; Kondziolka, D; Barker, FG; Michael, LM; Klimo, P				Oravec, Chesney S.; Motiwala, Mustafa; Reed, Kevin; Kondziolka, Douglas; Barker, Fred G., II; Michael, L. Madison, II; Klimo, Paul, Jr.			Big Data Research in Neurosurgery: A Critical Look at this Popular New Study Design	NEUROSURGERY			English	Article						Administrative databases; Databases; Data; Outcomes; Cost; Complications	NATIONWIDE INPATIENT SAMPLE; TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; UNRUPTURED INTRACRANIAL ANEURYSMS; STANDARD PERFORMANCE-MEASURES; HOSPITAL-ACQUIRED CONDITIONS; CERVICAL SPONDYLOTIC MYELOPATHY; ENDOSCOPIC 3RD VENTRICULOSTOMY; PATIENT SAFETY INDICATORS; SURGICAL SITE INFECTION	The use of"big data" in neurosurgical research has become increasingly popular. However, using this type of data comes with limitations. This study aimed to shed light on this new approach to clinical research. We compiled a list of commonly used databases that were not specifically created to study neurosurgical procedures, conditions, or diseases. Three North American journalsweremanually searched for articles published since 2000 utilizing these and other non-neurosurgery-specific databases. A number of data points per article were collected, tallied, and analyzed. A total of 324 articles were identified since 2000 with an exponential increase since 2011 (257/324, 79%). The Journal of Neurosurgery Publishing Group published the greatest total number (n =200). The National Inpatient Sample was themost commonly used database (n =136). The average study size was 114 841 subjects (range, 30-4 146 777). The most prevalent topics were vascular (n =77) and neuro-oncology (n =66). When categorizing study objective (recognizing that many papers reported more than 1 type of study objective),"Outcomes" was themost common (n=154). The top 10 institutions by primary or senior author accounted for 45%-50% of all publications. Harvard Medical School was the top institution, using this research technique with 59 representations (31 by primary author and 28 by senior). The increasing use of data from non-neurosurgery-specific databases presents a unique challenge to the interpretation and application of the study conclusions. The limitations of these studies must be more strongly considered in designing and interpreting these studies.	[Oravec, Chesney S.; Motiwala, Mustafa; Reed, Kevin] Univ Tennessee, Hlth Sci Ctr, Coll Med, Memphis, TN USA; [Kondziolka, Douglas] NYU, Dept Neurosurg, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Barker, Fred G., II] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Michael, L. Madison, II; Klimo, Paul, Jr.] Univ Tennessee, Dept Neurosurg, Hlth Sci Ctr, Memphis, TN USA; [Michael, L. Madison, II; Klimo, Paul, Jr.] Semmes Murphey Clin, Memphis, TN USA; [Klimo, Paul, Jr.] Le Bonheur Childrens Hosp, Dept Neurosurg, Memphis, TN USA		Klimo, P (corresponding author), Semmes Murphey Neurol & Spine Inst, 6325 Humphreys Blvd, Memphis, TN 38120 USA.	pklimo@semmes-murphey.com		Kondziolka, Douglas/0000-0001-8925-7344			Ackerman SJ, 2014, J NEUROSURG-SPINE, V20, P354, DOI 10.3171/2014.1.SPINE13188; Adams H, 2013, WORLD NEUROSURG, V80, pE237, DOI 10.1016/j.wneu.2013.02.010; Ahmed KA, 2014, WORLD NEUROSURG, V82, pE291, DOI 10.1016/j.wneu.2013.10.035; Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alan N, 2014, J NEUROSURG, V120, P811, DOI 10.3171/2014.1.JNS131852; Alan N, 2014, J NEUROSURG, V120, P764, DOI 10.3171/2013.10.JNS131028; Alawi A, 2014, J NEUROSURG-PEDIATR, V14, P23, DOI 10.3171/2014.4.PEDS13464; Algattas H, 2016, WORLD NEUROSURG, V87, P531, DOI 10.1016/j.wneu.2015.09.020; Algattas H, 2015, WORLD NEUROSURG, V84, P1372, DOI 10.1016/j.wneu.2015.06.033; Ali R, 2016, J NEUROSURG-SPINE, V25, P537, DOI 10.3171/2015.10.SPINE14582; Amin BY, 2013, J NEUROSURG-SPINE, V18, P134, DOI 10.3171/2012.10.SPINE12559; Amin-Hanjani S, 2005, J NEUROSURG, V103, P794, DOI 10.3171/jns.2005.103.5.0794; Andaluz N, 2008, J NEUROSURG, V108, P1163, DOI 10.3171/JNS/2008/108/6/1163; Andaluz N, 2009, J NEUROSURG, V110, P403, DOI 10.3171/2008.5.17559; Anumula N, 2011, AM J NEURORADIOL, V32, P2000, DOI 10.3174/ajnr.A2912; Arrigo RT, 2011, NEUROSURGERY, V68, P1520, DOI 10.1227/NEU.0b013e31820cd426; Attenello FJ, 2015, J NEUROSURG PEDIAT, V17, P156; Attenello FJ, 2015, J NEUROSURG-PEDIATR, V15, P560, DOI 10.3171/2014.11.PEDS14451; Attenello FJ, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.053; Austin MT, 2016, J NEUROSURG-PEDIATR, V18, P585, DOI 10.3171/2016.5.PEDS15704; Baaj AA, 2011, J NEUROSURG-SPINE, V15, P367, DOI 10.3171/2011.5.SPINE10934; Baaj AA, 2010, J NEUROSURG-SPINE, V13, P61, DOI 10.3171/2010.3.SPINE09530; Baaj AA, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC/2008/25/9/E10; Babu MA, 2011, NEUROSURGERY, V69, P659, DOI 10.1227/NEU.0b013e31821bc667; Babu R, 2014, J NEUROSURG-SPINE, V21, P502, DOI 10.3171/2014.5.SPINE13283; Babu R, 2014, J NEUROSURG, V121, P262, DOI 10.3171/2014.5.JNS1314; Babu R, 2013, J NEUROSURG, V119, P434, DOI 10.3171/2013.4.JNS122329; Babu R, 2013, J NEUROSURG, V119, P121, DOI 10.3171/2013.1.JNS121370; Backes D, 2016, J NEUROSURG, V125, P737, DOI 10.3171/2015.8.JNS151473; Bagley JH, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2012.12.FOCUS12343; Bakhsheshian J, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16268; Barker FG, 2004, NEUROSURGERY, V55, P506, DOI 10.1227/01.NEU.0000134284.47965.71; Barker FG, 2004, NEUROSURGERY, V54, P18, DOI 10.1227/01.NEU.0000097195.48840.C4; Barker FG, 2003, NEUROSURGERY, V52, P995, DOI 10.1227/01.NEU.0000057743.56678.5F; Barnholtz-Sloan JS, 2008, J NEUROSURG, V108, P642, DOI 10.3171/JNS/2008/108/4/0642; Barnholtz-Sloan JS, 2003, J NEUROSURG, V99, P458, DOI 10.3171/jns.2003.99.3.0458; Barton SE, 2013, J NEUROSURG-PEDIATR, V11, P392, DOI 10.3171/2013.1.PEDS12362; Bateman BT, 2005, NEUROSURGERY, V57, P866, DOI 10.1227/01.NEU.0000179923.66729.87; Bekelis K, 2017, J NEUROSURG, V126, P805, DOI 10.3171/2016.2.JNS152994; Bekelis K, 2017, J NEUROSURG, V126, P811, DOI 10.3171/2016.1.JNS152028; Bekelis K, 2016, WORLD NEUROSURG, V95, P542, DOI 10.1016/j.wneu.2016.08.042; Bekelis K, 2016, J NEUROSURG, V125, P1390, DOI 10.3171/2015.11.JNS151841; Bekelis K, 2017, J NEUROSURG, V126, P29, DOI 10.3171/2015.11.JNS151725; Bekelis K, 2016, J NEUROSURG-PEDIATR, V18, P623, DOI 10.3171/2016.5.PEDS16137; Bekelis K, 2016, WORLD NEUROSURG, V94, P551, DOI 10.1016/j.wneu.2016.07.077; Bekelis K, 2015, J NEUROSURG, V123, P1223, DOI 10.3171/2014.11.JNS142111; Bekelis K, 2015, WORLD NEUROSURG, V84, P82, DOI 10.1016/j.wneu.2015.02.032; Bekelis K, 2014, J NEUROSURG, V120, P591, DOI 10.3171/2013.8.JNS13228; Benchimol EI, 2011, J CLIN EPIDEMIOL, V64, P821, DOI 10.1016/j.jclinepi.2010.10.006; Bernstein DN, 2016, WORLD NEUROSURG, V96, P538, DOI 10.1016/j.wneu.2016.09.058; Berry JG, 2008, NEUROSURGERY, V62, P445, DOI 10.1227/01.neu.0000316012.20797.04; Boakye M, 2008, NEUROSURGERY, V63, P295, DOI 10.1227/01.NEU.0000327028.45886.2E; Boakye M, 2008, NEUROSURGERY, V62, P455, DOI 10.1227/01.neu.0000316013.97926.4c; Bohman LE, 2014, WORLD NEUROSURG, V82, P806, DOI 10.1016/j.wneu.2014.07.005; Borgstedt-Bakke JH, 2017, J NEUROSURG-PEDIATR, V19, P227, DOI 10.3171/2016.8.PEDS1654; Bowers C, 2015, WORLD NEUROSURG, V84, P202, DOI 10.1016/j.wneu.2015.06.035; Brockmeyer D, 2016, J NEUROSURG-PEDIATR, V18, P413, DOI 10.3171/2016.2.PEDS1639; Busl KM, 2013, J NEUROSURG, V119, P1296, DOI 10.3171/2013.4.JNS122236; Bydon M, 2015, NEUROSURGERY, V77, P347, DOI 10.1227/NEU.0000000000000852; Bydon M, 2015, J NEUROSURG, V122, P955, DOI 10.3171/2014.11.JNS14890; Cahill KS, 2015, J NEUROSURG-SPINE, V23, P86, DOI 10.3171/2014.10.SPINE14338; Cahill KS, 2011, J NEUROSURG, V115, P259, DOI 10.3171/2011.3.JNS101748; Cahill KS, 2011, NEUROSURGERY, V68, P705, DOI 10.1227/NEU.0b013e31820773b2; Carlson ML, 2016, J NEUROSURG, V125, P1120, DOI 10.3171/2015.7.JNS151056; Chan AK, 2016, J NEUROSURG-SPINE, V25, P31, DOI 10.3171/2015.10.SPINE15670; Chan AK, 2013, NEUROSURGERY, V73, P951, DOI 10.1227/NEU.0000000000000129; Charland Kim, 2007, Healthc Financ Manage, V61, P60; Cherian J, 2016, J NEUROSURG-PEDIATR, V18, P416, DOI 10.3171/2016.1.PEDS15674; Chi JH, 2005, J NEUROSURG, V103, P113, DOI 10.3171/ped.2005.103.2.0113; Christian EA, 2016, J NEUROSURG-PEDIATR, V17, P260, DOI 10.3171/2015.7.PEDS15140; Claassen J, 2007, NEUROSURGERY, V61, P60, DOI 10.1227/01.neu.0000279724.05898.e7; Claassen J, 2007, NEUROSURGERY, V61, P64, DOI 10.1227/01.NEU.0000255504.51096.DE; Claus EB, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2014.10.FOCUS12367; Claus EB, 2013, J NEUROSURG, V118, P649, DOI 10.3171/2012.9.JNS12811; Clement RC, 2013, J NEUROSURG, V118, P687, DOI 10.3171/2012.10.JNS12682; Cohen HW, 2011, AM J HYPERTENS, V24, P18, DOI 10.1038/ajh.2010.205; Connolly ID, 2015, WORLD NEUROSURG, V84, P1864, DOI 10.1016/j.wneu.2015.08.018; Corliss BM, 2015, NEUROSURGERY, V77, P44, DOI 10.1227/NEU.0000000000000734; Couldwell WT, 2014, J NEUROSURG, V121, P1474, DOI 10.3171/2014.8.JNS132139; Cowan JA, 2003, J NEUROSURG, V99, P947, DOI 10.3171/jns.2003.99.6.0947; Cowan JA, 2003, NEUROSURGERY, V52, P48, DOI 10.1097/00006123-200301000-00005; Cowan JA, 2007, J NEUROSURG, V107, P530, DOI 10.3171/JNS-07/09/0530; Cowan JA, 2006, NEUROSURGERY, V59, P15, DOI 10.1227/01.NEU.0000219836.54861.CD; Cross DT, 2003, J NEUROSURG, V99, P810, DOI 10.3171/jns.2003.99.5.0810; Crowley RW, 2009, J NEUROSURG, V111, P60, DOI 10.3171/2008.11.JNS081038; Curry WT, 2010, NEUROSURGERY, V66, P427, DOI 10.1227/01.NEU.0000365265.10141.8E; Curry WT, 2005, J NEUROSURG, V102, P977, DOI 10.3171/jns.2005.102.6.0977; Curry WT, 2005, NEUROSURGERY, V57, P97, DOI 10.1227/01.NEU.0000163094.23923.E5; D'Oro A, 2016, J NEUROSURG-SPINE, V24, P476, DOI 10.3171/2015.7.SPINE15442; Daniels AH, 2016, J NEUROSURG-SPINE, V25, P165, DOI 10.3171/2015.11.SPINE15776; Dasenbrock HH, 2012, NEUROSURGERY, V70, P1353; Dasenbrock HH, 2017, J NEUROSURG, V127, P36, DOI 10.3171/2016.4.JNS152562; Dasenbrock HH, 2017, J NEUROSURG, V126, P677, DOI 10.3171/2016.2.JNS152345; Dasenbrock HH, 2017, J NEUROSURG, V126, P537, DOI 10.3171/2015.12.JNS151107; Dasenbrock HH, 2016, WORLD NEUROSURG, V88, P459, DOI 10.1016/j.wneu.2015.10.054; Dasenbrock HH, 2016, NEUROSURGERY, V78, P412, DOI 10.1227/NEU.0000000000001065; Dasenbrock HH, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.10.FOCUS15386; Dasenbrock HH, 2012, NEUROSURGERY, V70, P1346, DOI 10.1227/NEU.0b013e318251791a; Dasenbrock HH, 2012, NEUROSURGERY, V70, P586, DOI 10.1227/NEU.0b013e318232d1ee; Davies JM, 2017, J NEUROSURG, V127, P69, DOI 10.3171/2016.7.JNS15925; Davies JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.5.FOCUS12107; De la Garza Ramos R, 2016, WORLD NEUROSURG, V95; Ramos RD, 2016, WORLD NEUROSURG, V95, P480, DOI 10.1016/j.wneu.2016.06.096; De la Garza-Ramos R, 2016, J NEUROSURG-SPINE, V25, P15, DOI 10.3171/2015.11.SPINE151021; Deorah Sundeep, 2006, Neurosurg Focus, V20, pE1, DOI 10.3171/foc.2006.20.4.E1; Dorsi MJ, 2010, J NEUROSURG-PEDIATR, V5, P573, DOI 10.3171/2010.3.PEDS09538; Drazin D, 2016, J NEUROSURG-SPINE, V24, P686, DOI 10.3171/2015.7.SPINE14133; Dudley RWR, 2015, NEUROSURGERY, V76, P313, DOI 10.1227/NEU.0000000000000619; Duhaime AC, 2012, J NEUROSURG-PEDIATR, V10, P255, DOI 10.3171/2012.4.PEDS12143; Dumont TM, 2012, NEUROSURGERY, V71, P1041, DOI 10.1227/NEU.0b013e31826cdd73; Dumont TM, 2012, J NEUROSURG, V116, P1251, DOI 10.3171/2012.3.JNS111320; Englot DJ, 2013, J NEUROSURG, V118, P169, DOI 10.3171/2012.9.JNS12776; Eskandar EN, 2003, J NEUROSURG, V99, P863, DOI 10.3171/jns.2003.99.5.0863; Fargen KM, 2015, J NEUROSURG, V122, P870, DOI 10.3171/2014.12.JNS14646; Fargen KM, 2013, J NEUROSURG, V119, P1633, DOI 10.3171/2013.7.JNS13595; Fargen KM, 2013, J NEUROSURG, V119, P966, DOI 10.3171/2013.5.JNS122378; Fennell VS, 2016, J NEUROSURG, V124, P13, DOI 10.3171/2014.11.JNS141030; Finn MA, 2010, NEUROSURGERY, V67, P993, DOI 10.1227/NEU.0b013e3181f209db; Flynn-O'Brien KT, 2015, NEUROSURGERY, V76, P451, DOI 10.1227/NEU.0000000000000693; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Garcia RM, 2016, WORLD NEUROSURG, V96, P230, DOI 10.1016/j.wneu.2016.08.114; Gephart MGH, 2012, J NEUROSURG-PEDIATR, V10, P555, DOI 10.3171/2012.9.PEDS1272; Gephart MGH, 2012, WORLD NEUROSURG, V78, P545, DOI 10.1016/j.wneu.2011.12.089; Ghia AJ, 2013, NEUROSURGERY, V72, P203, DOI 10.1227/NEU.0b013e31827b9e68; Gittleman H, 2014, J NEUROSURG, V121, P527, DOI 10.3171/2014.5.JNS131819; Golinvaux NS, 2014, SPINE J, V14, P2923, DOI 10.1016/j.spinee.2014.04.025; Gologorsky Y, 2014, J NEUROSURG-SPINE, V21, P984, DOI 10.3171/2014.8.SPINE131113; Gonda DD, 2014, J NEUROSURG, V120, P1349, DOI 10.3171/2014.3.JNS131159; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Greenberg JK, 2016, J NEUROSURG-PEDIATR, V17, P525, DOI 10.3171/2015.10.PEDS15369; Greenberg JK, 2015, NEUROSURGERY, V77, P261, DOI 10.1227/NEU.0000000000000777; Grimes DA, 2015, HUM REPROD, V30, P1749, DOI 10.1093/humrep/dev151; Grimes DA, 2010, OBSTET GYNECOL, V116, P1018, DOI 10.1097/AOG.0b013e3181f98300; Grossman R, 2011, WORLD NEUROSURG, V75, P279, DOI 10.1016/j.wneu.2010.09.003; Hammers R, 2010, J NEUROSURG, V112, P257, DOI 10.3171/2009.6.JNS081235; Hankinson TC, 2016, J NEUROSURG-PEDIATR, V17, P289, DOI 10.3171/2015.7.PEDS15224; Harris DA, 2014, J NEUROSURG-PEDIATR, V13, P448, DOI 10.3171/2014.1.PEDS13479; Hassan AE, 2017, J NEUROSURG, V127, P270, DOI 10.3171/2016.6.JNS152476; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; Hirshman BR, 2016, WORLD NEUROSURG, V96, P237, DOI 10.1016/j.wneu.2016.07.105; Hoh BL, 2012, NEUROSURGERY, V70, P1369, DOI 10.1227/NEU.0b013e3182486a75; Hoh BL, 2011, WORLD NEUROSURG, V76, P548, DOI 10.1016/j.wneu.2011.05.054; Hoh BL, 2011, NEUROSURGERY, V69, P644, DOI 10.1227/NEU.0b013e31821bc46d; Holland CM, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.9.FOCUS15497; Hooten KG, 2015, NEUROSURGERY, V76, P239, DOI 10.1227/NEU.0000000000000594; Hsu S, 2011, J NEUROSURG-SPINE, V14, P742, DOI 10.3171/2011.1.SPINE10351; Hu KJ, 2016, WORLD NEUROSURG, V94, P409, DOI 10.1016/j.wneu.2016.07.023; Hubbard ME, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11179; Jacob RL, 2016, J NEUROSURG, V124, P1517, DOI 10.3171/2015.5.JNS15433; Jaja BNR, 2013, J NEUROSURG, V119, P1627, DOI 10.3171/2013.7.JNS13544; James WS, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.8.FOCUS14449; Jernigan SC, 2014, J NEUROSURG-PEDIATR, V13, P295, DOI 10.3171/2013.11.PEDS13138; Jeswani S, 2013, NEUROSURGERY, V73, P240, DOI 10.1227/01.neu.0000430288.85680.37; Jin DL, 2016, WORLD NEUROSURG, V88, P399, DOI 10.1016/j.wneu.2015.12.046; Johnson DR, 2013, WORLD NEUROSURG, V79, P110, DOI 10.1016/j.wneu.2012.03.033; Joseph JR, 2016, WORLD NEUROSURG, V92, P366, DOI 10.1016/j.wneu.2016.05.033; Kainth DS, 2013, NEUROSURGERY, V72, P210, DOI 10.1227/NEU.0b013e31827b9beb; KALAKOTI P, 2015, NEUROSURG FOCUS, V39; KALAKOTI P, 2015, NEUROSURG FOCUS, V38; Kalakoti P, 2016, WORLD NEUROSURG, V85, P114, DOI 10.1016/j.wneu.2015.08.020; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Kalkanis SN, 2003, NEUROSURGERY, V52, P1251, DOI 10.1227/01.NEU.0000065129.25359.EE; Karhade AV, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.5.FOCUS16168; Kesler H, 2008, J NEUROSURG-PEDIATR, V1, P351, DOI 10.3171/PED/2008/1/5/351; Kestle JRW, 2015, J NEUROSURG, V122, P441, DOI 10.3171/2014.4.JNS14689; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Kim BD, 2014, J NEUROSURG-SPINE, V20, P606, DOI 10.3171/2014.3.SPINE13699; Kim YW, 2013, NEUROSURGERY, V73, P450, DOI 10.1227/NEU.0000000000000001; Kim YW, 2013, NEUROSURGERY, V72, P143, DOI 10.1227/NEU.0b013e3182796af9; Kimmell KT, 2015, J NEUROSURG, V122, P1004, DOI 10.3171/2014.10.JNS14632; King JT, 2009, NEUROSURGERY, V65, P1011, DOI 10.1227/01.NEU.0000360347.10596.BD; Klimo P, 2015, NEUROSURGERY, V77, P1, DOI 10.1227/NEU.0000000000000743; Kondziolka D, 2015, BIG DATA-US, V3, P80, DOI 10.1089/big.2014.0069; Kshettry VR, 2014, J NEUROSURG-PEDIATR, V13, P666, DOI 10.3171/2014.3.PEDS13597; Kukreja S, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14825; Kurtz SM, 2012, J NEUROSURG-SPINE, V17, P342, DOI 10.3171/2012.7.SPINE12203; Kwon JW, 2013, WORLD NEUROSURG, V79, P499, DOI 10.1016/j.wneu.2012.07.032; Lad SP, 2007, J NEUROSURG-SPINE, V7, P305, DOI 10.3171/SPI-07/09/305; Lad SP, 2013, NEUROSURGERY, V73, P440, DOI 10.1227/NEU.0000000000000018; Lad SP, 2013, NEUROSURGERY, V72, P1000, DOI 10.1227/01.neu.0000429284.91142.56; Lad Shivanand P, 2007, Neurosurg Focus, V23, pE3; Lad Shivanand P, 2009, Neurosurg Focus, V26, P1, DOI 10.3171/FOC.2009.26.1.E10; Lad SP, 2010, NEUROSURGERY, V66, P953, DOI 10.1227/01.NEU.0000368545.83463.91; Lai PMR, 2014, WORLD NEUROSURG, V82, P380, DOI 10.1016/j.wneu.2013.07.015; Lam S, 2016, J NEUROSURG-PEDIATR, V17, P763, DOI 10.3171/2015.8.PEDS15481; Lam S, 2014, J NEUROSURG-PEDIATR, V14, P455, DOI 10.3171/2014.8.PEDS13680; Lam SK, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.8.FOCUS14454; Lam SK, 2014, J NEUROSURG-PEDIATR, V14, P476, DOI 10.3171/2014.7.PEDS1499; Larsen AMG, 2016, WORLD NEUROSURG, V93, P299, DOI 10.1016/j.wneu.2016.06.020; Larson AN, 2016, J NEUROSURG-SPINE, V24, P116, DOI 10.3171/2015.4.SPINE131119; Lau T, 2012, J NEUROSURG, V117, P514, DOI 10.3171/2012.5.JNS111858; Lawson EH, 2015, ANN SURG, V261, P290, DOI 10.1097/SLA.0000000000000707; Lawson EH, 2012, ANN SURG, V256, P973, DOI 10.1097/SLA.0b013e31826b4c4f; Lawson MF, 2013, WORLD NEUROSURG, V79, P472, DOI 10.1016/j.wneu.2012.01.038; Leake CB, 2011, J NEUROSURG, V115, P1179, DOI 10.3171/2011.7.JNS11590; Lee EJ, 2012, J NEUROSURG, V117, P53, DOI 10.3171/2012.3.JNS111221; Lieber B, 2016, WORLD NEUROSURG, V89, P517, DOI 10.1016/j.wneu.2015.12.085; Lieber BA, 2016, WORLD NEUROSURG, V91, P149, DOI 10.1016/j.wneu.2016.03.052; Lieber BA, 2016, J NEUROSURG, V125, P187, DOI 10.3171/2015.4.JNS142719; Lieber BA, 2016, J NEUROSURG, V125, P213, DOI 10.3171/2015.4.JNS142149; Lieber BA, 2016, WORLD NEUROSURG, V89, P126, DOI 10.1016/j.wneu.2016.01.033; Lim S, 2015, J NEUROSURG, V122, P962, DOI 10.3171/2014.11.JNS1494; Lin YM, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.9.FOCUS15383; Lin YM, 2015, J NEUROSURG-PEDIATR, V15, P243, DOI 10.3171/2014.9.PEDS1473; Lindekleiv H, 2015, J NEUROSURG, V123, P631, DOI 10.3171/2014.12.JNS142106; Little AS, 2013, J NEUROSURG, V119, P504, DOI 10.3171/2013.1.JNS121375; Lukasiewicz AM, 2016, J NEUROSURG, V124, P760, DOI 10.3171/2015.2.JNS142721; Majercik S, 2015, NEUROSURGERY, V77, P927, DOI 10.1227/NEU.0000000000000957; Malone H, 2015, WORLD NEUROSURG, V84, P1084, DOI 10.1016/j.wneu.2015.05.025; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Marcus LP, 2014, J NEUROSURG, V120, P1201, DOI 10.3171/2014.1.JNS131264; Marguerie M, 2016, J NEUROSURG-PEDIATR, V18, P509, DOI 10.3171/2016.4.PEDS16222; Maud A, 2009, J NEUROSURG, V110, P880, DOI 10.3171/2008.8.JNS0858; Mcclelland S, 2007, J NEUROSURG, V107, P469, DOI 10.3171/PED-07/12/469; McCutcheon BA, 2016, WORLD NEUROSURG, V91, P272, DOI [10.1016/J.WNEU.2016.04.039, 10.1016/j.wneu.2016.04.039]; McCutcheon BA, 2016, WORLD NEUROSURG, V89, P101, DOI 10.1016/j.wneu.2016.01.089; McCutcheon BA, 2016, WORLD NEUROSURG, V88, P350, DOI 10.1016/j.wneu.2015.12.068; McCutcheon BA, 2015, J NEUROSURG, V123, P406, DOI 10.3171/2015.3.JNS131356; McDonald JS, 2013, J NEUROSURG-SPINE, V18, P280, DOI 10.3171/2012.12.SPINE12300; McDonald RJ, 2012, J NEUROSURG, V116, P157, DOI 10.3171/2011.8.JNS11324; McGirt MJ, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.9.FOCUS15335; McGirt MJ, 2011, J NEUROSURG-SPINE, V14, P771, DOI 10.3171/2011.1.SPINE10571; McGovern RA, 2013, J NEUROSURG, V119, P1546, DOI 10.3171/2013.8.JNS13475; McGuire CS, 2009, J NEUROSURG, V110, P725, DOI 10.3171/2008.9.JNS08117; McKinley BP, 2000, J NEUROSURG, V93, P932, DOI 10.3171/jns.2000.93.6.0932; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Menger RP, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.8.FOCUS14436; Michalak SM, 2016, NEUROSURGERY, V79, P182, DOI 10.1227/NEU.0000000000001251; Missios S, 2016, J NEUROSURG-SPINE, V25, P264, DOI 10.3171/2016.1.SPINE151155; Missios S, 2015, WORLD NEUROSURG, V83, P957, DOI 10.1016/j.wneu.2015.04.052; Missios S, 2014, J NEUROSURG-PEDIATR, V14, P688, DOI 10.3171/2014.8.PEDS14112; Moghavem N, 2015, J NEUROSURG, V123, P189, DOI 10.3171/2014.12.JNS14447; Mukherjee D, 2011, WORLD NEUROSURG, V76, P580, DOI 10.1016/j.wneu.2011.05.016; Mukherjee D, 2011, J NEUROSURG-SPINE, V14, P143, DOI 10.3171/2010.10.SPINE10189; Mukhtar TK, 2016, J NEUROSURG, V125, P698, DOI 10.3171/2015.5.JNS142115; Murphy ME, 2017, J NEUROSURG-SPINE, V26, P353, DOI 10.3171/2016.8.SPINE16616; Muszynski CA, 2005, J NEUROSURG, V102, P374, DOI 10.3171/ped.2005.102.4.0374; Newman WC, 2016, J NEUROSURG, V125, P713, DOI 10.3171/2015.8.JNS14553; Noonan VK, 2013, J NEUROTRAUM, V30, P173, DOI 10.1089/neu.2012.2441; Noorbakhsh A, 2014, J NEUROSURG, V120, P31, DOI 10.3171/2013.9.JNS13877; Norby K, 2014, J NEUROSURG, V121, P247, DOI 10.3171/2014.4.JNS131191; Nuno M, 2015, J NEUROSURG, V123, P1247, DOI 10.3171/2014.10.JNS141516; Nuno M, 2015, J NEUROSURG-PEDIATR, V16, P515, DOI 10.3171/2015.3.PEDS14544; Nuno M, 2014, NEUROSURGERY, V74, P196, DOI 10.1227/NEU.0000000000000243; Nuno M, 2013, NEUROSURGERY, V73, P458, DOI 10.1227/01.neu.0000431477.02408.5e; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; O'Kane R, 2013, J NEUROSURG-PEDIATR, V12, P227, DOI 10.3171/2013.5.PEDS12514; O'Kelly CJ, 2010, J NEUROSURG, V113, P795, DOI 10.3171/2009.9.JNS081645; O'Kelly CJ, 2009, J NEUROSURG, V111, P1029, DOI 10.3171/2008.9.JNS08881; Ohya J, 2015, WORLD NEUROSURG, V83, P603, DOI 10.1016/j.wneu.2014.12.019; Ong KL, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.4.FOCUS1440; Padwal JA, 2016, WORLD NEUROSURG, V90, P186, DOI 10.1016/j.wneu.2016.02.078; PAN IW, 2015, NEUROSURG FOCUS, V39; Pandey AS, 2015, NEUROSURGERY, V77, P462, DOI 10.1227/NEU.0000000000000850; Park HS, 2016, J NEUROSURG, V124, P1018, DOI 10.3171/2015.4.JNS1573; Parker SL, 2015, WORLD NEUROSURG, V83, P382, DOI 10.1016/j.wneu.2014.06.010; Parker SL, 2015, J NEUROSURG, V122, P443, DOI 10.3171/2014.10.JNS13395; Patel S, 2013, WORLD NEUROSURG, V80, P142, DOI 10.1016/j.wneu.2012.06.029; Patil Chirag G, 2007, Neurosurg Focus, V23, pE7; Patil CG, 2012, WORLD NEUROSURG, V78, P640, DOI 10.1016/j.wneu.2011.10.042; Patil PG, 2005, NEUROSURGERY, V57, P753, DOI 10.1227/01.NEU.0000175729.79119.1d; Patwardhan RV, 2005, NEUROSURGERY, V56, P139, DOI 10.1227/01.NEU.0000146206.40375.41; Piatt JH, 2016, J NEUROSURG-SPINE, V25, P69, DOI 10.3171/2015.9.SPINE15771; Piatt JH, 2015, J NEUROSURG-PEDIATR, V16, P463, DOI 10.3171/2015.2.PEDS1515; Piatt JH, 2014, J NEUROSURG-PEDIATR, V14, P179, DOI 10.3171/2014.5.PEDS1421; Piatt JH, 2014, J NEUROSURG-PEDIATR, V14, P48, DOI 10.3171/2014.3.PEDS13618; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Piatt Joseph H Jr, 2011, J Neurosurg Pediatr, V7, P567, DOI 10.3171/2011.3.PEDS10504; Piatt Joseph H Jr, 2005, Neurosurg Focus, V19, pE6; Piper K, 2017, J NEUROSURG-SPINE, V26, P90, DOI 10.3171/2016.6.SPINE1656; Puvanesarajah V, 2016, WORLD NEUROSURG, V96, P267, DOI 10.1016/j.wneu.2016.09.014; Puvanesarajah V, 2016, J NEUROSURG-SPINE, V25, P486, DOI 10.3171/2016.2.SPINE151345; Qureshi AI, 2015, NEUROSURGERY, V76, P34, DOI 10.1227/NEU.0000000000000551; Qureshi AI, 2014, NEUROSURGERY, V75, P380, DOI 10.1227/NEU.0000000000000450; Qureshi AI, 2013, J NEUROSURG-PEDIATR, V12, P49, DOI 10.3171/2013.4.PEDS12568; Qureshi AI, 2011, J NEUROSURG, V114, P834, DOI 10.3171/2010.6.JNS091486; Qureshi AI, 2005, NEUROSURGERY, V57, P1, DOI 10.1227/01.NEU.0000163081.55025.CD; Qureshi AI, 2005, NEUROSURGERY, V57, P647, DOI 10.1227/01.NEU.0000175546.62088.D6; Qureshi SA, 2013, J NEUROSURG-SPINE, V19, P546, DOI 10.3171/2013.8.SPINE12623; Rahman M, 2013, WORLD NEUROSURG, V80, P699, DOI 10.1016/j.wneu.2013.08.024; Rambachan A, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.08.020; Ramos RD, 2016, J NEUROSURG-PEDIATR, V18, P730, DOI 10.3171/2016.6.PEDS16200; Rao G, 2009, NEUROSURGERY, V65, P483, DOI 10.1227/01.NEU.0000350876.91495.E0; Rincon F, 2014, J NEUROSURG, V121, P950, DOI 10.3171/2014.7.JNS132470; Rincon F, 2013, NEUROSURGERY, V73, P217, DOI 10.1227/01.neu.0000430290.93304.33; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rocque BG, 2014, J NEUROSURG-PEDIATR, V14, P635, DOI 10.3171/2014.8.PEDS13665; Rolston JD, 2014, J NEUROSURG, V121, P908, DOI 10.3171/2014.6.JNS131419; Rolston JD, 2014, J NEUROSURG, V120, P736, DOI 10.3171/2013.10.JNS122419; Romano PS, 2002, MED CARE, V40, P856, DOI 10.1097/00005650-200210000-00004; Ronning PA, 2016, J NEUROSURG, V125, P393, DOI 10.3171/2015.6.JNS15985; Rughani AI, 2010, J NEUROSURG, V113, P585, DOI 10.3171/2009.11.JNS09857; Rughani AI, 2011, J NEUROSURG, V115, P202, DOI 10.3171/2011.4.JNS101924; Rumalla K, 2016, J NEUROSURG-SPINE, V25, P500, DOI 10.3171/2016.2.SPINE151377; Rumalla K, 2016, WORLD NEUROSURG, V91, P542, DOI 10.1016/j.wneu.2016.03.003; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; Sampson JH, 2014, J NEUROSURG, V120, P297, DOI 10.3171/2013.6.JNS13993; Sarda S, 2015, J NEUROSURG-PEDIATR, V15, P544, DOI 10.3171/2014.9.PEDS14459; Sarrazin MSV, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6636; Sarrazin MSV, 2012, JAMA-J AM MED ASSOC, V307, P1433, DOI 10.1001/jama.2012.404; Savage JW, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.7.FOCUS15240; Seicean A, 2015, J NEUROSURG, V123, P91, DOI 10.3171/2014.10.JNS14551; Seicean A, 2012, J NEUROSURG, V116, P1097, DOI 10.3171/2012.1.JNS111760; Semrad TJ, 2007, J NEUROSURG, V106, P601, DOI 10.3171/jns.2007.106.4.601; Shah SS, 2008, NEUROSURGERY, V62, P1095, DOI 10.1227/01.neu.0000325871.60129.23; Shamji MF, 2008, J NEUROSURG-SPINE, V9, P10, DOI 10.3171/SPI/2008/9/7/010; Shamji MF, 2009, NEUROSURGERY, V65, P490, DOI 10.1227/01.NEU.0000350863.69524.8E; Sharma M, 2014, J NEUROSURG-SPINE, V20, P125, DOI 10.3171/2013.9.SPINE13274; Sharma M, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.8.FOCUS13295; Shea AM, 2007, NEUROSURGERY, V61, P1131, DOI 10.1227/01.neu.0000306090.30517.ae; Sherrod BA, 2016, J NEUROSURG-PEDIATR, V18, P350, DOI 10.3171/2016.2.PEDS15604; Shi HY, 2014, J NEUROSURG, V121, P1323, DOI 10.3171/2014.8.JNS131526; Shi HY, 2013, J NEUROSURG, V118, P732, DOI 10.3171/2012.12.JNS12693; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Shweikeh F, 2016, J NEUROSURG-PEDIATR, V17, P27, DOI 10.3171/2015.4.PEDS14342; Shweikeh F, 2015, J NEUROSURG-PEDIATR, V15, P427, DOI 10.3171/2014.9.PEDS14241; Siddiq F, 2015, NEUROSURGERY, V77, P726, DOI 10.1227/NEU.0000000000000905; Siddiq F, 2014, WORLD NEUROSURG, V82, P678, DOI 10.1016/j.wneu.2013.07.079; Siddiq F, 2012, NEUROSURGERY, V71, P670, DOI 10.1227/NEU.0b013e318261749b; Simon SD, 2015, WORLD NEUROSURG, V83, P431, DOI 10.1016/j.wneu.2015.01.011; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Simon TD, 2010, J NEUROSURG-PEDIATR, V6, P277, DOI 10.3171/2010.5.PEDS09457; Simon TD, 2009, J NEUROS-PEDIATR, V4, P156, DOI 10.3171/2009.3.PEDS08215; Smith ER, 2006, J NEUROSURG, V105, P169, DOI 10.3171/ped.2006.105.3.169; Smith ER, 2004, NEUROSURGERY, V54, P553, DOI 10.1227/01.NEU.0000108421.69822.67; Smith ER, 2004, J NEUROSURG, V100, P90, DOI 10.3171/ped.2004.100.2.0090; Smith GA, 2011, J NEUROSURG, V114, P1768, DOI 10.3171/2011.1.JNS101528; So L, 2010, HEALTH INFORM J, V16, P101, DOI 10.1177/1460458210364784; Solheim O, 2014, J NEUROSURG, V120, P827, DOI 10.3171/2013.12.JNS131312; Solheim O, 2012, J NEUROSURG, V116, P825, DOI 10.3171/2011.12.JNS11339; Sonabend AM, 2014, J NEUROSURG, V120, P300, DOI 10.3171/2013.10.JNS13113; Sonig A, 2012, NEUROSURG FOCUS, V33, pE3, DOI DOI 10.3171/2012.7.F0CUS12193; Sonig A, 2016, J NEUROSURG, V124, P1228, DOI 10.3171/2015.4.JNS141631; Sonig A, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.5.FOCUS1269; Starke RM, 2012, NEUROSURGERY, V71, P93, DOI 10.1227/NEU.0b013e318253ab8e; Stessin AM, 2012, J NEUROSURG, V117, P669, DOI 10.3171/2012.7.JNS111439; Taylor BES, 2016, NEUROSURGERY, V79, P356, DOI 10.1227/NEU.0000000000001110; Taylor CL, 2014, NEUROSURGERY, V75, P609, DOI 10.1227/NEU.0000000000000543; Thomas AJ, 2000, J NEUROSURG, V93, P927, DOI 10.3171/jns.2000.93.6.0927; Trinh VT, 2015, J NEUROSURG, V122, P280, DOI 10.3171/2014.9.JNS131648; Tseng CH, 2015, J NEUROSURG, V123, P1528, DOI 10.3171/2014.11.JNS141269; Vadera S, 2015, NEUROSURGERY, V77, P185, DOI 10.1227/NEU.0000000000000815; Van Cleve W, 2013, NEUROSURGERY, V73, P746, DOI 10.1227/NEU.0000000000000097; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; Veeravagu A, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.3.FOCUS1669; Veeravagu A, 2015, J NEUROSURG-SPINE, V23, P374, DOI 10.3171/2014.12.SPINE14659; Veeravagu A, 2014, WORLD NEUROSURG, V82, pE235, DOI 10.1016/j.wneu.2014.02.030; Verla T, 2016, WORLD NEUROSURG, V87, P591, DOI 10.1016/j.wneu.2015.10.061; Vigneswaran HT, 2015, J NEUROSURG-PEDIATR, V16, P322, DOI 10.3171/2015.3.PEDS14649; Villelli NW, 2017, J NEUROSURG, V126, P167, DOI 10.3171/2015.7.JNS15786; Vivas AC, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11322; Washington CW, 2014, J NEUROSURG, V121, P482, DOI 10.3171/2014.4.JNS131100; Weaver KJ, 2012, NEUROSURGERY, V71, P562, DOI 10.1227/NEU.0b013e31825ea51b; Wen T, 2015, WORLD NEUROSURG, V84, P58, DOI 10.1016/j.wneu.2015.02.028; Wen T, 2014, J NEUROSURG, V121, P580, DOI 10.3171/2014.4.JNS131253; Wen T, 2014, NEUROSURGERY, V75, P43, DOI 10.1227/NEU.0000000000000352; Westwick HJ, 2015, J NEUROSURG-SPINE, V23, P368, DOI 10.3171/2014.12.SPINE14974; Wilkinson DA, 2017, J NEUROSURG-PEDIATR, V19, P208, DOI 10.3171/2016.8.PEDS16273; Williams C, 2012, J NEUROSURG-PEDIATR, V9, P524, DOI 10.3171/2012.1.PEDS11465; Williams MA, 2007, J NEUROSURG, V107, P21, DOI 10.3171/JNS-07/07/0021; Wilson D, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2014.11.FOCUS14694; Wilson TA, 2016, WORLD NEUROSURG, V91, P97, DOI 10.1016/j.wneu.2016.03.043; Winkler EA, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15613; Winkler EA, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.7.FOCUS15270; Woodworth GF, 2009, NEUROSURGERY, V65, P251, DOI 10.1227/01.NEU.0000347003.35690.7A; Wu JC, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.4.FOCUS13122; Wu JC, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10268; Wu Y, 2007, NEUROSURGERY, V61, P557, DOI 10.1227/01.NEU.0000290903.07943.AF; Yen YS, 2014, J NEUROSURG, V120, P655, DOI 10.3171/2013.10.JNS131357; Youngerman BE, 2016, J NEUROSURG, V125, P461, DOI 10.3171/2015.7.JNS142599; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612; Zacharia BE, 2017, NEUROSURGERY, V80, P73, DOI 10.1227/NEU.0000000000001270; Zacharia BE, 2014, NEUROSURGERY, V74, P638, DOI 10.1227/NEU.0000000000000342; Zada G, 2012, WORLD NEUROSURG, V77, P518, DOI 10.1016/j.wneu.2011.05.051; Zaidi HA, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.8.FOCUS14366	376	35	35	1	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	MAY	2018	82	5					728	745		10.1093/neuros/nyx328			18	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GO1FE	WOS:000439693800047	28973512	Bronze			2022-02-06	
J	Motamedi, V; Kanefsky, R; Matsangas, P; Mithani, S; Jeromin, A; Brock, MS; Mysliwiec, V; Gill, J				Motamedi, Vida; Kanefsky, Rebekah; Matsangas, Panagiotis; Mithani, Sara; Jeromin, Andreas; Brock, Matthew S.; Mysliwiec, Vincent; Gill, Jessica			Elevated tau and interleukin-6 concentrations in adults with obstructive sleep apnea	SLEEP MEDICINE			English	Article						Tau; Interleukin-6 (IL-6); Obstructive sleep apnea (OSA); Biomarkers; Neurodegeneration; Inflammation	POSITIVE AIRWAY PRESSURE; C-REACTIVE PROTEIN; ALZHEIMERS-DISEASE; AMYLOID-BETA; INTERMITTENT HYPOXIA; COGNITIVE DECLINE; DISORDERS; RISK; BIOMARKERS; DYSFUNCTION	Obstructive sleep apnea (OSA) is characterized by apneas and hypopneas that result in hypoxia, cerebral hypoperfusion, endothelial dysfunction, inflammation, and oxidative stress. These pathophysiologic processes likely contribute to neuronal damage. Tau is a protein that stabilizes microtubules and, along with amyloid beta (A beta), is associated with neurodegenerative processes. We sought to determine if tau and other biomarkers of inflammation were related to OSA severity. Concentrations of tau, A beta 40, A beta 42, c-reactive protein (CRP), TNF-alpha, interleukin (IL)-6, and IL-10 were measured in blood and compared between participants with moderate-severe OSA (n = 28), those with mild OSA (n = 22), and healthy controls (n = 24). The cohort included relatively young, primarily male active duty military personnel without a history of traumatic brain injury or neurodegenerative disease. Total biomarker concentrations were determined from plasma samples using an ultra-sensitive detection method, Simoa (TM), and CRP was assayed by ELISA. Total tau and IL-6 concentrations were elevated in participants with moderate-severe OSA, with a mean apnea-hypopnea index (AHI) of 26.1/h, compared to those with mild OSA (mean AHI 8.6/h) and healthy controls (mean AHI 2.1/h). Tau concentrations were also significantly correlated with the AHI (r = 0.342, p = 0.004). Our findings show that tau is elevated in the blood of young patients with moderate-severe OSA, suggesting that this degree of sleep-disordered breathing is a contributing factor in the development of neurodegenerative disorders. The finding of increased IL-6 further suggests that inflammatory biomarkers are present early in the course of this chronic disease. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Motamedi, Vida; Kanefsky, Rebekah; Mithani, Sara; Gill, Jessica] NINR, NIH, 1 Cloisters Dr, Bethesda, MD 20892 USA; [Matsangas, Panagiotis] Naval Postgrad Sch, Dept Operat Res, Monterey, CA USA; [Jeromin, Andreas] Quanterix, 133 Hartwell Ave, Lexington, MA 02421 USA; [Brock, Matthew S.; Mysliwiec, Vincent] San Antonio Mil Med Ctr, Dept Sleep Med, 1100 Wilford Hall Loop,Bldg 4554, Jbsa Lackland, TX 78236 USA		Gill, J (corresponding author), NINR, 1 Cloister Court,Rm 256, Bethesda, MD 20892 USA.	vida.motamedi@nih.gov; rebekah.kanefsky@nih.gov; pmatsang@nps.edu; sara.mithani@nih.gov; ajeromin@quanterix.com; Matthew.s.brock.mil@mail.mil; vincent.mysliwiec.mil@mail.mil; gillj@mail.nih.gov	Gill, Gill M/Q-2020-2017; Matsangas, Panagiotis/L-1154-2015	Matsangas, Panagiotis/0000-0002-9829-4347	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]; National Institutes of Health Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000027, ZIENR000016] Funding Source: NIH RePORTER	No author has any conflicts of interest to disclose. This work was supported by the Center for Neuroscience and Regenerative Medicine (Grant 60855) and the National Institutes of Health Intramural Research Program.	Ancoli-Israel S, 2008, J AM GERIATR SOC, V56, P2076, DOI 10.1111/j.1532-5415.2008.01934.x; Archontogeorgis K, 2014, PULM MED, V2014, DOI 10.1155/2014/930535; Arnardottir ES, 2012, SLEEP, V35, P921, DOI 10.5665/sleep.1952; Avci AY, 2017, SLEEP BREATH, V21, P703, DOI 10.1007/s11325-017-1486-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry RB, 2012, AASM MANUAL SCORING; Blennow Kaj, 2004, NeuroRx, V1, P213, DOI 10.1007/BF03206605; Bu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13917; Cardenas-Aguayo M.d.C., 2014, NEUROCHEMISTRY; Ciftci TU, 2004, CYTOKINE, V28, P87, DOI 10.1016/j.cyto.2004.07.003; Daulatzai MA, 2015, J NEUROSCI RES, V93, P1778, DOI 10.1002/jnr.23634; DELACOURTE A, 1986, J NEUROL SCI, V76, P173, DOI 10.1016/0022-510X(86)90167-X; Drager LF, 2010, BEST PRACT RES CL EN, V24, P843, DOI 10.1016/j.beem.2010.08.011; Gharibeh T, 2010, NAT SCI SLEEP, V2, P233, DOI 10.2147/NSS.S6844; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Heeschen C, 2000, J AM COLL CARDIOL, V35, P1535, DOI 10.1016/S0735-1097(00)00581-7; Iber C., 2007, AASM MANUAL SCORING, P7; Ju YE, 2017, BRAIN, V140, P2104, DOI 10.1093/brain/awx148; Kasasbeh E, 2006, SOUTH MED J, V99, P58, DOI 10.1097/01.smj.0000197705.99639.50; Kheirandish-Gozal L, 2016, SLEEP, V39, P1225, DOI 10.5665/sleep.5838; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lavie L, 2009, RESPIRATION, V78, P361, DOI 10.1159/000243552; Liguori C, 2017, SLEEP, V40; Lutsey PL, 2016, SLEEP, V39, P309, DOI 10.5665/sleep.5434; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Meston N, 2003, J INTERN MED, V254, P447, DOI 10.1046/j.1365-2796.2003.01212.x; Mielke MM, 2017, JAMA NEUROL, V74, P1073, DOI 10.1001/jamaneurol.2017.1359; Miller MA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00224; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Ooms S, 2014, JAMA NEUROL, V71, P971, DOI 10.1001/jamaneurol.2014.1173; Osorio RS, 2014, NEUROBIOL AGING, V35, P1318, DOI 10.1016/j.neurobiolaging.2013.12.030; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Rothman SM, 2013, BRAIN RES, V1529, P200, DOI 10.1016/j.brainres.2013.07.010; Schulz R, 2000, AM J RESP CRIT CARE, V162, P566, DOI 10.1164/ajrccm.162.2.9908091; Shekhar S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159099; Shiota S, 2013, J ALZHEIMERS DIS, V37, P325, DOI 10.3233/JAD-130419; Sprecher KE, 2017, NEUROLOGY, V89, P445, DOI 10.1212/WNL.0000000000004171; Su DF, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/726178; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Suzuki YJ, 2006, FREE RADICAL BIO MED, V40, P1683, DOI 10.1016/j.freeradbiomed.2006.01.008; Tam CS, 2007, SLEEP, V30, P723, DOI 10.1093/sleep/30.6.723; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thunstrom E, 2015, SLEEP, V38, P463, DOI 10.5665/sleep.4510; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Vgontzas AN, 1997, J CLIN ENDOCR METAB, V82, P1313, DOI 10.1210/jc.82.5.1313; Volpato S, 2001, CIRCULATION, V103, P947; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Yang QC, 2013, NEUROPSYCH DIS TREAT, V9, P1077, DOI 10.2147/NDT.S49868; Yaouhi K, 2009, J SLEEP RES, V18, P36, DOI 10.1111/j.1365-2869.2008.00705.x; Yokoe T, 2003, CIRCULATION, V107, P1129, DOI 10.1161/01.CIR.0000052627.99976.18	54	35	37	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	MAR	2018	43						71	76		10.1016/j.sleep.2017.11.1121			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FX3MO	WOS:000425976300014	29482817	hybrid			2022-02-06	
J	Vogelaar, CF; Mandal, S; Lerch, S; Birkner, K; Birkenstock, J; Buhler, U; Schnatz, A; Raine, CS; Bittner, S; Vogt, J; Kipnis, J; Nitsch, R; Zipp, F				Vogelaar, Christina F.; Mandal, Shibajee; Lerch, Steffen; Birkner, Katharina; Birkenstock, Jerome; Buehler, Ulrike; Schnatz, Andrea; Raine, Cedric S.; Bittner, Stefan; Vogt, Johannes; Kipnis, Jonathan; Nitsch, Robert; Zipp, Frauke			Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation	SCIENCE TRANSLATIONAL MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; T-CELLS; IN-VIVO; NOGO-A; FUNCTIONAL RECOVERY; NEURITE OUTGROWTH; AXON REGENERATION; NERVOUS-SYSTEM	Ongoing axonal degeneration is thought to underlie disability in chronic neuroinflammation, such as multiple sclerosis (MS), especially during its progressive phase. Upon inflammatory attack, axons undergo pathological swelling, which can be reversible. Because we had evidence for beneficial effects of T helper 2 lymphocytes in experimental neurotrauma and discovered interleukin-4 receptor (IL-4R) expressed on axons in MS lesions, we aimed at unraveling the effects of IL-4 on neuroinflammatory axon injury. We demonstrate that intrathecal IL-4 treatment during the chronic phase of several experimental autoimmune encephalomyelitis models reversed disease progression without affecting inflammation. Amelioration of disability was abrogated upon neuronal deletion of IL-4R. We discovered direct neuronal signaling via the IRS1-PI3K-PKC pathway underlying cytoskeletal remodeling and axonal repair. Nasal IL-4 application, suitable for clinical translation, was equally effective in improving clinical outcome. Targeting neuronal IL-4 signaling may offer new therapeutic strategies to halt disability progression in MS and possibly also neurodegenerative conditions.	[Vogelaar, Christina F.; Mandal, Shibajee; Lerch, Steffen; Birkner, Katharina; Birkenstock, Jerome; Buehler, Ulrike; Bittner, Stefan; Zipp, Frauke] Johannes Gutenberg Univ Mainz, Dept Neurol, Focus Program Translat Neurosci FTN, Univ Med Ctr, D-55131 Mainz, Germany; [Vogelaar, Christina F.; Mandal, Shibajee; Lerch, Steffen; Birkner, Katharina; Birkenstock, Jerome; Buehler, Ulrike; Bittner, Stefan; Zipp, Frauke] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Rhine Main Neurosci Network Rmn2, D-55131 Mainz, Germany; [Schnatz, Andrea; Vogt, Johannes] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Rhine Main Neurosci Network Rmn2, Inst Microanat & Neurobiol,Focus Program Translat, D-55131 Mainz, Germany; [Raine, Cedric S.] Albert Einstein Coll Med, Dept Pathol, Neuropathol, Bronx, NY 10461 USA; [Kipnis, Jonathan] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Gutenberg Res Fellowship Grp Neuroimmunol, Focus Program Translat Neurosci FTN, D-55131 Mainz, Germany; [Kipnis, Jonathan] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Rhine Main Neurosci Network Rmn2, D-55131 Mainz, Germany; [Kipnis, Jonathan] Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia, Charlottesville, VA 22908 USA; [Nitsch, Robert] Westfal Wilhelms Univ Munster, Univ Med Ctr, Inst Translat Neurosci, Albert Schweitzer Campus, D-48149 Munster, Germany		Zipp, F (corresponding author), Johannes Gutenberg Univ Mainz, Dept Neurol, Focus Program Translat Neurosci FTN, Univ Med Ctr, D-55131 Mainz, Germany.; Zipp, F (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Res Ctr Immunotherapy FZI, Rhine Main Neurosci Network Rmn2, D-55131 Mainz, Germany.	frauke.zipp@unimedizin-mainz.de	Nitsch, Robert/AAI-9129-2021; Vogt, Johannes/O-4289-2019; Vogelaar, Christina Francisca/AAA-8484-2021; Zipp, Frauke/C-9968-2015; Vogt, Johannes/K-2278-2015	Vogelaar, Christina Francisca/0000-0002-9683-7336; Zipp, Frauke/0000-0002-1231-1928; Bittner, Stefan/0000-0003-2179-3655; Schnatz, Andrea/0000-0003-4855-8663; MANDAL, SHIBAJEE/0000-0002-6112-6972; Birkenstock, Jerome/0000-0002-3418-9847; Vogt, Johannes/0000-0003-2439-8247	German Research Foundation (DFG)German Research Foundation (DFG) [CRC 1080, CRC-TR-128]; Progressive MS Alliance [PA-1604-08492]; NIH/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS096967]	This work was supported by the German Research Foundation (DFG; CRC 1080 to J.K. and F.Z. and CRC-TR-128 to F.Z.), Progressive MS Alliance (PA-1604-08492, BRAVEinMS to F.Z.), and NIH/National Institute of Neurological Disorders and Stroke (NS096967 to J.K.).	2004 Allen Institute for Brain Science, 2004, ALL MOUS BRAIN ATL; Arrant AE, 2017, BRAIN, V140, P1447, DOI 10.1093/brain/awx060; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Blair LAC, 1997, NEURON, V19, P421, DOI 10.1016/S0896-6273(00)80950-2; Broberg EK, 2004, NEUROSCI LETT, V364, P173, DOI 10.1016/j.neulet.2004.04.059; Butti E, 2008, GENE THER, V15, P504, DOI 10.1038/gt.2008.10; Carlton SM, 2002, J COMP NEUROL, V448, P102, DOI 10.1002/cne.10250; Carter LM, 2008, J NEUROSCI, V28, P14107, DOI 10.1523/JNEUROSCI.2217-08.2008; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Cummings BS, 2004, CURR PROTOC PHARM, V12, P12, DOI DOI 10.1002/04711; DeLuca GC, 2004, BRAIN, V127, P1009, DOI 10.1093/brain/awh118; Ellwardt E, 2016, TRENDS IMMUNOL, V37, P154, DOI 10.1016/j.it.2015.12.008; Ferreira R, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00153; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Franklin RJM, 2012, NAT REV NEUROL, V8, P624, DOI 10.1038/nrneurol.2012.200; Freeley M, 2011, CELL SIGNAL, V23, P753, DOI 10.1016/j.cellsig.2010.10.013; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hasan M, 2016, NEUROSCIENCE, V319, P168, DOI 10.1016/j.neuroscience.2016.01.045; Heller N., 2012, ALLERGIC DIS HIGHLIG, P43; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Holahan MR, 2015, RES REP BIOCHEM, V5, P137, DOI 10.2147/RRBC.S73846; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Huebner EA, 2011, J BIOL CHEM, V286, P18026, DOI 10.1074/jbc.M110.208108; Inobe J, 1996, ANN NY ACAD SCI, V778, P390, DOI 10.1111/j.1749-6632.1996.tb21153.x; Keating P, 2009, IMMUNOL CELL BIOL, V87, P534, DOI 10.1038/icb.2009.37; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Kurland DB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0599-2; Lang DM, 2017, J COMP NEUROL, V525, P936, DOI 10.1002/cne.24112; Larochelle C, 2016, TRENDS NEUROSCI, V39, P325, DOI 10.1016/j.tins.2016.02.001; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Liu XB, 2012, EPILEPSIA, V53, P45, DOI 10.1111/j.1528-1167.2012.03474.x; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Lu Ruirui, 2013, Methods Mol Biol, V1020, P215, DOI 10.1007/978-1-62703-459-3_14; Metz I, 2007, BRAIN, V130, P1254, DOI 10.1093/brain/awl370; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Nicholson-Fish JC, 2016, NEUROCHEM RES, V41, P534, DOI 10.1007/s11064-015-1663-5; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Paolillo A, 1999, NEUROLOGY, V53, P751, DOI 10.1212/WNL.53.4.751; Paterka M, 2017, J AUTOIMMUN, V76, P108, DOI 10.1016/j.jaut.2016.09.008; Payne NL, 2012, CELL ADHES MIGR, V6, P179, DOI 10.4161/cam.20341; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; Rommer PS, 2014, CLIN EXP IMMUNOL, V175, P397, DOI 10.1111/cei.12206; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Steward O, 2004, J COMP NEUROL, V472, P463, DOI 10.1002/cne.20090; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Walsh JT, 2015, J CLIN INVEST, V125, P699, DOI [10.1172/JCI176210, 10.1172/JCI76210]; Wang XJ, 2013, BRAIN RES, V1518, P9, DOI 10.1016/j.brainres.2013.04.042; Williams PR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6683; Wright KT, 2007, BIOCHEM BIOPH RES CO, V354, P559, DOI 10.1016/j.bbrc.2007.01.013; Xiao C, 2013, J ALZHEIMERS DIS, V35, P777, DOI 10.3233/JAD-122419; Zipp F, 2013, JAMA NEUROL, V70, P1569, DOI 10.1001/jamaneurol.2013.4391	59	35	35	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	1946-6234	1946-6242		SCI TRANSL MED	Sci. Transl. Med.	FEB 28	2018	10	430							eaao2304	10.1126/scitranslmed.aao2304			12	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	FX7SS	WOS:000426291800002	29491183				2022-02-06	
J	Broussard, JI; Acion, L; De Jesus-Cortes, H; Yin, T; Britt, JK; Salas, R; Costa-Mattioli, M; Robertson, C; Pieper, AA; Arciniegas, DB; Jorge, R				Broussard, John I.; Acion, Laura; De Jesus-Cortes, Hector; Yin, Terry; Britt, Jeremiah K.; Salas, Ramiro; Costa-Mattioli, Mauro; Robertson, Claudia; Pieper, Andrew A.; Arciniegas, David B.; Jorge, Ricardo			Repeated mild traumatic brain injury produces neuroinflammation, anxiety-like behaviour and impaired spatial memory in mice	BRAIN INJURY			English	Article						Animal model; mild traumatic brain injury; spatial memory; anxiety; chronic traumatic encephalopathy	FLUID PERCUSSION INJURY; MOUSE MODEL; SYNAPTIC PLASTICITY; AXONAL INJURY; ANIMAL-MODEL; RAT MODEL; ENCEPHALOPATHY; IMPAIRMENTS; CONCUSSION; DEPRESSION	Primary Objective: Repeated traumatic brain injuries (rmTBI) are frequently associated with debilitating neuropsychiatric conditions such as cognitive impairment, mood disorders, and post-traumatic stress disorder. We tested the hypothesis that repeated mild traumatic brain injury impairs spatial memory and enhances anxiety-like behaviour. Research Design: We used a between groups design using single (smTBI) or repeated (rmTBI) controlled cranial closed skull impacts to mice, compared to a control group. Methods and Procedures: We assessed the effects of smTBI and rmTBI using measures of motor performance (Rotarod Test [RT]), anxiety-like behaviour (Elevated Plus Maze [EPM] and Open Field [OF] tests), and spatial memory (Morris Water Maze [MWM]) within 12 days of the final injury. In separate groups of mice, astrocytosis and microglial activation were assessed 24 hours after the final injury using GFAP and IBA-1 immunohistochemistry. Main Outcomes and Results: RmTBI impaired spatial memory in the MWM and increased anxiety-like behaviour in the EPM and OFT. In addition, rmTBI elevated GFAP and IBA-1 immunohistochemistry throughout the mouse brain. RmTBI produced astrocytosis and microglial activation, and elicited impaired spatial memory and anxiety-like behaviour. Conclusions: rmTBI produces acute cognitive and anxiety-like disturbances associated with inflammatory changes in brain regions involved in spatial memory and anxiety.	[Broussard, John I.; Acion, Laura; Salas, Ramiro; Arciniegas, David B.; Jorge, Ricardo] Baylor Coll Med, Beth K & Stuart C Yudofsky Div Neuropsychiat, Houston, TX 77030 USA; [Acion, Laura] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Calculo, CONICET, Buenos Aires, DF, Argentina; [De Jesus-Cortes, Hector; Yin, Terry; Britt, Jeremiah K.; Pieper, Andrew A.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Salas, Ramiro; Jorge, Ricardo] Michael E DeBakey VA Med Ctr, Dept Vet Affairs, Houston, TX USA; [Costa-Mattioli, Mauro] Univ Iowa, Free Radical & Radiat Biol Program, Dept Radiat Oncol, Holden Comprehens Canc Ctr, Iowa City, IA USA; [Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Pieper, Andrew A.] Univ Iowa, Neurol, Iowa City, IA USA; [Pieper, Andrew A.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Pieper, Andrew A.] Univ Iowa, Carver Coll Med, Dept Vet Affairs, Iowa City, IA USA; [Pieper, Andrew A.] Weill Cornell Med Coll, Cornell Autism Res Program, New York, NY USA		Jorge, R (corresponding author), 2002 Holcombe Blvd 2b-122, Houston, TX 77030 USA.	Ricardo.Jorge@bcm.edu	De Jesus-Cortes, Hector/ABC-9091-2020; Salas, Ramiro/A-9602-2015	De Jesus-Cortes, Hector/0000-0001-6983-6963; Broussard, John/0000-0001-7778-1747; Pieper, Andrew/0000-0001-6299-6577; Acion, Laura/0000-0001-5213-6012	Brain Injury Medicine Program; Beth K and Stuart C Yudofsky Division of Neuropsychiatry, Baylor College of Medicine; BCM IDDRC [U54HD083092]; University of Iowa Carver College of Medicine; Michael E DeBakey VA Medical Center	This work was supported by the Brain Injury Medicine Program; Beth K and Stuart C Yudofsky Division of Neuropsychiatry, Baylor College of Medicine [N/A]; BCM IDDRC [U54HD083092]; Brain Injury Medicine program; Beth K and Stuart C Yudofsky Division of Neuropsychiatry, Baylor College of Medicine [N/A]; Unrestricted funds to AAP from the University of Iowa Carver College of Medicine [N/A]; Anonymous donor to the Mary Alice Smith Fund for Neuropsychiatry Research to A.A.P. [N/A]; Michael E DeBakey VA Medical Center.	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Avale ME, 2008, P NATL ACAD SCI USA, V105, P15991, DOI 10.1073/pnas.0807635105; Bailey KR, 2009, METHODS BEHAV ANAL M, V2; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Broussard JI, 2016, CELL REP, V14, P1930, DOI 10.1016/j.celrep.2016.01.070; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McNamara CG, 2014, NAT NEUROSCI, V17, P1658, DOI 10.1038/nn.3843; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Salas R, 2008, MOL PHARMACOL, V74, P1641, DOI 10.1124/mol.108.048454; Salas R, 2007, NEUROPHARMACOLOGY, V53, P863, DOI 10.1016/j.neuropharm.2007.08.017; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Small KM, 2016, NEUROSCI LETT, V616, P80, DOI 10.1016/j.neulet.2016.01.057; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; WELKER WI, 1957, PSYCHOL REP, V3, P95, DOI 10.2466/pr0.1957.3.g.95; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Yang KC, 2017, EUR J NEUROSCI, V45, P138, DOI 10.1111/ejn.13406	44	35	36	4	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	1					113	122		10.1080/02699052.2017.1380228			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7VS	WOS:000427072300013	29156991				2022-02-06	
S	McKee, AC; Abdolmohammadi, B; Stein, TD		Hainline, B; Stern, RA		McKee, Ann C.; Abdolmohammadi, Bobak; Stein, Thor D.			The neuropathology of chronic traumatic encephalopathy	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							BRAIN-INJURY; DEMENTIA-PUGILISTICA; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; TAU PATHOLOGY; PUNCH-DRUNK; HEAD-INJURY; CONSENSUS; CRITERIA; PHOSPHORYLATION	Chronic traumatic encephalopathy (CTE) is a neurodegenerative tauopathy associated with repetitive head trauma, including concussion and subconcussion. CTE was first recognized in boxers nearly a century ago as "dementia pugilistica" or "punch drunk," but has been recently identified in contact sports athletes (including American football, ice hockey, soccer, baseball, rugby, boxing, and wrestling) and military veterans exposed to blast. Similar to many other neurodegenerative diseases, CTE is diagnosed conclusively only by neuropathologic examination of brain tissue. CTE is characterized by the buildup of hyperphosphorylated tau as neurofibrillary tangles, abnormal neurites, and inclusions in astrocytes around small blood vessels with a tendency to occur in clusters at the sulcal depths of the cortex. Using the McKee criteria, a consensus panel of expert neuropathologists confirmed CTE as a unique neurodegenerative disease with a pathognomonic CTE lesion that has only been found in individuals exposed to brain trauma. Recently, 177 instances of CTE were reported in a convenience sample of 202 former American football players, including 110 of 111 former National Football League players (99%), 48 of 53 former college football players (91%), and 3 of 14 former high school players (21%), by far the largest case series ever reported. Significant increases in active microglia and inflammation also occur after repetitive head impact injury and in CTE. A preliminary study showed that inflammatory cytokines were elevated in the brain tissue and cerebrospinal fluid of individuals with pathologically confirmed CTE compared to controls and individuals with Alzheimer disease, which may some day be useful in diagnosis of CTE during life. Although many fundamental questions remain to be answered regarding CTE, postmortem analysis of tissue from brain donors and tissue-based research have accelerated and expanded our current understanding of CTE and its pathogenesis. Guided by the neuropathologic findings, current research efforts are underway to develop biomarkers to diagnose CTE and effective ways to treat the disorder during life.	[McKee, Ann C.; Stein, Thor D.] VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA; [McKee, Ann C.; Abdolmohammadi, Bobak; Stein, Thor D.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [McKee, Ann C.; Abdolmohammadi, Bobak; Stein, Thor D.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [McKee, Ann C.; Abdolmohammadi, Bobak; Stein, Thor D.] Boston Univ, CTE Ctr, Boston, MA 02215 USA		McKee, AC (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA.	amckee@bu.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146			Armstrong RA, 2017, OPTOMETRY VISION SCI, V94, P33, DOI 10.1097/OPX.0000000000000911; Bieniek K, 2014, BRAIN PATHOL, V84; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cherry JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185079; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Critchley M, 1949, PUNCH DRUNK SYNDROME; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jordan B, 1992, MED ASPECTS BOXING; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Mufson EJ, 2018, J NEUROTRAUM, V35, P1260, DOI 10.1089/neu.2017.5368; Mufson EJ, 2016, BRAIN INJURY, V30, P1399, DOI 10.1080/02699052.2016.1219058; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Thal Dietmar R, 2006, Sci Aging Knowledge Environ, V2006, pre1, DOI 10.1126/sageke.2006.6.re1; Williams DJ, 1996, PATHOLOGY, V28, P102, DOI 10.1080/00313029600169653; Woerman AL, 2016, P NATL ACAD SCI USA, V113, pE8187, DOI 10.1073/pnas.1616344113; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	56	35	35	3	8	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						297	307		10.1016/B978-0-444-63954-7.00028-8			11	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100030	30482357				2022-02-06	
J	Tal, S; Hadanny, A; Sasson, E; Suzin, G; Efrati, S				Tal, Sigal; Hadanny, Amir; Sasson, Efrat; Suzin, Gil; Efrati, Shai			Hyperbaric Oxygen Therapy Can Induce Angiogenesis and Regeneration of Nerve Fibers in Traumatic Brain Injury Patients	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						hyperbaric oxygen; DTI; tractography; angiogenesis; MRI; perfusion; TBI; post-concussion	POST-CONCUSSION SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; HIGH-RESOLUTION MEASUREMENT; WHITE-MATTER INTEGRITY; TRACER BOLUS PASSAGES; HEAD-INJURIES; CEREBRAL-ISCHEMIA; UNITED-STATES; VISUAL MEMORY; MILD	Background: Recent clinical studies in stroke and traumatic brain injury (TBI) victims suffering chronic neurological injury present evidence that hyperbaric oxygen therapy (HBOT) can induce neuroplasticity. Objective: To assess the neurotherapeutic effect of HBOT on prolonged post-concussion syndrome (PPCS) due to TBI, using brain microstructure imaging. Methods: Fifteen patients afflicted with PPCS were treated with 60 daily HBOT sessions. Imaging evaluation was performed using Dynamic Susceptibility Contrast-Enhanced (DSC) and Diffusion Tensor Imaging (DTI) MR sequences. Cognitive evaluation was performed by an objective computerized battery (NeuroTrax). Results: HBOT was initiated 6 months to 27 years (10.3 +/- 3.2 years) from injury. After HBOT, DTI analysis showed significantly increased fractional anisotropy values and decreased mean diffusivity in both white and gray matter structures. In addition, the cerebral blood flow and volume were increased significantly. Clinically, HBOT induced significant improvement in the memory, executive functions, information processing speed and global cognitive scores. Conclusions: The mechanisms by which HBOT induces brain neuroplasticity can be demonstrated by highly sensitive MRI techniques of DSC and DTI. HBOT can induce cerebral angiogenesis and improve both white and gray microstructures indicating regeneration of nerve fibers. The micro structural changes correlate with the neurocognitive improvements.	[Tal, Sigal; Hadanny, Amir; Efrati, Shai] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Tal, Sigal] Assaf Harofeh Med Ctr, Radiol Dept, Zerifin, Israel; [Hadanny, Amir; Suzin, Gil; Efrati, Shai] Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel; [Hadanny, Amir] Bar Ilan Univ, Fac Med, Ramat Gan, Israel; [Sasson, Efrat] WiseImage, Hod Hasharon, Israel; [Efrati, Shai] Assaf Harofeh Med Ctr, Res & Dev Unit, Zerifin, Israel; [Efrati, Shai] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel		Hadanny, A; Efrati, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Hadanny, A; Efrati, S (corresponding author), Assaf Harofeh Med Ctr, Sagol Ctr Hyperbar Med & Res, Zerifin, Israel.; Hadanny, A (corresponding author), Bar Ilan Univ, Fac Med, Ramat Gan, Israel.; Efrati, S (corresponding author), Assaf Harofeh Med Ctr, Res & Dev Unit, Zerifin, Israel.; Efrati, S (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.	amir.had@gmail.com; efratishai@013.net					Achiron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071058; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; BAUER RM, 1984, J CLIN NEURO-OPHTHAL, V4, P39; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Bucur B, 2008, NEUROBIOL AGING, V29, P1070, DOI 10.1016/j.neurobiolaging.2007.02.008; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen ZQ, 2010, J MAGN RESON IMAGING, V31, P1054, DOI 10.1002/jmri.22142; CHIU WT, 1993, J TRAUMA, V35, P969, DOI 10.1097/00005373-199312000-00034; Doniger GM, 2014, GUIDE NORMATIVE DATA; Duan SS, 2015, INT J NEUROSCI, V125, P625, DOI 10.3109/00207454.2014.956101; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Efrati S, 2014, EXPERT REV NEUROTHER, V14, P233, DOI 10.1586/14737175.2014.884928; Efrati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053716; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Hadanny A, 2016, EXPERT REV NEUROTHER, V16, P875, DOI 10.1080/14737175.2016.1205487; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Heilman K M, 1970, Trans Am Neurol Assoc, V95, P259; Hu Q, 2014, STROKE, V45, P1807, DOI 10.1161/STROKEAHA.114.005116; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jiang Q, 2005, NEUROIMAGE, V28, P698, DOI 10.1016/j.neuroimage.2005.06.063; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lee YS, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/512978; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Li L, 2016, CHINESE MED J-PEKING, V129, P1091, DOI 10.4103/0366-6999.180518; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lockhart SN, 2014, NEUROPSYCHOL REV, V24, P271, DOI 10.1007/s11065-014-9268-3; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Melton JL, 2005, PSYCHOMETRIC EVALUAT; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mu J, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-14; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Neubauer RA, 1998, NEUROL RES, V20, pS33; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Ostergaard L, 1996, MAGNET RESON MED, V36, P726, DOI 10.1002/mrm.1910360511; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Peng ZR, 2014, J NEUROL SCI, V342, P114, DOI 10.1016/j.jns.2014.04.037; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Rocha FT, 2005, COGNITIVE BRAIN RES, V22, P359, DOI 10.1016/j.cogbrainres.2004.09.008; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Sasson E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00032; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Sepulcre J, 2009, NEUROIMAGE, V47, P773, DOI 10.1016/j.neuroimage.2009.04.054; Shi XY, 2006, CHINESE MED J-PEKING, V119, P1978, DOI 10.1097/00029330-200612010-00007; Shi Xiao-yan, 2003, Chin J Traumatol, V6, P346; Shinoura N, 2007, NEUROCASE, V13, P127, DOI 10.1080/13554790701399254; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Simon ES., 2003, ACTA NEUROPSYCHOLOGI, V1, P407, DOI DOI 10.5604/17307503/9168; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; Tal S, 2015, RESTOR NEUROL NEUROS, V33, P943, DOI 10.3233/RNN-150585; Thaler A, 2012, NEUROLOGY, V79, P1027, DOI 10.1212/WNL.0b013e3182684646; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wright JK, 2009, UNDERSEA HYPERBAR M, V36, P391; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003; Zur D, 2015, J NEURO-OPHTHALMOL, V35, P26, DOI 10.1097/WNO.0000000000000199	80	35	40	0	15	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	OCT 19	2017	11								508	10.3389/fnhum.2017.00508			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FK1LQ	WOS:000413243300001	29097988	gold, Green Published			2022-02-06	
J	Esnault, P; Nguyen, C; Bordes, J; D'Aranda, E; Montcriol, A; Contargyris, C; Cotte, J; Goutorbe, P; Joubert, C; Dagain, A; Boret, H; Meaudre, E				Esnault, Pierre; Nguyen, Cedric; Bordes, Julien; D'Aranda, Erwan; Montcriol, Ambroise; Contargyris, Claire; Cotte, Jean; Goutorbe, Philippe; Joubert, Christophe; Dagain, Arnaud; Boret, Henry; Meaudre, Eric			Early-Onset Ventilator-Associated Pneumonia in Patients with Severe Traumatic Brain Injury: Incidence, Risk Factors, and Consequences in Cerebral Oxygenation and Outcome	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Ventilator; associated pneumonia; Risk factors; Incidence; Cerebral oxygenation; PbtO(2); Outcome	PULMONARY INFECTION SCORE; SUBARACHNOID HEMORRHAGE; ACQUIRED PNEUMONIA; PRACTICAL SCALE; PREVENTION; MANAGEMENT; DIAGNOSIS; BACTERIA; HYPOXIA; RATS	Early-onset ventilator-associated pneumonia (EOVAP) occurs frequently in severe traumatic brain-injured patients, but potential consequences on cerebral oxygenation and outcome have been poorly studied. The objective of this study was to describe the incidence, risk factors for, and consequences on cerebral oxygenation and outcome of EOVAP after severe traumatic brain injury (TBI). We conducted a retrospective, observational study including all intubated TBI admitted in the trauma center. An EOVAP was defined as a clinical pulmonary infection score > 6, and then confirmed by an invasive method. Patient characteristics, computed tomography (CT) scan results, and outcome were extracted from a prospective register of all intubated TBI admitted in the intensive care unit (ICU). Data concerning the cerebral oxygenation monitoring by PbtO(2) and characteristics of EOVAP were retrieved from patient files. Multivariate logistic regression models were developed to determine the risk factors of EOVAP and to describe the factors independently associated with poor outcome at 1-year follow-up. During 7 years, 175 patients with severe TBI were included. The overall incidence of EOVAP was 60.6% (47.4/1000 days of ventilation). Significant risk factors of EOVAP were: therapeutic hypothermia (OR 3.4; 95% CI [1.2-10.0]), thoracic AIS score ae<yen>3 (OR 2.4; 95% CI [1.1-5.7]), and gastric aspiration (OR 5.2, 95% CI [1.7-15.9]). Prophylactic antibiotics administration was a protective factor against EOVAP (OR 0.3, 95% CI [0.1-0.8]). EOVAP had negative consequences on cerebral oxygenation. The PbtO(2) was lower during EOVAP: 23.5 versus 26.4 mmHg (p < 0.0001), and there were more brain hypoxia episodes: 32 versus 27% (p = 0.03). Finally, after adjusting for confounders, an EOVAP was an independent factor associated with unfavorable neurologic functional outcome at the 1-year follow-up (OR 2.71; 95% CI [1.01-7.25]). EOVAP is frequent after a severe TBI (overall rate: 61%), with therapeutic hypothermia, severe thoracic lesion, and gastric aspiration as main risk factors. EOVAP had a negative impact on cerebral oxygenation measured by PbtO(2) and was independently associated with unfavorable outcome at 1-year follow-up. This suggests that all precautions available should be taken to prevent EOVAP in this population.	[Esnault, Pierre; Nguyen, Cedric; Bordes, Julien; D'Aranda, Erwan; Montcriol, Ambroise; Contargyris, Claire; Cotte, Jean; Goutorbe, Philippe; Boret, Henry; Meaudre, Eric] St Anne Mil Hosp, Intens Care Unit, Toulon, France; [Joubert, Christophe; Dagain, Arnaud] St Anne Mil Hosp, Dept Neurosurg, Toulon, France; [Dagain, Arnaud; Meaudre, Eric] Ecole Val de Grace, French Mil Hlth Serv, Acad Unit, Paris, France		Esnault, P (corresponding author), St Anne Mil Hosp, Intens Care Unit, Toulon, France.	pierre.esnault@gmail.com; ced040@hotmail.fr; bordes.julien@neuf.fr; erwanm3d@gmail.com; ambroise.montcriol@free.fr; contargyris@hotmail.com; jean.cotte@gmail.com; goutorbephil@live.fr; christophe.joubert@neurochirurgie.fr; dr.adagain@gmail.com; henryboret@me.com; eric.meaudre@club-internet.fr	Esnault, Pierre/AAN-5792-2020; Joubert, Christophe/AAU-4807-2020				Acquarolo A, 2005, INTENS CARE MED, V31, P510, DOI 10.1007/s00134-005-2585-5; Alali AS, 2015, VALUE HEALTH, V18, P721, DOI 10.1016/j.jval.2015.04.012; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388; ANTONELLI M, 1994, CHEST, V105, P224, DOI 10.1378/chest.105.1.224; Bao L, 2014, PLOS ONE, V13; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Browne E, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000066; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Cinotti R, 2014, EUR J CLIN MICROBIOL, V33, P823, DOI 10.1007/s10096-013-2020-8; Cotte J, 2013, BURNS, V39, P892, DOI 10.1016/j.burns.2012.12.003; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Damas P, 2015, CRIT CARE MED, V43, P22, DOI 10.1097/CCM.0000000000000674; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Fartoukh M, 2003, AM J RESP CRIT CARE, V168, P173, DOI 10.1164/rccm.200212-1449OC; Giantsou E, 2005, INTENS CARE MED, V31, P1488, DOI 10.1007/s00134-005-2697-y; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; JENNETT B, 1975, LANCET, V1, P480; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Manoel ALD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1193-9; Michelet P, 2010, J TRAUMA, V68, P395, DOI 10.1097/TA.0b013e3181a601cb; Monton C, 1999, CRIT CARE MED, V27, P1745, DOI 10.1097/00003246-199909000-00008; Muscedere J, 2008, J CRIT CARE, V23, P138, DOI 10.1016/j.jcrc.2007.12.008; O'Phelan Kristine H, 2015, World J Crit Care Med, V4, P296, DOI 10.5492/wjccm.v4.i4.296; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Park David R, 2005, Respir Care, V50, P742; Pelosi P, 2008, CHEST, V134, P101, DOI 10.1378/chest.07-2546; Perbet S, 2011, AM J RESP CRIT CARE, V184, P1048, DOI 10.1164/rccm.201102-0331OC; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; Shan J, 2011, RESP CARE, V56, P1087, DOI 10.4187/respcare.01097; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; TEASDALE G, 1974, LANCET, V2, P81; Trouillet JL, 1998, AM J RESP CRIT CARE, V157, P531, DOI 10.1164/ajrccm.157.2.9705064; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	41	35	41	1	10	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2017	27	2					187	198		10.1007/s12028-017-0397-4			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FJ4VC	WOS:000412739900006	28432539				2022-02-06	
J	Brabazon, F; Wilson, CM; Jaiswal, S; Reed, J; Frey, WH; Byrnes, KR				Brabazon, Fiona; Wilson, Colin M.; Jaiswal, Shalini; Reed, John; Frey, William H., II; Byrnes, Kimberly R.			Intranasal insulin treatment of an experimental model of moderate traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Glucose uptake; intranasal insulin; microglia; positron emission tomography; traumatic brain injury	MORRIS WATER MAZE; CONTROLLED CORTICAL IMPACT; MEMORY DYSFUNCTION; GLUCOSE-UPTAKE; COMBINED MICRODIALYSIS; MICROGLIAL ACTIVATION; EMISSION-TOMOGRAPHY; SPINAL-CORD; (18)FDG PET; RAT-BRAIN	Traumatic brain injury (TBI) results in learning and memory dysfunction. Cognitive deficits result from cellular and metabolic dysfunction after injury, including decreased cerebral glucose uptake and inflammation. This study assessed the ability of intranasal insulin to increase cerebral glucose uptake after injury, reduce lesion volume, improve memory and learning function and reduce inflammation. Adult male rats received a controlled cortical impact (CCI) injury followed by intranasal insulin or saline treatment daily for 14 days. PET imaging of [F-18]-FDG uptake was performed at baseline and at 48 h and 10 days post-injury and MRI on days three and nine post injury. Motor function was tested with the beam walking test. Memory function was assessed with Morris water maze. Intranasal insulin after CCI significantly improved several outcomes compared to saline. Insulin-treated animals performed better on beam walk and demonstrated significantly improved memory. A significant increase in [F-18]-FDG uptake was observed in the hippocampus. Intranasal insulin also resulted in a significant decrease in hippocampus lesion volume and significantly less microglial immunolabeling in the hippocampus. These data show that intranasal insulin improves memory, increases cerebral glucose uptake and decreases neuroinflammation and hippocampal lesion volume, and may therefore be a viable therapy for TBI.	[Brabazon, Fiona; Reed, John; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Neurosci Program, Bethesda, MD 20814 USA; [Wilson, Colin M.; Jaiswal, Shalini] Uniformed Serv Univ Hlth Sci, Dept Radiol, Bethesda, MD 20814 USA; [Wilson, Colin M.; Jaiswal, Shalini; Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Frey, William H., II] Hlth Partners Neurosci Res, St Paul, MN USA; [Byrnes, Kimberly R.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		Byrnes, KR (corresponding author), Dept Anat Physiol & Genet, Room C2115,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	kimberly.byrnes@usuhs.edu		Brabazon, Fiona/0000-0003-1642-808X	Cosmos Club Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS073667-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073667] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Cosmos Club Foundation and NIH grant number 1R01NS073667-01A1.	Apostolatos A, 2012, J BIOL CHEM, V287, P9299, DOI 10.1074/jbc.M111.313080; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Berg J.M, 2002, BIOCHEMISTRY-US; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Cashion MF, 1996, HORM BEHAV, V30, P280, DOI 10.1006/hbeh.1996.0034; Chen YX, 2014, EXP NEUROL, V261, P610, DOI 10.1016/j.expneurol.2014.06.004; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chiu SL, 2008, NEURON, V58, P708, DOI 10.1016/j.neuron.2008.04.014; Cooney SJ, 2014, FREE RADICAL RES, V48, P929, DOI 10.3109/10715762.2014.927578; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dhuria SV, J PHARM SCI, V99, P1654; Dineley KT, 2014, NEUROBIOL DIS, V72, P92, DOI 10.1016/j.nbd.2014.09.001; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Duarte Ana I, 2012, J Aging Res, V2012, P384017, DOI 10.1155/2012/384017; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Gallagher M, 2015, BEHAV NEUROSCI, V129, P540, DOI 10.1037/bne0000080; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Jauch-Chara K, 2012, DIABETES, V61, P2261, DOI 10.2337/db12-0025; LEMAY DR, 1988, STROKE, V19, P1411, DOI 10.1161/01.STR.19.11.1411; Li J, 2012, J NEUROTRAUM, V29, P2635, DOI 10.1089/neu.2012.2411; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lochhead JJ, 2015, J CEREBR BLOOD F MET, V35, P371, DOI 10.1038/jcbfm.2014.215; Maimaiti S, 2016, J GERONTOL A-BIOL, V71, P30, DOI 10.1093/gerona/glu314; Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014; MARKS JL, 1990, ENDOCRINOLOGY, V127, P3234, DOI 10.1210/endo-127-6-3234; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; OLDENDORF WH, 1971, AM J PHYSIOL, V221, P1629, DOI 10.1152/ajplegacy.1971.221.6.1629; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Renner DB, 2012, J PHARM PHARMACOL, V64, P1709, DOI 10.1111/j.2042-7158.2012.01555.x; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schulingkamp RJ, 2000, NEUROSCI BIOBEHAV R, V24, P855, DOI 10.1016/S0149-7634(00)00040-3; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Selwyn RG, 2016, J NEUROTRAUM, V33, P1479, DOI 10.1089/neu.2015.4129; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Song JP, 2015, TRANSL STROKE RES, V6, P290, DOI 10.1007/s12975-015-0396-8; Spielman LJ, 2015, CURR ALZHEIMER RES, V12, P684, DOI 10.2174/1567205012666150710104428; Sun MY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11445; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Uemura E, 2006, EXP NEUROL, V198, P48, DOI 10.1016/j.expneurol.2005.10.035; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	54	35	35	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	2017	37	9					3203	3218		10.1177/0271678X16685106			16	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	FF2EV	WOS:000408711600012	28058996	Bronze, Green Published			2022-02-06	
J	Viglione, DJ; Giromini, L; Landis, P				Viglione, Donald J.; Giromini, Luciano; Landis, Patricia			The Development of the Inventory of Problems-29: A Brief Self-Administered Measure for Discriminating Bona Fide From Feigned Psychiatric and Cognitive Complaints	JOURNAL OF PERSONALITY ASSESSMENT			English	Article							PERSONALITY-ASSESSMENT INVENTORY; MMPI-2; VALIDATION; PATTERNS; PSYCHOPATHOLOGY; SCALE; SIMS; PAI	This article describes the development of the Inventory of Problems-29 (IOP-29), a new, short, paper-and-pencil, self-administered measure of feigned mental and cognitive disorders. Four clinical comparison simulation studies were conducted. Study 1 (n = 451) selected the items and produced an index of potential feigning. Study 2 (n = 331) scaled this index to produce a probability score, and examined its psychometric properties. Study 3 tested the generalizability of Study 2's findings with 2 additional samples (ns = 128 and 90). Results supported the utility of the IOP-29 for discriminating bona fide from feigned psychiatric and cognitive complaints. Validity was demonstrated in feigning mild traumatic brain injury, psychosis, posttraumatic stress disorder, and depression. Within the independent samples of Studies 2 and 3, the brief IOP-29 performed similarly to the MMPI-2 and Personality Assessment Inventory, and perhaps better than the Test of Memory Malingering. Classifications within these samples with base rates of .5 produced sensitivity, specificity, positive predictive power, and negative predictive power statistics of about .80. Further research is needed testing the IOP-29 in ecologically valid field studies.	[Viglione, Donald J.; Landis, Patricia] Alliant Int Univ, Calif Sch Profess Psychol, 10455 Pomerado Rd, San Diego, CA 92131 USA; [Giromini, Luciano] Univ Turin, Dept Psychol, Turin, Italy		Viglione, DJ (corresponding author), Alliant Int Univ, Calif Sch Profess Psychol, 10455 Pomerado Rd, San Diego, CA 92131 USA.	dviglione@alliant.edu	Giromini, Luciano/AAF-9386-2019	Giromini, Luciano/0000-0002-9540-4803			Abramsky A. B, 2005, THESIS; Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Archer RP, 2006, J PERS ASSESS, V87, P84, DOI 10.1207/s15327752jpa8701_07; Bagby, 1991, PSYCHOL ASSESSMENT J, V3, P89, DOI [DOI 10.1037/1040-3590.3.1.89, 10.1037/1040-3590.3.1.89]; BEABER RJ, 1985, AM J PSYCHIAT, V142, P1478; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Blanchard DD, 2003, J PERS ASSESS, V80, P197, DOI 10.1207/S15327752JPA8002_08; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Connell K, 2004, THESIS; Edens JF, 2007, J PERS ASSESS, V88, P33, DOI 10.1207/s15327752jpa8801_05; Elhai JD, 2000, J PERS ASSESS, V75, P449, DOI 10.1207/S15327752JPA7503_06; First MB, 1995, STRUCTURED CLIN INTE; Green Lawrence C, 1999, THESIS; Green P., 1996, WORD MEMORY TEST USE; Green R.L., 1991, MMPI 2 MMPI INTERPRE; Hawes SW, 2009, PSYCHOL ASSESSMENT, V21, P112, DOI 10.1037/a0015036; Jansak D., 1996, THESIS; Lally SJ, 2003, PROF PSYCHOL-RES PR, V34, P491, DOI 10.1037/0735-7028.34.5.491; Landis P. E., 1996, THESIS; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; McCullaugh J. M, 2011, THESIS; McDougall A., 1996, THESIS; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Mellin D., 1996, THESIS; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Miller H.A., 2001, M FAST MILLER FORENS; Morey, 1991, PERSONALITY ASSESSME; Morey L.C., 2007, PERSONALITY ASSESSME; Morey L. C., 1996, INTERPRETIVE GUIDE P; O'Brien S. M, 2004, THESIS; Peters L, 2012, PSYCHOL ASSESSMENT, V24, P66, DOI 10.1037/a0024544; Pizitz T. D, 2001, THESIS; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rogers R, 1998, LAW HUMAN BEHAV, V22, P353, DOI 10.1023/A:1025714808591; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R, 1996, J PERS ASSESS, V67, P629, DOI 10.1207/s15327752jpa6703_15; Rogers R, 1998, BEHAV SCI LAW, V16, P147, DOI 10.1002/(SICI)1099-0798(199824)16:1<147::AID-BSL298>3.0.CO;2-3; Rogers R., 2011, RES METHODS FORENSIC, P174; Rogers R., 1995, ASSESSMENT, V2, P81, DOI DOI 10.1177/1073191195002001008; ROGERS R, 1988, CLIN ASSESSMENT MALI; Rogers R., 1991, PSYCHOL ASSESSMENT J, V3, P673, DOI DOI 10.1037/1040-3590.3.4.673; Rogers R., 2010, STRUCTURED INTERVIEW; Rogers R., 2008, CLIN ASSESSMENT MALI, P14; Rogers R., 2013, HDB PSYCHOL FORENSIC, V11, P517; Schaich D., 2000, THESIS; Sellbom M., 2008, CLIN ASSESSMENT MALI, V3rd ed., P182; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Thompson G. B., 2005, VSVT VICTORIA SYMPTO; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Viglione D. J., 1994, BIENN M AM PSYCH LAW; Viglione DJ, 2001, ASSESSMENT, V8, P237, DOI 10.1177/107319110100800301; WATSON CG, 1991, J CLIN PSYCHOL, V47, P179, DOI 10.1002/1097-4679(199103)47:2<179::AID-JCLP2270470202>3.0.CO;2-P; Weber K. A., 2008, THESIS; Widows MR, 2004, SIMS STRUCTURED INVE; Wood S. M, 2008, THESIS	56	35	35	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3891	1532-7752		J PERS ASSESS	J. Pers. Assess.	SEP-OCT	2017	99	5					534	544		10.1080/00223891.2016.1233882			11	Psychology, Clinical; Psychology, Social	Social Science Citation Index (SSCI)	Psychology	FB4UB	WOS:000406136100011	27767344	Green Submitted			2022-02-06	
J	Di Pietro, V; Lazzarino, G; Amorini, AM; Signoretti, S; Hill, LJ; Porto, E; Tavazzi, B; Lazzarino, G; Belli, A				Di Pietro, Valentina; Lazzarino, Giacomo; Amorini, Angela Maria; Signoretti, Stefano; Hill, Lisa J.; Porto, Edoardo; Tavazzi, Barbara; Lazzarino, Giuseppe; Belli, Antonio			Fusion or Fission: The Destiny of Mitochondria In Traumatic Brain Injury of Different Severities	SCIENTIFIC REPORTS			English	Article							PROTEOLYTIC CLEAVAGE; GENE-EXPRESSION; QUALITY-CONTROL; IN-VITRO; OPA1; MODEL; MORPHOLOGY; NEUROPROTECTION; DEATH; DYSFUNCTION	Mitochondrial dynamics are regulated by a complex system of proteins representing the mitochondrial quality control (MQC). MQC balances antagonistic forces of fusion and fission determining mitochondrial and cell fates. In several neurological disorders, dysfunctional mitochondria show significant changes in gene and protein expression of the MQC and contribute to the pathophysiological mechanisms of cell damage. In this study, we evaluated the main gene and protein expression involved in the MQC in rats receiving traumatic brain injury (TBI) of different severities. At 6, 24, 48 and 120 hours after mild TBI (mTBI) or severe TBI (sTBI), gene and protein expressions of fusion and fission were measured in brain tissue homogenates. Compared to intact brain controls, results showed that genes and proteins inducing fusion or fission were upregulated and downregulated, respectively, in mTBI, but downregulated and upregulated, respectively, in sTBI. In particular, OPA1, regulating inner membrane dynamics, cristae remodelling, oxidative phosphorylation, was post-translationally cleaved generating differential amounts of long and short OPA1 in mTBI and sTBI. Corroborated by data referring to citrate synthase, these results confirm the transitory (mTBI) or permanent (sTBI) mitochondrial dysfunction, enhancing MQC importance to maintain cell functions and indicating in OPA1 an attractive potential therapeutic target for TBI.	[Di Pietro, Valentina; Hill, Lisa J.; Porto, Edoardo; Belli, Antonio] Univ Birmingham, Neurosci & Ophthalmol Res Grp, Inst Inflammat & Ageing, Sch Clin & Expt Med,Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Di Pietro, Valentina; Hill, Lisa J.; Belli, Antonio] Queen Elizabeth Hosp, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham B15 2TH, W Midlands, England; [Lazzarino, Giacomo; Amorini, Angela Maria; Tavazzi, Barbara] Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Largo F Vito 1, I-00168 Rome, Italy; [Signoretti, Stefano] San Camillo Hosp, Dept Neurosci Head & Neck Surg, Div Neurosurg, Circonvallaz Gianicolense 87, I-00152 Rome, Italy; [Lazzarino, Giuseppe] Univ Catania, Div Med Biochem, Dept Biomed & Biotechnol Sci, Viale A Doria 6, I-95125 Catania, Italy		Tavazzi, B (corresponding author), Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, Largo F Vito 1, I-00168 Rome, Italy.; Lazzarino, G (corresponding author), Univ Catania, Div Med Biochem, Dept Biomed & Biotechnol Sci, Viale A Doria 6, I-95125 Catania, Italy.	barbara.tavazzi@unicatt.it; lazzarig@unict.it	Signoretti, stefano/AAL-5631-2020; Belli, Antonio/I-3799-2015; Hill, Lisa J/AAO-1560-2021; TAVAZZI, BARBARA/AAB-9830-2019; lazzarino, giuseppe/K-2277-2015	Signoretti, stefano/0000-0002-8086-1622; Belli, Antonio/0000-0002-3211-9933; Hill, Lisa J/0000-0001-8431-7029; TAVAZZI, BARBARA/0000-0001-8743-0895; Porto, Edoardo/0000-0002-1442-9137; lazzarino, giuseppe/0000-0002-5917-7279; Lazzarino, Giacomo/0000-0003-1639-0966	research funds of Catholic University of Rome; University of Catania; University of Birmingham	This work has been funded in part by research funds of the Catholic University of Rome (BT) the University of Catania (Giuseppe L) and the University of Birmingham (AB).	Alavi MV, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-32; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Amorini AM, 2016, BBA-MOL BASIS DIS, V1862, P679, DOI 10.1016/j.bbadis.2016.01.023; Ashrafi G, 2015, AUTOPHAGY, V11, P187, DOI 10.1080/15548627.2014.996021; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bohovych I, 2015, ANTIOXID REDOX SIGN, V22, P977, DOI 10.1089/ars.2014.6199; Borgia D, 2017, HUM MOL GENET, V26, P1087, DOI 10.1093/hmg/ddx019; Bracko O, 2014, J CEREBR BLOOD F MET, V34, P1522, DOI 10.1038/jcbfm.2014.112; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Guskiewicz Kevin M, 2015, Handb Clin Neurol, V127, P157, DOI 10.1016/B978-0-444-52892-6.00010-6; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jahani-Asl A, 2011, J BIOL CHEM, V286, P4772, DOI 10.1074/jbc.M110.167155; Jiang X, 2014, P NATL ACAD SCI USA, V111, P14782, DOI 10.1073/pnas.1417253111; Kaminskyy VO, 2014, ANTIOXID REDOX SIGN, V21, P86, DOI 10.1089/ars.2013.5746; Kannurpatti SS, 2017, J CEREBR BLOOD F MET, V37, P381, DOI 10.1177/0271678X16680637; Kao SH, 2015, INVEST OPHTH VIS SCI, V56, P2269, DOI 10.1167/iovs.14-16288; Kumar R, 2016, MOL CELL NEUROSCI, V76, P68, DOI 10.1016/j.mcn.2016.08.010; Lehmann S, 2013, J MOL MED, V91, P665, DOI 10.1007/s00109-013-1044-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mahad D, 2008, NEUROPATH APPL NEURO, V34, P577, DOI 10.1111/j.1365-2990.2008.00987.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mead B, 2016, CYTOTHERAPY, V18, P487, DOI 10.1016/j.jcyt.2015.12.002; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; O'Brien LC, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13080; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Ramonet D, 2013, CELL DEATH DIFFER, V20, P77, DOI 10.1038/cdd.2012.95; Rappold PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6244; Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38; Ruszkiewicz J, 2015, NEUROCHEM INT, V88, P66, DOI 10.1016/j.neuint.2014.12.012; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; Signoretti S., 2014, CONCUSSIONS ATHLETIC, P89; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252; Szklarz LKS, 2012, BBA-BIOENERGETICS, V1817, P1886, DOI 10.1016/j.bbabio.2012.05.001; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Voigt A, 2016, J NEUROCHEM, V139, P232, DOI 10.1111/jnc.13655; Wang X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.473; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zhao YX, 2014, CNS NEUROSCI THER, V20, P528, DOI 10.1111/cns.12266	67	35	35	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 23	2017	7								9189	10.1038/s41598-017-09587-2			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8AC	WOS:000408427000007	28835707	Green Published, gold			2022-02-06	
J	Sandel, N; Reynolds, E; Cohen, PE; Gillie, BL; Kontos, AP				Sandel, Natalie; Reynolds, Erin; Cohen, Paul E.; Gillie, Brandon L.; Kontos, Anthony P.			Anxiety and Mood Clinical Profile Following Sport-Related Concussion: From Risk Factors to Treatment	SPORT EXERCISE AND PERFORMANCE PSYCHOLOGY			English	Article						concussion; anxiety; mood; sport	TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; 4TH INTERNATIONAL-CONFERENCE; CHRONIC SUBJECTIVE DIZZINESS; POSTCONCUSSION-LIKE SYMPTOMS; RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSIVE DISORDER; MILITARY SERVICE MEMBERS; SCHOOL FOOTBALL PLAYERS; MOTOR SCREENING VOMS	Conceptual models for assessing and treating sport-related concussion (SRC) have evolved from a homogenous approach to include different clinical profiles that reflect the heterogeneous nature of this injury and its effects. There are six identified clinical profiles, or subtypes, from SRC, and one such clinical profile is the anxiety and mood profile. Athletes with this profile experience predominant emotional disturbance and anxiety following SRC. The purpose of this targeted review was to present an overview of the empirical evidence to support factors contributing to the anxiety and mood profile, along with methods of evaluation and treatment of this clinical profile following SRC. We discuss the potential underlying mechanisms and risk factors for this clinical profile, describe comprehensive assessments to evaluate concussed athletes with an anxiety and mood clinical profile, and explore behavioral and other interventions for treating these athletes. Although there is limited, but growing, empirical evidence for the anxiety and mood clinical profile following SRC, understanding this clinical profile is germane for clinicians who are treating athletes with emotional sequelae after SRC.	[Sandel, Natalie; Reynolds, Erin; Cohen, Paul E.; Gillie, Brandon L.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr Sports Concuss Program, Dept Orthopaed Surg, 3200 South Water St, Pittsburgh, PA 15203 USA; [Reynolds, Erin; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA		Sandel, N (corresponding author), Univ Pittsburgh, Med Ctr Sports Concuss Program, Dept Orthopaed Surg, 3200 South Water St, Pittsburgh, PA 15203 USA.	sandelnk@upmc.edu		Kontos, Anthony/0000-0002-3749-4310	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [1K01DC012332-01A1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [K01DC012332] Funding Source: NIH RePORTER	This research was supported in part by a grant to the University of Pittsburgh from the National Institute on Deafness and Other Communication Disorders (1K01DC012332-01A1) to Anthony P. Kontos.	Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alvaro PK, 2017, J AFFECT DISORDERS, V207, P167, DOI 10.1016/j.jad.2016.08.032; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Armistead-Jehle P, 2016, APPL NEUROPSYCH-ADUL, V23, P264, DOI 10.1080/23279095.2015.1055564; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Balaban CD, 1998, J VESTIBUL RES-EQUIL, V8, P7; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; Balasundaram AP, 2016, ARCH CLIN NEUROPSYCH, V31, P197, DOI 10.1093/arclin/acw001; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck AT, 2010, BIB, V1988, P54; Beck J.S., 2011, COGNITIVE BEHAV THER, V2nd ed; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1056/NEJMra073096; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Briere J., 1996, TRAUMA SYMPTOM INVEN; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Butcher J. N., 2003, MMPI 2 MINNESOTA MUL; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Carroll LJ, 2006, PAIN, V124, P18, DOI 10.1016/j.pain.2006.03.012; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Centers for Disease Control and Prevention, 2011, BURD MENT ILLN; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Clement D, 2013, J ATHL TRAINING, V48, P512, DOI 10.4085/1062-6050-48.3.21; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Conn VS, 2010, NURS RES, V59, P224, DOI 10.1097/NNR.0b013e3181dbb2f8; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Edelman S, 2012, AM J OTOLARYNG, V33, P395, DOI 10.1016/j.amjoto.2011.10.009; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Elbin RJ, 2016, APPL NEUROPSYCH-CHIL, V5, P294, DOI 10.1080/21622965.2015.1077334; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; Erikson E, 1993, CHILDHOOD SOC; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldberg J.M., 2012, VESTIBULAR SYSTEM 6; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hou R, 2011, J NEUROL NEUROSUR PS, V83, P217; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jacob RG, 2001, CURR OPIN NEUROL, V14, P41, DOI 10.1097/00019052-200102000-00007; Jayakody K, 2014, BRIT J SPORT MED, V48, P187, DOI 10.1136/bjsports-2012-091287; Jensen MP, 2001, J CONSULT CLIN PSYCH, V69, P655, DOI 10.1037/0022-006X.69.4.655; Jones RM, 2014, PERS RELATIONSHIP, V21, P51, DOI 10.1111/pere.12017; KABATZINN J, 1992, AM J PSYCHIAT, V149, P936; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kemper K. J., 2017, J EVIDENCE BASED COM; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Kontos AP, 2013, RES SPORTS MED, V21, P367, DOI 10.1080/15438627.2013.825801; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Lu W, 2016, NEUROREHABILITATION, V38, P59, DOI 10.3233/NRE-151296; MacPherson E, 2016, PSYCHOL SPORT EXERC, V23, P73, DOI 10.1016/j.psychsport.2015.10.002; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Morey, 1991, PERSONALITY ASSESSME; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; National Institute of Neurological Disorders and Stroke, 2017, SPORT REL CONC COMM; O'Brien LM, 2009, CHILD ADOL PSYCH CL, V18, P813, DOI 10.1016/j.chc.2009.04.008; O'Leary K, 2017, COGNITION EMOTION, V31, P435, DOI 10.1080/02699931.2015.1126554; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Parks A. C., 2016, APPL NEUROPSYCHOLOGY; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Martinez MP, 2014, J BEHAV MED, V37, P683, DOI 10.1007/s10865-013-9520-y; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rains JC, 2008, CURR NEUROL NEUROSCI, V8, P167, DOI 10.1007/s11910-008-0027-9; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Ritterband LM, 2017, JAMA PSYCHIAT, V74, P68, DOI 10.1001/jamapsychiatry.2016.3249; Roesch SC, 2001, J PSYCHOSOM RES, V50, P205, DOI 10.1016/S0022-3999(01)00188-X; Ruckenstein MJ, 2009, OTOLARYNG CLIN N AM, V42, P71, DOI 10.1016/j.otc.2008.09.011; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smyth K, 2014, DEV MED CHILD NEUROL, V56, P73, DOI 10.1111/dmcn.12263; Stubbs B, 2017, J AFFECT DISORDERS, V208, P545, DOI 10.1016/j.jad.2016.10.028; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tracey J, 2003, J APPL SPORT PSYCHOL, V15, P279, DOI 10.1080/714044197; Tsai MC, 2014, J PEDIATR-US, V164, P136, DOI 10.1016/j.jpeds.2013.08.042; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Venzala E, 2013, EUR NEUROPSYCHOPHARM, V23, P697, DOI 10.1016/j.euroneuro.2012.05.010; Wiese-Bjornstal DM, 1998, J APPL SPORT PSYCHOL, V10, P46, DOI 10.1080/10413209808406377; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; WOLPE J, 1964, BEHAV RES THER, V2, P27, DOI 10.1016/0005-7967(64)90051-8; Womble Melissa N, 2016, Am J Orthop (Belle Mead NJ), V45, P352; Wood RL, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/HTR.0b013e31827eabba; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	137	35	36	4	34	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	2157-3905	2157-3913		SPORT EXERC PERFORM	Sport Exerc. Perform. Psychol.	AUG	2017	6	3					304	323		10.1037/spy0000098			20	Hospitality, Leisure, Sport & Tourism; Psychology, Applied	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology	FD8RW	WOS:000407792800009	29130023	Green Accepted, Bronze			2022-02-06	
J	Adams, H; Donnelly, J; Czosnyka, M; Kolias, AG; Helmy, A; Menon, DK; Smielewski, P; Hutchinson, PJ				Adams, Hadie; Donnelly, Joseph; Czosnyka, Marek; Kolias, Angelos G.; Helmy, Adel; Menon, David K.; Smielewski, Peter; Hutchinson, Peter J.			Temporal profile of intracranial pressure and cerebrovascular reactivity in severe traumatic brain injury and association with fatal outcome: An observational study	PLOS MEDICINE			English	Article							CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; BLOOD-FLOW; DECOMPRESSIVE CRANIECTOMY; TIME-COURSE; AUTOREGULATION; HYPERTENSION; EPIDEMIOLOGY; HYPERVENTILATION; CIRCULATION	Background Both intracranial pressure (ICP) and the cerebrovascular pressure reactivity represent the dysregulation of pathways directly involved in traumatic brain injury (TBI) pathogenesis and have been used to inform clinical management. However, how these parameters evolve over time following injury and whether this evolution has any prognostic importance have not been studied. Methods and findings We analysed the temporal profile of ICP and pressure reactivity index (PRx), examined their relation to TBI-specific mortality, and determined if the prognostic relevance of these parameters was affected by their temporal profile using mixed models for repeated measures of ICP and PRx for the first 240 hours from the time of injury. A total of 601 adults with TBI, admitted between September 2002 to January 2016, and with high-resolution continuous monitoring from a single centre, were studied. At 6 months postinjury, 133 (19%) patients had a fatal outcome; of those, 88 (78%) died from nonsurvivable TBI or brain death. The difference in mean ICP between those with a fatal outcome and functional survivors was only significant for the first 168 hours after injury (all p < 0.05). For PRx, those patients with a fatal outcome also had a higher (more impaired) PRx throughout the first 120 hours after injury (all p < 0.05). The separation of ICP and PRx was greatest in the first 72 hours after injury. Mixed models demonstrated that the explanatory power of the PRx decreases over time; therefore, the prognostic weight assigned to PRx should similarly decrease. However, the ability of ICP to predict a fatal outcome remained relatively stable over time. As control of ICP is the central purpose of TBI management, it is likely that some of the information that is reflected in the natural history of ICP changes is no longer apparent because of therapeutic intervention. Conclusions We demonstrated the temporal evolution of ICP and PRx and their relationship with fatal outcome, indicating a potential early prognostic and therapeutic window. The combination of dynamic monitoring variables and their time profile improved prediction of outcome. Therefore, time-driven dynamic modelling of outcome in patients with severe TBI may allow for more accurate and clinically useful prediction models. Further research is needed to confirm and expand on these findings.	[Adams, Hadie; Donnelly, Joseph; Czosnyka, Marek; Kolias, Angelos G.; Helmy, Adel; Smielewski, Peter; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Anaesthesia, Cambridge, England		Adams, H (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England.	ha356@cam.ac.uk	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018; Helmy, Adel/AAS-3084-2020	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Helmy, Adel/0000-0002-0531-0556; Kolias, Angelos/0000-0003-3992-0587; Smielewski, Peter/0000-0001-5096-3938	Senior Investigator award from the NIHR; European Union Seventh Framework Program grant (CENTER-TBI) [602150]; Research Professorship from the NIHR; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025, G0600986, G1002277] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G1002277, G0601025, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090, NIHR-RP-R3-12-013] Funding Source: researchfish	DKM is supported by a Senior Investigator award from the NIHR and a European Union Seventh Framework Program grant (CENTER-TBI; grant no. 602150). PJH is supported by a Research Professorship from the NIHR, the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameloot K, 2015, RESUSCITATION, V90, P121, DOI 10.1016/j.resuscitation.2015.03.001; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Dias C, 2015, NEUROCRIT CARE, V22, P192, DOI 10.1007/s12028-014-0045-1; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Donnelly J, 2015, NEUROCRIT CARE, V22, P20, DOI 10.1007/s12028-014-0042-4; Fanelli V, 2015, INTENSIVE CARE MED E, V3, pA509; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; GUILLAUME J, 1951, PRESSE MED, V59, P953; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; JENNETT B, 1975, LANCET, V1, P480; Johnson U, 2014, NEUROCRIT CARE; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Lundberg N, 1959, ACTA PSYCHIAT SCAND, V36, P1; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2012, LANCET NEUROL, V11, P12, DOI 10.1016/S1474-4422(11)70267-8; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Moons KGM, 2015, ADV ANAT PATHOL, V22, P303, DOI 10.1097/PAP.0000000000000072; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Ogawa Y, 2010, ANESTH ANALG, V111, P1279, DOI 10.1213/ANE.0b013e3181f42fc0; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pfeifer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148844; Pfister D, 2008, CRIT CARE, V12, DOI 10.1186/cc6891; R Development Core Team, 2013, R LANG ENV STAT COMP; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salam Adil, 2003, Respir Care, V48, P1033; Salehpour F, 2011, J CRIT CARE, V26, P352, DOI 10.1016/j.jcrc.2010.12.005; Schramm P, 2011, J NEUROSURG ANESTH, V23, P41, DOI 10.1097/ANA.0b013e3181f35854; Sekhon MS, 2015, NEUROCRIT CARE, V23, P210, DOI 10.1007/s12028-015-0141-x; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Souter MJ, 1999, CRIT CARE MED, V27, P177, DOI 10.1097/00003246-199901000-00048; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Taccone FS, 2010, NEUROCRIT CARE, V12, P35, DOI 10.1007/s12028-009-9289-6; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	61	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1676			PLOS MED	PLos Med.	JUL	2017	14	7							e1002353	10.1371/journal.pmed.1002353			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1QA	WOS:000406611200023	28742817	Green Published, Green Submitted, gold			2022-02-06	
J	Esopenko, C; Chow, TW; Tartaglia, MC; Bacopulos, A; Kumar, P; Binns, MA; Kennedy, JL; Muller, DJ; Levine, B				Esopenko, Carrie; Chow, Tiffany W.; Tartaglia, Maria Carmela; Bacopulos, Agnes; Kumar, Priya; Binns, Malcolm A.; Kennedy, James L.; Muller, Daniel J.; Levine, Brian			Cognitive and psychosocial function in retired professional hockey players	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; FOOTBALL LEAGUE PLAYERS; APOLIPOPROTEIN-E; HEAD-INJURY; ALZHEIMERS-DISEASE; RECURRENT CONCUSSION; EARLY ADULTHOOD; APOE GENOTYPE; NFL PLAYERS; ENCEPHALOPATHY	Background and Objective The relationship between repeated concussions and neurodegenerative disease has received significant attention, particularly research in postmortem samples. Our objective was to characterise retired professional ice hockey players' cognitive and psychosocial functioning in relation to concussion exposure and apolipoprotein epsilon 4 status. Methods Alumni athletes (N=33, aged 34-71 years) and an age-matched sample of comparison participants (N=18) were administered measures of cognitive function and questionnaires concerning psychosocial and psychiatric functioning. Results No significant group differences were found on neuropsychological measures of speeded attention, verbal memory or visuospatial functions, nor were significant differences observed on computerised measures of response speed, inhibitory control and visuospatial problem solving. Reliable group differences in cognitive performance were observed on tests of executive and intellectual function; performance on these measures was associated with concussion exposure. Group differences were observed for cognitive, affective and behavioural impairment on psychosocial questionnaires and psychiatric diagnoses. There was no evidence of differential effects associated with age in the alumni athletes. Possession of an apolipoprotein e4 allele was associated with increased endorsement of psychiatric complaints, but not with objective cognitive performance. Conclusions We found only subtle objective cognitive impairment in alumni athletes in the context of high subjective complaints and psychiatric impairment. Apolipoprotein e4 status related to psychiatric, but not cognitive status. These findings provide benchmarks for the degree of cognitive and behavioural impairment in retired professional athletes and a point of comparison for future neuroimaging and longitudinal studies.	[Esopenko, Carrie; Bacopulos, Agnes; Kumar, Priya; Binns, Malcolm A.; Levine, Brian] Baycrest Hlth Sci, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada; [Esopenko, Carrie] Rutgers State Univ, Dept Rehabil & Movement Sci, 65 Bergen St, Newark, NJ 07107 USA; [Chow, Tiffany W.] Univ Southern Calif, Los Angeles, CA USA; [Tartaglia, Maria Carmela] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Tartaglia, Maria Carmela] Krembil Neurosci Ctr, Div Neurol, Toronto, ON, Canada; [Kumar, Priya] CAMH, Toronto, ON, Canada; [Binns, Malcolm A.; Levine, Brian] Univ Toronto, Toronto, ON, Canada; [Kennedy, James L.; Muller, Daniel J.] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Kennedy, James L.; Muller, Daniel J.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada		Esopenko, C; Levine, B (corresponding author), Baycrest Hlth Sci, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.; Esopenko, C (corresponding author), Rutgers State Univ, Dept Rehabil & Movement Sci, 65 Bergen St, Newark, NJ 07107 USA.	carrie.esopenko@rutgers.edu	Levine, Brian/G-4328-2010; Muller, Daniel J./L-4159-2016; Kennedy, James Lowery/AAZ-6947-2020; Binns, Malcolm/AAQ-9195-2020; Levine, Brian/O-2725-2019	Levine, Brian/0000-0003-4343-811X; Muller, Daniel J./0000-0003-4978-4400; Kennedy, James Lowery/0000-0002-8733-3806; Binns, Malcolm/0000-0001-9998-6612; Levine, Brian/0000-0003-4343-811X; Esopenko, Carrie/0000-0001-8607-5633	Canadian Institutes of Health Research Catalyst (CIHR) [CBT 127060]; Ontario Neurotrauma Foundation [2012-ABI-CAT3-973]; CIHR Operating GrantCanadian Institutes of Health Research (CIHR) [MOP133728]; Alzheimer's Society of Canada's Research Program Post Doctoral Fellowship	Canadian Institutes of Health Research Catalyst (CIHR; Grant # CBT 127060) Ontario Neurotrauma Foundation (Grant # 2012-ABI-CAT3-973) CIHR Operating Grant (Grant # MOP133728) Alzheimer's Society of Canada's Research Program Post Doctoral Fellowship awarded to CE.	Amen DG, 2011, J NEUROPSYCH CLIN N, V23, P98, DOI 10.1176/appi.neuropsych.23.1.98; Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; Evans S, 2014, NEUROBIOL AGING, V35, P1615, DOI 10.1016/j.neurobiolaging.2014.01.145; First M.B., 1996, STRUCTURED CLIN INTE; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hampshire A, 2012, NEURON, V76, P1225, DOI 10.1016/j.neuron.2012.06.022; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ihle A, 2012, NEUROPSYCHOLOGY, V26, P267, DOI 10.1037/a0026769; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lichtman SW, 2000, NEUROLOGY, V55, P1536, DOI 10.1212/WNL.55.10.1536; Lineweaver TT, 2014, AM J PSYCHIAT, V171, P201, DOI 10.1176/appi.ajp.2013.12121590; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martens MP, 2006, J SUBST ABUSE TREAT, V31, P305, DOI 10.1016/j.jsat.2006.05.004; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Tomaszczyk JC, 2014, NEUROPSYCHOL REV, V24, P409, DOI 10.1007/s11065-014-9273-6; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122	49	35	36	3	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2017	88	6					512	519		10.1136/jnnp-2016-315260			8	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	EX0JI	WOS:000402906000010	28396361				2022-02-06	
J	Semple, BD; Dixit, S; Shultz, SR; Boon, WC; O'Brien, TJ				Semple, Bridgette D.; Dixit, Shilpi; Shultz, Sandy R.; Boon, Wah Chin; O'Brien, Terence J.			Sex-dependent changes in neuronal morphology and psychosocial behaviors after pediatric brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Social behavior; Brain development; Golgi staining; Mouse model; Traumatic brain injury; Sex	MEDIAL PREFRONTAL CORTEX; DEFICIT HYPERACTIVITY DISORDER; NEONATAL EXCITOTOXIC LESIONS; CORTICAL IMPACT INJURY; TRAUMATIC BRAIN; SOCIAL-BEHAVIOR; DENDRITIC MORPHOLOGY; MOUSE MODEL; VENTRAL HIPPOCAMPUS; PYRAMIDAL NEURONS	Chronic social behavior problems after pediatric traumatic brain injury (TBI) significantly contribute to poor quality of life for survivors. Using a well-characterized mouse model of early childhood TBI, we have previously demonstrated that young brain-injured mice develop social deficits by adulthood. As biological sex may influence both normal and aberrant social development, we here evaluated potential sex differences in post-TBI psychosocial deficits by comparing the behavior of male and female mice at adulthood (8 weeks post-injury). Secondly, we hypothesized that pediatric TBI would influence neuronal morphology identified by Golgi-Cox staining in the hippocampus and prefrontal cortex, regions involved in social cognition and behavior, before the onset of social problems (3 weeks post-injury). Morphological analysis of pyramidal neurons in the ipsilateral prefrontal cortex and granule cells of the hippocampal dentate gyrus revealed a reduction in dendritic complexity after pediatric TBI. This was most apparent in TBI males, whereas neurons from females were less affected. At adulthood, consistent with previous studies, TBI males showed deficits in sociability and social recognition. TBI females also showed a reduction in sociability, but intact social recognition and increased sociosexual avoidance. Together, these findings indicate that sex is a determinant of regional neuroplasticity and social outcomes after pediatric TBI. Reduced neuronal complexity in the prefrontal cortex and hippocampus, several weeks after injury in male mice, appears to precede the subsequent emergence of social deficits. Sex-specific alterations in the social brain network are thus implicated as an underlying mechanism of social dysfunction after pediatric TBI. (C) 2016 Elsevier B.V. All rights reserved.	[Semple, Bridgette D.; Shultz, Sandy R.; O'Brien, Terence J.] Univ Melbourne, Melbourne Brain Ctr, Royal Melbourne Hosp, Dept Med, Kenneth Myer Bldg, Parkville, Vic, Australia; [Dixit, Shilpi; Boon, Wah Chin] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia		Semple, BD (corresponding author), Univ Melbourne, Melbourne Brain Ctr, Royal Melbourne Hosp, Dept Med, Kenneth Myer Bldg, Parkville, Vic, Australia.	Bridgette.Semple@unimelb.edu.au	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	O'Brien, Terence/0000-0002-7198-8621; Dixit, Shilpi/0000-0003-4837-0548	CJ Martin Overseas Early Career Fellowship from National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [1052505]; Early Career Researcher Grant from the University of Melbourne	BDS was supported by a CJ Martin Overseas Early Career Fellowship (#1052505) from the National Health and Medical Research Council of Australia, and an Early Career Researcher Grant from the University of Melbourne. The authors thank A/Prof. Ann Turnley for providing access to the controlled cortical impactor device, and Victorian State Government Infrastructure Support.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Antshel KM, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-72; Bachevalier J, 1999, BIOL PSYCHIAT, V46, P329, DOI 10.1016/S0006-3223(99)00123-7; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beauregard M, 1995, NEUROREPORT, V6, P2521, DOI 10.1097/00001756-199512150-00018; Bicks LK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01805; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Breau LM, 2015, J CHILD NEUROL, V30, P588, DOI 10.1177/0883073814528282; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Brydges NM, 2014, HIPPOCAMPUS, V24, P684, DOI 10.1002/hipo.22259; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Camacho-Abrego I, 2014, SYNAPSE, V68, P114, DOI 10.1002/syn.21722; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Choleris E, 2009, FRONT NEUROENDOCRIN, V30, P442, DOI 10.1016/j.yfrne.2009.05.003; Collins NC, 2013, EMERG MED J, V30, P675, DOI 10.1136/emermed-2011-200496; Crews F, 2007, PHARMACOL BIOCHEM BE, V86, P189, DOI 10.1016/j.pbb.2006.12.001; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Despins E. H., 2015, ARCH PHYS MED REHABI; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Drzewiecki CM, 2016, SYNAPSE, V70, P361, DOI 10.1002/syn.21909; Dumais KM, 2013, HORM BEHAV, V64, P693, DOI 10.1016/j.yhbeh.2013.08.012; ELY DL, 1977, PHYSIOL BEHAV, V18, P1075, DOI 10.1016/0031-9384(77)90014-2; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2013, J INT NEUROPSYCH SOC, V19, P497, DOI 10.1017/S1355617713000210; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Faul M, 2010, TRAUMATIC BRAIN INJU; Fenn A. M., 2013, BIOL PSYCHIAT, V25; Fernandes C, 1999, PHARMACOL BIOCHEM BE, V64, P731, DOI 10.1016/S0091-3057(99)00139-2; Flores G, 2005, NEUROSCIENCE, V133, P463, DOI 10.1016/j.neuroscience.2005.02.021; Flores G, 2005, SYNAPSE, V56, P147, DOI 10.1002/syn.20140; Forgie ML, 2003, BEHAV NEUROSCI, V117, P257, DOI 10.1037/0735-7044.117.2.257; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Garrett JE, 2009, NEUROSCIENCE, V162, P195, DOI 10.1016/j.neuroscience.2009.04.057; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Giedd JN, 1997, PROG NEURO-PSYCHOPH, V21, P1185, DOI 10.1016/S0278-5846(97)00158-9; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Greco T, 2015, DEV NEUROBIOL, V75, P193, DOI 10.1002/dneu.22218; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Gregoire CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086237; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Humphreys KL, 2016, J ABNORM CHILD PSYCH, V44, P1023, DOI 10.1007/s10802-015-0095-7; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; JURASKA JM, 1990, DEV BRAIN RES, V53, P291, DOI 10.1016/0165-3806(90)90021-P; Kaldoja ML, 2015, J CHILD NEUROL, V30, P860, DOI 10.1177/0883073814544705; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; KARLSSON SA, 2015, BMC NEUROSCI, V16, DOI DOI 10.1186/S12868-12015-10221-Z; Karlsson SA, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00041; Kim Y, 2015, CELL REP, V10, P292, DOI 10.1016/j.celrep.2014.12.014; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; KOLB B, 1974, PHYSIOL BEHAV, V13, P637, DOI 10.1016/0031-9384(74)90234-0; Kolb B, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00015; Kolb B, 2012, P NATL ACAD SCI USA, V109, P17186, DOI 10.1073/pnas.1121251109; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lipska BK, 1998, NEUROPSYCHOPHARMACOL, V19, P451, DOI 10.1016/S0893-133X(98)00045-1; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; Llorente R, 2009, INT J DEV NEUROSCI, V27, P233, DOI 10.1016/j.ijdevneu.2009.01.002; Maaswinkel H, 1996, PHYSIOL BEHAV, V60, P55, DOI 10.1016/0031-9384(95)02233-3; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Meziane H, 2007, GENES BRAIN BEHAV, V6, P192, DOI 10.1111/j.1601-183X.2006.00249.x; Misra V, 2014, ANN NEUROSCI, V21, P69, DOI 10.5214/ans.0972.7531.210208; Moadab G, 2015, BEHAV NEUROSCI, V129, P339, DOI 10.1037/bne0000062; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Moreno JA, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/914134; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Neumann ID, 2012, TRENDS NEUROSCI, V35, P649, DOI 10.1016/j.tins.2012.08.004; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Paxinos G., 1997, MOUSE BRAIN STEREOTA; Pellis SM, 2006, BEHAV NEUROSCI, V120, P72, DOI 10.1037/0735-7044.120.1.72; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Ramon-Moliner E., 1970, CONT RES METHODS NEU, P32, DOI [10.1007/978-3-642-85986-1_3, DOI 10.1007/978-3-642-85986-1_3]; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rudebeck PH, 2007, EUR J NEUROSCI, V26, P2315, DOI 10.1111/j.1460-9568.2007.05844.x; Ryan N. P., 2016, NEUROSCI BIOBEHAV RE; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; SamsDodd F, 1997, PSYCHOPHARMACOLOGY, V132, P303, DOI 10.1007/s002130050349; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Semple B. D., 2014, NEUROBIOL DIS, V74; Semple BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143386; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Semple BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103386; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; SERESS L, 1992, HIPPOCAMPUS, V2, P127, DOI 10.1002/hipo.450020205; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; SHOLL DA, 1953, J ANAT, V87, P387; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Sigurdsson T, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00190; Silva-Gomez AB, 2003, BRAIN RES, V983, P128, DOI 10.1016/S0006-8993(03)03042-7; Soztutar E, 2016, EXP NEUROL, V275, P274, DOI 10.1016/j.expneurol.2015.06.005; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; Stevenson EL, 2014, EUR J NEUROSCI, V40, P3294, DOI 10.1111/ejn.12689; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Uekita T, 2011, BEHAV BRAIN RES, V219, P302, DOI 10.1016/j.bbr.2011.01.042; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31, DOI DOI 10.1007/s00429-005-0042-4; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Yang LY, 2016, PEDIATR RES, V80, P356, DOI 10.1038/pr.2016.85; Yang M., 2011, CURR PROTOC NEUROSCI, V56; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zitman FMP, 2013, NEUROSCIENCE, V249, P21, DOI 10.1016/j.neuroscience.2013.05.030	132	35	35	1	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 15	2017	319						48	62		10.1016/j.bbr.2016.10.045			15	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	EI5TS	WOS:000392558300007	27829127				2022-02-06	
J	Tucker, LB; McCabe, JT				Tucker, Laura B.; McCabe, Joseph T.			Behavior of Male and Female C57BL/6J Mice Is More Consistent with Repeated Trials in the Elevated Zero Maze than in the Elevated Plus Maze	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						anxiety; memory; sex differences; behavior; one-trial tolerance	ANXIETY-LIKE BEHAVIOR; TRAUMATIC BRAIN-INJURY; RECEPTOR BETA KNOCKOUT; SEX-DIFFERENCES; ANIMAL-MODELS; TYPE-1 5-ALPHA-REDUCTASE; SOCIAL BEHAVIORS; INBRED STRAINS; DRUG DISCOVERY; BASE-LINE	The elevated plus maze (EPM) and elevated zero maze (EZM) are behavioral tests that are widely employed to assess anxiety-like behaviors in rats and mice following experimental manipulations, or to test the effects of pharmacological agents. Both tests are based on approach/avoidance conflict, with rodents perceived as less anxious being more willing to explore the brighter, open and elevated regions of the apparatus as opposed to remaining in the darkened and enclosed regions. The goal of this research was to compare, under identical laboratory conditions, the behavior of male and female C57BL/6J mice in EZM and EPM during repeated trials. Mice were tested either daily or weekly, exclusively in the EPM or EZM, for a total of five exposures. During the first trial, the mazes were explored equally as measured by the total distance traveled during the test session. However, mice tested in the EZM spent nearly twice the amount of time in the anxiogenic regions (open quadrants) as the mice tested in the EPM spent in the open arms of that apparatus. After the first trial in the EPM, amounts of ambulation and percent time in the open arms decreased significantly (independent of inter-trial interval) which has been well-described in previous research as the one-trial tolerance phenomenon. In contrast, behavior in the EZM remained comparatively stable for several trials when the animals were tested weekly or daily. Sex differences were limited to activity levels, with females being more active than males. In conclusion, the design of the EZM encourages greater exploration of the anxiogenic regions of the apparatus, and may also be a more suitable test than the EPM for experimental designs in which assessment of anxiety-related behaviors is needed at more than one time point following experimental manipulations.	[Tucker, Laura B.; McCabe, Joseph T.] Ctr Neurosci & Regenerat Med, Preclin Studies Core, Bethesda, MD 20894 USA; [Tucker, Laura B.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		McCabe, JT (corresponding author), Ctr Neurosci & Regenerat Med, Preclin Studies Core, Bethesda, MD 20894 USA.; McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.	Joseph.McCabe@usuhs.edu	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442; Tucker, Laura/0000-0002-5984-6399	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855-300600-7.01]	This work was supported by The Center for Neuroscience and Regenerative Medicine, 60855-300600-7.01.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Amani M, 2013, NEUROPHARMACOLOGY, V73, P87, DOI 10.1016/j.neuropharm.2013.04.056; An XL, 2011, EXP ANIM TOKYO, V60, P111, DOI 10.1538/expanim.60.111; ARCHER J, 1975, BEHAV BIOL, V14, P451, DOI 10.1016/S0091-6773(75)90636-7; Blokland A, 2012, BEHAV BRAIN RES, V228, P16, DOI 10.1016/j.bbr.2011.11.042; Bolivar VJ, 2000, BEHAV GENET, V30, P285, DOI 10.1023/A:1026545316455; Braun AA, 2011, PHARMACOL BIOCHEM BE, V97, P406, DOI 10.1016/j.pbb.2010.09.013; Cook MN, 2002, BEHAV GENET, V32, P113, DOI 10.1023/A:1015249706579; Cook MN, 2001, BEHAV NEUROSCI, V115, P468, DOI 10.1037/0735-7044.115.2.468; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Cryan JF, 2011, BRIT J PHARMACOL, V164, P1129, DOI 10.1111/j.1476-5381.2011.01362.x; Ennaceur A, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.223; FILE SE, 1990, PSYCHOPHARMACOLOGY, V102, P98, DOI 10.1007/BF02245751; Frye CA, 2004, BRAIN RES, V1004, P116, DOI 10.1016/j.brainres.2004.01.020; Galeeva A, 2001, BEHAV BRAIN RES, V119, P41, DOI 10.1016/S0166-4328(00)00341-7; Gangitano D, 2009, GENES BRAIN BEHAV, V8, P398, DOI 10.1111/j.1601-183X.2009.00476.x; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Gomes KS, 2009, PROG NEURO-PSYCHOPH, V33, P1261, DOI 10.1016/j.pnpbp.2009.07.015; Griebel G, 2013, NAT REV DRUG DISCOV, V12, P667, DOI 10.1038/nrd4075; Haller J, 2013, NEUROSCI BIOBEHAV R, V37, P2318, DOI 10.1016/j.neubiorev.2012.09.001; Hendershott TR, 2016, BEHAV BRAIN RES, V314, P215, DOI 10.1016/j.bbr.2016.08.004; Holmes A, 1998, PHARMACOL BIOCHEM BE, V60, P473, DOI 10.1016/S0091-3057(98)00008-2; Holmes A, 1999, NEUROSCI BIOBEHAV R, V23, P971, DOI 10.1016/S0149-7634(99)00030-5; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; Kokras N, 2014, BRIT J PHARMACOL, V171, P4595, DOI 10.1111/bph.12710; Koonce CJ, 2013, BEHAV BRAIN RES, V253, P232, DOI 10.1016/j.bbr.2013.07.025; Koonce CJ, 2012, BEHAV BRAIN RES, V226, P376, DOI 10.1016/j.bbr.2011.09.028; LEE C, 1990, PSYCHOPHARMACOLOGY, V102, P507, DOI 10.1007/BF02247133; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Milner LC, 2008, GENES BRAIN BEHAV, V7, P496, DOI 10.1111/j.1601-183X.2007.00385.x; O'Leary TP, 2013, BEHAV GENET, V43, P34, DOI 10.1007/s10519-012-9572-8; Olesen KM, 2011, HORM BEHAV, V60, P318, DOI 10.1016/j.yhbeh.2011.06.005; Painsipp E, 2007, NEUROSCIENCE, V150, P522, DOI 10.1016/j.neuroscience.2007.09.024; Pearson BL, 2015, PHYSIOL BEHAV, V146, P98, DOI 10.1016/j.physbeh.2015.03.035; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; RODGERS RJ, 1993, PSYCHOPHARMACOLOGY, V113, P237, DOI 10.1007/BF02245704; Rodgers RJ, 1997, BRAZ J MED BIOL RES, V30, P289, DOI 10.1590/S0100-879X1997000300002; Rodgers RJ, 2002, GENES BRAIN BEHAV, V1, P242, DOI 10.1034/j.1601-183X.2002.10406.x; RODGERS RJ, 1993, PHYSIOL BEHAV, V54, P729, DOI 10.1016/0031-9384(93)90084-S; RODGERS RJ, 1992, PSYCHOPHARMACOLOGY, V106, P102, DOI 10.1007/BF02253596; Roy V, 2009, PSYCHOPHARMACOLOGY, V203, P131, DOI 10.1007/s00213-008-1378-2; Schneider P, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00043; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Tarantino LM, 2000, MAMM GENOME, V11, P555, DOI 10.1007/s003350010107; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Walf AA, 2008, BEHAV NEUROSCI, V122, P974, DOI 10.1037/a0012749; Walf AA, 2009, BEHAV BRAIN RES, V196, P254, DOI 10.1016/j.bbr.2008.09.016; Zhou H, 2015, PHARMACOL BIOCHEM BE, V135, P40, DOI 10.1016/j.pbb.2015.05.009	52	35	36	0	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JAN 26	2017	11								13	10.3389/fnbeh.2017.00013			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EI7CT	WOS:000392655700001	28184191	Green Published, gold			2022-02-06	
J	Goverover, Y; Genova, H; Smith, A; Chiaravalloti, N; Lengenfelder, J				Goverover, Yael; Genova, Helen; Smith, Angela; Chiaravalloti, Nancy; Lengenfelder, Jeanie			Changes in activity participation following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Activities of daily living; rehabilitation; quality of life	EXECUTIVE FUNCTION; OCCUPATIONAL PERFORMANCE; COMMUNITY INTEGRATION; ECOLOGICAL VALIDITY; LEISURE ACTIVITIES; UNITED-STATES; MODERATE; RELIABILITY; DEPRESSION; MILD	Traumatic brain injury (TBI) often results in impairments in cognitive skills as well as depression. As a result of these changes in cognition and mood, individuals with TBI may reduce their levels of participation and often report reduced health-related quality of life (HrQOL). The current study compares levels of past and present activity participation between healthy participants and persons with TBI using a client-centred approach in measurement. We additionally examine the relationship between activity participation, emotional functioning and HrQOL in persons with TBI. Fifty-two individuals with TBI who live in the community and 30 healthy age-matched controls performed a battery of cognitive tests and rated their affective symptomatology and activity participation (using the Activity Card Sort Test). Participants with TBI reported significantly lower current activity participation compared to controls. Current levels of activity and participation in the TBI sample were significantly related to age, time since injury, and HrQOL. Additionally, depressive symptomatology was significantly associated with HrQOL, but not with activity participation. Following TBI, levels of activity participation are reduced in most aspects of life, but more profoundly in social activities, high demand leisure activities and household activities. Additionally, high levels of depressive symptoms are associated with negative reports of HrQOL, regardless of current levels of activity participation.	[Goverover, Yael] NYU, Dept Occupat Therapy, 82 Washington Sq East,6th Floor, New York, NY 10003 USA; [Goverover, Yael; Genova, Helen; Smith, Angela; Chiaravalloti, Nancy; Lengenfelder, Jeanie] Kessler Fdn, W Orange, NJ USA; [Genova, Helen; Chiaravalloti, Nancy; Lengenfelder, Jeanie] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA		Goverover, Y (corresponding author), NYU, Dept Occupat Therapy, 82 Washington Sq East,6th Floor, New York, NY 10003 USA.	yg243@nyu.edu		Chiaravalloti, Nancy/0000-0003-2943-7567	New Jersey Commission on Brain Injury Research [10-3218-BIR]	This research was supported by New Jersey Commission on Brain Injury Research [grant number 10-3218-BIR].	Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Baum C. M., 2001, ACS ACTIVITY CARD SO; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Brzuzy S, 1996, J HEAD TRAUMA REHAB, V11, P74, DOI 10.1097/00001199-199606000-00011; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Delis D, 2000, DELIS KAPLAN EXECUTI; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Everard KM, 1999, J APPL GERONTOL, V18, P325, DOI 10.1177/073346489901800304; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Goverover Y, 2005, ARCH PHYS MED REHAB, V86, P2303, DOI 10.1016/j.apmr.2005.05.016; Goverover Y, 2015, BRAIN INJURY, V29, P715, DOI 10.3109/02699052.2015.1004744; Goverover Y, 2014, BRAIN INJURY, V28, P174, DOI 10.3109/02699052.2013.860474; Hartman-Maeir A, 2007, DISABIL REHABIL, V29, P559, DOI 10.1080/09638280600924996; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Katz N, 2003, OTJR-OCCUP PARTICI H, V23, P10, DOI 10.1177/153944920302300102; Kobayashi LC, 2015, J EPIDEMIOL COMMUN H, V69, P278, DOI 10.1136/jech-2014-204733; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Martin RC, 2012, J HEAD TRAUMA REHAB, V27, pE81, DOI 10.1097/HTR.0b013e318273de49; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Singh-Manoux A, 2003, J EPIDEMIOL COMMUN H, V57, P907, DOI 10.1136/jech.57.11.907; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spitzer J, 2011, OTJR-OCCUP PART HEAL, V31, pS8, DOI 10.3928/15394492-20101108-03; Tabachnick B.G., 2001, USING MULTIVARIATE S; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Wood RL, 2008, EUR J ANAESTH, V25, P115, DOI 10.1017/S0265021507003432; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; World Health Organization, 2007, INT CLASS FUNCT DIS; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; [No title captured], DOI DOI 10.1375/BRIM.7.2.107	47	35	35	2	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	4					472	485		10.1080/09602011.2016.1168746			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	ES4KR	WOS:000399503600002	27043964				2022-02-06	
J	Villalba, N; Sackheim, AM; Nunez, IA; Hill-Eubanks, DC; Nelson, MT; Wellman, GC; Freeman, K				Villalba, Nuria; Sackheim, Adrian M.; Nunez, Ivette A.; Hill-Eubanks, David C.; Nelson, Mark T.; Wellman, George C.; Freeman, Kalev			Traumatic Brain Injury Causes Endothelial Dysfunction in the Systemic Microcirculation through Arginase-1-Dependent Uncoupling of Endothelial Nitric Oxide Synthase	JOURNAL OF NEUROTRAUMA			English	Article						in vitro studies; oxidative stress; traumatic brain injury; vascular injury; vascular reactivity	L-ARGININE; SMALL-CONDUCTANCE; ARTERIAL TONE; ARGINASE-II; ACTIVATION; OXIDATION; CATECHOLAMINES; INHIBITION; EXPRESSION; HISTONES	Endothelial dysfunction is a hallmark of many chronic diseases, including diabetes and long-term hypertension. We show that acute traumatic brain injury (TBI) leads to endothelial dysfunction in rat mesenteric arteries. Endothelial-dependent dilation was greatly diminished 24 h after TBI because of impaired nitric oxide (NO) production. The activity of arginase, which competes with endothelial NO synthase (eNOS) for the common substrate l-arginine, were also significantly increased in arteries, suggesting that arginase-mediated depletion of l-arginine underlies diminished NO production. Consistent with this, substrate restoration by exogenous application of l-arginine or inhibition of arginase recovered endothelial function. Moreover, evidence for increased reactive oxygen species production, a consequence of l-arginine starvation-dependent eNOS uncoupling, was detected in endothelium and plasma. Collectively, our findings demonstrate endothelial dysfunction in a remote vascular bed after TBI, manifesting as impaired endothelial-dependent vasodilation, with increased arginase activity, decreased generation of NO, and increased O-2-production. We conclude that blood vessels have a "molecular memory'' of neurotrauma, 24 h after injury, because of functional changes in vascular endothelial cells; these effects are pertinent to understanding the systemic inflammatory response that occurs after TBI even in the absence of polytrauma.	[Villalba, Nuria; Hill-Eubanks, David C.; Nelson, Mark T.; Wellman, George C.; Freeman, Kalev] Univ Vermont, Dept Pharmacol, Burlington, VT 05405 USA; [Sackheim, Adrian M.; Nunez, Ivette A.; Wellman, George C.; Freeman, Kalev] Univ Vermont, Dept Surg, Given E301, Burlington, VT 05405 USA; [Nelson, Mark T.] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England		Freeman, K (corresponding author), Univ Vermont, Dept Surg, Given E301, Burlington, VT 05405 USA.	Kalev.Freeman@uvm.edu		Nelson, Mark/0000-0002-6608-8784; Nunez, Ivette/0000-0003-3213-3628	Totman Medical Research Trust; Fondation LeducqLeducq Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20-RR-16435, P01-HL-095488, UM1-HL-120877-01, R01-HL-044455, R01-HL-098243, R37-DK-053832, P30-RR-032135-02, P30-GM-103498-02, K08-GM-098795-01, R01-HL-121706-01]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P30RR032135, P20RR016435] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL121706, P01HL095488, R01HL098243, R01HL044455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R37DK053832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM098795, P30GM103498] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD017969] Funding Source: NIH RePORTER	We thank Sheila Russell for her technical expertise in performing the trauma surgeries. This work was supported by the Totman Medical Research Trust, Fondation Leducq and National Institutes of Health (P20-RR-16435, P01-HL-095488, UM1-HL-120877-01, R01-HL-044455, R01-HL-098243, R37-DK-053832, P30-RR-032135-02, P30-GM-103498-02, K08-GM-098795-01, R01-HL-121706-01).	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Alef MJ, 2011, J CLIN INVEST, V121, P1646, DOI 10.1172/JCI44079; Alkaitis Matthew S, 2012, Curr Heart Fail Rep, V9, P200, DOI 10.1007/s11897-012-0097-5; Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Arribas SM, 2007, CLIN HEMORHEOL MICRO, V37, P205; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Bryan RM, 2005, ANESTHESIOLOGY, V102, P1261, DOI 10.1097/00000542-200506000-00028; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Crane GJ, 2003, J PHYSIOL-LONDON, V553, P183, DOI 10.1113/jphysiol.2003.051896; DHANAKOTI SN, 1990, AM J PHYSIOL, V259, pE437, DOI 10.1152/ajpendo.1990.259.3.E437; Dioguardi FS, 2011, J NUTRIGENET NUTRIGE, V4, P90, DOI 10.1159/000327777; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GRANGER DL, 1990, J CLIN INVEST, V85, P264, DOI 10.1172/JCI114422; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Hannah RM, 2011, J CEREBR BLOOD F MET, V31, P1175, DOI 10.1038/jcbfm.2010.214; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Larson BE, 2012, J SURG RES, V173, pE73, DOI 10.1016/j.jss.2011.09.056; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Liu YL, 2013, EXP MOL PATHOL, V94, P160, DOI 10.1016/j.yexmp.2012.10.015; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Mann KG, 2015, J THROMB HAEMOST, V13, pS63, DOI 10.1111/jth.12981; MONCADA S, 1991, PHARMACOL REV, V43, P109; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ochoa JB, 2001, ANN SURG, V233, P393, DOI 10.1097/00000658-200103000-00014; OHARA Y, 1993, J CLIN INVEST, V91, P2546, DOI 10.1172/JCI116491; Okamoto M, 2001, GERONTOLOGY, V47, P131, DOI 10.1159/000052786; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pribis JP, 2012, JPEN-PARENTER ENTER, V36, P53, DOI 10.1177/0148607111414579; Rael LT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-57; Rael LT, 2009, J NEUROTRAUM, V26, P1203, DOI 10.1089/neu.2008-0816; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rangel-Castilla L, 2010, NEUROL RES, V32, P1033, DOI 10.1179/016164110X12767786356598; RECZKOWSKI RS, 1994, ARCH BIOCHEM BIOPHYS, V312, P31, DOI 10.1006/abbi.1994.1276; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Schulman SP, 2006, JAMA-J AM MED ASSOC, V295, P58, DOI 10.1001/jama.295.1.58; Settergren M, 2009, ATHEROSCLEROSIS, V204, P73, DOI 10.1016/j.atherosclerosis.2008.08.034; SHAPIRO HM, 1972, J SURG RES, V13, P138, DOI 10.1016/0022-4804(72)90057-1; Shemyakin A, 2012, CIRCULATION, V126, P2943, DOI 10.1161/CIRCULATIONAHA.112.140335; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Taylor MS, 2003, CIRC RES, V93, P124, DOI 10.1161/01.RES.0000081980.63146.69; Villalba N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001474; WALSH MP, 1995, CAN J PHYSIOL PHARM, V73, P565, DOI 10.1139/y95-072; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yu Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0113-z; Zimmermann C, 2004, CEREBROVASC DIS, V17, P128, DOI 10.1159/000075781	61	35	37	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					192	203		10.1089/neu.2015.4340			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100021	26757855	Green Published, Green Submitted			2022-02-06	
J	Wong, D; Sinclair, K; Seabrook, E; McKay, A; Ponsford, J				Wong, Dana; Sinclair, Kelly; Seabrook, Elizabeth; McKay, Adam; Ponsford, Jennie			Smartphones as assistive technology following traumatic brain injury: a preliminary study of what helps and what hinders	DISABILITY AND REHABILITATION			English	Article						Cognitive rehabilitation; smartphones; traumatic brain injury; memory aids; apps	ANXIETY STRESS SCALES; MEMORY IMPAIRMENTS; REHABILITATION; INDIVIDUALS; PEOPLE; TRIAL; AIDS; DEPRESSION; RECALL; TBI	Purpose: Smartphones have great potential as a convenient, multifunction tool to support cognition and independence following traumatic brain injury (TBI). However, there has been limited investigation of their helpful and less helpful aspects for people with TBI. We aimed to investigate patterns of smartphone use amongst individuals with TBI, identify potential barriers to use, and examine the relationships between smartphone use and daily functioning. Method: Twenty-nine participants with TBI and 33 non-injured participants completed the Smartphone Survey, and measures of subjective and objective cognitive functioning, mood, and community integration. Results: Smartphone use was equally common in both groups, and patterns of app use were similar. More participants with TBI than the comparison group listed using their smartphone as a memory aid as its main benefit. Difficulty in learning how to use the smartphone was identified by participants with TBI, however only 10% had been shown how to use it by a clinician. Those with poorer subjective cognitive function used memory/organisational apps more frequently; and higher communication app use with better social integration, in participants with TBI. Conclusions: These findings suggest that smartphones have potential in improving independence following TBI, but receiving support in using them is vital. Implications for Rehabilitation Smartphones are accessible, acceptable, convenient devices for most individuals with traumatic brain injury (TBI), and are perceived as a useful memory and organizational aid as well as having multiple other helpful functions. Use of communication apps such as text messages and social media is associated with better social and community integration in people with TBI. Direct instruction on how to use smartphone apps is more important for people with TBI than for non-injured individuals. Developers of apps designed for this population should prioritize ease of app use, large displays, and availability of technical support, while maintaining an engaging design and interface.	[Wong, Dana; Seabrook, Elizabeth; McKay, Adam; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, 18 Innovat Walk, Clayton, Vic 3800, Australia; [Wong, Dana; Seabrook, Elizabeth; McKay, Adam; Ponsford, Jennie] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Wong, Dana; Sinclair, Kelly; McKay, Adam; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [McKay, Adam] Epworth Med Fdn, Melbourne, Vic, Australia		Wong, D (corresponding author), Monash Univ, Sch Psychol Sci, 18 Innovat Walk, Clayton, Vic 3800, Australia.	dana.wong@monash.edu	McKay, Adam/M-6003-2017	McKay, Adam/0000-0002-0479-7681; Seabrook, Elizabeth/0000-0003-1844-127X; Wong, Dana/0000-0001-9619-1929	Centre of Excellence in Traumatic Brain Injury Research, National Trauma Research Institute, Alfred Hospital, Melbourne	This work was partly supported by the Centre of Excellence in Traumatic Brain Injury Research, National Trauma Research Institute, Alfred Hospital, Melbourne [N/A].	BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; CALLAHAN CD, 1994, J CLIN PSYCHOL MED S, V1, P261, DOI 10.1007/BF01989627; Chu Y, 2014, DISABIL REHABIL-ASSI, V9, P279, DOI 10.3109/17483107.2013.823631; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; De Joode EA, 2013, NEUROPSYCHOL REHABIL, V23, P133, DOI 10.1080/09602011.2012.726632; de Joode EA, 2012, BRAIN INJURY, V26, P1257, DOI 10.3109/02699052.2012.667590; Dowds MM, 2011, J HEAD TRAUMA REHAB, V26, P339, DOI 10.1097/HTR.0b013e3181f2bf1d; Evald L, 2015, NEUROPSYCHOL REHABIL, V25, P283, DOI 10.1080/09602011.2014.970557; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Ferguson S, 2015, BRAIN INJURY, V29, P583, DOI 10.3109/02699052.2014.1002109; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Gavett BE, 2012, ARCH CLIN NEUROPSYCH, V27, P125, DOI 10.1093/arclin/acr104; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Jamieson M, 2017, NEUROPSYCHOL REHABIL, V27, P919, DOI 10.1080/09602011.2015.1103760; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lannin N, 2014, CLIN REHABIL, V28, P470, DOI 10.1177/0269215513512216; Lovibond SH, 2004, MANUAL DEPRESSION AN; Lund ML, 2011, DISABIL REHABIL-ASSI, V6, P402, DOI 10.3109/17483107.2011.574309; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Rey A., 1964, EXAMEN CLIN PSYCHOL; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wong D, 2013, BRAIN INJURY, V27, P1377, DOI 10.3109/02699052.2013.823662	28	35	35	2	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2017	39	23					2387	2394		10.1080/09638288.2016.1226434			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FF8IJ	WOS:000409260200003	27748145				2022-02-06	
J	Kraus, N; Thompson, EC; Krizman, J; Cook, K; White-Schwoch, T; LaBella, CR				Kraus, Nina; Thompson, Elaine C.; Krizman, Jennifer; Cook, Katherine; White-Schwoch, Travis; LaBella, Cynthia R.			Auditory biological marker of concussion in children	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; SPEECH-PERCEPTION; PITCH DISCRIMINATION; FOOTBALL PLAYERS; HEARING-LOSS; HEAD-INJURY; NOISE; PLASTICITY; INDIVIDUALS; PERFORMANCE	Concussions carry devastating potential for cognitive, neurologic, and socio-emotional disease, but no objective test reliably identifies a concussion and its severity. A variety of neurological insults compromise sound processing, particularly in complex listening environments that place high demands on brain processing. The frequency-following response captures the high computational demands of sound processing with extreme granularity and reliably reveals individual differences. We hypothesize that concussions disrupt these auditory processes, and that the frequency-following response indicates concussion occurrence and severity. Specifically, we hypothesize that concussions disrupt the processing of the fundamental frequency, a key acoustic cue for identifying and tracking sounds and talkers, and, consequently, understanding speech in noise. Here we show that children who sustained a concussion exhibit a signature neural profile. They have worse representation of the fundamental frequency, and smaller and more sluggish neural responses. Neurophysiological responses to the fundamental frequency partially recover to control levels as concussion symptoms abate, suggesting a gain in biological processing following partial recovery. Neural processing of sound correctly identifies 90% of concussion cases and clears 95% of control cases, suggesting this approach has practical potential as a scalable biological marker for sports-related concussion and other types of mild traumatic brain injuries.	[Kraus, Nina; Thompson, Elaine C.; Krizman, Jennifer; White-Schwoch, Travis] Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA; [Kraus, Nina; Thompson, Elaine C.; Krizman, Jennifer; White-Schwoch, Travis] Northwestern Univ, Dept Commun Sci, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Kraus, Nina] Northwestern Univ, Dept Otolaryngol, Feinberg Sch Med, Chicago, IL 60611 USA; [Cook, Katherine; LaBella, Cynthia R.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Pediat Orthopaed Surg & Sports Med, Chicago, IL 60611 USA; [Cook, Katherine; LaBella, Cynthia R.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA		Kraus, N (corresponding author), Northwestern Univ, Auditory Neurosci Lab, Evanston, IL 60208 USA.; Kraus, N (corresponding author), Northwestern Univ, Dept Commun Sci, Evanston, IL 60208 USA.; Kraus, N (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.; Kraus, N (corresponding author), Northwestern Univ, Dept Otolaryngol, Feinberg Sch Med, Chicago, IL 60611 USA.	nkraus@northwestern.edu			Knowles Hearing Center	Supported by the Knowles Hearing Center. We thank Trent Nicol for his comments on this manuscript, Greta Weber, Jamie Burgess, PhD, and Kelly Trainor, APN, for their assistance with this project, and colleagues in the Auditory Neuroscience Laboratory and the Institute for Sports Medicine.	Anderson S, 2013, HEARING RES, V300, P18, DOI 10.1016/j.heares.2013.03.006; Anderson S, 2012, J NEUROSCI, V32, P14156, DOI 10.1523/JNEUROSCI.2176-12.2012; Anderson S, 2010, J NEUROSCI, V30, P4922, DOI 10.1523/JNEUROSCI.0107-10.2010; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Bajo VM, 2010, NAT NEUROSCI, V13, P253, DOI 10.1038/nn.2466; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Carcagno S, 2011, JARO-J ASSOC RES OTO, V12, P89, DOI 10.1007/s10162-010-0236-1; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; DUBNO JR, 1984, J ACOUST SOC AM, V76, P87, DOI 10.1121/1.391011; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gosselin N, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12253; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kraus N, 2005, TRENDS NEUROSCI, V28, P176, DOI 10.1016/j.tins.2005.02.003; Kraus N, 2015, TRENDS COGN SCI, V19, P642, DOI 10.1016/j.tics.2015.08.017; Krizman J, 2012, P NATL ACAD SCI USA, V109, P7877, DOI 10.1073/pnas.1201575109; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maro II, 2014, EAR HEARING, V35, P306, DOI 10.1097/01.aud.0000439101.07257.ed; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGee T, 1996, EAR HEARING, V17, P419, DOI 10.1097/00003446-199610000-00008; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Munjal SK, 2010, J TRAUMA, V68, P13, DOI 10.1097/TA.0b013e3181c9f274; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Pruitt DT, 2016, J NEUROTRAUM, V33, P871, DOI 10.1089/neu.2015.3972; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Sanchez JT, 2007, J NEUROSCI, V27, P1954, DOI 10.1523/JNEUROSCI.2894-06.2007; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shaheen LA, 2015, JARO-J ASSOC RES OTO, V16, P727, DOI 10.1007/s10162-015-0539-3; Skoe E, 2015, CEREB CORTEX, V25, P1415, DOI 10.1093/cercor/bht311; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Song JH, 2011, J COGNITIVE NEUROSCI, V23, P2268, DOI 10.1162/jocn.2010.21556; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; van der Roer N, 2006, SPINE, V31, P578, DOI 10.1097/01.brs.0000201293.57439.47; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; White-Schwoch T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002196; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Ziegler JC, 2005, P NATL ACAD SCI USA, V102, P14110, DOI 10.1073/pnas.0504446102	47	35	35	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 22	2016	6								39009	10.1038/srep39009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EF4NC	WOS:000390304800001	28005070	Green Published, gold			2022-02-06	
J	Buckley, TA; Vallabhajosula, S; Oldham, JR; Munkasy, BA; Evans, KM; Krazeise, DA; Ketcham, CJ; Hall, EE				Buckley, Thomas A.; Vallabhajosula, Srikant; Oldham, Jessie R.; Munkasy, Barry A.; Evans, Kelsey M.; Krazeise, David A.; Ketcham, Caroline J.; Hall, Eric E.			Evidence of a conservative gait strategy in athletes with a history of concussions	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Balance; Brain injury; Gait performance; Locomotion; Mild traumatic; Postural control; Postural stability; Variability	TRAUMATIC BRAIN-INJURY; GAITRITE(R) WALKWAY SYSTEM; HEART-RATE-VARIABILITY; HIGH-SCHOOL; POSTURAL-CONTROL; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION; CEREBRAL CONCUSSION; LENGTH VARIABILITY; BALANCE CONTROL	Background: A history of 3 or more concussions is frequently associated with numerous short-and long-term neuropathologies. Impairments in postural control are a known acute consequence of concussion; however, limited evidence exists on the effects of multiple concussions on gait. The purpose of this study was to assess gait stepping characteristics in collegiate aged student-athletes based on concussion history. Methods: There were 63 participants divided into 3 even groups based on concussion history: >= 3 concussions, 1-2 concussions, and 0 concussion. All participants completed 10 trials of gait on a 4.9 m instrumented walkway. The dependent variables of interest included both gait stepping characteristics (step velocity, length, and width, double support time, and the percentage of the gait cycle in stance) and coefficient of variability (CoV) measures (step length, time, and width). The gait stepping characteristics were compared first with a MANOVA with follow-up 1-way ANOVAs and Tukey post hoc tests as appropriate. The CoV measures were compared with 1-way ANOVAs and Tukey post hoc tests. Results: There were main effects for group for step velocity, length, width, and double support time. Overall, the 0 concussion group displayed typical healthy young gait parameters and performed significantly better than either concussion group. The 0 concussion group had a significantly greater step length CoV, but there were no differences in the step time or width CoV. Conclusion: This finding provides evidence of subtle impairments in postural control during gait among individuals with prior history of concussion which could be an early indicator of future neurological deficiencies. The limited difference in the variability measures is consistent with prior static stance studies and could suggest the individuals constrain their motor systems to reduce variability. Taken together, these findings suggest a conservative gait strategy which is adopted by individuals with a history of concussions. (C) 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Buckley, Thomas A.; Oldham, Jessie R.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA; [Vallabhajosula, Srikant] Elon Univ, Dept Phys Therapy Educ, Elon, NC 27244 USA; [Munkasy, Barry A.; Evans, Kelsey M.] Georgia Southern Univ, Dept Hlth & Kinesiol, Statesboro, GA 30460 USA; [Krazeise, David A.] Stetson Univ, Dept Intercollegiate Athlet, Deland, FL 32723 USA; [Ketcham, Caroline J.; Hall, Eric E.] Elon Univ, Dept Exercise Sci, Elon, NC 27244 USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA.	TBuckley@UDel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Ketcham, Caroline/0000-0002-6713-130X; Vallabhajosula, Srikant/0000-0002-7984-1106; Oldham, Jessie/0000-0003-2801-2110	NIH/NINDS grant [1R15NS070744-01A1]; Georgia Southern University Faculty Development grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS070744] Funding Source: NIH RePORTER	This project was funded, in part, by an NIH/NINDS grant (1R15NS070744-01A1) and a Georgia Southern University Faculty Development grant. Two authors, Drs. Buckley and Munkasy, arc primary investigators on both grants. The funding agency had no role in the development of the manuscript, the interpretation of the results, or the decision where to submit the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Caderby T, 2013, GAIT POSTURE, V37, P144, DOI 10.1016/j.gaitpost.2012.06.012; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guzzetti S, 2001, AUTON NEUROSCI-BASIC, V90, P102, DOI 10.1016/S1566-0702(01)00274-0; Hass CJ, 2004, ARCH PHYS MED REHAB, V85, P1593, DOI 10.1016/j.apmr.2004.01.020; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Inc CS, 2013, GAITRITE EL WALKW TE; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Lord S, 2011, GAIT POSTURE, V34, P443, DOI 10.1016/j.gaitpost.2011.07.010; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Mbourou GA, 2003, GERONTOLOGY, V49, P21, DOI 10.1159/000066506; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Menz HB, 2004, GAIT POSTURE, V20, P20, DOI 10.1016/S0966-6362(03)00068-7; Nakamura T, 1996, GERONTOLOGY, V42, P108, DOI 10.1159/000213780; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Owings TM, 2003, J BIOMECH, V36, P1215, DOI 10.1016/S0021-9290(03)00108-8; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Preatoni E, 2013, SPORT BIOMECH, V12, P69, DOI 10.1080/14763141.2012.738700; Preatoni E, 2010, J SPORT SCI, V28, P1327, DOI 10.1080/02640414.2010.507250; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Roemmich RT, 2012, GAIT POSTURE, V36, P340, DOI 10.1016/j.gaitpost.2012.01.018; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Socie MJ, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/645197; Solomon GS, 2013, ARCH CLIN NEUROPSYCH, V28, P9, DOI 10.1093/arclin/acs108; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005	72	35	35	0	14	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	DEC	2016	5	4					417	423		10.1016/j.jshs.2015.03.010			7	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	EJ0UA	WOS:000392924800011	30356549	gold, Green Published			2022-02-06	
J	Coulson-Thomas, VJ; Lauer, ME; Soleman, S; Zhao, C; Hascall, VC; Day, AJ; Fawcett, JW				Coulson-Thomas, Vivien J.; Lauer, Mark E.; Soleman, Sara; Zhao, Chao; Hascall, Vincent C.; Day, Anthony J.; Fawcett, James W.			Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) Is Constitutively Expressed in Adult Central Nervous System (CNS) and Associated with Astrocyte-mediated Glial Scar Formation following Spinal Cord Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; glycosaminoglycan; hyaluronan; inflammation; proteoglycan; glial scar	INTER-ALPHA-INHIBITOR; SMOOTH-MUSCLE-CELLS; ANTIINFLAMMATORY PROTEIN TSG-6; HEAVY-CHAIN TRANSFER; HYALURONAN-BINDING PROTEINS; FIBRILLARY ACIDIC PROTEIN; HUMAN AMNIOTIC MEMBRANE; REACTIVE ASTROCYTES; EXTRACELLULAR-MATRIX; CD44 EXPRESSION	Tumor necrosis factor (TNF)-stimulated gene-6 (TSG-6) binds to hyaluronan and can reorganize/stabilize its structure, also enhancing the binding of this glycosaminoglycan to its cell surface receptor, CD44. TSG-6 is rapidly up-regulated in response to inflammatory cytokines protecting tissues from the damaging effects of inflammation. Despite TSG-6 treatment having been shown to improve outcomes in an experimental model of traumatic brain injury, TSG-6 expression has not been extensively studied in the central nervous system (CNS). We hereby analyzed the expression profile of TSG-6 in the developing CNS and following injury. We show that TSG-6 is expressed in the rat CNS by GFAP(+) and CD44(+) astrocytes, solely in the mature brain and spinal cord, and is not present during the development of the CNS. TSG-6(-/-) mice present a reduced number of GFAP(+) astrocytes when compared with the littermate TSG-6(+/-) mice. TSG-6 expression is drastically up-regulated after injury, and the TSG-6 protein is present within the glial scar, potentially coordinating and stabilizing the formation of this hyaluronan-rich matrix. This study shows that TSG-6 is expressed in the CNS, suggesting a role for TSG-6 in astrocyte activation and tissue repair. We hypothesize that within this context TSG-6 could participate in the formation of the glial scar and confer anti-inflammatory properties. Further studies are required to elucidate the therapeutic potential of targeting TSG-6 after CNS injury to promote its protective effects while reducing the inhibitory properties of the glial scar in axon regeneration.	[Coulson-Thomas, Vivien J.; Soleman, Sara; Fawcett, James W.] Univ Cambridge, John Van Geest Cambridge Ctr Brain Repair, ED Adrian Bldg,Forvie Site,Robinson Way, Cambridge CB2 0PY, England; [Lauer, Mark E.; Hascall, Vincent C.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Zhao, Chao] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Clifford Allbutt Bldg, Cambridge CB2 0AH, England; [Zhao, Chao] Univ Cambridge, Dept Clin Neurosci, Clifford Allbutt Bldg, Cambridge CB2 0AH, England; [Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England		Coulson-Thomas, VJ (corresponding author), Univ Houston, Coll Optometry, 505 J Davis Armistead Bldg,Rm 2103, Houston, TX 77204 USA.; Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.; Fawcett, JW (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Forvie Site,Robinson Way, Cambridge CB2 0PY, England.	vcoulsonthomas@gmail.com; anthony.day@manchester.ac.uk; jf108@cam.ac.uk	Day, Anthony/O-1658-2015	Day, Anthony/0000-0002-1415-3134	European Research Council ECMneuro; National Institutes of Health NHLBI Award [PO1HL107147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL107147] Funding Source: NIH RePORTER; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_PC_12009] Funding Source: researchfish	This work was supported by the European Research Council ECMneuro and National Institutes of Health NHLBI Award PO1HL107147. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Asher RA, 2000, J NEUROSCI, V20, P2427; Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002; Baranova NS, 2014, J BIOL CHEM, V289, P30481, DOI 10.1074/jbc.M114.568154; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Beltran SR, 2015, J PERIODONTOL, V86, P62, DOI 10.1902/jop.2014.140187; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Bignami A, 1984, J Neurosurg Sci, V28, P127; Bogdani M, 2014, DIABETES, V63, P2727, DOI 10.2337/db13-1658; Bollyky PL, 2011, P NATL ACAD SCI USA, V108, P7938, DOI 10.1073/pnas.1017360108; Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Briggs DC, 2015, J BIOL CHEM, V290, P28708, DOI 10.1074/jbc.M115.669838; Buggey H, 2013, THESIS; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Choi S, 2009, ASN NEURO, V1, DOI 10.1042/AN20090009; Coulson-Thomas VJ, 2016, OCUL SURF, V14, P121, DOI 10.1016/j.jtos.2015.11.004; Coulson-Thomas VJ, 2014, J BIOL CHEM, V289, P23465, DOI 10.1074/jbc.M114.557447; Coulson-Thomas YA, 2008, J NEUROSCI METH, V171, P19, DOI 10.1016/j.jneumeth.2008.01.030; Cragnolini AB, 2009, GLIA, V57, P1386, DOI 10.1002/glia.20857; DAHL D, 1976, BRAIN RES, V116, P150, DOI 10.1016/0006-8993(76)90257-2; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Dyer DP, 2016, J BIOL CHEM, V291, P12627, DOI 10.1074/jbc.M116.720953; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 2006, ADV EXP MED BIOL, V557, P11; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; GIRGRAH N, 1991, J NEUROPATH EXP NEUR, V50, P779, DOI 10.1097/00005072-199111000-00009; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HATHCOCK KS, 1993, J IMMUNOL, V151, P6712; He H, 2014, INVEST OPHTH VIS SCI, V55, P1647, DOI 10.1167/iovs.13-13094; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; Hull RL, 2012, J HISTOCHEM CYTOCHEM, V60, P749, DOI 10.1369/0022155412457048; HUTTON LA, 1992, J NEUROSCI RES, V32, P375, DOI 10.1002/jnr.490320309; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Jaworski DM, 1999, EXP NEUROL, V157, P327, DOI 10.1006/exnr.1999.7062; Kandel ER, 2000, SCIENCE, V290, P1113, DOI 10.1126/science.290.5494.1113; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; KUMAR S, 1993, MOL BRAIN RES, V17, P163, DOI 10.1016/0169-328X(93)90086-5; Kuznetsova SA, 2006, J CELL SCI, V119, P4499, DOI 10.1242/jcs.03171; Lauer M. E., 2015, INT J CELL BIOL; Lauer ME, 2015, J BIOL CHEM, V290, P23124, DOI 10.1074/jbc.M115.663823; Lauer ME, 2015, METHODS MOL BIOL, V1229, P543, DOI 10.1007/978-1-4939-1714-3_42; Lauer ME, 2014, J BIOL CHEM, V289, P29171, DOI 10.1074/jbc.M114.600809; Lauer ME, 2014, J BIOL CHEM, V289, P6791, DOI 10.1074/jbc.M113.512491; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lemons ML, 2001, J NEUROSCI, V21, P4772, DOI 10.1523/JNEUROSCI.21-13-04772.2001; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; MANSOUR H, 1990, J NEUROSCI RES, V25, P300, DOI 10.1002/jnr.490250306; Marson A, 2009, GLYCOBIOLOGY, V19, P1537, DOI 10.1093/glycob/cwp132; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Metea MR, 2006, GLIA, V54, P650, DOI 10.1002/glia.20352; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x; MORETTO G, 1993, J NEUROPATH EXP NEUR, V52, P419, DOI 10.1097/00005072-199307000-00009; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Nagy N, 2015, J CLIN INVEST, V125, P3928, DOI 10.1172/JCI79271; Nagyeri G, 2011, J BIOL CHEM, V286, P23559, DOI 10.1074/jbc.M111.222026; Naruse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053109; Niclou SP, 2006, J NEUROTRAUM, V23, P409, DOI 10.1089/neu.2006.23.409; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Oh JW, 1998, J IMMUNOL, V161, P4992; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Park Y, 2016, BIOCHEMISTRY-US, V55, P262, DOI 10.1021/acs.biochem.5b01148; Parkar AA, 1998, FEBS LETT, V428, P171, DOI 10.1016/S0014-5793(98)00523-7; Rodriguez-Grande B, 2014, J CEREBR BLOOD F MET, V34, P480, DOI 10.1038/jcbfm.2013.224; RUDGE JS, 1994, EUR J NEUROSCI, V6, P693, DOI 10.1111/j.1460-9568.1994.tb00981.x; Scavenius C, 2016, J BIOL CHEM, V291, P4658, DOI 10.1074/jbc.M115.678748; Shinoe T, 2010, J NEUROCHEM, V115, P1633, DOI 10.1111/j.1471-4159.2010.07072.x; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smith PD, 2015, EXP NEUROL, V274, P100, DOI 10.1016/j.expneurol.2015.08.004; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Spasova MS, 2014, EXP BIOL MED, V239, P724, DOI 10.1177/1535370213519195; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tan KT, 2011, J EUR ACAD DERMATOL, V25, P317, DOI 10.1111/j.1468-3083.2010.03792.x; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; Wang H, 2015, EUR J PHARMACOL, V751, P42, DOI 10.1016/j.ejphar.2015.01.040; Wang Y, 1998, ACTA NEUROPATHOL, V96, P357, DOI 10.1007/s004010050906; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Ye L, 1997, CIRC RES, V81, P289, DOI 10.1161/01.RES.81.3.289; YOKOYAMA M, 1993, EXP NEUROL, V124, P377, DOI 10.1006/exnr.1993.1209; Zhang SZ, 2012, J BIOL CHEM, V287, P12433, DOI 10.1074/jbc.M112.342873; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	115	35	40	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19939	19952		10.1074/jbc.M115.710673			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	WOS:000383243100018	27435674	Green Published, hybrid			2022-02-06	
J	Lipponen, A; Paananen, J; Puhakka, N; Pitkanen, A				Lipponen, Anssi; Paananen, Jussi; Puhakka, Noora; Pitkanen, Asla			Analysis of Post-Traumatic Brain Injury Gene Expression Signature Reveals Tubulins, Nfe2l2, Nfkb, Cd44, and S100a4 as Treatment Targets	SCIENTIFIC REPORTS			English	Article							RAT CEREBRAL-CORTEX; CHEMOKINE EXPRESSION; CELL-DEATH; HIPPOCAMPAL; RESPONSES; NEUROPROTECTION; ACTIVATION; MECHANISMS; PATTERNS; EPILEPSY	We aimed to define the chronically altered gene expression signature of traumatic brain injury (TBI-sig) to discover novel treatments to reverse pathologic gene expression or reinforce the expression of recovery-related genes. Genome-wide RNA-sequencing was performed at 3 months post-TBI induced by lateral fluid-percussion injury in rats. We found 4964 regulated genes in the perilesional cortex and 1966 in the thalamus (FDR < 0.05). TBI-sig was used for a LINCS analysis which identified 11 compounds that showed a strong connectivity with the TBI-sig in neuronal cell lines. Of these, celecoxib and sirolimus were recently reported to have a disease-modifying effect in in vivo animal models of epilepsy. Other compounds revealed by the analysis were BRD-K91844626, BRD-A11009626, NO-ASA, BRD-K55260239, SDZ-NKT-343, STK-661558, BRD-K75971499, ionomycin, and desmethylclomipramine. Network analysis of overlapping genes revealed the effects on tubulins (Tubb2a, Tubb3, Tubb4b), Nfe2l2, S100a4, Cd44, and Nfkb2, all of which are linked to TBI-relevant outcomes, including epileptogenesis and tissue repair. Desmethylclomipramine modulated most of the gene targets considered favorable for TBI outcome. Our data demonstrate long-lasting transcriptomics changes after TBI. LINCS analysis predicted that these changes could be modulated by various compounds, some of which are already in clinical use but never tested in TBI.	[Lipponen, Anssi; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Epilepsy Res Lab, POB 1627, FIN-70211 Kuopio, Finland; [Paananen, Jussi] Univ Eastern Finland, Inst Biomed, FIN-70211 Kuopio, Finland; [Paananen, Jussi] Univ Eastern Finland, Bioinformat Ctr, FIN-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Epilepsy Res Lab, POB 1627, FIN-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Paananen, Jussi/0000-0001-5100-4907; Lipponen, Anssi/0000-0002-4403-9084	Academy of FinlandAcademy of FinlandEuropean Commission; EpiGENet EUROEPINOMICS; FP7-HEALTH project [602102]; ERA-NET Neuron [TBI Epilepsy]	This study was supported by the Academy of Finland (A.P.), EpiGENet EUROEPINOMICS (A.P.), FP7-HEALTH project 602102 (EPITARGET), ERA-NET Neuron [TBI Epilepsy]. We thank Mr. Jarmo Hartikainen and Mrs. Merja Lukkari for their excellent technical assistance. We also grateful to Mr. Juha Kekalainen, for his excellent help in bioinformatics analysis.	Chattopadhyay M, 2010, J PHARMACOL EXP THER, V335, P443, DOI 10.1124/jpet.110.171017; Colak T, 2012, INJURY, V43, P1264, DOI 10.1016/j.injury.2012.01.021; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Cushion TD, 2014, AM J HUM GENET, V94, P634, DOI 10.1016/j.ajhg.2014.03.009; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; DELEON M, 1991, J NEUROSCI RES, V29, P155; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dmytriyeva O, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2202; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolenec P, 2015, J NEUROPATH EXP NEUR, V74, P512, DOI 10.1097/NEN.0000000000000194; Dougall D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009221.pub2; Faul M., 2010, BRAIN INJURY US EMER; Gallorini M, 2015, BIOMATERIALS, V56, P114, DOI 10.1016/j.biomaterials.2015.03.047; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P389, DOI 10.1007/978-3-211-85578-2_75; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Hardingham GE, 2016, NAT REV NEUROSCI, V17, P1, DOI 10.1038/nrn.2015.19; Hellmich HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053230; Ishikawa Y, 2006, ACTA NEUROCHIR SUPPL, V96, P163; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; LIU CM, 1978, J BIOL CHEM, V253, P5892; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Pitkanen A, 2014, NEUROBIOL DIS, V72, P224, DOI 10.1016/j.nbd.2014.05.037; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Renato B., 2015, J NEUROL NEUROPHYSIO; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Samal BB, 2015, J MOL NEUROSCI, V57, P282, DOI 10.1007/s12031-015-0626-2; Sandberg M, 2014, NEUROPHARMACOLOGY, V79, P298, DOI 10.1016/j.neuropharm.2013.11.004; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Stylli SS, 2000, J CLIN NEUROSCI, V7, P137, DOI 10.1054/jocn.1999.0187; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Vonder Haar C, 2014, J NEUROTRAUM, V31, P961, DOI 10.1089/neu.2013.3119; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; White TE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2412-0; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wingett S., FASTQC QUALITY CONTR; Wong YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020216; Zhang XY, 2014, GENET MOL RES, V13, P9220, DOI 10.4238/2014.November.7.9	55	35	35	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 17	2016	6								31570	10.1038/srep31570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4YH	WOS:000381487000001	27530814	Green Published, gold			2022-02-06	
J	Clark, KC; Josephson, A; Benusa, SD; Hartley, RK; Baer, M; Thummala, S; Joslyn, M; Sword, BA; Elford, H; Oh, U; Dilsizoglu-Senol, A; Lubetzki, C; Davenne, M; DeVries, GH; Dupree, JL				Clark, Kareem C.; Josephson, Anna; Benusa, Savannah D.; Hartley, Rebecca K.; Baer, Matthew; Thummala, Suneel; Joslyn, Martha; Sword, Brooke A.; Elford, Howard; Oh, Unsong; Dilsizoglu-Senol, Aysegul; Lubetzki, Catherine; Davenne, Marc; DeVries, George H.; Dupree, Jeffrey L.			Compromised Axon Initial Segment Integrity in EAE Is Preceded by Microglial Reactivity and Contact	GLIA			English	Article						multiple sclerosis; demyelination; axonal domain; inflammation; axonal pathology	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RIBONUCLEOTIDE REDUCTASE INHIBITORS; ACTIVITY-DEPENDENT RELOCATION; CHRONIC MULTIPLE-SCLEROSIS; TRAUMATIC BRAIN-INJURY; SODIUM-CHANNEL; WHITE-MATTER; MOUSE MODEL; CORTICAL DEMYELINATION; MOLECULAR DOMAINS	Axonal pathology is a key contributor to long-term disability in multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system (CNS), but the mechanisms that underlie axonal pathology in MS remain elusive. Evidence suggests that axonal pathology is a direct consequence of demyelination, as we and others have shown that the node of Ranvier disassembles following loss of myelin. In contrast to the node of Ranvier, we now show that the axon initial segment (AIS), the axonal domain responsible for action potential initiation, remains intact following cuprizone-induced cortical demyelination. Instead, we find that the AIS is disrupted in the neocortex of mice that develop experimental autoimmune encephalomyelitis (EAE) independent of local demyelination. EAE-induced mice demonstrate profound compromise of AIS integrity with a progressive disruption that corresponds to EAE clinical disease severity and duration, in addition to cortical microglial reactivity. Furthermore, treatment with the drug didox results in attenuation of AIS pathology concomitantly with microglial reversion to a less reactive state. Together, our findings suggest that inflammation, but not demyelination, disrupts AIS integrity and that therapeutic intervention may protect and reverse this pathology.	[Clark, Kareem C.; Josephson, Anna; Benusa, Savannah D.; Hartley, Rebecca K.; Baer, Matthew; Thummala, Suneel; DeVries, George H.; Dupree, Jeffrey L.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, POB 980709,1101 East Marshall St, Richmond, VA 23298 USA; [Clark, Kareem C.; Benusa, Savannah D.] VCU, Neurosci Curriculum, Richmond, VA USA; [Joslyn, Martha; Sword, Brooke A.; DeVries, George H.; Dupree, Jeffrey L.] Hunter Holmes McGuire VA Med Ctr, Dept Res, Richmond, VA USA; [Elford, Howard] Mol Hlth Inc, Richmond, VA USA; [Oh, Unsong] VCU, Dept Neurol, Richmond, VA USA; [Dilsizoglu-Senol, Aysegul; Lubetzki, Catherine; Davenne, Marc] Univ Paris 04, Univ Paris 06, UMR S 1127,CNRS UMR 7225, Inst Cerveau & Moelle Epiniere,ICM,INSERM,U 1127, F-75013 Paris, France; [Lubetzki, Catherine] Hop La Pitie Salpetriere, AP HP, F-75013 Paris, France		Dupree, JL (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, POB 980709,1101 East Marshall St, Richmond, VA 23298 USA.	jldupree@vcu.edu		Benusa, Savannah/0000-0002-1430-9928	National Multiple Sclerosis Society pilot grant; Veterans Affairs MeritUS Department of Veterans Affairs [5IO1BX002565, 101BX001759]; VAUS Department of Veterans Affairs; NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5P30NS047463]	Grant sponsors: National Multiple Sclerosis Society pilot grant and Veterans Affairs Merit; Grant number: 5IO1BX002565 (to J.L.D.) and 101BX001759 (to G.H.D.V.); Grant sponsor: VA provided salary support (to J.L.D.; G.H.D.V.).; Grant sponsor: NIH-NINDS; Grant number: 5P30NS047463	Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; Arnett HA, 2002, J IMMUNOL, V168, P427, DOI 10.4049/jimmunol.168.1.427; Baalman K, 2015, J NEUROSCI, V35, P2283, DOI 10.1523/JNEUROSCI.3751-14.2015; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Bhasin M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-10; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bhave S, 2013, ANTIVIR RES, V100, P151, DOI 10.1016/j.antiviral.2013.07.016; Bjartmar C, 2001, NEUROLOGY, V57, P1248, DOI 10.1212/WNL.57.7.1248; Black JA, 2007, J NEUROPATH EXP NEUR, V66, P828, DOI 10.1097/nen.0b013e3181462841; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Burns T, 2014, J NEUROPATH EXP NEUR, V73, P335, DOI 10.1097/NEN.0000000000000058; Buttermore ED, 2013, J NEUROSCI RES, V91, P603, DOI 10.1002/jnr.23197; Calabrese M, 2015, NAT REV NEUROSCI, V16, P147, DOI 10.1038/nrn3900; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; Criste G, 2014, HAND CLINIC, V122, P101, DOI 10.1016/B978-0-444-52001-2.00005-4; Das A, 2013, J NEUROCHEM, V124, P133, DOI 10.1111/jnc.12064; Das A, 2011, J ENDOCRINOL, V208, P171, DOI 10.1677/JOE-10-0338; DeLuca GC, 2006, BRAIN, V129, P1507, DOI 10.1093/brain/awl074; Desmazieres A, 2012, MULT SCLER J, V18, P133, DOI 10.1177/1352458511434370; DeVries G, 2012, FASEB J, V26, P3414; Doring A, 2015, J NEUROSCI, V35, P1136, DOI [10.1523/JNEUROSCI.1797-14.2015, 10.1523/JNEUROSCI.1797-14]; Dupree JL, 2004, NEURON GLIA BIOL, V1, P179, DOI 10.1017/S1740925X04000304; Dupree JL, 2015, J NEUROCHEM, V134, P302, DOI 10.1111/jnc.13114; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005; Dutta R, 2011, ANN NEUROL, V69, P445, DOI 10.1002/ana.22337; Elford HL, 2013, INT J MS CARE, V15, P54; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Evans MD, 2013, J NEUROSCI, V33, P6950, DOI 10.1523/JNEUROSCI.0277-13.2013; Figul M, 2003, CANCER CHEMOTH PHARM, V52, P41, DOI 10.1007/s00280-003-0611-2; Fjaer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084162; Furukawa K, 1998, J NEUROCHEM, V70, P1876; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Greer JM, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/151427; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Gudi V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00073; Guemez-Gamboa A, 2011, J NEUROPATH EXP NEUR, V70, P1020, DOI 10.1097/NEN.0b013e3182358e4e; Gutzmann A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00011; Guyton MK, 2009, J NEUROCHEM, V110, P1895, DOI 10.1111/j.1471-4159.2009.06287.x; Guyton MK, 2005, J NEUROSCI RES, V81, P53, DOI 10.1002/jnr.20470; Haji N, 2012, EXP NEUROL, V237, P296, DOI 10.1016/j.expneurol.2012.07.010; Hamada MS, 2015, J NEUROSCI, V35, P7272, DOI 10.1523/JNEUROSCI.4747-14.2015; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hendrickx DAE, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-64; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hinman JD, 2013, STROKE, V44, P182, DOI 10.1161/STROKEAHA.112.668749; Howell OW, 2010, J NEUROPATH EXP NEUR, V69, P1017, DOI 10.1097/NEN.0b013e3181f3a5b1; Huizinga R, 2012, GLIA, V60, P422, DOI 10.1002/glia.22276; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Inayat MS, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-43; Inayat MS, 2002, CANCER BIOL THER, V1, P539, DOI 10.4161/cbt.1.5.174; Ishibashi T, 2002, J NEUROSCI, V22, P6507; Janssens K, 2015, GLIA, V63, P1729, DOI 10.1002/glia.22840; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kornek B, 1999, BRAIN PATHOL, V9, P651; Kuba Hiroshi, 2010, Commun Integr Biol, V3, P597, DOI 10.4161/cib.3.6.13242; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Lassmann H, 1999, ACTA NEUROL BELG, V99, P6; Lewis ND, 2014, J NEUROIMMUNOL, V277, P26, DOI 10.1016/j.jneuroim.2014.09.014; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Mangiardi M, 2011, BRAIN PATHOL, V21, P263, DOI 10.1111/j.1750-3639.2010.00444.x; Marik C, 2007, BRAIN, V130, P2800, DOI 10.1093/brain/awm236; Matsebatlela TM, 2015, CHEM-BIOL INTERACT, V233, P95, DOI 10.1016/j.cbi.2015.03.027; Mayhew CN, 2002, ANTIVIR RES, V56, P167, DOI 10.1016/S0166-3542(02)00108-0; McMahon EJ, 2002, J NEUROIMMUNOL, V130, P32, DOI 10.1016/S0165-5728(02)00205-9; McVoy JRS, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0247-2; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Noor NA, 2015, INT J CLIN EXP PATHO, V8, P6269; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Pomicter AD, 2010, BRAIN, V133, P389, DOI 10.1093/brain/awp341; Popescu Bogdan F Gh, 2013, Continuum (Minneap Minn), V19, P901, DOI 10.1212/01.CON.0000433291.23091.65; Povlishock JT, 1999, ACT NEUR S, V73, P15; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; Rawji KS, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/948976; Recks MS, 2013, CLIN IMMUNOL, V149, P32, DOI 10.1016/j.clim.2013.06.004; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Rosenbluth J, 2003, GLIA, V41, P318, DOI 10.1002/glia.10179; Sama DM, 2013, AGEING RES REV, V12, P982, DOI 10.1016/j.arr.2013.05.008; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Shepherd MN, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.001; Skripuletz T, 2008, AM J PATHOL, V172, P1053, DOI 10.2353/ajpath.2008.070850; Spence RD, 2014, NEUROIMAGE, V101, P625, DOI 10.1016/j.neuroimage.2014.07.017; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Sun JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14235; Susuki K, 2008, CURR OPIN CELL BIOL, V20, P616, DOI 10.1016/j.ceb.2008.09.007; Suzuki A, 2004, GLIA, V46, P274, DOI 10.1002/glia.20008; Taetzsch T, 2015, GLIA, V63, P423, DOI 10.1002/glia.22762; Trager N, 2014, J NEUROCHEM, V130, P268, DOI 10.1111/jnc.12659; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Turchan J, 2003, NEUROLOGY, V60, P307, DOI 10.1212/01.WNL.0000042048.85204.3D; Vogel PA, 2015, HYPERTENSION, V66, P374, DOI 10.1161/HYPERTENSIONAHA.115.05274; Waxman SG, 2008, ANN NEUROL, V63, P411, DOI 10.1002/ana.21361; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zoupi L, 2013, GLIA, V61, P1236, DOI 10.1002/glia.22511	108	35	35	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JUL	2016	64	7					1190	1209		10.1002/glia.22991			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DX9WW	WOS:000384748700006	27100937				2022-02-06	
J	Leeper, CM; Kutcher, M; Nasr, I; McKenna, C; Billiar, T; Neal, M; Sperry, J; Gaines, BA				Leeper, Christine M.; Kutcher, Matthew; Nasr, Isam; McKenna, Christine; Billiar, Timothy; Neal, Matthew; Sperry, Jason; Gaines, Barbara A.			Acute traumatic coagulopathy in a critically injured pediatric population: Definition, trend over time, and outcomes	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	29th Annual Scientific Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 09-16, 2016	San Antonio, TX	Eastern Assoc Surg Trauma		Acute traumatic coagulopathy; pediatric; international normalized ratio; mortality; transfusion	INTERNATIONAL NORMALIZED RATIO; FROZEN PLASMA TRANSFUSION; MULTIPLE ORGAN FAILURE; BRAIN-INJURY; HEAD TRAUMA; CHILDREN; MORTALITY; ADMISSION; PREDICTS; MODERATE	BACKGROUND: While our understanding of acute traumatic coagulopathy (ATC) in adults is advancing, the pediatric literature on ATC is limited. Children have a unique injury profile and physiologic response to trauma; however, the impact of this phenomenon on ATC has not been fully elucidated. METHODS: We performed a retrospective review of our trauma registry from 2005 to 2014. Level 1 trauma patients age 0 year to 17 years requiring admission to the intensive care unit were included. Variables included admission vital signs and laboratory studies, product transfusion, injuries, and mortality. Youden index was used to determine optimum cutoff point for admission international normalized ratio (INR) as a predictor of mortality. Logistic regression modeling was used to determine independent predictors of mortality adjusting for hypotension, hypothermia, acidosis, injury severity, hemorrhage, and head injury. chi (2) tests were performed evaluating for association between mortality and 24-hour INR as well as between transfusion and INR correction. RESULTS: A total of 776 patients were analyzed: 29.2% (n = 227) had an admission INR of 1.3 or greater, and 13.3% (n = 103) had an admission INR of 1.5 or greater. Youden index demonstrated optimum cutoff at INR of 1.3 or greater to distinguish survivors and nonsurvivors. Overall mortality rate was 11.1% (n = 86). Elevated INR was independently associated with mortality (odds ratio, 3.77; p < 0.001) after controlling for other predictors in regression modeling. Death was also associated with elevated INR at 24 hours and worsening INR trend over time. Patients who received plasma were equally likely to normalize their INR compared with those who were not transfused (p = nonsignificant). Findings were consistent across age groups. CONCLUSION: INR likely serves as a marker of systemic dysregulation rather than a treatment target in ATC. Elevated admission INR, elevated INR at 24 hours, and overall trend in INR strongly predict mortality in a diverse pediatric trauma population; however, product transfusion did not influence the INR trend or clinical outcome. Further research is warranted to evaluate potential upstream mediators of ATC and targets for intervention in pediatric trauma patients. (J Trauma Acute Care Surg. 2016; 81: 34-41. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Leeper, Christine M.; Kutcher, Matthew; Billiar, Timothy; Neal, Matthew; Sperry, Jason] Univ Pittsburgh, Dept Surg, Div Gen Surg & Trauma, Med Ctr, Pittsburgh, PA 15224 USA; [Leeper, Christine M.; McKenna, Christine; Gaines, Barbara A.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Nasr, Isam] Johns Hopkins Univ Hosp, Div Pediat Surg, Baltimore, MD 21287 USA		Gaines, BA (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, UPMC, 7th Floor,Fac Pavil,One Childrens Hosp Dr, Pittsburgh, PA 15224 USA.	Barbara.Gaines@chp.edu		Kutcher, Matthew/0000-0003-4566-5359			Abdel-Wahab OI, 2006, TRANSFUSION, V46, P1279, DOI 10.1111/j.1537-2995.2006.00891.x; Acker SN, 2015, J PEDIATR SURG, V50, P331, DOI 10.1016/j.jpedsurg.2014.08.009; Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Agren A, 2013, SCAND J CLIN LAB INV, V73, P214, DOI 10.3109/00365513.2013.765960; Attard C, 2013, J THROMB HAEMOST, V11, P1850, DOI 10.1111/jth.12372; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Calkins CM, 2002, J TRAUMA, V53, P1058, DOI 10.1097/00005373-200212000-00005; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2013, 10 LEAD CAUS DEATH A; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; DZIK WH, 2009, ROSSIS PRINCIPLES TR, P575; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Esmon CT, 2011, J THROMB HAEMOST, V9, P182, DOI 10.1111/j.1538-7836.2011.04323.x; Eswald MB, 2010, TXB PEDIAT EMERGENCY, V6, P1009; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Frith D, 2010, SURG-J R COLL SURG E, V8, P159, DOI 10.1016/j.surge.2009.10.022; Gardner AR, 2015, J TRAUMA ACUTE CARE, V78, P1143, DOI 10.1097/TA.0000000000000658; Gonzalez E, 2014, SCAND J SURG, V103, P89, DOI 10.1177/1457496914531927; Hendrickson JE, 2012, J PEDIAT, V160; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Janus J, 2010, AM FAM PHYSICIAN, V81, P1462; Kleinman ME, 2010, PEDIATRICS, V126, pE1361, DOI 10.1542/peds.2010-2972D; Lao ZQ, 2012, INT J PREVENTIVE MED, V3, P303; Leeper C, 2015, J TRAUMA ACUTE CARE; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Peltan ID, 2015, CRIT CARE MED, V43, P1429, DOI 10.1097/CCM.0000000000000981; Rowell SE, 2014, J TRAUMA ACUTE CARE, V77, P846, DOI 10.1097/TA.0000000000000459; Soundar EP, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0064-1; Stewart CL, 2013, J PEDIATR SURG, V48, P2106, DOI 10.1016/j.jpedsurg.2013.05.009; Suominen P, 1998, INJURY, V29, P425; Swanson CA, 2010, J TRAUMA, V68, P1072, DOI 10.1097/TA.0b013e3181d7a6f2; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5; Upperman JS, 2010, J TRAUMA, V69, P1304, DOI 10.1097/TA.0b013e3181fa4858; Vallipakorn SAO, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-60; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P13, DOI 10.1097/00008506-200101000-00003; Vogel AM, 2013, J PEDIATR SURG, V48, P1371, DOI 10.1016/j.jpedsurg.2013.03.036; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	48	35	37	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2016	81	1					34	41		10.1097/TA.0000000000001002			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	DS5BV	WOS:000380796400007	26886002				2022-02-06	
J	Poole, VN; Robinson, ME; Singleton, O; DeGutis, J; Milberg, WP; McGlinchey, RE; Salat, DH; Esterman, M				Poole, Victoria N.; Robinson, Meghan E.; Singleton, Omar; DeGutis, Joseph; Milberg, William P.; McGlinchey, Regina E.; Salat, David H.; Esterman, Michael			Intrinsic functional connectivity predicts individual differences in distractibility	NEUROPSYCHOLOGIA			English	Article						Attention; Distraction; Functional connectivity; Support vector regression; Resting-State fMRI	DEFAULT-MODE NETWORK; TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN-INJURY; FRONTAL EYE FIELD; RESTING-STATE; ATTENTIONAL CAPTURE; VISUAL-ATTENTION; TOP-DOWN; PSYCHOLOGICAL SYMPTOMS; INTERFERENCE CONTROL	Distractor suppression, the ability to filter and ignore task-irrelevant information, is critical for efficient task performance. While successful distractor suppression relies on a balance of activity in neural networks responsible for attention maintenance (dorsal attention network; DAN), reorientation (ventral attention network; VAN), and internal thought (default mode network, DMN), the degree to which intrinsic connectivity within and between these networks contributes to individual differences in distractor suppression ability is not well-characterized. For the purposes of understanding these interactions, the current study collected resting-state fMRI data from 32 Veterans and, several months later (7 5 months apart), performance on the additional singleton paradigm, a measure of distractor suppression. Using multivariate support vector regression models composed of resting state connectivity between regions of the DAN, VAN, and DMN, and a leave-one-subject-out cross-validation procedure, we were able to predict an individual's task performance, yielding a significant correlation between the actual and predicted distractor suppression (r=0.48, p=0.0053). Network-level analyses revealed that greater within-network DMN connectivity was predictive of better distractor suppression, while greater connectivity between the DMN and attention networks was predictive of poorer distractor suppression. The strongest connection hubs were determined to be the right frontal eye field and temporoparietal junction of the DAN and VAN, respectively, and medial (ventromedial prefrontal and posterior cingulate cortices) and bilateral prefrontal regions of the DMN. These results are amongst a small but growing number of studies demonstrating that resting state connectivity is related to stable individual differences in cognitive ability, and suggest that greater integrity and independence of the DMN is related to better attentional ability. Published by Elsevier Ltd.	[Poole, Victoria N.; Robinson, Meghan E.; DeGutis, Joseph; Milberg, William P.; McGlinchey, Regina E.; Salat, David H.; Esterman, Michael] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, VA RR&D TBI Ctr Excellence, 150 S Huntington Ave, Boston, MA 02130 USA; [Poole, Victoria N.] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA; [Poole, Victoria N.; DeGutis, Joseph; Milberg, William P.; McGlinchey, Regina E.; Salat, David H.] Harvard Univ, Sch Med, Boston, MA USA; [Poole, Victoria N.; Robinson, Meghan E.; Salat, David H.; Esterman, Michael] VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, 150 S Huntington Ave, Boston, MA 02130 USA; [Poole, Victoria N.; Singleton, Omar; DeGutis, Joseph; Esterman, Michael] VA Boston Healthcare Syst, Boston Attent & Learning Lab BAL1LAB, 150 S Huntington Ave, Boston, MA 02130 USA; [Robinson, Meghan E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, 150 S Huntington Ave, Boston, MA 02130 USA; [Salat, David H.] AA Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Esterman, Michael] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA		Poole, VN (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA.	vpoole@bidmc.harvard.edu	McGlinchey, Regina E/R-1971-2016	Poole, Victoria/0000-0003-0974-2564	Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B9254-C]; Department of Veterans Affairs Clinical Sciences Research and DevelopmentUS Department of Veterans Affairs [1IK2CX000706-01A2]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5T32AG023480]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG023480] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX000706] Funding Source: NIH RePORTER	This research was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B9254-C), a Career Development award to M. E. from the Department of Veterans Affairs Clinical Sciences Research and Development (1IK2CX000706-01A2), and an institutional training award to V. P. from National Institutes of Health (T32 Grant 5T32AG023480).	Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Balthazar MLF, 2014, HUM BRAIN MAPP, V35, P1237, DOI 10.1002/hbm.22248; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bourel-Ponchel E, 2011, EUR J PAEDIATR NEURO, V15, P123, DOI 10.1016/j.ejpn.2010.08.008; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Clapp WC, 2012, NEUROBIOL AGING, V33, P134, DOI 10.1016/j.neurobiolaging.2010.01.012; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Connor CE, 2004, CURR BIOL, V14, pR850, DOI 10.1016/j.cub.2004.09.041; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Havas JA, 2012, NEUROIMAGE, V59, P1745, DOI 10.1016/j.neuroimage.2011.08.026; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; Eglin M, 1989, J Cogn Neurosci, V1, P372, DOI 10.1162/jocn.1989.1.4.372; Esterman M, 2015, NEUROIMAGE, V111, P542, DOI 10.1016/j.neuroimage.2015.01.044; Esterman M, 2014, J NEUROSCI, V34, P1724, DOI 10.1523/JNEUROSCI.2658-13.2014; Esterman M, 2013, J INT NEUROPSYCH SOC, V19, P835, DOI 10.1017/S135561771300057X; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Finn ES, 2015, NAT NEUROSCI, V18, P1664, DOI 10.1038/nn.4135; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037//0096-1523.18.4.1030; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Forstmann BU, 2008, J COGNITIVE NEUROSCI, V20, P1854, DOI 10.1162/jocn.2008.20122; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Halko MA, 2014, J NEUROSCI, V34, P12049, DOI 10.1523/JNEUROSCI.1776-14.2014; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Hung J, 2011, J NEUROSCI, V31, P15904, DOI 10.1523/JNEUROSCI.2626-11.2011; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kucyi A, 2014, NEUROIMAGE, V100, P471, DOI 10.1016/j.neuroimage.2014.06.044; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Mayer JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048586; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Moser JS, 2012, EMOTION, V12, P213, DOI 10.1037/a0026156; Reineberg AE, 2015, NEUROIMAGE, V104, P69, DOI 10.1016/j.neuroimage.2014.09.045; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Rosenberg MD, 2016, NAT NEUROSCI, V19, P165, DOI 10.1038/nn.4179; Rosenberg MD, 2015, NEUROIMAGE, V114, P249, DOI 10.1016/j.neuroimage.2015.03.032; Sala-Llonch R, 2012, CORTEX, V48, P1187, DOI 10.1016/j.cortex.2011.07.006; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Theeuwes J, 2004, PSYCHON B REV, V11, P65, DOI 10.3758/BF03206462; Theeuwes J, 1998, J EXP PSYCHOL HUMAN, V24, P1342, DOI 10.1037/0096-1523.24.5.1342; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Theeuwes J, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0055; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Visintin E, 2015, BEHAV BRAIN RES, V278, P315, DOI 10.1016/j.bbr.2014.10.002; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Weathers F. W., 1994, PCL C FOR DSM 4; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wotruba D, 2014, SCHIZOPHRENIA BULL, V40, P1095, DOI 10.1093/schbul/sbt161; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	72	35	36	0	24	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JUN	2016	86						176	182		10.1016/j.neuropsychologia.2016.04.023			7	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	DP4GC	WOS:000378453400018	27132070				2022-02-06	
J	Kroshus, E; Baugh, CM				Kroshus, Emily; Baugh, Christine M.			Concussion Education in US Collegiate Sport: What Is Happening and What Do Athletes Want?	HEALTH EDUCATION & BEHAVIOR			English	Article						college health; dissemination and implementation; health communications; injury prevention; safety; school-based	ICE HOCKEY; KNOWLEDGE; PLAYERS; BRAIN; EPIDEMIOLOGY; SYMPTOMS; INJURIES; MEDICINE; BEHAVIOR; POLICY	Concussion education for athletes has the potential to play a role in reducing the health burden of concussions from sport by modifying individual risk-related behaviors. In U.S. collegiate sport, decisions about content and delivery of concussion education are left up to the individual institution. This may result in a high degree of variability in what educational materials athletes receive and is particularly problematic as few concussion education programs have demonstrated efficacy. Health educators can play an important role in working collaboratively with sports medicine clinicians to design and evaluate evidence-based concussion education materials for athletes that meet their learning needs. As a first step in this process, the present study characterizes the content, source, and delivery modalities of concussion currently being provided to U.S. collegiate athletes. It also describes the reported concussion education preferences of a sample of U.S. collegiate athletes. Participants were 789 athletic trainers from 276 schools and 325 athletes from four schools. Results indicated that education is most frequently provided by athletic trainers but that many athletes would also like coaches and physicians to be involved in this process. Athletes also indicated a preference for content provision across a range of topics, including athletic and academic consequences of continued play with a concussion. Implications for the design and delivery of concussion education for athletes are discussed.	[Kroshus, Emily] Univ Washington, Dept Pediat, 2001 Eighth Ave,Suite 400, Seattle, WA 98121 USA; [Kroshus, Emily] Ctr Child Hlth Behav & Dev, Seattle Childrens Res Inst, Seattle, WA USA; [Kroshus, Emily] Natl Collegiate Athlet Assoc, Indianapolis, IN USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Baugh, Christine M.] Boston Childrens Hosp, Micheli Ctr Sports Injury Prevent, Boston, MA USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, 2001 Eighth Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338	National Institute of Mental Health of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Christine Baugh was supported by the National Institute of Mental Health of the National Institutes of Health under Award No. T32MH019733.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Campbell, 2005, NEEDS CAPACITY ASSES; Chan DKC, 2012, SPORTS MED, V42, P725, DOI 10.2165/11633040-000000000-00000; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dickinson D, 2003, BRIT MED J, V327, P861, DOI 10.1136/bmj.327.7419.861-a; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, EAT DISORD, V22, P136, DOI 10.1080/10640266.2013.867744; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; LaBrie JW, 2010, ADDICT BEHAV, V35, P1094, DOI 10.1016/j.addbeh.2010.08.003; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; National Collegiate Athletic Association, CONC FACT SHEET STUD; National Collegiate Athletic Association, 2013, NCAA SPORTS MED HDB; National Collegiate Athletic Association, 2014, DIV I STEER COMM GOV; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Verhagen EALM, 2010, SPORTS MED, V40, P899, DOI 10.2165/11536890-000000000-00000	42	35	35	0	30	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1090-1981	1552-6127		HEALTH EDUC BEHAV	Health Educ. Behav.	APR	2016	43	2					182	190		10.1177/1090198115599380			9	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DI7RN	WOS:000373699600009	26293460	Green Accepted			2022-02-06	
J	Gao, X; Wang, XT; Xiong, WH; Chen, JH				Gao, Xiang; Wang, Xiaoting; Xiong, Wenhui; Chen, Jinhui			In vivo reprogramming reactive glia into iPSCs to produce new neurons in the cortex following traumatic brain injury	SCIENTIFIC REPORTS			English	Article							CONTROLLED CORTICAL IMPACT; PLURIPOTENT STEM-CELLS; CARDIAC FIBROBLASTS; NERVOUS-SYSTEM; SOX2 FUNCTIONS; DENTATE GYRUS; RAT; NEUROGENESIS; HIPPOCAMPUS; ASTROCYTES	Traumatic brain injury (TBI) results in a significant amount of cell death in the brain. Unfortunately, the adult mammalian brain possesses little regenerative potential following injury and little can be done to reverse the initial brain damage caused by trauma. Reprogramming adult cells to generate induced pluripotent stem cell (iPSCs) has opened new therapeutic opportunities to generate neurons in a non-neurogenic regions in the cortex. In this study we showed that retroviral mediated expression of four transcription factors, Oct4, Sox2, Klf4, and c-Myc, cooperatively reprogrammed reactive glial cells into iPSCs in the adult neocortex following TBI. These iPSCs further differentiated into a large number of neural stem cells, which further differentiated into neurons and glia in situ, and filled up the tissue cavity induced by TBI. The induced neurons showed a typical neuronal morphology with axon and dendrites, and exhibited action potential. Our results report an innovative technology to transform reactive glia into a large number of functional neurons in their natural environment of neocortex without embryo involvement and without the need to grow cells outside the body and then graft them back to the brain. Thus this technology offers hope for personalized regenerative cell therapies for repairing damaged brain.	[Gao, Xiang; Wang, Xiaoting; Xiong, Wenhui; Chen, Jinhui] Indiana Univ, Stark Neurosci Res Inst, Dept Neurosurg, Spinal Cord & Brain Injury Res Grp, 320 W 15th St, Indianapolis, IN 46202 USA		Chen, JH (corresponding author), Indiana Univ, Stark Neurosci Res Inst, Dept Neurosurg, Spinal Cord & Brain Injury Res Grp, 320 W 15th St, Indianapolis, IN 46202 USA.	chen204@iupui.edu			Indiana Spinal Cord & Brain Injury Research [SCBI 200-12]; Ralph W. and Grace M. Showalter Research Award; Indiana University Biological Research Grant; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RR025761, 1R21NS072631-01A]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS072631] Funding Source: NIH RePORTER	The retroviral vector expressing hOKSM was a gift from Dr. Wen-Shu Wu. This work was supported by funding from the Indiana Spinal Cord & Brain Injury Research Grants (SCBI 200-12), the Ralph W. and Grace M. Showalter Research Award, Indiana University Biological Research Grant, NIH grants RR025761 and 1R21NS072631-01A.	About I, 2000, AM J PATHOL, V157, P287, DOI 10.1016/S0002-9440(10)64539-7; Andressen C, 2001, STEM CELLS, V19, P419, DOI 10.1634/stemcells.19-5-419; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Chung S, 2006, J NEUROCHEM, V97, P1467, DOI 10.1111/j.1471-4159.2006.03841.x; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Gupta Y K, 2006, Indian J Physiol Pharmacol, V50, P7; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jiang Taipeng, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P392; Kelly Kevin M, 2004, Epilepsy Curr, V4, P160, DOI 10.1111/j.1535-7597.2004.44015.x; Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lee MO, 2013, P NATL ACAD SCI USA, V110, pE3281, DOI 10.1073/pnas.1303669110; Li R, 2013, PROTEIN CELL, V4, P415, DOI 10.1007/s13238-013-2089-y; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Magavi S. S. P., 2003, J NEUROSCI, V25, P10729; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Minino Arialdi M, 2006, Natl Vital Stat Rep, V54, P1; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Nishimura K, 2013, BIOL PHARM BULL, V36, P171, DOI 10.1248/bpb.b12-00929; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Prigatano GP, 2005, ACT NEUR S, V93, P39; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; Rakic P, 2006, SCIENCE, V313, P928, DOI 10.1126/science.1131713; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Stiles J, 2005, TRENDS COGN SCI, V9, P136, DOI 10.1016/j.tics.2005.01.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2013, DEVELOPMENT, V140, P2457, DOI 10.1242/dev.092551; Tanabe K, 2013, P NATL ACAD SCI USA, V110, P12172, DOI 10.1073/pnas.1310291110; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	70	35	37	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 9	2016	6								22490	10.1038/srep22490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF8IF	WOS:000371600400001	26957147	Green Published, gold			2022-02-06	
J	Lin, CM; Tseng, YC; Hsu, HL; Chen, CJ; Chen, DYT; Yan, FX; Chiu, WT				Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian; Chiu, Wen-Ta			Arterial Spin Labeling Perfusion Study in the Patients with Subacute Mild Traumatic Brain Injury	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; SEVERE HEAD-INJURY; TECHNETIUM-99M-HMPAO SPECT; ISCHEMIA; FLOW; MRI; 3T; CT	Background This study uses a MRI technique, three-dimension pulse continuous arterial spin labeling (3D-PCASL), to measure the patient's cerebral blood flow (CBF) at the subacute stage of mild traumatic brain injury (MTBI) in order to analyze the relationship between cerebral blood flow and neurocognitive deficits. Objective To provide the relationship between cortical CBF and neuropsychological dysfunction for the subacute MTBI patients. Methods After MTBI, perfusion MR imaging technique (3D-PCASL) measures the CBF of MTBI patients (n = 23) within 1 month and that of normal controls (n = 22) to determine the quantity and location of perfusion defect. The correlation between CBF abnormalities and cognitive deficits was elucidated by combining the results of the neuropsychological tests of the patients. Result We observed a substantial reduction in CBF in the bilateral frontal and left occipital cortex as compared with the normal persons. In addition, there were correlation between post concussive symptoms (including dizziness and simulator sickness) and CBF in the hypoperfused areas. The more severe symptom was correlated with higher CBF in bilateral frontal and left occipital lobes. Conclusion First, this study determined that despite no significant abnormality detected on conventional CT and MRI studies, hypoperfusion was observed in MTBI group using 3D-PCASL technique in subacute stage, which suggested that this approach may increase sensitivity to MTBI. Second, the correlation between CBF and the severity of post concussive symptoms suggested that changes in cerebral hemodynamicsmay play a role in pathophysiology underlies the symptoms.	[Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian; Chiu, Wen-Ta] Taipei Med Univ, Shuang Ho Hosp, Dept Diagnost Radiol, New Taipei, Taiwan; [Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian; Chiu, Wen-Ta] Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Lin, Che-Ming; Tseng, Ying-Chi; Hsu, Hui-Ling; Chen, Chi-Jen; Chen, David Yen-Ting; Yan, Feng-Xian] Taipei Med Univ, Sch Med, Dept Radiol, Coll Med, New Taipei, Taiwan; [Chen, Chi-Jen] Minist Hlth & Welf, Chia Yi Hosp, Chiayi, Taiwan		Hsu, HL (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Diagnost Radiol, New Taipei, Taiwan.; Hsu, HL (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan.; Hsu, HL (corresponding author), Taipei Med Univ, Sch Med, Dept Radiol, Coll Med, New Taipei, Taiwan.	anne.hlh@gmail.com					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Audenaert K., 2003, MED SCI MONITOR, V9, P112; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; Chang TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076072; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Davis P, 2012, EXPERT PANEL ON NEUR, V14; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2009, J MAGN RESON IMAGING, V29, P1425, DOI 10.1002/jmri.21794; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; Nariai T, 2001, J NEUROTRAUM, V18, P1323, DOI 10.1089/08977150152725623; Piker EG, 2008, J AM ACAD AUDIOL, V19, P337, DOI 10.3766/jaaa.19.4.6; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schroder ML, 1998, NEUROSURGERY, V42, P1276, DOI 10.1097/00006123-199806000-00042; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wong AM, 2014, J MAGN RESON IMAGING, V39, P427, DOI 10.1002/jmri.24178	32	35	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2016	11	2							e0149109	10.1371/journal.pone.0149109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD6SI	WOS:000370054100107	26871696	Green Published, Green Submitted, gold			2022-02-06	
J	Ownsworth, T; Haslam, C				Ownsworth, Tamara; Haslam, Catherine			Impact of rehabilitation on self-concept following traumatic brain injury: An exploratory systematic review of intervention methodology and efficacy	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Rehabilitation; Self-concept; Systematic review; Self-identity	RANDOMIZED CONTROLLED-TRIAL; HEAD-INJURY; GROUP MEMBERSHIPS; THERAPY; PROGRAM; ADJUSTMENT; COMMUNITY; ESTEEM; HEALTH; QUESTIONNAIRE	To date, reviews of rehabilitation efficacy after traumatic brain injury (TBI) have overlooked the impact on sense of self, focusing instead on functional impairment and psychological distress. The present review sought to address this gap by critically appraising the methodology and efficacy of intervention studies that assess changes in self-concept. A systematic search of PsycINFO, Medline, CINAHL and PubMed was conducted from inception to September 2013 to identify studies reporting pre- and post-intervention changes on validated measures of self-esteem or self-concept in adults with TBI. Methodological quality of randomised controlled trials (RCTs) was examined using the Physiotherapy Evidence Database (PEDro) scale. A total of 17 studies (10 RCTs, 4 non-RCT group studies, 3 case studies) was identified, which examined the impact of psychotherapy, family-based support, cognitive rehabilitation or activity-based interventions on self-concept. The findings on the efficacy of these interventions were mixed, with only 10 studies showing some evidence of improvement in self-concept based on within-group or pre-post comparisons. Such findings highlight the need for greater focus on the impact of rehabilitation on self-understanding with improved assessment and intervention methodology. We draw upon theories of identity reconstruction and highlight implications for the design and evaluation of identity-oriented interventions that can supplement existing rehabilitation programmes for people with TBI.	[Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia; [Ownsworth, Tamara] Griffith Univ, Griffith Hlth Inst, Mt Gravatt, Qld 4122, Australia; [Haslam, Catherine] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia		Ownsworth, T (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia.	t.ownsworth@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021; Haslam, Catherine/Y-5763-2018	Ownsworth, Tamara/0000-0003-1835-7094; Haslam, Catherine/0000-0003-0124-9601			Allport G.W., 1961, PATTERN GROWTH PERSO; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Ashworth F, 2011, BRAIN IMPAIR, V12, P128, DOI 10.1375/brim.12.2.128; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Berry E, 2009, J NEUROL NEUROSUR PS, V80, P1202, DOI 10.1136/jnnp.2008.164251; Best D, 2014, THER COMMUNITIES, V35, P10, DOI 10.1108/TC-04-2013-0007; Blake H, 2009, CLIN REHABIL, V23, P589, DOI 10.1177/0269215508101736; Bowen C., 2010, RELATIONAL APPROACH; Brenner LA, 2012, J HEAD TRAUMA REHAB, V27, pE57, DOI 10.1097/HTR.0b013e318273414c; Brindley R, 2011, MEMORY, V19, P745, DOI 10.1080/09658211.2010.493893; Bryan-Hancock C, 2010, INJURY PREV, V16, pA99, DOI 10.1136/ip.2010.029215.356; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Coopersmith S., 1989, SELF ESTEEM INVENTOR; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; D'Argembeau A, 2008, SOC COGN AFFECT NEUR, V3, P244, DOI 10.1093/scan/nsn020; Diller, 2011, HDB HOLISTIC NEUROPS; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Doering BK, 2011, NEUROPSYCHOL REHABIL, V21, P42, DOI 10.1080/09602011.2010.525947; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Feeney T. J., 2010, J BEHAV NEUROSCIENCE, V8, P70; Feinberg TE, 2011, CONSCIOUS COGN, V20, P75, DOI 10.1016/j.concog.2010.09.017; Fines L., 1994, J COGNITIVE REHABILI, P10; Fitts WH., 1996, TENNESSEE SELF CONCE; Gelech JM, 2011, QUAL HEALTH RES, V21, P62, DOI 10.1177/1049732310377454; Gracey F., 2012, THE SOCIAL CURE, P273; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gracey F, 2009, NEUROPSYCHOL REHABIL, V19, P867, DOI 10.1080/09602010903027763; Harter S., 2012, CONSTRUCTION SELF; Haslam C, 2012, SOCIAL CURE IDENTITY, P319; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Haslam S.A., 2012, SOCIAL CURE IDENTITY, P97; Haslam S.A., 2009, PSYCHOL PROSOCIAL BE, DOI DOI 10.1002/9781444307948.CH7; Hawley CA, 2012, NEUROREHABILITATION, V30, P173, DOI 10.3233/NRE-2012-0742; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Howes H, 2005, BRAIN INJURY, V19, P135, DOI 10.1080/02699050410001720077; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Iyer A, 2009, BRIT J SOC PSYCHOL, V48, P707, DOI 10.1348/014466608X397628; Jetten J, 2014, SOC ISS POLICY REV, V8, P103, DOI 10.1111/sipr.12003; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; Jones Janelle M., 2012, SOCIAL CURE IDENTITY, P255; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Kelly A, 2013, NEUROPSYCHOL REHABIL, V23, P563, DOI 10.1080/09602011.2013.795903; Klonoff P. S., 2010, PSYCHOTHERAPY BRIAN; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kristensen OS, 2004, BRAIN INJURY, V18, P1049, DOI 10.1080/02699050410001672279; Lemmon J., 1996, J COGNITIVE REHABILI, V14, P18; Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI 10.7326/0003-4819-151-4-200908180-00136; Maher CG, 2003, PHYS THER REHABIL J, V83, P713, DOI 10.1093/ptj/83.8.713; Manchester D, 2007, NEUROPSYCHOL REHABIL, V17, P206, DOI 10.1080/09602010600696472; Marsh H. W., 1992, SELF DEFINITIONAL ME, P44; Marsh HW, 1996, RES Q EXERCISE SPORT, V67, P249, DOI 10.1080/02701367.1996.10607952; MCGUIRE BE, 1990, CLIN REHABIL, V4, P319, DOI DOI 10.1177/026921559000400412; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; OCEBM Levels of Evidence Working Group, 2011, OXFORD 2011 LEVELS E; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth TL, 2008, NEUROPSYCHOL REHABIL, V18, P692, DOI 10.1080/09602010701595136; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; ROBSON P, 1989, PSYCHOL MED, V19, P513, DOI 10.1017/S003329170001254X; Rosenberg M., 1965, SOC ADOLESCENT SELF; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Sinnakaruppan I, 2005, BRAIN INJURY, V19, P283, DOI 10.1080/02699050400003924; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; TREXLER LE, 2000, INT HDB NEUROPSYCHOL, P137; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Turner J. C., 1982, SOCIAL IDENTITY INTE, P15; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; Tyerman A., 1997, HEAD INJURY SEMANTIC; Vickery CD, 2006, REHABIL PSYCHOL, V51, P30, DOI 10.1037/0090-5550.51.1.30; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; Walsh RS, 2014, HEALTH PSYCHOL REV, V8, P458, DOI 10.1080/17437199.2012.733914; Wilcock A. A., 1999, AUST OCCUP THER J, V46, P1, DOI [10.1046/j.1440-1630.1999.00174.x, DOI 10.1177/000841749806500501]; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wright JC, 1996, BRIT J CLIN PSYCHOL, V35, P399, DOI 10.1111/j.2044-8260.1996.tb01194.x; Ylvisaker M, 2008, NEUROPSYCHOL REHABIL, V18, P713, DOI 10.1080/09602010802201832; [No title captured]	97	35	35	1	35	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2016	26	1					1	35		10.1080/09602011.2014.977924			35	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CU7EM	WOS:000363699300001	25384260	Green Accepted			2022-02-06	
J	Saban, KL; Griffin, JM; Urban, A; Janusek, MA; Pape, TLB; Collins, E				Saban, Karen L.; Griffin, Joan M.; Urban, Amanda; Janusek, Marissa A.; Pape, Theresa Louise-Bender; Collins, Eileen			Perceived health, caregiver burden, and quality of life in women partners providing care to Veterans with traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						brain injuries; caregiver burden; caregiving; fatigue; informal caregiver; perceived health; quality of life; somatic symptoms; stress; Veterans	CORONARY-HEART-DISEASE; US SERVICE MEMBERS; LOW-BACK-PAIN; SPOUSAL CAREGIVERS; FAMILY CAREGIVERS; CANCER; INDIVIDUALS; ASSOCIATION; IMPAIRMENTS; PREVALENCE	Families of Veterans with traumatic brain injury (TBI) are often faced with providing long-term informal care to their loved one. However, little is known about how their perceived health and caregiving burden contribute to their quality of life (QOL). The purpose of this descriptive study was to describe perceived health, somatic symptoms, caregiver burden, and perceived QOL and to identify the extent to which these variables are associated with QOL in female partners/spouses of Veterans with TBI. Participants completed a written questionnaire including the general health subscale of the 12-Item Short Form Survey version 2, the Patient Health Questionnaire-15, Caregiver Reaction Assessment, and Quality of Life Index. Caregivers reported moderate levels of QOL, and over a quarter of the sample reported high levels of somatic symptoms, particularly fatigue and sleep disturbance. Age, perceived general health, somatic symptoms, the five subscales of caregiver burden (self-esteem, disrupted schedule, effect on finances, lack of family support, and effect on health) predicted QOL and explained 64% of its variance (adjusted r(2) = 0.64, F(8,31) = 9.59). However, only somatic symptoms and the caregiver burden subscales of self-esteem and effect on finances were significant predictors in the model. These findings have implications for development of family-centered interventions to enhance the QOL of informal caregivers of Veterans with TBI.	[Saban, Karen L.; Pape, Theresa Louise-Bender; Collins, Eileen] Edward Hines Jr Dept Vet Affairs VA Hosp, Ctr Innovat Complex Chron Healthcare, Hines, IL USA; [Saban, Karen L.] Loyola Univ, Marcella Niehoff Sch Nursing, Chicago, IL 60611 USA; [Griffin, Joan M.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA; [Griffin, Joan M.] Minneapolis VA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Urban, Amanda] Edward Hines Jr VA Hosp, 5000 S 5th Ave 151H,Bldg 1,B261, Hines, IL 60141 USA; [Janusek, Marissa A.] Ochsner Med Ctr, Jefferson, LA USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA; [Collins, Eileen] Univ Illinois, Dept Biobehav Hlth Sci, Chicago, IL USA		Saban, KL (corresponding author), Edward Hines Jr VA Hosp, 5000 S 5th Ave 151H,Bldg 1,B261, Hines, IL 60141 USA.	Karen.Saban@va.gov		Saban, Karen/0000-0001-5767-5453; Bender Pape, Theresa/0000-0001-7738-5963	VA Nursing Research Initiative [HSRD NRI 12-413]	This material was based on work supported by the VA Nursing Research Initiative (award #HSR&D NRI 12-413).	Ahn S, 2012, MATURITAS, V71, P62, DOI 10.1016/j.maturitas.2011.10.011; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Baldassarre M, 2015, PM&R, V7, P845, DOI 10.1016/j.pmrj.2015.03.003; Bardak AN, 2012, J REHABIL MED, V44, P858, DOI 10.2340/16501977-1043; Berg Jenny, 2004, Eur J Health Econ, V5 Suppl 1, pS84, DOI 10.1007/s10198-005-0293-2; Berglund E, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0309-2; Buyck JF, 2013, J GERONTOL A-BIOL, V68, P1316, DOI 10.1093/gerona/glt025; Buyck JF, 2011, AM J PUBLIC HEALTH, V101, P1971, DOI 10.2105/AJPH.2010.300044; Carlsson ME, 2012, PALLIAT SUPPORT CARE, V10, P165, DOI 10.1017/S1478951511000836; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dhruva A, 2012, CANCER NURS, V35, P70, DOI 10.1097/NCC.0b013e3182194a25; DVBIC, 2015, DOD WORLDW NUMB TBI; Ferrans C. E., 2001, QUALITY LIFE INDEX; Fredman L, 2010, J GERONTOL A-BIOL, V65, P565, DOI 10.1093/gerona/glq025; GIVEN CW, 1992, RES NURS HEALTH, V15, P271, DOI 10.1002/nur.4770150406; Griffin J.M., 2014, MILITARY DEPLOYMENT, P259, DOI [10.1007/978-1-4614-8712-8_14, DOI 10.1007/978-1-4614-8712-8_14]; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Hanly P, 2015, SUPPORT CARE CANCER, V23, P1941, DOI 10.1007/s00520-014-2551-2; Jackson D, 2009, BRAIN INJURY, V23, P433, DOI 10.1080/02699050902788451; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jenkins LS, 2007, J CARDIOVASC NURS, V22, P472, DOI 10.1097/01.JCN.0000297378.98754.06; Joreskog K, 1996, LISREL 8 USERS REFER; Kim Y, 2015, CANCER-AM CANCER SOC, V121, P302, DOI 10.1002/cncr.29040; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kruithof WJ, 2012, J STROKE CEREBROVASC, V21, P801, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.011; Lavela Sherri L, 2013, Womens Health Issues, V23, pe225, DOI 10.1016/j.whi.2013.04.001; Lee S, 2003, AM J PREV MED, V24, P113, DOI 10.1016/S0749-3797(02)00582-2; Lefaiver CA, 2009, PROG TRANSPLANT, V19, P142; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Li QP, 2013, EUR J ONCOL NURS, V17, P578, DOI 10.1016/j.ejon.2013.01.007; Mausbach BT, 2007, PSYCHOSOM MED, V69, P816, DOI 10.1097/PSY.0b013e318157d461; Milbury K, 2013, SUPPORT CARE CANCER, V21, P2371, DOI 10.1007/s00520-013-1795-6; National Alliance of Caregiving, 2009, CAR IN THE US; Norup A, 2015, ARCH PHYS MED REHAB, V96, P56, DOI 10.1016/j.apmr.2014.08.009; Nwankwo Yoon SS, 2013, HYPERTENSION ADULTS; Qutub K, 2014, AMYOTROPH LAT SCL FR, V15, P292, DOI 10.3109/21678421.2014.886699; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Ruiz-Robledillo N, 2013, PSYCHOL HEALTH, V28, P1246, DOI 10.1080/08870446.2013.800517; Rumpold T, 2016, SUPPORT CARE CANCER, V24, P1975, DOI 10.1007/s00520-015-2987-z; Saban KL, 2016, BIOL RES NURS, V18, P50, DOI 10.1177/1099800414568661; Saban KL, 2015, REHABIL NURS, V40, P277, DOI 10.1002/rnj.182; Salonen P, 2014, EUR J CANCER CARE, V23, P274, DOI 10.1111/ecc.12153; Schafer JL, 1997, ANAL INCOMPLETE MULT; Smeets SM, 2012, ARCH PHYS MED REHAB, V93, P834, DOI 10.1016/j.apmr.2011.10.029; STOMMEL M, 1992, RES NURS HEALTH, V15, P399, DOI 10.1002/nur.4770150508; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Utne I, 2013, SUPPORT CARE CANCER, V21, P2527, DOI 10.1007/s00520-013-1824-5; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Ware J.E., 2002, SCORE VERSION 2 SF 1; Yalcinkaya EY, 2010, TOP STROKE REHABIL, V17, P389, DOI 10.1310/tsr1705-389	55	35	36	0	2	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	6					681	691		10.1682/JRRD.2015.07.0143			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EK5SC	WOS:000393985100004	27997670	gold			2022-02-06	
J	Singh, AK; Ditkofsky, NG; York, JD; Abujudeh, HH; Avery, LA; Brunner, JF; Sodickson, AD; Lev, MH				Singh, Ajay K.; Ditkofsky, Noah G.; York, John D.; Abujudeh, Hani H.; Avery, Laura A.; Brunner, John F.; Sodickson, Aaron D.; Lev, Michael H.			Blast Injuries: From Improvised Explosive Device Blasts to the Boston Marathon Bombing	RADIOGRAPHICS			English	Article							TRAUMATIC BRAIN-INJURY; TERRORIST BOMBINGS; THORACIC TRAUMA; FOREIGN-BODIES; EXPERIENCE; PATTERN; MECHANISM; SYSTEM; INCIDENTS; HOSPITALS	Although most trauma centers have experience with the imaging and management of gunshot wounds, in most regions blast wounds such as the ones encountered in terrorist attacks with the use of improvised explosive devices (IEDs) are infrequently encountered outside the battlefield. As global terrorism becomes a greater concern, it is important that radiologists, particularly those working in urban trauma centers, be aware of the mechanisms of injury and the spectrum of primary, secondary, tertiary, and quaternary blast injury patterns. Primary blast injuries are caused by barotrauma from the initial increased pressure of the explosive detonation and the rarefaction of the atmosphere immediately afterward. Secondary blast injuries are caused by debris carried by the blast wind and most often result in penetrating trauma from small shrapnel. Tertiary blast injuries are caused by the physical displacement of the victim and the wide variety of blunt or penetrating trauma sustained as a result of the patient impacting immovable objects such as surrounding cars, walls, or fences. Quaternary blast injuries include all other injuries, such as burns, crush injuries, and inhalational injuries. Radiography is considered the initial imaging modality for assessment of shrapnel and fractures. Computed tomography is the optimal test to assess penetrating chest, abdominal, and head trauma. The mechanism of blast injuries and the imaging experience of the victims of the Boston Marathon bombing are detailed, as well as musculoskeletal, neurologic, gastrointestinal, and pulmonary injury patterns from blast injuries. (C) RSNA, 2016.	[Singh, Ajay K.; Abujudeh, Hani H.; Avery, Laura A.; Lev, Michael H.] Massachusetts Gen Hosp, Dept Radiol, 55 Fruit St,FND-210, Boston, MA 02114 USA; [Ditkofsky, Noah G.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Imaging, Toronto, ON, Canada; [York, John D.] Naval Med Ctr, Dept Radiol, Portsmouth, VA USA; [Brunner, John F.] Univ So Calif, Dept Radiol, Los Angeles, CA USA; [Sodickson, Aaron D.] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA		Singh, AK (corresponding author), Massachusetts Gen Hosp, Dept Radiol, 55 Fruit St,FND-210, Boston, MA 02114 USA.	mghpartners@yahoo.com	Singh, Ajay/AAF-4414-2020; Ditkofsky, Noah/AAE-7817-2021	Ditkofsky, Noah/0000-0002-5851-8166; Sodickson, Aaron/0000-0003-1275-681X	GE HealthcareGeneral ElectricGE Healthcare; Millennium PharmaceuticalsTakeda Pharmaceutical Company Ltd	M.H.L. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: institutional grant and personal fees from GE Healthcare; personal fees from Millennium Pharmaceuticals. Other activities: disclosed no relevant relationships.	[Anonymous], 2002, AM HER SCI DICT; Aras MH, 2010, DENTOMAXILLOFAC RAD, V39, P72, DOI 10.1259/dmfr/68589458; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Bala M, 2010, J TRAUMA, V69, P1022, DOI 10.1097/TA.0b013e3181f35c71; Barnard E, 2013, NEW ENGL J MED, V368, P1045, DOI 10.1056/NEJMicm1203842; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Brunner J, 2015, SEMIN ULTRASOUND CT, V36, P68, DOI 10.1053/j.sult.2014.10.006; Brunner J, 2014, RADIOLOGY, V273, P78, DOI 10.1148/radiol.14140253; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; FRYKBERG ER, 1988, ANN SURG, V208, P569, DOI 10.1097/00000658-198811000-00005; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; Golden T., 2004, NY TIMES; Goldstein AL, 2014, AM SURGEON, V80, P98; Guermazi A, 2013, ARTHRIT CARE RES, V65, P1893, DOI 10.1002/acr.22113; Heldenberg E, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00047; Hong Seok Min, 2014, Korean J Audiol, V18, P137, DOI 10.7874/kja.2014.18.3.137; Horrocks C L, 2001, J R Army Med Corps, V147, P28; Hull JB, 1996, J TRAUMA, V40, pS198, DOI 10.1097/00005373-199603001-00044; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; Kellermann AL, 2013, NEW ENGL J MED, V368, P1956, DOI 10.1056/NEJMp1305304; Landman A, 2015, ANN EMERG MED, V66, P51, DOI 10.1016/j.annemergmed.2014.06.009; Larson P S, 2000, Neurosurg Focus, V8, pe4; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Luks FI, 2010, ACTA CHIR BELG, V110, P517, DOI 10.1080/00015458.2010.11680667; Mao ZQ, 2012, ACTA NEUROCHIR, V154, P2187, DOI 10.1007/s00701-012-1487-x; Marti M, 2006, EMERG RADIOL, V13, P113, DOI 10.1007/s10140-006-0534-4; MELLOR SG, 1989, BRIT J SURG, V76, P1006, DOI 10.1002/bjs.1800761006; Meriot P, 1997, RADIOGRAPHICS, V17, P1445, DOI 10.1148/radiographics.17.6.9397457; Millham FH, 2014, J TRAUMA ACUTE CARE, V77, P501, DOI 10.1097/TA.0000000000000397; Oikonomou A, 2012, BMJ CASE REP    0320, P2012; Patel HDL, 2012, J TRAUMA ACUTE CARE, V73, P276, DOI 10.1097/TA.0b013e318256dd80; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Popivanov G, 2014, J ROY ARMY MED CORPS, V160, P52, DOI 10.1136/jramc-2013-000132; Proud WG, 2013, J ROY ARMY MED CORPS, V159, P4, DOI 10.1136/jramc-2013-000030; Putnam AT, 2010, J TRAUMA, V69, P1028; Raja AS, 2010, J TRAUMA, V68, P1421, DOI 10.1097/TA.0b013e3181cf7d32; Ramasamy A, 2008, J TRAUMA, V65, P910, DOI 10.1097/TA.0b013e3181848cf6; Remenschneider AK, 2014, OTOL NEUROTOL, V35, P1825, DOI 10.1097/MAO.0000000000000616; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Rodoplu U, 2005, J TRAUMA, V59, P195; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Sasser SM, 2006, PREHOSP EMERG CARE, V10, P165, DOI 10.1080/10903120500540912; Shaham D, 2002, ISRAEL MED ASSOC J, V4, P564; Shinkman PD., 2013, BOMB EXPERTS OFFER A; Shoichet CE, PROSECUTORS TSARNAEV; Singh AK, 2014, AM J ROENTGENOL, V203, P235, DOI 10.2214/AJR.14.12549; Stuhmiller JH, 2008, BLAST INJURY TRANSLA; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Turegano-Fuentes F, 2014, EUR J TRAUMA EMERG S, V40, P451, DOI 10.1007/s00068-014-0397-4; Turegano-Fuentes F, 2008, WORLD J SURG, V32, P1168, DOI 10.1007/s00268-008-9557-1; U.S. Department of Homeland Security Web site, IED ATT FACT SHEET W; Walls RM, 2013, JAMA-J AM MED ASSOC, V309, P2441, DOI 10.1001/jama.2013.5965; Watchorn J, 2013, CLIN RADIOL, V68, P39, DOI 10.1016/j.crad.2012.05.013; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Yeh DD, 2012, WORLD J SURG, V36, P966, DOI 10.1007/s00268-012-1500-9	65	35	35	1	21	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0271-5333			RADIOGRAPHICS	Radiographics	JAN-FEB	2016	36	1					295	307		10.1148/rg.2016150114			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	DE0TD	WOS:000370336700020	26761543	Bronze			2022-02-06	
J	Zhao, H; Cheng, L; Du, XW; Hou, Y; Liu, Y; Cui, ZQ; Nie, L				Zhao, Hua; Cheng, Lei; Du, Xinwen; Hou, Yong; Liu, Yi; Cui, Zhaoqiang; Nie, Lin			Transplantation of Cerebral Dopamine Neurotrophic Factor Transducted BMSCs in Contusion Spinal Cord Injury of Rats: Promotion of Nerve Regeneration by Alleviating Neuroinflammation	MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury; Cell therapy; Bone marrow-derived mesenchymal stem cells; Cerebral dopamine neurotrophic factor; Nerve regeneration; Neuroinflammation	OLFACTORY ENSHEATHING GLIA; ENDOPLASMIC-RETICULUM STRESS; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; FUNCTIONAL RECOVERY; STROMAL CELLS; BONE-MARROW; ADULT RATS; AXONAL REGENERATION; BEHAVIORAL RECOVERY	Traumatic spinal cord injury (SCI) causes neuron death and axonal damage resulting in functional motor and sensory loss, showing limited regeneration because of adverse microenvironment such as neuroinflammation and glial scarring. Currently, there is no effective therapy to treat SCI in clinical practice. Bone marrow-derived mesenchymal stem cells (BMSCs) are candidates for cell therapies but its effect is limited by neuroinflammation and adverse microenvironment in the injured spinal cord. In this study, we developed transgenic BMSCs overexpressing cerebral dopamine neurotrophic factor (CDNF), a secretory neurotrophic factor that showed potent effects on neuron protection, anti-inflammation, and sciatic nerve regeneration in previous studies. Our results showed that the transplantation of CDNF-BMSCs suppressed neuroinflammation and decreased the production of proinflammatory cytokines after SCI, resulting in the promotion of locomotor function and nerve regeneration of the injured spinal cord. This study presents a novel promising strategy for the treatment of spinal cord injury.	[Zhao, Hua; Cheng, Lei; Hou, Yong; Liu, Yi; Nie, Lin] Shandong Univ, Qilu Hosp, Dept Spine Surg, Jinan 250012, Peoples R China; [Zhao, Hua; Liu, Yi; Cui, Zhaoqiang] Shandong Univ, Qilu Hosp, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Peoples R China; [Du, Xinwen] Laizhou Peoples Hosp, Dept Pediat Surg, Laizhou, Peoples R China		Nie, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Spine Surg, Jinan 250012, Peoples R China.	niemedmail@126.com			Ph.D. Programs Foundation of Ministry of Education of ChinaMinistry of Education, China [20110131120079]; Natural Science Foundation of Shandong Province, ChinaNatural Science Foundation of Shandong Province [ZR2013HM095]	The authors are grateful to Prof. Tang DQ, Wang XL, Research Center for Cell Therapy, Qilu Hospital of Shandong University, and Prof. Chen ZY, Department of Neurobiology, Shandong University, for their kind advice and help with this research. The study was supported by the grant from Ph.D. Programs Foundation of Ministry of Education of China (20110131120079) and Natural Science Foundation of Shandong Province, China (ZR2013HM095).	Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Bernardo ME, 2012, BONE MARROW TRANSPL, V47, P164, DOI 10.1038/bmt.2011.81; Bolton DAE, 2006, BEHAV BRAIN RES, V168, P272, DOI 10.1016/j.bbr.2005.11.017; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Bydon M, 2014, WORLD NEUROSURG, V82, P848, DOI 10.1016/j.wneu.2013.02.062; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Cheng L, 2013, BIOCHEM BIOPH RES CO, V440, P330, DOI 10.1016/j.bbrc.2013.09.084; Cheng L, 2013, BIOCHEM BIOPH RES CO, V435, P34, DOI 10.1016/j.bbrc.2013.04.029; Cho JS, 2009, NEUROSCI LETT, V454, P43, DOI 10.1016/j.neulet.2009.02.024; Cho SR, 2009, CELL TRANSPLANT, V18, P1359, DOI 10.3727/096368909X475329; Deumens R, 2006, NEUROSCI LETT, V400, P208, DOI 10.1016/j.neulet.2006.02.050; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Forraz N, 2013, J TISSUE ENG REGEN M, V7, P523, DOI 10.1002/term.552; Guest JD, 2008, EXP NEUROL, V212, P261, DOI 10.1016/j.expneurol.2008.03.010; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Johnston H, 2011, BIOCHEM SOC T, V39, P886, DOI 10.1042/BST0390886; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kubasak MD, 2008, BRAIN, V131, P264, DOI 10.1093/brain/awm267; Kwiatkoski M, 2013, EXP NEUROL, V240, P88, DOI 10.1016/j.expneurol.2012.11.008; Li Wei, 2006, Neurosci Bull, V22, P34; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Lindstrom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073928; Lu J, 2001, BRAIN RES, V889, P344, DOI 10.1016/S0006-8993(00)03235-2; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Markandaya M, 2012, CURR TREAT OPTION NE, V14, P175, DOI 10.1007/s11940-011-0162-5; Martin D, 1996, J NEUROSCI RES, V45, P588; Mei JM, 2014, NEUROL SCI, V35, P1275, DOI 10.1007/s10072-014-1700-1; Messmer K, 2005, NEUROSCI LETT, V388, P39, DOI 10.1016/j.neulet.2005.06.047; Miller SM, 2008, J NEUROSURG ANESTH, V20, P140, DOI 10.1097/01.ana.0000314442.40952.0d; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Okano H, 2013, CIRC RES, V112, P523, DOI 10.1161/CIRCRESAHA.111.256149; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Ramer LM, 2005, SPINAL CORD, V43, P134, DOI 10.1038/sj.sc.3101715; Ritfeld GJ, 2014, BIOMATERIALS, V35, P1924, DOI 10.1016/j.biomaterials.2013.11.062; Ritfeld GJ, 2012, CELL TRANSPLANT, V21, P1561, DOI 10.3727/096368912X640484; Ruff CA, 2010, PANMINERVA MED, V52, P125; Schiwy N, 2009, EUR J NEUROSCI, V30, P1544, DOI 10.1111/j.1460-9568.2009.06929.x; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Sun ZP, 2011, J NEUROCHEM, V117, P121, DOI 10.1111/j.1471-4159.2011.07179.x; TAKAKUWA T, 1994, RES COMMUN CHEM PATH, V84, P283; Takami T, 2002, J NEUROSCI, V22, P6670; Takami T, 2002, J NEUROTRAUM, V19, P653, DOI 10.1089/089771502753754118; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; van den Berg MEL, 2010, J NEUROTRAUM, V27, P1517, DOI 10.1089/neu.2009.1138; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Wright KT, 2011, STEM CELLS, V29, P169, DOI 10.1002/stem.570; Wu W, 2014, BIOMATERIALS, V35, P2355, DOI 10.1016/j.biomaterials.2013.11.074; Wu WL, 2011, NEUROSCI LETT, V491, P73, DOI 10.1016/j.neulet.2011.01.009; Yoon SH, 2007, STEM CELLS, V25, P2066, DOI 10.1634/stemcells.2006-0807; Zhang N, 2012, INDIAN J MED RES, V135, P287; Zhao H, 2014, J MOL NEUROSCI, V52, P186, DOI 10.1007/s12031-013-0120-7; Zhao H, 2013, J MOL NEUROSCI, V51, P671, DOI 10.1007/s12031-013-0042-4; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	66	35	36	2	13	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2016	53	1					187	199		10.1007/s12035-014-9000-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB0CN	WOS:000368176300017	25421210				2022-02-06	
J	Zgaljardic, DJ; Seale, GS; Schaefer, LA; Temple, RO; Foreman, J; Elliott, TR				Zgaljardic, Dennis J.; Seale, Gary S.; Schaefer, Lynn A.; Temple, Richard O.; Foreman, Jack; Elliott, Timothy R.			Psychiatric Disease and Post-Acute Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						caregiver distress; maladaptive behaviors; mood disorder; TBI	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSIVE DISORDER; OF-THE-LITERATURE; COGNITIVE-BEHAVIORAL THERAPY; ANTERIOR CINGULATE CORTEX; HEAD-INJURY; POSTCONCUSSION SYNDROME; FRONTAL-LOBE; FAMILY CAREGIVERS	Psychiatric disorders are common following traumatic brain injury (TBI) and can include depression, anxiety, and psychosis, as well as other maladaptive behaviors and personality changes. The epidemiologic data of psychiatric disorders post-TBI vary widely, although the incidence and prevalence rates typically are higher than in the general population. Although the experience of psychiatric symptoms may be temporary and may resolve in the acute period, many patients with TBI can experience psychopathology that is persistent or that develops in the post-acute period. Long-term psychiatric disorder, along with cognitive and physical sequelae and greater risk for substance use disorders, can pose a number of life-long challenges for patients and their caregivers, as they can interfere with participation in rehabilitation as well as limit functional independence in the community. The current review of the literature considers the common psychiatric problems affecting individuals with TBI in the post-acute period, including personality changes, psychosis, executive dysfunction, depression, anxiety, and substance misuse. Although treatment considerations (pharmacological and nonpharmacological) are referred to, an extensive description of such protocols is beyond the scope of the current review. The impact of persistent psychiatric symptoms on perceived caregiver burden and distress is also discussed.	[Zgaljardic, Dennis J.; Seale, Gary S.; Foreman, Jack] Transit Learning Ctr, Galveston, TX 77550 USA; [Zgaljardic, Dennis J.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Schaefer, Lynn A.] Nassau Univ Med Ctr, E Meadow, NY USA; [Elliott, Timothy R.] Texas A&M Univ, College Stn, TX USA		Zgaljardic, DJ (corresponding author), Transit Learning Ctr, Dept Neuropsychol, 1528 PO St, Galveston, TX 77550 USA.	dzgaljardic@tlc-galveston.org	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714	Moody Endowment	This work was funded by the generous support of the Moody Endowment.	Abreau B. C., 2009, LIFE BALANCE MULTIDI, P223; Ahmed A, 2013, THER CLIN RISK MANAG, V9, P483, DOI 10.2147/TCRM.S53906; Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; ANDERSEN G, 1993, LANCET, V342, P837, DOI 10.1016/0140-6736(93)92696-Q; Anderson, 1998, Semin Clin Neuropsychiatry, V3, P232; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1056/NEJMra073096; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; BERGLAND MM, 1991, REHABIL COUNS BULL, V35, P5; Berry JW, 2012, REHABIL PSYCHOL, V57, P98, DOI 10.1037/a0028229; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Blackerby W.F., 1990, J HEAD TRAUMA REHAB, V5, P47; Bogner J, 2013, BRAIN IMPAIR, V14, P77, DOI 10.1017/BrImp.2013.5; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Brossart DF, 2008, REHABIL PSYCHOL, V53, P357, DOI 10.1037/a0012973; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Campbell LC, 2003, BIOL PSYCHIAT, V54, P399, DOI 10.1016/S0006-3223(03)00545-6; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cimino C.R., 1994, CLIN GUIDE NEUROPSYC, P69; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2007, BRAIN INJURY, V21, P343, DOI 10.1080/02699050701253103; Corrigan JD, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1315; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; D'Zurilla TJ., 2004, SOCIAL PROBLEM SOLVI, P11, DOI [10.1037/10805-001, DOI 10.1037/10805-001]; Damasio A., 1994, DESCARTES ERROR EMOT; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; DAVIDSON DLW, 1983, SCOT MED J, V28, P325, DOI 10.1177/003693308302800402; De Reuck J, 2011, CLIN NEUROL NEUROSUR, V113, P469, DOI 10.1016/j.clineuro.2011.02.004; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Deb S, 1999, AM J PSYCHIAT, V156, P374; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Elliott TR, 2008, BEHAV RES THER, V46, P1220, DOI 10.1016/j.brat.2008.08.004; Elliott TR, 2001, J COUNS PSYCHOL, V48, P223, DOI 10.1037//0022-0167.48.2.223; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Fazel S, 2009, J NEUROL, V256, P1591, DOI 10.1007/s00415-009-5134-2; Feinstein A, 2000, BRAIN COGNITION, V44, P78; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii D., 1996, J NEUROPSYCHIATRY CL, V24, P278; Fujii D, 2012, J NEUROPSYCH CLIN N, V24, P278, DOI 10.1176/appi.neuropsych.11070176; Fujii DE, 2014, PSYCHIAT CLIN N AM, V37, P113, DOI 10.1016/j.psc.2013.11.006; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; George M.S., 1994, DEPRESSION, V2, P59, DOI [10.1002/depr.3050020202, DOI 10.1002/DEPR.3050020202]; GLENN MB, 1989, AM J PHYS MED REHAB, V68, P221, DOI 10.1097/00002060-198910000-00004; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Gray J A, 1996, Nebr Symp Motiv, V43, P61; Greve KW, 2001, BRAIN INJURY, V15, P255; Guerreiro DF, 2009, BRAIN INJURY, V23, P358, DOI 10.1080/02699050902800918; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Handel SF, 2007, PSYCHOSOMATICS, V48, P67, DOI 10.1176/appi.psy.48.1.67; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Heilman K.M., 1991, AWARENESS DEFICIT BR, P53; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Isaac F, 2011, NEUROPSYCH DIS TREAT, V7, P57, DOI 10.2147/NDT.S16267; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnson CL, 2010, REHABIL PSYCHOL, V55, P180, DOI 10.1037/a0019480; Jones G.A., 1992, NEUROREHABILITATION, V2, P27; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kalpinski RJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/102570; Kerr K, 2011, BRAIN INJURY, V25, P729, DOI 10.3109/02699052.2011.580315; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; KREUTZER JS, 1991, J HEAD TRAUMA REHAB, V6, P12; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; Leavitt VM, 2010, PM&R, V2, P332, DOI 10.1016/j.pmrj.2010.03.027; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MAYBERG HS, 1994, J NUCL MED, V35, P929; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCALLISTER TW, 1985, J CLIN PSYCHIAT, V46, P393; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morawetz D., 2003, SLEEP RES ONLINE, V5, P77; Morris PLP, 1996, J NEUROPSYCH CLIN N, V8, P399; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Paradiso S, 1999, J NEUROL NEUROSUR PS, V67, P664, DOI 10.1136/jnnp.67.5.664; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; PASSINGHAM RE, 1972, NEUROPSYCHOLOGIA, V10, P41, DOI 10.1016/0028-3932(72)90041-3; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Pfeiffer K, 2014, J CONSULT CLIN PSYCH, V82, P628, DOI 10.1037/a0036987; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Ramkumar NA, 2010, NEUROREHABILITATION, V27, P105, DOI 10.3233/NRE-2010-0585; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Reischies FM, 1999, ANN NY ACAD SCI, V877, P775, DOI 10.1111/j.1749-6632.1999.tb09321.x; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; ROSENBAUM A, 1994, J CONSULT CLIN PSYCH, V62, P1187, DOI 10.1037/0022-006X.62.6.1187; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Sander AM, 2012, J HEAD TRAUMA REHAB, V27, P319, DOI 10.1097/HTR.0b013e318269838c; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Seton J.D., 1990, J HEAD TRAUMA REHAB, V5, P41; Sheline YI, 1999, J NEUROSCI, V19, P5034; Sherer M, 1999, BRAIN INJURY, V13, P973; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Smith LM, 1995, FAMILY SUPPORT PROGR; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; STEBBINS P, 1997, AUSTR J REHABILITATI, V3, P30; Stein S., 1996, CLASSIFICATION HEAD; Stern Judith M, 2004, Curr Neurol Neurosci Rep, V4, P179, DOI 10.1007/s11910-004-0034-4; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Tweedly L, 2012, J HEAD TRAUMA REHAB, V27, P331, DOI 10.1097/HTR.0b013e318262200a; Tyerman A, 2008, PSYCHOL APPROACHES R; Upton D, 1999, ARCH CLIN NEUROPSYCH, V14, P203, DOI 10.1016/S0887-6177(98)00013-4; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Vungkhanching M, 2007, J HEAD TRAUMA REHAB, V22, P167, DOI 10.1097/01.HTR.0000271117.19652.98; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Walling SM, 2012, J MARITAL FAM THER, V38, P471, DOI 10.1111/j.1752-0606.2011.00226.x; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Warden DL, 1997, J NEUROPSYCH CLIN N, V9, P18; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WILSON J T L, 1990, Brain Injury, V4, P349; Wood RLL, 2013, BRAIN INJURY, V27, P253, DOI 10.3109/02699052.2012.743181; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; World Health Organization, 2007, INT CLASS FUNCT DIS; Zaloshnja E, 2005, AM J PREV MED, V28, P88, DOI 10.1016/j.amepre.2004.09.016; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zgaljardic DJ, 2010, ENCYCLOPEDIA OF MOVEMENT DISORDERS, VOL 1: A-G, P458; Zgaljardic DJ, 2014, BRAIN INJURY, V28, P389, DOI 10.3109/02699052.2014.884242	211	35	35	2	25	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2015	32	23			SI		1911	1925		10.1089/neu.2014.3569			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CX4TW	WOS:000365694200008	25629222				2022-02-06	
J	Sajja, VSSS; Hubbard, WB; Hall, CS; Ghoddoussi, F; Galloway, MP; VandeVord, PJ				Sajja, Venkata Siva Sai Sujith; Hubbard, W. Brad; Hall, Christina S.; Ghoddoussi, Farhad; Galloway, Matthew P.; VandeVord, Pamela J.			Enduring deficits in memory and neuronal pathology after blast-induced traumatic brain injury	SCIENTIFIC REPORTS			English	Article							INDUCED NEUROTRAUMA; OXIDATIVE STRESS; BARRIER DYSFUNCTION; AMYLOID LOAD; US VETERANS; GLUTAMATE; ANXIETY; NEUROTRANSMITTERS; PATHOPHYSIOLOGY; MYOINOSITOL	Few preclinical studies have assessed the long-term neuropathology and behavioral deficits after sustaining blast-induced neurotrauma (BINT). Previous studies have shown extensive astrogliosis and cell death at acute stages (<7 days) but the temporal response at a chronic stage has yet to be ascertained. Here, we used behavioral assays, immmunohistochemistry and neurochemistry in limbic areas such as the amygdala (Amy), Hippocampus (Hipp), nucleus accumbens (Nac), and prefrontal cortex (PFC), to determine the long-term effects of a single blast exposure. Behavioral results identified elevated avoidance behavior and decreased short-term memory at either one or three months after a single blast event. At three months after BINT, markers for neurodegeneration (FJB) and microglia activation (Iba-1) increased while index of mature neurons (NeuN) significantly decreased in all brain regions examined. Gliosis (GFAP) increased in all regions except the Nac but only PFC was positive for apoptosis (caspase-3). At three months, tau was selectively elevated in the PFC and Hipp whereas a-synuclein transiently increased in the Hipp at one month after blast exposure. The composite neurochemical measure, myo-inositol+glycine/creatine, was consistently increased in each brain region three months following blast. Overall, a single blast event resulted in enduring long-term effects on behavior and neuropathological sequelae.	[Sajja, Venkata Siva Sai Sujith; Hubbard, W. Brad; Hall, Christina S.; VandeVord, Pamela J.] Virginia Polytech & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA; [Ghoddoussi, Farhad; Galloway, Matthew P.] Wayne State Univ, Sch Med, Dept Anesthesiol, Detroit, MI USA; [Galloway, Matthew P.] Wayne State Univ, Sch Med, Dept Psychiat, Detroit, MI USA; [VandeVord, Pamela J.] Salem VA Med Ctr, Res & Dev Serv, Salem, VA USA		VandeVord, PJ (corresponding author), Virginia Polytech & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.	pvord@vt.edu	Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501			Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Bowery NG, 2006, BRIT J PHARMACOL, V147, pS109, DOI 10.1038/sj.bjp.0706443; Candiota AP, 2011, JBR-BTR, V94, P319, DOI 10.5334/jbr-btr.698; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cheng LL, 1997, P NATL ACAD SCI USA, V94, P6408, DOI 10.1073/pnas.94.12.6408; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Cirstea CM, 2011, STROKE, V42, P1004, DOI 10.1161/STROKEAHA.110.601047; Edison P, 2008, J NEUROL NEUROSUR PS, V79, P1331, DOI 10.1136/jnnp.2007.127878; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Fernandez-Lopez B, 2014, GLIA, V62, P1254, DOI 10.1002/glia.22678; Gecz J, 2010, NAT GENET, V42, P925, DOI 10.1038/ng1110-925; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Jett S, 2010, NURS FORUM, V45, P237, DOI 10.1111/j.1744-6198.2010.00195.x; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kantarci K, 2011, NEUROLOGY, V77, P951, DOI 10.1212/WNL.0b013e31822dc7e1; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Miller SM, 2011, PHARMACOL BIOCHEM BE, V100, P130, DOI 10.1016/j.pbb.2011.08.002; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Pederzolli CD, 2009, METAB BRAIN DIS, V24, P283, DOI 10.1007/s11011-009-9137-6; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Pugh KR, 2014, J NEUROSCI, V34, P4082, DOI 10.1523/JNEUROSCI.3907-13.2014; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Sajja VSSS, 2015, SHOCK, V44, P71, DOI 10.1097/SHK.0000000000000311; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; VandeVord PJ, 2016, J NEUROTRAUM, V33, P82, DOI 10.1089/neu.2014.3786; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilcox CS, 2010, PHARMACOL THERAPEUT, V126, P119, DOI 10.1016/j.pharmthera.2010.01.003; Xie K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064907; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7	46	35	35	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 5	2015	5								15075	10.1038/srep15075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CV3HY	WOS:000364151100001	26537106	Green Published, gold, Green Submitted			2022-02-06	
J	Kerrey, BT; Mittiga, MR; Rinderknecht, AS; Varadarajan, KR; Dyas, JR; Geis, GL; Luria, JW; Frey, ME; Jablonski, TE; Iyer, SB				Kerrey, Benjamin T.; Mittiga, Matthew R.; Rinderknecht, Andrea S.; Varadarajan, Kartik R.; Dyas, Jenna R.; Geis, Gary Lee; Luria, Joseph W.; Frey, Mary E.; Jablonski, Tamara E.; Iyer, Srikant B.			Reducing the incidence of oxyhaemoglobin desaturation during rapid sequence intubation in a paediatric emergency department	BMJ QUALITY & SAFETY			English	Article							TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; TRACHEAL INTUBATION; HYPOXIA; CHECKLIST; RATS; NEUROINFLAMMATION; INTERVENTION; SIMULATION; ANESTHESIA	Objectives Rapid sequence intubation (RSI) is the standard for definitive airway management in emergency medicine. In a video-based study of RSI in a paediatric emergency department (ED), we reported a high degree of process variation and frequent adverse effects, including oxyhaemoglobin desaturation (SpO(2)<90%). This report describes a multidisciplinary initiative to improve the performance and safety of RSI in a paediatric ED. Methods We conducted a local improvement initiative in a high-volume academic paediatric ED. We simultaneously tested: (1) an RSI checklist, (2) a pilot/copilot model for checklist execution, (3) the use of a video laryngoscope and (4) the restriction of laryngoscopy to specific providers. Data were collected primarily by video review during the testing period and the historical period (2009-2010, baseline). We generated statistical process control charts (G-charts) to measure change in the performance of six key processes, attempt failure and the occurrence of oxyhaemoglobin desaturation during RSI. We iteratively revised the four interventions through multiple plan-do-study-act cycles within the Model for Improvement. Results There were 75 cases of RSI during the testing period (July 2012-September 2013). Special cause variation occurred on the G-charts for three of six key processes, attempt failure and desaturation, indicating significant improvement. The frequency of desaturation was 50% lower in the testing period than the historical (16% vs 33%). When all six key processes were performed, only 6% of patients experienced desaturation. Conclusions Following the simultaneous introduction of four interventions in a paediatric ED, RSI was performed more reliably, successfully and safely.	[Kerrey, Benjamin T.; Mittiga, Matthew R.; Rinderknecht, Andrea S.; Varadarajan, Kartik R.; Dyas, Jenna R.; Geis, Gary Lee; Luria, Joseph W.; Frey, Mary E.; Iyer, Srikant B.] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA; [Kerrey, Benjamin T.; Geis, Gary Lee] Cincinnati Childrens Hosp Med Ctr, Ctr Simulat & Res, Cincinnati, OH 45229 USA; [Jablonski, Tamara E.] Cincinnati Childrens Hosp Med Ctr, Dept Emergency Serv, Cincinnati, OH 45229 USA; [Iyer, Srikant B.] Cincinnati Childrens Hosp Med Ctr, James M Anderson Ctr Hlth Syst Excellence, Cincinnati, OH 45229 USA		Kerrey, BT (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, 3333 Burnet Ave,ML 12000, Cincinnati, OH 45229 USA.	benjamin.kerrey@cchmc.org	Rinderknecht, Andrea/AAD-8184-2020		Division of Emergency Medicine and Emergency Services at Cincinnati Children's Hospital; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000077] Funding Source: NIH RePORTER	We gratefully acknowledge the support of the following individuals and groups, without whom our project would have been impossible to complete: Karen Ahaus and Tina Eubanks, Rachel Talley, Michelle Caruso, Richard Ruddy and the entire Division of Emergency Medicine and Emergency Services at Cincinnati Children's Hospital.	Bosk CL, 2009, LANCET, V374, P444, DOI 10.1016/S0140-6736(09)61440-9; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Gawande A., 2010, CHECKLIST MANIFESTO; Green SM, 2009, J EMERG MED, V37, P359, DOI 10.1016/j.jemermed.2007.05.048; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Jaber S, 2010, INTENS CARE MED, V36, P248, DOI 10.1007/s00134-009-1717-8; Kerrey BT, 2012, ANN EMERG MED, V60, P251, DOI 10.1016/j.annemergmed.2012.02.013; Leape LL, 2014, NEW ENGL J MED, V370, P1063, DOI 10.1056/NEJMe1315851; Martinon C, 2011, PEDIATR CRIT CARE ME, V12, P65, DOI 10.1097/PCC.0b013e3181e2a244; Mayo Paul H, 2011, J Intensive Care Med, V26, P50, DOI 10.1177/0885066610384070; Mittiga MR, 2013, ANN EMERG MED, V61, P263, DOI 10.1016/j.annemergmed.2012.06.021; Nishisaki A, 2012, RESP CARE, V57, P1121, DOI 10.4187/respcare.01472; Nishisaki A, 2010, ANESTHESIOLOGY, V113, P214, DOI 10.1097/ALN.0b013e3181e19bf2; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Provost LP., 2011, HLTH CARE DATA GUIDE, V1st ed.; SCHOENFELD PS, 1993, PEDIATRICS, V91, P726; Thomassen O, 2010, ACTA ANAESTH SCAND, V54, P1179, DOI 10.1111/j.1399-6576.2010.02302.x; Tobin JM, 2013, ANESTH ANALG, V117, P1178, DOI 10.1213/ANE.0b013e3182a44d3e; Walls RM, 2012, MANUAL EMERGENCY AIR; Wittenberg MD, 2013, INT J OBSTET ANESTH, V22, P264, DOI 10.1016/j.ijoa.2013.03.001; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037	28	35	35	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-5415	2044-5423		BMJ QUAL SAF	BMJ Qual. Saf.	NOV	2015	24	11					709	+		10.1136/bmjqs-2014-003713			9	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	CU4BV	WOS:000363472000008	26183713				2022-02-06	
J	Alberts, JL; Thota, A; Hirsch, J; Ozinga, S; Dey, T; Schindler, DD; Koop, MM; Burke, D; Linder, SM				Alberts, Jay L.; Thota, Anil; Hirsch, Joshua; Ozinga, Sarah; Dey, Tanujit; Schindler, David D.; Koop, Mandy M.; Burke, Daniel; Linder, Susan M.			Quantification of the Balance Error Scoring System with Mobile Technology	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						POSTURAL STABILITY; ACCELEROMETER; GYROSCOPE; CONCUSSION; IBESS; BESS	CEREBRAL CONCUSSION; POSTURAL STABILITY; SPORT; STATEMENT; RECOVERY; INJURY	Purpose The aim of this project was to develop a biomechanically based quantification of the Balance Error Scoring System (BESS) using data derived from the accelerometer and gyroscope of a mobile tablet device. Methods Thirty-two healthy young adults completed the BESS while an iPad was positioned at the sacrum. Data from the iPad were compared to position data gathered from a three-dimensional motion capture system. Peak-to-peak (P2P), normalized path length (NPL), and root mean squared (RMS) were calculated for each system and compared. Additionally, a 95% ellipsoid volume, iBESS volume, was calculated using center of mass (CoM) movements in the anteroposterior (AP), mediolateral (ML), and trunk rotation planes of movement to provide a comprehensive, 3D metric of postural stability. Results Across all kinematic outcomes, data from the iPad were significantly correlated with the same outcomes derived from the motion capture system (rho range, 0.37-0.94; P < 0.05). The iBESS volume metric was able to detect a difference in postural stability across stance and surface, showing a significant increase in volume in increasingly difficult conditions, whereas traditional error scoring was not as sensitive to these factors. Conclusions The kinematic data provided by the iPad are of sufficient quality relative to motion capture data to accurately quantify postural stability in healthy young adults. The iBESS volume provides a more sensitive measure of postural stability than error scoring alone, particularly in conditions 1 and 4, which often suffer from floor effects, and condition 5, which can experience ceiling effects. The iBESS metric is ideally suited for clinical and in the field applications in which characterizing postural stability is of interest.	[Alberts, Jay L.; Thota, Anil; Hirsch, Joshua; Ozinga, Sarah; Schindler, David D.; Koop, Mandy M.; Burke, Daniel; Linder, Susan M.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Alberts, Jay L.; Thota, Anil; Ozinga, Sarah] Cleveland Clin, Ctr Neurol Restorat, Cleveland, OH 44106 USA; [Alberts, Jay L.; Thota, Anil; Hirsch, Joshua; Dey, Tanujit; Burke, Daniel; Linder, Susan M.] Cleveland Clin, Concuss Ctr, Cleveland, OH 44106 USA; [Dey, Tanujit] Cleveland Clin, Qualitat Hlth Serv, Cleveland, OH 44106 USA		Alberts, JL (corresponding author), Cleveland Clin Fdn, Dept Biomed Engn ND20, 9500 Euclid Ave, Cleveland, OH 44195 USA.	albertj@ccf.org	Thota, Anil/J-3305-2019; Thota, Anil/C-5395-2015	Thota, Anil/0000-0003-0605-2269; Thota, Anil/0000-0003-0605-2269	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS073717-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073717] Funding Source: NIH RePORTER	This project was supported by NIH 1R01NS073717-01 to JLA.	Alberts JL, J ATHL TRAI IN PRESS; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Ozinga SJ, 2014, EXP BRAIN RES, V232, P3861, DOI 10.1007/s00221-014-4069-8; Ozinga SJ, 2014, SOC NEUR C 2014 NOV; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Putukian M, 2011, CLIN SPORT MED, V30, P49, DOI 10.1016/j.csm.2010.09.005; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015	19	35	35	2	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	OCT	2015	47	10					2233	2240		10.1249/MSS.0000000000000656			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CR5DP	WOS:000361360500027	26378948	Green Accepted			2022-02-06	
J	Ceccanti, M; Hamilton, D; Coriale, G; Carito, V; Aloe, L; Chaldakov, G; Romeo, M; Ceccanti, M; Iannitelli, A; Fiore, M				Ceccanti, Mauro; Hamilton, Derek; Coriale, Giovanna; Carito, Valentina; Aloe, Luigi; Chaldakov, George; Romeo, Marina; Ceccanti, Marco; Iannitelli, Angela; Fiore, Marco			Spatial learning in men undergoing alcohol detoxification	PHYSIOLOGY & BEHAVIOR			English	Article						Virtual Morris maze; Ethanol detoxification	MORRIS WATER MAZE; TRAUMATIC BRAIN-INJURY; SOCIAL DRINKERS; SEX-DIFFERENCES; MEMORY-SYSTEMS; ADULT RATS; NAVIGATION; TASK; DEFICITS; ETHANOL	Alcohol dependence is a major public health problem worldwide. Brain and behavioral disruptions including changes in cognitive abilities are common features of alcohol addiction. Thus, the present study was aimed to investigate spatial learning and memory in 29 alcoholic men undergoing alcohol detoxification by using a virtual Morris maze task. As age-matched controls we recruited 29 men among occasional drinkers without history of alcohol dependence and/or alcohol related diseases and with a negative blood alcohol level at the time of testing. We found that the responses to the virtual Morris maze are impaired in men undergoing alcohol detoxification. Notably they showed increased latencies in the first movement during the trials, increased latencies in retrieving the hidden platform and increased latencies in reaching the visible platform. These findings were associated with reduced swimming time in the target quadrant of the pool where the platform had been during the 4 hidden platform trials of the learning phase compared to controls. Such increasing latency responses may suggest motor control, attentional and motivational deficits due to alcohol detoxification. (C) 2015 Elsevier Inc. All rights reserved.	[Ceccanti, Mauro; Coriale, Giovanna; Romeo, Marina] Univ Roma La Sapienza, Dept Clin Med, Ctr Alcohol Abuse Ctr Riferimento Alcol Reg Lazio, Rome, Italy; [Hamilton, Derek] Univ New Mexico, Albuquerque, NM 87131 USA; [Carito, Valentina; Aloe, Luigi; Fiore, Marco] Natl Res Council IBCN CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Chaldakov, George; Ceccanti, Marco] Med Univ, Div Cell Biol, BG-9002 Varna, Bulgaria; [Iannitelli, Angela] Univ Aquila, Dept Hlth Sci, I-67100 Laquila, Italy		Fiore, M (corresponding author), CNR, Ist Biol Cellulare & Neurobiol, Via Fosso di Fiorano 64, I-00143 Rome, Italy.	marco.fiore@cnr.it	Hamilton, Derek A/H-4447-2013; Fiore, Marco/B-6112-2015; Ceccanti, Marco/AAC-5111-2022; Iannitelli, Angela/AAM-7689-2020	Hamilton, Derek A/0000-0001-7021-3288; Fiore, Marco/0000-0001-6806-9715; Ceccanti, Marco/0000-0001-8897-3736; CECCANTI, Mauro/0000-0001-9981-8715			Abernathy K, 2010, INT REV NEUROBIOL, V91, P289, DOI 10.1016/S0074-7742(10)91009-X; Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Astur RS, 2002, BEHAV BRAIN RES, V132, P77, DOI 10.1016/S0166-4328(01)00399-0; Beatty WW, 1996, J STUD ALCOHOL, V57, P136, DOI 10.15288/jsa.1996.57.136; Boccia M, 2014, NEUROPSYCHOL REV, V24, P236, DOI 10.1007/s11065-014-9247-8; Boulouard M, 2002, BEHAV BRAIN RES, V136, P239, DOI 10.1016/S0166-4328(02)00134-1; Brandt T, 2005, BRAIN, V128, P2732, DOI 10.1093/brain/awh617; Brown SA, 2000, ALCOHOL CLIN EXP RES, V24, P164, DOI 10.1111/j.1530-0277.2000.tb04586.x; Bueters T, 2008, EXP NEUROL, V209, P114, DOI 10.1016/j.expneurol.2007.09.005; Coriale G, 2012, ADDICT BEHAV, V37, P1224, DOI 10.1016/j.addbeh.2012.05.018; Cornwell BR, 2010, AM J PSYCHIAT, V167, P836, DOI 10.1176/appi.ajp.2009.09050614; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Driscoll I, 2005, HORM BEHAV, V47, P326, DOI 10.1016/j.yhbeh.2004.11.013; Fajnerova I, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00157; Fein G, 2006, ALCOHOL CLIN EXP RES, V30, P1538, DOI 10.1111/j.1530-0277.2006.00185.x; Fiore M, 2002, NEUROTOXICOL TERATOL, V24, P179, DOI 10.1016/S0892-0362(01)00214-8; Fiore M, 2000, BEHAV BRAIN RES, V112, P165, DOI 10.1016/S0166-4328(00)00180-7; First M., 1997, STRUCTURED CLIN INTE; Goodrich-Hunsaker NJ, 2010, HIPPOCAMPUS, V20, P481, DOI 10.1002/hipo.20651; Gordan ML, 2012, BEHAV BRAIN RES, V235, P7, DOI 10.1016/j.bbr.2012.07.027; Hamilton DA, 2003, BEHAV BRAIN RES, V143, P85, DOI 10.1016/S0166-4328(03)00028-7; Hamilton DA, 2009, BEHAV PROCESS, V81, P154, DOI 10.1016/j.beproc.2008.12.003; Hartley T, 2005, TRENDS NEUROSCI, V28, P169, DOI 10.1016/j.tins.2005.02.004; Harvanko AM, 2012, J ADDICT MED, V6, P106, DOI 10.1097/ADM.0b013e31823ae56d; He J, 2005, EUR J NEUROSCI, V21, P2711, DOI 10.1111/j.1460-9568.2005.04120.x; Heinz AJ, 2011, NAT REV NEUROSCI, V12, P400, DOI 10.1038/nrn3042; KRAMER JH, 1991, J CLIN EXP NEUROPSYC, V13, P455, DOI 10.1080/01688639108401063; Maguire EA, 1999, CURR OPIN NEUROBIOL, V9, P171, DOI 10.1016/S0959-4388(99)80023-3; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1097/00000374-199804000-00018; Matthews DB, 2004, NEUROBIOL LEARN MEM, V82, P299, DOI 10.1016/j.nlm.2004.06.007; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nam HW, 2013, MOL CELLS, V36, P195, DOI 10.1007/s10059-013-0192-9; Oscar-Berman M, 2003, ALCOHOL RES HEALTH, V27, P125; Oscar-Berman M, 1987, Recent Dev Alcohol, V5, P59; Oscar-Berman M, 1990, NIDA Res Monogr, V101, P136; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Pasqualotto A, 2012, NEUROSCI BIOBEHAV R, V36, P1179, DOI 10.1016/j.neubiorev.2012.01.008; Rajendran P, 2004, ANN NY ACAD SCI, V1021, P441, DOI 10.1196/annals.1308.060; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; Scaife JC, 2009, PHARMACOL BIOCHEM BE, V93, P354, DOI 10.1016/j.pbb.2009.05.015; Schottenbauer MA, 2007, AGING NEUROPSYCHOL C, V14, P505, DOI 10.1080/13825580600681305; Schulte T, 2012, ALCOHOL CLIN EXP RES, V36, P2017, DOI 10.1111/j.1530-0277.2012.01831.x; Sircar R, 2005, ALCOHOL CLIN EXP RES, V29, P1402, DOI 10.1097/01.alc.0000175012.77756.d9; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Sneider J.T., 2013, J ADDICTION A; Sneider J. T., 2013, J ADDICTION RES T S7; Sneider JT, 2011, PERCEPT MOTOR SKILL, V113, P461, DOI 10.2466/04.22.24.27.PMS.113.5.461-480; Sobell L, 1992, TIMELINE FOLLOW BACK; SULLIVAN EV, 1992, BIOL PSYCHIAT, V32, P312, DOI 10.1016/0006-3223(92)90036-Y; Tabakoff B, 2013, PHARMACOL BIOCHEM BE, V113, P20, DOI 10.1016/j.pbb.2013.10.009; Trudell J. R., 2014, TRENDS PHARM SCI; Weissenborn R, 2003, PSYCHOPHARMACOLOGY, V165, P306, DOI 10.1007/s00213-002-1281-1	55	35	35	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	OCT 1	2015	149						324	330		10.1016/j.physbeh.2015.06.034			7	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	CO2ZR	WOS:000359026400044	26143187				2022-02-06	
J	Jenkins, MM; Colvonen, PJ; Norman, SB; Afari, N; Allard, CB; Drummond, SPA				Jenkins, Melissa M.; Colvonen, Peter J.; Norman, Sonya B.; Afari, Niloofar; Allard, Carolyn B.; Drummond, Sean P. A.			Prevalence and Mental Health Correlates of Insomnia in First-Encounter Veterans with and without Military Sexual Trauma	SLEEP			English	Article						insomnia; military sexual trauma; prevalence; veterans	COGNITIVE-BEHAVIORAL THERAPY; POSTTRAUMATIC-STRESS-DISORDER; SLEEP DISTURBANCE; SERVICE; IRAQ; DISSEMINATION; EPIDEMIOLOGY; ASSOCIATION; VALIDATION; DEPRESSION	Study Objectives: There is limited information about prevalence of insomnia in general populations of veterans of recent wars in Iraq and Afghanistan. No studies have examined insomnia in veterans with military sexual trauma (MST). We assess prevalence of insomnia, identify types of services sought by veterans with insomnia, and examine correlates of insomnia in veterans with and without MST. Design: A cross-sectional study of first-encounter veterans registering to establish care. Setting: Veteran Affairs San Diego Healthcare System. Participants: Nine hundred seventeen veterans completed questionnaires assessing insomnia, MST, service needs, traumatic brain injury, resilience, and symptoms of depression, posttraumatic stress disorder (PTSD), pain, alcohol misuse, and hypomania. Interventions: N/A. Measurements and Results: 53.1% of veterans without MST and 60.8% of veterans with MST had clinically significant insomnia symptoms, with the MST subsample reporting more severe symptoms, P < 0.05. Insomnia was more prevalent than depression, hypomania, PTSD, and substance misuse. Veterans with insomnia were more likely to seek care for physical health problems and primary care versus mental health concerns, P < 0.001. For the veteran sample without MST, age, combat service, traumatic brain injury, pain, and depression were associated with worse insomnia, P < 0.001. For the MST subsample, employment status, pain, and depression were associated with worse insomnia, P < 0.001. Conclusions: Study findings indicate a higher rate of insomnia in veterans compared to what has been found in the general population. Insomnia is more prevalent, and more severe, in veterans with military sexual trauma. Routine insomnia assessments and referrals to providers who can provide evidence-based treatment are crucial.	[Jenkins, Melissa M.; Norman, Sonya B.; Afari, Niloofar; Allard, Carolyn B.; Drummond, Sean P. A.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Jenkins, Melissa M.; Norman, Sonya B.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Colvonen, Peter J.; Norman, Sonya B.; Afari, Niloofar; Allard, Carolyn B.; Drummond, Sean P. A.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Colvonen, Peter J.; Norman, Sonya B.; Afari, Niloofar; Allard, Carolyn B.; Drummond, Sean P. A.] Ctr Excellence Stress & Mental Hlth CESAMH, San Diego, CA USA; [Norman, Sonya B.] Natl Ctr PTSD, White River Jct, VT USA; [Drummond, Sean P. A.] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia		Drummond, SPA (corresponding author), Monash Univ, Sch Psychol Sci, Clin Neurosci, Clayton, Vic 3800, Australia.	sean.drummond@monash.edu	Allard, Carolyn B./B-3521-2013	Allard, Carolyn B./0000-0002-7803-2243; Drummond, Sean/0000-0002-9815-626X	Department of Veterans Affairs Center of Excellence for Stress and Mental Health (CESAMH)US Department of Veterans Affairs; Veterans Affairs Center for Innovation; VA San Diego Healthcare SystemUS Department of Veterans Affairs; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH018399] Funding Source: NIH RePORTER	This was not an industry supported study. Dr. Drummond has received fees from Arena Pharmaceuticals and grants from Actelion Clinical Research, Inc., unrelated to this paper. The other authors have indicated no financial conflicts of interest. This material is based upon work supported by the Department of Veterans Affairs Center of Excellence for Stress and Mental Health (CESAMH) and the Veterans Affairs Center for Innovation. This material also is the result of work supported with resources of the VA San Diego Healthcare System. The views expressed in this paper are those of the authors and do not reflect the official policy or position of the Department of Veterans Affairs or any of the institutions with which the authors are affiliated. The funding source did not play a role in the study design, in the collection, analysis, and interpretation of data, in the writing of the manuscript, or in the decision to submit the paper for publication.	Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; Allard CB, 2011, J TRAUMA DISSOCIATIO, V12, P324, DOI 10.1080/15299732.2011.542609; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2005, SLEEP, V28, P1049; Bernert RA, 2014, JAMA PSYCHIAT, V71, P1129, DOI 10.1001/jamapsychiatry.2014.1126; Bjorngaard JH, 2011, SLEEP, V34, P1155, DOI 10.5665/SLEEP.1228; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Bryant RA, 2010, SLEEP, V33, P69, DOI 10.1093/sleep/33.1.69; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cozza S.J., 2004, IRAQ WAR CLIN GUIDE, V2nd; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Edinger JD, 2001, JAMA-J AM MED ASSOC, V285, P1856, DOI 10.1001/jama.285.14.1856; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Germain A, 2008, SLEEP MED REV, V12, P185, DOI 10.1016/j.smrv.2007.09.003; Hermes E, 2014, SLEEP MED, V15, P508, DOI 10.1016/j.sleep.2013.12.010; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Karlin BE, 2015, INT J GERIATR PSYCH, V30, P308, DOI 10.1002/gps.4143; Karlin BE, 2013, J CONSULT CLIN PSYCH, V81, P912, DOI 10.1037/a0032554; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LeBlanc M, 2007, J PSYCHOSOM RES, V63, P157, DOI 10.1016/j.jpsychores.2007.03.004; Leger D, 2002, SLEEP, V25, P625; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Manber R, 2012, J CLIN SLEEP MED, V8, P209, DOI 10.5664/jcsm.1786; Manber R, 2011, J CLIN SLEEP MED, V7, P645, DOI 10.5664/jcsm.1472; Margolies SO, 2013, J CLIN PSYCHOL, V69, P1026, DOI 10.1002/jclp.21970; McIntyre LM, 1999, J GEN INTERN MED, V14, P186, DOI 10.1046/j.1525-1497.1999.00311.x; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Morin CM, 2013, SLEEP MED CLIN, V8, P281, DOI 10.1016/j.jsmc.2013.05.002; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2009, JAMA-J AM MED ASSOC, V301, P2005, DOI 10.1001/jama.2009.682; Mustafa Masroor, 2005, Sleep Breath, V9, P57, DOI 10.1007/s11325-005-0016-z; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Niebuhr RE, 1997, SEXUAL HARASSMENT TH, P250; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Simon GE, 1997, AM J PSYCHIAT, V154, P1417; Sivertsen B, 2012, PSYCHOSOM MED, V74, P758, DOI 10.1097/PSY.0b013e3182648619; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Suris A, 2008, TRAUMA VIOLENCE ABUS, V9, P250, DOI 10.1177/1524838008324419; Taylor MK, 2014, MIL MED, V179, P744, DOI 10.7205/MILMED-D-13-00551; Trockel M, 2014, BEHAV RES THER, V53, P41, DOI 10.1016/j.brat.2013.11.006; Weathers F. W., 1994, PCL C FOR DSM 4; Yaeger D, 2006, J GEN INTERN MED, V21, pS65, DOI 10.1111/j.1525-1497.2006.00377.x	49	35	35	0	15	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA		1550-9109		SLEEP	Sleep	OCT 1	2015	38	10					1547	1554		10.5665/sleep.5044			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CT3CP	WOS:000362684500005	26085301	Green Published, Bronze			2022-02-06	
J	Abbasi, SH; Mohammadinejad, P; Shahmansouri, N; Salehiomran, A; Beglar, AA; Zeinoddini, A; Forghani, S; Akhondzadeh, S				Abbasi, Seyed Hesameddin; Mohammadinejad, Payam; Shahmansouri, Nazila; Salehiomran, Abbas; Beglar, Akram Arjmandi; Zeinoddini, Atefeh; Forghani, Saeedeh; Akhondzadeh, Shahin			Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Atorvastatin; Coronary artery bypass; Depression; Simvastatin	TRAUMATIC BRAIN-INJURY; CLINICAL-TRIAL; HEART-DISEASE; STATIN USE; MYOCARDIAL-INFARCTION; COGNITIVE FUNCTION; MAJOR DEPRESSION; RISK-FACTOR; DISORDER; FLUOXETINE	Background: A decreased risk of developing depression has been reported among statin users. Aside from their lipid-lowering effects, statins are considered immunomodulatory agents and have protective effects against oxidative stress and inflammation which are well known for their association with depression. The aim of the present study was to compare the probable antidepressant effects of simvastatin and atorvastatin among post-coronary artery bypass graft (CABG) surgery patients with high and low potentials for blood-brain-barrier penetration, respectively. Method: Forty-six outpatients who had undergone CABG in the last 6 months and suffered from mild to moderate depression participated in a parallel, double-blind, placebo-controlled trial, and were randomized to undergo 6 weeks of treatment with either simvastatin (20 mg/day) or atorvastatin (20 mg/day). Participants were evaluated using Hamilton depression rating scale (HDRS) at baseline and weeks 3 and 6. The primary outcome was to evaluate the efficacy of simvastatin in improving the depressive symptoms. Result: General linear model repeated measures demonstrated significant effect for time x treatment interaction on the HDRS scores IF (1.62, 71.06)=3.41, P=0.048]. There was no significant difference between the treatment groups regarding the adverse events. No one experienced serious adverse event. Limitation: The limitations of the present study were its small sample size and the short-term follow-up period. Conclusion: Treatment with simvastatin seems to be well tolerated with superior antidepressant effects compared to atorvastatin in post-CABG patients. Long-term outcomes of this practice and its probable influence on other psychological aspects are yet to be investigated in future studies. (C) 2015 Elsevier B.V. All rights reserved.	[Abbasi, Seyed Hesameddin; Shahmansouri, Nazila; Salehiomran, Abbas; Beglar, Akram Arjmandi] Univ Tehran Med Sci, Tehran Heart Ctr, Tehran, Iran; [Abbasi, Seyed Hesameddin] Iranian Petr Ind Hlth Res Inst, Family Hlth Res Ctr, Tehran, Iran; [Mohammadinejad, Payam; Zeinoddini, Atefeh; Akhondzadeh, Shahin] Univ Tehran Med Sci, Roozbeh Psychiat Hosp, Psychiat Res Ctr, Tehran, Iran; [Forghani, Saeedeh] Razi Vaccine & Serum Res Inst, Karaj, Iran		Akhondzadeh, S (corresponding author), Univ Tehran Med Sci, Roozbeh Psychiat Hosp, Psychiat Res Ctr, Tehran, Iran.	s.akhond@neda.net	Akhondzadeh, Shahin/F-2914-2018; Forghani, Saeedeh/M-9792-2017; Mohammadinejad, Payam/N-8138-2015; Abbasi, Seyed Hesameddin/D-5420-2009	Akhondzadeh, Shahin/0000-0002-2277-5101; Abbasi, Seyed Hesameddin/0000-0002-1068-8860	Tehran University of Medical SciencesTehran University of Medical Sciences [19164]	This trial was supported by a grant from Tehran University of Medical Sciences (Grant no: 19164).	Abbasi SH, 2012, J AFFECT DISORDERS, V141, P308, DOI 10.1016/j.jad.2012.03.033; Bernick C, 2005, NEUROLOGY, V65, P1388, DOI 10.1212/01.wnl.0000182897.18229.ec; Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6; Bosel J, 2005, J NEUROCHEM, V92, P1386, DOI 10.1111/j.1471-4159.2004.02980.x; Bush D E, 2005, Evid Rep Technol Assess (Summ), P1; Carney RM, 2003, BIOL PSYCHIAT, V54, P241, DOI 10.1016/S0006-3223(03)00111-2; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Dang YH, 2014, CURR PHARM DESIGN, V20, P5151, DOI 10.2174/1381612819666140110120435; Dortland AKBV, 2010, J CLIN PSYCHIAT, V71, P729, DOI 10.4088/JCP.08m04865blu; Frasure-Smith N, 2005, PSYCHOSOM MED, V67, pS19, DOI 10.1097/01.psy.0000162253.07959.db; Ghanizadeh A, 2013, DEPRESS ANXIETY, V30, P1084, DOI 10.1002/da.22195; Gougol A, 2015, J PSYCHOPHARMACOL, V29, P575, DOI 10.1177/0269881115578160; Haghighi M, 2014, J PSYCHIATR RES, V58, P109, DOI 10.1016/j.jpsychires.2014.07.018; Hajjar L, 2002, J GERONTOL A-BIOL, V57, pM414, DOI 10.1093/gerona/57.7.M414; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Han XG, 2011, NEUROSCI LETT, V487, P255, DOI 10.1016/j.neulet.2010.09.007; Hayashi T, 2005, BRAIN RES, V1037, P52, DOI 10.1016/j.brainres.2004.12.051; Hillis LD, 2012, J THORAC CARDIOV SUR, V143, P4, DOI 10.1016/j.jtcvs.2011.10.015; Khajavi D, 2012, J CLIN PSYCHIAT, V73, P1428, DOI 10.4088/JCP.12m07706; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lin PY, 2014, PHARMACOL BIOCHEM BE, V124, P174, DOI 10.1016/j.pbb.2014.06.006; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Ludka FK, 2013, EUR NEUROPSYCHOPHARM, V23, P400, DOI 10.1016/j.euroneuro.2012.05.005; Maany I, 2004, JAMA-J AM MED ASSOC, V292, P2833, DOI 10.1001/jama.292.23.2833-b; Machado-Vieira R, 2008, J CLIN PSYCHIAT, V69, P946, DOI 10.4088/JCP.v69n0610; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P664, DOI 10.1016/j.pnpbp.2010.06.014; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Mandas A, 2014, NEUROL RES, V36, P247, DOI 10.1179/1743132813Y.0000000287; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Meijer A, 2011, GEN HOSP PSYCHIAT, V33, P203, DOI 10.1016/j.genhosppsych.2011.02.007; Modabbernia A, 2012, PSYCHOPHARMACOLOGY, V223, P381, DOI 10.1007/s00213-012-2729-6; Muldoon MF, 2000, AM J MED, V108, P538, DOI 10.1016/S0002-9343(00)00353-3; Mulhaupt F, 2003, CARDIOVASC RES, V59, P755, DOI 10.1016/S0008-6363(03)00515-7; Otte C, 2012, J CLIN PSYCHIAT, V73, P610, DOI 10.4088/JCP.11m07038; Parsaik AK, 2014, J AFFECT DISORDERS, V160, P62, DOI 10.1016/j.jad.2013.11.026; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Santos T, 2012, NEUROPSYCH DIS TREAT, V8, P413, DOI 10.2147/NDT.S31714; SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785; Shahmansouri N, 2014, J AFFECT DISORDERS, V155, P216, DOI 10.1016/j.jad.2013.11.003; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sierra S, 2011, J ALZHEIMERS DIS, V23, P307, DOI 10.3233/JAD-2010-101179; Stafford L, 2011, J CLIN PSYCHIAT, V72, P1229, DOI 10.4088/JCP.09m05825blu; Stewart RA, 2000, ARCH INTERN MED, V160, P3144, DOI 10.1001/archinte.160.20.3144; Trivedi Madhukar H, 2009, J Clin Psychiatry, V70, pe01; Tsai SJ, 2007, MED HYPOTHESES, V68, P1296, DOI 10.1016/j.mehy.2006.09.043; Vuletic S, 2006, DEMENT GERIATR COGN, V22, P392, DOI 10.1159/000095679; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Weidner G, 2009, PSYCHOL HEALTH MED, V14, P255, DOI 10.1080/13548500902730101; Wood WG, 2010, ANN NY ACAD SCI, V1199, P69, DOI 10.1111/j.1749-6632.2009.05359.x; Young-Xu Y, 2003, J AM COLL CARDIOL, V42, P690, DOI 10.1016/S0735-1097(03)00785-X; Zeinoddini A, 2015, DEPRESS ANXIETY, V32, P167, DOI 10.1002/da.22340	51	35	36	0	22	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	SEP 1	2015	183						149	155		10.1016/j.jad.2015.04.049			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	CK6TQ	WOS:000356361500020	26005776				2022-02-06	
J	Konigs, M; Heij, HA; van der Sluijs, JA; Vermeulen, J; Goslings, JC; Luitse, JSK; Poll-The, BT; Beelen, A; van der Wees, M; Kemps, RJJK; Catsman-Berrevoets, CE; Oosterlaan, J				Konigs, Marsh; Heij, Hugo A.; van der Sluijs, Johannes A.; Vermeulen, Jeroen; Goslings, J. Carel; Luitse, Jan S. K.; Poll-The, Bwee Tien; Beelen, Anita; van der Wees, Marleen; Kemps, Rachel J. J. K.; Catsman-Berrevoets, Coriene E.; Oosterlaan, Jaap			Pediatric Traumatic Brain Injury and Attention Deficit	PEDIATRICS			English	Article							CHILDREN; RECOVERY; SKILLS; ADOLESCENTS; VARIABILITY; DISORDERS; OUTCOMES	BACKGROUND: We investigated the impact of pediatric traumatic brain injury (TBI) on attention, a prerequisite for behavioral and neurocognitive functioning. METHODS: Children aged 6 to 13 years who were diagnosed with TBI (n = 113; mean 1.7 years postinjury) were compared with children with a trauma control injury (not involving the head) (n = 53). TBI severity was defined as mild TBI with or without risk factors for complicated TBI (mild(RF+) TBI, n = 52; mild(RF-) TBI, n = 24) or moderate/severe TBI (n = 37). Behavioral functioning was assessed by using parent and teacher questionnaires, and the Attention Network Test assessed alerting, orienting, and executive attention. Ex-Gaussian modeling determined the contribution of extremely slow responses (lapses of attention) to mean reaction time (MRT). RESULTS: The TBI group showed higher parent and teacher ratings of attention and internalizing problems, higher parent ratings of externalizing problems, and lower intelligence than the control group (P < .05, >= 0.34). No effect of TBI on alerting, orienting, and executive attention was observed (P >= .55). MRT was slower in the TBI group (P = .008, d = 0.45), traced back to increased lapses of attention (P = .002, d = 0.52). The mild(RF-) TBI group was unaffected, whereas the mild(RF+) TBI and moderate/severe TBI groups showed elevated parent ratings of behavior problems, lower intelligence, and increased lapses of attention (P <= .03, d >= 0.48). Lapses of attention fully explained the negative relation between intelligence and parent-rated attention problems in the TBI group (P = .02). CONCLUSIONS: Lapses of attention represent a core attention deficit in children with mild(RF+) TBI (even in the absence of intracranial pathology) or moderate/severe TBI, and relate to daily life problems after pediatric TBI.	[Konigs, Marsh; Oosterlaan, Jaap] Vrije Univ Amsterdam, Clin Neuropsychol, NL-1081 BT Amsterdam, Netherlands; [Heij, Hugo A.] Emma Childrens Hosp, Acad Med Ctr, Pediat Surg Ctr Amsterdam, Amsterdam, Netherlands; [Heij, Hugo A.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [van der Sluijs, Johannes A.] Vrije Univ Amsterdam Med Ctr, Dept Pediat Orthoped, Amsterdam, Netherlands; [Vermeulen, Jeroen] Vrije Univ Amsterdam Med Ctr, Dept Pediat Neurol, Amsterdam, Netherlands; [Goslings, J. Carel] Univ Amsterdam, Acad Med Ctr, Trauma Unit, NL-1105 AZ Amsterdam, Netherlands; [Luitse, Jan S. K.] Univ Amsterdam, Acad Med Ctr, Dept Emergency Med, NL-1105 AZ Amsterdam, Netherlands; [Poll-The, Bwee Tien] Univ Amsterdam, Acad Med Ctr, Dept Pediat Neurol, NL-1105 AZ Amsterdam, Netherlands; [Beelen, Anita] Merem Rehabil Ctr De Trappenberg, Huizen, Netherlands; [Beelen, Anita] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1105 AZ Amsterdam, Netherlands; [van der Wees, Marleen] Libra Rehabil Med & Audiol Blixembosch, Eindhoven, Netherlands; [Kemps, Rachel J. J. K.] Libra Rehabil Med & Audiol Leijpk, Tilburg, Netherlands; [Catsman-Berrevoets, Coriene E.] Erasmus MC, Dept Pediat Neurol, Rotterdam, Netherlands; [Oosterlaan, Jaap] Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands		Konigs, M (corresponding author), Vrije Univ Amsterdam, Clin Neuropsychol, Boechorststr 1, NL-1081 BT Amsterdam, Netherlands.	m.konigs@vu.nl		Vermeulen, R. Jeroen/0000-0002-3503-3625; Poll-The, Bwee Tien/0000-0002-8118-5419	Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [022.003.010]	This work was supported by the Netherlands Organization for Scientific Research, grant number 022.003.010.	American College of Surgeons, 2004, ATLS ADV TRAUM LIF S, V7th ed; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barriga AQ, 2002, J EMOT BEHAV DISORD, V10, P233, DOI 10.1177/10634266020100040501; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Cohen J., 2013, STAT POWER ANAL BEHA; Conklin HM, 2010, J CLIN ONCOL, V28, P4465, DOI 10.1200/JCO.2010.28.4026; de Kieviet JF, 2012, J PEDIATR-US, V161, P824, DOI 10.1016/j.jpeds.2012.05.010; Epstein JN, 2011, NEUROPSYCHOPHARMACOL, V36, P1060, DOI 10.1038/npp.2010.243; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Geurts HM, 2008, NEUROPSYCHOLOGIA, V46, P3030, DOI 10.1016/j.neuropsychologia.2008.06.013; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hussain-Gambles M, 2004, HEALTH SOC CARE COMM, V12, P382, DOI 10.1111/j.1365-2524.2004.00507.x; Kaufman AS, 1996, J CLIN CHILD PSYCHOL, V25, P97, DOI 10.1207/s15374424jccp2501_11; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lacouture Y, 2008, TUTOR QUANT METHODS, V4, P35, DOI 10.20982/tqmp.04.1.p035; LOGAN GD, 1994, J EXP PSYCHOL LEARN, V20, P1022, DOI 10.1037/0278-7393.20.5.1022; Logan GD, 2002, PSYCHOL REV, V109, P376, DOI 10.1037//0033-295X.109.2.376; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Statistics Netherlands, STAND OND 2006; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tabachnick BG., 2012, USING MULTIVARIATE S; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thaler NS, 2010, ARCH CLIN NEUROPSYCH, V25, P781, DOI 10.1093/arclin/acq073; Van der Ende J, 2013, HANDLEIDING ASEBA VR; van Widenfelt BM, 2003, EUR CHILD ADOLES PSY, V12, P281, DOI 10.1007/s00787-003-0341-3; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Winslade WJ, 1999, CONFRONTING TRAUMATI	35	35	35	0	16	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	SEP	2015	136	3					534	541		10.1542/peds.2015-0437			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	CQ6IN	WOS:000360708100042	26240208				2022-02-06	
J	Martinez-Morillo, E; Childs, C; Garcia, BP; Menendez, FVA; Romaschin, AD; Cervellin, G; Lippi, G; Diamandis, EP				Martinez-Morillo, Eduardo; Childs, Charmaine; Prieto Garcia, Belen; Alvarez Menendez, Francisco V.; Romaschin, Alexander D.; Cervellin, Gianfranco; Lippi, Giuseppe; Diamandis, Eleftherios P.			Neurofilament medium polypeptide (NFM) protein concentration is increased in CSF and serum samples from patients with brain injury	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						biomarker; brain injury; cerebrospinal fluid; neurofilament; serum; stroke	COMMERCIAL IMMUNOASSAYS; CEREBROSPINAL-FLUID; CHAIN LEVELS; BIOMARKERS; STROKE; DAMAGE; S100B	Background: Brain injury is a medical emergency that needs to be diagnosed and treated promptly. Several proteins have been studied as biomarkers of this medical condition. The aims of this study were to: 1) evaluate the selectivity and precision of a commercial ELISA kit for neurofilament medium polypeptide (NFM) protein; and 2) evaluate the concentration in cerebrospinal fluid (CSF) and serum of healthy individuals and patients with brain damage. Methods: An ELISA from Elabscience was used. The selectivity was evaluated using size-exclusion chromatography and mass spectrometry. Intra-and inter-batch coefficients of variation (CV) were also studied. Fifty-one CSF samples from 36 age-matched patients with hemorrhagic stroke (HS) (n = 30), ischemic stroke (IS) (n = 11) and healthy individuals (n = 10) were assayed. In addition, serum samples from healthy volunteers (n = 47), 68 serum samples from seven patients with HS, 106 serum samples from 12 patients with traumatic brain injury (TBI) and 68 serum samples from 68 patients with mild traumatic brain injury (mTBI) were also analyzed. Results: NFM was identified in the chromatographic fraction with highest immunoreactivity. The intra-and inter-batch CVs were <= 10% and <= 13%, respectively. The CSF-NFM concentration in HS was significantly higher (p < 0.0001) than in IS and controls. Serum NFM concentration ranged from 0.26 to 8.57 ng/mL in healthy individuals (median = 2.29), from 0.97 to 42.4 ng/mL in HS (median = 10.8) and from 3.48 to 45.4 ng/mL in TBI (median = 14.7). Finally, 44% of patients with mTBI had increased NFM concentration, with significantly higher levels (p = 0.01) in patients with polytrauma. Conclusions: To our knowledge this is the first study describing increased NFM levels in CSF and serum from patients with brain damage.	[Diamandis, Eleftherios P.] Mt Sinai Hosp, Pathol & Lab Med Dept, Toronto, ON M5T 3L9, Canada; [Diamandis, Eleftherios P.] Univ Hlth Network, Dept Clin Biochem, Toronto, ON, Canada; [Martinez-Morillo, Eduardo] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5T 3L9, Canada; [Martinez-Morillo, Eduardo] Hosp Univ Cent Asturias, Lab Med, Dept Clin Biochem, Oviedo, Spain; [Childs, Charmaine] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Ctr Hlth & Social Care Res, Sheffield S1 1WB, S Yorkshire, England; [Prieto Garcia, Belen; Alvarez Menendez, Francisco V.] Hosp Univ Cent Asturias, Lab Med, Dept Clin Biochem, Oviedo, Spain; [Romaschin, Alexander D.] Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Cervellin, Gianfranco] Acad Hosp Parma, Emergency Dept, Parma, Italy; [Lippi, Giuseppe] Acad Hosp Parma, Lab Clin Chem & Hematol, Parma, Italy		Diamandis, EP (corresponding author), Mt Sinai Hosp, Pathol & Lab Med Dept, Suite 6-201,Box 32,60 Murray St, Toronto, ON M5T 3L9, Canada.	ediamandis@mtsinai.on.ca	Lippi, Giuseppe/X-7198-2018	Lippi, Giuseppe/0000-0001-9523-9054; Diamandis, Eleftherios/0000-0002-1589-820X			Arlen RK, 2007, NEW RES NEUROFILAMEN; Brea D, 2009, CLIN CHEM LAB MED, V47, P1513, DOI 10.1515/CCLM.2009.337; Cai JY, 2013, CLIN CHIM ACTA, V424, P182, DOI 10.1016/j.cca.2013.06.019; Cervellin G, 2012, CLIN BIOCHEM, V45, P408, DOI 10.1016/j.clinbiochem.2012.01.006; Childs C, 2013, CLIN CHEM LAB MED, V51, pE195, DOI 10.1515/cclm-2013-0216; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gresle MM, 2014, J NEUROL NEUROSUR PS, V85, P1209, DOI 10.1136/jnnp-2013-306789; Kuhle J, 2010, J NEUROIMMUNOL, V220, P114, DOI 10.1016/j.jneuroim.2010.01.004; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Martinez-Morillo E, 2014, J PROTEOME RES, V13, P969, DOI 10.1021/pr401111h; Martinez-Morillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045676; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Moritz S, 2010, J NEUROSURG ANESTH, V22, P21, DOI 10.1097/ANA.0b013e3181bdf50d; Petzold A, 2006, J NEUROL NEUROSUR PS, V77, P753, DOI 10.1136/jnnp.2005.085175; Petzold A, 2005, J NEUROTRAUM, V22, P407, DOI 10.1089/neu.2005.22.407; Prassas I, 2014, CLIN CHEM LAB MED, V52, P765, DOI 10.1515/cclm-2013-1078; Puentes F, 2014, J NEUROL NEUROSUR PS, V85, P274, DOI [10.1136/jnnp-2013-305494, 10.1136/jnnp-2013-307454]; Rifai N, 2012, CLIN CHEM, V58, P1387, DOI 10.1373/clinchem.2012.192351; Schiavi Paolo, 2012, Acta Biomed, V83, P5; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Zanier ER, 2011, J NEUROL NEUROSUR PS, V82, P157, DOI 10.1136/jnnp.2009.177667	23	35	36	0	19	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	SEP	2015	53	10					1575	1584		10.1515/cclm-2014-0908			10	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	CQ8IT	WOS:000360851500023	25720124	Green Accepted			2022-02-06	
J	Pavey, GJ; Qureshi, AT; Hope, DN; Pavlicek, RL; Potter, BK; Forsberg, JA; Davis, TA				Pavey, Gabriel J.; Qureshi, Ammar T.; Hope, Donald N.; Pavlicek, Rebecca L.; Potter, Benjamin K.; Forsberg, Jonathan A.; Davis, Thomas A.			Bioburden Increases Heterotopic Ossification Formation in an Established Rat Model	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							COMBAT-RELATED AMPUTATIONS; TRAUMATIC BRAIN-INJURY; TOLL-LIKE RECEPTORS; ACINETOBACTER-BAUMANNII; OSTEOMYELITIS; EXPRESSION; PERSONNEL; WOUNDS; PREVALENCE; FRACTURES	Background Heterotopic ossification (HO) develops in a majority of combat-related amputations wherein early bacterial colonization has been considered a potential early risk factor. Our group has recently developed a small animal model of trauma-induced HO that incorporates many of the multifaceted injury patterns of combat trauma in the absence of bacterial contamination and subsequent wound colonization. Questions/purposes We sought to determine if (1) the presence of bioburden (Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus [MRSA]) increases the magnitude of ectopic bone formation in traumatized muscle after amputation; and (2) what persistent effects bacterial contamination has on late microbial flora within the amputation site. Methods Using a blast-related HO model, we exposed 48 rats to blast overpressure, femur fracture, crush injury, and subsequent immediate transfemoral amputation through the zone of injury. Control injured rats (n = 8) were inoculated beneath the myodesis with phosphate-buffered saline not containing bacteria (vehicle) and treatment rats were inoculated with 1 x 10(6) colony-forming units of A baumannii (n = 20) or MRSA (n = 20). All animals formed HO. Heterotopic ossification was determined by quantitative volumetric measurements of ectopic bone at 12-weeks postinjury using micro-CT and qualitative histomorphometry for assessment of new bone formation in the residual limb. Bone marrow and muscle tissue biopsies were collected from the residual limb at 12 weeks to quantitatively measure the bioburden load and to qualitatively determine the species-level identification of the bacterial flora. Results At 12 weeks, we observed a greater volume of HO in rats infected with MRSA (68.9 +/- 8.6 mm(3); 95% confidence interval [CI], 50.52-85.55) when compared with A baumannii (20.9 +/- 3.7 mm(3); 95% CI, 13.61-28.14; p < 0.001) or vehicle (16.3 +/- 3.2 mm(3); 95% CI, 10.06-22.47; p < 0.001). Soft tissue and marrow from the residual limb of rats inoculated with A baumannii tested negative for A baumannii infection but were positive for other strains of bacteria (1.33 x 10(2) +/- 0.89 x 10(2); 95% CI,-0.42 x 10(2)-3.08 x 10(2) and 1.25 x 10(6) +/- 0.69 x 10(6); 95% CI,-0.13 x 10(6)-2.60 x 10(6) colony-forming units in bone marrow and muscle tissue, respectively), whereas tissue from MRSA-infected rats contained MRSA only (4.84 x 10(1) +/- 3.22 x 10(1); 95% CI,-1.47 x 10(1)-11.1 x 10(1) and 2.80 x 10(7) +/- 1.73 x 10(7); 95% CI, -0.60 x 10(7)-6.20 x 10(7) in bone marrow and muscle tissue, respectively). Conclusions Our findings demonstrate that persistent infection with MRSA results in a greater volume of ectopic bone formation, which may be the result of chronic soft tissue inflammation, and that early wound colonization may be a key risk factor.	[Pavey, Gabriel J.; Qureshi, Ammar T.; Hope, Donald N.; Potter, Benjamin K.; Forsberg, Jonathan A.; Davis, Thomas A.] Naval Med Res Ctr, Regenerat Med Dept, Silver Spring, MD 20910 USA; [Pavey, Gabriel J.; Hope, Donald N.; Potter, Benjamin K.; Forsberg, Jonathan A.] Walter Reed Natl Mil Med Ctr, Dept Orthopaed, Bethesda, MD USA; [Pavlicek, Rebecca L.] Naval Med Res Ctr, Dept Wound Infect, Silver Spring, MD 20910 USA; [Potter, Benjamin K.; Forsberg, Jonathan A.; Davis, Thomas A.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Davis, TA (corresponding author), Naval Med Res Ctr, Regenerat Med Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	thomas.davis1@med.navy.mil	Potter, Benjamin/U-1769-2019	Potter, MD, Benjamin K./0000-0002-8771-0317; Pavlicek, Rebecca/0000-0002-7109-9576	USAMRAA BAA [10083004]; USAMRAA PRORP-CDMRP [120056]	This work was supported by USAMRAA BAA #10083004 (Principal Investigator JAF) and USAMRAA PRORP-CDMRP #120056 (Principal Investigator JAF).	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Be NA, 2014, J CLIN MICROBIOL, V52, P2583, DOI 10.1128/JCM.00556-14; Brown KV, 2010, J TRAUMA, V69, pS116, DOI 10.1097/TA.0b013e3181e44cc7; Burns TC, 2012, J TRAUMA ACUTE CARE, V72, P1062, DOI 10.1097/TA.0b013e318241f534; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Calhoun JH, 2008, CLIN ORTHOP RELAT R, V466, P1356, DOI 10.1007/s11999-008-0212-9; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Collinet-Adler S, 2011, CLIN ORTHOP RELAT R, V469, P274, DOI 10.1007/s11999-010-1488-0; Davis TA, 2013, BONE, V56, P119, DOI 10.1016/j.bone.2013.05.016; Evans KN, 2014, CLIN ORTHOP RELAT R, V472, P396, DOI 10.1007/s11999-013-3325-8; Forsberg JA, 2014, CLIN ORTHOP RELAT R, V472, P1; Forsberg Jonathan Agner, 2010, J Surg Orthop Adv, V19, P54; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; GARLAND DE, 1988, CLIN ORTHOP RELAT R, P86; Hospenthal DR, 2011, J TRAUMA, V71, pS52, DOI 10.1097/TA.0b013e31822118fb; Johnson EN, 2007, CLIN INFECT DIS, V45, P409, DOI 10.1086/520029; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; Mo IFY, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-52; Murray CK, 2005, CURR OPIN INFECT DIS, V18, P502, DOI 10.1097/01.qco.0000185985.64759.41; Murray CK, 2008, J TRAUMA, V64, pS239, DOI 10.1097/TA.0b013e318163cd14; Murray CK, 2008, J TRAUMA, V64, pS221, DOI 10.1097/TA.0b013e318163c40b; Murray CK, 2006, MIL MED, V171, P826, DOI 10.7205/MILMED.171.9.826; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Polfer EM, 2015, BONE JOINT J, P97; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Salisbury E, 2011, J CELL BIOCHEM, V112, P2748, DOI 10.1002/jcb.23225; Sheppard FR, 2010, AM J SURG, V200, P489, DOI 10.1016/j.amjsurg.2010.03.001; Thompson MG, 2014, ANTIMICROB AGENTS CH, V58, P1332, DOI 10.1128/AAC.01944-13; Tintle SM, 2014, J ORTHOP TRAUMA, V28, P232, DOI 10.1097/BOT.0b013e3182a53130; Uematsu S, 2008, TOLL LIKE RECEPTORS, P240; Yin LY, 2013, MIL MED, V178, P696, DOI 10.7205/MILMED-D-12-00550; Yun HC, 2008, J TRAUMA, V64, pS163, DOI 10.1097/TA.0b013e318160868c	33	35	36	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	SEP	2015	473	9					2840	2847		10.1007/s11999-015-4272-3			8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	CO1TA	WOS:000358936900017	25822455	Green Published			2022-02-06	
J	Astafiev, SV; Shulman, GL; Metcalf, NV; Rengachary, J; MacDonald, CL; Harrington, DL; Maruta, J; Shimony, JS; Ghajar, J; Diwakar, M; Huang, MX; Lee, RR; Corbetta, M				Astafiev, Serguei V.; Shulman, Gordon L.; Metcalf, Nicholas V.; Rengachary, Jennifer; MacDonald, Christine L.; Harrington, Deborah L.; Maruta, Jun; Shimony, Joshua S.; Ghajar, Jamshid; Diwakar, Mithun; Huang, Ming-Xiong; Lee, Roland R.; Corbetta, Maurizio			Abnormal White Matter Blood-Oxygen-Level-Dependent Signals in Chronic Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assessments; diffusion tensor imaging; MRI; traumatic brain injury	SACCADIC EYE-MOVEMENTS; POST-CONCUSSIVE SYMPTOMS; DIFFUSION-TENSOR; FUNCTIONAL MRI; SMOOTH-PURSUIT; WORKING-MEMORY; HEAD-INJURY; CORPUS-CALLOSUM; REACTION-TIME; MILITARY PERSONNEL	Concussion, or mild traumatic brain injury (mTBI), can cause persistent behavioral symptoms and cognitive impairment, but it is unclear if this condition is associated with detectable structural or functional brain changes. At two sites, chronic mTBI human subjects with persistent post-concussive symptoms (three months to five years after injury) and age- and education-matched healthy human control subjects underwent extensive neuropsychological and visual tracking eye movement tests. At one site, patients and controls also performed the visual tracking tasks while blood-oxygen-level-dependent (BOLD) signals were measured with functional magnetic resonance imaging. Although neither neuropsychological nor visual tracking measures distinguished patients from controls at the level of individual subjects, abnormal BOLD signals were reliably detected in patients. The most consistent changes were localized in white matter regions: anterior internal capsule and superior longitudinal fasciculus. In contrast, BOLD signals were normal in cortical regions, such as the frontal eye field and intraparietal sulcus, that mediate oculomotor and attention functions necessary for visual tracking. The abnormal BOLD signals accurately differentiated chronic mTBI patients from healthy controls at the single-subject level, although they did not correlate with symptoms or neuropsychological performance. We conclude that subjects with persistent post-concussive symptoms can be identified years after their TBI using fMRI and an eye movement task despite showing normal structural MRI and DTI.	[Astafiev, Serguei V.; Shulman, Gordon L.; Metcalf, Nicholas V.; Rengachary, Jennifer; MacDonald, Christine L.; Corbetta, Maurizio] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Harrington, Deborah L.; Diwakar, Mithun; Huang, Ming-Xiong; Lee, Roland R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Maruta, Jun; Ghajar, Jamshid] Brain Trauma Fdn, New York, NY USA; [Ghajar, Jamshid] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA; [Shimony, Joshua S.] Washington Univ, Med Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA		Corbetta, M (corresponding author), Washington Univ, Dept Neurol, 660 S Euclid Ave, St Louis, MO 63110 USA.	mau@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020; Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605; Astafiev, Serguei/0000-0003-3736-7095; CORBETTA, MAURIZIO/0000-0001-8295-3304	James S. McDonnell Foundation; National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD061117-05A2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095741] Funding Source: NIH RePORTER	We gratefully acknowledge Robert Fucetola, PhD, for neuropsychological consultation; A.Z. Snyder, M.D., PhD, for image analysis assistance; K.L. Zinn, P.T., for scheduling patients; David L. Brody, M.D., PhD, for referral of some mTBI subjects; Jerrel Rutlin for TBBS analysis and M.P. McAvoy, PhD, and M.J. Strube, PhD, for statistical advice. Supported by James S. McDonnell Foundation grant for the Attention Dynamics Consortium in Traumatic Brain Injury (ADC-TBI) and National Institute of Child Health and Human Development (NICHD) grant R01 HD061117-05A2.	Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; BAHILL AT, 1983, VISION RES, V23, P1573; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chang DJ, 2002, EPILEPSIA, V43, P68, DOI 10.1046/j.1528-1157.2002.21601.x; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Chen Y, 2002, PROG BRAIN RES, V140, P255; COLLEWIJN H, 1984, J PHYSIOL-LONDON, V351, P217, DOI 10.1113/jphysiol.1984.sp015242; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coronado V. G., 2012, EPIDEMIOLOG IN PRESS; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; DeFina P, 2009, CLIN NEUROPSYCHOL, V23, P1391, DOI 10.1080/13854040903058978; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; Fabri M, 2011, BRAIN RES, V1370, P99, DOI 10.1016/j.brainres.2010.11.039; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fraser LM, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-91; Gawryluk JR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00239; Gawryluk JR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00589; Gawryluk JR, 2011, NEUROIMAGE, V54, P10, DOI 10.1016/j.neuroimage.2010.07.028; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ghajar J, 2009, NEUROSCIENTIST, V15, P232, DOI 10.1177/1073858408326429; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Heiss WD, 2010, J CEREBR BLOOD F MET, V30, P1671, DOI 10.1038/jcbfm.2010.131; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Krauzlis RJ, 2005, NEUROSCIENTIST, V11, P124, DOI 10.1177/1073858404271196; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laitinen T. P., 2009, P INT SOC MAG RESON; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Liotti M, 2001, J CLIN EXP NEUROPSYC, V23, P121, DOI 10.1076/jcen.23.1.121.1223; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Martin LF, 2011, J PSYCHIATR RES, V45, P670, DOI 10.1016/j.jpsychires.2010.09.015; Maruta J, 2013, BEHAV RES METHODS, V45, P289, DOI 10.3758/s13428-012-0248-3; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Mazerolle EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058130; Mazerolle EL, 2010, NEUROIMAGE, V50, P616, DOI 10.1016/j.neuroimage.2009.12.102; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McWhinney SR, 2012, J NEUROSCI METH, V209, P351, DOI 10.1016/j.jneumeth.2012.06.014; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Muthukumaraswamy SD, 2012, HUM BRAIN MAPP, V33, P455, DOI 10.1002/hbm.21223; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Newman AJ, 2010, P NATL ACAD SCI USA, V107, P7539, DOI 10.1073/pnas.1003174107; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; Palmer HS, 2010, J NEUROTRAUM, V27, P853, DOI 10.1089/neu.2009.1225; Patel MJ, 2012, PSYCHIAT RES-NEUROIM, V204, P117, DOI 10.1016/j.pscychresns.2012.09.006; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; PETIT L, 1993, J NEUROPHYSIOL, V69, P1009, DOI 10.1152/jn.1993.69.4.1009; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rowland DJ, 2005, NUCL MED BIOL, V32, P567, DOI 10.1016/j.nucmedbio.2005.05.002; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Sweeney JA, 1996, J NEUROPHYSIOL, V75, P454, DOI 10.1152/jn.1996.75.1.454; Talairach J., 1988, COPLANAR STEREOTAXIC; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wang P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00085; Yang Z, 2012, J NEUROTRAUM, V29, P2124, DOI 10.1089/neu.2012.2395; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	101	35	35	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1254	1271		10.1089/neu.2014.3547			18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400010	25758167	Green Published, Green Submitted			2022-02-06	
J	Kobeissy, FH; Liu, MC; Yang, ZH; Zhang, ZQ; Zheng, WR; Glushakova, O; Mondello, S; Anagli, J; Hayes, RL; Wang, KKW				Kobeissy, Firas H.; Liu, Ming Cheng; Yang, Zhihui; Zhang, Zhiqun; Zheng, Wenrong; Glushakova, Olena; Mondello, Stefania; Anagli, John; Hayes, Ronald L.; Wang, Kevin K. W.			Degradation of beta II-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions	MOLECULAR NEUROBIOLOGY			English	Article						Cell death; Neurodegeneration; Protease; TBI; beta II-Spectrin apoptotic; Calpain-2; Caspase-3	CULTURED HIPPOCAMPAL SLICES; CALCIUM-DEPENDENT PROTEASE; DIFFUSE AXONAL INJURY; ALPHA-II; CEREBROSPINAL-FLUID; BREAKDOWN PRODUCTS; NEURONAL APOPTOSIS; MEMBRANE SKELETON; PROTEOLYSIS; ANKYRIN	A major consequence of traumatic brain injury (TBI) is the rapid proteolytic degradation of structural cytoskeletal proteins. This process is largely reflected by the interruption of axonal transport as a result of extensive axonal injury leading to neuronal cell injury. Previous work from our group has described the extensive degradation of the axonally enriched cytoskeletal alpha II-spectrin protein which results in molecular signature breakdown products (BDPs) indicative of injury mechanisms and to specific protease activation both in vitro and in vivo. In the current study, we investigated the integrity of beta II-spectrin protein and its proteolytic profile both in primary rat cerebrocortical cell culture under apoptotic, necrotic, and excitotoxic challenge and extended to in vivo rat model of experimental TBI (controlled cortical impact model). Interestingly, our results revealed that the intact 260-kDa beta II-spectrin is degraded into major fragments (beta II-spectrin breakdown products (beta sBDPs)) of 110, 108, 85, and 80 kDa in rat brain (hippocampus and cortex) 48 h post-injury. These beta sBDP profiles were further characterized and compared to an in vitro beta II-spectrin fragmentation pattern of naive rat cortex lysate digested by calpain-2 and caspase-3. Results revealed that beta II-spectrin was degraded into major fragments of 110/85 kDa by calpain-2 activation and 108/80 kDa by caspase-3 activation. These data strongly support the hypothesis that in vivo activation of multiple protease system induces structural protein proteolysis involving beta II-spectrin proteolysis via a specific calpain and/or caspase-mediated pathway resulting in a signature, protease-specific beta sBDPs that are dependent upon the type of neural injury mechanism. This work extends on previous published work that discusses the interplay spectrin family (alpha II-spectrin and beta II-spectrin) and their susceptibility to protease proteolysis and their implication to neuronal cell death mechanisms.	[Kobeissy, Firas H.; Liu, Ming Cheng; Yang, Zhihui; Zhang, Zhiqun; Zheng, Wenrong; Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32610 USA; [Glushakova, Olena; Anagli, John; Hayes, Ronald L.] Banyan Biomarkers Inc, Banyan Lab, Alachua, FL 32615 USA; [Mondello, Stefania] Univ Messina, Dept Neurosci, I-98125 Messina, Italy; [Kobeissy, Firas H.] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon		Kobeissy, FH (corresponding author), Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32610 USA.	firasko@gmail.com; kwang@ufl.edu	Glushakova, Olena/AAY-1130-2021; Mondello, Stefania/A-1813-2012; Kobeissy, Firas/E-7042-2017	Glushakova, Olena/0000-0002-2109-3651; Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944; Wang, Kevin/0000-0002-9343-6473	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS049175-01, R01 NS052831-01]; Department of DefenseUnited States Department of Defense [DAMD17-03-1-0066]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049175, R01NS052831] Funding Source: NIH RePORTER	We would like to thank Dr. Hussam Jourdi for his critical and thorough discussion. Special thanks to Mr. Danny Johnson for his technical support in animal surgeries and tissue collection. This work was supported by the National Institutes of Health grants R01 NS049175-01 and R01 NS052831-01 and the Department of Defense grant DAMD17-03-1-0066. KKW and RLH hold equity in Banyan Biomarkers, Inc., a company commercializing technology of detecting brain injury biomarkers. RLH and OG are employees at Banyan Biomarkers Inc.	AZUMA M, 1991, CURR EYE RES, V10, P657, DOI 10.3109/02713689109013857; BACKMAN L, 1991, J BIOL CHEM, V266, P3835; Baskin-Bey ES, 2007, AM J TRANSPLANT, V7, P218, DOI 10.1111/j.1600-6143.2006.01595.x; Beneke R, 2005, EUR J APPL PHYSIOL, V95, P307, DOI 10.1007/s00421-005-0010-y; BENNETT M, 1995, IRISH MED J, V88, P59; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cb.09.110193.000331; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Buki A, 2000, J NEUROSCI, V20, P2825; Chen ZM, 2005, NEUROSCI LETT, V376, P166, DOI 10.1016/j.neulet.2004.11.051; Chiesa R, 1998, J NEUROCHEM, V70, P1474; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Cryns VL, 1996, J BIOL CHEM, V271, P31277, DOI 10.1074/jbc.271.49.31277; Czogalla A, 2007, MOL MEMBR BIOL, V24, P215, DOI 10.1080/09687860601102427; DAVIS LH, 1994, J BIOL CHEM, V269, P4409; De Matteis MA, 2000, J CELL SCI, V113, P2331; DELCERRO S, 1994, NEUROSCI LETT, V167, P149, DOI 10.1016/0304-3940(94)91049-9; DISTASI AMM, 1991, NEURON, V6, P445, DOI 10.1016/0896-6273(91)90252-U; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Garbe DS, 2007, DEVELOPMENT, V134, P273, DOI 10.1242/dev.02653; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Glantz SB, 2007, BIOCHEMISTRY-US, V46, P502, DOI 10.1021/bi061504y; GOODMAN SR, 1980, J BIOL CHEM, V255, P8082; HARRIS AS, 1990, P NATL ACAD SCI USA, V87, P3009, DOI 10.1073/pnas.87.8.3009; Hayes NVL, 2000, J CELL SCI, V113, P2023; Hoglen NC, 2007, LIVER TRANSPLANT, V13, P361, DOI 10.1002/lt.21016; HU RJ, 1991, J BIOL CHEM, V266, P18200; Huh GY, 2001, NEUROSCI LETT, V316, P41, DOI 10.1016/S0304-3940(01)02371-0; IVY G, 1988, BRAIN RES, V459, P233, DOI 10.1016/0006-8993(88)90639-7; Jourdi H, 2005, NEUROCHEM INT, V46, P31, DOI 10.1016/j.neuint.2004.07.002; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kizhatil K, 2009, EXP EYE RES, V88, P55, DOI 10.1016/j.exer.2008.09.022; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kondo K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-147; Koumura A, 2008, NEUROSCIENCE, V157, P309, DOI 10.1016/j.neuroscience.2008.09.007; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Liu MC, 2010, ASN NEURO, V3; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lofvenberg L, 1999, FEBS LETT, V443, P89, DOI 10.1016/S0014-5793(98)01697-4; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Morrow JS, 1989, CURR OPIN CELL BIOL, V1, P23, DOI 10.1016/S0955-0674(89)80032-8; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; MUSACCHIO A, 1992, FEBS LETT, V307, P55, DOI 10.1016/0014-5793(92)80901-R; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; Nath R, 2000, NEUROCHEM INT, V36, P119, DOI 10.1016/S0197-0186(99)00112-6; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pockros PJ, 2007, HEPATOLOGY, V46, P324, DOI 10.1002/hep.21664; Poordad F Fred, 2004, Curr Opin Investig Drugs, V5, P1198; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; ROBERTSLEWIS JM, 1993, ANN NY ACAD SCI, V679, P78; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Rolius R, 2010, CELL MOL BIOL LETT, V15, P395, DOI 10.2478/s11658-010-0015-3; SEUBERT P, 1989, BRAIN RES, V492, P366, DOI 10.1016/0006-8993(89)90921-9; SEUBERT P, 1989, NEUROSCIENCE, V31, P195, DOI 10.1016/0306-4522(89)90041-9; Shirasaki Y, 2005, BIOORGAN MED CHEM, V13, P4473, DOI 10.1016/j.bmc.2005.04.059; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; Stankewich MC, 2011, J CELL SCI, V124, P3956, DOI 10.1242/jcs.080374; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; Ursitti JA, 2001, DEV BRAIN RES, V129, P81, DOI 10.1016/S0165-3806(01)00160-2; Vanags DM, 1996, J BIOL CHEM, V271, P31075, DOI 10.1074/jbc.271.49.31075; Viel A, 1996, CURR OPIN CELL BIOL, V8, P49, DOI 10.1016/S0955-0674(96)80048-2; WANG DS, 1994, BIOCHEM BIOPH RES CO, V203, P29, DOI 10.1006/bbrc.1994.2144; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Waterhouse N, 1996, J BIOL CHEM, V271, P29335, DOI 10.1074/jbc.271.46.29335; Zhang CS, 2013, J CELL BIOL, V203, P437, DOI 10.1083/jcb.201308116; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	86	35	35	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2015	52	1					696	709		10.1007/s12035-014-8898-z			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN3QO	WOS:000358341600060	25270371	Green Accepted			2022-02-06	
J	Magnoni, S; Mac Donald, CL; Esparza, TJ; Conte, V; Sorrell, J; Macri, M; Bertani, G; Biffi, R; Costa, A; Sammons, B; Snyder, AZ; Shimony, JS; Triulzi, F; Stocchetti, N; Brody, DL				Magnoni, Sandra; Mac Donald, Christine L.; Esparza, Thomas J.; Conte, Valeria; Sorrell, James; Macri, Mario; Bertani, Giulio; Biffi, Riccardo; Costa, Antonella; Sammons, Brian; Snyder, Abraham Z.; Shimony, Joshua S.; Triulzi, Fabio; Stocchetti, Nino; Brody, David L.			Quantitative assessments of traumatic axonal injury in human brain: concordance of microdialysis and advanced MRI	BRAIN			English	Article						traumatic brain injury; traumatic axonal injury; diffusion tensor imaging; microdialysis; tau	POSITRON-EMISSION-TOMOGRAPHY; WHITE-MATTER INTEGRITY; HEAD-INJURY; CEREBRAL MICRODIALYSIS; OUTCOME PREDICTION; METABOLIC CRISIS; MOUSE MODEL; IN-VIVO; MILD; DAMAGE	Axonal injury is a major contributor to adverse outcomes following brain trauma. However, the extent of axonal injury cannot currently be assessed reliably in living humans. Here, we used two experimental methods with distinct noise sources and limitations in the same cohort of 15 patients with severe traumatic brain injury to assess axonal injury. One hundred kilodalton cut-off microdialysis catheters were implanted at a median time of 17 h (13-29 h) after injury in normal appearing (on computed tomography scan) frontal white matter in all patients, and samples were collected for at least 72 h. Multiple analytes, such as the metabolic markers glucose, lactate, pyruvate, glutamate and tau and amyloid-beta proteins, were measured every 1-2 h in the microdialysis samples. Diffusion tensor magnetic resonance imaging scans at 3 T were performed 2-9 weeks after injury in 11 patients. Stability of diffusion tensor imaging findings was verified by repeat scans 1-3 years later in seven patients. An additional four patients were scanned only at 1-3 years after injury. Imaging abnormalities were assessed based on comparisons with five healthy control subjects for each patient, matched by age and sex (32 controls in total). No safety concerns arose during either microdialysis or scanning. We found that acute microdialysis measurements of the axonal cytoskeletal protein tau in the brain extracellular space correlated well with diffusion tensor magnetic resonance imaging-based measurements of reduced brain white matter integrity in the 1-cm radius white matter-masked region near the microdialysis catheter insertion sites. Specifically, we found a significant inverse correlation between microdialysis measured levels of tau 13-36 h after injury and anisotropy reductions in comparison with healthy controls (Spearman's r = -0.64, P = 0.006). Anisotropy reductions near microdialysis catheter insertion sites were highly correlated with reductions in multiple additional white matter regions. We interpret this result to mean that both microdialysis and diffusion tensor magnetic resonance imaging accurately reflect the same pathophysiological process: traumatic axonal injury. This cross-validation increases confidence in both methods for the clinical assessment of axonal injury. However, neither microdialysis nor diffusion tensor magnetic resonance imaging have been validated versus post-mortem histology in humans. Furthermore, future work will be required to determine the prognostic significance of these assessments of traumatic axonal injury when combined with other clinical and radiological measures.	[Magnoni, Sandra; Conte, Valeria; Stocchetti, Nino] IRCCS Ca Granda Osped Maggiore Policlin, Dept Anaesthesiol & Intens Care, Milan, Italy; [Mac Donald, Christine L.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; [Esparza, Thomas J.; Sorrell, James; Sammons, Brian; Brody, David L.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Macri, Mario; Stocchetti, Nino] Univ Milan, Milan, Italy; [Bertani, Giulio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosurg, Milan, Italy; [Biffi, Riccardo; Costa, Antonella; Triulzi, Fabio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neuroradiol, Milan, Italy; [Snyder, Abraham Z.; Shimony, Joshua S.] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Brody, David L.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA		Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu	Bertani, Giulio/ABD-8401-2021; Magnoni, Sandra/AAC-7479-2022; Stocchetti, Nino/O-7444-2017	Bertani, Giulio/0000-0003-1470-3391; Magnoni, Sandra/0000-0002-1723-0844; Stocchetti, Nino/0000-0003-3250-6834	Burroughs Wellcome Career Award in the Biomedical SciencesBurroughs Wellcome Fund; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08 NS049237, R01 NS065069]; Fondazione IRCCS Ca Granda-Ospedale Maggiore Policlinico; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS049237, R01NS065069] Funding Source: NIH RePORTER	This work was supported by funds from a Burroughs Wellcome Career Award in the Biomedical Sciences to D.L.B.; National Institutes of Health [grant numbers K08 NS049237 to D.L.B. and R01 NS065069 to D.L.B.; and departmental fund of the Fondazione IRCCS Ca Granda-Ospedale Maggiore Policlinico.	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Das C, 2014, J NEUROTRAUM, V31, pA1; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gentry LR, 1988, AIR AM J ROENTGENL, P663; Hillered L, 2006, CURR OPIN CRIT CARE, V12, P112, DOI 10.1097/01.ccx.0000216576.11439.df; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hutchinson P, 2009, ACTA NEUROCHIR, V151, P51, DOI 10.1007/s00701-008-0169-1; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Seunarine K.K., 2014, DIFFUSION MRI, P105, DOI [10.1016/B978-0-12-396460-1.00006-8, DOI 10.1016/B978-0-12-396460-1.00006-8]; Shimony JS, 2009, BIOL PSYCHIAT, V66, P245, DOI 10.1016/j.biopsych.2009.02.032; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Van Essen D.C, 2014, DIFFUSION MRI, P337, DOI DOI 10.1016/B978-0-12-396460-1.00016-0; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	60	35	36	1	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	AUG 1	2015	138		8				2263	2277		10.1093/brain/awv152			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ4MJ	WOS:000360578700023	26084657	Bronze, Green Published			2022-02-06	
J	Gagnon, DJ; Nielsen, N; Fraser, GL; Riker, RR; Dziodzio, J; Sunde, K; Hovdenes, J; Stammet, P; Friberg, H; Rubertsson, S; Wanscher, M; Seder, DB				Gagnon, David J.; Nielsen, Niklas; Fraser, Gilles L.; Riker, Richard R.; Dziodzio, John; Sunde, Kjetil; Hovdenes, Jan; Stammet, Pascal; Friberg, Hans; Rubertsson, Sten; Wanscher, Michael; Seder, David B.			Prophylactic antibiotics are associated with a lower incidence of pneumonia in cardiac arrest survivors treated with targeted temperature management	RESUSCITATION			English	Article						Cardiac arrest; Pneumonia; Hypothermia; Intensive care; Antibiotics; Temperature	VENTILATOR-ASSOCIATED PNEUMONIA; TRAUMATIC BRAIN-INJURY; EARLY-ONSET PNEUMONIA; THERAPEUTIC HYPOTHERMIA; CARDIOPULMONARY-RESUSCITATION; INFECTIOUS COMPLICATIONS; ADVERSE EVENTS; CARE; METAANALYSIS; GUIDELINES	Introduction: Prophylactic antibiotics (PRO) reduce the incidence of early-onset pneumonia in comatose patients with structural brain injury, but have not been examined in cardiac arrest survivors undergoing targeted temperature management (TTM). We investigated the effect of PRO on the development of pneumonia in that population. Methods: We conducted a retrospective cohort study comparing patients treated with PRO to those not receiving PRO (no-PRO) using Northern Hypothermia Network registry data. Cardiac arrest survivors >= 18 years of age with a GCS < 8 at hospital admission and treated with TTM at 32-34 degrees C were enrolled in the registry. Differences were analyzed in univariate analyses and with logistic regression models to evaluate independent associations of clinical factors with incidence of pneumonia and good functional outcome. Results: 416 of 1240 patients (33.5%) received PRO. Groups were similar in age, gender, arrest location, initial rhythm, and time from collapse to return of spontaneous circulation. PRO patients had less pneumonia (12.6% vs. 54.9%, p < 0.001) and less sepsis (1.2 vs. 5.7%, p < 0.001) compared to no-PRO patients. ICU length of stay (98 vs. 100 h, p = 0.2) and incidence of a good functional outcome (41.1 vs. 36.6%, p = 0.19) were similar between groups. Backwards stepwise logistic regression demonstrated PRO were independently associated with a lower incidence of pneumonia (OR 0.09, 95% 0.06-0.14, p < 0.001) and a similar incidence of good functional outcome. Conclusions: Prophylactic antibiotics were associated with a reduced incidence of pneumonia but a similar rate of good functional outcome. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Gagnon, David J.; Fraser, Gilles L.] Maine Med Ctr, Dept Pharm, Portland, ME 04102 USA; [Nielsen, Niklas] Helsingborg Hosp, Dept Anesthesia & Intens Care, Helsingborg, Sweden; [Fraser, Gilles L.; Riker, Richard R.; Dziodzio, John; Seder, David B.] Maine Med Ctr, Dept Crit Care Serv, Portland, ME 04102 USA; [Riker, Richard R.; Seder, David B.] Maine Med Ctr, Neurosci Inst, Portland, ME 04102 USA; [Riker, Richard R.; Seder, David B.] Maine Med Ctr, Div Pulm Med, Portland, ME 04102 USA; [Sunde, Kjetil] Oslo Univ Hosp Ulleval, Dept Anesthesiol, Div Emergencies & Crit Care, Oslo, Norway; [Hovdenes, Jan] Natl Hosp Norway, Oslo Univ Hosp, Dept Anesthesiol, Div Emergencies & Crit Care, Oslo, Norway; [Stammet, Pascal] Ctr Hosp Luxembourg, Dept Anesthesia & Intens Care, Luxembourg, Luxembourg; [Friberg, Hans] Lund Univ, Dept Clin Sci, Lund, Sweden; [Rubertsson, Sten] Uppsala Univ, Dept Anesthesiol & Intens Care, Uppsala, Sweden; [Wanscher, Michael] Rigshosp, Copenhagen Univ Hosp, Dept Cardiothorac Anesthesia, DK-2100 Copenhagen, Denmark		Gagnon, DJ (corresponding author), Maine Med Ctr, Dept Pharm, Portland, ME 04102 USA.	dgagnon@mmc.org	Seder, David B./M-4829-2019; Riker, Richard/AAP-1760-2020; Stammet, Pascal/ABA-7580-2020	Riker, Richard/0000-0002-0682-6204; Stammet, Pascal/0000-0002-0298-1012; Seder, David/0000-0002-9717-1038	Scandinavian Critical Care Trials Group; Scandinavian Society of Anesthesiology and Intensive Care; Stig and Ragna Gorthon Foundation; Torsten Birger Segerfalk Foundation; Laerdal Foundation; Gyllenstierna Krapperup Foundation (Nyhamnslage, Sweden); Skane County Council's research and development foundation	Northern Hypothermia Network was supported, in part, by the Scandinavian Critical Care Trials Group and the Scandinavian Society of Anesthesiology and Intensive Care, the Stig and Ragna Gorthon Foundation, the Torsten Birger Segerfalk Foundation, the Laerdal Foundation, the Gyllenstierna Krapperup Foundation (Nyhamnslage, Sweden), and the Skane County Council's research and development foundation.	Acquarolo A, 2005, INTENS CARE MED, V31, P510, DOI 10.1007/s00134-005-2585-5; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arrich J, 2012, COCHRANE DB SYST REV, V4, P9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Gajic O, 2004, RESUSCITATION, V60, P65, DOI 10.1016/j.resuscitation.2003.08.005; Geurts M, 2014, CRIT CARE MED, V42, P231, DOI 10.1097/CCM.0b013e3182a276e8; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hong JM, 2014, STROKE, V45, P134, DOI 10.1161/STROKEAHA.113.003143; Jarrah S, 2011, NEUROCRIT CARE, V14, P382, DOI 10.1007/s12028-011-9506-y; JENNETT B, 1975, LANCET, V1, P480; Kalanuria AA, 2014, CRIT CARE, V18, DOI 10.1186/cc13775; Langhelle A, 2005, RESUSCITATION, V66, P271, DOI 10.1016/j.resuscitation.2005.06.005; Levi AD, 2009, J NEUROTRAUM, V26, P407, DOI 10.1089/neu.2008.0745; MacLaren R, 2014, ANN PHARMACOTHER, V48, P17, DOI 10.1177/1060028013511228; Mongardon N, 2011, CRIT CARE MED, V39, P1359, DOI 10.1097/CCM.0b013e3182120b56; Moss M, 2003, CHEST, V123, P923, DOI 10.1378/chest.123.3.923; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nielsen N, 2011, CRIT CARE MED, V39, P57, DOI 10.1097/CCM.0b013e3181fa4301; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Noyes AM, 2013, J INTENSIVE CARE MED; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Perbet S, 2011, AM J RESP CRIT CARE, V184, P1048, DOI 10.1164/rccm.201102-0331OC; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; Seder DB, 2009, CRIT CARE MED, V37, pS211, DOI 10.1097/CCM.0b013e3181aa5bad; Seule MA, 2009, NEUROSURGERY, V64, P86, DOI 10.1227/01.NEU.0000336312.32773.A0; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Soleimanpour H, 2014, J CARDIOVASC THORAC, V6, P1, DOI 10.5681/jcvtr.2014.001; Stravitz RT, 2008, NEUROCRIT CARE, V9, P90, DOI 10.1007/s12028-008-9090-y; Torres A, 2009, INTENS CARE MED, V35, P9, DOI 10.1007/s00134-008-1336-9; Tsai MS, 2005, INTENS CARE MED, V31, P621, DOI 10.1007/s00134-005-2612-6; Vincent JL, 2006, CLIN CHEST MED, V27, P725, DOI 10.1016/j.ccm.2006.06.010; Woo JH, 2014, AM J EMERG MED, V32, P150, DOI 10.1016/j.ajem.2013.10.035; Xiao GG, 2013, EMERG MED J, V30, P91, DOI 10.1136/emermed-2012-201120; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	38	35	36	3	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	JUL	2015	92						154	159		10.1016/j.resuscitation.2015.01.035			6	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	CQ1JD	WOS:000360352500038	25680823				2022-02-06	
J	Maneshi, MM; Sachs, F; Hua, SSZ				Maneshi, Mohammad Mehdi; Sachs, Frederick; Hua, Susan Z.			A Threshold Shear Force for Calcium Influx in an Astrocyte Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blast; intracellular Ca2+; mechanosensitive ion channel (MSC); shear stress; traumatic brain injury (TBI)	REACTIVE ASTROCYTES; PEPTIDE INHIBITOR; CA2+ CHANNELS; ION CHANNELS; RELEASE; GLUTAMATE; DYNAMICS; STRAIN; ROLES; CONSEQUENCES	Traumatic brain injury (TBI) refers to brain damage resulting from external mechanical force, such as a blast or crash. Our current understanding of TBI is derived mainly from in vivo studies that show measurable biological effects on neurons sampled after TBI. Little is known about the early responses of brain cells during stimuli and which features of the stimulus are most critical to cell injury. We generated defined shear stress in a microfluidic chamber using a fast pressure servo and examined the intracellular Ca2+ levels in cultured adult astrocytes. Shear stress increased intracellular Ca2+ depending on the magnitude, duration, and rise time of the stimulus. Square pulses with a fast rise time (approximate to 2ms) caused transient increases in intracellular Ca2+, but when the rise time was extended to 20ms, the response was much less. The threshold for a response is a matrix of multiple parameters. Cells can integrate the effect of shear force from repeated challenges: A pulse train of 10 narrow pulses (11.5dyn/cm(2) and 10ms wide) resulted in a 4-fold increase in Ca2+ relative to a single pulse of the same amplitude 100ms wide. The Ca2+ increase was eliminated in Ca2+-free media, but was observed after depleting the intracellular Ca2+ stores with thapsigargin suggesting the need for a Ca2+ influx. The Ca2+ influx was inhibited by extracellular Gd3+, a nonspecific inhibitor of mechanosensitive ion channels, but it was not affected by the more specific inhibitor, GsMTx4. The voltage-gated channel blockers, nifedipine, diltiazem, and verapamil, were also ineffective. The data show that the mechanically induced Ca2+ influx commonly associated with neuron models for TBI is also present in astrocytes, and there is a viscoelastic/plastic coupling of shear stress to the Ca2+ influx. The site of Ca2+ influx has yet to be determined.	[Maneshi, Mohammad Mehdi; Hua, Susan Z.] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA; [Sachs, Frederick; Hua, Susan Z.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA		Hua, SSZ (corresponding author), SUNY Buffalo, Dept Mech & Aerosp Engn, 340 Jarvis Hall, Buffalo, NY 14260 USA.	zhua@buffalo.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS085517]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL054887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS085517] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) grant NS085517. The authors thank Dr. Paul Blank at the NIH for the encouragement and useful discussion at the beginning of the project.	Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Besch SR, 2002, PFLUG ARCH EUR J PHY, V445, P161, DOI 10.1007/s00424-002-0903-0; Bowman CL, 2007, TOXICON, V49, P249, DOI 10.1016/j.toxicon.2006.09.030; BRODE HL, 1959, PHYS FLUIDS, V2, P217, DOI 10.1063/1.1705911; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Daschil N, 2013, J ALZHEIMERS DIS, V37, P439, DOI 10.3233/JAD-130560; De Bock M, 2014, BBA-MOL CELL RES, V1843, P2211, DOI 10.1016/j.bbamcr.2014.04.016; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Ermakov YA, 2001, BIOPHYS J, V80, P1851, DOI 10.1016/S0006-3495(01)76155-3; Ermakov YuA, 1997, Membr Cell Biol, V11, P539; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Gu LX, 2012, COMPOS PART B-ENG, V43, P3160, DOI 10.1016/j.compositesb.2012.04.014; Haeberle H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001750; Hua SZ, 2010, AM J PHYSIOL-CELL PH, V298, pC1424, DOI 10.1152/ajpcell.00503.2009; Jackson JG, 2006, J NEUROPHYSIOL, V96, P1093, DOI 10.1152/jn.00283.2006; Jensen MEJ, 2007, J AM SOC NEPHROL, V18, P2062, DOI 10.1681/ASN.2006070700; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; KIMELBERG HK, 1995, J CEREBR BLOOD F MET, V15, P409, DOI 10.1038/jcbfm.1995.51; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Liao SL, 2001, NEUROREPORT, V12, P3519, DOI 10.1097/00001756-200111160-00029; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; Meng F., 2011, CARDIAC MECHANO ELEC, P431; Meng FJ, 2012, J CELL SCI, V125, P743, DOI 10.1242/jcs.093104; Meng FJ, 2011, J CELL SCI, V124, P261, DOI 10.1242/jcs.071928; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Niggel J, 2000, J MEMBRANE BIOL, V174, P121, DOI 10.1007/s002320001037; North SH, 2012, ANNU REV ANAL CHEM, V5, P35, DOI 10.1146/annurev-anchem-062011-143105; Ostrow KL, 2003, TOXICON, V42, P263, DOI 10.1016/S0041-0101(03)00141-7; Ostrow LW, 2005, BRAIN RES REV, V48, P488, DOI 10.1016/j.brainresrev.2004.09.005; Ostrow LW, 2011, BIOCHEM BIOPH RES CO, V410, P81, DOI 10.1016/j.bbrc.2011.05.109; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Rahimzadeh J, 2011, AM J PHYSIOL-CELL PH, V301, pC646, DOI 10.1152/ajpcell.00099.2011; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Reinert M, 2000, Neurosurg Focus, V8, pe10; Rzigalinski BA, 1997, J NEUROCHEM, V68, P289; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Sanborn B, 2012, J BIOMECH, V45, P434, DOI 10.1016/j.jbiomech.2011.12.017; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Tamayol A., 2009, P ASME FLUIDS ENG DI; Usachev YM, 1997, J NEUROSCI, V17, P7404; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; Verma D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044167; Wang JB, 2010, LAB CHIP, V10, P235, DOI 10.1039/b914874d; Wang Yuexiu, 2011, Commun Integr Biol, V4, P385, DOI 10.4161/cib.4.4.15505; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Young JA, 2012, PHARMACOL THERAPEUT, V134, P1, DOI 10.1016/j.pharmthera.2011.08.003; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	68	35	37	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2015	32	13					1020	1029		10.1089/neu.2014.3677			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0SU	WOS:000363964200011	25442327	Green Published			2022-02-06	
J	Brooks, JC; Shavelle, RM; Strauss, DJ; Hammond, FM; Harrison-Felix, CL				Brooks, Jordan C.; Shavelle, Robert M.; Strauss, David J.; Hammond, Flora M.; Harrison-Felix, Cynthia L.			Long-Term Survival After Traumatic Brain Injury Part II: Life Expectancy	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Life Expectancy; Mortality trends; Prognosis; Rehabilitation; Survival	MORTALITY; REHABILITATION; TRENDS	Objectives: To compute the life expectancy of persons with traumatic brain injury (TBI) based on validated prognostic models from 2 cohorts, to compare mortality and life expectancy of persons with TBI with those of the U.S. general population, and to investigate trends toward improved survival over the last 2 decades. Design: Survival analysis. Setting: Postdischarge from rehabilitation units and long-term follow-up at regional centers. Participants: Two cohorts of long-term survivors of TBI (N=12,481): the Traumatic Brain Injury Model Systems (TBIMS) cohort comprised 7365 persons who were admitted to a TBIMS facility with moderate to severe TBI and were assessed at >= 1 years postinjury, and the California Department of Developmental Services (CDDS) cohort comprised 5116 persons who sustained a TBI and received long-term services from the CDDS. Interventions: Not applicable. Main Outcome Measures: Life expectancy. Results: The estimates of age-, sex-, and disability-specific life expectancy of persons with TBI derived from the CDDS and TBIMS were similar. The estimates of age- and sex-specific life expectancy were lower than those of the U.S. general population. Mortality rates of persons with TBI were higher than those of the U.S. general population. Mortality rates did not improve and the standardized mortality ratio increased over the study period from 1988 to 2010. Conclusions: Life expectancy of persons with TBI is lower than that of the general population and depends on age, sex, and severity of disability. When compared, the survival outcomes in the TBIMS and CDDS cohorts are remarkably similar. Because there have been no marked trends in the last 20 years, the life expectancies presented in this article may remain valid in the future. (C) 2015 by the American Congress of Rehabilitation Medicine	[Brooks, Jordan C.; Shavelle, Robert M.; Strauss, David J.] Life Expectancy Project, San Francisco, CA 94122 USA; [Hammond, Flora M.] Indiana Univ, Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Harrison-Felix, Cynthia L.] Univ Colorado, Dept Phys Med & Rehabil, Denver, CO 80202 USA		Brooks, JC (corresponding author), Life Expectancy Project, 1439 17th Ave, San Francisco, CA 94122 USA.	Brooks@LifeExpectancy.org			National Institute on Disability and Rehabilitation Research (NIDRR) of the U.S. Department of Education	Supported by the National Institute on Disability and Rehabilitation Research (NIDRR) of the U.S. Department of Education. However, the contents do not necessarily reflect the opinions or views of the Traumatic Brain Injury Model Systems Centers, NIDRR, or the U.S. Department of Education.	[Anonymous], 1992, INT STAT CLASS DIS I; Arias M, 1983, PACIFIC STATE ARCH, P28; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Baguley IJ, 2008, BRAIN INJURY, V22, P919, DOI 10.1080/02699050802448578; Brooks JC, 2015, ARCH PHYS M IN PRESS; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; California Department of Developmental Services, 1986, CLIENT DEV EV REP CD; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; De Vivo MI, 2012, TOP SPINAL CORD I S1, V18, P214; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Harris C, 1983, INTERRATER RELIABILI; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Harrison-Felix CL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P319; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; Middleton JW, 2012, SPINAL CORD, V50, P803, DOI 10.1038/sc.2012.55; Preston DL, 2005, ENCY BIOSTATISTICS, P1; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Shavelle R, 2000, J Insur Med, V32, P163; Shavelle RM, 2007, BRAIN INJURY MED PRI, P247; Strauss D, 2004, NEUROREHABILITATION, V19, P257; Strauss D, 1999, J INSUR MED, V31, P104; Strauss DJ, 2006, ARCH PHYS MED REHAB, V87, P1079, DOI 10.1016/j.apmr.2006.04.022; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Strauss DJ, 2003, NEUROLOGY, V60, P395, DOI 10.1212/WNL.60.3.395; UB Foundation Activities Inc, IRF PAI TRAIN MAN	29	35	35	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2015	96	6					1000	1005		10.1016/j.apmr.2015.02.002			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CK7FM	WOS:000356398200005	26043195				2022-02-06	
J	Dickstein, BD; Weathers, FW; Angkaw, AC; Nievergelt, CM; Yurgil, K; Nash, WP; Baker, DG; Litz, BT				Dickstein, Benjamin D.; Weathers, Frank W.; Angkaw, Abigail C.; Nievergelt, Caroline M.; Yurgil, Kate; Nash, William P.; Baker, Dewleen G.; Litz, Brett T.		Marine Resiliency Study Team	Diagnostic Utility of the Posttraumatic Stress Disorder (PTSD) Checklist for Identifying Full and Partial PTSD in Active-Duty Military	ASSESSMENT			English	Article						PCL; CAPS; PTSD; military; Marines; Sailors; subthreshold	BECK ANXIETY INVENTORY; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; PSYCHOMETRIC PROPERTIES; COMBAT; SUBTHRESHOLD; AFGHANISTAN; IRAQ; IMPAIRMENT; SYMPTOMS	The aim of this study was to determine optimally efficient cutoff scores on the Posttraumatic Stress Disorder Checklist (PCL) for identifying full posttraumatic stress disorder (PTSD) and partial PTSD (P-PTSD) in active-duty Marines and Sailors. Participants were 1,016 Marines and Sailors who were administered the PCL and Clinician-Administered PTSD Scale (CAPS) 3 months after returning from Operations Iraqi and Enduring Freedom. PCL cutoffs were tested against three CAPS-based classifications: full PTSD, stringent P-PTSD, and lenient P-PTSD. A PCL score of 39 was found to be optimally efficient for identifying full PTSD. Scores of 38 and 33 were found to be optimally efficient for identifying stringent and lenient P-PTSD, respectively. Findings suggest that the PCL cutoff that is optimally efficient for detecting PTSD in active-duty Marines and Sailors is substantially lower than the score of 50 commonly used by researchers. In addition, findings provide scores useful for identifying P-PTSD in returning service members.	[Dickstein, Benjamin D.] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Weathers, Frank W.] Auburn Univ, Auburn, AL 36849 USA; [Angkaw, Abigail C.; Nievergelt, Caroline M.; Yurgil, Kate; Baker, Dewleen G.] VA San Diego Healthcare Syst, San Diego, CA USA; [Angkaw, Abigail C.; Nievergelt, Caroline M.; Baker, Dewleen G.] Univ Calif San Diego, San Diego, CA 92103 USA; [Nash, William P.] Def Ctr Excellence Psychol Hlth Traumat Brain Inj, Washington, DC USA; [Litz, Brett T.] VA Boston Healthcare Syst, Boston, MA USA; [Litz, Brett T.] Boston Univ, Boston, MA 02215 USA		Dickstein, BD (corresponding author), Cincinnati VA Med Ctr, Ft Thomas Div, 1000 South Ft Thomas Ave, Ft Thomas, KY 41075 USA.	benjamin.dickstein@va.gov	Baker, Dewleen/O-4957-2019	Baker, Dewleen/0000-0002-1736-9838; Litz, Brett/0000-0002-0479-8887; Nievergelt, Caroline/0000-0001-5766-8923	VA Health Service Research and Development Project [SDR 09-0128]; Marine Corps; Navy Bureau of Medicine and Surgery; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH093500] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the VA Health Service Research and Development Project No. SDR 09-0128 and by the Marine Corps and the Navy Bureau of Medicine and Surgery.	Adams RE, 2006, AM J DRUG ALCOHOL AB, V32, P203, DOI 10.1080/00952990500479522; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Baker DG, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110134; BECK AT, 1991, J ANXIETY DISORD, V5, P213, DOI 10.1016/0887-6185(91)90002-B; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1993, BECK ANXIETY INVENTO; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Breslau N, 2004, PSYCHOL MED, V34, P1205, DOI 10.1017/S0033291704002594; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Creamer M, 2005, J AFFECT DISORDERS, V86, P175, DOI 10.1016/j.jad.2005.01.015; Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Gorman LA, 2011, PSYCHIAT SERV, V62, P28, DOI 10.1176/ps.62.1.pss6201_0028; Hewitt P. L., 1993, PSYCHOL ASSESSMENT, V5, P408, DOI DOI 10.1037/1040-3590.5.4.408; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jacoby WG, 2000, ELECT STUD, V19, P577, DOI 10.1016/S0261-3794(99)00028-1; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Karam EG, 2010, BIOL PSYCHIAT, V68, P465, DOI 10.1016/j.biopsych.2010.04.032; Keane T. M., 2004, ASSESSING PSYCHOL TR, P262; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; KRAEMER HC, 1987, PSYCHONEUROENDOCRINO, V12, P411, DOI 10.1016/0306-4530(87)90076-X; Kraemer HC, 1992, EVALUATING MED TESTS; Litz B. T., FACILITATIN IN PRESS, P69; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; Mylle J, 2004, J AFFECT DISORDERS, V78, P37, DOI 10.1016/S0165-0327(02)00218-5; Nash WP, 2011, PSYCHOSOC STRES, P33; O'Donnell ML, 2010, PSYCHIAT RES, V176, P257, DOI 10.1016/j.psychres.2009.05.012; Osman A, 1997, J CLIN PSYCHOL, V53, P7, DOI 10.1002/(SICI)1097-4679(199701)53:1<7::AID-JCLP2>3.0.CO;2-S; Pereda N, 2012, J TRAUMA STRESS, V25, P587, DOI 10.1002/jts.21736; Pietrzak RH, 2009, DEPRESS ANXIETY, V26, P739, DOI 10.1002/da.20574; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Smith M., 2000, WHODAS 2 TRAINING MA; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Weathers F., 1993, INT SOC TRAUM STRESS; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Weiss D. S., 2004, ASSESSING PSYCHOL TR, P103; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zlotnick C, 2002, COMPR PSYCHIAT, V43, P413, DOI 10.1053/comp.2002.35900	44	35	35	1	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	JUN	2015	22	3					289	297		10.1177/1073191114548683			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	CI0FZ	WOS:000354413600003	25178804	Green Published			2022-02-06	
J	Johansson, B; Wentzel, AP; Andrell, P; Mannheimer, C; Ronnback, L				Johansson, B.; Wentzel, A. -P.; Andrell, P.; Mannheimer, C.; Ronnback, L.			Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury	BRAIN INJURY			English	Article						Cognition; mental fatigue; methylphenidate; pain; TBI	SF-36 HEALTH SURVEY; POST-CONCUSSION SYMPTOMS; QUALITY-OF-LIFE; DOUBLE-BLIND; CHRONIC PAIN; HEAD-INJURY; CONTROLLED-TRIAL; MILD; PLACEBO; RELIABILITY	Objective: Post-traumatic brain injury symptoms, such as mental fatigue, have considerable negative impacts on quality-of-life. In the present study the effects of methylphenidate in two different dosages were assessed with regard to mental fatigue, pain and cognitive functions in persons who had suffered a traumatic brain injury. Methods: Fifty-one subjects were included and 44 completed the study. The treatment continued for 12 weeks, including three treatment periods with no medication for 4 weeks, administration of low dose methylphenidate (up to 5 mg x 3) for 4 weeks and normal dose methylphenidate (up to 20 mg x 3) for a further 4 weeks. The patients were randomized into three groups where all groups were given all treatments. Results: Significantly reduced mental fatigue, assessed with the Mental Fatigue Scale (MFS) and increased information processing speed (coding, WAIS-III), were detected. The SF-36 vitality and social functioning scales were also improved significantly. Pain was not reduced by methylphenidate. The positive effects of treatment were dose-dependent, with the most prominent effects being at 60 mg methylphenidate/day spread over three doses. Observed side-effects were increased blood pressure and increased heart rate. Conclusions: Methylphenidate was generally well-tolerated and it improved long-lasting mental fatigue and processing speed after traumatic brain injury.	[Johansson, B.; Ronnback, L.] Univ Gothenburg, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, S-41345 Gothenburg, Sweden; [Wentzel, A. -P.; Andrell, P.] Univ Gothenburg, Sahlgrenska Acad, Multidisciplinary Pain Ctr, Dept Mol & Clin Med, S-41345 Gothenburg, Sweden; [Wentzel, A. -P.; Mannheimer, C.] Kungalv Hosp, Multidisciplinary Pain Ctr, Kungalv, Sweden		Johansson, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Dubbsgatan 14, S-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se		, Birgitta/0000-0003-0240-1142	Health & Medical Care Committee of the Region, Vastra Gotaland	The authors report no conflicts of interest. The study was funded by grants from The Health & Medical Care Committee of the Region, Vastra Gotaland.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; Altman D.G., 1990, PRACTICAL STAT MED R; ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Jamora CW, 2013, BRAIN INJURY, V27, P1134, DOI 10.3109/02699052.2013.804196; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; Johansson B., 2014, TRAUMATIC BRAIN INJU; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson Birgitta, 2012, ISRN Psychiatry, V2012, P686425, DOI 10.5402/2012/686425; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; LINDQVIST G, 1993, ACTA PSYCHIAT SCAND, V88, P5, DOI 10.1111/j.1600-0447.1993.tb05611.x; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Reitan R, 1985, HALSTEAD REITAN NEUR; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Rodholm M, 2001, ACTA NEUROL SCAND, V103, P379, DOI 10.1034/j.1600-0404.2001.103006379.x; Senn S., 2002, CROSS OVER TRIALS CL, V2nd ed.; Speech Thomas J., 1993, Brain Injury, V7, P333, DOI 10.3109/02699059309034959; Sullivan M, 1998, J CLIN EPIDEMIOL, V51, P1105, DOI 10.1016/S0895-4356(98)00102-4; Sullivan M, 1982, SOC SCI MED, V41, P1349; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wechsler D., 2003, WECHSLER ADULT INTEL; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632	42	35	35	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2015	29	6					758	765		10.3109/02699052.2015.1004747			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CL8RL	WOS:000357241700011	25794299				2022-02-06	
J	Fournier, CN; Gearing, M; Upadhyayula, SR; Klein, M; Glass, JD				Fournier, Christina N.; Gearing, Marla; Upadhyayula, Saila R.; Klein, Mitch; Glass, Jonathan D.			Head injury does not alter disease progression or neuropathologic outcomes in ALS	NEUROLOGY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CHRONIC TRAUMATIC ENCEPHALOPATHY; MOTOR-NEURON DISEASE; TDP-43 PROTEINOPATHY; SURVIVAL; RILUZOLE; RISK; DIAGNOSIS; FOOTBALL	Objectives:To study the effects of head injury on disease progression and on neuropathologic outcomes in amyotrophic lateral sclerosis (ALS).Methods:Patients with ALS were surveyed to obtain head injury history, and medical records were reviewed. Linear regression was performed to determine if head injury was a predictor for mean monthly decline of Amyotrophic Lateral Sclerosis Functional Rating Scale-revised (ALSFRS-R), while controlling for confounders. Head injury history was obtained from family members of ALS autopsy cases. The frequency of tau proteinopathy, brain TDP-43 inclusions, and pathologic findings of Alzheimer disease (AD) were examined in ALS cases with head injury compared to cases without. Logistic regression was performed with each neuropathologic diagnosis as an outcome measure and head injury as a predictor variable.Results:No difference was seen in rate of decline of the ALSFRS-R between patients with head injury (n = 24) and without (n = 76), with mean monthly decline of -0.9 for both groups (p = 0.18). Of 47 ALS autopsy cases (n = 9 with head injury, n = 38 without), no significant differences were seen in the frequency of tau proteinopathy (11% with head injury; 24% without), TDP-43 in the brain (44% with head injury; 45% without), or AD pathology (33% with head injury; 26% without). Independent logistic regression models showed head injury was not a predictor of tau pathology (p = 0.42) or TDP-43 in the brain (p = 0.99).Conclusions:Head injury was not associated with faster disease progression in ALS and did not result in a specific neuropathologic phenotype. The tau pathology described with chronic traumatic encephalopathy was found in ALS autopsy cases both with and without head injury.	[Fournier, Christina N.; Gearing, Marla; Upadhyayula, Saila R.; Glass, Jonathan D.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Gearing, Marla; Glass, Jonathan D.] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Klein, Mitch] Emory Univ, Sch Med, Dept Environm Hlth, Atlanta, GA USA		Fournier, CN (corresponding author), Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.	christina.nicole.fournier@emory.edu			National Center for Advancing Translational Sciences of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454]; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG025688-03]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG025688] Funding Source: NIH RePORTER	Supported in part by the National Center for Advancing Translational Sciences of the NIH under award number UL1TR000454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Supported in part by a grant from the National Institute of Aging P50 AG025688-03.	Appel SH, 2010, MUSCLE NERVE, V42, P851, DOI 10.1002/mus.21939; Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Armon C, 2011, J NEUROPATH EXP NEUR, V70, P97, DOI 10.1097/01.JNEN.0000392910.86750.32; Bedlack RS, 2011, J NEUROPATH EXP NEUR, V70, P96, DOI 10.1097/NEN.0b013e318204782b; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; de Jong SW, 2012, AM J EPIDEMIOL, V176, P233, DOI 10.1093/aje/kws015; Georgoulopoulou E, 2013, AMYOTROPH LAT SCL FR, V14, P338, DOI 10.3109/21678421.2013.763281; Huisman MHB, 2013, J NEUROL NEUROSUR PS, V84, P976, DOI 10.1136/jnnp-2012-304724; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; Lacomblez L, 1996, NEUROLOGY, V47, pS242, DOI 10.1212/WNL.47.6_Suppl_4.242S; Lee CTC, 2013, J EPIDEMIOL, V23, P35, DOI 10.2188/jea.JE20120119; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Picard M., 1991, HELPS TBI SCREENING; Qureshi M, 2009, AMYOTROPH LATERAL SC, V10, P324, DOI 10.3109/17482960903009054; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Traxinger Kim, 2013, Neurol Clin Pract, V3, P313; Turner MR, 2010, J NEUROL SCI, V288, P45, DOI 10.1016/j.jns.2009.10.010; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9	25	35	35	2	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 28	2015	84	17					1788	1795		10.1212/WNL.0000000000001522			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CH5GB	WOS:000354062200017	25832660	Green Published			2022-02-06	
J	Camfield, C; Camfield, P				Camfield, Carol; Camfield, Peter			Injuries from seizures are a serious, persistent problem in childhood onset epilepsy: A population-based study	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Childhood; Epilepsy; Injury; Accidents; Population-based	CHILDREN; CLASSIFICATION; SHOULDER; PEOPLE; RISK	Purpose: Document the frequency, types and risk factors for injuries caused by seizures for people with childhood onset epilepsy. Method: We contacted patients with all types of epilepsy except childhood absence from the Nova Scotia Childhood Epilepsy population-based cohort. Seizure onset was between 1977 and 1985. Patients and parents were asked about serious injuries resulting from a seizure, defined as severe enough for an urgent physician or dentist visit. Results: Of 595 eligible patients, we contacted 472 (79%). During an average follow up of 23.9 +/- 8 years, 52 (11%) experienced >= 1 serious injury for a total of 81 injuries. Of all injuries, 24 (30%) were lacerations requiring sutures, 15 (19%) fractures, 11(14%) broken teeth, 8(10%) concussions, 4(5%) burns, and 20(25%) other. "Other" included 1 fatal drowning, 2 near-drownings, 3 shoulder dislocations and 1 severe eye injury. Four injuries occurred with the first seizure; all others after a long gap from seizure onset (range 1.5-30 years). Injuries occurred in all epilepsy syndromes, most commonly with symptomatic generalized epilepsy (17% vs. 11% p = 0.03) and intractable epilepsy (28% vs. 8% p < 0.0001). Most injuries occurred during normal daily activities and were judged not to be easily preventable. Conclusions: During 24 years of follow up 1 out of 10 patients with childhood onset epilepsy had a serious injury as the result of a seizure. Most injuries occurred years after the initial diagnosis and were more common when seizures were more frequent. The only practical solution to injury prevention is better seizure control. (C) 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Camfield, Peter] Dalhousie Univ, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Camfield, Peter] IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada		Camfield, P (corresponding author), Dalhousie Univ, Dept Pediat, Halifax, NS B3K 6R8, Canada.	camfield@dal.ca					[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Appleton RE, 2002, EPILEPSIA, V43, P764, DOI 10.1046/j.1528-1157.2002.41101.x; Baca CB, 2013, J PEDIATR-US, V163, P1684, DOI 10.1016/j.jpeds.2013.07.046; Beghi E, 2002, EPILEPSIA, V43, P1076, DOI 10.1046/j.1528-1157.2002.18701.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; CAMFIELD C, 1993, J PEDIATR-US, V122, P861, DOI 10.1016/S0022-3476(09)90008-7; Camfield CS, 2009, NEUROLOGY, V73, P1041, DOI 10.1212/WNL.0b013e3181b9c86f; Camfield P, 2007, EPILEPSIA, V48, P1128, DOI 10.1111/j.1528-1167.2007.01072.x; Deekollu D, 2005, SEIZURE-EUR J EPILEP, V14, P347, DOI 10.1016/j.seizure.2005.04.008; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Gosens T, 2000, SEIZURE-EUR J EPILEP, V9, P446, DOI 10.1053/seiz.2000.0418; Goudie EB, 2012, J BONE JOINT SURG BR, V94B, P721, DOI 10.1302/0301-620X.94B6.28259; Kwon CS, 2010, EPILEPSIA, V51, P2247, DOI 10.1111/j.1528-1167.2010.02697.x; Prasad V, 2014, PEDIATRICS, V133, P827, DOI 10.1542/peds.2013-2554; Tellez-Zenteno JF, 2008, EPILEPSIA, V49, P954, DOI 10.1111/j.1528-1167.2007.01499.x; Vestergaard P, 2005, ACTA NEUROL SCAND, V112, P277, DOI 10.1111/j.1600-0404.2005.00474.x; Wirrell EC, 1996, ARCH NEUROL-CHICAGO, V53, P929, DOI 10.1001/archneur.1996.00550090141020; Wirrell EC, 2006, EPILEPSIA, V47, P79, DOI 10.1111/j.1528-1167.2006.00666.x; Wirrell EC, 2011, EPILEPSY RES, V95, P110, DOI 10.1016/j.eplepsyres.2011.03.009	19	35	36	0	6	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	APR	2015	27						80	83		10.1016/j.seizure.2015.02.031			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CH0XH	WOS:000353745200016	25891933	Bronze			2022-02-06	
J	Kerr, ZY; Mihalik, JP; Guskiewicz, KM; Rosamond, WD; Evenson, KR; Marshall, SW				Kerr, Zachary Y.; Mihalik, Jason P.; Guskiewicz, Kevin M.; Rosamond, Wayne D.; Evenson, Kelly R.; Marshall, Stephen W.			Agreement Between Athlete-Recalled and Clinically Documented Concussion Histories in Former Collegiate Athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; injury; epidemiology; traumatic brain injury; concurrent validity	RECURRENT CONCUSSION; FOOTBALL PLAYERS; EPIDEMIOLOGY; ASSOCIATION; DEPRESSION; MANAGEMENT; STATEMENT; DIAGNOSIS; KNOWLEDGE; SYMPTOMS	Background: Athlete-recalled and clinically documented concussion histories have been used in research on former athletes, but both have limitations. Comparisons of these 2 types of concussion histories are needed to improve the accuracy of estimates of concussion history for future research and clinical care. Purpose: To estimate the agreement between athlete-recalled and clinically documented concussion histories during college and to explore reasons for differences. Study: Cohort study (diagnosis); Level of evidence, 3. Methods: Athlete-recalled concussion histories were provided by a convenience sample of 130 former collegiate athletes using an online questionnaire, and they were individually linked to previously collected clinical data that tracked medically diagnosed concussions at the host institution from 1996 to 2012. The intraclass correlation coefficient (ICC2,1) was used to assess agreement between athlete-recalled and clinically documented concussion histories. Descriptive analyses were performed to assess reasons for disagreement. Results: Agreement between athlete-recalled and clinically documented concussion histories was low (ICC2,1 = 0.21; 95% confidence interval, 0.05-0.37), but it was higher for women (ICC2,1 = 0.65; 95% confidence interval, 0.44-0.79) and for athletes playing more recently (2005-2012; ICC2,1 = 0.39; 95% confidence interval, 0.01-0.67). Of the 53 athletes who self-reported college sports-related concussions, 40% believed that they sustained impacts that should have been diagnosed as concussions but were undetected, and 21% admitted nondisclosure of suspected concussions. Common reasons for nondisclosure included the following: did not think injury was serious enough (91%), did not know it was a concussion (73%), and did not want to leave the game/practice (73%). Conclusion: Given the low agreement between athlete-recalled and clinically documented concussion histories, methodologic research is needed to improve the quality of tools used to assess concussion histories in former athletes.	[Kerr, Zachary Y.; Mihalik, Jason P.; Guskiewicz, Kevin M.; Rosamond, Wayne D.; Evenson, Kelly R.; Marshall, Stephen W.] Univ N Carolina, Chapel Hill, NC USA		Kerr, ZY (corresponding author), Datalys Ctr Sports Injury Res & Prevent, NCAA Injury Surveillance Program, 401 West Michigan St,Suite 500, Indianapolis, IN 46202 USA.	zkerr@datalyscenter.org		Guskiewicz, Kevin/0000-0002-8682-2130; Mihalik, Jason/0000-0001-6085-8322; Kerr, Zachary/0000-0003-1423-1259; Evenson, Kelly/0000-0002-3720-5830	National Center for Injury Prevention and ControlUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49-CE001495]	The Matthew A. Gfeller Sport-Related Traumatic Brain Injury Research and the Center for the Study of Retired Athletes are funded by private donations and various grant-funding agencies interested in understanding the current and late-life consequences and benefits of sports participation. The Injury Prevention Research Center is partially supported by the National Center for Injury Prevention and Control to facilitate research that increases knowledge of the consequences of injuries and opportunities for injury prevention. S.W.M. is partly supported by grant R49-CE001495 from the Centers for Disease Control and Prevention to the University of North Carolina Injury Prevention Research Center.	[Anonymous], ATHL TRAIN FILL NEC; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bandura A, 1986, SOCIAL FDN THOUGHT A; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2013, AM J PREV MED, V44, P8, DOI 10.1016/j.amepre.2012.09.058; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Mueller FO, 2012, PREVENTING SUDDEN DE, P1; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279	28	35	35	1	21	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2015	43	3					606	613		10.1177/0363546514562180			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	CC6JP	WOS:000350471500013	25560539	Green Submitted			2022-02-06	
J	Howells, T; Johnson, U; McKelvey, T; Enblad, P				Howells, Tim; Johnson, Ulf; McKelvey, Tomas; Enblad, Per			An optimal frequency range for assessing the pressure reactivity index in patients with traumatic brain injury	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Cerebral pressure autoregulation; Intracranial pressure; Cerebral perfusion pressure; Clinical monitoring; Optimization	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; NEUROINTENSIVE CARE; SPECTRAL-ANALYSIS; BLOOD-PRESSURE; AUTOREGULATION; FLUCTUATIONS; VARIABILITY; FACTS; WAVES	The objective of this study was to identify the optimal frequency range for computing the pressure reactivity index (PRx). PRx is a clinical method for assessing cerebral pressure autoregulation based on the correlation of spontaneous variations of arterial blood pressure (ABP) and intracranial pressure (ICP). Our hypothesis was that optimizing the methodology for computing PRx in this way could produce a more stable, reliable and clinically useful index of autoregulation status. The patients studied were a series of 131 traumatic brain injury patients. Pressure reactivity indices were computed in various frequency bands during the first 4 days following injury using bandpass filtering of the input ABP and ICP signals. Patient outcome was assessed using the extended Glasgow Outcome Scale (GOSe). The optimization criterion was the strength of the correlation with GOSe of the mean index value over the first 4 days following injury. Stability of the indices was measured as the mean absolute deviation of the minute by minute index value from 30-min moving averages. The optimal index frequency range for prediction of outcome was identified as 0.018-0.067 Hz (oscillations with periods from 55 to 15 s). The index based on this frequency range correlated with GOSe with rho = -0.46 compared to -0.41 for standard PRx, and reduced the 30-min variation by 23 %.	[Howells, Tim; Johnson, Ulf; Enblad, Per] Univ Uppsala Hosp, Dept Neurosci, Sect Neurosurg, S-75185 Uppsala, Sweden; [McKelvey, Tomas] Chalmers, Dept Signals & Syst, S-41296 Gothenburg, Sweden		Howells, T (corresponding author), Univ Uppsala Hosp, Dept Neurosci, Sect Neurosurg, S-75185 Uppsala, Sweden.	timothy.howells@lul.se	McKelvey, Tomas/B-6801-2016; McKelvey, Tomas/R-7193-2019	McKelvey, Tomas/0000-0003-2982-5535; McKelvey, Tomas/0000-0003-2982-5535; Johnson, Ulf/0000-0002-3879-6476			Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Caricato A, 2012, CRIT CARE MED, V40, P2526, DOI 10.1097/CCM.0b013e318256b9af; Consonni F, 2009, NEUROCRIT CARE, V10, P232, DOI 10.1007/s12028-008-9151-2; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Goldman D, 2001, J THEOR BIOL, V209, P189, DOI 10.1006/jtbi.2000.2254; Greensted AJ, 2010, FINITE IMPULSE RESPO; Guiza F, 2013, CRIT CARE S2, V17, P327; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Joseph VR, 2008, J QUAL TECHNOL, V40, P282, DOI 10.1080/00224065.2008.11917734; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Kirkness C J, 2001, Biol Res Nurs, V2, P175, DOI 10.1177/109980040100200303; Lescot T, 2005, ACTA NEUROCHIR, V147, P125, DOI 10.1007/s00701-004-0355-8; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6, DOI 10.1152/ajpheart.2002.282.1.H6; Nilsson Holger, 2003, Mol Interv, V3, P79, DOI 10.1124/mi.3.2.79; O'Leary DD, 2004, AM J PHYSIOL-REG I, V287, pR670, DOI 10.1152/ajpregu.00408.2003; PARATI G, 1995, HYPERTENSION, V25, P1276, DOI 10.1161/01.HYP.25.6.1276; Press WH., 1992, NUMERICAL RECIPES FO, V2; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Smielewski PC, 2010, P 14 INT C INTR PRES, P48; Stauss HM, 2007, CLIN EXP PHARMACOL P, V34, P362, DOI 10.1111/j.1440-1681.2007.04588.x; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; TEASDALE G, 1974, LANCET, V2, P81; Turalska M, 2008, ACTA NEUROCHIR SUPPL, V102, P43, DOI 10.1007/978-3-211-85578-2_9; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	35	35	35	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	FEB	2015	29	1					97	105		10.1007/s10877-014-9573-7			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	CA5ID	WOS:000348941200015	24664812				2022-02-06	
J	Carlozzi, NE; Kirsch, NL; Kisala, PA; Tulsky, DS				Carlozzi, Noelle E.; Kirsch, Ned L.; Kisala, Pamela A.; Tulsky, David S.			An Examination of the Wechsler Adult Intelligence Scales, Fourth Edition (WAIS-IV) in Individuals with Complicated Mild, Moderate and Severe Traumatic Brain Injury (TBI)	CLINICAL NEUROPSYCHOLOGIST			English	Article						Memory; TBI; WAIS-IV; Wechsler Adult Intelligence Scale-Fourth Edition; Assessment.; Traumatic Brain Injury	CONFIRMATORY FACTOR-ANALYSIS; INDEX SCORE PATTERNS; OF-THE-LITERATURE; COGNITIVE REHABILITATION; MEMORY SCALE; INSUFFICIENT EFFORT; CLINICAL UTILITY; HEAD-INJURY; DIGIT SPAN; WMS-III	This study examined the clinical utility of the Wechsler Adult Intelligence Scales-Fourth Edition (WAIS-IV) in individuals with complicated mild, moderate or severe TBI. One hundred individuals with TBI (n = 35 complicated mild or moderate TBI; n = 65 severe TBI) and 100 control participants matched on key demographic variables from the WAIS-IV normative dataset completed the WAIS-IV. Univariate analyses indicated that participants with severe TBI had poorer performance than matched controls on all index scores and subtests (except Matrix Reasoning). Individuals with complicated mild/moderate TBI performed more poorly than controls on the Working Memory Index (WMI), Processing Speed Index (PSI), and Full Scale IQ (FSIQ), and on four subtests: the two processing speed subtests (SS, CD), two working memory subtests (AR, LN), and a perceptual reasoning subtest (BD). Participants with severe TBI had significantly lower scores than the complicated mild/moderate TBI on PSI, and on three subtests: the two processing speed subtests (SS and CD), and the new visual puzzles test. Effect sizes for index and subtest scores were generally small-to-moderate for the group with complicated mild/moderate and moderate-to-large for the group with severe TBI. PSI also showed good sensitivity and specificity for classifying individuals with severe TBI versus controls. Findings provide support for the clinical utility of the WAIS-IV in individuals with complicated mild, moderate, and severe TBI.	[Carlozzi, Noelle E.; Kirsch, Ned L.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Kisala, Pamela A.; Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE 19713 USA; [Tulsky, David S.] Kessler Fdn, Neuropsychol & Neurosci Lab, Spinal Cord Injury Lab, W Orange, NJ 07052 USA		Carlozzi, NE (corresponding author), Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, North Campus Res Complex,Bldg 14,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu		Tulsky, David/0000-0002-4335-4509	National Institute on Disability and Rehabilitation Research [H133G070138]	This study was supported in part by the National Institute on Disability and Rehabilitation Research (grant # H133G070138). Standardization data derived from the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV). Copyright (c) NCS Pearson, Inc. Used with permission. All rights reserved.	Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Axelrod BN, 2002, INT J NEUROSCI, V112, P1479, DOI 10.1080/00207450290158377; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P293, DOI 10.1016/S0887-6177(00)00048-2; Baxendale S, 2014, J CLIN EXP NEUROPSYC, V36, P137, DOI 10.1080/13803395.2013.870535; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Canivez G. L., 2010, 18 MENTAL MEASUREMEN, P684; Canivez GL, 2010, PSYCHOL ASSESSMENT, V22, P827, DOI 10.1037/a0020429; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J., 2013, STAT POWER ANAL BEHA; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2001, ASSESSMENT, V8, P193, DOI 10.1177/107319110100800207; Donders J, 2002, PSYCHOL ASSESSMENT, V14, P360, DOI 10.1037//1040-3590.14.3.360; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Drozdick LW, 2011, ASSESSMENT, V18, P141, DOI 10.1177/1073191110382843; Esbjornsson E, 2013, BRAIN INJURY, V27, P521, DOI 10.3109/02699052.2012.743179; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Holdnack J, 2011, ASSESSMENT, V18, P192, DOI 10.1177/1073191110394771; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Langeluddecke PM, 2004, CLIN NEUROPSYCHOL, V18, P423, DOI 10.1080/1385404049052422; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Michel NM, 2013, ASSESSMENT, V20, P462, DOI 10.1177/1073191113478153; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson JM, 2013, PSYCHOL ASSESSMENT, V25, P618, DOI 10.1037/a0032086; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Pearson, WMS 3 WMS 4 RATIONAL; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Reynolds MR, 2013, RES DEV DISABIL, V34, P3235, DOI 10.1016/j.ridd.2013.06.029; Ryan JJ, 2005, INT J NEUROSCI, V115, P129, DOI 10.1080/00207450490512704; Ryan JJ, 2012, J CLIN EXP NEUROPSYC, V34, P571, DOI 10.1080/13803395.2012.666229; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Strauss E, 2000, PSYCHOL ASSESSMENT, V12, P237, DOI 10.1037/1040-3590.12.3.237; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Strong CAH, 2005, J CLIN EXP NEUROPSYC, V27, P746, DOI 10.1081/13803390490919155; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; The Psychological Corporation, 2008, WAIS 4 TECHN INT MAN; Theiling J, 2013, GESUNDHEITSWESEN, V75, P768, DOI 10.1055/s-0033-1357163; Theiling J, 2016, J ATTEN DISORD, V20, P913, DOI 10.1177/1087054713518241; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Traumatic Brain Injury Model Systems National Data Center, 2006, TRAUM BRAIN INJ MOD; Tulsky D., 2003, CLIN INTERPRETATION, P147; Tulsky D. S., 2000, HDB PSYCHOL ASSESSME; Tulsky DS, 2000, PSYCHOL ASSESSMENT, V12, P253, DOI [10.1037/1040-3590.12.3.253, 10.1037//1040-3590.12.3.253]; Tulsky DS, 2003, PSYCHOL ASSESSMENT, V15, P149, DOI 10.1037/1040-3590.15.2.149; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; van der Heijden P, 2003, J CLIN EXP NEUROPSYC, V25, P59, DOI 10.1076/jcen.25.1.59.13627; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	68	35	36	2	54	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2015	29	1					21	37		10.1080/13854046.2015.1005677			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CC4CS	WOS:000350299000003	25646823				2022-02-06	
J	Burke, MJ; Fralick, M; Nejatbakhsh, N; Tartaglia, MC; Tator, CH				Burke, Matthew J.; Fralick, Michael; Nejatbakhsh, Nasrin; Tartaglia, Maria C.; Tator, Charles H.			In search of evidence-based treatment for concussion: characteristics of current clinical trials	BRAIN INJURY			English	Article						Brain concussion; brain injuries; clinical trials; post-concussion syndrome; therapeutics	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; US SOLDIERS; STATEMENT; CLINICALTRIALS.GOV; MANAGEMENT; BIOMARKERS; CONSENSUS; QUALITY; REST	Objective: To assess the characteristics of current clinical trials investigating the treatment of concussion. Background: Recent systematic literature reviews have concluded that there is minimal evidence to support any specific treatment for concussion, including the principles of return-to-activity protocols such as type or duration of rest. Design/methods: Clinical trial data was extracted from Clinicaltrials.gov and seven additional World Health Organization primary registries. The trial databases were accessed up until 3 October 2013. This study used search terms of 'concussion' or 'mild traumatic brain injury' (mTBI) and filtered for interventional trials. Trials that were terminated, already published or not interventional trials of concussion/mTBI were excluded. Results: Of the 142 concussion/mTBI interventional clinical trials identified, 71 met inclusion criteria. Trials had a median estimated enrolment of 60 participants. There was a wide-range of treatments studied, including cognitive/behavioural therapies (28.2%), medications (28.2%), devices (11.3%), dietary supplements (8.5%), return-to-activity/rest (1.4%) and others (22.4%). Heterogeneity among trials for concussion identification/diagnosis and primary outcomes utilized was evident. Symptom-based questionnaires (39.4%) and neuropsychological tests (28.2%) were the most common outcome measures. Conclusions: Diverse, potentially promising therapeutics are currently being studied for the treatment of concussion. However, several deficiencies were identified including a paucity of trials addressing return-to-activity principles. Also, small sample size and trial heterogeneity may threaten scientific evaluation and subsequent clinical application.	[Burke, Matthew J.] Univ Toronto, Div Neurol, Toronto, ON M5T 2S8, Canada; [Fralick, Michael; Nejatbakhsh, Nasrin] Univ Toronto, Toronto, ON M5T 2S8, Canada; [Tartaglia, Maria C.; Tator, Charles H.] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; [Tator, Charles H.] Univ Toronto, Div Neurosurg, Toronto, ON M5T 2S8, Canada		Tator, CH (corresponding author), Univ Toronto, 399 Bathurst St,Room 4W-422, Toronto, ON M5T 2S8, Canada.	charles.tator@uhn.ca					Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; De Angelis C, 2004, NEW ENGL J MED, V351, P1250, DOI 10.1056/NEJMe048225; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickersin K, 2012, JAMA-J AM MED ASSOC, V307, P1861, DOI 10.1001/jama.2012.4230; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; National Institutes of Health, NAT I NEUR DIS STROK; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Petraglia Anthony L, 2011, Surg Neurol Int, V2, P146, DOI 10.4103/2152-7806.85987; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Tator CH, 2009, CAN J NEUROL SCI, V36, P405, DOI 10.1017/S031716710000771X; Todd Jamie L, 2013, Ann Am Thorac Soc, V10, P411, DOI 10.1513/AnnalsATS.201305-111OC; World Health Organization, INT STAND CLIN TRIAL; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	34	35	35	0	21	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					300	305		10.3109/02699052.2014.974673			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000003	25383510	Green Published			2022-02-06	
J	Siracusa, R; Paterniti, I; Impellizzeri, D; Cordaro, M; Crupi, R; Navarra, M; Cuzzocrea, S; Esposito, E				Siracusa, Rosalba; Paterniti, Irene; Impellizzeri, Daniela; Cordaro, Marika; Crupi, Rosalia; Navarra, Michele; Cuzzocrea, Salvatore; Esposito, Emanuela			The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Autophagy; luteolin; neuroinflammation; neuroprotection; palmitoylethanolamide; Parkinson's disease	FATTY-ACID AMIDE; TRAUMATIC BRAIN-INJURY; MOUSE MODEL; KAPPA-B; N-PALMITOYLETHANOLAMIDE; ALPHA-SYNUCLEIN; ANANDAMIDE; FLAVONOIDS; INFLAMMATION; ACTIVATION	Parkinson's disease (PD) is a disorder resulted by degeneration of dopaminergic neurons. To counteract the neuroinflammation and oxidative stress of PD, we decided to test a new composite constituted by palmitoylethanolamide (PEA) and luteolin (Lut), in a mass ratio of 10: 1, respectively (co-ultraPEALut). In this study the neuroprotective property of the new compound was investigated. For the in vivo model of PD, mice received four injections of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Starting 24 h after the first administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), we treated animals with co-ultraPEALut daily until 7 days. On day 8, brains were processed for Western blotting and immunohistochemical analysis. Treatment with co-ultraPEALut reduced the specific markers of PD (tyrosine hydroxylase immunopositive), and the increased levels of activated astrocytes and pro-inflammatory cytokines as well as inducible nitric oxide synthase. Further, the possible association of autophagy with the beneficial effects of co-ultraPEALut. Western blot analysis and immunofluorescence staining showed that co-ultraPEALut administration increased autophagy process. These data were confirmed by an in vitro model, using SH-SY5Y neuroblastoma cells. Western blot analysis showed that co-ultraPEALut pre-treatment maintained high Beclin-1 and p62 expression, while continued to inhibit the p70S6K expression. Altogether, these results put forward that treatment with co-ultraPEALut is able to modulate both the neuroinflammatory process and the autophagic pathway involved in PD, actions which may underlie its neuroprotective effect.	[Siracusa, Rosalba; Paterniti, Irene; Impellizzeri, Daniela; Cordaro, Marika; Crupi, Rosalia; Cuzzocrea, Salvatore; Esposito, Emanuela] Univ Messina, Dept Biol & Environm Sci, I-98166 Messina, Italy; [Navarra, Michele] Univ Messina, Pharmacobiol Dept, I-98166 Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA		Esposito, E (corresponding author), Univ Messina, Dept Biol & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy.	eesposito@unime.it	Siracusa, Rosalba/AAC-3110-2022; Cordaro, Marika/K-7329-2016; Crupi, Rosalia/U-4364-2019	Siracusa, Rosalba/0000-0001-7868-2505; Cordaro, Marika/0000-0002-3980-0043; Crupi, Rosalia/0000-0002-7629-3132; Cuzzocrea, Salvatore/0000-0001-6131-3690; Impellizzeri, Daniela/0000-0001-9492-3161	 [PON 01_02512]	The authors would like to thank Maria Antonietta Medici for her excellent technical assistance during this study and Mr. Francesco Soraci for his secretarial and administrative assistance and Miss Valentina Malvagni for her editorial assistance with the manuscript. This study was supported by PON 01_02512.	Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1; Bouchard JF, 2003, LIFE SCI, V72, P1859, DOI 10.1016/S0024-3205(02)02474-8; Calignano A, 2001, EUR J PHARMACOL, V419, P191, DOI 10.1016/S0014-2999(01)00988-8; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Capasso R, 2001, BRIT J PHARMACOL, V134, P945, DOI 10.1038/sj.bjp.0704339; Capuano A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-43; Chen CC, 2004, MOL PHARMACOL, V66, P683; Cordaro M, 2015, J NEUROTRAUMA; Crupi R, 2013, CNS NEUROL DISORD-DR, V12, P989, DOI 10.2174/18715273113129990084; Cui YW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-42; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; De Petrocellis L, 2002, FUND CLIN PHARMACOL, V16, P297, DOI 10.1046/j.1472-8206.2002.00094.x; Di Marzo V, 2001, BIOCHEM J, V358, P249, DOI 10.1042/0264-6021:3580249; Esposito E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041880; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Franklin A, 2003, J NEUROSCI, V23, P7767; Genovese T, 2008, J PHARMACOL EXP THER, V326, P12, DOI 10.1124/jpet.108.136903; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Hansen HS, 2009, BIOCHEM PHARMACOL, V78, P553, DOI 10.1016/j.bcp.2009.04.024; Hansen HS, 2000, CHEM PHYS LIPIDS, V108, P135, DOI 10.1016/S0009-3084(00)00192-4; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hsieh CF, 2008, OPT LETT, V33, P1174, DOI 10.1364/OL.33.001174; Jaggar SI, 1998, PAIN, V76, P189, DOI 10.1016/S0304-3959(98)00041-4; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kumazawa Y, 2006, CURR PHARM DESIGN, V12, P4271, DOI 10.2174/138161206778743565; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lambert DM, 2001, EPILEPSIA, V42, P321, DOI 10.1046/j.1528-1157.2001.41499.x; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu KY, 2013, NEUROCHEM RES, V38, P201, DOI 10.1007/s11064-012-0909-8; Luo YQ, 1998, J BIOL CHEM, V273, P3756, DOI 10.1074/jbc.273.6.3756; Lynch-Day MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009357; Mazzari S, 1996, EUR J PHARMACOL, V300, P227, DOI 10.1016/0014-2999(96)00015-5; McGeer Patrick L, 2002, Sci Aging Knowledge Environ, V2002, pre3, DOI 10.1126/sageke.2002.29.re3; Middleton E, 2000, PHARMACOL REV, V52, P673; Miller RL, 2009, NEUROCHEM RES, V34, P55, DOI 10.1007/s11064-008-9656-2; Mizushima N, 2010, FEBS LETT, V584, P1279, DOI 10.1016/j.febslet.2010.02.053; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Muccioli GG, 2008, NEUROPHARMACOLOGY, V54, P16, DOI 10.1016/j.neuropharm.2007.05.015; Muramatsu Y, 2003, J NEURAL TRANSM, V110, P1129, DOI 10.1007/s00702-003-0021-y; Nagatsu T, 2000, J NEURAL TRANSM-SUPP, P143; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Park JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100819; Paterniti I, 2014, CNS NEUROL DISORD-DR, V13, P1530, DOI 10.2174/1871527313666140806124322; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Schulz JB, 2004, CELL TISSUE RES, V318, P135, DOI 10.1007/s00441-004-0954-y; Seelinger G, 2008, PLANTA MED, V74, P1667, DOI 10.1055/s-0028-1088314; Sheerin AH, 2004, EPILEPSIA, V45, P1184, DOI 10.1111/j.0013-9580.2004.16604.x; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Song X, 1997, NEUROTOXICOLOGY, V18, P341; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Walter L, 2002, J BIOL CHEM, V277, P20869, DOI 10.1074/jbc.M110813200; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Xagorari A, 2001, J PHARMACOL EXP THER, V296, P181; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang QA, 2010, NEUROSCIENTIST, V16, P335, DOI 10.1177/1073858409357118	66	35	35	1	7	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2015	14	10					1350	1366		10.2174/1871527314666150821102823			17	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	CX6JW	WOS:000365808000018	26295827				2022-02-06	
J	Sinopoli, KJ; Chen, JK; Wells, G; Fait, P; Ptito, A; Taha, T; Keightley, M				Sinopoli, Katia J.; Chen, Jen-Kai; Wells, Greg; Fait, Philippe; Ptito, Alain; Taha, Tim; Keightley, Michelle			Imaging "Brain Strain" in Youth Athletes with Mild Traumatic Brain Injury during Dual-Task Performance	JOURNAL OF NEUROTRAUMA			English	Article						dual-task; fMRI; mild TBI; working memory	SPORTS-RELATED CONCUSSION; STABILITY FOLLOWING CONCUSSION; WORKING-MEMORY DYSFUNCTION; EVENT-RELATED FMRI; MINOR HEAD-INJURY; PREFRONTAL CORTEX; FUNCTIONAL MRI; DIVIDED ATTENTION; POSTCONCUSSIVE SYMPTOMS; ANTERIOR CINGULATE	Mild traumatic brain injury (mTBI) is a common cause of injury in youth athletes. Much of what is known about the sequelae of mTBI is yielded from the adult literature, and it appears that it is mainly those with persistent post-injury symptoms who have ongoing cognitive and neural abnormalities. However, most studies have employed single-task paradigms, which may not be challenging enough to uncover subtle deficits. We sought to examine the neural correlates of dual-task performance in male athletes aged 9-15 years using a functional neuroimaging protocol. Participants included 13 youths with a history of mTBI three to six months prior to testing and 14 typically-developing controls. All participants completed a working memory task in isolation (single-task) and while completing a concurrent motor task (dual-task); neural activity during performance was then compared between groups. Although working memory performance was similar during the single-task condition, increased working memory load resulted in an altered pattern of neural activation in key working memory areas (i.e., dorsolateral prefrontal and parietal cortices) in youth with mTBI relative to controls. During the dual-task condition, accuracy was similar between groups but injured youth performed slower than typically-developing controls, suggesting a speed-accuracy tradeoff in the mTBI group only. The injured youths also exhibited abnormal recruitment of brain structures involved in both working memory and dual-tasking. These data show that the dual-task paradigm can uncover functional impairments in youth with mTBI who are not highly symptomatic and who do not exhibit neuropsychological dysfunction. Moreover, neural recruitment abnormalities were noted in both task conditions, which we argue suggests mTBI-related disruptions in achieving efficient cognitive control and allocation of processing resources.	[Sinopoli, Katia J.] Hosp Sick Children, Div Neurol, Dept Psychol, Toronto, ON M5G 1X8, Canada; [Wells, Greg] Hosp Sick Children, Dept Physiol & Expt Med, Toronto, ON M5G 1X8, Canada; [Chen, Jen-Kai; Ptito, Alain] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Chen, Jen-Kai; Ptito, Alain] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Wells, Greg; Taha, Tim] Univ Toronto, Dept Kinesiol & Phys Educ, Toronto, ON M5S 1A1, Canada; [Keightley, Michelle] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5S 1A1, Canada; [Keightley, Michelle] Univ Toronto, Grad Dept Rehabil Sci & Psychol, Toronto, ON M5S 1A1, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Dept Phys Act Sci, Trois Rivieres, PQ GA9 5H7, Canada; [Fait, Philippe] Univ Quebec Trois Rivieres, Res Grp Neuromusculoskeletal Dysfunct, Trois Rivieres, PQ GA9 5H7, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada		Keightley, M (corresponding author), 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	michelle.keightley@utoronto.ca	Meijer, Anna/K-5118-2016; Sinopoli, Katia/AAO-7803-2020	Fait, Philippe/0000-0002-2554-9273	Ontario Neurotrauma Foundation [ONF 2009-ABI-IMAGING-750]; Rita G. Rudel Early Career Award	This project was funded by the Ontario Neurotrauma Foundation (ONF 2009-ABI-IMAGING-750) awarded to Drs. Keightley and Wells and the Rita G. Rudel Early Career Award awarded to Dr. Sinopoli.	ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Adelson P D, 2000, Clin Neurosurg, V47, P319; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baddeley A, 2001, J EXP PSYCHOL GEN, V130, P641, DOI 10.1037//0096-3445.130.4.641; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Charron S, 2010, SCIENCE, V328, P360, DOI 10.1126/science.1183614; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; CHEN JK, 2007, PSYCHIATRY, V78, P1231; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Collette F, 2005, COGNITIVE BRAIN RES, V24, P237, DOI 10.1016/j.cogbrainres.2005.01.023; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Dennis M., 2013, NEUROSCI BIOBEHAV RE; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ellenbogen R, 2008, MEM COGNITION, V36, P968, DOI 10.3758/MC.36.5.968; Fait P, 2009, BRAIN INJURY, V23, P362, DOI 10.1080/02699050902788485; Fait PE, 2011, PERCEPT MOTOR SKILL, V112, P29, DOI 10.2466/05.10.23.25.PMS.112.1.29-43; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GARDNER A, 2010, ARCH CLIN NEUROPSYCH, V64, P25; Gazes Y, 2010, BEHAV BRAIN RES, V210, P229, DOI 10.1016/j.bbr.2010.02.036; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Goldberg TE, 1998, NEUROIMAGE, V7, P296, DOI 10.1006/nimg.1998.0338; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Haggard P, 2000, J NEUROL NEUROSUR PS, V69, P479, DOI 10.1136/jnnp.69.4.479; Hartley AA, 2011, BRAIN COGNITION, V75, P281, DOI 10.1016/j.bandc.2011.01.004; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Jaeggi SM, 2007, COGN AFFECT BEHAV NE, V7, P75, DOI 10.3758/CABN.7.2.75; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lien MC, 2010, J EXP PSYCHOL HUMAN, V36, P1, DOI 10.1037/a0015875; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Marois R, 2006, PSYCHOL RES-PSYCH FO, V70, P436, DOI 10.1007/s00426-005-0022-6; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; Miller EK, 1996, J NEUROSCI, V16, P5154; Mochizuki H, 2007, BRAIN RES, V1172, P82, DOI 10.1016/j.brainres.2007.07.046; Muller NG, 2002, J COGNITIVE NEUROSCI, V14, P673, DOI 10.1162/08989290260138582; Nebel K, 2005, COGNITIVE BRAIN RES, V25, P760, DOI 10.1016/j.cogbrainres.2005.09.011; OWEN AM, 1995, NEUROPSYCHOLOGIA, V33, P1, DOI 10.1016/0028-3932(94)00098-A; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Poldrack RA, 2005, J NEUROSCI, V25, P5356, DOI 10.1523/JNEUROSCI.3880-04.2005; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; Reed N., 2013, NEUROL NEUROPHYSIOL, V4, P171, DOI DOI 10.4172/2155-9562.1000171; Ricciardi E, 2006, NEUROSCIENCE, V139, P339, DOI 10.1016/j.neuroscience.2005.08.045; Russo RN, 2012, DEV NEUROREHABIL, V15, P13, DOI 10.3109/17518423.2011.625558; Sander MC, 2012, NEUROSCI BIOBEHAV R, V36, P2007, DOI 10.1016/j.neubiorev.2012.06.004; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schubert T, 2003, COGNITIVE BRAIN RES, V17, P733, DOI 10.1016/S0926-6410(03)00198-8; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Szameitat AJ, 2011, NEUROIMAGE, V54, P1765, DOI 10.1016/j.neuroimage.2010.07.069; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu T, 2013, NEUROIMAGE, V65, P466, DOI 10.1016/j.neuroimage.2012.10.004; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	119	35	35	0	32	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 1	2014	31	22					1843	1859		10.1089/neu.2014.3326			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CB4ZO	WOS:000349637400004	24902051				2022-02-06	
J	Kim, J; Parker, D; Whyte, J; Hart, T; Pluta, J; Ingalhalikar, M; Coslett, HB; Verma, R				Kim, Junghoon; Parker, Drew; Whyte, John; Hart, Tessa; Pluta, John; Ingalhalikar, Madhura; Coslett, H. B.; Verma, Ragini			Disrupted Structural Connectome Is Associated with Both Psychometric and Real-World Neuropsychological Impairment in Diffuse Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Graph theory; Diffusion tensor imaging; Observational rating scales; Frontal Systems Behavior Scale; Executive function; Verbal learning	WHITE-MATTER INTEGRITY; HUMAN CEREBRAL-CORTEX; TENSOR TRACTOGRAPHY; CORTICAL NETWORKS; CONNECTIVITY; NEUROPATHOLOGY; ORGANIZATION; RECOVERY; HEALTH; MRI	Traumatic brain injury (TBI) is likely to disrupt structural network properties due to diffuse white matter pathology. The present study aimed to detect alterations in structural network topology in TBI and relate them to cognitive and real-world behavioral impairment. Twenty-two people with moderate to severe TBI with mostly diffuse pathology and 18 demographically matched healthy controls were included in the final analysis. Graph theoretical network analysis was applied to diffusion tensor imaging (DTI) data to characterize structural connectivity in both groups. Neuropsychological functions were assessed by a battery of psychometric tests and the Frontal Systems Behavior Scale (FrSBe). Local connection-wise analysis demonstrated reduced structural connectivity in TBI arising from subcortical areas including thalamus, caudate, and hippocampus. Global network metrics revealed that shortest path length in participants with TBI was longer compared to controls, and that this reduced network efficiency was associated with worse performance in executive function and verbal learning. The shortest path length measure was also correlated with family-reported FrSBe scores. These findings support the notion that the diffuse form of neuropathology caused by TBI results in alterations in structural connectivity that contribute to cognitive and real-world behavioral impairment.	[Kim, Junghoon; Whyte, John; Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Parker, Drew; Pluta, John; Ingalhalikar, Madhura; Verma, Ragini] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Pluta, John; Coslett, H. B.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA		Kim, J (corresponding author), CUNY City Coll, Sophie Davis Sch Biomed Educ, Dept Physiol Pharmacol & Neurosci, 160 Convent Ave, New York, NY 10031 USA.	jkim@med.cuny.edu	Kim, Junghoon John/I-6702-2019	Kim, Junghoon John/0000-0001-5729-8993; Whyte, John/0000-0002-4381-1474	Pennsylvania Department of Health; NINDS, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS065980-02]; NIMH, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [1R01MH092862]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH092862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065980] Funding Source: NIH RePORTER	The authors declare no competing financial interests. This work was funded by a grant with the Pennsylvania Department of Health (PI: J.W.). The department specifically disclaims responsibility for any analyses, interpretations, or conclusions. Part of the funding also came from grant 5R01NS065980-02 (PI: J.K.) from the NINDS, NIH and 1R01MH092862 (PI: R.V.) from the NIMH, NIH. The authors thank John Slattery, Grayce Selig, and Tincy Philip for their assistance in data collection and analysis.	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delis D.C., 2000, CALIFORNIA VERBAL LE; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Graham DI, 2005, PROG BRAIN RES, V150, P445, DOI 10.1016/S0079-6123(05)50031-1; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hamster K., 1983, MULTILINGUAL APHASIA; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kim J, 2005, J INT NEUROPSYCH SOC, V11, P434, DOI 10.1017/S1355617705050563; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Levin HS., 1982, NEUROBEHAVIORAL CONS; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Li Y, 2013, HUM BRAIN MAPP, V34, P3376, DOI 10.1002/hbm.22158; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; Reitan R., 1985, HALSTEAD REITAN NEUR; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schwartz MF, 2005, ARCH PHYS MED REHAB, V86, P1807, DOI 10.1016/j.apmr.2005.03.009; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54	53	35	36	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2014	20	9					887	896		10.1017/S1355617714000812			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	AT4YD	WOS:000344947600002	25287217	Green Accepted			2022-02-06	
J	Alural, B; Duran, GA; Tufekci, KU; Allmer, J; Onkal, Z; Tunali, D; Genc, K; Genc, S				Alural, Begum; Duran, Gizem Ayna; Tufekci, Kemal Ugur; Allmer, Jens; Onkal, Zeynep; Tunali, Dogan; Genc, Kursad; Genc, Sermin			EPO mediates neurotrophic, neuroprotective, anti-oxidant and anti-apoptotic effects via downregulation of miR-451 and miR-885-5p in SH-SY5Y neuron-like cells	FRONTIERS IN IMMUNOLOGY			English	Article						erythropoietin; miRNAs; cell death; proliferation; apoptosis; migration; neurite outgrowth; oxidative stress	TRAUMATIC BRAIN-INJURY; NERVOUS-SYSTEM; RECOMBINANT ERYTHROPOIETIN; GENE-EXPRESSION; MICRORNAS; RECEPTOR; MODEL; DIFFERENTIATION; PROLIFERATION; PLASTICITY	Erythropoietin (EPO) is a neuroprotective cytokine, which has been applied in several animal models presenting neurological disorders. One of the proposed modes of action resulting in neuroprotection is post-transcriptional gene expression regulation. This directly brings to mind microRNAs (miRNAs), which are small non-coding RNAs that regulate gene expression at the post-transcriptional level. It has not yet been evaluated whether miRNAs participate in the biological effects of EPO or whether it, inversely, modulates specific miRNAs in neuronal cells. In this study, we employed miRNA and mRNA arrays to identify how EPO exerts its biological function. Notably, miR-451 and miR-885-5p are downregulated in EPO-treated SH-SY5Y neuronal-like cells. Accordingly, target prediction and transcriptome analysis of cells treated with EPO revealed an alteration of the expression of genes involved in apoptosis, cell survival, proliferation, and migration. Low expression of miRNAs in SHSY5Y was correlated with high expression of their target genes, vascular endothelial growth factor A, matrix metallo peptidase 9 (MMP9), cyclin-dependent kinase 2 (CDK2), erythropoietin receptor, Mini chromosome maintenance complex 5 (MCM5), B-cell lymphoma 2 (BCL2), and Galanin (GAL). Cell viability, apoptosis, proliferation, and migration assays were carried out for functional analysis after transfection with miRNA mimics, which inhibited some biological actions of EPO such as neuroprotection, anti-oxidation, anti-apoptosis, and migratory effects. In this study, we report for the first time that EPO downregulates the expression of miRNAs (miR-451 and miR-885-5p) in SH-SY5Y neuronal-like cells. The correlation between the over-expression of miRNAs and the decrease in EPO-mediated biological effects suggests that miR-451 and miR-885-5p may play a key role in the mediation of biological function.	[Alural, Begum; Tufekci, Kemal Ugur; Genc, Sermin] Dokuz Eylul Univ, Adv Biomed Res Ctr, TR-35340 Izmir, Turkey; [Alural, Begum; Duran, Gizem Ayna; Tufekci, Kemal Ugur; Onkal, Zeynep; Tunali, Dogan; Genc, Kursad; Genc, Sermin] Dokuz Eylul Univ, Hlth Sci Inst, Dept Neurosci, TR-35340 Izmir, Turkey; [Allmer, Jens] Izmir Inst Technol, Dept Mol Biol & Genet, Urla, Turkey		Genc, K (corresponding author), Dokuz Eylul Univ, Hlth Sci Inst, Dept Neurosci, TR-35340 Izmir, Turkey.	kemal.genc@deu.edu.tr	Genc, Kemal Kursad/AAC-6920-2019; Tufekci, Kemal Ugur/A-2850-2014; Allmer, Jens/E-2335-2016; Genc, Sermin/AAG-5348-2019	Genc, Kemal Kursad/0000-0003-2120-091X; Tufekci, Kemal Ugur/0000-0003-0935-1360; Allmer, Jens/0000-0002-2164-7335; Genc, Sermin/0000-0001-6126-7460	Dokuz Eylul UniversityDokuz Eylul University [2009-KB-SAG-46, 2009-KB-SAG-78]	The research was supported by grants from the Dokuz Eylul University (2009-KB-SAG-46 and 2009-KB-SAG-78).	Afanasyeva EA, 2011, CELL DEATH DIFFER, V18, P974, DOI 10.1038/cdd.2010.164; Anderson GD, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00129; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brines M, 2012, MOL MED, V18, P486, DOI 10.2119/molmed.2011.00414; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Chong ZZ, 2013, EXPERT OPIN THER TAR, V17, P707, DOI 10.1517/14728222.2013.780599; D'Eustachio P, 2011, METHODS MOL BIOL, V694, P49, DOI 10.1007/978-1-60761-977-2_4; Chamorro ME, 2013, BBA-MOL CELL RES, V1833, P1960, DOI 10.1016/j.bbamcr.2013.04.006; Ferracin M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-130; Follert P, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00005; Genc S, 2004, BRAIN RES, V1000, P19, DOI 10.1016/j.brainres.2003.12.037; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Hobson SA, 2008, CELL MOL LIFE SCI, V65, P1806, DOI 10.1007/s00018-008-8154-7; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Jelkmann W, 2013, TRANSFUS MED HEMOTH, V40, P302, DOI 10.1159/000356193; Juul SE, 2008, DEV NEUROSCI-BASEL, V30, P231, DOI 10.1159/000110348; Juul SE, 2009, PEDIATR RES, V65, P485, DOI 10.1203/PDR.0b013e31819d90c8; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; Kosaka N, 2008, BRIT J HAEMATOL, V142, P293, DOI 10.1111/j.1365-2141.2008.07151.x; Kumral A, 2011, BRAIN DEV-JPN, V33, P632, DOI 10.1016/j.braindev.2010.10.014; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Maiese K, 2012, INT J MOL SCI, V13, P11102, DOI 10.3390/ijms130911102; Maurer MH, 2002, NEUROSCI LETT, V327, P181, DOI 10.1016/S0304-3940(02)00425-1; Mengozzi M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00115; Mengozzi M, 2012, P NATL ACAD SCI USA, V109, P9617, DOI 10.1073/pnas.1200554109; Nairz M, 2012, MICROBES INFECT, V14, P238, DOI 10.1016/j.micinf.2011.10.005; Ogunshola Omolara O, 2013, Methods Mol Biol, V982, P13, DOI 10.1007/978-1-62703-308-4_2; Patz S, 2013, J NEUROTRAUM, V30, P1232, DOI 10.1089/neu.2012.2596; Pregi N, 2006, BBA-MOL CELL RES, V1763, P238, DOI 10.1016/j.bbamcr.2005.12.011; Qiu J, 2013, MOL MED REP, V7, P1955, DOI 10.3892/mmr.2013.1431; Renzi MJ, 2002, MOL BRAIN RES, V104, P86, DOI 10.1016/S0169-328X(02)00323-6; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stachurska A, 2013, MOL NUTR FOOD RES, V57, P504, DOI 10.1002/mnfr.201200456; Tufekci KU, 2014, METHODS MOL BIOL, V1107, P15, DOI 10.1007/978-1-62703-748-8_2; Um M, 2007, CELL SIGNAL, V19, P634, DOI 10.1016/j.cellsig.2006.08.014; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wenker SD, 2013, FEBS J, V280, P1630, DOI 10.1111/febs.12172; Yuen CM, 2010, J INVEST MED, V58, P893, DOI 10.231/JIM.0b013e3181e80c40; Zeng L, 2014, GENE THER, V21, P37, DOI 10.1038/gt.2013.55	44	35	40	4	14	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	SEP 30	2014	5								475	10.3389/fimmu.2014.00475			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI0TZ	WOS:000354452400001	25324845	Green Published, gold			2022-02-06	
J	Xiang, J; Collins, CL; Liu, D; McKenzie, LB; Comstock, RD				Xiang, Joe; Collins, Christy L.; Liu, Daniel; McKenzie, Lara B.; Comstock, R. Dawn			Lacrosse Injuries Among High School Boys and Girls in the United States Academic Years 2008-2009 Through 2011-2012	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						lacrosse; epidemiology; injury prevention	WOMENS LACROSSE; DESCRIPTIVE EPIDEMIOLOGY; COLLEGIATE LACROSSE; SURVEILLANCE SYSTEM; HEAD-INJURIES; CONCUSSIONS; SPORTS; MENS; SYMPTOMS	Background: Lacrosse is a fast growing youth sport in the United States. Although there have been published studies examining injuries associated with lacrosse, significantly less research has been conducted in high school lacrosse players than in older lacrosse players. The objective of this study was to compare high school lacrosse injury rates and patterns by type of athletic activity (ie, competition vs practice) and sex. Hypothesis: Lacrosse injury rates and patterns differ by type of athletic activity and sex. Study Design: Descriptive epidemiology study. Methods: Using the High School RIO (Reporting Information Online) database, lacrosse exposure and injury data were collected during 4 academic years, 2008-2012, from a large sample of high schools in the United States. Schools' certified athletic trainers submitted exposure and injury information weekly. Results: During the study period, 1406 injuries occurred during 716,812 athlete exposures, for an injury rate of 1.96 per 1000 athlete exposures (AEs). Injury rates were higher in competition than in practice (3.61 vs 1.23 per 1000 AEs, respectively; rate ratio [RR], 2.94; 95% CI, 2.65-3.27). Boys had a higher injury rate than girls (2.26 vs 1.54 per 1000 AEs, respectively; RR, 1.47; 95% CI, 1.32-1.64). The most common injury diagnoses among both boys and girls were sprains/strains (boys: 35.6%; girls: 43.9%) and concussions (boys: 21.9%; girls: 22.7%). The most commonly injured body sites in competition were the head/face (32.0%), lower leg/ankle/foot (17.8%), and knee (12.2%), while in practice, the most commonly injured body sites were the lower leg/ankle/foot (34.9%), head/face (16.4%), and knee (12.7%). Among boys, the most common mechanisms of injury were contact with another person (40.9%) and no contact (21.1%). Among girls, the most common mechanisms of injury were no contact (26.2%), contact with a playing apparatus (24.0%), and overuse/chronic (17.7%). Most injured athletes (71.8%) returned to activity in 21 days, but 6.9% of all injuries required surgery. Conclusion: Lacrosse injury rates and patterns among high school athletes in the United States differ by type of athletic activity and sex. Future studies should continue to compare differences in injury rates and patterns in high school lacrosse, with particular emphasis placed on high-risk plays in competition and the prevention and management of concussions in both boys and girls.	[Xiang, Joe; Collins, Christy L.; Liu, Daniel; McKenzie, Lara B.; Comstock, R. Dawn] Nationwide Childrens Hosp, Columbus, OH 43205 USA		McKenzie, LB (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, RBIII, 700 Childrens Dr, Columbus, OH 43205 USA.	Lara.McKenzie@nationwidechildrens.org		McKenzie, Lara/0000-0003-2889-0001	National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack	The authors acknowledge the generous research funding contributions of the National Federation of State High School Associations, National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack. This research would not be possible without the dedication of the certified athletic trainers across the United States who have generously shared their professional expertise and their time to report data to the High School RIO.	Bowers AL, 2010, AM J SPORT MED, V38, P527, DOI 10.1177/0363546509348754; Carter EA, 2010, INT J INJ CONTROL SA, V17, P111, DOI 10.1080/17457300903524888; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick R, 2007, J ATHL TRAINING, V42, P262; Dick R, 2007, J ATHL TRAINING, V42, P255; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hall C, 2013, RES SPORTS MED, V21, P229, DOI 10.1080/15438627.2013.792085; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Matz SO, 2004, AM J SPORT MED, V32, P608, DOI 10.1177/0363546503262172; Mihata LCS, 2006, AM J SPORT MED, V34, P899, DOI 10.1177/0363546505285582; National Federation of State High School Association, 2011 12 HIGH SCH ATH; Nelson AJ, 2007, J ATHL TRAINING, V42, P381; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Otago L, 2007, Int J Inj Contr Saf Promot, V14, P259, DOI 10.1080/17457300701602381; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Swenson DM, 2013, MED SCI SPORT EXER, V45, P462, DOI 10.1249/MSS.0b013e318277acca; United States Census Bureau, CENS REG DIV US; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	30	35	35	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2014	42	9					2082	2088		10.1177/0363546514539914			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	AP9GQ	WOS:000342387400006	25053695				2022-02-06	
J	Atmaca, N; Atmaca, HT; Kanici, A; Anteplioglu, T				Atmaca, Nurgul; Atmaca, Hasan Tarik; Kanici, Ayse; Anteplioglu, Tugce			Protective effect of resveratrol on sodium fluoride-induced oxidative stress, hepatotoxicity and neurotoxicity in rats	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Fluoride toxicity; Oxidative stress; Liver; Brain; Resveratrol; Rats	TRAUMATIC BRAIN-INJURY; DNA-DAMAGE; ANTIOXIDANT PROPERTIES; HISTOPATHOLOGICAL CHANGES; LIPID-PEROXIDATION; BLACK BERRY; TOXICITY; ACID; PARAMETERS; FLUOROSIS	Protective effect of resveratrol on sodium fluoride-induced oxidative stress, hepatotoxicity and neurotoxicity were studied in rats. A total of 28 Wistar albino male rats were used. Four study groups were randomly formed with seven animals in each. The groups were treated for 21 days with distilled water (control group), with water containing 100 ppm fluoride (fluoride group), with resveratrol (12.5 mg/kg i.p., resveratrol group), or with 100 ppm fluoride + 12.5 mg/kg resveratrol i.p. (fluoride + resveratrol group). At the end of the trial, blood samples were collected by cardiac puncture and tissue samples were taken simultaneously. The total antioxidant and oxidant status in plasma and tissues as well as plasma 8-hydroxydeoxyguanosine levels were measured. Histopathological analyses of rat liver and brain tissues were performed in all groups to identify any changes. In the fluoride group, the total oxidant levels increased in plasma, liver and brain and total antioxidant levels decreased, as did the plasma 8-hydroxy-deoxyguanosine levels. These changes were prevented by co-administration of resveratrol. In addition, fluoride-associated severe histopathological changes in brain and liver tissues were not observed in the fluoride + resveratrol group. Consequently, these data suggested that resveratrol had beneficial effects in alleviating fluoride-induced oxidative stress. (C) 2014 Elsevier Ltd. All rights reserved.	[Atmaca, Nurgul] Kirikkale Univ, Fac Vet Med, Dept Physiol, Kirikkale, Turkey; [Atmaca, Hasan Tarik; Anteplioglu, Tugce] Kirikkale Univ, Fac Vet Med, Dept Pathol, Kirikkale, Turkey; [Kanici, Ayse] Kafkas Univ, Fac Vet Med, Dept Pharmacol & Toxicol, Kars, Turkey		Atmaca, N (corresponding author), Kirikkale Univ, Fac Vet Med, Dept Physiol, TR-71450 Kirikkale, Turkey.	nurgulzengin@yahoo.com; ht_atmaca@yahoo.com; akanici@hotmail.com; tugceanteplioglu@gmail.com	Das, Kusal/E-8167-2011; , HTA/AAG-2944-2019; TARHANE, Ayse KANICI/ABI-4581-2020	Das, Kusal/0000-0002-3641-2117; ATMACA, HASAN TARIK/0000-0001-8379-4114	Kirikkale University Research FundKirikkale University [2011/44]	Financial support for this Project (Project No: 2011/44) was provided by the Kirikkale University Research Fund.	Agha FE, 2012, LIFE SCI J, V9, P1260; de la Lastra CA, 2006, OXIDAT STRESS DIS, V20, P33; ARICHI H, 1982, CHEM PHARM BULL, V30, P1766; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; Bharti VK, 2009, BIOL TRACE ELEM RES, V130, P131, DOI 10.1007/s12011-009-8320-2; Bouaziz H, 2006, PESTIC BIOCHEM PHYS, V86, P124, DOI 10.1016/j.pestbp.2006.02.004; Burkhardt S, 2001, INT J BIOCHEM CELL B, V33, P775, DOI 10.1016/S1357-2725(01)00052-8; CARLSON CH, 1960, P SOC EXP BIOL MED, V104, P235; Chlubek D, 2003, FLUORIDE, V36, P217; Dalaklioglu S, 2013, HUM EXP TOXICOL, V32, P662, DOI 10.1177/0960327112468178; Edmunds WM, 1996, GEOL SOC SP, P91, DOI 10.1144/GSL.SP.1996.113.01.08; Eraslan G, 2007, PESTIC BIOCHEM PHYS, V88, P273, DOI 10.1016/j.pestbp.2007.01.002; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Flora SJS, 2009, J NEUROL SCI, V285, P198, DOI 10.1016/j.jns.2009.07.001; GEERAERTS F, 1986, FLUORIDE, V19, P108; GruckaMamczar E, 1997, FLUORIDE, V30, P157; Gulcin I, 2010, INNOV FOOD SCI EMERG, V11, P210, DOI 10.1016/j.ifset.2009.07.002; Guo L, 2007, J AGR FOOD CHEM, V55, P5881, DOI 10.1021/jf070440a; Gusman J, 2001, CARCINOGENESIS, V22, P1111, DOI 10.1093/carcin/22.8.1111; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S; Hassan HA, 2010, FOOD CHEM TOXICOL, V48, P1999, DOI 10.1016/j.fct.2010.05.018; Hassan HA, 2009, FOOD CHEM TOXICOL, V47, P2332, DOI 10.1016/j.fct.2009.06.023; Ignatowicz E, 2001, POL J PHARMACOL, V53, P557; Inkielewicz-Stepniak I, 2010, FOOD CHEM TOXICOL, V48, P1607, DOI 10.1016/j.fct.2010.03.033; KAPOOR V, 1993, FLUORIDE, V26, P105; Karadeniz A, 2008, FLUORIDE, V41, P67; Karaoz E., 2003, TURK KLIN TIP BILIM, V23, P129; Kasdallah-Grissa A, 2007, LIFE SCI, V80, P1033, DOI 10.1016/j.lfs.2006.11.044; KESSABI M, 1986, VET HUM TOXICOL, V28, P300; Kolouchova-Hanzlikova I, 2004, FOOD CHEM, V87, P151, DOI 10.1016/j.foodchem.2004.01.028; Leonard SS, 2003, BIOCHEM BIOPH RES CO, V309, P1017, DOI 10.1016/j.bbrc.2003.08.105; Loft S, 1996, J MOL MED, V74, P297, DOI 10.1007/s001090050031; Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212; Mittal M, 2006, CHEM-BIOL INTERACT, V162, P128, DOI 10.1016/j.cbi.2006.05.018; Mokni M, 2007, NEUROCHEM RES, V32, P981, DOI 10.1007/s11064-006-9255-z; MULLENIX PJ, 1995, NEUROTOXICOL TERATOL, V17, P169, DOI 10.1016/0892-0362(94)00070-T; Nabavi SF, 2013, IND CROP PROD, V44, P50, DOI 10.1016/j.indcrop.2012.10.024; Nabavi SM, 2012, FOOD CHEM, V132, P931, DOI 10.1016/j.foodchem.2011.11.070; Panneerselvam L, 2013, BIOL TRACE ELEM RES, V151, P85, DOI 10.1007/s12011-012-9534-2; Reddy GB, 2003, TOXICOL SCI, V72, P363, DOI 10.1093/toxsci/kfg030; Rzeuski R, 1998, FLUORIDE, V31, P43; Shanthakumari D, 2004, TOXICOLOGY, V204, P219, DOI 10.1016/j.tox.2004.06.058; Shashi A, 2003, FLUORIDE, V36, P95; Shashi A, 2001, FLUORIDE, V34, P34; Silan C, 2007, BIOL PHARM BULL, V30, P79, DOI 10.1248/bpb.30.79; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Tatlidede E, 2009, FREE RADICAL RES, V43, P195, DOI 10.1080/10715760802673008; Trivedi MH, 2012, FLUORIDE, V45, P13; Tunali-Akbay T, 2010, J PHARM PHARM SCI, V13, P303, DOI 10.18433/J30K5Q; USNRC, 1993, HLTH EFF ING FLUOR; Vani ML, 2000, FLUORIDE, V33, P17; Wang AG, 2004, FLUORIDE, V37, P107; Wang Y, 2002, J AGR FOOD CHEM, V50, P431, DOI 10.1021/jf010812u; WATSON BD, 1993, PROG BRAIN RES, V96, P69; Whitford G M, 1983, Dent Hyg (Chic), V57, P16; Yan Y, 2012, FOOD CHEM TOXICOL, V50, P168, DOI 10.1016/j.fct.2011.10.046; Zhang WQ, 2013, FOOD CHEM TOXICOL, V51, P87, DOI 10.1016/j.fct.2012.09.023; Zini R, 1999, DRUG EXP CLIN RES, V25, P87	62	35	38	0	27	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	AUG	2014	70						191	197		10.1016/j.fct.2014.05.011			7	Food Science & Technology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Food Science & Technology; Toxicology	AM1IO	WOS:000339599800025	24857819				2022-02-06	
J	Cossette, I; Ouellet, MC; McFadyen, BJ				Cossette, Isabelle; Ouellet, Marie-Christine; McFadyen, Bradford J.			A Preliminary Study to Identify Locomotor-Cognitive Dual Tasks That Reveal Persistent Executive Dysfunction After Mild Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Attention; Brain concussion; Gait; Rehabilitation; Walking	CONCUSSION; GAIT; ATTENTION	Objective: To identify different combinations of physical (level, obstacle avoidance, stepping down) and cognitive (visual, mental) demands within a locomotor navigational context that best discriminates between persons with mild traumatic brain injury (MTBI) and control subjects for an eventual clinical tool to assess residual executive dysfunction. Design: Group comparison study. Setting: Rehabilitation facility. Participants: Volunteer sample (N=14) of persons with MTBI (n=7) (6 women; age, 20 +/- 1.6y) and a comparison group (n=7) of subjects without neurologic problems (6 women; age, 22.4 +/- 1.4y). Interventions: Not applicable. Main Outcome Measures: Gait speed (m/s) and dual-task cost calculated as the relative change in gait speed from single (no cognitive task) to dual tasks for the same gait condition. Results: There were significant interactions between groups and cognitive tasks and between groups and cognitive and physical tasks for gait speed. Specifically, the MTBI group walked slower than control subjects in the dual-task conditions when stepping over an obstacle combined with each cognitive task. When gait speed was measured as dual-task costs, group differences were more evident, except for stepping down. Conclusions: These preliminary results suggest that both absolute gait speed and calculated dual-task costs during the combination of stepping over an obstacle with a simultaneous cognitive task are sensitive to revealing executive dysfunction in persons with MTBI. Gait speed can be easily measured in the clinic to provide important information to make diagnoses and decide about return to play or function. Continued work building on these preliminary results is needed toward the development of a clinical tool. (C) 2014 by the American Congress of Rehabilitation Medicine	[Cossette, Isabelle; Ouellet, Marie-Christine; McFadyen, Bradford J.] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Cossette, Isabelle; McFadyen, Bradford J.] Univ Laval, Fac Med, Dept Rehabil, Quebec City, PQ G1K 7P4, Canada; [Ouellet, Marie-Christine] Univ Laval, Sch Psychol, Fac Social Sci, Quebec City, PQ, Canada		McFadyen, BJ (corresponding author), CIRRIS IRDPQ, 525 Hamel, Quebec City, PQ G1M 2S8, Canada.	brad.mcfadyen@rea.ulaval.ca		McFadyen, Bradford/0000-0003-1992-4927; Ouellet, Marie-Christine/0000-0003-3477-1893	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CBI-127052] Funding Source: Medline		Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Goldie PA, 1996, ARCH PHYS MED REHAB, V77, P1074, DOI 10.1016/S0003-9993(96)90072-6; Guskiewicz KM, 2011, PM&R, V3, pS445, DOI 10.1016/j.pmrj.2011.08.009; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	11	35	35	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2014	95	8					1594	1597		10.1016/j.apmr.2014.03.019			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AM2ND	WOS:000339687200025	24726561				2022-02-06	
J	Shay, N; Yeates, KO; Walz, NC; Stancin, T; Taylor, HG; Beebe, DW; Caldwell, CT; Krivitzky, L; Cassedy, A; Wade, SL				Shay, Nicole; Yeates, Keith O.; Walz, Nicolay C.; Stancin, Terry; Taylor, H. Gerry; Beebe, Dean W.; Caldwell, Carolyn T.; Krivitzky, Lauren; Cassedy, Amy; Wade, Shari L.			Sleep Problems and Their Relationship to Cognitive and Behavioral Outcomes in Young Children with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavior; cognitive ability; preschool; sleep; traumatic brain injury	DISTURBANCES; SYMPTOMS; HYPERACTIVITY; ASSOCIATION; ADOLESCENTS; DISORDERS; MODERATE; RISK	This study examined the effect of traumatic brain injury (TBI) in young children on sleep problems and the relationship of sleep problems to neuropsychological and psychosocial functioning. Participants were drawn from an ongoing longitudinal study of injury in young children recruited from 3 to 6 years of age. They constituted three groups: orthopedic injury (OI; n = 92), complicated mild/moderate TBI (mTBI; n = 55); and severe TBI (sTBI; n = 20). Caregivers completed the Children's Sleep Habits Questionnaire (CSHQ), as well as ratings of behavioral adjustment, adaptive functioning, and everyday executive function at 1, 6, 12, and 18 months postinjury. Retrospective ratings of preinjury sleep and psychosocial functioning were obtained at the initial assessment. Children completed neuropsychological testing at all occasions. Children with complicated mTBI demonstrated more total sleep problems than children with OI at 6 months postinjury, but not at 12 or 18 months. Children with sTBI displayed more bedtime resistance and shorter sleep duration than those with complicated mTBI or OI at several occasions. Across groups, total sleep problems predicted more emotional and behavioral problems and worse everyday executive function as rated by parents across follow-up occasions. In contrast, sleep problems were generally not related to neuropsychological test performance. The results suggest that young children with TBI demonstrate more sleep problems than children with injuries not involving the head. Sleep problems, in turn, significantly increase the risk of poor psychosocial outcomes across time, but are not associated with worse neuropsychological test performance.	[Shay, Nicole] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA; [Yeates, Keith O.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith O.] Nationwide Childrens Hosp, Ctr Behav Hlth, Res Inst, Columbus, OH USA; [Walz, Nicolay C.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Stancin, Terry; Taylor, H. Gerry] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Beebe, Dean W.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Caldwell, Carolyn T.] US Army Northern Reg Med Command, Aberdeen Proving Ground, MD USA; [Krivitzky, Lauren] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat, Philadelphia, PA 19104 USA; [Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Cassedy, Amy] Univ Cincinnati, Dept Sociol, McMicken Coll Arts & Sci, Cincinnati, OH USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Dept Phys Med & Rehabil, Cincinnati, OH USA		Yeates, KO (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kyeates@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Stancin, Terry/L-7993-2019	Yeates, Keith/0000-0001-7680-2892	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER	The research reported here was supported by grant R01 HD42729 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (to Dr. Shari Wade). The authors acknowledge the contributions of Christine Abraham, Andrea Beebe, Lori Bernard, Anne Birnbaum, Beth Bishop, Tammy Matecun, Karen Oberjohn, Elizabeth Roth, and Elizabeth Shaver in data collection and coding. The Cincinnati Children's Medical Center Trauma Registry, Rainbow Pediatric Trauma Center, Rainbow Babies and Children's Hospital, Nationwide Children's Hospital Trauma Program, and MetroHealth Center Department of Pediatrics and Trauma Registry provided assistance with recruitment.	Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Ali NJ, 1996, EUR J PEDIATR, V155, P56, DOI 10.1007/BF02115629; Archbold Kristen Hedger, 2004, Biol Res Nurs, V5, P168, DOI 10.1177/1099800403260261; Aronen ET, 2000, J AM ACAD CHILD PSY, V39, P502, DOI 10.1097/00004583-200004000-00020; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Beebe DW, 2006, SLEEP, V29, P1115, DOI 10.1093/sleep/29.9.1115; Beebe DW, 2012, CHILD NEUROPSYCHOL, V18, P313, DOI 10.1080/09297049.2011.602014; Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002; Bourke RS, 2011, SLEEP MED, V12, P222, DOI 10.1016/j.sleep.2010.08.011; Chervin RD, 2002, PEDIATRICS, V109, P449, DOI 10.1542/peds.109.3.449; Elliott C. D., 1990, DIFFERENTIAL ABILITY; Espy KA, 1997, DEV NEUROPSYCHOL, V13, P495, DOI 10.1080/87565649709540690; Faul M, 2010, TRAUMATIC BRAIN INJU; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Gioia G., 2000, BEHAV RATING EXECUTI; Gottlieb DJ, 2004, J PEDIATR-US, V145, P458, DOI 10.1016/j.jpeds.2004.05.039; Gregory AM, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00015; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Johnson EO, 2000, PSYCHIAT RES, V94, P93, DOI 10.1016/S0165-1781(00)00145-1; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kemp, 1998, NEPSY DEV NEUROPSYCH; Kheirandish L, 2006, DEVELOPMENTAL SCI, V9, P388, DOI 10.1111/j.1467-7687.2006.00504.x; Luginbuehl M, 2009, CHILD ADOL PSYCH CL, V18, P825, DOI 10.1016/j.chc.2009.04.012; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Osorio MB, 2013, PM&R, V5, P554, DOI 10.1016/j.pmrj.2012.11.006; Owens JA, 2000, SLEEP, V23, P1043; Picchietti DL, 1999, MOVEMENT DISORD, V14, P1000, DOI 10.1002/1531-8257(199911)14:6<1000::AID-MDS1014>3.0.CO;2-P; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Spruyt K, 2011, SLEEP MED REV, V15, P19, DOI 10.1016/j.smrv.2010.07.005; Stores G, 2013, DEV MED CHILD NEUROL, V55, P797, DOI 10.1111/dmcn.12163; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; Taylor H.G., 2008, J INT NEUROPSYCH SOC, V7, P755; TEASDALE G, 1974, LANCET, V2, P81; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Thaxton L, 2002, J HEAD TRAUMA REHAB, V17, P335, DOI 10.1097/00001199-200208000-00007; Woodcock R. W., 2001, WOODCOCKJOHNSON 3 TE; Yeates K. O., 2010, PEDIAT NEUROPSYCHOLO, P112	41	35	35	0	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2014	31	14					1305	1312		10.1089/neu.2013.3275			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	AN4CA	WOS:000340534000007	24665961	Green Published			2022-02-06	
J	Amaranath, JE; Ramanan, M; Reagh, J; Saekang, E; Prasad, N; Chaseling, R; Soundappan, S				Amaranath, Jeevaka E.; Ramanan, Mahesh; Reagh, Jessica; Saekang, Eilen; Prasad, Narayan; Chaseling, Raymond; Soundappan, Sannappa			Epidemiology of traumatic head injury from a major paediatric trauma centre in New South Wales, Australia	ANZ JOURNAL OF SURGERY			English	Article						epidemiology; paediatric; traumatic head injury	BRAIN-INJURY; CANCER-RISKS	Background Traumatic brain injury (TBI) is common and is a leading cause of presentations to emergency departments. Understanding the epidemiology of TBI can aid in improving overall management and identifying opportunities for prevention. Currently, there is a paucity of data on paediatric TBI in NSW. The purpose of this study was to determine the demographics, causes, treatment and outcome of TBI at The Children's Hospital at Westmead (CHW), a large trauma referral paediatric hospital. Methods A retrospective chart review was conducted of patients admitted to CHW emergency from 2006 to 2011 with a TBI. Patients who presented to the emergency department and had a history of TBI with either symptoms of concussion and/or positive computed tomography (CT) findings of head injury were selected. Information regarding demographics, injury pattern, CT findings, treatment and outcome were retrieved. Results Over the 6-year period, there were 1489 presentations at the CHW. Of these, 65% were male and 35% were female. The mean age was 7 years. A total of 93% were classified as mild, 1.5% as moderate and 5.5% as severe. Sports and recreational injuries accounted for 26% of all TBI presentations, while motor vehicle accidents (MVAs) accounted for 77% of all TBI deaths. Sixty-two percent of children underwent a CT brain, and of those, 40% were normal. Conclusion The majority of TBI are mild in nature, with younger children and males at greatest risk. There was a low rate of operative intervention and a high rate of good outcomes. Many injuries may be preventable with the adaptation of better public health education programmes, particularly in very young children and those related to MVAs.	[Amaranath, Jeevaka E.; Reagh, Jessica; Saekang, Eilen; Prasad, Narayan] Childrens Hosp Westmead, Douglas Cohen Dept Paediat Surg, Sydney, NSW, Australia; [Ramanan, Mahesh; Chaseling, Raymond] Childrens Hosp Westmead, Dept Neurosurg, Sydney, NSW, Australia; [Soundappan, Sannappa] Childrens Hosp Westmead, Douglas Cohen Dept Paediat Surg & Trauma, Sydney, NSW, Australia		Amaranath, JE (corresponding author), Unit 7-9-27 Pk Ave, Sydney, NSW 2047, Australia.	jamaranath@optusnet.com.au	Ramanan, Mahesh/H-2523-2012; Sannappa Venkatraman, Soundappan Soundappan/AAY-7965-2021	Ramanan, Mahesh/0000-0003-4509-4015; 			AAP AAFP, 2009, MIN HEAD INJ CHILDR; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; BASS JL, 1993, PEDIATRICS, V92, P544; BERNEY J, 1994, CHILD NERV SYST, V10, P509, DOI 10.1007/BF00335073; Cooksley D, 2006, TXB PAEDIAT EMERGENC, P245; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Debono P, 2011, ADV CLIN NEUROSCI RE, V10, P30; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; ITIM. NSWIoTaIM, 2009, NSW TRAUM REG PROF S; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kleinerman RA, 2006, PEDIATR RADIOL, V36, P121, DOI 10.1007/s00247-006-0191-5; Lam WH, 1999, PAEDIATR ANAESTH, V9, P377; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; National Health Performance Authority, 2011, EM DEP SERV; NOLAN T, 1992, J PAEDIATR CHILD H, V28, P27, DOI 10.1111/j.1440-1754.1992.tb02613.x; NSW Health, 2010, INF CHILDR AC MAN HE; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Premier & Cabinet NSW Government, 2011, DEM; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Reid SR, 2001, ARCH PEDIAT ADOL MED, V155, P784, DOI 10.1001/archpedi.155.7.784; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Swaminathan A, 2009, J EMERG MED, V37, P63, DOI 10.1016/j.jemermed.2009.02.003; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004	26	35	36	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	JUN	2014	84	6					424	428		10.1111/ans.12445			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AJ3JB	WOS:000337561300008	24405988	Bronze			2022-02-06	
J	Kurowski, BG; Wade, SL; Kirkwood, MW; Brown, TM; Stancin, T; Taylor, HG				Kurowski, Brad G.; Wade, Shari L.; Kirkwood, Michael W.; Brown, Tanya M.; Stancin, Terry; Taylor, H. Gerry			Long-term Benefits of an Early Online Problem-Solving Intervention for Executive Dysfunction After Traumatic Brain Injury in Children A Randomized Clinical Trial	JAMA PEDIATRICS			English	Article							BEHAVIOR RATING INVENTORY; PRELIMINARY EFFICACY; YOUNG-CHILDREN; FAMILY INTERVENTION; SOCIAL COMPETENCE; HEAD-INJURY; FOLLOW-UP; SKILLS; ADOLESCENTS; PREDICTORS	IMPORTANCE Executive dysfunction after traumatic brain injury (TBI) in children is common and leads to significant short-and long-term problems in functioning across multiple settings. We hypothesized that improvements in short-term executive function would be maintained to 24 months after injury and that improvements would increase over time in a counselor-assisted problem-solving (CAPS) intervention. OBJECTIVE To evaluate the efficacy of a CAPS intervention administered within 7 months of complicated mild to severe TBI compared with an Internet resource condition in improving long-term executive dysfunction. DESIGN, SETTING, AND PARTICIPANTS Multisite, assessor-blinded, randomized clinical trial at 3 tertiary pediatric hospitals and 2 tertiary general medical centers. Participants included 132 adolescents aged 12 to 17 years who sustained a moderate to severe TBI 1 to 7 months before study enrollment. INTERVENTION Web-based CAPS intervention. MAIN OUTCOMES AND MEASURES The primary outcome was the parent-reported Global Executive Composite (GEC) of the Behavior Rating Inventory of Executive Function. Secondary outcomes included the Behavioral Regulation Index (BRI) and Metacognition Index (MI) of the GEC. RESULTS In older (> 14 to 17 years) adolescents, the CAPS intervention was associated with lower GEC ratings at 12 (beta = -0.46; P =.03) and 18 (beta = -0.52; P =.02) months after enrollment. Trends were also observed for older adolescents toward lower GEC ratings at 6 months (beta = -0.40; P =.05), lower BRI ratings at 12 (beta = -0.40; P =.06) and 18 (beta = -0.47; P =.04) months, and lower MI ratings at 6 (beta = -0.41; P =.05), 12 (beta = -0.46; P =.03), and 18 (beta = -0.50; P =.03) months. In younger (12-14 years) adolescents, no group differences were found on the GEC, BRI, or MI ratings. CONCLUSIONS AND RELEVANCE Delivery of the CAPS intervention early after TBI in older adolescents improves long-term executive function. This trial is, to our knowledge, one of the few large, randomized clinical treatment trials performed in pediatric TBI to demonstrate the efficacy of an intervention for management of executive dysfunction and long-term benefits of an intervention delivered soon after injury. Use of the CAPS intervention clinically should be considered; however, further research should explore ways to optimize delivery.	[Kurowski, Brad G.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Kurowski, Brad G.; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Brown, Tanya M.] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Cleveland, Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org	Stancin, Terry/L-7993-2019		National Institute of Mental Health, National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH073764]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2K12 HD001097-16]; Colorado Traumatic Brain Injury Trust Fund Research Program; Colorado Department of Human Services; Division of Vocational Rehabilitation; Traumatic Brain Injury Program; National Institute on Disability Rehabilitation Research, Department of Education [H133B090010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683, K12HD001097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This study was supported in part by grant R01-MH073764 from the National Institute of Mental Health, National Institutes of Health (NIH); by grant 2K12 HD001097-16 from the NIH; by a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; and by grant H133B090010 from the National Institute on Disability Rehabilitation Research, Department of Education.	Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Chan DYK, 2011, DISABIL REHABIL, V33, P2023, DOI 10.3109/09638288.2011.556207; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Faul M, 2010, TRAUMATIC BRAIN INJU; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Galvin J, 2009, DEV NEUROREHABIL, V12, P352, DOI 10.3109/17518420903087293; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia G.A., 2003, BRIEF P BEHAV RATING; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Kehle TJ, 1996, J LEARN DISABIL, V29, P633, DOI 10.1177/002221949602900607; Kurowski BG, 2013, PM&R, V5, P1026, DOI 10.1016/j.pmrj.2013.08.589; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wade SL, 2005, J PEDIATR PSYCHOL, V30, P437, DOI 10.1093/jpepsy/jsi067; Wade SL, 2005, REHABIL PSYCHOL, V50, P337, DOI 10.1037/0090-5550.50.4.337	45	35	35	2	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	JUN	2014	168	6					523	531		10.1001/jamapediatrics.2013.5070			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	AI4MZ	WOS:000336840800010	24781374	Green Accepted, Bronze			2022-02-06	
J	Zheng, P; Shultz, SR; Hovens, CM; Velakoulis, D; Jones, NC; O'Brien, TJ				Zheng, Ping; Shultz, Sandy R.; Hovens, Chris M.; Velakoulis, Dennis; Jones, Nigel C.; O'Brien, Terence J.			Hyperphosphorylated Tau is Implicated in Acquired Epilepsy and Neuropsychiatric Comorbidities	MOLECULAR NEUROBIOLOGY			English	Article						Hyperphosphorylated tau; Acquired epilepsy; Traumatic brain injury; Post-status epilepticus; Neuropsychiatric comorbidities	TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; NEURODEGENERATIVE DISEASES; PROTEIN PHOSPHATASES; MULTIPLE-SCLEROSIS; NEURONAL LOSS; OKADAIC ACID; RISK-FACTOR	Epilepsy is a common group of neurological diseases. Acquired epilepsy can be caused by brain insults, such as trauma, infection or tumour, and followed by a latent period from several months to years before the emergence of recurrent spontaneous seizures. More than 50 % of epilepsy cases will develop chronic neurodegenerative, neurocognitive and neuropsychiatric comorbidities. It is important to understand the mechanisms by which a brain insult results in acquired epilepsy and comorbidities in order to identify targets for novel therapeutic interventions that may mitigate these outcomes. Recent studies have implicated the hyperphosphorylated tubulin-associated protein (tau) in rodent models of epilepsy and Alzheimer's disease, and in experimental and clinical studies of traumatic brain injury. This potentially represents a novel target to mitigate epilepsy and associated neurocognitive and psychiatric disorders post-brain injury. This article reviews the potential role of tau-based mechanisms in the pathophysiology of acquired epilepsy and its neurocognitive and neuropsychiatric comorbidities, and the potential to target these for novel disease-modifying treatments.	[Zheng, Ping; Shultz, Sandy R.; Jones, Nigel C.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Hovens, Chris M.] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Melbourne, Vic 3050, Australia; [Velakoulis, Dennis] Royal Melbourne Hosp, Melbourne Neuropsychiat Ctr, Melbourne, Vic 3050, Australia		Zheng, P (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, 4th Floor,Clin Sci Bldg, Melbourne, Vic 3050, Australia.	zhp@student.unimelb.edu.au	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013; Velakoulis, Dennis/A-4778-2008	Velakoulis, Dennis/0000-0002-8842-8479; Hovens, Christopher/0000-0002-0610-1289; O'Brien, Terence/0000-0002-7198-8621; Jones, Nigel/0000-0002-1080-8439; Shultz, Sandy/0000-0002-2525-8775			Adams SJ, 2008, BRIT J PSYCHIAT, V192, P464, DOI 10.1192/bjp.bp.107.046664; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bouilleret V, 2009, NEUROIMAGE, V45, P267, DOI 10.1016/j.neuroimage.2008.12.019; Braithwaite SP, 2012, PROG MOL BIOL TRANSL, V106, P343, DOI 10.1016/B978-0-12-396456-4.00012-2; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Corcoran NM, 2010, RSC DRUG DISCOV, V2, P195; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; Deters N, 2009, BIOCHEM BIOPH RES CO, V379, P400, DOI 10.1016/j.bbrc.2008.12.140; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Engel T, 2006, J NEUROCHEM, V99, P1445, DOI 10.1111/j.1471-4159.2006.04139.x; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Galanopoulou AS, 2012, EPILEPSIA, V53, P571, DOI 10.1111/j.1528-1167.2011.03391.x; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Guillozet AL, 2003, ARCH NEUROL-CHICAGO, V60, P729, DOI 10.1001/archneur.60.5.729; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Hanyu Y, 2009, GENES CELLS, V14, P539, DOI 10.1111/j.1365-2443.2009.01290.x; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Hesdorffer DC, 2010, EPILEPSY CURR, V10, P55, DOI 10.1111/j.1535-7511.2010.01355.x; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Honig A, 1999, INT CLIN PSYCHOPHARM, V14, P167, DOI 10.1097/00004850-199905002-00003; Hung C, 2012, CURR TREAT OPTION NE, V14, P293, DOI 10.1007/s11940-012-0178-5; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Irizarry MC, 2012, ARCH NEUROL-CHICAGO, V69, P368, DOI 10.1001/archneurol.2011.830; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jensen FE, 2011, EPILEPSIA, V52, P1, DOI 10.1111/j.1528-1167.2010.02904.x; Jeong HS, 2012, MOL CELL BIOCHEM, V367, P43, DOI 10.1007/s11010-012-1317-8; Johnston MV, 2005, BRAIN PATHOL, V15, P234; Jones NC, 2012, NEUROBIOL DIS, V45, P897, DOI 10.1016/j.nbd.2011.12.005; Jupp B, 2012, EPILEPSIA, V53, P1233, DOI 10.1111/j.1528-1167.2012.03525.x; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lee SM, 2011, J ALZHEIMERS DIS, V26, P355, DOI 10.3233/JAD-2011-102016; Leroy K, 2010, J ALZHEIMERS DIS, V19, P705, DOI [10.3233/JAD-2009-1276, 10.3233/JAD-2010-1276]; Liang ZH, 2009, J ALZHEIMERS DIS, V17, P531, DOI 10.3233/JAD-2009-1069; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu XP, 2012, GLIA, V60, P1279, DOI 10.1002/glia.22347; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Mazanetz MP, 2007, NAT REV DRUG DISCOV, V6, P464, DOI 10.1038/nrd2111; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Medders KE, 2011, J NEUROIMMUNE PHARM, V6, P202, DOI 10.1007/s11481-011-9260-0; Morris M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029257; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Pachet AK, 2003, PSYCHOPHARMACOLOGY, V170, P225, DOI 10.1007/s00213-003-1592-x; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Ramirez-Munguia N, 2003, NEUROCHEM RES, V28, P1517, DOI 10.1023/A:1025670308663; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Schoch KM, 2012, NEUROTHERAPEUTICS, V9, P323, DOI 10.1007/s13311-012-0107-z; Sereno L, 2009, NEUROBIOL DIS, V35, P359, DOI 10.1016/j.nbd.2009.05.025; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Tian FF, 2010, CLIN LAB, V56, P127; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; Walaas SI, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00050; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wu PR, 2011, CELL DEATH DIFFER, V18, P1507, DOI 10.1038/cdd.2011.2; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Yang TH, 2010, J NEUROL SCI, V296, P1, DOI 10.1016/j.jns.2010.06.002; Yang Y, 2012, J CELL BIOCHEM, V113, P1314, DOI 10.1002/jcb.24003; Zhang Z, 2010, BRAIN RES, V1359, P233, DOI 10.1016/j.brainres.2010.08.077; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	82	35	37	0	19	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2014	49	3					1532	1539		10.1007/s12035-013-8601-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AG8KE	WOS:000335666500030	24323428	Green Submitted			2022-02-06	
J	Charland-Verville, V; Jourdan, JP; Thonnard, M; Ledoux, D; Donneau, AF; Quertemont, E; Laureys, S				Charland-Verville, Vanessa; Jourdan, Jean-Pierre; Thonnard, Marie; Ledoux, Didier; Donneau, Anne Francoise; Quertemont, Etienne; Laureys, Steven			Near-death experiences in non-life-threatening events and coma of different etiologies	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						Near-death experiences; Greyson NDE scale; coma; cardiac arrest; traumatic brain injury; memory; non-life threatening events	CARDIAC-ARREST SURVIVORS; OF-BODY EXPERIENCE; BRAIN; ANESTHESIA; AWARENESS; FEATURES; AROUSAL; ORIGIN; STATE; MRI	Background: Near death experiences (NDEs) are increasingly being reported as a clearly identifiable physiological and psychological reality of clinical significance. However, the definition and causes of the phenomenon as well as the identification of NDE experiencers is still a matter of debate. To date, the most widely used standardized tool to identify and characterize NDEs in research is the Greyson NDE scale. Using this scale, retrospective and prospective studies have been trying to estimate their incidence in various populations but few studies have attempted to associate the experiences' intensity and content to etiology. Methods: This retrospective investigation assessed the intensity and the most frequently recounted features of self-reported NDEs after a non-life-threatening event (i.e., "NDE-like" experience) or after a pathological coma (i.e., "real NDE") and according to the etiology of the acute brain insult. We also compared our retrospectively acquired data in anoxic coma with historical data from the published literature on prospective post-anoxic studies using the Greyson NDE scale. Results: From our 190 reports who met the criteria for NDE (i.e., Greyson NDE scale total score >7/32), intensity (i.e., Greyson NDE scale total score) and content (i.e., Greyson NDE scale features) did not differ between "NDE-like" (n = 50) and "real NDE" (n = 140) groups, nor within the "real NDE" group depending on the cause of coma (anoxic/traumatic/other). The most frequently reported feature was peacefulness (89-93%). Only 2 patients (1%) recounted a negative experience. The overall NDE core features' frequencies were higher in our retrospective anoxic cohort when compared to historical published prospective data. Conclusions: It appears that "real NDEs" after coma of different etiologies are similar to "NDE-like" experiences occurring after non-life threatening events. Subjects reporting NDEs retrospectively tend to have experienced a different content compared to the prospective experiencers.	[Charland-Verville, Vanessa; Thonnard, Marie; Ledoux, Didier; Laureys, Steven] Univ Hosp Liege, Dept Neurol, Coma Sci Grp, Cyclotron Res Ctr, B-4000 Liege, Belgium; [Jourdan, Jean-Pierre] Int Associat Near Death Studies, Oraison, France; [Donneau, Anne Francoise] Univ Liege, Dept Publ Hlth, Liege, Belgium; [Quertemont, Etienne] Univ Liege, Dept Psychol, Cognit Behav Neurosci Ctr, Liege, Belgium		Laureys, S (corresponding author), Univ Hosp Liege, Dept Neurol, Coma Sci Grp, Cyclotron Res Ctr, B-4000 Liege, Belgium.	steven.laureys@ulg.ac.be	Laureys, Steven/AAN-2097-2021; Laureys, Steven/A-3349-2011; Ledoux, Didier/ABA-8401-2021	Laureys, Steven/0000-0002-3096-3807; Ledoux, Didier/0000-0002-9314-6564	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [FP7-247919 DECODER]; Belgian National Funds for Scientific Research (FNRS)Fonds de la Recherche Scientifique - FNRS; Tinnitus Prize [FNRS 9.4501.12]; FEDER structural fund [RADIOMED-930549]; Fonds Leon Fredericq; James McDonnell Foundation; French Speaking Community Concerted Research Action; University and University Hospital of Liege	The authors thank Guy Vander Linden from the IANDS Flanders (www.bijnadoodervaring.be) for their help in recruiting NDE testimonies. This research was supported by the European Commission (European ICT Programme Projects FP7-247919 DECODER), the Belgian National Funds for Scientific Research (FNRS), the Tinnitus Prize 2011 (FNRS 9.4501.12), FEDER structural fund RADIOMED-930549, Fonds Leon Fredericq, the James McDonnell Foundation, the French Speaking Community Concerted Research Action and the University and University Hospital of Liege. The funding sources are not liable for any use that may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammermann H, 2007, J NEUROL SCI, V260, P65, DOI 10.1016/j.jns.2007.03.026; Arzy S, 2006, NATURE, V443, P287, DOI 10.1038/443287a; Beauregard M, 2009, RESUSCITATION, V80, P1006, DOI 10.1016/j.resuscitation.2009.05.006; Blackmore S., 1993, DYING LIVE SCI NEAR; Blanke O, 2005, BRAIN RES REV, V50, P184, DOI 10.1016/j.brainresrev.2005.05.008; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Britton WB, 2004, PSYCHOL SCI, V15, P254, DOI 10.1111/j.0956-7976.2004.00661.x; Charland-Verville V, 2013, CORTEX, V49, P1997, DOI 10.1016/j.cortex.2013.03.003; COBCROFT MD, 1993, ANAESTH INTENS CARE, V21, P837, DOI 10.1177/0310057X9302100616; Els T, 2004, ACTA NEUROL SCAND, V110, P361, DOI 10.1111/j.1600-0404.2004.00342.x; Facco E, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00490; French CC, 2005, PROG BRAIN RES, V150, P351, DOI 10.1016/S0079-6123(05)50025-6; French CC, 2001, LANCET, V358, P2010, DOI 10.1016/S0140-6736(01)07133-1; Gabbard G., 1991, J NEAR DEATH STUD, V10, P41, DOI [DOI 10.1007/BF01073295, 10.1007/BF01073295]; GABBARD GO, 1981, J NERV MENT DIS, V169, P374, DOI 10.1097/00005053-198106000-00006; Gallup G., 1982, ADVENTURES IMMORTALI; Greyson B, 2000, VARIETIES OF ANOMALOUS EXPERIENCE: EXAMINING THE SCIENTIFIC EVIDENCE, P315, DOI 10.1037/10371-010; Greyson B, 2003, PSYCHIAT SERV, V54, P1649, DOI 10.1176/appi.ps.54.12.1649; Greyson B, 2003, GEN HOSP PSYCHIAT, V25, P269, DOI 10.1016/S0163-8343(03)00042-2; Greyson B, 1998, PERSPECT BIOL MED, V42, P14; GREYSON B, 1983, J NERV MENT DIS, V171, P369, DOI 10.1097/00005053-198306000-00007; Greyson B., 1990, J NEAR DEATH STUD, V8, P151, DOI [http://dx.doi.org/10.1007/BF01074000, DOI 10.1007/BF01074000]; Greyson B, 2007, RESUSCITATION, V73, P407, DOI 10.1016/j.resuscitation.2006.10.013; Heim A., 1891, ALPENCLUB, V27, P327; Hoepner R, 2013, J NEUROL, V260, P742, DOI 10.1007/s00415-012-6689-x; Hou YM, 2013, ANN INDIAN ACAD NEUR, V16, P75, DOI 10.4103/0972-2327.107715; Kelly EW, 2001, DEATH STUD, V25, P229, DOI 10.1080/07481180125967; Klemenc-Ketis Z, 2010, CRIT CARE, V14, DOI 10.1186/cc8952; Lai CF, 2007, AM J KIDNEY DIS, V50, P124, DOI 10.1053/j.ajkd.2007.04.021; Lange R, 2004, BRIT J PSYCHOL, V95, P161, DOI 10.1348/000712604773952403; LEMPERT T, 1994, LANCET, V344, P829, DOI 10.1016/S0140-6736(94)92389-2; Lindley J. H., 1981, J NEAR DEATH STUDIES, V1, P104; Lopez U, 2006, PEDIATR ANESTH, V16, P85, DOI 10.1111/j.1460-9592.2005.01607.x; MARTENS PR, 1994, RESUSCITATION, V27, P171, DOI 10.1016/0300-9572(94)90010-8; McKay R, 2007, CONSCIOUS COGN, V16, P349, DOI 10.1016/j.concog.2006.06.001; Mobbs D, 2011, TRENDS COGN SCI, V15, P447, DOI 10.1016/j.tics.2011.07.010; Moody R.A., 1975, LIFE LIFE; Nelson KR, 2007, NEUROLOGY, V68, P794, DOI 10.1212/01.wnl.0000256784.85952.6f; Nelson KR, 2006, NEUROLOGY, V66, P1003, DOI 10.1212/01.wnl.0000204296.15607.37; Osterman JE, 2001, GEN HOSP PSYCHIAT, V23, P198, DOI 10.1016/S0163-8343(01)00142-6; OWENS JE, 1990, LANCET, V336, P1175, DOI 10.1016/0140-6736(90)92780-L; Parnia S, 2001, RESUSCITATION, V48, P149, DOI 10.1016/S0300-9572(00)00328-2; Posner J., 2007, DIAGNOSIS STUPOR COM, V4th; Ring K., 1984, HEADING OMEGA SEARCH; Ring K., 1980, LIFE DEATH SCI INVES; RODIN EA, 1980, J NERV MENT DIS, V168, P259, DOI 10.1097/00005053-198005000-00001; Sabom M.B., 1982, RECOLLECTIONS DEATH; Schwaninger J, 2002, J NEAR DEATH STUD, V20, P215, DOI [10.1023/A:1015258818660, DOI 10.1023/A:1015258818660]; STEVENSON I, 1989, OMEGA-J DEATH DYING, V20, P45, DOI 10.2190/D8Q9-HHKX-5JWC-FD3V; van Lommel P, 2001, LANCET, V358, P2039, DOI 10.1016/S0140-6736(01)07100-8; Woerlee G.M., 2005, MORTAL MINDS BIOL NE	52	35	35	0	20	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	MAY 27	2014	8								203	10.3389/fnhum.2014.00203			8	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	AL9XZ	WOS:000339498200001	24904345	Green Published, gold, Green Submitted			2022-02-06	
J	Anbari, F; Khalili, MA; Bahrami, AR; Khoradmehr, A; Sadeghian, F; Fesahat, F; Nabi, A				Anbari, Fatemeh; Khalili, Mohammad Ali; Bahrami, Ahmad Reza; Khoradmehr, Arezoo; Sadeghian, Fatemeh; Fesahat, Farzaneh; Nabi, Ali			Intravenous transplantation of bone marrow mesenchymal stem cells promotes neural regeneration after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; bone marrow mesenchymal stem cells; traumatic brain injury; intravenous administration; cell differentiation; neurologic function, cerebral cortex; rats; neural regeneration	STROMAL CELLS; THERAPEUTIC BENEFIT; FUNCTIONAL RECOVERY; RATS; NEUROGENESIS; TRANSMIGRATE; STROKE; MODEL	To investigate the supplement of lost nerve cells in rats with traumatic brain injury by intravenous administration of allogenic bone marrow mesenchymal stem cells, this study established a Wistar rat model of traumatic brain injury by weight drop impact acceleration method and administered 3 x 106 rat bone marrow mesenchymal stem cells via the lateral tail vein. At 14 days after cell transplantation, bone marrow mesenchymal stem cells differentiated into neurons and astrocytes in injured rat cerebral cortex and rat neurological function was improved significantly. These findings suggest that intravenously administered bone marrow mesenchymal stem cells can promote nerve cell regeneration in injured cerebral cortex, which supplement the lost nerve cells.	[Anbari, Fatemeh; Khalili, Mohammad Ali; Khoradmehr, Arezoo; Sadeghian, Fatemeh; Fesahat, Farzaneh; Nabi, Ali] Shahid Sadoughi Univ Med Sci, Res & Clin Ctr Infertil, Yazd, Iran; [Bahrami, Ahmad Reza] Ferdowsi Univ Mashhad, Inst Biotechnol, Mashhad, Iran		Khalili, MA (corresponding author), Shahid Sadoughi Univ Med Sci, Res & Clin Ctr Infertil, Yazd, Iran.	khalili59@hotmail.com	fesahat, farzaneh/AAF-4822-2020; Bahrami, Ahmad Reza/AAA-4090-2020; Nabi, Ali/R-9349-2017	Bahrami, Ahmad Reza/0000-0001-9122-7216; Nabi, Ali/0000-0002-3794-6073; Sadeghian-Nodoushan, Fatemeh/0000-0003-2767-7882	Shahid Sadoughi University of Medical Sciences, Yazd, Iran	This study was supported by research center from Shahid Sadoughi University of Medical Sciences, Yazd, Iran.	Azari MF, 2010, CURR NEUROPHARMACOL, V8, P316, DOI 10.2174/157015910793358204; Bonilla C, 2009, BRAIN INJURY, V23, P760, DOI 10.1080/02699050903133970; Brodhun M, 2004, EXP TOXICOL PATHOL, V56, P103, DOI 10.1016/j.etp.2004.04.004; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Collins TR, 2013, NEUROL TODAY, V13, P1; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Hamano K, 2000, CELL TRANSPLANT, V9, P439, DOI 10.1177/096368970000900315; Harting MT, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E17; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Joers VL, 2010, ILAR J, V51, P24, DOI 10.1093/ilar.51.1.24; Karaoz E, 2009, HISTOCHEM CELL BIOL, V132, P533, DOI 10.1007/s00418-009-0629-6; Khalili Mohammad Ali, 2014, Exp Neurobiol, V23, P77, DOI 10.5607/en.2014.23.1.77; Khalili MA, 2012, J STROKE CEREBROVASC, V21, P445, DOI 10.1016/j.jstrokecerebrovasdis.2010.10.005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee DH, 2013, CHILD NERV SYST, V29, P403, DOI 10.1007/s00381-012-1969-4; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu KM, 2008, MICROVASC RES, V75, P59, DOI 10.1016/j.mvr.2007.06.003; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Marquez-Curtis LA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/561098; Matsushita T, 2011, NEUROSCI LETT, V502, P41, DOI 10.1016/j.neulet.2011.07.021; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Opydo-Chanek M, 2007, ACTA NEUROBIOL EXP, V67, P187; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pitkanen A, 2006, DRUG DISCOV TODAY, V2, P409; Reitz M, 2012, STEM CELL TRANSL MED, V1, P866, DOI 10.5966/sctm.2012-0045; Schmidt A, 2006, EUR J CELL BIOL, V85, P1179, DOI 10.1016/j.ejcb.2006.05.015; Vaquero J, 2011, PROG NEUROBIOL, V93, P341, DOI 10.1016/j.pneurobio.2010.12.002; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890	35	35	37	1	13	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2014	9	9					919	923		10.4103/1673-5374.133133			5	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AI7KH	WOS:000337068600005	25206912	gold, Green Published, Green Submitted			2022-02-06	
J	Cockshell, SJ; Mathias, JL				Cockshell, Susan J.; Mathias, Jane L.			Cognitive Functioning in People With Chronic Fatigue Syndrome: A Comparison Between Subjective and Objective Measures	NEUROPSYCHOLOGY			English	Article						chronic fatigue syndrome; cognition; self-report; cognitive tests	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL DEFICITS; PERFORMANCE; DEPRESSION; EVERYDAY; COMPLAINTS; IMPAIRMENT; PATTERNS; QUALITY; MEMORY	Objective: The purpose of this study was to examine the relationship between subjective and objective assessments of memory and attention in people with chronic fatigue syndrome (CFS), using tests that have previously detected deficits in CFS samples and measures of potential confounds. Method: Fifty people with CFS and 50 healthy controls were compared on subjective (memory and attention symptom severity, Cognitive Failures Questionnaire, Everyday Attention Questionnaires) and objective (California Verbal Learning Test, Rey-Osterreith Complex Figure Test, Paced Auditory Serial Addition Test, Stroop task) measures of memory and attention. Fatigue, sleep, depression, and anxiety were also assessed. Results: The CFS group reported experiencing more cognitive problems than the controls, but the two groups did not differ on the cognitive tests. Scores on the subjective and objective measures were not correlated in either group. Depression was positively correlated with increased severity of cognitive problems in both the CFS and control groups. Conclusions: There is little evidence for a relationship between subjective and objective measures of cognitive functioning for both people with CFS and healthy controls, which suggests that they may be capturing different constructs. Problems with memory and attention in everyday life are a significant part of CFS. Depression appears to be related to subjective problems but does not fully explain them.	[Cockshell, Susan J.; Mathias, Jane L.] Univ Adelaide, Sch Psychol, Adelaide, SA 5005, Australia		Mathias, JL (corresponding author), Univ Adelaide, Sch Psychol, North Terrace Campus, Adelaide, SA 5005, Australia.	jane.mathias@adelaide.edu.au		Mathias, Jane/0000-0001-8957-8594			ABBEY SE, 1991, REV INFECT DIS, V13, pS73; ALTAY HT, 1990, INT J PSYCHIAT MED, V20, P141, DOI 10.2190/T6GX-JJ2L-VCVV-T81B; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Bultmann U, 2000, J Occup Health Psychol, V5, P411, DOI 10.1037/1076-8998.5.4.411; Busichio K, 2004, J INT NEUROPSYCH SOC, V10, P278, DOI 10.1017/S1355617704102178; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Capuron L, 2006, NEUROPSYCHOPHARMACOL, V31, P1777, DOI 10.1038/sj.npp.1301005; Claypoole KH, 2007, NEUROPSYCHOLOGY, V21, P507, DOI 10.1037/0894-4105.21.4.507; Cockshell SJ, 2010, PSYCHOL MED, V40, P1253, DOI 10.1017/S0033291709992054; Cockshell SJ, 2013, NEUROPSYCHOLOGY, V27, P230, DOI 10.1037/a0032084; Cockshell SJ, 2012, J CLIN EXP NEUROPSYC, V34, P679, DOI 10.1080/13803395.2012.668176; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Constant EL, 2011, CLIN NEUROL NEUROSUR, V113, P295, DOI 10.1016/j.clineuro.2010.12.002; COPE H, 1995, BRIT J PSYCHIAT, V167, P86, DOI 10.1192/bjp.167.1.86; Cumming G, 2012, UNDERSTANDING NEW ST, P2012; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; DELUCA J, 1993, ARCH NEUROL-CHICAGO, V50, P301, DOI 10.1001/archneur.1993.00540030065016; DELUCA J, 1995, J NEUROL NEUROSUR PS, V58, P38, DOI 10.1136/jnnp.58.1.38; DeLuca J, 1997, J NEUROL NEUROSUR PS, V62, P151, DOI 10.1136/jnnp.62.2.151; Dickson A, 2009, PSYCHOL MED, V39, P1567, DOI 10.1017/S0033291708004960; Duits A, 2008, J NEUROL NEUROSUR PS, V79, P143, DOI 10.1136/jnnp.2007.114595; Fischler B, 1996, NEUROPSYCHOBIOLOGY, V34, P175, DOI 10.1159/000119307; Friedberg F, 2000, J PSYCHOSOM RES, V48, P59, DOI 10.1016/S0022-3999(99)00077-X; Fuentes K, 2001, CLIN NEUROPSYCHOL, V15, P210, DOI 10.1076/clin.15.2.210.1896; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GRAFMAN J, 1993, J NEUROL NEUROSUR PS, V56, P684, DOI 10.1136/jnnp.56.6.684; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Knoop H, 2007, J NEUROL NEUROSUR PS, V78, P434, DOI 10.1136/jnnp.2006.100974; Knoop H, 2010, J PSYCHOSOM RES, V68, P489, DOI 10.1016/j.jpsychores.2010.01.022; KRUPP LB, 1994, ARCH NEUROL-CHICAGO, V51, P705, DOI 10.1001/archneur.1994.00540190089021; Lawrie SM, 2000, PSYCHOL MED, V30, P433, DOI 10.1017/S0033291799001816; Mahurin RK, 2004, NEUROPSYCHOLOGY, V18, P232, DOI 10.1037/0894-4105.18.2.232; Majer M, 2008, PSYCHOSOM MED, V70, P829, DOI 10.1097/PSY.0b013e31817b9793; Mantyla T, 2010, APPL NEUROPSYCHOL, V17, P289, DOI 10.1080/09084282.2010.525090; Marshall PS, 1997, PSYCHOSOM MED, V59, P58, DOI 10.1097/00006842-199701000-00008; MARTIN M, 1983, B PSYCHONOMIC SOC, V21, P97; MARTIN M, 1986, HUM LEARN, V5, P63; MCDONALD E, 1993, J NEUROL NEUROSUR PS, V56, P812, DOI 10.1136/jnnp.56.7.812; Metzger FA, 2002, ANN BEHAV MED, V24, P106, DOI 10.1207/S15324796ABM2402_07; Michiels V, 2001, ACTA PSYCHIAT SCAND, V103, P84, DOI 10.1034/j.1600-0447.2001.00017.x; Morriss RK, 1998, J ROY SOC MED, V91, P365, DOI 10.1177/014107689809100706; MossMorris R, 1996, J NEUROL NEUROSUR PS, V60, P474, DOI 10.1136/jnnp.60.5.474; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; PRASHER D, 1990, J NEUROL NEUROSUR PS, V53, P247, DOI 10.1136/jnnp.53.3.247; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; RAY C, 1993, BRIT J CLIN PSYCHOL, V32, P357, DOI 10.1111/j.2044-8260.1993.tb01068.x; Ray C, 1997, J PSYCHOSOM RES, V43, P405, DOI 10.1016/S0022-3999(97)00111-6; SARGENT CA, 1997, J CHRONIC FATIGUE SY, V3, P53, DOI DOI 10.1300/J092V03N03_04; SCHEFFERS MK, 1992, NEUROLOGY, V42, P1667, DOI 10.1212/WNL.42.9.1667; Schmaling KB, 2003, PSYCHOSOM MED, V65, P129, DOI 10.1097/01.PSY.0000038942.33335.9B; SCHMALING KB, 1994, PSYCHOSOM MED, V56, P383, DOI 10.1097/00006842-199409000-00001; Short K, 2002, J PSYCHOSOM RES, V52, P475, DOI 10.1016/S0022-3999(02)00290-8; Smarr K., 2003, ARTHRIT CARE RES, V49, pS134, DOI DOI 10.1002/ART.11410; Smith A, 1996, HUM PSYCHOPHARM CLIN, V11, P161, DOI 10.1002/(SICI)1099-1077(199605)11:3<161::AID-HUP784>3.0.CO;2-5; SMITH AP, 1993, BRIT J PSYCHOL, V84, P411, DOI 10.1111/j.2044-8295.1993.tb02492.x; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sullivan KA, 2012, BRAIN INJURY, V26, P1098, DOI 10.3109/02699052.2012.666367; Thomas Marie, 2009, Open Neurol J, V3, P13, DOI 10.2174/1874205X00903010013; Tiersky LA, 1997, J CLIN EXP NEUROPSYC, V19, P560, DOI 10.1080/01688639708403744; Tiersky LA, 1998, CLIN NEUROPSYCHOL, V12, P503, DOI 10.1076/clin.12.4.503.7237; Tucker-Drob EM, 2011, NEUROPSYCHOLOGY, V25, P368, DOI 10.1037/a0022348; Van den Eede F, 2011, PSYCHIAT RES, V186, P367, DOI 10.1016/j.psychres.2010.07.022; Vercoulen JHMM, 1998, J CLIN EXP NEUROPSYC, V20, P144, DOI 10.1076/jcen.20.2.144.1160; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Wagner David L., 2005, P8; Wearden A, 1997, PSYCHOL MED, V27, P81, DOI 10.1017/S0033291796004035; Wearden AJ, 1996, J PSYCHOSOM RES, V41, P197, DOI 10.1016/0022-3999(96)00131-6; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	72	35	35	2	33	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2014	28	3					394	405		10.1037/neu0000025			12	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	AG3QH	WOS:000335334000010	24364389				2022-02-06	
J	Liu, SJ; Zou, Y; Belegu, V; Lv, LY; Lin, N; Wang, TY; McDonald, JW; Zhou, X; Xia, QJ; Wang, TH				Liu, Su-Juan; Zou, Yu; Belegu, Visar; Lv, Long-Yun; Lin, Na; Wang, Ting-Yong; McDonald, John W.; Zhou, Xue; Xia, Qing-Jie; Wang, Ting-Hua			Co-grafting of neural stem cells with olfactory en sheathing cells promotes neuronal restoration in traumatic brain injury with an anti-inflammatory mechanism	JOURNAL OF NEUROINFLAMMATION			English	Article						Neural stem cells (NSCs); Olfactory en sheathing cells (OECs); Traumatic brain injury (TBI); Anti-inflammation	SPINAL-CORD; ENSHEATHING CELLS; APOPTOSIS; REPAIR; TRANSPLANTATION; EXPRESSION; RAT; INTERLEUKIN-6; PROTEIN; BAD	Background: We sought to investigate the effects of co-grafting neural stem cells (NSCs) with olfactory ensheathing cells (OECs) on neurological behavior in rats subjected to traumatic brain injury (TBI) and explore underlying molecular mechanisms. Methods: TBI was established by percussion device made through a weight drop (50 g) from a 30 cm height. Cultured NSCs and OECs isolated from rats were labeled by Hoechst 33342 (blue) and chloromethyl-benzamidodialkyl carbocyanine (CM-Dil) (red), respectively. Then, NSCs and/or OECs, separately or combined, were transplanted into the area surrounding the injury site. Fourteen days after transplantation, neurological severity score (NSS) were recorded. The brain tissue was harvested and processed for immunocytochemistry, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL), and reverse transcription-polymerase chain reaction (RT-PCR). Results: Significant neurological function improvement was observed in the three transplant groups, compared to the TBI group, and co-transplantation gave rise to the best improvement. Morphological evaluation showed that the number of neurons in cortex from combination implantation was more than for other groups (P < 0.05); conversely, the number of apoptotic cells showed a significant decrease by TUNEL staining. Transplanted NSCs and OECs could survive and migrate in the brain, and the number of neurons differentiating from NSCs in the co-transplantation group was significantly greater than in the NSCs group. At the molecular level, the expressions of IL-6 and BAD in the co-graft group were found to be down regulated significantly, when compared to either the NSC or OEC alone groups. Conclusion: The present study demonstrates for the first time the optimal effects of co-grafting NSCs and OECs as a new strategy for the treatment of TBI via an anti-inflammation mechanism.	[Liu, Su-Juan; Zhou, Xue; Wang, Ting-Hua] Sichuan Univ, West China Sch Preclin & Forens Med, Dept Histol Embryol & Neurobiol, Chengdu 610041, Sichuan, Peoples R China; [Zou, Yu; Xia, Qing-Jie; Wang, Ting-Hua] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Inst Neurol Dis, Chengdu 610041, Sichuan, Peoples R China; [Belegu, Visar; McDonald, John W.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Lv, Long-Yun; Lin, Na; Wang, Ting-Yong; Wang, Ting-Hua] Kunming Med Univ, Inst Neurosci, Kunming 650031, Yunnan, Peoples R China		Xia, QJ (corresponding author), Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Inst Neurol Dis, Chengdu 610041, Sichuan, Peoples R China.	193374073@qq.com; tinghua_neuron@263.net	ZHOU, XUE/F-6129-2013	Belegu, Visar/0000-0002-1361-4517	China National Science FoundationNational Natural Science Foundation of China (NSFC) [81271358, 81070991]	This research was supported by a grant from the China National Science Foundation (number: 81271358, 81070991).	Abraham AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084838; Amaranath JE, 2014, ANZ J SURG, V84, P424, DOI 10.1111/ans.12445; Blumenthal J, 2013, TISSUE ENG PT A, V19, P2284, DOI [10.1089/ten.tea.2012.0090, 10.1089/ten.TEA.2012.0090]; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512000-00014; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Farkas G, 1998, NEUROSCI LETT, V242, P147, DOI 10.1016/S0304-3940(98)00060-3; Hirjak D, 2013, NEUROPSYCHOBIOLOGY, V68, P91, DOI 10.1159/000350999; Jia YY, 2014, CHEM PHARM BULL, V62, P45, DOI 10.1248/cpb.c13-00556; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lama D, 2008, PROTEINS, V73, P492, DOI 10.1002/prot.22075; Lang BC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-80; Lepore AC, 2005, EXP NEUROL, V194, P230, DOI 10.1016/j.expneurol.2005.02.020; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Okano H, 2010, P JPN ACAD B-PHYS, V86, P438, DOI 10.2183/pjab.86.438; Oudega M, 2007, ACTA PHYSIOL, V189, P181, DOI 10.1111/j.1748-1716.2006.01658.x; PITUELLO F, 1990, CELL DIFFER DEV, V32, P71, DOI 10.1016/0922-3371(90)90101-2; Quan JH, 2013, EXP PARASITOL, V133, P462, DOI 10.1016/j.exppara.2013.01.005; Richter MW, 2005, J NEUROSCI, V25, P10700, DOI 10.1523/JNEUROSCI.3632-05.2005; Sasaki M, 2011, EXP NEUROL, V229, P88, DOI 10.1016/j.expneurol.2011.01.010; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Sobrado M, 2003, NEUROSCIENCE, V118, P107, DOI 10.1016/S0306-4522(02)00912-0; Son D, 2014, J BIOL CHEM, V289, P6225, DOI 10.1074/jbc.M113.508994; Toft A, 2013, GLIA, V61, P513, DOI 10.1002/glia.22452; Tran LV, 2014, J TRAUMA NURS, V21, P30, DOI 10.1097/JTN.0000000000000026; Wang G, 2010, CELL TRANSPLANT, V19, P1325, DOI 10.3727/096368910X505855; Wang HH, 2012, NEUROIMMUNOMODULAT, V19, P304, DOI 10.1159/000339302; Wang YC, 2014, CYTOTHERAPY, VS1465-3249, P00841; Wewetzer K, 2011, EXP NEUROL, V229, P80, DOI 10.1016/j.expneurol.2010.08.029; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xie F, 2013, TOXICOL APPL PHARM, V272, P598, DOI 10.1016/j.taap.2013.07.020	32	35	41	1	19	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	APR 2	2014	11								66	10.1186/1742-2094-11-66			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	AF8FS	WOS:000334951600001	24690089	gold, Green Published			2022-02-06	
J	Wojcik, SM				Wojcik, Susan M.			Predicting mild traumatic brain injury patients at risk of persistent symptoms in the Emergency Department	BRAIN INJURY			English	Article						Closed head injury; emergency care; head injury	POST-CONCUSSION SYMPTOMS; MINOR HEAD-INJURY; COMA SCALE SCORE; POSTCONCUSSION-SYNDROME; COGNITIVE PERFORMANCE; DIAGNOSIS THREAT; HIGH-SCHOOL; SPORTS; MANAGEMENT; RECOVERY	Objective: To identify factors that can predict which emergency department (ED) patients with mTBI are likely to develop persistent post-concussion symptoms (PPCS). Design: A matched case-control study was conducted at a Level 1 trauma centre between June 2006 and July 2009. Patients diagnosed with mTBI in the ED and diagnosed at a concussion management programme with at least one PPCS (85 cases) were compared to patients diagnosed with mTBI in the ED (340 controls) to determine if factors assessed at the time of ED presentation could predict patients likely to develop persistent symptoms. Results: Multivariable hierarchical logistic regression with variables indicating increased risk for PPCS (prior mTBI, history of depression, history of anxiety, multiple injury, forgetfulness/poor memory, noise sensitivity, or light sensitivity) resulted in a final predictive model including prior mTBI, history of anxiety, forgetfulness/poor memory and light sensitivity. The final model had a specificity of 87.9% and a sensitivity of 69.9%. Conclusions: A strong prediction model to identify those ED patients with mTBI at risk for PPCS was developed and could be easily implemented in the ED; therefore, helping to target those patients who would potentially benefit from close follow-up.	[Wojcik, Susan M.] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY 13210 USA		Wojcik, SM (corresponding author), 550 E Genesee St, Syracuse, NY 13202 USA.	wojciks@upstate.edu					Adirim TA, 2007, CLIN PEDIATR EMERG M, V8, P2, DOI 10.1016/j.cpem.2007.02.002; Bay Esther, 2007, J Neurosci Nurs, V39, P43; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Cunningham J, 2011, J EMERG MED, V40, P262, DOI 10.1016/j.jemermed.2008.08.017; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Falconer EK, 2006, BRAIN INJURY, V20, P1251, DOI 10.1080/02699050601049601; Faul M, 2010, TRAUMATIC BRAIN INJU; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; Hsiang John N K, 2005, J Long Term Eff Med Implants, V15, P153, DOI 10.1615/JLongTermEffMedImplants.v15.i2.40; Hulley S, 2007, DESIGNING CLIN RES, P112; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lovell M, 2005, OPER TECHN SPORT MED, V13, P212, DOI 10.1053/j.otsm.2006.01.005; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McMillan TM, 2009, BRAIN INJURY, V23, P509, DOI 10.1080/02699050902970729; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff RM, 1999, BRAIN INJURY, V13, P943; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tellier A, 1999, BRAIN INJURY, V13, P463; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Uchino Y, 2001, ACTA NEUROCHIR, V143, P1031, DOI 10.1007/s007010170008; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543	75	35	35	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2014	28	4					422	430		10.3109/02699052.2014.884241			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AF5GL	WOS:000334741900004	24564636				2022-02-06	
J	Li, ZZ; Dong, XH; Zhang, JF; Zeng, G; Zhao, HM; Liu, Y; Qiu, RB; Mo, LJ; Ye, Y				Li, Zhengzhao; Dong, Xianhong; Zhang, Jianfeng; Zeng, Guang; Zhao, Huimin; Liu, Yun; Qiu, Rubiao; Mo, Linjian; Ye, Yu			Formononetin protects TBI rats against neurological lesions and the underlying mechanism	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Formononetin; Traumatic brain injury; Rat; Inflammation; Oxidative stress; Neuroprotection	TRAUMATIC BRAIN-INJURY; INDUCED APOPTOSIS; NEUROINFLAMMATION; INFLAMMASOME; ACTIVATION; MANAGEMENT; KINASE; CELLS; NRF2	Traumatic brain injury (TB!) is a major cause of disability or death worldwide, especially in the young. Thus, effective medication with few side effects needs to be developed. This work aimed to explore the potential benefits of formononetin (FN) on TBI rodent model and to discuss the regarding mechanism. These findings showed that FN effectively increased the activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) in brain tissue of TB! rats (P < 0.01), while it reduced intracephalic malonaldehyde (MDA), tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) concentrations (P < 0.01). Meanwhile, the hydrocephalus in the TBI rat was alleviated, and the injured nerve cell of the lesioned brain was reduced as showed in hematoxylin-eosin (HE) staining assay. In addition, the endogenous mRNA level of cyclooxygenase-2 (COX-2) in the brain of the TBI rat was significantly down-regulated (P < 0.01). Furthermore, the protein expression of nuclear factor E2-related factor 2 (Nrf2) was effectively up-regulated (P < 0.01). Taken together, we conclude that formononetin mediates the promising anti-TBI effects against neurocyte damage, whichthe underlying mechanisms are associated with inhibiting intracephalic inflammatory response and oxidative stress for neuroprotection. (C) 2013 Elsevier B.V. All rights reserved.	[Li, Zhengzhao; Zhang, Jianfeng; Zeng, Guang; Zhao, Huimin; Ye, Yu] Guangxi Med Univ, Affiliated Hosp 1, Western Hosp, Emergency Dept, Nanning 530007, Guangxi Zhuang, Peoples R China; [Dong, Xianhong] Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang 453003, Peoples R China; [Qiu, Rubiao] Guangxi Maternal & Child Hlth Hosp, Nanning 530003, Guangxi Zhuang, Peoples R China; [Mo, Linjian] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning 530021, Guangxi Zhuang, Peoples R China; [Liu, Yun] Guangxi Med Univ, Affiliated Hosp 1, Spine & Osteopathy Surg Div, Nanning 530021, Guangxi Zhuang, Peoples R China		Ye, Y (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Western Hosp, Emergency Dept, Nanning 530007, Guangxi Zhuang, Peoples R China.	yeyu_doctor@126.com		Zhang, Jianfeng/0000-0003-4213-9310			Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Chen J, 2012, HORM METAB RES, V44, P943, DOI 10.1055/s-0032-1321818; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cosentino-Gomes D, 2012, INT J MOL SCI, V13, P10697, DOI 10.3390/ijms130910697; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Dokic I, 2012, GLIA, V60, P1785, DOI 10.1002/glia.22397; Elliott J, 2010, ANESTH ANALG, V110, P1419, DOI 10.1213/ANE.0b013e3181d568c8; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Guerra-Araiza C, 2013, FREE RADICAL RES, V47, P451, DOI 10.3109/10715762.2013.795649; Gupta K, 2013, BRIT J CLIN PHARMACO, V75, P907, DOI 10.1111/bcp.12022; Hurley LL, 2013, NEUROTOX RES, V23, P131, DOI 10.1007/s12640-012-9348-1; Imhoff BR, 2009, BIOCHEM J, V424, P491, DOI 10.1042/BJ20091286; Lannin NA, 2013, AM J OCCUP THER, V67, P543, DOI 10.5014/ajot.2013.008094; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Levy M, 2005, NEUROREHABILITATION, V20, P279; Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lo YL, 2013, CHEM-BIOL INTERACT, V205, P188, DOI 10.1016/j.cbi.2013.07.003; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Marosova L, 2013, ACTA VIROL, V57, P273, DOI 10.4149/av_2013_03_273; Mu H, 2009, PHYTOMEDICINE, V16, P314, DOI 10.1016/j.phymed.2008.07.005; Muccio CF, 2009, BRAIN INJURY, V23, P466, DOI 10.1080/02699050902841912; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Roschek B, 2009, J MED FOOD, V12, P615, DOI 10.1089/jmf.2008.0133; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Saito H, 2013, BIOCHEM PHARMACOL, V85, P865, DOI 10.1016/j.bcp.2013.01.006; Torsdottir G, 2010, J NEUROL SCI, V299, P51, DOI 10.1016/j.jns.2010.08.047; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yang XJ, 2011, INVEST OPHTH VIS SCI, V52, P8442, DOI 10.1167/iovs.11-8152	35	35	37	7	34	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAR 15	2014	338	1-2					112	117		10.1016/j.jns.2013.12.027			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AE3NO	WOS:000333883400019	24411660				2022-02-06	
J	Teng, SX; Molina, PE				Teng, Sophie X.; Molina, Patricia E.			Acute Alcohol Intoxication Prolongs Neuroinflammation without Exacerbating Neurobehavioral Dysfunction following Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						alcohol and drug abuse; animal studies; behavior assessments; inflammation	BINGE ETHANOL EXPOSURE; CLOSED-HEAD INJURY; HOST-DEFENSE; TNF-ALPHA; COGNITIVE DEFICITS; GABA(A) RECEPTORS; DAMAGE; TISSUE; RAT; MECHANISMS	Traumatic brain injury (TBI) represents a leading cause of death and disability among young persons with approximate to 1.7 million reported cases in the United States annually. Although acute alcohol intoxication (AAI) is frequently present at the time of TBI, conflicting animal and clinical reports have failed to establish whether AAI significantly impacts short-term outcomes after TBI. The objective of this study was to determine whether AAI at the time of TBI aggravates neurobehavioral outcomes and neuroinflammatory sequelae post-TBI. Adult male Sprague-Dawley rats were surgically instrumented with gastric and vascular catheters before a left lateral craniotomy. After recovery, rats received either a primed constant intragastric alcohol infusion (2.5g/kg+0.3g/kg/h for 15h) or isocaloric/isovolumic dextrose infusion followed by a lateral fluid percussion TBI (approximate to 1.4J, approximate to 30ms). TBI induced apnea and a delay in righting reflex. AAI at the time of injury increased the TBI induced delay in righting reflex without altering apnea duration. Neurological and behavioral dysfunction was observed at 6h and 24h post-TBI, and this was not exacerbated by AAI. TBI induced a transient upregulation of cortical interleukin (IL)-6 and monocyte chemotactic protein (MCP)-1 mRNA expression at 6h, which was resolved at 24h. AAI did not modulate the inflammatory response at 6h but prevented resolution of inflammation (IL-1, IL-6, tumor necrosis factor-, and MCP-1 expression) at 24h post-TBI. AAI at the time of TBI did not delay the recovery of neurological and neurobehavioral function but prevented the resolution of neuroinflammation post-TBI.	[Teng, Sophie X.; Molina, Patricia E.] Louisiana State Univ, Hlth Sci Ctr, Alcohol & Drug Abuse Ctr Excellence, Dept Physiol, New Orleans, LA 70112 USA		Molina, PE (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Alcohol & Drug Abuse Ctr Excellence, Dept Physiol, 1901 Perdido St,Room 7212, New Orleans, LA 70112 USA.	pmolin@lsuhsc.edu	Molina, Patricia E./AAK-9814-2021	Molina, Patricia E./0000-0002-3598-384X	 [NIAAA-AA7577];  [LEQSF-EPS(2012)-PFUND-283]	This research was supported by grants NIAAA-AA7577 and LEQSF-EPS(2012)-PFUND-283.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahmad A., 2013, PLOS ONE, V8; Arbabi S, 1999, J IMMUNOL, V162, P7441; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Boyko M, 2011, BEHAV BRAIN RES, V223, P17, DOI 10.1016/j.bbr.2011.03.019; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; *CDC N C F I P A C, 2003, REP C MILD TRAUM BRA; CHANDLER LJ, 1993, ALCOHOL CLIN EXP RES, V17, P54, DOI 10.1111/j.1530-0277.1993.tb00726.x; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Crews FT, 2003, ALCOHOL CLIN EXP RES, V27, P1075, DOI 10.1097/01.ALC.0000075826.35688.0D; Crews F, 2006, ALCOHOL CLIN EXP RES, V30, P1938, DOI 10.1111/j.1530-0277.2006.00239.x; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DSOUZA NB, 1989, ALCOHOL CLIN EXP RES, V13, P295, DOI 10.1111/j.1530-0277.1989.tb00329.x; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; Faul M, 2010, TRAUMATIC BRAIN INJU; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; French LM, 2009, J HEAD TRAUMA REHAB, V24, P1, DOI 10.1097/HTR.0b013e318197a14c; GONZALES RA, 1990, TRENDS PHARMACOL SCI, V11, P137, DOI 10.1016/0165-6147(90)90059-H; Gonzales RA, 1997, ALCOHOL HEALTH RES W, V21, P120; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Green JA, 2013, NEUROCRIT CARE, V18, P20, DOI 10.1007/s12028-012-9797-7; Greiffenstein P, 2008, J TRAUMA, V64, P230, DOI 10.1097/TA.0b013e318158a4ad; Greiffenstein P, 2007, ALCOHOL CLIN EXP RES, V31, P704, DOI 10.1111/j.1530-0277.2007.00355.x; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hirono M, 2009, NEUROPHARMACOLOGY, V57, P109, DOI 10.1016/j.neuropharm.2009.04.012; HURST PM, 1994, ACCIDENT ANAL PREV, V26, P647, DOI 10.1016/0001-4575(94)90026-4; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Katada R, 2009, J NEUROTRAUM, V26, P2015, DOI 10.1089/neu.2008.0552; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Ling G.S., 2004, CURR PROTOC NEUROSCI, V9, pUnit; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; LUNA GK, 1984, J TRAUMA, V24, P695, DOI 10.1097/00005373-198408000-00001; Mathis KW, 2006, SHOCK, V26, P55, DOI 10.1097/01.shk.0000215320.06866.30; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mihic SJ, 1997, ALCOHOL HEALTH RES W, V21, P127; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Molina PE, 2013, SHOCK, V39, P240, DOI 10.1097/SHK.0b013e318285b86d; Molina PE, 2010, ALCOHOL RES HEALTH, V33, P97; Molina PE, 2003, ALCOHOL CLIN EXP RES, V27, P563, DOI 10.1097/01.ALC.0000057946.57330.F7; Molina PE, 2004, ALCOHOL, V33, P217, DOI 10.1016/j.alcohol.2004.07.002; Molina PE, 2002, ALCOHOL CLIN EXP RES, V26, P120, DOI 10.1097/00000374-200201000-00017; Molina PE, 1999, LIFE SCI, V66, P399; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Pandey SC, 2005, ALCOHOL CLIN EXP RES, V29, P176, DOI 10.1097/01.ALC.0000153550.31168.1D; Patel M, 1996, ALCOHOL CLIN EXP RES, V20, P275, DOI 10.1111/j.1530-0277.1996.tb01640.x; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Phelan H, 2002, J TRAUMA, V52, P675, DOI 10.1097/00005373-200204000-00010; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Ryabinin AE, 1998, PSYCHOPHARMACOLOGY, V139, P34, DOI 10.1007/s002130050687; Santhakumar V, 2007, ALCOHOL, V41, P211, DOI 10.1016/j.alcohol.2007.04.011; Schneider BSP, 2007, SPORTS MED, V37, P837; Shellito JE, 1998, ALCOHOL CLIN EXP RES, V22, p208S, DOI 10.1111/j.1530-0277.1998.tb04003.x; Shellito JE, 1998, ALCOHOL CLIN EXP RES, V22, P658, DOI 10.1111/j.1530-0277.1998.tb04308.x; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Standiford TJ, 1997, ALCOHOL CLIN EXP RES, V21, P1212, DOI 10.1111/j.1530-0277.1997.tb04440.x; Sulzer JK, 2013, J TRAUMA ACUTE CARE, V74, P196, DOI 10.1097/TA.0b013e31826fc747; Sulzer JK, 2011, SHOCK, V35, P74, DOI 10.1097/SHK.0b013e3181e9aaaf; Szabo G, 1998, ALCOHOL CLIN EXP RES, V22, p216S, DOI 10.1111/j.1530-0277.1998.tb04005.x; TAKADERA T, 1990, BRAIN RES, V537, P109, DOI 10.1016/0006-8993(90)90346-D; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; U. S. Department of Health and Human Services. National Institute Alcohol Abuse Alcoholism, 2004, NIAAA NEWSLETTER, V3, P3, DOI DOI 10.1037/E306662005-004; Venters HD, 2000, TRENDS NEUROSCI, V23, P175, DOI 10.1016/S0166-2236(99)01533-7; Wakita M, 2012, J PHARMACOL EXP THER, V341, P809, DOI 10.1124/jpet.111.189126; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; Whitaker AM, 2011, AM J PHYSIOL-REG I, V301, pR1529, DOI 10.1152/ajpregu.00035.2011; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; Zambell KL, 2004, ALCOHOL CLIN EXP RES, V28, P635, DOI 10.1097/01.ALC.0000122104.85971.55; Zhang P, 2002, ALCOHOL CLIN EXP RES, V26, P65, DOI 10.1097/00000374-200201000-00010; Zhang P, 2002, FRONT BIOSCI-LANDMRK, V7, pD1314; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7	91	35	36	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2014	31	4					378	386		10.1089/neu.2013.3093			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	AA7PY	WOS:000331290600010	24050411	Green Published			2022-02-06	
J	Sinclair, KL; Ponsford, J; Rajaratnam, SMW				Sinclair, Kelly L.; Ponsford, Jennie; Rajaratnam, Shantha M. W.			Actigraphic Assessment of Sleep Disturbances following Traumatic Brain Injury	BEHAVIORAL SLEEP MEDICINE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; 1ST 2 YEARS; FATIGUE; DISORDERS; PREVALENCE; DEPRESSION; INSOMNIA; QUALITY; REHABILITATION; QUESTIONNAIRE	The current study examined the use of actigraphy in measurement of sleep following traumatic brain injury (TBI). Twenty-one patients with TBI and self-reported sleep and/or fatigue problems and 21 non-injured controls were studied over seven days using actigraphy and sleep diary reports. Although strong associations between diary and actigraphic assessment of sleep duration were observed in both participant groups, agreement between these methods appeared to weaken in patients with TBI. Associations between sleep diary and actigraphic assessments of sleep disturbance, i.e., wake after sleep onset (WASO) and sleep onset latency (SOL) were not apparent in either group, although weaker agreement between methods for WASO was again observed in patients with TBI. Actigraphy may prove useful to supplement self-report measures of sleep following TBI. More work is required to understand the accuracy of these measures in this population.	[Sinclair, Kelly L.; Ponsford, Jennie; Rajaratnam, Shantha M. W.] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Clayton, Vic, Australia		Rajaratnam, SMW (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton Campus, Clayton, Vic 3800, Australia.	shantha.rajaratnam@monash.edu		Rajaratnam, Shantha/0000-0001-7527-8558	Victorian Neurotrauma Initiative; Jack Brockhoff Foundation; NHMRC Centre for Integrated Research and Understanding of Sleep (CIRUS)National Health and Medical Research Council of Australia; University of SydneyUniversity of Sydney; RACV Sir Edmund Herring Memorial Scholarship	We thank the Monash Epworth Rehabilitation Research Centre for assistance with participant recruitment. This work was supported by funding from the Victorian Neurotrauma Initiative, Jack Brockhoff Foundation, NHMRC Centre for Integrated Research and Understanding of Sleep (CIRUS), The University of Sydney, and RACV Sir Edmund Herring Memorial Scholarship. Thank you also to Dr. Stuart Baulk, CQ University, Australia, for his assistance in data analysis and interpretation.	Aaronson L S, 1999, Image J Nurs Sch, V31, P45; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kanady JC, 2011, J SLEEP RES, V20, P214, DOI 10.1111/j.1365-2869.2010.00858.x; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Ludbrook J, 2010, CLIN EXP PHARMACOL P, V37, P143, DOI 10.1111/j.1440-1681.2009.05288.x; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Manconi M, 2010, J SLEEP RES, V19, P478, DOI 10.1111/j.1365-2869.2009.00801.x; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mccall C, 2012, J SLEEP RES, V21, P122, DOI 10.1111/j.1365-2869.2011.00917.x; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Pallant J., 2011, SURVIVAL MANUAL STEP; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; RAO V, 2005, TXB TRAUMATIC BRAIN, P369; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Spruyt K, 2011, J SLEEP RES, V20, P223, DOI 10.1111/j.1365-2869.2010.00857.x; Tabachnick B.G., 2001, USING MULTIVARIATE S; Tryon WW, 2004, SLEEP, V27, P158, DOI 10.1093/sleep/27.1.158; Vaishnavi S, 2010, PSYCHIAT ANN, V40, P553, DOI 10.3928/00485713-20101018-06; Verma A, 2007, J CLIN SLEEP MED, V3, P357; WALKER GC, 1991, ARCH PHYS MED REHAB, V72, P469; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Werner H, 2008, ARCH PEDIAT ADOL MED, V162, P350, DOI 10.1001/archpedi.162.4.350; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Worthington AD, 2006, BRAIN INJURY, V20, P327, DOI 10.1080/02699050500488249; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167; [No title captured]; [No title captured]; [No title captured]; [No title captured]	66	35	35	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1540-2002	1540-2010		BEHAV SLEEP MED	Behav. Sleep Med.	JAN 2	2014	12	1					13	27		10.1080/15402002.2012.726203			15	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	268SZ	WOS:000328192100002	23394102				2022-02-06	
J	O'Keeffe, F; Liegeois, F; Eve, M; Ganesan, V; King, J; Murphy, T				O'Keeffe, Fiadhnait; Liegeois, Frederique; Eve, Megan; Ganesan, Vijeya; King, John; Murphy, Tara			Neuropsychological and neurobehavioral outcome following childhood arterial ischemic stroke: Attention deficits, emotional dysregulation, and executive dysfunction	CHILD NEUROPSYCHOLOGY			English	Article						Childhood arterial ischemic stroke; Neuropsychology; Neurobehavior; Attention; Executive function; Emotional regulation	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; PEDIATRIC STROKE; CHILDREN; LESION; PLASTICITY; AGE; VULNERABILITY; REMEDIATION; LANGUAGE	Objectives. To investigate neuropsychological and neurobehavioral outcome in children with arterial ischemic stroke (AIS).Background. Childhood stroke can have consequences on motor, cognitive, and behavioral development. We present a cross-sectional study of neuropsychological and neurobehavioral outcome at least one year poststroke in a uniquely homogeneous sample of children who had experienced AIS.Method. Forty-nine children with AIS aged 6 to 18 years were recruited from a specialist clinic. Neuropsychological measures of intelligence, reading comprehension, attention, and executive function were administered. A triangulation of data collection included questionnaires completed by the children, their parents, and teachers, rating behavior, executive functions, and emotions.Key Findings. Focal neuropsychological vulnerabilities in attention (response inhibition and dual attention) and executive function were found, beyond general intellectual functioning, irrespective of hemispheric side of stroke. Difficulties with emotional and behavioral regulation were also found. Consistent with an early plasticity hypothesis, earlier age of stroke was associated with better performance on measures of executive function.Conclusions. A significant proportion of children poststroke are at long-term risk of difficulties with emotional regulation, executive function, and attention. Data also suggest that executive functions are represented in widespread networks in the developing brain and are vulnerable to unilateral injury.	[O'Keeffe, Fiadhnait; King, John] UCL, Res Dept Clin Educ & Hlth Psychol, London WC1E 6BT, England; [Liegeois, Frederique; Ganesan, Vijeya] UCL, Inst Child Hlth, London WC1E 6BT, England; [Eve, Megan; Murphy, Tara] Great Ormond St Hosp Children NHS Fdn Trust, Dept Clin Neuropsychol, London, England		O'Keeffe, F (corresponding author), UCL, Dept Clin Educ & Hlth Psychol, Gower St, London WC1E 6BT, England.	fiokeeffe@gmail.com	king, john/G-3570-2011	Liegeois, Frederique/0000-0002-8640-6217	University of London Central Research Fund; Graduate School University College London; Research Department of Clinical, Educational and Health Psychology University College London	Special appreciation to all the children, parents, and their teachers without whose generous participation this research would not have been possible. This research was partially funded by The University of London Central Research Fund, the Graduate School University College London, and The Research Department of Clinical, Educational and Health Psychology University College London to the first author (F. O'Keeffe). No conflict of interest exists.	Allman C, 2013, CHILD NEUROPSYCHOL, V19, P97, DOI 10.1080/09297049.2011.639756; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Ballantyne AO, 2008, BRAIN, V131, P2975, DOI 10.1093/brain/awn176; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Block GW, 1999, CHILD NEUROPSYCHOL, V5, P81, DOI 10.1076/chin.5.2.81.3169; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Cnossen MH, 2010, DEV MED CHILD NEUROL, V52, P394, DOI 10.1111/j.1469-8749.2009.03580.x; Delis DC., 2001, DELIS KAPLAN EXECUTI; Everts R, 2008, CHILD NEUROPSYCHOL, V14, P323, DOI 10.1080/09297040701792383; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Ganesan V, 2000, DEV MED CHILD NEUROL, V42, P455, DOI 10.1017/S0012162200000852; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Jordan LC, 2006, NEUROLOGIST, V12, P94, DOI 10.1097/01.nrl.0000195826.72179.0b; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Long B, 2011, DEV NEUROPSYCHOL, V36, P971, DOI 10.1080/87565641.2011.581537; Long B, 2011, J CHILD NEUROL, V26, P279, DOI 10.1177/0883073810380049; Manly T., 1998, TEST EVERYDAY ATTENT; Marcantuono JT, 2008, NEUROREHABILITATION, V23, P457; Max JE, 2004, J INT NEUROPSYCH SOC, V10, P976, DOI 10.1017/S1355617704107066; Max JE, 2004, J INT NEUROPSYCH SOC, V10, P698, DOI 10.1017/S1355617704105092; Max JE, 2003, J INT NEUROPSYCH SOC, V9, P815, DOI 10.1017/S1355617703960012; Max JE, 2002, J AM ACAD CHILD PSY, V41, P555, DOI 10.1097/00004583-200205000-00013; Max JE, 2010, J NEUROPSYCH CLIN N, V22, P30, DOI 10.1176/appi.neuropsych.22.1.30; Norwood S, 2007, VULNERABLE CHILD YOU, V2, P89, DOI 10.1080/17450120701403136; O'Keeffe F, 2012, BRAIN INJURY, V26, P1072, DOI 10.3109/02699052.2012.661117; Pavlovic J, 2006, NEUROPEDIATRICS, V37, P13, DOI 10.1055/s-2006-923932; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Royal College of Physicians London. Pediatric Stroke Working Group, 2004, STROK CHILDH CLIN GU; Schatz J, 1999, CHILD NEUROPSYCHOL, V5, P92, DOI 10.1076/chin.5.2.92.3170; Schatz J, 2004, NEUROPSYCHOLOGY, V18, P340, DOI 10.1037/0894-4105.18.2.340; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Steinlin M, 2004, EUR J PEDIATR, V163, P245, DOI 10.1007/s00431-003-1357-x; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Wechsler D, 2005, WECHSLER INDIVIDUAL, VII; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 2004, WECHSLER INTELLIGENC, Vfourth; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Westmacott R, 2010, DEV MED CHILD NEUROL, V52, P386, DOI 10.1111/j.1469-8749.2009.03403.x; White DA, 2000, J CLIN EXP NEUROPSYC, V22, P257, DOI 10.1076/1380-3395(200004)22:2;1-1;FT257; Williams TS, 2012, DEV MED CHILD NEUROL, V54, P30, DOI 10.1111/j.1469-8749.2011.04144.x; [No title captured]	49	35	35	1	24	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2014	20	5					557	582		10.1080/09297049.2013.832740			26	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AJ8QE	WOS:000337970600005	24028185	Green Published			2022-02-06	
J	Raj, SP; Wade, SL; Cassedy, A; Taylor, HG; Stancin, T; Brown, TM; Kirkwood, MW				Raj, Stacey P.; Wade, Shari L.; Cassedy, Amy; Taylor, H. Gerry; Stancin, Terry; Brown, Tanya M.; Kirkwood, Michael W.			Parent Psychological Functioning and Communication Predict Externalizing Behavior Problems After Pediatric Traumatic Brain Injury	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						externalizing behavior problems; parent-adolescent interaction; protective factors; traumatic brain injury	PSYCHIATRIC-DISORDERS; FAMILY-INTERACTION; HEAD-INJURY; CHILDREN; ADOLESCENTS; ADAPTATION; QUALITY; BURDEN; YOUTH	Objective Adolescents sustaining traumatic brain injury (TBI) show increased prevalence of behavior problems. This study investigated the associations of parent mental health, family functioning, and parent-adolescent interaction with adolescent externalizing behavior problems in the initial months after TBI, and examined whether injury severity moderated these associations. Methods 117 parent-adolescent dyads completed measures of family functioning, adolescent behavior, and parent mental health an average of 108 days post-TBI. Dyads also engaged in a 10-min video-recorded problem-solving activity coded for parent behavior and tone of interaction. Results Overall, higher ratings of effective parent communication were associated with fewer externalizing behavior problems, whereas poorer caregiver psychological functioning was associated with greater adolescent externalizing behaviors. Results failed to reveal moderating effects of TBI severity on the relationship between socio-environmental factors and behavior problems. Conclusions Interventions targeting parent communication and/or improving caregiver psychological health may ameliorate potential externalizing behavior problems after adolescent TBI.	[Raj, Stacey P.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil, Cincinnati, OH 45229 USA; [Raj, Stacey P.] Miami Univ, Dept Psychol, Oxford, OH 45056 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, Dept Pediat, Cleveland, OH 44106 USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Psychiat, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Brown, Tanya M.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado Denver, Sch Med, Denver, CO USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil, 3333 Burnet Ave,ML 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Stancin, Terry/L-7993-2019		NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH073764, R01-MH073764] Funding Source: Medline		Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Alderfer MA, 2008, J PEDIATR PSYCHOL, V33, P1046, DOI 10.1093/jpepsy/jsm083; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Celano M, 2008, FAM PROCESS, V47, P7, DOI 10.1111/j.1545-5300.2008.00236.x; Collins W. A., 2008, CHILD ADOLESCENT DEV, P551; Collins WA, 2004, J EARLY ADOLESCENCE, V24, P55, DOI 10.1177/0272431603260882; Deater-Deckard K, 1998, DEV PSYCHOPATHOL, V10, P469, DOI 10.1017/S0954579498001709; DeLambo KE, 2004, J PEDIATR PSYCHOL, V29, P343, DOI 10.1093/jpepsy/jsh038; Derogatis L. R., 1994, USE PSYCHOL TESTING, P217; Dunn MJ, 2011, J PEDIATR PSYCHOL, V36, P565, DOI 10.1093/jpepsy/jsq062; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Faul M, 2010, TRAUMATIC BRAIN INJU; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Pettit GS, 2008, J ABNORM CHILD PSYCH, V36, P711, DOI 10.1007/s10802-008-9242-8; PRINZ RJ, 1979, J APPL BEHAV ANAL, V12, P691, DOI 10.1901/jaba.1979.12-691; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Scaramella L., 1998, IOWA FAMILY INTERACT; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Wade S. L., 2012, COUNSELOR ASSISTED P; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williamson HC, 2011, J FAM PSYCHOL, V25, P993, DOI 10.1037/a0025903	35	35	35	1	28	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	JAN-FEB	2014	39	1					84	95		10.1093/jpepsy/jst075			12	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	300EG	WOS:000330446600009	24065551	Bronze, Green Published			2022-02-06	
J	Silverberg, JI; Joks, R; Durkin, HG				Silverberg, J. I.; Joks, R.; Durkin, H. G.			Allergic disease is associated with epilepsy in childhood: a US population-based study	ALLERGY			English	Article						asthma; eczema; food allergies; obesity; seizure disorders	BODY-MASS INDEX; SERUM IMMUNOGLOBULIN-E; PSYCHOLOGICAL DISTRESS; ATOPIC-DERMATITIS; NATIONAL-HEALTH; ASTHMA SEVERITY; UNITED-STATES; OBESITY; VALIDATION; ECZEMA	BackgroundPrevious studies using animal models suggest an association between allergic disease and epilepsy. We sought to determine whether allergic disease is associated with epilepsy in children. MethodsWe used the 2007-2008 National Survey of Children's Health, a US population-based study of 91642 children aged 0-17years to determine the association between the prevalence of epilepsy and allergic disease, including asthma, atopic dermatitis (AD)/eczema, hay fever, and food allergies. Multivariate logistic regression models were constructed that controlled for confounding variables. ResultsThe US lifetime prevalence of childhood epilepsy was 1.03% and was significantly associated with older age, male sex, lower household income, family structure and history of brain injury or concussion. Children with 1 allergic disease had more epilepsy in their lifetime than nonallergic children (logistic regression, adjusted odds ratio [95% confidence interval]=1.79 [1.37-2.33]). Lifetime prevalence (2.30 [1.50-3.52]) and one-year prevalence of asthma (2.00 [1.41-2.84]), AD/eczema (1.73 [1.17-2.56]), hay fever (1.93 [1.41-2.65]) and food allergies (2.69 [1.38-4.01]) were associated with increased odds of ever being diagnosed with epilepsy. Similar results were found for current history of epilepsy. Severe AD/eczema (23.89 [1.34-11.32]) and hay fever (2.46 [1.11-5.41]) were associated with even higher odds of epilepsy compared with mild/moderate disease. As the number of allergic diseases increased, so did the odds of lifetime history and current history of epilepsy. ConclusionsThe US prevalence of epilepsy is associated with allergic diseases in children. Further studies are needed to determine whether allergic inflammation contributes toward epileptogenesis.	[Silverberg, J. I.] Northwestern Univ, Dept Dermatol, Chicago, IL 60611 USA; [Silverberg, J. I.] Northwestern Univ, Dept Prevent Med, Chicago, IL 60611 USA; [Silverberg, J. I.] Northwestern Univ, Dept Med Social Sci, Chicago, IL 60611 USA; [Silverberg, J. I.] Beth Israel Deaconess Med Ctr, Dept Dermatol, New York, NY 10003 USA; [Silverberg, J. I.] St Lukes Roosevelt Hosp, New York, NY USA; [Joks, R.; Durkin, H. G.] Suny Downstate Med Ctr, Ctr Allergy & Asthma Res, Brooklyn, NY 11203 USA; [Joks, R.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Joks, R.] Suny Downstate Med Ctr, Dept Allergy, Brooklyn, NY 11203 USA; [Joks, R.] Suny Downstate Med Ctr, Dept Immunol, Brooklyn, NY 11203 USA; [Durkin, H. G.] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA		Silverberg, JI (corresponding author), Northwestern Univ, Dept Dermatol, Suite 1400,680 Lakeshore Dr, Chicago, IL 60611 USA.	JonathanISilverberg@Gmail.com	silverberg, jonathan/ABH-2765-2021	silverberg, jonathan/0000-0003-3686-7805			Akinbami LJ, 2009, OBESITY, V17, P1574, DOI 10.1038/oby.2009.1; Arif AA, 2010, J ASTHMA, V47, P792, DOI 10.3109/02770903.2010.491148; Babu CS, 2009, EPILEPSY RES, V86, P146, DOI 10.1016/j.eplepsyres.2009.05.015; Barr J, 1998, CLIN NEUROL NEUROSUR, V100, P196, DOI 10.1016/S0303-8467(98)00040-7; Brooks DR, 2012, EPILEPSY BEHAV, V23, P57, DOI 10.1016/j.yebeh.2011.11.002; Busi LE, 2012, PEDIATR PULM, V47, P1, DOI 10.1002/ppul.21500; Chen Y, 2006, CHEST, V130, P890, DOI 10.1378/chest.130.3.890; Chen Y, 2010, INT ARCH ALLERGY IMM, V153, P372, DOI 10.1159/000316348; Delclos GL, 2006, OCCUP ENVIRON MED, V63, P173, DOI 10.1136/oem.2005.021634; Elliott JO, 2008, EPILEPSY BEHAV, V12, P434, DOI 10.1016/j.yebeh.2007.12.001; Emerson RM, 2000, BRIT J DERMATOL, V142, P288, DOI 10.1046/j.1365-2133.2000.03300.x; Fasmer OB, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-128; Figueroa-Munoz JI, 2001, THORAX, V56, P133, DOI 10.1136/thorax.56.2.133; Fitzpatrick S, 2012, CLIN EXP ALLERGY, V42, P747, DOI 10.1111/j.1365-2222.2011.03863.x; Grammer LC, 2010, J ASTHMA, V47, P491, DOI 10.3109/02770901003801980; Hashizume H, 2006, CURR OPIN ALLERGY CL, V6, P335, DOI 10.1097/01.all.0000244793.03239.40; Housman TS, 2002, BRIT J DERMATOL, V147, P1192, DOI 10.1046/j.1365-2133.2002.05031.x; Kiguchi N, 2009, BIOCHEM BIOPH RES CO, V384, P311, DOI 10.1016/j.bbrc.2009.04.121; Kobau R, 2004, EPILEPSY BEHAV, V5, P358, DOI 10.1016/j.yebeh.2004.02.007; Lavoie KL, 2006, RESP MED, V100, P648, DOI 10.1016/j.rmed.2005.08.001; Lord GM, 2002, J LEUKOCYTE BIOL, V72, P330; Magin PJ, 2011, INT J DERMATOL, V50, P1486, DOI 10.1111/j.1365-4632.2011.04883.x; Mai XM, 2003, ACTA PAEDIATR, V92, P1144, DOI 10.1080/08035250310005666; Martin-Romero C, 2000, CELL IMMUNOL, V199, P15, DOI 10.1006/cimm.1999.1594; Mokran V, 1997, Bratisl Lek Listy, V98, P229; Mosen DM, 2008, J ALLERGY CLIN IMMUN, V122, P507, DOI 10.1016/j.jaci.2008.06.024; Murray CS, 2011, CLIN EXP ALLERGY, V41, P78, DOI 10.1111/j.1365-2222.2010.03598.x; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Scahill L, 1997, J Child Adolesc Psychiatr Nurs, V10, P36, DOI 10.1111/j.1744-6171.1997.tb00279.x; Schmitt J, 2009, JAMA-J AM MED ASSOC, V301, P724, DOI 10.1001/jama.2009.136; SENTHILSELVAN A, 1993, J ASTHMA, V30, P185, DOI 10.3109/02770909309054516; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Silverberg J, 2010, BRAIN BEHAV IMMUN, V24, P263, DOI 10.1016/j.bbi.2009.10.006; Silverberg JI, 2008, J ALLERGY CLIN IMMUN, V121, pS117, DOI 10.1016/j.jaci.2007.12.464; Silverberg JI, 2012, BRIT J DERMATOL, V166, P498, DOI 10.1111/j.1365-2133.2011.10694.x; Silverberg JI, 2011, J ALLERGY CLIN IMMUN, V127, P1180, DOI 10.1016/j.jaci.2011.01.063; Strine TW, 2005, EPILEPSIA, V46, P1133, DOI 10.1111/j.1528-1167.2005.01605.x; SUSITAIVAL P, 1995, SCAND J WORK ENV HEA, V21, P30, DOI 10.5271/sjweh.5; Tai A, 2009, J ASTHMA, V46, P362, DOI 10.1080/02770900902759260; Van Lieshout RJ, 2012, CHEM IMMUNOL ALLERGY, V98, P1, DOI 10.1159/000336493; Vieira VJ, 2005, AM J CLIN NUTR, V82, P504, DOI 10.1093/ajcn/82.3.504; Visness CM, 2009, J ALLERGY CLIN IMMUN, V123, P1163, DOI 10.1016/j.jaci.2008.12.1126; von Mutius E, 2001, THORAX, V56, P835, DOI 10.1136/thorax.56.11.835; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yaghmaie P, 2013, J ALLERGY CLIN IMMUN, V131, P428, DOI 10.1016/j.jaci.2012.10.041; Yang YW, 2010, ALLERGY, V65, P801, DOI 10.1111/j.1398-9995.2009.02249.x	46	35	38	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0105-4538	1398-9995		ALLERGY	Allergy	JAN	2014	69	1			SI		95	103		10.1111/all.12319			9	Allergy; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Allergy; Immunology	291BB	WOS:000329801500011	24251558				2022-02-06	
J	Thiagarajan, P; Ciuffreda, KJ				Thiagarajan, Preethi; Ciuffreda, Kenneth J.			Versional eye tracking in mild traumatic brain injury (mTBI): Effects of oculomotor training (OMT)	BRAIN INJURY			English	Article						Neuroplasticity; oculomotor coordination; oculomotor training; traumatic brain injury; versional eye movement disorders; vision therapy	VISUAL FUNCTION; FIXATION; MOVEMENTS; SACCADES; DEFICITS; SEQUENCES; ATTENTION; NETWORK; REHABILITATION; MILITARY	Objective: To evaluate a range of objective measures of versional eye movements before and after oculomotor training (OMT) in individuals with mTBI. The results were compared with placebo (P) training. Methods: Twelve individuals with mTBI (mean age 29 +/- 3 years) having oculomotor-based near-vision symptoms participated in the study. Versional eye movements were recorded objectively before and after OMT (fixation, predictable saccades, simulated reading) and P training (6 weeks each, two sessions/week, 45 minutes/session). Results: Following OMT, there was a significant (p < 0.05) reduction in the horizontal fixational error. Saccadic gain increased both horizontally and vertically (p < 0.05). The saccade ratio for the simulated reading, multiple-line paradigm reduced significantly (p < 0.05). None of the measures changed significantly following the P training. Conclusions: The versional-based OMT had a significant, positive effect on most aspects of versional tracking. These findings are suggestive of improved rhythmicity, accuracy and sequencing of saccades following OMT in mTBI as a result of oculomotor learning.	[Thiagarajan, Preethi; Ciuffreda, Kenneth J.] SUNY State Coll Optometry, Dept Biol & Vis Sci, New York, NY 10036 USA		Thiagarajan, P (corresponding author), SUNY State Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	pthiagarajan@sunyopt.edu					Abernethy B, 2005, BIOPHYSICAL FDN HUMA, VSecond; ANDERSON TJ, 1994, BRAIN, V117, P1073, DOI 10.1093/brain/117.5.1073; BAHILL AT, 1981, INVEST OPHTH VIS SCI, V21, P116; Bahill AT, 1975, MATH BIOSCI, V24, P19; BON L, 1992, EXP BRAIN RES, V89, P571, DOI 10.1007/BF00229882; Chiu YC, 2009, J NEUROSCI, V29, P3930, DOI 10.1523/JNEUROSCI.5737-08.2009; Ciuffreda K. J., 2005, BRAIN INJURY PROFESS, V2, P16; Ciuffreda K. J., 2007, OPTOMETRY, V78, P55; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Ciuffreda Kenneth J, 2002, Optometry, V73, P735; Ciuffreda KJ, 2004, OCULOMOTOR FIXATION; Ciuffreda MA, 2003, J BEHAV OPTOM, V14, P60; Fayos B, 1998, J BEHAV OTPOM, V9, P1; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; GAYMARD B, 1990, ANN NEUROL, V28, P622, DOI 10.1002/ana.410280504; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Han Y, 2004, BRAIN RES PROTOC, V14, P1, DOI 10.1016/j.brainresprot.2004.06.002; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; Heide W, 2001, EUR J NEUROSCI, V13, P1177, DOI 10.1046/j.0953-816x.2001.01472.x; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1254, DOI 10.1152/jn.1983.49.5.1254; Hikosaka O, 1989, J NEUROPHYSIOL, V49, P1254; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Khan A. A., 2005, DIGITAL SIGNAL PROCE; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kraus MF, 2010, COGN BEHAV NEUROL, V23, P210, DOI 10.1097/WNN.0b013e3181cefe2e; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Pierrot-Deseilligny C, 2002, ANN NY ACAD SCI, V956, P16; RON S, 1978, SCAND J REHABIL MED, V10, P39; Ron S, 1981, PROGR OCULOMOTOR RES, P237; SELHORST JB, 1976, BRAIN, V99, P497, DOI 10.1093/brain/99.3.497; Solan HA, 2003, J LEARN DISABIL-US, V36, P556, DOI 10.1177/00222194030360060601; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Tannen B., 1995, EYE MOVEMENT BASICS; Taylor E. A., 1966, FUNDAMENTAL READING; Thiagarajan P, J REHABILIT IN PRESS; Thiagarajan P, 2012, THESIS SUNY COLL OPT; Thiagarajan P, 2013, J REHABIL RES DEV, V50, P1223, DOI 10.1682/JRRD.2012.12.0235; van Donkelaar P, 2006, EXERC SPORT SCI REV, V34, P77, DOI 10.1249/00003677-200604000-00007; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Xu J. J., 2009, J BEHAV OPTOMETRY, V20, P67	49	35	35	0	30	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	7					930	943		10.3109/02699052.2014.888761			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9XL	WOS:000336498600007	24826956				2022-02-06	
J	Williams, D; Sullivan, SJ; Schneiders, AG; Ahmed, OH; Lee, H; Balasundaram, AP; McCrory, PR				Williams, David; Sullivan, S. John; Schneiders, Anthony G.; Ahmed, Osman Hassan; Lee, Hopin; Balasundaram, Arun Prasad; McCrory, Paul R.			Big hits on the small screen: an evaluation of concussion-related videos on YouTube	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Concussion; Head injuries; Injury Prevention	SOCIAL NETWORKING; RUGBY PLAYERS; INFORMATION; QUALITY; COVERAGE	Background YouTube is one of the largest social networking websites, allowing users to upload and view video content that provides entertainment and conveys many messages, including those related to health conditions, such as concussion. However, little is known about the content of videos relating to concussion. Objective To identify and classify the content of concussion-related videos available on YouTube. Study design An observational study using content analysis. Methods YouTube's video database was systematically searched using 10 search terms selected from MeSH and Google Adwords. The 100 videos with the largest view counts were chosen from the identified videos. These videos and their accompanying text were analysed for purpose, source and description of content by a panel of assessors who classified them into data-driven thematic categories. Results 434 videos met the inclusion criteria and the 100 videos with the largest view counts were chosen. The most common categories of the videos were the depiction of a sporting injury (37%) and news reports (25%). News and media organisations were the predominant source (51%) of concussion-related videos on YouTube, with very few being uploaded by professional or academic organisations. The median number of views per video was 26191. Conclusions Although a wide range of concussion-related videos were identified, there is a need for healthcare and educational organisations to explore YouTube as a medium for the dissemination of quality-controlled information on sports concussion.	[Williams, David; Sullivan, S. John; Schneiders, Anthony G.; Ahmed, Osman Hassan; Lee, Hopin; Balasundaram, Arun Prasad] Univ Otago, Ctr Physiotherapy Res, Sch Physiotherapy, Dunedin 9054, New Zealand; [McCrory, Paul R.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic, Australia; [McCrory, Paul R.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [McCrory, Paul R.] Monash Univ, Australian Ctr Res Sports Injury Prevent, Melbourne, Vic 3004, Australia		Sullivan, SJ (corresponding author), Univ Otago, Ctr Physiotherapy Res, Sch Physiotherapy, POB 56, Dunedin 9054, New Zealand.	sjohn.sullivan@otago.ac.nz	McCrory, Paul/Q-8688-2019; Balasundaram, Arun Prasad/D-1270-2017; Schneiders, Anthony/F-4212-2015	Balasundaram, Arun Prasad/0000-0001-8256-857X; Lee, Hopin/0000-0001-5692-0314; Schneiders, Anthony/0000-0002-1583-3879; Williams, David/0000-0001-8980-6446; McCrory, Paul/0000-0003-4850-0568	University of Otago Medical Research Foundation summer student scholarship	University of Otago Medical Research Foundation summer student scholarship.	Ache KA, 2008, AM J PREV MED, V35, P389, DOI 10.1016/j.amepre.2008.06.029; Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Alexa: the web information company, TOP SIT TOP 500 SIT; [Anonymous], 2019, INT US STAT INT BIG; Bernstam EV, 2008, CANCER-AM CANCER SOC, V112, P1206, DOI 10.1002/cncr.23308; Briones R, 2012, HEALTH COMMUN, V27, P478, DOI 10.1080/10410236.2011.610258; Cheng X., 2008, 16 INT WORKSH QUAL S; Evans MF, 2012, BRIT J SPORT MED, V46, P461, DOI 10.1136/bjsports-2012-091113; Eysenbach G, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1030; Google, GOOGL ADW; Grossman L, 2012, TIME, V179, P38; Hughes S, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1716; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Oh H, 2005, J MED INTERNET RES, V7; OReilly T., 2007, COMMUNICATIONS STRAT, VQuarter, P17, DOI DOI 10.1109/KIMAS.2003.1245106; Perotti V, 2011, 44 HAW INT C SYST SC; Pew Internet & American Life Project, UND PART NEWS CONS; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Randeree E, 2009, TELEMED J E-HEALTH, V15, P255, DOI 10.1089/tmj.2008.0093; Richardson CG, 2011, SUBST USE MISUSE, V46, P893, DOI 10.3109/10826084.2011.570628; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; van der Marel S, 2009, INFLAMM BOWEL DIS, V15, P1891, DOI 10.1002/ibd.20976; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yoo JH, 2012, HEALTH COMMUN, V27, P86, DOI 10.1080/10410236.2011.569003; YouTube, WHAT SHOULD I PUT MY; YouTube, WHATS DIFF KEYW TAGS; YouTube, DO I OPT MY VID WATC	35	35	36	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2014	48	2					107	111		10.1136/bjsports-2012-091853			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	276KK	WOS:000328749000011	23446643	Bronze			2022-02-06	
J	Metraux, S; Clegg, LX; Daigh, JD; Culhane, DP; Kane, V				Metraux, Stephen; Clegg, Limin X.; Daigh, John D.; Culhane, Dennis P.; Kane, Vincent			Risk Factors for Becoming Homeless Among a Cohort of Veterans Who Served in the Era of the Iraq and Afghanistan Conflicts	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							MENTAL-HEALTH PROBLEMS; PAST HOMELESSNESS; AFFAIRS; ASSOCIATION; DISORDERS; SERVICES; FEMALE; LIFE; CARE	Objectives. In this population-based cohort study, we assessed baseline risk factors for homelessness, including the role of service in the Iraq or Afghanistan conflicts, among a large cohort of recent veterans. Methods. Data for this study came from administrative records for 310 685 veterans who separated from active military duty from July 1, 2005, to September 30, 2006. We used survival analysis methods to determine incidence rates and risk factors for homelessness, based on baseline data for military factors, demographic characteristics, and diagnoses of behavioral health disorders and traumatic brain injury. Results. Service in Iraq or Afghanistan and, more specifically, posttraumatic stress disorder among veterans deployed there, were significant risk factors of modest magnitude for homelessness, and socioeconomic and behavioral health factors provided stronger indicators of risk. Gender was not a significant indicator of differential risk. Conclusions. Although service in Iraq and Afghanistan was significant, socioeconomic and behavioral health indicators show more promise in efforts to use administrative data to inform prevention efforts by identifying veterans who are at elevated risk for becoming homeless upon their return to civilian life.	[Metraux, Stephen; Culhane, Dennis P.; Kane, Vincent] US Dept Vet Affairs, Natl Ctr Homelessness Vet, Philadelphia, PA 19104 USA; [Metraux, Stephen] Univ Sci, Dept Hlth Policy & Publ Hlth, Philadelphia, PA USA; [Culhane, Dennis P.] Univ Penn, Sch Social Welf Policy & Practice, Philadelphia, PA 19104 USA; [Clegg, Limin X.; Daigh, John D.] US Dept Vet Affairs, Off Inspector Gen, Washington, DC USA		Metraux, S (corresponding author), US Dept Vet Affairs, Ctr Homelessness Vet, 4200 Chester Ave,Suite 201, Philadelphia, PA 19104 USA.	stephen.metraux@va.gov		Metraux, Stephen/0000-0003-4741-1010	US Department of Veterans Affairs, National Center on Homelessness Among Veterans	This project was funded by the US Department of Veterans Affairs, National Center on Homelessness Among Veterans.	Blackstock OJ, 2012, MED CARE, V50, P347, DOI 10.1097/MLR.0b013e318245a738; COX DR, 1972, J R STAT SOC B, V34, P187; Draine J, 2002, PSYCHIAT SERV, V53, P565, DOI 10.1176/appi.ps.53.5.565; Eckholm E., 2007, NY TIMES, pA22; Edens EL, 2011, AM J ADDICTION, V20, P412, DOI 10.1111/j.1521-0391.2011.00166.x; Fairweather A., 2006, RISK PROTECTIVE FACT; Fargo J, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110112; Fothergill KE, 2012, J URBAN HEALTH, V89, P432, DOI 10.1007/s11524-011-9641-y; Greenberg GA, 2010, J HEALTH CARE POOR U, V21, P1234, DOI 10.1353/hpu.2010.0926; Greenberg GA, 2010, ADM POLICY MENT HLTH, V37, P357, DOI 10.1007/s10488-009-0243-x; Greer A, 2011, BIENN M SOC COMM RES; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge CW, 2002, AM J PSYCHIAT, V159, P1576, DOI 10.1176/appi.ajp.159.9.1576; Johnson TP, 2007, AM J PREV MED, V32, pS211, DOI 10.1016/j.amepre.2007.02.015; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; LEDA C, 1992, HOSP COMMUNITY PSYCH, V43, P1026; Montgomery AE., 2012, ANN M NAT ALL END HO; *NAT CTR HLTH STAT, 1980, DHHS PUBL PHS; Office of Public Health Veterans Health Administration, 2012, AN VA HLTH CAR UT OP; ROSENHECK R, 1994, AM J PSYCHIAT, V151, P421; Rosenheck RA, 1996, HOMELESSNESS AM REFE, P97; Rosenheck RA, 1998, PRACT LESS 1998 NAT, P2; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tsai J, 2012, COMMUNITY MENT HLT J, V48, P705, DOI 10.1007/s10597-012-9482-5; US Department of Veterans Affairs Office of Inspector General, 2010, REV COMB STRESS WOM; US Department of Veterans Affairs Office of Inspector General, 2007, QUANT ASS CAR TRANS; US Department of Veterans Affairs Office of the Inspector General, 2012, INC HOM VET RISK FAC; US Interagency Council on Homelessness, 2012, REP C HOM VET; Washington DL, 2010, J HEALTH CARE POOR U, V21, P81, DOI 10.1353/hpu.0.0237; Williamson V, 2009, COMING HOME HOUSING; Zoroya G., 2012, US TODAY	36	35	35	1	22	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	DEC	2013	103			2			S255	S261		10.2105/AJPH.2013.301432			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	AA4NP	WOS:000331073100023	24148066	Green Published			2022-02-06	
J	Zhao, ZR; Faden, AI; Loane, DJ; Lipinski, MM; Sabirzhanov, B; Stoica, BA				Zhao, Zaorui; Faden, Alan I.; Loane, David J.; Lipinski, Marta M.; Sabirzhanov, Boris; Stoica, Bogdan A.			Neuroprotective effects of geranylgeranylacetone in experimental traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						controlled cortical impact; functional recovery; GGA; HSP70; neuroprotection; traumatic brain injury	HEAT-SHOCK-PROTEIN; CONTROLLED CORTICAL IMPACT; FOCAL CEREBRAL-ISCHEMIA; ACID-INDUCED SEIZURES; RAT HEAT-SHOCK-PROTEIN-70; TRANSIENT ISCHEMIA; GASTRIC-MUCOSA; CELL-DEATH; HSP70; MICE	Geranylgeranylacetone (GGA) is an inducer of heat-shock protein 70 (HSP70) that has been used clinically for many years as an antiulcer treatment. It is centrally active after oral administration and is neuroprotective in experimental brain ischemia/stroke models. We examined the effects of single oral GGA before treatment (800 mg/kg, 48 hours before trauma) or after treatment (800 mg/kg, 3 hours after trauma) on long-term functional recovery and histologic outcomes after moderate-level controlled cortical impact, an experimental traumatic brain injury (TBI) model in mice. The GGA pretreatment increased the number of HSP70(+) cells and attenuated posttraumatic alpha-fodrin cleavage, a marker of apoptotic cell death. It also improved sensorimotor performance on a beam walk task; enhanced recovery of cognitive/affective function in the Morris water maze, novel object recognition, and tail-suspension tests; and improved outcomes using a composite neuroscore. Furthermore, GGA pretreatment reduced the lesion size and neuronal loss in the hippocampus, cortex, and thalamus, and decreased microglial activation in the cortex when compared with vehicle-treated TBI controls. Notably, GGA was also effective in a posttreatment paradigm, showing significant improvements in sensorimotor function, and reducing cortical neuronal loss. Given these neuroprotective actions and considering its longstanding clinical use, GGA should be considered for the clinical treatment of TBI.	Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA		Zhao, ZR (corresponding author), Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Hlth Sci Facil HSFI 1, 685 W Baltimore St,Room 263, Baltimore, MD 21201 USA.	zzhao@anes.umm.edu	STOICA, BOGDAN/H-9782-2013; Loane, David/ABD-5177-2021	STOICA, BOGDAN/0000-0002-2501-6434; Loane, David/0000-0003-0393-3503; Lipinski, Marta/0000-0002-7537-9014; Faden, Alan I./0000-0003-0128-2348	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 (NS052568), R01 (NS061839)]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052568, R01NS061839] Funding Source: NIH RePORTER	This work was supported by NIH grants R01 (NS052568) and R01 (NS061839) to AIF.	Abe E, 2010, BRAIN RES, V1330, P151, DOI 10.1016/j.brainres.2010.02.074; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Faden AI, 2003, J CEREBR BLOOD F MET, V23, P355, DOI 10.1097/01.WCB.0000046144.31247.33; Faul M, 2010, TRAUMATIC BRAIN INJU, P13, DOI DOI 10.3171/2009.10.JNS091500; Fujiki M, 2004, BRAIN RES, V1021, P281, DOI 10.1016/j.brainres.2004.06.054; Fujiki M, 2004, BRAIN RES, V1020, P210, DOI 10.1016/j.brainres.2004.06.031; Fujiki M, 2003, BRAIN RES, V991, P254, DOI 10.1016/S0006-8993(03)03540-6; Fujiki M, 2006, J NEUROTRAUM, V23, P1164, DOI 10.1089/neu.2006.23.1164; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; IIZUKA H, 1990, STROKE, V21, P790, DOI 10.1161/01.STR.21.5.790; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kawai T, 2000, J LAB CLIN MED, V136, P138, DOI 10.1067/mlc.2000.108157; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee SH, 2001, STROKE, V32, P2905, DOI 10.1161/hs1201.099604; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luo FC, 2012, FREE RADICAL BIO MED, V52, P1218, DOI 10.1016/j.freeradbiomed.2012.01.004; Mailer JJ, 2012, HUM BRAIN MAPP, DOI 101002/hbm.22171; Matsumori Y, 2006, STROKE, V37, P507, DOI 10.1161/01.STR.0000199057.00365.20; Matsumori Y, 2005, J CEREBR BLOOD F MET, V25, P899, DOI 10.1038/sj.jcbfm.9600080; Nakamoto T, 2012, AURIS NASUS LARYNX, V39, P270, DOI 10.1016/j.anl.2011.06.001; Otaka M, 2007, BIOCHEM BIOPH RES CO, V353, P399, DOI 10.1016/j.bbrc.2006.12.031; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sakamoto C, 2007, DIGESTION, V75, P215, DOI 10.1159/000110654; Sinn DI, 2007, BRAIN RES, V1135, P167, DOI 10.1016/j.brainres.2006.11.098; SUMIGAMA K, 1983, PROG MED, V3, P1053; Sun YJ, 2006, J CEREBR BLOOD F MET, V26, P937, DOI 10.1038/sj.jcbfm.9600246; Tsuchiya D, 2003, NEUROSURGERY, V53, P1179, DOI 10.1227/01.NEU.0000090341.38659.CF; Tsuchiya D, 2003, J CEREBR BLOOD F MET, V23, P718, DOI 10.1097/01.WCB.0000054756.97390.F7; Wang ZY, 2011, KIDNEY INT, V79, P861, DOI 10.1038/ki.2010.527; Yasuda H, 2005, BRAIN RES, V1032, P176, DOI 10.1016/j.brainres.2004.11.009; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Yenari MA, 1998, ANN NEUROL, V44, P584, DOI 10.1002/ana.410440403; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	39	35	37	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2013	33	12					1897	1908		10.1038/jcbfm.2013.144			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	266DI	WOS:000328002200010	23942364	Green Published, Bronze			2022-02-06	
J	Brennan, FH; Cowin, GJ; Kurniawan, ND; Ruitenberg, MJ				Brennan, Faith H.; Cowin, Gary J.; Kurniawan, Nyoman D.; Ruitenberg, Marc J.			Longitudinal assessment of white matter pathology in the injured mouse spinal cord through ultra-high field (16.4 T) in vivo diffusion tensor imaging	NEUROIMAGE			English	Article						Magnetic resonance imaging; Neurotrauma; Spinal cord injury; Tractography; Demyelination; Wallerian degeneration	WALLERIAN DEGENERATION; WATER DIFFUSION; CLINICAL-TRIALS; AXONAL INJURY; EX-VIVO; MODEL; RECOVERY; DAMAGE; DYSMYELINATION; MRI	This study examined the sensitivity of ultra-high field (16.4 T) diffusion tensor imaging (DTI; 70 mu m in-plane resolution, 1 mm slice thickness) to evaluate the spatiotemporal development of severe mid-thoracic contusive spinal cord injury (SCI) in mice. In vivo imaging was performed prior to SCI, then again at 2 h, 1 day, 3 days, 7 days, and 30 days post-SCI using a Bruker 16.4 T small animal nuclear magnetic resonance spectrometer. Cross-sectional spinal cord areas were measured in axial slices and various DTI parameters, i.e. fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (lambda(parallel to)) and radial diffusivity (lambda(perpendicular to)), were calculated for the total spared white matter (WM), ventral funiculi (VF), lateral funiculi (LF) and dorsal columns (DCs) and then correlated with histopathology. Cross-sectional area measurements revealed significant atrophy (32% reduction) of the injured spinal cord at the lesion epicentre in the chronic phase of injury. Analysis of diffusion tensor parameters further showed that tissue integrity was most severely affected in the DCs, i.e. the site of immediate impact, which demonstrated a rapid and permanent decrease in FA and lambda(parallel to). In contrast, DTI parameters for the ventrolateral white matter changed more gradually with time, suggesting that these regions are undergoing more delayed degeneration in a manner that may be amenable to therapeutic intervention. Of all the DTI parameters, lambda(perpendicular to) was most closely correlated to myelin content whereas changes in FA and lambda(parallel to) appeared more indicative of axonal integrity, Wallerian degeneration and associated presence of macrophages. We conclude that longitudinal DTI at 16.4 T provides a clinically relevant, objective measure for assessing white matter pathology following contusive SCI in mice that may aid the translation of putative neuroprotective strategies into the clinic. (C) 2013 Elsevier Inc. All rights reserved.	[Brennan, Faith H.; Ruitenberg, Marc J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Cowin, Gary J.; Kurniawan, Nyoman D.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [Ruitenberg, Marc J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia		Kurniawan, ND (corresponding author), Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia.	nyoman.kurniawan@cai.uq.edu.au; m.ruitenberg@uq.edu.au	Cowin, Gary J/E-6147-2011; Cowin, Gary/U-8721-2019; Kurniawan, Nyoman/D-9764-2011	Cowin, Gary J/0000-0002-3400-3109; Cowin, Gary/0000-0002-3400-3109; Kurniawan, Nyoman/0000-0001-6340-182X; Brennan, Faith/0000-0002-9201-2476; Ruitenberg, Marc/0000-0002-6917-0708	SpinalCure Australia (Career Development Fellowship); University of QueenslandUniversity of Queensland; Australian Postgraduate Award (The University of Queensland); Queensland Government	This study was funded by SpinalCure Australia (Career Development Fellowship to M.J.R.) and The University of Queensland. F.H.B. was supported by an Australian Postgraduate Award (The University of Queensland). The authors also thank the Queensland Government for funding and operational support of the 16.4 T NMR spectrometer through the QLD NMR Network Initiative.	BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; Blomster LV, 2013, NMR BIOMED, V26, P141, DOI 10.1002/nbm.2829; Boekhoff TM, 2012, J SPINAL DISORD TECH, V25, pE81, DOI 10.1097/BSD.0b013e31823f2f55; Bosma R. L., 2012, Critical Reviews in Biomedical Engineering, V40, P1, DOI 10.1615/CritRevBiomedEng.v40.i1.10; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; BUNGE RP, 1993, ADV NEUROL, V59, P75; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Chang Y, 2010, J NEUROTRAUM, V27, P2033, DOI 10.1089/neu.2009.1265; Cheran S, 2011, J NEUROTRAUM, V28, P1881, DOI 10.1089/neu.2010.1741; Cohen-Adad J, 2008, NEUROIMAGE, V40, P685, DOI 10.1016/j.neuroimage.2007.11.031; Cohen-Adad J, 2011, NEUROIMAGE, V57, P1068, DOI 10.1016/j.neuroimage.2011.04.068; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Ellingson BM, 2010, MAGN RESON IMAGING, V28, P1353, DOI 10.1016/j.mri.2010.06.006; Ellingson BM, 2010, J NEUROSURG-SPINE, V13, P181, DOI 10.3171/2010.3.SPINE09523; Ellingson BM, 2008, J MAGN RESON IMAGING, V28, P1068, DOI 10.1002/jmri.21578; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7; Gonzalez-Lara LE, 2009, J NEUROTRAUM, V26, P753, DOI 10.1089/neu.2008.0704; Harrison M, 2013, NEUROIMAGE, V68, P22, DOI 10.1016/j.neuroimage.2012.11.048; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Harsan LA, 2007, J NEUROSCI RES, V85, P935, DOI 10.1002/jnr.21201; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Hesseltine SM, 2006, AM J NEURORADIOL, V27, P1189; Hofling AA, 2009, NMR BIOMED, V22, P1100, DOI 10.1002/nbm.1420; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Huisman TAGM, 2001, RADIOLOGE, V41, P1038, DOI 10.1007/s001170170003; Kamble Ravindra B, 2011, Indian J Radiol Imaging, V21, P221, DOI 10.4103/0971-3026.85372; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Kim JH, 2012, EXP NEUROL, V235, P188, DOI 10.1016/j.expneurol.2011.11.015; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Krzyzak AT, 2005, ACTA NEUROBIOL EXP, V65, P255; Kwon BK, 2010, SPINE, V35, pS263, DOI 10.1097/BRS.0b013e3181f3286d; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Loy DN, 2007, J NEUROTRAUM, V24, P979, DOI 10.1089/neu.2006.0253; Maas L. C., 2005, APPL RADIOL, V34, P44; Martirosyan NL, 2010, NEUROSURGERY, V66, P131, DOI 10.1227/01.NEU.0000361997.08116.96; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Mulcahey MJ, 2012, SPINE, V37, pE797, DOI 10.1097/BRS.0b013e3182470a08; Ni Mhuircheartaigh N, 2006, SEMIN MUSCULOSKEL R, V10, P293, DOI 10.1055/s-2007-972000; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; OBEIRNE J, 1993, INJURY, V24, P149, DOI 10.1016/0020-1383(93)90278-E; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Qin W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041441; Rajasekaran S, 2010, J MAGN RESON IMAGING, V32, P978, DOI 10.1002/jmri.22320; Sandner B, 2009, J MAGN RESON IMAGING, V29, P725, DOI 10.1002/jmri.21477; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Scholtes F, 2011, SPINAL CORD, V49, P345, DOI 10.1038/sc.2010.129; Schwartz ED, 2003, EXP NEUROL, V184, P570, DOI 10.1016/S0014-4886(03)00295-4; Shanmuganathan K, 2008, AM J NEURORADIOL, V29, P655, DOI 10.3174/ajnr.A0916; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stroman PW, 2012, CLIN NEUROL NEUROSUR, V114, P460, DOI 10.1016/j.clineuro.2012.01.003; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Takahashi T, 1996, SPINE, V21, P166, DOI 10.1097/00007632-199601150-00002; Tatar Ilkan, 2009, BMC Med Imaging, V9, P10, DOI 10.1186/1471-2342-9-10; Tu TW, 2010, J NEUROTRAUM, V27, P253, DOI 10.1089/neu.2009.1026; Underwood CK, 2011, NEUROIMAGE, V55, P455, DOI 10.1016/j.neuroimage.2010.12.044; Yin B, 2010, J CLIN NEUROSCI, V17, P1173, DOI 10.1016/j.jocn.2010.02.020; Zhang JY, 2012, TRENDS NEUROSCI, V35, P412, DOI 10.1016/j.tins.2012.04.010; Zhang JY, 2009, J NEUROSCI, V29, P3160, DOI 10.1523/JNEUROSCI.3941-08.2009	71	35	36	1	38	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	NOV 15	2013	82						574	585		10.1016/j.neuroimage.2013.06.019			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	220FQ	WOS:000324568400054	23770410	Green Submitted			2022-02-06	
J	Galetto, V; Andreetta, S; Zettin, M; Marini, A				Galetto, Valentina; Andreetta, Sara; Zettin, Marina; Marini, Andrea			Patterns of impairment of narrative language in mild traumatic brain injury	JOURNAL OF NEUROLINGUISTICS			English	Article						Mild traumatic brain injury; Narrative analysis; Neurolinguistics; Neuropsychology	CLOSED-HEAD-INJURY; DISCOURSE PRODUCTION; COMMUNICATION DISORDERS; MEASURING GOODNESS; STORY NARRATIVES; APHASIC ADULTS; ABILITIES; AGREEMENT; COHERENCE; SPEECH	Mild traumatic brain injury (mTBI) represents a condition whose cognitive and behavioral sequelae are often underestimated, even when it exerts a profound impact on the patients' every-day life. The present study aimed to analyze the features of narrative discourse impairment in a group of adults with mTBI. 10 mTBI non-aphasic speakers (GCS>13) and 13 neurologically intact participants were recruited for the experiment. Their cognitive, linguistic and narrative skills were thoroughly assessed. The group of mTBIs exhibited normal phonological, lexical and grammatical skills. However, their narratives were characterized by the presence of frequent interruptions of ongoing utterances, derailments and extraneous utterances that at times made their discourse vague and ambiguous. They produced more errors of global coherence [F (1; 21)=24.242; p=.000; eta(2)(p)=0. 536] and fewer Lexical Information Units [F (1; 21)=7.068; p=.015; eta(2)(p)=.252]. The errors of global coherence correlated negatively with non-perseverative errors on the WCST (r=.755; p <.012). The macrolinguistic problems made their narrative samples less informative than those produced by the group of control participants. These disturbances may reflect a deficit at the interface between cognitive and linguistic processing rather than a specific linguistic disturbance. These findings suggest that also persons with mild forms of TBI may experience linguistic disturbances that may hamper the quality of their every-day life. (C) 2013 Elsevier Ltd. All rights reserved.	[Galetto, Valentina] Ctr Puzzle, Turin, Italy; [Galetto, Valentina; Zettin, Marina] Univ Turin, Dipartimento Psicol, I-10124 Turin, Italy; [Andreetta, Sara; Marini, Andrea] Univ Udine, Dipartimento Sci Umane, I-33100 Udine, Italy; [Marini, Andrea] IRCCS E Medea Nostra Famiglia, San Vito Al Tagliamento, Pn, Italy		Marini, A (corresponding author), Univ Udine, Via Margreth 3, I-33100 Udine, Italy.	andrea.marini@uniud.it	Andreetta, Sara/AAL-5932-2021; Marini, Andrea/A-1206-2012	Andreetta, Sara/0000-0002-8067-2629; Marini, Andrea/0000-0002-6058-3864	IRCCS "E. Medea"	Funding for this study was provided by IRCCS "E. Medea". The IRCCS "E. Medea" had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Adamovich B. L. B., 1997, APHASIA RELATED NEUR, P93; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Blyth T, 2012, BRAIN INJURY, V26, P234, DOI 10.3109/02699052.2012.654587; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Body R., 1999, COMMUNICATION TRAUMA; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Cannizzaro MS, 2002, BRAIN INJURY, V16, P1065, DOI 10.1080/02699050210155230; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; CHRISTIANSEN JA, 1995, BRAIN LANG, V51, P291, DOI 10.1006/brln.1995.1062; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; Coelho C. A., 1994, STUDIES ADULT CLIN P, P96; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho C, 2012, NEUROPSYCHOLOGIA, V50, P3564, DOI 10.1016/j.neuropsychologia.2012.09.005; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Davis GA, 2000, APHASIOLOGY DISORDER; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; GRAHAM DI, 1999, REHABILITATION ADULT, P19; Groher ME, 1997, DYSPHAGIA DIAGNOSIS, V3rd; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; HUBER W, 1982, BRAIN LANG, V16, P1, DOI 10.1016/0093-934X(82)90069-4; Kertesz A., 1982, W APHASIA BATTERY; Kraus J. F., 1996, NEUROLOGY TRAUMA; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le K, 2011, APHASIOLOGY, V25, P748, DOI 10.1080/02687038.2010.539696; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Luzzatti C., 1991, AACHENER APHASIE TES; Marini A, 2005, BRAIN LANG, V93, P46, DOI 10.1016/j.bandl.2004.08.002; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Marini A, 2011, APHASIOLOGY, V25, P1372, DOI 10.1080/02687038.2011.584690; Marini A, 2012, J COGNITIVE NEUROSCI, V24, P2211, DOI 10.1162/jocn_a_00283; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McDonald S, 2000, APHASIOLOGY, V14, P339, DOI 10.1080/026870300401397; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Monsell Stephen, 1996, UNSOLVED MYSTERIES M, P93; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Parrish C., 2011, PERSPECTIVES NEUROPH, P47; Raven, 1938, PROGR MATRICES PERCE; REITAN RM, 1992, CLIN NEUROPSYCHOL, V6, P287; Reitan RM, 1992, TRAIL MAKING TEST; Rey A., 1964, EXAMEN CLIN PSYCHOL; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; SAFFRAN EM, 1989, BRAIN LANG, V37, P440, DOI 10.1016/0093-934X(89)90030-8; SHEWAN CM, 1988, J COMMUN DISORD, V21, P103, DOI 10.1016/0021-9924(88)90001-9; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow PC, 2000, BRAIN INJURY, V14, P397; Spalletta G, 2010, PSYCHIAT RES-NEUROIM, V182, P77, DOI 10.1016/j.pscychresns.2009.11.001; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Thompson PM, 1996, NEUROIMAGE, V3, P19, DOI 10.1006/nimg.1996.0003; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Whelan BM, 2006, BRAIN LANG, V99, P183, DOI 10.1016/j.bandl.2006.06.100; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	66	35	35	0	37	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0911-6044			J NEUROLINGUIST	J. Neurolinguist.	NOV	2013	26	6					649	661		10.1016/j.jneuroling.2013.05.004			13	Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Linguistics; Neurosciences & Neurology; Psychology	213RS	WOS:000324078000005					2022-02-06	
J	Ganesh, S; Guernon, A; Chalcraft, L; Harton, B; Smith, B; Pape, TLB				Ganesh, Shanti; Guernon, Ann; Chalcraft, Laura; Harton, Brett; Smith, Bridget; Pape, Theresa Louise-Bender			Medical Comorbidities in Disorders of Consciousness Patients and Their Association With Functional Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Comorbidity; Consciousness disorders; Rehabilitation	TRAUMATIC BRAIN-INJURY; RECOVERY; STATE; HYDROCEPHALUS; COMPLICATIONS; DYSAUTONOMIA; OVERACTIVITY; PREDICTION; EMERGENCE; PROGNOSIS	Objective: To identify, for patients in states of seriously impaired consciousness, comorbid conditions present during inpatient rehabilitation and their association with function at 1 year. Design: Abstracted data from a prospective cross-sectional observational study with data collection occurring January 1996 through December 2007. Setting: Four inpatient rehabilitation facilities in metropolitan areas. Participants: The study sample of 68 participants is abstracted from a database of 157 patients remaining in states of seriously impaired consciousness for at least 28 days. Interventions: Not applicable. Main Outcome Measure: One-year cognitive, motor, and total FIM score. Results: The most common medical complications during inpatient rehabilitation for the study sample are active seizures (46%), spasticity (57%), urinary tract infections (47%), and hydrocephalus with and without shunt (38%). Presence of >= 3 medical complications during inpatient rehabilitation, controlling for injury severity, is significantly (P<.05) associated with poorer total FIM and FIM motor scores 1 year after injury. The presence of hydrocephalus with and without shunt (r=-.20, -.21, -.18; P <=.15), active seizures (r=-.31, -.22, -.42), spasticity (r=-.38, -.28, -.40), and urinary tract infections (r=-.25, -.24, -.26) were significantly (P<.10) associated with total FIM, FIM cognitive, and FIM motor scores, respectively. Conclusions: Reported findings indicate that persons in states of seriously impaired consciousness with higher numbers of medical complications during inpatient rehabilitation are more likely to have lower functional levels 1-year postinjury. The findings indicate that persons with >= 3 medical complications during inpatient rehabilitation are at a higher risk for poorer functional outcomes at 1 year. It is, therefore, prudent to evaluate these patients for indications of these complications during inpatient rehabilitation. (c) 2013 by the American Congress of Rehabilitation Medicine	[Ganesh, Shanti; Harton, Brett; Smith, Bridget; Pape, Theresa Louise-Bender] US Dept Vet Affairs, Dept Vet Affairs, Res Serv, Edward Hines Jr Vet Affairs Hosp, Hines, IL 60141 USA; [Ganesh, Shanti; Harton, Brett; Smith, Bridget; Pape, Theresa Louise-Bender] US Dept Vet Affairs, Ctr Management Complex Chron Care, Ctr Excellence, Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; [Ganesh, Shanti; Chalcraft, Laura] US Dept Vet Affairs, Phys Med & Rehabil Serv, Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; [Guernon, Ann] Marianjoy Rehabil Hosp, Wheaton, IL USA; [Smith, Bridget] Loyola Univ Chicago, Program Hlth Serv Res, Stritch Sch Med, Maywood, IL USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA		Pape, TLB (corresponding author), Hines VA Hosp, Ctr Management Complex Chron Care, 5000 S 5th Ave 151H,Bldg 1B260, Hines, IL 60141 USA.	Theresa.Pape@va.gov		Bender Pape, Theresa/0000-0001-7738-5963	United States Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development Merit [CCN 07-133]	Supported by the United States Department of Veterans Affairs, Office of Research and Development, Health Services Research and Development Merit (grant no. CCN 07-133).	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Baguley IJ, 2008, MED HYPOTHESES, V70, P26, DOI 10.1016/j.mehy.2007.04.037; Bernat JL, 2010, NEUROLOGY, V75, pS33, DOI 10.1212/WNL.0b013e3181fb35dd; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Bernat JL, 2002, NEUROLOGY, V58, P337, DOI 10.1212/WNL.58.3.337; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; Hong KS, 2008, EUR J NEUROL, V15, P1324, DOI 10.1111/j.1468-1331.2008.02310.x; Intiso D, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/802893; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kozlowski DA, 2013, COMPR PHYSIOL, V3, P121, DOI 10.1002/cphy.c110005; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; *MULT SOC TASK FOR, 1994, NEW ENGL J MED, V21, P330; Nakase-Richardson R, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127795; Nakase-Richardson R, 2009, NEUROLOGY, V73, P1120, DOI 10.1212/WNL.0b013e3181bacf34; Pape TLB, 2006, BRAIN INJURY, V20, P743, DOI 10.1080/02699050600676933; Pickard JD, 2005, NEUROPSYCHOL REHABIL, V15, P224, DOI 10.1080/09602010443000614; Pohl M, 2007, BRAIN INJURY, V21, P421, DOI 10.1080/02699050701311109; Stott DJ, 2009, QJM-INT J MED, V102, P243, DOI 10.1093/qjmed/hcp012; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091	33	35	39	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2013	94	10					1899	1907		10.1016/j.apmr.2012.12.026			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	231TU	WOS:000325442100008	23735521				2022-02-06	
J	Rock, EM; Kopstick, RL; Limebeer, CL; Parker, LA				Rock, E. M.; Kopstick, R. L.; Limebeer, C. L.; Parker, L. A.			Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus	BRITISH JOURNAL OF PHARMACOLOGY			English	Article						THCA; THC; conditioned gaping; vomiting; SR141716; CB1 receptor	CISPLATIN-INDUCED EMESIS; LITHIUM-PAIRED CONTEXT; ARACHIDONOYL-L-SERINE; CHEMOTHERAPY-INDUCED NAUSEA; CANNABINOID CB1 RECEPTORS; TRAUMATIC BRAIN-INJURY; HOUSE MUSK SHREW; ANTICIPATORY NAUSEA; REJECTION REACTIONS; TASTE AVOIDANCE	Background and PurposeWe evaluated the anti-emetic and anti-nausea properties of the acid precursor of (9)-tetrahydrocannabinol (THC), tetrahydrocannabinolic acid (THCA), and determined its mechanism of action in these animal models. Experimental ApproachWe investigated the effect of THCA on lithium chloride- (LiCl) induced conditioned gaping (nausea-induced behaviour) to a flavour, and context (a model of anticipatory nausea) in rats, and on LiCl-induced vomiting in Suncus murinus. Furthermore, we investigated THCA's ability to induce hypothermia and suppress locomotion [rodent tasks to assess cannabinoid(1) (CB1) receptor agonist-like activity], and measured plasma and brain THCA and THC levels. We also determined whether THCA's effect could be blocked by pretreatment with SR141716 (SR, a CB1 receptor antagonist). Key ResultsIn rats, THCA (0.05 and/or 0.5mgkg(-1)) suppressed LiCl-induced conditioned gaping to a flavour and context; the latter effect blocked by the CB1 receptor antagonist, SR, but not by the 5-hydroxytryptamine-1A receptor antagonist, WAY100635. In S.murinus, THCA (0.05 and 0.5mgkg(-1)) reduced LiCl-induced vomiting, an effect that was reversed with SR. A comparatively low dose of THC (0.05mgkg(-1)) did not suppress conditioned gaping to a LiCl-paired flavour or context. THCA did not induce hypothermia or reduce locomotion, indicating non-CB1 agonist-like effects. THCA, but not THC was detected in plasma samples. Conclusions and ImplicationsTHCA potently reduced conditioned gaping in rats and vomiting in S.murinus, effects that were blocked by SR. These data suggest that THCA may be a more potent alternative to THC in the treatment of nausea and vomiting.	[Rock, E. M.; Kopstick, R. L.; Limebeer, C. L.; Parker, L. A.] Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada		Parker, LA (corresponding author), Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada.	parkerl@uoguelph.ca			GW Pharmaceuticals; Natural Sciences and Engineering Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC) [NSERC-92057]	This research was supported by grants from GW Pharmaceuticals to L. A. P. and from the Natural Sciences and Engineering Council of Canada (NSERC-92057) to L. A. P. The authors would like to thank Quotient Bioresearch (Fordham, Cambridgeshire, UK) for the analysis of plasma samples. The authors would also like to thank Linda Groocock for management of the shrew colony at the University of Guelph, and Martin Sticht for assistance with these studies.	Ahmed SA, 2008, J NAT PROD, V71, P536, DOI 10.1021/np070454a; Bolognini D, 2013, BRIT J PHARMACOL, V168, P1456, DOI 10.1111/bph.12043; CAREY MP, 1983, ANN INTERN MED, V99, P106, DOI 10.7326/0003-4819-99-1-106; Cluny NL, 2008, BASIC CLIN PHARMACOL, V103, P150, DOI 10.1111/j.1742-7843.2008.00253.x; Cohen-Yeshurun A, 2013, J CEREBR BLOOD F MET, V33, P1242, DOI 10.1038/jcbfm.2013.75; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Cotter J, 2009, ONCOL NURS FORUM, V36, P345, DOI 10.1188/09.ONF.345-352; CRAWFORD SM, 1986, MED ONCOL TUMOR PHAR, V3, P39; CUNNINGHAM D, 1988, EUR J CANCER CLIN ON, V24, P685, DOI 10.1016/0277-5379(88)90300-8; Darmani NA, 2004, EUR J PHARMACOL, V488, P201, DOI 10.1016/j.ejphar.2004.02.018; Darmani NA, 1998, J NEURAL TRANSM, V105, P1143, DOI 10.1007/s007020050118; Darmani NA, 2001, PHARMACOL BIOCHEM BE, V69, P239, DOI 10.1016/S0091-3057(01)00531-7; Darmani NA, 2001, NEUROPSYCHOPHARMACOL, V24, P198, DOI 10.1016/S0893-133X(00)00197-4; Darmani NA, 2007, EUR J PHARMACOL, V563, P187, DOI 10.1016/j.ejphar.2007.01.093; FRYTAK S, 1979, ANN INTERN MED, V91, P825, DOI 10.7326/0003-4819-91-6-825; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; GRUNFELD Y, 1969, PSYCHOPHARMACOLOGIA, V14, P200, DOI 10.1007/BF00404218; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kwiatkowska M, 2004, PSYCHOPHARMACOLOGY, V174, P254, DOI 10.1007/s00213-003-1739-9; Limebeer CL, 2010, BRIT J PHARMACOL, V161, P336, DOI 10.1111/j.1476-5381.2010.00885.x; Limebeer CL, 2006, PHYSIOL BEHAV, V88, P398, DOI 10.1016/j.physbeh.2006.04.014; Limebeer CL, 1999, NEUROREPORT, V10, P3769, DOI 10.1097/00001756-199912160-00009; Limebeer CL, 2000, J EXP PSYCHOL-ANIM B, V26, P371, DOI 10.1037//0097-7403.26.4.371; MARTIN BR, 1991, PHARMACOL BIOCHEM BE, V40, P471, DOI 10.1016/0091-3057(91)90349-7; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Milman G, 2006, P NATL ACAD SCI USA, V103, P2428, DOI 10.1073/pnas.0510676103; ORR L E, 1980, Archives of Internal Medicine, V140, P1431, DOI 10.1001/archinte.140.11.1431; ORR LE, 1981, J CLIN PHARMACOL, V21, pS76, DOI 10.1002/j.1552-4604.1981.tb02578.x; Parker LA, 2009, PHYSIOL BEHAV, V97, P121, DOI 10.1016/j.physbeh.2009.02.014; Parker LA, 2006, PHYSIOL BEHAV, V87, P66, DOI 10.1016/j.physbeh.2005.08.045; Parker LA, 2004, PSYCHOPHARMACOLOGY, V171, P156, DOI 10.1007/s00213-003-1571-2; Parker LA, 2003, INTEGR PHYS BEH SCI, V38, P133, DOI 10.1007/BF02688831; Parker LA, 2003, LEARN BEHAV, V31, P165; Parker LA, 2003, PSYCHOPHARMACOLOGY, V166, P156, DOI 10.1007/s00213-002-1329-2; Parker LA, 2002, NEUROREPORT, V13, P567, DOI 10.1097/00001756-200204160-00006; Parker LA, 2001, NEUROREPORT, V12, P749, DOI 10.1097/00001756-200103260-00027; Parker LA, 2008, CAN J EXP PSYCHOL, V62, P198, DOI 10.1037/a0012531; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rock EM, 2013, BRIT J PHARMACOL, V169, P685, DOI 10.1111/bph.12162; Rock EM, 2012, BRIT J PHARMACOL, V165, P2620, DOI 10.1111/j.1476-5381.2011.01621.x; Rock EM, 2008, PSYCHOPHARMACOLOGY, V196, P389, DOI 10.1007/s00213-007-0970-1; Tramer MR, 2001, BMJ-BRIT MED J, V323, P16, DOI 10.1136/bmj.323.7303.16; UNGERLEIDER JT, 1984, RADIOLOGY, V150, P598, DOI 10.1148/radiology.150.2.6318262; Van Sickle MD, 2001, GASTROENTEROLOGY, V121, P767, DOI 10.1053/gast.2001.28466; Verhoeckx KCM, 2006, INT IMMUNOPHARMACOL, V6, P1, DOI 10.1016/j.intimp.2005.05.013; Wiley JL, 2003, EUR J PHARMACOL, V471, P185, DOI 10.1016/S0014-2999(03)01856-9	46	35	35	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	OCT	2013	170	3					641	648		10.1111/bph.12316			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	222SN	WOS:000324751600016	23889598	Green Published			2022-02-06	
J	Hasbani, DM; Topjian, AA; Friess, SH; Kilbaugh, TJ; Berg, RA; Christian, CW; Dlugos, DJ; Huh, J; Abend, NS				Hasbani, Daphne M.; Topjian, Alexis A.; Friess, Stuart H.; Kilbaugh, Todd J.; Berg, Robert A.; Christian, Cindy W.; Dlugos, Dennis J.; Huh, Jimmy; Abend, Nicholas S.			Nonconvulsive Electrographic Seizures are Common in Children With Abusive Head Trauma	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						abusive head trauma; electroencephalographic monitoring; electroencephalography; seizure; traumatic brain injury	CONTINUOUS VIDEO-EEG; INTENSIVE-CARE-UNIT; BRAIN-INJURY; STATUS EPILEPTICUS; YOUNG-CHILDREN; COMATOSE CHILDREN; PREDICTORS	Objective: To determine the prevalence of nonconvulsive seizures in children with abusive head trauma. Design: Retrospective study of children with abusive head trauma undergoing clinically indicated continuous electroencephalographic monitoring. Setting: PICU of a tertiary care hospital. Subjects: Children less than or equal to 2 years old with evidence of abusive head trauma determined by neuroimaging, physical examination, and determination of abuse by the Child Protection Team. Interventions: None. Measurements and Main Results: Thirty-two children with abusive head trauma were identified with a median age of 4 months (interquartile range 3, 5.5 months). Twenty-one of 32 children (66%) underwent electroencephalographic monitoring. Those monitored were more likely to have a lower admission Glasgow Coma Scale (8 vs 15, p = 0.05) and be intubated (16 vs 2, p = 0.002). Electrographic seizures occurred in 12 of 21 children (57%) and constituted electrographic status epilepticus in 8 of 12 children (67%). Electrographic seizures were entirely nonconvulsive in 8 of 12 children (67%). Electroencephalographic background category (discontinuous and slow-disorganized) (p = 0.02) and neuroimaging evidence of ischemia were associated with the presence of electrographic seizures (p = 0.05). Subjects who had electrographic seizures were no more likely to have clinical seizures at admission (67% electrographic seizures vs 33% none, p = 0.6), parenchymal imaging abnormalities (61% electrographic seizures vs 39% none, p = 0.40), or extra-axial imaging abnormalities (56% electrographic seizures vs 44% none, p = 0.72). Four of 21 (19%) children died prior to discharge; none had electrographic seizures, but all had attenuated-featureless electroencephalographic backgrounds. Follow-up outcome data were available for 16 of 17 survivors at a median duration of 9.5 months following PICU admission, and the presence of electrographic seizures or electrographic status epilepticus was not associated with the Glasgow Outcome Scale score (p = 0.10). Conclusions: Electrographic seizures and electrographic status epilepticus are common in children with abusive head trauma. Most seizures have no clinical correlate. Further study is needed to determine whether seizure identification and management improves outcome.	[Hasbani, Daphne M.; Dlugos, Dennis J.; Abend, Nicholas S.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat & Neurol, Perelman Sch Med,Div Neurol, Philadelphia, PA 19104 USA; [Topjian, Alexis A.; Kilbaugh, Todd J.; Berg, Robert A.; Huh, Jimmy] Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Perelman Sch Med,Div Crit Care Med, Philadelphia, PA 19104 USA; [Friess, Stuart H.] Washington Univ, St Louis Childrens Hosp, Sch Med, Div Crit Care Med,Dept Pediat, St Louis, MO 63110 USA; [Christian, Cindy W.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Perelman Sch Med,Div Pediat, Philadelphia, PA 19104 USA		Abend, NS (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Dept Pediat & Neurol, Perelman Sch Med,Div Neurol, Philadelphia, PA 19104 USA.	abend@email.chop.edu		Kilbaugh, Todd/0000-0002-4959-3092	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01HL094345, K23NS075363, K08NS064051, R01HD061963, K23NS076550]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061963] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL094345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS064051, K23NS076550, K23NS075363] Funding Source: NIH RePORTER	Supported, in part, by grants U01HL094345 and K23NS075363 (Dr. Topjian), K08NS064051 (to Dr. Friess), R01HD061963 (to Dr. Huh), and K23NS076550 (to Dr. Abend) from the NIH.; Dr. Topjian received grant support from the National Institutes of Health (NIH). Dr. Friess received grant support from NIH. Dr. Christian provided expert opinions and testimony in child abuse cases. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2007, PEDIATR NEUROL, V37, P165, DOI 10.1016/j.pediatrneurol.2007.05.012; Abend NS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0330-3; Abend NS, 2011, J CLIN NEUROPHYSIOL, V28, P15, DOI 10.1097/WNP.0b013e3182051123; Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Alehan FK, 2001, J CHILD NEUROL, V16, P484, DOI 10.2310/7010.2001.17060; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Bourgeois M, 2008, CHILD NERV SYST, V24, P169, DOI 10.1007/s00381-007-0493-4; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; Goldstein JL, 2011, NEUROCRIT CARE, V15, P63, DOI 10.1007/s12028-010-9468-5; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Hosain SA, 2005, PEDIATR NEUROL, V32, P162, DOI 10.1016/j.pediatrneurol.2004.09.008; Hyllienmark L, 2007, EUR J PAEDIATR NEURO, V11, P70, DOI 10.1016/j.ejpn.2006.11.005; JENNETT B, 1975, LANCET, V1, P480; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kemp AM, 2011, ARCH DIS CHILD, V96, P1103, DOI 10.1136/archdischild-2011-300630; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kirkham FJ, 2012, INTENS CARE MED, V38, P853, DOI 10.1007/s00134-012-2529-9; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; Piteau SJ, 2012, PEDIATRICS, V130, P315, DOI 10.1542/peds.2011-1545; Saengpattrachai M, 2006, EPILEPSIA, V47, P1510, DOI 10.1111/j.1528-1167.2006.00624.x; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x	36	35	36	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	SEP	2013	14	7					709	715		10.1097/PCC.0b013e3182917b83			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	235GN	WOS:000325705100014	23842589	Green Accepted			2022-02-06	
J	Robson, MJ; Turner, RC; Naser, ZJ; McCurdy, CR; Huber, JD; Matsumoto, RR				Robson, Matthew J.; Turner, Ryan C.; Naser, Zachary J.; McCurdy, Christopher R.; Huber, Jason D.; Matsumoto, Rae R.			SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation	EXPERIMENTAL NEUROLOGY			English	Article						Methamphetamine; Sigma receptor; Microglial activation; Cytokine; Neurotoxicity	TRAUMATIC BRAIN-INJURY; INDUCED NEUROTOXICITY; PARKINSONS-DISEASE; DOPAMINE TRANSPORTERS; MOLECULAR-BASES; IN-VIVO; MICE; EXPRESSION; MINOCYCLINE; STRIATUM	Methamphetamine (METH) abuse is associated with several negative side effects including neurotoxicity in specific brain regions such as the striatum. The precise molecular mechanisms by which METH usage results in neurotoxicity remain to be fully elucidated, with recent evidence implicating the importance of microglial activation and neuroinflammation in damaged brain regions. METH interacts with sigma receptors which are found in glial cells in addition to neurons. Moreover, sigma receptor antagonists have been shown to block METH-induced neurotoxicity in rodents although the cellular mechanisms underlying their neuroprotection remain unknown. The purpose of the current study was to determine if the prototypic sigma receptor antagonist, SN79, mitigates METH-induced microglial activation and associated increases in cytokine expression in a rodent model of METH-induced neurotoxicity. METH increased striatal mRNA and protein levels of cluster of differentiation 68 (CD68), indicative of microglial activation. METH also increased ionized calcium binding adapter molecule 1 (IBA-1) protein expression, further confirming the activation of microglia. Along with microglial activation, METH increased striatal mRNA expression levels of IL-6 family pro-inflammatory cytokines, leukemia inhibitory factor (lif), oncostatin m (osm), and interleukin-6 (il-6). Pretreatment with SN79 reduced METH-induced increases in CD68 and IBA-1 expression, demonstrating its ability to prevent microglial activation. SN79 also attenuated METH-induced mRNA increases in IL-6 pro-inflammatory cytokine family members. The ability of a sigma receptor antagonist to block METH-induced microglial activation and cytokine production provides a novel mechanism through which the neurotoxic effects of METH may be mitigated. (C) 2013 Elsevier Inc. All rights reserved.	[Robson, Matthew J.; Huber, Jason D.; Matsumoto, Rae R.] W Virginia Univ, Hlth Sci Ctr, Sch Pharm, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Turner, Ryan C.; Naser, Zachary J.] W Virginia Univ, Hlth Sci Ctr, Sch Med, Dept Neurosurg, Morgantown, WV 26506 USA; [Turner, Ryan C.; Huber, Jason D.; Matsumoto, Rae R.] W Virginia Univ, Hlth Sci Ctr, Sch Med, Ctr Neurosci, Morgantown, WV 26506 USA; [McCurdy, Christopher R.] Univ Mississippi, Sch Pharm, Dept Med Chem, University, MS 38677 USA; [McCurdy, Christopher R.] Univ Mississippi, Sch Pharm, Dept Pharmacol, University, MS 38677 USA		Matsumoto, RR (corresponding author), W Virginia Univ, Sch Pharm, POB 9500, Morgantown, WV 26506 USA.	rmatsumoto@hsc.wvu.edu	Robson, Matthew/H-3127-2013	Robson, Matthew/0000-0002-3277-3062; Turner, Ryan/0000-0001-5523-0645	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA013978, D023205, NS061954, T32 GM081741]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM081741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS061954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA023205, R01DA013978] Funding Source: NIH RePORTER	This research was supported by grants from the National Institutes of Health (DA013978, D023205, and NS061954). Ryan C. Turner was also supported by a grant from the National Institutes of Health (T32 GM081741).	Ajmo CT, 2006, CURR NEUROVASC RES, V3, P89, DOI 10.2174/156720206776875849; Bourrie B, 1996, IMMUNOLOGY, V88, P389, DOI 10.1046/j.1365-2567.1996.d01-657.x; BOWYER JF, 1994, J PHARMACOL EXP THER, V268, P1571; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Callaghan RC, 2012, DRUG ALCOHOL DEPEN, V120, P35, DOI 10.1016/j.drugalcdep.2011.06.013; Callaghan RC, 2010, MOVEMENT DISORD, V25, P2333, DOI 10.1002/mds.23263; Cooper ZD, 2012, EXPERT OPIN INV DRUG, V21, P169, DOI 10.1517/13543784.2012.651123; Cruickshank CC, 2009, ADDICTION, V104, P1085, DOI 10.1111/j.1360-0443.2009.02564.x; Cuevas J, 2011, J PHARMACOL EXP THER, V339, P161, DOI 10.1124/jpet.111.182816; Czeh M, 2011, DEV NEUROSCI-BASEL, V33, P199, DOI 10.1159/000328989; DEROCQ JM, 1995, J PHARMACOL EXP THER, V272, P224; Escubedo E, 2005, J PHARMACOL EXP THER, V315, P658, DOI 10.1124/jpet.105.089748; Escubedo E, 1998, BRAIN RES, V814, P120, DOI 10.1016/S0006-8993(98)01065-8; Goncalves J, 2008, ANN NY ACAD SCI, V1139, P103, DOI 10.1196/annals.1432.043; Hall AA, 2009, GLIA, V57, P744, DOI 10.1002/glia.20802; Hashimoto K, 2007, BIOL PSYCHIAT, V61, P577, DOI 10.1016/j.biopsych.2006.03.019; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hebert MA, 2000, ANN NY ACAD SCI, V914, P238, DOI 10.1111/j.1749-6632.2000.tb05200.x; Kaushal N., 2011, 2011 M PLANN SOC NEU; Kaushal N., 2012, EUR NEUROPSYCHOPHARM, DOI DOI 10.1016/JEUR0NEUR0.2012.08.005; Kaushal N, 2012, MOL PHARMACOL, V81, P299, DOI 10.1124/mol.111.074120; Kaushal N, 2011, NEUROPHARMACOLOGY, V61, P992, DOI 10.1016/j.neuropharm.2011.06.028; Kaushal N, 2011, AAPS J, V13, P336, DOI 10.1208/s12248-011-9274-9; Kelly KA, 2012, J NEUROCHEM, V122, P995, DOI 10.1111/j.1471-4159.2012.07864.x; Kita T, 2000, NEUROPHARMACOLOGY, V39, P399, DOI 10.1016/S0028-3908(99)00175-6; Komohara Y, 2011, J CLIN EXP HEMATOP, V51, P93, DOI 10.3960/jslrt.51.93; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Kuhn DM, 2006, ANN NY ACAD SCI, V1074, P31, DOI 10.1196/annals.1369.003; Ladenheim B, 2000, MOL PHARMACOL, V58, P1247, DOI 10.1124/mol.58.6.1247; LaVoie MJ, 2004, EXP NEUROL, V187, P47, DOI 10.1016/j.expneurol.2004.01.010; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Matsumoto RR, 2008, EUR NEUROPSYCHOPHARM, V18, P871, DOI 10.1016/j.euroneuro.2008.07.006; Mizoguchi H, 2008, PSYCHOPHARMACOLOGY, V196, P233, DOI 10.1007/s00213-007-0955-0; Mori T, 2012, J PHARMACOL EXP THER, V341, P663, DOI 10.1124/jpet.111.190868; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagai A, 2005, J NEUROSCI RES, V81, P342, DOI 10.1002/jnr.20478; Nguyen EC, 2005, NEUROPHARMACOLOGY, V49, P638, DOI 10.1016/j.neuropharm.2005.04.016; Niino D, 2010, PATHOL INT, V60, P278, DOI 10.1111/j.1440-1827.2010.02514.x; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Robson MJ, 2012, CURR PHARM DESIGN, V18, P902; Rodvelt Kelli R, 2010, Curr Drug Abuse Rev, V3, P156; Romanelli F, 2006, PHARMACOTHERAPY, V26, P1148, DOI 10.1592/phco.26.8.1148; Ruscher K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045118; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Seminerio MJ, 2011, PHARMACOL BIOCHEM BE, V98, P12, DOI 10.1016/j.pbb.2010.11.023; Seminerio MJ, 2012, INT J NEUROPSYCHOPH, V29, P1; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Smith KJ, 2010, NEUROSCI LETT, V481, P144, DOI 10.1016/j.neulet.2010.06.069; Tanibuchi Y., 2010, GEN HOSP PSYCHIAT, V32, pe551; Thomas DM, 2005, J NEUROCHEM, V92, P790, DOI 10.1111/j.1471-4159.2004.02906.x; Thomas DM, 2004, J PHARMACOL EXP THER, V311, P1, DOI 10.1124/jpet.104.070961; Thomas DM, 2004, NEUROSCI LETT, V367, P349, DOI 10.1016/j.neulet.2004.06.065; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Wang GJ, 2012, MOL PSYCHIATR, V17, P918, DOI 10.1038/mp.2011.86; Yao HH, 2010, BLOOD, V115, P4951, DOI 10.1182/blood-2010-01-266221; Yue X, 2012, J HUAZHONG U SCI-MED, V32, P415, DOI 10.1007/s11596-012-0072-0; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015; Zhang ZR, 2012, BRAIN RES, V1461, P102, DOI 10.1016/j.brainres.2012.04.038	62	35	37	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	SEP	2013	247						134	142		10.1016/j.expneurol.2013.04.009			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	204VO	WOS:000323399600018	23631864	Green Accepted			2022-02-06	
J	Soberg, HL; Roe, C; Anke, A; Arango-Lasprilla, JC; Skandsen, T; Sveen, U; von Steinbuchel, N; Andelic, N				Soberg, Helene L.; Roe, Cecilie; Anke, Audny; Carlos Arango-Lasprilla, Juan; Skandsen, Toril; Sveen, Unni; von Steinbuechel, Nicole; Andelic, Nada			HEALTH-RELATED QUALITY OF LIFE 12 MONTHS AFTER SEVERE TRAUMATIC BRAIN INJURY: A PROSPECTIVE NATIONWIDE COHORT STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; quality of life; depression; rehabilitation; outcome assessment	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; MULTIPLE INJURIES; SCALE; PREVALENCE; DISORDERS; MODERATE; QOLIBRI; CLASSIFICATION; SATISFACTION	Objective: To assess health-related quality of life in individuals with severe traumatic brain injury at 12 months post-injury, applying the Quality of Life after Brain Injury (QOLIBRI) instrument, and to study the relationship between injury-related factors, post-injury functioning and health-related quality of life. Design/subjects: The study is part of a prospective, Norwegian multicentre study of adults (>= 16 years old) with severe traumatic brain injury, as defined by a Glasgow Coma Scale score of 3-8 during the first 24 h post-injury. A total of 126 patients were included. Methods: Socio-demographic data and injury severity variables were collected. Functioning at 3 and 12 months was assessed with the Glasgow Outcome Scale Extended (GOSE), the Functional Independence Measure (FIM), the Rivermead Post-concussion Questionnaire (RPQ), and the Hospital Anxiety and Depression Scale (HADS). Hierarchical regression analysis was applied. Results: Mean QOLIBRI score was 68.5 (standard deviation =18.8). Predictors of the QOLIBRI in the final regression model were: employment status (p=0.05), GOSE (p=0.05), RPQ (p<0.001) and RADS (p<0.001). The adjusted R-2 showed that the model explained 64.0% of the variance in the QOLIBRI score. Conclusion: Symptom pressure and global functioning in the sub-acute phase of traumatic brain injury and psychological distress in the post-acute phase are important for health-related quality of life at 12 months post-injury. These domains should be the focus in rehabilitation aiming to improve health-related quality of life in patients with severe traumatic brain injury.	[Soberg, Helene L.; Roe, Cecilie; Sveen, Unni; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway; [Anke, Audny] Univ Tromso, Inst Clin Med, Fac Hlth Sci, Tromso, Norway; [Carlos Arango-Lasprilla, Juan] Univ Deusto Bilbao, Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Neurosci, Trondheim, Norway; [Skandsen, Toril] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Sveen, Unni] Oslo & Akershus Univ, Coll Appl Sci, Oslo, Norway; [von Steinbuechel, Nicole] Univ Gottingen, Dept Med Psychol & Med Sociol, Gottingen, Germany		Soberg, HL (corresponding author), Ullevaal Univ Hosp, Dept Phys Med & Rehabil, NO-0407 Oslo, Norway.	h.l.soberg@medisin.uio.no	Skandsen, Toril/P-6767-2014	Skandsen, Toril/0000-0001-5495-9338; Andelic, Nada/0000-0002-3719-4406; Anke, Audny/0000-0002-2491-2560	Norwegian Research CouncilResearch Council of NorwayEuropean Commission	We thank the Trauma Registry at Oslo University Hospital and Haukeland University Hospital for providing data regarding injury severity. We also thank Tone Jerstad, neuroradiologist for her effort in analysing the majority of CT scans and providing the Rotterdam scores. This multicentre study was funded by the Norwegian Research Council.	Ahmadi SA, 2010, BRAIN INJURY, V24, P1539, DOI 10.3109/02699052.2010.523049; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; [Anonymous], 2008, ABBR INJ SCAL AIS 20; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; Ayuso-Mateos JL, 2001, BRIT J PSYCHIAT, V179, P308, DOI 10.1192/bjp.179.4.308; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Sasse N, 2012, J HEAD TRAUMA REHABI; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Seeley HM, 2009, BRIT J NEUROSURG, V23, P530, DOI 10.1080/02688690903078874; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; TEASDALE G, 1974, LANCET, V2, P81; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Uniform Data System for Medical Rehabilitation, 1996, GUID UN DAT SET MED; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zigmond AS, 1983, PSYCHIAT SCAND, V76, P361, DOI DOI 10.1111/J.1600-0447.1983.TB09716.X	41	35	35	1	11	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					785	791		10.2340/16501977-1158			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500014	24002315	Green Published, gold			2022-02-06	
J	Donaldson, L; Asbridge, M; Cusimano, MD				Donaldson, Laura; Asbridge, Mark; Cusimano, Michael D.			Bodychecking Rules and Concussion in Elite Hockey	PLOS ONE			English	Article							ICE HOCKEY; INJURY SURVEILLANCE; BRAIN-INJURY; PLAYERS; NHL; NEWSPAPERS; VIOLENCE; SPORTS; LEAGUE	Athletes participating in contact sports such as ice hockey are exposed to a high risk of suffering a concussion. We determined whether recent rule changes regulating contact to the head introduced in 2010-11 and 2011-12 have been effective in reducing the incidence of concussion in the National Hockey League (NHL). A league with a longstanding ban on hits contacting the head, the Ontario Hockey League (OHL), was also studied. A retrospective study of NHL and OHL games for the 2009-10 to 2011-12 seasons was performed using official game records and team injury reports in addition to other media sources. Concussion incidence over the 3 seasons analyzed was 5.23 per 100 NHL regular season games and 5.05 per 100 OHL regular season games (IRR 1.04; 95% CI 1.01, 1.50). When injuries described as concussion-like or suspicious of concussion were included, incidences rose to 8.8 and 7.1 per 100 games respectively (IRR 1.23; 95% CI 0.81, 1.32). The number of NHL concussions or suspected concussions was lower in 2009-10 than in 2010-11 (IRR 0.61; 95% CI 0.45, 0.83), but did not increase from 2010-11 to 2011-12 (IRR 1.05; 95% CI 0.80, 1.38). 64.2% of NHL concussions were caused by bodychecking, and only 28.4% of concussions and 36.8% of suspected concussions were caused by illegal incidents. We conclude that rules regulating bodychecking to the head did not reduce the number of players suffering concussions during NHL regular season play and that further changes or stricter enforcement of existing rules may be required to minimize the risk of players suffering these injuries.	[Donaldson, Laura; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada; [Donaldson, Laura; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Toronto, ON, Canada; [Donaldson, Laura; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Canadian Brain Injury & Violence Res Team, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Clin Res Ctr, Halifax, NS, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Emergency Med, Clin Res Ctr, Halifax, NS, Canada		Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; University of Toronto Faculty of Medicine CREMS	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research # TIR-103946, the Ontario Neurotrauma Foundation, as well as University of Toronto Faculty of Medicine CREMS funding to LD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, HOCKEY NEWS; Barss P, 2009, J SCI MED SPORT, V12, P164, DOI 10.1016/j.jsams.2007.08.016; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Cusimano Michael D, 2011, Open Med, V5, pe57; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Drakos MC, 2010, SPORTS HEALTH, V2, P284, DOI 10.1177/1941738109357303; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; JONES JCH, 1993, AM J ECON SOCIOL, V52, P63, DOI 10.1111/j.1536-7150.1993.tb02742.x; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; NHL concussions put player insurance in question, 2012, CBC SPORTS; Orchard J., 2001, INT SPORT MED J, V2, P1; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Paul RJ, 2003, AM J ECON SOCIOL, V62, P345, DOI 10.1111/1536-7150.t01-2-00003; Powell JW, 1998, SAFETY ICE HOCKEY, P19; RAINEY DY, 1992, AM J PUBLIC HEALTH, V82, P745, DOI 10.2105/AJPH.82.5.745; Smith AM, 2011, PM&R, V3, P605, DOI 10.1016/j.pmrj.2011.05.013; [Social Scienced and Humanities Research Council of Canada Natural Sciences and Engineering Research Council of Canada Canadian Institutes of Health Research], 2014, TRIC POL STAT ETH CO; The National Hockey League, 2011, NAT HOCK LEAG OFF RU; The National Hockey League, 2010, NAT HOCK LEAG OFF RU; The Ontario Hockey League, 2011, ONT HOCK LEAG OFF RU; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X	28	35	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2013	8	7							e69122	10.1371/journal.pone.0069122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	185WH	WOS:000322000600041	23874888	Green Published, Green Submitted, gold			2022-02-06	
J	Bernick, C; Banks, S; Phillips, M; Lowe, M; Shin, W; Obuchowski, N; Jones, S; Modic, M				Bernick, Charles; Banks, Sarah; Phillips, Michael; Lowe, Mark; Shin, Wanyong; Obuchowski, Nancy; Jones, Stephen; Modic, Michael			Professional Fighters Brain Health Study: Rationale and Methods	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						boxing; chronic traumatic encephalopathy; mixed martial arts; traumatic brain injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; INJURY; CONCUSSION; EDUCATION	Repetitive head trauma is a risk factor for Alzheimer's disease and is the primary cause of chronic traumatic encephalopathy. However, little is known about the natural history of, and risk factors for, chronic traumatic encephalopathy or about means of early detection and intervention. The Professional Fighters Brain Health Study is a longitudinal study of active professional fighters (boxers and mixed martial artists), retired professional fighters, and controls matched for age and level of education. The main objective of the Professional Fighters Brain Health Study is to determine the relationships between measures of head trauma exposure and other potential modifiers and changes in brain imaging and neurological and behavioral function over time. The study is designed to extend over 5 years, and we anticipate enrollment of more than 400 boxers and mixed martial artists. Participants will undergo annual evaluations that include 3-tesla magnetic resonance imaging scanning, computerized cognitive assessments, speech analysis, surveys of mood and impulsivity, and blood sampling for genotyping and exploratory biomarker studies. Statistical models will be developed and validated to predict early and progressive changes in brain structure and function. A composite fight exposure index, developed as a summary measure of cumulative traumatic exposure, shows promise as a predictor of brain volumes and cognitive function.	[Bernick, Charles; Banks, Sarah] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV 89106 USA; [Phillips, Michael; Lowe, Mark; Shin, Wanyong; Obuchowski, Nancy; Jones, Stephen; Modic, Michael] Cleveland Clin, Dept Diagnost Radiol, Cleveland, OH 44106 USA; [Phillips, Michael; Lowe, Mark; Jones, Stephen] Cleveland Clin, Mellen Ctr Multiple Sclerosis, Cleveland, OH 44106 USA; [Obuchowski, Nancy] Cleveland Clin, Cleveland, OH 44106 USA		Bernick, C (corresponding author), Cleveland Clin, Lou Ruvo Ctr Brain Hlth, 888 West Bonneville Ave, Las Vegas, NV 89106 USA.	bernicc@ccf.org		Banks, Sarah/0000-0001-7536-2370	Lincy Foundation	Funding for this study was provided by the Lincy Foundation.	Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; Kirsch W, 2009, J ALZHEIMERS DIS, V17, P599, DOI 10.3233/JAD-2009-1073; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEVIN HS, 1987, J NEUROSURG, V67, P657, DOI 10.3171/jns.1987.67.5.0657; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Moseley IF, 2000, NEURORADIOLOGY, V42, P1, DOI 10.1007/s002340050001; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Weiner MF, 2011, INT PSYCHOGERIATR, V23, P1602, DOI 10.1017/S1041610211000767; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001; Zhang L, 2006, AM J NEURORADIOL, V27, P2000	29	35	35	0	50	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	JUL 15	2013	178	2					280	286		10.1093/aje/kws456			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	186DD	WOS:000322021300014	23735309	Bronze			2022-02-06	
J	Cruz, VT; Pais, J; Bento, V; Mateus, C; Colunas, M; Alves, I; Coutinho, P; Rocha, NP				Cruz, Vitor Tedim; Pais, Joana; Bento, Virgilio; Mateus, Catia; Colunas, Marcio; Alves, Ivania; Coutinho, Paula; Rocha, Nelson Pacheco			A Rehabilitation Tool Designed for Intensive Web-Based Cognitive Training: Description and Usability Study	JMIR RESEARCH PROTOCOLS			English	Article						cognitive training; cognitive deficits; neurorehabilitation; Web-based applications; eHealth systems; usability test		Background: Cognitive deficits are among the most disabling of neurological diseases and have a serious impact on the quality of life of patients and families. Cognitive training has been proven successful in improving or compensating for neuropsychological deficits after acute brain injury, but its efficacy highly depends on the intensity of treatment over an extended period of time. Therefore, cognitive training indicates expensive human resources and renders the rehabilitation process vulnerable to physical and economic barriers for the majority of patients. Objective: The aim of this study was to develop and test a new Web-based rehabilitation tool that provides intensive cognitive training at home under clinical prescription and monitoring, at affordable costs. Methods: From a pool of 60 original exercises, designed and used over the past 10 years for cognitive training at our center, we developed 27 exercises on a computer game format, with automatic increase or decrease of difficulty levels. These exercises were assembled in a clean, user-friendly design and covered various cognitive domains such as attention (n=4), memory (n=11), language (n=3), calculus (n=3), praxis (n=2), and executive functions (n=3). A Web 2.0 platform was also designed to provide medical prescription of cognitive training sessions, performed at the patient's home. These sessions included continuous monitoring of compliance, performance, and evolution; algorithms for automatic adjustment and long-term learning through use, and database recording of all activities. The end-user interaction test included 80 patients from our memory clinic from several groups including subjective memory complaints (n=20), traumatic brain injury (n=20), stroke and other static brain lesions (n=20), and mild Alzheimer's disease (n=20). During a 1-hour session, patients and their relatives were taught to use the system and allowed to practice using it. At the end of the session, they were asked to complete a questionnaire. Results: A total of 48/80 patients (60%) attended the training session. The mean age of the patients was 60 years (SD 13.3, range 41-78), and the mean level of formal education was 6 years (range 4-16). Of all the participants, 32/48 patients (66%) have previously used a computer. All patients and their relatives made a positive evaluation of the cognitive training tool. Only 2/48 patients (4%) were not interested in performing the exercises at home; 19/48 patients (39%) mentioned the need for further coaching from a relative or health care professional. The patients who mentioned difficulties in performing the exercises have not used the computer earlier. Conclusions: This new Web-based system was very well accepted by patients and their relatives, who showed high levels of motivation to use it on a daily basis at home. The simplicity of its use and comfort were especially outlined. This tool will have an important effect on human resource management, in increasing the patient access to specialized health care and improving the quality and national health system costs of rehabilitation programs.				vitor.cruz@chedv.min-saude.pt	Cruz, Vitor Tedim/AAM-3014-2020; Pais, Joana/AAM-4435-2020; Pais, Joana/AAM-4422-2020; Rocha, Nelson/I-5943-2012	Cruz, Vitor Tedim/0000-0002-5333-4771; Pais, Joana/0000-0003-4663-8184; Rocha, Nelson/0000-0003-3801-7249; Bento, Virgilio/0000-0001-6025-8511; Alves, Ivania/0000-0002-5622-4631	Portuguese Society of Neurology; Grunenthal Foundation	This project was funded by research grants from the Portuguese Society of Neurology in 2009 and Grunenthal Foundation in 2010.	Ackerman PL, 2010, PSYCHOL AGING, V25, P753, DOI 10.1037/a0019277; Ball K, 2010, J AM GERIATR SOC, V58, P2107, DOI 10.1111/j.1532-5415.2010.03138.x; Barbay S, 2009, NEUROREHABILITATION, V25, P5, DOI 10.3233/NRE-2009-0495; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Bavelier D, 2013, NATURE, V494, P425, DOI 10.1038/494425a; Bavelier D, 2011, NAT REV NEUROSCI, V12, P763, DOI 10.1038/nrn3135; Bisson E, 2007, CYBERPSYCHOL BEHAV, V10, P16, DOI 10.1089/cpb.2006.9997; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Cappa S.F., 2010, EUROPEAN HDB NEUROLO, V1, P545; Carod-Artal FJ, 2009, CEREBROVASC DIS, V27, P204, DOI 10.1159/000200461; Cavallini E, 2010, AGING CLIN EXP RES, V22, P314, DOI [10.1007/BF03337728, 10.3275/6704]; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; CLARK JE, 1987, J GERONTOL, V42, P82, DOI 10.1093/geronj/42.1.82; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Cruz VT, 2012, COGWEB SISTEMA INTEG; Cruz VT, 2013, COGWEB WEB BASED COG; Cruz VT, 2013, COGWEB SISTEMA INTEG; de Bruin ED, 2013, CLIN REHABIL, V27, P215, DOI 10.1177/0269215512453352; Eckroth-Bucher M, 2009, AM J ALZHEIMERS DIS, V24, P234, DOI 10.1177/1533317509332624; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; European Comunnity, 1995, OFFICIAL J EC, V281, P31; Fernandez-Calvo B, 2011, PSICOTHEMA, V23, P44; Franco MA, 2002, PSIQUIATRIA GERITRIC, P665, DOI [10.3389/fnhum.2013.00292, DOI 10.3389/FNHUM.2013.00292]; George DR, 2011, GERONTOLOGIST, V51, P590, DOI 10.1093/geront/gnr042; Gonzalez-Abraldes Isabel, 2010, Rev Esp Geriatr Gerontol, V45, P26, DOI 10.1016/j.regg.2009.10.005; Gray SA, 2012, J CHILD PSYCHOL PSYC, V53, P1277, DOI 10.1111/j.1469-7610.2012.02592.x; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Gross AL, 2012, AGING MENT HEALTH, V16, P722, DOI 10.1080/13607863.2012.667783; Huda S, 2008, NEUROREPORT, V19, P1573, DOI 10.1097/WNR.0b013e328311ca1c; Iuculano T, 2013, J NEUROSCI, V33, P4482, DOI 10.1523/JNEUROSCI.4927-12.2013; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kluwe-Schiavon B, 2013, J PSYCHIATR RES, V47, P91, DOI 10.1016/j.jpsychires.2012.10.001; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Langenbahn DM, 2013, ARCH PHYS MED REHAB, V94, P271, DOI 10.1016/j.apmr.2012.09.011; Li SC, 2008, PSYCHOL AGING, V23, P731, DOI 10.1037/a0014343; McKibbon KA, 2012, J AM MED INFORM ASSN, V19, P22, DOI 10.1136/amiajnl-2011-000304; Mozolic JL, 2011, NEUROBIOL AGING, V32, P655, DOI 10.1016/j.neurobiolaging.2009.04.013; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Peretz C, 2011, NEUROEPIDEMIOLOGY, V36, P91, DOI 10.1159/000323950; Rabipour S, 2012, BRAIN COGNITION, V79, P159, DOI 10.1016/j.bandc.2012.02.006; Rebok GW, 2013, J AGING HEALTH, V25, p21S, DOI 10.1177/0898264312461937; Rosser N, 2008, NEUROREHABILITATION, V23, P95; Rosti-Otajarvi EM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009131.pub2; RUFF R, 1994, BRAIN INJURY, V8, P3, DOI 10.3109/02699059409150954; Schoenberg MR, 2008, PROF PSYCHOL-RES PR, V39, P169, DOI 10.1037/0735-7028.39.2.169; Shatil E, 2010, NEUROREHABILITATION, V26, P143, DOI 10.3233/NRE-2010-0546; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Sternberg DA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00292; Tarraga L, 2006, J NEUROL NEUROSUR PS, V77, P1116, DOI 10.1136/jnnp.2005.086074; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; Vincent C, 2009, CEREBROVASC DIS, V27, P456, DOI 10.1159/000210092; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Woods B, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005562.pub2; Zickefoose S, 2013, BRAIN INJURY, V27, P707, DOI 10.3109/02699052.2013.775484	58	35	36	1	12	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	JUL-DEC	2013	2	2							e59	10.2196/resprot.2899			16	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	V4B5Q	WOS:000218782100038	24334248	gold, Green Published			2022-02-06	
J	Levant, B				Levant, Beth			N-3 (Omega-3) Polyunsaturated Fatty Acids in the Pathophysiology and Treatment of Depression: Pre-Clinical Evidence	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Brain-derived neurotrophic factor; corticosterone; docosahexaenoic acid; dopamine; elevated plus maze; forced swim test; neuroimmune; serotonin	FORCED-SWIMMING TEST; TRAUMATIC BRAIN-INJURY; POSTNATAL RAT-BRAIN; DOCOSAHEXAENOIC ACID; MAJOR DEPRESSION; NEUROTROPHIC FACTOR; FEMALE RATS; OMEGA-3-FATTY-ACID DEFICIENCY; DIETARY DEFICIENCY; RECEPTOR-BINDING	A growing literature suggests the association of low tissue levels and/or dietary intake of n-polyunsaturated fatty acids (PUFA) with depressive illnesses. Animal studies show that low tissue and/or dietary n-3 PUFAs can lead to behaviors and neurobiological effects associated with depression and can potentiate the consequences of stress, whereas higher levels have the opposite effect. These data support the involvement of n-3 PUFAs levels in the disease processes underlying depression. In addition, these pre-clinical findings indicate neurobiological mechanisms whereby n-3 PUFAs may contribute to the disease including control of serotonergic and dopaminergic function, modulation of brain-derived neurotrophic factor (BDNF) in the hippocampus, regulation of the hypothalamic-pituitary-adrenal axis, and effects on neuroinflammation. This evidence for a role for n-3 PUFA in the pathophysiology and treatment of depressive illness are reviewed. The implications of these finding for future pre-clinical research and clinical application are discussed.	[Levant, Beth] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA		Levant, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol, MS-1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	blevant@kumc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH071599, P30 HD02528, P20 RR016475]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH071599] Funding Source: NIH RePORTER	The author thanks Heather Spalding for expert assistance in the preparation of this manuscript. Supported by NIH R01 MH071599, P30 HD02528, and P20 RR016475.	aan het Rot M, 2009, CAN MED ASSOC J, V180, P305, DOI 10.1503/cmaj.080697; Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Anisman H, 2009, J PSYCHIATR NEUROSCI, V34, P4; ARANGO V, 1990, ARCH GEN PSYCHIAT, V47, P1038; Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Baldessarini R., 2001, PHARM BASIS THERAPEU, P447; Bannenberg G, 2007, THESCIENTIFICWORLDJO, V7, P1440, DOI 10.1100/tsw.2007.188; Bannenberg GL, 2009, CURR OPIN DRUG DISC, V12, P644; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Belzung C, 1998, J NUTR, V128, P1537, DOI 10.1093/jn/128.9.1537; BESKOW J, 1976, ACTA PSYCHIAT SCAND, V53, P7, DOI 10.1111/j.1600-0447.1976.tb00054.x; BIEGON A, 1988, BRAIN RES, V442, P199, DOI 10.1016/0006-8993(88)91453-9; Birch EE, 2000, DEV MED CHILD NEUROL, V42, P174, DOI 10.1017/S0012162200000311; Bjornebekk A, 2007, NEUROREPORT, V18, P1039; Blondeau N, 2009, NEUROPSYCHOPHARMACOL, V34, P2548, DOI 10.1038/npp.2009.84; BOURRE JME, 1992, BIOCHIM BIOPHYS ACTA, V1124, P119, DOI 10.1016/0005-2760(92)90087-C; BROWN AS, 1993, J NEURAL TRANSM-GEN, V91, P75, DOI 10.1007/BF01245227; CARPENTER WT, 1971, AM J PSYCHIAT, V128, P31, DOI 10.1176/ajp.128.1.31; Carrie I, 2000, J LIPID RES, V41, P465; Carrie I, 2000, J LIPID RES, V41, P473; CARROLL BJ, 1968, LANCET, V1, P1373; CARROLL BJ, 1976, PSYCHOL MED, V6, P43, DOI 10.1017/S0033291700007480; Chalon S, 2009, NEUROPHARMACOLOGY, V57, P636, DOI 10.1016/j.neuropharm.2009.08.012; Charney D. S., 2004, SCI STKE, V2004, pre5; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen HF, 2012, J NUTR BIOCHEM, V23, P299, DOI 10.1016/j.jnutbio.2010.12.010; CLANDININ MT, 1980, EARLY HUM DEV, V4, P131, DOI 10.1016/0378-3782(80)90016-X; CLANDININ MT, 1980, EARLY HUM DEV, V4, P121, DOI 10.1016/0378-3782(80)90015-8; Clarke SD, 1999, AM J CLIN NUTR, V70, P566; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Curtis MA, 2011, EUR J NEUROSCI, V33, P1170, DOI 10.1111/j.1460-9568.2011.07616.x; Cysneiros RM, 2010, EPILEPSY BEHAV, V17, P33, DOI 10.1016/j.yebeh.2009.11.006; Davis PF, 2010, NUTR NEUROSCI, V13, P161, DOI 10.1179/147683010X12611460764282; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Dean B, 2010, J AFFECT DISORDERS, V120, P245, DOI 10.1016/j.jad.2009.04.027; Delion S, 1996, J NEUROCHEM, V66, P1582; DELION S, 1994, J NUTR, V124, P2466, DOI 10.1093/jn/124.12.2466; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; Dinan T, 2009, J PSYCHIATR RES, V43, P471, DOI 10.1016/j.jpsychires.2008.06.003; Drevets WC, 2000, NUCL MED BIOL, V27, P499, DOI 10.1016/S0969-8051(00)00119-0; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2004, NEUROBIOLOGY MENTAL, P421; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fedorova I, 2007, PROSTAG LEUKOTR ESS, V77, P269, DOI 10.1016/j.plefa.2007.10.013; Ferraz AC, 2011, BEHAV BRAIN RES, V219, P116, DOI 10.1016/j.bbr.2010.12.028; Ferraz AC, 2008, PROSTAG LEUKOTR ESS, V78, P183, DOI 10.1016/j.plefa.2008.02.001; FRANCES H, 1995, LIFE SCI, V57, P1935, DOI 10.1016/0024-3205(95)02180-Q; Frances H, 2000, NEUROSCI LETT, V285, P223, DOI 10.1016/S0304-3940(00)01065-X; Frazer A, 2005, NEUROSCI BIOBEHAV R, V29, P515, DOI 10.1016/j.neubiorev.2005.03.006; Freeman MP, 2011, J CLIN PSYCHIAT, V72, P258, DOI 10.4088/JCP.11ac06830; Gaiteri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009970; GALLI C, 1971, BIOCHIM BIOPHYS ACTA, V248, P449, DOI 10.1016/0005-2760(71)90233-5; Garlow SJ, 2004, NEUROBIOLOGY MENTAL, P440; Geraldine M, 2010, NEUROCHEM INT, V56, P94, DOI 10.1016/j.neuint.2009.09.006; Gershon AA, 2007, BIOL PSYCHIAT, V61, P145, DOI 10.1016/j.biopsych.2006.05.031; Gordon N, 1997, BRAIN DEV-JPN, V19, P165, DOI 10.1016/S0387-7604(96)00560-8; Green P, 1996, LIPIDS, V31, P859, DOI 10.1007/BF02522981; Gronli J, 2006, PHARMACOL BIOCHEM BE, V85, P842, DOI 10.1016/j.pbb.2006.11.021; GUZE BH, 1991, PSYCHOSOMATICS, V32, P390, DOI 10.1016/S0033-3182(91)72039-2; Hannestad J, 2011, NEUROPSYCHOPHARMACOL, V36, P2452, DOI 10.1038/npp.2011.132; Harauma A, 2011, LIPIDS, V46, P409, DOI 10.1007/s11745-010-3523-z; Harvey PO, 2007, MOL PSYCHIATR, V12, P767, DOI 10.1038/sj.mp.4002021; He CW, 2009, P NATL ACAD SCI USA, V106, P11370, DOI 10.1073/pnas.0904835106; Hirvonen J, 2008, PSYCHOPHARMACOLOGY, V197, P581, DOI 10.1007/s00213-008-1088-9; Laino CH, 2010, EUR J PHARMACOL, V648, P117, DOI 10.1016/j.ejphar.2010.08.047; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Huang SY, 2008, J PSYCHIATR RES, V42, P58, DOI 10.1016/j.jpsychires.2006.09.004; INNIS SM, 1992, J PEDIATR-US, V120, pS56, DOI 10.1016/S0022-3476(05)81237-5; Innis SM, 2004, ADV EXP MED BIOL, V554, P27; Joardar A, 2006, J LIPID RES, V47, P571, DOI 10.1194/jlr.M500415-JLR200; Johnson RA, 2003, NEUROSCIENCE, V121, P1, DOI 10.1016/S0306-4522(03)00422-6; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Kelsey JE, 1998, PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, P95; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kram ML, 2002, PROG NEURO-PSYCHOPH, V26, P639, DOI 10.1016/S0278-5846(01)00222-6; Kuperstein F, 2005, J NEUROCHEM, V95, P1550, DOI 10.1111/j.1471-4159.2005.03513.x; Kuperstein F, 2008, J NEUROCHEM, V106, P662, DOI 10.1111/j.1471-4159.2008.05418.x; Lakhwani Lalit, 2007, Acta Pol Pharm, V64, P271; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Levant B, 2008, PSYCHONEUROENDOCRINO, V33, P1279, DOI 10.1016/j.psyneuen.2008.06.012; Levant B, 2007, J NUTR, V137, P130, DOI 10.1093/jn/137.1.130; Levant B, 2006, LIPIDS, V41, P407, DOI 10.1007/s11745-006-5114-6; Levant B, 2006, J NUTR, V136, P2236, DOI 10.1093/jn/136.8.2236; Levant B, 2010, PHYSIOL BEHAV, V101, P176, DOI 10.1016/j.physbeh.2010.04.038; Lloyd K G, 1974, Adv Biochem Psychopharmacol, V11, P387; Lu DY, 2010, NEUROPSYCHOPHARMACOL, V35, P2238, DOI 10.1038/npp.2010.98; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Makrides M, 2010, NESTLE NUTR WORKS SE, V65, P123, DOI 10.1159/000281154; Mann JJ, 1999, NEUROBIOLOGY MENTAL, P385; Mathieu G, 2008, PROSTAG LEUKOTR ESS, V78, P391, DOI 10.1016/j.plefa.2008.05.003; Mathieu G, 2011, PROSTAG LEUKOTR ESS, V85, P129, DOI 10.1016/j.plefa.2011.07.001; McNamara RK, 2008, SYNAPSE, V62, P725, DOI 10.1002/syn.20542; McNamara RK, 2007, BIOL PSYCHIAT, V62, P17, DOI 10.1016/j.biopsych.2006.08.026; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; McNamara RK, 2010, PROSTAG LEUKOTR ESS, V83, P185, DOI 10.1016/j.plefa.2010.08.004; McNamara RK, 2009, PROSTAG LEUKOTR ESS, V81, P223, DOI 10.1016/j.plefa.2009.05.017; McNamara RK, 2009, J PSYCHIATR RES, V43, P656, DOI 10.1016/j.jpsychires.2008.09.011; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Moses-Kolko EL, 2012, NEUROPSYCHOPHARMACOL, V37, P1422, DOI 10.1038/npp.2011.328; NAKASHIMA Y, 1993, J LIPID RES, V34, P239; Naliwaiko K, 2004, NUTR NEUROSCI, V7, P91, DOI 10.1080/10284150410001704525; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Owens SD, 1999, J NUTR, V129, P2088, DOI 10.1093/jn/129.11.2088; PAPP M, 1994, PSYCHOPHARMACOLOGY, V115, P441, DOI 10.1007/BF02245566; PAPP M, 1991, PSYCHOPHARMACOLOGY, V104, P255, DOI 10.1007/BF02244188; Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X; Park Y, 2012, J NUTR BIOCHEM, V23, P924, DOI 10.1016/j.jnutbio.2011.04.018; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; POST RM, 1973, AM J PSYCHIAT, V130, P67, DOI 10.1176/ajp.130.1.67; REDDY PL, 1992, BIOL PSYCHIAT, V31, P112; ROY A, 1992, ARCH GEN PSYCHIAT, V49, P447; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sapolsky RM, 2000, BIOL PSYCHIAT, V48, P755, DOI 10.1016/S0006-3223(00)00971-9; Sargent PA, 2000, ARCH GEN PSYCHIAT, V57, P174, DOI 10.1001/archpsyc.57.2.174; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Schmidt HD, 2011, NEUROPSYCHOPHARMACOL, V36, P2375, DOI 10.1038/npp.2011.151; SHAW DM, 1967, BRIT J PSYCHIAT, V113, P1407, DOI 10.1192/bjp.113.505.1407; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; SINCLAIR AJ, 1975, P NUTR SOC, V34, P287, DOI 10.1079/PNS19750051; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; SMITH MA, 1995, ENDOCRINOLOGY, V136, P3743, DOI 10.1210/en.136.9.3743; Song C, 2004, STRESS, V7, P43, DOI 10.1080/10253890410001667188; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Stillwell W, 2005, REPROD NUTR DEV, V45, P559, DOI 10.1051/rnd:2005046; Stockmeier CA, 2003, J PSYCHIAT RES, V37, P357, DOI 10.1016/S0022-3956(03)00050-5; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Takeuchi T, 2002, BEHAV BRAIN RES, V131, P193, DOI 10.1016/S0166-4328(01)00392-8; Tonelli LH, 2008, ACTA PSYCHIAT SCAND, V117, P198, DOI 10.1111/j.1600-0447.2007.01128.x; Trofimiuk E, 2011, LIPIDS, V46, P417, DOI 10.1007/s11745-011-3551-3; Van Praag HM, 1975, PSYCHOL MED, V4, P21; Vancassel S, 2008, J LIPID RES, V49, P340, DOI 10.1194/jlr.M700328-JLR200; Venna VR, 2009, PSYCHONEUROENDOCRINO, V34, P199, DOI 10.1016/j.psyneuen.2008.08.025; Vetulani J, 1975, NATURE, V22, P181; Vines A, 2012, NEUROPHARMACOLOGY, V62, P184, DOI 10.1016/j.neuropharm.2011.06.017; Willatts P, 1998, LIPIDS, V33, P973, DOI 10.1007/s11745-998-0294-7; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Xiao Y, 2005, BRIT J NUTR, V94, P544, DOI 10.1079/BJN20051539; YATES M, 1990, BIOL PSYCHIAT, V27, P489, DOI 10.1016/0006-3223(90)90440-D; YATES M, 1990, J PSYCHOPHARMACOL, V4, P59; Zimmer L, 2000, J LIPID RES, V41, P32; Zimmer L, 1998, NEUROSCI LETT, V240, P177, DOI 10.1016/S0304-3940(97)00938-5; Zimmer L, 2002, AM J CLIN NUTR, V75, P662, DOI 10.1093/ajcn/75.4.662; [No title captured]	155	35	38	0	34	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	JUN	2013	12	4					450	459		10.2174/1871527311312040003			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	173UY	WOS:000321108000003	23574159	Green Accepted			2022-02-06	
J	Sim, P; Power, E; Togher, L				Sim, Phoebe; Power, Emma; Togher, Leanne			Describing conversations between individuals with traumatic brain injury (TBI) and communication partners following communication partner training: Using exchange structure analysis	BRAIN INJURY			English	Article						Assessment; discourse analysis; discourse profiles; rehabilitation; social communication skills	QUALITY-OF-LIFE; DISCOURSE ABILITIES; SOCIAL INTEGRATION; PEOPLE; SKILLS; APHASIA; ADULTS; COHESION; OUTCOMES; IMPACT	Primary objective: To describe conversational discourse change after joint communication training for individuals with TBI and their everyday communication partners (ECPs), as compared to untrained controls. Hypothesis: Joint training would lead to significantly greater changes in the discourse behaviour of trained participants. Methods and procedures: In this multi-centre non-randomized controlled trial, 29 participants with severe TBI and their ECPs were allocated to either the JOINT training or CONTROL group. Social communication training aimed to train ECPs to better support their partner with TBI to produce more effective conversations. Pre- and post-training casual conversations were compared using exchange structure analysis (ESA) and productivity analysis. Results: ESA and productivity analysis revealed significant change in the use of testing moves by trained ECPs and significant change in productivity by trained participants with TBI. ESA facilitated development of discourse profiles (excessive or impoverished) for participants with TBI, which distinguished the groups at baseline. Conclusions: This study extends one's understanding of individual discourse styles in people with TBI. The impact of different discourse styles on group outcome studies has been highlighted. These discourse findings may facilitate goal-setting in social skills intervention after TBI, with focus on training ECPs to support people with TBI in conversations.	[Sim, Phoebe; Power, Emma; Togher, Leanne] Univ Sydney, Discipline Speech Pathol, Fac Hlth Sci, Lidcombe, NSW 1825, Australia		Togher, L (corresponding author), Univ Sydney, Discipline Speech Pathol, Fac Hlth Sci, 75 East St,POB 170, Lidcombe, NSW 1825, Australia.	leanne.togher@sydney.edu.au	Togher, Leanne/AAC-7083-2019; Power, Emma/A-9263-2015	Power, Emma/0000-0002-2638-0406; Togher, Leanne/0000-0002-4518-6748	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This study was supported by a National Health and Medical Research Council project grant.	Adamovich B. B., 1992, SCALES COGNITIVE ABI; [Anonymous], 2011, IBM SPSS STAT 20 WIN; Argyrous, 2005, STAT RES GUIDE SPSS; Auerbach S., 1986, J HEAD TRAUMA REHAB, V3, P1; BELLACK AS, 1983, BEHAV RES THER, V21, P29, DOI 10.1016/0005-7967(83)90123-7; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Boles L, 1998, APHASIOLOGY, V12, P547, DOI 10.1080/02687039808249557; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho C. A., 1999, BRAIN DAM B; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cunningham R, 2003, APHASIOLOGY, V17, P687, DOI 10.1080/02687030344000184; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Eggins S., 1997, ANAL CASUAL CONVERSA; Field A., 2017, DISCOVERING STAT USI, V5th; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Goldblum G, 2009, APHASIOLOGY, V23, P87, DOI 10.1080/02687030802024094; Halliday M., 2004, INTRO FUNCTIONAL GRA; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hopper T, 2002, APHASIOLOGY, V16, P745, DOI 10.1080/02687030244000059; Hough MS, 2003, APHASIOLOGY, V17, P183, DOI 10.1080/02687030244000608; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Isaki E, 2000, BRAIN INJURY, V14, P441; Johnson K, 1998, BEHAV MODIF, V22, P502, DOI 10.1177/01454455980224004; Johnston MV, 2006, BRAIN INJURY, V20, P391, DOI 10.1080/02699050500487795; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kilov AM, 2009, APHASIOLOGY, V23, P584, DOI 10.1080/02687030701855382; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Lane-Brown AT, 2011, BRAIN IMPAIR, V12, P43, DOI 10.1375/brim.12.1.43; Larkins B, 1999, ASIA PACIFIC J SPEEC, V4, P183; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1999, COMMUNICATION DISORD; McDonald S., 2005, FUNCTIONAL ASSESSMEN; McDonald S., 2002, AWARENESS SOCIAL INF; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; RIPICH DN, 1994, ALZ DIS ASSOC DIS, V8, P95, DOI 10.1097/00002093-199424004-00011; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Ruff R, 1991, COGNITIVE REHABILITA, P23; Shelton C, 2007, BRAIN INJURY, V21, P1259, DOI 10.1080/02699050701716935; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Snow PC, 1995, TRAUMATIC BRAIN INJU; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 2000, APHASIOLOGY, V14, P365, DOI 10.1080/026870300401414; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2001, J COMMUN DISORD, V34, P131, DOI 10.1016/S0021-9924(00)00045-9; TOGHER L, 1999, COMMUNICATION DISORD; Togher L, 2010, ISL OF PALMS SC CLIN; Togher L, 2010, TBI EXPRESS PEOPLE T; TOGHER L, 2006, BRAIN IMPAIR, V7, P190, DOI DOI 10.1375/brim.7.3.190; Togher L., 1998, ANAL INTERPERSONAL M; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Turkstra L.S., 2006, BRAIN IMPAIR, V7, P234, DOI [DOI 10.1375/BRIM.7.3.234, 10.1375/brim.7.3.234]; Turner S, 2006, APHASIOLOGY, V20, P483, DOI 10.1080/02687030600589991; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; VENTOLA E, 1987, STRUCTURE SOCIAL INT; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wedcliffe T, 2001, S Afr J Commun Disord, V48, P77; Worrall L, 2002, J COMMUN DISORD, V35, P107, DOI 10.1016/S0021-9924(02)00060-6; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P303; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	88	35	36	0	25	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2013	27	6					717	742		10.3109/02699052.2013.775485			26	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	143QO	WOS:000318882500011	23672447				2022-02-06	
J	Downing, MG; Stolwyk, R; Ponsford, JL				Downing, Marina G.; Stolwyk, Rene; Ponsford, Jennie L.			Sexual Changes in Individuals With Traumatic Brain Injury: A Control Comparison	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						sexual changes; sexuality; Sexuality Questionnaire; traumatic brain injury	SELF-ESTEEM; HOSPITAL ANXIETY; DEPRESSION SCALE; BODY-IMAGE; VALIDITY	Background: Previous research has suggested that sexuality is compromised following traumatic brain injury (TBI), but there has been limited comparison with healthy samples. Objectives: The aim of the current study was to compare sexuality in individuals with TBI with that in healthy controls matched for age and gender. In doing this, the current study aimed to characterize those individuals who reported a decrease in sexuality relative to those reporting an increase according to certain demographic and injury variables. Method: A total of 865 participants with predominantly moderate to severe TBI and 142 controls completed the Brain Injury Questionnaire of Sexuality (BIQS), the Hospital Anxiety and Depression Scale, and the Rosenberg Self-Esteem Scale on one occasion. Results: The results indicated that there was a significant difference between participants with TBI and controls on all the BIQS subscales as well as the total score. Age, depression, anxiety, and self-esteem levels significantly differentiated participants with TBI who reported decreased sexuality from those who reported increased sexuality. Participants with TBI attributed sexual changes to various causes-most commonly, fatigue, low confidence, pain, decreased mobility, and feeling unattractive. Conclusions: Further research examining the factors contributing to sexual changes is warranted.	[Downing, Marina G.; Stolwyk, Rene; Ponsford, Jennie L.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Downing, Marina G.; Ponsford, Jennie L.] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Natl Trauma Res Inst, Melbourne, Vic, Australia		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	jennie.ponsford@med.monash.edu.au	Downing, Marina/AAX-2380-2020	Downing, Marina/0000-0002-3126-6632	Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research (ISCRR)	This project is funded by the Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research (ISCRR).	Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; GrayLittle B, 1997, PERS SOC PSYCHOL B, V23, P443, DOI 10.1177/0146167297235001; Howes H, 2005, BRAIN INJURY, V19, P135, DOI 10.1080/02699050410001720077; Keppel CC, 2000, NEUROPSYCHOL REHABIL, V10, P15, DOI 10.1080/096020100389273; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; Rosenberg M., 1965, SOC ADOLESCENT SELF; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Snaith R., 1994, HOSP ANXIETY DEPRESS; Stowyk RJ, 2013, J HEAD TRAUMA REHAB, V28, P164; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; ZENCIUS A, 1990, Brain Injury, V4, P175, DOI 10.3109/02699059009026163	24	35	35	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2013	28	3					171	178		10.1097/HTR.0b013e31828b4f63			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	149PS	WOS:000319334000003	23661068				2022-02-06	
J	Ng, EMW; Polatajko, HJ; Marziali, E; Hunt, A; Dawson, DR				Ng, Edith M. W.; Polatajko, Helene J.; Marziali, Elsa; Hunt, Anne; Dawson, Deirdre R.			Telerehabilitation for addressing executive dysfunction after traumatic brain injury	BRAIN INJURY			English	Article						Community integration; cognitive orientation to daily occupational performance	QUALITY-OF-LIFE; SCHEDULED TELEPHONE INTERVENTION; COGNITIVE REHABILITATION; PERFORMANCE; INDIVIDUALS; AWARENESS; PROGRAM; STROKE; ADULTS; CARE	Primary objective: To investigate the feasibility of implementing the Cognitive Orientation to daily Occupational Performance approach (CO-OP) in a telerehabilitation format and to examine its impact on community integration and executive dysfunction for adults with traumatic brain injury (TBI). Research design: A pilot series of three case studies with 3-month follow-up was conducted. Methods and procedures: Three adults (all males, >10 years post-TBI) and their significant others were recruited. The CO-OP intervention, a meta-cognitive approach, was delivered through videoconferencing via Internet to train three of five participant-identified goals. Two goals were not trained to allow examination of transfer. Outcome measures included the Canadian Occupational Performance Measure, the Mayo-Portland Adaptability Inventory-4 Participation Index, and the Dysexecutive Questionnaire. Descriptive statistical analysis was used. Main outcomes and results: The CO-OP approach administered in a telerehabilitation format was found to be feasible. All participants indicated self-reported improvement in both trained and untrained goals. Trends toward fewer symptoms of executive dysfunction and greater community integration were demonstrated. All participants expressed satisfaction with the Internet delivery method. Conclusions: Telerehabilitation shows promise as a way to deliver the CO-OP approach and may help promote community integration of individuals living with TBI. Further study is warranted.	[Ng, Edith M. W.; Dawson, Deirdre R.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Ng, Edith M. W.; Polatajko, Helene J.; Dawson, Deirdre R.] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Polatajko, Helene J.; Hunt, Anne; Dawson, Deirdre R.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Marziali, Elsa] Univ Toronto, Fac Social Work, Toronto, ON M5S 1A1, Canada; [Marziali, Elsa] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Marziali, Elsa; Hunt, Anne; Dawson, Deirdre R.] Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada		Ng, EMW (corresponding author), Univ Hlth Network, Acquired Brain Injury Serv, Toronto Rehabil Inst, 550 Univ Ave,Room 11-075, Toronto, ON M5G 2A2, Canada.	edith.ng@uhn.ca	Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121	Canadian Occupational Therapy Foundation; Toronto Rehabilitation InstituteUniversity of Toronto; Ontario Ministry of Health and Long Term Care through the Ontario Research Coalition of Research Institutes/Centres on Health and Aging; Ontario Neurotrauma Foundation; Quebec Rehabilitation Research Network (ONF-REPAR); Ontario Rehabilitation Research Advisory Network	The authors report no conflicts of interest. The researchers and organizations involved in this study had no affiliation with Logitech (R), Skype (TM), or Pamela for Skype (TM). This study was conducted by the primary author while she was an MSc student in the Graduate Department of Rehabilitation Science at the University of Toronto. Personnel funding for her graduate studies was received from the Canadian Occupational Therapy Foundation, the Toronto Rehabilitation Institute and the Ontario Ministry of Health and Long Term Care through the Ontario Research Coalition of Research Institutes/Centres on Health and Aging. The study was supported by a grant to D. Dawson from the Ontario Neurotrauma Foundation in collaboration with the Quebec Rehabilitation Research Network (ONF-REPAR) and a grant to D. Dawson from the Ontario Rehabilitation Research Advisory Network.	Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Benedict, 2001, HOPKINS VERBAL LEARN; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Bergquist T, 2008, BRAIN INJURY, V22, P891, DOI 10.1080/02699050802405487; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Berson T, 2005, SKYPE SECURITY EVALU; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Boelen DHE, 2011, J NEUROPSYCHOL, V5, P73, DOI 10.1348/174866410X516434; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Burckhardt CS., 2003, HEALTH QUAL LIFE OUT, V1, P1, DOI [10.1186/1477-7525-1-1, DOI 10.1186/1477-7525-1-1]; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burton CL, 2002, CLIN NEUROPSYCHOL, V16, P264, DOI 10.1076/clin.16.3.264.13854; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Dawson D, 2010, BRAIN INJURY, V24, P380; Dawson DR, 2000, BRAIN COGNITION, V44, P35; Dawson DR, 2009, CAN J OCCUP THER, V76, P74; Doig E, 2011, BRAIN INJURY, V25, P1114, DOI 10.3109/02699052.2011.607788; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; FLANAGAN JC, 1978, AM PSYCHOL, V33, P138, DOI 10.1037/0003-066X.33.2.138; Hermens H, 2008, ANN I SUPER SANITA, V44, P154; Huijgen BCH, 2008, J TELEMED TELECARE, V14, P249, DOI 10.1258/jtt.2008.080104; Jenkinson N, 2007, BRAIN INJURY, V21, P1283, DOI 10.1080/02699050701739531; Kairy D, 2009, DISABIL REHABIL, V31, P427, DOI 10.1080/09638280802062553; Keightley ML, 2009, BRAIN INJURY, V23, P250, DOI 10.1080/02699050902748331; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Laurent S, 2002, RURAL CANADA ACCESS; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2005, MANUAL MAYO PORTLAND; Man DWK, 2006, NEUROREHABILITATION, V21, P205; Mandich, 2004, ENABLING OCCUPATION; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; McEwen SE, 2010, NEUROPSYCHOL REHABIL, V20, P541, DOI 10.1080/09602011003638194; McEwen SE, 2009, BRAIN INJURY, V23, P1041, DOI 10.3109/02699050903421107; McGrath N, 2008, J HEAD TRAUMA REHAB, V23, P388, DOI 10.1097/01.HTR.0000341434.74875.c8; Meichenbaum, 1977, COGNITIVE BEHAV MODI; Mrazik M, 2010, ARCH CLIN NEUROPSYCH, V25, P236, DOI 10.1093/arclin/acq006; Pollock N, 1998, CANADIAN OCCUPATIONA; Rodger S, 2009, AUST OCCUP THER J, V56, P41, DOI 10.1111/j.1440-1630.2008.00739.x; Romanow R.J., 2002, BUILDING VALUES FUTU; Skidmore ER, 2011, NEUROPSYCHOL REHABIL, V21, P208, DOI 10.1080/09602011.2011.552559; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Tam Sing-Fai, 2003, Occup Ther Int, V10, P20, DOI 10.1002/oti.175; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Tulsky D., 1997, WAIS 3 WMS 3 TECHNIC; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; Wressle E., 1999, SCAND J OCCUP THER, V6, P84, DOI [DOI 10.1080/110381299443771, 10.1080/110381299443771]; YLVISAKER M, 1989, TOP LANG DISORD, V9, P34, DOI 10.1097/00011363-198903000-00005	64	35	36	1	21	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2013	27	5					548	564		10.3109/02699052.2013.766927			17	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	124UK	WOS:000317493000005	23472964				2022-02-06	
J	Asher, SR; Curry, P; Sharma, D; Wang, J; O'Keefe, GE; Daniel-Johnson, J; Vavilala, MS				Asher, Shyamal R.; Curry, Parichat; Sharma, Deepak; Wang, Jin; O'Keefe, Grant E.; Daniel-Johnson, Jennifer; Vavilala, Monica S.			Survival Advantage and PaO2 Threshold in Severe Traumatic Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						traumatic brain injury; hyperoxemia; hyperoxia; cerebral oxygenation	SEVERE HEAD-INJURY; HYPEROXIA; ARTERIAL; OXYGENATION; THERAPY	Background: Hypoxemia can adversely affect outcome after traumatic brain injury (TBI). However, the effect of high PaO2 on TBI outcomes is controversial. The primary aim of this study was to identify the optimal PaO2 range early after severe TBI. Methods: In this single-center retrospective study conducted at a level-1 trauma center, patients with severe TBI (head Abbreviated Injury Scale score > 3, admission Glasgow Coma Scale score <= 8) were included. The crude and adjusted (including chest injuries and acute respiratory distress syndrome) effects of 50 mm Hg incremental PaO2 thresholds during the first 72 hours on discharge survival were examined. Results: Data from 193 patients (44 +/- 18 y; 77% male; admission Glasgow Coma Scale score 4 +/- 2) were reviewed. Overall survival was 57%. PaO2 thresholds in increments of 50 mm Hg between 250 and 486 mm Hg (68%) were associated with discharge survival in patients with severe TBI compared with PaO2 60 mm Hg < PaO2 < threshold. This association between PaO2 thresholds and survival was sustained until a PaO2 of 486 mm Hg (adjusted odds ratio 3.4; 95% confidence interval, 1.5-7.7). Although most patients had at least 1 PaO2 >= 250 mm Hg during the first 72 hours, in-hospital hypoxemia was common (24%) and was associated with mortality (survival adjusted odds ratio 0.46; 95% confidence interval, 0.22-0.95). Conclusions: In this series, a PaO2 threshold between 250 and 486 mm Hg during the first 72 hours after injury was associated with improved all-cause survival in patients with severe TBI, independent of hypocarbia or hypercarbia.	[Asher, Shyamal R.; Curry, Parichat; Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Sharma, Deepak; O'Keefe, Grant E.; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [O'Keefe, Grant E.] Univ Washington, Dept Gen Surg, Seattle, WA 98104 USA; [Daniel-Johnson, Jennifer] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98104 USA; [Wang, Jin; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu					Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Ahn Edward S, 2005, Clin Neurosurg, V52, P348; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Bullock MR, 2008, J NEUROSURG, V109, P421, DOI 10.3171/JNS/2008/109/9/0421; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Neumar RW, 2011, CURR OPIN CRIT CARE, V17, P236, DOI 10.1097/MCC.0b013e3283454c8c; Rossi S, 2000, ACTA NEUROCHIR SUPPL, V76, P243; SIGGAARDANDERSEN O, 1995, CRIT CARE MED, V23, P1284, DOI 10.1097/00003246-199507000-00020; Singhal AB, 2007, NEUROL RES, V29, P173, DOI 10.1179/016164107X181815; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tasman W, 2006, AM J OPHTHALMOL, V141, P167, DOI 10.1016/j.ajo.2005.07.034; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	23	35	37	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	2013	25	2					168	173		10.1097/ANA.0b013e318283d350			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	103XN	WOS:000315952900008	23343758				2022-02-06	
J	Kotchoubey, B; Merz, S; Lang, S; Markl, A; Muller, F; Yu, T; Schwarzbauer, C				Kotchoubey, Boris; Merz, Susanne; Lang, Simone; Markl, Alexandra; Mueller, Friedemann; Yu, Tao; Schwarzbauer, Christian			Global functional connectivity reveals highly significant differences between the vegetative and the minimally conscious state	JOURNAL OF NEUROLOGY			English	Article						Traumatic brain injury; Anoxic brain injury; Coma; Consciousness; Functional connectivity; Unresponsive wakefulness syndrome	CORTICAL CONNECTIVITY; EMPATHY; RECOVERY; PAIN; FMRI	A major challenge in the diagnosis of disorders of consciousness is the differential diagnosis between the vegetative state (VS) and the minimally conscious state (MCS). Clinically, VS is defined by complete unawareness, whereas MCS is defined by the presence of inconsistent but clearly discernible behavioural signs of consciousness. In healthy individuals, pain cries have been reported to elicit functional activation within the pain matrix of the brain, which may be interpreted as empathic reaction. In this study, pain cries were presented to six VS patients, six MCS patients, and 17 age-matched healthy controls. Conventional task-related functional magnetic resonance imaging (fMRI) showed no significant differences in functional activation between the VS and MCS groups. In contrast to this negative finding, the application of a novel data-driven technique for the analysis of the brain's global functional connectivity yielded a positive result. The weighted global connectivity (WGC) was significantly greater in the MCS group compared to the VS group (p < 0.05, family-wise error corrected). Using areas of significant WGC differences as 'seed regions' in a secondary connectivity analysis revealed extended functional networks in both MCS and healthy groups, whereas no such long-range functional connections were observed in the VS group. These results demonstrate the potential of functional connectivity MRI (fcMRI) as a clinical tool for differential diagnosis in disorders of consciousness.	[Kotchoubey, Boris; Markl, Alexandra; Yu, Tao] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Merz, Susanne; Schwarzbauer, Christian] Univ Aberdeen, Aberdeen Coma Sci Grp, Aberdeen AB25 2ZD, Scotland; [Lang, Simone] Heidelberg Univ, Inst Psychol, Dept Clin Psychol & Psychotherapy, Heidelberg, Germany; [Markl, Alexandra; Mueller, Friedemann] Schon Klin, Bad Aibling, Germany		Schwarzbauer, C (corresponding author), Univ Aberdeen, Aberdeen Coma Sci Grp, Lilian Sutton Bldg,Foresterhill, Aberdeen AB25 2ZD, Scotland.	c.schwarzbauer@abdn.ac.uk		Merz, Susanne/0000-0001-8638-0267	Chief Scientist Office of Scotland; Scottish Funding Council (SFC) through the SINAPSE initiative (Scottish Imaging Network: A Platform for Scientific Excellence); German Research Society (Deutsche Forschungsgemeinschaft, DFG)German Research Foundation (DFG); European UnionEuropean Commission; Chief Scientist Office [ETM/127] Funding Source: researchfish	CS would like to thank the Chief Scientist Office of Scotland for partly funding this research. SM and CS acknowledge the support of the Scottish Funding Council (SFC) through the SINAPSE initiative (Scottish Imaging Network: A Platform for Scientific Excellence; http://www.sinapse.ac.uk). BK, SL, AM, FM and TY were supported by the German Research Society (Deutsche Forschungsgemeinschaft, DFG). In addition BK acknowledges the support from the European Union (Grant DECODER).	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Baars B.J., 1988, COGNITIVE THEORY CON; Baars BJ, 1997, THEATER CONSCIOUSNES; Bekinschtein TA, 2009, NAT NEUROSCI, V12, P1343, DOI 10.1038/nn.2391; Benuzzi F, 2008, J NEUROSCI, V28, P923, DOI 10.1523/JNEUROSCI.4012-07.2008; Block N, 2007, BEHAV BRAIN SCI, V30, P481, DOI 10.1017/S0140525X07002786; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Brooks J, 2005, TCE-THE CHEM ENG, P19; Calhoun VD, 2012, NEUROIMAGE, V59, P25, DOI 10.1016/j.neuroimage.2011.06.037; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Damasio A., 1999, FEELING WHAT HAPPENS; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Kotchoubey B, 2011, ADV CLIN NEUROSCI RE, V11, P10; Kotchoubey B., 2009, ENCY NEUROSCIENCE, P61, DOI [10.1016/B978-008045046-9.00620-3, DOI 10.1016/B978-008045046-9.00620-3]; Lang, 1999, INT AFFECTIVE DIGITI; Lang S, 2011, COGN AFFECT BEHAV NE, V11, P386, DOI 10.3758/s13415-011-0035-0; Laureys S, 2005, NAT REV NEUROSCI, V6, P899, DOI 10.1038/nrn1789; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Peltier SJ, 2005, NEUROREPORT, V16, P285, DOI 10.1097/00001756-200502280-00017; Perrin JS, 2012, P NATL ACAD SCI USA, V109, P5464, DOI 10.1073/pnas.1117206109; Sander K, 2007, HUM BRAIN MAPP, V28, P1007, DOI 10.1002/hbm.20333; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Tononi G, 2008, BIOL BULL-US, V215, P216, DOI 10.2307/25470707	40	35	35	0	14	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	APR	2013	260	4					975	983		10.1007/s00415-012-6734-9			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	122XM	WOS:000317351900004	23128970				2022-02-06	
J	Cusimano, MD; Cho, N; Amin, K; Shirazi, M; McFaull, SR; Do, MT; Wong, MC; Russell, K				Cusimano, Michael D.; Cho, Newton; Amin, Khizer; Shirazi, Mariam; McFaull, Steven R.; Do, Minh T.; Wong, Matthew C.; Russell, Kelly			Mechanisms of Team-Sport-Related Brain Injuries in Children 5 to 19 Years Old: Opportunities for Prevention	PLOS ONE			English	Article							HEAD-INJURIES; ICE HOCKEY; BODY-CHECKING; SOCCER; EPIDEMIOLOGY; CONCUSSIONS; AGREEMENT; RISK	Background: There is a gap in knowledge about the mechanisms of sports-related brain injuries. The objective of this study was to determine the mechanisms of brain injuries among children and youth participating in team sports. Methods: We conducted a retrospective case series of brain injuries suffered by children participating in team sports. The Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP) database was searched for brain injury cases among 5-19 year-olds playing ice hockey, soccer, American football (football), basketball, baseball, or rugby between 1990 and 2009. Mechanisms of injury were classified as "struck by player,'' "struck by object,'' "struck by sport implement,'' "struck surface,'' and "other.'' A descriptive analysis was performed. Results: There were 12,799 brain injuries related to six team sports (16.2% of all brain injuries registered in CHIRPP). Males represented 81% of injuries and the mean age was 13.2 years. Ice hockey accounted for the greatest number of brain injuries (44.3%), followed by soccer (19.0%) and football (12.9%). In ice hockey, rugby, and basketball, striking another player was the most common injury mechanism. Football, basketball, and soccer also demonstrated high proportions of injuries due to contact with an object (e.g., post) among younger players. In baseball, a common mechanism in the 5-9 year-old group was being hit with a bat as a result of standing too close to the batter (26.1% males, 28.3% females). Interpretation: Many sports-related brain injury mechanisms are preventable. The results suggest that further efforts aimed at universal rule changes, safer playing environments, and the education of coaches, players, and parents should be targeted in maximizing prevention of sport-related brain injury using a multifaceted approach.	[Cusimano, Michael D.; Cho, Newton; Amin, Khizer; Shirazi, Mariam; Wong, Matthew C.; Russell, Kelly] Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [McFaull, Steven R.; Do, Minh T.] Publ Hlth Agcy Canada, Hlth Surveillance & Epidemiol Div, Ottawa, ON, Canada		Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada.	cusimanom@smh.ca	Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650; Russell, Kelly/0000-0002-9159-9201	Canadian Institute of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]	This research was supported by Canadian Institute of Health Research Strategic Team Grant in Applied Injury Research #TIR-103946. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.cihr-irsc.gc.ca/e/193.html	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Canadian Fitness & Lifestyle Research Institute, 2011, GETT KIDS ACT 2010 P; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cusimano Michael D, 2011, Open Med, V5, pe57; Cusimano MD, 2010, NEUROSURGERY, V67, P1404, DOI 10.1227/NEU.0b013e3181f209f1; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Hassan A, 2009, CAN J CARDIOL, V25, P207, DOI 10.1016/S0828-282X(09)70062-5; Juhn MS, 2002, CLIN J SPORT MED, V12, P46, DOI 10.1097/00042752-200201000-00014; Kang J., 2012, INT J INJ CONTROL SA, P1; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Macarthur C, 1997, AM J EPIDEMIOL, V145, P834; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Pickett W, 2000, Inj Prev, V6, P9, DOI 10.1136/ip.6.1.9; Statistics Canada, 2010, AGE SEX; Turk EE, 2008, BRIT J SPORT MED, V42, P604, DOI 10.1136/bjsm.2007.038505; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	25	35	35	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2013	8	3							e58868	10.1371/journal.pone.0058868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	121RP	WOS:000317262200007	23555602	Green Published, gold			2022-02-06	
J	Jacoby, M; Averbuch, S; Sacher, Y; Katz, N; Weiss, PL; Kizony, R				Jacoby, Michele; Averbuch, Sara; Sacher, Yaron; Katz, Noomi; Weiss, Patrice L.; Kizony, Rachel			Effectiveness of Executive Functions Training Within a Virtual Supermarket for Adults With Traumatic Brain Injury: A Pilot Study	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						Executive functions; randomized controlled trial; traumatic brain injury; virtual environment	MULTIPLE ERRANDS TEST; COGNITIVE REHABILITATION; ECOLOGICAL VALIDITY; SIMPLIFIED VERSION; REALITY; DYSFUNCTION; RELIABILITY; ENVIRONMENT; PEOPLE	Impairments of executive functions (EF) significantly affect the ability to lead an independent lifestyle. Virtual environments offer a way to rehabilitate EF due to their ecological validity. The purpose of this pilot study was to examine the effectiveness of a virtual reality (VR) supermarket (VMall) for treatment of EF in patients with Traumatic Brain Injury (TBI), compared to conventional occupational therapy (OT), in order to provide initial data regarding the effect sizes for calculation of sample size as well as to establish an intervention protocol for future Randomized Control Trials (RCTs). Twelve men and women, aged 19-55 years, who had TBI resulting in EF impairments participated in this study. Outcome measures were the Multiple Errands Test-Simplified Version (MET-SV) and the Executive Function Performance Test (EFPT). Cognitive treatment provided to both groups was based on the same principles; the participants in the experimental group received 10 45-min VR-based treatment sessions and the control group participants received 10 sessions of occupational therapy cognitive retraining without VR. Baseline performance prior to intervention showed no statistically significant differences between groups. Most participants improved their performance after therapy. Following a Bonferroni correction for multiple comparisons, no significant between or within group differences were found, Nevertheless, large effect sizes (0.51) for the percent (%) relative change of the MET-SV total score and EFPT total score after intervention were high in favor of the experimental group indicating a larger improvement in EF. Based on this pilot study, results show a trend towards an advantage to VR therapy compared to cognitive retraining OT without VR, as it leads to greater improvement in complex everyday activities.	[Jacoby, Michele; Averbuch, Sara; Sacher, Yaron] Loewenstein Hosp & Rehabil Ctr, Dept Occupat Therapy, IL-43100 Raanana, Israel; [Jacoby, Michele; Averbuch, Sara; Sacher, Yaron] Loewenstein Hosp & Rehabil Ctr, Dept Traumat Brain Injury, IL-43100 Raanana, Israel; [Katz, Noomi] Ono Acad Coll, Res Inst Hlth & Med Profess, IL-60375 Or Yehuda, Israel; [Weiss, Patrice L.; Kizony, Rachel] Univ Haifa, Dept Occupat Therapy, IL-31905 Haifa, Israel; [Kizony, Rachel] Chaim Sheba Med Ctr, Dept Occupat Therapy, IL-52621 Tel Hashomer, Israel		Jacoby, M (corresponding author), Loewenstein Hosp & Rehabil Ctr, Dept Occupat Therapy, IL-43100 Raanana, Israel.	ohadjacoby@gmail.com; sarahab@clalit.org.il; ysacher@clalit.org.il; noomi.katz@ono.ac.il; tamar@research.haifa.ac.il; rkizony@univ.haifa.ac.il			Loewenstein Legacy Heritage Fund	This work was supported by the Loewenstein Legacy Heritage Fund.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Averbach S., 2011, COGNITION OCCUPATION, P277; Baum C., 2007, EXECUTIVE FUNCTION P; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Corder GW., 2009, NONPARAMETRIC STAT N; Cromby J. J., 1996, P 1 EUR C DIS VIRT R, P103; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Fong KNK, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-19; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Gitlin LA, 2001, MEASURING OCCUPATION, P161; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Groswasser Z., 1990, REHABILITATION BRAIN, P143; Holm MB, 2000, AM J OCCUP THER, V54, P575, DOI 10.5014/ajot.54.6.575; Josman N, 2006, 2006 INTERNATIONAL WORKSHOP ON VIRTUAL REHABILITATION, P106, DOI 10.1109/IWVR.2006.1707536; Josman N, 2009, SCHIZOPHR RES, V115, P270, DOI 10.1016/j.schres.2009.09.015; Katz N., 2005, DISABIL REHABIL, V29, P177; Katz N., 2007, OCCUPATIONAL THERAPY, V27, P1; Katz N., 2011, COGNITION OCCUPATION, V3rd ed., P13; Kizony R, 2003, J VISUAL COMP ANIMAT, V14, P261, DOI 10.1002/vis.323; Kizony R., 2008, ISR J OCCUP THER, V17, pE47; Kizony R., 2011, COGNITION OCCUPATION, P143; Klinger E, 2004, CYBERPSYCHOL BEHAV, V7, P292; Klinger E, 2006, CYBERPSYCHOL BEHAV, V9, P342, DOI 10.1089/cpb.2006.9.342; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Lam YS, 2006, NEUROREHABILITATION, V21, P245; Levav M, 2005, VALIDITY MULTIPLE ER; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mantovani F., 2003, CONCEPTS EFFECTS MEA; Mayer S. A, 2005, MERRITTS NEUROLOGY, P483; McComas J, 2002, CYBERPSYCHOL BEHAV, V5, P185, DOI 10.1089/109493102760147150; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; Rabinowicz S, 2010, ISRAELI J OCCUPAT TH, V19, pH209; Rand D, 2005, ANN REV CYBERTHERAPY, V3, P193; Rand D, 2007, DISABIL REHABIL, V29, P1710, DOI 10.1080/09638280601107450; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Rand D, 2009, AM J OCCUP THER, V63, P535, DOI 10.5014/ajot.63.5.535; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Rizzo AA, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199712000-00002; Roley S., 2008, AM OCCUPATIONAL THER, V62, P625, DOI [10.5014/ajot.62.6.625, DOI 10.5014/AJOT.62.6.625]; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; Sohlberg M., 2001, COGNITIVE REHABILITA; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Sweeney S, 2010, NEUROPSYCHOL REHABIL, V20, P239, DOI 10.1080/09602010903080531; Toglia J.P., 2011, COGNITION OCCUPATION, P116; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Weiss P, 2006, TXB NEURAL REPAIR RE, p182 197, DOI [10.1017/CBO9780511545078.015, DOI 10.1017/CBO9780511545078.015, DOI 10.1017/CB09780511545078.015]; Weiss PL, 2009, PHYS THER REV, V14, P307, DOI 10.1179/108331909X12488667117339; Weiss PL, 2004, J REHABIL RES DEV, V41, pVII; Werner P, 2009, DEMENT GERIATR COGN, V27, P301, DOI 10.1159/000204915; Yip BCB, 2009, BRAIN INJURY, V23, P1017, DOI 10.3109/02699050903379412	55	35	37	2	68	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	MAR	2013	21	2					182	190		10.1109/TNSRE.2012.2235184			9	Engineering, Biomedical; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Rehabilitation	108AW	WOS:000316264100004	23292820				2022-02-06	
J	McDonald, S; Darke, S; Kaye, S; Torok, M				McDonald, Skye; Darke, Shane; Kaye, Sharlene; Torok, Michelle			Deficits in social perception in opioid maintenance patients, abstinent opioid users and non-opioid users	ADDICTION			English	Article						Emotion perception; opioid users; social perception	TRAUMATIC BRAIN-INJURY; FACIAL EXPRESSIONS; FRONTOTEMPORAL DEMENTIA; COGNITIVE IMPAIRMENT; EMOTION RECOGNITION; OPIATE DEPENDENCE; NEURAL BASIS; MIND; SCHIZOPHRENIA; DEPRESSION	Aims This study aimed to compare emotion perception and social inference in opioid maintenance patients with abstinent ex-users and non-heroin-using controls, and determine whether any deficits in could be accounted for by cognitive deficits and/or risk factors for brain damage. Design Casecontrol. Setting Sydney, Australia. Participants A total of 125 maintenance patients (MAIN), 50 abstinent opiate users (ABST) and 50 matched controls (CON). Measurements The Awareness of Social Inference Test (TASIT) was used to measure emotion perception and social inference. Measures were also taken of executive function, working memory, information processing speed, verbal/non-verbal learning and psychological distress. Findings After adjusting for age, sex, pre-morbid IQ and psychological distress, the MAIN group was impaired relative to CON (=0.19, P<0.05) and ABST (=0.19, P<0.05) on emotion perception and relative to CON (=0.25, P<0.001) and ABST (=0.24, P<0.01) on social inference. In neither case did the CON and ABST groups differ. For both emotion perception (P<0.001) and social inference (P<0.001), pre-morbid IQ was a significant independent predictor. Cognitive function was a major predictor of poor emotion perception (=0.44, P<0.001) and social inference (=0.48, P<0.001). Poor emotion recognition was also predicted by number of heroin overdoses (=0.14, P<0.05). Neither time in treatment or type of maintenance medication (methadone or buprenorphine) were related to performance. Conclusions People in opioid maintenance treatment may have an impaired capacity for emotion perception and ability to make inferences about social situations.	[McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Darke, Shane; Kaye, Sharlene; Torok, Michelle] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Torok, Michelle/R-3231-2018; McDonald, Skye/G-4118-2014	Torok, Michelle/0000-0003-3741-8075; McDonald, Skye/0000-0003-0723-6094; Kaye, Sharlene/0000-0002-7657-5105	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	This research was funded by the National Health and Medical Research Council of Australia. SM is an author on The Awareness of Social Inference Test and received royalties based upon sales.	Blair RJR, 2002, J ABNORM PSYCHOL, V111, P682, DOI 10.1037//0021-843X.111.4.682; Botting N, 2008, BRIT J DEV PSYCHOL, V26, P281, DOI 10.1348/026151007X235891; Braun M, 2005, BRAIN COGNITION, V58, P193, DOI 10.1016/j.bandc.2004.11.003; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Cusi AM, 2012, J PSYCHIATR NEUROSCI, V37, P154, DOI 10.1503/jpn.100179; Darke, 2011, LIFE HEROIN USER TYP; Darke S, 2000, ADDICTION, V95, P687, DOI 10.1046/j.1360-0443.2000.9556874.x; Darke S., 2012, ADDICT THEO IN PRESS, DOI [10.3109/16066359.2012.672600, DOI 10.3109/16066359.2012.672600]; Darke S, 2012, DRUG ALCOHOL DEPEN, V126, P309, DOI 10.1016/j.drugalcdep.2012.05.032; Davis PE, 2002, DRUG ALCOHOL DEPEN, V67, P105, DOI 10.1016/S0376-8716(02)00012-1; Ersche KD, 2006, NEUROPSYCHOPHARMACOL, V31, P1036, DOI 10.1038/sj.npp.1300889; Ersche KD, 2005, PSYCHOPHARMACOLOGY, V180, P612, DOI 10.1007/s00213-005-2205-7; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fernandez-Duque D, 2005, NEUROPSYCHOLOGIA, V43, P1673, DOI 10.1016/j.neuropsychologia.2005.01.005; Foisy ML, 2005, J STUD ALCOHOL, V66, P673, DOI 10.15288/jsa.2005.66.673; Henry JD, 2008, NEUROPSYCHOLOGIA, V46, P1363, DOI 10.1016/j.neuropsychologia.2007.12.012; Joormann J, 2006, J ABNORM PSYCHOL, V115, P705, DOI 10.1037/0021-843X.115.4.705; Karch S. B., 2009, KARCHS PATHOLOGY DRU; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Kohler CG, 2005, AM J GERIAT PSYCHIAT, V13, P926, DOI 10.1176/appi.ajgp.13.11.926; Kornreich C, 2003, PSYCHIAT RES, V119, P251, DOI 10.1016/S0165-1781(03)00130-6; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Martin L, 2006, ADDICTION, V101, P1598, DOI 10.1111/j.1360-0443.2006.01574.x; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S., 2011, AWARENESS SOCIAL INF; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; Meyers JE., 1995, REY COMPLEX FIGURE T; Mintzer MZ, 2005, DRUG ALCOHOL DEPEN, V78, P225, DOI 10.1016/j.drugalcdep.2004.10.008; Mintzer MZ, 2002, DRUG ALCOHOL DEPEN, V67, P41, DOI 10.1016/S0376-8716(02)00013-3; Monnot M, 2002, J NEUROPSYCH CLIN N, V14, P321, DOI 10.1176/appi.neuropsych.14.3.321; Naranjo C, 2011, J AFFECT DISORDERS, V128, P243, DOI 10.1016/j.jad.2010.06.039; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Shamay-Tsoory SG, 2010, CORTEX, V46, P668, DOI 10.1016/j.cortex.2009.04.008; Sparks A, 2010, SCHIZOPHR RES, V122, P172, DOI 10.1016/j.schres.2010.06.011; SPSS Inc, 2010, PSAW 19 0; Uekermann J, 2008, J INT NEUROPSYCH SOC, V14, P55, DOI 10.1017/S1355617708080016; Uekermann J, 2007, ADDICTION, V102, P232, DOI 10.1111/j.1360-0443.2006.01656.x; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weschler D., 2007, WESCHLER TEST ADULT	50	35	35	0	30	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0965-2140			ADDICTION	Addiction	MAR	2013	108	3					566	574		10.1111/add.12040			9	Substance Abuse; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry	093HS	WOS:000315182900022	23164063				2022-02-06	
J	Post, A; Oeur, A; Hoshizaki, B; Gilchrist, MD				Post, Andrew; Oeur, Anna; Hoshizaki, Blaine; Gilchrist, Michael D.			An examination of American football helmets using brain deformation metrics associated with concussion	MATERIALS & DESIGN			English	Article						Concussion; American football; Helmets; Impact biomechanics; Protective devices	INTRACRANIAL-PRESSURE; PROFESSIONAL FOOTBALL; ANGULAR ACCELERATION; HEAD; IMPACT; INJURY; RECONSTRUCTION; MODEL	The sport of American football is associated with a high incidence of concussion, which research has identified may lead to long term neurological damage. As a result, it is important that protective technologies be developed to help mitigate the incidence of this type of brain trauma. This research examines how the design characteristics between different American football helmet models affect the linear and rotational acceleration responses as well as brain deformation metrics using a centric/non-centric impacting protocol. The protocol involved impacting the helmets at nine centric/non-centric sites. Brain deformation metrics were calculated using the University College Dublin Brain Trauma Model. The results revealed that design characteristics do influence the brain deformation metrics associated with incidence of concussion. Further analysis revealed that rotational acceleration was more related to brain deformation metrics than linear acceleration. These results show that when attempting to reduce brain deformation metrics, the development of rotational acceleration diminishing technologies may be beneficial. This research indicates that helmet design may be able to reduce the risk of concussive injury. (C) 2012 Elsevier Ltd. All rights reserved.	[Post, Andrew; Oeur, Anna; Hoshizaki, Blaine; Gilchrist, Michael D.] Univ Ottawa, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland		Post, A (corresponding author), 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca; aoeur016@uottawa.ca; thoshiza@uottawa.ca; Michael.gilchrist@ucd.ie	Gilchrist, Michael D/B-6100-2017	Gilchrist, Michael D/0000-0003-1765-429X; Post, Andrew/0000-0002-5960-5552			Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; Augustine G., 2001, NEUROSCIENCE; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cui L, 2009, MATER DESIGN, V30, P3414, DOI 10.1016/j.matdes.2009.03.044; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBLIN; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Gadd C. W., 1966, P 10 STAPP CAR CRASH; Gennarelli T, 1971, P 15 STAPP CAR CRASH; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Gennarelli TA, 1972, P 16 STAPP CAR CRASH; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P112; Hardy WN, 2001, STAPP CAR CRASH J; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; King AI, 2003, IRCOBI C LISB PORT; Kleiven S, 2002, P IRCOBI, P161; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Miller RT, 1998, P 42 STAPP CAR CRASH; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Nahum AM, 1977, P 21 STAPP CAR CRASH; Ommaya A. K., 1967, P 11 STAPP CAR CRASH; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Post A, 2011, COMPUT METHOD BIOMEC; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Ruan J. S., 1994, THESIS WAYNE STATE U; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Schreiber DI, 1997, P 41 STAPP CAR CRASH; Singh A, 2006, STAPP CAR CRASH J, V2006, P602; Tinard V, 2012, MATER DESIGN, V37, P79, DOI 10.1016/j.matdes.2011.12.005; Tinard V, 2011, MATER DESIGN, V32, P3112, DOI 10.1016/j.matdes.2010.12.019; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	50	35	35	2	72	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-1275	1873-4197		MATER DESIGN	Mater. Des.	MAR	2013	45						653	662		10.1016/j.matdes.2012.09.017			10	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	061OD	WOS:000312856800082		Green Submitted			2022-02-06	
J	Armstead, WM; Riley, J; Vavilala, MS				Armstead, William M.; Riley, John; Vavilala, Monica S.			Dopamine Prevents Impairment of Autoregulation After Traumatic Brain Injury in the Newborn Pig Through Inhibition of Up-regulation of Endothelin-1 and Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						cerebral autoregulation; cerebral perfusion pressure; dopamine; endothelin; signal transduction; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; K+ CHANNEL FUNCTION; INTRACRANIAL-PRESSURE; ENDOGENOUS TPA; ERK MAPK; AGE; NOREPINEPHRINE; HYPOTENSION; CHILDREN; THERAPY	Objective: Traumatic brain injury contributes to morbidity in children and boys are disproportionately represented. Autoregulation is impaired more in male compared with female piglets after traumatic brain injury through sex-dependent up-regulation of the spasmogen endothelin-1 and extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK), a family of three kinases: ERK, p38, and JNK). Elevation of mean arterial pressure leading to increased cerebral perfusion pressure via phenylephrine improves impairment of autoregulation after traumatic brain injury in female but not male piglets through modulation of endothelin-1 and ERK MAPK up-regulation, blocked in females, but aggravated in males. We hypothesized that pressor choice to elevate cerebral perfusion pressure is important in improving cerebral hemodynamics after traumatic brain injury and that dopamine will prevent impairment of autoregulation in both male and female piglets through blockade of endothelin-1 and ERK MAPK. Design: Prospective, randomized animal study. Setting: University laboratory. Subjects: Newborn (1-5 days old) pigs. Interventions: Cerebral perfusion pressure and pial artery diameter were determined before and after lateral fluid percussion brain injury was produced in piglets equipped with a closed cranial window. Dopamine (15 mu g/kg/min IV) was administered 30 mins post fluid percussion injury. Cerebrospinal fluid ERK MAPK was determined by enzyme-linked immunosorbent assay. Measurements and Main Results: Dopamine increased cerebral perfusion pressure equivalently in both sexes and prevented sex-dependent reductions in pial artery diameter after fluid percussion injury. Loss of pial artery dilation during hypotension was greater in male than in female piglets after fluid percussion injury, but dopamine prevented such impairment equivalently in both sexes post injury. endothelin-1 and ERK MAPK release was greater in male compared to female piglets after fluid percussion injury, but dopamine also blocked their up-regulation equivalently in male and female piglets after fluid percussion injury. Conclusions: These data indicate that dopamine is protective of autoregulation after fluid percussion injury in both sexes. These observations advocate for the consideration of development of sex based therapies for treatment of hemodynamic sequalae of pediatric traumatic brain injury. (Pediatr Crit Care Med 2013; 14:e103-e111)	[Armstead, William M.; Riley, John] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol Pediat & Neurol Surg, Seattle, WA 98195 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD 57355]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER	This research was supported, in part, by HD 57355 (Dr. Armstead) from the National Institutes of Health.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Armstead WM, 2007, J CEREBR BLOOD F MET, V27, P1702, DOI 10.1038/sj.jcbfm.9600473; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Armstead WM, 2012, J NEUROTRAUM, V29, P1794, DOI 10.1089/neu.2012.2328; Armstead WM, 2011, NEUROL RES, V33, P127, DOI 10.1179/016164111X12881719352138; Armstead WM, 2011, J NEUROTRAUM, V28, P105, DOI 10.1089/neu.2010.1581; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Armstead WM, 1997, STROKE, V28, P2280; Beaumont A, 2001, J NEUROTRAUM, V18, P1359, DOI 10.1089/08977150152725650; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Catala-Temprano A, 2007, J NEUROSURG, V106, P463, DOI 10.3171/ped.2007.106.6.463; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6	30	35	36	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1529-7535			PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	FEB	2013	14	2					E103	E111		10.1097/PCC.0b013e3182712b44			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	088GC	WOS:000314820800007	23314184	Green Accepted			2022-02-06	
J	Dulin, JN; Karoly, ED; Wang, Y; Strobel, HW; Grill, RJ				Dulin, Jennifer N.; Karoly, Edward D.; Wang, Ying; Strobel, Henry W.; Grill, Raymond J.			Licofelone Modulates Neuroinflammation and Attenuates Mechanical Hypersensitivity in the Chronic Phase of Spinal Cord Injury	JOURNAL OF NEUROSCIENCE			English	Article							CENTRAL NEUROPATHIC PAIN; INFLAMMATORY RESPONSE; SECONDARY INJURY; CONTUSION INJURY; IN-VIVO; RAT; EXPRESSION; BRAIN; METABOLOMICS; GLUTATHIONE	Inflammation is a major factor shaping outcome during the early, acute phase of traumatic spinal cord injury (SCI). It is known that pro-inflammatory signaling within the injured spinal cord drives pathological alterations in neurosensory processing and shapes functional outcome early after injury. However, it is unclear whether inflammation persists into the chronic phase of injury or shapes sensory processing long after injury. To investigate these possibilities, we have performed biochemical and behavioral assessments 9 months after moderate thoracic spinal contusion injury in the rat. We have found that levels of the pro-inflammatory lipid mediators leukotriene B4 and prostaglandin E2 are elevated in the chronic spinal cord lesion site. Additionally, using metabolomic profiling, we have detected elevated levels of pro-oxidative and inflammatory metabolites, along with alterations in multiple biological pathways within the chronic lesion site. We found that 28 d treatment of chronically injured rats with the dual COX/5-LOX inhibitor licofelone elevated levels of endogenous anti-oxidant and anti-inflammatory metabolites within the lesion site. Furthermore, licofelone treatment reduced hypersensitivity of hindpaws to mechanical, but not thermal, stimulation, indicating that mechanical sensitivity is modulated by pro-inflammatory signaling in the chronic phase of injury. Together, these findings provide novel evidence of inflammation and oxidative stress within spinal cord tissue far into the chronic phase of SCI, and demonstrate a role for inflammatory modulation of mechanical sensitivity in the chronic phase of injury.	[Dulin, Jennifer N.; Grill, Raymond J.] Univ Texas Med Sch Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Karoly, Edward D.] Metabolon Inc, Durham, NC 27713 USA; [Wang, Ying; Strobel, Henry W.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA		Grill, RJ (corresponding author), Univ Texas Med Sch Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St,Med Sch Bldg 4-110, Houston, TX 77030 USA.	Raymond.J.Grill@uth.tmc.edu		Dulin, Jennifer/0000-0001-5767-4290	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 49409, NS 44174, MH 70054]; Paralyzed Veterans of America [2511]; Gillson-Longenbaugh Foundation; Institute for Rehabilitation and Research Foundation; University of Texas Center for Clinical and Translational Sciences; NIH from the National Center for Research Resources (NCRR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [TL1 RR024147]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024148, TL1RR024147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH070054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049409, R01NS044174] Funding Source: NIH RePORTER	This work is supported by grants from the National Institutes of Health (NIH) (NS 49409 to R.J.G., NS 44174 and MH 70054 to H.W.S.); Paralyzed Veterans of America (#2511 to R.J.G.); The Gillson-Longenbaugh Foundation (R.J.G.); Mission Connect, a project of The Institute for Rehabilitation and Research Foundation (R.J.G.); and the University of Texas Center for Clinical and Translational Sciences, funded by NIH Clinical and Translational Award (TL1 RR024147 to J.N.D.) from the National Center for Research Resources (NCRR). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the views of the NCRR or the NIH. We gratefully acknowledge Drs. Robyn Crook and Olivera Nesic-Taylor for assistance with behavioral analysis.	Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Alexander JK, 2009, PROG BRAIN RES, V175, P125, DOI 10.1016/S0079-6123(09)17508-8; Baastrup C, 2008, CNS DRUGS, V22, P455, DOI 10.2165/00023210-200822060-00002; Baker M, 2011, NAT METHODS, V8, P117, DOI 10.1038/nmeth0211-117; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bedi SS, 2010, J NEUROSCI, V30, P14870, DOI 10.1523/JNEUROSCI.2428-10.2010; Benowitz LI, 2011, CURR OPIN NEUROL, V24, P577, DOI 10.1097/WCO.0b013e32834c208d; Buczynski MW, 2010, J NEUROCHEM, V114, P981, DOI 10.1111/j.1471-4159.2010.06815.x; Byrnes KR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-130; Carlton SM, 2009, PAIN, V147, P265, DOI 10.1016/j.pain.2009.09.030; Cartagena CM, 2008, J NEUROTRAUM, V25, P1087, DOI 10.1089/neu.2007.0444; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cheng O, 2010, NEUROSCIENCE, V166, P1101, DOI 10.1016/j.neuroscience.2010.01.024; Cicero AFG, 2007, CLIN INTERV AGING, V2, P73, DOI 10.2147/ciia.2007.2.1.73; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; DIXON WJ, 1991, NEUROSCI BIOBEHAV R, V15, P47, DOI 10.1016/S0149-7634(05)80090-9; Dulin JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016456; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; ERIKSSON B, 1967, ACTA CHEM SCAND, V21, P1304, DOI 10.3891/acta.chem.scand.21-1304; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Finnerup NB, 2001, SPINAL CORD, V39, P256, DOI 10.1038/sj.sc.3101161; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Fujieda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043152; Genovese T, 2008, BRIT J PHARMACOL, V153, P568, DOI 10.1038/sj.bjp.0707577; Genovese T, 2005, J NEUROIMMUNOL, V166, P55, DOI 10.1016/j.jneuroim.2005.05.009; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hains BC, 2003, J NEUROSCI, V23, P8881; Hains BC, 2001, J NEUROTRAUM, V18, P409, DOI 10.1089/089771501750170994; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Herrera JJ, 2010, J NEUROTRAUM, V27, P423, DOI 10.1089/neu.2009.0997; Huang WL, 2009, J NEUROTRAUM, V26, P1429, DOI [10.1089/neu.2008.0835, 10.1089/neu.2008-0835]; Hulsebosch CE, 2009, BRAIN RES REV, V60, P202, DOI 10.1016/j.brainresrev.2008.12.010; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Lin CR, 2006, J PHARMACOL EXP THER, V319, P1096, DOI 10.1124/jpet.106.105569; Liu NK, 2010, MOL NEUROBIOL, V41, P197, DOI 10.1007/s12035-010-8101-0; Morales JR, 2008, CIRCULATION, V118, P1450, DOI 10.1161/CIRCULATIONAHA.108.782300; Nesic O, 2005, J NEUROCHEM, V95, P998, DOI 10.1111/j.1471-4159.2005.03462.x; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Noguchi K, 2011, BIOL PHARM BULL, V34, P1163, DOI 10.1248/bpb.34.1163; Okubo M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-57; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; SHARMA HS, 1993, NEUROSCIENCE, V57, P443, DOI 10.1016/0306-4522(93)90076-R; Singh Vijay Pal, 2005, Indian Journal of Experimental Biology, V43, P247; Singh VP, 2006, FUND CLIN PHARMACOL, V20, P65, DOI 10.1111/j.1472-8206.2005.00387.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Velardo MJ, 2004, J NEUROSCI, V24, P8562, DOI 10.1523/JNEUROSCI.3316-04.2004; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wu YJ, 2012, BASIC CLIN PHARMACOL, V111, P166, DOI 10.1111/j.1742-7843.2012.00882.x; XU J, 1990, J NEUROCHEM, V55, P907, DOI 10.1111/j.1471-4159.1990.tb04577.x; Yoshida Y, 2005, BIOFACTORS, V24, P7, DOI 10.1002/biof.5520240102; Zhao P, 2007, J NEUROSCI, V27, P2357, DOI 10.1523/JNEUROSCI.0138-07.2007	61	35	36	0	13	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JAN 9	2013	33	2					652	664		10.1523/JNEUROSCI.6128-11.2013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	071EN	WOS:000313569600027	23303944	Green Accepted, Green Published, Bronze			2022-02-06	
J	Juengst, S; Skidmore, E; Arenth, PM; Niyonkuru, C; Raina, KD				Juengst, Shannon; Skidmore, Elizabeth; Arenth, Patricia M.; Niyonkuru, Christian; Raina, Ketki D.			Unique Contribution of Fatigue to Disability in Community-Dwelling Adults With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Fatigue; Rehabilitation	MINOR HEAD-INJURY; QUALITY-OF-LIFE; REHABILITATION; IMPACT; PREDICTORS; DEPRESSION; PATTERNS; SEQUELAE; DEFICITS; OUTCOMES	Objective: To examine the unique contribution of fatigue to self-reported disability in community-dwelling adults with traumatic brain injury (TBI). Design: A cross-sectional cohort design. Setting: Community dwellings. Participants: Adults (N=50) with a history of mild to severe TBI were assessed. Intervention: Not applicable. Main Outcome Measures: This study assessed the contribution of fatigue (Modified Fatigue Impact Scale) to disability (Mayo-Portland Adaptability Inventory), controlling for executive functions (Frontal Systems Behavior Scale), depression status (major depression in partial remission/current major depression/depressive symptoms or no history of depression), and initial injury severity (uncomplicated mild, complicated mild, moderate, or severe). Results: Fatigue was found to contribute uniquely to the variance in self-reported disability (beta=.47, P<.001) after controlling for injury severity, executive functions, and depression status. The overall model was significant (F-4,F-45=17.32, P<001) and explained 61% of the variance in self-reported disability, with fatigue alone accounting for 12% of the variance in self-reported disability (F-1,F-45=13.97, P<.001). Conclusions: Fatigue contributes uniquely to disability status among community-dwelling adults with chronic TBI, independent of injury severity, executive functions, and depression. Addressing fatigue through targeted interventions may help to improve self-perceived disability in this population. Archives of Physical Medicine and Rehabilitation 2013;94:74-9 (C) 2013 by the American Congress of Rehabilitation Medicine	[Juengst, Shannon; Skidmore, Elizabeth; Raina, Ketki D.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, Pittsburgh, PA 15260 USA; [Skidmore, Elizabeth; Arenth, Patricia M.; Niyonkuru, Christian] Univ Pittsburgh, Med Ctr, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA		Juengst, S (corresponding author), Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, 5012 Forbes Tower, Pittsburgh, PA 15260 USA.	sbj7@pitt.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X	School of Health and Rehabilitation Science Research Development Fund, School and Health of Rehabilitation Science, University of Pittsburgh; National Institutes of Health (NIH) National Center for Medical Rehabilitation Research (NCMRR)/National Institute of Neurological Disorders and Stroke (NINDS) [KI2 HD 055931]; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W8IXWH-10-1-0920]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD055931] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER	Supported in part by the School of Health and Rehabilitation Science Research Development Fund, School and Health of Rehabilitation Science, University of Pittsburgh; the National Institutes of Health (NIH) National Center for Medical Rehabilitation Research (NCMRR)/National Institute of Neurological Disorders and Stroke (NINDS) (grant no. KI2 HD 055931); and the U.S. Army Medical Research and Material Command (award no. W8IXWH-10-1-0920).	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arciniegas DB, 2000, CURRENT TREATMENT OP, V2, P169; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; de Groot MH, 2003, ARCH PHYS MED REHAB, V84, P1714, DOI 10.1053/S0003-9993(03)00346-0; Deb S, 1999, AM J PSYCHIAT, V156, P374; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fisk J., 1994, CLIN INFECT DIS, V8, pS79; Flachenecker P, 2002, MULT SCLER J, V8, P523, DOI 10.1191/1352458502ms839oa; Fleming JM, 1996, BRAIN INJURY, V10, P1; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hicks E, 2007, COCHRANE DB SYST REV; Hillier SL, 1997, BRAIN INJURY, V11, P661; KESHAVAN MS, 1981, BRIT J PSYCHIAT, V138, P157, DOI 10.1192/bjp.138.2.157; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MONTGOMERY GK, 1995, BRAIN INJURY, V9, P453, DOI 10.3109/02699059509008205; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tellez N, 2005, MULT SCLER J, V11, P198, DOI 10.1191/1352458505ms1148oa; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	40	35	35	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2013	94	1					74	79		10.1016/j.apmr.2012.07.025			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	067PV	WOS:000313308500011	22885286	Green Accepted			2022-02-06	
J	Coelho, C; Le, K; Mozeiko, J; Krueger, F; Grafman, J				Coelho, Carl; Le, Karen; Mozeiko, Jennifer; Krueger, Frank; Grafman, Jordan			Discourse production following injury to the dorsolateral prefrontal cortex	NEUROPSYCHOLOGIA			English	Article						Dorsolateral prefrontal cortex; Discourse production; Language production; Discourse analysis; Working memory	CLOSED-HEAD-INJURY; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; EXECUTIVE FUNCTIONS; ELICITATION TASK; LANGUAGE; NARRATIVES; ABILITIES; CHILDREN; LESIONS	Individuals with damage. to the prefrontal cortex, and the dorsolateral prefrontal cortex (DLPFC) in particular, often demonstrate difficulties with the formulation of complex language not attributable to aphasia. The present study employed a discourse analysis procedure to characterize the language of individuals with left (L) or right (R) DLPFC lesions. All participants were 30-35 years post-onset of injury and presented with persistent discourse impairments. The discourse performance of the R DLPFC group was not significantly different from either the L DLPFC group or the non-injured comparison group. Individuals from the L DLPFC group demonstrated specific difficulties with narrative coherence and inclusion of critical story components. Both measures were significantly different from the comparison group. The discourse ability of the DLPFC groups was significantly correlated with measures of working memory. Findings support the use of discourse analysis for examining language impairments in individuals with PFC lesions. (C) 2012 Elsevier Ltd. All rights reserved.	[Coelho, Carl; Le, Karen; Mozeiko, Jennifer] Univ Connecticut, Speech Language & Hearing Sci Dept, Storrs, CT 06269 USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res Program, Chicago, IL 60611 USA		Coelho, C (corresponding author), Univ Connecticut, Speech Language & Hearing Sci Dept, 850 Bolton Rd, Storrs, CT 06269 USA.	coelho@uconn.edu		Grafman, Jordan H./0000-0001-8645-4457			Alexander MP, 2006, J INT NEUROPSYCH SOC, V12, P236, DOI 10.1017/S1355617706060309; Baddeley A.D., 1986, WORKING MEMORY; BARBIZET J, 1975, REV NEUROL-FRANCE, V131, P525; Barrett J., 1998, OLD MCDONALD HAD APA, V2nd; Beeman M, 1998, RIGHT HEMISPHERE LANGUAGE COMPREHENSION, P255; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Brookshire R. H., 1997, DISCOURSE COMPREHENS; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Coelho C, 2003, APHASIOLOGY, V17, P173, DOI 10.1080/729255216; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; Fletcher P., 1997, HUMAN BRAIN FUNCTION; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; Grafman J., 2002, HDB NEUROPSYCHOLOGY, P157; Henson R., 2001, WORKING MEMORY PERSP; Hughes DL., 1997, GUIDE NARRATIVE LANG; KACZMAREK BLJ, 1984, BRAIN LANG, V21, P52, DOI 10.1016/0093-934X(84)90035-X; Kaplan E, 1983, BOSTON NAMING TEST; Kurczek J, 2011, APHASIOLOGY, V25, P700, DOI 10.1080/02687038.2010.537345; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LILES BZ, 1985, J SPEECH HEAR RES, V28, P123, DOI 10.1044/jshr.2801.123; Luria A. R., 1970, TRAUMATIC APHASIA IT; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Osaka N., 2007, COGNITIVE NEUROSCIEN, P213; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; Robinson G, 1998, BRAIN, V121, P77, DOI 10.1093/brain/121.1.77; Sirigu A, 1998, CORTEX, V34, P771, DOI 10.1016/S0010-9452(08)70780-9; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Talairach J., 1988, COPLANAR STEREOTAXIC; Tyler E., 2012, CLIN APH C LAK TAH C; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; U. S. Department of Defense, 1984, TEST MAN ARM SERV VO; Van Leer E, 1999, J COMMUN DISORD, V32, P327, DOI 10.1016/S0021-9924(99)00008-8; WAPNER W, 1981, BRAIN LANG, V14, P15, DOI 10.1016/0093-934X(81)90061-4; Wechsler D., 1997, WECHSLER MEMORY SCAL; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	48	35	35	0	24	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	DEC	2012	50	14					3564	3572		10.1016/j.neuropsychologia.2012.09.005			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	065IT	WOS:000313142700041	22982512				2022-02-06	
